{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "Project_main.ipynb",
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Ust2zpgnrf_p"
      },
      "source": [
        "Import Libraries\n"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "mZiChcV8rYNP"
      },
      "source": [
        "import re\n",
        "import pandas as pd\n",
        "import bs4\n",
        "import requests\n",
        "import spacy\n",
        "from spacy import displacy\n",
        "nlp = spacy.load('en_core_web_sm')\n",
        "from spacy.matcher import Matcher \n",
        "from spacy.tokens import Span \n",
        "import networkx as nx\n",
        "import matplotlib.pyplot as plt\n",
        "from tqdm import tqdm"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "x73VN5kRtMBA"
      },
      "source": [
        "Check for Sample Data"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "X8dXIkPermtH"
      },
      "source": [
        "doc = nlp(\"Phytoplasmas are insect-vectored bacteria that cause disease in a wide range of plant species.\")"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wYbTmVnLrz42",
        "outputId": "10e6e7ec-5b92-4518-8ba3-e2c4aa7a5d46"
      },
      "source": [
        "for tok in doc:\n",
        "  print(tok.text, \"...\", tok.dep_)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Phytoplasmas ... nsubj\n",
            "are ... ROOT\n",
            "insect ... npadvmod\n",
            "- ... punct\n",
            "vectored ... amod\n",
            "bacteria ... attr\n",
            "that ... nsubj\n",
            "cause ... relcl\n",
            "disease ... dobj\n",
            "in ... prep\n",
            "a ... det\n",
            "wide ... amod\n",
            "range ... pobj\n",
            "of ... prep\n",
            "plant ... compound\n",
            "species ... pobj\n",
            ". ... punct\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "HO0vJh7Mr5i5"
      },
      "source": [
        "pd.set_option('display.max_colwidth', 200)\n",
        "#%matplotlib inline\n"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "F8_t6YrVtX_Q"
      },
      "source": [
        "Read Dataset"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "p_9JlhMpsStW",
        "outputId": "6e359b6d-ffe3-4c38-d4cd-ff4a3880eec7"
      },
      "source": [
        "data = pd.read_csv(\"X.csv\")\n",
        "print(\"\\n\\nData\")\n",
        "print(data.shape)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "\n",
            "Data\n",
            "(62197, 1)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "p1N0FgCZseer",
        "outputId": "cddb0769-227f-4751-8dd1-a30ad6941bda"
      },
      "source": [
        "print(data)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "                                                                                                                                                                                                      sentence\n",
            "0                                                                                                                Phytoplasmas are insect-vectored bacteria that cause disease in a wide range of plant species\n",
            "1       The increasing availability of molecular DNA analyses expertise and additional methods in recent years has led to a proliferation of discoveries of phytoplasma-plant host associations and in the ...\n",
            "2       The widespread use of common names based on the diseases with which they are associated as well as separate phenetic and taxonomic systems for classifying phytoplasmas based on variation at the 1...\n",
            "3       We explore this issue and related trends through a focus on Australian pathosystems providing the first comprehensive compilation of information for this continent covering the phytoplasmas host ...\n",
            "4       Of the 33 16Sr groups reported internationally only groups I II III X XI and XII have been recorded in Australia and this highlights the need for ongoing biosecurity measures to prevent the intro...\n",
            "...                                                                                                                                                                                                        ...\n",
            "62192                                                                                       The ordinary description of artificial neural networks is a special case of the description proposed in this paper\n",
            "62193                                                                                 It also contains a description of the use of the ZTANN for automatic identification of objects in digital control system\n",
            "62194                                                                                                                                                                                      (C) 2015 Elsevier B\n",
            "62195                                                                                                                                                                                                        V\n",
            "62196                                                                                                                                                                                      All rights reserved\n",
            "\n",
            "[62197 rows x 1 columns]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "6FC5NnHSuDNE"
      },
      "source": [
        "Function to create entities/Keywords"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "uhydgoOftzf-"
      },
      "source": [
        "def get_entities(sent):\n",
        "  ## chunk 1\n",
        "  ent1 = \"\"\n",
        "  ent2 = \"\"\n",
        "\n",
        "  prv_tok_dep = \"\"    \n",
        "  prv_tok_text = \"\"   \n",
        "\n",
        "  prefix = \"\"\n",
        "  modifier = \"\"\n",
        "\n",
        "  \n",
        "  \n",
        "  for tok in nlp(sent):\n",
        "    if tok.dep_ != \"punct\":\n",
        "      # check: token is a compound word or not\n",
        "      if tok.dep_ == \"compound\":\n",
        "        prefix = tok.text\n",
        "        # if the previous word was also a 'compound' then add the current word to it\n",
        "        if prv_tok_dep == \"compound\":\n",
        "          prefix = prv_tok_text + \" \"+ tok.text\n",
        "      \n",
        "      # check: token is a modifier or not\n",
        "      if tok.dep_.endswith(\"mod\") == True:\n",
        "        modifier = tok.text\n",
        "        # if the previous word was also a 'compound' then add the current word to it\n",
        "        if prv_tok_dep == \"compound\":\n",
        "          modifier = prv_tok_text + \" \"+ tok.text\n",
        "      \n",
        "      ## chunk 3\n",
        "      if tok.dep_.find(\"subj\") == True:\n",
        "        ent1 = modifier +\" \"+ prefix + \" \"+ tok.text\n",
        "        prefix = \"\"\n",
        "        modifier = \"\"\n",
        "        prv_tok_dep = \"\"\n",
        "        prv_tok_text = \"\"      \n",
        "\n",
        "      ## chunk 4\n",
        "      if tok.dep_.find(\"obj\") == True:\n",
        "        ent2 = modifier +\" \"+ prefix +\" \"+ tok.text\n",
        "        \n",
        "      ## chunk 5  \n",
        "      # update variables\n",
        "      prv_tok_dep = tok.dep_\n",
        "      prv_tok_text = tok.text\n",
        "  #############################################################\n",
        "\n",
        "  return [ent1.strip(), ent2.strip()]"
      ],
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Jq9heULRtqrR"
      },
      "source": [
        "Extraction of Entities and Entity Pairs"
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "e6MWygVetDGv",
        "outputId": "1f2236a4-6949-436a-803d-1a3b92695c55"
      },
      "source": [
        "entities = get_entities(\"the temple is set on fire\")\n",
        "print(entities)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "['temple', 'fire']\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8V2Dqv0cuNwm",
        "outputId": "e728a4bf-bf2a-4441-8a39-ae10ce03fb49"
      },
      "source": [
        "\n",
        "entity_pairs = []\n",
        "\n",
        "for i in tqdm(data[\"sentence\"]):\n",
        "  entity_pairs.append(get_entities(i))\n",
        "  \n",
        "print(entity_pairs)"
      ],
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "100%|██████████| 62197/62197 [11:19<00:00, 91.49it/s]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "[['vectored  that', 'wide plant species'], ['molecular  analyses', 'taxonomic plant host phytoplasmas'], ['common  they', 'encoding  literature'], ['We', 'comprehensive phytoplasmas vectors'], ['this', 'additional pathogen groups'], ['unrecognized  groups', 'well 16Sr groups'], ['Wide host plant ranges', 'crop  some'], ['putative  vectors', 'especially  Australia'], ['', 'studied plant pathogens'], ['unsaturated sesquiterpene that', 'inflammatory skin properties'], ['natural  habitat', 'threat'], ['microbial  production', 'renewable -)-alpha feedstock'], ['Here  we', 'natural vegetable oils'], ['German Matricaria titer', 'biosynthetic mevalonate pathway'], ['mg  L', 'bisabolol  diphosphate'], ['Combinatorial  expression', 'engineered L bioreactor E'], ['', '-)-alpha bisabolol -)-alpha synthase'], ['batch  fermentation', 'bisabolol culture 9'], ['', ''], ['downstream extraction process', 'high yield recovery'], ['', ''], ['coli  strains', 'large -)-alpha scale'], ['universal  feature', 'intracellular strand RNA membranes'], ['CIRV ringspot replication', 'mitochondrial outer membrane'], ['product', 'plant mitochondrial cells'], ['Here yeast Saccharomyces cerevisiae', 'CIRV cell survival'], ['p36', 'cell growth rate'], ['p36', 'phosphatidylserine cell externalization'], ['tight  association', 'CIRV acid yeast'], ['work', 'molecular RNA viruses'], ['', ''], ['rights', ''], ['dichloromethane', 'causative Osaka Japan'], ['few  reports', 'rodent carcinogenicity studies'], ['combined  effects', 'compounds'], ['present  we', 'alone gpt delta'], ['200mgkg(-1 body weight DCM', 'National Toxicology Program'], ['', 'mutation vivo rats'], ['major protein enzymes', 'quantitative polymerase chain reaction'], ['mutation frequencies', 'DCM  group'], ['', 'gene  group'], ['DCM', 'experimental gpt conditions'], ['', ''], ['simulation results', '130 CMOS power 2'], ['', ''], ['which', 'digital control circuit'], ['operational  modes', 'saturated power 2'], ['', ''], ['lowest power mode', '8'], ['1', ''], ['highest power mode', '18'], ['9', ''], ['', '415 mW P 18'], ['', ''], ['', ''], ['', ''], ['', ''], ['which', 'nutritional glycogen food'], ['that', 'high  temperature'], ['Using', 'branching Malaysia Genome Institute'], ['size', 'molecular  protein'], ['', ''], ['gene sequence', 'dimensional thermostability enzyme'], ['gene', 'E'], ['', 'predicted  result'], ['purified  enzyme', 'inhibitory enzyme activity'], ['55 degrees C', '60 degrees C'], ['thermostable glycogen branching enzyme', 'molecular biology technique'], ['microbial  populations', '2-year ribosomal RNA period'], ['dynamics', 'previous Communities Aalborg University'], ['microbial  diversity', 'Polish  WWTPs'], ['Danish  30', 'activated sludge community'], ['acculumating oxygen demand bacteria', 'Danish  plants'], ['seasonal  which', 'Danish  WWTPs'], ['16S  PCR', 'high  infection'], ['aims', 'clinical cost test'], ['16S', 'clinical  specimens'], ['microbiological  cultures', 'appropriate laboratory protocol'], ['clinical  data', 'medical  records'], ['rRNA PCR', 'validated reference amplification'], ['outcomes', 'rRNA rationalization therapy'], ['Concordance', 'also rRNA tissue'], ['equal  number', '16S rRNA PCR'], ['rRNA PCR', '32  cases'], ['culture  three', '2  which'], ['sensitivity', ''], ['', ''], ['5  specificity', ''], ['', '70 13 %'], ['', ''], ['', 'predictive  77'], ['', ''], ['', ''], ['', ''], ['Antimicrobial therapy', 'five PCR patients'], ['6  %', 'negative  results'], ['', ''], ['16S rRNA PCR result', '28 antimicrobial patients'], ['highest  concordance', 'fluid heart valve tissue'], ['', 'patient antimicrobial therapy'], ['yield', '16S heart valves'], ['', ''], ['', 'Infectious International Diseases'], ['widespread phytoplasma that', 'economic  losses'], ['eighteen BLL samples', 'little phytoplasma identification'], ['Presence', 'specific primer pairs'], ['16SrVI proliferation group', '16SrII Gorakhpur Uttar group'], ['virtual RFLP analysis', '16SrVI BLL subgroups'], ['BLL phytoplasma strains', 'widespread BLL India'], ['', 'symptomatic weed species viz'], ['Cannabis', 'subsp'], ['Pradesh New Delhi', '16S sequence comparison phylogeny'], ['only Hishimonas phycitis', 'virtual RFLP analysis'], ['CILY Cote phytoplasma', 'affected Grand 2015'], ['Leaves inflorescences', 'coconut symptomless trees'], ['Total DNA', '16S rRNA ribosomal protein'], ['CILY phytoplasma', '82'], ['', 'surveyed plant parts'], ['Trunk borings', 'suitable plant tissue sampling'], ['westward', 'growing Grand Lahou'], ['strains', 'eastern rp region'], ['nucleotide  polymorphisms', 'Cape St'], ['', 'Lethal Yellowing Mozambique'], ['Advances', 'microbial  communities'], ['Time Single platform', 'low template costs'], ['qSMRT  that', 'environmental ribosomal samples'], ['9  regions', 'Austral Ross 2011'], ['We', 'natural rDNA environments'], ['ability', 'cost ecosystem diversity'], ['', ''], ['', ''], ['rights', ''], ['DRIM', \"targeting  3'-terminus\"], ['43 yeast which', '18S rRNA processing'], ['1A6 DRIM DRIM', 'U3'], ['silencing', 'delayed 18S rRNA processing'], ['1A6  DRIM', 'also HeLa cells'], ['1A6  DRIM', '18S rRNA processing'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['', ''], ['2DS', 'developing  schizophrenia'], ['negative  symptoms', 'clinical  22q11'], ['2DS', 'strongly  outcome'], ['psychological  mechanisms', 'population'], ['negative  symptoms', 'negative performance beliefs'], ['', 'Thirty five Thirty 22q11'], ['2DS', '11  study'], ['schizotypal  symptoms', 'negative performance approval'], ['Measures', 'cognitive evaluation protocol'], ['', '22q11'], ['2DS', 'anxiety Schizotypal Personality depression'], ['paranoid  symptoms', 'negative performance beliefs'], ['negative performance beliefs', 'significantly face recognition'], ['negative performance beliefs', 'negative  22q11'], ['', ''], ['Implications', 'article'], ['', ''], ['', ''], ['neurogenetic  that', '25-fold  schizophrenia'], ['', '22q11'], ['putatively brain that', 'cognitive  information'], ['study', 'young brain 22q11'], ['', 'unaffected  controls'], ['Results', '22q11'], ['2DS', 'longitudinal thalamo frontal fasciculus'], ['', 'addition 22q11'], ['2DS', 'social Social Responsiveness Scale'], ['', 'Further  22q11'], ['2DS', 'well DTI 22q11'], ['2DS', 'prodromal overt symptoms'], ['specifically  disrupted', 'cognitive fronto 22q11'], ['', ''], ['2481 amino acid TPR', 'big  Keio'], ['25 TPR which', 'biological  functions'], ['Orthologous  genes', 'widely plants fungi'], ['TPRBK gene', 'human cell monkey'], ['then  it', 'midbody'], ['adequate  TPRBK', 'Aurora B'], ['proteins', 'together  mitosis'], ['two  that', 'intracellular actin TPRBK'], ['', 'spindle midbody cells'], ['TPRBK', 'mammalian cell cycle'], ['', ''], ['', ''], ['rights', ''], ['Graphene', 'potential nano electronics'], ['Here  we', 'ferroelectric nanosheets film'], ['where Fe poly', 'gate dielectric'], ['', 'retention erase performance'], ['possible  mechanism', 'qualitatively band theory'], ['comprehensive  study', 'different MoSe2 thicknesses'], ['Increasing', 'reduced memory window'], ['MoSe2  thickness', 'write erase 10(3'], ['Fe FET combination', 'ferroelectric gate memory'], ['2-MIB  cyanobacteria', 'three southeast Queensland Australia'], ['', ''], ['', 'one  reservoir'], ['Densities', 'bottom polymerase chain 0'], ['', '775'], ['bottom  2-MIB', 'highest surface water'], ['Concentrations', 'light  conditions'], ['Presence', 'different PCR approaches'], ['Cloning', 'high PCR cyanobacteria'], ['more  research', 'emerging T&O episodes'], ['We', 'Ministry chemical safety Japan'], ['Here  we', 'combined repeat dose'], ['old  CD', '0 20 100'], ['Males', '14  d'], ['Females', '4  lactation'], ['spontaneous  locomotion', 'nervous system depression'], ['notable  changes', 'consumption functional battery tests'], ['Increased hepatocyte hypertrophy', '100'], ['', 'biochemical  hepatotoxicity'], ['basophilic dilatation', 'kg hyaline d'], ['Immunohistochemical staining', 'alpha(2u)-globulin nephropathy'], ['mg  it', 'mg  d'], ['Pup weights', 'postnatal  day'], ['adverse effect level', 'developmental  butoxy-4-chlorobenzene'], ['mu opioid receptor', 'such morphine fentanyl'], ['deficiency', 'markedly noncoding opioids'], ['present human OPRM1 we', 'abundant OPRM1 gene transcripts'], ['poly(A  signal', '13612 OPRM1 gene'], ['region', 'poly(A stop signal'], ['3  we', 'rich  regions'], ['Furthermore  we', 'apparent  homology'], ['same size band', \"human MOR-1 3'UTR\"], ['present gene characterization', 'individual OPRM1 gene opioids'], ['', 'Elsevier B'], ['', ''], ['locked  loop', 'wave  FMCW'], ['proposed  lidar', '180k range second'], ['rms depth precision', '5 range baseline'], ['range window', ''], ['', '4  4'], ['', '2  window'], ['Optical  circuitry', 'mm silicon photonic chip'], ['', ''], ['m CMOS ASIC', 'digital analog electro circuitry'], ['', '7 1'], ['', ''], ['', '1 5-V supply'], ['latter', '12'], ['', 'tunable Bragg reflector laser'], ['two  chips', 'through silicon photonic chip'], ['3D printing', 'well defect cells'], ['light  therapy', 'degenerative  nerves'], ['neural  coupling', 'neural  degeneration'], ['we', 'subsequent cell proliferation'], ['15 s laser stimulation', '1 d culture'], ['glial stem differentiation', 'immunocytochemistry studies'], ['integration', 'neural tissue engineering'], ['mimicked biofabrication tissue', 'intelligent cell research biomaterials'], ['biofabrication', 'single cell manipulation'], ['enabling  technology', 'regenerative  medicine'], ['current  advances', 'thermal vasculature muscle cartilage'], ['mammalian drug which', 'precise tissue construction'], ['', 'medical  images'], ['Therefore  bioprinting', 'thick  tissues'], ['Collectively  bioprinting', 'potential tissue engineering'], ['future  advances', 'further stem cell biology'], ['novel H2S)-synthesizing that', 'thiosulfate cyanide biosynthesis'], ['considerable  attention', 'biochemistry H2S synthesizing enzyme'], ['', 'concerted disease states'], ['cellular impact TBI', 'present  study'], ['3-MST', 'normal mice brain cortex'], ['It', 'third  day'], ['Importantly  3-MST', 'neuron'], ['post injury', 'elevated  LC3'], ['induced  expression', 'partly  LC3'], ['', 'partly propidium iodide'], ['3-MST', 'living  TBI'], ['Oxidative  stress', 'neurodegenerative  diseases'], ['present  study', 'behavioral imaging biochemistry histochemistry'], ['motor dysfunctions', 'significantly DHM treatment'], ['metabolic  abnormality', 'SOD superoxide enzyme'], ['3NP DHM number', 'apoptotic  cells'], ['Bcl-2 Cleaved changes', 'significantly DHM treatment'], ['DHM', 'apoptosis  mechanisms'], ['45 element analysis method', '29 degrees C theory'], ['real deformation which', 'laser speckle chip temperature sensor'], ['out plane displacement value', 'temperature'], ['fitting  which', 'further  research'], ['thermotolerant  bacterium', 'soil sample'], ['Bacterium', '50 degrees C'], ['culture conditions', 'high level -mannanase'], ['', ''], ['', ''], ['', ''], ['5', 'old  culture'], ['50 degrees 48H', 'higher  production'], ['Optimum  temperature', 'crude enzyme enzyme'], ['0  60', ''], ['enzyme', '37 degrees C'], ['hydrolytic  activity', 'various agro residues'], ['manno  enzyme', 'classic endo activity'], ['prebiotic  potential', 'pure culture method'], ['', ''], ['', 'derived  oligosaccharides'], ['', 'International Union International Biochemistry'], ['Serotonin N hydroxycinnamoyltransferase', 'key  feruloylserotonin'], ['strong antioxidant them', 'nutritional  humans'], ['Ectopic  expression', 'mediated  transformation'], ['SHT expression', 'transgenic SHT enzyme seeds'], ['low prolamin promoter', 'high  SHT'], ['', 'wild type rice'], ['rather phenylpropanid CoAs', 'transgenic rice seeds'], ['noise preamplifier circuit', 'ultraviolet Schottky photodiode experiments'], ['readout', 'low leakage channels'], ['circuit configuration', 'reiterative sample integrate'], ['sampling technique', 'femtoampere readout noise performance'], ['Commercial acquisition electronics', 'preamplifier analog signals'], ['bandwidth', 'different integration circuit'], ['370 spectral nm', 'equivalent array power'], ['', 'Elsevier B'], ['', ''], ['RF power amplifiers', 'today end handset'], ['based RF PAs', 'added RF functionalities'], ['', ''], ['', 'digital matching predistortion etc'], ['which', 'band handset transmitters'], ['key  techniques', 'wireless silicon PAs'], ['that', 'selection'], ['microRNA processor Drosha', 'microRNA copy number profiles'], ['Here  we', 'cervical SCC cells'], ['Drosha depletion', 'resistant phenotype rescue'], ['Unsupervised', 'two Drosha expression levels'], ['Altering Drosha levels', 'resistant gene depletion mutation'], ['differential  that', 'clinical Drosha samples'], ['miR-31 up regulation', 'northern p blotting'], ['associated  that', 'coding  genes'], ['', '2011 Great Britain'], ['', 'John Wiley'], ['seq  analysis', '236-nucleotide Salmonella enterica'], ['Here  we', 'molecular  characteristics'], ['invasion assay', 'transcript'], [\"malS 5'-untranslated which\", 'flagellar HeLa S'], ['', ''], ['Deletion', 'invasive invasion S'], ['expression', 'malS bax'], [\"malS 5'-UTR\", 'invasive  S'], ['', ''], ['60-GHz phase that', 'forming degrees phase systems'], ['phase shifter', 'bridged T type topology'], ['topologies', 'signal equivalent circuit model'], ['Furthermore design equations', ''], ['360 degrees phase shifters', 'commercial 65-nm CMOS technology'], ['shifter', '64 rms phase 4'], ['4', 'total insertion 14'], ['', 'dB rms gain 0'], ['', 'better  9'], ['', 'almost power zero'], ['360  degrees', 'shifter  0'], ['094  mm(2', 'passive phase frequencies'], ['8 product that', 'regulatory 6S-1 template'], ['seq  data', 'vitro transcription experiments'], ['we', 'potentially 6S-2 RNA'], ['However  pRNAs', '6S-2 B'], ['', ''], ['stationary pRNA synthesis', 'stationary  phase'], ['Most', '8'], ['average  length', 'conditions'], ['Synthesis', \"5'-terminal G\"], ['', ''], ['lower pRNA reference', 'wild type 6S-1 RNA'], ['A', 'lower pRNA levels'], ['We', 'cellular GTP pool'], ['how  information', 'finally  proteins'], ['information', 'DNA'], ['nucleic  they', 'nucleic  information'], ['damaged  importance', 'past  decade'], ['Modification', 'pairing DNA replication'], ['recent  studies', 'unwanted mRNA translation'], ['Oxidation', 'drastic protein synthesis'], ['surveillance RNA pathways', 'clear'], ['cDNA clone', 'Eucommia'], ['seasonal  expression', 'western PCR blotting'], ['cambial ABP1 expression', 'respectively cambium periodicity'], ['signal  abundance', 'cambial activity dormancy cycle'], ['why  IAA', 'resting quiescent cambium'], ['also ABP1 expression', 'ABA'], ['monkey', 'new  drugs'], ['We', 'various substrate specificity'], ['amino acid sequence', 'reported human MRP2 cDNA'], ['', ''], ['tissue distribution', 'partially  humans'], ['We', 'Northern monkey blotting'], ['Substrate specificity', 'human  MRP2'], ['affinity', 'human monkey MRP2'], ['Functional  differences', 'human candidate drugs'], ['', ''], ['', ''], ['rights', ''], ['disseminated  cancers', 'biologically chemotherapy radiotherapy therapy'], ['major  factor', 'responsible multidrug resistance'], ['thus anticancer drug', 'effect'], ['we', 'ongoing ABC transporters'], ['We', 'clinical  trials'], ['We', 'therapeutic cancer cells'], ['tailored ABC that', 'MDR'], ['good  pharmacokinetics', 'low  toxicity'], ['based drug delivery systems', 'off  toxicity'], ['PurposeDespite', 'variant Stargardt c'], ['>  C', ''], ['purpose', 'molecular  variant'], ['', 'variant MethodsFibroblast c'], ['>  C', 'specific RT variant'], ['', 'monoclonal ABCA4 antibody'], ['', ''], ['where length exon', 'spliced length mRNAs'], ['reduced  level', 'full length ABCA4 variant'], ['ConclusionsThis study', 'ABCA4 variant c'], ['', ''], ['functionally  it', 'reduced ABCA4 protein'], ['Objective  Background', 'aortic Matrix aneurysm'], ['current  data', ''], ['protein levels', 'collagen I'], ['40  AAA', 'healthy kidney transplantation'], ['8 9 8 TIMP)1', 'reverse polymerase chain reaction'], ['', 'CTX enzyme'], ['addition immunohistochemistry', ''], ['mRNA  expression', '12  controls'], ['', ''], ['MMPs', 'significantly  macrophages'], ['', ''], ['', ''], ['', 'smooth muscle MMPs'], ['', ''], ['', ''], ['', ''], ['', 'significantly protein AAA'], ['', ''], ['', ''], ['', ''], ['significant  protein', 'MMP'], ['AAA', 'intact collagen I'], ['collagen III', ''], ['', ''], ['', ''], ['degraded collagen I', 'intact collagens observations'], ['', 'CTX-1  p'], ['', 'fivefold CTX III'], ['', ''], ['MMPs', '9 collagen I'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'respectively collagen I'], ['', ''], ['', ''], ['', ''], ['significant  relationship', 'protein'], ['MMPs', '9 protein level'], ['MMP-2', 'synthetic  SMCs'], ['Collagen I', 'inverse AAA'], ['', '9 I collagen III'], ['', '2017 Vascular Surgery'], ['', 'Elsevier Ltd'], ['rights', ''], ['Purpose  One', 'abdominal wall closure'], ['primary  closure', ''], ['we', 'synthetic component separation mesh'], ['abdominal wall composite', 'orthotopic AW vascularization'], ['abdominal rectus fascia', ''], ['Furthermore  use', 'intestinal  allograft'], ['', 'intestinal wall transplantation'], ['long term benefits', 'abdominal  full'], ['New  developments', 'reconstructive  surgery'], ['embryogenesis abundant embryogenesis gene', 'latter seed maturation'], ['tolerance', 'salt'], ['three plant species Oryza', 'L'], ['', ''], ['', ''], ['Agrobacterium LBA4404', 'AtEm6'], ['Integration', 'white polymerase chain reaction'], ['', 'transgenic cell O'], ['', ''], ['', ''], ['salt', 'AtEm6  gene'], ['expression', 'transgenic cell lines'], ['lipid  increment', 'transgenic cell control'], ['', 'OsCPK10 OsCPK19 salt'], ['transgenic cell salt', 'Ca2'], ['Overexpression', 'abiotic stress tolerance'], ['novel  gene', 'transcription PCR'], ['full length cDNA', '1062-bp  ORF'], ['353-amino acid which', 'five alpha helix regions'], ['NgAOX1a', 'AQX1'], ['NgAOX1a', 'known  AOXs'], ['blotting DNA NgAOX1a', 'genomic DNA sequence'], ['series', \"5'-flanking  NgAOX1a\"], ['acid cycle metabolite', 'exogenous response salicylic acid'], ['expression', 'ethylene'], ['', 'pathogens tobacco mosaic virus'], ['NgAOX1a', 'important defence response'], ['identify', 'SSH suppression C'], ['album', 'present salt study'], ['high GenBank ID which', '88  contigs'], ['They', '12 function annotations'], ['', ''], ['97  %', '190 gene ESTs'], ['03  %', 'low  similarities'], ['transcriptional  profiles', 'different NaCl points'], ['high  proportion', 'tested salt stress'], ['Four', 'when expression ABA'], ['northern  which', 'RT PCR'], ['genes', 'stress response'], ['complete  sequences', 'detailed  ESTs'], ['Phosphorylation', 'other protein proteins'], ['typical receptor tyrosine kinase', 'plants'], ['Dual specificity kinases', 'potentially target proteins'], ['dual specificity protein kinase', 'AD fusion soybean'], ['entire  length', \"5'-rapid cDNA ends\"], ['serine/ protein kinases', 'serine/  threonine'], ['SXXXS phosphorylation GmSTY1', 'addition'], ['GmSTY1 protein', 'vivo'], ['Southern blotting analysis', 'single  genome'], ['exogenous abscisic acid', 'significantly mRNA accumulation'], ['Interestingly  transcript', 'early  response'], ['protein kinase', 'independent  pathway'], ['extracellular', 'cellular  responses'], ['Plant MAPK cascades', 'development'], ['we', 'novel MAPKK gene maize'], ['ZmMKK4 transcript expression', 'exogenous abscisic acid'], ['Over expression', 'catalase control plants'], ['Furthermore ZmMKK4', '37 kDa kinase activity'], ['transcript  levels', 'expressing control plants'], ['ZmMKK4 protein', 'nucleus'], ['ZmMKK4', 'cold  plants'], ['', ''], ['', ''], ['', ''], ['medicinal  seeds', 'nutritive  qualities'], ['', ''], ['colosynthis', 'high North Africa'], ['', ''], ['likely  that', 'transgenic stress plants'], ['molecular  latter', 'other Citrullus genus'], ['genetic transformation protocols', 'plant'], ['aim', 'biotechnological  C'], ['', ''], ['review', 'many  field'], ['We', 'surgical term procedures'], ['neuropsychological  impairments', 'social  cognition'], ['', ''], ['long term outcome', 'neuropsychological  outcome'], ['epilepsy  epilepsy', 'neuropsychological  diagnostics'], ['relevant  that', 'routinely  epilepsy'], ['long term outcome', 'epilepsy  surgery'], ['Stereotactic  thermocoagulation', ''], ['however tissue effects', 'infertile semen males'], ['we', 'miRNA expression microarray'], ['52  miRNAs', 'healthy  males'], ['miR-122 miR-1275 miR-373 miR-193b', 'change  >'], ['', ''], ['miR-100  3p', ''], ['', ''], ['', 'infertile semen abnormalities'], ['specific  arc', 'infertile semen males'], ['Respiratory  morbidity', 'urban  residence'], ['particularly  that', 'upper airway disease'], ['We', 'Indigenous airway children'], ['', 'northern Brisbane Australia'], ['demographic  data', 'bilateral anterior nasal enrolment'], ['Polymerase chain reaction', 'respiratory nasal viruses'], ['primary  outcome', 'enrolment'], ['Logistic regression', 'respiratory specimen collection'], ['164  children', 'February'], ['median  age', 'enrolment'], ['', ''], ['', ''], ['', ''], ['4  %', ''], ['2  %', ''], ['81 nasal swabs', 'one  organism'], ['', '9  bacteria'], ['', '2  virus'], ['', '8  viruses'], ['detection', 'more  males'], ['', '4  38'], ['', ''], ['', ''], ['microbes', 'significantly  presence'], ['prevalence', 'same upper airways region'], ['Determining', 'upper  airways'], ['1  which', 'yeast two hybrid assay'], ['low degrees 4A', 'degrees  C'], ['Strong GUS staining', 'young abscission siliques'], ['biological  we', 'transgenic overexpression Arabidopsis'], ['enhanced heat susceptibility', 'transgenic  lines'], ['probably  AtNRP1', 'negative ABA synthesis pathway'], ['application', 'related gene expression'], ['great  deal', 'many ABA signalling pathway'], ['Here strawberry gene', 'homologous Arabidopsis gene'], ['conserved amino domains', 'homology analysis'], ['Ser protein phosphatase PP2C1', 'negative fruit regulator'], ['mediated gene regulation', 'FaABI1 strawberry fruit'], ['Furthermore alteration', 'ripening ABI4 ABI5 CHS'], ['phosphatase ABI1', 'negative  regulator'], ['possible core mechanism', 'strawberry fruit ripening'], ['concept', 'integrated circuits layout design'], ['proximity which', 'desired proximity requirements'], ['simulated', 'absolute proximity group'], ['final design front', 'combined design hierarchy'], ['also analog designer', 'design tradeoffs'], ['previous  efforts', 'obtained  floorplans'], ['obtained Pareto fronts', 'cascode operational United Microelectronics Corporation'], ['', ''], ['', ''], ['rights', ''], ['abuse history', 'indirectly teen mothers attachment'], ['', 'maternal abuse reports'], ['higher  which', 'subsequent  Grade'], ['more history group which', 'Grade'], ['history', 'indirect  problems'], ['Fostering', 'at abuse histories'], ['', ''], ['rights', ''], ['study', 'developmental safety knowledge'], ['exploratory  study', 'community mental health setting'], ['personal safety knowledge', 'varied  knowledge'], ['results', 'inappropriate risk touch'], ['lack', 'themselves'], ['Conclusion Results', 'developmental  disabilities'], ['how  PTS', 'obstetric  care'], ['psychological  distress', 'obstetric care needs'], ['pregnant abuse survivors', 'obstetric care needs'], ['medical  records', 'obstetric  procedures'], ['', ''], ['', 'obstetric abuse visit'], ['majority', 'physical  assault'], ['Obstetricians', 'one abuse cases'], ['Nearly  half', 'routine  reasons'], ['PTS', 'obstetric care preferences'], ['Women', 'least  obstetricians'], ['Results', 'obstetric distress practices'], ['attachment style', 'childhood maltreatment'], ['Associations', 'psychiatric Personality inpatients'], ['SIPP-118  domains', 'relational self control responsibility'], ['direct  effect', 'indirect childhood attachment'], ['indirect adult attachment style', 'relational integration self control'], ['anxious  attachment', 'significant control identity integration'], ['childhood trauma', 'romantic attachment style'], ['potential childhood abuse', 'psychopathology'], ['prior cortex research', 'adults'], ['abuse', 'subcortical mater adolescence'], ['Structural MRI scans', 'sexual  abuse'], ['Abuse', 'dichotomous  measures'], ['We', 'subcortical brain GMV'], ['Significance', 'p'], ['', 'false discovery rate correction'], ['parahippocampal  gyrus', 'temporal  pole'], ['abuse measure', 'cortical surface area'], ['Bilateral PHG thickness', 'inversely  symptoms'], ['experience', 'temporal  adolescence'], ['prospective mediator linking research', 'possibility'], ['significant  occurrence', 'female  partners'], ['how child safety', 'family violence mothers'], ['issue', 'intimate partner violence'], ['professional  that', 'isafe protocol'], ['Hypothetical  scenarios', 'future  discussion'], ['sexual  abuse', 'individual health child'], ['school nurses', 'one child abuse'], ['adequate  disclosure', 'available  person'], ['aim', 'sexually school children'], ['It', 'secondary school nurses'], ['Thematic  analysis', ''], ['school nurses', 'strong emotions ambivalence'], ['abused', 'physical  illhealth'], ['current  study', 'abuse peer neglect'], ['total', '2070 path analysis'], ['key  findings', 'study'], ['physical  abuse', 'significant  problems'], ['direct  effect', 'behavioral  problems'], ['Secondly teacher relationship', 'behavioral  problems'], ['Thirdly peer relationship', 'behavioral  problems'], ['indirect  effect', 'parental peer abuse'], ['effective peer who', 'abuse'], ['parental peer limitations', 'future  study'], ['', ''], ['rights', ''], ['related  trauma', ''], ['', 'nationwide  reports'], ['We', 'clinical  Taiwan'], ['before  diagnosis', '1 million 1 beneficiaries'], ['medical resource utilization', 'chi square chi test'], ['Risk factors', 'next Cox regression analysis'], ['Ninety three Ninety patients', ''], ['', ''], ['', '3  61'], ['', '18  age'], ['', '68 trauma patients'], ['1  %', 'emergency room'], ['7  %', 'intervention'], ['', ''], ['', ''], ['years  old', 'intensive  care'], ['', ''], ['5  %', 'rehabilitation'], ['', 'sexual  abuse'], ['Men', 'more mood stabilizers'], ['', '0  10'], ['', ''], ['', 'psychotherapy'], ['', '0  P'], ['', ''], ['Risk factors', 'next trauma extremities'], ['', ''], ['', ''], ['', 'antibiotics'], ['', ''], ['', ''], ['', 'first trauma event'], ['related  trauma', 'heterogeneous  subgroups'], ['Clinicians', 'timely  diagnosis'], ['general child practitioner', 'certified child abuse 2009'], ['findings  Researchers', 'child abuse pediatrics'], ['Several  articles', 'physical child hospitals'], ['that', 'unexplained nonambulatory infant'], ['Professionals', 'best  effects'], ['Summary', 'physical abuse pediatrics abuse'], ['medical  presence', 'abusive head injury'], ['article', 'ocular history AHT'], ['what', 'course'], ['study', 'SIP information abuse'], ['physical  measures', 'physical Protection Services records'], ['solving  capacities', 'physical  abuse'], ['Hostile attributions', 'positively abuse severity'], ['Controlling', 'physical SIP abuse'], ['preliminary  evidence', 'maternal abuse perpetration'], ['Future research directions', 'intervention'], ['Shaken baby syndrome', 'abusive  infants'], ['Advances', 'abusive  trauma'], ['abusive head trauma', 'blunt y impact'], ['chapter', 'abusive mechanismand injury'], ['obvious  injuries', 'many  infants'], ['pediatricians', 'crucial diagnosis AT'], ['article', 'Hodgkin 1832'], ['morphological  phenotypic', 'targeted risk therapies'], ['seminal  contribution', 'early stage HL'], ['ACBC boosting frequency method', 'paper'], ['procedure', 'biasing aspect transistors'], ['presented design guide', 'unnecessary circuit constraint introduction'], ['', 'Simulation TSMC'], ['', 'proposed process verifies procedure'], ['it', 'frequency response MOSFETs'], ['Programmable AC power sources', 'wide Test Procedure Specifications'], ['Traditionally power sources', 'current load limit'], ['proven  it', 'drawbacks'], ['digital DSP implementation', 'high switching frequencies'], ['programmable poser this', 'ATE system use'], ['paper', 'programmable voltage Josephson'], ['synchronous  system', 'digital processing control'], ['It', 'minimum human intervention'], ['operation measurement techniques', ''], ['voltage source converters', 'hybrid power system'], ['harmonic', ''], ['also  which', 'interfaces'], ['flexible control strategy', 'hybrid  paper'], ['current  harmonic', 'unbalanced  conditions'], ['Furthermore  methods', 'negative ac grid voltages'], ['protected control methods', 'theoretical  analysis'], ['active  k', 'active  parameter'], ['meanwhile dc k', 'meanwhile dc link'], ['Finally  validity', 'simulating  results'], ['', 'three power transmission phase'], ['two  which', 'three phase output voltage'], ['back type ac part', 'three type ac converters'], ['adjustable phase ranges', 'ideal control detail'], ['then phase method', 'close loop control parameters'], ['three phase prototype', 'three phase ACCPA'], ['experimental  waveforms', 'theoretical control strategy'], ['article', 'voltage source voltage inverter'], ['repetitive control system', ''], ['control which', 'opposite output phase'], ['repetitive  which', 'smaller CPU load'], ['power converter', '5 output linear'], ['paper', 'improved MATLAB Simulink environment'], ['advantages', 'transform harmonic Fourier transform compensation'], ['performance', 'new simulation results'], ['so S Function it', 'real time control systems'], ['Various  species', 'many  world'], ['strains', 'human  diseases'], ['', 'Currently Acanthamoeba environment'], ['pharmaceutical factory drains', 'Qinghai Province China'], ['material', 'then  LAMP'], ['', 'Acanthamoeba 32'], ['68  %', 'also samples PCR'], ['Acanthamoeba 18S rRNA isolates', 'common AK cases'], ['surface water', 'pathogenic pharmaceutical China'], ['also LAMP assays', 'useful  Acanthamoeba'], ['', ''], ['', ''], ['rights', ''], ['enormous  many', 'pulse  voltage'], ['Such accelerator components', 'precise  beams'], ['pulse power supplies', 'performances'], ['One  example', 'scanning beam proton therapy'], ['They', 'current voltage control'], ['However  use', 'precise power supplies'], ['We', 'digital control system'], ['previous  work', 'main power magnets'], ['next  we', 'such power magnets'], ['high performance method', 'board'], ['we', 'small scale power supply'], ['paper', 'ambulatory motor output'], ['device', 'minor SD card components'], ['It', 'outside  system'], ['slight  period', 'several  months'], ['accompanying  software', 'immobility file frequencies'], ['Applications', 'gait'], ['high performance interface circuit', 'many circuit processing work'], ['electrostatic feedback linearization circuit', 'simultaneously design indicators'], ['OSR', 'modulator'], ['It', 'highly  circuit'], ['about power dissipation', '60 sampling kHz'], ['SNR', 'full scale DC CMOS'], ['', ''], ['dc nonlinearity', 'it'], ['', ''], ['which', 'both interface it'], ['we', 'nonnative  decision'], ['experimental  we', 'influenced  choice'], ['when English message', 'Mandarin Chinese'], ['turn expectation violations', 'accent'], ['3  we', 'Indian  accents'], ['American effects bias', 'indirect expectation violations'], ['Theoretical  implications', 'study'], ['Acceptance', 'emotive behavior therapy'], ['objectives', 'REBT emotions'], ['sample', 'three  mindfulness'], ['ACT acceptance', 'significant ACT outcome'], ['only  ACT', 'outcome acceptance'], ['acceptance ACT acceptance', 'different  ways'], ['results', 'cognitive ACT processing'], ['outcome acceptance', 'two  conditions'], ['Future research', 'cognitive  measurements'], ['Immigrant', 'various  settings'], ['systematic  review', 'alternative care interventions'], ['policies', 'mental health immigrant'], ['Key policy recommendations', 'social claims immigrants'], ['Cervical imaging practices', 'traumatic brain injury'], ['We', 'cervical imaging performance'], ['imaging decisions', 'injured hospital children'], ['We', '2 Premier Perspective Database'], ['patient  we', 'magnetic resonance falls'], ['', '2347  TBI'], ['7  %', 'abuse'], ['1  %', 'falls'], ['Fifteen  percent', 'cervical  imaging'], ['severe head injuries', 'cervical  AHT'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'injured hospital children'], ['adjusted  probability', '4'], ['', '3  84'], ['', '3  AHT'], ['', '39'], ['', '0  falls'], ['', ''], ['highlight variation', 'patient  characteristics'], ['further  research', 'imaging practices'], ['ObjectiveThe aim', 'subcontinental acculturation Australia'], ['ethnocultural  that', 'migrant  acculturation'], ['dependent  variables', 'which'], ['Multivariate data analysis', ''], ['multiple regression analyses', 'study variables'], ['ResultsIntegration', 'ethnic  groups'], ['Acculturation preferences', 'acculturative stress mastery'], ['findings', 'psychological integration strategies'], ['especially  information', 'teacher training materials'], ['inclusion', 'ethnic relations groups'], ['digital control method', 'paper'], ['which', 'dynamic output transition'], ['which', 'dynamic output performance'], ['maximum undershoot voltage', 'proposed control study'], ['', ''], ['', ''], ['They', 'much  1'], ['', ''], ['', 'traditional control scheme'], ['undershoot recovery times', '10'], ['', '1'], ['', ''], ['', '53'], ['', ''], ['proposed control scheme', 'controlled  prototype'], ['high voltage controller that', 'alone phase inverters'], ['which', 'then  controller'], ['design methodology', 'feedback controller'], ['stability', 'repetitive error transfer function'], ['repetitive  controller', ''], ['experimental  performance', 'proposed  1'], ['', ''], ['work', 'mixed power factor correction'], ['inductor peak', 'current conduction sensing'], ['lookup  table', 'calculated input thresholds'], ['high input converter', 'reduced inductor footprint'], ['locked  loop', 'current frequency variations'], ['LUT', 'broad highmains line conditions'], ['150-W PFC prototype', '5  %'], ['theoretical  analysis', 'discontinuous conduction paper'], ['current switch voltage', 'output voltage'], ['converter reliability', 'RDSon converter specification'], ['digital control technique', 'current distortion DCM'], ['100-W  prototype', 'equal  95'], ['', ''], ['magnetic gradient driver', 'gradient  field'], ['', 'very  quality'], ['paper', 'different  driver'], ['high BW power inverter', 'commercial power semiconductor modules'], ['high  voltage', 'new silicon carbide devices'], ['control', 'digital  implementation'], ['Digital control', 'response'], ['large switching currents', 'low frequency variation'], ['well  filter', 'ripple  frequency'], ['digital control compensation', 'unregulated  performance'], ['900 A/1200 V platform', ''], ['experimental  results', 'proposed  structure'], ['Drug release', 'molecular  biology'], ['obvious  challenges', 'high drug load'], ['', 'analgetic drug release'], ['ZrO](2+)[AAP](2-', '68 prodrug wt'], ['', ''], ['ZrO](2+)[AAP](2-  nanoparticles', 'stable  water'], ['chemical composition', 'energy dispersive ray analysis thermogravimetry'], ['Moreover  release', 'labeled carbon nanoparticles'], ['data', '80  wt'], ['', 'up 48 h'], ['', ''], ['rights', ''], ['administrated  acetate', 'adipose Evans Tokushima Fatty'], ['aim', 'skeletal  tissues'], ['Treatment', 'white lipid adipose'], ['acetate OLETF transcripts', 'white  adipose'], ['adipose lipid that', 'obesity  type'], ['transcription that', 'several fatty liver'], ['oral  administration', 'lypogenic  obesity'], ['We', 'orally  5'], ['Otsuka Tokushima Fatty', 'linked kg type'], ['treatment', 'adipose glucose tolerance'], ['Northern  transcripts', 'acetate OLETF treatment'], ['acetate', 'obesity  type'], ['Research', 'PMBL molecular biology year'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['extracts', 'test insects'], ['Toxic  effect', 'T'], ['', ''], ['', ''], ['CE acid phosphatases', 'spectrophotometrically  assay'], ['extracts', 'stored grain insect species'], ['', 'T'], ['', ''], ['', ''], ['granarius', 'that'], ['indica  extract', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['inoxia', '15'], ['', ''], ['', ''], ['', 'maximum  T'], ['', ''], ['', ''], ['', ''], ['results', 'tested beta CE plants'], ['', 'Plant A'], ['indica', 'stored grain insect pests'], ['ability', 'safe grains insecticides'], ['Bacterial community analyses', 'like iron strains'], ['pure  culture', 'novel life bacteria'], ['Here  we', 'like  AMD'], ['Gallionellaceae', 'still  microaerophilic'], ['Availability', 'pH sequence homeostasis'], ['genome  sequences', 'G'], ['', ''], ['biochemical  that', 'acidic  conditions'], ['distinct Gallionellaceae that', 'closely iron oxidizer S'], ['', ''], ['Key hypotheses', 'pH Sideroxydans homeostasis'], ['', 'interpenetrating entrapment method'], ['Optimum temperatures values', '5'], ['', ''], ['0  40', 'free degrees laccase'], ['', '55%-73 degrees C %'], ['Percent decolorization', 'between Acid 63'], ['73 Acid %', '73  %'], ['', 'International Union International Biochemistry'], ['c Myc overexpression', 'gastric  cancer'], ['bile  acids', 'gastric c Myc vitro'], ['protein levels', 'real polymerase chain reaction'], ['gastric cell line MGC803', 'deoxycholic L glycochenodeoxycholic anacidmedium'], ['daily  60weeks', 'MGC803-resistant cell line'], ['Control MGC803 cells', 'bile  control'], ['proliferation colony formation', 'MGC803-resistant  60weeks'], ['MGC803-resistant tumor we', 'measured vivo telomerase activity'], ['mRNA c levels', 'gastric cancer samples'], ['MGC803-resistant  cells', 'increased colony vitro'], ['phenotypic changes', 'c Myc inhibitor'], ['MGC803-resistant  cells', 'dependent telomerase vivo'], ['gastric telomerase effects', 'c Myc activity'], ['bile  acids', 'recurrent gastric cancer'], ['sustainable  they', 'low quality electricity'], ['', 'easy flexibility availability'], ['novel  method', 'common TE acids'], ['prepared Seebeck coefficients', 'remarkably  treatments'], ['significantly PSS films', 'experimental base treatment'], ['optimal PSS films', 'Seebeck 39'], ['2 mu V', '2170 room temperature'], ['enhancement', 'high base treatment'], ['Background', 'important burn patients'], ['study', 'MBL metallo beta A'], ['baumannii isolates', 'burn patients'], ['', 'nonduplicated  A'], ['burn who', 'Taleghani Burn Iran'], ['Testing', 'disk diffusion'], ['double disk synergy', 'MBL production'], ['', 'polymerase chain reaction'], ['based  PCR', 'isolates clonality'], ['', ''], ['5  %', 'isolates'], ['Polymyxin B colistin', '100 susceptibility %'], ['', ''], ['', ''], ['', 'double disk synergy'], ['', ''], ['3  %', 'isolates'], ['20  %', 'bla(OXA-24-like'], ['However encoding genes', 'bla(VIM'], ['predominant B clones', 'four B C'], ['carbapenem it', 'carbapenem A'], ['baumannii', ''], ['result', 'predominant  A'], ['baumannii', 'burn patients'], ['effective infection control plan', 'resistant burn patients'], ['', ''], ['', 'Elsevier Taiwan LLC'], ['cefoperazone  sulbactam', 'imipenem  vitro'], ['', '16 drug resistance A'], ['baumannii strains', 'antibacterial  agents'], ['inhibitory  concentration', 'agar dilution method'], ['polymorphic polymerase chain reaction', 'carrying rmtB parC adeB'], ['Expression', 'reverse polymerase chain reaction'], ['', '15 drug 93'], ['8  %', 'vitro  induction'], ['Notable  8-', 'resistant  test'], ['PCR data', 'significant  differences'], ['', 'resistant OXA-24 TEM-1'], ['comparative adeB that', 'sensitive drug strains'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['active efflux pump adeB', 'important multidrug A'], ['', 'antibacterial  vitro'], ['We', 'reduced  carbapenems'], ['one  Enterobacter', 'one Sofia Bulgaria'], ['Different -lactamase genes', 'polymerase chain reaction'], ['well multilocus sequence', 'selected  isolates'], ['majority', 'harbored carbapenemase genes'], ['baumannii', 'genes'], ['', 'PFGE A'], ['baumannii', 'eight sequence types'], ['Molecular  characterization', 'one  NDM-1-producing'], ['', ''], ['', '13 mirabilis VIM-1'], ['Furthermore NDM-1', 'P'], ['', ''], ['', 'P'], ['', ''], ['', 'producing  A'], ['baumannii', 'repeated  P'], ['', ''], ['coli ST101 clone', 'intensified  investigations'], ['Background Acotiamide', 'few  action'], ['aim', 'controlled HR study'], ['Methods  We', 'controlled  study'], ['Japanese FD patients', '2  weeks'], ['2  we', 'gastrointestinal symptom rating scale'], ['medication data', '24 placebo patients'], ['Acotiamide', 'gastric  placebo'], ['', ''], ['', ''], ['', ''], ['Acotiamide', 'gastric  emptying'], ['', ''], ['', ''], ['', ''], ['Acotiamide', 'total GSRS placebo'], ['', ''], ['', ''], ['', ''], ['two  acotiamide', 'significantly HADS anxiety placebo'], ['', ''], ['', ''], ['', ''], ['acotiamide', 'Japanese FD patients'], ['Acotiamide', 'symptoms  score'], ['objective', 'molecular transduction growth'], ['', 'prior tumor growth rate'], ['Following', 'sporadic tissue VS'], ['labeled antisense which', 'dChip software'], ['Differential gene expression', '1'], ['', 'growing  tumors'], ['', 'p  value'], ['', ''], ['Deregulated  transcripts', 'established gene ontology'], ['Ingenuity Pathway Analysis', 'molecular tumor growth'], ['109  genes', 'tumor growth rate'], ['Genes', 'apoptosis growth'], ['Gene ontology', 'other cycle cell functions'], ['Fourteen  pathways', 'tumor growth'], ['molecular  networks', ''], ['first  study', 'functional tumor progression'], ['Specific  genes', 'growing apoptosis cell tumors'], ['Fourteen  pathways', 'tumor growth'], ['functional  networks', 'PI3 K others'], ['work', 'sound radiating surfaces'], ['method', 'efficient target application'], ['determined transfer functions', 'electrical drive trains'], ['proposed  model', 'electrical material properties'], ['model', 'vibration measurements'], ['benefits', 'closed time domain'], ['proposed  potential', 'electrical design machine'], ['mechanical forces which', 'electronic kinetic devices'], ['However  most', 'W kinetic energy cm(3'], ['it', 'sufficient  level'], ['Herein  we', 'electrospun acoustoelectric conversion trifluoroethylene'], ['optimized  device', 'peak 14'], ['', ''], ['', '5 power density 306'], ['', ''], ['', 'mW nanofiber web thickness'], ['energy storage electricity', 'electrochemical nanofiber corrosion'], ['novel acoustoelectric generator', 'usable noise electricity'], ['Intergeneric  hybridization', 'common  improvement'], ['presence', 'reported Kr1 genes'], ['control primer control system', 'Kr1 chromosome gene'], ['expressed  fragments', 'Kr1 gene'], ['Further  expression', 'northern blotting analysis'], ['Sequence analysis', 'responsive  transduction'], ['unravel', 'cellular gene expression'], ['H9 T cells', 'differential  display'], ['HIV-1(Lai)-infected P4-CCR5 HeLa which', 'quantitative PCR p24 ELISA'], ['knockdown  effect', 'cellular microarray analysis'], ['PDS5A tissue expression', 'Northern  blotting'], ['cohesion A', 'down  HIV-1'], ['HIV-1 replication', ''], ['PDS5A', 'lesser lung kidney liver'], ['Microarray analysis', 'previously PCAF HIV-1'], ['data', 'cellular host pathogenesis'], ['', ''], ['', ''], ['they', 'attention'], ['components', 'many corrosion others'], ['However  presence', 'adverse  situations'], ['wt Cloisite 15A', 'flame retardants'], ['characterization', 'thermogravimetric  analysis'], ['application', 'substrates flammability tests'], ['coatings', 'especially flammability tests'], ['Flames', 'other  systems'], ['surface  temperatures', 'MMT-15A fire scenarios'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Purpose  aim', 'bipolar II depression'], ['Methods  This', ''], ['actigraphic Rating Scale data', 'cosinor analysis'], ['Findings  Results', 'entire Medication group'], ['', ''], ['', ''], ['', ''], ['specifically  acrophase', 'significantly  weeks'], ['', ''], ['', 'respectively quetiapine XR group'], ['F statistics', 'entire  group'], ['', '4 quetiapine XR group'], ['', ''], ['', '4 lithium group'], ['', ''], ['', ''], ['addition scores', 'entire F group'], ['', ''], ['lithium', 'bipolar II depression'], ['depressive  symptoms', 'circadian  treatment'], ['Actinobacteria', 'commonly soil freshwater'], ['', 'well codon contexts'], ['inverse GC Nc', '4'], ['most GGC GCC GAG', 'frequent context codons'], ['2 codon traits', 'actinobacterial codon species'], ['', ''], ['', 'Elsevier Masson SAS'], ['rights', ''], ['inferior parietal which', 'actions'], ['cortical  which', 'such basal ganglia'], ['own  which', 'particular adult MN system'], ['motor it', 'perceptual  cognitive'], ['findings', 'neurophysiological monkey MN system'], ['new  framework', 'active distribution networks'], ['Distributed energy resources', 'proposed  market'], ['reactive power bidding structures', 'capability curves'], ['hourly speed variations', 'proposed wind model'], ['distribution company', 'wholesale  market'], ['active  loads', 'bidding buyback program'], ['objective  function', 'demand bidding buyback program'], ['effectiveness', 'radial distribution test system'], ['merged analog baseband', 'wireless power brief'], ['MABB', 'merged biquad topology'], ['long  it', 'different BW gain'], ['high GBW Opamp', 'order active RC MABB'], ['20 cutoff frequency gain', '0'], ['reconfigurable  MABB', 'wireless  receivers'], ['continuous time filter', 'integrated  circuits'], ['order universal order filter', 'Feedback Operational Amplifier'], ['proposed  circuit', 'proposed filter circuit'], ['proposed  this', 'integration view'], ['PSPICE simulations', '0'], ['mu m CMOS technology', 'low pass filter circuit'], ['', 'C  GmbH'], ['rights', ''], ['different state feedback approaches', 'connected LCL filter'], ['multivariable control approaches', 'theoretical line evaluation'], ['AD resonance methods', 'FCS MPC'], ['practical control implementation issues', ''], ['dynamic FCS MPC', 'same switching time'], ['Eventually  feasibility', 'theoretical laboratory environment'], ['active  damping', 'connected LCL filter'], ['digital control delay', 'low switching frequencies'], ['paper', 'low switching frequencies'], ['', 'grid current grid feedback'], ['This', 'high switching frequencies'], ['active damping loop', 'current  loop'], ['when grid impedance', ''], ['active damping performance', 'current  simulations'], ['connected  inverters', 'LCL filters'], ['Current  control', 'connected inverter control system'], ['AD LCL methods', 'active LCL damping'], ['control which', 'digital control implementation process'], ['lag phase', 'due control system'], ['effects', 'low switching frequency'], ['paper', 'connected LCL filter'], ['which', 'effectively AD performance'], ['', 'multisampled  control'], ['current inverter system', 'current loop multisampling'], ['it', 'dynamic  performance'], ['proposed control schemes', ''], ['Resonant  poles', 'pulse width modulation'], ['active damping solutions', 'resonance issues'], ['where notch frequency', 'resonant LCL filter'], ['thus resonance alignment', 'original  damping'], ['effectiveness', 'resonant  frequency'], ['notch itself', 'resonance'], ['when grid current', 'resonant  frequency'], ['current  influence', 'resonant phase frequency'], ['Accordingly notch frequency', 'resonant  frequency'], ['Simulations', '2'], ['connected PWM inverter', 'digital notch filters'], ['Control', 'high LCL filter'], ['damping  performance', 'low switching frequency applications'], ['simple delay compensation which', 'area equalization concept'], ['method', 'negative computation delay'], ['It', 'controlled PWM converter'], ['validity', 'experimental  results'], ['fed wind power systems', 'weak  networks'], ['impedances', 'careful  attention'], ['when DFIG system', 'weak  network'], ['paper', 'two DFIG details'], ['following  factors', 'L grid side converter'], ['active damping HFR', 'virtual impedance concept'], ['Energy storage systems', 'active  power'], ['important  that', 'important  ESSs'], ['distributed  generators', 'suitable  outcomes'], ['', 'coordinated DG paper'], ['proposed  place', 'same  time'], ['active  powers', 'ESSs'], ['active  capacities', 'network'], ['coordinated  ESS', 'deregulated electricity market'], ['Objective  function', 'secure distribution network'], ['planning', 'Meta heuristic optimization technique'], ['Simulation results', 'proposed  network'], ['results', 'individual ESS planning'], ['considering', 'realistic  outputs'], ['proposed  planning', 'several security constraints'], ['we', 'active voltage electrodes'], ['active  electrodes', 'general  literature'], ['First  figures', 'orthogonal input modes'], ['DD electrode', 'EMG crosstalk components'], ['Then  effect', 'finite input impedance'], ['', 'two impedance freedom'], ['novel circuit design', 'operational  amplifier'], ['design', 'electrode unity gain input'], ['interference rejection limits', 'input stage'], ['replicable  implementation', 'specific parameter design needs'], ['established sample sEMG signals', 'successfully interference sources'], ['current detection algorithms', 'paper'], ['which', 'slight  fluctuation'], ['', ''], ['', 'equal  periods'], ['Discrete Fourier Transform', 'respectively radix-2 time'], ['based  solution', 'real time implementation'], ['it', 'specialized  tools'], ['performance one', 'run  DSP'], ['synchronized power which', 'difficult load conditions'], ['high density buffer architecture', 'power dc'], ['yields', 'existing circuit solutions'], ['main energy storage capacitor', 'active dc bus'], ['low voltage transistors', 'buffer converter'], ['Moreover series capacitor', 'active circuit volume'], ['circuit operation', 'design detail'], ['lossy  converter', 'voltage balancing power loss compensation'], ['We', 'small voltage balance'], ['also buffer architecture', 'sufficient loss compensation'], ['2-kW hardware prototype', 'proposed voltage GaN solution'], ['', 'rectangular box 98'], ['9  %', 'wide load range'], ['which', 'bidirectional broadband system applications'], ['bidirectional amplifier which', 'artificial transmission lines'], ['divider BiCMOS technology combiner', 'digital control blocks'], ['2  which', 'S- C-'], ['it', 'amplitude  0'], ['8  phase', '3'], ['', '100-mW dc power consumption'], ['Equivalently  implementing', 'chaotic  signals'], ['generalized memristor emulator', 'grounded  restriction'], ['fingerprints', 'different sinusoidal voltage stimuli'], ['experimental  emulator', 'operational  amplifier'], ['', 'chaotic inductance element'], ['chaotic phase portraits', 'typical circuit parameters'], ['which', 'unstable origin saddle point'], ['dynamical Lyapunov exponent behaviors', 'chaotic inductorless circuit'], ['Results', 'chaotic state circuit'], ['prototype circuit', 'common circuit components'], ['Results', 'theoretical  analyses'], ['Transformation', 'large data sets'], ['curricular  who', 'mathematical life science courses'], ['new Faculty Learning Community', 'Midwestern research university'], ['Participants', 'planned teaching practice'], ['Overall  FLC', 'pedagogical  skills'], ['Interestingly  confidence', 'teaching'], ['Implications', 'science faculty'], ['', 'International Biochemistry'], ['TFT nonuniformity compensation', 'current speed accuracy'], ['hybrid column driver IC', 'horizontal AMOLED 7'], ['7 mu s', 'back TFT variation compensation'], ['3T1C pixel circuit', 'pixel'], ['high noise immunity', 'current sensing circuit'], ['current OLED I', 'OLED luminance degradation compensation'], ['hybrid driving method', 'gray level 0'], ['', 'gray  12'], ['', ''], ['current mode ADC', ''], ['', ''], ['', ''], ['active power which', 'current tracking control'], ['traditional PR paper', 'vector resonant controller vector controller'], ['greater resonance it', 'current compensation control'], ['digital  controller', 'detailed control design'], ['control strategy', 'harmonic compensation accuracy'], ['unbalanced power which', 'involved  unbalance'], ['modeling', 'dq0 system'], ['solely  tuning', 'decentralized  approach'], ['adopted control strategy', 'experimental signal 17'], ['properly  converter', 'single phase loads'], ['effectively  converter', 'neutral transformer current'], ['paper', 'active wideband systems'], ['Z(out source which', 'simply unity gain filter'], ['Applying', 'also stopband rejection performance'], ['DC unity gain which', 'active  filter'], ['proposed biquad filter', '0'], ['26 IIP3 +12', 'tunable frequency range'], ['proposed biquad filter', '14  1'], ['8 V supply', '1000x500  mu'], ['Recently  we', 'accurately excimer laser pulses'], ['', ''], ['', ''], ['', ''], ['', ''], ['dithering', 'long laser synchronization'], ['update we', 'numerical simulation results'], ['electromagnetic control algorithm', 'experiments'], ['system', 'real delay applications'], ['compact  system', 'multidisciplinary  applications'], ['active  elements', 'present  paper'], ['operational transconductance which', 'integrated  circuit'], ['pole frequency pole response', 'electronically dc bias OTAs'], ['high output which', 'high buffering device'], ['current mode quadrature oscillator', 'proposed  filter'], ['results', 'theoretical PSPICE analysis'], ['active RC BPF', 'digital nm process'], ['new  technique', 'zero integrator frequency compensation'], ['significant power savings', '40 nm CMOS process'], ['BPF', '5%-40 center %'], ['CF', ''], ['It', 'in frequency response 0'], ['', '33  1'], ['', ''], ['Activin E', 'transforming growth factor'], ['glucose energy we', 'transcriptional activin liver'], ['PCR immunoprecipitation assays', 'study'], ['', 'regulated HepG2 cells'], ['functional promoter sequence', 'activin E insulin'], ['binding  proteins', 'stimulatory activin E transcription'], ['C  EBPs', 'HepG2 cells'], ['expression', 'obese activin E mice'], ['activin E', 'pathophysiological glucose metabolism'], ['', ''], ['rights', ''], ['why  patients', 'medical  consultations'], ['We', 'discontinuous clinic attendance'], ['Participants', 'UH university clinics'], ['We', 'also  UH'], ['annual  rate', 'discontinuation'], ['0  %', 'mean  discontinuation'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['BPSD scale score', 'UH  patients'], ['', ''], ['best  predictor', 'discontinuation'], ['common  reason', 'family doctor'], ['', 'own hospital discretion'], ['', '3  LH'], ['We', 'own hospital discretion'], ['best  predictors', 'discontinuation'], ['', 'UH  dementia'], ['paper', 'high performance microgrids'], ['even  they', 'distribution system'], ['when  size', 'major  challenge'], ['challenge', 'independent distribution subnetworks'], ['computational  subnetwork', 'independent actor model'], ['solution algorithm', 'multiple  parallel'], ['', 'computational speed communication accuracy'], ['them', 'smart grid applications'], ['paper', 'incremental flyback actuator'], ['paper', 'low input voltage'], ['', 'incremental dc flyback actuator'], ['incremental  actuator', 'capacitive  actuators'], ['It', 'voltage  HV'], ['', 'capacitive dc dc actuators'], ['bidirectional flyback converter', 'charge output HV side'], ['Experimental  results', '3-kV polypropylene film load'], ['energy loss distributions', 'converter'], ['5-kV HV MOSFETs', 'HV side'], ['flyback prototype', '0 charge energy 2'], ['', '84 discharge energy 2'], ['', '5  0'], ['immune  system', 'developing  child'], ['Aberrations', 'such liver injury'], ['however  little', 'respective  disease'], ['liver disorders', 'intrahepatic liver hyperemesis pregnancy'], ['autoimmune liver injury', 'pregnancy'], ['review', 'potential liver biomarkers'], ['how  virus', 'neurological EV D68 AFM'], ['', 'left Case arm'], ['earlier  he', 'mild  fever'], ['child', 'admission'], ['left  which', 'left  arm'], ['CSF  examination', 'white blood cell count'], ['molecular  tests', 'viral  CSF'], ['patient', 'intravenous  ceftriaxone'], ['four muscle which', 'reduced  mobility'], ['Intensive Care he', 'four  limbs'], ['also spine MRI', 'spinal  myelitis'], ['Signal alteration', 'anterior grey horns'], ['Molecular biology tests', 'bronchoalveolar D68 clade B3'], ['Plasmapheresis', ''], ['significantly  weakness', 'four  limbs'], ['reported  alterations', '3  weeks'], ['AFM', 'Europe'], ['various EV D68 that', 'AFM'], ['Acute Graft Acute Disease', 'first line systemic corticosteroids'], ['Reliable  biomarkers', 'disease management'], ['3 acutephase protein', 'novel  acute'], ['murine we', 'increased GvHD onset'], ['Similarly plasma PTX3', 'clinical GvHD disease'], ['PTX3', 'active  disease'], ['disease they', 'severe  patients'], ['Multiple  injections', 'disease course'], ['PTX3', 'early GvHD patients'], ['perioperative cancer which', 'renal  injury'], ['anesthetic  adjuvant', 'acute kidney injury'], ['Materials Acute kidney injury', 'cisplatin'], ['Treatments Mice', '3 cisplatin treatment'], ['renal  function', '72 cisplatin administration'], ['Apoptotic tubular Apoptotic cells', 'TUNEL assay'], ['T cells', 'immunohistochemistry staining'], ['Tumor necrosis factor', 'real polymerase chain reaction'], ['Results DEX treatment', 'tubular cisplatin administration'], ['tubular cisplatin which', 'reduced  p53'], ['cisplatin which', 'kappa B activation'], ['renoprotective  effect', 'DEX'], ['DEX', 'induced  apoptosis'], ['1 growth levels', 'cirrhosis which'], ['exogenous  administration', 'healthy liver controls'], ['Additionally  impact', 'partial IGF-1 hormone'], ['male  mice', 'Igf(+/+  protocol'], ['Wt', '10 body days'], ['three Hz groups', 'three IGF-1-deficient mice'], ['time levels liver histology', 'MDA  groups'], ['represent', ''], ['healthy IGF-1 therapy', 'healthy  mice'], ['IGF1 mice', 'when damage Wt'], ['', 'Moreover MDA levels'], ['', ''], ['similar IGF-1-deficient mice findings', 'hepatic  parenchyma'], ['low liver doses', 'acute liver damage'], ['that', 'vulnerable  patients'], ['intermediate  that', 'parental  strains'], ['study', 'nasopharyngeal fiber aspirates'], ['It', 'different HAdV D genotypes'], ['HAdV D', 'respiratory  infections'], ['due  them', 'host cell repertoire'], ['data', 'recombinant bioinformatics HAdV'], ['lymphoblastic  leukemia', 'common  children'], ['CNS  relapse', 'significant treatment failure'], ['', 'directed leukemia therapies'], ['Extensive  research', 'BM leukemia development maintenance'], ['Moreover', 'promising cancer therapy'], ['leukemia reservoir', 'CNS microenvironment'], ['how  components', 'survival chemoresistance'], ['unique CNS that', 'patients'], ['genomic  that', 'SLC7A10 locus'], ['Reverse', 'together fusion transcript'], ['FAM53B fusion transcript', 'chimeric  protein'], ['However  it', '19q13 amino sequence'], ['truncated  FAM53B', 'FAM53B  accession'], ['', ''], ['', ''], ['', ''], ['', ''], ['truncated  protein', 'conserved FAM53 protein family'], ['single  it', 'single  which'], ['patients', 'hematological  treatment'], ['which', 'favorable  prognosis'], ['ETV6 ALL patients', 'prognostic  variables'], ['Materials Methods Sixty patients', '2011'], ['Prognostic  variables', 'cytogenetic  abnormalities'], ['free  survival', ''], ['', ''], ['10  patients', '28'], ['', 'cumulative  15'], ['', ''], ['', ''], ['presence MRD', 'negatively remission outcome'], ['', 'overall disease 82'], ['', ''], ['', ''], ['structural remission who', 'poor  outcome'], ['fusion ETV6-RUNX1', 'frequent B lymphoblastic leukemia'], ['Society protocol treatment stratification', 'activated cell sorting'], ['RT qPCR', 'reliable MRD analysis'], ['MethodsSeventy eight bone marrow samples', 'reverse polymerase chain reaction'], ['Fusion transcript MRD', 'ETV6-RUNX1 GUSB diagnosis'], ['ResultsMRD analysis', 'strong ETV6-RUNX1 fusion correlation'], ['cases', 'two time points 0'], ['', ''], ['where  FACS', 'MRD analysis'], ['Glucocorticoids', 'related lymphoid lineage malignancies'], ['related  mirtrons', 'biological polymerase II apoptosis'], ['encoding transcription units', ''], ['We', 'mature GC miRNAs'], ['regulations', 'host genes'], ['miRNAs  that', '16 cell clusters'], ['', '16 GC sensitivity'], ['complex  changes', 'dependent GC manner'], ['mostly  prognosis', 'patients'], ['significant  that', 'genetic AML patients'], ['dismal AML rates', 'such AML outcomes'], ['residual  that', 'treatment'], ['', 'sensitive MRD detection'], ['real polymerase chain reaction', 'next MRD assessment'], ['we', 'clinical MRD measurement'], ['different MRD that', 'laboratories'], ['mammalian  target', 'endothelial growth factor'], ['mTOR', 'acute myeloid leukaemia'], ['rapamycin CCI-779', ''], ['effects', 'primary AML cells'], ['3)H thymidine incorporation survival', 'Northern blotting RT PCR'], ['Rapamycin', '14/18 AML patients'], ['effects', 'rapamycin'], ['also  exposure', 'leukaemic  cells'], ['', 'direct proliferation VEGF'], ['other  mTOR', 'potential drug AML'], ['Background  Purpose', 'acute myeloid leukemia'], ['Reports', 'TET2 children'], ['We', 'Taiwanese TET2 prognosis'], ['total', 'consecutive Taiwan University Hospital'], ['analysis', 'direct TET2 sequencing'], ['Clinical  characteristics', 'overall TET2 alterations'], ['Intronic  mutations', ''], ['nonsense', ''], ['causing missense mutations', 'one A1865 patient'], ['prevalence', 'patient TET2 population'], ['', ''], ['common  polymorphism', ''], ['Patients', '10-year survival I1762V'], ['', ''], ['', ''], ['', ''], ['Chi square Chi OS', 'when Kaplan Meier method'], ['', ''], ['prevalence', 'TET2 AML'], ['Patient prognosis', 'further TET2 investigation'], ['', ''], ['', 'Elsevier Taiwan LLC'], ['acute myeloid leukemia', 'Northern RT blotting'], ['diagnostic  utility', 'WT1 immunohistochemistry'], ['normal bone marrow specimens', 'WT1'], ['22/55 AML cases', '20/47 bone marrow trephines'], ['ALL', ''], ['nuclear  that', 'previously  tumor'], ['traditional myeloid markers', 'extramedullary round which'], ['karyotype', 'acute myeloid diagnosis'], ['Cytogenetic  abnormalities', 'prognostic  factors'], ['It', 'clinical  trials'], ['common chromosomal abnormalities', 'defined  type'], ['molecular biology that', 'prognosis'], ['limited follow it', 'clinical  relapse'], ['WHO World Health classification', 'cytogenetic  AML'], ['Karyotype', 'therefore  AML'], ['', 'retinal DNA copy necrosis'], ['', ''], ['14  eyes', 'American Uveitis Society 324'], ['', ''], ['', ''], ['Anterior chamber fluid', '14  eyes'], ['', ''], ['Varicella zoster virus', 'four simplex eyes'], ['', ''], ['DNA copy number', ''], ['', ''], ['10(6)/mL', ''], ['', ''], ['', 'quantitative DNA copy 5'], ['x', 'visual  acuity'], ['', ''], ['', '0'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'DNA copy number'], ['', ''], ['', 'DNA copy 5'], ['10(6)/mL', '5 funduscopic exam'], ['', 'retinal  detachment'], ['', ''], ['Quantitative  DNA', '5'], ['10(6)/mL', 'retinal  necrosis'], ['review', 'present diagnosis cardiovascular'], ['YKL-40', 'Mendelian randomization design'], ['YKL-40  that', 'largely  causation'], ['blinded  it', 'causality'], ['Moreover  review', 'healthy reference cardiovascular'], ['YKL-40', 'molecular terminal amino 40kDa'], ['It', 'laden vessel wall'], ['levels', 'cardiovascular disease severity'], ['YKL-40', 'rather  atherosclerosis'], ['7 liver YKL-40', 'alcoholic liver cirrhosis'], ['elevated randomization levels', 'causal  diseases'], ['disease diagnosis', 'cardiovascular  diseases'], ['Acyclovir resistance', 'rarely herpes simplex I'], ['Prevalence rates', '0'], ['', 'immunocompetent  patients'], ['', ''], ['', ''], ['', 'immunocompromised 5 patients'], ['', ''], ['previous  who', 'febrile prodromal stage aphasia'], ['Cerebral', 'temporal resonance lobe'], ['CSF  analysis', 'lymphocytic  pleocytosis'], ['HSV I', 'positive repeat lumbar puncture'], ['intravenous acyclovir treatment', ''], ['', ''], ['', ''], ['', ''], ['Acyclovir treatment', '1000 mg t'], ['', ''], ['', ''], ['', 'antiviral  therapy'], ['parallel acyclovir resistance testing', 'prompting foscarnet therapy'], ['', ''], ['', ''], ['', ''], ['condition', ''], ['Acyclovir resistance', 'clinical  condition'], ['first HSV I', 'previously  Austria'], ['', 'recent  adalimumab'], ['', 'available  ophthalmologists'], ['Immunomodulatory', 'financial orphan incentive'], ['Here  we', 'uveitic  patients'], ['Topics', 'therapeutic side effects'], ['Expert We', 'sight threatening sight disease'], ['We', 'ocular  immunology'], ['Trophoblast fusion', 'pathological  it'], ['complete  ADAM12', 'complete  event'], ['ADAM12 gene', 'long  form'], ['Methods  We', 'several cell lines'], ['1st', '3rd trimester ADAM12-L'], ['1st placental syncytium', 'variants'], ['3rd trimester ADAM12-S', 'often  cytotrophoblast'], ['it', 'placental cell syncytium'], ['', 'GmbH'], ['rights', ''], ['paper', 'sensorless synchronous reluctance drive systems'], ['effects', 'mutual position estimation error'], ['PI  that', 'sensorless drive systems'], ['adaptive  controller', 'synchronous reluctance motor drive'], ['proposed drive that', 'PI controller'], ['high frequency injection method', 'synchronous reluctance drive systems'], ['it', '48 voltage regulators'], ['equivalent output voltage regulation', 'synchronous duty MOSFET'], ['', 'zero input voltage'], ['synchronous  which', 'current power path'], ['hybrid control strategy', 'secondary side control'], ['bank', 'polynomial sub filters'], ['variable  that', 'signal parameter changes'], ['therefore plant it', 'closed  configurations'], ['bandwidth  it', 'random model maneuvers'], ['it', 'steady state response'], ['', ''], ['', 'transient noise response'], ['', ''], ['', 'closed input discontinuities'], ['', ''], ['ADP  algorithm', 'residential microgrid systems'], ['which', 'load  rate'], ['value which', 'iterative control law period'], ['policy which', 'iterative control law sequence'], ['Properties', 'iterative ADP algorithm'], ['iterative value function', 'monotonically Bellman equation'], ['performance index function', 'iterative control law sequence'], ['numerical  results', 'developed  algorithm'], ['paper', 'interior  lighting'], ['adaptive voltage which', 'current power regulator'], ['employing', 'digital dc dc converter'], ['digital control methodology', 'maximum regulation speed'], ['proposed  concept', 'experimental  setup'], ['24 LED driver', 'wide output voltage 3'], ['', ''], ['Output current', 'than state 98'], ['pulsewidth modulation', '4 mu s'], ['', 'complete  93'], ['9  %', ''], ['Environmental governance systems', 'social climate change'], ['environmental governance systems', 'social  shape'], ['We', 'key decision society'], ['adaptive  governance', 'social  change'], ['that', 'conflict'], ['fundamental self determination changes', 'environmental  governance'], ['We', 'common governance solutions'], ['', ''], ['', 'methodological participation recommendations'], ['how  scholars', 'adaptive  governance'], ['Adjuvants', 'immunogenicity'], ['human  that', 'such  HIV'], ['New  adjuvants', 'emerging Adjuvant pathogens'], ['Adjuvant Systems concept', 'serendipity'], ['how  they', 'it'], ['knowledge', 'new vaccine vaccines'], ['recent  immunotherapy', 'solid  tumors'], ['premise', 'immune tumor cells'], ['Development', 'evasive cancer immunotherapy'], ['addition studies', 'immune liver cancer'], ['Preclinical  studies', 'potential liver cancer'], ['we', 'primary liver cancers'], ['Matrix metalloproteinases', 'immunomodulating bowel effects'], ['imbalance', 'aberrant  IBD'], ['recurrent  phases', 'such IBD fistulas'], ['how animal model knowledge', 'prognostic  levels'], ['CRISPR Cas', 'prokaryotic  cells'], ['molecular  that', 'molecular  memory'], ['discovery', 'prokaryotic  genomes'], ['complete  that', 'immune  system'], ['biological  what', 'biological  role'], ['', 'Motor Permanent PMSM'], ['rotor position', 'Extended Kalman AEKF'], ['performance', 'defined estimation algorithm'], ['proposed  solution', 'floating control point'], ['VSSLLMS control algorithm', 'active power filter'], ['weight vector', 'distorted VSSLLMS load'], ['VSSLLMS algorithm', 'new  computations'], ['adopted shunt hybrid APF', 'passive  phase'], ['performance', 'MATLAB Simulink environment'], ['Experimental  results', 'proposed control algorithm'], ['locked  loop', 'pulse capacitance measurement'], ['fundamental sine wave', 'MWF'], ['which', 'unknown  capacitance'], ['FLL', 'center capacitance'], ['MWF', 'closed center loop'], ['magnitude  errors', 'sampling frequency pulses'], ['Experimental  investigation', 'wider capacitance measurement'], ['10 acquisition V', 'real time delay'], ['its', ''], ['system', 'new particle CERN'], ['Initial  specifications', 'system requirements'], ['proposed  system', 'demanding  requirements'], ['', 'switched capacitor circuits'], ['undesirable ring which', 'transient  stability'], ['based ring which', 'oscillation'], ['two auto zero schemes', 'common mode voltage stability'], ['prototype ADC', '90-nm CMOS technology'], ['measured  SNDR', ''], ['', ''], ['15  dB', 'MS Nyquist frequency s'], ['', ''], ['organization', 'glomerular filtration barrier'], ['cAMP pathway', 'important actin network cells'], ['However  role', 'cAMP podocytes'], ['neuronal  that', 'cAMP'], ['we', 'kidney'], ['Expression', 'situ  hybridization'], ['role', 'Adcy1 knockout mice'], ['Adcy1', 'specifically  podocytes'], ['physiological kidney histology', 'physiological  functioning'], ['wild type control mice', 'mild albumin urine'], ['novel  that', 'physiological  glomerulus'], ['', ''], ['', ''], ['endogenous oxytocin system', 'social parturition humans'], ['It', 'endocrine immune endocrine systems'], ['regulated oxytocin system', 'mental  illness'], ['external  that', 'receptor substance use'], ['paper', 'parental substance use'], ['We', 'older  age'], ['dysregulation', 'endogenous anxiety addiction'], ['where time system', 'natural oxytocin levels'], ['that', 'oxytocin adversity'], ['', ''], ['rights', ''], ['Background', 'interpersonal use disorder'], ['meta analysis', 'confounding effect studies'], ['literature review', '1990 research January'], ['Twenty five Twenty studies', 'healthy recognition inclusion'], ['sizes', 'basic emotion emotions'], ['Facial emotion recognition', ''], ['', ''], ['', ''], ['', 'particularly  disgust'], ['AUDwas', 'also  ToM'], ['', ''], ['', ''], ['', ''], ['deficits', 'decoding'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '06  ToM'], ['depressive alcohol symptoms', 'facial  emotions'], ['disorder', 'facial emotion mind'], ['young problems tobacco use', '14 cannabis use'], ['', 'linked child maltreatment'], ['', 'Mater University Brisbane Australia'], ['Participants', 'prenatal child community'], ['3  %', 'young  age'], ['Measurements Exposure', 'substantiated government agency reports'], ['Cannabis outcomes', 'International Diagnostic age'], ['Associations', 'potential  confounders'], ['Additional  adjustment', '14-youth behaviour problems'], ['substantiated child maltreatment', 'time cannabis use'], ['', ''], ['', ''], ['', 'prior cannabis age'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Externalizing', 'all cannabis outcomes'], ['', 'behaviour'], ['', ''], ['who', 'daily cannabis dependence'], ['Externalizing', 'partly adult cannabis use'], ['purpose', 'mental  health'], ['We', 'emotional receiver condition type'], ['', ''], ['', ''], ['', 'health caregiver disorders'], ['descriptive Care regression', 'emotional receiver condition type'], ['very  they', 'short caregiving responsibilities'], ['health  caregivers', 'physical health conditions'], ['prevalent behaviours internet that', 'problematic  engagement'], ['superordinate cognitions', 'addictive desire behaviours'], ['', 'negative pornography affect'], ['that', 'negative desire metacognitions'], ['Participants', 'problematic internet pornography use'], ['Path analyses', '191  participants'], ['metacognitive desire thinking', 'negative  affect'], ['Additionally  results', 'revised metacognition desire thinking'], ['Collectively  findings', 'problematic pornography use'], ['metacognitive  that', 'treatment prevention strategies'], ['', ''], ['rights', ''], ['factor corrector converters', 'low switching loss'], ['current input distortion', 'delayed switching period'], ['on  method', 'current input distortion'], ['quantitative  analysis', 'exact  time'], ['explicit  form', 'digital  control'], ['optimized', 'only input voltage'], ['circulating load currents', 'gate turning gate technique'], ['', '90 V rms input'], ['surgical type II approach', 'lymph nodes dissection'], ['Immunohistochemistry', 'lymph node AEJ'], ['prospective case who', '2015 University Union Siewert'], ['outcomes', ''], ['total', '3 lymph groups'], ['2  groups', 'monoclonal Ber Ep4'], ['incidence', '37 Ber Ep4'], ['histological  number', 'positive lymph nodes'], ['When  staining', '28 lymph patients'], ['Micrometastases', 'tumor invasion'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Ber Ep4', ''], ['', ''], ['', ''], ['3-  rates', 'patients'], ['also LNMM which', '68  %'], ['', 'LNMM group'], ['Patients', 'lower Ber Ep4 survival'], ['', ''], ['CD44v6-positive group', 'reduced  survival'], ['', ''], ['patients group', 'significant survival benefit'], ['', ''], ['routine  test', 'negative lymph nodes'], ['prognostic  factor', 'invasive  approach'], ['Ber Ep4', 'great  LNMM'], ['Human papillomavirus', 'infrequently sinonasal tract'], ['morphological  overlap', 'minor salivary glands'], ['related  carcinoma', 'nine  cases'], ['we', 'like  carcinoma'], ['identified  tumours', 'clinicopathological  cases'], ['Methods', 'Forty seven candidate HPV'], ['HPV', '33  35'], ['six  cases', 'heterogeneous mucosal morphologies'], ['largely MYB what', 'ACC'], ['five  patients', 'disease'], ['small  prognosis', 'more  ACC'], ['', 'MYB MYBL1 NFIB gene status'], ['aim', '4 C adenomyosis'], ['chain reaction analysis', 'eutopic foci tissue samples'], ['33 tissue who', 'same control period'], ['standard  deviation', 'SPSS software'], ['', ''], ['Analysis', 'hoc difference test'], ['protein expression', 'endometrial tissue AD'], ['CXCL12 protein expression', 'significantly control group'], ['', 'group comparisons'], ['significant  differences', 'proliferative protein group'], ['Furthermore expression', 'endometrial control group'], ['', 'group comparisons'], ['mRNA expression', 'endometrial ectopic foci AD'], ['expression', 'endometrial ectopic foci tissue'], ['', 'group comparisons'], ['significant  differences', 'proliferative  group'], ['', 'endometrial  AD'], ['We', 'potential Tumor Necrosis adenomyosis'], ['52  all', '2011 University Changchun September'], ['IFN gamma', 'Linked Immunosorbent Assay'], ['We', 'operating characteristic receiver operating curve'], ['correlation', 'individual  cytokines'], ['Results', '69'], ['', 'other  30'], ['', '52 sera controls'], ['eight  cytokines', '16 sera adenomyosis'], ['lower  TNF', 'when adenomyosis controls'], ['', ''], ['Serum TNF', 'significantly  adenomyosis'], ['Inflammatory  response', 'various cytokine conditions'], ['inflammatory  cytokine', 'skeletal  muscle'], ['', 'skeletal muscle effects'], ['A2B adenosine receptors', 'L6 skeletal muscle cells'], ['skeletal muscle cells', '25 cm2 flasks'], ['reverse polymerase chain reaction', 'different treatment conditions'], ['', 'skeletal muscle cells'], ['effect', 'selective receptor PSB'], ['', 'IL-6 up induction'], ['IL-6  regulation', 'mainly cAMP pathway'], ['A2B  receptors', 'skeletal muscle tissues'], ['binding cassette proteins', 'extracellular  membranes'], ['Increased drug efflux', 'binding cancer cell chemoresistance'], ['Several  articles', 'clinicopathological tumor features'], ['multiple  which', 'relevant tumor information'], ['binding cassette profiles', 'new  carcinogenesis'], ['combined  cohort', 'patients- breast colorectal'], ['polymerase chain reaction', 'RNA isolation'], ['Gene expression data', 'merged bioinformatics tools'], ['binding cassette profiles', 'such tumor size'], ['A3 A8 A12', 'upregulated  ones'], ['results', 'well research levels'], ['presence', 'various symbol cancers'], ['', 'conjunctivitis Patras June'], ['structured  questionnaire', 'retrospective  cases'], ['molecular  detection', 'nested  PCR'], ['Positive  results', ''], ['phylogenetic  analysis', 'isolated  sequences'], ['epidemiological  analysis', 'conjunctivitis  cases'], ['', ''], ['', ''], ['Based', 'viral  origin'], ['', ''], ['50 % 22', 'bacterial % origin'], ['excess  cases', '156 age groups'], ['', 'positive  that'], ['5  %', ''], ['', '5  AdV54'], ['epidemiological  data', 'preventive risk measures'], ['study', 'viral  Greece'], ['outbreak', 'infectious conjunctivitis outbreaks'], ['rather  which', 'viral surveillance conjunctivitis'], ['dopamine receptor D4', 'deficit hyperactivity children'], ['Reports', 'mixed  results'], ['aim', 'DRD4 number tandem children'], ['healthy  controls', 'tertiary care Mumbai'], ['number tandem repeats', '8 PCR AGE'], ['allele  repeats', 'screened  subjects'], ['Statistical  significance', \"10R/10R DAT1 3'UTR cases\"], ['Endothelial  activation', 'atherogenesis'], ['role', 'endothelial PPAR activation'], ['we', 'inflammatory PPAR delta'], ['GW0742', 'real time RT PCR'], ['Activation', 'reactive oxygen species ECs'], ['GW0742', 'vascular cell adhesion molecule'], ['nonliganded PPAR delta', 'opposite  effect'], ['ligand activation', 'nuclear PPAR corepressors'], ['PPAR delta agonists', 'such  atherosclerosis'], ['aim', 'nitric insulin oxide'], ['Sprague Dawley rats', 'Larginine methyl ester'], ['rats', 'plain drinking water'], ['', 'insulin C peptide levels'], ['administration', '4 insulin vitro'], ['insulin binding assay', 'number insulin adipocytes'], ['Adipocyte Retn Adipocyte levels', 'northern  blotting'], ['Successful  induction', 'systemic blood pressure'], ['difference', 'two plasma glucose groups'], ['', 'deficient C peptide rats'], ['stimulated glucose uptake', 'deficient insulin rats'], ['deficient  rats', 'negatively insulin sensitivity'], ['deficient  this', 'Retn  expression'], ['NO', 'regulatory  metabolism'], ['Dysregulation', 'metabolic  disorders'], ['that', 'reduced energy expenditure'], ['Leptin expression', 'various  hormones'], ['short chain fatty that', 'humans'], ['fatty acid', 'human leptin adipocytes'], ['differentiated  adipocytes', 'increasing  butyrate'], ['mRNA  expression', 'Northern blot analysis'], ['which', 'Northern leptin blotting'], ['phospho CREB', 'dependent  manner'], ['signal protein antagonist PD98059', 'leptin mRNA expression'], ['butyrate', 'transcriptional leptin level'], ['This', 'short P13 pathways'], ['4  gene', 'hormonal  control'], ['adipose tissue transcription that', 'regimens'], ['refeeding', 'adipose GLUT4 mRNA tissue'], ['increased mRNA levels', 'adipose  tissue'], ['diabetic rats insulin treatment', 'adipose mRNA tissue'], ['putative sterol response element', 'human GLUT4 promoter'], ['differentiated 3T3-L1 adipocytes', 'SREBP-1c mRNA GLUT4'], ['refeeding', 'putative sterol response GLUT4'], ['Furthermore  treating', 'diabetic  SREBP-1'], ['we', 'functional GLUT4 promoter'], ['Sp1 site', 'mediated GLUT4 gene upregulation'], ['upregulation', 'adipose GLUT4 gene tissue'], ['poor survival rate', 'grafted  method'], ['poor posttransplantation viability', 'application'], ['overexpression', 'fat transplant survival'], ['adenoviral  vectors', 'healthy  woman'], ['Hsp70 expression', 'quantitative polymerase chain reaction'], ['', 'green fluorescent protein'], ['nude graft survival', '3  months'], ['derived stem cells', 'significantly Hsp70 vitro'], ['cell population', 'other treatment vivo'], ['fat  grafts', 'viable control groups'], ['Hsp70 overexpression', 'transplanted fat tissues'], ['', 'white obesity mediates'], ['Chronic intermittent hypoxia', 'inducible insulin factor'], ['male  mice', '12 IH SH'], ['', 'quantitative polymerase chain reaction'], ['IH vWAT P>>SH', 'vWAT hypoxia'], ['', ''], ['IH', 'prominent  SH'], ['early HIF-1 alpha that', 'vascular rarefaction inflammation'], ['adipose apneic that', 'SH'], ['Adipose  tissue', 'perivascular multipotent niche'], ['surface these', 'main  categories'], ['populations', 'unknown  significance'], ['functional  marker', 'ASC PC subclasses'], ['vascular  fraction', 'activated cell sorting'], ['Individual ASCs', 'set marker genes'], ['single cell we', 'principal  analysis'], ['perivascular progenitor cell subclasses', 'following  maturity'], ['order', 'signaling  pathways'], ['transcriptional  analysis', 'perivascular mesenchymal stem markers'], ['', ''], ['Extensive  research', 'stromal stem cells'], ['which', 'full  recovery'], ['agents', 'thaw heat shock ASCs'], ['temporal postheat shock', 'western polymerase chain assays'], ['3 heat HSP90', '3 heat shock'], ['thaw maximal HSPs nonheat', 'samples'], ['ASC differentiation potential', ''], ['freezing  insult', 'cryoprotective  agents'], ['long term effect', 'subcutaneous adipose tissue'], ['Large White pigs', '14 28 14 d'], ['FAS fatty acid glucose', 'Northern stearoyl CoA blotting'], ['RAC', 'mg BW d'], ['', 'increased loin eye d'], ['', ''], ['Expression', '2  P'], ['d  expression', 'PPAR alpha'], ['', '14  28'], ['14 d expression', 'P'], ['mg RAC concentrations', 'd FAS 28'], ['adipose CoA desaturase expression', 'less  expression'], ['', 'mg  RAC'], ['anabolic metabolism transcription glucose', 'still FAS d'], ['Conversely transcription factor', 'oxidative metabolism expression'], ['lean  effect', 'practical  significance'], ['them', 'material handling material industries'], ['Many  kinds', 'different conveying industries'], ['Adjustable speed drives', 'industries'], ['We', 'industrial  applications'], ['adjustable speed drive', 'induction motor'], ['control system', 'actual speed loop'], ['well sensorless solutions', 'industrial applications speed sensors'], ['economic speed sensor trend', 'computational speed solutions'], ['persistent sensorless that', 'new  solutions'], ['advanced control approach', 'industrial FOC drives'], ['current stator controller', 'various FOC systems'], ['', 'classical FOC solution PI'], ['However  PCCs', 'better  properties'], ['System sensitivity', 'electrical circuit drives'], ['robust  structure', 'control'], ['real time implementation', 'electric  drives'], ['streptococcal glycolipopeptide vaccine candidates', 'adjuvanting  moieties'], ['immunogenicity', 'systemic IgG ELISA'], ['Three', 'significant IgG response'], ['', 'human immunodeficiency virus malaria'], ['recent  advances', 'improved design opening vaccines'], ['Some', 'iii microparticle fabrication'], ['Advances', 'based shape surface characteristics'], ['collaborative  efforts', 'next generation vaccines'], ['process', 'immunological vaccine antigenicity immunogenicity'], ['physicochemical  review', 'based vaccine design efforts'], ['Critical  issues', 'given  study'], ['ago prevention that', 'unique  opportunity'], ['which', 'out state information system'], ['original time period', 'comparable  study'], ['same data patterns', 'two archival outcome variables'], ['reproduced  analyses', 'clear effect intervention'], ['out placements effect sizes', 'preventive  impact'], ['population outcome which', 'public health CM'], ['', ''], ['rights', ''], ['Ancient  DNA', 'microbial  DNA'], ['wide  range', 'DNA quantification methods'], ['aim', 'common DNA quantification aDNA'], ['Quantification methods', 'medieval burial site'], ['ultraviolet', 'forensic fluorescent DNA'], ['Differences', 'paired t test'], ['R UV fluorometer', 'highest  concentrations'], ['Methods', 'real time aDNA'], ['fragmentary aDNA which', 'desired PCR inhibitors'], ['ancient  they', 'microbial  DNA'], ['qPCR  methods', 'due PCR inhibitors'], ['DNA quantification methods', 'only fragment analysis DNA'], ['psychoactive  component', 'early  adulthood'], ['present  we', 'adolescent THC rats'], ['THC exposure', 'clinical  populations'], ['adolescent THC exposure', 'mesocorticolimbic  dopamine'], ['Furthermore  we', 'DAergic  dysregulation'], ['findings', 'neuropsychiatric adulthood pathology'], ['maltreatment', 'problems'], ['Less', 'severe  adversities'], ['study', 'years 15 age'], ['', ''], ['', ''], ['Youth', 'concurrent conduct problem adversities'], ['', 'self reports'], ['4  %', 'deviant problem range'], ['', '1  boys'], ['', ''], ['', 'deviant conduct problem group'], ['1  %', 'concurrent  26'], ['3  %', 'deviant  group'], ['', ''], ['', ''], ['', ''], ['deviant conduct problem group', '1'], ['', '8'], ['', 'different  adversities'], ['mental health problems', 'deviant conduct problem SDQ'], ['additive  relationship', 'adversities'], ['Two  thirds', 'concurrent conduct problem adversities'], ['Clinicians', 'based conduct treatment'], ['', 'clinical  sample'], ['sectional field study', '2014 school years'], ['Data', 'Expressed Emotion Scale'], ['SPSS', '21 data analysis'], ['', '487  subjects'], ['57  %', ''], ['43  %', ''], ['median  age', ''], ['', 'emotional  problems'], ['', ''], ['', ''], ['', 'relationship problems'], ['', ''], ['', 'social  emotion'], ['', ''], ['concept', 'mental  disorders'], ['new  that', 'health adolescents'], ['Specifically  we', 'perceived religion health relations'], ['religion health that', 'spirituality'], ['psychosocial  we', 'future spirituality religion'], ['aim', 'major age gender'], ['sectional  study', 'main Saudi 2012'], ['16 sampling 939', 'adolescents'], ['Screening Tool Child', 'data collection'], ['previous  occurrence', 'violence exposure'], ['80  %', 'biological  parents'], ['2012  assessment', '0'], ['', ''], ['', 'psychological  abuse'], ['when  they', 'biological  parent'], ['significantly violence girls', 'sexual  boys'], ['More  attention', 'particularly  girls'], ['sexual abuse prevention programme', 'boys'], ['Background Studies', 'related food life'], ['aims', 'parent age HRQL'], ['Quality Methods Questionnaires', '29 peanut hazelnut'], ['Parents', '120 FAQLQ Parent form'], ['Clinical  data', 'hospital database'], ['Significant  factors', 'univariate  regression'], ['Results Female patients', 'greater food males'], ['lower peanut threshold', 'worse  HRQL'], ['reported life HRQL', 'social  life'], ['Severity', 'significantly  HRQL'], ['risk', 'worse allergen HRQL'], ['Fathers', 'greater food allergy research'], ['behavioral incentive it', 'affective  anhedonia'], ['study', 'depressive reward symptoms'], ['Participants', '76 adolescents ages'], ['study', 'concurrent anhedonia nonanhedonic'], ['Findings', 'future dopaminergic anhedonia'], ['recently  volumes', 'healthy stress controls'], ['study', 'traumatic  experiences'], ['magnetic resonance imaging that', 'pediatric region PTSD'], ['We', 'PubMed Medline Knowledge'], ['meta that', 'groups'], ['meta analysis', 'cerebral corpus callosum PTSD'], ['also matter differences', 'amygdala matter lobe'], ['functional  studies', 'PTSD stress group'], ['structural brain some', 'different brain adults'], ['strongly  which', 'reduced  reactivity'], ['that', 'early  intervention'], ['high reward reactivity', 'depressive childhood maltreatment'], ['', '59  maltreatment'], ['', ''], ['', 'emotional fMRI stimuli'], ['signal  changes', 'neutral basal ganglia interest'], ['Participants', 'processing  scanner'], ['Depression symptoms', 'MRI'], ['Greater reward reactivity', 'baseline  depression'], ['faster reaction time', 'maltreated depression youth'], ['higher depression levels', 'maltreated reward youths'], ['Reactivity', 'potential  maltreatment'], ['findings', 'neurodevelopmental  depression'], ['exposure', 'less childhood AFE'], ['2012 Health we', 'demographic obesity factors'], ['nine body mass index', 'CDC Disease guidelines'], ['Mayo we', 'demographic  factors'], ['multinomial logistic regression models', 'composite BMI category'], ['Exposure', 'increased  overweight'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '73 education level race'], ['', 'parent'], ['', ''], ['', ''], ['', 'family income'], ['', ''], ['', ''], ['50', 'other obesity AFEs'], ['results', 'strongly childhood others'], ['individual family which', 'strongly  obesity'], ['', ''], ['rights', ''], ['few age studies', 'clinical  populations'], ['14  suffering', 'healthy Childhood Trauma comparison'], ['longitudinally mediation who', 'psychotherapy intervention'], ['', ''], ['mentalization that', 'standard comparison subjects'], ['whole  levels', 'inversely  BDI'], ['', ''], ['', ''], ['', ''], ['', ''], ['Moreover MZQ scores', 'large childhood depression'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['effect', 'entirely Affect Regulation subscale'], ['four  decrease', 'MZQ scores'], ['', ''], ['', ''], ['clinical sample deficits', 'depressogenic childhood trauma'], ['Social network sites', 'new  SNSs'], ['purpose', 'depressive adolescents them'], ['study', ''], ['sample', 'depressive K SADS PL'], ['Use Questionnaire', ''], ['amount', 'depressed  adolescents'], ['depressed  adolescents', 'anhedonia concentration SNSs'], ['intensity', 'depressed depression group'], ['young  people', 'social  symptoms'], ['disclosure', 'social relatives friends'], ['', 'neuropsychological hyperactivity tests'], ['comorbid test performance results', 'different anxiety disorders'], ['Alternatively trait anxiety', 'diagnosable anxiety disorders'], ['cognitive  study', 'Diagnostic Disorders Fourth Edition'], ['trait anxiety', 'attention ADHD'], ['overall response inhibition', 'ADHD'], ['pathological  levels', 'neuropsychological test performance'], ['anxiety', 'protective  ADHD'], ['ADHD  adolescents', 'beneficial  effects'], ['often  autonomy', 'adolescent  development'], ['Emotional  maltreatment', 'rarely  adolescents'], ['review', 'emotional maltreatment report'], ['rapid review methodology', '2568 hand abstracts'], ['independent  reviews', 'critical  appraisal'], ['', 'reported  features'], ['maltreated teenage girls', 'externalising  symptoms'], ['1 violence neglect', '2 self studies'], ['neglected school boys', 'neglected school girls'], ['emotionally  adolescents', 'social  relationships'], ['contributory  that', 'developmental  stage'], ['Rumination', 'adults'], ['research', 'report parenting measures'], ['', 'parental modelling behaviour'], ['sectional  design', ''], ['Daughters', '154 questionnaire rumination'], ['Five Minute Speech which', 'maternal  criticism'], ['', 'high rumination ruminators'], ['Mothers', 'critical  comments'], ['reported  rumination', 'potential  role'], ['maternal  positivity', 'female  adolescents'], ['maternal  rumination', 'adolescent  rumination'], ['results', 'observational parenting measures'], ['however evidence base', 'promising treatment recovery'], ['', 'Journey  program'], ['aged  participants', 'viewed Nemours discretion'], ['Participants', '3 core months'], ['Lesson content', 'relapse prevention skills'], ['3-month  6-month', 'four time points'], ['We', 'mixed modeling outcome'], ['Participants', 'up control participants'], ['Participants', 'greater control participants'], ['potential  intervention', 'older  adolescents'], ['Greater  use', 'reported self time'], ['Relapse prevention treatment', 'online  interventions'], ['', ''], ['secondary  that', 'main  groups'], ['which', 'beta carotene molecules'], ['carotenoid  we', 'Adonis aestivalis'], ['CrtH1 protein', 'four histidine enzymes'], ['Sequence analysis', 'putative amino terminus'], ['CrtH1', 'three multicopy gene A'], ['', ''], ['Northern  it', 'low flower petals seeds'], ['CrtH1', 'functional beta E'], ['', ''], ['Expression', 'endogenous beta carotene seeds'], ['encoding', 'first Branchiostoma becheri tsingtauense'], ['2 N terminal which', 'ARFs'], ['183 C terminal which', 'like ARF proteins'], ['new ARF which', 'phylogenetic  analysis'], ['extended C terminal', 'vertebrate  split'], ['transcript', 'vesicular  proteins'], ['whole patch clamp we', 'II)-stimulated cortisol secretion'], ['both', 'hyperpolarized  potentials'], ['One', 'Northern  blotting'], ['', ''], ['other', 'previously L type Ca2'], ['piperidin-4-ylmethyl]-benzamide TTA P2', ''], ['stimulated cortisol that', 'L type currents'], ['', 'effectively TTA P2'], ['', 'pimozide Diphenylbutylpiperidine penfluridol'], ['', 'similar cortisol potency'], ['dependent  gating', 'complex action depolarization'], ['slowly  activating', 'particular L type respect'], ['selective  inhibition', 'critical AZF cell physiology'], ['surprisingly  little', 'mechanism key blood pressure fluid'], ['ANP disruption', 'local  RAS'], ['2 RNA expression levels', 'real polymerase chain reaction'], ['angiotensin II peptide levels', 'radioimmunoassay'], ['acute natriuresis response changes', 'anaesthetized  mice'], ['mice', 'mice'], ['mice', 'other AT2 mRNA genotypes'], ['RAP', 'significantly  mice'], ['', 'blunted RAP RIHP ANP(-/-'], ['ANP disruption', 'local pressure natriuresis RAS'], ['epidemiological  data', 'threatening  which'], ['treatment', 'European Academy Clinical guidelines'], ['Patient  data', 'April'], ['Emergency doctors', 'emergency St'], ['', 'Pierre anaphylaxis'], ['Inclusion criteria', 'Sampson anaphylaxis'], ['Data', 'Microsoft Excel database'], ['', ''], ['', '04 emergency anaphylaxis'], ['64  %', 'min symptom onset'], ['89  %', 'IV glucocorticosteroids'], ['87  %', 'medical self administration'], ['74  %', 'adequate  diagnosis'], ['54/100  patients', ''], ['only EAACI minority', 'recommended self discharge'], ['min auto injector prescription', 'medical  help'], ['', 'close adrenaline auto allergologists'], ['Allergy immunotherapy', 'threatening epinephrine administration'], ['objective', 'sublingual immunotherapy tablets'], ['', ''], ['', ''], ['', ''], ['', ''], ['2800 SQ T', 'SLIT tablet trials'], ['SLIT tablet trials', 'grass'], ['Eight  administrations', 'local SLIT mouth'], ['', 'protracted placebo anaphylaxis'], ['Four  administrations', 'local SLIT mouth'], ['', 'SLIT tablet trials'], ['Four  administrations', 'local  events'], ['1 tablet 5', 'administrations tablet day'], ['Epinephrine administrations', 'first  treatment'], ['related  events', 'epinephrine'], ['', '2016 Allergy Asthma'], ['adrenal type II hyperplasia', 'abnormal  46XY'], ['ambiguous  that', 'androgen insensitivity syndrome'], ['correct  diagnosis', 'adrenarche'], ['Genotyping', 'two compound alleles'], ['', ''], ['', ''], ['', ''], ['', ''], ['3bHSD2  enzyme', 'cortisol production'], ['markedly  effects', 'androgen glucocorticoid'], ['current  guidelines', 'sexual work differentiation'], ['Attachment anxiety', 'worry'], ['relationship', 'attachment IOU'], ['present  study', 'online Relationships Scale Revised'], ['positively anxiety attachment avoidance', 'positively  worry'], ['when attachment avoidance', 'covariate'], ['only attachment anxiety', 'only attachment association'], ['IOU', 'key adult attachment worry'], ['findings', 'related  difficulties'], ['', ''], ['rights', ''], ['Psychosocial  factors', 'lung transplant outcomes'], ['However  it', ''], ['such lung transplant history', 'mortality'], ['Patients', 'Other lung transplant 2004'], ['main Main Outcome outcome', ''], ['secondary  outcomes', 'psychological abuse survivorship'], ['', ''], ['5  %', ''], ['history', 'abuse survivorship'], ['2  %', 'decreased lung transplantation'], ['', ''], ['marital abuse who', 'abuse'], ['Abuse survivors', 'maladaptive personality traits'], ['', ''], ['Abuse survivorship', 'posttransplant lung transplant mortality'], ['lung transplant patients', 'potentially health transplantation'], ['Symptom clusters', 'atrial  type'], ['purpose', 'cluster  membership'], ['This', 'paroxysmal data persistent'], ['We', 'symptom cluster clusters'], ['', 'SD  72'], ['', ''], ['symptom  clusters', 'vagal  cluster'], ['We', 'patient  cluster'], ['significant  differences', 'antiarrhythmic heart cluster'], ['Women', 'more heart symptom men'], ['Individuals', 'heart cluster'], ['', ''], ['', ''], ['', 'antiarrhythmic heart medications'], ['atrial fibrillation symptom clusters', 'study population'], ['attention deficit hyperactivity who', 'adulthood'], ['adolescent children patients', 'health care services'], ['when drug treatment', 'economic South Korea ADHD'], ['transition period', 'ADHD'], ['ADHD  symptoms', 'adult psychiatrists'], ['Further  studies', 'transition period'], ['especially  it', 'appropriate  illness'], ['', 'ADHD adult services'], ['suicidal self injury', 'suicidal autism spectrum disorder'], ['spectrum disorder', 'suicidal self depression'], ['online  we', 'initial autism spectrum disorder'], ['We', 'matched autism spectrum disorder'], ['50 autism spectrum %', 'suicidal self injury'], ['adults', 'suicidal self injury'], ['spectrum disorder', 'suicidal autism spectrum disorder'], ['history', 'current autism spectrum disorder'], ['suicidal self injury characteristics', 'suicidal autism spectrum disorder'], ['preliminary  findings', 'suicidal autism spectrum disorder'], ['one', 'continuously implementation devices'], ['novel FPGA that', 'industrial  applications'], ['embedded design paradigm which', 'SoC hardware platforms'], ['great memory they', 'designers'], ['strongly design paradigm which', 'better software developers'], ['Focusing', 'recent software resources'], ['real time simulation', 'mechatronics robotics power systems design'], ['how  they', 'new FPGA features'], ['', 'negative health lifespan'], ['individual factors that', 'good  adversity'], ['Resilience Portfolio study', 'high child abuse'], ['rural community sample', 'average  software'], ['Participants', 'protective health resilience'], ['emotion community', 'better  health'], ['', 'related meaning adversity'], ['Prevention  efforts', 'child strengths'], ['foundation', 'early  lifespan'], ['', ''], ['rights', ''], ['mental  study', 'adverse lifetime those'], ['Data', '2012 National Epidemiologic Conditions'], ['traumatic stress alcohol', 'drug use'], ['Gender differences', 'interaction effects'], ['', 'sample'], ['', '2  women'], ['0  %', 'one  ACE'], ['other substance abuse', ''], ['6  %', 'physical  abuse'], ['Child abuse', 'consistently substance MSUDs'], ['', ''], ['', ''], ['28 95 28 %', ''], ['', ''], ['', 'other substance misuse'], ['total  associations', 'separation  men'], ['study', 'late lifetime life'], ['why  ACEs', 'older gender effects'], ['Adverse childhood experiences', 'increased  cancer'], ['how ACEs impact cancer', 'intermediate  outcome'], ['present  study', 'Pap  21'], ['Analyses', 'different Pap adversities'], ['logistic regression models', 'this'], ['bivariate  adults', 'ever Pap test'], ['physical bivariate abuse', 'recent Pap test'], ['latter  association', 'confounders'], ['early childhood experiences', 'cervical  cancer'], ['modifications', 'better child women'], ['early  adversity', 'diminished life generations'], ['well  relationship', 'socioeconomic education employment'], ['Collectively  outcomes', 'overall life opportunity'], ['10  that', '2010 Factor Surveillance ACEs'], ['those', 'federal poverty level'], ['health  that', 'generations'], ['more  they', 'public  understanding'], ['', ''], ['', 'early  adversity'], ['structural  that', 'intergenerational child abuse'], ['', ''], ['', 'Elsevier Ltd'], ['Adverse childhood experiences', 'later tobacco life'], ['However  studies', 'smokeless tobacco products'], ['2011 Factor Surveillance which', 'years  102716'], ['Logistic regression models', 'current tobacco ACEs'], ['Results', 'currently smokeless tobacco 44'], ['', ''], ['57  %', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'drug user'], ['', ''], ['', ''], ['who', 'someone'], ['', ''], ['', ''], ['who', 'parents'], ['', ''], ['', ''], ['57', 'unadjusted smokeless tobacco models'], ['', 'physical  abuse'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'problem drinker'], ['', ''], ['', ''], ['', 'drug user'], ['', ''], ['', ''], ['who', 'other'], ['', ''], ['', ''], ['62', 'smokeless tobacco use'], ['who', 'someone'], ['', ''], ['', ''], ['92', 'smokeless tobacco confounders'], ['childhood adversities', 'smokeless tobacco products'], ['Special  attention', 'different tobacco ACEs'], ['', 'VPA UKAED register'], ['', ''], ['', ''], ['n=91  LEV', 'healthy control medication'], ['patients', 'anonymously Adverse Event Profile'], ['/LTG LEV=60%/79%/67%/67 %', 'related generalized epilepsy'], ['Mean LAEP scores', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['significantly  patients', 'active  depression'], ['restlessness memory problems feelings', 'more CBZ VPA CTR'], ['feeling', 'other  drugs'], ['', 'reported  efficacy'], ['adverse  effects', 'more  controls'], ['anger', 'CBZ'], ['Confounding  factors', ''], ['tolerant  grass', 'widely arid regions'], ['close  that', 'harsh  deserts'], ['main  aim', 'inducible  A'], ['lagopoides', 'fragment length polymorphism'], ['', 'A'], ['induction', 'northern  blotting'], ['many  parameters', 'radioactive  which'], ['', 'derived  fragments'], ['4  percent', 'high expression salt'], ['northern  that', 'applied  method'], ['some', 'osmotic transcription cation transportation'], ['modified DD AFLP method', 'expressed  genes'], ['previously Vibrio hollisae', 'iron starvation'], ['eight  hatCDB', 'eight  genes'], ['hatCDB genes', 'ferric cassette transport aerobactin'], ['iucABCD', 'aerobactin biosynthesis enzymes'], ['', 'respective hatC iucA'], ['monocistronic iutA transcript', 'northern  blotting'], ['biological gene that', 'respective homology search'], ['arrangement', 'evolutionary aerobactin gene view'], ['', ''], ['rights', ''], ['next generation radars', 'wide frequency range'], ['receive  which', 'synchronized  manner'], ['This', 'front  antennas'], ['emerging  technologies', 'complex timing synchronization'], ['based  which', 'wide channel bandwidths'], ['paper', 'radar systems'], ['how test system advances', 'challenging  requirements'], ['Obesity', ''], ['molecular tumour biology', 'early  diagnosis'], ['Genes', 'important  obesity'], ['Few  genes', '2 melanocortin-4 obesity'], ['', 'mRNA degradation'], ['Overexpression', 'regulated kinase-5 activities'], ['Cancers', 'also  obesity'], ['disturbance', 'cell proliferation differentiation'], ['possible  mechanism', 'adipokines'], ['mediators', 'cancer therapy'], ['cancerous  drugs', 'also  obesity'], ['few  which', 'both  cancer'], ['present  review', 'therapeutic clinicians treating options'], ['2-year follow subtype', 'suicidal ideation'], ['MethodA total', '2-year follow up'], ['Affect lability', 'French Affect Lability Scale'], ['ResultsBipolar patients', 'current level anxiety disorder'], ['', ''], ['', ''], ['', ''], ['', ''], ['risk', 'affect suicidal lability'], ['depressive  affect', 'suicidal ideation'], ['affective  lability', 'bipolar suicidal disorder'], ['', 'old 37 infants'], ['sample', 'chronic risk illnesses'], ['NA Negative Extraversion', 'Infant Behavior Questionnaire'], ['health', 'nonroutine birth'], ['Analyses', '41 weeks contrasts'], ['Extraversion', '41 weeks GA'], ['NA', 'similar  effect'], ['odds', 'medical  visit'], ['', 'times  infants'], ['Infants', '41 weeks GA'], ['findings', 'early term delivery'], ['ability', 'social  life'], ['thus  rehabilitation', 'significant  benefits'], ['emotion recognition capacity', 'AD'], ['cognitive control that', 'usual  group'], ['participants', 'correctly  emotions'], ['', 'fewer  commission'], ['', 'greater  processing'], ['', ''], ['', ''], ['Specifically  EG', 'sadness'], ['', ''], ['', ''], ['', 'quicker processing disgust'], ['', ''], ['one processing which', 'one processing surprise'], ['Capacity', 'one month follow'], ['rehabilitation that', 'social  population'], ['Australian  aspects', 'target paper'], ['historical  background', 'experimental  evidence'], ['here  issue', 'further  attention'], ['practical  what', 'emotional  life'], ['Embracing', 'adaptive  dysphoria'], ['immemorial  research', 'relatively  psychologists'], ['', 'positive  affect'], ['negative  affect', 'affective signalling states'], ['psychological paper theories', 'social  thinking'], ['negative  affect', 'social judgements motivation'], ['negative  affect', 'externally thinking strategy'], ['practical cognition implications', 'applied  fields'], ['One', 'twenty five mood disorder'], ['Current  treatments', 'uncertain  action'], ['how  these', 'affective  disorders'], ['Systems biology approaches', 'affective  disorders'], ['review', 'experimental systems biology'], ['future  recommendations', 'affective  disorders'], ['Experimental systems biology', 'genome  levels'], ['However data generation', 'human  tissue'], ['computational systems biology', 'few  occasions'], ['studies', 'computational  field'], ['', 'experimental  datasets'], ['next  step', 'biological  datasets'], ['This', 'affective diagnosis disorders'], ['', ''], ['', ''], ['rights', ''], ['different processing they', 'different processing situations'], ['social cognition that', 'different processing strategies'], ['thus  mood', 'cognitive  processing'], ['negative knowledge mood', 'specific processing information'], ['neutralizing  antibodies', 'HIV-1 infection'], ['HIV-1 vaccine that', 'infected  subjects'], ['effective  BNAbs', 'necessary affinity maturation'], ['successful neutralization that', 'natural  infection'], ['mutational  that', 'initial V(D)J rearrangement'], ['statistical  we', 'tasks'], ['structures', 'recent  these'], ['This', 'structural HIV-1 antibody development'], ['what', 'structural vaccine design'], ['Alterations', 'reactive oxygen species'], ['Ubiquinol reductase hinge protein', 'serving cytochrome bc1 mitochondria'], ['present  we', 'clinical UQCRH patients'], ['UQCRH expression', 'positive virus surface antigen'], ['UQCRH', 'frequently HCC tissues'], ['', '%  2'], ['', ''], ['UQCRH overexpression', 'poorer  differentiation'], ['Kaplan Meier analysis', ''], ['', ''], ['', 'UQCRH'], ['prognostic  impact', 'AFP  level'], ['patient  subgroup', 'significant AFP 5-year'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '4 UQCRH overexpression'], ['marked survival differences', 'lower AFP levels'], ['Multivariate analysis', 'prognostic  factor'], ['UQCRH overexpression', 'poor HCC patients'], ['', 'clinical UQCRH treatment'], ['African  countries', 'current electricity 2030'], ['renewable  resources', 'significantly  demand'], ['Southern Africa Power potential', 'many  countries'], ['regrets  that', 'regrets  options'], ['low carbon that', 'renewable hydropower expansion'], ['Additionally  interconnections', 'conventional generation 9'], ['', 'conventional % cost technology'], ['Strategic  selection', 'cost  interconnections'], ['Overall  results', 'multiple load growth scenarios'], ['multicriteria site selection', 'conventional  generation'], ['linked  agammaglobulinemia', 'damaging  infections'], ['intramuscular immunoglobulin rate', 'intravenous immunoglobulin replacement'], ['Enteroviruses', 'often XLA dermatomyositis'], ['Difficulty', 'poor  outcomes'], ['fluid Furthermore detection', 'enteroviruses'], ['Reluctance', 'significant brain delays'], ['other feature compromising outcomes', 'specific  therapy'], ['failure', ''], ['antienteroviral  drugs', 'threatening  enterovirus'], ['', '2016 Allergy Asthma'], ['1V Automatic Gain Control', '1V  -70dB'], ['feedback gain', 'feedback topologies'], ['type resistors network', 'passive gain accuracy'], ['hysteresis comparator', 'rapidly Peak Detector threshold'], ['design', '0'], ['', 'active mu m 0'], ['', ''], ['power consumption', 'AGC'], ['', '1V supply voltage'], ['gain', 'more gain 0'], ['', ''], ['integrated  noise', '20 audio kHz'], ['when mu gain', '40dB'], ['harmonic  distortion', 'audio  0'], ['', ''], ['Age', 'hepatocellular transition home'], ['However  that', 'this'], ['aim', '2 Q65 discharge'], ['prospective study design', 'recruited teaching Taiwan'], ['Data', '1  discharge'], ['set', 'supportive symptom distress anxiety'], ['total', '104 data collection process'], ['Supportive care needs', '2 unmet groups'], ['overall unmet they', '2  discharge'], ['Age', 'potential unmet transition'], ['physical health discharge', 'personalized education discharge'], ['proportion', '50s 60s'], ['older  people', 'later  ages'], ['Research', 'disparate age treatment'], ['more  attention', 'adverse selection impact'], ['We', 'human resource management research'], ['', ''], ['rights', ''], ['Patients', 'major liver resections'], ['derived', 'partial liver hepatectomy'], ['we', 'aged Nos2 PH'], ['type Nos2 mice', '2/3 PH'], ['Liver tissues', '11 time PH'], ['Mice survival ratio', ''], ['Transcript', 'reverse polymerase chain reaction'], ['aged Nos2 KO mice', 'lower survival ratio'], ['', ''], ['', 'termination phase'], ['transcript  level', 'obviously Nos2 KO mice'], ['associated JNK1 NF STAT3', 'transcript proliferation marker'], ['apoptotic CAS PASE3 CASPASE9', 'Nos2 KO mice'], ['Decreased survival ratio', 'decreased liver cell proliferation'], ['older  adults', 'enough  exercise'], ['full  it', 'older  adults'], ['week  it', 'executive football health function'], ['Walking waiting groups', 'per  football'], ['health  benefits', 'brief  intervention'], ['question', 'specific  history'], ['question', 'diverging  opinions'], ['special  forces', 'living  entities'], ['human  controversies', 'practical self medicine'], ['organisms', 'physicochemical  machines'], ['solely component resistance', 'view'], ['successfully  science', 'physiological  organisms'], ['mere  continuation', 'living  entities'], ['first  quest', 'analytical  empiricists'], ['today  it', 'specific  life'], ['mysterious  it', 'generated  knowledge'], ['view', 'practical  usefulness'], ['different  authors', 'single  them'], ['living  they', 'contemporary  science'], ['results', 'organismic  functions'], ['Important energy reductions', 'energy consumption levels'], ['Recent  studies', 'social peer norms'], ['promising  literature', 'rather  buildings'], ['that', 'buildings'], ['based  that', 'building stock'], ['', ''], ['', ''], ['sensitivity connecting', 'different energy reductions'], ['findings', 'socially energy conservation initiatives'], ['', '2017 Civil Engineers'], ['mother  fetus', 'transient  pregnancy'], ['different  which', 'feminist materialist literatures'], ['developmental placenta I', 'simultaneous  differentiation'], ['maternal  that', 'biosocial  pregnancy'], ['new  what', 'healthy  pregnancy'], ['collection', 'paper points'], ['However  collection', 'intraoral  surfaces'], ['sampling strategy', 'quadrant site MT4'], ['50  patients', 'deepest saline mouthrinse'], ['Analysis', 'periodontal chain reaction pathogens'], ['64%/30 Prevotella intermedia', '90%/82 Eikenella MSP'], ['', '100%/100 Fusobacterium test'], ['Only detection frequency', '68%/74 Capnocytophaga MT4'], ['Differences', 'P'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'key pathogen A'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['nodatum', 'higher detection MT4'], ['well market prices', 'well imbalance forecasts'], ['optimization strategy', 'intertemporal  constraints'], ['proposed  formulation', 'temporal electricity spot markets'], ['Intertemporal  constraints', 'day market clearing'], ['Each', 'short computation times'], ['benefits', 'deterministic sample strategies'], ['better  aggregators', 'power markets'], ['paper', 'supervisory exposure mothers'], ['It', '20 birth cohort U'], ['', ''], ['', ''], ['study', 'year follow Great Recession'], ['Interview dates', 'Great  Recession'], ['', 'prior  parenting'], ['Great Recession', 'decreased child neglect'], ['Households', 'social  fathers'], ['direct unemployment which', 'mental level health'], ['', ''], ['rights', ''], ['bipolar spectrum disorders', 'high  aggression'], ['how  aggression', 'depressive  episodes'], ['aggression', 'behavioral approach system BSDs'], ['diagnosed', 'months bipolar II 3'], ['', ''], ['Participants', 'depressive mood problems'], ['physical  aggression', 'manic mood problems'], ['Aggression', 'same  covariates'], ['related  behaviors', 'depressive  BSDs'], ['Fipronil', 'thereby birds animals'], ['', 'Japanese fipronil quail'], ['Therefore  aim', '60 gavage days'], ['Fipronil administration', 'significant feed intake'], ['histological  changes', '60  recovery'], ['elevated hormone levels', 'elevated serum estradiol'], ['changes', 'various recovery periods'], ['ER alpha gene expression', 'quantitative polymerase chain reaction'], ['1 Vtg transcript', 'exposure'], ['estrogenic  that', 'males'], ['Nevertheless  most', '30 45 30 days'], ['', ''], ['rights', ''], ['violent childhood understanding', 'underlying  mechanisms'], ['suicidal attempts', 'forensic psychiatry inpatients'], ['Adverse childhood experiences', 'official court records'], ['data', 'generalized linear models'], ['violent suicide crimes', 'appetitive  aggression'], ['etiological  pathways', 'adverse childhood experiences'], ['Considering', 'forensic  patients'], ['', ''], ['rights', ''], ['2  nSMase2', 'well  odontoblasts'], ['However  effects', 'PDL  cells'], ['authors', 'human PDL human cells'], ['Smpd3', 'related HPDL cells'], ['inhibitor', 'clearly enhances HPDL cytodifferentiation'], ['Next  authors', 'aggressive  periodontitis'], ['unrelated  authors', 'Japanese  people'], ['such  it', 'HPDL cells'], ['Smpd3', 'crucial PDL tissue'], ['Dendritic  cells', 'immune  responses'], ['aim', 'chronic gingival tissue periodontitis'], ['', '10 control group'], ['significant difference test', 'mDC S100 immunomarkers'], ['CP  groups', 'only  S100'], ['Conversely mDCs', 'AgP  groups'], ['', ''], ['CD1a+ cells', 'lesser  groups'], ['DC maturation predominance', 'immune cell activation'], ['Further  studies', 'periodontal DC disease'], ['Fragile  syndrome', 'mental retardation disease'], ['This', \"1 5'-untranslated gene\"], ['FMR-1 gene', 'complete protein product'], ['', 'mental retardation patients'], ['however  it', 'predominantly  neurons'], ['It', 'alternative FMR-1 transcript'], ['immunohistochemical  we', 'dependent mice manner'], ['present  finding', 'various brain functions'], ['', ''], ['', 'learning memory cognition'], ['that', 'advancing  age'], ['Early life addiction', 'related  diseases'], ['However  role', 'crack cocaine addiction'], ['dependent  who', 'elderly reference senescence'], ['study', 'psychiatric cocaine dependents diagnosis'], ['crack cocaine sample', 'CTQ ELS history'], ['TL', 'quantitative PCR assay'], ['CRACK CRACK subjects', 'younger ELD age'], ['CRACK ELS group', 'shorter CRACK group'], ['crack cocaine TL', 'emotional abuse scores'], ['results', 'ELS  addiction'], ['study', 'dependent  ELS'], ['biological senescence hypothesis', 'ELS experience'], ['', ''], ['rights', ''], ['', 'immune baby system'], ['inflamm  which', 'immune  cells'], ['phagocytes', 'inflammatory organ aged'], ['Critical  we', 'critical  process'], ['aged  compilation', 'field'], ['Rationale', 'adverse cardiovascular outcomes'], ['regenerative  capacity', 'mechanism'], ['circulating progenitor cells', 'tissue repair'], ['Main  objective', 'adverse cardiovascular outcomes'], ['We', '76 coronary artery disease'], ['Circulating progenitor cells', 'flow cytometry'], ['10 LTL CD34', '10 % shorter'], ['', ''], ['', ''], ['short  LTL', 'independently hazard 1'], ['', '95 % confidence 1'], ['', '2'], ['', 'hazard 2'], ['', '95 % confidence 1'], ['', '3'], ['', 'respectively  4'], ['who', 'adverse cell outcomes'], ['', ''], ['', ''], ['', ''], ['regenerative  LTL', 'adverse artery disease patients'], ['biological  aging', 'conventional risk factors'], ['One', 'significant mode power supplies'], ['paper', 'step dc dc converter'], ['Changes', 'voltage step capacitance'], ['sensitivity', 'main circuit model'], ['feasibility', 'experimental converter prototype'], ['presented  method', 'various operating conditions'], ['detection', 'nuclear power reactors'], ['', 'impending level health failures'], ['paper', 'passive mode power converters'], ['nonparametric system response', 'optimized multitone sinusoidal mVs'], ['parametric system model', 'square system algorithm'], ['Finally stage component values', 'assumed Laplace system model'], ['extracted component values', 'diagnostic  components'], ['same  methodology', 'other  SMPC'], ['Circulating  levels', 'positively blood pressure'], ['1  which', 'hypertension'], ['aim', 'chemerin'], ['human  1', 'vasoconstriction'], ['smooth  CMKLR1', 'smooth  muscle'], ['C9', 'saphenous chemerin149 vein'], ['', ''], ['', ''], ['', ''], ['', 'blood 9'], ['', ''], ['', '200  nmol'], ['vascular  we', 'highly  GPR1'], ['preconstricted rat aorta', 'observed vasoconstrictor action'], ['Downstream signaling', 'further  chemerin'], ['CMKLR1 exhibits', 'agonism'], ['chemerin', 'blood pressure'], ['vascular  actions', 'additional cardiovascular disease'], ['study', 'selective CMKLR1 antagonists'], ['antimicrobial Staphylococcus which', 'staphylococcal  infections'], ['Very  little', 'dominant resistance S'], ['', 'aureus clonal China'], ['disk diffusion method', 'different microtiter plate S'], ['aureus', 'dominant clonal China'], ['isolates', 'forming clonal capacity'], ['Resistance', 'frequently  erythromycin'], ['', ''], ['', ''], ['significant polymerase chain correlation', 'resistance genes'], ['Overall  results', 'biofilm S'], ['aureus', 'biofilm resistance producers'], ['further  biofilm', 'antibiotic resistance determinants'], ['Practical applicationsStaphylococcus aureus', 'often food poisoning'], ['', 'Biofilm S'], ['however antimicrobial knowledge', 'different clonal lineages'], ['', 'dominant resistance S'], ['aureus clonal lineages', 'information gap'], ['molecular plant which', 'directed  genome'], ['international  they', 'conventional  breeding'], ['dilemma', 'only safety information'], ['It', 'sound borrowing decision'], ['BACKGROUNDWeeds', 'greater animal pests'], ['cropping  that', 'emergence  herbicides'], ['we', 'emergence Western herbicides'], ['first study that', 'randomly  L'], ['selection', 'three S generations'], ['', ''], ['rigidum traits', 'new herbicide commercialisation'], ['resistant ecology they', 'field'], ['evolved resistance', 'weeds'], ['cultural weed control that', 'herbicide resistance evolution'], ['', '2016 Chemical Industry'], ['AtbZIP60 transcription factor', 'stress'], ['molecular  mechanism', ''], ['different plant species Oryza', 'L'], ['', ''], ['Agrobacterium LBA4404', 'Agrobacterium tumefaciens'], ['Integration', 'white polymerase chain reaction'], ['', 'transgenic cell O'], ['', 'transgenic cell P'], ['strobus', 'cold AtbZIP60 gene'], ['expression', 'white transgenic cell lines'], ['transcription factor AtbZIP60', 'OsCPK10 salt drought'], ['overexpression', 'cold stress Ca2'], ['Overexpression', 'abiotic stress tolerance'], ['Chinese Agrobacterium LBA4404', 'plasmid'], ['Various  factors', 'transformation efficiency'], ['age', 'transformation frequency transformation regeneration'], ['transformed Qingmaye C', 'other Qingmaye lines'], ['sucrose H+ symporter', 'l Oryza sativa'], ['GUS beta analysis', 'specific GUS citrus'], ['efficient RSs1 promoter', 'gus gene citrus'], ['results', 'real polymerase chain reaction'], ['transgene  which', 'four  genome'], ['transgene  expression', 'Gram negative Gram bacterium'], ['', 'transformation wheat'], ['Agrobacterium we', 'apical wheat explants'], ['Three  genotypes', 'A'], ['', 'beta-1 3-glucanase beta-1 gene'], ['seeds', 'vernalization'], ['basal portions', 'A'], ['', ''], ['average transformation efficiency', 'as  9'], ['', ''], ['Evident segregation', 'PCR blotting analysis'], ['transformed  plants', 'higher powdery controls'], ['T-2  which', 'increased powdery mildew'], ['exogenous  gene', 'transgenic  progeny'], ['inoculum', 'wheat seedling'], ['It', 'practicable target wheat'], ['elevated  temperatures', 'physio biochemical physio tomato'], ['fruit', ''], ['genetic engineering which', 'new heat stress'], ['early tissue which', 'gene'], ['aim', 'interfering RNA strategy'], ['Agrobacterium', 'gus transformation study'], ['selectable mannopine marker', 'vis1  fruit'], ['Polymerase chain reaction', 'transgenic blotting plants'], ['transgenic tomato cultivars', 'ripening heat stress'], ['RNA expression system', 'inverted Potato virus Y'], ['35S leucine zipper which', 'specific  activity'], ['PVY resistance ratios', ''], ['', ''], ['', ''], ['54  %', 'transgenic PVY pUbi PVY'], ['RSV resistance', ''], ['', ''], ['', ''], ['33  %', 'transgenic RSV pUbi RSV'], ['virus resistance levels', 'promoter activity'], ['Therefore  choice', 'transgenic  plants'], ['Potato', 'genetic gene transfer'], ['aim', 'green neomycin phosphotransferase'], ['Agrobacterium LBA4404', 'binary  vector'], ['selection', 'transgenic plant selection identification'], ['Genetic  transformation', 'mean  13'], ['', ''], ['marker gfp genes', 'transgenic  tissues'], ['They', 'organogenesis potato genotypes'], ['gfp that', 'chimeric dihaploid line'], ['regeneration', 'transgenic plant cultivation'], ['AtbZIP60 transcription factor', 'pathogen defense pathogen development'], ['molecular  mechanism', 'transcription factor AtbZIP60'], ['', 'different plant species cotton'], ['', ''], ['', ''], ['Agrobacterium LBA4404', 'AtZIP60'], ['', 'G'], ['', ''], ['', ''], ['', ''], ['thaliana', 'polymerase chain reaction'], ['transgenic cell lines', 'four salt AtbZIP60'], ['improved salt tolerance', 'transgenic cell cotton'], ['H+-ATPase cell overexpression', 'plant salt tolerance'], ['AtbZIP60 transcription factor', 'stress'], ['However  involvement', 'plant salt tolerance'], ['tabacum plant Oryza', 'L'], ['', ''], ['Agrobacterium LBA4404', 'AtbZIP60deltaC'], ['Integration', 'polymerase chain reaction'], ['transgenic cell lines', 'three salt AtbZIP60deltaC'], ['improved salt tolerance', 'ascorbate  peroxidase'], ['oxidative antioxidant overexpression', 'alternative plant salt tolerance'], ['aim', 'complementary hairpin RNAs'], ['method', 'transgenic hairpin PCR'], ['', 'first pH82892 construct'], ['well RT blotting', 'transgenic plant selection'], ['regeneration  efficiency', 'cvs'], ['', ''], ['Agave', 'lower  figures'], ['', 'second  step'], ['Regenerated  PCR', 'repeated PVY CP sequences'], ['large  number', 'responsive  cv'], ['', 'only  cv'], ['', 'out  cv'], ['', ''], ['two step strategy', 'other  cvs'], ['', ''], ['disciplinary  structure', 'social  life'], ['we', 'scientific  roots'], ['Scientific  communications', 'bibliometric  methods'], ['field', 'social  relevance'], ['bibliometric  analysis', 'interacting Chemistry Engineering'], ['text mining field', 'three Disciplinary Dimensions'], ['most  group', 'Sciences Social Sciences'], ['which', 'technological Chemistry Engineering'], ['third  group', 'emerging  biofuels'], ['Disciplinary that', 'socially  biofuels'], ['also  that', 'other research field'], ['transport sector', 'national road transport'], ['Therefore road contribution', 'proposed climate change'], ['Policies', 'compensatory mitigation mitigation'], ['Spanish case Segovia', 'different agriculture agroforestry afforestation'], ['We', 'especially fuel taxes'], ['offsetting carbon emissions', 'highly sequestration biodiversity improvement'], ['which', 'political  citizens'], ['', ''], ['', ''], ['rights', ''], ['African horse sickness', 'global equine industry'], ['Detection', 'reverse AHSV nucleic acid'], ['described TS RT assays', 'AHSV equine host'], ['attenuated nucleic which', 'routinely South Africa'], ['aim', 'qPCR serum neutralisation tests'], ['when vaccine combinations', 'prior 1 types'], ['when  vaccines', 'longer  interval'], ['use', 'diagnostic testing results'], ['', ''], ['rights', ''], ['time', 'genetic  variation'], ['activated transcription factor', 'viral replication AIDS'], ['OBJECTIVE', 'PXR rs3814057 rs6785049 patients'], ['METHODS Blood samples', 'informed  consent'], ['DNA', 'real polymerase chain NR1I2'], ['demographic  time', 'medical chart analysis'], ['FINDINGS Patients', 'GA disease genotypes'], ['result', 'HLA B*27 HLA polymorphisms'], ['Recent MAIN studies', 'immune T response'], ['such HIV mechanism', 'thoroughly  date'], ['first  association', 'genetic AIDS progression'], ['presence', 'infected term patients'], ['genetic  defects', 'slow Korean Red progressors'], ['study', '20-yr  period'], ['28 ART these', '36 control patients'], ['in g Delta insertion', 'three phases control'], ['proportion', 'on nef patients'], ['', '6  baseline'], ['', ''], ['', '6  KRG'], ['', 'on  ART'], ['', ''], ['', ''], ['in  deletions', 'alone  controls'], ['', ''], ['fewer  instances', 'KRG ART phase'], ['', ''], ['', ''], ['earliest  defects', '67 KRG intake'], ['KRG treatment', 'genetic nef gene'], ['report', 'genetic  AIDS'], ['', 'Korean Elsevier Korea LLC'], ['CSF PCR', 'rich CNS infection'], ['However  it', 'routine CSF China'], ['Knowledge', 'opportunistic  China'], ['CSF  testing', 'viral  etiologies'], ['specific  primers', 'real polymerase chain reaction'], ['Cryptococcal meningitis', '63'], ['', '0  meningitis'], ['', '0  TB'], ['3  %', 'Toxoplasma'], ['', 'viral  PCR'], ['5  %', ''], ['', '2  CMV'], ['', '7  VZV'], ['', '9  EBV'], ['', '9  HHV-6'], ['', '9  JCV'], ['patient', 'HSV'], ['lower mortality patients', 'higher pathogens infection death'], ['frequent  pathogens', 'often  CSF'], ['Cryptococcal meningitis', 'prevalent CNS AIDS'], ['developing cost efficacy', 'developing pathogen countries'], ['Three differential amplifier topologies', 'flexible IGZO paper'], ['designs', 'single IGZO date'], ['three  amplifiers', '14  dB'], ['', '2  kHz'], ['Also input referred noise', 'Also  circuit'], ['front  end', 'bio potential electro hysterogram'], ['variable air terminals', 'minimum airflow set points'], ['These', 'cooling energy spaces'], ['We', 'institutional UC Berkeley issue'], ['average VAV airflow', 'predefined ventilation setpoint'], ['single max VAV strategy', 'mean zone airflow 0'], ['', '0'], ['', 'intervention period'], ['corresponding  reductions', 'average heating cooling'], ['low cost retrofit that', 'digital VAV terminal'], ['', ''], ['', ''], ['rights', ''], ['Numerous  studies', 'fine particulate matter'], ['', ''], ['environmental  that', 'environmental  factor'], ['that', 'fuel PM2'], ['', ''], ['Determining', 'specific disease prevention'], ['we', 'PM2'], ['', 'Blood Pressure High Blood Canada'], ['Then  we', 'generation association changes'], ['age study We', 'dispersed Poisson regression risk'], ['We', 'clean fuel outcomes'], ['study', '117 health 2007'], ['findings', 'strong  PM2'], ['', 'diabetes asthma'], ['', 'm(3 year PM2'], ['5', '534  %'], ['', ''], ['', ''], ['', ''], ['', '538 asthma incidence'], ['', ''], ['', ''], ['', '98 HBP incidence'], ['sensitivity analysis findings', 'higher diabetes asthma'], ['when  we', 'clean energy generation'], ['risk', 'clean health electricity'], ['% fuel risk', 'clean health electricity'], ['risk factors', 'Canadians health regions'], ['', ''], ['', ''], ['rights', ''], ['Effectively  analyzing', 'related pollution treatment'], ['paper', 'end prevention process pipe'], ['13 Jiangsu cities', 'local pollution prevention'], ['primary air pollution pattern', 'pollute'], ['13 city cities', 'four air pollution treatment'], ['', 'whole process treatment'], ['whole pollution control', 'clean  energy'], ['', ''], ['rights', ''], ['paper', 'small air tank'], ['basic  idea', 'available air set'], ['first  goal', 'High Level Programming Language'], ['future  work', 'fuzzy optimal control'], ['main  parts', 'mainly car compressor'], ['operation', ''], ['solution', 'digital  Honeywell'], ['platform', 'pneumatic microelectronics interface elements'], ['adequate spoilage yeasts', 'osmotic  products'], ['', 'microbiological product analyses'], ['efficacy', 'spoilage yeasts'], ['RESULTSThe', 'closest end 1'], ['', '4'], ['', ''], ['spoilage yeasts', 'air  surfaces'], ['denaturing gel electrophoresis analysis', 'closest  Z'], ['bailii', 'counts<1logcfug(-1'], ['Susceptibility testing', 'alkyl dimethyl benzyl ammonium chloride'], ['Different  responses', 'tested  disinfectants'], ['end methods', 'end products'], ['Moreover  hygiene', 'efficient manufacturing contamination'], ['', '2016 Chemical Industry'], ['digital  autopilot', 'unmeasured  paper'], ['autopilot', 'given roll angles'], ['controller', 'parametric  uncertainties'], ['Autoimmune  regulator', 'perinatal multiorgan autoimmunity'], ['positive thymocyte trafficking', 'neonatal thymic egress'], ['Reduced thymic emigration', '2 T age'], ['neonatal Aire(-/- mice thymic expression', 'decreased thymocyte motility'], ['reduction', 'early thymic S1P(1'], ['reduced thymic emigration', 'autoreactive T cells'], ['Characterizing associations', 'upper asthma management'], ['', 'allergic asthma rhinitis'], ['nitric rhinitis questionnaire score', 'nitric score FEV1 oxide'], ['AR', 'inhaled  allergens'], ['ACQ', 'controlled ACQ >'], ['', ''], ['that', 'incomplete multivariate analysis'], ['108  patients', 'incomplete asthma control'], ['controlled  group', ''], ['', 'more airway inflammation'], ['', ''], ['controlled  group', 'more nasal corticosteroids'], ['', ''], ['', 'FENO rhinitis'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'NCSs'], ['', ''], ['', ''], ['81', 'incomplete asthma control'], ['persistence', 'asthma AR'], ['appropriate  treatment', 'asthma control'], ['', '2016 Allergy Asthma'], ['Asthma', 'inflammatory  T(h'], ['Profiling', 'patient airway cohorts'], ['low mRNA expression', '10th/90th control group'], ['hierarchical  clustering', 'sputum cytokine profiles'], ['', 'patients'], ['6  %', 'classical  T(h'], ['Unsupervised cluster analysis', '5  clusters'], ['Patients', '5  clusters'], ['IL-5-  IL-17A-/F', 'poor lung baseline'], ['other  clusters', ''], ['Cluster', 'high cytokine IL-13'], ['We', 'biological  clustering'], ['', '5 cytokines clusters'], ['Unsupervised  analysis', 'molecular priori phenotypes'], ['Al  toxicity', 'agricultural  practice'], ['transcriptional  responses', 'northern blotting analysis'], ['others', 'differentially  which'], ['four encode ion transporters', 'signal  cysteine'], ['that', 'potentially Al adaptation'], ['other  transcription', 'strongly Al stress'], ['genes', 'possible Al toxicity'], ['expressed  that', 'Al responses'], ['ion transport', 'major Al rice'], ['Properly  designed', 'routine emergency tasks'], ['various  that', 'tile  style'], ['innovative alarm bar interface', 'paper'], ['preliminary lab experiment', 'traditional alarm tile'], ['two emergency scenarios Loss', 'Coolant Accident'], ['experiment task', 'two  parts'], ['subjective  ratings', 'better parameter trend perception'], ['better alarm bar interface', 'same alarm tile interface'], ['alarm system', 'industrial  system'], ['more  it', ''], ['it', 'overwhelmingly design shows operators'], ['', ''], ['', ''], ['rights', ''], ['25  %', 'than US treatment'], ['how  factors', 'geographic  subpopulations'], ['MethodsWe', 'mental South Dakota'], ['We', 'mental phone treatment'], ['ResultsWe', 'mental  health'], ['', ''], ['rural  that', 'tribal  land'], ['', ''], ['AI', '8  reservation'], ['', ''], ['how treatment participants', 'mental health alcohol'], ['Mental health disorders', 'substantial life event'], ['treatment gaps', 'community level interventions'], ['rural  populations', 'mental health alcohol'], ['Enhancing access', 'based treatment uptake'], ['outcomes', 'preinjury abuse'], ['meta analysis', 'issue'], ['alcohol substance who', 'TBIs'], ['mean Bayes outcomes', 'mean Bayes probability'], ['Patients', 'reduced substance hippocampal'], ['', ''], ['', ''], ['', 'cerebral  ventricles'], ['', ''], ['', ''], ['', 'cognitive  outcomes'], ['', ''], ['', ''], ['moderately  attention', ''], ['findings', 'perception general construction perception cognition'], ['', ''], ['', ''], ['', ''], ['', '-0'], ['44', 'alcohol substance abuse'], ['TBI many', 'recovery'], ['TBI', 'alcohol substance abuse'], ['ethanolic fermentation that', 'anoxia plants'], ['study', 'employing Ghadh2 cotton'], ['beta subunit', 'Ospdc1'], ['asPdc1 under seedlings', 'also  observations'], ['transgene PCR Southern', 'Western  blotting'], ['Pdc', 'wild type seedlings'], ['', ''], ['rights', ''], ['psychological  which', 'interpersonal  deficits'], ['interpersonal  difficulties', 'emotional  states'], ['However  pattern', 'deficits'], ['thus alcohol dependence', 'altered  emotions'], ['contextual  they', 'them'], ['healthy  ADI', 'negative  Cohen'], ['', ''], ['', 'emotional  states'], ['alcohol dependence', 'preserved emotion sharing'], ['Therefore  results', 'emotional  states'], ['emotional  competences', 'therapeutic alcohol levers'], ['social cognition that', 'special treatment success'], ['that', 'adjunctive  treatment'], ['Considerable  evidence', 'important alcohol use disorders'], ['exposure', 'powerful alcohol cravings'], ['Little', 'personal  AUDs'], ['attentional  biases', 'induced alcohol population'], ['', ''], ['', ''], ['neutral  that', 'visual  pictures'], ['that', 'alcohol stimuli'], ['', ''], ['Participants', 'before cue exposure alcohol'], ['surprisingly  exposure', 'significant alcohol cravings'], ['Consistent', 'higher alcohol craving'], ['that', 'later drinking AUDs'], ['', ''], ['rights', ''], ['before sleep substance', 'treatment episode'], ['', 'Treatment Outcome 1994'], ['SettingData', 'residential methadone maintenance'], ['primary treatment substance', 'entry'], ['', ''], ['', ''], ['', ''], ['MeasurementsLife time history', 'self report'], ['Type', 'treatment entry'], ['Substance use', 'also treatment completion'], ['Associations', 'logistic substance covariates'], ['FindingsLife time history', 'insomnia 26'], ['', ''], ['', ''], ['', ''], ['', '2  participants'], ['life time insomnia', 'higher substance use'], ['', ''], ['types', 'higher 12-month entry'], ['', ''], ['', ''], ['ConclusionsThere', 'higher treatment episode'], ['Rationale Social cognition', 'social  interactions'], ['Alcohol', 'social  interactions'], ['acute  effects', 'social  cognition'], ['We', 'social order drinkers'], ['We', 'visual analog scales'], ['Alcohol', 'talkative VAS others'], ['subjective  effects', 'higher trait inhibitedness'], ['Alcohol', 'low  trait'], ['Pictures', 'alcoholic  beer'], ['sexual  pictures', 'particularly  women'], ['Alcohol', 'oxytocin'], ['Alcohol', 'positive emotion stimuli'], ['support', 'modulatory oxytocin'], ['sexual  it', 'sexual  arousal'], ['effects', 'likely  sociability'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Background', 'least HIV treatment'], ['Integration', 'extended substance use'], ['opioid use alcohol', 'HIV clinics'], ['', 'randomized pharmacotherapy TAU'], ['', 'primary Vancouver BC Canada'], ['', 'infected ParticipantsFifty OUD'], ['MeasurementsPrimary outcomes', 'first XR NTX 16weeks'], ['point estimates', 'viral  suppression'], ['FindingsTwo thirds', '88 XR 16weeks'], ['50 TAU %', '16weeks'], ['Mean  days', '30  17'], ['', ''], ['', '20'], ['', '7'], ['', 'XR NTX'], ['heavy drinking days', '15'], ['', '5'], ['', 'TAU'], ['', '2'], ['', 'XR NTX'], ['', '% XR TAU'], ['XR NTX', 'precipitated  withdrawals'], ['opioid use alcohol', 'HIV clinics'], ['Treatment initiation', 'XR treatment'], ['operational  amplifier', 'low power ALD'], ['', 'TSMC'], ['static power consumption', 'open loop gain'], ['51dB supply rejection ratio', ''], ['One methyl K', 'recent  years'], ['Herein', 'mild aldol temperature'], ['kinetic  studies', 'new  process'], ['wherein side reactions', '10 min 100 min'], ['based kinetic model', 'experimental  data'], ['factor  energy', 'reaction step'], ['equilibrium  change', \"also Van't Hoff formula\"], ['', ''], ['', ''], ['rights', ''], ['molecular  aldosterone', 'inflammation'], ['immune  that', 'sterile danger inflammation'], ['type interleukin-1 receptor mice', '1 % saline'], ['NLRP3 inflammasome', 'vascular  dysfunction'], ['Long term infusion', 'plasma interleukin-1 levels'], ['Mice', 'vascular inflammasome damage'], ['aldosterone', 'signaling oxygen species generation'], ['hematopoietic  NLRP3', 'vascular  damage'], ['aldosterone', 'peripheral blood mononuclear cells'], ['increased NLRP3 effect', 'high blood pressure'], ['NLRP3', 'high aldosterone levels'], ['Aldosterone', 'beta(1  expression'], ['However  mechanisms', 'mesangial  cells'], ['We', 'TGF rat mesangial cells'], ['DNA binding DNA activity', 'western ERK1/2 JNK blotting'], ['Aldosterone', 'dependent TGF manner'], ['Aldosterone', 'mesangial  cells'], ['treatment', 'AP-1 inhibitor curcumin'], ['Aldosterone', 'mesangial  cells'], ['treatment', 'TGF JNK production'], ['beta(1  expression', 'mesangial ERK1/2 pathways'], ['objective', 'AD  mink'], ['antibody relative', 'farmed mink disease mink'], ['Carcasses', 'negative CIEP time'], ['where CIEP P animals', '20  years'], ['severity', 'histopathological heart 4'], ['Sensitivity', 'relative  PCR'], ['', ''], ['', ''], ['PCR CIEP N which', 'virus Canada'], ['tolerant CIEP animals', '9'], ['', ''], ['', 'respectively CIEP P animals'], ['', ''], ['CIEP N mink', 'higher  chance'], ['', 'lower lesion severity'], ['', 'tolerant CIEPP mink'], ['tolerant  mink', 'viral AD virus'], ['', ''], ['', 'Elsevier Ltd'], ['objective', 'DNA extraction'], ['presence', '16 plasma virus'], ['Samples', 'also lymph Klentaq'], ['DNA', 'commercial Dynabeads PCR'], ['', 'whole serum plasma spleen'], ['Klentaq', 'directly mink blood'], ['lower success rate', 'extracted extraction process'], ['infected  which', 'AMDV copy bloodstream'], ['Direct AMDV detection', 'also sample contamination'], ['Childhood adversities', 'chronic pain alexithymia'], ['Longitudinal  studies', 'pain situation'], ['influence', 'clinical alexithymia depression sample'], ['baseline  data', '1 self report questionnaires'], ['Study variables', 'disability alexithymia pain disability depression'], ['Statistical  analyses', 'alexithymic follow treatment'], ['', 'daily pain living'], ['None', 'better treatment outcome'], ['Alexithymic patients', 'more follow up'], ['effect', 'pain depression'], ['use', 'alexithymia'], ['Alexithymia', 'poorer  outcome'], ['Severe pain intensity', 'improvement'], ['Depression', 'probably  interventions'], ['occurrence', 'psychological pain experience'], ['Background  Alexithymia', 'DIF components feelings'], ['Different  features', 'cognitive  emotions'], ['aim', 'tracking alexithymia technology'], ['EOT', 'negative  images'], ['positive gaze behavior', 'positive  images'], ['Alexithymia', '20 Toronto Alexithymia Scale'], ['visual anxiety intelligence', 'anxiety depression'], ['main  effect', 'dwell times'], ['Viewing time', 'related  images'], ['Gender', 'significant dwell times'], ['EOT', 'anxiety dwell images'], ['', 'anxiety intelligence DIF'], ['Alexithymia', 'exclusively self report'], ['EOT', 'emotional attention pictures'], ['EOT', 'dysphoric attention information'], ['attentional  characteristic', 'social EOT competencies'], ['', ''], ['rights', ''], ['uricase gene', 'symbiotic nitrogen nodules'], ['pot experiment', 'major alfalfa Medicago sativa'], ['alfalfa plant', 'mainly type legume nodules'], ['application', 'MsU2 alfalfa plants'], ['excessive  application', 'negative uricase alfalfa'], ['application', 'fixed legume plant production'], ['imminent  depletion', 'nonconventional energy sources'], ['third fossil which', 'most parts microalgae'], ['versatile growth microalgae', 'present  time'], ['present  article', 'algal microalgae cultures'], ['advantages limitations', 'extent'], ['Major  concerns', 'economic cost effectiveness'], ['This', 'robust  one'], ['We', 'tabulated biodiesel form'], ['', 'International Union International Biochemistry'], ['natural  variation', 'environmental freshwater biodiversity'], ['', 'physiological freshwater invertebrates'], ['formation muscle it', 'other stress functions'], ['environmental research studies', 'this'], ['environmental calcium concentrations', 'effective management them'], ['environmental calcium Concentration', 'Iberian Corbicula rivers'], ['key calcium that', 'best distribution C'], ['', ''], ['calcium content', 'the freshwater concentration'], ['expression', 'rich freshwater basins'], ['', 'lower fluminea growth rates'], ['environmental calcium concentration', 'determinant invasion C'], ['', 'freshwater environments'], ['results', 'environmental calcium levels'], ['', ''], ['', ''], ['rights', ''], ['medical  that', 'caregiver'], ['affected  children', 'diagnostic  attempts'], ['We', 'confirmed  alimemazine'], ['repetitively Pediatric Emergency he', 'intermittent clonic fever'], ['rest', 'significant  alterations'], ['toxicological  analysis', 'urine'], ['Alimemazine', 'biological  samples'], ['administration', 'subsequent  MSBP'], ['neurological  symptoms', 'cerebellar  symptoms'], ['maximum serum level', 'fluid chromatography mass spectrometry'], ['', ''], ['Hair quantification', 'different tandem mass hair'], ['results', 'last substance months'], ['', ''], ['', ''], ['', ''], ['', 'proximal mg segment'], ['us', 'acute  MSBP'], ['', ''], ['rights', ''], ['Immunohistochemistry', 'available ancillary pathology'], ['several  studies', 'particularly Growth Factor Receptor'], ['critical  examination', 'predictive IHC NSCLC'], ['very  time', 'clinical screening practice'], ['specific  antibodies', 'predictive  biomarkers'], ['brief  comment', 'preliminary BRAF RET HER2'], ['regulatory  which', 'neural  routes'], ['regulatory  mechanism', 'gene expression'], ['we', 'occurring prawn Macrobrachium'], ['asMacro ASTA', 'complementary Macro ASTA'], ['this', 'endogenous antisense all'], ['where sense gene', 'thoracic ganglia'], ['Furthermore  we', 'complementary RNasc protection analysis'], ['antisense gene', 'gene expression'], ['', ''], ['rights', ''], ['digital  controls', 'digital analog control'], ['paper', 'digital analog converter'], ['approach', 'DPMW bit signal'], ['we', '10-bit DPWM signal resolution'], ['proposed  circuit', ''], ['', '35 core 0'], ['987  system', '500 input voltage 3'], ['', ''], ['', '5 output voltage V'], ['99  system', '91 output 500'], ['', ''], ['rights', ''], ['gated Na v', 'responsible  pyrethroid'], ['different Aedes mutations', 'Asia North America'], ['synonymous  mutations', 'mostly Na v segments'], ['Phe1534Cys kdr mutation', 'most Na v Ae'], ['aegypti', 'also  Ae'], ['', 'Singapore'], ['Herein  we', 'natural Na v Ae'], ['', 'Brazil'], ['', 'Brazilian  Ae'], ['albopictus natural albopictus populations', 'corresponding Na v segments'], ['Additionally  samples', '1534 Na v site'], ['synonymous  substitutions', 'IIS6 sequences'], ['However Phe1534Cys kdr mutation', 'Ae'], ['', 'Mato Grosso Mato state'], ['10  Foz', '10  %'], ['paper', 'possible kdr Ae'], ['', 'South America'], ['', 'likely kdr Ae'], ['vector control PY', 'popular  residents'], ['frequency', 'faster  compounds'], ['dengue South importance', 'extensively  Ae'], ['albopictus', 'sylvatic  environments'], ['Therefore  resistance', 'also  Ae'], ['', 'efficient vector control tool'], ['PXA BRAF V600E which', 'diagnostic  entities'], ['Targeted  therapies', 'promising BRAF V600 GNT'], ['aim', 'molecular IHC clone techniques'], ['We', '140 BRAF V600E cases'], ['sufficient BRAF V600E amount', 'materiel'], ['BRAF V600E immunostaining', '29'], ['', '5  cases'], ['GC  AGG', ''], ['', ''], ['47  MB', 'two Sanger cases'], ['initial Sanger sequencing', 'BRAF V600E 19'], ['', ''], ['ASQ PCR', '48'], ['', ''], ['five GG cases', 'wild MB techniques'], ['which', 'IHC'], ['mutated  e', 'mutated  cells'], ['', ''], ['BRAF V600E IHC', 'more Sanger sequencing'], ['gold standard', 'BRAF GG'], ['combination', 'glioneuronal ASQ tumors'], ['allergen', 'allergic pollen reactions'], ['SLIT  CSI', 'increased safety risk'], ['Cochrane Library databases', 'pollen allergen'], ['Congress abstracts', ''], ['2668  subjects', ''], ['Study characteristics', ''], ['epinephrine administrations', ''], ['Discontinuation frequencies', 'less  SCIT'], ['allergic reaction frequency', '% peak placebo'], ['severe  AEs', 'to  2'], ['allergic reaction frequency', '%  placebo'], ['related  AEs', 'SLIT CSI'], ['Severe AE frequency', '%  placebo'], ['additional SLIT data', 'standardized  regimens'], ['', '2016 Allergy Asthma'], ['Allergic  diseases', 'early  life'], ['life course perspective', 'allergen immunotherapy'], ['al treatment', 'old age adults'], ['current  paper', 'active European Innovation ageing'], ['strategic age framework', 'active  ageing'], ['BackgroundClinical  efficacy', 'controlled pollen allergen trials'], ['clinical  endpoints', 'seasonal background pollen concentration'], ['However  validated', 'relevant pollen exposure time'], ['Therefore Task Force initiative', 'expert consensus'], ['MethodsA Task Force', 'relevant AIT trials'], ['Underlying principles', 'methodological pollen consensus'], ['ResultsThe Task Force', 'different pollen types'], ['Definitions', 'peak pollen period'], ['EAACI position paper', 'different AIT trials'], ['standards', 'future  studies'], ['', 'allergic grading anaphylaxis'], ['anaphylaxis', 'research  practice'], ['it', 'clinical safety practice'], ['World Allergy Organization', 'uniform allergen immunotherapy SARs'], ['basis', 'grading system'], ['physician health care event', 'physician health care professional'], ['appropriate allergen immunotherapy it', 'cause'], ['it', 'cause'], ['severe  which', 'adverse surveillance event'], ['universal  use', 'different safety venues'], ['', '2016 Allergy Asthma'], ['Keratinocytes', 'key skin sensitization'], ['We', 'molecular weight chemicals'], ['aim', 'IL-18 inflammasome production'], ['total reference contact RNA', 'Chain Reaction Polymerase Chain array'], ['like receptor P12', 'further  investigation'], ['Blimp-1', 'NLRP12 monocytes'], ['expression', 'KCs'], ['', 'extreme Blimp-1 sensitizer'], ['Allergens', 'rapidly  PPD'], ['inversely Blimp-1 silencing', 'induced NLRP12 production'], ['contact allergens', 'IL-18  production'], ['Data', 'IL-18 inflammasome maturation'], ['food allergen exposure', 'oral  tolerance'], ['dietary egg ingestion', 'human egg breastmilk'], ['', 'one three one week'], ['Breastmilk samples', '4  ovalbumin'], ['permeability', 'mammary potassium ratio'], ['specific  IgE', '16 infant weeks'], ['maternal egg ingestion', 'breastmilk ovalbumin concentration'], ['', '25 ovalbumin concentration'], ['', ''], ['Breastmilk ovalbumin concentrations', 'free  group'], ['', ''], ['one  third', 'breastmilk ovalbumin'], ['detectable  associations', 'mammary epithelium permeability'], ['specific IgG4 levels', 'additional IgG4 week'], ['', ''], ['maternal egg ingestion', 'immune breastmilk infants'], ['maternal  diet', 'oral tolerance lactation'], ['environmental irritants it', 'immune  integrity'], ['immune  system', 'potentially  antigens'], ['such mucosal it', 'other mucosal surfaces'], ['purpose', 'special mucosal immunology concepts'], ['information', '1981 PubMed October'], ['Allergic  rhinitis', 'common  life'], ['many  children', 'antihistamine  therapies'], ['clinical  immunotherapy', 'clinical  juncture'], ['current treatment it', 'allergic  rhinitis'], ['', 'SLIT ragweed tablet US'], ['Approaches', 'allergic  rhinitis'], ['', '2016 Allergy Asthma'], ['Background', 'chronic  children'], ['modified  classification', 'recently AR children'], ['surgery', 'obstructive  disorders'], ['objective', 'medical persistent AR'], ['', 'paediatric PER patients'], ['', ''], ['8years', ''], ['septal analogue deformity', 'modified Pediatric Asthma criterion'], ['NR group', 'when R group'], ['septal  deformity', 'strongly treatment refractoriness'], ['prevalence', 'also NR group'], ['Higher asthma control scores', 'induced  improvement'], ['medical therapy refractoriness', 'septal  enlargement'], ['ENT examination', 'corrective NOD surgery'], ['primary  that', 'clinical allergy immunotherapy'], ['Objective  We', 'birch pollen allergens'], ['Methods CS', 'birch pollen solution'], ['CS', 'equal Rescue Medication symptoms'], ['AdSS', 'rescue medication use'], ['Efficacy end points', 'covariance linear model'], ['Results', 'similarly placebo group'], ['Treatment effect', 'daily pollen season'], ['Minor  differences', 'same  interpretation'], ['combined  scores', 'statistical  conclusions'], ['Limited  accessibility', 'appropriate asthma exacerbations'], ['objective', 'ED healthcare providers'], ['We', '2012 Health Resource Files'], ['We', 'dichotomous  hospitalization'], ['Key covariates', 'primary care physicians'], ['proportions', 'hospital visits'], ['', ''], ['', ''], ['additional  RHC', 'ED  visit'], ['', ''], ['', ''], ['cost PCP', 'cost barriers'], ['', ''], ['', 'more hospital those'], ['cost specialist', 'cost barriers'], ['', ''], ['', ''], ['', ''], ['', 'respectively hospital those'], ['Conclusions', 'financial  barriers'], ['financial  support', 'interested policy hospitalizations'], ['Pg Porphyromonas capsule', 'phagocytosis keratinocytes'], ['also  which', 'characteristic  monoinfection'], ['aim', 'mixed Fusobacterium nucleatum'], ['Mixed  infections', 'same coaggregation inhibitor'], ['experimental  periodontitis', 'disease severity'], ['Primary polymorphonuclear leukocytes', 'phagocytosis  invasion'], ['', 'capsulated bone Pg'], ['', 'mixed bone infection'], ['mixed  Pg', 'greater  keratinocytes'], ['Pg capsule', 'mixed virulence Fn'], ['dependent  coaggregation', 'mixed  Fn'], ['powerful Aggregatibacter which', 'host response'], ['Immunoreactivity', 'leukotoxic A'], ['that', 'colonized disease individuals'], ['aim', 'systemic  A'], ['', 'clinical actionmycetemcomitans ='], ['39  patients', 'periodontal  treatment'], ['Systemic  biomarkers', '3  treatment'], ['Presence', 'periodontal  treatment'], ['immunoreactivity', 'systemic  A'], ['', ''], ['', 'systemic  A'], ['actinomycetemcomitans Ltx', 'periodontal  treatment'], ['nutritional recovery periods', 'immune infection episodes'], ['study', 'intermittent team nature'], ['Thus  review', 'national  topic'], ['correlations', 'individual team sports'], ['modulations', 'possibly repair URTI'], ['Modulations', 'directly  URTI'], ['Moreover  understanding', 'unique performance marker'], ['Adrenaline auto injectors', 'high  anaphylaxis'], ['true AAI extent', 'AAI prescription'], ['', 'issued UK 2000'], ['primary care that', 'THIN Health Improvement database'], ['annual device prescription rates', 'Stata'], ['', '1'], ['06 million UK children', '5'], ['', 'follow person data'], ['837  children', '737 AAI devices'], ['This', '4'], ['', ''], ['', '4'], ['', ''], ['', ''], ['', '19'], ['', '1000 person years'], ['', '1000 person UK'], ['number', '33 risk %'], ['number', 'primary AAI 2000'], ['discussion', 'rational  NHS'], ['European Academy', 'insect venom allergy'], ['we', 'insect venom allergy'], ['systematic  which', 'published  evidence'], ['Studies', 'established  instruments'], ['Data', ''], ['eligible  17', 'inclusion criteria'], ['venom immunotherapy', 'systemic sting reactions'], ['', ''], ['', ''], ['it', 'specific  life'], ['', ''], ['', ''], ['', ''], ['build up build most', 'fatalities'], ['cost VIT', 'quality sting life'], ['VIT', 'specific sting life'], ['fatalities', 'review'], ['cost effectiveness', 'VIT'], ['Ig hyper E', 'primary  immunodeficiencies'], ['However  detection', 'little immunology attention'], ['We', 'patient serum IgE immunodeficiency'], ['correlation', 'clinical IgG phenotype'], ['patients', 'immunodeficiencies IgG3'], ['', 'allergy IgG2'], ['referrals', 'lower IgG1 IgG2'], ['IgE immunoglobulin levels', 'clinic referral'], ['', ''], ['', 'low IgE patients'], ['suggesto', 'low serum IgE levels'], ['chronic  rhinosinusitis', 'cause allergy relationship'], ['complex  that', 'diseases'], ['Advances', 'complex  cases'], ['cytokines', 'innate lymphoid cells'], ['that', 'reduced asthma severity'], ['Moreover  it', 'refractory asthma cases'], ['clinical  we', 'refractory  asthma'], ['patient  this', 'multidisciplinary airway diseases'], ['', 'adverse drug reactions'], ['We', 'patient NA cADR'], ['observational inpatient cohort study', '2004  August'], ['Patients', 'NA  analysis'], ['fixed drug eruption acute', 'toxic epidermal necrolysis'], ['', '48  %'], ['', '32 % P'], ['', 'median  stay'], ['', '11  days'], ['', '1 Charlson comorbidity P'], ['', '5 % P'], ['', 'NA cADR'], ['median drug latency', '20 days P'], ['', ''], ['Sulfonamide antibiotics', '20 AA cADR'], ['DRESS', 'frequently AA cADR'], ['antibiotic  therapy', '24 NA 44'], ['', ''], ['', '21 % P'], ['', '38 % P'], ['', '13 % P'], ['11', 'commonly AA cADR'], ['Antibiotics', 'index shorter drug latency'], ['', 'cADR  glycopeptide'], ['', '2016 Allergy Asthma'], ['recreational scuba diver', 'elastic rubber cord necklace'], ['', 'left  face'], ['other  items', 'potential scuba causes'], ['dive', 'hypersensitive  reaction'], ['', 'ImmunoCap IgE latex'], ['Infra Red spectroscopy', 'unidentified ethylene propylene compounds'], ['Allergy', '6 rubber Americans'], ['American three residents', 'scuba dive'], ['such  which', 'typically rubber filaments'], ['Allogenic lymphocyte immunotherapy', 'enough  effectiveness'], ['controlled  trials', 'meta analysis'], ['overall odds ratio', 'LIT'], ['success rate', 'treatment group'], ['', ''], ['07', '4'], ['', ''], ['LIT', 'live birth URSA'], ['', ''], ['', 'similar  5'], ['', ''], ['overall  OR', ''], ['', ''], ['16', '6'], ['which', 'low  URSA'], ['LIT', 'beneficial  URSA'], ['10(6  lymphocytes', 'better  outcome'], ['', ''], ['', 'such risk ABO'], ['', ''], ['allogenic Medline response', 'specific  antibodies'], ['Publications', 'methodology language publication'], ['English meta analysis', 'English review articles'], ['search', '4717  articles'], ['', 'relevance'], ['', ''], ['considerable  step', 'immunosuppressive knowledge allogeneic drugs'], ['first allogeneic response', 'first  article'], ['actual  management', 'immunosuppression'], ['Eventually  modalities', 'such risk ABO'], ['', ''], ['knowledge', 'renal allogeneic transplantation'], ['', ''], ['rights', ''], ['universal  that', 'contemporary  society'], ['Dysfunctions', 'vulnerable  infants'], ['they', 'neurobiological  expression'], ['how  lack', 'social laboratory behavior'], ['they', 'alloparental model care'], ['we', 'alloparental prerequisites care'], ['alloparental  that', 'human research health'], ['', ''], ['', ''], ['Objective', 'human  population'], ['They', 'personal  lives'], ['affective  steroids', 'predictive  diseases'], ['We', '20 group anxiety'], ['OPLS multivariate regression models', 'statistical  analysis'], ['1', 'controls'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['good  predictivity', 'also group AN'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['that', 'affective adult men'], ['', 'C Elsevier Inc'], ['Neurosteroids', 'fetal  neurodevelopment'], ['Pregnancy compromises', 'particularly growth adolescence'], ['pathologies', 'impaired steroid neurodevelopment'], ['specific programming mechanisms', 'traumatic stress disorder'], ['changes', 'adolescent guinea pig model'], ['Pregnant guinea pigs', '71 days gestation'], ['20 juvenile equivalence', '24 GABA h'], ['Females', 'female allopregnanolone controls'], ['intrauterine GAT1 staining', 'intrauterine vehicle hippocampus'], ['study', 'long term allopregnanolone concentrations'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['important  element', 'conserved serine proteases'], ['characteristic  feature', 'allosteric  activation'], ['regulatory L3 L2 L1', 'allosteric  signal'], ['role', 'LD'], ['Therefore  we', 'proteolytic LD HtrA'], ['We', 'oligomeric model substrate HtrA'], ['interactions', 'proteolytic  HtrA'], ['increased G174S which', 'LD'], ['HtrAG174S protein', 'order oligomeric order forms'], ['broad  spectrum', 'soft tissue defects'], ['techniques', 'reconstructive transplant ladder'], ['technical  study', 'functional VCA outcomes'], ['APF Pass topology', 'grounded  capacitor'], ['current  which', 'five MOS transistors'], ['It', 'low power consumption'], ['resonance frequency', 'only resistor value'], ['However  it', 'single matching condition'], ['quadrature oscillator example', 'application'], ['ideality  analysis', 'proposed  APF'], ['number', 'experimental test theory'], ['', '2015 Sharif Technology'], ['rights', ''], ['transcription factor', 'apical homeodomain meristem'], ['KN1 expression specifies', 'herbaceous shoot plants'], ['gene', 'such shoot Prunoideae'], ['We', 'almond'], ['', 'conserved Knotted1 gene'], ['cDNA ends RACE gene', 'cDNA ends polymerase chain reaction'], ['', ''], ['PdKn1  transcripts', 'apical  meristems'], ['PCR PdKn1 expression', 'adventitious shoot meristems'], ['Apricot RNA', 'Northern almond blotting'], ['almond PdKn1', 'other organogenic Prunoideae'], ['', 'certain endothelium tumors'], ['we', 'two cell immunohistochemistry'], ['tumors immunoreactivity', '4 Lm vasculature'], ['Basement membranes', '34/37 tumor cell tumors'], ['They', '28/34 Lm cases'], ['Western Caki-2 ACHN', '4 chain Lms'], ['', 'inhibited carcinoma fibronectin'], ['cell cells', 'more  Fn'], ['4 chain Lms', 'renal carcinoma vivo'], ['receptor subunit GluR2', 'neurological  insults'], ['suppression', 'cortical subunit neurons'], ['RT PCR', 'cultured KA exposure'], ['GluR2 KA exposure', 'GluR2  promoter'], ['Furthermore  expression', 'GluR2 mobility shift assay'], ['cultured KA exposure', 'H4'], ['results', 'GluR2 KA exposure'], ['transcriptional  suppression', 'GluR2 KA exposure'], ['reduction', 'induced neurons tolerance'], ['', ''], ['rights', ''], ['all alpha-16-linked branches', 'important storage cells'], ['alpha glucans', 'bioactive beta glucans'], ['many alpha glucans', 'immune  response'], ['main  challenge', 'immune  recognition'], ['structural alpha characteristics', 'immunostimulatory weight properties'], ['final  we', 'particularly mucosal vaccination'], ['', ''], ['rights', ''], ['Changes', 'such Inflammatory Bowel Diseases'], ['relationship', 'individual gut microbiota'], ['diverse Altered Schaedler one', 'bacterial  species'], ['important  aspect', 'microbial population member'], ['Herein  we', 'individual ASF member abundance'], ['approach', '16S assay specificity'], ['We', 'inbred mouse lines'], ['We', 'different ASF member diets'], ['Additionally  we', 'abundant ASF members'], ['qPCR  method', 'physiological ASF conditions'], ['', ''], ['', ''], ['rights', ''], ['how  levels', 'SP1 germ spermatogenesis'], ['factors', 'sharply  meiosis'], ['later  spermatocytes', 'early pachytene stage'], ['SP3', 'round  spermatids'], ['transition', 'normal pachytene 8'], ['', '2-kb  prevalent'], ['which', ''], ['first  sequence', 'reading  frames'], ['', 'specific Sp1 2'], ['4  kb', ''], ['', '8'], ['it', ''], ['We', 'Northern  that'], ['', ''], ['', ''], ['4-kb  variants', 'major  testis'], ['unexpected  decline', 'novel testis transcripts'], ['we', 'spliced Glcci1 gene'], ['Modern  drives', 'such torque speed'], ['control algorithm', 'control properties'], ['Motor phase currents', 'digital control interval'], ['mean phase currents', 'mechanical reference variables'], ['continuously  transformation', 'angular  position'], ['displacement', 'control interval'], ['continuous time model', 'oriented  errors'], ['how  errors', 'drive operating conditions'], ['analytical  solution', 'computer simulation'], ['when  drive', 'high  speed'], ['errors', 'presented  solution'], ['', ''], ['rights', ''], ['how  we', 'alternative food economies'], ['economies', 'which'], ['close agrifood they', 'environmental health impacts'], ['increasingly  we', 'alternative food initiatives'], ['oriented  paper', 'organic  market'], ['assemblage presences', 'AFIs'], ['plastics', 'alternative food economies'], ['sometimes  that', 'important  plastics'], ['We', 'human complement plasma'], ['assay', '96-well microplate reader'], ['activity', 'healthy  adults'], ['conversion', '50 calibration curve'], ['linearity', 'classical hemolysis pathway'], ['within day', 'available liposome immunoassay'], ['complement activity', 'complement deficiencies'], ['We', '200 blood donors'], ['evaluated', '94  LIA'], ['', '5  ELISA'], ['cost', 'LIA'], ['assay', 'previously  HAs'], ['assay', '96-well  plate'], ['use', 'good calibration reproducibility'], ['same  technique', 'alternative  pathway'], ['alternative  pathway', 'excessive reducing photosynthesis'], ['Alternative pathway', 'various  stresses'], ['However  mechanisms', 'drought stress'], ['how drought AP', 'different drought tolerance'], ['Longchun22 cultivar', 'more 98SN146 cultivar'], ['significant  it', 'more  Longchun22'], ['especially bar photoinhibition', 'drought stress'], ['Pretreatment', 'malondialdehyde hydrogen peroxide'], ['', 'AOX1a drought content'], ['mediated  AP', 'oxidative oxygen species wheat'], ['specific cell gene many', 'independent polyadenylation signals'], ['Cleavage factor', 'somatic polyadenylation site cell'], ['NUDT21  CPSF6', 'somatic germ cells'], ['spermatogenic  that', 'somatic  transcripts'], ['shorter Northern Nudt21', 'proximal germ signals'], ['sets', 'male germ cells'], ['developmental protein spermatogenesis', 'dependent  translational'], ['CFIm binding CFIm sites', 'independent germ cell sites'], ['CFIm complexes', 'poly(A  spermatogenesis'], ['synaptic brain we', 'neocortical PCR cultures'], ['novel zinc finger which', '38 amino acid seven'], ['', '72 carboxyl region'], ['alternative HIT-4 use', 'distinct  HIT-4'], ['HIT-4 mRNA', 'such lung 1'], ['5  kb', 'only  testis'], ['HIT-4  mutagenesis', 'mice'], ['Homozygous  mutation', 'embryonic  day'], ['', ''], ['mice', 'striatum cingulate cortex'], ['results', 'biological brain development'], ['highly  existence', 'nearly animal kingdom'], ['dsx  mab3', 'similar DM domain phyla'], ['six  transcripts', 'alternative chicken splicing'], ['nine  which', 'alternatively DMRT1 transcripts'], ['expression', 'testis chicken adults'], ['situ DMRT1 b', 'female embryo stage'], ['male DMRT1 f', 'key sex gonadal differentiation'], ['differential  expression', 'alternative sex chicken'], ['alternative splice site which', '12  isoforms'], ['expression', 'vivo'], ['present  we', '15 Fmr1 isoforms'], ['variant  proteins', 'differentially kissing complex RNA'], ['binding  each', 'translational  modifications'], ['RT PCR RT we', 'neuronal isoforms differentiation'], ['display', '15-containing  transcripts'], ['complex RNA that', 'fragile X syndrome'], ['', ''], ['rights', ''], ['', 'different Abcc4 gene cells'], ['important  drugs', 'bile nucleotides folates prostaglandins'], ['multiple  that', 'diverse protein functions'], ['we', 'novel mouse Abcc4 bioinformatics'], ['first  that', 'first  intron'], ['different  we', 'developmental  stages'], ['Expression level', 'real time PCR'], ['translational  modifications', 'novel  transcript'], ['half Translation life', 'encoded protein silico'], ['Molecular modelling', 'structural  isoforms'], ['diversity', 'diverse protein mouse'], ['', ''], ['', ''], ['rights', ''], ['critical Boiler equipments', 'abnormal  conditions'], ['failure', 'power generation'], ['cost', 'equipments'], ['Boiler', 'temperature abnormal furnace pressure'], ['Turbine', 'axial abnormal turbine speed'], ['Similarly  generator', 'following  protections'], ['', ''], ['incomplete stator inter', 'current overvoltage rotor overvoltage'], ['protections', 'b class c protections'], ['numerical  relays', 'real project kit'], ['However  effort', 'programmable logic controller'], ['few  suggestions', 'existing  system'], ['stable  individuals', 'social group vertebrates'], ['physiological  traits', 'social  relationships'], ['', 'developmental  modes'], ['', ''], ['role', 'across  sociality'], ['', 'developmental brain mode'], ['significant example brain which', 'social building complexity'], ['Here  we', 'altricial  mammals'], ['several  forms', 'developmental  spectrum'], ['minor  individuals', 'social  relationships'], ['some', 'developmental  mode'], ['This', 'social  systems'], ['DOM water that', 'coagulant  cations'], ['work', 'different absorbance Ca2'], ['100 mu observation', 'higher  6'], ['', '8'], ['', ''], ['zeta competition', 'efficiently hardness Al3'], ['significantly hardness which', 'unsaturated  DOM'], ['', ''], ['rights', ''], ['infectious  that', 'bone loss'], ['associated tissue mechanism', 'periodontal tissue diabetes'], ['how  diabetes', 'STZ bone mice'], ['Material', 'C57 intraperitoneal BL6J'], ['silk ligature', 'type  WT'], ['Bone loss', '3  ligation'], ['mRNA expression levels', '3 d ligation'], ['resistant acid phosphatase', 'histological phosphatase analysis'], ['hyperglycemia', 'mRNA  expression'], ['mRNA tumor expression', '1 WT mice'], ['ligation alveolar bone loss', 'WT mice'], ['severe alveolar bone loss', '7 d ligation'], ['metabolic  analysis', 'ligated WT mice'], ['Gli1 expression levels', 'ligated WT mice'], ['Histological analysis', 'alkaline STZ mice'], ['increased  number', 'ligated STZ mice'], ['deficient alveolar bone loss', 'early  condition'], ['lung alveolar epithelium', 'II pneumocytes'], ['type II cell', 'progenitor which'], ['conventional  they', 'rapidly phenotypic type'], ['that', 'differentially type II cells'], ['stop C2 subunit gene', '4 type II days'], ['reverse polymerase chain reaction', 'isolated type II cells'], ['90 % reduction', 'real time PCR'], ['situ  Atp6v1c2', 'surfactant protein B'], ['tissue Northern blotting', 'Atp6v1c2 lung kidney'], ['presence', 'alternative gene transcript splicing'], ['Elucidation', 'alveolar epithelial cells'], ['Avian leukosis virus', 'hemangiomas ALV chickens'], ['', 'many  cancer'], ['IL-6  expression', 'ALV J chickens'], ['ALV J', 'IL-6 tumor development'], ['IL-6  expression', 'peripheral blood lymphocytes'], ['IL-6  production', 'envelope protein gp85'], ['', 'endothelial growth cells'], ['VEGF VEGFR-2 expression', 'IL-6'], ['IL-6', 'therapeutic ALV J infections'], ['degrading  enzyme', 'key amyloid disease'], ['2 diabetes we', 'Caenorhabditis elegans'], ['', 'related  outcomes'], ['bioinformatics', 'putative IDE C'], ['', ''], ['seven C elegans that', 'identifying HXXEH IDE'], ['expressing C elegans', 'reactive FOXO transcription factor'], ['putative  IDE', 'uncharacterized  gene'], ['4', 'tested  endpoints'], ['', ''], ['4', 'DAF-16 stress response protein'], ['studies', 'further insulin AD'], ['Further  studies', 'common modulating AD'], ['', ''], ['', ''], ['rights', ''], ['disease', 'IL-1 AD patients'], ['beta expression', '2  AD'], ['We herein', 'L threonate magnesium L MgT'], ['signaling  MgT', 'glial  cells'], ['activated PPAR which', 'IL-1 beta suppression'], ['PPAR gamma', 'glial beta cells'], ['', 'vitro  data'], ['', ''], ['transgenic APP)/PS1 brain slices', 'IL-1 protein beta'], ['These', '5 vivo months'], ['2  influx', 'cerebrospinal amyloid beta fluid'], ['transgenic beta which', 'potentially  neuroinflammation'], ['Cellular', ''], ['current  study', 'cyclic beta amyloid'], ['p140(trkA)-NIH-3T3 cells', 'cyclic  peptide'], ['1 Peptide binding', ''], ['Duplicate cultures', 'then  beta'], ['Peptide ability', 'mediated JNK activation'], ['NGF', 'p75(NTR'], ['beta', 'c jun transcription'], ['', ''], ['', 'cyclic  peptide'], ['250  peptide', '40)-induced  71'], ['', ''], ['', 'pretreated % cultures'], ['', 'pretreated  cultures'], ['', ''], ['', 'pretreated  cells'], ['', ''], ['', ''], ['', 'microscopic  fields'], ['cyclic  peptide', '28 amino beta'], ['already fv we', 'especially  mind'], ['old  who', 'fv AD'], ['false belief Reading', 'social Eyes norms'], ['FT', 'social  onset'], ['initially  disease', ''], ['disease', 'pathological  complexity'], ['important  role', 'calcium'], ['temporal hormone that', 'hours'], ['single  that', 'such AD amyloid'], ['where  Ca2', 'specificity'], ['temporal  hypothesis', 'updated  discoveries'], ['useful crossover that', 'effective  therapy'], ['', ''], ['rights', ''], ['AimsTo', 'geriatric default mode depression'], ['one  subjects', 'neuropsychological state fMRI baseline'], ['FC  analysis', 'DMN patterns'], ['mainly cortical midline interaction', 'limbic RGD system'], ['consistent  effects', 'RGD groups'], ['such TT compensation', 'CLU CC carriers'], ['ConclusionThe CLU gene', 'neural DMN changes'], ['better  memorize', 'neutral  expressions'], ['older  participants', 'positive  expressions'], ['positivity effect', 'positive subserving emotion regulation'], ['older  participants', 'happy  faces'], ['question', 'compensatory  strategies'], ['Thus  we', 'such AD tasks'], ['older  participants', 'young positivity participants'], ['positivity effect', 'entirely  faces'], ['Chronic neuroinflammation', 'MTL memory disease'], ['other  that', 'AD development'], ['CSF  biomarkers', '24 AD months'], ['multiplex mass panels', '50%/50 % model validation'], ['Neuronal Pentraxin', 'synaptic Chitinase-3-like plasticity'], ['mixed  models', 'global CSF amyloid'], ['baseline NPTX2 levels', 'less MTL atrophy'], ['', ''], ['', ''], ['', ''], ['', 'month'], ['higher  C3LP1', 'more MTL atrophy'], ['', ''], ['', 'significantly memory time'], ['novel  that', 'substantially brain atrophy'], ['microglial  biomarker', 'longitudinal memory decline'], ['research', 'such AD NPTX2'], ['also  NPTX2', 'causally MTL morphometry'], ['', ''], ['rights', ''], ['disease patients', 'neuropathological amyloid beta'], ['mechanisms', 'critical  disease'], ['present  we', 'regulatory disease progression'], ['First  we', 'adoptive transfer model'], ['Systemic  transplantation', 'reduced beta plaques'], ['adoptive  transfer', 'behavioral  function'], ['Next  we', 'CD25 Treg antibody'], ['Depletion', '3xTg AD mice'], ['D positron emission glucose', 'positron emission tomography'], ['Importantly  deposition', '3xTg AD group'], ['systemic Treg administration', 'ameliorates disease progression'], ['preclinical disease', 'heterogeneous  SCD'], ['differential  cognitive', 'rated memory clinic'], ['We', 'cognitive memory difficulties'], ['subclinical amyloid beta depression', 'medical  help'], ['Cognitive tests', 'group differences'], ['results', 'clinic  groups'], ['', 'heterogeneous study characteristics'], ['', ''], ['', 'Elsevier Inc'], ['rights', ''], ['paper', 'low power consumption'], ['transmitter', 'high TSMC CMOS'], ['', ''], ['', '500 LO 1'], ['5  GHz', 'RF conversion 14'], ['25  dB', '300  1'], ['', ''], ['reference', 'V dd'], ['2  amplifier', '42'], ['1 dB phase margin', '56 degrees 1'], ['', '291 V mu s'], ['overall power consumption', ''], ['', '3 chip 9'], ['', ''], ['chip', 'rectangular pad size'], ['', ''], ['RF power amplifiers', 'PM radio frequency'], ['AM PM distortion curves', 'AM  AM'], ['digital  control', 'look test table'], ['polynomial  that', 'real nonlinearity PAs'], ['', ''], ['', ''], ['rights', ''], ['Considerable  interest', 'public policy implications'], ['how forest conservation', 'public health outcomes'], ['', 'use Amazonia contradictions'], ['others', 'opposite'], ['Assessing malaria risk', 'main  components'], ['', ''], ['', ''], ['', ''], ['mosquito', 'distributions vector activity'], ['', ''], ['', ''], ['we', 'three malaria components'], ['key  that', 'future  research'], ['article', 'themed Conservation biodiversity'], ['theoretical vantage that', 'enabling transactive memory systems'], ['specific management that', 'strategic  ambidexterity'], ['ambidextrous transactive memory impact', 'functional transactive teams'], ['We', 'future  practice'], ['wide intensity that', 'such  cornea'], ['industry safety standards', 'critical arc flash safety'], ['Accurate  measurement', 'first eye protection'], ['light measurement devices', 'detecting cadmium sulfide'], ['However response times', 'initial arc flash'], ['brightness', 'traditional light measurement devices'], [\"lambda l'Eclairage luminosity which\", 'ambient light conditions'], ['paper', 'traditional light measurement approaches'], ['design', 'human arc eyes'], ['results', 'arc eyes'], ['Evidence', 'mental ambient temperature disorders'], ['we', 'mean Shanghai China'], ['We', '2008 pollution December'], ['other air Poisson', 'temperature exposure response MDs'], ['daily hospital admissions', 'study period'], ['', 'median  temperature'], ['', 'positive degrees threshold'], ['', '1 hospital admission days'], ['', 'hot  temperatures'], ['99 % percentile', 'median  temperature'], ['', ''], ['', ''], ['', ''], ['effect', 'cold hospital MDs'], ['significant health counseling', 'susceptible  population'], ['', ''], ['', ''], ['rights', ''], ['', 'different symmetry science'], ['utilitarian symmetry which', 'twentieth century science'], ['pivotal  discoveries', 'classical  symmetry'], ['personal  presentation', 'recent  them'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Recently  most', 'Pterocarpus indicus Malang'], ['death rate', 'ca'], ['', ''], ['addition death', 'other East Java'], ['specific ambrosia that', 'causal sonokembang Malang'], ['Wilting', 'pathogenic ambrosia beetles'], ['', 'microbial  E'], ['that', 'sonokembang E'], ['parallelus', 'attacked Malang city'], ['Isolation', 'State University Malang'], ['Results', 'one  bacterium'], ['microbial  that', 'namely Aspergillus spp'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['ecological  that', 'spatial  processes'], ['how  forms', 'spatial aggregation interest'], ['that', 'areal  data'], ['topic', 'spatial  statisticians'], ['spatial aggregation we', 'optimal regionalization'], ['we', 'multiscale Karhunen Loeve expansion'], ['multiscale Karhunen Loeve expansion', 'Obled Creutin eigenfunctions'], ['effectiveness', 'environmental ocean winds'], ['ObjectiveWe', 'American Indian pregnancy prevention'], ['Attention', 'sexual decision relationships'], ['Study DesignOur sample', '24  reservation'], ['Data', 'in  interviews'], ['participatory research framework', 'topic'], ['attitudinal  factors', 'sexual risk behavior'], ['Attitudes', 'positive condom condoms'], ['Consistent condom use', 'multiple sex partners'], ['STI HIV that', 'sexual risk perception'], ['clinical health that', 'multiple sex partners'], ['converting  enzymes', 'carboxylic  nitriles'], ['bioconversion approaches', 'purified food additives pharmaceutical'], ['review', 'recent mechanism years'], ['Molecular biology aspects', 'biocatalytic microbial nitrilase'], ['process developments', 'organic microbial synthesis'], ['Aminoacylase', 'numerous  cancer'], ['However  expression', 'colorectal  cancer'], ['', 'colorectal blood cancer'], ['', 'colorectal tumor tissue'], ['', ''], ['', ''], ['ACY1 mRNA expression', 'positively tumor stage'], ['plasma ACY1 concentration', 'healthy  controls'], ['human colorectal cells', 'apoptosis'], ['effect', 'ERK1'], ['present  ACY1', 'colorectal tumor cancer'], ['cell surface which', 'susceptible insect midgut insect'], ['We', 'fat  moth'], ['two  transcripts', 'different  midgut'], ['respectively  which', '950 amino acids'], ['33 acid sequence both', 'binding gluzincin motif HEXXHX18E'], ['APN', 'tissue'], ['', 'low APN tissue'], ['midgut  APNs', 'various Cry1A toxins'], ['', 'intrahaemocoelic Cry injections'], ['fat  body', 'alternative toxin target moth'], ['cardiac  effects', 'many  hypothyroidism'], ['arrhythmic  potential', 'like  condition'], ['controversial  we', 'gene expression hypothyroidism'], ['male  rats', 'systemic  hypothyroidism'], ['', ''], ['', ''], ['recordings gene', 'DNA microarray'], ['Amiodarone', 'RR  ECGs'], ['Microarray analysis', 'significant expression Hypothyroidism'], ['', ''], ['', ''], ['gene expression profiles', '200  genes)were'], ['', ''], ['', ''], ['Northern  blots', 'heavy  Hypothyroidism'], ['Northern blots', 'different representative Hypothyroidism'], ['long term treatment', 'like gene expression profiles'], ['arrhythmic  activity', 'transcriptional  remodeling'], ['', ''], ['', ''], ['rights', ''], ['functional gene which', 'specific target genes'], ['which', 'hpRNA expression'], ['hp RNA expression cassettes', 'genetic plant transformation'], ['nt  gene', 'artificial target gene(s'], ['functionality', 'transgenic vector plants'], ['Strong  regulation', 'viral tobacco PAmiR(159'], ['processing', 'northern  blotting'], ['important plant molecular which', 'various plant cells'], ['tricyclic  antidepressant', 'various  pain'], ['amitriptyline', 'inflammation'], ['', 'intercellular adhesion molecule'], ['vitro model system', 'induced paw rat'], ['expression', 'Real time PCR'], ['soluble  forms', 'ELISA'], ['expression', 'significantly iNOS amitriptyline'], ['finding', 'study'], ['', ''], ['', 'induced rat paw edema'], ['results', 'inflammatory  amitriptyline'], ['effect', 'inflammatory down genes'], ['fed cDNA Oryza', 'L'], ['which', 'up  nitrate'], ['silico RT cDNA', '186 rice metallothionein type'], ['gene', 'barely rice buds'], ['gene transcripts', 'low temperature Pb2'], ['induced OsMT3 expression', 'oxidative  signals'], ['aim', 'oral tissue cavity'], ['molecular tissue that', 'tissue'], ['Transplantation', 'long term immunosuppression'], ['', 'oral bone osteoradionecrosis'], ['antro oral antro defects', 'antro oral antro fistulas'], ['5 tissue we', '1  case'], ['2 PLLA differences', 'morphometric  analysis'], ['Autologous  transplants', 'modern tissue engineering'], ['we', 'amorphous gallium zinc oxide'], ['IGZO TFTs', 'suitable solution circuits'], ['experimental  we', 'overall op 30'], ['', 'frequency  1'], ['47  kHz', '6'], ['when supply voltage', ''], ['proposed op amp', 'display applications'], ['we', 'adaptive display driving systems'], ['only type TFTs', 'overall  24'], ['', '32 gain +'], ['error which', 'PWM controller'], ['external dc dc that', '100 duty 24'], ['', '3  66'], ['when reference voltage', '6  V'], ['Background', 'periodontal gingival diseases'], ['Numerous  bacteria', 'gingival crevicular fluid'], ['negative  bacteria', 'dental  butyrate'], ['gingival epithelial gingival cells', 'dental  starvation'], ['present  we', 'gingival epithelial cell death'], ['Material', 'vitro gingival epithelial cells'], ['when  it', 'stranded  DNA'], ['AMPK protein amount', 'western  blot'], ['1 light chain', 'reverse polymerase chain reaction'], ['dependent  cells', 'dependent  manner'], ['when starvation they', 'starvation conditions'], ['starvation  exposure', 'AMPK  activity'], ['when cell cells', 'induced cell death'], ['combination', 'inducing butyrate autophagy'], ['induced LC3B production', 'AMPK  inhibition'], ['LC3B', 'induced cell death'], ['dependent LC3B induction', 'induced cell death'], ['AMPK LC3B this', 'histone  proteins'], ['ConclusionTaken', 'strong LC3B induction'], ['findings', 'periodontal disease initiation'], ['MicroRNAs', 'such  cancer'], ['MiRs', 'time PCR time techniques'], ['time  techniques', 'on miR determination'], ['study amperometric magnetobiosensors', 'selective miR quantification'], ['p19-based magnetosensors', ''], ['4  fmol', 'total PCR amplification'], ['results', 'human drug discovery programs'], ['potentiostat  circuit', 'glucose sensor'], ['high Test which', 'potentiostat  designs'], ['high  linearity', 'operational  amplifier'], ['current  consumption', 'circuit'], ['potentiostat', 'glucose 30'], ['design', '0'], ['bulk CMOS process', 'core  layout'], ['', ''], ['low power potentiostat', 'low power operation'], ['such Branchiostoma belcheri finding', 'basal chordate'], ['main  features', 'apolipoprotein D'], ['phylogenetic  AmphiApoD', 'vertebrate ApoD genes'], ['hind which', 'ectodermal ApoD mammals'], ['alternatively ApoD gene', 'ectodermal endo mammals'], ['', 'Cell Biology'], ['', 'Elsevier Ltd'], ['rights', ''], ['many  responses', 'homeostatic plasma glucocorticoid hormones'], ['', 'typically functions individuals'], ['We', 'living Mountain dusky salamanders'], ['We', 'current facilitation hypothesis'], ['Differential white blood cell count', 'induced CRH neurons'], ['we', 'current tradeoff reproduction'], ['differential blood cell we', 'immune facilitation function'], ['thorough blood cell examination', 'immune  HPA'], ['Resource availability', 'significantly host parasite dynamics'], ['more  hosts', 'also host food'], ['abundant food favors', 'host resource'], ['', ''], ['', ''], ['which', 'infection'], ['low resource diets', 'penetrating nematode Aplectana sp'], ['', 'infection'], ['worms', 'gut'], ['low resource diet', 'increased  infection'], ['resource food diet', 'enhanced host parasites'], ['parasitized  mass', 'parasitized  frogs'], ['established frog frogs', 'fully  parasites'], ['when  parasites', 'infection'], ['full length amphioxus encoding', 'first Branchiostoma belcheri'], ['It', '28 amino kDa'], ['hepatic epipharyngeal it', 'neural  tube'], ['Amphi PhLP', 'CHO cells'], ['work', 'physiological Amphi B'], ['', ''], ['yet  little', 'invertebrates'], ['Here  we', 'transient nodal vertebrates'], ['It', '167 amino acids'], ['like  homolog', 'vertebrate transmembrane promethins'], ['Phylogenetic  analysis', 'that'], ['vertebrate  it', 'vertebrate  promethins'], ['Northern  blotting', 'mammalian expression promethins'], ['This', 'further  promethins'], ['amphioxus', 'AmphiGM2AP Branchiostoma belcheri'], ['It', '14 amino acids'], ['deduced amino acid sequence', 'conserved glycosylation cysteines'], ['invertebrate  AmphiGM2AP', 'closely  GM2APs'], ['digestive adult which', 'human GM2AP genes'], ['AmphiGM2AP', 'digested lipid molecules'], ['gene fixation gene cluster', 'first amphioxus Branchiostoma belcheri'], ['situ hybridization cDNA', 'gene'], ['nifUlike gene', '66 86 vertebrates invertebrates'], ['It', 'endostyle hepatic gill ovary'], ['highly  protein', 'dependent  amphioxus'], ['fixation gene cluster', 'first amphioxus Branchiostoma belcheri'], ['situ hybridization cDNA', 'Iike gene'], ['like  gene', 'like vertebrates invertebrates'], ['It', 'hepatic gill ovary'], ['like  protein', 'dependent  amphioxus'], ['amphioxus p23', 'amphioxus Branchiostoma belcheri'], ['It', '170 amino acids'], ['p23 p23 genes', 'common  ancestor'], ['whole adult mount', 'stage expression embryos'], ['specific expression pattern', 'anterior posterior patterning'], ['', ''], ['rights', ''], ['neurula  results', 'furthermore CaM evolution'], ['Trypsin', 'model organism model vertebrates'], ['Here  we', 'Branchiostoma japonicum'], ['bp  ORF', '272 amino acids'], ['Asp(209  which', 'trypsinogens'], ['prototypic substrate which', 'specific soybean trypsin inhibitor'], ['situ trypsin gene', 'hepatic caecum gut'], ['hepatic 2-day caecum', 'later  development'], ['amphioxus', 'common  ancestor'], ['Amphiregulin', 'binding EGF receptors'], ['Amphiregulin', 'gastrointestinal  tract'], ['we', 'subepithelial  myofibroblasts'], ['epiregulin', 'Northern  blotting'], ['trophic  effects', 'MTT assays'], ['Amphiregulin', 'unstimulated  SEMFs'], ['', 'epiregulin necrosis factor expression'], ['responses', 'specific receptor tyrosine kinases'], ['Amphiregulin', 'also protein level'], ['amphiregulin', 'SEMFs'], ['We', 'SEMFs'], ['Amphiregulin', 'colonic wound mucosa'], ['', 'fungal  endophthalmitis'], ['Retrospective  who', 'tertiary referral center'], ['Nineteen  eyes', '15  study'], ['Four  patients', 'unilateral  disease'], ['Sixteen eyes', 'vitreous polymerase chain reaction'], ['affected  eyes', '5 amphotericin mu'], ['', ''], ['Fourteen  patients', 'systemic antifungal therapy'], ['23-G  vitrectomy', '75  eyes'], ['Candida', 'causative  62'], ['', '5  12'], ['', '5  eyes'], ['Retinal detachment', '42  eyes'], ['EFE', '23-G  vitrectomy'], ['Several frequency compensation schemes', 'negative multistage feedback'], ['performance', 'frequency response'], ['many output it', 'small signal expressions'], ['certain  techniques', 'such DC gain'], ['nondominant  which', 'nano scale amplifiers'], ['work', 'systematic frequency compensation'], ['key', 'equivalent compensation output'], ['effectiveness', 'proposed transfer literature'], ['', 'C  GmbH'], ['rights', ''], ['', 'particularly CMOS technology'], ['innovative Frequency Integrated designs', 'still THz gap'], ['band THz amplifier', 'adaptive band selection technique'], ['smart  amplifier', 'signal  power'], ['circuit performance', 'maximum power gain'], ['In', 'tunable transmission lines'], ['smart  system', 'on control chip'], ['fabricated  amplifier', '1 P 6'], ['', '1  14'], ['', ''], ['', '288 GHz frequency range'], ['proposed  amplifier', 'state CMOS technologies'], ['STCB  circuit', 'capacitive stage loads'], ['proposed STCB circuit', 'capacitive stage loads'], ['on  capacitor', 'on  chip'], ['STCB amplifier', 'commercial'], ['', ''], ['active chip area', ''], ['', ''], ['supply', ''], ['8  V', ''], ['', ''], ['capacitive  load', 'about C 4'], ['', '19'], ['', 'FOMS  GBW'], ['', 'large C merit'], ['O  power', ''], ['', ''], ['respectively  which', '1'], ['', ''], ['', 'prior  art'], ['achieved phase margin', 'margin'], ['', ''], ['', ''], ['signal  platforms', 'increased design cost effort'], ['Programmable ANalog Device Array', 'rapid analog circuits'], ['paper', 'reconfigurable interconnect configuration memory'], ['PANDA paper', 'placement routing bit stream generation'], ['current amplifiers filters', 'successfully PANDA platform'], ['Dynamic reconfiguration capability', 'closed input offset loop'], ['Initial measurement results', 'prototyping analog circuits'], ['Analog layout generation', 'increasing layout constraints'], ['situation', 'parasitic  variability'], ['first layout which', 'constrained Delaunay triangulation'], ['later crossing graph', 'multiple  reconnection'], ['also  wire', 'performance metrics'], ['approach', 'variable gain amplifier'], ['75 % routing', 'migrated  approach'], ['Additionally  it', 'different  designs'], ['genomic profile risk score', 'such status association'], ['cohorts', 'amygdala infant volume'], ['Asian  cohort', 'prefrontal  cortex'], ['significant  interaction', 'right infant volumes'], ['right interaction effect', 'right  hippocampus'], ['neurotransmitter  neurotrophic', 'cortico limbic cortico development'], ['findings', 'emotional brain function'], ['signaling brain that', 'synaptic  development'], ['amyloid beta', 'major beta precursor disease'], ['limiting  step', 'important AD etiology'], ['We', 'therefore  4'], ['', 'Northern T blotting'], ['BACE1 promoter', 'regulatory  4'], ['positive  activity', \"regulatory 5'-most sequence\"], ['We', 'proximal BACE1 promoter'], ['141-bp  that', 'observed brain extracts'], ['50-bp which', 'electrophoretic mobility shift assay'], ['strong 91-bp fragment', 'potential stem loop sites'], ['differentially 91-bp fragment', 'specific cell regulation'], ['fragment', 'useful beta AD'], ['Emotion processing abilities', 'lateral  sclerosis'], ['Previous  studies', 'inconsistent task difficulty modalities'], ['current  study', 'nondemented emotion processing ALS'], ['abbreviated Affect Testing which', 'semantic face prosody affect'], ['Participants', 'executive function mood'], ['ALS participants', 'facial affect recognition'], ['affect  recognition', 'semantic  affect'], ['ALS participants', 'functional emotion processing'], ['however  relationship', 'single  modality'], ['people', 'basic recognizing cognition'], ['emotion processing difficulties', 'interpersonal  life'], ['lateral  sclerosis', 'upper motor neurons'], ['patterns', 'structural brain alterations'], ['few PET studies', 'cerebral glucose metabolism'], ['aim', 'based ALS method'], ['Thirty seven Thirty patients', 'structural  MRI'], ['PET data', 'partial volume effects'], ['Structural', 'parametric sample t mapping'], ['Then  we', 'cognitive  scores'], ['Finally GM atrophy', 'paired t SPM'], ['We', 'temporal motor lobe'], ['We', 'cognitive  mind'], ['right  hypometabolism', 'frontal superior medial cortex'], ['findings', 'regional GM ALS'], ['cerebral  hypermetabolism', 'cognitive  ALS'], ['study', 'potential  ToM'], ['', ''], ['clinical  neuropsychological', 'frontotemporal lobar degeneration'], ['', 'well Advanced ToM'], ['ALS patients', 'lower  EAT'], ['significant  difference', 'two  ATT'], ['', 'spinal bulbar ET'], ['EAT', 'Health QoL items'], ['only  cognitive', 'potential  patients'], ['social exchange that', 'analytical computer \"'], ['input', 'bulk SOI structures'], ['resistive  elements', 'wide temperature range'], ['Such  elements', 'intellectual microsystemon chip'], ['', 'based production product'], ['intact  which', 'quantitative polymerase chain reaction'], ['single  that', 'full adenovirus process'], ['samples', '214 UV nm'], ['Only  samples', 'simple sample benzonase'], ['Adenovirus particles', '125 cell mM'], ['', 'v  pH'], ['', ''], ['factorial  design', 'analytical method design'], ['method', 'representative manufacturing 0'], ['', ''], ['', 'similar adenovirus 250'], ['CE method', 'intermediate  7'], ['', '95 110 95 %'], ['CE', 'in adenovirus vaccine manufacturing'], ['anammox  process', 'promising sewage treatment approach'], ['it', 'unfavorable anammox conditions'], ['anammox bacteria', 'environmental c di stresses'], ['revealing', 'predicted  enzymes'], ['capable c di which', 'enzymatic polymerase chain reaction'], ['catalytic  mechanism', 'dimensional homology modeling'], ['identification', 'further wastewater treatment process'], ['', ''], ['rights', ''], ['Henoch Schonlein purpura', 'immune  complex'], ['Animal models', 'HSP'], ['Here  we', 'acute HSP rabbit phase'], ['First  we', 'immunosorbent HSP rabbit assay'], ['Histomorphological  characteristics', 'haematoxylin eosin immunofluorescence'], ['model group rabbits', 'skin ecchymosis'], ['decreased reaction inflammation', 'joints gastrointestinal lung'], ['CD8 IgG TropI Alb', ''], ['IgA', 'skin'], ['rabbit model', 'therapeutic symptoms HSP'], ['allergic  that', 'adrenaline autoinjectors'], ['prompt  administration', 'significant  anaphylaxis'], ['many  people', 'how  them'], ['This', 'continuous  feedback'], ['Assistive smartphone healthcare technologies', 'cardiovascular  anaphylaxis'], ['paper', 'healthy feedback participants'], ['training', 'practiced AllergiSense injection 90'], ['5  %', 'only  28'], ['', 'only control group'], ['results', 'traditional technology design process'], ['mechanisms', 'mast cell anaphylaxis'], ['Mouse models', 'critical  neutrophils'], ['immune  cells', 'local  inflammation'], ['', 'human neutrophil anaphylaxis'], ['', 'subsequent time points'], ['mast cell tryptase', 'ELISA'], ['soluble cytometric bead both', 'healthy  controls'], ['60  histamine', '72  patients'], ['', 'enrolment myeloperoxidase concentrations'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '5 symptom onset'], ['', '5 % h'], ['', 'myeloperoxidase'], ['human  they', 'mast cell activation'], ['important  finding', 'necessary  treatment'], ['diagnostic  criteria', 'Second Anaphylaxis'], ['criteria', ''], ['', 'NIAID emergency department'], ['We', '2010  March'], ['Patients', 'allergic  reaction'], ['Patients', 'onset trigger'], ['certified allergist immunologists', 'final reference standard'], ['test characteristics', 'Two  two'], ['', 'NIAID FAAN anaphylaxis'], ['allergist immunologists', 'NIAID FAAN criteria'], ['interrater  agreement', 'allergist immunologists'], ['', ''], ['Test characteristics', 'NIAID FAAN criteria'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['NIAID FAAN criteria', 'retrospective  assessment'], ['criteria', 'ED'], ['', '2016 Allergy Asthma'], ['sBT serum basal levels', 'allergic risk reactions'], ['aim', 'sex drug hypersensitivity DHRs'], ['0 culprit drug intake', '0 6 h'], ['Following inquiries patients', 'hypersensitive provocation patients'], ['Serum BT levels', 'patients'], ['', '106  patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'drug hypersensitive'], ['Ninety eight Ninety controls', ''], ['hypersensitive control group', 'hypersensitive  anaphylaxis'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'cutaneous sBT symptoms'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'lg  anaphylaxis'], ['', ''], ['', ''], ['lg  l', 'also  >'], ['', ''], ['', '18 sBT levels'], ['sBT levels', 'allergic risk food'], ['Anaphylaxis', ''], ['ED emergency visits', 'United States'], ['', 'ED  2014'], ['We', 'insured Medicare patients'], ['We', '100000  enrollees'], ['Rates', 'age'], ['ED time visits', 'anaphylaxis'], ['interquartile range interquartile age', ''], ['4  %', 'venom'], ['overall  rate', '101  14'], ['', '28'], ['', '2014'], ['', ''], ['greatest age increase', 'children'], ['', ''], ['rate', '124  %'], ['rate', '212  %'], ['', ''], ['ED  visits', '2005'], ['Increases', 'ED  children'], ['', '2016 Allergy Asthma'], ['prescribing  pattern', 'secular  anaphylaxis'], ['However  it', 'well United States'], ['', 'County Minn residents'], ['Outpatient prescriptions', 'Olmsted County January'], ['We', 'first incidence rates'], ['Incidence rates', 'specific Olmsted denominator'], ['relationships', 'fitting SAS procedure GENMOD'], ['overall incidence rate', 'study period'], ['prescription rates', '8  %'], ['rates', 'patient'], ['', ''], ['incidence rates', 'overall  men'], ['', ''], ['', '19 incidence girls'], ['', '20 incidence men'], ['epinephrine autoinjector rate', 'first time 2010'], ['more childhood this', 'later  ages'], ['', '2016 Allergy Asthma'], ['worldwide zoonotic which', 'northern  Africa'], ['Anaplasma platys', 'zoonotic  potential'], ['recent  article', 'human  A'], ['data', 'canine bacteria'], ['Therefore  we', 'human  Anaplasma'], ['', 'Morocco'], ['11 dog owners', 'four  Morocco'], ['Canine blood samples', 'Anaplasma'], ['', 'immunosorbent  A'], ['', ''], ['', 'real msp2 gene'], ['Human sera', 'specific  A'], ['', 'immunofluorescence assay immunofluorescence kit'], ['', ''], ['', ''], ['platys DNA', '21'], ['', ''], ['', '5  dogs'], ['Anaplasma phagocytophilum DNA', ''], ['Anaplasma platys DNA', 'working  dogs'], ['', 'significant  Anaplasma'], ['', ''], ['platys DNA detection', 'sexes age ticks'], ['348 Rhipicephalus ticks', 'urban  dogs'], ['majority', 'dog A'], ['one phagoyctophilum sample', 'hemolysis'], ['study', 'Anaplasma'], ['', ''], ['', 'platys dogs'], ['', 'phagocytophilum  Morocco'], ['ponticle  process', 'cervical atlas spine'], ['lateral  ponticle', 'transverse articular process'], ['vertebral  artery', 'transverse  foramen'], ['we', 'left adult side'], ['like  structure', 'lateral  surface'], ['Relevant  literature', 'lateral groups sex race'], ['genesis', 'ventral  sclerotomes'], ['like  structure', 'ponticle'], ['simultaneous  occurrence', 'epitransverse  knowledge'], ['intervertebral  disc', 'joint  structure'], ['adjacent  it', 'primary  spine'], ['Various  aspects', 'better dynamics aging'], ['we', 'lumbar anatomy imaging IVD'], ['', ''], ['', ''], ['', ''], ['', ''], ['Granulomatosis', 'respiratory  tract'], ['inflammatory  that', 'necrotizing  lesions'], ['', 'Immunology Szczeklik etal'], ['', ''], ['', ''], ['', ''], ['', ''], ['724  733', 'possible T cell disease'], ['prospective  study', 'inflammatory  process'], ['immunosuppressive follow treatment', 'particularly follow patients'], ['associated  vasculitides', 'small cytoplasmic antigens PR3'], ['We', 'rare immunology diseases'], ['neutrophil neutrophil', 'primary ANCA autoantigens'], ['attempts', 'immune cell mediators'], ['neutrophils', 'associated vasculitis detail'], ['clinical  that', 'under  monocytes'], ['Refocusing', 'useful disease activity'], ['I phytochelatin synthase which', 'metal binding plant cells'], ['encoding', '528 amino acids'], ['PCs gene history', 'Notung phylogeny'], ['', 'several Proteobacteria Bilateria'], ['eleven gene duplication events', 'external gene duplication nodes'], ['Cd Cr', 'real polymerase chain reaction'], ['Pdpcsl  overexpression', 'P'], ['Pdpcsl  gene', 'metal detoxification mechanisms'], ['Additionally  structure', 'Discovery studio PyMol software'], ['phytochelatin synthase I', 'binding consensus amino cavity'], ['', 'eastern sturgeon Atlantic'], ['primarily American Acipenser that', 'date'], ['aim', '2500 sturgeon years'], ['question', 'international restoration programmes'], ['', ''], ['study', 'archaeological Ems Weser Elbe'], ['bones', 'mitochondrial DNA fragments'], ['data', '1000  years'], ['4  %', 'A'], ['', ''], ['species', 'south'], ['', 'Elbe northwards'], ['oxyrinchus', 'dominant sturgeon species'], ['genetic  identification', 'oldest sturgeon A'], ['oxyrinchus', 'eastern  Atlantic'], ['Consequently  immigration', 'last North glacial'], ['two sturgeon distribution', 'environmental  conditions'], ['', 'strong museum A'], ['', 'North Sea area'], ['oxyrinchus', '1000'], ['Therefore Holocene distribution', 'complex  pattern'], ['Determining', 'ecological restoration programmes'], ['importance', 'already frequency regulators'], ['based regulation market model', 'regulation mileage paper'], ['', 'higher performance regulation market'], ['Market clearing prices', 'Lagrange relaxation'], ['analysis', 'accurately regulation capacity'], ['proposed AGC allocation algorithm', 'market clearing results'], ['clearing procedure', 'illustrative market case'], ['proposed market design', 'dynamic market simulations'], ['Simulation results', 'proposed market design'], ['', ''], ['rights', ''], ['increased  penetration', 'necessary electricity market mechanisms'], ['renewable energy generation', 'scheduled energy generation'], ['', 'additional power fluctuations'], ['costs', 'eventually electricity customers'], ['We', 'related power regulation costs'], ['various attribution we', 'strategic market participants'], ['how  mechanisms', 'various market participants'], ['ancillary markets opportunity costs', 'instead energy sales'], ['generator', 'clearing market U'], ['', ''], ['Recent  interest', 'associated opportunity costs'], ['paper', 'time'], ['This', 'daily energy efficiency'], ['numeric  example', 'method'], ['properly  adjusting', 'ancillary opportunity services'], ['Androgen insensitivity syndrome', 'even androgen levels'], ['AIS', 'usually androgen receptor'], ['We', 'evident AR gene mutations'], ['genital skin Western', 'reverse polymerase chain reaction'], ['gene DNA sequence', 'single strand conformation analysis'], ['GSF', ''], ['Northern  blots', 'reduced  10'], ['', 'semiquantitative RT PCR'], ['spanning  exons', 'single splicing errors'], ['Western  analyses', 'low  P1'], ['molecular abnormality sequencing', '472  codon'], ['Intriguingly P1', 'unaltered intronexon boundaries'], ['polymorphic AR gene regions', 'molecular AR gene'], ['particularly AIS those', 'molecular AR gene'], ['we', 'induced  asthma'], ['histological cell which', 'Andrographolide'], ['choalveolar  serum', 'well lung tissue'], ['', 'thus TNF alpha'], ['ROS scavenging', 'NF kappa B'], ['possible  which', 'therapeutic  disease'], ['Therapeutic  options', 'myelodysplastic  agents'], ['which', 'RAS binding RAS domain'], ['Discovery mechanism', 'clinical  trials'], ['safety pharmacokinetics', 'rigosertib'], ['studies', 'molecular  disease'], ['high risk MDS who', 'high risk MDS patients'], ['new Phase III trial', 'findings'], ['Oral  rigosertib', 'recombinant risk erythropoietin'], ['based  signature', 'two  groups'], ['Validation', 'clinical  trials'], ['Most  data', 'specialized  centres'], ['Little', 'clinical CSU practice'], ['AWARE', 'real life setting'], ['', 'refractory AWARE CSU'], ['interventional  study', '2 18 months'], ['demographic characteristics comorbidities', ''], ['Quality', 'DLQI AE angioedema'], ['Previous healthcare resource utilization', ''], ['1539  patients', '256  Germany'], ['age body mass index', 'females'], ['', ''], ['mean control test score', ''], ['frequent  comorbidities', 'two  angioedema'], ['', ''], ['', ''], ['', ''], ['', ''], ['6  %', 'second generation H1-antihistamines'], ['', ''], ['', ''], ['', ''], ['total AE QoL scores', ''], ['', ''], ['', ''], ['', ''], ['CSU patients', 'frequent emergency services'], ['', ''], ['', ''], ['', ''], ['refractory CSU patients', 'heavily healthcare resources'], ['AimsThymomas', ''], ['vascular  study', 'histological World Health account'], ['WHO', 'quantitative trypsin digestion'], ['2 PDGF B', 'reverse polymerase chain reaction'], ['tight B thymomas', 'increasing B3 thymomas'], ['VEGFR1', 'A tumour thymomas'], ['', 'highest thymoma thymomas'], ['', 'TSQCCs'], ['Hif-1', 'up B3 thymomas'], ['ConclusionThymomas', 'angiogenic growth factors'], ['findings', 'major thymoma subtypes'], ['immune  that', 'immune  pathogenesis'], ['', 'transcriptomic Immunology V2 platform'], ['', ''], ['', ''], ['', 'tubal control ligation'], ['Menstrual  stage', 'secretory participants'], ['', 'eutopic transcriptomics patients'], ['Endometria', 'fertile control subjects'], ['eutopic control 396', 'ectopic control endometrium'], ['91/579 control genes', 'particularly cell apoptosis'], ['We', 'fertile endometriosis women'], ['', 'Reproductive Medicine'], ['Fish protein hydrolysate', 'fungus Penicillium digitatum'], ['strongly  I', 'radical scavenging assay'], ['two size exclusion chromatography', 'high purification 2'], ['', 'initial  protein'], ['major  peptides', 'following mass sequences'], ['', ''], ['', ''], ['high amino I', 'enzyme inhibitory activities'], ['two novel peptides', 'functional muscle hypertension'], ['', 'International Union International Biochemistry'], ['-activated Cl channels', 'physiological  processes'], ['However  role', 'endothelial  hypertension'], ['we', 'endothelial  function'], ['confocal patch clamp recordings', 'confocal polymerase chain imaging'], ['TMEM16A', 'endothelial -activated Cl cells'], ['Angiotensin II', 'endothelial TMEM16A expression'], ['induced blood overexpression', 'opposite  effects'], ['reactive p22phox protein that', 'hypertensive angiotensin challenge'], ['Moreover  TMEM16A', 'dependent degradation pathway'], ['reactive Nox2-containing NADPH which', 'endothelial  dysfunction'], ['Modification', 'associated  diseases'], ['', ''], ['Ang  II', 'vascular  remodelling'], ['tissue inhibitors', 'remodelling  processes'], ['present  AngII', 'smooth muscle vivo'], ['', ''], ['', 'ng min s'], ['', ''], ['AngII', 'mg  day'], ['', ''], ['normal  saline', '1 Sprague week'], ['effect', 'hypertensive TIMP-2 rats'], ['Control', 'renal sham artery'], ['blotting polymerase chain expression', 'immunohistochemistry'], ['Systolic blood pressure', 'week tail cuff method'], ['', ''], ['Exogenous AngII administration', 'expected  SBP'], ['', 'treated  group'], ['increase', 'AngII'], ['Administration', 'significant TIMP-2 expression'], ['smooth muscle that', 'treated  rats'], ['hypertensive rats SBP', 'P'], ['', 'operated  rats'], ['Plasma renin activity', ''], ['', 'other  groups'], ['expression', 'TIMP-2'], ['05', '2K1C  rats'], ['', ''], ['exogenous vivo AngII', 'smooth muscle cells'], ['effect', 'induced blood angiotensin'], ['Angiotensin II', 'eclampsia  pathogenesis'], ['', 'angiotensin II type'], ['We', 'pregnant  women'], ['endothelial  cells', 'puerperant  women'], ['cells', 'microRNA-155  plasmid'], ['situ  hybridization', 'real PCR immunofluorescent staining'], ['', 'regulated kinase immunoprecipitation'], ['pregnant  women', 'pregnant  women'], ['1 receptor expression', 'eclamptic  patients'], ['Mature miR-155', 'kinase 1/2 kinase activation'], ['miR-155  expression', 'severe  eclampsia'], ['secreting renin cells', 'vertebrate  phylogeny'], ['vertebrate  variation', '1 5 Ang I'], ['Variations', 'cartilaginous amino acid fish'], ['Angiotensin homologues', 'nonmammalian  vertebrates'], ['RAS renin angiotensin those', 'particularly peptide tissues'], ['important  functions', 'ion fluid ion kidney'], ['Stimulation', 'molecular paracrine RAS'], ['review', 'nonmammalian angiotensin vertebrates'], ['fundamental  that', 'physiological  implications'], ['biological  us', 'complex RAS mammals'], ['suitable  models', 'primitive  animals'], ['', ''], ['Several eel species', 'local  level'], ['aim', 'important eel conservation plans'], ['', ''], ['records', 'migratory eel period'], ['data', 'loss'], ['additional  information', 'three eel species'], ['', ''], ['', ''], ['records', 'local eel past'], ['which', 'local  factors'], ['', ''], ['three eel species', 'various  factors'], ['correlations', 'eel glass eel fisheries'], ['which', 'natural glass stocks'], ['', ''], ['current FAO numbers', '109 aquaculture specimens'], ['requirement', 'largely  A'], ['glass eel trade', 'international  level'], ['', ''], ['when  they', 'certain  ways'], ['great  that', 'other  perception'], ['that', 'goal  memory'], ['better  that', 'better  displays'], ['', 'lower level factors'], ['when  they', 'actively  target'], ['that', 'oriented  target'], ['Subjects', 'matching shapes'], ['', 'efficient control matching'], ['perceiving  animacy', 'such  stimuli'], ['', ''], ['', ''], ['rights', ''], ['than  researchers', 'human  line'], ['many  findings', 'studies'], ['associated  capacities', 'humans'], ['gestural  that', 'gestural  communication'], ['Social network analysis', 'social  information'], ['Here  we', 'captive Automated Learning baboons'], ['We', 'behavioral observation techniques'], ['presence  network', 'social  group'], ['best  correlation', '500 computer day'], ['what', 'located testing booths'], ['social  that', 'social network analysis'], ['It', 'cognitive network individuals'], ['', 'endometrial horse inflammation'], ['protein-3 plasma lactoferrin', 'immune  vitro'], ['addition', 'susceptible mRNA mares'], ['1 seminal spermatozoa', 'two  stallions'], ['endometrial  biopsy', 'selected  inflammation'], ['Seminal plasma treatment', '1 mRNA beta'], ['', ''], ['', 'mRNA TNF'], ['', ''], ['Lactoferrin', 'also mRNA TNF'], ['', ''], ['exogenous  lactoferrin', 'susceptible  mares'], ['various  forms', 'domestic family violence'], ['little animal research', 'interpersonal animal offenses'], ['present  study', 'Behavioral Analysis Unit'], ['III which', 'sexual animal cruelty U'], ['', ''], ['', '2004'], ['sample', 'demographic  characteristics'], ['28 child %', 'restraining  order'], ['Significant  relationships', 'sexual animal humans'], ['results', 'domestic risk groups'], ['', 'C Elsevier Ltd'], ['neuropsychiatric  which', 'neuropsychiatric animal disorders'], ['Advances', 'neuropsychiatric animal disorders'], ['Genetics', 'new animal models'], ['effects', 'therapy'], ['Parallel', 'such NIH MATRICS'], ['latter  changes', 'thus  psychology'], ['', ''], ['rights', ''], ['We', 'evolutionary  immunity'], ['exploratory risk individuals', 'parasite  exposure'], ['behavioral  styles', 'immune  function'], ['responsiveness  both', 'intricately  immunity'], ['Here  we', 'wrens Malurus cyaneus'], ['also body condition none', 'behavioral corticosterone birds'], ['fast  explorers', 'natural  antibodies'], ['result', 'fast  species'], ['', 'immune exploration indices'], ['behavioral  style', 'CORT'], ['Taken', 'proactive  individuals'], ['', ''], ['rights', ''], ['therapeutic  hypothermia', 'traumatic brain injury'], ['neuronal  TBI', 'neuronal  sprouting'], ['We', 'pericontusion neuronal pericontusion rats'], ['rats', '3 normothermia h'], ['rats', '7  FPI'], ['expression', 'immunofluorescence  blot'], ['expression levels', 'real polymerase chain reaction'], ['mild  hypothermia', 'ipsilateral normothermia TBI group'], ['pericontusion neuronal', 'TBI'], ['Moreover  mechanism', 'decreased  SOCS3'], ['We', 'CCA human CCA cells'], ['Expression', 'human cell lines QBC939'], ['negative control plasmid', 'QBC939 cells'], ['infection efficiency expression', 'QBC939 cell'], ['expression', 'significantly RBE cell'], ['QBC939 cell', 'scramble QBC939 plasmid'], ['ratio', 'QBC939-KD cell'], ['proliferation activity', 'QBC939-NC QBC939-KD cells'], ['ANXA5', 'important CCA cells'], ['Inhibiting', 'proliferation migration QBC939 cells'], ['tumor suppressor', 'dependent cell cycle kinases'], ['endogenous lectin changes', 'anoikis carcinoma signals'], ['dependent  impact', 'also  galectin-3'], ['', 'negative lectin lectin'], ['steady galectin-3-specific that', 'transcriptional  rate'], ['cell surface which', 'anoikis caspase-8 activation'], ['opposite  effects', 'anoikis  activity'], ['undescribed  orchestrated', 'fine tumor suppressor'], ['local  which', 'early rectal cancer'], ['related T2N0 rectal who', 'alternative  approach'], ['This', ''], ['American College', 'Oncology Group trial'], ['cT2N0 rectal adenocarcinomas', 'local chemoradiation excision'], ['Anorectal MAIN OUTCOME function', 'Functional Therapy Colorectal Questionnaire'], ['multivariable  analysis', 'outcome'], ['Seventy one Seventy patients', '1  year'], ['significant  differences', '1 Severity Index year'], ['Incontinence Quality Fecal Incontinence results', 'significantly  lifestyle'], ['', 'p'], ['', ''], ['', ''], ['significantly well being', 'surgery'], ['perception chemoradiation scores', 'worse Cancer Therapy'], ['short cancer diagnosis', 'short follow information'], ['Chemoradiation', 'year  surgery'], ['Overall  quality', 'different  subscales'], ['information', 'expected  outcomes'], ['Numerous  patients', 'surgical  procedures'], ['important  that', 'defecation'], ['regulatory  which', 'important muscle development'], ['reverse model that', 'ethylenethiourea'], ['expression', 'developing model rat embryos'], ['gradually rat embryos', 'normal  embryos'], ['however model rat expression', 'normal rat embryos'], ['Western  blotting', 'normal rat embryos'], ['expression', 'potential ARM ARMs'], ['individuals', 'autism spectrum difficulties'], ['healthy comparison age', 'adolescent onset AN'], ['We', 'short Test Animated Triangles'], ['social episode which', 'first episode AN'], ['Mood problems', 'difficulties'], ['Parents', 'recovered Vineland II'], ['', 'bodily  gesture'], ['social episode which', 'stable  disorder'], ['Only  participants', 'social  cognition'], ['', '2016 Adolescent Health'], ['rights', ''], ['perception', 'experimental type videos'], ['distance', 'it'], ['observed  individual', 'comfortable  distance'], ['male  individual', 'interpersonal  controls'], ['individual person object', 'individual anorexic patients'], ['results', 'third  perspectives'], ['', ''], ['We', 'avian influenza virus'], ['We', 'various PCR methods'], ['positive  we', 'virus'], ['RNA', '1'], ['', ''], ['', ''], ['', '48  Mallards'], ['Overall  prevalence', 'AIV Mallards'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['respectively  difference', ''], ['', ''], ['Hemagglutinin subtypes', 'H5'], ['Mallards', 'greatest  subtypes'], ['We', 'late AIV winter'], ['two  peaks', 'AIV Mallards'], ['prevalence', 'seasonal Mute patterns'], ['Glutamatergic system abnormalities', 'depressive  disorder'], ['Subsequent', 'clinical mood disorders'], ['stabilizer lithium', 'antidepressant  effects'], ['We', 'riluzole  BDep'], ['aged', '8  weeks'], ['Rating scale scores', 'Anxiety Mania Rating Scale'], ['significant  differences', 'depressive  placebo'], ['', ''], ['Anxiety scores', 'significantly placebo group'], ['', ''], ['subjects', 'treatment response'], ['depressive BDep trial', 'subject  withdrawals'], ['demonstrate', 'adjunctive  disorder'], ['system', 'OAM OAM states'], ['which', 'digital  baseband'], ['near field scanning platform', 'OAM system'], ['platform', 'multiple transmitting array'], ['Iteration', 'feed port'], ['experimental  results', 'tunable OAM beams'], ['', 'temporoparietal  junction'], ['cognitive  mechanism', 'domains'], ['we', 'one  task'], ['mental context states', 'spatial cueing paradigm'], ['This', 'cortical cue networks'], ['We', 'discriminable rTPJ anterior'], ['functional  regions', 'attention cueing'], ['ventral ToM function', 'respective  network'], ['present  results', 'further  mechanism'], ['', 'anterior cruciate ligament reconstruction'], ['72 New Zealand rabbits', '48 group group'], ['incidence', 'CT 3D reconstruction'], ['tendon bone healing', 'nuclear bone graft'], ['Reverse polymerase chain reaction', 'OPG RANKL expression'], ['group C', 'best time points surgery'], ['OPG mRNA levels', 'OPG group A'], ['', ''], ['RANKL  levels', 'group A'], ['', ''], ['3  incidence', 'groups B'], ['', ''], ['underlying tendon bone mechanism', 'early bone operation'], ['Words', 'cortical  presentation'], ['', ''], ['', ''], ['standing  patterns', 'conceptual capture modality information'], ['semantic  studies', 'precise  function'], ['current  investigation', 'functional imaging ATL'], ['voxel pattern analysis', 'temporal input lobe'], ['resting state that', 'auditory default mode network'], ['analytic  decoding', 'such connectivity comprehension'], ['Thus  we', 'meaning  ATL'], ['Humans', 'human  animals'], ['internal  they', 'adaptive  behavior'], ['we', 'attributing resonance humans'], ['undergoing fMRI participants', 'subsequently  emotional'], ['', ''], ['', ''], ['', ''], ['', 'same baring images'], ['', 'prior causal studies'], ['moreover observation degree', 'human  animals'], ['gratuitous  humans', 'other  ourselves'], ['C1q', 'immune  complexes'], ['Impaired  clearance', 'C1q antibody formation'], ['C1q antibody', 'well Systemic Lupus Erythematosus'], ['Significance', 'Indian SLE patients'], ['aim', 'serological  SLE'], ['2012 classification criteria', 'Clinical Vellore March'], ['C1q antibody', 'ELISA'], ['Logistic regression analysis', 'serological Lupus Nephritis'], ['', ''], ['76  %', '126 SLE LN'], ['C1q  levels', 'those'], ['', ''], ['C1q antibody', 'biopsy C1q immunofluorescence specimens'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'C1q  serum'], ['low  C4', 'anti SLE patients'], ['isoquinoline alkaloid berberine', 'antibacterial  infection'], ['bactericidal  effect', 'antibacterial  macrophages'], ['bacterial  we', 'murine macrophages'], ['berberine', 'IL-1 interleukin-1 macrophages'], ['Such  effects', 'AMPK AMPKa process'], ['IL-1 beta ability', 'also engulfed berberine'], ['bacterial  load', 'berberine treatment'], ['Moreover berberine administration', 'peritoneal neutrophil cavity'], ['berberine', 'AMPK inflammasome signaling'], ['antibacterial  which', 'negative inhibition bacteria'], ['it', 'bacterial  invasion'], ['study', 'antibacterial Bombyx mori'], ['BmGLP', 'reported clone BmGloverin2'], ['transcription', 'Northern blotting hybridization analysis'], ['genomic  gene', '3  introns'], ['Interestingly  we', 'relative  introns'], ['BmGLP2 gene', 'relative-  genome'], ['prokaryotic cell we', 'truncated  existence'], ['', 'physiological cell conditions'], ['further expression system', 'actual insect organism'], ['type', 'evolutionary immunity gene variation'], ['white lifecycle Litopenaeus', 'white lifecycle shrimp'], ['small heat shock protein', 'peroxinectin'], ['expression', '3  PL1'], ['Peroxinectin', 'different  substages'], ['Lysozyme Penaeidin', 'experimental  eggs'], ['Lysozyme', 'shrimp Zoea'], ['however expression transcription', 'larvae  11'], ['proPO', 'larval  substages'], ['Heat shock', 'first larval substages'], ['early larval shrimp', 'metamorphic  substages'], ['human  they', 'leading  death'], ['', 'bacterial novel strains'], ['Therefore  attention', 'conventional antimicrobial chemotherapies'], ['bacterial cell quorum', 'biofilms'], ['communication', 'infectious quorum diseases'], ['mariculture  study', 'mariculture  China'], ['total  concentrations', 'range'], ['', ''], ['', ''], ['', ''], ['', 'respectively water range'], ['', ''], ['', ''], ['', ''], ['', 'respectively sediments samples'], ['occurrence', 'antibiotic resistance sites'], ['absolute copy number', 'relative sulfonamides resistance genes'], ['', ''], ['dominant resistance genes', 'mariculture  sites'], ['significantly water abundance', 'significantly sulfadiazine concentrations'], ['abundance', 'significantly sediment oxytetracycline'], ['findings', 'mariculture Southeast China'], ['', ''], ['', ''], ['rights', ''], ['alga Cladophora glomerata', 'lower Great Lakes'], ['we', 'large Lake Ontario'], ['up gradient wetland they', 'urban surface run sources'], ['significant  differences', 'down gradient beach samples'], ['', ''], ['Decaying', 'treated  plates'], ['', 'different ABR genes pattern'], ['Some', 'coastal wetland sites'], ['environmental  Cladophora', 'bacterial life cycle stage'], ['aquatic  which', 'further  research'], ['antibiotic tetG ereA', 'typical wastewater treatment winter'], ['1 integron gene', 'real polymerase chain reaction'], ['', ''], ['', ''], ['52 log variation', 'raw swine summer'], ['ermB ermF', ''], ['abundance', 'individual removal summer'], ['relative  fate', 'ARGs'], ['relative lagoon treatment', 'relative  ermF'], ['tetM biofilters', 'two sampling seasons'], ['concerned', 'total  abundance'], ['relative  abundances', 'tetG'], ['tetG', 'ereA wastewater treatment'], ['This', 'public  health'], ['genetic kinetic genes', 'furthermore silico tools'], ['catalytic penams none', 'well  clavulanate'], ['Bla(Mmas', 'higher  cefotaxime'], ['which', 'least carbapenemase BlaMmas'], ['flexible class which', 'hydrolysis antibiotics'], ['3 consensus which', 'bla(Mab'], ['probably  that', 'important mycobacterial carbapenems'], ['broad spectrum they', 'positive pathogens mycoplasmas'], ['second  generation', 'improved antimicrobial 1960s'], ['third generation TC', '2006'], ['two TC analogues omadacycline', 'clinical  evaluation'], ['key  intermediate', '50 TC years'], ['approaches', 'biosynthetic engineering efforts'], ['new  opportunities', 'biosynthetic TC drug engineering'], ['', 'two TC decades'], ['based antibody research that', 'integrated antibody sequence'], ['sophisticated  that', 'structural  constraints'], ['available  version', 'well Protein Data Bank'], ['own  sequences', 'also web interface'], ['sequences', 'determining  regions'], ['mutations', 'which'], ['This', 'different  species'], ['abYsis', 'developing antibody drugs'], ['abYsis', 'www'], ['', ''], ['', ''], ['', 'C Elsevier Ltd'], ['introduction', 'clinical transplantation practice'], ['interpretation', 'potential organ donor'], ['aim', 'dependent assays cytotoxicity'], ['retrospective  analysis', '2012 transplantation waiting March'], ['samples', 'CDC assay'], ['', '563  302'], ['7  %', 'HLA antibodies'], ['', 'positive  assays'], ['', '173'], ['7  %', 'discordant  results'], ['5  %', ''], ['3  %', ''], ['positive  seven', 'immunizing  events'], ['Evaluation', 'clinical organ events'], ['Effects', 'binary toxin ricin'], ['We', 'macrophages Kupffer cells'], ['Chemokine profiles', '2 ribonuclease protection neutrophils'], ['blood cell pooling', 'progressive hypoglycemia fibrin deposition'], ['Monoclonal antibody', 'intravenously  death'], ['ricin  antibody', '10 toxin exposure'], ['specific amino acid chain', 'therapeutic  effect'], ['emergence', 'full Kupffer host'], ['data', 'therapeutic ricin intervention'], ['HIV-1 infection', 'primarily mucosal transmission'], ['HIV protection', 'based vaccine development'], ['broadly SHIV challenge that', 'functionally  isotype'], ['IgA2 CH31 isoforms', 'potently HIV-1JR CSF'], ['However  IgG1', 'expressing effector tissue'], ['respectively dose SHIV nnAbs', 'high dose SHIV challenge'], ['IgG1 isotype bnAbs', 'greater IgG1 variants'], ['findings', 'primary HIV-1 vaccine development'], ['', ''], ['', 'Elsevier B'], ['', ''], ['Immunoglobulin therapy', 'primary immunodeficiency disease'], ['Allergist  immunologists', 'best immunoglobulin patients'], ['equally  they', ''], ['Minimizing', 'minor patient care'], ['Immunoglobulin', ''], ['choice', 'clinical immunoglobulin product care'], ['', '2016 Allergy Asthma'], ['antibody production number', 'conventional  methods'], ['Hybridoma technology', 'autoimmune target disorders'], ['humanized murine antibodies', 'several  limitations'], ['recent  advances', 'recombinant phage display antibodies'], ['engineered  antibodies', 'conserved affinity targets'], ['Advanced antibody engineering techniques', 'extensive immunology biotechnology diagnostics'], ['', 'dynamic antibody development approaches'], ['Therefore  review', 'polyclonal  antibodies'], ['together technologies immunomodulation', 'healthier antibody humans'], ['Somatic  mutations', 'immune antibody variable repertoire'], ['mutational  we', 'VEGF antibody G6'], ['31', 'binding  function'], ['beneficial variable domain mutations', 'variable  domains'], ['We', 'binding interdomain conformational fragment'], ['somatic  mutations', 'corresponding domain G6'], ['', ''], ['Therefore  modulation', 'important antibody vivo'], ['most cancer patients', 'advanced  stage'], ['early risk detection', 'mortality rate'], ['positive  rate', 'unnecessary follow up scans'], ['negative  results', 'delayed lung cancer'], ['thereby CT that', 'earlier lung cancer'], ['immune lung system', 'high affinity autoantibodies'], ['autoantibody response', 'early stage lung years'], ['Identification', 'early lung cancer'], ['expressed autoantibody that', 'early lung cancer'], ['Immune  defenses', 'wild parasite animals'], ['However  understanding', 'immune nonmodel organisms'], ['Here  we', 'immune Soay sheep parameters'], ['evaluation', 'different cell isotypes'], ['crucially age they', 'demographic  groups'], ['immune age trends', 'immune  markers'], ['other delta T markers', 'sexes'], ['overwinter  sheep', 'winter independent age sex'], ['different study circulating', 'natural antibody selection'], ['certain antibody types', 'natural  conditions'], ['', 'novel HIV vaccine research'], ['ultimate  vaccines', 'immune  responses'], ['growing  evidence', 'induced antibody infection'], ['candidate  vaccines', 'traditional antibody immunity'], ['', 'based vaccine design approaches'], ['Ultimately  neutralizing', 'robust vaccine HIV'], ['humoral response that', 'high  resolution'], ['humoral vaccine that', 'protective  responses'], ['cellular immunology that', 'functional vaccine strategies'], ['Acute myeloid leukemia', 'immature myeloid lineage blasts'], ['', 'acquired drug resistance'], ['AML blasts', 'antibody therapy'], ['well HLA which', 'therapeutic effector antibodies'], ['Importantly IFN', 'therapeutic antibody daratumumab'], ['IFN treatment', 'MV4 daratumumab'], ['IFN', 'mediated Cr-51 release'], ['also  combination', 'AML cells'], ['treatment', 'significantly tumor growth'], ['together  studies', 'therapeutic  AML'], ['Bacillus thuringiensis', 'different insect agriculture'], ['Moreover Bt toxin genes', 'modified  crops'], ['new biology potentials', 'Bt'], ['environmental  features', 'due metal nanoparticles parasporins'], ['review', 'genetic cry engineering'], ['suitable cell that', 'valuable  bioproducts'], ['aim', 'experimental autoimmune myocarditis'], ['Characteristics', 'myocardial  hematoxylin'], ['messenger RNA messenger levels', 'real polymerase chain reaction'], ['Serum concentrations', 'IFN ELISA'], ['immune inflammatory score levels', 'CTLA4'], ['Furthermore  parameters', 'CD40L intervention mAb'], ['IL-4 levels', 'costimulation blockade serum'], ['Therefore costimulation blockade', 'CD40L CD40L mAb'], ['Objective', 'periodontal Porphyromonas diseases'], ['therapeutic  that', 'proinflammatory enzymes'], ['we', 'selective proinflammatory proteinases'], ['B NF activation', 'northern  blotting'], ['Rgps', 'activated protein kinase'], ['DX-9065a', 'mRNA  expression'], ['DX-9065a', 'amidolytic  vitro'], ['inflammatory  DX-9065a', 'periodontal  disease'], ['', 'Cytoscape software'], ['Designed  series', 'reference standard insilico modeling'], ['3a j 3a analogs', 'antidepressant  activity'], ['', 'benzo 4-(1H benzo[d]imidazol-2-yl)-4-oxobutanoic d'], ['synthesized  compounds', 'IR H-1-NMR'], ['antidepressant  activities', '20mg drug kg'], ['most', 'potent  depression'], ['3d 3e it', '50mg immobility kg'], ['prevalence  who', 'antidepressant treatment emergent mania'], ['ATEM- that', 'stringent  criteria'], ['We', 'classified ATEM+ cases'], ['87  %', 'antidepressant ATEM monotherapy'], ['substance', 'disorder'], ['', 'one suicide attempts'], ['', 'depressive  illness'], ['', '73  males'], ['84  %', 'positive thyroid disorder'], ['', 'positive BD I'], ['', ''], ['', ''], ['first risk profiles', 'significantly  gender'], ['40  %', 'antidepressant'], ['depressive  who', 'partially  citalopram'], ['Seventy nine Seventy adults', '6 label weeks'], ['symptomatic  6-weeks', '6  weeks'], ['who', '6  weeks'], ['3  %', '50 Depression Rating Scale'], ['40mg  19', '40mg  vilazodone'], ['groups', 'significant outcome groups'], ['Initial  nonresponders', 'higher  citalopram'], ['increase', 'adverse event profile'], ['depressive  disorder', 'usual  approaches'], ['Patients', 'verbal fluency test'], ['reactions', 'initial NIRS investigation'], ['subjects', 'psychological  anxiety'], ['VFT', 'frontotemporal  lobes'], ['We', '12 serotonin reuptake weeks'], ['Subjects', '19 Response response'], ['hemodynamic  responses', 'Response  treatment'], ['hemodynamic  responses', 'Response Response treatment'], ['Patients', 'several  measures'], ['Response  groups', 'interpersonal Anxiety Cognition Scale'], ['one stepwise regression variable', 'independent  response'], ['relatively  we', 'future  studies'], ['spatial  which', 'when measurement NIRS'], ['Cognitive  vulnerabilities', 'SSRI treatment response'], ['hemodynamic  activities', 'frontotemporal SSRI MDD'], ['panic  which', 'study'], ['study', 'psychiatric Tokyo Japan'], ['they', 'diagnostic panic disorder'], ['Assessments', 'Severity Symptomatology Self Report'], ['Eighty four Eighty individuals', '30  patients'], ['7  %', 'psychological  antidepressants'], ['', ''], ['', 'total  SDS'], ['PDSS scores', 'total illness scores'], ['binary regression model', 'remission'], ['', ''], ['longer  duration', 'antidepressants'], ['one  third', 'psychological disorder drugs'], ['especially  who', 'chronic  illness'], ['', ''], ['rights', ''], ['', 'human  placenta'], ['medical literature information', 'MEDLINE PubMed SCOPUS'], ['Electronic  searches', 'antidepressant  exposure'], ['clinical  significance', 'biochemical  architecture'], ['exposure', 'fetal  behavior'], ['Two  cases', 'fetal  tachyarrhythmia'], ['Future  research', 'placental depression functioning'], ['Moreover ultrasound studies', 'fetal  antidepressants'], ['behavioral  patterns', 'gestational  period'], ['Analyses', 'maternal mood symptoms'], ['Antibodies', 'potential safety risk'], ['immunized LMB that', 'human T cell SS1P'], ['BALB c mice', 'two  epitopes'], ['human subdominant both', 'LMB T20'], ['drug T cell mice', 'developed T cell assays'], ['ability', 'other LMB antigens'], ['elimination', 'foreign T cell protein'], ['Cellular  Immunology', ''], ['immunologically  treat', 'suggested  autoantibody'], ['Therefore  we', 'cognitive resonance decline'], ['uncontrolled  study', 'negative methylprednisolone immunotherapy'], ['patients', 'seizures'], ['when pulse therapy', 'antiepileptic  drugs'], ['9/28  mood', '11  %'], ['Immunotherapy', '75  %'], ['Clinical  changes', 'other'], ['Outcomes', ''], ['Immunological  treatment', 'MRI seizure improvements'], ['Treatment success', 'immunological  treatment'], ['immunosuppressive MRI seizures treatment', 'negative MRI seizures cognition'], ['ERp57', 'endogenous antigen presentation'], ['length rainbow that', 'signal  16aa'], ['nuclear localization which', 'highly  mammals'], ['Amino acid sequence alignment', 'classical  trout'], ['Trout ERp57 protein', '57  kDa'], ['two  copies', 'highest gene liver'], ['ERp57  transcript', 'stranded  RNA'], ['trout protein expression levels', '6 cell h'], ['findings', 'immune  response'], ['', ''], ['rights', ''], ['respectively helper T cells', 'respectively helper T pathogens'], ['detected T cells', 'immune cytotoxic T response'], ['immune  surveillance', 'processing tumour detection'], ['Evasion', 'significant event tumour cancer'], ['significantly cytotoxic T', 'tumour'], ['MHC class MHC I', 'significantly  peptides'], ['modified peptide repertoires', 'immune  evasion'], ['how  it', 'therapeutic cell targets'], ['20%-30 % risk', 'dominant healthcare providers'], ['Immune tolerance induction', 'emotional  burden'], ['certain risk factors', 'confidently FVIII inhibitor'], ['predictive  tool', 'untreated tolerance patient'], ['growing  body', 'therapeutic  interventions'], ['we', 'translational  medicine'], ['838 dideoxymy that', 'presenting T molecule'], ['', ''], ['tuberculosis', 'solid sub milligram quantities'], ['esterification amidation that', 'equivalent Z antigenicity'], ['that', 'restricted T cell receptors'], ['TCRs', 'natural DDM stereochemistry'], ['', 'immunizing transfusion pregnancy'], ['antibodies', 'organ transplant'], ['when kidney they', 'immunizing antecedent event'], ['antibodies', 'natural  antibodies'], ['work', 'HLA kidney transplant'], ['', ''], ['One C1q Lambda', 'Luminex  Results'], ['HLA antibodies', '25'], ['', ''], ['antibodies', ''], ['', ''], ['study', 'low HLA literature'], ['', '63  %'], ['involvement', 'renal  transplant'], ['', ''], ['', 'Elsevier Masson SAS'], ['rights', ''], ['Glycyrrhiza uralensis', 'medicinal  properties'], ['', 'G'], ['adventitious  roots', 'active  compounds'], ['', 'Monomorphic mother G'], ['uralensis', 'adventitious DNA roots'], ['liquiritin', 'glycyrrhizic G'], ['', 'performance liquid mass spectrometry analysis'], ['adventitious  roots', 'native  roots'], ['', 'G'], ['uralensis active components elicitors', 'adventitious roots culture'], ['combination', 'synergistically glycyrrhetinic acid'], ['', ''], ['', 'single  treatment'], ['', 'conclusion'], ['adventitious  roots', 'exploitable  licorice'], ['', 'International Union International Biochemistry'], ['significant  which', 'burn  fatalities'], ['related  aims', 'six year period'], ['', 'burn burn 2009'], ['patient urine stool which', 'antibiotic  profiles'], ['inhibitory concentration pathogen', 'resistant  antibiotic'], ['aggregated  data', 'six year study period'], ['', 'negative  study'], ['positive culture group', ''], ['', ''], ['', 'longer  hospitalizations'], ['', ''], ['', 'negative  group'], ['', 'isolated resistance heat pathogens'], ['aureus Pseudomonas aeruginosa', 'individual resistance pathogens'], ['together  results', 'related  pathogens'], ['antibiotic  choice', 'in burn trends'], ['antibiotic polymerase chain reaction', 'antibiotic  choice'], ['Antimicrobial  peptides', 'central skin immunology'], ['growth factors', 'such atopic dermatitis'], ['', ''], ['impact', 'bacteremic antimicrobial stewardship patients'], ['', ''], ['adult who', 'infectious diseases specialist'], ['they', 'common skin contaminants'], ['', ''], ['', ''], ['antibiotic  that', 'empirical antimicrobial dose'], ['', ''], ['total', 'bacteremic  analysis'], ['Implementation', 'empirical order entry bacteremia'], ['median  TFAD', '1:23  hr'], ['', ''], ['Patients', 'related  mortality'], ['30-day  mortality', ''], ['', ''], ['Early  notification', 'related drug mortality'], ['Extrapulmonary  tuberculosis', '%  tuberculosis'], ['confirmation', 'always laboratory personnel'], ['We', 'various  EPTB'], ['Materials  We', 'fine needle aspirates'], ['These', 'nested chain IS6110'], ['Results', 'gold standard'], ['Diagnostic  MPT64', 'gold standard'], ['overall sensitivity specificity', 'predictive  MPT64'], ['Immunostaining', 'early Mycobacterium tuberculosis infection'], ['technique', 'routine pathology laboratories'], ['Panax notoginseng', 'bioactive  compounds'], ['we', 'cultivation'], ['', 'adventitious  root'], ['', ''], ['g(-1', 'native  one'], ['', ''], ['', ''], ['bioactive  we', 'adventitious root culture'], ['It', 'total  saponins'], ['', ''], ['g(-1', '5  mg'], ['which', ''], ['', 'native  roots'], ['', '45-fold control group'], ['new mass spectrometry compounds', 'elicitors'], ['JA', 'CYP450 enzyme superoxide activities'], ['', 'International Union International Biochemistry'], ['Bioactive antioxidant peptides', 'oxidative food stress'], ['', 'commercial wheat emmer enzymes'], ['', ''], ['Hydrolysates', 'purified antioxidant activity'], ['thirteen ESI QTOF peptides', 'sequence'], ['Four  peptides', 'lipid ABTS peroxidation'], ['impact', 'promoting  ingredients'], ['', ''], ['rights', ''], ['few nutrient which', 'biological  ageing'], ['present  we', 'one carbon transfer length'], ['MethodsThe study', 'based 40 cohort'], ['We', '2003 food frequency vitamins'], ['We', '2011 follow up November'], ['potential  LTL', 'positively vitamin C'], ['', ''], ['', ''], ['', 'participants'], ['', 'stratified vitamin C'], ['', 'P'], ['', ''], ['', 'only  participants'], ['which', 'aged  adults'], ['Cigarette smoke extract', 'epithelial chloride cells'], ['Oxidants', 'cystic transmembrane conductance regulator'], ['CFTR', 'cigarette vivo'], ['effects', 'Calu-3 cell CFTR expression'], ['17  who', 'detectable CFTR gene infertility'], ['Northern', 'Western  blotting'], ['Extensive CFTR genotyping', 'subject'], ['Nasal PD measurements', 'free  buffer'], ['Cigarette smoke', 'Calu-3 cell lines'], ['nasal  PDs', 'free CFTR nonsmokers'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['CFTR deficiency', 'respiratory cigarette smokers'], ['CFTR deficiency', 'chronic  bronchitis'], ['', 'endothelial  cells'], ['Expression', 'Northern  blotting'], ['Western  blotting', 'HO-1 ferritin protein levels'], ['ROS oxygen formation', 'enhanced  chemiluminescence'], ['15-kb HO-1 that', 'vivo bioluminescence imaging'], ['Lansoprazole', 'endothelial HO-1 protein macrophages'], ['', 'induced cell systems'], ['ferritin', 'mediated ROS formation'], ['scavenging  properties', 'chromium mesoporphyrin IX'], ['Induction', 'activated protein kinase pathway'], ['3-kinase inhibitor LY294002', 'dependent  mRNA'], ['Activation', 'gastric  LY294002'], ['', ''], ['rights', ''], ['Plasma gelsolin', 'mainly actin filaments'], ['several  it', 'diagnostic  values'], ['pGSN  level', 'Indian  study'], ['study', 'disease age sex status'], ['Blood samples', 'immunosorbent flow assay'], ['level', 'infected  patients'], ['', ''], ['3g  ml', 'healthy  volunteers'], ['', ''], ['', ''], ['CD4 cell patients', 'pGSN CD4 levels'], ['however treatment reduces', 'pGSN  level'], ['healthy  difference', '24  %'], ['mm(3 CD4 cell group', 'treated % patients'], ['pGSN  it', 'inversely CD4 cell counts'], ['Treatment', 'pGSN ARV normal'], ['monitoring', 'important  treatment'], ['Antisynthetase syndrome', 'inflammatory  myopathies'], ['It', 'acid  synthetase'], ['digital  association', 'digital  ischemia'], ['rare  that', 'interstitial lung disease'], ['Comprehensive  evaluation', 'subclinical  myositis'], ['initial screening autoimmune serologies', ''], ['different lighting lamps', 'outdoor advertising facilities'], ['order', 'occasionally advertising lamps'], ['thefts security system', 'digital control paper'], ['system', 'on  line'], ['which', 'outdoor advertising lighting'], ['Graft  disease', 'hematopoietic cell transplantation'], ['prior GVHD evidence', 'efficacy'], ['We', 'ATG allo HCT'], ['relative  risk', '95 % confidence outcome'], ['Rabbit ATG', 'overall  acute'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['overall  chronic', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'increased  relapse'], ['', ''], ['', ''], ['', ''], ['', ''], ['horse ATG', 'overall  aGVHD'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['ATG', 'related  mortality'], ['', ''], ['', ''], ['', ''], ['', 'increased  infections'], ['Further  studies', 'varied optimal graft'], ['DV Dermacentor that', 'release factor histamine release homolog'], ['', 'three wood tick D'], ['lone Boophilus star', 'Boophilus microplus'], ['respectively polypeptide comparisons', '91 DAHRF AAHRF'], ['Phylogenetically  tick', 'vertebrate % bootstrap clades'], ['northern blotting probe', '900 RNA blots'], ['', 'mouse polyclonal mouse E'], ['', ''], ['immature RNA DVHRF transcription', 'immature RNA DVHRF ticks'], ['binding TCTP function', 'CaCl2)-Ca-45 tick HRF assay'], ['protein family', 'multiple tick species'], ['Purpose  Aciclovir', 'first herpes simplex virus'], ['Long term administration', 'immunocompromised drug resistance'], ['Furthermore  emergence', 'herpetic  keratitis'], ['review', 'refractory ACV therapy'], ['Recent Genotypic testing', 'resistant  HSV'], ['based  systems', 'unknown drug phenotypes'], ['antiviral generation which', 'patient  management'], ['that', 'clinical DNA development'], ['drug resistance monitoring', 'high risk populations'], ['biochemical  that', 'certain  disorders'], ['objective', 'compulsive anxiety disorders disorder'], ['Findings', 'international Disorders Research Network'], ['present  article', 'such natriuretic NGF'], ['accompanying  paper', 'Part neuroimaging'], ['high quality that', 'neurobiological anxiety OCD'], ['typically autism spectrum which', 'social  impairment'], ['present  study', '57 SRS-2 children'], ['', 'all parent report'], ['Children', 'four SRS-2 subscales'], ['Children', 'two  subscales'], ['social  deficits', 'anxiety'], ['parents', 'violence substance abuse'], ['children', 'psychosocial  problems'], ['study', 'related anxiety depression life'], ['sectional  study', 'six  hospitals'], ['consecutive  parent', '2014 suicide children'], ['5  17years', 'participation'], ['Parents', 'related Youth Self life'], ['reference data', 'normed cutoff score'], ['eligible  families', '46  study'], ['Participating  children', 'reported community instruments'], ['differences', 'total sum scores'], ['', ''], ['', ''], ['', ''], ['', 'statistically community children'], ['traumatic stress difference', 'statistically community difference'], ['psychosocial  parents', 'community samples'], ['traumatic stress we', 'traumatic stress symptoms'], ['different  that', 'etiological behavior differences'], ['work', 'longitudinal community sample'], ['old  age', 'psychological parents children'], ['Growth Mixture Modeling', 'six  trajectories'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['2  that', 'older  subjects'], ['specifier  ODD', 'null functioning trajectory'], ['secondary  variant', 'worse  age'], ['It', 'disruptive preschool age'], ['identification', 'etiological  class'], ['', ''], ['rights', ''], ['Psychosocial  distress', 'cancer patients'], ['adult cancer little', 'social  adolescents'], ['aims', 'same distress population'], ['551 AYA patients', 'Chinese Network Distress Thermometer'], ['prevalence', 'psychological  distress'], ['', 'Chinese  cancer'], ['old DT scores', 'positively  anxiety'], ['', 'medical  coping'], ['', ''], ['prevalence', 'general cancer population'], ['coping  support', 'psychological AYA cancer patients'], ['Findings', 'social AYA cancer patients'], ['Nurses', 'psychological AYA cancer patients'], ['study', 'acute coronary syndrome'], ['illness  beliefs', 'cardiac event threat time'], ['total', '97  hospital'], ['Perceived  threat', 'partly threat reappraisal'], ['high illness concern', 'emotional  distress'], ['', 'acute coronary syndrome event'], ['people', 'inappropriate illness beliefs'], ['purpose', 'metabolic anxiety Taiwan'], ['Purposive  sampling', 'experimental  study'], ['Participants', '3 exercise program'], ['Study measures', 'personal behaviors anxiety levels'], ['Of', 'experimental control group'], ['Participants', 'repeated estimating measures'], ['State anxiety levels', 'experimental  group'], ['Finally  prevalence', 'experimental metabolic group'], ['HB exercise program', 'Taiwanese anxiety disorders'], ['Health providers', 'mental anxiety communities'], ['anxiety', 'related goal conflict stimuli'], ['emotional target faces', 'distracting  words'], ['related accuracy trade off', 'conflicting target word'], ['positive  stimuli', 'differentially information processing'], ['positive  stimuli', 'related  stimuli'], ['', ''], ['rights', ''], ['secondary products drug they', 'secondary products drug metabolites'], ['cyanobacterial  that', 'psychoactive  effects'], ['Cyanobacteria', 'dichloromethane CNS targets'], ['major  peak', 'cyanobacterial  HPLC'], ['behavioral animal that', 'open  field'], ['2064H', 'known serotonin depression'], ['2064H', '59'], ['6 % inhibition', 'other IC50 receptors'], ['2064H', 'first tail suspension test'], ['2064H', 'open field test'], ['2064H', 'nocifensive formalin test'], ['', 'affective pain behaviors'], ['results', 'active  compounds'], ['Symptoms', 'traumatic fibromyalgia patients'], ['patient control differences', 'mental stress disorder health'], ['30  patients', 'traumatic stress disorder'], ['Fibromyalgia patients', 'mental stress controls'], ['Patient control differences', 'traumatic stress disorder symptoms'], ['Healthcare providers', 'mental trauma health'], ['Monitoring', 'good quality care practice'], ['', 'prospective  distress'], ['clinical  we', 'longitudinal anxiety distress'], ['Brazilian cancer patients', 'three time chemotherapy'], ['first anxiety depression', 'last midway chemotherapy'], ['', 'significant  anxiety'], ['prevalence', '4'], ['', '6  anxiety'], ['', '1  depression'], ['', ''], ['Female patients', 'male  counterparts'], ['', ''], ['elevated  levels', 'treatment completion'], ['aged  patients', 'heightened  distress'], ['psychosocial  intervention', 'chronic illness distress'], ['possible  extent', 'attentional control bias'], ['We', 'cognitive threat load'], ['high  worriers', 'low  worriers'], ['', 'significant  condition'], ['', 'attentional control ability'], ['more  individuals', 'cognitive control resources'], ['finding', 'biased control threat'], ['anxiety that', 'ambiguous anxiety situations'], ['younger assessment that', 'interpretive self processing'], ['interpretive  bias', 'older  adults'], ['However  evidence', 'only self report measures'], ['older text comprehension that', 'self report memory measures'], ['older  adults', 'ambiguous trait information'], ['report  that', 'interpretive anxiety bias'], ['Extensive  studies', 'such autism spectrum disorder'], ['stress', 'cognitive  functions'], ['we', 'TD stress children'], ['Cognitive functions', 'emotional TD others'], ['higher salivary which', 'respectively TD children'], ['Autism spectrum quotient', 'positively ASD children'], ['negative  correlation', 'spatial TD children'], ['chronic stress hormone elevation', 'cognitive ASD subjects'], ['', ''], ['', 'Elsevier IBRO'], ['individual Attachment differences', 'primary adult attachment caregivers'], ['who', 'secure  relationships'], ['who', 'insecure attachments'], ['', 'research self compassion'], ['', ''], ['psychological  lack', 'psychological self distress'], ['', ''], ['', ''], ['Additionally  fear', 'negatively self compassion'], ['how self compassion', 'Korean college students'], ['self compassion', 'expected self directions'], ['Results', 'Korean self compassion'], ['', ''], ['rights', ''], ['however ubiquitin proteasome roles', 'squamous cell carcinoma'], ['purpose', 'functional  OSCCs'], ['We', 'reverse polymerase chain reaction'], ['correlations', 'UBE2S IHC scoring system'], ['We', 'functional OSCC assays'], ['UBE2S', 'vivo'], ['', 'primary tumoral size'], ['cell cycle', 'shUBE2S M cells'], ['lower anaphase that', 'E3 ubiquitin shMock cells'], ['oral cancer UBE2S', 'potential  OSCCs'], ['', ''], ['rights', ''], ['', 'microbial receptor teeth'], ['inflammasomes', 'periapical  immunohistochemistry'], ['relative gene expression levels', 'real polymerase chain reaction'], ['forty seven forty teeth', 'bacterial sinus PCR'], ['THP-1-derived  treated', 'immunosorbent beta secretion assay'], ['AIM2', 'inflammatory  cells'], ['that', 'also NLRP3 mRNA'], ['Porphyromonas endodontalis', '47  cases'], ['', '4 Fusobacterium nucleatum'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Furthermore  we', 'P'], ['gingivalis', 'IL-1 THP-1 inflammasomes'], ['NLRP3  proteins', 'periapical  periodontitis'], ['', 'such  P'], ['', ''], ['', ''], ['microbial  that', 'periapical  tissues'], ['', ''], ['rights', ''], ['Ligands', 'specific gene manner'], ['vitamin D metabolite', 'biological  effects'], ['expression HepG2 hepatocytes', '24  25-(OH)(2)D(3'], ['Main I protein levels', 'Western  blotting'], ['I promoter activity', 'chlorampenicol acetytransferase assay'], ['HepG2 apo I', 'I HepG2 cells'], ['expression HepG2 cells', 'plasmids'], ['containing plasmid lacking A', 'containing 24 25-(OH)(2)D(3'], ['Likewise  treatment', 'heterologous site promoter'], ['mediated VDR depletion', 'silencing 24 apo'], ['endogenous apo I', 'independent signaling mechanism'], ['', ''], ['rights', ''], ['Apolipoprotein E', 'synaptic membrane brain'], ['genotype', 'sporadic  disease'], ['when  injury', 'related  AD'], ['how  level', 'aging  brain'], ['Therefore  we', 'male mRNA mice'], ['level', 'old mouse cerebral cortex'], ['normal  level', 'mediated brain functions'], ['critical  process', 'outer  membrane'], ['process', 'domain Bcl-2 family proteins'], ['apoptotic  Bax', 'MOM'], ['apoptotic  proteins', 'forming Bcl process'], ['apoptotic  structures', 'apoptotic  functions'], ['apoptotic Bcl-2 family we', 'bio informatics cell questions'], ['All', 'apoptotic Bcl-2 family property'], ['N termini', 'apoptotic  function'], ['apoptotic  potency', 'alpha 5/6 helix domains'], ['Charge distribution', 'apoptotic alpha potency'], ['different  members', 'apoptotic domain process'], ['Degenerative disc disease', 'costly  society'], ['principle  NCCM', 'nucleus pulposus disc nucleus cells'], ['STUDY DESIGN/ This', 'vitro'], ['pulpous  cells', 'spinal Fas NCCM'], ['antiapoptotic  events', 'usingWestern blotting methods'], ['We', 'NP inflammatory cytokine secretion'], ['', 'apoptotic human pathway'], ['induced apoptosis we', 'Western  blotting'], ['immunosorbent assay results', 'distinct NP NCCM'], ['that  NCCM', 'stressinduced human NP cells'], ['Soluble  factors', 'novel  DDD'], ['', ''], ['rights', ''], ['PCD', 'important development homeostasis'], ['cDNA microarray', 'mouse embryonic mouse brain'], ['Cortical  cells', 'serum deprivation'], ['', '8  hours'], ['We', 'apoptotic  cells'], ['Based', 'four RT PCR'], ['ULK2  we', 'cell death ULK2'], ['several  that', 'PCD'], ['Especially  GAPDH', 'ULK2'], ['ULK2', 'p53 pathway'], ['Background', 'several domain family systems'], ['we', 'hepatocellular Qidong County'], ['Methods', 'Northern polymerase chain HCC'], ['Qidong Institute cell we', 'formation cell cycle progression'], ['We', 'cellular mitomycin treatment'], ['RASSF1A transcript', 'primary HCC cell biopsies'], ['positive virus surface who', 'tumor'], ['wt)-RASSF1A expression', 'fewer G(1)/S vivo'], ['also D1 protein which', 'transcriptional  control'], ['when DNA cells', 'mitomycin'], ['RASSF1A', 'tumor HCC'], ['loss', 'RASSF1A hepatocarcinogenesis'], ['inactivation', 'important  HCC'], ['Neutrophil function', 'infecto inflammatory infecto diseases'], ['', 'such biofilm ages'], ['study', 'different  F'], ['nucleatum', 'neutrophil function'], ['Methods', 'like leukemia F'], ['nucleatum', 'subspecies'], ['nucleatum', ''], ['', ''], ['', ''], ['', 'Neutrophil F'], ['strains', 'flow cytometry'], ['Superoxide generation', 'M cytochrome C stimulation'], ['Proinflammatory cytokine release', 'different 2 F'], ['nucleatum', ''], ['B mRNA B levels', 'real polymerase chain reaction'], ['experiment', 'times  triplicate'], ['Data', 'hoc Bonferroni correction'], ['', 'F'], ['nucleatum', 'phagocytic  neutrophils'], ['', 'Neutrophil F'], ['nucleatum', ''], ['polymorphum', 'significantly  F'], ['nucleatum', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['nucleatum', ''], ['', ''], ['polymorphum', 'induced superoxide generation'], ['', ''], ['', 'F'], ['25 superoxide impact', 'as  ssp'], ['', ''], ['', ''], ['', ''], ['strains', 'significant neutrophil control'], ['', 'increased B k neutrophils'], ['', ''], ['Levels', 'significantly necrosis factor F'], ['', 'nucleatum control'], ['', ''], ['findings', 'different  F'], ['', 'different neutrophil ways'], ['', 'oxidative neutrophil superoxide neutrophils'], ['previously  they', 'dental  ecosystem'], ['High  glucose', 'reactive oxygen species'], ['We', 'treated rat mesangial cells'], ['RMCs', '5'], ['Cellular  apoptosis', 'dUTP nick end labeling'], ['Collagen', 'reverse polymerase chain reaction'], ['Mitochondrial capacity', 'fluorescence cytometry'], ['Cellular ATP production', 'MDA luciferin luciferase reaction'], ['c release polymerase cleavage', 'Western  blotting'], ['treated  RMCs', 'cellular  apoptosis'], ['reactions', '1 m M NAC'], ['', ''], ['generation activities', 'effectively  NAC'], ['NAC', 'oxidative  stress'], ['', ''], ['', ''], ['Many  microRNAs', 'smooth muscle cells'], ['real polymerase chain it', 'expressed  vitro'], ['Subsequently  gain', 'function vivo'], ['miR-30e', 'VSMCs  vivo'], ['overexpression', 'significantly phenotypic VSMCs'], ['Knockdown', 'as miR-30e mimic'], ['protein which', 'NF'], ['', ''], ['miR-30e', 'atherosclerosis  VSMCs'], ['kappa Ba NF kappa B', 'pathway'], ['Ascorbic acid', 'commercial China South Korea'], ['we', 'discovered color A'], ['', 'green japonicus morph'], ['Six test diets', '800 ascorbic acid 1-ascorbyl-2-polyphosphate'], ['60 growth energy budget', '60 test days'], ['ascorbic acid levels', 'significant  A'], ['', ''], ['', ''], ['Superoxide dismutase', 'other ascorbic acid treatments'], ['dietary ascorbic acid', 'beneficial  growth'], ['when ascorbic acid levels', 'mg  kg'], ['those', 'significant  level'], ['high  levels', 'dietary ascorbic growth'], ['green  morphs', 'immune system capacity'], ['', 'Optimum  A'], ['japonicus', 'green ascorbic morphs'], ['Appendiceal cancers', 'mucocele pseudomyxoma peritonei'], ['surgical  standard', 'metastatic  disease'], ['Samples', 'certified  laboratory'], ['total', 'female tumor 2'], ['rest', '9 % goblet cell'], ['next  generation', 'situ gene hybridization'], ['5  %', '12  TLE3'], ['NGS', 'following  genes'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['0  %', ''], ['', ''], ['high drug resistance which', 'individualized  treatment'], ['incidence', '5FU  capecitabine'], ['Therapeutic includeTOPO1 inhibitors', 'irinotecan  inhibitors'], ['Clinical PIK3CA FBXW7', 'Clinical SMAD4 APC ATM'], ['statistical  analysis', 'colorectal  cancers'], ['findings', 'personalized Caris Life Sciences'], ['abundant  which', 'cholesterol  effect'], ['therapeutic  efficacy', 'lowering  effect'], ['', 'increased serum lipids level'], ['rabbits', 'baseline stage'], ['eight APCs group', 'normal  diet'], ['resected medial aorta', 'molecular  biology'], ['Results', 'significantly control group'], ['Serum lipid profiles', 'groups'], ['Immunohistochemistry', '1 APCs group'], ['Western  blotting', 'increased APCs group'], ['APCs administration', 'atherosclerosis'], ['APCs', 'atherosclerotic  agent'], ['', ''], ['', ''], ['rights', ''], ['Apples', 'high polyphenol content'], ['aim', 'stored apple cubes'], ['then degrees samples', '5 degrees C'], ['pulsed V vacuum', '5  process'], ['lower temperature process', 'higher temperature process'], ['50 degrees C', 'better polyphenol oxidase inactivation'], ['PVOD OH treatment', 'fresh degrees apples'], ['We', '2'], ['', ''], ['', 'real 4-D applications'], ['gain control subaperture beamformer', 'digital transducer 0'], ['', '019-mm(2  element'], ['transducer assembly', '10-Fr'], ['diameter  catheter', 'preclinical ultrasound imaging studies'], ['image quality image modes', '2-D ICE catheters'], ['4-D field', 'cardiac  anatomy'], ['4-D ICE', 'ray electrophysiology ablation procedures'], ['4-D ICE', 'structural heart procedures'], ['', 'closely  humans'], ['', ''], ['dogs', 'attentional  stance'], ['', 'rather information companionship'], ['We', 'attentional  humans'], ['first  we', 'human approach goats'], ['when  experimenter', 'account head orientation'], ['only experiment one', 'them'], ['head orientation', 'alone choice behaviour'], ['', 'two training trials'], ['subsequent probe test goats', 'attentional  states'], ['inattentive  person', 'away  subject'], ['attentive experiment who', 'whole  blind'], ['one  person', 'only  eyes'], ['rather  companionship', 'attentive choice state'], ['However  results', 'validating head results'], ['Understanding', 'neural action persons'], ['approach avoidance action that', 'target'], ['', ''], ['rejected  Petra', 'bank'], ['We', 'target word'], ['we', 'approach avoidance action'], ['component', 'more approach sentences'], ['related  potential', 'negative avoidance actions'], ['less fear avoidance negativity', 'greater approach trait'], ['differently avoidance target', 'approach avoidance actions'], ['Implications', 'emotional action language'], ['we', 'time nonlinear control systems'], ['network  one', 'desired  accuracy'], ['given  that', 'given  pattern'], ['length that', 'most length m'], ['such computer techniques', 'k'], ['length approximate string matching', 'molecular string biology'], ['We', 'length approximate string edit'], ['length approximate string matching', 'circular sequence alignment'], ['how  it', 'regulatory  regions'], ['how  it', 'increasing distance thresholds'], ['Fixed approximate string matching', 'classic approximate string matching problem'], ['We', 'fixed approximate string matching'], ['further  maintenance', ''], ['high efficiency method', 'bridge core PSFB'], ['current power sensor', 'lower power loss'], ['time domain model', 'secondary side rectifiers'], ['asymmetric phase which', 'imbalance'], ['60  prototype', 'proposed  method'], ['numerical  difference', 'approximately side peak 0'], ['Meanwhile PCM efficiency', '93 PSFB 93'], ['', ''], ['We', 'resistant expression apricot'], ['', 'Plum fragment length polymorphism'], ['expressed twenty cDNA', 'metabolism transduction defense stress'], ['Seven', 'quantitative RT PCR'], ['expression patterns', 'resistant P armeniaca cv'], ['', 'susceptible  genotype'], ['susceptible class III which', 'resistant  phenotype'], ['like kinesin protein', 'susceptible  interaction'], ['candidate  genes', 'quantitative virus PPV'], ['', ''], ['rights', ''], ['high harvesting which', 'short shelf life'], ['spoilage shelf reactions', 'finished  products'], ['products', 'whole food year'], ['possible Southern Italy industry', 'aseptic steam treatment'], ['last food industries', 'friendly quality productions'], ['Therefore  aim', 'production Life Cycle study'], ['environmental  impacts', 'dry LCA basis'], ['Data', 'SimaPro'], ['', ''], ['5 Ecoinvent database', 'industrial reference LCA'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['regardless power market prices', 'electricity'], ['large  that', 'considerable consumer prices'], ['medium APT we', 'wavelet decomposition approach'], ['APT price effects', 'market'], ['2 months we', 'corresponding NordPool market prices'], ['significant APT effects', 'long  run'], ['', ''], ['asymmetric price transmission effects', 'short  run'], ['we', 'dependent months decomposition variable'], ['', ''], ['large  changes', 'asymmetric price transmission effects'], ['retail  which', 'efficient  market'], ['temporal  inefficiencies', 'still  consumers'], ['wavelet quantile methods', 'empirical  evidence'], ['viral animal it', 'bacterial  aquaculture'], ['adjuvant  which', 'rarely fish species'], ['', 'study recombination plasmid'], ['molecular  adjuvant', 'several channel catfish'], ['injection', 'response humoral response immunity'], ['relative  percent', '%  S'], ['', '4 week post'], ['', ''], ['', 'higher  73'], ['', 'pcENO+pcIL-8  pcENO'], ['', '8 weeks p'], ['', ''], ['together  results', 'long channel S'], ['', ''], ['study', 'long DNA time'], ['Fish', 'human  consumption'], ['Sustainable aquaculture procedures', 'conventional aquaculture procedures'], ['sustainable  they', 'sustainable aquaculture products'], ['combination', 'face choice face'], ['Data', 'different  Germany'], ['sustainable  aquaculture', 'high animal welfare standards'], ['Overall  participants', 'local fish products'], ['two aquaculture claims', 'positive choice purchase'], ['specific  labels', 'sustainable buying decision'], ['Overall  consumers', 'sustainable  aquaculture'], ['However communication measures', 'decisive buying behavior'], ['', ''], ['rights', ''], ['study', 'genetic Lactococcus sequencing'], ['report', 'sorubim Pseudoplatystoma sp'], ['', 'two  vaccines'], ['efficacy', '30 days vaccination'], ['', ''], ['', ''], ['', 'L'], ['', '15 30'], ['', ''], ['', ''], ['immune  response', 'treatments'], ['', ''], ['', 'relative percentage survival 81'], ['', '30  d'], ['', ''], ['', ''], ['adjuvanted  vaccine', 'greater agglutination antibody d'], ['', ''], ['', ''], ['immune sorubim responses', 'studied  animals'], ['adjuvanted  vaccine', 'effective  L'], ['', ''], ['connective tunica etiology', 'connective tunica albuginea'], ['molecular  mechanisms', 'mechanical  PD'], ['Aquaporin', 'primarily collagen network'], ['ever  AQP1', 'differentially  patients'], ['AQP1 PD', 'patients'], ['AQP1 overexpression', 'mechanical  trauma'], ['AQP1', 'promising  PD'], ['4 degenerate PCR', '4  cDNA'], ['complete coding region', 'then  5'], ['other dogfish AQP4', 'high  levels'], ['', 'lower  Agnathan'], ['', ''], ['', ''], ['dogfish', ''], ['2  kb', 'highly rectal gland'], ['where  level', '>  intestine'], ['when  fish', 'rectal gland kidney'], ['quantitative PCR experiments', 'significant RNA 63'], ['', 'acclimated gill AQP4 dogfish'], ['function', 'AQP4 Xenopus laevis oocytes'], ['osmotic P this', 'pH'], ['Permeability', 'other mercury species'], ['enhanced  which', 'other  species'], ['small membrane that', 'osmotic plasma gradient'], ['Mammals', 'subcellular  AQPs'], ['inner AQP AQPs', 'distinct fluids endolymph'], ['inner ear we', 'inner expression ear'], ['inner expression levels', '8  E18'], ['particular expression level', 'P3-P21'], ['We', 'outer hair cells'], ['Immunohistochemistry', 'supporting root cells'], ['AQP9 which', 'marked expression level'], ['quantification  we', 'inner ear function'], ['worldwide  vaccines', 'friendly  control'], ['AQP water channels', 'good tick infestations'], ['Here  we', 'AQP conserved I'], ['', 'tick larval mortality'], ['vaccination', 'respectively  I'], ['', 'cumulative tick survival'], ['effect', 'previous tick R'], ['', 'cattle tick infestations'], ['AQP', 'different tick species'], ['', ''], ['rights', ''], ['previous  work', 'canalicular bile water'], ['we', 'canalicular bile secretion'], ['', ''], ['', 'defective cholestasis hepatocyte'], ['5 bile flow', '58  %'], ['', ''], ['34 kDa AQP8', 'vesicular liver membranes'], ['induced alpha cholestasis', 'subcellular sinusoidal AQP9'], ['Immunohistochemistry', 'liver observations'], ['Osmotic water permeability', 'canalicular stopped flow spectrophotometry'], ['', 'functional  expression'], ['mRNA  expression', 'posttranscriptional protein level reduction'], ['lysosomal protease inhibitor leupeptin', 'induced AQP8 downregulation'], ['AQP8 protein expression', 'mediated  degradation'], ['canalicular membrane AQP8 expression', 'osmotic membrane water permeability'], ['data', 'cholestatic bile secretory hepatocytes'], ['black fly species', 'striatum species Thailand'], ['species', 'pupal gill filaments'], ['we', 'multiple cytology molecular S'], ['', ''], ['', ''], ['', ''], ['c oxidase I', 'taxa'], ['1  sequences', 'clearly  S'], ['', 'S'], ['', ''], ['', ''], ['two  taxa', 'molecular DNA sequences'], ['', ''], ['nakhonense', 'undifferentiated chromosome banding patterns'], ['Morphological  examination', 'intermediate gill forms'], ['', ''], ['', ''], ['biological  that', 'gill filaments'], ['Thus  we', 'S'], ['', 'S'], ['', ''], ['study', 'immune gilthead sea bream'], ['onshore aquaculture noise that', 'concrete fish farming'], ['third  group', 'acoustic  control'], ['albumin control fish', 'other  groups'], ['mild stress that', 'sea bream welfare'], ['potential  recovery', 'industrial yeast waste residue'], ['two phase systems', 'therefore  residue'], ['PEG)-potassium phosphate ATPS', 'molecular partition invertase'], ['then brewery yeast that', 'potential  enzyme'], ['Results', '400 g 45'], ['0  %', 'bottom purification 29'], ['', 'to recovery 66'], ['', 'total  15'], ['', ''], ['This', '15'], ['', 'bottom  phase'], ['single stage ATPS process', 'invertase'], ['', 'International Union International Biochemistry'], ['', ''], ['function', 'virulent Pseudomonas syringae'], ['transcript blotting abundances', 'avirulent AZI1 P'], ['mRNA accumulation', 'avirulent DNA knockout avrRpm1'], ['', 'avirulent  P'], ['soluble data carbonhydrates', 'systemic  Arabidopsis'], ['', 'avirulent  P'], ['syringae', ''], ['transcript  abundances', 'signaling HXK1 HXK2 SNRK1'], ['', ''], ['', ''], ['bZIP11', 'systemic AZI1 AZI1'], ['immune  system', 'important sugar Arabidopsis'], ['', ''], ['rights', ''], ['individual thaliana ecotype flowers', 'thaliana ecotype Columbia'], ['harboring', 'flattened flower tip'], ['like inflorescence inflorescence', 'reduced cell pedicels'], ['triple crm1 mutants', 'additive  phenotype'], ['which', 'polar auxin transport'], ['CRM1  BIG', 'floral inflorescence meristems'], ['rlr root which', 'developmental crm1 defects'], ['mutant doc1 alleles', 'crm1 doc1 1'], ['responsive DR5rev::GFP expression', '1  pedicels'], ['CRM1  BIG', 'pedicels'], ['', 'increased  PIN1'], ['CRM1  BIG', 'pedicels auxin action'], ['time PCR time PCR', 'routine microarray biomarkers'], ['However  concerns', 'well qRT world'], ['We', 'hydroponic growth conditions'], ['nutritional Arabidopsis technologies', 'same  results'], ['qRT PCR results', 'different nitrate phosphate'], ['expressions', 'PCR blotting analyses'], ['Arabidopsis thaliana', 'established molecular biology A'], ['thaliana gene function', 'important  species'], ['', 'comprehensive  A'], ['thaliana genome', 'research  applications'], ['Such  goal', 'new data acquisition'], ['We', 'wide  A'], ['', 'high throughput transcriptome sequencing'], ['expression', '79  organs'], ['30 splice %', 'intergenic  regions'], ['spliced  that', 'TAIR10  database'], ['data', 'based database TraVA'], ['which', 'differential gene organs'], ['driven laboratory exercise', 'molecular physiology context'], ['Students', 'theoretical plant Arabidopsis thaliana'], ['They', 'experimental  approach'], ['Students', 'such  qPCR'], ['Following', 'sufficient iron supply'], ['Arabidopsis plants', 'fit function mutants'], ['fit mutants', 'acquisition transcription growth'], ['Students', 'quantitative iron reductase manner'], ['Then  students', 'reverse transcription quantitative PCR'], ['Finally  students', 'physiological iron deficiency responses'], ['course concept', ''], ['', 'International Biochemistry'], ['immune cell that', 'pathogen plants'], ['microRNA  miR164', 'essential Arabidopsis thaliana'], ['Cell death symptoms', 'bacterial mir164 mutant pathogens'], ['NAC4 expression', 'negatively miR164 expression'], ['NAC4-binding DNA sequences', 'oligonucleotide site sequences'], ['WRKY40 NAC4 target which', 'negative cell death'], ['immune target process', 'negative  miR164'], ['Hydrogen peroxide', 'various  plants'], ['However reference used', 'H2O2 signaling'], ['inaccurate reference normalization', 'false  conclusions'], ['12 candidate reference genes', 'different  H2O2'], ['UKN', 'oxidative RT qPCR stress'], ['conclusion', 'methyl viologen methyl stress'], ['', 'northern reference blotting'], ['other  researchers', 'oxidative gene expression stress'], ['', ''], ['fiber', 'experimental plant cell elongation'], ['Arabinogalactan  proteins', 'various plant growth'], ['four GhAGP2 GhAGP3 GhAGP4', 'rapid cDNA ends'], ['genes', 'Pro Ala Hyp'], ['putative  proteins', 'like  domain'], ['20 post GhAGP3', 'secondary cell wall synthesis'], ['like AGP genes', 'only  G'], ['', 'also Gossypium barbadense fibers'], ['like  domains', 'cell cotton fiber elongation'], ['Eicosanoids', 'crucial immunity development'], ['potential  links', 'especially PUFA invertebrates'], ['model we', 'exposed eicosapentaenoic animals'], ['Gene expression', 'prostanoid PUFA immunity'], ['Vitellogenin gene expression', 'reproductive food system'], ['dietary PUFA supply', 'immune  functions'], ['', ''], ['rights', ''], ['World experts', 'ecological cave laboratories'], ['intriguing model organisms', 'anthropogenic hypogean disturbance'], ['comprehensive spider biology review', 'topics'], ['information', 'origin population structure ecology'], ['currently hypogean spiders', 'future  research'], ['formed', 'symbiotic plant nature'], ['molecular AM we', 'differential display RT PCR'], ['expressed  genes', 'Northern  blotting'], ['Eleven fragments', 'homologous  alignment'], ['related  five', 'later plant fungus stage'], ['ESTs sequence sequences', 'PCR plant'], ['target genes', 'binding family transporter gene'], ['results', 'molecular woody plants'], ['Arbuscular mycorrhizal', 'terrestrial'], ['They', 'entire  ecosystems'], ['Here  we', 'recognition phylogenetic AMF diversity approaches'], ['Research', 'molecular biology techniques'], ['morphological community level that', 'currently information exchange'], ['We', 'critical AMF species'], ['that', 'different  AMF'], ['', ''], ['rights', ''], ['Archaea', 'every  Earth'], ['molecular  biology', 'archaea'], ['cellular  which', 'extensively  bacteria'], ['', 'dynamic RNA date'], ['wide RNA we', 'used Euryarchaeota Haloferax volcanii'], ['pulse  labeling', 'time  manner'], ['uracil prototrophy', '4TU RNA molecules'], ['4TU  incorporation', 'unprecedented expression network detail'], ['historic  newspapers', 'archaeological  data'], ['where  sites', 'urban  areas'], ['archived  newspapers', 'archaeological  sites'], ['case study', 'archaeological city Fort sites'], ['species', 'Arcobacter genus'], ['', 'However  Arcobacter'], ['most  studies', 'animal origin'], ['few line data', 'currently Arcobacter species'], ['Therefore  aim', 'such lettuces spinaches chards'], ['Resistance', 'isolates'], ['fresh vegetables samples', 'eight  months'], ['study', '41  lettuces'], ['Samples', 'molecular  enrichment'], ['twenty five twenty isolates', 'them'], ['Direct  detection', '4  Arcobacter'], ['', ''], ['percentage', '% 48 h enrichment'], ['fragment length polymorphism', '25 PCR A'], ['', 'A'], ['', ''], ['', ''], ['butzleri isolates', 'levofloxacin'], ['sequencing', '254 gyrA gene'], ['study', 'pathogenic  Arcobacter'], ['fresh  vegetables', 'transmission humans'], ['', 'Moreover  A'], ['butzleri quinolone', 'public health risk'], ['', ''], ['rights', ''], ['', 'Arcobacter'], ['', 'susceptibility'], ['One hundred One samples', '2013 Valencia June'], ['samples', 'directly polymerase chain enrichment'], ['susceptibility', 'disk diffusion test'], ['clarify', 'determining gyrA gene'], ['49  isolates', 'culture'], ['DNA', '32  PCR'], ['positive  68', 'specific Arcobacter spp'], ['', ''], ['49  isolates', 'fragment length polymorphism'], ['Arcobacter 25', ''], ['03 Arcobacter 19', '03 Arcobacter cryaerophilus'], ['77 Arcobacter 5', ''], ['', ''], ['', 'three  A'], ['butzleri', 'antibiotics'], ['mutation C', 'resistant gyrA isolates'], ['pathogenic  arcobacters', 'edible shellfish samples'], ['Moreover  this', ''], ['', ''], ['cryaerophilus', 'cockles'], ['Arctigenin', 'mechanistic rapamycin complex'], ['present  study', 'underlying estrogen receptor'], ['primary Th17-polarization arctigenin', 'dependent  manner'], ['ER which', 'complex transcription activity'], ['Following  activation', 'mTOR complex assembly'], ['Deficiency', 'mediated cell differentiation'], ['colitis mTORC1 response', 'PHTPP treatment'], ['ER beta', 'resultant cell differentiation'], ['that', 'human body communication'], ['proposed method Arduino technology', 'wearable  device'], ['Baseband communication', 'study'], ['Baseband communication', 'operational Arduino noise'], ['study', 'equivalent  phantom'], ['application', 'string'], ['We', 'simple  circuit'], ['In', 'addition electrode'], ['experimental  results', '300 Hz band'], ['Endothelial cell dysfunction', 'renal  failure'], ['NO synthase NO activity', 'crucial  ECD'], ['L arginine', 'sole  biosynthesis'], ['several  that', 'specific arginine transporter'], ['CAT-1', 'major eNOS CRF'], ['orally drinking which', 'endothelial  function'], ['glomerular arginine transport', 'significantly  CRF'], ['Treatment', 'arginine CRF'], ['Northern polymerase chain we', 'glomerular CAT-1 mRNA CRF'], ['CAT-1 protein', 'arginine atorvastatin administration'], ['Renal arginine uptake', 'CAT-1 protein'], ['findings', 'endothelial eNOS uremia'], ['We', 'social dopamine receptor cognition'], ['Participants', ''], ['when  infants', 'tasks'], ['6  mothers', 'social infant cognition'], ['long  DRD4', 'social  cognition'], ['', ''], ['', 'negative crying beta'], ['', ''], ['', ''], ['', ''], ['respectively  which', 'maternal  behavior'], ['', ''], ['', ''], ['indirect  effects', '95 % confidence interval'], ['', ''], ['', ''], ['', '03  AVPR'], ['', ''], ['', ''], ['', 'DRD4'], ['', 'maternal  sensitivity'], ['', ''], ['', ''], ['', ''], ['', ''], ['results', 'European  mothers'], ['', ''], ['', ''], ['maternal  genes', 'social  cognition'], ['main NMDA finding', 'healthy  control'], ['schizophrenic  subjects', 'small control sample'], ['P-[AVP  response', 'psychiatric P screening'], ['This', 'physiological  schizophrenia'], ['NMDA receptor activity', 'glutamate patients'], ['', 'reduced modelling NMDA'], ['clinical  trials', 'depressed NMDA antagonist patients'], ['We', 'proof NMDA receptor function'], ['translational NMDA receptor', 'arginine vasopressin arginine bloodstream'], ['mediated AVP release', 'hypertonic saline infusion'], ['', ''], ['', ''], ['', 'schizophrenia patients'], ['', ''], ['', ''], ['Slopes', 'healthy control subjects'], ['', ''], ['09  which', 'depressed  group'], ['findings', 'related vivo dichotomy'], ['Arginine', 'potent growth activity'], ['acute  treatment', 'also GH gene expression'], ['diabetogenic  Arg', 'ITT glucose decay rate'], ['that', 'GH  content'], ['', 'reduced glucose decay rate'], ['', ''], ['', 'control group'], ['food  it', 'arterial control group'], ['', ''], ['oral  administration', 'insulin resistance'], ['neuronal  that', 'cardiac  function'], ['', ''], ['rights', ''], ['Antimicrobial  peptides', 'pathogenic spectrum microbicidal microbes'], ['big  defensin', 'rapid cDNA ends'], ['scallop AiBD', 'amino signal sequence acids'], ['Tachypleus tridentatus Branchiostoma belcheri AiBD', 'big defensin family'], ['expression', 'Northern blotting analysis'], ['mRNA  transcripts', 'unchallenged  scallops'], ['temporal Vibrio anguilarum challenge', 'real  time'], ['relative expression level', 'drastic  increase'], ['', '32 h injection'], ['bacterial  it', 'immune  A'], ['', ''], ['recombinant  AiBD', 'fungicidal expression host'], ['it', 'therapeutic disease aquaculture'], ['', ''], ['rights', ''], ['injectable  antipsychotics', 'long treatment schizophrenia'], ['400 episode AOM', 'score Syndrome week'], ['negative Marder factor symptoms', 'repeated tension measures'], ['differences', '2  week'], ['Thus  AOM', 'excited component score'], ['AOM', 'extension long term patient outcomes'], ['paper', 'dependent latent structure'], ['state that', 'distributed moving innovations'], ['extreme value distribution', 'tailed error terms'], ['efficient Monte Carlo algorithm', 'normal Gumbel distribution'], ['methodology', 'real  data'], ['Monthly minima', 'proposed model comparison'], ['autoregressive  process', 'minimum stock returns'], ['Superconducting', 'direct wind turbine applications'], ['', 'magnetic air SCSG'], ['paper', 'short 10-MW SCSGs'], ['concept', 'electronic armature winding converters'], ['Four SCSG designs', 'different  topologies'], ['one SCSG segment', 'terminal'], ['second Sigma Delta modulator', 'Capacitor integrator Switched Capacitor'], ['many  people', 'periodic Fourier signal'], ['when  harmonics', 'way'], ['harmonic  expression', 'discrete  moments'], ['we', 'discrete time moments'], ['square  method', 'calculation'], ['harmonic Sigma Delta distortion', 'first Switched Capacitor stage'], ['transfer function', 'second power series'], ['so  feasibility', 'analysis'], ['', 'Korsakovian Arnica dilution'], ['53  women', 'randomly  A'], ['montana', '5  days'], ['main end point', 'serum drainages'], ['Secondary end points', 'self pain'], ['per  analysis', 'mean  A'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['regression model', 'significant patient A'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['following  days', 'significantly  A'], ['', 'days'], ['', ''], ['', ''], ['Secondary end points', 'significant  differences'], ['', ''], ['1000  K', 'total seroma mastectomy'], ['Larger  studies', 'different  A'], ['montana', 'further  data'], ['scientific  life', 'nucleic acids'], ['initial publication scientists', 'extraordinary  claim'], ['active learning classroom exercise', 'scientific presentation argumentation'], ['undergraduate semester biochemistry students', 'civil classroom debate'], ['students', 'scientific life support'], ['based semester biochemistry assignment', 'molecular science curriculum'], ['', 'International Biochemistry'], ['Artemisinin', 'sesquiterpene L'], ['sweet  wormwood', 'extensively  malaria'], ['', 'better  A'], ['annua', 'GUS beta fusion'], ['ADH2', 'biochemical carveol analysis'], ['ADH2 promoter', 'genome walking method'], ['acting promoter ADH2', 'complex regulation mechanism'], ['biosynthetic  genes', 'mainly  leaves'], ['expression', 'quickly leaf PCR'], ['', 'transgenic GUS expression A'], ['ADH2 expression', 'shaped  trichome'], ['', 'International Union International Biochemistry'], ['', ''], ['HS cell lines', 'brain FCR tumors'], ['2 HS cell lines', 'phagocytic  ability'], ['immunocytochemical HS01 cell line', 'HS cells'], ['HS02 cell line', 'dendritic cell markers'], ['Moreover chain reaction analyses', 'histiocytic HS cell lines'], ['HS', 'other  organs'], ['immunodeficient cell lines', 'histiocytic tumor diseases'], ['exogenous RNA interference siRNAs', 'target genes'], ['reagents', 'such activity shRNAs'], ['small  we', 'Drosha  process'], ['fidelity', 'used pri miRNA insert'], ['structural siRNA features', 'Drosha cleavage site selection'], ['shmiR Dicer selects', 'further  processing'], ['basic  results', 'genetic RNAi technology'], ['', ''], ['', ''], ['rights', ''], ['paper', 'signal pressure sensor'], ['bellow', ''], ['deflection', 'monitoring wireless transmission'], ['ferromagnetic  wire', 'thereby self coil'], ['proportional OISCC voltage', 'stray nonlinearity inductances'], ['', 'ANN modeling OISCC'], ['embedded  unit', 'ANN learning process'], ['pressure transducer', 'high  +'], ['', '0  psig'], ['design  aspects', 'technique'], ['One', 'economic power performance'], ['other heat transfer one', 'molten  salt'], ['optimum  designs', 'best ANN topology'], ['economic  potentials', 'hourly thermic performances'], ['it', 'minimum  8'], ['', ''], ['', 'oil  configurations'], ['generation field aperture factor', '26 oil %'], ['', ''], ['rights', ''], ['7 AR V7', 'resistant prostate cancer'], ['available AR V7 identification', 'clinical detection practice'], ['', 'derived exosomal RNA'], ['36 CRPC they', 'second line hormonal treatment'], ['RNA', 'AR ddPCR'], ['Outcome measurements', 'copies target gene ddPCR'], ['Statistical  analyses', 'SPSS software'], ['', ''], ['39  %', 'patients'], ['free  survival', 'AR V7(+ AR patients'], ['', ''], ['Overall  survival', 'V7(- AR participants'], ['', ''], ['reliable AR that', 'sensitively ddPCR assay'], ['hormonal AR it', 'hormonal AR V7'], ['7 AR detection', 'cancer cell blood'], ['Results', 'hormonal AR therapy'], ['reliable AR V7 method', 'reliable AR V7 RNA'], ['', '2016 European Urology'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['most  animals', 'environmental  cycles'], ['ascidian model that', 'vertebrates'], ['', ''], ['such Per that', 'vertebrates'], ['Here  we', 'physiological  levels'], ['dark  rhythm', 'constant  darkness'], ['', '396 microarray spots'], ['corresponding', 'circadian  expression'], ['We', 'northern candidate blotting'], ['expressed  genes', 'light phase period'], ['However  most', 'known clock genes'], ['data', 'that'], ['intestinalis', 'when sea vertebrates'], ['Ascorbate  peroxidase', 'central hydrogen peroxide'], ['approach', 'physiological APX gene enzymes'], ['ascorbate peroxidase ascorbate related', 'RT PCR'], ['coding cytosolic ascorbate that', 'complete cDNA sequence'], ['deduced amino acid sequence', 'virtual cytosolic ascorbate cDNA'], ['southern blotting results', 'possible gene organization'], ['Type VII collagen', 'major epidermal basement membrane'], ['expression', 'Northern protein level'], ['we', 'collagenous type VII domain-1'], ['Ascorbic acid', 'when control culture'], ['effect', 'growth factor'], ['synthesis', 'derived TGF alpha'], ['synthesis', 'elevated protein level'], ['Safety', 'pulsed power supply systems'], ['', 'prone  components'], ['This', 'MST Medium Sized program'], ['which', 'additional  complications'], ['generator', 'integrated drive control'], ['Most  challenging', 'originally motor generator system'], ['accurate control modeling', 'controller'], ['effort', 'calculated design values'], ['Finally  system', 'good AUG plasma experiments'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['Host parasitoid systems', 'defence defence parasitoids'], ['evolutionary arms race', 'immune host responses'], ['However  knowledge', 'such trade offs'], ['', ''], ['aim', 'related Asecodes beetles'], ['geographic  variation', 'northern parasitism sites'], ['', ''], ['such host differences', 'immune  systems'], ['This', 'infected parasitism larvae'], ['', ''], ['results', 'parasitism A'], ['parviclava', 'previous host host'], ['Virulence', 'general  G'], ['', 'G'], ['', ''], ['', 'same  time'], ['pusilla larvae', 'immune  response'], ['', ''], ['observations', 'virulent encapsulation parasitoids'], ['', ''], ['immune  system', 'further host race formation'], ['article', 'suitable diodes construction'], ['that', 'communications'], ['whole  design', 'Mentor Graphics'], ['integrated  they', 'integrated  which'], ['results', 'article'], ['Recurrent  pneumonia', 'hyper IgE syndrome'], ['signs lung symptoms', 'such fever chills'], ['Early  imaging', 'diagnosis'], ['mainstay', 'therapy'], ['progressive disease condition', 'prophylactic  therapy'], ['', '2016 Allergy Asthma'], ['specific T cells', 'invasive  aspergillosis'], ['influence', 'sample cells'], ['Six hour delay', 'cellular cell sample'], ['This', '87 ) A'], ['', 'unstimulated background samples'], ['isolated  PBMCs', 'comparable assay reliability'], ['', ''], ['', ''], ['', ''], ['', ''], ['bound  lipase', 'organic kinetic solvent'], ['various reaction parameters', 'acyl temperature enzyme concentration'], ['optimum reaction conditions', '60 enzyme g'], ['when substrate concentration', '1'], ['', ''], ['enzyme', 'to substrate 1'], ['', ''], ['AOL', 'promising kinetic RS)-1-PE'], ['', 'International Union International Biochemistry'], ['study', 'copolymer poly(3-hydroxybutyrate co-3-hydroxyhexanoate'], ['Large scale PHA biosynthesis', 'biological PHA recovery'], ['microbial biology populations', 'recovered  PHA'], ['Penicillium citrinum Penicillium griseofulvum', 'P(3HB co-3HHx'], ['recovered PHA that', 'spontaneously laboratory conditions'], ['Fungi', 'recovered  PHA'], ['Indoor air pollution', 'public health impact'], ['Monitoring', 'fungal  contaminants'], ['problems', 'increasingly  alternative'], ['real time PCR', 'fungal  detection'], ['which', 'species'], ['HRM  which', 'obtained  amplicon'], ['we', 'airborne Aspergillus occurrence'], ['good qPCR discrimination', 'previously  A'], ['', ''], ['we', 'HRM A'], ['', ''], ['Using', '3 Aspergillus species'], ['positive  negatives', '20 performance Aspergillus'], ['limit', 'species'], ['', ''], ['', ''], ['', '5  A'], ['', ''], ['', ''], ['', '1  A'], ['', ''], ['HRM analysis', 'environmental  samples'], ['We', 'HRM A'], ['', ''], ['', ''], ['', ''], ['study HRM', 'indoor air contaminants'], ['This', 'hence health problems'], ['current  study', 'standardized bone marrow care'], ['multidisciplinary Marrow Working Group', '2012 Europe North America'], ['transferable  recommendations', 'bone marrow disease'], ['current  study', 'present tumor trephinebiopsies'], ['quantitative  analysis', 'polymerase chain reaction'], ['inclusion', 'like polymerase chain reaction'], ['marrow response', 'recording bone'], ['bilateral needle biopsies evaluation', 'aspirates'], ['5 % disease', 'achievable disease assessment'], ['quantitative  assessment', 'numerical bone marrow response'], ['clinical bone impact', 'bone marrow'], ['wide  adoption', 'collaborative trial design'], ['', ''], ['aspirin usage', 'colorectal  cancer'], ['molecular  mechanisms', 'aspirin colon cancer'], ['Quantitative', 'certain target compound'], ['However  method', 'internal expression targets'], ['internal reference genes', 'more cell lines'], ['colon cancer we', 'molecular colon vivo'], ['internal colon which', 'aspirin colon cancer'], ['consideration', 'past assembly decade'], ['Most', 'sheltered work disabled'], ['recently  community', 'when worker heterogeneity'], ['step', 'heterogeneous productivity levels'], ['we', 'cycle workers'], ['We', 'two  goals'], ['trade  that', 'well  objectives'], ['', ''], ['rights', ''], ['thorough  understanding', 'molecular  hypotheses'], ['few  they', 'visual  literacy'], ['list', 'visual core literacy'], ['We', 'visual  literacy'], ['We', 'online resource development'], ['stage overarching stage themes', 'atomic biosciences geometry'], ['corresponding learning many', 'overarching  themes'], ['learning  goals', 'molecular  classrooms'], ['framework', 'visual biology literacy'], ['work', 'visual learning literacy'], ['', 'International Biochemistry'], ['Parental  sense', 'at  families'], ['Researchers', 'parental  families'], ['PSOC  scale', 'Portuguese  parents'], ['reliability validity', 'psychosocial Child Protective Services'], ['Portuguese  version', 'psychometric  properties'], ['obtained  factors', 'negatively parenting stress'], ['parental self it', 'at  mothers'], ['', ''], ['', ''], ['', 'rich North Island'], ['Agathis australis', 'ecologically  ecophysiology'], ['', 'environmental  A'], ['australis trees', ''], ['We', 'active assimilation rates'], ['We', 'stomatal behaviour model'], ['A', 'old leaf leaves'], ['Instantaneous water use efficiency', ''], ['diurnal  results', 'that'], ['0900  A', 'comparatively  day'], ['Overall water use efficiency', 'intrinsic water use efficiency'], ['Isotopic  analysis', 'other temperate conifers'], ['information', 'water A'], ['', 'forest giants'], ['', 'immune leukocyte antigens pregnancy'], ['AimsTo', 'viable HLA E pregnancy'], ['specific  who', 'assisted reproduction treatment'], ['ResultsThere', 'significant ART couples'], ['allele HLA E*01:03', '63'], ['', '2 ART 35'], ['', 'fertile  men'], ['', ''], ['E allelic variants', 'viable  pregnancy'], ['reproductive  medicine', 'oocyte embryo donation'], ['Pregnancy', 'parasitic  infections'], ['parasitic antigen field', 'immune  phenomena'], ['', ''], ['', ''], ['recent  research', 'reproductive  medicine'], ['research', 'maternal pregnancy tolerance'], ['immune  pathways', 'also organ self'], ['', ''], ['', 'autoimmunity'], ['Identifying', 'reproductive  immunology'], ['Recent  studies', 'controversial serine threonine results'], ['Here frequencies', 'normotensive WNK4 controls'], ['dry  people', 'essential salt hypertension'], ['Genotypes', 'direct fragment length sequencing'], ['Expression pattern', 'vitro hormone stimulation assays'], ['systolic blood pressures', 'Ala589Ser polymorphism'], ['', 'other WNK4 gene organs'], ['acting  elements', 'promoter gene'], ['glucocorticoid hormone', 'dependent  manner'], ['WNK4 gene', 'essential  hypertension'], ['Ala589Ser polymorphism', 'increased  disease'], ['Asthenozoospermia', 'male  infertility'], ['mutations', 'subsequently sperm asthenozoospermia'], ['purpose', 'high sperm motility'], ['Semen samples', 'northern  Iran'], ['extraction', 'total polymerase chain reaction'], ['deletion', '85'], ['', '14  controls'], ['', ''], ['', ''], ['', ''], ['', ''], ['It', 'induced mtDNA 4977-bp population'], ['mtDNA  deletions', 'bioenergetic  disorders'], ['Nevertheless', 'broader  research'], ['Current US guidelines', 'disease treatment'], ['goal', 'severe asthma exacerbations'], ['18 Race years', 'southeastern health Michigan'], ['baseline  which', 'ACT'], ['severe asthma exacerbation', 'oral emergency department visit'], ['operator characteristic Receiver operator curves', 'severe asthma exacerbations'], ['', ''], ['0  %', 'baseline asthma evaluation'], ['composite ACT score', 'rescue medication use'], ['', ''], ['based  records', 'composite ACT score'], ['composite  score', 'severe asthma exacerbations'], ['', '2016 Allergy Asthma'], ['uncontrolled  asthma', 'increased asthma exacerbations'], ['high blood eosinophil counts', 'burden'], ['', 'exacerbations SUA'], ['Patients', 'acting asthma beta(2)-agonist'], ['prospective II follow up', 'prospective  phase'], ['2  %', 'eosinophil count'], ['year index date', 'multivariable  regression'], ['eosinophil cutoff point', '2 asthma exacerbations'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '95 % CI 691'], ['high blood eosinophil count', 'limited emergency department power'], ['', '2016 Allergy Asthma'], ['ie', 'developing asthma age'], ['most', 'United States'], ['objective', 'severe US birth cohort'], ['We', 'pregnant Obstetric Maternal 1998'], ['they', 'health system'], ['electronic health we', 'underlying pregnancy study'], ['birth cohort', ''], ['9  %', 'severe  bronchiolitis'], ['', ''], ['', 'developed  age'], ['', 'severe  bronchiolitis'], ['', 'developed  age'], ['severe risk bronchiolitis', '5 risk years'], ['', ''], ['', ''], ['', ''], ['large Boston birth frequency', 'published  data'], ['', 'prior  studies'], ['', ''], ['difference', 'different study designs populations'], ['', '2016 Allergy Asthma'], ['born  children', 'other US children'], ['Mexican AZ)Sonora border', 'environmental asthma region'], ['prevalence', 'AZ Sonora border'], ['video questionnaires', 'middle  schools'], ['prevalence', 'American AZ students'], ['', 'significantly US schools'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['adjusted  OR', 'significantly schools A'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'significantly  A'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'school E'], ['', 'significantly United States'], ['that', 'asthma'], ['', '2016 Allergy Asthma'], ['FDC dose inhaler', 'uncontrolled UK guideline asthma'], ['evidence', 'separate LABA inhaler'], ['objective', 'uncontrolled FDC asthma'], ['primary care databases', '2-year follow up period'], ['children', 'first ICS monotherapy'], ['Two  cohorts', 'add FDC inhaler'], ['Matching variables', 'baseline follow up'], ['Outcomes', 'subsequent  year'], ['primary  outcome', 'acting room visit bagonist'], ['final  study', '1330  cohort'], ['separate ICSDLABA odds', 'adjusted odds ratio'], ['', ''], ['', ''], ['', ''], ['', 'FDC cohort'], ['separate asthma this', 'current guideline recommendations'], ['', '2016 Allergy Asthma'], ['increased  fraction', 'based asthma study'], ['', 'S ECP asthma asthmatics'], ['Methods Measurements', '339 adult asthmatics'], ['Asthma events', ''], ['normal S ECP', '48 FeNO subjects'], ['Subjects', 'normal S ECP'], ['', ''], ['', ''], ['This', 'elevated S ECP'], ['', ''], ['', ''], ['Elevated S ECP', 'potential asthma confounders'], ['', ''], ['', ''], ['', ''], ['FeNO S levels', '3 asthma months'], ['This', 'high  exacerbations'], ['FeNO S ECP', 'inflammatory  pathways'], ['', 'better adult asthmatics'], ['Obesity', 'common United States'], ['objective', 'acute asthma 2012'], ['wherein Inpatient data', 'Healthcare Research'], ['discharge records', 'United States'], ['we', 'Clinical Modification code'], ['', ''], ['total  charges', 'obese inpatient patients'], ['total', 'patient  discharges'], ['', 'medical  conditions'], ['discharge weight we', 'years asthma 2012'], ['Obesity', 'mechanical  ventilation'], ['', ''], ['', ''], ['', 'longer hospital stay'], ['', ''], ['', ''], ['', '32  nonobesity'], ['severe asthma that', 'mechanical  ventilation'], ['', '2016 Allergy Asthma'], ['particularly  females', 'inadequate disease control'], ['poor disease mechanism', 'association'], ['Poor quality sleep', 'uncontrolled  asthma'], ['', 'quality symptoms control'], ['This', 'previous Fortaleza Brazil'], ['Beck Depression quality', 'PSQI Asthma Control Test'], ['', 'Inadequate asthma 99'], ['', '10 daytime 34'], ['', ''], ['Depressive  symptoms', 'poor quality sleep'], ['', ''], ['', ''], ['depressive  symptoms', 'independent asthma control'], ['routine sleep screening', 'controlled  cases'], ['health  burden', 'United States'], ['self management education', 'care public health asthma'], ['economic  sustainability', ''], ['Thus  we', 'based United States'], ['We', 'based intervention investment'], ['few  programs', 'selected  populations'], ['Interpretation', 'heterogeneous ROI calculations'], ['Nevertheless  literature', 'based United States'], ['definitive  knowledge', 'economic program assessments'], ['', 'Elsevier Inc'], ['', 'Allergy Asthma'], ['that', 'significant minority populations'], ['One  approach', 'behavioral modification education'], ['improve', 'inner  patients'], ['We', 'technological minority populations'], ['16 exclusion all', 'childhood'], ['interventions', 'based systems video games'], ['Many', 'specific behavior theory'], ['interventions', 'special  staffing'], ['improvements', 'adherence asthma life'], ['health care utilization', 'typically emergency department interventions'], ['based  interventions', 'positive  results'], ['', 'low asthma outcomes'], ['such  interventions', 'health asthma'], ['', '2016 Allergy Asthma'], ['yet asthma little', 'environmental  school'], ['We', 'particulate air asthma'], ['controlled  we', 'elementary air particulate schools'], ['We', '25  asthma'], ['air pollutant measurements', 'before  randomization'], ['Asthma symptoms', ''], ['', 'fine particulate <'], ['', ''], ['black  carbon', ''], ['', ''], ['', ''], ['When  comparing', 'control group classroom'], ['42 BC levels', 'follow  periods'], ['', 'comparisons'], ['', '1 expiratory second'], ['', 'significant air PM2'], ['', ''], ['large scale studies', 'pediatric asthma morbidity'], ['', '2016 Allergy Asthma'], ['Compelling  evidences', 'inflammatory adenosine conditions'], ['', 'P2Y- modulates migration family'], ['P2RX4', 'dendritic muscle cells'], ['P2RX4', 'NLRP3 inflammasome activation'], ['allergic  role', 'airway inflammation'], ['Therefore  we', 'induced airway inflammation'], ['P2rx4 deficiency', 'inflammation Th2 cytokine production'], ['Furthermore P2rx4-deficient bone marrow', 'WT priming vitro'], ['Moreover  mice', 'diminished P2rx4-deficient vivo'], ['AAI DC', 'allergic beta asthma'], ['protective childhood we', '2016 MEDLINE SCOPUS'], ['total', '227  databases'], ['systematic  9', 'postnatal  factors'], ['83  %', 'methodological Systematic Reviews tool'], ['', 'established childhood asthma'], ['interventional  interventions', 'interventional  studies'], ['', '2016 Allergy Asthma'], ['active Astragaloside component', 'biological antitumor activity'], ['we', 'small lung cancer cells'], ['Counting Kit-8 analysis', 'cell viability'], ['Real polymerase chain reaction', 'western messenger RNA'], ['astragaloside IV treatment', 'small lung cancer cells'], ['combined  treatment', 'small NCI H1299 HCC827'], ['treated messenger RNA expression', 'small astragaloside IV'], ['addition downregulation', 'small interference RNA technology'], ['SIRT6 inhibition', 'small lung cancer cells'], ['astragaloside IV', 'therapeutic lung cancer'], ['self lesbian gay', 'June'], ['84  %', 'torture'], ['disclosure', 'sexual  origin'], ['several  efforts', 'forced  marriage'], ['same sex relationships', 'often  tragedy'], ['sexual experience men', 'more  street'], ['All', 'depression'], ['Providers', 'sexual  orientation'], ['paper', 'such asylum activity'], ['29 asylum who', '2013 immigration detention'], ['6  who', '2012'], ['they', 'coping  strategy'], ['so  they', 'physical  activity'], ['further  six', 'physical  barriers'], ['why  they', 'physical  activity'], ['physical  activity', 'prolonged asylum uncertainty'], ['physical  which', 'social  exclusion'], ['welfare which', 'financial  community'], ['sublibrary', 'important aptamer screening process'], ['separation PCR amplification', 'separation lambda which'], ['different PCR which', 'even quality failure'], ['Cycle number optimization', 'insufficient product amounts'], ['asymmetric emulsion which', 'conventional  PCR'], ['nonspecific  hybridization', 'single molecule which'], ['Overamplification', 'by products'], ['direct  amplification', 'ssDNA  library'], ['asymmetric emulsion PCR', 'exponential screening enrichment'], ['', ''], ['', 'Wiley Periodicals Inc'], ['', 'International Biochemistry'], ['current multiphase power that', 'portable power supply electronics'], ['current  ripple', 'conventional  interleaving'], ['technique', 'current  waveforms'], ['possible performance improvement', 'simulations'], ['experimental 3x that', 'multiphase'], ['pure butyl 6-cyano-(3R 5R)-dihydroxyhexanoate', 'key atorvastatin calcium'], ['optically t R)-1b', 'physiological Rhodotorula tests'], ['heat treatment', 'significantly degrees R'], ['', ''], ['asymmetric  bioreduction', 'most  pH'], ['5 35', ''], ['', ''], ['', ''], ['', ''], ['g sodium lactate', 'substrate'], ['', 'optimal  conditions'], ['R)-1b', 'excess  99'], ['', '40 H conversion'], ['', ''], ['broad substrate it', 'chiral pharmaceutical intermediates synthesis'], ['', 'International Union International Biochemistry'], ['', ''], ['traditional power control schemes', 'pulse frequency modulation'], ['they', 'power control efficiency'], ['AFM control scheme', 'full bridge inverter'], ['proposed output power', 'two  variables'], ['Better efficiency performance', 'when output power PFM'], ['zero power losses', 'switches'], ['that', 'signal control processor'], ['load adaption noise', 'thermal distribution switches'], ['Antithymocyte globulin', 'often conditioning graft'], ['', 'stem cell stem transplantation'], ['off target effects', 'human  cells'], ['humanized  that', 'human cell tissues'], ['accordingly  it', 'hematopoietic  cells'], ['Interestingly  efficacy', 'less  blood'], ['human  that', 'bone marrow niches'], ['depletion  failure', 'transplantation'], ['when  ATG', 'preparative  conditioning'], ['Cellular  Immunology', ''], ['Autophagy', 'lived proteins protein aggregates'], ['key autophagy that', 'autophagosome  biogenesis'], ['how  ULK1', 'especially  disease'], ['Polyglutamine expansion', 'lysosomal degradation disease'], ['precise Htt mechanism', 'autophagy impairment'], ['in  assays', 'molecular  biomarkers'], ['ATG14-mediated autophagy we', 'well autophagy vivo'], ['We', 'molecular autophagy kinase activity'], ['ULK1', 'dependent  manner'], ['phosphorylation', 'critically autophagy level'], ['ATG14-associated Vps34 activity', '1 Q175 mouse disease'], ['ATG14 phosphorylation', 'proteasomal proteotoxic inhibition'], ['reduction', 'cellular  fraction'], ['mimetic  ATG14', 'polyQ cells'], ['regulatory ATG14-Vps34 kinase which', 'therapeutic polyglutamine disease protein'], ['Remodeling', 'endothelial basement atherogenesis'], ['shear blood we', 'high shear stress'], ['mRNA', 'static type IV condition'], ['', ''], ['3)H proline uptake analysis', 'shear type IV stress'], ['', ''], ['similar  positivity', 'exposed intracellular ECs'], ['shear  intracellular', 'expression protein MMP-2'], ['down MMP-2 which', 'endothelial basement atherogenesis'], ['Purpose ATP citrate lyase', 'LDL cholesterol'], ['therapeutic  genetics', 'therapeutic  strategy'], ['Recent findings ACLY', 'critical fatty acid'], ['genetic  variants', 'dietary fish oil'], ['specific Acly deletion', 'therapeutic  ACLY'], ['potently animal it', 'atherosclerosis'], ['bempedoic acid', 'hypercholesterolemic LDL patients'], ['efficacy', 'therapeutic bempedoic strategy'], ['patient  studies', 'new cardiovascular medicine'], ['regulatory Forkhead cells', 'immune  homeostasis'], ['Tregs', 'environmental  inflammation'], ['Treg mechanisms', 'phenomenon'], ['Apoe(-/- Treg plasticity', 'atherosclerosis'], ['atherosclerosis', 'Th1 Treg aorta'], ['', 'rather T effector cells'], ['Th1  Tregs', 'atherosclerotic suppression assays'], ['gamma(+)Mir146a(-/-)Th1  Tregs', 'Apoe(-/- macrophage Mir146a(+/+'], ['Th1  Tregs', 'related Ikzf4 Tigit Lilrb4'], ['ingenuity pathway analysis', 'related Treg plasticity'], ['Th1 Treg that', 'arterial  inflammation'], ['aim', 'periodontal  treatment'], ['total', '40  study'], ['20', 'test group'], ['20  patients', 'chronic control group'], ['patients', 'periodontal  treatment'], ['dental PLT fibrinogen creatinine', 'blood samples'], ['significant  reduction', 'test  groups'], ['significantly HDL levels', 'test  groups'], ['periodontopathogenic microorganism levels', 'test  groups'], ['positive  correlation', 'periodontopathogenic test group'], ['periodontal PLT fibrinogen treatment', 'risk atherosclerosis'], ['results', 'order'], ['Objective UVB irradiation', 'immune  response'], ['UVB irradiation', 'such immunoinflammatory atherosclerosis'], ['UVB exposure', 'proatherogenic T cell responses'], ['epidermal Langerhans cells', 'atherosclerotic plaque development'], ['findings', 'novel  atherosclerosis'], ['critical  pathogenesis', 'critical  atherosclerosis'], ['regulatory  that', 'immune  inflammation'], ['study', 'psychological peripheral B atherosclerosis'], ['Peripheral blood samples', 'coronary artery atherosclerosis'], ['B cells', 'real polymerase chain reaction'], ['B cell', 'healthy  controls'], ['serum cortisol levels', 'healthy  controls'], ['B cell frequency', 'negatively serum cortisol levels'], ['Exposure', 'B cells'], ['also B miR-98', 'critical  role'], ['Treating B cells', 'miR-98 atherosclerosis cells'], ['peripheral B which', 'miR-98  liposomes'], ['such background abnormality', 'disturbed background which'], ['', 'consciousness'], ['seconds minutes', 'movement disturbance'], ['Neurological  examination', 'typically  episodes'], ['PDs', 'various  aetiologies'], ['main  groups', 'rather  phenomenology'], ['', 'recent  humans'], ['pathophysiological  mechanism', 'reported  mutations'], ['Progress', 'called cramping syndrome'], ['review', 'veterinary classification examples'], ['genetic  advancement', 'future  dogs'], ['that', 'progress'], ['', 'Elsevier Ltd'], ['rights', ''], ['nitrous greenhouse ozone', 'atmospheric  CO2'], ['CO2', '90 warming %'], ['meanwhile  halocarbons', 'photocatalytic acid halides'], ['Photocatalysis', 'atmospheric  components'], ['', 'solar updraft chimney'], ['Then  we', 'CO2  GHGs'], ['We', 'CO2 chimney power GHGs'], ['200 Worldwide MW', 'renewable account construction time'], ['16  years', 'atmospheric growth concentrations'], ['radiative  it', 'more OH troposphere'], ['overall  reduction', 'global temperature rise'], ['hybrid electricity concept', 'other climate engineering proposals'], ['', ''], ['', 'Elsevier Ltd'], ['Exposure', 'active  molecules'], ['many  tumors', 'them'], ['lymphocyte population', 'malignant cell cells'], ['However  number', 'phenotypical TH features'], ['redox activity', 'potential antitumor plasma vivo'], ['Na+/H+ antiporter gene', 'mediated  transformation'], ['resistant  lines', ''], ['blotting AtNHX1 gene', 'resistant soybean lines'], ['stability', '6 soybean generations'], ['transgenic  lines', 'high selection pressure'], ['RT PCR AtNHX1', 'transgenic  progenies'], ['T-5  plants', 'homozygous  plants'], ['constitutive  expression', 'genetic salt engineering'], ['advent', 'physiological force conditions'], ['AFM', 'molecular piconewton force sensitivity'], ['it', 'biomedical  issues'], ['Characterizing', 'much life cell'], ['we', 'single molecule assay'], ['then molecule progress', 'molecular cell surface'], ['challenges', ''], ['enabling  which', 'dimensional  2D'], ['cyclic  which', 'terminating phase precursor molecules'], ['when film quality', 'high aspect ratios'], ['ALD', 'large thickness areas'], ['index it', 'functional 2D devices'], ['capabilities', '4 Si substrates'], ['discussed  advantages', 'unique nanostructure 2D properties'], ['', ''], ['', ''], ['rights', ''], ['Atopic dermatitis', ''], ['It', 'immune  changes'], ['Current  therapies', 'immune skin responses'], ['', 'Immunology Sehra'], ['', ''], ['', ''], ['', ''], ['', ''], ['Flaky tail which', 'Flg  genes'], ['active Stat6 that', 'immune  AD'], ['additional predisposing factors', 'disease development'], ['', 'current Sehra et al'], ['', 'therapeutic  AD'], ['Atopic dermatitis', 'moderate treatment disease'], ['IL-23p40  that', 'commonly psoriasis patients'], ['We', 'moderate  AD'], ['33  patients', '32  weeks'], ['Background therapy', 'topical  retention'], ['Study endpoints', 'protein gene expression studies'], ['weeks SCORAD50 difference', 'groups'], ['profile  transcriptome', 'initial ustekinumab group'], ['Th2-related AD genes', '4 ustekinumab treatment'], ['', ''], ['', ''], ['', ''], ['Epidermal responses', '32 ustekinumab group'], ['adverse  events', ''], ['clinical  outcomes', 'insufficient  AD'], ['goal', 'dental  socket'], ['immunologic root that', 'root resorption'], ['little root information', 'immune  replantation'], ['Therefore  aim', 'atopic  patients'], ['Clinical  examinations', '5-year  period'], ['evaluation', 'personal  histories'], ['Z tests', 'replanted  teeth'], ['', ''], ['', 'replanted  teeth'], ['teeth', '5 root years'], ['', ''], ['fewer replacement being', '5 root trauma'], ['', ''], ['binding transporter family', 'such  digoxin'], ['we', 'heart cDNA library'], ['', ''], ['deduced  protein', 'common  ABC'], ['It', 'similar  human'], ['', ''], ['We', 'other ABCA genes'], ['', ''], ['acute mRNA expression', '24 h 24 injection'], ['', '7 vehicle heart'], ['', ''], ['Real chain reaction analysis', 'reduction'], ['Similar ABCA9 mRNA', 'Similar  ABCA5'], ['comparable  amount', 'mRNA  liver'], ['', ''], ['ABCA8', 'digoxin liver'], ['', 'large attachment styles'], ['measure', 'dismissing  styles'], ['personality factors', 'attachment measures'], ['two NEO PI R', 'personality'], ['high PI R that', 'RSQ'], ['secure  style', 'lower  neuroticism'], ['Fearful attachment', 'higher  neuroticism'], ['Individuals', 'higher  neuroticism'], ['Finally  individuals', 'lower  trust'], ['results', \"Bartholemew's(1994  anxiety\"], ['lower  those', 'lower  trust'], ['', 'Elsevier Ltd'], ['rights', ''], ['relationship', 'Scottish adolescent pet owners'], ['variable  attachment', 'also  relationship'], ['best mother quality', 'when  dogs'], ['', 'when cat cats'], ['', 'higher  life'], ['Higher  attachment', 'best  pets'], ['Mediation effects', 'caring  pets'], ['when childhood victim', 'positive self others'], ['United States they', 'structural equation modeling approach'], ['emotional  authors', 'internal child abuse'], ['adults', 'childhood mothers'], ['Much', 'attachment style formation'], ['negative reinforcement schedules', 'seeking shock threat paradigm'], ['Participants', 'ostensibly  room'], ['they', 'help'], ['supporter', 'imminent  shock'], ['continuous  others', 'supporters'], ['responsive  others', 'explicit decision supporter'], ['dangerously  that', 'sometimes  children'], ['article', 'new Child Interview'], ['Parents', 'likely Parent Development child'], ['MotC constructs', 'subjective parenting representations'], ['theoretical  background', 'coding  system'], ['validity', 'MotC'], ['social stress cognition', 'attachment PTSD'], ['cognitive  perspective', 'PTSD  adolescents'], ['social attachment it', 'PTSD inpatient treatment'], ['where  adolescents', 'admission'], ['cognitive  those', 'insecure  attachment'], ['Social cognition', 'self parent measures'], ['Social cognition', 'maternal attachment admission'], ['study', 'cognitive Sharp impairment'], ['improvement', 'clinical attachment PTSD'], ['immune  cytokines', 'children'], ['Nevertheless  studies', 'inflammatory  ADHD'], ['', 'possible TNF cortisol'], ['108  adults', '18 DSM years'], ['psychiatric  disorders', ''], ['Serum samples', 'same awakening day'], ['Analysis', 'TNF groups'], ['Pearson correlations', 'TNF alpha'], ['', 'combined TNF alpha patients'], ['', 'Negative r=-0386 p=0'], ['', ''], ['', ''], ['inattentive  association', 'combined  subtype'], ['negative  correlation', 'also control group'], ['', ''], ['', ''], ['primarily  role', 'inflammatory  markers'], ['inattentive morning cortisol that', 'further  studies'], ['', ''], ['rights', ''], ['Two  experiments', 'saccadic  responses'], ['solitary  who', 'same  time'], ['where antisaccade they', 'visual  stimulus'], ['visual discrimination that', 'manual  orientation'], ['controlled  responses', 'coactors'], ['findings', 'dual task paradigms'], ['particular  prosaccades', 'social  context'], ['Additionally  number', 'saccadic  responses'], ['results', 'social  influences'], ['Moving', 'scientific  disciplines'], ['such  influence', 'parsimonious  way'], ['paper', 'human  nature'], ['It', 'reductionist  discipline'], ['', 'specific brain attentional'], ['individuals', 'different  information'], ['social  identities', 'individual  cognition'], ['Finally  paper', 'distinct  analysis'], ['how brain processes they', 'higher  aggregation'], ['how  they', 'social cognition abilities'], ['We', 'facial  expressions'], ['First  we', 'posterior processing negativity'], ['Then  we', 'identity emotion abilities'], ['who', 'neutral  faces'], ['', ''], ['shorter N170 latencies', 'better face perception'], ['', ''], ['', ''], ['N170 amplitude', 'individual face cognition'], ['latent EPN factor', 'emotion perception'], ['', ''], ['', 'also face perception abilities'], ['', ''], ['Interestingly latent factor', 'also emotion perception'], ['', 'facial  expressions'], ['LPC factor', 'facial  expressions'], ['links', 'social brain communication'], ['heterosexual individuals attention', 'opposite  sex'], ['', 'romantic relationship relationship'], ['single sex effect', 'romantic  partner'], ['attractive sex participants', 'such  effect'], ['previous relationship maintenance that', 'social  cognition'], ['Fearful', 'it'], ['However  little', 'emotional time faces'], ['three dot probe we', 'time course'], ['', ''], ['2 dot probe targets', '266 face Experiment'], ['1 conditions reaction times', 'baseline reaction two'], ['same  pattern', '84  Experiment'], ['', 'significant time conditions'], ['third dot probe experiment', 'happy time faces'], ['happy  faces', '168 ms conditions'], ['happy ms faces', '336 time ms'], ['Explicit  tests', 'pervasive  schizophrenia'], ['Less', 'social  schizophrenia'], ['We', '29 eye patients'], ['preceded  that', 'cue'], ['examine', 'automatic target location'], ['Cue target intervals', ''], ['social control trials arrows', 'eye gaze cues'], ['when reaction arrows', 'cue target intervals'], ['800 congruency which', 'delayed incongruent target locations'], ['incongruent eyeshift patients', 'direct gaze cues'], ['schematic eye that', 'attentional  schizophrenia'], ['shared gaze attention', 'gazed gaze location'], ['Attentional  lapses', 'internal information processing'], ['study', '29 spina bifida myelomeningocele'], ['Assessments', 'phasic Digit Modalities Test'], ['group', 'cognitive  attention'], ['ADHD group', 'lower SBH group'], ['ANOVA results', 'neuropsychological shunt performance'], ['Lapses', 'cognitive reaction SBH'], ['inferential hyperactivity that', 'story comprehension'], ['However  studies', 'offline  tasks'], ['', ''], ['', 'indirect story measurements'], ['', ''], ['', 'inconclusive think aloud techniques'], ['elementary  ADHD', 'listening story comprehension'], ['textual  they', 'online  ADHD'], ['predictive  that', 'predictive  episode'], ['textual word that', 'when control texts'], ['inferential  question', 'probe'], ['predictive  that', 'predictive  sentences'], ['Participants', 'false  questions'], ['when  texts', 'questions'], ['findings', 'comprehension ADHD'], ['Cannabis users', 'general  population'], ['However  that', 'mental health treatment'], ['study', 'mental health treatment'], ['', ''], ['attitudinal  barriers', 'mental health symptoms'], ['', ''], ['coping', 'relationship'], ['Washington State who', 'illegal cannabis use'], ['Data', 'two cannabis harm reduction'], ['coping', 'mental health symptoms'], ['Coping', 'negative  use'], ['', ''], ['', ''], ['', ''], ['direction', 'mediator  variable'], ['model', 'well  data'], ['', ''], ['', ''], ['', ''], ['', ''], ['Conclusions', 'higher cannabis motives'], ['Addressing attitudes', 'seeking health behaviors'], ['Further  studies', 'finding'], ['', 'Elsevier Ltd'], ['study', 'molecular knowledge sciences'], ['use', 'students'], ['203  who', 'randomly  three'], ['They', 'Modified  Organisms'], ['module', 'specific knowledge gain'], ['Furthermore  module', 'positively learning experiences'], ['', 'International Biochemistry'], ['valent  complexes', 'many  reactions'], ['Au(III  catalysts', 'oxidized metal preparation'], ['Au(III  catalysts', 'phase  CuCl2'], ['that', 'active electron species'], ['IL AC catalyst', 'high turnover 168'], ['', ''], ['8  %', 'product vinyl chloride'], ['IL AC catalyst', 'industrial acetylene hydrochlorination'], ['Therefore  findings', 'industrial VCM production'], ['', ''], ['', ''], ['rights', ''], ['high AB headphone amplifier', ''], ['resistive  load', 'audio power amplifier'], ['assisted  offset', 'improved frequency compensation'], ['This', 'low quiescent power'], ['65-nm CMOS amplifier', '0'], ['', ''], ['', '4  +'], ['gain bandwidth gain product', '16  pF'], ['', 'total compensation 8'], ['', ''], ['Other performance metrics', 'harmonic  distortion'], ['', 'signal  noise'], ['It', '35 peak mW'], ['', 'representative quiescent works'], ['It', 'low voltage process technologies'], ['analog transistor characteristics', 'short transistor reliability concerns'], ['we', '55 nm CMOS'], ['systematic  approach', 'digital feedback domain'], ['versatility', 'simultaneously THD+ N'], ['overall  architecture', 'scaled  CMOS'], ['measured  prototype', '105 dBA SNR'], ['', '8 speaker load'], ['performance', 'highest output power'], ['', 'deep submicron designs'], ['auditory  version', 'auditory infant sensitivity'], ['Eighty  adults', 'two Empathy Quotient'], ['implicit infant associations', 'empathy infant scores'], ['implicit  associations', 'noise sensitivity'], ['fresh infant that', 'adult infant relationships'], ['', ''], ['very fruit little', 'different plum seasons'], ['study', 'Japanese fruit plum'], ['', 'maturing  season'], ['', ''], ['Japanese plum cultivars', ''], ['days weights fruit stone', 'hardening'], ['total SSC contents', 'alternate fruit ripening'], ['', ''], ['plum cultivars', 'distinct fruit DAFB'], ['AG fruit', 'BA  fruits'], ['AG AJ', 'dry BA DASH'], ['sharp AG fruit', 'suppressed climacteric ripening'], ['ripening AG fruit', 'BA AJ fruits'], ['', 'ascorbic acid'], ['100  g(-1', 'AG fruit'], ['', ''], ['total  antioxidants', 'AJ BA fruit'], ['', ''], ['physico chemical changes', 'endogenous ethylene production'], ['Japanese', 'ripe TA ratio fruits'], ['intimate  standards', 'interaction'], ['way model users', 'gendered  self'], ['that', 'self'], ['that', 'ways'], ['based design that', 'design work'], ['research', 'instructional  learning'], ['', 'sub field progress'], ['much  design', 'much  fact'], ['paper', 'present design work'], ['how design work', 'technological  support'], ['here  we', 'available design EDS'], ['We', 'four design task'], ['We', 'different working methods'], ['data', 'digital design Studio'], ['', ''], ['rights', ''], ['cognitive  that', 'functioning autism spectrum abilities'], ['41  adults', 'functional  outcomes'], ['directly  former', 'other  two'], ['findings', 'functional triadic population'], ['psychosocial  interventions', 'social  ASD'], ['Background Cognitive differences', 'fruitful autism spectrum intervention'], ['current  project', 'personal  ASD'], ['Method Two Method groups', 'well  satisfaction'], ['Visual  inspection', 'thematic  data'], ['interactive  parents', 'socialising'], ['', 'adverse  effects'], ['', ''], ['', ''], ['results', 'certain MCT protocol'], ['', 'novel autism spectrum disorder'], ['Thirty  children', 'study'], ['', ''], ['other  half', 'half  ASD'], ['Children', 'later avatar interviewer'], ['participants', 'misleading  suggestibility'], ['Bayesian  analysis', 'avatar ASD'], ['results', 'future encouraging applications'], ['ability', 'processing context processing'], ['individuals', 'social context processing'], ['context processing', 'task complexity'], ['current  study', 'human  stimuli'], ['tasks', 'congruent  incongruent'], ['Local  processing', 'low frequency frequency'], ['high functioning 16', 'typically  adolescents'], ['Reaction time', 'condition'], ['human  stimuli', 'one  which'], ['', ''], ['target', 'low  frequency'], ['performance deficit', 'cognitive ASD overload'], ['findings', 'complexity it'], ['associative  priming', 'human context ASD'], ['Autism', ''], ['', '2016 Wiley Periodicals Inc'], ['Autism Spectrum Disorder', 'social  cognition'], ['Numerous  studies', 'promising thickness surface results'], ['underpowered sample sizes', 'external population level'], ['minded Imaging Data scientists', 'further brain disorders'], ['study', 'largest classification ASD'], ['healthy  age', 'intracranial surface area'], ['We', '6 classification %'], ['novel  findings', 'driven brain disorders'], ['Machine learning approaches', 'neuroimaging  data'], ['However  approaches', 'protocol  data'], ['We', 'novel Imaging Data database'], ['We', 'different autism spectrum sites'], ['main domain adaptation stage', 'whole brain severity prediction'], ['proposed  method', 'site correlation data'], ['demonstration', 'agglomerative machine learning data'], ['neural autism spectrum mechanisms', 'deficits'], ['coding prediction discrepancies', 'social  information'], ['social prediction signal', 'autism spectrum disorder'], ['Importantly  degree', 'social prediction error deficits'], ['typically spectrum magnitude', 'prefrontal prediction cortex'], ['data', 'social autism spectrum disorder'], ['We', 'social autism spectrum disorders'], ['false belief tasks', 'significant SC FBT'], ['significant  correlation', 'only FEC ASD'], ['fragmented FEC tasks', 'facial  emotion'], ['difficulties', 'social SC schemata'], ['Objective Children', 'on behavior class'], ['effect', 'regular classroom behavior'], ['Materials', 'multiple School Mashhad 2014'], ['common air sit', 'phase C'], ['on Sitting behaviors', '8 time wk'], ['Additionally Second Edition test', 'before  research'], ['', 'in Results 86'], ['', 'on  53'], ['', 'when therapy balls'], ['Air cushions', 'in  behaviors'], ['results', 'social  students'], ['teachers', 'cushioned  students'], ['Therapy ball chairs', 'related Autism Spectrum class'], ['People', 'autism spectrum face'], ['This', 'social  cognition'], ['characteristics', 'voice recognition ASD'], ['Here  we', 'matched voice controls'], ['discriminating  recognizing', 'famous  voices'], ['vocal pitch that', 'acoustic  processing'], ['', ''], ['', ''], ['functioning  difficulty', 'unfamiliar novel voices'], ['coherent percepta that', 'human  brain'], ['Autism', ''], ['', '2016 Wiley Periodicals Inc'], ['Individuals', 'social autism spectrum mind'], ['aim', 'TD processing children'], ['social information processing abilities', 'ToM competences'], ['children', 'social  skills'], ['mediation ToM', 'social ToM behavior'], ['Responding', 'social  communication'], ['RJA', 'early intervention programs'], ['exaggerating', 'gestural  gaze'], ['current  we', 'emotional  ASD'], ['moving  that', 'moving  expression'], ['', 'neutral gaze shift'], ['', 'developing studies peers'], ['', 'different task conditions'], ['facial  expression', 'gestural  pointing'], ['initial content preschoolers', 'RJA  opportunities'], ['early  interventions', 'young  ASD'], ['', ''], ['rights', ''], ['Oxytocin', 'adverse autism spectrum effects'], ['', 'major  research'], ['paper', 'repetitive oxytocin ASD'], ['Electronic literature searches', 'PsycINFO PubMed June'], ['12  RCTs', 'review'], ['11  that', 'social  improvements'], ['Additionally  one', 'repetitive oxytocin administration'], ['meta oxytocin', '2  domains'], ['Previous  evidence', 'mixed  ASD'], ['limited  summary', 'ASD'], ['purpose', 'recorded autism spectrum Scales'], ['24months autism spectrum disorder', 'developmental  delays'], ['performance', 'Composite Social Communication'], ['Codes', 'overall Red scale'], ['Results', 'good Red Flags curve=0'], ['', ''], ['', 'Composite Social Red Flags score'], ['Systematic Observation', 'good discrimination sensitivity'], ['cutoff', 'optimally spectrum disorder risk'], ['individuals', 'social cognition interactions'], ['different  paradigms', 'social ASD grasp interactions'], ['2 eye tracking participants', 'virtual  reality'], ['paper', 'new  paradigms'], ['Autism', 'other  people'], ['most  studies', 'real  interaction'], ['Here  we', 'interactive interactionsgaze setting'], ['deception experimenter', 'live video feed'], ['experimenter video', 'less  person'], ['Interestingly  reduction', 'social  presence'], ['autistic trait individuals', 'autistic trait individuals'], ['active gaze engagement', 'reduced  looking'], ['difficulties', 'social spatio effects'], ['results', 'social  cognition'], ['Autism', ''], ['', 'Wiley Periodicals Inc'], ['', 'Autism Research'], ['68 Autism Spectrum mothers', '15  years'], ['', ''], ['6  years', 'single ASD Behaviour setting'], ['strongest  relationship', 'restricted communication behaviours'], ['intense  reactions', 'related  mothers'], ['Several  suggestions', 'behavioural  symptomatology'], ['children', 'parental discipline issue'], ['few  studies', 'parental risk population'], ['We', 'physical  ASD'], ['parental  discipline', 'broader parenting community'], ['total', 'standardized Hong Kong questionnaires'], ['hypotheses', 'bivariate correlation'], ['economic parenting pressure', 'psychological  aggression'], ['Moreover child symptom severity', 'physical parenting assault'], ['psychological child symptom severity', 'physical parenting assault'], ['psychological  aggression', 'physical  assault'], ['Theoretically  findings', 'harsh parenting ASD'], ['Practically  findings', 'effective maltreatment intervention programs'], ['', ''], ['rights', ''], ['autism spectrum disorder', 'aberrant  anatomic'], ['', 'neural brain development wiring'], ['such  process', 'neural  connectivity'], ['Careful  analysis', 'neurological EEG autism'], ['exact autism spectrum nature', 'differences'], ['Here  we', 'autistic autism peers'], ['where  partners', 'social  interaction'], ['atypical gaze processing', 'autism'], ['children', 'typical gaze accuracy'], ['detection', 'less autism spectrum disorder'], ['synthetic intelligence which', 'two  objects'], ['angle', 'individual  thresholds'], ['gaze direction detection', 'less control participants'], ['precision', 'social autism spectrum disorder'], ['emotional  which', 'autism spectrum disorder'], ['how  ability', 'typical  development'], ['We', 'interoceptive  ASD'], ['4 time intervals', 'actual heart IA'], ['Effects', 'multiple counting regression'], ['hoc  correlations', 'significant  interactions'], ['Age', 'groups'], ['<  relationship', 'typical  ASD'], ['cognitive  ability', 'differently  autism'], ['Autism spectrum disorder', 'sexually brain structure genetics'], ['yet study sex', 'clearly study outcome'], ['we', 'temporal noncoding males'], ['well  they', ''], ['temporal sncRNA expression that', 'regions'], ['which', 'neuronal oligodendrocyte differentiation anxiety'], ['targets', 'mRNA system studies'], ['', 'specific  target'], ['a Guidance Signaling third', 'sexes'], ['findings', 'molecular ASD brain'], ['such  results', 'such  eyes'], ['atypicalities', 'social  ASD'], ['controls', 'age sex'], ['visual group effect', 'visual  targets'], ['orienting', 'young  ASD'], ['Autism', ''], ['', 'Wiley Periodicals Inc'], ['', 'Autism Research'], ['verbally  that', 'label'], ['same  phenomenon', 'such autism spectrum disorder'], ['tracking  hearing', 'typically  peers'], ['verbally  that', 'label'], ['special ASD it', 'special ASD status'], ['', 'labeled contrast objects'], ['reduced  responsivity', 'young  ASD'], ['incidence', '1 diabetes world'], ['', ''], ['', 'higher degree disease'], ['aim', 'T1DM Sardinia'], ['total', 'university  Sardinia'], ['recruitment', 'diagnosed  T1DM'], ['Autoantibodies', 'GAD IA2 subjects'], ['HLA risk genotypes', 'positive DQ FDR'], ['prevalence', 'single  FDR'], ['', ''], ['', 'autoantibodies'], ['3  %', '1  autoantibody'], ['6  %', '2  autoantibodies'], ['55  %', '3  autoantibodies'], ['55  %', '4  autoantibodies'], ['89 HLA %', 'low risk genotypes'], ['prevalence', 'T1DM T1DM'], ['', 'other United Finland'], ['Autoantibody positivity', 'strongly HLA risk'], ['study', 'high risk populations'], ['', 'clinical auto practice'], ['old  who', 'antenatal screening tests'], ['Immunological  assay', 'dot immuno gold filtration'], ['Positive  case', 'primary  infertility'], ['positive  case', 'significantly  male'], ['', ''], ['Ovary auto Antibody', 'secondary Pellucida infertility'], ['', ''], ['positive  case', 'secondary auto fertility'], ['study results', 'primary reproduction infertility'], ['primary  this', 'immunological  infertility'], ['objective', 'microstructural brain damage'], ['microstructural brain white integrity', 'matched  controls'], ['Fatigue', 'clinical plasma inflammation'], ['', 'Fifty one Fifty age'], ['', ''], ['3  years', ''], ['Mean diffusivity', 'healthy SLE controls'], ['', ''], ['Fatigue', 'normal reference range'], ['', 'lower  MD'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'adjusted  analyses'], ['cognitive  function', 'longer SLE disease duration'], ['', ''], ['', 'higher  levels'], ['', ''], ['', 'MD'], ['present  patients', 'higher  controls'], ['general matter this', 'lower  SLE'], ['cognitive  function', 'larger  datasets'], ['Objectives', 'unknown  etiology'], ['we', 'KRAS AIP'], ['hypermethylation', 'pancreatic carcinoma areas'], ['KRAS mutation', 'direct  sequencing'], ['Hypermethylation events', '6 AIP NCA'], ['However TFPI2 methylation ratio', 'significantly  NCA'], ['Direct sequencing results', 'single point AIP'], ['These', 'first methylation AIP'], ['inflammatory  condition', 'carcinogenesis'], ['Further  study', 'methylation AIP'], ['process', 'blood'], ['ago  phlebotomy', 'illness'], ['old  process', 'clinical  practice'], ['Therapeutic plasma exchange', '40 fiber years'], ['renal authors herein', 'autoimmune  diseases'], ['Updated  information', 'modern apheresis therapies'], ['biologic  TA', 'immunosuppressive  therapy'], ['biologic disease agents', 'immunosuppressive disease therapies'], ['prognosis', 'aggressive therapy schemes'], ['guidelines', 'German American Apheresis'], ['TA', 'clinical  improvement'], ['Immune checkpoint inhibitors', 'cancer  therapies'], ['sometimes  life', 'new  oncologists'], ['they', ''], ['Rash pruritus', ''], ['rare side case', 'finally side effects'], ['transcriptional  profiles', 'clinical  diabetes'], ['transcriptional  variation', 'large patient cohorts'], ['novel transcriptome assessment that', 'fingerstick study volunteers'], ['FifteenL', 'throughput polymerase chain reaction'], ['We', '6  months'], ['average', '99  samples'], ['high  degree', '3 mL venipuncture sample'], ['transcriptional gene changes', 'assay'], ['longitudinal  monitoring', 'extended gene periods'], ['repertoire diversity', 'human murine pathologies'], ['how TCR diversity', 'health'], ['', 'previous Immunology Lossius'], ['', ''], ['', ''], ['', ''], ['', ''], ['44', 'fluid TCR beta samples'], ['TCR repertoire', 'reactive MS patients'], ['Studies', 'technical  literature'], ['However TCR sequencing methodologies', 'such T cell MS'], ['CD13-specific which', 'inflammation tissue damage'], ['biliary  little', 'neonatal  cholestasis'], ['We', 'healthy blood donors'], ['activated cell we', 'mentioned autoantibody groups'], ['effect', 'neonatal  macrophages'], ['CD13-specific autoantibodies', 'healthy HCMV seropositivity'], ['inhibited  this', 'CD13-specific  autoantibodies'], ['healthy  they', 'healthy  association'], ['complicated HCMV IgG that', 'active HCMV individuals'], ['autoantibodies', 'epiphenomenon'], ['tolerogenic  mechanisms', 'immune self responses'], ['qualitative  changes', 'factors autoimmune disease'], ['ultimately effector graft', 'alloantigen reactive effector cells'], ['potential  modulations', 'well organ transplantation'], ['we', 'autoimmune auto diseases'], ['solid organ which', 'therapeutic  strategies'], ['', ''], ['', ''], ['rights', ''], ['polygenic  that', 'polygenic  disorders'], ['who', 'erroneously  SAID'], ['blistering skin lesions', 'systemic laboratory inflammation'], ['empirical work therapies', 'final proxy syndrome'], ['MBPS', 'differential  diagnosis'], ['human  microbiome', 'human skin mucous body'], ['contact', 'microbial defence antigens'], ['immune lupus system', 'inflammatory  state'], ['Specific  bacteria', 'local mucosal inflammation'], ['Proinflammatory lymphocytes', 'such  joints'], ['intestinal  permeability', 'autoantibody production'], ['critical  finding', 'such diet interventions'], ['review', 'current microbiome SADs connection'], ['', 'active hardware Bode'], ['LabVIEW graphical programming environment', 'operational  amplifier'], ['one op amp filters', 'one software simulation'], ['main  contribution', 'manual automat Bode'], ['frequency response it', 'often input frequency'], ['variable filters response', 'variable test frequency'], ['scan  rate', 'front panel controls'], ['square triangular calculating', 'square signal level'], ['automatic gain amplifier', 'aid device'], ['proposed  design', 'forward  device'], ['Input', 'dual output control'], ['weak input signal', 'three  modes'], ['High  gain', 'high  amplification'], ['average power dissipation', 'dual power +'], ['', '180 nm technology node'], ['Frequency', 'operation'], ['signal integrated circuit design', 'behavioral circuit blocks'], ['Such  models', 'behavioral description language'], ['manually  which', 'behavioral  models'], ['behavioral model generation method', 'SC  integrator'], ['behavioral integrator model', 'symbolic circuit which'], ['parametric  models', 'severe circuit design process'], ['furthermore circuit they', 'acceptable Sigma Delta accuracy'], ['generated  models', 'several simulation settings'], ['Technology', 'rapidly service providers'], ['', '2025  technology'], ['', ''], ['numerous service article', 'critical technology infusions'], ['Specifically  it', 'social novel presence'], ['', ''], ['customers', 'social services literature'], ['that', 'future literature research'], ['related customer that', 'ASP'], ['', ''], ['', ''], ['how technology infusion', 'particularly frontline future'], ['epidemiological  studies', 'close  depression'], ['comorbidity', 'significant  individuals'], ['', 'preclinical  depression'], ['like stress syndrome', 'rodent  CVD'], ['research', 'immune  mood'], ['Recent  investigations', 'pharmacological comorbid conditions'], ['up rodent which', 'mood  disturbances'], ['', ''], ['rights', ''], ['devastating  who', 'motor  impairment'], ['mental  which', 'nervous  system'], ['well  subjects', 'ANS regulation mechanisms'], ['social emotion recognition which', 'poor ANS regulation'], ['We', '10 heart rate SCI'], ['5-min baseline HRV', 'eyes test'], ['healthy  subjects', 'greater  RMET'], ['level', 'baseline HRV group'], ['Also  group', 'higher  SCI'], ['Finally  changes', 'healthy SCI participants'], ['autonomic regulation which', 'daily cognition life'], ['Filamentous plant pathogens', 'effector infection'], ['Phytophthora', 'selective binds potato autophagy'], ['structural  basis', 'interaction'], ['crystal which', 'disordered C terminus'], ['AIM we', 'small x ray scattering'], ['informed  deletion', 'binding PexRD54 tandem planta'], ['how RXLR proteins', 'host cell disease'], ['', ''], ['Southern', 'professor Oxford'], ['He', 'Southern  blot'], ['when  he', 'landmark paper'], ['basic DNA method', 'specific  probe'], ['basic polymerase chain concept', 'molecular  biology'], ['new task force', 'annual Graz 2015'], ['abuse task it', 'forensic postmortem imaging'], ['main  focus', 'particularly task postmortem'], ['manuscript', 'current mission statement experience'], ['SI system algorithm', 'effective output filter'], ['Dithering', 'steady state converter operation'], ['noise', 'output filter configuration'], ['moreover converter core', 'SI algorithm'], ['modified  structure', 'nonparametric SI identification'], ['resonant  second', 'control feedback error'], ['SI method', 'automotive safety application'], ['Lignocellulosic biomass gasification', 'combined cycle electricity'], ['thermodynamic  performance', 'exergy analysis'], ['base case process', 'gasification FT synthesis'], ['alternative  configurations', 'conditioned electricity production'], ['biomass conversion plants', 'assessment'], ['gas combustor', '21 exergy destruction %'], ['gasification subsystem', '68 % efficiency'], ['power generation subsystem', 'thermodynamic fuel cycle'], ['exergetic plant efficiencies', '24  %'], ['ATR case', 'lower electricity production'], ['configuration', 'increased power generation'], ['', ''], ['rights', ''], ['', 'operational auto 4'], ['5 supply voltage range', '0'], ['', '5 V CMOS'], ['It', 'maximum offset voltage 0'], ['', '145 noise 6'], ['', ''], ['1 MHz unity', '840 mu current'], ['modulated chopper ripple', 'auto zeroing'], ['800 input kHz', 'clocks'], ['This', 'glitch 4'], ['', '800  kHz'], ['signal pass glitch bandwidth', 'low pass glitch filter'], ['Maximum input bias current', 'charge injection 1'], ['150  pA', 'on mismatch compensation circuit'], ['Short enoyl CoA hydratase', 'lesser extent isoleucine'], ['Deficiency', 'early Leigh syndrome phenotype'], ['two compound that', 'SCEH'], ['We', '2  life'], ['whole  we', 'homozygous splice site mutation'], ['', 'two  cases'], ['Analysis', 'aberrant  transcript'], ['', 'premature  protein'], ['', ''], ['reverse polymerase chain reaction', 'mediated ECHS1 decay'], ['first truncating which', 'severe  phenotype'], ['canonical splicing which', 'exome genome sequencing'], ['review', 'broader animal ROH'], ['homozygous  that', 'individuals'], ['useful  that', 'demographic  time'], ['Furthermore ROH', 'deleterious inbreeding genome'], ['frequency size', 'natural structure mutation level'], ['inbreeding F estimates', 'pedigree data'], ['F ROH', 'genealogical  information'], ['selection', 'various ROH genome'], ['homozygosity', 'frequently ROH regions'], ['how  architecture', 'genetic  background'], ['wide  information', 'endangered livestock breeds'], ['new voltage regulator that', 'transient load events'], ['hybrid VRM exhibits', 'reduced output capacitance'], ['that', 'further circuit complexity'], ['that', 'varying load conditions'], ['operation', '20-W 12V to-1'], ['', 'transient power conversion recovery'], ['high LC filter', 'current snubber ripple'], ['closed loop control', 'additional LC filter'], ['Therefore  paper', 'current damping system'], ['Most', 'zero damping resistance'], ['However load resistance', 'drive system'], ['Therefore load resistance', 'digital control paper'], ['improved loading method', 'duty ratio range'], ['prototype', 'controller'], ['soft  switching', 'entire load range'], ['maximum duty ratio', '0'], ['', 'proposed loading method'], ['resonance', 'proposed control method'], ['9 glycoside hydrolase Oryza', 'L'], ['', ''], ['', '51  kDa'], ['enzyme', 'of II cell wall'], ['OsCel9A', '2 C terminus'], ['expression', 'different organ specificity'], ['OsCel9A', 'KORRIGAN seed homolog'], ['situ OsCel9A expression', 'lateral root primordia'], ['Northern blotting analysis', 'single  OsCel9A'], ['entire CBM2 region', '51 kDa nascent kDa'], ['translational CBM2 truncation', 'lateral root development'], ['PLFCC  technique', 'high line voltage'], ['enhanced feed forward which', 'leading filter capacitors'], ['so switching loss', 'dead  nature'], ['proposed  PLFCC', 'light load conditions'], ['proposed  performance', 'universal  input'], ['paper', 'three wire inverter configuration'], ['APF', 'one load harmonic currents'], ['significantly core it', 'control laws'], ['fundamental source which', 'complex calculation frame transformation'], ['various scheduling which', 'system stability'], ['results', 'three phase APF'], ['', 'solar energy wind'], ['', 'four wire grid'], ['Therefore  inverter', 'function  compensator'], ['active phase power', 'active power injection rectification'], ['paper', 'digital division control'], ['significantly control laws', 'directly voltage switching period'], ['average power method', 'fundamental source side'], ['various scheduling which', 'system stability'], ['results', 'four wire analysis'], ['activity', 'valenced  events'], ['exposure', 'GABA(B)-mediated  LHb'], ['This', 'like LHb phenotypes'], ['However  mechanisms', 'driven  plasticity'], ['exposing', 'mediated  LHb'], ['signaling', 'pathways'], ['systemic  administration', 'induced receptor LHb'], ['we', 'control dopamine'], ['manipulations', 'mediated  currents'], ['dopamine', 'evoked  LHb'], ['However  activation', 'based  plasticity'], ['findings', 'driven  LHb'], ['stretching', 'budgerigars'], ['Here  we', 'contagious experiment species'], ['16  birds', 'visual  barriers'], ['when  birds', 'observational  contagion'], ['first  we', 'ingroup response'], ['when cage mates', 'familiarity contagious conspecific familiarity stretching'], ['findings', 'social  species'], ['We', 'mixed virus infections'], ['avian  that', 'several  infections'], ['paper', 'well IBV IBDV poultry'], ['cloacal  swabs', 'epidemiological IBDV characteristics'], ['microarray', 'diagnostic  sensitivity'], ['16  %', '95 % CI'], ['', ''], ['Specificity', 'direct  NP'], ['Diagnostic  effectiveness', 'developed DNA microarray'], ['therefore  it', 'epidemiological AIV NDV surveillance'], ['shortens  duration', 'diagnostic  methods'], ['domestic egg that', 'scavenging village areas'], ['objectives', 'northeastern duck raising Bangladesh'], ['tested duck egg yolk', 'rRT virus RNA'], ['median flock size', 'ducks'], ['95 % confidence 28', 'one H5-specific antibodies'], ['Of', 'detectable % RNA'], ['fecal  sample', 'influenza RNA'], ['ConclusionsNomadic  ducks', 'wild waterfowl backyard Bangladesh'], ['Magellanic  penguins', 'Argentina Chile'], ['Magellanic  penguins', 'borne blood Plasmodium'], ['which', 'zoos  centres'], ['this', 'diagnostic sampling methods'], ['We', 'nested Haemoproteus Plasmodium Leucocytozoon'], ['blood parasites', ''], ['strong  haemosporidians', 'Argentinean  coast'], ['such  parasites', 'Chilean Falkland Islands'], ['northward distribution expansion', 'novel blood parasites'], ['', ''], ['molecular  genetics', 'intellectual  others'], ['social conducts morality', 'neuronal  substrata'], ['', ''], ['often  which', 'epistemology'], ['psychic  which', 'back  sense'], ['', ''], ['takes', 'forever  silence'], ['aside  he', 'aside  which'], ['cerebral  he', 'shape'], ['it', 'which'], ['what', 'brain'], ['he', 'also  mortal'], ['neurobiological  explanation', 'alcohol life'], ['it', 'real life experience'], ['sick  we', 'human  fate'], ['', ''], ['always  life', 'always  mind'], ['scientific  it', 'asphyxiation'], ['', ''], ['rights', ''], ['recent transportation electrification', 'energy efficiency'], ['electric infrastructure that', 'them'], ['electric  vehicles', 'electrical charging grid'], ['electric  vehicles', 'stationary  charging'], ['many  works', 'holistic transportation electricity nexus'], ['paper', 'dynamic transportation electrification'], ['It', 'next traffic simulation multimodality'], ['model', 'also transportation fleet operations'], ['dynamic system model', 'kinematic state evolution'], ['model', 'moderate  size'], ['doped zinc oxide', 'transparent photovoltaic applications'], ['AZO films', 'radio frequency'], ['influences', 'optical AZO films'], ['AZO films', 'preferred c orientation'], ['substrate temperatures', 'optical AZO films'], ['AZO film', 'average  transparency'], ['minimum  resistivity', 'as  6'], ['', ''], ['carrier concentration', 'as  3'], ['', ''], ['', ''], ['Finally  performances', 'transparent AZO electrode'], ['efficient  device', '7'], ['', 'current  28'], ['', '430 fill 62'], ['', 'standard  conditions'], ['', ''], ['', ''], ['rights', ''], ['present  study', 'CaCDR1 CaCDR2 FPZ'], ['tested  which', 'CaCDR1 CaCDR2 transcript levels'], ['nulls', 'when  antagonism'], ['tested  isolates', 'transcriptional  CaCDR1'], ['transcriptional  activation', 'induced AS isolates'], ['distinct  strategies', 'therapeutic AS approaches'], ['Testicular maturation arrest', 'germ cell development'], ['Genetic  factors', 'male  infertility'], ['objective', 'SNP microarray technique'], ['fluorescence', 'STS SNP microarray findings'], ['two chromosomal Klinefelter', 'dicentric  Y'], ['AZF deletion', '14'], ['%  cases', 'AZFc 6'], ['', ''], ['2  CNVs', '5'], ['', ''], ['3  CNVs', '19  cases'], ['TSPY2 gene gain', '16  cases'], ['CNV', 'five  cases'], ['SNP microarray', 'underlying  55'], ['', 'critical AZFc 0'], ['51  mb', 'RBMY1J PRY genes'], ['SNP microarray', 'genomic testicular maturation arrest'], ['present  study', 'idiopathic testicular maturation arrest'], ['regulated  immunity', 'precise  signals'], ['other lymphocytes B cells', 'activating  receptor'], ['', ''], ['gamma that', 'B cell activation'], ['negative feedback that', 'BCR'], ['inhibitory lipid receptors', 'actively protein tyrosine BCRs'], ['inhibitory  receptors', 'such Fc gamma BCR'], ['', 'Immunology Manno'], ['directly  that', 'B lymphocyte activation'], ['negative feedback that', 'excessive  signaling'], ['Foot disease virus', ''], ['Antibodies', 'FMDV  infection'], ['Serological  protection', 'FMDV interserotype protection'], ['interserotype protection', 'FMDV  serotypes'], ['we', 'FMDV vaccination regimes'], ['kinetics', 'FMDV vaccination regime'], ['FMDV B cell response', 'FMDV SAT1'], ['lived  hallmark', 'antigenic T FMDV'], ['IMPORTANCE  We', 'FMDV vaccination serotypes'], ['indication', 'TI-2  response'], ['Chronic tumor effector', 'oncogenesis cancer progression'], ['immune  system', 'immune  responses'], ['Thus  understanding', 'established immunotherapy tumors'], ['Here  we', 'Interferon adapter molecule Genes'], ['65  %', 'primary  immunodeficiencies'], ['Functional  tests', 'useful B cell vitro'], ['accepted  guidelines', 'functional  tests'], ['Here  we', 'B cell childhood'], ['We', 'independent memory B cells'], ['memory B cells', 'better memory B cells'], ['dependent  stimulus', 'naive B cells'], ['', 'memory B cells'], ['response', 'age'], ['memory B cells', 'memory B cells'], ['IgA plasma cells', 'CpG'], ['Unexpectedly B cells', 'proliferative SIgAD CD40L'], ['functional  tests', 'immune  system'], ['several  reports', 'tumorigenic tumor development'], ['tumorigenic  functions', ''], ['derived  OPN', 'transgenic mouse prostate'], ['Rag2(-/-  OPN', 'immune  response'], ['derived  OPN', 'NK TRAMP tumors'], ['requirement', 'cell migration assay'], ['In', 'mediated cell recruitment'], ['B16 OPN', 'immune cell recruitment'], ['also  contribution', 'well tumor OPN'], ['Design', 'PV  paper'], ['major B4 inverter', 'total PV system'], ['massive PV system', 'switches'], ['active B4 inverter', 'nonlinear  loads'], ['TMS320F28335 DSP processor', 'effective B4 inverter'], ['Various  features', 'necessary control algorithms'], ['first PV system', 'Matlab  Simulink'], ['second hardware circuits', 'simulation results'], ['nonlinear PV which', 'accuracy'], ['B7-H4  one', 'multiple tumor progression'], ['However  role', 'precancerous  lesions'], ['208 C57BL/6 drinking', 'pathological  process'], ['pathological carcinogenesis features', 'humans'], ['B7-H4 expression', 'pathological  stage'], ['', 'well  differentiation'], ['', ''], ['control which', 'reverse chain reaction analysis'], ['Similarly B7-H4 protein expression', 'IL-6 control expression'], ['B7-H4 expression', 'signaling pathway activation'], ['Babesiosis', 'tick- haemoprotozoan parasites'], ['severity', 'factors'], ['pathogenic  that', 'pathogenicity'], ['', 'instance'], ['Xinjiang', 'virulent  B'], ['bovis', 'cattle'], ['immune  which', 'variant  erythrocyte'], ['We', '8'], ['', 'nuclear draft B'], ['', ''], ['genomic Babesia datasets', 'VESA Bx'], ['availability', 'immune host animal'], ['genomic  resource', 'new intervention babesiosis'], ['apicoplast', 'most apicomplexan parasites'], ['it', 'widely  apicomplexans'], ['ap  genomes', 'molecular  therapeutics'], ['', 'available apicomplexan parasites'], ['ap  genomes', 'taxonomic Babesia sp'], ['', ''], ['', 'parallel  sequencing'], ['', 'similar gene 30'], ['genetic  differences', 'size'], ['genomic data relationships', 'genomic data sets'], ['25 transfer RNA genes', 'protein encoding Babesia bovis'], ['', ''], ['that', 'genetic Babesia species'], ['', 'close Babesia cattle'], ['orientalis', 'water buffalo'], ['sequencing bioinformatic sequencing approach', 'veterinary  importance'], ['', ''], ['', ''], ['rights', ''], ['systematic abuse that', 'unwanted neo Nigeria'], ['first  it', 'first  2006'], ['paper', 'scientific media perspective'], ['Children', 'civil baby rights'], ['They', 'such baby places'], ['abuse', 'immediate  term'], ['Immediate  abuse', 'inadequate birth registration'], ['related  consequences', 'sexual child soldiers'], ['baby factory which', 'local infertility adoptions'], ['Programmes', 'infant trafficking'], ['that', 'country  adoption'], ['child', 'trafficking routes'], ['', ''], ['new baby that', 'breeding infants'], ['more baby factories', 'years'], ['Infertile  women', 'cultural Southern surrogacy'], ['which', 'psychological  victims'], ['multifaceted  that', 'harsh infant patrons'], ['Also  programs', 'unwanted  pregnancies'], ['Methods', 'infertile baby factories'], ['mostly  which', 'clinically jaundice hemoglobinuria'], ['main predisposing that', 'condition'], ['authors', 'naturally bovine disease'], ['consistent  finding', 'hepatic  lobes'], ['Other  findings', 'red urinary bladder'], ['characteristic  lesions', 'necrotizing  thrombosis'], ['3  cells', 'apoptosis'], ['Ultrastructural  evaluation', 'hepatocyte necrosis liver'], ['', 'Polymerase chain C'], ['beta toxin gene', 'selected liver samples'], ['undetermined predisposing factors', 'BH'], ['Deeper  understanding', 'new plant endophyte phytoprotection'], ['Many  studies', 'pollutant plant endophyte auxin'], ['However  little', 'reactive oxygen species'], ['possible  effect', 'pollutant plant stress response'], ['Here  we', 'contaminated plant stress soil'], ['ROS tryptophan ROS levels', 'inoculated  formaldehyde'], ['specific polymerase chain reaction', 'endophyte colonization'], ['', 'more  IAA'], ['higher IM which', 'selectively  B'], ['', ''], ['higher  levels', 'more ROS roots'], ['Higher  levels', 'potent driving B'], ['cereus', 'shoots'], ['', 'contaminated soil B'], ['cereus ERBP', 'significant ROS shoots'], ['Pollutant phase', 'endophytic colonization patterns'], ['', ''], ['rights', ''], ['', 'mobile cereus group bacteria'], ['biotinylated bcr1 element', 'whole cell protein B'], ['', ''], ['genetic  pBClin15', 'strain'], ['DNA binding', ''], ['', 'transcriptional blotting ORF'], ['', 'binding  protein'], ['ORF', 'alternative transcription termination'], ['', ''], ['cereus group', 'medical  importance'], ['Bacteriophages', 'therapeutic  agents'], ['Understanding', 'high  relevance'], ['-PGA poly(-glutamic synthesis', 'hydrogen Bacillus'], ['', 'maximum addition 33'], ['L', '100 mu M 24H'], ['concentration', ''], ['', '%  control'], ['addition', 'H2O2-induced ROS ROS'], ['Transcriptional  levels', 'improve ROS production'], ['significantly transfer chain which', 'reducing ATP biosynthesis'], ['synthetic  genes', 'directly  formation'], ['possible ROS control ROS', 'B'], ['', ''], ['', 'International Union International Biochemistry'], ['food  additives', 'modified  microorganisms'], ['riboflavin subtilis production strains', 'vitamin B2'], ['presence', 'recombinant EU food'], ['vitamin B2 product', '80 % feed China'], ['', ''], ['DNAs', 'different genome devices'], ['WGS data', 'putative rib operons'], ['real time PCR methods', 'food GM products'], ['', ''], ['', 'Elsevier Ltd'], ['heterogonous Escherichia we', 'chitinase MY75 Bacillus thuringiensis'], ['pair', '8-bp chi gene'], ['Chi ORFs', 'truncated  E'], ['', ''], ['activity', 'significantly chitinase DRS'], ['part', 'approximately chi gene 1'], ['', ''], ['', ''], ['revealed  deletion', 'chiB chiMY75 expression'], ['', 'binding  E'], ['coli cell lyaste', 'chiB chiMY75 promoter regions'], ['This', 'heterologous Bacillus chi E'], ['upstream DRS which', 'acting  elements'], ['', ''], ['rights', ''], ['predictive  control', 'different power electronics applications'], ['MPC', 'fast control response'], ['computational  burden', 'digital control boards'], ['which', 'computational  implementation'], ['proposed control approach', 'back power flow management'], ['Simulation results', 'several operating conditions'], ['work', 'back space vector modulator'], ['power control method', 'grid side converter'], ['sides', 'few tuning efforts'], ['predictive  controllers', 'based  platform'], ['calculation time compensation', 'SCTL  technique'], ['effectiveness', 'experimental  data'], ['refined control strategies', 'predictive  control'], ['wide ac mains', 'frequency range'], ['dynamic operating number', 'ac mains frequency'], ['digital control schemes', 'sensed  voltages'], ['variable sampling that', 'mains frequency'], ['predictive  control', 'constant sampling frequency'], ['high performance mains', 'frequency range'], ['proposed control which', 'mathematical  analysis'], ['paper', 'uninterruptible power supply applications'], ['inverter', 'four ground wires'], ['Both', 'based division summation'], ['power flow', 'link voltage power factor correction'], ['output stage', 'three reference voltages'], ['proposed control laws', 'current inductance levels'], ['Thus distortion', 'input current'], ['Moreover  circulating', 'common  ground'], ['Simulated  results', 'proposed control approach'], ['aim', 'human Pernambuco state Brazil'], ['Blood', 'legal heart brain T'], ['', ''], ['', 'T'], ['gondii', '37'], ['', '9 immunofluorescence antibody test'], ['Tissue samples', 'seropositive  mice'], ['Tissue samples', 'seropositive polymerase chain reaction'], ['', '1 pig tissue samples'], ['7  %', 'bioassayed mouse T'], ['pig  tissues', 'histopathology analysis'], ['', 'risk questionnaire'], ['', '21'], ['', ''], ['', ''], ['data', 'indicative sanitary T'], ['', 'backyard pigs'], ['Preventive  measures', 'human pig meat'], ['Waterborne  diseases', 'great water importance'], ['water it', 'public drinking consumption'], ['VBNCs  microorganisms', 'positive  results'], ['numerous  methods', 'pathogenic  water'], ['rapid  methods', 'biosensor detection methods'], ['review', 'bacterial  pathogens'], ['situ Illumina that', 'based  methods'], ['immunosorbent  immunofluorescence', 'based  methods'], ['mass  biosensors', 'based  methods'], ['Overall  methods', 'bacterial  diseases'], ['simple sequence ISSR)-PCR', 'molecular type Pseudomonas syringae'], ['strains', 'different seed production Japan'], ['PSS population', 'genetic  diversity'], ['producing GF genotype epidemic', 'mainly seed infection'], ['bacterial plant that', 'multiple infection routes'], ['objective', 'bacterial dairy calves'], ['Twelve Holstein calves', 'three Lactobacillus plantarum GF103'], ['milk replacer', 'age'], ['respectively ad orts', 'ad age'], ['ruminal  fluid', 'rumen fermentation characteristics'], ['gradient gel number', 'real polymerase chain reaction'], ['dry  intake', 'average body control'], ['', ''], ['DGGE  fingerprint', 'blended ribosomal RNA age'], ['number', 'LB Ruminococcus treatment'], ['', ''], ['Oral  administration', 'cellulolytic rumen bacterial bacteria'], ['biological livestock we', 'different methane oxytetracycline'], ['removal', 'oxytetracycline'], ['84 control group', '84  %'], ['richness gradient gel values', 'bacterial  0'], ['', '0'], ['control group', ''], ['addition oxytetracycline', 'bacterial livestock wastewater'], ['Results', 'bacterial livestock oxytetracycline'], ['Watermelon', 'important fruit production'], ['', 'bacterial Acidovorax citrulli'], ['citrulli', 'important limiting crops'], ['pathogen', 'primary seed borne inoculum'], ['', 'rapid  A'], ['citrulli', 'important  BFB'], ['we', 'A'], ['citrulli bacterial citrulli cells', 'PCR  TiiPCR'], ['specific  primers', 'specific DNA A'], ['', ''], ['Then PCR amplification', 'such PCR primers'], ['10  copies', 'modified plasmid TiiPCR'], ['bacterial  cells', '100 fluorescent signal 1'], ['', ''], ['rapid  method', 'bacterial  A'], ['', ''], ['bacterial III secretion which', 'microbial virulence drugs'], ['', ''], ['', ''], ['', ''], ['bacterial  which', 'leaf blight leaf diseases'], ['two  we', 'phenolic  Xoo'], ['Ten', 'significantly harpin gene'], ['inhibitors', 'host tobacco plants'], ['coumaric TS010 TS015', 'bacterial  growth'], ['translocation', 'four T3 inhibitors'], ['four  expression', 'Xoo T3SS'], ['other virulence which', 'specific  inhibition'], ['inhibitors', 'varying Oryza extents'], ['', ''], ['spontaneous preterm detection', 'risk'], ['', ''], ['', 'medical  societies'], ['', ''], ['-Bacterial', 'protective  Lactobacilli'], ['diagnosis', 'clinical Nugent score'], ['58  it', 'first  pregnancy'], ['link', 'premature odds 1'], ['', 'recent  studies'], ['Metronidazole', 'EL3'], ['It', 'symptomatic  BV'], ['testing', 'spontaneous preterm delivery'], ['premature  it', 'spontaneous preterm delivery'], ['high preterm it', 'spontaneous preterm delivery'], ['', 'genital preterm infection'], ['', ''], ['screening', 'premature grade C'], ['', ''], ['British  Journal', 'biomedical Biomedical science'], ['These', 'one  Editor'], ['majority', 'cellular infection cytopathology'], ['another', 'chromosomal abnormalities'], ['key  that', 'greatest  scientists'], ['how  concept', 'microbial  life'], ['fundamental  relatedness', 'phylogenetic schemes genomes'], ['approach', 'molecular  decades'], ['today  influence', 'time'], ['older  approaches', 'reductionist  worldview'], ['directly  who', 'explosive  biotechnology'], ['we', 'gastrointestinal phage rats'], ['temporal  modification', 'administered Wroclaw intestine'], ['yogurt', 'relatively phage transit'], ['immunomodulating  phages', 'oral phage therapy'], ['orally  phages', 'acidic size bloodstream'], ['whilst T4 phage', 'higher  dose'], ['also phage penetration', 'digestive  blood'], ['key  that', 'molecular  biology'], ['particular  interpretation', 'Poisson distribution'], ['I', 'biological Poisson investigations'], ['binding  that', 'generally endonuclease life'], ['HNH endonucleases', 'thermophilic HNH bacteriophages'], ['Here  we', 'thermophilic bacteriophage GVE2'], ['recombinant GVE2 HNH endonuclease', 'high cleavage temperature'], ['degrees C', '30 A degrees enzyme'], ['GVE2 HNH endonuclease', 'wide  5'], ['', '9'], ['', 'enzyme activity'], ['', ''], ['', ''], ['Furthermore HNH endonuclease activity', 'divalent metal ion'], ['GVE2 HNH endonuclease', 'varied cleavage Mg2'], ['HNH endonuclease activity', 'NaCl'], ['study', 'molecular bacteriophage biology'], ['Bacteriophages', 'practical  application'], ['', 'bacterial  discovery'], ['advances', 'medical phage application fields'], ['construction', 'antibiotic host treatment'], ['Insertion', 'active biofilm disposal'], ['They', 'bacterial vaccine drug'], ['lytic  enzymes', 'bacterial expression strains'], ['', 'based food biosorbents'], ['secreting  cells', 'also mucosal immunity'], ['study', 'different palatine ages'], ['Bactrian  camels', 'three age groups'], ['histological palatine densities', 'statistical  methods'], ['age SIgA', 'extrafollicular crypt region'], ['densities', 'significantly  turn'], ['', ''], ['However  densities', 'same IgG regions'], ['densities', 'ASC age'], ['camel palatine tonsils', 'functional crypt SIgA'], ['first oleae chorion peroxidase', 'essentially  B'], ['oleaechorion formation', 'homologous melanogaster chorion peroxidase'], ['central regionwhich encodes', '98 Pxd counterpart'], ['highly  chorion', 'di- tri tyrosine bonds'], ['bPxd RNA transcripts', 'total adult flies'], ['', ''], ['', ''], ['', ''], ['specific bPxd RNA transcript', 'situ 12 hybridization'], ['developmental bPxd which', 'maximally  stage'], ['54 kDa band', 'purified adult preparations'], ['bPxd peroxidase', 'successive chorionic membrane'], ['genus  Potexvirus', 'eight International Viruses'], ['', ''], ['', ''], ['', ''], ['Currently  genus', 'important  viruses'], ['', ''], ['', ''], ['Members', '470  length'], ['potexvirus', '0 5 end'], ['PVX Bamboo mosaic that', 'molecular  virus'], ['we', 'functional 155kDa ORF1'], ['which', 'alphavirus'], ['identified  interactions', 'replication protein'], ['We', 'different Musa paradisiaca'], ['significant SSH total', 'northern  them'], ['Out', 'significant expression differences'], ['Out', '87  clones'], ['five  sequences', 'highly Rs eng-1b'], ['467 base GW395922', '5 RACE PCR'], ['complete  length', 'Rs eng-1b'], ['Rs C', 'high host plants'], ['', 'low host plants'], ['Furthermore  gene', 'different development stages'], ['order', 'high expression low'], ['Rs C which', 'first Rs eng-1b'], ['Rs eng-1b expression', 'positive  population'], ['less nematode population', ''], ['endogenous  gfp', 'significant Rs R'], ['', ''], ['Rs eng-1b', 'related  R'], ['', ''], ['', 'Fusarium oxysporum f'], ['', ''], ['cubense', 'destructive  banana'], ['', ''], ['credible control measures', 'genetic  engineering'], ['fungal intron hairpin velvet', 'effective Fusarium transcription Foc'], ['Partial  sequences', 'embryogenic banana cv'], ['', 'genetic  transformation'], ['transformed  lines', 'long greenhouse bioassays'], ['transgenic  lines', '8 months postinoculation'], ['Presence', 'transgenic banana plants'], ['mediated gene silencing', 'debilitating crop plants'], ['low voltage bandgap reference', '0'], ['18 m CMOS process', ''], ['bandgap reference circuit', 'operational  amplifier'], ['100 degrees which', '0'], ['', ''], ['simulated supply rejection ratio', ''], ['line regulation', ''], ['', '5mV  0'], ['', '1'], ['', ''], ['sensitive TCXO reaction', 'thermal TCXO chips'], ['structure', 'controlled NPN detection'], ['range', 'voltage output'], ['130  it', 'than  0'], ['restart', 'than  0'], ['', ''], ['good temperature protection which', 'practical TCXO chip'], ['paper', 'high supply reject ratio'], ['dual differential input amplifier', 'temperature voltage'], ['voltage', 'curvature  compensation'], ['Experimental  characterization', 'bandgap reference 0'], ['5 m CMOS process', 'temperature 4'], ['ppm A degrees C', 'temperature 125'], ['PSRR', 'external buffer amplifier'], ['paper', '32 nm CMOS technology'], ['reference generator', 'proposed BGR circuits'], ['proposed  design', 'Synopsys HSPICE simulator'], ['circuit', 'output reference 0'], ['', '25 supply 1'], ['', ''], ['low temperature coefficient', 'of-40 degrees 100'], ['poly silicon area', 'current  consumption'], ['low bandgap reference', 'period'], ['operational  amplifier', 'switched capacitor network sampling'], ['charge', ''], ['bandgap reference', ''], ['', 'design standard'], ['', ''], ['circuit', ''], ['', ''], ['', ''], ['noise', 'low  frequency'], ['mu V root Hz', ''], ['Grid voltage feedforward', 'connected  converters'], ['stability margins', 'high impedance grid'], ['effect mechanism', 'equivalent control block diagrams'], ['delay', 'digital root effect'], ['bandpass filter', 'robust grid impedance variations'], ['selection method', 'also grid voltage sag'], ['converter', 'proposed grid approach'], ['experimental  results', 'based voltage feedforward strategy'], ['operational  amplifier', 'paper'], ['pole', 'integrated transfer capacitor'], ['op amp', 'integrated NMOS capacitor'], ['bandwidth', 'voltage resistor'], ['operational voltage amplifiers', 'low frequency applications'], ['proposed DVCC op amp', 'wide  frequencies'], ['theoretical op analysis', 'reported op PSPICE'], ['low band pass filter', ''], ['filter', 'passive  components'], ['Two  resistors', 'independent Q factor'], ['which', 'integrated  technology'], ['circuit', 'high frequency range'], ['PSpice simulations', 'theoretical  analysis'], ['paper', '6th transconductance order'], ['2-stage BiCMOS OTA', 'together output resistance'], ['combination', 'gainbandwidth loop voltage 5'], ['8  stability', '520 mu A'], ['MFB Butterworth frequency response', 'ideal OTA transfer function'], ['filter center frequency', 'measured dB 15'], ['5MHz', ''], ['200 on filter', 'than state 115'], ['filter', 'only nm BiCMOS 1'], ['', '2'], ['', 'bias circuits'], ['plant source', 'especially South Fujian'], ['', 'Recent  B'], ['further chemical analysis', 'effective gene compounds'], ['Real polymerase chain reaction', 'powerful gene expression analysis'], ['It', 'suitable RT qPCR results'], ['Ten candidate reference genes', 'transcriptome B'], ['expression stability', 'different plant organs'], ['conjugating enzyme E2', 'different plant organs'], ['', 'specifically gene expression B'], ['', 'particular RT qPCR analyses'], ['study', 'Southeastern  Brazil'], ['391 fish larvae', 'Rio de Janeiro RJ'], ['identification', 'molecular DNA barcode'], ['white marlin larvae', 'white marlin larvae'], ['further  inferences', 'early life fish'], ['article', 'three  aims'], ['First  it', 'recently  Trent'], ['different Catholic that', 'divine  love'], ['why  it', 'also  Europe'], ['emphasis', 'political Baroque actors'], ['genomic  screening', 'secreted maturation amelotin'], ['we', 'related gene protein'], ['Scpppq1 gene', 'binding secretory phosphoprotein'], ['SCPPPQ1', 'secreted proline leucine glutamine'], ['', 'known data sequences'], ['various rat expression', 'tooth'], ['where maturation it', 'atypical cell tooth interface'], ['that', 'mineralised tooth surfaces'], ['low antioxidant neurons', 'reactive oxygen species'], ['Thus  repair', 'normal brain function'], ['Base excision repair', 'damaged DNA base'], ['overlapping NEIL2 NEIL3 OGG1', 'oxidative DNA base lesions'], ['Here  we', 'Northern glycosylase activity assays'], ['NEIL1 NEIL2 OGG1', 'widespread  ages'], ['situ mouse expression', 'age'], ['newborn mouse brain mNeil3', 'discrete stem cell populations'], ['', ''], ['', 'hippocampal migratory formation'], ['decreased', 'only layer neocortex'], ['MNth1', 'constitutively  lifespan'], ['Northern mOgg1 expression', '8  age'], ['Assays', 'increased brain regions'], ['', 'human islet transplantation'], ['ethical  it', 'directly islet humans'], ['Here  we', 'adoptive lymphocyte transfer'], ['Human islet grafts', 'treated perigraft lymphocyte'], ['specific  miR-375', 'treated  hyperglycemia'], ['human islet results', 'real polymerase chain reaction'], ['miR-4454', 'prior islet hyperglycemia'], ['circulating human -cell miR-4454', 'human -cell HIT'], ['expanded  exvivo', 'clinically organ transplantation'], ['adoptive animal transfer', 'polyclonal graft Tregs'], ['synthetic fusion that', 'designated T antigens'], ['which', 'ubiquitously  allografts'], ['HLA A2-specific novel HLA CARs', 'signaling  domain'], ['CAR Tregs', 'polyclonal cytotoxic activity'], ['Furthermore CAR', 'endothelial cell monolayers'], ['', 'polyclonal blood mononuclear Tregs'], ['use', 'applicable organ transplantation'], ['Basic fibroblast growth factor', 'various cell types'], ['bFGF', 'deciduous stem teeth'], ['aim', 'present REX1 SHEDs'], ['SHEDs', ''], ['mRNA expression levels', 'real polymerase chain reaction'], ['chemical inhibitors', 'signaling culture pathways'], ['Cells', 'mesenchymal cell surface markers'], ['cells', 'osteogenic  lineages'], ['induced REX1 mRNA effect', 'inhibitors'], ['Cycloheximide pretreatment', 'intermediate REX1 molecule(s'], ['Further  addition', 'induced REX1 SHEDs'], ['enhanced REX1 expression', 'pathways'], ['', 'induced REX1 SHEDs'], ['', ''], ['professional  who', 'medicine'], ['knowledge', 'unpredictable  ways'], ['basic  sciences', 'physician'], ['basic science material', 'practice'], ['Much  effort', 'medical  curriculum'], ['effort', ''], ['conceptual  that', 'cybernetic living robustness'], ['MethodsLiterature', 'hierarchical  frameworks'], ['ResultsAn organizing framework', 'molecular health systems management'], ['application', 'glycaemic diabetes care'], ['distributed  robustness', 'underlying patient safety'], ['ConclusionsEach', 'clinical organizing study'], ['systems which', 'medical core practice'], ['esterase gene EST1', 'heterologously Escherichia coli'], ['recombinant  Est1', 'P'], ['', 'host'], ['', 'P'], ['expression K', ''], ['EST1 gene', 'inducible alcohol oxidase'], ['Est1', 'ion exchange'], ['recombinant  Est1', 'pH'], ['50 degrees C', 'natural wheat bran'], ['unique  Est1', 'current FAE classification model'], ['Transferuloylation synthesis', 'feruloyl saccharide esters'], ['', 'International Union International Biochemistry'], ['', ''], ['Large  collections', 'tailored supreme information extraction'], ['fit  pipeline', 'voluminous gene expression data'], ['Three  analyses', 'underlying leukaemia types'], ['main disease groups', 'standard case control study'], ['basic  knowledge', 'quantitatively literature references'], ['Second pairwise comparison testing', 'main leukaemia other'], ['general similarity relations', 'coefficient similarity measure'], ['Moreover lists', 'candidate main leukaemia group biomarkers'], ['third  analysis', 'four leukaemia subtype biomarkers'], ['DEG signature', 'class data classifiers'], ['developed  methodology', 'throughput molecular biology experiments'], ['lactic  acid', 'effective production medium'], ['Based', 'high DLA titer'], ['', ''], ['', ''], ['effective  medium', 'carbon whey protein sources'], ['PJ WPH', 'significant DLA production'], ['design surface methodology', 'PJ  concentrations'], ['', ''], ['', '14  222'], ['', '24  PJ'], ['', '99  WPH'], ['experimental  results', 'maximum DLA titer'], ['', ''], ['', ''], ['', ''], ['24  which', 'renewable batch process'], ['enhanced DLA which', '2'], ['', 'conventional DLA production medium'], ['', 'International Union International Biochemistry'], ['Selection', 'reproductive  success'], ['However  predictions', 'female mating system fitness'], ['Selection viamale fitness', 'floral  evolution'], ['where pollen limitation', 'seed'], ['We', 'two sex functions'], ['protandry fitness that', 'autonomous  selfing'], ['', 'higher trait success'], ['intermediate fitness phenotypes', 'less  males'], ['male fertility selfing', 'seed discounting'], ['stable selfing rate', 'deleterious segregating mutations'], ['old  who', 'unconscious emergency state'], ['child', 'ground'], ['consulted  ophthalmologist', 'retinal  eyes'], ['shaken baby syndrome', 'clinical  findings'], ['increasing child importance', 'forensic work reasons'], ['objective', 'intimate emergency department'], ['structured  interviews', 'ED university Netherlands'], ['interviews', 'qualitative content Atlas'], ['', ''], ['Constraining factors', 'knowledge ED'], ['ED employees', 'many  IPV'], ['Facilitating factors', 'one child abuse'], ['IPV priorities', 'physical  problems'], ['considerable  which', 'ambivalent  feelings'], ['ED  employees', 'ED awareness feelings'], ['also ED employees', 'also  tensions'], ['perpetrators', 'batterer intervention program'], ['programs', 'minimally  IPV'], ['authors', 'social science BIPs'], ['400  studies', 'conducted United States'], ['furthermore state standards', 'empirical research evidence'], ['all', 'LGBT practitioner education'], ['Recommendations', 'based national BIP review'], ['Treatment', 'domestic  Germany'], ['study', 'domestic child violence'], ['longitudinal risk inventory', 'German program sites'], ['German  version', 'self report'], ['child abuse potential', 'significantly program baseline'], ['Longitudinal  results', 'moderate risk specialists'], ['self report', 'cognitive  empathy'], ['However  risk', 'child maltreatment'], ['evidence', 'selective  victims'], ['classification', 'well  Germany'], ['such energy which', 'innovative storage solutions'], ['electrochemical  that', 'interrupted electricity generation'], ['conventional chemical energy', 'electrical  energy'], ['metal hydride', 'quickly supply interruption'], ['concept', 'electrical power future'], ['paper', 'additional battery equalizers'], ['This', 'integrated battery module'], ['modular battery design', 'extra power equalizers'], ['battery system', 'integrated  modules'], ['integrated  module', 'digital control techniques'], ['design considerations', 'control system'], ['power electronics', 'battery cell'], ['distributed module system', 'centralized  charger'], ['energy storage systems', 'renewable energy sources'], ['BESSs', 'high capital costs'], ['economic  paper', 'multiple multimarket business operations'], ['proposed  HiEMS', 'annualized price cost'], ['same cost performance index', 'BESS aggregation'], ['impact', 'photovoltaic system performance'], ['Battery energy storage', 'renewable  generation'], ['price arbitrage', 'major energy storage income'], ['electricity price', 'tightly  government'], ['optimal electricity response', 'when arbitrage BES'], ['electricity which', 'optimal energy storage'], ['when  factors', 'also  influence'], ['optimal pricing strategy', 'grid'], ['where price gap', 'peak  periods'], ['Appropriate  subsidies', 'quantitatively sensitivity analysis'], ['social energy storage', 'suitable price mechanism'], ['', ''], ['rights', ''], ['paper', 'hybrid energy storage system'], ['key  feature', 'reduced  PMS'], ['PMS', 'local availability electricity loads'], ['It', 'load currents'], ['single voltage source converter', 'common unity power coupling'], ['usage', 'current  battery'], ['PMS', 'islanded storage systems grid'], ['performance', 'digital  simulation'], ['fed electric controller design', 'current  sharing'], ['proposed battery energy which', 'proposed fuel cell'], ['High  efficiency', 'required load voltage'], ['adequate FC voltage', 'fast load demand'], ['fuel cell', 'excess load battery'], ['performance', 'static control simulation'], ['control scheme', 'digitally  PCI'], ['efficacy', 'experimental controller validation'], ['', ''], ['rights', ''], ['Herein  we', 'efficient power management'], ['key  components', 'RF energy harvester'], ['External RF energy', 'rectifying  stages'], ['BAC', 'current power battery'], ['gated sensor block supports', 'efficient sensing manner'], ['sensor interface', 'chopper amplifier'], ['nonvolatile memory', 'programmable  memory'], ['EPCglobal Gen-2 that', 'sensing operation'], ['tag chip', 'standard'], ['', ''], ['tag IC', '1 mu leakage'], ['estimated % lifespan', 'BAP tag IC'], ['', ''], ['', ''], ['', 'random  vector'], ['', 'one  kernels'], ['conditional  i', 'joint  distribution'], ['', ''], ['', ''], ['improperly  they', 'improper probability distribution'], ['', 'paper compatibility'], ['Q(n', 'functional  form'], ['particular  Q(i', 'parameter exponential parameter family'], ['Special  attention', 'autoregressive  models'], ['', ''], ['', ''], ['rights', ''], ['Efficient performance modeling', 'important analog circuits'], ['novel regression modeling method', 'high performance accuracy'], ['defined model templates', 'hybrid design dictionary'], ['', 'Bayesian shrinkage model'], ['proposed  method', 'state modeling cost'], ['We', 'routinely  own'], ['Prior  work', 'past  choices'], ['social  that', 'social  groups'], ['choices', 'groups'], ['we', 'behavioral model experiments'], ['past  choices', 'past  model'], ['choice choices', 'latent group structure'], ['We', 'developmental  changes'], ['how  model', 'theoretical influence model'], ['together structure learning', 'social  contexts'], ['', 'Clinical Immunology K'], ['', ''], ['', ''], ['', ''], ['', ''], ['00360  16', 'dual immunodeficiency virus vaccine'], ['immunized infant macaques', 'nonimmunized  animals'], ['susceptibility', 'trained T immunity'], ['commentary', 'human immunodeficiency virus'], ['', ''], ['channel scalp electroencephalography', 'listening cocktail party'], ['EEG', 'valuable neuro feedback'], ['', ''], ['compatible EEG we', '64 Ear scalp'], ['', 'concurrent tone audiobooks'], ['forward encoding model', 'single EEG channels'], ['', ''], ['attentional  focus', 'in Ear EEG electrode'], ['differences', 'neural  morphology'], ['', ''], ['', 'subjects'], ['', ''], ['EEG response', 'valuable channel attention'], ['BCI brain system', 'many  applications'], ['', 'also brain EEG'], ['technique', 'other signal techniques'], ['low frequency signals', 'low frequency signals'], ['paper', 'brain signals'], ['operational  amplifier', ''], ['suitable  filter', 'low EEG signals'], ['consists', 'voltage follower circuit'], ['Cadence which', 'virtual  layouts'], ['blocks', 'virtual  layouts'], ['which', 'different voltage levels'], ['Embryo implantation', 'successful  pregnancy'], ['Many', 'differentially embryo implantation'], ['transcriptional expression regulator', 'receptive rat phases'], ['Here  microarray', 'receptive rat phases'], ['receptive rat results', 'Northern  blotting'], ['miR-29a', 'artificial miR-29a level'], ['apoptotic factor genes', 'apoptotic Bcl miR-29a'], ['', 'apoptotic factor gene'], ['endometrial stromal which', 'apoptotic  factors'], ['Collectively miR-29a', 'apoptotic embryo factors'], ['miR-29a', 'apoptotic cell apoptosis'], ['Sequential  measurement', 'patient myeloid disease'], ['provider', 'changing BCR ABL1 CML'], ['technical BCR ABL1 we', 'EQA trial 2015'], ['however decision results', 'unconverted data sets'], ['We', 'median UKNEQAS LI'], ['development', 'molecular  CML'], ['drug CYP3A5', 'CYP3A  vivo'], ['polymorphism', 'related P gp'], ['aim', 'Chinese  subjects'], ['single  dose', 'Chinese mg subjects'], ['serum concentration', 'MS  MS'], ['cytochromes P450 which', 'Chinese drug population'], ['felodipine AUC((0 administration', 'significantly BCRP421 CC'], ['subjects', 'felodipine  exposure'], ['genetic  polymorphisms', 'Chinese  population'], ['gender findings', 'gender differences'], ['cortisol we', 'four stress tasks'], ['Blood cortisol', 'immediately  task'], ['', 'two way Val66Met'], ['Val Val genotype', 'larger Met men'], ['Further  contrast', 'Val Val men'], ['gender', 'Val66Met stress reactivity'], ['treatment that', 'high  risk'], ['', ''], ['rights', ''], ['mechanistic stress correlation', 'strongly stress depression'], ['BDNF associated', 'genetic risk CVD'], ['related  we', 'thrombosis'], ['BDNFMet Met mice', 'concomitantly hypercoagulable state'], ['Proteomic  analysis', 'coagulation aorta cascades'], ['BDNF Met allele', 'collagen epinephrine injection'], ['Interestingly  transfection', 'prothrombotic WT cells'], ['BDNFMet Met cells', 'Met'], ['Conversely  inhibition', 'prothrombotic WT mice'], ['BDNF Met homozygosity', 'myocardial  humans'], ['BDNFMet Met features', 'anxiety depression condition'], ['BDNFVal66Met polymorphism', 'arterial  AMI'], ['improved phase electron diffractometer', 'improved  Balzers'], ['beam stop', 'scattered  experiment'], ['Different beam stops', 'present  setup'], ['Modifications', 'medium temperature nozzle'], ['measures', 'complete data collection'], ['synchronous  motors', 'few  decades'], ['high performance we', 'accurate suspension force BPMSM'], ['conventional modeling scheme', 'tensor modeling scheme'], ['theoretical calculation value', 'closely  one'], ['test platform', 'experiments'], ['corresponding rotor stabilization', 'magnetic  levitation'], ['results', 'further  BPMSM'], ['switched reluctance motor', 'more  attention'], ['suspending  force', 'stable  levitation'], ['', 'independent levitation force'], ['complex control algorithm', 'lookup  table'], ['radial force channel', 'radial  force'], ['Therefore  control', ''], ['mathematical operating relationship', 'levitation current'], ['levitation force', 'four  freedom'], ['experimental  platform', 'suspending  TMS320F28335'], ['proposed  BLSRM', 'steadily  conditions'], ['electronic  converters', 'SIMO frequency domain'], ['frequency components', 'SIMO characteristics'], ['which', 'system instability'], ['paper', 'based power DPS'], ['buck converter', 'specifically  demonstration'], ['variation', 'also system instability'], ['traditional  models', 'proposed  model'], ['proposed switching frequencies', 'based power systems'], ['Simulation', 'proposed  method'], ['', 'than climate 1'], ['degrees', 'negative CO2 capture'], ['therefore  investors', 'public return money'], ['solar dispatch load factor', 'small  capacity'], ['This', 'primary  atmosphere'], ['we', 'scale annual CO2 removal target'], ['lower efficiency BECCS plant', 'environmental efficiency perspectives'], ['it', 'needed base load basis'], ['We', 'spare  e'], ['', ''], ['injection', 'environmental carbon system'], ['where CO2 emissions', 'sufficiently CO2 removal'], ['symptoms', 'cognitive  functioning'], ['depressive  symptoms', 'depressive self report'], ['', 'outpatient neuropsychological outpatient sample'], ['', 'Sixty two Sixty diagnoses'], ['', ''], ['cognitive  impairment', 'neuropsychological  tests'], ['Informants', 'functional  abilities'], ['larger  differences', 'verbal  learning'], ['moderate  level', 'clinical patient populations'], ['results', 'neuropsychological  evaluations'], ['aim', 'Nigerian childhood enuresis'], ['Parents', 'pretested  questionnaire'], ['responses', 'common  themes'], ['We', '448  study'], ['5  %', ''], ['2  %', 'one  enuresis'], ['3  %', 'it'], ['Enuresis', 'much  69'], ['', ''], ['', '2  respondents'], ['parents', '23'], ['', 'hot  charcoal'], ['', ''], ['parents', 'that'], ['', '0  child'], ['', '9  nothing'], ['', ''], ['playing', 'much childhood enuresis'], ['rarely self help that', 'child abuse'], ['black cDNA clone', 'RT PCR'], ['linearized RNA polymerase that', 'viral  cDNA'], ['Leaves', 'wild type virus'], ['presence', 'Northern coat blotting'], ['', 'specific BBSV p24 E'], ['purified p24 gene', 'coat protein'], ['Based', 'frame shift mutant'], ['entire CP ORF', 'central amino protein'], ['wild type leaves', 'reduced RNA accumulation'], ['entire CP gene', 'wild type virus transcripts'], ['Two expression pBGUS', '23 CP gene'], ['vitro  pBGUS', 'confocal GUS microscopy'], ['BBSV', 'considerable virus expression vehicle'], ['infection', 'usually helper viruses'], ['sat RNA', 'systemic Nicotiana benthamiana'], ['Northern blotting hybridization', 'interfering sat BBSV'], ['infected BBSV abundance', 'mediated sat RNA BBSV'], ['5  termini', 'sat Uridines'], ['respectively  which', 'high  targets'], ['work', 'complicated helper virus'], ['delivery', '3 management skill months'], ['Data', 'based Disease program'], ['more behavior management sessions', 'more  depression'], ['strapped  agencies', 'well program IWDs'], ['Depression', 'behavioural  activities'], ['wide  range', 'mental  imagery'], ['Mental  imagery', 'adaptive  depression'], ['repeated  engagement', 'controlled  trial'], ['', 'Clin Psychol Sci'], ['', ''], ['', ''], ['Participants', 'imagery control internet'], ['Behavioural  activation', 'follow up Depression Scale'], ['BADS scores', 'greater imagery condition'], ['Investigating', 'future imagery research'], ['We', 'high level Simulink models'], ['equivalence', 'predefined performance models'], ['where input models', 'equivalent performance parameters'], ['specified performance threshold', 'success criteria'], ['input parameters', 'evolutionary  computation'], ['border', 'success criteria'], ['where buck approach', 'analog equivalence circuits'], ['', ''], ['', ''], ['rights', ''], ['generated network functions', 'integrated  circuit'], ['variety', 'simplification literature'], ['which', 'small signal circuit'], ['decision diagram pair decision that', 'binary decision diagram'], ['Two  types', 'directly GPDD data structure'], ['performance variation', 'monitored response metrics'], ['reduced performance which', 'reduced performance GPDD'], ['small signal circuit', 'simultaneously  reduction'], ['Applications', 'proposed amplifier methodology'], ['model', 'operational VHDL AMS'], ['when  performance', 'operational  account'], ['amplifier  model', 'modeled radiation effect parameter'], ['external  model', 'TID'], ['Finally  example', 'operational TID model'], ['', ''], ['Behavioral  changes', 'psychosocial brain life'], ['often  they', 'often  way'], ['behavioral  TBI', 'better  assessment'], ['cognitive  that', 'conceptual  model'], ['', ''], ['We', 'how face regard'], ['', ''], ['behavioral state symptoms', 'cognitive  impairment'], ['behavioral  symptoms', 'emotional  symptoms'], ['', ''], ['cognitive  characteristics', 'conceptual  behavior'], ['conceptual  model', 'personalized  population'], ['frontotemporal  subtypes', 'bilateral GM bvFTD'], ['hemispheric  predilection', 'such brain connectivity'], ['study', 'hemispheric connectivity differences'], ['Eight  SD', '3 diffusion tensor T'], ['Whole brain WM microstructure', 'distinct WM SD'], ['lateralization indices', 'diffusivity measures'], ['Functional  connectivity', 'early stage SD'], ['Results', 'direct  SD'], ['Whole WM microstructure abnormalities', 'slight  right'], ['Lateralization', 'left  hemisphere'], ['Functional  connectivity', 'right  bvFTD'], ['different connectivity that', 'right  bvFTD'], ['This', 'hemispheric brain connectivity SD'], ['', 'orofacial self help pain'], ['controlled  trial', 'usual  treatment'], ['total', 'orofacial intervention group'], ['Validated outcome measures', 'Anxiety pain life'], ['Bootstrap confidence intervals', 'baseline outcome covariance'], ['11 intervention 7', 'outcome measures'], ['intervention', 'feasibly  telephone'], ['it', 'significant  P'], ['', 'physical  functioning'], ['them', 'orofacial  pain'], ['It', 'functioning outcome perception'], ['Further  research', 'orofacial cost pain'], ['Imagination', 'biological  capacities'], ['approach', 'combined  processes'], ['sole  function', 'spiritual  conquests'], ['social  these', 'own  evolution'], ['thus  itself', 'own  path'], ['Anatomic modernisation', 'abstract  thought'], ['relationship', 'harmonious nature animals'], ['abrupt  it', 'evolution  Asia'], ['', 'moral audacity rules'], ['biological  life', 'social  sharing'], ['soon  they', 'animal behaviours'], ['they', 'natural  chaos'], ['Mastery', 'new  destiny'], ['united disciplines', 'ethical  requirements'], ['', 'C Academie des sciences'], ['dynamic  processing', 'information'], ['individual', 'subsequent  response'], ['frontotemporal youngeronset dementia syndrome', 'face processing network'], ['divergent  damage', 'predominantly  frontal'], ['Specific  predictions', 'temporal face model'], ['', 'Cognitive Sciences 4(6'], ['model', 'predictive face model'], ['existing FTD review', 'key face processing network'], ['type', 'FTD subtype'], ['evidence', 'future face FTD'], ['TGF)-beta Growth inhibitors', 'outmost  candidates'], ['we', 'effective drug nominees'], ['Beliefs', 'physical  symptoms'], ['current  study', 'global emotions support fibromyalgia'], ['eighty two eighty participants', 'potential mediation analysis'], ['model', 'serial  emotions'], ['two  forms', 'symptom support mediators'], ['Emotional  suppression', 'serially  emotions'], ['seeking  variable', 'significantly  relationship'], ['global  which', 'future  fibromyalgia'], ['dynamic  interaction', 'cellular proliferation differentiation growth'], ['prostatic  we', 'prostatic gene hyperplasia'], ['culture  that', 'human  prostate'], ['110  genes', 'cultured  cells'], ['Eighty four', 'Northern  blotting'], ['6  25', 'separate  cultures'], ['known  five', 'cultured  cells'], ['Human kallikrein gene', 'epithelial  cells'], ['5-monooxygenase protein cyclin I', 'cultured  fibroblasts'], ['', ''], ['Western blot analysis', 'protein levels'], ['stromal cell interaction', 'BPH'], ['Epithelial cells', 'physiological gene changes'], ['D3R  they', '5-HT2A receptor antagonists'], ['They', 'social  cognitive'], ['improved  that', 'likewise  5-HT6R'], ['compounds that', 'significant  D2R'], ['', ''], ['rights', ''], ['Selective  inhibitors', 'neurodegenerative diseases cancer'], ['pharmacophoric  unit', 'tetrahydrobenzothiazepine  core'], ['octahydro-6H  which', 'new HDAC6 inhibitors'], ['nanomolar HDAC6 which', 'enzymatic  levels'], ['Ames fluctuation which', 'mutagenic  structures'], ['Berberine', 'GI motility disorders'], ['gastrointestinal pacemaker which', 'gut movements'], ['', 'underlying ICC action'], ['experiments', 'whole ICC clusters'], ['', 'current clamp mode PPs'], ['However  effects', 'ATP sensitive K+ channel blocker'], ['induced PP ICI', 'inhibitory opioid receptor berberine'], ['however kinase A pretreatment', '43-a  quinoxalin-1-one'], ['berberine', 'cGMP guanosine ICCs'], ['berberine', 'opioid K+ receptors'], ['Therefore berberine', 'novel GI motility dysfunction'], ['Psychological  adaptation', 'other homicide losses'], ['bereavement it', 'traumatic  loss'], ['social  that', 'positive bereavement outcomes'], ['African  we', 'perceived  depression'], ['less stress disorder need', 'complicated follow up'], ['Clinical  implications', 'future  research'], ['Mental health issues', 'public health problems'], ['burden', 'several  decades'], ['Additional  therapies', 'existing healthcare approaches'], ['Essential oil aromatherapy', 'mental  problems'], ['pilot study', 'mental Utah USA'], ['eligible Fifty participants', '23 women age analysis'], ['Fifteen  minutes', 'positive control group'], ['essential oil people', 'clinical  trials'], ['bergamot essential oil aromatherapy', 'mental  health'], ['', ''], ['', 'John Wiley'], ['dietary  fibers', 'vivo'], ['Here  we', 'dependent 2 effects'], ['germ  mice', '5 chain days'], ['gut microbiota composition', 'fecal rRNA samples'], ['We', 'independent 2 effects'], ['Moreover  effects', 'beta ->1-fructans type polymer'], ['2 chain ->1-fructans', 'CD11b(-)CD103(-)dendritic T MLN'], ['->1-fructan  treatment', 'conventional IL-22-dependent mice'], ['effects', 'short chain fatty acids'], ['short  chain', 'independent gut microbiota'], ['Also  effects', '2 chain ->1-fructans'], ['', 'free B cell mice'], ['conclusion support', '2 chemical ->1-fructans'], ['IFNb Interferon preparations', 'multiple line sclerosis'], ['They', 'IFNb  patients'], ['pilot we', '49 RRMS patients'], ['Antibody levels', '1 treatment withdrawal'], ['3  that', 'Avonex Bayer Pharma antigens'], ['BAbs', '24'], ['', '%  expression'], ['4  they', '4  patients'], ['Rebif Betaferon existence', 'tested interferon beta'], ['however choice methods', 'further BAbs decisions'], ['neutralizing antibodies we', 'binding  antibodies'], ['disease glatiramer acetate switch', 'probably  benefit'], ['Plant beta-1 3-glucanases', 'plant development'], ['little  data', 'various rice stresses'], ['we', 'putative twenty glucanases'], ['OsGlu genes', 'seven Group DNA'], ['Northern OsGlu they', 'biotic  stress'], ['OsGlu11', '5 Group ABA'], ['', ''], ['10  11', 'incompatible  M'], ['', 'compatible  one'], ['OsGlu gene products', 'hormonal plant development'], ['beta Carotene', 'biological provitamin A'], ['Key vitamin formation', 'beta carotene'], ['expression', 'retinoic acid'], ['However  regulation', 'other BCM gene tissues'], ['present  we', 'several vitamin deficiency'], ['We', 'intestinal hybridization screening'], ['BCM gene expression', 'Northern transcription PCR analysis'], ['also BCM gene expression', 'deficient vitamin rats'], ['Sequence analysis', '566 amino acids'], ['predicted  polypeptide', '66 mouse BCM'], ['Rat BCM mRNA', 'weak testes kidneys'], ['rat BCM', ''], ['small control upregulation', 'trans RA'], ['BCM gene expression', 'also vitamin deficiency'], ['hepatic BCM gene expression', 'renal  retinoid'], ['small  intestine', 'major beta carotene conversion'], ['BCM gene expression', 'down beta carotene'], ['prevent', 'several beta tissues'], ['directly  that', 'desired  phenotype'], ['1 beta gene', 'quantitative RT PCR analysis'], [\"1981-bp 5'-upstream region\", 'beta Arabidopsis'], ['strong  that', '1'], ['', 'transcriptional cauliflower mosaic levels'], ['Furthermore GUS enzyme activity', 'AtBch1 promoter'], ['', '8-fold 35S promoter'], ['', 'ubiquitous AtBch1 Arabidopsis'], ['further  promoter', 'transgene dicot plants'], ['work', 'vascular HP dementia'], ['CD First HP BCP', ''], ['BCP', 'cannabinoid receptor type'], ['CD HP BCP', 'significantly  BCP'], ['CD HP BCP', 'learning  rats'], ['CD HP BCP', 'CBF'], ['CD HP BCP', 'well PI3 K'], ['Overall  findings', 'vascular HP beta future'], ['novel  type', 'covalently beta enzyme'], ['impact', 'enzyme activity'], ['', 'multifunctional N-3)(7)-beta initiator'], ['final  product', 'acid N-3)(7)-beta arms'], ['PAA', 'immobilized self pectinase'], ['results', 'fluorescence spectroscopy'], ['responsive  polymer', 'controllable  enzymes'], ['', 'International Union International Biochemistry'], ['1 angiotensin receptor', 'plasma streptozotocin'], ['plasma glucose concentration', 'glucose oxidase method'], ['concentration', 'immunosorbent beta assay'], ['hepatic soleus PEPCK', 'Western blotting analysis'], ['', 'diabetic plasma glucose rats'], ['Naloxone', 'sufficient opioid mu receptors'], ['', 'knockout diabetic receptor knockout mice'], ['Bilateral  adrenalectomy', 'elevating  valsartan'], ['', 'spontaneous BER secretion'], ['', 'cholinergic  1'], ['l  acetylcholine', 'diabetic BER 1'], ['nmol l Ang valsartan', 'dependent Ang manner'], ['', 'diabetic  valsartan'], ['mg  kg', 'hepatic soleus PEPCK'], ['Both', 'opioid mu receptor antagonist'], ['receptor', 'diabetic plasma rats'], ['Endonuclease cleavage', 'human erythroid cells'], [\"5'-truncated intermediates\", 'more  parent'], ['full S1 nuclease protection', 'decay intermediates'], ['We', 'sensitive MBRACE assay'], ['Nucleic Acids Res', 'full length beta globin'], ['Beta hydroxy beta methylbutyrate', 'widely sports performance'], ['skeletal protein balance', 'skeletal term muscle'], ['GH  I', 'GH  IGF'], ['Rats', '4 kg decapitation'], ['Blood', 'serum insulin glucose'], ['skeletal IGF I', 'Northern  blotting'], ['IGF I', 'IGF I concentration'], ['changes', 'skeletal mRNA expression'], ['', 'exhibited  hyperinsulinemia'], ['GH HM beta I', 'GH HM beta IGF'], ['apparent insulin resistance which', 'status  conditions'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['nervous noncoding functions', 'regulation'], ['rapid p it', 'AD development'], ['SP SY5Y cell model', 'synthetic 1 vitro'], ['mediated beta(1 oligomers', 'mediated beta(1 42'], ['western blot mRNA', 'Ki-67 AD model day'], ['exogenous beta(1 42', 'cleaving  enzyme'], ['Furthermore IncRNA BACE1-AS', 'RNA BACE1'], ['IncRNA BACE1-AS expression', 'SY5Y cell model'], ['MT  expression', 'vitro'], ['biological  effects', 'molecular  which'], ['purpose', 'MT mRNA BT'], ['Northern blotting', 'mRNA H7 HA1004'], ['CAT assays', 'transcriptional promorter CAT MT'], ['radical scavenger N NAC', 'oxidative MT gene BT'], ['BT', 'dependent HaCaT cells'], ['increase', 'completely CAT HA1004'], ['chelerythrin', 'inducible IIA promoter activation'], ['Furthermore NAC', 'BT4'], ['potent PKC activation', 'inducible IIA gene expression'], ['BT', 'useful IIA promoter activation'], ['BackgroundRetinoblastoma', 'malignant  children'], ['rare cure rates', '50  %'], ['1  expression', 'adverse outcome parameters'], ['like  kinase', 'G2 M transition'], ['1  inhibition', 'paediatric  tumours'], ['Here  we', 'retinoblastoma cell lines'], ['MethodsExpression', '1 polymerase chain reaction'], ['assay cell cycle propidium', '1 inhibitors BI6727'], ['Activation', 'signalling  TP53'], ['', 'proliferative cell cycle arrest'], ['1  inhibition', 'also  pathway'], ['Analysis', '1 retinoblastoma cell lines'], ['1  inhibitors', 'clinical chemotherapy trials'], ['paper', 'short term profit'], ['It', 'biding term planning curves'], ['Stochastic programming', 'dynamic price consumption tariffs'], ['case study', 'Sweden'], ['real time selling price', 'low price periods'], ['optimal bidding curves', 'specific trading periods'], ['risk averse risk retailer', 'larger  imbalances'], ['benefit', 'low profit risk'], ['However  aversion', 'certain  level'], ['larger  imbalance', 'quick  scenarios'], ['paper', 'scale electric energy company'], ['company', 'competitive electricity market'], ['Demand response programs', 'wholesale  market'], ['mathematical equilibrium constraint that', 'robust  optimization'], ['min bilevel model', 'single Tucker optimality conditions'], ['duality theory', 'ordinary max min problem'], ['Strong duality theory', 'final M strategy'], ['Applicability', '118-bus test system'], ['novel', 'switched dc dc inductors'], ['capacitor  cells', 'parallel autocurrent inductors'], ['thus  that', 'high power levels'], ['we', 'bidirectional dc dc converters'], ['Then  evolution', 'steady state operating inductor'], ['switched optimal design', 'switched chip switches'], ['driving that', 'actual  applications'], ['1-kW prototype converter', 'optimal conversion efficiency'], ['', ''], ['VRM voltage regulator structure', 'high end server applications'], ['efficiently  which', 'then  1'], ['', 'phase Buck converter'], ['light load efficiency', 'very energy saving'], ['light load output', '6 LLC dc V'], ['This', 'reduced multiphase Buck converter'], ['optimal trajectory control', 'FB configuration'], ['experiments', 'two stage VRM'], ['paper', 'width modulation control method'], ['different control it', 'different voltage gains'], ['three voltage gain which', 'wide voltage variation'], ['digital  it', 'resonant  converter'], ['performance', 'maximum output current'], ['Bifenthrin  BF', 'two  enantiomers'], ['stereoselective  degradation', 'active  sludge'], ['hence nanometer materials', 'BF'], ['that', 'active gradient gel electrophoresis'], ['onions', 'that'], ['where adsorption BF', 'chiral  pesticide'], ['studies', 'first order kinetics'], ['', 'domesticated  sludge'], ['active  sludge', 'whole  process'], ['BF', 'direct  bacteria'], ['bacteria', 'small  nutrition'], ['instead Acidobacteria Betaproteobacteria Sphingobacteriia', 'also Alphaproteobacteria domestication'], ['paper', 'bipolar  effect'], ['', ''], ['architectures', 'BJTs JFETs'], ['feature', 'steady input transistors'], ['It', 'radiation stability'], ['experimental  oriented', 'demanding sensor application'], ['JFET  transistors', 'operational  bipolar'], ['', 'differential input stages'], ['you', 'classical field effect reference'], ['circuit engineering', 'low offset voltages'], ['experimental  oriented', 'responsible sensor application'], ['light dc dc converter', 'load current'], ['Further bifrequency operation', 'PT spread spectrum'], ['periodic  BFO', 'existing PT control methods'], ['width voltage modulator', 'periodic  BFO'], ['extra frequency multiplexer', 'smooth skipping transition'], ['Analysis design methods', 'predictable ripple parameters'], ['proposed  control', 'FPGA device'], ['a b hta c', 'tuber Helianthus tuberosus L'], ['147 amino acid sequences', 'related agglutinin family'], ['induced Escherichia expressing', 'tested hemagglutination sugars'], ['inhibitory  activity', 'induced  E'], ['', 'native polyacrylamide gel'], ['mechanism', 'molecular  modeling'], ['HTA trypsin complex', 'active HTA trypsin'], ['above  HTA', 'inhibitory  activity'], ['hta', 'predominantly  H'], ['tuberosus', 'other  tissues'], ['hta', 'gene  family'], ['insect resistance traits', 'paper'], ['distribution power systems', 'constant power loads'], ['when switching frequency', 'significantly cutoff filter'], ['However dc distribution systems', 'high transportation applications'], ['they', 'switching effect'], ['paper', 'discrete dc distribution systems'], ['model', 'here dc power CPL'], ['switching  effects', 'simple discretization approach'], ['proposed  method', 'fast scale instabilities'], ['active  stabilizer', 'also stability system'], ['Finally  observations', 'experimentally laboratory test bench'], ['We', 'operational jerky amplifier'], ['triode which', 'chaotic voltage circuit'], ['We', 'dynamical  circuit'], ['numerical  which', 'good  measurements'], ['Smart  meters', 'such energy efficiency improvement'], ['Massive  amounts', 'smart  meters'], ['main  issues', 'context'], ['One', 'reduced  cost'], ['other', 'massive  dataset'], ['hidden electricity consumption patterns', 'partial usage patterns'], ['based  method', 'extracted load patterns'], ['Comprehensive  comparisons', 'real component Ireland'], ['results', 'proposed compression ratio'], ['new  that', 'individual genes environment'], ['Precision medicine', 'clinical cancer efficacy'], ['such Human Genome which', 'precision medicine'], ['Head', 'high incidence rate'], ['Current  therapies', 'considerable side effects'], ['now precision medicine', 'improved  results'], ['we', 'potential precision HNSCC'], ['We', 'cellular epidermal growth pathways'], ['Gene therapy', 'HNSCC'], ['Disease', 'significant crop losses'], ['worldwide  demand', 'new  disease'], ['One  mechanism', 'plant immune system'], ['application elicitor properties', 'plant immune plant system'], ['inducing  molecules', 'environmentally  pathogens'], ['bacterial Erwinia amylovora', 'bacterial  phytopathogens'], ['', ''], ['We', 'transcriptional plant level'], ['induced  genes', 'reverse polymerase chain reaction'], ['abiotic  stress', 'moderate DCA defence'], ['Finally  we', 'encoding RbohD gene'], ['promising plant which', 'salicylic jasmonic pathways'], ['', 'cholestatic liver injury'], ['however bile mechanisms', 'inflammatory bile response'], ['Recent  studies', 'liver inflammation'], ['chenodeoxycholic  acid', 'inflammatory ROS production'], ['Mechanistically CDCA', 'downstream protein kinases'], ['also ATP which', 'subsequently P2X7 receptor'], ['Furthermore', 'beta bile duct ligation'], ['excessive  CDCA', 'endogenous liver cholestasis'], ['finding', 'cholestatic inflammasome activation'], ['natural gas consumption', 'natural electricity units'], ['Supply', 'firm  interconnection'], ['paper', 'G wind process'], ['lower electricity level', 'natural gas system'], ['Natural gas system', 'detail'], ['security constraints', 'integrated energy systems'], ['objective  function', 'total production electricity'], ['level optimization model', 'integer linear programming'], ['PJM-5bus integrated', 'bi level ED model'], ['', ''], ['rights', ''], ['paper', 'digital CMOS VLSI technology'], ['number', 'flying conversion 2(n'], ['scheme', 'switch'], ['switching power loss', 'spectre simulation results'], ['open loop converter circuit', 'switching frequency'], ['open loop converter efficiency', '1 input 0'], ['', '4 switching 4/3'], ['flying gain capacitor', '180 nm CMOS technology'], ['back annotation results', 'MIM cap'], ['piece', 'information'], ['paper', 'schizophrenia'], ['Twenty five Twenty patients', '25 control proverbs'], ['', ''], ['', 'celebrities'], ['', ''], ['', ''], ['they', 'previously  proverbs'], ['binding  they', 'corresponding  context'], ['', ''], ['', ''], ['Analysis', 'worse destination controls'], ['populations destination memory', 'binding  task'], ['findings', 'appropriate  schizophrenia'], ['difficulty', 'coherent  memory'], ['open label extension study', 'eating lisdexamfetamine disorder'], ['30-mg target', '50-or 70-mg maintenance'], ['Safety evaluations', 'adverse  events'], ['', '78 safety analysis study'], ['LDX exposure', ''], ['', ''], ['cumulative LDX exposure duration', '344  participants'], ['', ''], ['', '506  participants'], ['5  %', 'treatment discontinuation'], ['', ''], ['', ''], ['', ''], ['adverse Treatment events', '10  participants'], ['', ''], ['', ''], ['', ''], ['', ''], ['early blood termination', 'SD blood week'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '572  minute'], ['', ''], ['', ''], ['', 'positive suicidal suicides'], ['long term safety', 'deficit hyperactivity disorder'], ['ObjectiveThis study', 'emotional mind assessments'], ['MethodsOverall', 'social disorder psychopathology'], ['obese  patients', 'impaired  alexithymia'], ['positive  correlations', 'interoceptive  awareness'], ['ConclusionsBinge', 'obese disorder patients'], ['impairment', 'highly  depression'], ['', ''], ['study', 'abdominal bowel sounds'], ['Different', 'opposite  directions'], ['Bowel sounds', '100  0'], ['signal  strength', 'amplifying  circuit'], ['second  microphone', 'such examination room noise'], ['signals', 'ADC'], ['that', 'real  time'], ['that', 'increasing water agriculture'], ['enteric  that', 'most wastewater treatment plants'], ['risks', 'agricultural  WW'], ['particular health which', 'viral  France'], ['Water air samples', 'activated sludge WW'], ['enteric  viruses', 'before water treatment'], ['Norovirus', 'GC  treatment'], ['', 'GC emission m(3)/s'], ['when  distance', 'emission source'], ['information', 'distance wastewater reuse'], ['', ''], ['', ''], ['rights', ''], ['Synergistic  effects', 'ecological  interactions'], ['where  activity', 'evolved  response'], ['focused meta that', 'multiple  insects'], ['phytochemical meta mixtures', 'specialist generalist herbivores'], ['We', 'future hypothesis tests'], ['rather  we', 'organic chemical ecology bioassays'], ['Data', 'ultimately interclass diversification'], ['synergistic  defenses', 'diverse chemical plants'], ['strictly redox cofactor', 'reductive amino group donor'], ['dependent alcohol we', 'protein engineering'], ['', 'catalytic acid M=54'], ['', 'wild type NADH'], ['9 K M=14', ''], ['Conversely  recognition', 'mutated  enzyme'], ['L197R', 'dicyclic Ralstonia sp'], ['', 'two alcohol cosubstrates'], ['excellent l Ala', 'small scale biocatalysis experiment'], ['This', 'high performance polymers'], ['', 'International Union International Biochemistry'], ['indispensable gene that', 'specific protein DNA interactions'], ['genomic ChIP that', 'chromatin'], ['However ChIP seq', 'hundred base pairs'], ['refined ChIP that', 'substantially  resolution'], ['key  distinction', 'right DNA crosslink site'], ['ChIP exo libraries', 'high throughput sequencing'], ['resulting  data', 'functional  genome'], ['ChIP exo we', 'generation sequencing generation synthesis'], ['m(6)A  modifications', 'eukaryotes'], ['They', ''], ['reversible RNA modifications', 'splicing translation degradation'], ['physiological  processes', 'm(6)A triglyceride modifications'], ['Immunoprecipitation  sequencing', 'm(6)A mass modifications'], ['Herein  we', 'northeastern m6A modifications'], ['current  protocol', 'various size RNA'], ['m(6)A  modifications', 'physiological  states'], ['Therefore  investigations', 'molecular m6A physiology'], ['Considerable  effort', 'digital microfluidic biochips'], ['reconfigurable  devices', 'on  chip'], ['manual  intervention', 'gene expression analysis'], ['we', 'experimental biochip design specification'], ['We', 'quantitative gene expression DMFBs'], ['real resource allocation that', 'promptly firmware layer'], ['framework', 'quantitative gene expression'], ['adaptive  framework', 'on  lifetime'], ['Various  grafts', 'sinus lift procedures'], ['ongoing  developments', 'therefore bone substitute BSBs'], ['understanding', 'composite replacement biomaterial'], ['Indeed  choice', 'still sinus augmentation procedures'], ['present  article', 'cellular sinus aspects'], ['where crime objective', 'suspects crime interest'], ['forensic  area', 'biological sample fluids'], ['', 'crime scene'], ['we', 'forensic  applications'], ['biocomputing that', 'well blood spot age'], ['however  addition', 'extra  certainty'], ['We', 'forensic biocomputing analysis'], ['social  conditions', 'transcriptional proinflammatory adversity'], ['previous  research', 'cultural  which'], ['WEIRD system gene we', '5 child Nepal'], ['CTRA gene expression', 'former child soldiers'], ['associated  that', 'severity child soldier status'], ['former child soldiers', 'free  civilians'], ['cultural life they', 'adverse  environments'], ['', 'natural petroleum hydrocarbon extent'], ['severe  they', 'organic  pollutants'], ['conventional physico chemical methods', 'remediation'], ['Biodegradation', 'cost petroleum hydrocarbon pollutants'], ['It', 'ultimate pollutants removal'], ['microbial  cells', 'polluted bioremediation sites'], ['which', 'lesser pollutants growth conditions'], ['factors', 'present research scenario'], ['review', 'available bioremediation pollutants'], ['Role', 'modified petroleum hydrocarbon immobilized'], ['', ''], ['rights', ''], ['Microbiological  deterioration', 'retouched glass plate negatives'], ['burnt manor that', 'World War Ilnd'], ['photographs', '19th  century'], ['negatives glass 4', 'possible  microorganisms'], ['collection', 'negatives'], ['Initially  viability', 'luminescence adenosine phosphate'], ['fungi', 'molecular Trichoderma longibrachiatum'], ['protective varnish impact', 'negative gelatine image layer'], ['', 'most gelatine emulsion'], ['', ''], ['All', 'silver gelatine sandarac'], ['microorganisms', 'quickly gelatin varnish'], ['however  fungi', 'also  varnish'], ['', ''], ['rights', ''], ['', 'prone hydrogen sulphide'], ['composed', '75 blast furnace slag'], ['evolution', 'cement materials'], ['4 OPC materials', 'high  speed'], ['Best  performances', 'higher aluminium ion'], ['rank', 'site'], ['microbial  diversity', 'well exposure duration'], ['Humans', 'marine  exploitation'], ['indirect food that', 'dramatically ecosystem function'], ['additional  implications', 'coastal nutrient areas'], ['that', 'fundamentally  processes'], ['primary  consumers', 'nutrient excretion'], ['marine consumer consumers', 'organismal  biomass'], ['how  consumers', 'primary  press'], ['forward  we', 'theory'], ['', ''], ['', 'environmental ecosystem function change'], ['how  consumers', 'marine  ecosystems'], ['Plant virus ecology', 'mainly host environment'], ['many  which', 'host plants it'], ['molecular biology which', 'important virus populations growth'], ['interacting life that', 'spread'], ['managed  factors', 'also  review'], ['better  which', 'exciting research future'], ['', 'recent  years'], ['Such  processes', 'main  steps'], ['', 'developing biomass feedstock'], ['otherwise pretreatment it', 'detrimental process products'], ['work', 'biomass novel'], ['microbial heat that', 'drying rate'], ['novel  technology', 'gasification process'], ['Fixed capital investment', 'different biodrying M$4'], ['', ''], ['', ''], ['economic gasification performances', 'scenarios'], ['major viability risk', 'biomass'], ['Bioelectrochemical  systems', 'directly digester CH4'], ['objective', 'methanogenic carbon BES'], ['abiotic  anode', 'abiotic AAn biocathode'], ['Transport', 'commonly anode 3'], ['', '6'], ['2L d atm', 'proton exchange membrane'], ['CO2', 'anode 3'], ['', '5'], ['', ''], ['abiotic cathode headspace', '1 AAn BCa day'], ['7-day carbon balance', 'net carbon cathode'], ['initial  CO2', 'biocathode anode'], ['methanogenic BES which', 'alternative BES designs'], ['', ''], ['', ''], ['', ''], ['', ''], ['performance', 'ionic liquid membranes'], ['behavior', 'such electricity acetate'], ['ionic energy production', 'polymeric R'], ['NTf2]-based  SILM', 'low acetate loading'], ['', 'm(-2 polymeric Nafion N115'], ['however SILM characteristics', 'cell polarization measurements'], ['ionic membrane liquids', 'bioelectrochemical system research'], ['', ''], ['rights', ''], ['microbial  which', 'medium chain fatty acids'], ['gaseous chemicals which', 'cleaner  environment'], ['Additionally  bottlenecks', 'lower conversion yields'], ['infant stage this', 'organic waste remediation'], ['Henceforth  review', 'future research advances'], ['', ''], ['rights', ''], ['2  C', 'industrial energy revolution'], ['meet', 'integrated carbon capture'], ['goal', ''], ['key climate policy actors', 'BECCS'], ['article', 'long electricity supply sector'], ['711 change conference article', 'large scale BECCS deployment'], ['Exposure', 'solid biomass fuels'], ['renewable  which', 'climate change'], ['Little', 'mainly electricity sector'], ['research', 'direct bioenergy pellets'], ['single bioenergy pathway', 'impacts'], ['human health BIGCC', 'least impact categories'], ['However bioenergy systems', 'human change impact'], ['environmental electricity grid it', 'existing electricity production province'], ['', ''], ['rights', ''], ['fired power plants', 'three electricity sector'], ['carbon dioxide changeover', 'States electricity sector'], ['vast Southeastern United majority', 'wood pellet Europe'], ['that', 'firing electricity generation'], ['avoided life cycle emissions', 'wood Europe'], ['assessment modeling scenarios', 'nine impact categories'], ['stricter emission regulations', 'fired Southeastern United States'], ['', 'C Elsevier Ltd'], ['Substrate nanotopography', 'potent cell phenotype'], ['enough  cells', 'nanotopography'], ['current nanofabrication techniques', 'large  area'], ['Herein  we', 'large stitch technique'], ['soft  PDMS', 'polystyrene master substrates'], ['PS master we', 'nanotopographical working cell'], ['method', 'hybrid micro-/nanoscale components'], ['Biofouling', 'economic  impacts'], ['engineered biofilm phage', 'bacterial  system'], ['synthetic life it', 'synthetic  phage'], ['study', 'wt carbon phage'], ['Optimal results', '30 carbon days'], ['competition', '4h'], ['conditions', 'engineered monoculture system'], ['mix', '8  days'], ['Biofuels', 'technical  solution'], ['Initial  hopes', 'numerous Global controversies'], ['sustainability which', 'certification schemes'], ['paper', 'two  countries'], ['European land we', 'two land cases'], ['current governance framework', 'existing  inequalities'], ['present research study', 'directly power biogas'], ['', 'energy  system'], ['based  system', 'three heat exchangers'], ['appropriate simulation that', 'whole exergy system'], ['simulated Optimization which', 'such chemical reactions'], ['use', 'pure  optimization'], ['', ''], ['rights', ''], ['economic  assessment', 'thermal biogas cogeneration'], ['Seven energy crops', ''], ['', 'northern climate Greece'], ['high irrigation that', 'total production costs'], ['', '1000 biogas plant kW(el'], ['public funding biogas production', 'smaller  area'], ['inclusion', 'entire biogas system'], ['', 'total income income'], ['specific biomass factors', 'more biomass production costs'], ['microRNA  biogenesis', 'clinical  diseases'], ['Several  methods', 'northern production cells'], ['However  development', 'human production medicine'], ['Here  we', 'mature  regulation'], ['optical  that', 'living  subjects'], ['imaging  strategy', 'multiple throughput diseases'], ['primordial germ which', 'essential germ cell development'], ['However  target', 'regulatory  PGCs'], ['Here  we', 'cellular control PGC pathways'], ['We', 'gonads postnatal testes'], ['miRNAs', 'situ hybridization assay'], ['regulatory  miRNAs', 'potential PGC development'], ['cellular  that', 'germ cell development'], ['Tripterygium', ''], ['', ''], ['medicinal  it', 'triptolide terpenoid celastrol'], ['All', 'biosynthetic  system'], ['dimethylallyl  which', 'isopentenyl'], ['', 'encoding IPI TwIPI GenBank accession'], ['KT279355', 'cultured  T'], ['', ''], ['full length cDNA', '288 amino acids'], ['deduced TwIPI sequence', 'TNTCCSHPL  motif'], ['transcription level', 'fivefold methyl elicitor'], ['Escherichia TwIPI', 'functional  protein'], ['', 'International Union International Biochemistry'], ['', ''], ['resistance', 'anhydrobiotic dehydration stress'], ['Larvae', 'high radiation exposure'], ['further stress we', 'low LET radiation'], ['transcriptional expression response', 'regulated irradiation exposure'], ['extensive  group', 'overlapped  desiccation'], ['', 'related  genes'], ['aspartate O probes', 'LEA proteins'], ['functional  analysis', 'enriched protein methylation'], ['active  processes', 'DNA repair'], ['tolerance', 'complex irradiation anhydrobiosis'], ['Hepatitis B virus', 'public DNA sequence databases'], ['multiple sequence alignments', 'length  genotype'], ['Such  alignments', 'mining analysis analyses'], ['sequence data', 'public  database'], ['which', 'full length sequences'], ['Further  curation', 'alignment'], ['multiple sequence which', 'length  fragments'], ['new  sequences', 'public  sequence'], ['alignments', 'http://hvdr'], ['', ''], ['', ''], ['', ''], ['', ''], ['they', 'regenerative  therapy'], ['Osteoinductive  which', 'prior cell transplantation'], ['molecular  basis', 'osteoinductive  medium'], ['Therefore  we', 'osteoblastic gene hMSCs'], ['hMSCs', 'multipotency self renewal ability'], ['expression', 'significantly BTB hMSCs'], ['protein expression', 'OIM'], ['interfering  RNA', 'mineralized nodule OIM'], ['which', 'markedly  ZBTB16'], ['canonical Sp1 which', 'canonical Sp1 sequence'], ['acts', 'osteoblastic  differentiation'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Recent  developments', 'high cell throughput'], ['developmental trajectory inference cells', 'developmental trajectory inference path'], ['we', 'individual  methods'], ['new  methods', 'wiring cell differentiation'], ['future  that', 'immune cell differentiation'], ['Bioinformatics field', 'structural gene expression studies'], ['Bioinformatics', 'biological computer information'], ['GSP signal techniques', 'biomedical  issues'], ['GSP', 'genomic signal data'], ['', ''], ['', ''], ['Recently  applications', 'such frames cancer detection'], ['so  detection', 'promising  risk'], ['cancerous  that', 'genetic  abnormality'], ['systematic  review', 'GSP bioinformatics'], ['recent cancer what', 'new  research'], ['tertiary  structure', 'functions'], ['Therefore  predicting', 'important biochemistry molecular biology'], ['One', 'polar amino environment'], ['we', 'cubic optimization lattice'], ['results', 'genetic colony optimization algorithm'], ['biological  that', 'such yield disease resistance'], ['how  interactions', 'crop development'], ['relevant trait data', 'variable data quality'], ['general genomescale knowledge that', 'effective knowledge mining'], ['methods work we', 'major crop species wheat'], ['orthologous WRKY transcription we', 'biological knowledge discovery'], ['we', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['created', 'evidence crop improvement'], ['', ''], ['', 'Elsevier B'], ['', ''], ['This', 'open CC BY license'], ['primary liver which', 'related  men'], ['signaling growth that', 'hepatocellular  carcinoma'], ['Wnt proto overexpression', 'hepatocellular  carcinoma'], ['microRNAs', 'D1 messenger RNA'], ['', 'targeting D1 messenger RNA'], ['Luciferase assay', 'bioinformatic prediction results'], ['Cyclin D1 expression', 'real HepG2 cell line'], ['Afterward HepG2 cells', 'miR-20a'], ['Then  expression', 'miR-20a'], ['results', 'D1 messenger miR-20a'], ['238-fold  decline', 'lentiviral HepG2 cells'], ['results', 'considerable Cyclin D1 gene'], ['miR-20a', 'hepatocellular carcinoma diagnosis'], ['red  alga', ''], ['transcriptional gene research', 'E'], ['', ''], ['we', 'high bioinformatics analysis'], ['BLAST', '126  potential'], ['conservation  families', 'comparative plant alignment'], ['total', 'thereby sequencing data'], ['potential target genes', 'psRobot'], ['Target genes classification', 'Gene Ontology analysis'], ['functions', 'metabolic Kyoto Genes'], ['Cytoscape network', 'miRNAs target genes'], ['large  number', 'biological target E'], ['', ''], ['uncovered  information', 'red  future'], ['', ''], ['', ''], ['', 'oomycete  Pennisetum'], ['', ''], ['', ''], ['', 'young  seedlings'], ['', 'motile plant tissue'], ['Resistance', 'associated  proteins'], ['present zoospore protein', 'size exclusion'], ['fractionated  protein', 'resistant pearl millet'], ['resistant cell percentage', 'susceptible cell cells'], ['Cultures', 'crude  elicitor'], ['oxidative  burst', 'crude  elicitor'], ['purified  elicitor', 'unique  properties'], ['purified  protein', '5'], ['elicitor', '7040  daltons'], ['primary  structure', 'known plant pathogenic'], ['Higher  activities', 'purified cell elicitor'], ['oxalate mRNA transcripts', '30 elicitor treatment'], ['purified  elicitor', 'dependent sterol binding'], ['purified elicitor protein', 'weight oomycete sterol carrier properties'], ['unique  that', 'friendly crop protection'], ['social  relationships', 'which'], ['social  environments', 'biologically infant cortisol reactivity'], ['pregnant seventy women', '6 months postpartum'], ['social  support', 'maternal infant cortisol depression'], ['social  relationships', 'biologically child development'], ['fast  growth', 'fast crop diseases'], ['wide  that', 'adequate disease losses'], ['therefore control strategies', 'infected plant material'], ['smallest  identification', ''], ['reliable  steps', 'final  detection'], ['several  methods', 'various host advantages'], ['fast  combination', 'reliable  identification'], ['biological  which', 'epidemiological  studies'], ['definition', 'based  accounts'], ['several  participants', 'biological  individual'], ['considerably  philosophers', 'two  elements'], ['physiological  fields', 'biological  individuality'], ['notions', 'organism'], ['biological  that', 'scientific  practices'], ['Salivary biomarkers', 'breast cancer'], ['Therefore  review', 'biological breast cancer'], ['they', 'biological breast cancer'], ['search', 'Cochrane LILACS Direct Scopus Science'], ['biomarkers', 'clinical  application'], ['pertinent  13', 'inclusion criteria'], ['Combined biomarker approaches', 'individual breast cancer biomarkers'], ['single  biomarlcer', 'early breast cancer diagnosis'], ['Taurine', 'early breast cancer individuals'], ['Furthermore valine', 'advanced breast cancer'], ['seven  studies', 'sensitivity'], ['', 'et'], ['', ''], ['', ''], ['', ''], ['', ''], ['2009  which', '97  %'], ['', 'early breast stages'], ['', 'diagnostic breast cancer'], ['current  review', 'new research directions'], ['', ''], ['rights', ''], ['miR-148a  that', 'gastric tumor cancer'], ['We', 'surgical GC patients'], ['Kaplan Meier curves', 'overall log rank GC'], ['Besides  we', 'vitro proliferation migration invasion'], ['median', 'high expression groups'], ['Down regulation', 'shorter test set'], ['', ''], ['', ''], ['', ''], ['', ''], ['both', 'prognostic  GC'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'negative control groups'], ['', ''], ['findings', 'prognostic  GC'], ['Power', 'curtailed energy gas'], ['economically  systems', 'concentrated  CO2'], ['Biogas', '60 % methane'], ['', 'surplus methane output'], ['potential CO2 production', 'curtailed  electricity'], ['Wind energy curtailment', 'conservatively  2175GW(e)h'], ['Thus P2 G', 'rather biogas systems'], ['1  GW(e)h', '97 P2 G tonnes'], ['cost', 'sic)0'], ['when  price', 'electricity'], ['This', 'renewable  sic)1'], ['', ''], ['This', 'sic)1'], ['when  electricity', ''], ['', ''], ['', ''], ['rights', ''], ['beamline BL19U2', 'material small ray scattering'], ['which', 'high BL19U2 end stations'], ['111 silicon monochromator', '15 photon keV'], ['manual', 'growing crystallographers biochemists'], ['Pilatus 1 M detector', 'dynamic data range'], ['EMBL which', 'friendly data processing'], ['BL19U2 beamline', 'officially  March'], ['number', 'experimental  BL19U2'], ['new setup characteristics', 'together  data'], ['Biologics', 'monoclonal fusion medicine'], ['', 'human Administration use'], ['critical mAb lessons', 'improved  biologics'], ['approved  they', 'date'], ['', ''], ['rights', ''], ['Background', 'cruciate graft healing ligament'], ['ability', 'clinical ACL reconstruction'], ['tracking', 'ACL reconstruction'], ['necrotic donor cells', 'early graft healing phase'], ['', ''], ['engineered Tg which', 'wild type pigs'], ['Tissue samples', 'immunohistochemical microscopic analyses'], ['postoperatively recipient cells', 'central  graft'], ['cells', 'regular collagen orientation'], ['necrotic weeks regions', 'native weeks ACL'], ['cellular  distributions', '24  weeks'], ['mean collagen fibril diameter', ''], ['engineered  pigs', 'cellular ACL reconstruction'], ['reconstructed  graft', 'native  stage'], ['24 collagen matrix', 'native  ACL'], ['risks', '24 sports surgery'], ['Food poisoning', 'major foodborne illness'], ['Staphylococcal enterotoxin D', '300 food poisoning children'], ['inactive  which', 'threat'], ['methods', 'ethical  concerns'], ['quantitative bioluminescence assay', 'lymphoblastoid antigen presentation'], ['ng  which', 'more splenocyte proliferation monkey'], ['Pasteurization', '5 degrees min'], ['also  milk', 'protective  SED'], ['bioluminescence assay', 'biological  SED'], ['Disease surveillance', 'optimised bladder treatment'], ['', 'FGFR3 tumour mutations'], ['tumour DNA', 'FGFR3 PIK3CA hotspot mutations'], ['One  cohort', 'invasive bladder cancer'], ['other  cohort', 'radical bladder cystectomy'], ['39 Cx 27', 'ddPCR  assays'], ['Outcome measurements', ''], ['rank sum test', ''], ['', 'FGFR3 Cx mutation'], ['high NMIBC levels', 'later disease NMIBC'], ['', ''], ['high  levels', 'Cx cohort'], ['', ''], ['positive  correlation', 'tDNA  urine'], ['', ''], ['retrospective study design', 'available  study'], ['', 'later bladder cancer'], ['Patient  Urine', 'bladder assays'], ['', '2016 European Urology'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['incidence', 'nonaccidental head trauma'], ['decompressive PTV PTV', 'permanent  shunt'], ['NAHT PTV cases', 'temporal  discharge'], ['authors', '10-year  period'], ['ventricular  dilation', 'earliest  time'], ['Discharge outcomes', 'Head Injury score'], ['Thirty nine RESULTS Thirty percent', 'PTV'], ['GCS Coma score', 'early PTV presentation'], ['ischemic subarachnoid hemorrhage', 'PTV  NAHT'], ['', ''], ['6  patients', '67  PTV'], ['', ''], ['patients', 'lower GCS ventriculomegaly'], ['2  patients', 'shunt placement'], ['particularly  DC', 'early  NAHT'], ['PTV NAHT patients', 'dependent  hydrocephalus'], ['CRC  genetics', 'sporadic  CRC'], ['genetic data which', 'molecular  CRC'], ['incidence', 'genetic  factors'], ['molecular  basis', 'CRC disease chemotherapy'], ['we', 'inherited  CRC'], ['ductal adenocarcinoma cancer', 'leading cancer death'], ['two chemotherapy regimens', 'overall  gemcitabine'], ['Based', 'targeted monoclonal PDAC'], ['Preclinical  trials', 'pancreatic cancer treatment'], ['review', 'targeted IGF-1 R checkpoints'], ['preclinical  I', 'pancreatic cancer patients'], ['patient  selection', 'efficacious toxicity drugs'], ['flexibly  that', 'different energy system'], ['conceptual design which', 'Danish energy utility Horsens'], ['total CO2 it', 'thermal utility butchery'], ['Selection', 'long investment costs'], ['considered system design', 'hourly  period'], ['optimal  design', 'existing CHP unit'], ['when process integration synergies', 'present  case'], ['Assessing', 'present optimal range'], ['', ''], ['', 'different electricity price scenarios'], ['change', 'lower interest 181'], ['', '3 reference operating conditions'], ['particular methanol price', 'corresponding investment costs'], ['study outcomes', 'systematic FMG concepts'], ['', ''], ['rights', ''], ['paper', 'relevant CO2 literature'], ['Later  paper', 'statistically CO2 US'], ['paper', 'asymmetric literature output'], ['biomass energy consumption', 'CO2 capita'], ['hence biomass production technologies', 'well biomass US'], ['other policy makers', 'such biomass production'], ['possible  works', 'worsening climate change'], ['quality', 'thermal power plants'], ['biomass', 'particular wood paper'], ['latter', 'prior  collection'], ['large  that', 'large  ash'], ['main  that', 'earlier biomass studies'], ['Biomass', 'renewable energy world'], ['It', 'liquid  fuels'], ['utilization', 'modern energy times'], ['Biomass', 'rural  Turkey'], ['Biomass', 'industrial process facilities'], ['Biomass potential', 'animal  wastes'], ['most  share', '14 energy %'], ['total biomass energy potential', '33 million oil equivalents'], ['amount', 'usable biomass Turkey'], ['electrical production potential', '280000 bioenergy jobs'], ['study', 'important energy Turkey'], ['', ''], ['rights', ''], ['3D carbon materials', 'high surface area'], ['Here  we', 'porous MnO2 carbon'], ['porous carbon materials', 'carbonization  hemp'], ['porous carbon materials', 'one step hydrothermal method'], ['XRD  results', 'alpha MnO2 wires'], ['98 conversion which', 'expressly plastics recycling industry'], ['', ''], ['', ''], ['rights', ''], ['Greenhouse gas emissions', 'green transport alternatives'], ['alternative fuel concepts', 'sustainable feedstock synthesis technology'], ['fuel net fuel production', 'political climate change'], ['Results', 'economic methodology factors'], ['standardized  methodology', 'FT fuel production synthesis'], ['methodology', 'in software tool TEPET'], ['standardized  approach', 'predefined framework conditions'], ['Power electricity PtL', 'low electricity prices'], ['', 'Fuel production 1'], ['', ''], ['sic)(2014)/1', ''], ['', ''], ['rights', ''], ['Controversy', 'violent  impact'], ['objective', 'improved test biofidelity'], ['series', 'violent infant surrogate'], ['', ''], ['5 infant surrogate', ''], ['percentile Japanese adult male', 'sagittal infant plane'], ['Triaxial linear accelerometers', 'recorded  accelerations'], ['4 test sec', 'duration'], ['Outcome measures', 'accelerometer trends'], ['peak neck flexion', 'events'], ['113 peak neck extension', ''], ['', ''], ['angular  acceleration', 'chin test contact'], ['angular  velocity', ''], ['', 'chin  contact'], ['Acceleration pulse Acceleration durations', '72'], ['', '168'], ['', ''], ['previously infant surrogate', 'experiments'], ['Findings', 'surrogate  biofidelity'], ['brief', 'capacitive  sensor'], ['system', '13'], ['', '640 mu s'], ['capacitance  converter', 'switched capacitor amplifier'], ['fast gain compensation method', 'high energy CDC'], ['two step autocalibration', 'offset'], ['whole oxide semiconductor system', '8'], ['', '9-bit  linearity'], ['', ''], ['Drug Ontology', 'OWL2-based action forms'], ['complete National Drug that', 'so drug products'], ['molecular  we', 'therapeutic  indication'], ['we', 'three research use cases'], ['We', 'Uganda Resistance Immunology project'], ['2016 DrOn that', 'new  action'], ['therapeutic  indication', 'therapeutic drug DrOn'], ['therapeutic drug product', 'therapeutic drug which'], ['work', 'adverse drug design'], ['work', 'namely modeling receptor'], ['DrOn', ''], ['', ''], ['', ''], ['', ''], ['smaller  version', 'NDCs'], ['', ''], ['', ''], ['', ''], ['that', 'gain power dissipation'], ['design', 'capacitive Miller compensation'], ['power operational power amplifier', ''], ['proposed Op Amp', '+'], ['', 'total 75V supply 1'], ['', 'gain'], ['proposed  design', '90 nm CMOS node'], ['Finger vein recognition', 'increasing biometrics security'], ['binary learning method', 'finger vein recognition'], ['First', 'subject relation subjects'], ['binary relation templates', 'vein subjects'], ['different  templates', 'maximum  subjects'], ['', 'binary code bit'], ['', 'binary vein recognition DBC'], ['which', 'performance'], ['Experimental  results', 'finger vein recognition'], ['mostly  that', 'skeletal  matrix'], ['skeletal biomineralization matrix', 'recent  transcriptomics'], ['deposition', 'high throughput approaches'], ['rapid  identification', 'associated  proteins'], ['', ''], ['', 'calcifying animal echinoderms'], ['simple  definition', 'skeletal  matrix'], ['however  it', 'evolutionary matrix components'], ['', ''], ['rights', ''], ['mathematical  model', 'tooth'], ['proposed  model', 'balanced Wien bridge oscillator'], ['phase we', 'tooth'], ['discovery', 'intense drug candidates'], ['US FDA approval', 'effective leukemia molecules'], ['ligand protein that', 'new Abl kinase inhibitors'], ['molecular mode which', 'Abl kinase inhibitors'], ['Siglec cell surface which', 'immune  cells'], ['immune sialic system', 'autoimmunity'], ['Siglec Sialic interactions', 'specific  tools'], ['Here  we', 'sialic living Siglecs'], ['different sialic acid that', 'different Siglec family members'], ['Rational  design', 'selective Siglec-5/14 ligands'], ['engineered  cells', 'monocytic NF kappa B'], ['AimsThe aim', 'pharmaceutical cell formulations'], ['Methods', '16SrRNA Nadkarni etal'], ['', ''], ['', '18SrRNA  study'], ['genomic Candida albicans', 'dynamic  range'], ['successful  establishment', 'based microbial target preparations'], ['commercial DNA extraction methods', 'Isolation Kit choice'], ['different detection CFU', 'mammalian  ml'], ['ConclusionsThis study', 'based sample matrix'], ['Significance', 'short shelf life'], ['', 'pharmacopoeial incubation periods guidelines'], ['microbiological quality control methods', 'such  products'], ['', 'further time PCR challenges'], ['inner cell mass', 'confined  blastocyst'], ['Embryonic stem cells', 'often mouse droplets'], ['cells', 'physical  confinement'], ['difference', 'increased cell cell interactions'], ['geometric  degree', 'also  spherogenesis'], ['balance', 'finely mESC aggregates'], ['Physical  confinement', 'developing  cells'], ['', ''], ['', 'commonly  St'], ['wort', 'alternative  depression'], ['adverse  that', 'commercial biopolymer chitosan'], ['right  stimulus', 'desired  delay'], ['', 'synthesizing biopolymeric St'], ['commercial  capsules', 'effective brain drug'], ['nanoparticulated  suspension', 'antidepressant vivo studies'], ['FT IR nanoparticles', 'average particle 211'], ['', 'positive zeta 45'], ['', ''], ['mice models', 'force swimming tail suspension test'], ['commercial  capsules', ''], ['', ''], ['', ''], ['animal despair studies', 'CAT GP(x control groups'], ['outcomes', 'St'], ['lower wort that', 'side effects'], ['Building blocks', 'new polymer systems'], ['', 'mechanical polymer properties'], ['far cellulose that', 'processed CNC nanocomposites'], ['particular  grade', 'stable phosphoric acid'], ['mixing  process', 'polyurethane  elastomer'], ['significant  improvement', '120 room temperature MPa'], ['introduction', 'also shape memory nanocomposite'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['noise operational noise amplifier', 'biomedical  applications'], ['amplifier', 'referred  noise'], ['thermal  we', 'bias transistors'], ['', 'weak gate inversion'], ['then  which', 'periodically  accnmnlation'], ['This', 'fnrther flicker transistors'], ['thus  us', 'trading noise'], ['we', 'low input 2'], ['', 'small snpply 4'], ['', ''], ['minimal  power', 'average power amplifier'], ['it', 'implantable  applications'], ['gain', 'amplifier'], ['', 'greater phase frequencies'], ['circuit', 'TSMC'], ['', '18 Cadence Virtuoso'], ['performance', 'process corners'], ['simulations', '36'], ['', ''], ['Industrialization', 'cellular core biology'], ['Modeling', 'such  processes'], ['metabolic  it', 'bioprocess'], ['additional  focus', 'liquid mass transfer'], ['Biological  modeling', 'increasing  complexity'], ['steady state models', 'integrated  models'], ['closing discussion', 'biopharmaceutical  industry'], ['', 'Institute Chemical Engineers'], ['Recombinant consensus interferon', 'molecular  19'], ['', 'antiviral  activity'], ['human  CIFN', 'metabolizable d inducer'], ['scale recombinant protein it', 'limited processing cost'], ['', 'E'], ['coli  induction', 'instead  IPTG'], ['Lactose induction', '1mM flask IPTG'], ['pure DEAE sepharose rhCIFN', 'single DEAE sepharose >'], ['present  attempt', 'high quality purity'], ['Methods', 'low pilot scale cost'], ['', 'International Union International Biochemistry'], ['115 iliac crest bone', 'resistant prostate test'], ['lactate dehydrogenase which', 'biopsy  result'], ['bone marrow biopsy', 'molecular  characterization'], ['urgent  need', 'primarily prostate cancer bone'], ['use', 'clinical bone marrow biopsies'], ['We', 'BMB'], ['derivation 58', 'validation'], ['computed tomography parameters', ''], ['score', 'logistic derivation validation'], ['', '115  75'], ['5  %', ''], ['', '69 test validation'], ['', 'univariable analysis hemoglobin'], ['', ''], ['', ''], ['', 'HUs'], ['004', ''], ['score', 'IU validation set'], ['', ''], ['', ''], ['', ''], ['', ''], ['area', 'score'], ['79', 'test'], ['', 'validation'], ['BMB', 'resistant prostate cancer bone'], ['signature', 'internal LDH validity'], ['Prospective  studies', 'external  score'], ['', ''], ['', 'Elsevier Inc'], ['', 'sustainability challenges'], ['', ''], ['circular resource bioeconomy', 'coming  decades'], ['South Africa', 'global sugar market'], ['South Africa', 'existing sugar industry'], ['economic  evaluation', 'sufficient biorefinery system'], ['Economic  assessment', 'internal methanol 16'], ['', ''], ['15 investment latter', 'lowest market scenarios'], ['sugarcane cultivation', 'significant tetrahydrofuran contribution'], ['thermochemical  routes', 'biochemical impact acidification'], ['environmental methanol production', 'low reagent consumption'], ['economic  assessments', 'circular bioeconomy context'], ['important  role', 'remediation treatment recovery'], ['microbial fuel electrode', 'electron acceptor'], ['', 'current W density'], ['38 A m(-3', 'sole  substrate'], ['bacterial anode which', 'electron transmission'], ['Trace metabolites', 'anaerobic chromatography mass spectrometry'], ['that', 'vital field applications'], ['', ''], ['rights', ''], ['Here  we', 'DNA damage'], ['Primarily C dots', 'one citric diethylenetriamine'], ['C dots', '4  %'], ['', 'addition'], ['', ''], ['8  nm', 'positive surface neutral'], ['DNA binding', 'photoluminescent C dots'], ['binding', 'decreased ethidium bromide'], ['excitation energy EtBr', 'acceptor'], ['When  DNA', '612  nm'], ['concept', 'genomic melanoma tissues'], ['paper', 'bio potential monitoring system'], ['It', 'high power efficiency'], ['stabilized transconductance boost technique', 'low noise amplifier'], ['MOS transistors', 'subthreshold supply 0'], ['5  V', 'power consumption'], ['Moreover DC servo loop', 'high electrode offset cancellation'], ['', '0'], ['18 CMOS process', ''], ['', ''], ['', ''], ['referred  noise', '800'], ['5 mu V rms', '0'], ['1  which', '3'], ['', '7'], ['', ''], ['whole  circuit', 'dB  CMRR'], ['referred  noise', 'front end instrumentation DSL'], ['3 mu V rms', '0'], ['', ''], ['', ''], ['rights', ''], ['Foodborne pathogens', 'developing  countries'], ['This', 'economic  impact'], ['early  detection', 'them'], ['Detection', 'such polymerase chain reaction'], ['aim', 'specific  method'], ['futuristic biosensor methods', 'common  goal'], ['recent  that', 'years'], ['immune  responses', 'severely  safety'], ['related host that', 'local product immunogenicity'], ['immune response modulating that', 'immune  response'], ['We', '10  pg'], ['01  EU', 'inflammatory CpG rhesusmacaques'], ['PRR that', 'increased gene rasburicase'], ['therapeutic antibody that', 'product immunogenicity'], ['', 'Elsevier Inc'], ['', 'American Pharmacists Association'], ['biological  it', '21st  century'], ['I', 'ethnographic  research'], ['schema', 'ethnographic  Italy'], ['biopolitical  that', 'explicit research other'], ['particularity  that', 'them'], ['wide novel enzyme biocatalysis', 'great  challenge'], ['', ''], ['', ''], ['Key tools', 'whole discovery processes'], ['technological  innovations', 'pharmaceutical environmental pharmaceutical industries'], ['review', 'integrated cell processes'], ['Biocatalysis', 'fundamental  biotechnology'], ['biological  which', 'biochemistry curricula'], ['particular sterol we', 'provitamin'], ['how sterol pathways', 'diverse sterol moieties'], ['students', 'sterols'], ['They', 'bioinformatic  analysis'], ['Additionally  students', 'biotransformation bioreactor'], ['Finally  they', 'microscopy  biotransformation'], ['key  which', 'final  mark'], ['', 'pharmaceutical laboratory moieties'], ['', 'International Biochemistry'], ['', 'scientific study biotechnologies'], ['formal applications learnings', 'biotechnology applications'], ['Sample', '205 science majors'], ['Biotechnology Knowledge Questionnaire', ''], ['Descriptive t test', 'biotechnological  majors'], ['they', 'sufficient  biotechnologies'], ['attitudes', 'considerably  biotechnology'], ['', 'International Biochemistry'], ['weaned growth Escherichia', 'lipopolysaccharide  challenge'], ['weaned Thirty pigs', 'dietary basal 0'], ['', 'main LPS factors'], ['21  pigs', 'sterile kg body saline'], ['Blood samples', 'TNF alpha TNF PGE(2'], ['Body weight', 'weekly feed experiment'], ['LPS challenges', 'daily  gain'], ['', ''], ['BV', 'gain  P'], ['05', 'pigs'], ['LPS challengexdiet interactions', 'ADG'], ['', ''], ['', 'challenge'], ['LPS challenge', 'white cells lymphocytes monocytes'], ['', ''], ['LPS challengexdiet interaction', 'plasma TNF alpha'], ['decreased TNF alpha response', 'BV'], ['challenge diet interaction', 'plasma cortisol'], ['', 'plasma insulin'], ['', ''], ['increased LPS challengexdiet interaction', 'increased BV supplementation'], ['BV', 'immunological proinflammatory cytokine release'], ['operational radiation opamp', 'different  manufacturers'], ['Pulsed ray experiments', 'unirradiated fission devices'], ['developed simulation tool', 'electrical displacement damage phenomenon'], ['good  agreement', 'model outputs'], ['influence', 'single event effect'], ['so loop ASET', 'amplifier loop stability'], ['Qualitative  explanations', 'external feedback resistor values'], ['TID effects', 'integrated AD844 circuit'], ['multiple Integrated Circuits', 'first  time'], ['ASETs', 'integrated BJT analog circuit'], ['This', 'talk charge effects'], ['multiple output transients', 'device'], ['how  MOTs', 'integrated analog circuit'], ['analysis methodology', 'current s domain'], ['approach', 'continuous interconnect path'], ['', 'healthy emotion controls'], ['', 'emotion processing'], ['sample', 'healthy gender education intelligence'], ['subjects', 'Consensus Cognitive Battery'], ['Emotion processing', 'Emotional Intelligence Test'], ['Psychosocial  functioning', 'Assessment Short Test'], ['bipolar  patients', 'using emotions branch'], ['Likewise EBP', 'neurocognitive  domains'], ['Correlation', 'strategic area measures'], ['', ''], ['', ''], ['depressive  symptomatology', '9'], ['', 'functional  outcome'], ['strategic area score', 'additional  8'], ['', ''], ['Neurocognition', 'emotion processing'], ['bipolar  patients', 'emotion processing'], ['Emotion processing', 'social  patients'], ['traumatic  which', 'higher  comorbidity'], ['thus  studies', 'BD'], ['EMDR  focusing', 'cognitive mood BD'], ['82 multicentre patients', 'two treatment arms'], ['Patients', '6  months'], ['primary  outcome', '12 EMDR group'], ['secondary  we', 'social Cognitive Psychiatry'], ['Traumatic  events', 'PTSD Stress Event'], ['specific EMDR protocol', 'affective  symptoms'], ['bipolar  studies', 'bipolar  disorder'], ['facial expression recognition', 'naturalistically BD patients'], ['271  patients', 'facial expression recognition task'], ['effects', 'demographic mood variables'], ['only monotherapy sub who', 'monotherapy sub lithium'], ['Accuracy', 'currently dopamine antagonists'], ['Higher  levels', 'happy  faces'], ['Use', 'reduced anger BD'], ['Findings', 'depressive mood BD'], ['Observational cohort studies', 'cognitive  performance'], ['patients', 'large brain networks'], ['Network dysfunction', 'animal gamma depression'], ['subanesthetic dose that', 'neurochemical  e'], ['', ''], ['functional gamma correlates', 'effect'], ['antidepressant  response', 'physiological  disturbances'], ['homogeneous  subgroups', 'glutamatergic treatment response modulation'], ['theoretical  frameworks', 'psychosocial episode disorder'], ['', 'major life stressors'], ['', 'proximal life events'], ['', 'bipolar  participants'], ['', ''], ['', '2 % 20'], ['', ''], ['75  years', 'Bipolar Spectrum Project'], ['Participants', '4-month follow ups'], ['early childhood adversity', 'hypomanic  BD'], ['This', 'negative  events'], ['current  study', 'rigorous life stressors'], ['early  it', 'future  stressors'], ['Bipolar disorder', 'all cause mortality'], ['gold standard mood stabilizer identification', 'clinical  settings'], ['We', 'bipolar multicentre I'], ['clinical  factors', 'three response groups'], ['Results', 'bipolar  disorder'], ['17  %', '31  response'], ['', 'mixed Lifetime episodes'], ['alcohol', ''], ['both', 'good response cases'], ['bipolar Family I', 'response response group'], ['', ''], ['', 'bipolar disorder response'], ['three  factors', 'significantly response sample'], ['they', 'underlying  factor'], ['prospective  studies', 'Alda scale'], ['yet Toxoplasma gondii it', 'yet Toxoplasma gondii date'], ['aim', 'summary T'], ['', 'published  studies'], ['systematic  review', 'PubMed LILACS PsycINFO'], ['which', 'meta BD analysis'], ['hundred eighteen One hundred citations', ''], ['Thirteen  studies', 'systematic  review'], ['Eight', 'thirteen meta analysis'], ['Statistical  analyses', ''], ['gondii infection', 'BD'], ['', ''], ['major  that', 'serological  analyses'], ['available  studies', 'bipolar  disorder'], ['Also  it', 'pregnancy status'], ['Future studies', 'aforementioned  topics'], ['heterogeneous results patients', 'more  T'], ['', 'controls'], ['', ''], ['gondii infection', 'BD'], ['', ''], ['gondii infection', 'pathophysiological  mechanisms'], ['widely  which', 'objective motor activity'], ['which', 'better up monitoring strategies'], ['aim', 'bipolar  disorder'], ['We', 'healthy meta controls'], ['primary outcome measures', 'activity mean sleep duration'], ['secondary  we', 'sleep onset'], ['Thirteen  studies', '821 quality inclusion'], ['results', 'bipolar  patients'], ['bipolar  which', 'manic  episodes'], ['study', 'bipolar  disorders'], ['', ''], ['rights', ''], ['', ''], ['disorder', 'EI Emotional schizophrenia'], ['study', 'social EI EI'], ['', ''], ['Fifty eight Fifty schizophrenia', 'bipolar Brief Schizophrenia'], ['Analyses', 'BACS composite score'], ['', ''], ['bipolar subjects schizophrenia patients', 'EI  cognition'], ['BACS composite difference', 'EI'], ['differences', 'social  cognition'], ['', ''], ['schizophrenia patients EI', 'cognitive  functioning'], ['This', 'cognitive MSCEIT remediation'], ['degradation', 'different dose irradiation'], ['significantly dose rate', 'total ionizing dose effects'], ['01  that', 'bipolar  devices'], ['low dose rate which', 'existing radiation tests'], ['paper', 'such radiation ELDRS'], ['Bipolar disorder', ''], ['Neuroimaging studies', 'familial  BD'], ['', ''], ['', 'LR degree youth'], ['', ''], ['those', 'based degree risk'], ['', ''], ['', ''], ['', 'magnetic resonance imaging'], ['', ''], ['', ''], ['', '24'], ['8  years', 'behaviorally face emotion BD'], ['We', 'three  results'], ['', ''], ['', ''], ['where  BD', 'order face processing regions'], ['', ''], ['', ''], ['where disorder HR', 'other face processing'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['who', 'prevention measures'], ['novel  that', 'neural  risk'], ['Urban  habitats', 'such bird immunity'], ['parasitic resource that', 'urban  habitats'], ['difference', 'natural  habitats'], ['We', 'urban Parus areas'], ['inflammatory plasma marker', 'body mass'], ['we', 'haemosporidian  adults'], ['activation', 'urban  forest'], ['We', 'habitats'], ['urban  adults', 'reduced forest towns'], ['Overall  study', 'urban  populations'], ['organism it', 'prime  difference'], ['especially disease that', 'especially disease infections'], ['infectious  agents', 'native animal population'], ['European conservation bison', 'European  countries'], ['European  herbivore', 'parasitic nematode Ashworthius 1998'], ['prevalence', 'wild  ruminants'], ['European bison individuals', 'Czech Republic'], ['current  we', 'red  Z'], ['', ''], ['', ''], ['morphological infection intensity', 'deer'], ['findings', 'European Czech territory'], ['results', 'well ashworthiosis intravital diagnostics'], ['One', 'A'], ['', 'native ruminant hosts'], ['', 'bacterial BPA sediment'], ['BPA', 'sediment'], ['Biodegradation efficiency', 'mg L 64'], ['', ''], ['', 'first  day'], ['gel electrophoresis BPA', 'densities bacteria'], ['response', 'other BPA competitors'], ['', 'vital  BPA'], ['bacterial  both', 'controls'], ['Laccase', 'BPA'], ['bacterial BPA which', 'BPA sediment'], ['Aberrant  expression', 'epithelial ligands colon'], ['colorectal CpG we', 'ovarian cancer cell lines'], ['promoters', 'specific polymerase chain reaction'], ['results', 'direct bisulphite sequencing'], ['', 'ovarian cancer cell lines'], ['promoter hypermethylation', 'major EPHB2 tumors'], ['Children', 'short  animals'], ['face', 'young  children'], ['Wounds', ''], ['which', 'frequency argument'], ['when  child', 'direct  animal'], ['functional  goal', 'pediatric animal specificities'], ['Animal bites', 'specialized  structure'], ['Hospitalization', 'more  children'], ['even  wounds', 'surgical  environment'], ['Emergency surgery', 'functional  consequences'], ['surgical  treatment', 'first skin place'], ['Immobilization drainage', 'surgery'], ['healing process', 'remodeling  phase'], ['Psychological  care', 'acute  phase'], ['', ''], ['rights', ''], ['BK polyomavirus', 'kidney transplant patient'], ['kidney tropic which', 'significant transplant host'], ['experimental  BKPyV', 'experimental  animals'], ['BKPyV DNA sequences', 'Shouthern blot hybridization methods'], ['immunological  which', 'such  JC'], ['specific  BKPyV', 'humans'], ['structural capsid protein', 'immunological human serum samples'], ['immunosorbent  assay', 'healthy adult subjects'], ['immunological serum antibodies', 'healthy BKPyV VP1 subjects'], ['serum that', 'BKPyV VP1 mimotopes'], ['strong  points', 'immunological VP1 mimotopes'], ['Infections', 'renal transplant recipients'], ['Infections', 'transplant  period'], ['', 'new antivirals antifungal'], ['much  this', 'infectious  population'], ['infectious  agents', 'immunocompromised Chigunkunya West host'], ['Malignancies', 'also  immunosuppression'], ['Skin cancers', 'skin  cancers'], ['usually  cancer', 'third transplant recipients'], ['', 'malignant skin lesions'], ['', ''], ['', 'Elsevier Masson SAS'], ['rights', ''], ['purpose', 'BKV decoy urine'], ['who', 'renal  transplantation'], ['urine', 'quantitative BKV urine'], ['Three hundred sixty examinations', '12  attendance'], ['Urine cytology results', ''], ['', ''], ['', 'cytopathic BKV infection'], ['', 'degenerated  cells'], ['', 'unsatisfactory  analysis'], ['bearing  virus', 'voided  urine'], ['12 BKV trend', 'exclusively BKV month'], ['viral  cells', 'renal transplant patients'], ['', ''], ['thrombotic  events', 'previously Trichinella nativa infection'], ['', ''], ['10 chart who', 'black bear meat'], ['Trichinella serology', 'well meat samples'], ['', ''], ['exposed  individuals', 'fever abdominal fever 0'], ['9', '6'], ['', ''], ['', 'exposed myalgia periorbital edema'], ['myocardial  infarction', '2  patients'], ['75  sera', '75  whom'], ['Multiplex PCR', 'T'], ['', 'microscopic larval identification'], ['', ''], ['We', '100 % attack T'], ['species', 'thrombotic  humans'], ['Education', 'prior  ingestion'], ['', 'Black Xanthomonas campestris'], ['Pammel  Dowson', 'damaging  cauliflower'], ['SSH cDNA library', 'isogenic line tester'], ['total', 'northern  blotting'], ['homology clones', 'unique  sequences'], ['library', 'such defensin gene PDF1'], ['', ''], ['Gene expression profiles', 'real time RT PCR'], ['more line reaction', 'more line C731'], ['regulated  genes', 'Xcc infection'], ['molecular  mechanisms', 'disease Xcc'], ['Instrumental  test', 'massive panel attention'], ['study', 'black NIR spectroscopy spectra'], ['BPANN  models', 'optimal variables'], ['', 'best correlation 0'], ['root', 'square  prediction'], ['', 'better color parameters'], ['Therefore NIR spectroscopy technique', 'black tea samples'], ['', ''], ['', ''], ['rights', ''], ['altered gene expression patterns', 'cDNA gene expression profiles'], ['Sprague Dawley rats', 'drinking water'], ['', '28 BBN ad weeks'], ['Equal  numbers', 'tap BBN'], ['rat bladders', 'RNA extraction'], ['Total RNAs', 'TCC cell tissues'], ['which', '1081 rat genes'], ['Some', 'Northern rat bladder blotting'], ['included', 'proto oncogene proto Lipocortin'], ['down rat bladder they', 'B7'], ['', ''], ['normal rat bladder epithelia', 'different gene statement profiles'], ['increased  expressions', 'induced bladder carcinogenesis'], ['similar fingerprinting studies', 'squamous cell carcinoma'], ['study', 'transitional carcinoma microarray data'], ['specimens', 'molecular urinary bladder'], ['Validation', 'Northern blotting technique'], ['', '82 microarray genes'], ['total', 'up  bladder'], ['44  genes', 'down  bladder'], ['findings', 'aggressive  bladder'], ['Such gene profiling studies', 'also bladder cancer'], ['', ''], ['rights', ''], ['', ''], ['', 'molecular bladder treatments'], ['', ''], ['data PubMed', 'following  keywords'], ['', ''], ['histological  classification', 'histological  difficulties'], ['Cancer Genome Atlas', 'genetic bladder cancer'], ['several  studies', 'predictive bladder value'], ['Urobasal A Urobasal B', 'luminal bladder cancers'], ['latter  subgroup', ''], ['', ''], ['molecular  biology', 'patient bladder management'], ['', ''], ['rights', ''], ['1 transmembrane that', 'recently cell proliferation angiogenesis'], ['main  objective', 'biological bladder cancer cells'], ['western polymerase chain we', 'glycoprotein nonmetastatic bladder cancer tissues'], ['effects', 'interfering CCK-8 Transwell'], ['glycoprotein nonmetastatic protein B protein', 'highly bladder cancer tissues'], ['nonmetastatic melanoma protein B', 'bladder cancer cells'], ['Glycoprotein nonmetastatic protein B expression', 'poor immunohistochemistry analysis'], ['glycoprotein nonmetastatic melanoma protein B', 'patient  prognosis'], ['highly bladder which', 'poor bladder cancer patients'], ['Glycoprotein nonmetastatic melanoma protein B', 'bladder cancer cells'], ['We', 'clinical bladder utility'], ['1 beta propeller that', 'paired reaction array tissue'], ['Afterward  we', 'urological bladder lesions'], ['expression levels', 'significantly control group'], ['', ''], ['urinary autophagy transcripts', 'bladder cancer patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['We', 'novel bladder cancer diagnosis'], ['Bladder cancer', 'leading  morbidity'], ['', 'invasive  disease'], ['40 survival %', 'major tumor response'], ['patients', 'targeted  NAC'], ['NAC paradigm', 'clinical precision MIBC'], ['Abundant  tissue', 'residual  MIBC'], ['Technologic  advances', 'even microarray tissue'], ['technologies', 'cotargeting  strategies'], ['target which', 'primary  xenografts'], ['PDX', 'radical  NAC'], ['patient  PDX', 'most PDX patient'], ['advanced tumor it', 'systemic  therapy'], ['tools', 'based precision oncology MIBC'], ['', ''], ['rights', ''], ['study', 'Related Operation Enduring Freedom'], ['aims', 'potential blast exposure'], ['sample', 'mTBI blast exposure'], ['53', 'PTSD'], ['We', 'exploratory exposure mTBI history'], ['BC PSI factors', 'affective  anger'], ['Items', 'blast controls'], ['affective  factors', 'significantly blast exposure'], ['PTSD symptom severity', 'covariate'], ['Cognitive anger', 'significantly interaction history'], ['', 'differentiated exposure mTBI history'], ['liquid blast level', 'high blast uncertainty'], ['liquid blast furnace which', 'liquid  level'], ['appropriate  treatment', 'neural time network'], ['TDNN  model', 'better forecasting performance'], ['liquid blast information', 'blast furnace'], ['that', 'liquid level hearth'], ['analysis', 'molten blast furnace'], ['signal', 'one digital control hour'], ['', 'safety tool aids gains'], ['aims', 'negative pressure value'], ['', 'different suction pressures'], ['molecular biology methods', 'conditions macrophage HA'], ['wound healing rate', 'best mmHg effects'], ['macrophage count', 'control group'], ['HA level fluctuation', 'significant mmHg fluctuation'], ['CD44', 'obvious mmHg expression'], ['VSD', 'significantly macrophage count'], ['It', 'also CD44 expression'], ['mmHg', ''], ['Blastocystis', 'colorectal diarrheal cancer'], ['aim', 'possible Makkah Saudi Arabia'], ['Stool samples', 'gastrointestinal CRC tract'], ['Blastocystis isolates', 'multiplex fragment length polymorphism'], ['Blastocystis  hominis', '29'], ['', '25 CRC COGT'], ['2  which', 'different  subtypes'], ['Interestingly  I', ''], ['', 'significant association risk'], ['', ''], ['', ''], ['', ''], ['', ''], ['current  study', 'genetic Makkah KSA'], ['possible Blastocystis which', 'potential CRC condition'], ['Further  studies', 'Blastocystis hominis subtype'], ['most von Willebrand prevalent', 'clinical von Willebrand disease'], ['quantitative locus that', 'clinical  VWD'], ['review', 'pathobiological  VWD'], ['molecular  basis', 'recent  decades'], ['However  knowledge', 'external modifying loci'], ['additional linkage that', '1 VWD phenotype'], ['Summary', 'molecular novel type'], ['objective', 'Argentina'], ['old  who', 'moderate bleeding tendency'], ['Some', 'mild bleeding tendency'], ['mother', ''], ['immunological biology techniques', ''], ['moderately  they', 'slightly  mother'], ['FX  activity', '3 assay systems'], ['FX antigen', ''], ['Other clotting factors', ''], ['Genetic  analysis', 'known compound mutation'], ['children', 'present FX proposita'], ['This', 'first FX Argentina'], ['', ''], ['rights', ''], ['low noise paper', 'electric control system'], ['structure', 'main system installation'], ['electric control system', 'good energy saving effect'], ['It', 'expected  goal'], ['', ''], ['michiganensis', 'economic tomato production'], ['like  spots', 'infected  leaves'], ['wide  repertoire', 'degrading cell wilt'], ['like  which', 'secondary tomato nurseries'], ['Cmm virulence factors', 'different blister formation'], ['green fluorescent penetration', 'mainly  trichomes'], ['which', 'crucial blister formation'], ['degrading serine enzymes', 'significantly blister formation'], ['8  they', 'low  levels'], ['chpC', 'host defence'], ['sized  that', 'large  materials'], ['based  devices', 'molecular DNA biology'], ['many DNA structures', 'quickly bodily nucleases'], ['glycol)-polylysine block which', 'electrostatically origami polyplex micelles'], ['unprotected DNA origami', 'therefore  biology'], ['reproductive Brucella dogs', 'economic breeding kennels'], ['', 'B'], ['', 'commercial Paulo State Brazil'], ['clinically blood samples', 'blood culture'], ['association', 'positive blood culture'], ['', '753  166'], ['0  %', 'clinical sign brucellosis'], ['9  %', 'positive blood cultures'], ['clinical blood culture', 'clinical manifestation brucellosis'], ['', '38  kennels'], ['1  %', ''], ['prevalence', '3'], ['', '8  62'], ['', ''], ['stillbirth  failure', 'significantly lymph female'], ['association', 'positive blood males'], ['None', 'zoonotic  infection'], ['Invasive  candidiasis', 'acquired  infections'], ['Candida detection methods', 'various Candida species'], ['rapid  that', 'automatically acid extraction purification'], ['Here  we', 'serological blood testing'], ['We', 'advanced candida detection'], ['Eccentric exercise training', 'insulin sensitivity'], ['potential muscle damage symptoms', 'clinical muscle populations'], ['extensive muscle number', 'adverse intervention effects'], ['ischemic  preconditioning', 'EIMD'], ['IPC', 'lethal  extremity'], ['', ''], ['using', 'I R surgery'], ['present  hypothesis', 'clinical muscle surgery'], ['primary  origin', 'essential oxygen both'], ['I R which', 'soft  tissue'], ['far  IPC', 'I R Injury'], ['Based', 'underlying muscle mechanisms'], ['', ''], ['rights', ''], ['Systemic lupus erythematosus', 'premature cardiovascular disease'], ['platelet endothelium interaction', 'cardiovascular  disease'], ['we', 'endothelial platelet cells'], ['Approach Results Platelet aggregability', '54 antiplatelet therapy'], ['', ''], ['82  %', 'sex  controls'], ['Platelets', 'endothelial RNA array'], ['disease activity index', '22'], ['', ''], ['', ''], ['', 'significantly submaximal agonist stimulation'], ['agnostic  microarray', 'endothelial cell activation'], ['Sera', 'interleukin-1-dependent proinflammatory gene pathway'], ['Incubation', 'endothelial interleukin-1 receptor cells'], ['Platelet activity measurements', 'interleukin-1-dependent  SLE'], ['endothelial  interactions', 'cardiovascular  SLE'], ['We', 'vascular tone remodeling'], ['we', 'specific CNP knockout'], ['mice', 'systemic  CNP'], ['specific CNP knockout mice', 'nitric oxide synthetase inhibition'], ['dependent  vasorelaxation', 'specific CNP knockout mice'], ['specific CNP knockout which', 'greater control littermates'], ['specific B knockout mice', 'mesenteric blood arteries'], ['acute  vasorelaxation', 'specific B knockout mice'], ['results', 'smooth muscle GC B'], ['', ''], ['Ehrlichiosis', 'severe lung outcomes'], ['Ehrlichia ewingii', 'cytoplasmic  neutrophils'], ['We', 'E'], ['', 'molecular blood smear studies'], ['social isolation rearing', 'nonpharmacological alterations psychosis'], ['social  isolation', 'oxidative NOX2 elevations'], ['Here  we', 'increased  brain'], ['16 ORLs Vnr1', 'real blood brain barrier'], ['Western blotting analysis', 'isolated  animals'], ['', 'social associated isolation'], ['BBB permeability', '1 dye controls'], ['induced BBB disruption', 'significant  Interleukin'], ['Conversely  differences', 'time point'], ['BBB disruption', 'NOX2 brain'], ['results', 'mental brain disorders'], ['white screening system', 'various Escherichia coli'], ['chromogenic visual reporter substrate', 'visible pigment production'], ['we', 'ribosomal phosphopantetheinyl Bacillus'], ['posttranslational holo it', 'blue amino acid substrate'], ['white screening system', 'recipient'], ['coli', 'close sfp terminal'], ['based screening which', 'external substrate addition'], ['Bluetongue', 'borne  ruminants'], ['causative agent bluetongue virus', 'Reoviridae family'], ['26 BTV serotypes', ''], ['global  distribution', 'timely animal movement restrictions'], ['molecular  assays', 'BTV'], ['methods', 'skilled assays results'], ['isothermal RT that', 'low resource field conditions'], ['60  results', 'automatically data interpretation'], ['RT iiPCR assay', '26 BTV serotypes'], ['assay', 'related animal orbiviruses'], ['analytical  sensitivity', 'stranded BTV RNA'], ['whole RT iiPCR assay', 'real time RT PCR'], ['assay', 'routine bluetongue laboratory'], ['intestinal  injury', 'seldom child abuse'], ['Signs', 'often  diagnosis'], ['We', 'physical child abuse'], ['He', ''], ['diagnostic  laparoscopy', 'proximal jejuno jejunal fistula'], ['Symptoms', 'fully  resection'], ['even imaging studies', 'specific  abnormalities'], ['', ''], ['facial  affect', 'negative  schizophrenia'], ['cognitive  that', 'schizophrenia'], ['pharmacological  agents', 'clinical  significance'], ['hypothalamic neuropeptide oxytocin', 'social prosocial schizophrenia'], ['facial  effects', 'facial  population'], ['', ''], ['emotional  participants', 'over trustworthiness rating design'], ['Participants', 'evocative  photographs'], ['facial  expressivity', 'manualized  approach'], ['', ''], ['', ''], ['', ''], ['facial  it', 'facial  schizophrenia'], ['', ''], ['', 'healthy trend controls'], ['', ''], ['', ''], ['', ''], ['emotional  oxytocin', 'facial  schizophrenia'], ['We', 'younger body mass adults'], ['We', 'verbal  memory'], ['dwelling Fifty adults', 'Test Revised HVLT R'], ['reported  years', 'cognitive reserve'], ['higher recall BMI', 'worse  performance'], ['education', 'verbal learning memory'], ['Results', 'clinical  settings'], ['NS3 protease', 'vital hepatitis C virus'], ['BMS-605339', 'novel protease genotype 1a'], ['168 HCV NS3 which', 'antiviral hepatitis C'], ['present  we', 'three representative mutations'], ['decrease', 'mainly van der Waals'], ['Y salt V', 'binding  BMS-605339'], ['obtained  results', 'potent HCV NS3'], ['', 'International Union International Biochemistry'], ['largest finger transcription that', 'transcriptional  repressors'], ['neurotrophic GDNF)-RET we', 'inducible differential display analysis'], ['expression', 'Northern GDNF blotting'], ['', 'transcriptional KRAB domain'], ['transcriptional repressor KAP-1', 'function'], ['', 'inhibited cell proliferation'], ['transcriptional  that', 'cell proliferation'], ['', ''], ['rights', ''], ['We', 'linear periodic time linear systems'], ['sensitivity  integral', 'complex unit plane'], ['theorem block Toeplitz which', 'open loop system'], ['result', 'commensurate data rates'], ['Bodily knowledge', 'two  decades'], ['10  discussions', 'bodily  knowledge'], ['phenomenological  purpose', 'embodied  practices'], ['embodied  that', 'moving  knowledge'], ['bodily  which', 'bodily training findings'], ['bodily  knowledge', 'physical body exercise'], ['fat muscle analysis', 'physical  activity'], ['prevalence', 'weight problems'], ['high body mass index', 'inhibitory control efficiency'], ['present  study', 'observations'], ['normal university students', '1  control'], ['previous  that', 'overweight  individuals'], ['cognitive control impairments', 'driven control adaptation'], ['high  BMI', 'cognitive control functioning'], ['', ''], ['rights', ''], ['study', 'South Youth Policy Institute'], ['We', 'longitudinal child BMI'], ['significantly  who', 'higher  BMI'], ['maltreatment', 'long term time'], ['aim', 'depressive  disorder'], ['depressive disorder inpatients', 'psychiatric South Taiwan'], ['ECT', '12  sessions'], ['Symptom severity', 'last ECT ECT'], ['generalized estimating equations method', 'potential  HAMD-17'], ['completing', 'three  ECT'], ['116  patients', 'analysis'], ['depressive symptom symptoms', 'acute symptom ECT'], ['', 'acute pain ECT'], ['clinical  predictors', 'future ECT studies'], ['majority', 'segregated neuroscience cortex'], ['such  someone', 'mental  states'], ['distinct processing components', 'neural  signals'], ['magnetic resonance we', 'social  perception'], ['that', 'based  information'], ['Additionally  we', 'theory body mind'], ['who', 'theory body network'], ['understanding', 'conceptual  knowledge'], ['', 'length nest body function'], ['However  it', 'direction'], ['', 'immune trade function'], ['nest them', 'positive  correlations'], ['We', 'European starlings Sturnus vulgaris'], ['Intrabrood competition', 'larger  broods'], ['positive brood size', 'positive  functioning'], ['', 'significant plasma cytokine'], ['associations', 'smallest body largest'], ['high C reactive protein', 'systematic body size'], ['immune phenotypic associations', 'competitive  context'], ['coding  RNAs', 'important gene eukaryotes'], ['only  microRNAs', 'silkworm Bombyx mori'], ['only  ncRNAs', 'systematically  silkworm'], ['Here  we', '18 Bombyx mori'], ['RIP we', 'small  BmAGO2'], ['similar multimodal length which', 'transposable  element'], ['derived  fragments', 'high  69'], ['', 'small  RNAs'], ['infected  tRFs', 'prominent BmNPV infection'], ['Additional  evidence', 'codon T psi tRNAs'], ['small  BmAgo2', 'small genome RNAs'], ['Northern  blotting', 'also  Bombyx'], ['small  RNAs', 'silkworm'], ['Northern RIP seq we', 'small BmAgo2 RNAs'], ['findings', 'small insect development'], ['Bombyx mori', 'melanin ommochromes'], ['mutual  interaction', 'unique pigment patterns'], ['q quail which', 'darker larval integument'], ['current GTP CH which', 'key  silkworm'], ['such  signals', 'background strain'], ['GTP CH I activities', 'background strain'], ['strongly pteridine biosynthesis', 'closely  melanin'], ['recessive  gene', 'pigment pattern formation'], ['growth TGF)-beta', 'osteoblast  differentiation'], ['Mechanical  stress', 'specific transcription factors'], ['However  role', 'TGF beta osteoblasts'], ['also Smad2 which', 'T beta rs'], ['like Smad2 cells', 'continuous  CF'], ['', ''], ['', '9  h'], ['beta T Runx2', 'real polymerase chain reaction'], ['Phosphorylation levels', 'Western blot analysis'], ['1 TGF beta', 'significantly  1'], ['', ''], ['6 h control T', 'CF condition'], ['', ''], ['also Smad2 expression', 'LY2109761'], ['present  findings', 'that'], ['g  CF', 'induced TGF osteoblasts'], ['Chimerism', 'conventional metaphase spreads'], ['proliferating latter', 'possible blood cell contamination'], ['Therefore  we', 'single marmoset cells'], ['We', 'specific  probes'], ['Herein  we', 'mixed bone marrow litters'], ['when bone litter', 'bone blood'], ['single  samples', 'one cell individual'], ['Cross sex chimerism', 'liver cells'], ['different cell which', 'specific  analysis'], ['Diamond Blackfan anemia', 'ribosome synthesis'], ['ribosome synthesis', 'Shwachman Diamond which'], ['Design  Northern', 'polysome yeast models'], ['Localization', '60S ribosomal RPL25eGFP'], ['wild disease model', 'underlying 60S subunit mechanisms'], ['', 'rapid 60S subunit degradation'], ['5S ribosomal RNA', 'extra ribosomal species'], ['subunit maturation', 'associated 5S ribosomal nucleus'], ['differences', 'abortive Diamond syndrome ribosome'], ['', 'clinical Diamond Blackfan anemia'], ['mesenchymal stromal cells', 'low multipotent CD99'], ['certain  MSCs', 'tumorigenic  properties'], ['induced  conditions', ''], ['Recently  we', 'cellular stress response'], ['Preliminary  observations', 'cultured  MSCs'], ['CD99', 'cellular  MSCs'], ['Hence  we', 'prolonged  survival'], ['primary marrow stromal cells', 'long term serum MSCs'], ['Cell proliferation', 'microscopic cytometry differentiation examination'], ['CD99 Hsp70 expression', 'western polymerase chain reaction'], ['Autophagy', 'specific cell morphology examination'], ['Chronic stress factors', 'spontaneous adipocyte lineage'], ['defective  which', 'usually tumor formation'], ['CD99 expression incorporation', 'recombinant  autophagy'], ['Obtained  results', 'highly  tumorigenesis'], ['Immunodeficient  mice', 'critical vivo hematopoiesis'], ['hematopoietic stem cell engraftment', 'methodically  them'], ['Four mouse strains', 'fetal bone marrow'], ['marrow blood spleen', 'weeks flow transplant'], ['peripheral blood cell chimerism', 'human liver spleen'], ['NSG mice', 'highest blood leukocyte engraftment'], ['Tg NSG mice', 'highest  CD133(+)CD34(++'], ['hSIRPa DKO', 'poor  breeding'], ['B cell engraftment', 'opposite  pattern'], ['NK cells', 'NSG-3GS mice'], ['Mast cell engraftment', 'also NSG-3GS mice'], ['Basophils', 'most NSG-3GS mice'], ['intermediate stem cell NSG', 'certain blood cell lineages'], ['genistein', 'p38 protein kinase'], ['activation', 'Western  blotting'], ['ALP  activity', 'stem cell mesenchymal stem cultures'], ['expression', 'protein levels'], ['activity', 'electrophoretic mobility shift assay'], ['gene transcription', 'also RT PCR'], ['', ''], ['dose', 'p38 mouse BMSC cultures'], ['Treatment', 'increased BMSC time'], ['Genistein', 'Cbfa1-regulated ALP BSP OC'], ['Concurrent treatment', 'p38 mouse BMSC cultures'], ['genistein', 'p38 MAPK Cbfa1 pathway'], ['Novel  therapies', 'particularly androgen receptor'], ['', 'molecular PC bone therapy'], ['other ve 12', 'principal component analysis'], ['Expression profiles', 'localized prostate disease'], ['Selected  proteins', 'immunohistochemistry'], ['cohort', 'prognostic follow evaluation'], ['majority', 'high AR AR regulators'], ['20 STEAP2 %', ''], ['Functional enrichment analysis', 'driven  metastases'], ['driven I ABC immunoreactivity', 'nuclear AR immunoreactivity'], ['RT PCR analysis', 'other prostate origins'], ['low I ABC immunoreactivity', 'high score bone metastasis'], ['Limitations', 'single metastasis patient'], ['Most CRPC bone metastases', 'high  AR'], ['subgroup', 'low  AR'], ['Targeted  therapy', 'groups'], ['Patient  We', 'resistant prostate cancer'], ['We', 'individual therapy patients'], ['', '2016 European Urology'], ['', 'Elsevier B'], ['', ''], ['Bone', 'vascular  development'], ['Angiotensin II', 'atherosclerosis'], ['However  effects', 'endothelial BMP-2 cells'], ['aim', 'effects'], ['HUVECs', 'various  agents'], ['SOD superoxide BMP-2', 'standard  methods'], ['Northern  blotting', 'BMP-2'], ['activation', 'NF kappa HUVECs'], ['AngII treatment', 'significantly kappa B'], ['effects', 'pyrrolidine dithiocarbamate'], ['increased  levels', 'total AngII probucol'], ['Probucol', 'nduced BMP-2 expression'], ['effects', 'kappa B activation'], ['Alveolar bone resorption', 'dental  clinicians'], ['we', '2 bone morphogenetic vivo'], ['osteogenic BMP2 treatment', 'successfully  lineage'], ['PCR chromatin which', 'altered gene expression'], ['significant HGF amount', 'transplanted bone hematoxylin'], ['functional  approach', 'therapeutic alveolar bone regeneration'], ['objective', 'heterotopic  ossification'], ['HO', 'severe ectopic trauma'], ['Characterization', 'tissue condition'], ['Lymphangiogenesis', 'thereby niche HO'], ['lymphatic  tissues', 'critical HO formation'], ['Mice', 'tendon transection burn HO'], ['popliteal', 'inguinal tenotomy site'], ['Flow cytometry', 'lymphoendothelium'], ['MicroCT', 'HO'], ['Enrichment', 'intact tendon transection LYVE1'], ['', '9  0'], ['', ''], ['', ''], ['Excision', 'weeks popliteal lymphatic injury'], ['', '9  3'], ['', ''], ['', ''], ['cartilage stromal progenitor cells', 'significantly lymph node excision'], ['', '2  0'], ['', ''], ['', ''], ['significant  decrease', 'soft novo tissues'], ['', '12  0'], ['', ''], ['soft novo formation presence', 'bone formation'], ['transverse radiodense metaphyseal that', 'local  insults'], ['growth recovery lines', 'low  abuse'], ['Reports', 'clinical American records'], ['Infants', 'low injury risk'], ['Infants', 'high  risk'], ['', ''], ['7  months', ''], ['', ''], ['2  months', ''], ['', ''], ['', ''], ['blinded  radiologists', 'one growth recovery line'], ['When growth recovery lines', 'low risk group'], ['', 'high risk group'], ['', ''], ['', ''], ['', ''], ['', ''], ['Growth recovery lines', 'high  risk'], ['', 'low  abuse'], ['abused  infants', 'physiological  stresses'], ['Determining', 'better growth reproduction'], ['immunological  methods', 'wild health populations'], ['', 'immune  animals'], ['Neopterin', 'immune  monocytes'], ['urinary neopterin', 'health bonobos'], ['First  we', 'bonobo immune urine'], ['We', 'respiratory bonobos infections'], ['neopterin levels', 'commercial  EIA'], ['Stability experiments', 'extended room temperature'], ['two sample years', 'urinary neopterin levels'], ['', 'healthy neopterin individuals'], ['urinary neopterin levels', 'urinary neopterin adults'], ['', 'respiratory neopterin infection'], ['regular urine sample collection', 'minimal disease subjects'], ['endocrinological life method', 'immunocompetence handicaps'], ['full load which', 'cost characteristic'], ['emulated ramp which', 'full load range'], ['Two control systems', 'paper'], ['first  system', 'boost cost compensator'], ['second  system', 'based ERF converters'], ['regulator', 'TSMC'], ['', ''], ['second  system', '300-mA load range'], ['Additionally  system', 'peak mode load 92'], ['', 'only chip 1'], ['', ''], ['', ''], ['Monte techniques', 'integrated production circuits'], ['high  yield', 'accurate  verification'], ['faster yield prediction', 'known C PK method'], ['We', 'generalized process capability index'], ['First  we', 'sided distribution part'], ['little yield model', 'little yield impact'], ['parametric  we', 'new tail parameter t'], ['flat  we', 'instead reference location mean'], ['other MC performance', 'negatively design complexity'], ['We', 'advanced bootstrap scheme'], ['We', 'operational MC amplifier'], ['other  that', 'insecure  attachment'], ['social  which', 'based  treatment'], ['whereby pilot mentalization', 'based  task'], ['ResultsBoth treatments', 'highly symptom severity'], ['combination', 'affective  mentalizing'], ['that', 'changes'], ['Dialectical behaviour therapy', 'based  treatment'], ['combination', 'more self DBT'], ['DBT', 'affective  mentalizing'], ['Short term combinations', 'psychiatric inpatient care'], ['such  approaches', 'further  research'], ['treatment condition', 'more control condition'], ['study', 'follow up assessment'], ['impact', 'treatment account'], ['Adherence', 'manualized  approach'], ['Borderline personality disorder', 'general  functioning'], ['poor  it', 'better  BPD'], ['This', 'novel treatment group'], ['recent  that', 'hypermentalizing  trust'], ['We', 'theoretical case BPD'], ['treatment that', 'hypermentalizing  mistrust'], ['We', 'future  area'], ['Impairments', 'core borderline personality disorder'], ['Social cognition dysfunction', 'impulsive aggression BPD'], ['social  cognition', 'social  BPD'], ['Emotion recognition tasks', 'social inference test'], ['stepwise multiple stepwise quality', 'social child relationship BPD'], ['Canine respiratory diseases', 'respiratory co viruses'], ['Virus infections', 'vaccinated  dogs'], ['differential  diagnosis', 'etiological  agents'], ['oligonucleotide microarray system', 'study'], ['type Bordetella bronchiseptica', 'microarray Mycoplasma chip'], ['detection limit', '50 virus CHV B'], ['', ''], ['', ''], ['nasal swab microarray', 'PCR agarose gel method'], ['positive detection rate', 'microarray'], ['', ''], ['', '56  samples'], ['CDV vaccine strain', 'multiplex PCR agarose gel'], ['efficient diagnosis that', 'greatly disease therapy'], ['', ''], ['', ''], ['rights', ''], ['Obesity', ''], ['Immune responses', 'certain  infections'], ['We', 'induced Borrelia mice'], ['DIO', 'immune  responses'], ['These', 'bacterial cytokine clearance'], ['', ''], ['bacterial clearance which', 'obese Escherichia B'], ['infected  mice', ''], ['', 'cooperative infection DIO'], ['', ''], ['', ''], ['', 'innate burgdorferi mice'], ['fever they', 'primarily  ixodid'], ['Tick host interactions', 'individual host species'], ['One', 'associated Borrelia sp'], ['', ''], ['we', 'selected cytokine nonpathogen'], ['THP-1 we', 'vitro host which'], ['', ''], ['Differentiated THP-1 cells', 'four  Borrelia'], ['', ''], ['', 'Borrelia LPS'], ['IFN)-gamma tumor necrosis TNF)-alpha', '6 24 postexposure time points'], ['', 'ANOVA cytokine treatment'], ['LPS', 'secreted TNF alpha'], ['Time point', 'intracellular gamma TNF alpha'], ['However  we', 'selected  Borrelia'], ['', ''], ['Thus  we', 'selected  cytokines'], ['larger  panel', 'cytokines'], ['controlled tumor protein', 'major cell animals'], ['', 'plant TCTP homologs'], ['full length BoTCTP', 'cabbage'], ['', ''], ['BoTCTP cDNA', 'conserved GTPase binding species'], ['BoTCTP', 'specifically  root'], ['significant salt changes', 'BoTCTP ABA stress'], ['RNAi plants', 'high growth temperature'], ['BoTCTP  gene', 'growth  cabbage'], ['Botulinum  toxin', 'medical exocrine gland hyperactivity'], ['BT drugs', 'botulinum neurotoxin'], ['Antibodies', 'BNT'], ['they', 'induced therapy failure'], ['BTAB', 'functional  body'], ['ABTF', 'BT therapy'], ['ABTF risk factors', 'immunological BT drug'], ['Testing', 'ABTF'], ['frustrating  prevention', 'major  importance'], ['Improved  antigenicity', 'substandard BT antigenicity'], ['Expert Concern', 'BT therapy'], ['Better  understanding', 'thus BT therapy'], ['when  CP', 'further  antigenicity'], ['They', 'however antigenicity problems'], ['PLIC compensation techniques', 'continuous power factor corrector'], ['precedent causes', 'boost input PFC'], ['boundary conduction current', 'large ripple current'], ['', 'BCM boost PFC'], ['digital control method', 'BCM boost IFC'], ['proposed  method', 'additional input component'], ['proposed  method', 'input power conditions'], ['derivation', '90 V rms input'], ['', ''], ['paper', 'digital inductor current'], ['proposed inductor current', 'instead sensing resistor'], ['zero crossing point', 'inductor current'], ['Importantly  prediction', 'single switching cycle'], ['Therefore  errors', 'predictive parameter variations'], ['prediction', 'good crossing accuracy'], ['proposed  method', 'high  inductance'], ['Experimental  results', 'digital PFC converters'], ['dynamic  that', 'minimum output voltage deviation'], ['large signal stability verification', 'control laws'], ['indirect energy transfer that', 'analytical signal approach'], ['stability analysis', 'resistive boost load'], ['stability conditions', '30  W'], ['programmable time optimal controller', 'large signal stability'], ['Finnish Internet who', 'Japanese hikikomori phenomenon'], ['individual  choices', 'social  settings'], ['young anxiety adults', 'valued  resources'], ['contingent life that', 'choice'], ['feeling', 'common self data'], ['social personality they', 'essential  survival'], ['they', 'everyday  lives'], ['We', 'bovine adrenal chromaffin cells'], ['NCX activity', 'K(+'], ['K(+)-enhanced  activity', 'Na(+)-dependent chromaffin cells'], ['NCX', 'chromaffin cells'], ['expression', 'further chromaffin PCR'], ['exchanger uptake', 'enriched chromaffin fraction'], ['bovine chromaffin regulation', 'more  NCKX'], ['we', 'bronchoalveolar lavage Mycoplasma'], ['', 'M'], ['', ''], ['', 'respiratory  disease'], ['real time PCR', 'three Mycoplasma species'], ['analytical  sensitivity', 'forming Buffered M'], ['', 'cfu  M'], ['', ''], ['', ''], ['analytical  sensitivity', '10 fg M'], ['', ''], ['', ''], ['', ''], ['real time PCR', 'as Mycoplasmas strains'], ['', ''], ['', '1  M'], ['', ''], ['', ''], ['', ''], ['real time PCR', 'DGGE  M'], ['', ''], ['', ''], ['', '44 BALF calves'], ['RespoCheck PCR assay', 'bovine respiratory disease'], ['Background', 'pathogenic lung stress'], ['open reference that', 'respiratory BRD cattle'], ['However  it', 'respiratory  tract'], ['objective', 'fatal BRD cases'], ['Cranial  lobe', 'healthy laboratory calves'], ['16S amplicon libraries', '16S Illumina MiSeq'], ['taxonomic  which', '16S rRNA gene sequences'], ['abundant lymph which', 'BRD'], ['Fusobacterium Mycoplasma Trueperella', 'healthy lung lesions'], ['Leptotrichiaceae Mycoplasma', 'healthy lung lesions'], ['Two Leptotrichiaceae sequence contigs', 'enriched shotgun sequences'], ['healthy H F calves', 'BRD'], ['Contigs', 'bacterial Leptotrichiaceae genus'], ['we', 'bacterial  BRD'], ['mesenchymal stem that', 'low  cost'], ['inflammatory tissues express them', 'many  diseases'], ['Umbilical cord mesenchymal cells', 'regenerative  medicine'], ['', '10 bovine Wharton passages'], ['seventh  cells', 'mean doubling 34'], ['', ''], ['33  hours', 'forming unit 221'], ['', ''], ['derived flow cytometry cells', 'mesenchymal stem cells'], ['They', 'CD34'], ['derived  cells', 'differentiation ability'], ['culture', 'specific media markers'], ['MHC I', 'based  therapies'], ['derived  cells', 'regenerative stem cell medicine'], ['detailed  evaluation', 'cellular  therapy'], ['', ''], ['rights', ''], ['Skeletal  dysplasia', 'congenital  anomalies'], ['diagnostic  that', 'obstetrical  management'], ['bent bony that', 'bent bony dysplasia'], ['first  case', 'campomelic SOX9 gene'], ['second  fetus', 'COLA1 gene'], ['campomelic SOX9 examination', 'campomelic dysplasia Cumming which'], ['unusual fades syndrome', ''], ['molecular  tests', 'skeletal ultrasound disorders'], ['', '2016 Taiwan Obstetrics'], ['', 'Elsevier Taiwan LLC'], ['', 'obese animal syndrome'], ['Parotid acinar cells', 'control  mice'], ['Total RNA', 'parotid acinar cells'], ['kit', ''], ['expression', 'situ microarray hybridization'], ['expression', '50 NOD age'], ['Acinar cells', 'foetus Bpifb1 stages'], ['parotid NOD expression', 'diabetes'], ['high expression levels', 'disease autoimmunity'], ['targeting', 'cognitive bradykinin disease'], ['cognition', 'mental brain ability'], ['Nevertheless  impact', 'hippocampal  function'], ['Therefore  we', 'aged bradykinin rats'], ['old  rats', 'spatial water maze task'], ['B2R antagonist Arg-[Hyp(3)Thi(5)D Hoe', 'learning  animals'], ['However  drugs', 'old nootropic properties'], ['old CA1 sub changes', 'aged B2R rats'], ['inappropriate  hippocampal', 'aged  rats'], ['peptide  antagonists', 'cognitive  decline'], ['', ''], ['', ''], ['rights', ''], ['OBJECTIVE Recent OBJECTIVE advancements', 'common BRAF melanoma'], ['wide  use', 'metastatic BRAF kinase melanoma'], ['objective', 'stereotactic BRAF mutation radiosurgery'], ['This', ''], ['charts', 'SRS tumor events'], ['Patients', 'wild type BRAF'], ['', 'known BRAF mutation 2010'], ['Kaplan Meier methodology', 'binary  parameter'], ['Median melanoma SRS', '8 Group months'], ['', ''], ['SRS', 'local tumor control 89'], ['', 'entire  patients'], ['local control rate', 'adjunct Group BMs'], ['BRAF mutation status', 'prognostic melanoma BM'], ['BRAFi', 'acceptable safety profile'], ['Little', 'primary brain tumors'], ['colorectal cancer who', 'neurosurgical  BM'], ['Tumor samples', 'KRAS NRAS BRAF'], ['molecular  profile', 'primary brain tumor'], ['molecular profile concordance rate', ''], ['', ''], ['Median  survival', 'neurosurgery'], ['', ''], ['', ''], ['overall  survival', ''], ['', ''], ['', ''], ['', ''], ['we', 'primary concordance tumors'], ['BackgroundThe role', 'solid tumor types'], ['very  role', 'However salivary gland tumors'], ['Thus  aim', 'malignant salivary gland tumors'], ['95 tissue who', 'salivary gland'], ['Immunohistochemical  staining', '600 BRAF gene'], ['VE1 BRAF protein', 'pleomorphic carcinoma five'], ['32  cases', 'pleomorphic carcinoma adenoma'], ['cases', 'based BRAF codon'], ['based prove mutations', 'BRAF V600'], ['molecular  analyses', 'targeted mutations therapies'], ['aging  we', 'transcriptional cDNA patterns'], ['old  SAMP', 'four  groups'], ['points', 'CV17  Zhongwan'], ['points stimuli', 'completely genes expression hippocampus'], ['Simultaneously  genes', 'brain acupuncture'], ['Meanwhile  acupoint', 'related genes genes'], ['three RT which', 'closely Hsp84 Hsp86'], ['', 'molecular conclusion mammals'], ['', ''], ['rights', ''], ['interacting  that', 'social sex roles'], ['Gender', 'factors'], ['skewed sex females', 'clinical picture prevalence'], ['social brain This', ''], ['many sex differences', 'social sex brain'], ['popular  females', 'particularly  disease'], ['neurobiological  sex', 'neuropsychiatric  disorders'], ['interaction', 'far  simplicity'], ['sex differences', 'possible effects retards field'], ['', ''], ['', ''], ['who', 'still  environment'], ['One', 'popular  BCI'], ['BCI users', 'target experiment'], ['same stimulus which', 'users'], ['Consequently users attention', 'adjacent  stimuli'], ['', ''], ['new  stimulus', 'user concentration'], ['shaped  figures', 'red  stimuli'], ['number', 'randomly BCI control'], ['instead  they', 'instead  times'], ['shaped  stimulus', 'red control condition'], ['', ''], ['shaped  stimuli', 'higher classification accuracies'], ['', 'red  dots'], ['', ''], ['proposed  method', 'daily BCI application'], ['Social  cognition', 'adaptive  manner'], ['increasingly  disorders', 'acquired brain injuries'], ['review', 'recent  research'], ['', 'social  cognition'], ['many  profession', 'many  clinicians'], ['social  cognition', 'cognitive upbringing performance'], ['also  that', 'social decision making'], ['Finally  review', 'intervention research'], ['Interventions', 'well brain injury'], ['generally  treatments', 'emotional self awareness'], ['BM brain pathologists', 'specific tumor therapies'], ['immunohistochemical  analysis', 'unknown  origin'], ['limited  array', 'known cancer breast cancer'], ['targeted  therapies', 'molecular cell lung anomalies'], ['substantial response brain which', 'molecular  profile'], ['combine', 'analytical tumor sample phase'], ['Appropriate  strategies', 'theranostic  markers'], ['article', 'targeted  therapies'], ['Lung cancer', 'leading brain metastases'], ['better cell lung understanding', 'further  field'], ['EGFR incidence recurrence', 'EGFR  mutations'], ['142  Caucasian', 'two  11'], ['', '27 EGFR mutant'], ['', 'KRAS mutant KRAS tumors'], ['04 % patients', 'BM'], ['BM incidence', 'more multivariate analyses'], ['', ''], ['', ''], ['', ''], ['', ''], ['patients', 'less KRAS mutation'], ['', ''], ['', ''], ['', ''], ['', ''], ['patients', 'univariate KRAS analysis'], ['', ''], ['', ''], ['', ''], ['', ''], ['Conclusions', 'Caucasian NSCLC patients'], ['results', 'routine  patients'], ['Further  studies', 'other NSCLC BM'], ['single emission computerized tomography', 'neurologic neuroreceptor imaging conditions'], ['imaging modality', 'risk stratification benign'], ['', 'medical  therapy'], ['We', 'epilepsy cerebral injury brain herpes'], ['This', 'trained  physicians'], ['clinical  information', 'existing  challenge'], ['which', 'many  ours'], ['Numerous  findings', 'cardiovascular adult offspring'], ['proinflammatory that', 'hypertensive adult offspring'], ['renal  RAAS', 'sensitization process'], ['chain reaction analyses', 'hypertensive proinflammatory dams'], ['Most', 'converting enzyme inhibitor water'], ['10 pressor dose', 'hypertensive pressor dams'], ['augmented blood pressure most', 'renal gene denervation'], ['male pressor upregulation', 'hypertensive proinflammatory II'], ['helix PAS domain proteins', 'growing transcription factors'], ['proteins', 'such oxygen concentration'], ['We', 'ischemic rat brain'], ['Npas4 mRNA', 'ischemic  tissue'], ['full length gene', 'situ rat hybridization'], ['Npas4 mRNA', 'ischemic  insults'], ['Immunohistochemistry', 'unchallenged  brain'], ['293  Npas4', '100  kDa'], ['immunoreactive kDa band', '100 kDa band'], ['Ischemic  challenge', '100 kDa immunoreactivity'], ['This', 'ischemic brain injury'], ['differences', 'increasing  neuroscientists'], ['Review', '3  brain'], ['available  we', 'such brain handedness'], ['structural  that', 'computerized neurocognitive battery'], ['Sex differences', 'spatial  processing'], ['Sex differences', 'limbic glucose males'], ['they', 'perhaps  puberty'], ['that', 'adaptive  diversity'], ['', ''], ['One  third', 'poor chemotherapy life'], ['Thus  study', 'depressive adult male rats'], ['cardioselective -adrenergic receptor that', 'dependent vasodilator properties'], ['Animals', 'four  groups'], ['aqueous control group', 'two  nebivolol'], ['', ''], ['daily  group', 'three  cisplatin'], ['', ''], ['consecutive  group', 'per  schedule'], ['treated  rats', 'open swimming tests'], ['histopathological  examination', 'neuronal  degeneration'], ['parallel cisplatin administration', 'cortical glutamate tissues'], ['Furthermore  it', 'nitric synthase genes expression'], ['', 'biochemical cell survival assay'], ['nebivolol', 'depressive  cisplatin'], ['Preclinical  evidence', 'bidirectional gut microbiome interactions'], ['subgroups', 'structural brain IBS'], ['Behavioral measures stool samples', '29 adult IBS'], ['16S gene sequencing', 'various microbial composition abundance'], ['metagenomic  content', '16S Unobserved States'], ['T1-weighted brain images', '165 brain regions'], ['Using', 'two IBS population'], ['', ''], ['', ''], ['', ''], ['Random Forest classifier', 'IBS1  groups'], ['Faecalibacterium Blautia', 'subclassification'], ['Clinical  features', 'early life IBS1'], ['Gut microbial composition', 'early brain life'], ['results', 'brain structural brain subgroups'], ['They', 'predicted  correlations'], ['deep brain -machine interfaces', 'greatly  neuroprosthetics'], ['molecular  it', 'powerful  ways'], ['neuromodulation that', 'neuropsychiatric  disorders'], ['Recent  developments', 'clinical neuromodulation disorders'], ['Here  we', 'clinical brain -machine method'], ['how  they', 'safety'], ['', ''], ['rights', ''], ['', ''], ['currently brain prognosis', '14  months'], ['Recently  indication', 'molecular DIPG biology'], ['assisted  workflow', 'especially  children'], ['authors', 'pediatric  population'], ['', ''], ['Retrospective  study', 'pediatric  period'], ['patients', 'transcerebellar  approach'], ['', ''], ['', 'median  8'], ['', '13  years'], ['Clinical  presentation', 'cranial nerve patients'], ['typical DIPG 3', 'hyper gadolinium enhancement'], ['mean procedure time', '67  minutes'], ['neurological  deficits', ''], ['Histological  diagnosis', 'cases'], ['', ''], ['assisted', 'highly  diagnosis'], ['', ''], ['rights', ''], ['malignant brain that', 'poor  prognosis'], ['it', 'first  3'], ['overall  survival', '2 survival years'], ['review', 'current background diagnosis'], ['terminal  we', 'chemotherapeutic  disease'], ['We', 'urban transportation networks'], ['electric arrival which', 'entire transportation system'], ['We', 'system level perspective'], ['traffic flow pattern', 'steady Wardrop user equilibrium'], ['robust dispatch that', 'current power flow constraints'], ['proposed power flow model', 'implicit convex optimization uncertainty'], ['second traffic assignment phase', 'delayed constraint generation framework'], ['Several  issues', 'scalability'], ['Case studies', 'proposed  method'], ['Three  genes', 'relevant L isoleucine production'], ['transcriptional  levels', 'pDXW-8-gnd fbp pgl'], ['respectively fbp fbp', 'carbon PPP'], ['36 fbp NADPH', 'quickly L isoleucine production'], ['', ''], ['', ''], ['g  L', 'pDXW-8-gnd flask cultivation'], ['IWJ001  pDXW-8', '40  g'], ['96 L isoleucine yield', 'pDXW-8-gnd fbp pgl'], ['', ''], ['carbon', 'efficient L isoleucine C'], ['', ''], ['', 'International Union International Biochemistry'], ['', ''], ['', 'normal retinoic development'], ['', 'negative cytochrome P450'], ['functions', 'three CYP26 enzymes'], ['little', 'CYP26  complements'], ['like basal that', 'large scale vertebrates'], ['2  that', 'specific  duplication'], ['amphioxus CYP26 cluster', 'signaling gene duplication'], ['independent CYP26 they', 'dependent RA levels'], ['RA homeostasis', 'CYP26 1'], ['negative feedback system', 'common  bilaterians'], ['dependent CYP26 that', 'genomic gene duplicates'], ['', ''], ['', ''], ['', ''], ['', 'N  ammonium'], ['two GS that', 'different  chloroplast'], ['directly plant ammonium', 'plant glutamine'], ['', 'Chinese GS1 cabbage'], ['cultivar  Suzhouqing', 'rapid cDNA ends'], ['It', 'motif B'], ['', ''], ['', ''], ['BcGS1', 'cells'], ['mainly  which', 'northern blotting analysis'], ['Additionally  expression', 'N source concentration'], ['BcGS1', 'novel GS plants'], ['Chinese N gene', 'important plant growth'], ['', '2010 Chemical Industry'], ['which', 'key box domain Arabidopsis'], ['several FLC homologues', 'flowering Arabidopsis FLC'], ['Here  we', 'early Purple Flowering Stalk'], ['', ''], ['', ''], ['', ''], ['', ''], ['splice site mutation', '5 splice site'], ['alternative splicing patterns', '6 Purple Flowering Stalk'], ['', 'normal splicing Pakchoi'], ['', ''], ['', ''], ['expression levels', 'three Purple Flowering Pakchoi'], ['downstream  SUPPRESSOR', '1 Purple Flowering Stalk'], ['natural splicing site mutation', 'flowering Purple Flowering Stalk'], ['however  little', 'currently pollen development'], ['exact PG gene', 'Chinese campestris Male cabbage'], ['', ''], ['', ''], ['', ''], ['', ''], ['situ antisense RNA technology', 'gene'], ['BcMF9', 'late pollen development'], ['morphological  that', 'reduced pollen germination efficiency'], ['pectic exintine layer', 'transgenic endintine pollen'], ['Inhibition', 'premature break tapetum'], ['Several  lines', 'gametophytic intine formation'], ['BcMF9', 'subsequently wall material turn'], ['BcMF9', 'dynamic intine pectin'], ['Based', 'isogenic Brassica napus lines'], ['resistance differences', 'backcross cDNA AFLP'], ['ORF open box', '40 RT Zhongyou821'], ['440 amino acid which', 'extracellular transmembrane domain'], ['conserved LRR it', 'rich  repeats'], ['DNA sequences', 'also  Zhongyou821'], ['Rsk', 'disease resistance pathways'], ['Oilseeds', 'human plant nutrition'], ['seed storage which', 'allergenic'], ['study', '190 Brassica nigra'], ['Cruciferin', 'further size exclusion chromatography'], ['amino acid sequence analysis', '82 Arabidopsis thaliana'], ['kDa monomeric kDa cruciferin', 'reduced SDS PAGE'], ['gel electrophoretic 2D gel analysis', 'major  5'], ['', ''], ['', ''], ['', ''], ['', ''], ['Dynamic Light Scattering', 'hydrodynamic  5'], ['', ''], ['', 'trimeric  protein'], ['CD Circular spectra', 'trimeric beta protein'], ['however  crystals', 'low resolution data'], ['angle x ray scattering', 'dimensional  solution'], ['radius', 'gyration'], ['', ''], ['', 'globular  shape'], ['', 'ab dummy B'], ['nigra cruciferin', 'PDB B'], ['which', 'conserved globular B'], ['', ''], ['comparison', 'minimized  1'], ['337', 'molecular  structure'], ['This', 'first cruciferin B'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['species', 'various vegetable crops'], ['Production', 'usually heat stress'], ['microRNAs', 'abiotic plant stress'], ['miRNAs', 'heat B'], ['', ''], ['novel that', 'B'], ['we', 'Chinese temperature cabbage'], ['', ''], ['small RNA that', '1 degrees h'], ['conserved  that', 'stress'], ['', '35 Arabidopsis thaliana'], ['families', 'stress'], ['putative  BracSPL2', 'inhibitive target gene'], ['21 novel families', '21 novel 19'], ['', 'putative expression targets'], ['', ''], ['3', 'putative target genes'], ['target precursors', 'target where'], ['results', 'important plant responses'], ['Recent  advances', 'ribose polymerase ADP ribose inhibitors'], ['therapeutic  that', 'homologous DNA repair pathway'], ['Early  studies', 'germline BRCA1/2 mutations'], ['that', 'therapeutic repair pathway approach'], ['companion homologous recombination deficiency scores', 'clinical PARP inhibition'], ['ovarian germ who', 'based  chemotherapy'], ['ovarian United States who', '3  chemotherapy'], ['', 'ovarian rucaparib niraparib veliparib'], ['review', 'evolving research area'], ['Germline BRCA2 mutations', 'ductal  adenocarcinoma'], ['germline BRCA2 it', '10 BRCA2 families'], ['PDAC', 'mainly  chemoresistance'], ['molecular  subgroup', 'systemic BRCA2-associated treatment'], ['2 blood relatives', 'magnetic resonance imaging'], ['goal', 'R0  resection'], ['poly(ADP DNA repair that', 'currently  investigation'], ['undifferentiated  that', 'characteristically  head'], ['NMC', 'chromosomal gene 15q14'], ['BRD4 gene', 'common fusion oncogene BRD4-NUT'], ['48  patients', 'NMC'], ['exceedingly  we', 'seven case cases'], ['Methods  We', 'English language literature'], ['diagnosis', 'in polymerase chain reaction'], ['We', 'four  own'], ['NMC', 'epithelioid  appearance'], ['tumours', 'squamous  differentiation'], ['mean  age', 'conventional laryngeal carcinoma'], ['five  patients', '11 8 months'], ['increased  awareness', 'pathologists'], ['morphological  features', 'positive NUT antibody'], ['aggressive  behaviour', 'promising treatment strategies'], ['Irinotecan', 'widely cancer therapy'], ['High group protein B1', 'fundamental gene expression'], ['', 'cell cycle breast cancer cells'], ['cells', 'blue  exclusion'], ['High group B proteins', 'drug  immunoblot'], ['High group protein B1', 'reverse polymerase chain reaction'], ['results', 'high B1 gene expression'], ['high protein B1 release', 'extracellular immunoblot analysis'], ['Irinotecan', 'superoxide production suggesting cells'], ['24 drug treatment', 'S phase'], ['overexpression', 'high B1 chromatin'], ['surgery', 'conserving breast therapy'], ['neoadjuvant breast which', 'high  emesis'], ['', 'adverse antiemetics patients'], ['CINV breast cancer', 'neoadjuvant  chemotherapy'], ['breast who', 'neoadjuvant  surgery'], ['Candidate factors', 'Anxiety Pittsburgh Sleep Scale'], ['CINV', 'Cancer Antiemesis Tool'], ['134 treatment patients', 'finally  analyses'], ['', ''], ['5  %', 'CINV  prevalence'], ['', ''], ['', ''], ['overall  CINV', 'late  chronotypes'], ['', ''], ['', ''], ['', ''], ['', 'nausea  vomiting'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'late  chronotypes'], ['', ''], ['', ''], ['', ''], ['history', 'nausea  vomiting'], ['', ''], ['', ''], ['', ''], ['008', 'significantly  CINV'], ['clinicians', 'CINV'], ['breast which', 'psychosocial  adjustment'], ['Women', 'functional cancer centre'], ['the  levels', 'depression'], ['greater  which', 'better  adjustment'], ['intimate relationships play', 'further breast research'], ['High  levels', 'shortly diagnosis breast cancer'], ['however cutoff score', 'diagnosed breast cancer'], ['aims', 'reported breast cancer problems'], ['Dutch  who', '1 breast cancer diagnosis'], ['Anxiety DT Scale', 'criterion distress'], ['predictive sensitivity value', 'predictive DT score'], ['181  women', 'study'], ['optimal DT cutoff score', '0'], ['', '73  0'], ['', '87  %'], ['Emotional  problems', ''], ['shortly breast cancer', 'chronic  distress'], ['clinically  they', 'most healthcare assistance'], ['largely target therapy which', 'distinctive  host'], ['which', 'estrogen HER2'], ['first  step', 'still breast morphology'], ['tubular carcinomas define who', 'surgical  excision'], ['patients', 'beneficial  chemotherapy'], ['second  step', 'prediction'], ['certainly progesterone receptors we', 'breast cancer diagnosis'], ['aim', 'molecular breast cancer biology'], ['methodologic  approaches', 'more  Africa'], ['We', 'suspicious breast cancer'], ['fecal blood samples', 'study subjects'], ['risk factor prevalences', 'established cancer risk factors'], ['', '54'], ['5  %', 'recruited  malignancies'], ['', 'benign  conditions'], ['', 'indeterminate  diagnoses'], ['Response rates', 'interviews'], ['', '2  cases'], ['', 'interviewed  saliva'], ['', '9  cases'], ['', ''], ['', '8  controls'], ['', ''], ['', ''], ['5  %', ''], ['', ''], ['', ''], ['1  %', 'fecal  samples'], ['risk factor prevalences', 'other  countries'], ['', ''], ['parity cancer risk factors', 'low breast parity'], ['Subjects', 'socioeconomic  profiles'], ['', ''], ['lower  malignancies', 'referral  influences'], ['interdisciplinary  studies', 'high quality data biospecimens'], ['epidemiologic  studies', 'rapidly  Africa'], ['Best  practices', 'study design'], ['authors', 'such recruitment data collection'], ['various risk magnitudes', 'those'], ['successful  studies', 'many  challenges'], ['Breast cancer', 'common  females'], ['Genetic  polymorphisms', 'carcinogenesis'], ['C', '9 breast cancer'], ['Peripheral  blood', 'Jordanian summer 2013'], ['DNA', 'restriction enzyme digestion'], ['D 25-hydroxy Vitamin level', 'competitive immunoassay Elecsys'], ['frequencies', '8 breast control'], ['D serum level', 'significantly breast cancer patients'], ['', ''], ['ng  ml', 'control group'], ['', ''], ['', ''], ['', ''], ['study', 'serum level'], ['', ''], ['', ''], ['', ''], ['inverse association', '25(OH)D serum level'], ['Statistical  difference', 'Jordanian breast cancer'], ['Breast carcinogenesis', 'metabolic DNA processes'], ['study', 'expression polymorphism'], ['Tissue samples', 'adjacent breast cancer tissues'], ['51  frequency', 'cancerous promoter tissue'], ['', 'normal  tissues'], ['', ''], ['hypermethylated  status', 'significantly protein expression'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['significant  association', 'promoter hypermethylation'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['GSTP1', 'consequent protein expression'], ['also gene polymorphism', 'independent breast cancer development'], ['Keratins', ''], ['hard  structures', 'such breast carcinoma'], ['However  expression', 'previously breast cancer'], ['We', 'human breast cancer'], ['Western  blotting', '55-kDa cancer cell lines'], ['full  size', '5 breast cells'], ['KRT81', 'cytoplasm'], ['we', 'MCF10A  cells'], ['such matrix MMP)9', 'such matrix metallopeptidase'], ['KRT81-knockdown', 'cell migration'], ['KRT81', 'normal breast epithelial cells'], ['KRT81', 'breast cancer cells'], ['major risk factors', 'unknown  etiology'], ['Studies', 'reduced breast cancer growth'], ['breast controversy', 'relationship'], ['3  ml', 'real polymerase chain reaction'], ['CC genotype', '4  women'], ['', '9 case 2'], ['', '0 control group'], ['GG genotype', 'rs6220  8'], ['', '5 case 5'], ['', '2 control group'], ['', ''], ['significant  difference', 'variant premenopausal case'], ['', 'significant  case'], ['', ''], ['GG it', '6'], ['', ''], ['difference', 'postmenopausal  women'], ['', ''], ['current SNP rs6220', 'significant breast women'], ['Breast cancer', 'diagnosed  women'], ['Therapeutic  treatments', 'generally chemotherapy radiotherapy endocrinotherapy'], ['', 'new breast cancer therapies'], ['we', 'recent vaccines bispecific antibodies'], ['additional immunotherapy modalities', 'early  development'], ['immunotherapeutic  strategies', 'current breast cancer therapies'], ['Breast cancer', 'frequent  women'], ['Tumor immunology', 'immune system chronic inflammation'], ['immune  system', 'carcinogenesis'], ['common  which', 'pivotal  pathways'], ['Using', 'common bioinformatics pathways'], ['MiR-590', 'III cancer cell lines'], ['time  quantitative', 'transfected Annexin V-7AAD assay'], ['time  quantitative', 'reverse polymerase chain MMP9'], ['', 'expression miR-590'], ['', ''], ['PI3 K MAPK1', 'h  transfection'], ['over genes', 'over expression'], ['significant  increase', 'significantly MDA MB-231 cells'], ['MiR-590', 'similar  cancer'], ['down apoptosis level', 'cancer cell lines'], ['Apparently  microRNAs', 'novel  cancer'], ['further  studies', 'breast cancer therapy'], ['Studies', 'wide cell tumors'], ['Here  we', 'breast cancer'], ['Total RNA', 'real polymerase chain reaction'], ['We', 'negative mimics control'], ['Cell proliferation', 'colony formation assays'], ['Cell proliferation', 'miR-145 suppression'], ['Cell migration', 'also breast cancer cells'], ['assays', 'inhibited growth factor'], ['1 protein which', 'tumor formation'], ['here Cell I', 'therapeutic breast cancer'], ['Gene expression Gene profiling', 'up breast cancer specimens'], ['other  expression', 'human  molecule'], ['cancer cell targeting', 'drastically cell proliferation'], ['Concordantly  introduction', 'oncogenic cell activity'], ['immunoprecipitation  experiments', 'GIGYF2 breast cancer cells'], ['Interestingly  knockdown', '473 cancer cell lines'], ['RQCD1', 'molecular breast cancer'], ['Elevation', 'increased tumor aggression'], ['genetic  mechanisms', 'metastatic breast carcinomas'], ['run tail assays', 'four cell lines'], ['', 'Western analysis FAS T47D'], ['', 'times  ZR75'], ['', 'neoplastic 184A1 cells'], ['FAS mRNA levels', 'specific protein content'], ['relative  rates', 'neoplastic T47D ZR75'], ['Stability', 'discrepancy'], ['', 'half 184A1 cells'], ['', '5-fold  ZR75'], ['FAS mRNA FAS species', 'nt cancer cell 500'], ['cancer cell lines', 'nonneoplastic 184A1 cells'], ['Yet 184A1 cells', 'higher FAS gene activation'], ['faster 184A1 stabilization', 'major breast cancer'], ['Increased  stability', 'simply  polyadenylation'], ['other  mechanism', 'breast cancer cells'], ['histological  characteristics', 'suppressing  genes'], ['several  mutations', 'several  oncogenes'], ['gene it', 'known  anthracyclines'], ['aim', 'Mexican protein BC'], ['total', 'adjacent  BC'], ['Sanger sequencing method', 'p53 gene'], ['Deletions', 'quantitative polymerase chain reaction'], ['expression', 'western  blotting'], ['p53 protein expression', 'proximity ligation assay'], ['', ''], ['average breast age', 'patients'], ['', ''], ['differences', 'well TOP2 TNBC'], ['However  patients', 'western p53 protein blotting'], ['', ''], ['Furthermore  we', 'TOP2 alpha TNBC'], ['', ''], ['Concerning p53 overexpression', 'lower  BC'], ['frequently breast that', 'significantly  life'], ['Symptom burden', 'likely disease treatment'], ['purpose', 'novel cancer undergoing chemotherapy'], ['Patients', 'then treatment conclusion'], ['Multiple linear regression analyses', 'SNP  genotype'], ['Two COMT variants', 'well pain treatment'], ['Genotype', 'sleep disturbance'], ['genotypes', 'early stage breast cancer'], ['therefore  identification', 'putative  diagnosis'], ['Selenium', 'oxidative DNA repair'], ['present  study', 'breast cancer'], ['present  study', 'reverse polymerase chain reaction'], ['MCF-7 MCF-10A Four', 'iodothyronine type II GPX2'], ['that', 'direct gene networks'], ['same selenoprotein that', 'three TP53 estrogen receptor'], ['human breast genes', 'breast cancer cells'], ['tumor exome tumor which', 'other  microenvironment'], ['Similar  characterizations', 'tumor specimen'], ['exome  files', 'solid microenvironment tumors'], ['scripted  that', 'high breast cancer'], ['analysis', 'infectious tumor pathogens'], ['Purpose  study', 'induced breast cancer patients'], ['when mitochondrial haplogroup we', 'induced  fibrosis'], ['Italian breast cancer who', 'breast conserving surgery'], ['Subcutaneous  fibrosis', 'Management Analytical LENT scale'], ['discriminative  accuracy', 'characteristic  curves'], ['Kaplan Meier curves', 'subcutaneous DNMT1 rs2228611 fibrosis'], ['', ''], ['Cox regression analysis', 'protective radiation -induced fibrosis'], ['', ''], ['', ''], ['', '0'], ['', ''], ['', ''], ['rs2228611to haplogroup H', 'discrimination 0'], ['', ''], ['', '0'], ['', '0'], ['', ''], ['', '0'], ['', ''], ['Conclusion DNMT1 rs2228611', 'predictive breast cancer models'], ['Aim', 'situ duct grading'], ['study', '161 resection patients'], ['first  specimen', 'one  DCIS'], ['side', 'margin'], ['Clonal analysis', 'selected  cases'], ['neoplastic  foci', '34'], ['', ''], ['residual  foci', 'frequently  nipple'], ['', ''], ['', ''], ['', 'specific  distribution'], ['1  foci', 'clonally  other'], ['DCIS  grade', 'mammary  lobe'], ['', 'independent cancer harbor'], ['', 'similar Surgical Oncology'], ['rights', ''], ['sialidase gene', 'tagged Escherichia coli'], ['tagged sialidase protein', 'agarose Ni chromatography'], ['SDS PAGE', '116  kDa'], ['sialidase', 'of  5'], ['', '37 degrees C'], ['neuraminic sodium salt hydrate', 'artificial V substrate'], ['', ''], ['', ''], ['which', 'commercially  polysialogangliosides'], ['', 'International Union International Biochemistry'], ['paper', 'continuous conduction mode'], ['current', 'proportional input AC integral'], ['distortion', 'harmonic  distortion'], ['predictive control algorithm', 'current control method'], ['advantages', 'current PFC topology'], ['proposed  method', 'experimental PSIM 1'], ['', ''], ['present  paper', 'experimental  research'], ['calculations', 'different V shapes'], ['specimens', 'multiaxial fracture loading'], ['Stress', 'finite element method'], ['Special  attention', 'loading  shape'], ['local fracture criterion', 'recent  literature'], ['', 'C Elsevier Ltd'], ['AimsThe aim', 'renal cell carcinoma'], ['negative RCC tissues', 'specific BRM gene'], ['BRM mutation', '78'], ['9  %', 'monosomy  43'], ['', 'CpG BRM promoter 42'], ['', '8  14'], ['results', 'that'], ['', 'two BRM 47'], ['', '4  19'], ['Such  alterations', 'composite grade tumours'], ['ConclusionsBRM', 'collectively BRM ccRCC'], ['composite BRM abnormality', 'tumour progression'], ['which', 'known radar AESA'], ['required product bandwidth', 'required product operation'], ['low loss apertures', 'operational array frequency'], ['whole multifunction they', 'array grid'], ['high power amplification', 'low harmonics performance'], ['Enablers', 'T R M'], ['paper', 'state multifunction RF Systems'], ['which', 'known radar AESA'], ['required product bandwidth', 'required product operation'], ['low loss apertures', 'operational array frequency'], ['whole multifunction they', 'array grid'], ['high power amplification', 'low harmonics performance'], ['Enablers', 'T R M'], ['paper', 'state multifunction RF Systems'], ['associated  pneumonia', 'ill  patients'], ['new  techniques', 'microbiological  identification'], ['trial', 'suspected time VAP'], ['48  h', 'suspected  VAP'], ['endotracheal aspirate', 'suspected VAP episode'], ['samples', 'conventional  culture'], ['', 'bacterial  sample'], ['clinical pulmonary infection score', '73'], ['', '5  patients'], ['culture results', 'agreed  75'], ['', '0  BAL'], ['', '2  ETA'], ['isolated  bacteria', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '% BAL samples'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['when molecular biology method', 'conventional reference standard'], ['molecular  method', 'common  VAP'], ['', '2016 Clinical Microbiology'], ['', 'Elsevier Ltd'], ['rights', ''], ['mainly  it', 'highly adult humans'], ['shivering  which', 'therefore ATP heat'], ['', ''], ['', ''], ['other  compounds', 'homologous domain protein'], ['centrally  which', 'adrenergic  BAT'], ['many  that', 'acute'], ['review', 'latest  BAT'], ['', ''], ['rights', ''], ['We', 'external room standard'], ['FABP3 5', 'room cold'], ['transcript  level', 'cold  exposure'], ['transcript room level', 'cold  exposure'], ['cold  amount', 'BAT'], ['venomous  that', 'predation'], ['humans bites', 'hematological  abnormalities'], ['signs', 'brown spider bite'], ['Brown spider venom', 'molecular mass proteins'], ['Characterization', 'expressed D metalloproteases'], ['serine protease inhibitors', 'like  toxins'], ['toxin', 'brown spider toxins'], ['class', 'inflammatory dermonecrosis hemolysis thrombocytopenia'], ['functional  role', 'spreading hyaluronidase loxoscelism'], ['noxious  effects', 'which'], ['aim', 'available spider venom literature'], ['identification processes', 'future x ray field'], ['useful life it', 'Gaussian  distribution'], ['Brownian degradation motion', 'nonlinear  degradation'], ['hitting time distribution', 'Brownian time space transformation'], ['previous drift coefficient', 'Brownian state space motion'], ['Brownian state space motion', 'hidden state space modeling'], ['then  it', 'rechargeable  batteries'], ['26  sets', 'prognostic battery degradation method'], ['prognostic cubature particle methods', 'prognostic  method'], ['average particle filter', 'useful life prediction'], ['', ''], ['rights', ''], ['', 'brain Gekko japonicus'], ['It', '107 amino acids'], ['molecular  weight', 'BRP44L  protein'], ['2664  kDa', ''], ['', ''], ['', 'other % species'], ['Brp44l', 'biological heart lung gene'], ['positive hybridization signals', 'spinal  cord'], ['spinal tail amputation', 'reverse polymerase chain reaction'], ['expression level', 'spinal cord injury'], ['We', 'Brucella sp'], ['', 'real time PCR'], ['d erythrulose-1-phosphate that', 'intracellular Brucella macrophage'], ['assay', 'negative amplification results'], ['It', '43 genome reactions'], ['', ''], ['', '10  GE'], ['Finally  applicability', 'sheep raw sheep milk'], ['real time PCR assay', '1 pig blood'], ['we', 'food Brucella environments'], ['economic  losses', 'neonatal abortion livestock'], ['Brucellosis', 'public health importance'], ['study', 'Brucella infections'], ['several  primers', 'biological Brucella Brucella'], ['Ba148/928 rRNA OMPs', '31ter  Brucella'], ['primers', 'reference Brucella strains'], ['oriented PCR assays', 'minimal  Brucella'], ['oriented PCR assays', 'minimal  Brucella'], ['Field samples', 'bacteriological  methods'], ['Overall  sensitivity', 'bacteriological PCR isolation'], ['Brucella DNA', '35'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'aborted PCR assays'], ['PCR assay', 'sensitive Brucella animals'], ['Careful  examination', 'traumatic  lesions'], ['vascular  lesions', 'bruises'], ['old  man', 'floor'], ['Dissection', 'haemorrhagic  area'], ['', 'left thyrohyoid muscle'], ['old  man', 'opened nitrogen gas'], ['', 'upper mucosal lip'], ['3  examination', '15 mm bruise'], ['Histological  examination', 'vascular  lesions'], ['lesions', 'inflicted  trauma'], ['Bruxism', 'dental  areas'], ['circadian  it', 'sleep bruxism wakefulness'], ['However  it', ''], ['nervous system neurotransmitters', 'BRX'], ['Serotonin', 'circadian response muscle tone'], ['Thus  serotonin', 'BRX pathogenesis'], ['aim', 'rs17260565 BRX treatment'], ['Patients', '61 sleep bruxism'], ['control group', 'healthy  BRX'], ['where C allele', 'increased  SB'], ['polymorphisms', 'serotonergic sleep bruxism'], ['Further  research', 'current BRX physiopathology'], ['', ''], ['pinnata', 'various healing wounds'], ['However anticancer properties', ''], ['', 'therapeutic  B'], ['we', 'active leaf principle'], ['', 'pulverized chloroform B'], ['pinnata leaves', 'petroleum ether'], ['Fractions', 'cervical cancer cells'], ['g leaf which', '91 Ethyl ml'], ['c Fos c which', 'HPV18 transcription'], ['', 'apoptotic Bax PARP-1'], ['fraction that', 'Bryophyllin A'], ['study', 'therefore  B'], ['that', 'HPV HPV infection'], ['effects', 'bacterial  community'], ['bacterial straw community', 'Bt DNA maize'], ['straw return', 'available soil nitrogen'], ['75th  which', 'CrylAb N protein'], ['', 'bacterial earthworm gut treatments'], ['three maize varieties which', 'CrylAb  protein'], ['bacterial  species', 'mainly Stenotrophomonas Methylobacterium Asticcacaulis'], ['which', 'mineralization metabolic plants'], ['straw return', 'bacterial  E'], ['fetida which', 'expected Bt straw'], ['', ''], ['rights', ''], ['digital control circuit', 'data'], ['affected', 'control circuit'], ['noiseless sampling that', 'switching noise'], ['synchronous sampling method', 'duty circuit'], ['noiseless sampling method', 'immediately  turn'], ['noiseless switching which', 'when multisampling method'], ['current  control', 'even noise filter'], ['paper', 'electric photovoltaic systems'], ['strategy', 'digital signal processor'], ['long battery which', 'simultaneously  approach'], ['converter', 'well  MPPT'], ['TMS320F2812 Texas which', 'proposed control system'], ['', ''], ['rights', ''], ['Implantable  devices', 'irregular  heart'], ['', 'beat power rhythm'], ['DC Buck converter', 'high process voltage'], ['which', 'conventional offset cancellation'], ['which', 'largely Monte Carlo analysis'], ['proposed SC Buck technique', 'long term usage'], ['97 output voltage mismatch', 'to error 1'], ['dead  that', 'buck boost converters'], ['steady voltage transfer which', 'duty cycle'], ['smooth mode transitions', ''], ['negative  effects', 'poor operating modes'], ['dead zone avoidance technique', 'efficient  converter'], ['which', 'well analog control circuits'], ['initial zone avoidance which', 'dead zone avoidance technique'], ['experiments', 'coupled buck boost inductors'], ['', 'erythroid leukemic erythroid cells'], ['HEL cells', 'cellular morphology proliferation assay'], ['mRNA expression levels', 'PCR DNA methyltransferase blot'], ['dependent suppression rates', '23'], ['', ''], ['', '1  87'], ['', ''], ['', 'maximal inhibit 0'], ['', ''], ['Typical apoptosis morphology', 'treated HEL cells'], ['proliferation index', 'cell 76'], ['', ''], ['', '9  49'], ['', ''], ['', ''], ['meanwhile methylation status', 'partially WT1 methylated'], ['protein', 'dependent bufalin manner'], ['arrest cell phase', 'down expression WT1'], ['increasing WT1 methylation which', 'leukemic HEL cells'], ['Information security', 'smart  grid'], ['consumption', 'electricity consumption aggregation'], ['periodic  messages', 'smart  meters'], ['when electricity cluster', 'total  demand'], ['scheme', 'security customer side networks'], ['', ''], ['', 'customers'], ['same  it', 'significantly  communication'], ['proposed  scheme', 'further computation complexity'], ['integrated  windows', 'efficiently energy daylight'], ['overall energy performance', 'comparative Hong Kong'], ['PV special', 'PV default'], ['solar heat gain coefficients', 'PV DSF'], ['', ''], ['U values', ''], ['', ''], ['', ''], ['solar heat it', 'thermal  insulation'], ['lower energy conversion efficiency', 'PV DSF'], ['', '% PV IGU'], ['Simulation models', 'experimental PV data'], ['overall energy performances', 'different PV China'], ['average energy saving potential', 'PV DSF'], ['', 'different glass climates'], ['average  performance', 'representative PV cities'], ['PV DSF', 'better PV IGU'], ['suitable design results', 'different PV climates'], ['', ''], ['rights', ''], ['energy consumption it', 'building existing'], ['study', 'existing land use regulations'], ['These', 'specific energy depth'], ['case study', 'commercial Belo Horizonte Brazil'], ['representative  typologies', ''], ['each', 'archetype energy EUI'], ['analysis', 'forthcoming energy buildings'], ['archetype analysis', 'further energy city'], ['', ''], ['', ''], ['rights', ''], ['study', 'urban  landscape'], ['We', 'seasonally electricity use relations'], ['study', 'considerable building use'], ['outside weekday effect', 'large electricity buildings'], ['cooling degree CDD', 'daily electricity 0'], ['degree day degree HDD', 'daily electricity 0'], ['', 'kW  0'], ['', 'kW transition months'], ['We', 'projected temperature 2030'], ['cases', 'also transition spring'], ['Overall electricity demand', '0'], ['', 'low emission scenario'], ['', ''], ['', 'high emission scenario'], ['which', 'overall energy 2030'], ['', ''], ['', ''], ['rights', ''], ['integrated photovoltaic which', 'preliminary  implementation'], ['technical shading effect', 'nonlinear electricity BIPB'], ['Particularly  width', 'PV BIPB'], ['economic  feasibility', 'investment values'], ['however PV SIR25', 'saving  year'], ['50 PV SIR25', '2'], ['when  width', 'PV panel'], ['clearly design which', 'technical client performance'], ['', ''], ['', 'BIPB'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['Electricity generators', 'national electricity grid'], ['study', 'selected Abeokuta city Nigeria'], ['dioxide hydrogen sulphide', 'portable  samplers'], ['Copies', 'additional generator information'], ['capacities', 'sampled  25'], ['', 'mean  PM1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['7  ppm', 'generator sites'], ['distance', '66 pollutants levels'], ['Ailments', 'exposed nasal congestion'], ['national  policy', 'urgently electricity Nigeria'], ['positive feedback bulk', 'operational  paper'], ['supply which', 'threshold voltage'], ['conventional  it', 'existing  MOSFET'], ['driven  transconductance', 'to  four'], ['', 'positive  feedback'], ['resulting  transconductance', 'referred voltage noise'], ['So  concept', 'standard CMOS technology'], ['power it', 'also  1V'], ['simulation', '180 nm technology'], ['', 'simple  0'], ['', 'DC level 0'], ['18 m CMOS technology', 'paper'], ['circuit', 'close DC voltage unity'], ['DC voltage shift', 'current  sinks'], ['application', 'also AB output paper'], ['operational  amplifier', 'proposed output detail'], ['', ''], ['effective  transconductance', 'common mode voltage'], ['variation', 'harmonic frequency distortion'], ['Thus  brief', 'common mode range'], ['idea', 'common mode voltage'], ['driven  opamp', 'proposed G(m)-stabilizing 0'], ['', ''], ['opamp', '900-mV supply voltage'], ['variation', 'rail  ICMR'], ['measured dc gain', ''], ['8  dB', ''], ['when  opamp', '1 M Omega'], ['new  solution', 'operational  paper'], ['amplifier', 'positive input feedback'], ['proposed input stage', 'referred performance voltage'], ['In', 'common mode amplifier'], ['', '50 supply 0'], ['4  V', 'gain bandwidth gain 2'], ['', '20 pF load capacitance'], ['paper', '0'], ['25-V', '130-nm CMOS process'], ['distributed layout OTA', 'implanted voltage transistors'], ['proposed  circuit', 'harmonic  0'], ['thus input it', 'low -C applications'], ['design solution', 'common mode work'], ['driven CMOS it', 'biasing transconductance tuning'], ['design robustness', '0'], ['', ''], ['', 'controlled input transconductance'], ['', '0'], ['proposed  transconductor', ''], ['', ''], ['', ''], ['', ''], ['62  MHz', 'current  consumption'], ['design robustness', 'triple computer well'], ['', ''], ['', 'input output swing'], ['consists', 'folded  cascode'], ['proposed input stage structure', 'adversely power performance'], ['presented  OTA', '0'], ['18 m CMOS technology', 'theoretical simulation analyses'], ['proposed  amplifier', 'DC gain 9'], ['', 'conventional input stage structure'], ['Finally  amplifier', ''], ['it', 'low power applications'], ['characterization', 'molecular causal livestock'], ['responsive element which', 'normal sperm fertilization motility'], ['bull CREM Tay', 'reverse polymerase chain reaction'], ['variant', 'homemade mouse antiserum'], ['motility', 'normal activator males'], ['percentages', 'normal  sperm'], ['', '0  90'], ['', ''], ['', ''], ['', '0  97'], ['', ''], ['relative expression levels', 'significantly activator CREM 0'], ['', '1'], ['', ''], ['', ''], ['individual activator CREM that', 'normal  motility'], ['', ''], ['rights', ''], ['retrospective  investigation', 'psychological college sample'], ['undergraduate eighty students', 'study'], ['', ''], ['', ''], ['sample', '65 % women'], ['', 'race  ethnicity'], ['4  %', ''], ['', ''], ['', 'grade level'], ['6  %', '104  38'], ['', ''], ['', ''], ['', ''], ['Participants', 'psychological victimization functioning'], ['bullying  victimization', 'other childhood victimization experiences'], ['PTS symptoms', 'bullying victimization'], ['College level practitioners', 'wide childhood victimization victimization'], ['Generic health status instruments', 'immune  deficiency'], ['However  tools', 'QoL'], ['objective', 'related  CVID'], ['32-item content', 'focus CVID_QoL groups'], ['118  who', 'single General Health session'], ['Principal  component', '3 factor analysis solution'], ['Validation', '3 construct validity'], ['reliability convergent validity', ''], ['Matrices', '32  CVID_QOL'], ['Factor analysis', '3  dimensions'], ['instrument', 'internal  consistency'], ['', ''], ['', 'GSS'], ['', ''], ['', 'high RF reproducibility'], ['', ''], ['', 'RF max'], ['', 'EF'], ['EF', 'other study scales'], ['Acute  infections', 'significant  EF'], ['QoL that', 'generic  instruments'], ['', ''], ['', 'Elsevier Inc'], ['', 'Allergy Asthma'], ['This', 'open NC- ND license'], ['Buddhist Rakhine plight', 'inside media country'], ['such  reporting', 'critical  analyses'], ['local how influence', 'specific news gathering conflicts'], ['personal freelance article', 'news production conflict'], ['various  they', 'local  producers'], ['challenges', 'binary reporting conflict'], ['encapsulated', 'weight availability performance advantages'], ['inherent  structures', 'high reliability field'], ['Screening test', 'marginal package components'], ['Failure analysis', 'package reliability'], ['failed components failure analysis', 'screening design'], ['', 'encapsulated burn components'], ['integrated  circuit', 'electrical  24hrs'], ['Failure analysis', 'failed root causes'], ['It', 'die pad interface'], ['also  design', 'different packaging PEMs'], ['most elongate tear', 'rich Victoria southeast Australia'], ['locally  Tears', '1854 Chthamalus antennatus cyanobacteria'], ['partially  which', 'elongate tear'], ['such  this', 'low  tides'], ['It', 'net balanomorph substrate'], ['delicate shell it', 'delicate shell wall'], ['brief  review', 'mollusc  verrucomorph'], ['low dropout regulator', 'low voltage operation'], ['However  tradeoff', 'transient response applications'], ['fine tuning technique', 'burst D LDO'], ['coarse load current', 'fixed sampling time'], ['fine  tuning', 'high state accuracy'], ['proposed D LDO', '65-nm CMOS 0'], ['', ''], ['measured voltage undershoot', '20-ns edge time'], ['quiescent current', '82 mu 0'], ['43-ps  figure', 'merit'], ['Moreover reference tracking speed', ''], ['', ''], ['paper', 'low power applications'], ['developed magnetron power supply', 'full phase magnetron'], ['', 'light power condition'], ['burst  which', 'power conditions'], ['zero field effect MPS', 'burst  mode'], ['proposed  method', 'high  efficiency'], ['power', 'proposed  1'], ['', 'burst  time'], ['Experimental  results', 'proposed driving method'], ['Gut microbial Gut translocation', 'immune HIV-1 infection'], ['intestinal  dysbiosis', 'mucosal  inflammation'], ['Thus  it', 'immune HIV-1 infection'], ['sectional  study', '14 study participants'], ['effect', 'intestinal cell culture model'], ['Species', '16S RNA sequence datasets'], ['isolated propria mononuclear cells', 'negative butyrate doses'], ['Relative  abundance', 'HIV-1-uninfected Roseburia individuals'], ['', 'HIV-1-infected study participants R'], ['relative  abundance', 'immune  activation'], ['Exogenous  butyrate', 'driven HIV-1 infection vitro'], ['Reductions', 'associated mucosal pathogenesis'], ['', ''], ['rights', ''], ['paradigmatic  system', 'totalitarian state systems'], ['civic  individuals', 'civic  which'], ['Similar  dynamics', 'child families'], ['most  extreme', 'psychological  domains'], ['Such  dynamics', 'dissociative omnipotent subjectivity'], ['what', 'always  knowing'], ['dynamics shift bystanders', 'actively  abusers'], ['difficile  rate', 'difficile  colonization'], ['CDI we', 'hospitalized nucleic acid testing'], ['2015 stool samples', '3 Stanford Hospital'], ['Stool samples', 'same  order'], ['', ''], ['assay', 'genomic PCR cycle equivalents'], ['Chart review', 'clinical  history'], ['We', 'asymptomatic  C'], ['', 'difficile carriage 11'], ['', ''], ['', ''], ['', 'symptomatic positivity 15'], ['', ''], ['', ''], ['', ''], ['', ''], ['median PCR cycle thresholds', 'asymptomatic  carriers'], ['', '27'], ['', ''], ['', ''], ['', 'asymptomatic  patients'], ['', '6  carriers'], ['', ''], ['56', 'same CDI hospitalization'], ['Single  analysis', 'difficile  carriage'], ['difficile carriage rate', 'symptomatic positivity rate'], ['majority', 'symptomatic  C'], ['', ''], ['specific  biomarkers', 'C difficile C disease'], ['', ''], ['rights', ''], ['ScopeNaturally  occurring', 'chemopreventive  actions'], ['limited  studies', 'hepatic S transferase ITCs'], ['present  study', 'RT PCR promoter assay'], ['single  dose', 'mRNA rats'], ['consecutive  injections', 'gene induction'], ['PEITC', 'potent  vivo'], ['PEITC', 'H4IIE cells'], ['PEITC', 'related  factor'], ['cells', 'deleted GSTA2 promoter PEITC'], ['effects', 'PI3 K N terminal kinase'], ['2  downstream', 'signaling  induction'], ['we', 'embryonic heart cDNA library'], ['ZNF552', 'two  19q13'], ['', ''], ['cDNA', 'ZNF552'], ['', 'seven zinc finger nucleus'], ['Northern blotting analysis', 'that'], ['3 kb transcript', 'human adult tissues'], ['transcriptional COS-7 which', 'RNAi analysis'], ['KRAB domain', 'inhibition'], ['BMB', ''], ['chronic  inflammation', 'useful complement prognosis'], ['We', 'cardiac resynchronization therapy'], ['We', 'months CRT implantation'], ['CRT', 'C3a'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'NT proBNP'], ['we', 'net reclassification improvement'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'elevated NT proBNP levels'], ['', 'inflammatory complement activation'], ['review', 'possible composition intracellular trichocysts'], ['Trichocyst release', 'Paramecium'], ['explosive  that', 'cooperatively  organelle'], ['Membrane fusion', 'like alveolar Ca2'], ['', 'physiological  trichocysts'], ['', ''], ['', 'local trichocyst discharge'], ['defined  period', 'expulsion'], ['secretory which', 'discharge'], ['Repulsion', 'only  trichocysts'], ['ciliary  reversal', 'activated trichocyst Ca2'], ['trichocyst they', 'cell surface components'], ['Some', 'exogenous proteins lectins'], ['endoplasmic Golgi which', 'molecular  biology'], ['fragile  these', 'filling tmp exocytosis'], ['This', 'frustrated  exocytosis'], ['', ''], ['', 'stimulated membrane exocytosis'], ['experimental  work', 'fascinating  organelles'], ['study', 'human varying temperatures'], ['Lactic acid bacteria', 'also NoV reduction'], ['', 'NoV G titer GII'], ['4', 'days chain reaction inoculation'], ['28 NoV recovery quantity', '1'], ['', ''], ['', ''], ['', '2'], ['57  logic', '10 degrees C'], ['NoV', 'persistently food Kimchi'], ['Therefore  preventing', 'NoV NoV contamination'], ['', ''], ['rights', ''], ['attributional life cycle assessment', 'primary cacao Philippines'], ['analysis', 'dried cacao beans'], ['biodegradable pesticides diesel outputs', 'dried lambda cyhalothrin mancozeb'], ['following  impacts', '1  ton'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Transportation', 'environmental impact study'], ['improvement measures', 'environmental cacao production'], ['harmful impact scores', 'cacao production'], ['This', 'production eco system'], ['feedback that', 'primary cacao system'], ['the', ''], ['policy', 'natural vegetation conservation requirements'], ['how  CAR', 'livelihoods'], ['livelihood  that', 'CAR registration'], ['We', 'key farmers governments'], ['livelihood impact they', 'natural market conditions'], ['especially policy intervention area', 'high poverty rates'], ['', ''], ['', 'Elsevier B'], ['', ''], ['This', 'open NC ND license'], ['', 'caesarean  section'], ['personality that', 'it'], ['sectional  questionnaire', 'one  delivery'], ['obstetrical  who', 'vaginal  delivery'], ['27  participants', 'group'], ['women', 'well background variables'], ['multiple Multivariate regression', 'Multivariate variance'], ['Preliminary  MANOVA', 'significant defence mechanism projection'], ['Hence  variables', 'multiple regression model'], ['model', 'good  fit'], ['', ''], ['', ''], ['Age FOC', 'maternal request CS'], ['Maternal request CS', 'strongly  age'], ['intrapsychic  variables', 'maternal request CS'], ['Possible  implications', ''], ['intronic  most', 'unrelated  genes'], ['Some', 'host genes'], ['Intronic  miRNAs', 'synergistic animal effects'], ['article', 'regulatory  plants'], ['NMT genes', 'reduced  caffeine'], ['Transcript  analysis', 'antisense NMT constructs'], ['altered  expression', 'NMT genes'], ['Bioinformatics analysis', 'theobromine synthase CaMTL1'], ['putative', ''], [\"5'-RLM RACE mapping\", 'experimentally Coffee canephora'], ['regulatory  mechanism', 'multigene  process'], ['', ''], ['', ''], ['rights', ''], ['NFAT)-regulated T genes', 'calcineurin inhibitors'], ['biomarker', 'different  laboratories'], ['However  implementation', 'comparable  laboratories'], ['Therefore  protocol', '2 comparison laboratories'], ['analytical blood samples', 'healthy  vitro'], ['Linearity imprecision', 'quantification'], ['interlaboratory comparison therapy', '24  hours'], ['', ''], ['mcg 25 L', 'regulated  vitro'], ['Within  6', 'Within  variations'], ['', 'stimulating factor genes'], ['Samples', '24  hours'], ['Interlaboratory  comparison', 'patient  samples'], ['', 'residual gene expression'], ['assay', 'comparable  laboratories'], ['reproducibility', 'different calcineurin centers'], ['Hormonal  responses', 'instructive corticosterone periphery'], ['Hypothalamic CRH neurons', 'therefore stress neurons'], ['histochemical biology evidence', 'GABA'], ['single CRH production', 'segregated identity neurons'], ['CRH mRNA transcripts', 'neuronal  hypothalamus'], ['constitutively  sensor', 'median  eminence'], ['CRH neurons', ''], ['where  they', 'cytoplasmic membrane Ca2'], ['synaptic excitation secretion', 'other  Ca2'], ['recent genome sequencing', 'molecular Ca v channels'], ['complex animal which', 'nervous Ca v system'], ['key Ca v that', 'cellular selectivity pore gating'], ['many', 'nervous system function'], ['experimental  that', 'diverging Ca v phyla'], ['molecular basal animal we', 'vertebrate  animals'], ['cellular Ca v which', 'perhaps metazoan it'], ['inducible Ipomoea expression', 'methyl jasmonate'], ['related  it', 'related  protein'], ['expression', 'signal  ethylene'], ['confocal  microscope', 'Northern IPO expression'], ['presence', '+ IPO ethylene'], ['Ca2 IPO expression', \"N'-tetraacetic ether)-N N acid\"], ['Ca2', 'IPO expression'], ['', 'mechanical IPO it'], ['higher plasma that', 'higher plasma Ca2'], ['ionophore', 'cytosolic IPO expression'], ['solely  Ca2', 'IPO expression'], ['MAPKK protein kinase inhibitor', 'IPO staurosporine'], ['cytosolic protein which', 'finally IPO expression'], ['SC sensor interface', 'resistive bridge sensor'], ['operating power modes', 'biasing op amp design'], ['', '474 mu s'], ['SC level shift design', 'further system level'], ['scheme', 'point feedback capacitor size'], ['together regulator voltage trimming', '0'], ['', ''], ['proposed SC amplifier', 'first Half Wheatstone Bridge'], ['', '2 kHz system clock'], ['Ratio  SNR', 'SC circuit'], ['', ''], ['', 'commercial test 0'], ['mV kPa interface', 'sensing 3'], ['', ''], ['prior  work', 'fractional resistance change'], ['response', 'rarely model animals'], ['constantly food they', 'energy pathogens'], ['that', 'ambient  conditions'], ['acute food restriction', 'LPS ad libitum'], ['when food intake', 'reduced fever development'], ['Bats', 'when ad libitum'], ['when  bats', 'restricted  diet'], ['effect', 'acute fish pathogens'], ['future  work', 'bat immune bat response'], ['', ''], ['', 'Elsevier GmbH'], ['rights', ''], ['two  which', 'crevicular fluid gingival crevicular inflammation'], ['release', 'periodontopathic  bacteria'], ['risk factor', 'periodontal stress norepinephrine'], ['aim', 'present calprotectin norepinephrine'], ['human monocytic cell line', 'beta- adrenergic receptor cortisol'], ['northern  amount', 'immunosorbent  assay'], ['binding transcription factor', 'electrophoretic mobility shift assay'], ['Norepinephrine', 'about calprotectin 3'], ['', 'control'], ['However  cortisol', 'calprotectin mRNA'], ['C DNA binding activity', 'activity'], ['stress modulator', 'human monocytic cells'], ['Calprotectin expression', 'inflammatory  factors'], ['Calprotectin', 'S100A8 family subunits'], ['IL-1 interleukin-1 which', 'keratinocyte differentiation'], ['Keratinocyte growth factor', 'epithelial  cells'], ['we', 'IL-1 calprotectin alpha'], ['Human keratinocytes', 'KGF receptor'], ['respectively MAPK phosphorylation', 'western blot analysis'], ['KGF', 'mRNAs calprotectin protein'], ['', 'S100A8 kinase S100A9'], ['IL-1 alpha alpha', 'KGF fibroblasts'], ['Cocultured fibroblast', 'IL-1  alpha'], ['calprotectin expression', 'epithelial mesenchymal interactions'], ['', ''], ['', ''], ['', ''], ['', ''], ['rapid  increase', 'extended spectrum beta bacteria'], ['such antimicrobial strains', 'human'], ['antimicrobial resistance', 'due camel meat'], ['', 'major study meat Egypt'], ['', 'cetrimide P'], ['aeruginosa  colonies', '2  system'], ['', ''], ['aeruginosa  isolates', 'double disk synergy test'], ['', 'Additionally susceptibility P'], ['aeruginosa  isolates', '11 disk diffusion method'], ['ESBL genotypes', 'M polymerase chain bla(SHV'], ['Pseudomonas aeruginosa', '45 camel meat sample'], ['', ''], ['', 'total  P'], ['aeruginosa', '45 camel meat isolates'], ['highest  resistance', 'c cefepime'], ['prevalence rates', 'beta lactamase genes'], ['', ''], ['', ''], ['', ''], ['study', 'high ESBL P'], ['that', 'current antibiotics therapy failure'], ['Livestock', 'ESBL P'], ['livestock associated ESBL which', 'human  beings'], ['major  aim', 'made tea plant'], ['present  experiment', '113 tea plants'], ['', ''], ['internal transcribed spacer', '104 trnL intron'], ['similarity', 'Research tea Substation'], ['', ''], ['', ''], ['amplified noncoding varieties', 'identical  sequences'], ['intergenic sequence proportion', 'more tea plant varieties'], ['', 'made ITS2 teas'], ['same  variety', 'other tea plants'], ['molecular  similarity', 'important tea Taiwan'], ['', 'molecular tea plants'], ['barcode comparison method', 'molecular cost frontline varieties'], ['', ''], ['', 'Elsevier Taiwan LLC'], ['', 'secondary  metabolites'], ['new cytochrome P450 that', 'medicinal RACE PCR'], ['', '509 amino acids'], ['CASS', 'other cytochrome P450 monooxygenases'], ['blotting  analysis', 'one Camptotheca acuminata'], ['CaSS', 'highly root leaf'], ['CaSS', 'phenylpropanoid pathway'], ['aim', 'molecular broiler chickens'], ['', 'six  multidrug'], ['jejuni', 'vivo methods'], ['whole  genome', 'selected multidrug isolate'], ['', ''], ['genomic  analyses', 'nucleotide polymorphisms deletions C'], ['', '1655 reference C'], ['', ''], ['emergence', 'pTet C'], ['1655 multidrug resistance', 'tetracycline'], ['combination', 'higher virulence C'], ['', ''], ['', 'mobile gene elements'], ['', ''], ['', 'CRISPR Cas C'], ['jejuni', 'important gene transfer'], ['present  study', 'phenotypic  C'], ['', 'high multidrug virulence'], ['Campylobacter species', ''], ['Campylobacter jejuni', 'gastroenteritis'], ['Campylobacter drug resistance', ''], ['national research we', 'bibliometric  Campylobacter'], ['study', 'global health policy campylobacateriosis'], ['Scopus database', 'following  keywords'], ['', ''], ['', ''], ['study period', '2015'], ['types', 'journal errata'], ['international publications collaboration', 'annual publications country'], ['quality', 'indirectly impact journals'], ['total', 'Q1-Q3 h 113'], ['Annual  number', 'fluctuating  increase'], ['leading  journals', 'Applied Food 246'], ['46  %', 'each'], ['', ''], ['6  %', ''], ['7  %', ''], ['Half', 'productive  countries'], ['France', 'lowest  percentage'], ['', 'international  collaboration'], ['7  %', 'international  collaboration'], ['', ''], ['1  %', 'immunology  microbiology'], ['Main  themes', 'public health campylobacteriosis'], ['', ''], ['articles', 'mainly drug quinolones'], ['', 'clear  Campylobacter'], ['Rational  use', 'humans poultry'], ['International  collaboration', 'global food safety'], ['radiologic fragility that', 'accidental Child Abuse'], ['radiologic vitamin D who', 'originally child abuse'], ['infants', 'University Medical period'], ['convincing child infants', 'parents'], ['IRB Institutional Review approval', ''], ['We', 'accidental  trauma'], ['infants', 'one  age'], ['', 'D deficiency infantile rickets'], ['Three', 'osteogenesis imperfecta'], ['common  fractures', 'classic metaphyseal lesions'], ['Serum levels', '48 25-hydroxyvitamin infants'], ['', ''], ['', '30  mothers'], ['', ''], ['', ''], ['D measured', 'serum'], ['mean serum level', 'deficiency  rickets'], ['', ''], ['fragility that', 'accidental child abuse'], ['gender sexuality intersections', 'liminal Ontario Canada'], ['survey', '704 PHQ-9 June'], ['group differences', 'mental healthcare services'], ['race gender class', 'mental discrimination healthcare'], ['', 'outcome variables'], ['Everyday discrimination', 'mental  healthcare'], ['that', 'vulnerabilities'], ['Future research', 'mental intersectionality healthcare'], ['Polycomb group proteins', 'various cell types'], ['repressive polycomb group complex', 'mammalian  cells'], ['', 'also histone modifications'], ['histone PRC2', 'histone lysine'], ['alterations', 'altered chromatin structure'], ['2 zeste EZH2', 'various EZH2 malignancies'], ['critical  EZH2', 'such cell proliferation differentiation'], ['cancer cells EZH2', 'decisive T effector'], ['molecular EZH2 aberrations', 'cancer  mechanisms'], ['Measuring cell proliferation', 'high throughput formatting'], ['mode cell that', 'counting cell algorithm'], ['method', 'own time cost'], ['method', 'cellular cell densities'], ['Additionally  measurement', 'continual cell time'], ['is', 'cell proliferation'], ['Molecular imaging agents', 'molecular  disease'], ['Recent  advances', 'molecular imaging targets'], ['biomarkers', 'objectively  pathology'], ['predominately PET utility', 'when  review'], ['1 measure target who', 'therapeutic tumor survival'], ['review', 'targeted cancer therapy'], ['Particular  attention', 'clinical  utility'], ['diverse  roles', 'clinical drug development'], ['', ''], ['rights', ''], ['', 'nucleus accumbens-1 cancer cell'], ['NAC1', 'ovarian  cancer'], ['we', 'regulatory cancer cell survival'], ['molecular  biology', 'pharmacology study'], ['NAC1', 'hypoxic cancer cell condition'], ['2  NAC1', 'novel  glycolysis'], ['3 culture NAC1', 'stability HIF-1 alpha'], ['hypoxia NAC1', 'HIF-1 alpha'], ['researches', 'single  cell'], ['Cancer research', 'normal cancer cells'], ['contemporary anticancer drugs', 'abnormal cancer cells'], ['', 'high anticancer drugs relapse'], ['we', 'current cancer research'], ['systemic cancer cells', 'systemic cancer modulation'], ['various  organ', 'specific cell networks'], ['Therefore  investigation', 'current cancer research'], ['specific cell which', 'new cancer disease'], ['derived suppressor cells', 'paraneoplastic tumor cell metastasis'], ['However  interaction', 'live tumor tissue'], ['we', 'metastasized mouse lungs'], ['', 'transgenic host mice'], ['mammary tumor cells', 'footpads'], ['energy transfer we', '4T1 tumor lungs'], ['4T1 we', 'further  OPN'], ['OPN', 'suppressed ERK lung'], ['deficient 4T1 OPN', 'paracrine manner'], ['PMNs', 'tumor NETosis'], ['inhibitor DNase NETosis inhibitor I', '4T1 cells'], ['OPN', '4T1 NETosis'], ['presenting  that', 'foreign  antigens'], ['node sinus macrophages', 'immune tumor cells'], ['high  density', 'clinical LN prognosis'], ['density', 'immune tumor patients'], ['Moreover antigen delivery', 'also LN vaccination'], ['we', 'tumor CD169-positive LN immunity'], ['Long term prognosis', 'advanced treatment HCC'], ['CIK  cells', 'NK- T cell markers'], ['CIK cell therapy', 'advanced  HCC'], ['treatment', 'synergistic mouse HCC'], ['MIC A MIC human', 'FACS'], ['that', 'C3H mouse HCC'], ['CIK cells', 'monoclonal mouse antibody'], ['synergistic  effect', 'mouse model'], ['MIC expression', '4 HCC cell control'], ['', 'MH-134'], ['', 'Huh-7'], ['', ''], ['', 'SNU-475'], ['vivo VPA that', 'significant  control'], ['CIK cells', 'well C3H mouse splenocytes'], ['synergistic CIK effect', 'relative mouse HCC'], ['relative tumor volume', 'untreated control 11'], ['', 'only combination treatment 5'], ['', ''], ['', ''], ['induced  increase', 'significantly mouse HCC'], ['progressive  growth', 'innate tumour lesion'], ['healthy tumour cells', 'positively  tumour'], ['cells', 'other  body'], ['Intercellular interactions', 'other cancer treatment'], ['metastases regress', 'same treatment method'], ['biological cancer that', 'tumor growth'], ['properties', 'traditional  cancer'], ['immune tumor that', 'response pathways'], ['review', 'immune treatment responses'], ['anti-  depletion', 'improved  outcomes'], ['cancer  we', 'Diphtheria toxin'], ['', 'BALB c FoxP3'], ['transgenic  mice', 'Treg depletion Treg growth'], ['DTX', 'dependent  manner'], ['Treg depletion', 'solid effector T tumors'], ['depletion', 'completely survival benefit'], ['when T cell activation', 'base line levels'], ['minimal Treg depletion', 'significantly tumor peptide vaccination'], ['', ''], ['', ''], ['dtr mice', 'tumor Treg immunity'], ['mediated Treg depletion', 'low tumor doses'], ['Together  data', 'current cancer immunotherapies'], ['crosstalk', 'vital M1 infections'], ['However  macrophages', 'present NK cells'], ['associated  macrophages', 'spontaneous mouse breast tumors'], ['well M2 TAMs', 'NK tumor cells'], ['mechanism', 'respective cell types'], ['macrophages', 'immunosuppressive  cytokine'], ['inhibition', 'NK cell inhibition'], ['also NK cell which', 'reduced  activation'], ['study', 'dependent TGF beta'], ['findings', 'effective cell cancer therapies'], ['field', 'new research field'], ['how  response', 'disease treatment'], ['Pheochromocytoma', 'characterized tumour types'], ['Hence  patients', 'two precision decades'], ['', 'mitogenic aberrant state'], ['Categorization', 'highly mutation subtypes'], ['different  syndromes', 'genetic causes phenotypes'], ['different  PPGL', 'related optimal tumours'], ['tailored options follow up', ''], ['new  developments', 'further disease initiation'], ['Identification', 'prospective treatment options'], ['orphan that', 'rare  conditions'], ['Fatigue', 'hematopoietic stem cell transplantation'], ['It', 'intense  treatment'], ['physical  activity', 'occasional HCT tiredness'], ['Data', 'cognitive fatigue functioning'], ['Differences', 'multivariate variance'], ['Survivors', 'physical  P'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'healthy  controls'], ['RBC Red blood levels', 'significantly HCT survivors'], ['', ''], ['Levels', 'normal  range'], ['Tumor necrosis', ''], ['', ''], ['05  levels', 'significantly HCT survivors'], ['Persistent  fatigue', 'decreased RBC counts'], ['Elevated necrosis factor alpha', ''], ['study', 'one  other'], ['Persistent fatigue', 'everyday HCT life'], ['', 'immune  tumors'], ['inhibitory NK that', 'tumor  immunity'], ['that', 'apoptotic sialic tumors'], ['It', 'tumor  immunity'], ['Siglecs', 'best animal cancer'], ['Modulators', 'few cancer years'], ['Methylation', 'histone'], ['Genes', 'chromosomal H3K36 cancer'], ['H3K36 KMTases', 'transcriptional  programs'], ['catalytic SET KMTases', 'small molecule inhibitors'], ['most  KMTases', 'yet target class'], ['strong drug development efforts', 'near novel future'], ['Background', 'common age cancer'], ['decisions', 'home'], ['aim', 'older symptom cancer'], ['total', 'standardized symptom representation'], ['Demographic', ''], ['Analysis', 'Pearson analysis'], ['noted  symptoms', ''], ['symptoms', 'cancer'], ['They', 'symptom symptoms'], ['related comorbid symptoms', 'higher  consequences'], ['related  actions', 'symptom severity'], ['This', 'active symptom self management'], ['Patient education strategies', 'self manage symptoms'], ['Herein  we', 'B16 melanoma cells'], ['critical  that', 'active  immunostimulant'], ['immunostimulant', 'RAW Blue JAWSII monocytes'], ['Conversion', 'enriched B16 melanoma cells'], ['culture experiments', 'immune B16 cells'], ['complex  pathology', 'molecular players genes pathways'], ['important body properties', 'single  atom'], ['omics  data', 'mechanistic cancer complexity'], ['molecular cellular which', 'developmental  processes'], ['Cancer state', 'whole  organism'], ['discovery', 'molecular biology systems'], ['decision network', 'experimental  knowledge'], ['', 'pathological cancer emerge'], ['dynamical  model', 'linear additive cancer research'], ['far  theory', 'initial  success'], ['quantitative  approaches', 'rules  biology'], ['Patients', 'prior symptom treatment'], ['related  symptoms', 'overall cancer treatment'], ['related  symptoms', 'induced  inflammation'], ['We', 'human papilloma virus'], ['model', 'mildly  cachexia'], ['previously  tumor', '1L-1 beta brain'], ['tumor', 'inflammatory cytokine expression'], ['', ''], ['IL-1 TNF alpha', 'healthy  tissue'], ['behavioral cytokine changes', 'behavioral cytokine model'], ['Therefore  we', 'low  LPS'], ['', ''], ['nest', 'h locomotor LPS'], ['However  mice', 'induced weight loss'], ['Further  heightened', 'liver cytokine expression'], ['Next  we', 'induced burrowing minocycline'], ['Minocycline', 'inflammation drinking deficits'], ['data', 'related syngeneic murine head'], ['state  changes', 'induced sickness behavior'], ['', ''], ['rights', ''], ['current  therapies', 'all  world'], ['tumor biology immunotherapy', 'immune cancer surveillance'], ['Unfortunately  efficacy', 'immune evasion mechanism'], ['Hence cancer immunotherapy', 'malignant tumor cells'], ['based  immunotherapy', 'traditional  immunotherapy'], ['recent  nanodevices', 'active cancer immunotherapy'], ['', 'important cancer tissues'], ['producing  that', 'ILC1 phenotypic'], ['current cancer studies', 'beneficial  effects'], ['how ILC subsets', 'friends'], ['', '2016 Immunological Societies'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['locus', 'palliative care consult'], ['', 'Palliative Care outpatient clinic'], ['Patients', 'Functional Illness Therapy Spiritual'], ['Regression models', 'mental well being'], ['', 'potential partnership status confounders'], ['study', '100  patients'], ['', 'decreased LOC QOL'], ['', ''], ['Higher  levels', 'increased LOC depression'], ['', ''], ['', ''], ['higher  levels', 'decreased LOC hope'], ['', ''], ['ill cancer patients', 'physical well life'], ['Efforts', 'physical well life'], ['precise  mechanisms', 'incompletely  determined'], ['how metal complexes', 'cancer'], ['how metal ligands', 'pharmacological  properties'], ['nt  that', 'negatively gene expression'], ['Disturbance', 'certain  diseases'], ['that', 'pancreatic  cancer'], ['This', 'chronic time PCR pancreatitis'], ['Hierarchical clustering', 'normal pancreas pancreatitis'], ['PAM algorithm', 'benign  tissues'], ['One hundred microRNA precursors', 'pancreatic  cancer'], ['', 'previously miR-155 miR21 cancer'], ['Most', 'increased  tumor'], ['Expression', 'mature time PCR blotting'], ['situ  three', 'expressed tumor stroma'], ['microRNA  expression', 'pancreatic  adenocarcinoma'], ['', ''], ['however cancer impact', 'little  attention'], ['study', 'obese symptom burden'], ['Patients', 'modified McGill Pain Inventory'], ['obese group analyses', 'patient  outcomes'], ['Results', 'significant symptom severity obese'], ['', ''], ['', 'obese  19'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Significant  differences', 'total pain obese'], ['', ''], ['', 'obese  2'], ['', ''], ['', ''], ['', ''], ['', ''], ['Obesity', 'significant symptom severity'], ['significant  predictors', 'treatment'], ['Cancer survivors', 'obese symptom survivors'], ['obesity that', 'clinically CIPN patients'], ['Future research', 'multifaceted cancer survivors'], ['that', 'chemotherapeutic steroids glucuronidation'], ['Pediatric cancers', 'more adult cancers'], ['aim', 'pediatric UGT2B17 deletion cancer'], ['MethodsA total', 'malignant DNA disease'], ['copy number variant', 'polymerase chain reaction'], ['Survival analysis', 'lymphoblastic UGT2B17 malignancy'], ['ResultsUGT2B17', 'lymphoblastic  malignancy'], ['lymphoblastic deletion polymorphism', 'relapse deletion polymorphism'], ['', ''], ['', ''], ['which', 'advanced  stage'], ['', ''], ['', ''], ['', ''], ['', 'significant UGT2B17 deletion'], ['intermediate deletion polymorphism', 'advanced  disease'], ['', ''], ['deletion polymorphism', 'lymphoblastic  malignancy'], ['Precision medicine', 'personalized service delivery model'], ['molecular information PM', 'environmental  data'], ['developed research community', 'significant precision cancer medicine'], ['PCM research', 'evidence healthcare systems'], ['social  that', 'appropriate health policy framework'], ['policy', 'fields'], ['Key  challenges', 'renewed trial endpoints'], ['issues', 'better health healthcare'], ['Major  advances', 'based cancer patients'], ['', 'growing radiation settings'], ['enhanced radiation that', 'durable disease control'], ['local multimodal that', 'metastatic tumor lesions'], ['', ''], ['', ''], ['rights', ''], ['Fatigue', 'adverse cancer therapy'], ['early cancer us', 'biologic  therapy'], ['We', 'nonmetastatic prostate cancer'], ['sample', '1 prostate EBRT'], ['Demographic  data', 'chart review'], ['Functional TherapyYFatigue', 'fatigue levels'], ['Plasma cytokine levels', 'Cytokine Assay Kits'], ['Significant  correlations', '1 interferon T3'], ['Immunological  changes', 'long radiation therapyYinduced damage'], ['distressing cancer nurses', 'chronic cancer treatment'], ['information', 'patient  education'], ['acid sterol which', 'human  cholesterol'], ['Esterification reactions', 'response surface methodology'], ['', ''], ['', ''], ['4  %', '0'], ['', ''], ['', '12 H reaction'], ['kinetic model', 'reaction process'], ['activation energy', 'reaction'], ['kJ  mol', 'further kinetic study'], ['optimization  research', 'near deodorizer future'], ['proposed  process', 'friendly oil deodorizer method'], ['', 'International Union International Biochemistry'], ['known Candida we', 'wide  C'], ['albicans cells', 'responsive Eurogentec cDNA genes'], ['that', 'differentially microarray experiments'], ['up  39', 'significantly  them'], ['CDR1 ATP Binding family', 'possible steroid stress'], ['Several  genes', 'hyphal pathogenesis'], ['affected NRG1 TUP1 MIG1', 'regulated  progesterone'], ['responsive  elements', 'responsive C4 genes'], ['data', 'new gene C'], ['', 'human resistance virulence morphogenesis'], ['comparison', 'induced stress response'], ['H3N2 canine influenza', 'greater Chicago area'], ['referring  that', 'quickly  death'], ['report', 'North American canine influenza'], ['larynx pharynx', 'fibrinonecrotic  membrane'], ['Bilaterally  lungs', 'caudal hemorrhage congestion'], ['Staphylococcus pseudointermedius', 'lung'], ['Mycoplasma cynos', 'real oropharynx larynx trachea'], ['influenza isolated', '98 Chicago area'], ['systemic parasite Leishmania which', 'clinical  signs'], ['Clinical  manifestations', 'systemic  disease'], ['therapeutic Leishmania treatments', 'vaccine dogs'], ['we', 'immune  L'], ['infantum we', 'required  parasite'], ['antigenic 2a that', 'many  countries'], ['subtypes', 'characteristic gastroenteritis signs'], ['Little  information', 'genetic  CPV-2'], ['aim', 'two Mozambique 2010'], ['total', 'fecal chain reaction assay'], ['partial length VP2 gene', 'positive  samples'], ['fecal Twenty samples', 'CPV-2'], ['length polymorphism analysis', 'positive CPV-2c subtype'], ['results', 'CPV-2a'], ['CPV-2', ''], ['Sequence analysis comparison', 'nucleotide  99'], ['', '6 100 CPV-2 isolates'], ['showed', 'amino acid changes'], ['Phylogenetically  all', 'African CPV-2a isolates'], ['French  one', 'American  strain'], ['present  study', 'Mozambican dog population'], ['resultant apoptotic cells accumulation', 'unstable  plaques'], ['underlying  mechanisms', 'detail'], ['selective  activation', 'macrophages'], ['', ''], ['primary peritoneal lavage macrophages', 'C57bI/6J mice'], ['possible flow mechanisms', 'molecular biology methods'], ['selective  agonists', 'low density lipoprotein'], ['', ''], ['', 'inhibited RhoA GTPase'], ['how CB2 activation', 'atherosclerotic  plaques'], ['Elsevier rights', ''], ['initial  expression', 'oxytocin dopamine systems'], ['systems', 'parenting effects'], ['article', '48 months partum'], ['Adversity Vulnerability Neurodevelopment which', 'two  Canada'], ['We', 'Etch operation task'], ['positive  which', 'making  task'], ['', ''], ['direct  effects', 'enhanced decision making'], ['', ''], ['', ''], ['OXTR polymorphism', 'executive months function'], ['research', 'maternal oxytocin infancy'], ['weak capacitance measurement system', 'two phase flows'], ['system', 'programmed Control Unit'], ['stray  capacitance', 'measurement system'], ['system', 'high measurement accuracy'], ['result', 'percentage error'], ['6  %', ''], ['', ''], ['which', '500 MCU kps'], ['', 'feedback operational feedback amplifier'], ['proposed  circuit', 'low temperature variations'], ['simulation results', 'theoretical PSPICE 100KHz-6MHz'], ['', 'sensitive reference signal'], ['noise', 'reference signal'], ['sensitivity', 'significantly  noise'], ['which', 'noise variable output gain'], ['feasibility', 'signal detection noise'], ['Vapor detection', 'industrial  applications'], ['that', 'chemical sensing applications'], ['circuit', '0'], ['', 'active power consumption channel'], ['open loop gain', 'locking  channels'], ['feasibility', 'developed chemical sensing application'], ['that', 'excellent volume 8'], ['', ''], ['', 'respectively  N-2'], ['paper', 'motion tracking profile detection'], ['sensor', 'digital control converter'], ['mesh', '4x4 capacitor matrix'], ['electrode  connections', 'multiple sense functionalities'], ['Statistical regression models', 'motion'], ['machine learning algorithm', 'measured surface profiles'], ['fabricated sensing system', '90 profile recognition'], ['coupled instrumentation that', 'neural recording applications'], ['high pass filter', 'residual capacitor size'], ['Multiple', 'residual RRL offsets'], ['dc servo loop', 'on pass capacitor'], ['complete  CCIA', 'standard'], ['', ''], ['It', '0'], ['', '23  DSL'], ['', ''], ['', '25-V noise efficiency 2'], ['that', 'favorably  art'], ['polices', 'residential energy areas'], ['We', 'smart home load grids'], ['varying electricity that', 'individual load market'], ['D capacity planning goal', 'overall planning period'], ['overall  expense', 'D days'], ['monetary  we', 'objective optimization problem'], ['noncooperative  which', 'smart pricing grids'], ['best response we', 'proximal point algorithm'], ['converged game theoretic solution', 'efficient  solutions'], ['disease virus skin disease species', 'significant sheep goats'], ['real polymerase chain assays', 'rapid management programs'], ['CaPV qPCR assays', 'commercial PCR tests'], ['modified  assays', 'original  assays'], ['Diagnostic sensitivities', 'modified Bowden assay'], ['qPCR  assays', 'negative beta results'], ['diagnostic singleplex assays', 'CaPVs'], ['chimeric antigen confer', 'therapeutic gene therapy efficacy'], ['Other  approaches', 'antitumor immunity'], ['These', 'presenting tumor antigens'], ['engineering', 'CD19-expressing B cell malignancies'], ['Recent  success', 'iterative CAR vectors'], ['review', 'human T cell future'], ['haematopoietic  necrosis', 'Carassius auratus Carassius auratus gibelio'], ['High water temperature treatments', 'goldfish mortality survivors'], ['Carassius auratus which', 'promising model species'], ['we', 'infected water temperature ginbuna'], ['100 ginbuna which', 'typical  HVHN'], ['6  shifting', 'indicating 2nd virus immunity'], ['goldfish CyHV-2 ginbuna', 'useful CyHV-2 infection'], ['Antimicrobial  resistance', ''], ['study', 'bibliometric carbapenem resistance'], ['articles', 'carbapenem resistance'], ['Specific  keywords', 'Scopus database'], ['Quantitative', 'bibliometric  indicators'], ['total journal articles', 'total  2617'], ['average  number', '21'], ['', ''], ['growth', 'dramatic  2015'], ['9  %', 'retrieved Antimicrobial Agents'], ['Retrieved articles', 'different  countries'], ['United States', 'most  437'], ['', '%  257'], ['', ''], ['population size Greece', 'first  France'], ['when  data', 'domestic  product'], ['Asian  countries', 'ten  list'], ['productive UK Greece two', 'productive  institutes'], ['active  institutes', 'Israeli'], ['cited Chemotherapy two', 'Lancet Infectious Diseases'], ['', 'few carbapenem years'], ['publications', 'different Europe Middle East'], ['International  collaboration', 'particularly  Asia'], ['Molecular biology', 'cited carbapenem resistance'], ['bibliometric  study', 'future carbapenem resistance'], ['objective', 'clinical K2 isolate'], ['virulence', 'vivo methods'], ['molecular biology methods', 'genomic carbapenem K'], ['', ''], ['Strain', 'positive kfu phenotype'], ['transmissible carbapenemase which', 'close  India'], ['Genetic  context', 'various Enterobacteriaceae China'], ['combination', 'higher virulence K'], ['', ''], ['', 'virulent metallo beta -lactamase'], ['', 'producing pneumoniae K'], ['pneumoniae', ''], ['study', 'phenotypic  K'], ['', 'high carbapenem virulence'], ['findings', 'like virulent K'], ['pneumoniae', ''], ['Infections', 'continuously health institution'], ['MDR which', 'sensitive treatment strains'], ['We', 'eastern  Malaysia'], ['Medical Microbiology Universiti Sains which', '700 teaching beds'], ['hospital', 'medical  conditions'], ['Suspected  CRE', 'standard  protocols'], ['assay', 'genotype'], ['8306  Enterobacteriaceae', 'clinical study period'], ['74  %', ''], ['Majority', 'isolated  CRE'], ['5 Klebsiella pneumoniae', '5  which'], ['CRE', 'rectal  swab'], ['', ''], ['', ''], ['', ''], ['1  %', 'tracheal'], ['One hundred thirty isolates', 'genotype determination'], ['', ''], ['4  %', '1 beta gene'], ['high  numbers', 'especially rectal swabs'], ['Active screening results', 'low resource settings'], ['physicochemical  properties', 'microbial fuel cells'], ['work carbon anode', 'functional sodium groups'], ['influence', 'electrochemical power MFCs'], ['anode pretreatments', 'pyridinic pyrrolic anode'], ['spectroscopy', 'electrochemical anode pretreatments'], ['26 chamber isopropanol', 'anode'], ['Additional  treatment', 'maximum power 844'], ['inverse liner relationship', 'functional electricity anodes'], ['Results', 'future anode studies'], ['', ''], ['China', 'largest carbon dioxide'], ['Considered', 'agricultural agriculture sector'], ['It', 'driving carbon dioxide sector'], ['local parameter which', 'spatial  systems'], ['Geographically  regression', 'point regression point'], ['weighted regression model', 'paper'], ['economic  growth', 'central  regions'], ['Urbanization', 'opposite effects pattern'], ['Energy intensity', 'central  regions'], ['Therefore  policymakers', 'spatial emission reduction policies'], ['vibrant worlds population democracy', 'profound  transformation'], ['however  it', 'also energy crisis'], ['Urbanization', 'Carbon Dioxide Carbon emissions'], ['paper', 'dynamic urbanization energy consumption'], ['study', 'urban census 1901'], ['rise', 'rapid energy urbanization'], ['that', 'residential quota management buildings'], ['Reduction', 'smart  grids'], ['Power  concepts', 'sustainable energy system'], ['that', 'such value traffic'], ['enabling energy which', 'additionally carbon cycles'], ['Here  we', 'high  electrolysis'], ['Advances', 'further performance electrolysis'], ['how precipitation events', 'multiple greenhouse gases'], ['Intact soil mesocosms', '10 piedmont Maryland'], ['', ''], ['wetland creek bank', 'controlled forcing temperature'], ['Automated  measurements', 'porewater chemistry analyses'], ['', ''], ['', 'microbial community structure'], ['Automated  measurements', 'pulse Forest events'], ['highest Forest soils', 'highest N2O experiment'], ['Creek soil', 'global warming potential'], ['', ''], ['Forest soils', '100-year  53'], ['', 'large N2O emissions'], ['results', 'wet soil GHGs fluxes'], ['Finally  study', 'biogeochemical ecosystem extremes'], ['much  luminescence', 'solid  state'], ['based  phosphors', ''], ['CDot@NaCl composite CDot@NaCl phosphors', 'emissive NaCl crystals'], ['composite g phosphors', 'organic  solvents'], ['5478 CIE coordinates', 'composite g phosphors'], ['', ''], ['rights', ''], ['comprehensive carbon footprint model', 'fossil fuel power plants'], ['effects', 'condition transmission ambient condition losses'], ['Investigating', 'proposed fuel power model'], ['sensitivity analysis', 'investigated  parameters'], ['electrical  that', '980 g CO2 equivalent'], ['Carbon footprint', 'main  fuel'], ['Other  factors', 'indicative  variation'], ['Fuel type', '28  %'], ['Ambient condition', 'result'], ['carbon footprint', '4  %'], ['', 'consumption  2'], ['', ''], ['low  humidity', 'low  lands'], ['possible  maintenance', ''], ['paper', 'compact Raychowdhury et al'], ['improvement', 'electronic drain access regions'], ['', ''], ['', 'electronic device channel'], ['', ''], ['compact noise that', 'circuit simulation purpose'], ['In', 'experimental simulation results'], ['Good agreement', 'large device biases'], ['Op Amp Op circuit', 'compact  model'], ['significant  degradation', 'large Op SB'], ['SB proprieties', 'CNT geometry'], ['', ''], ['suitable CNT that', 'suitable CNT diameters'], ['paper', 'SB field effect transistor'], ['compact noise sources', 'compact  shot'], ['operational Op Amp', 'conventional  CNTFET'], ['stationary  phases', 'peculiar  selectivity'], ['Herein  we', 'stationary anion exchange chromatography'], ['coated  particles', 'facile evaporation reduction method'], ['hydrophilic  particles', 'pellicular anion exchangers'], ['zeta potentials Fourier', 'infrared electron microscope'], ['capacities', 'graphene amount'], ['chromatographic  performance', 'organic acids carbohydrates'], ['Good  reproducibility', 'high chemical coating'], ['', 'C Elsevier B'], ['', ''], ['like  signaling', 'important  inflammation'], ['multiple  role', 'hepatocarcinogenesis'], ['study MyD88 expression', 'Western  blot'], ['relationships', 'MyD88 expression'], ['attenuated  expression', 'significantly B virus infection'], ['', ''], ['Western blot analysis', '28 gender disparity'], ['', ''], ['', 'cirrhotic  livers'], ['', ''], ['Low  expression', 'vascular  invasion'], ['', ''], ['attenuated  expression', 'tumor progression'], ['Gene polymorphisms', 'drugs'], ['', 'small Xinjiang Uygur population'], ['Material gene polymorphisms', 'fragment length polymorphism'], ['relationship', 'major outcome indicators'], ['median  PFS', 'advanced  NSCLC'], ['9  months', 'advanced Uygur NSCLC'], ['', ''], ['survival time', 'significantly AA gene'], ['survival time', 'significantly CC gene'], ['', ''], ['advanced Uygur who', 'based  chemotherapy'], ['Additionally  information', 'advanced Uygur NSCLC'], ['associated  fibroblasts', 'pivotal tumor cells'], ['', 'oncogenic  CAFs'], ['', 'microenvironmental liver metastases'], ['Tissue samples', 'colorectal liver study'], ['Histological  characterization', 'hybridization'], ['m RNA expression', 'northern alpha blotting'], ['expression', 'immunosorbent activator inhibitor assay'], ['normal liver samples', 'alpha SMA'], ['TNF tumor necrosis expression', 'TGF-1 alpha incubation'], ['derived growth factor', 'significant alpha SMA expression'], ['', ''], ['PAI-1 expression', 'TGF-1-treated  fibroblasts'], ['', ''], ['levels', 'healthy PAI-1 controls'], ['CAFs', 'PAI-1 CAFs'], ['opportunity', 'genomic cardiac era'], ['Numerous  methods', 'time reverse transcriptase PCR'], ['However  techniques', '10 expression time'], ['Today DNA microarrays', 'cardiovascular  diseases'], ['particular  tissue', 'genomic  profile'], ['Microarray techniques', 'therapeutic diseases drugs'], ['we', 'arrhythmogenic heart disease'], ['We', 'differential microarray analysis'], ['STZ)-diabetic  rats', '3  induction'], ['K ATP K channels', 'cardiac sarcolemmal membranes'], ['It', 'cardiac  contractility'], ['present  study', 'diabetic K ATP disorders'], ['30 glucose cells', 'cardiac K ATP channels'], ['cardiac tonic we', 'Western K ATP blot'], ['result', 'marked control group'], ['Furthermore  methods', 'Western K ATP channel'], ['', 'cardiac K ATP channel'], ['2', 'high rat cardiac myocytes'], ['Correction', 'diabetic cardiac K rats'], ['Conclusions', '8 K ATP weeks'], ['phenomenon', 'ATP channel drugs'], ['systolic heart pathogenesis', 'HFpEF'], ['myocardial heart role', 'HFpEF'], ['', 'technique rat myocardiocytes'], ['miR-21  expression', 'cardiac  myocardiocytes'], ['We', 'pathological rat HFpEF examination'], ['operated model rats', 'cardiac  atrophy'], ['cardiac  atrophy', 'miR-21  antagonist'], ['Both', 'over Bcl-2 expression'], ['miR-21', 'cardiac  fibrosis'], ['microRNAs', 'cardiac  hypertrophy'], ['expression', 'cardiac  hypertrophy'], ['endogenous  levels', 'real miRNA vivo'], ['We', 'cardiac miR-22 hypertrophy'], ['', 'CMV reporter system'], ['CMV firefly luciferase', 'positive miR-22 expression'], ['cardiac cardiomyocyte hypertrophy', 'isoproterenol PCR'], ['reporter imaging system', 'in  vivo'], ['bioluminescence signals', 'gradually isoproterenol vivo'], ['Overexpression', 'markedly  miR-22'], ['Furthermore knockdown', 'repressed Gluc vivo'], ['However Fluc activity', 'CMV isoproterenol treatment'], ['study', 'cardiac expression vivo'], ['Direct  reprogramming', 'injured  myocardium'], ['4 miR-1 miR-133 we', 'miR combo'], ['cardiac miR reprogramming', 'miR combo'], ['miR combo', 'epigenetic  mechanism'], ['epigenetic  that', 'treated  fibroblasts'], ['global H3K27me3 levels', 'miR combo treatment'], ['particular promoter region', 'quantitative polymerase chain reaction'], ['Polycomb Repressive Complex', 'miR combo treatment'], ['knockdown', 'treated gene fibroblasts'], ['repressive  H3K27me3', 'miR  combo'], ['data', 'also cell fate technique'], ['10  which', 'biological  research'], ['brightest  side', 'microbial ion channels'], ['Neuroscience', 'intact  organisms'], ['', 'neuronal subpopulations circuits'], ['some', 'cardiovascular  physiology'], ['we', 'excitable  cells'], ['present  we', 'underlying cell arrhythmias'], ['molecular  biology', 'cardiac  physiology'], ['Finally  we', 'heart rhythm disturbances'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['aim', 'usual rehabilitation program care'], ['study', '100  patients'], ['intervention group patients', '8 rehabilitation program weeks'], ['session', 'exercise training education'], ['Data', 'designed case report form'], ['Data', 'descriptive  tests'], ['sample', 'participants'], ['', 'cardiac rehabilitation group'], ['', 'between device malfunction'], ['', 'cardioverter type cardiac defibrillators'], ['Cardiac  rehabilitation', 'cardioverter rhythm management defibrillators'], ['clinical nurse specialists', 'physical rhythm device complications'], ['cardiac  pacemakers', 'cardiovascular  diseases'], ['magnetic coupling it', 'uninterruptedly  pacemakers'], ['WPT system', 'low  efficiency'], ['', 'theoretically WPT paper'], ['induced  which', 'experiments'], ['minimum  distance', 'induced pacemaker voltage'], ['that', 'power 5'], ['66 V/300 kHz', 'successfully Lithium ion 3'], ['', 'residual  4'], ['', '30  0'], ['15 mm thickness', '4  mm'], ['SAR  rise', 'tissues'], ['', ''], ['', ''], ['', 'C'], ['results', 'wireless charging system'], ['', 'dilated animal cardiomyopathy'], ['transgenic  plasmid', 'cTnT(R141W alpha MHC promoter'], ['expression level', 'Northern  blotting'], ['Pathologic  changes', 'electronic light echocardiography'], ['localization', 'mutant human cTnT immunohistochemistry'], ['hypertrophy markers', 'RT PCR'], ['Transgenic  mice', 'cTnT(R141W  mutation'], ['cTnT(R141W', '1'], ['', '2'], ['that', 'endogenous cTnT sarcomere'], ['transgenic  heart', 'ventricular  wall'], ['Interstitial  fibrosis', 'transgenic heart tissue'], ['function', 'ventricular  wall'], ['4  months', 'age'], ['', '8  mice'], ['increased NPPB ACTA1', 'transgenic  heart'], ['transgenic  mouse', 'human animal DCM'], ['', 'C Elsevier Ireland Ltd'], ['Mammalian  heart', 'regenerative  capacity'], ['cardiac', 'mechanical  stress'], ['Pressure  overload', 'hypertrophic  cardiomyocytes'], ['cardiac  hypertrophy', 'cardiac  hypertrophy'], ['novel  that', 'cardiac  hypertrophy'], ['Here  we', 'novel identification protein'], ['CIP', 'mouse embryonic mouse hearts'], ['CIP', 'recognizable  motifs'], ['hybridization gene CIP', 'highly  cardiomyocytes'], ['hybrid  screening', 'second heart CIP'], ['two  which', 'interaction'], ['CIP', 'transcriptional enhancer factor 2C'], ['expression', 'hypertrophic  cardiomyocytes'], ['', 'induced cardiomyocyte hypertrophy'], ['studies', 'cardiac  hypertrophy'], ['', ''], ['', ''], ['', ''], ['vasoconstrictor peptide', 'structural  characteristics'], ['intracellular calcium ETA receptor', 'unexpected  finding'], ['Database mining', 'ETR endothelin fugu'], ['branchial ETR subtype', 'Ca2  transit'], ['Immunohistochemistry', 'pillar cell'], ['results', 'coordinated membrane flexibility'], ['', ''], ['rights', ''], ['Endomyocardial  biopsy', 'cardiac catheter diseases'], ['It', '1960  Drs'], ['', 'Medical University'], ['myocarditis  which', 'often  modality'], ['', 'rejection'], ['', 'important heart failure heart'], ['molecular biology technology', 'detailed  information'], ['invasive  that', 'cardiac catheterization complications'], ['one', 'pathological  conditions'], ['We', 'young  pathology'], ['', 'cardiovascular HIV-1 infection'], ['MicroRNAs', 'inflammation'], ['HIV-1-infected  we', 'known CVD inflammation'], ['screening  cohort', 'peripheral blood mononuclear cells'], ['regulated  miRNAs', 'HIV-1-infected polymerase chain individuals'], ['Validated miRNAs', 'PBMCs CD4 +'], ['fasting  associations', 'multiple linear regression analysis'], ['Upregulation', 'uninfected miR-210 controls'], ['', ''], ['contrast miR-210', 'CD8(+'], ['T cells', 'negatively  LPS'], ['', ''], ['', 'positively necrosis factor alpha'], ['', ''], ['MiR-7', 'interleukin-6  ='], ['', 'glucose'], ['miR-331', 'negatively  LPS'], ['', ''], ['G miR-7 miR-29a miR-221', 'low  cytomegalovirus'], ['independent miR-210 miR-7', 'systemic  inflammation'], ['', 'cardiovascular disease phenotypes'], ['Previous  studies', 'small cardiovascular patients'], ['human  studies', 'novel RNAs'], ['We', '471 polymerase chain RNAs'], ['reverse polymerase chain reaction', 'additional FHS RNAs'], ['7 disease risk RNAs', 'stroke prevalent'], ['RNA  associations', 'prevalent'], ['This', 'small noncoding miRNAs'], ['observational extracellular miRNAs', 'stroke risk'], ['physicochemical  size', 'indoor particulate classrooms'], ['comparative hazard profiling', 'endothelial  cells'], ['high content disruption', 'fluorescence assay'], ['Scanning electron microscopy', 'different energy origins'], ['indoor endotoxin content', 'indoor  PM'], ['', ''], ['', 'indoor endotoxin PM8'], ['', ''], ['ability', 'indoor cell corridor'], ['indoor  PM', 'higher endotoxin content'], ['', ''], ['link parent child', 'young  subject'], ['when  adult', 'psychiatric  disorders'], ['article', 'psychiatric  child'], ['', ''], ['authors', 'ill team children'], ['We', 'multidisciplinary  evaluation'], ['We', 'therapeutic adult patients'], ['', ''], ['simplistic  which', 'ill  treatment'], ['', ''], ['one  what', 'other  hand'], ['stumbling  which', 'purpose'], ['', ''], ['clinical  experience', 'other  hand'], ['', ''], ['rights', ''], ['Anxiety', 'somatic postpartum health'], ['also health who', 'postpartum mental health issues'], ['mental health support', 'perinatal National anxiety'], ['study', 'available postpartum care'], ['structured  interviews', '13  May'], ['Participants', 'Skype'], ['Using', 'current service provision'], ['related healthcare which', 'heavy  workload'], ['current postpartum lack', 'mental health HVs'], ['HVs', 'specifically health anxiety'], ['study', 'specialist mental postpartum anxiety'], ['objectives', 'illness coherence'], ['Illness perceptions', 'Illness Perception Questionnaire'], ['We', 'coherence anxiety'], ['coherence factors responses', 'independently  coherence'], ['Results', 'dementia caregiving'], ['two  who', 'same  one'], ['one peer adult', 'laughing  adult'], ['Thus  infants', 'social  structures'], ['', ''], ['', ''], ['rights', ''], ['we', 'late trip arrival'], ['headway electricity cost', 'headway trip origin'], ['', ''], ['', ''], ['rights', ''], ['study', 'use'], ['', ''], ['aim', '3 % papain mice'], ['', ''], ['2  mice', '3 placebo gel'], ['Skin incisions', 'cutting blade edge'], ['lesion samples', '3  lesion'], ['lesion samples', '3  dye'], ['PCR polymerase chain protocol', 'samples'], ['', ''], ['treated  group', 'less  control'], ['lower  numbers', 'collagen  fibers'], ['treated PCR group', 'significant growth control'], ['', ''], ['', ''], ['3 % gel', 'cutaneous wound mice'], ['CarNAC3', '285 amino acids'], ['NAC genes', 'largest transcription factor plants'], ['member', 'abiotic plant stresses'], ['poplar  Populus', 'x P'], ['euramericana  Nanlin895', 'Agrobacterium tumefaciens'], ['PCR analysis', 'introduced target genome'], ['transformation', 'transgene copy number'], ['Fourteen  lines', 'drought  tolerances'], ['rooting growth those', 'wild type plants'], ['conditions CarNAC3 expression', 'proline antioxidant enzyme activities'], ['Furthermore  expression', 'wild type control'], ['CarNAC3  transgene', 'transgenic poplar plants'], ['Phase noise correction', 'high data rate communications'], ['OFDM channel estimation', 'continuing phase noise efforts'], ['Existing  methods', 'computational phase complexity'], ['existing frequency domain which', 'efficient majorization minimization technique'], ['respectively dimensionality that', 'computational estimation cost'], ['numerical  examples', 'large phase SNRs'], ['Adoptive  transfer', 'specific T cancer'], ['technology', 'vitro  preparation'], ['it', 'well immunity cytotoxicity'], ['stable tumor that', 'targeting T cell receptors'], ['genetic T that', 'chimeric antigen specificity'], ['CAR T cells', 'cancer treatment'], ['However  they', 'solid  malignancies'], ['toxicity', 'serious CAR therapy'], ['present CAR therapy', 'four  generations'], ['review', 'thus CAR T cells'], ['design construction', 'thermoacoustic  paper'], ['system', 'remote energy areas'], ['cost system air', 'conventional polyvinyl chloride'], ['Such  device', 'traveling wave series'], ['straight line series Gedeon', 'efficient energy conversion'], ['system', '57  Hz'], ['measured  results', 'predicted  results'], ['acoustic  which', '17 Carnot efficiency'], ['prime', 'thermoacoustic  refrigerator'], ['single bridge PV inverter', 'paper'], ['common mode loop model', 'phase cascaded bridge PV system'], ['that', 'leakage current'], ['H bridge inverter', 'current'], ['stray capacitor voltage', 'high frequency components'], ['current', 'way'], ['Finally  prototype', 'digital  control'], ['proposed H topologies', 'cascaded H bridge'], ['experimental  results', 'proposed  solution'], ['connected generation which', 'total harmonics distortion'], ['bidirectional power switch', 'cascaded CMI mode'], ['topology modes', 'MCM GCI'], ['when output voltage', 'HBI mode'], ['connected  inverters', 'advantages'], ['topology transformation ability', 'higher generation system'], ['Colorectal cancer', 'common  cancers'], ['other cancer involvement', 'reported HPV CRCs'], ['', 'large case control study'], ['CRC specimens', 'tumor'], ['samples', 'sigmoid diverticulosis resections'], ['Detection', 'real polymerase chain reaction'], ['Ten  percent', 'INNO LiPA technique'], ['467  samples', 'healthy tissue samples'], ['HPV16', 'viral tumor quantification'], ['New extraction', 'same tumor HPV'], ['reliable  HPV', 'more case control CRCs'], ['', ''], ['', ''], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['clinical  presentation', 'mycoplasma pneumoniae pneumonia'], ['Genetic  variability', 'also host MPP'], ['however  results', 'nucleotide  CAP'], ['Here  we', 'specific polymerase chain reaction'], ['gene gene interactions', 'Multifactor Dimensionality Reduction'], ['significantly NOS3 differences', 'Ins CYP1A1 groups'], ['ACE NOS3 rs1799983 T', 'Chinese  children'], ['antiviral milk that', 'immunostimulatory  effects'], ['present  we', 'such casein phosphopeptide'], ['RESULTSWe', 'different phosphate group'], ['dry sodium dephosphorylation', 'alkaline  phosphatase'], ['feline kidney cells', 'target virus'], ['Antiviral  activity', 'antiviral chain reaction cytokine'], ['Higher cell viability', 'native CPP III'], ['However  dephosphorylation', 'FCV CPP effect'], ['CONCLUSIONThe CPP effect', 'conversely  elimination'], ['Therefore CPP III phosphorylation', 'antiviral food agents'], ['', '2016 Chemical Industry'], ['small Louise which', 'original  homeland'], ['', 'valuable  horse'], ['marginal Caspian tissue', 'primary explant technique'], ['growth curve', ''], ['', 'population'], ['', 'cell lines'], ['cell lines', 'other  species'], ['Bacteria fungi', 'direct mycoplasma culture'], ['established cell lines', 'genetic  resources'], ['It', 'accessible  researchers'], ['scientific  community', 'relatively cat behavior'], ['however  role', 'social chemical relationships'], ['chemical signals', 'mother offspring mother environment'], ['stress  cats', 'environment'], ['cat humans', 'applied  settings'], ['social chemical information', 'human cat bond'], ['', ''], ['', ''], ['rights', ''], ['', 'reactive oxygen species'], ['scavenging hydrogen enzyme', 'important  plants'], ['abiotic plant we', 'treated catalase library'], ['cDNA', '1 479 1 bp'], ['deduced amino acid sequence', '87 % maize'], ['Northern blotting analysis', 'FaCat1  roots'], ['', 'Time course F'], ['FaCat1  expression', 'cold  stress'], ['FaCat1 abscisic gene', 'high ABA F'], ['arundinacea', ''], ['pain', 'gynecologic pain origin'], ['', 'obstetrics pain clinic'], ['daily activity pain', 'sexual  abuse'], ['intensity pain interference', 'significant  association'], ['Multiple regression analysis', 'significantly outcome measures'], ['depressive  symptoms', 'significantly pain interference'], ['who', 'severe pain catastrophizing'], ['Pain catastrophizing', 'pelvic pain pain'], ['additional risk pain', 'further pain morbidity'], ['MHC histocompatibility I', 'antigenic cytotoxic T cells'], ['immune MHC molecules', 'several  mechanisms'], ['generally  I', 'generally  MHC'], ['exogenous cell I', 'immune  cells'], ['I molecules', 'wild type counterparts'], ['novel THP-1 CatG', 'intercellular  cells'], ['pivotal checkpoint which', 'intracellular MHC I'], ['brief  comment', 'sexual Ballarat Victoria abuse'], ['criminal  that', 'further Catholic context'], ['Cationic copolymer emulsions', 'continuous emulsion polymerization'], ['properties', 'synthesized monomer conversion'], ['film performance', 'electricity microscopy'], ['K S values', 'dyed cotton fabrics'], ['St BA emulsion', 'St BA emulsion'], ['BA AA emulsion film', 'better  P'], ['addition', 'film performance'], ['acetic acid solution treatment', 'best water resistance'], ['GMA BA emulsion', 'better pigment dyeing P'], ['addition', 'cationic cotton binders'], ['rubbing dye fastness', 'dye fabrics'], ['handle', 'still use consumers'], ['', ''], ['control', 'cattle discomfort'], ['However acaricides that', 'chemical animals'], ['scenario', 'therapeutic cattle tick control'], ['objectives', 'R'], ['', '5 % R'], ['', 'infested  calves'], ['old Holstein calves', 'six  animals'], ['2 control animals', '1  R'], ['microplus biotherapic', 'dilution'], ['3  they', 'pour  formulation'], ['5  %', 'biotherapy'], ['', ''], ['biotherapic', '45'], ['', '86 % eugenol'], ['', '37  treatment'], ['ultrastructural  study', 'R'], ['', 'engorged oocyte exochorion'], ['results', 'larvae R'], ['', 'friendly microplus R'], ['', 'biotherapic'], ['full length cDNA', 'Egyptian Boophilus annulatus'], ['Antibodies', 'B'], ['annulatus larval proteins', 'cDNA expression library'], ['cloned  fragment', '171 amino acids'], ['deduced protein data sequence', 'hard tick Haemaphysalis qinghaiensis'], ['', 'Southern blot B'], ['cloned restriction cDNA', 'double restriction digest'], ['11 N terminal molecule', 'transduction gene expression pathways'], ['RT PCR', 'old Ba05 eggs'], ['cloned  gene', 'signal denaturation conditions'], ['purified  protein', 'molecular % SDS 22'], ['', '8 histidine vector'], ['Antibodies', 'purified  B'], ['annulatus homologue', 'whole tick larvae'], ['Immunoblotting', 'whole gut protein extract'], ['same  homologues', 'other Hyalomma dromedarii'], ['', 'Ornithodoros moubata'], ['', ''], ['', ''], ['rights', ''], ['objective', 'high conversion efficiency phenotypes'], ['study', 'high Holstein 8)'], ['commercial  vaccine', 'immune  responsiveness'], ['Stress responsiveness', 'plasma cortisol yarding'], ['significant  differences', 'high conversion efficiency phenotypes'], ['', ''], ['', ''], ['plasma cortisol concentrations', 'high conversion efficiency counterparts'], ['', ''], ['negative  correlation', 'immune  responsiveness'], ['', ''], ['', 'immune  responsiveness'], ['', ''], ['', ''], ['preliminary  cows', 'coping feed conversion abilities'], ['association', 'respiratory disease complex'], ['respiratory  tract', 'opportunistic  pathogens'], ['excessive tissue that', 'BRDC'], ['Neutrophilia', 'endothelial neutrophil apoptosis'], ['Several', 'important neutrophil margination'], ['dystonic  rat', 'generalized SD dystonia'], ['dt rat', 'prior Postnatal Day'], ['dt locus', '4'], ['candidate genes', 'quantitative RT PCR'], ['intracisternal Intron which', 'caytaxin'], ['real time RT PCR', 'dt  rats'], ['developmental  expression', 'situ QRT hybridization'], ['none', 'liver muscle kidney'], ['three time transcripts', 'Embryonic Day'], ['relative  proportion', 'smallest  transcript'], ['QRT PCR', 'cerebral striatum thalamus hippocampus'], ['Transcript  levels', 'cerebral  cortex'], ['Radioactive', 'neuronal Atcay brain'], ['transcript  density', 'molecular  P14'], ['dt  data', 'cerebellar  cortex'], ['', ''], ['', ''], ['rights', ''], ['therapist perfectionism', 'potentially client recovery'], ['Little', 'therapist perfectionism'], ['', 'drop perfectionism client treatment'], ['self report these', 'clinical  clients'], ['therapist perfectionism', ''], ['Overall  number', 'negative therapist perfectionism'], ['', ''], ['', 'high client treatment'], ['further  investigation', 'clinical  practice'], ['Eotaxin  CCL11', 'important  asthma'], ['It', 'hematopoietic chemokine lung'], ['', 'thereby CCL11 airway'], ['CCR3 expression', 'human lung tissue'], ['tritiated', 'proline  incorporation'], ['contribution', 'also lung experiments'], ['CCR3', 'human lung tissue'], ['Eotaxin  CCL11', 'collagen gel TGF release'], ['nonspecific lung effect', 'CCR3-neutralizing  antibodies'], ['eotaxin  CCL11', 'asthma'], ['Background', 'innate gingival immunity'], ['expression', 'differentiation stage'], ['present calprotectin that', 'differentiation'], ['retinoic which', 'differentiation'], ['S100A8 A9 production', 'northern gingival blotting'], ['C transcription factor', 'electrophoretic mobility shift assay'], ['S100A8 A9 production', 'TGF beta'], ['A9  which', 'interleukin-1 alpha'], ['binding EBP activity', 'human TGF beta'], ['C EBP alpha', 'calprotectin keratinocytes'], ['DREB transcription factors', 'abiotic  stress'], ['SlDREB1 transcription factor', 'one hybrid system'], ['SlDREB1', '6 tomato genome'], ['SlDREB1 protein', 'cell nucleus'], ['physiological SlDREB1 we', 'vitro stress experiments'], ['accumulation', 'strongly drought salt'], ['SlDREB1 protein', 'transgenic  Arabidopsis'], ['transgenic  Arabidopsis', 'obvious drought stress'], ['free SlDREB1 overexpression', 'physiological drought stress'], ['also tomato SlDREB1', 'transgenic DRE stress'], ['however psychotherapy strength', 'therapy processes'], ['', ''], ['process outcome relationships', 'patient  characteristics'], ['patient response patterns', 'active  treatment'], ['one  individual', 'more  PRP'], ['hypothesis  PRPs', 'prognostic  indicators'], ['Medium prognosis groups', 'easy process outcome like'], ['190  individuals', 'computerized  CBT'], ['They', ''], ['', ''], ['Engagement', 'cCBT program'], ['PRPs', 'prognostic regression model'], ['Outcomes', '12 BDI months'], ['engagement outcome relationship', 'group'], ['Engagement outcome correlations', 'easy  r'], ['', ''], ['', ''], ['', 'r'], ['', ''], ['', ''], ['like  group', 'only engagement outcome relationship'], ['Results', '6  12'], ['', 'prognosis moderation hypothesis'], ['pliant  group', 'most treatment procedures'], ['Future research', 'PRPs'], ['immense  work', 'passive frequency sinusoidal components'], ['CCCII', 'single Feedback Operational Amplifier'], ['frequency', 'external bias current'], ['performance', 'ICs AD844 ICs CFOA'], ['topology', 'monolithic IC fabrication'], ['CCHP  system', 'small scale power utilities'], ['which', 'cooling source heat load'], ['basic  following', 'Sino Singapore eco city'], ['', 'eff carbon strategy'], ['well PEC ATC', 'all electricity tariff'], ['performances', 'Max eff strategy'], ['Otherwise  application', 'FEL'], ['results', 'electricity  price'], ['', ''], ['rights', ''], ['paper', 'grounded waveform tuning'], ['It', 'better voltage op linearity'], ['passive  components', 'grounded capacitor interest'], ['degrees C', '+150'], ['comparison', 'proposed candidate aspects'], ['digital tuning control', 'tuning components'], ['', ''], ['expression', 'western B pathway blotting'], ['CCL2 expression', 'northern  blotting'], ['Interaction', 'electrophoretic mobility shift assay'], ['osteoblastic  expression', 'radiographic  examinations'], ['', ''], ['EGCG', 'human Cyr61 osteoblasts'], ['rictor Akt EGCG', 'action'], ['kappa B DNA binding', 'possibly nucleus p65'], ['Cyr61', 'induced  CCL2'], ['Moreover  EGCG', 'partially Cyr61 induction'], ['osteoblasts', 'osteolytic CIA model'], ['administration', 'markedly CIA macrophage osteoblasts'], ['', ''], ['Akt kappa B EGCG', 'osteoblastic macrophage chemotaxis'], ['data', 'therapeutic  arthritis'], ['study', 'recruitment percentage andwithout polyphenol'], ['untrained Thirty men', 'three  groups'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Blood samples', 'PPB postresistance CON'], ['Fine needle biopsies', 'PRE 1H 5H'], ['IL-8 granulocyte macrophage colony', 'multiplex GM assays'], ['Changes', 'circulating flow cytometry'], ['Intramuscular', 'significantly 1H 5H'], ['', ''], ['Area', 'intramuscular curve PPB'], ['', ''], ['', 'G IP'], ['', ''], ['', ''], ['GM CSF', 'IP'], ['', ''], ['', ''], ['Relative number', '1H'], ['', ''], ['', ''], ['', ''], ['', 'PPB'], ['groups expression', 'IP'], ['', ''], ['', ''], ['Results', 'intense resistance exercise'], ['Polyphenol supplementation', 'peripheral resistance exercise'], ['immune cell communication', 'immunological surface synapses'], ['', 'Immunology Gardell'], ['', ''], ['', ''], ['', 'dependent CD40L transfer'], ['transfer process', ''], ['CD40 expression', 'also Th1 cell'], ['possible B cells', 'help'], ['Abnormal  expression', 'axillary angiogenesis cancer progression'], ['We', 'reverse reaction gene sequencing'], ['histopathological TNM difference', 'histopathological TNM tumors'], ['', ''], ['overall  survival', 'high CD44st expression group'], ['', ''], ['', ''], ['low expression it', 'low expression group'], ['', ''], ['', ''], ['', ''], ['', ''], ['median  OS', 'MMP-2 expression group'], ['', ''], ['', ''], ['low expression it', 'low expression group'], ['06  months', ''], ['', ''], ['', ''], ['', ''], ['rates', 'closely TNM prognoses'], ['', ''], ['', ''], ['circulating  that', 'immune phase pathologies'], ['instead T cell it', 'tolerogenic  cells'], ['AAT', 'autoimmune NK cell activities'], ['associated  it', 'permissive  AAT'], ['Here AAT treatment', 'development metastatic tumor development spread'], ['Systemic AAT treatment', 'significant tumor growth'], ['AAT', 'dependent tumor manner'], ['cellular  we', 'treated T mice'], ['chemical  we', 'nitrogen oxygen species'], ['Indeed  macrophages', 'soon ischemia reperfusion challenge'], ['specific  changes', 'antigenic tumor targets'], ['elevated  levels', 'immune  responses'], ['mainly J Endocrinol', '33'], ['Background', 'major tumour therapy'], ['However  strategies', 'TICs'], ['Recent  studies', 'epithelial mesenchymal transition'], ['However  role', 'TICs'], ['Expression', 'human tissue microarray'], ['pharmacologic Cdk5 overexpression inhibition', 'small tumour vivo'], ['molecular biology methods', 'mechanistic  studies'], ['here  we', 'reduced tumour vivo'], ['tumorsphere which', 'human breast cancer TMA'], ['transcription factor which', 'apoptotic  protein'], ['study', 'potential cell TICs'], ['CDKs  family', 'signaling gene expression pathways'], ['However  effect', 'LSCC cell cells'], ['present  we', '60 LSCC patients'], ['Then  we', 'clinicopathological  features'], ['normal LSCC overexpression', 'lymph node metastasis'], ['high expression levels', 'short OS survival'], ['', 'interfering  vitro'], ['Wnt  CDK8', 'beta Wnt'], ['first  CDK8', 'prognostic LSCC patients'], ['phenolic phenylpropanoid which', 'medicinal  Danshen'], ['rapid sequence data', 'accession numbers'], ['Either', 'recombinant kinetic proteins'], ['substrate utilization profile', 'Sm4CL2'], ['K(m  values', '4-coumaric acid'], ['', ''], ['', ''], ['', ''], ['', ''], ['phenolic  Sm4CL1', 'minor  pathway'], ['Sm4CL1  genes', 'different  genome'], ['cut papaya fruit', 'rapid tissue storage'], ['comparative gene expression study', 'mRNA display RT PCR'], ['Differential display analysis', 'oligo degrees dT'], ['Confirmation', 'northern  blotting'], ['differentially  ranging', '777 GenBank sequences'], ['significant cell wall enzymes', 'plant defense responses'], ['partial  most', '8 days storage'], ['transcripts', 'northern PA19 blots'], ['fresh cut processing', 'global stress responses'], ['', ''], ['', ''], ['rights', ''], ['cDNA', 'Perinereis aibuhitensis Grube'], ['protein', 'serine Heterodera glycines'], ['cDNA', 'marine  earthworm'], ['cDNA', 'expression vector'], ['BL21(DE3 Escherichia overexpression', 'D thiogalactopyranoside induction'], ['fusion protein', 'Sepharose 4B diethylaminoethyl Sepharose column'], ['Rabbits', 'purified  protein'], ['antibody', 'Western blotting analysis'], ['recombinant  it', 'recombinant  PPA'], ['which', 'enteroendocrine Paneth intestine'], ['which', 'epithelial  cells'], ['Therefore  we', 'epithelial  cells'], ['Math1  expressions', 'blotting luciferase reporter assays'], ['expressing  Cdx2', 'intestinal  humans'], ['transgenic mouse they', 'gastric  humans'], ['derived cell line IEC-6', 'intestinal metaplastic mucosa'], ['Furthermore expression', 'Math1 enhancer'], ['Cdx2', 'epithelial Math1 cells'], ['cecropinA  that', 'human  cells'], ['mechanism', 'hybrid  peptides'], ['Herein  we', 'resistant Staphylococcus aureus'], ['minimum inhibitory concentration', ''], ['hybrid  peptides', 'MRSA'], ['hybrid  peptides', 'dye liposomes'], ['hybrid  peptides', 'outer plasma MRSA'], ['concentration', 'K+'], ['bacterial dye propidium iodide', 'cytoplasm'], ['antibacterial  peptide', 'MRSA'], ['', 'International Union International Biochemistry'], ['', ''], ['Squamous cell carcinoma', 'common cancer types'], ['It', 'tobacco  consumption'], ['Treatment options', 'typically cancer type'], ['biological  that', 'therapeutic cancer treatment'], ['genera  Celastraceae', 'context'], ['studies', 'cancer date'], ['results', 'molecular cell level'], ['Celiac disease', 'undigested gliadin peptides'], ['immune  that', 'intestinal  mucosa'], ['MCs', 'functional  studies'], ['We', 'CD'], ['biopsy  specimens', 'leukocyte infiltration'], ['Moreover MC reactivity', 'vitro  assays'], ['mucosal numbers', 'higher Marsh scores'], ['MCs', 'nonimmunodominant proinflammatory mediators'], ['Immunohistochemical  characterization', 'advanced proinflammatory MC disease'], ['This', 'increased tissue damage'], ['progressive  MCs', 'inflammatory  process'], ['contribution', 'therapeutic  approaches'], ['AimTo', 'human dental pulp cells'], ['MethodologyThe effect', '5 diphenyltetrazolium bromide'], ['expression', 'reverse polymerase chain reaction'], ['B transcription factors', 'Western blot analysis'], ['Statistical  analysis', 'variance'], ['', 'different ResultsThe E'], ['', ''], ['gingivalis LPS', 'significantly control cells'], ['', ''], ['LPS', 'significantly  P<0'], ['', ''], ['vascular cell adhesion', ''], ['', ''], ['', 'HDPCs'], ['Treatment', 'IL-6  VCAM-1'], ['', ''], ['Treatment', 'significantly  nucleus'], ['', ''], ['ConclusionsSimvastatin', 'inflammatory B transcription HDPCs'], ['Therefore  simvastatin', 'vital pulp therapy'], ['Pulmonary monocyte infiltration', 'common bile duct ligation'], ['also  origins', 'also  CBDL'], ['major  that', 'injured  tissues'], ['monocyte CBDL', 'monocyte alterations'], ['study', 'experimental monocyte HPS'], ['Splenectomy', 'CBDL  animals'], ['Monocyte levels', 'different  CD68'], ['Pulmonary  alterations', 'endothelial growth factor'], ['red  bile', 'proliferation'], ['Monocyte levels', 'circulating monocyte numbers'], ['Splenectomy', 'AaPO(2 CBDL animal levels'], ['hepatic monocyte levels fibrosis', 'further spleen removal'], ['CBDL lung monocyte removal', 'experimental  HPS'], ['Liver monocytes', 'splenic reservoir monocytes'], ['specific monocyte alterations', 'pulmonary liver disease'], ['fibronectin', 'vitro stimulates osteoblast vivo'], ['molecular F20 stimulates osteogenesis', 'molecular  which'], ['molecular  mechanism', 'osteoblast differentiation'], ['role', 'mouse ST2 cell line'], ['effect', 'interfering RNA knockdown'], ['transcriptional polymerase chain activation', 'luciferase reporter assays'], ['ERK Extracellular phosphorylation', ''], ['bone morphogenic bone protein', 'activated protein pathways'], ['Furthermore Runx2', 'F20induced osteoblast differentiation'], ['similar osteoblast BMP2', 'pathway'], ['F20', 'periodontal tissue regeneration'], ['biological  that', 'single  organisms'], ['biochemistry  biology', 'multiple life scales'], ['Imaging methods', 'inner organelles organs'], ['us', 'essential  understanding'], ['imaging  that', 'biological  events'], ['We', 'resolution  imaging'], ['how  technologies', 'whole organism resolution'], ['state imaging that', 'life'], ['forming  grasses', 'natural  pollutants'], ['important  introduction', 'dramatically remediation potential'], ['Transfer', 'key salt marsh cordgrass'], ['', ''], ['large food which', 'relevant life support systems'], ['', 'Embryogenic S'], ['alterniflora', 'respectively Agrobacterium strains merA'], ['resistant  lines', ''], ['merB genes', 'PCR  blotting'], ['overall Agrobacterium frequency', 'transformation'], ['Northern  blotting', 'individual  transformants'], ['steady state RNA levels', 'phenotype'], ['500 mu line', 'phenylmercuric  acetate'], ['WT Wild callus', '225 mu mu'], ['key host cell that', 'persistence'], ['human immunodeficiency virus', 'human  decades'], ['recent  advances', 'key HIV-1 lifecycle'], ['resolution imaging techniques', 'viral cell cell transmission'], ['powerful  methods', 'cellular HIV-1 machinery'], ['Specific  advancements', 'dynamic virus host interactions'], ['novel imaging that', 'lifecycle HIV-1 lifecycle'], ['Growing  leaves', 'pronounced diel growth rhythms'], ['However  mechanisms', 'different diel growth species'], ['transcriptomes', 'expanded  Bartr'], ['', ''], ['', 'high  night'], ['Tissues', 'quantitative dicot leaf growth'], ['plants', 'previously leaf P'], ['deltoides', 'minimal base tip dusk'], ['nocturnal  decline', 'cytoplasmic ribosomal protein growth'], ['ribosomal protein gene', 'cellular carbohydrate concentrations'], ['Thus  we', 'temporal growth P'], ['cytoplasmic  activity', 'thereafter  species'], ['', ''], ['12  mutant', 'Pchlide  dark'], ['photosensitizer', 'oxygen production'], ['that', 'tig d'], ['', ''], ['polysome protein gel analyses', 'binding photosystem oxygen'], ['effects', 'photosynthetic translation 80S'], ['observed  changes', 'ribosomal protein S6'], ['later ribosome dissociation', 'later  stages'], ['Together  results', 'higher cell plants'], ['10(-7)-10(-9 Lys M', 'significantly growth tobacco'], ['Epitalon', 'particular plant regenerants'], ['it', 'character'], ['investigated  peptides', 'responsible tissue formation'], ['peptides', 'such topoisomerases nucleases'], ['', 'known peptide growth'], ['peptides', 'new plant growth regulators'], ['They', 'botany  plant'], ['Early growth response-1', 'nuclear cell proliferation'], ['Fibroblast growth factor-1', 'various cell types'], ['Expression', 'oral wound tissue'], ['However  little', 'oral fibroblast cells'], ['aim', 'periodontal ligament cells'], ['Periodontal ligament cells', '30 45 60'], ['proliferation', \"5-bromo-2'-deoxyuridine ligament incorporation\"], ['early response-1 protein', 'northern  blotting'], ['directly  increases', 'min growth factor-1 treatment'], ['Early growth response-1 protein', 'low fibroblast growth 1'], ['Peak expression', '60 growth response-1 min'], ['early response-1 protein', '60  min'], ['Early  growth', '30  min'], ['concentration', 'periodontal fibroblast growth factor-1'], ['rectifier I which', 'cardiac  repolarization'], ['sudden QT which', 'cardiac  ischemia'], ['Cardiac  ischemia', 'proteolytic activation enzymes'], ['I Kr channel', 'serine protease proteinase'], ['S5-pore linker', 'proteinase K cleavage'], ['cardiac  ischemia', 'several ERG calpain'], ['calpain-1', 'extracellular S5-pore linker'], ['site  we', 'S5-pore hERG'], ['Clarification', 'mediated hERG regulation'], ['Damage', 'associated QT prolongation'], ['', 'simple stem system'], ['Main  methods', 'defined insulin supplement'], ['We', 'associated genes expression'], ['Expression', 'real polymerase chain reaction'], ['Quantitative evaluation', 'CXCR4-expressed cell population'], ['Cell viability', 'double staining test'], ['', 'time DE manner'], ['Cell apoptosis', 'significantly WNT3A BMP4'], ['This', 'indirectly DE generation'], ['Therefore  cocktail', 'efficient activin A'], ['optimal condition', 'minimal viability variation'], ['', ''], ['rights', ''], ['', ''], ['nuclear  factor-4', 'hepatic differentiation cells'], ['We', 'fetal liver fibrosis'], ['', ''], ['Hepatic progenitor cells', 'embryonic  day'], ['fetal mouse livers', 'hematopoietic cell cells'], ['We', 'reverse polymerase chain reaction'], ['then recipient which', 'dimethylnitrosamine'], ['', ''], ['5  cells', 'peripheral  cytokeratin'], ['mediated HNF-4 gene transfer', 'HNF-4 apolipoprotein'], ['mice', 'longer control mice'], ['', ''], ['plasma levels', 'total control mice'], ['', ''], ['mediated HNF-4 transfection', 'hepatic parenchymal vitro'], ['cells', 'liver diseases'], ['Nutritional immunology immunometabolism', 'active  parasitology'], ['active  that', 'homeostasis'], ['numbers', 'inflammation'], ['variety', 'beneficial nematode glucose'], ['metabolic nematode which', 'developed health areas'], ['undeveloped  areas', 'parasitic  nematodes'], ['parasitic  nematodes', 'metabolic effects tissues'], ['that', 'glucose'], ['complicated signaling that', 'sexual pollen tube reproduction'], ['pollen tubes', 'vivo'], ['Nevertheless  it', 'most model plants'], ['pollinated vivo pollen which', 'protein  profiles'], ['', 'total pollen tubes'], ['cultured pollen tubes', 'made array chips'], ['Microarray analyses', 'present vivo pollen tubes'], ['Reverse', 'induced expression features'], ['where vivo pollen tubes', 'tightly  pollination'], ['most', 'several  families'], ['Transient assay', 'generative  cell'], ['small  peptides', 'great pollen tube interest'], ['we', 'swapping Cellular pedestrians'], ['neighboring  pedestrians', 'opposite pedestrian flow'], ['which', 'low density region'], ['fundamental  diagram', 'measured  data'], ['Then  model', 'intermediate flow states'], ['formation  congestions', 'irregular  manner'], ['swapping', 'vital  gridlock'], ['Furthermore  influence', 'corridor detail'], ['', ''], ['', ''], ['rights', ''], ['', 'important food quality'], ['Most  tests', 'conventional  methods'], ['', ''], ['however biosensor methods', 'field analysis'], ['', 'on chromatography methods testing'], ['we', 'three electrode system'], ['working  electrodes', 'poly cell adhesion'], ['SPEs', 'potentiostat  transducer'], ['Quantitative results', 'cellular pistachio AFB(1'], ['method', 'good  sensitivity'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['critical  that', 'smooth muscle cell'], ['dramatic  that', 'near rat term'], ['growing  objective', 'late  labor'], ['pregnant  we', 'FN time proteins'], ['we', 'M Itga5 mRNA levels'], ['Itga5 mRNA levels', 'empty gravid uterine horn'], ['', ''], ['Immunoblot analysis', 'higher FN protein gravidity'], ['', ''], ['Immunodetection', 'empty gravid horn'], ['ITGA5', 'individual gravid SMCs'], ['', 'ITGA5 expression'], ['reinforcement', 'uterine force ECM'], ['paper', 'twentieth  century'], ['This', 'irreversible  contingent'], ['how stem cell it', 'cell  cell'], ['2012 Nobel Prize', 'jointly John Gurdon'], ['cellular differentiation that', 'plasticity'], ['We', 'epistemological emergence tool'], ['setting  plasticity', 'cell differentiation'], ['experimental  contributions', 'crucial  Gurdon'], ['Overall  paper', 'biomedical  sciences'], ['It', 'new cell fusion'], ['broadly  paper', 'biomedical priorities research'], ['immune tissue response', 'well tissue destruction'], ['triggering receptor', 'immune myeloid signaling'], ['negative  that', 'periodontal  disease'], ['We', 'immune  periodontitis'], ['Therefore  aim', 'periodontal gingival parameters'], ['study', 'periodontal protein expression tissues'], ['Material tissue sections', 'chronic  periodontitis'], ['Immunohistochemistry', 'mRNA gingival tissues'], ['clinical  parameters', 'clinical loss plaque index'], ['connective tissues TREM-1', 'also gingival epithelial cells'], ['particular  TREM-1', 'healthy gingival biopsies'], ['expression levels', 'healthy  group'], ['Increased  levels', 'periodontal  parameters'], ['expression', 'clinical  disease'], ['We', 'unidentified  cellulase'], ['I', '512  458'], ['EgII', '61 glycosyl hydrolases'], ['I', 'binding N I'], ['CbhI II', 'high  CBD'], ['I', 'substrate fruit body'], ['fruit body morphogenesis', 'substrate colonization phase'], ['Background  proteins', 'epithelial enamel origin'], ['amelogenins', 'cementoblast lineage cells'], ['However  residues', 'active  amelogenin'], ['purpose', 'osteogenic amelogenin cementoblasts'], ['C terminus N terminus', 'fragment C terminal rh174'], ['cementoblast lineage cells', 'ng rh163 rh128'], ['mRNA levels', 'real chain reaction analysis'], ['Alkaline phosphatase activity', ''], ['Mineralization', 'red  staining'], ['rh128 lineage rh163', 'untreated  controls'], ['ConclusionsThe C terminus', 'periodontal tissue regeneration'], ['paper', 'temporal household electricity demand'], ['household electricity which', 'household electricity ways'], ['', 'temporal household level'], ['Such  data', 'established household characteristics'], ['', 'instead household characteristics'], ['imputed  characteristics', 'small area indicators'], ['UK which', 'also electricity load profiles'], ['It', 'domestic household attributes'], ['paper', 'based  relationships'], ['small area statistics', 'particular load profile indicators'], ['discussion', 'wider census taking'], ['', ''], ['', 'Elsevier Ltd'], ['central carbon metabolism', 'biosynthetic pentose phosphate precursors'], ['changes', 'recombinant protein production'], ['', 'rapidly glutamine synthetase'], ['proliferating  cells', 'energetic TCA demands'], ['limiting  resource', 'rather energy provision'], ['multifaceted  role', 'G2 M phase cells'], ['', 'International Union International Biochemistry'], ['Ask', 'past  genes'], ['empirical gene many', 'recent biology decades'], ['established DNA sequence', 'also  expression'], ['broader  that', 'neural development structure function'], ['mutability expression patterns', 'intriguing  learning'], ['very  sequence', 'memories'], ['as  we', 'intervening  evidence'], ['mutability', 'experimental  purposes'], ['Projection neurons', 'nervous motor circuits'], ['few  studies', 'individual  cells'], ['', 'anatomical borealis projection regions'], ['anatomical motor distribution', 'less thoracic attention'], ['cell we', 'spatial CoG neurons'], ['somata', 'distinct projection ganglion'], ['Identified', '% CoG ganglion'], ['soma position', 'function'], ['closest  axons', 'pathway'], ['reduced self concept clarity', 'loved  one'], ['that', 'two bereavement outcome'], ['concepts', 'emotional  loss'], ['half  who', 'grief posttraumatic grief study'], ['Loss centrality', 'sectional outcome analyses'], ['prolonged loss centrality', 'months self baseline'], ['Implications', 'findings'], ['ductal  adenocarcinoma', 'multiple beta signaling pathway'], ['', 'thereby TGF signaling'], ['present  expression', 'pancreatic  cancer'], ['mRNA expression levels', 'blotting RT PCR'], ['Immunohistochemistry', 'YAP65 Smad7 expression'], ['mRNA TGF expression', 'quantitative RT PCR'], ['Enhanced  expression', 'normal RT pancreas'], ['chronic  1', 'chronic  pancreatitis'], ['', ''], ['normal  YAP65', 'strong centro acinar cells'], ['Tubular complexes', 'strong  staining'], ['', 'YAP65 cancer cells'], ['YAP65', 'cancer samples'], ['', 'induced Colo-357 cells'], ['YAP65', 'normal  pancreas'], ['YAP65', 'lesser cancer cells'], ['gene', 'normal  pancreas'], ['neural  basis', 'autism spectrum disorder'], ['ASD', 'cerebellar  abnormalities'], ['temporoparietal  that', 'social  cognition'], ['We', 'independent fMRI components'], ['neurotypical  organization', 'significantly  ASD'], ['Second  we', 'functional connectivity cerebellum'], ['cerebellum', 'lateralized  TPJ'], ['connectivity', 'striking TPJ ASD'], ['right  TPJ', 'left Crus II'], ['cerebellar  input', 'social  ASD'], ['right  TPJ', 'noninvasive brain stimulation therapies'], ['Autism spectrum disorders', 'mainly  mind'], ['cerebellum', 'brain ASDs'], ['cortical  disconnection', 'autistic  symptoms'], ['cerebellar CTC circuit that', 'ASD pathophysiology'], ['When ASD we', 'emotional cognition processes'], ['Further  pattern', 'cerebellar default mode network'], ['functional  connectivity', 'cerebral ASD patients'], ['dysfunction', 'impaired cortical cerebellum'], ['three  insights', 'emotional  processing'], ['methodological  refinements', 'exponential lesion topic'], ['It', 'current  emotion'], ['main  aim', 'key  emotion'], ['Experts', 'nine  topics'], ['Topics', 'motor cognitive motor behaviors'], ['', 'neuropsychiatric mood disorders'], ['composite brain topography that', 'emotional  processing'], ['metabolic  pathophysiology', ''], ['we', 'cerebral artery occlusion'], ['Metabolic', 'ischemia spectrometry group'], ['', '120-min pentose phosphate reperfusion'], ['mitogen protein signaling', 'cerebral  reperfusion'], ['In', 'real polymerase chain reaction'], ['Immunoblotting', '120-min HSP27 reperfusion'], ['Corresponding upregulation', '120-min  MCAO'], ['HSP27 phosphorylation HSP27 that', 'protein kinase HSP27 phosphorylation'], ['Consequently G6PD activation', 'earliest defense neuroprotection ischemia'], ['findings', 'therapeutic  stroke'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['chronic  that', 'children'], ['main  aim', 'occupations'], ['aim', 'Iran'], ['Materials', ''], ['', 'famous Google pediatrics'], ['ADL)Instrumental Activity', 'social leisure participation'], ['papers', 'Iranian CP 2000'], ['100 CP children articles', 'Iranian CP children which'], ['17  articles', 'articles'], ['lowest ADL articles', 'field'], ['Most', 'occupational life areas'], ['many  researchers', 'CP children'], ['Many  articles', 'motor  clients'], ['A  TiO2', 'based NH3-SCR reaction'], ['', 'brookite  B'], ['present  we', 'based NH3-SCR reaction'], ['CeO2 oxygen which', 'interaction'], ['', ''], ['', 'CeO2'], ['Especially CeO2/1102-R catalyst', 'largest oxygen species'], ['', ''], ['', ''], ['rights', ''], ['organometallic tetravalent cerium complexes', 'oxidizing  Ce(IV'], ['thus ligand it', 'reaction complexes'], ['review', 'N- C ligands'], ['Special  attention', 'tripodal oxygen ligand'], ['', ''], ['', ''], ['rights', ''], ['biological  characteristics', 'cervical  cancer'], ['Clinical  specimens', 'primary  cells'], ['', 'main population cells'], ['molecular biology morphology', 'Hela cells'], ['two  cells', 'obvious tumor cell morphology'], ['CK17 CK19 P63', ''], ['Tumorigenicity', 'main side population cells'], ['associated tumor markers', 'two  cells'], ['cervical tumor stem which', 'cervical  cancer'], ['We', 'cervical translation initiation carcinoma'], ['healthy case individuals', 'control group'], ['> T genotypes', 'nested fragment length polymorphism'], ['patients', 'efficacy'], ['> T polymorphism', 'cervical  carcinoma'], ['> T polymorphism', 'differentiation degree Gynecology'], ['overall response rate', 'case group'], ['', ''], ['response rate', 'CM+TT genotypes'], ['FIGO stage LNM', 'e1F3a chemoradiotherapy efficacy'], ['> T polymorphism', 'cervical risk carcinoma'], ['> T polymorphism', 'cervical  carcinoma'], ['', ''], ['', 'Elsevier Taiwan LLC'], ['risk human papillomavirus infection', 'cervical  carcinogenesis'], ['human papillomavirus screening', 'early  diagnosis'], ['we', 'early human diagnosis'], ['we', 'Uighur neoplasia II women'], ['Human papillomavirus infection', 'quantitative polymerase chain reaction'], ['normal cell controls', 'proteomics'], ['expression', 'reverse polymerase chain reaction'], ['67  that', 'normal cell cervix'], ['reverse chain reaction analysis', 'normal cell cervix'], ['', ''], ['transcription', 'normal neoplasia II cervix'], ['cervical neoplasia II III', 'normal  controls'], ['', ''], ['expression', 'human papillomavirus infection'], ['Further validation studies', 'based cancer prognosis'], ['quantify', 'pregnancy  weight'], ['pregnant  women', 'five  20'], ['', ''], ['Maternal plasma DNA', 'Real polymerase chain reaction'], ['hypermethylated RASSF1A concentrations', 'gestational  groups'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['correlation analysis', 'positive  cffDNA'], ['', ''], ['', ''], ['BMI', 'positively  cffDNA'], ['', ''], ['', ''], ['However  it', 'age  height'], ['epigenetic  marker', 'pregnant study women'], ['future pregnancy that', 'hypermethylated  RASSF1A'], ['current feedback instrumentation amplifier', 'EEG detection systems'], ['digital feedback control', 'current division network'], ['PSpice simulation results', '0'], ['', '25 IBM CMOS +'], ['', ''], ['CFIA', '126'], ['common mode rejection ratio', '695 mu 9'], ['V  root', ''], ['achieved  gain', '22'], ['', '45'], ['', ''], ['CFIA', 'EEG detection systems'], ['floating transistor techniques', 'low supply voltage'], ['current output stages', 'voltage follower'], ['CFOA circuits', '0'], ['mu m CMOS technology', ''], ['BD MOS transistor', 'floating output gate'], ['', ''], ['', ''], ['', ''], ['proposed BD QFG', 'low MOS transistors voltage'], ['high  they', 'complex  diseases'], ['', 'various safety stakeholders'], ['correlation', 'significant glycoform researchers'], ['various process parameters', 'glycan biology heterogeneity'], ['major  that', 'last  decade'], ['impact', 'real time glycan monitoring'], ['', 'American Institute Chemical Engineers'], ['', ''], ['', ''], ['Symptomatic chronic Chagas disease', '40 Trypanosoma cruzi'], ['early  therapy', 'new disease drugs'], ['We', 'immune follow parameters'], ['', 'benznidazole  patients'], ['This', 'chronic  T'], ['', ''], ['regulatory T cell', '16  levels'], ['', ''], ['Fourteen  patients', 'group'], ['93  %', ''], ['Benznidazole', '60  days'], ['Three  patients', 'adverse  reactions'], ['treated follow up patients', 'increased Thl response'], ['clinical  trial', 'inflammatory chronic Chagas status'], ['beneficial  response', 'antiparasitic  drugs'], ['', ''], ['', ''], ['rights', ''], ['causative protozoan Trypanosoma agent', '6 million endemic areas'], ['Much', 'T'], ['', 'well triatomine US'], ['', 'T'], ['cruzi DTUs', 'parasite transmission cycles'], ['acquired Chagas disease patients', 'T'], ['', ''], ['using', 'genomic satellite T'], ['', '12/15  patients'], ['Genotyping', 'intergenic miniexon T'], ['', ''], ['six DTUs which', 'DTUs TcII TcIII'], ['Two', 'mixed TcI individuals'], ['Electrocardiographic abnormalities', 'TcI  TcI'], ['results', 'greater  T'], ['cruzi DTUs', 'TcII TcV TcVI group'], ['cardiac  disease', 'parasite population'], ['', ''], ['', ''], ['rights', ''], ['acetic acid-[(h ydrazinylthioxomethypthiol depressant', 'study'], ['depressing  mechanisms', 'potential MR zeta potential measurements'], ['molybdenite  results', 'chalcopyrite selectivity AHS'], ['results', 'membered cheat ring'], ['depressant  mechanism', 'postulated surface AHS'], ['', ''], ['rights', ''], ['TFCP  method', 'energy systems uncertainty'], ['TFCP', 'fuzzy programming uncertainties'], ['', ''], ['fuzzy  sets', 'well  satisfying'], ['conversion technologies technologies', 'then energy systems Shanghai'], ['Solutions', 'different constraint violation risks'], ['natural  gas', 'major energy supply 13'], ['0 electricity generation structure', 'dominated  e'], ['', ''], ['photovoltaic energy supply security', 'renewable  1'], ['', ''], ['managers', 'well system cost'], ['', ''], ['rights', ''], ['sociological  interpretation', 'various  nature'], ['social  which', 'objective  reality'], ['social  reality', 'social  cognition'], ['', ''], ['', ''], ['social structures institutions which', 'objective  reality'], ['objective  they', 'own  knowledge'], ['different  people', 'subjective  perception'], ['social  which', 'subject  knowledge'], ['research object', 'reality'], ['subjective  people', 'own  reality'], ['perceptions', 'social  formation'], ['which', 'Russian  society'], ['different population it', 'family work'], ['nationwide  it', 'other family work'], ['old  which', 'new life paradigm'], ['chaotic  attractors', 'current  conveyor'], ['fourth  order', 'high order Jerk system'], ['which', 'respectively 2 control'], ['proposed  circuit', 'better circuit structure'], ['Numerical  simulations', ''], ['chaotic  circuit', 'signal  detection'], ['First  we', 'increasing root period'], ['chaotic  circuits', '1L-1C core multiplier'], ['new variables circuits', 'more  zero'], ['last  conclusions', 'deep precision voltage'], ['linked MHC I', 'linked MHC class'], ['manuscript', 'unique rainbow trout'], ['Both', '24 aa signal peptide'], ['only  one', 'mammalian phosphorylation homologs'], ['luminal  which', 'P copies'], ['two  copies', 'minor kbp calnexin 2'], ['3  kbp', 'strongly kidney spleen RTS11'], ['smaller  transcript', '24 h A23187'], ['100 kDa band', '120 kDa treatment'], ['that', 'biological  functions'], ['', ''], ['rights', ''], ['when recognition errors', 'discriminative  ability'], ['heterospecific Scotinomys males', 'rivals'], ['We', 'specific tuning modulates responses'], ['Heterospecific songs', 'less  sympatry'], ['results', 'sensory competitor sympatry'], ['only  child', 'sexual  which'], ['herself', 'sexual  abuse'], ['sample', 'social welfare Quebec'], ['two  groups', 'current family functioning'], ['Children', 'adaptation'], ['panic abuse disorders who', 'CSA'], ['CSA mothers', 'trusted problems person'], ['abused  mothers', 'sexual  abuse'], ['measurement', 'piezoelectric components sensors'], ['frequencies', 'ultrasonic audio 1MHz'], ['Such  measurements', 'associated interconnection cables'], ['high noise bandwidth', 'high noise gain'], ['piezoelectric amplifier circuit single', 'differential charge amplifiers'], ['effects', 'also noise perspective'], ['theoretical  analysis', 'practical  experiment'], ['paper', 'standalone'], ['nV chopper op that', '2'], ['', ''], ['', ''], ['Frequency compensation', 'current  attenuator'], ['overall op amp', 'result'], ['4 mA supply', ''], ['', '26  area'], ['modulated chopper ripple', 'local feedback technique'], ['charge injection', 'thermal offset noise'], ['adaptive NMOS amount', 'input common mode voltage changes'], ['This', '0'], ['5 mu V', ''], ['', 'common degrees 125'], ['design', '0'], ['', '5 V CMOS transistors'], ['aim', 'fast charge transistor'], ['design', '90 nm CMOS technology'], ['Carlo simulation output variation', 'PVT'], ['designed charge pump', ''], ['5', 'similar  1V'], ['', '320 mu W'], ['', 'current mismatch problem'], ['Charge sharing problem', 'transistors'], ['current mirror circuit', 'matching  characteristics'], ['I DN', 'UP time signals'], ['proposed  design', 'low power consumption'], ['simulations', '1'], ['', ''], ['', ''], ['ADC  stage', 'TSMC'], ['', 'digital supply 1'], ['', ''], ['It', 'based stage voltage 2'], ['Various  capacitances', 'required manufacturing cost'], ['proposed  stage', 'peak p differential'], ['MS  s', 'ADC'], ['', ''], ['respectively  which', 'digital calibration technique'], ['based  stage', 'power savings'], ['', ''], ['analog converter stage', 'Semiconductor Manufacturing Company'], ['', 'supply 1'], ['', 'CMOS metal oxide technology'], ['It', 'based capacitor power'], ['Various  capacitances', 'required manufacturing cost'], ['draw', 'operational switch capacitance'], ['However transformation', 'higher power speed'], ['power which', 'Digital Oscillator converters'], ['Analysis', 'Tanner environment'], ['power dissipation', '90 charge steering nm'], ['sensitive  preamplifier', 'operational core parts'], ['differential dual noise differential which', 'high input impedance'], ['differential  which', 'operational  amplifier'], ['Broadband', 'folded cascode bootstrap'], ['which', 'operational  amplifier'], ['open charge voltage conversion', 'stability'], ['Particularly voltage conversion gain', 'better signal noise ratio'], ['designed  CSP', '3'], ['', '662 gamma keV'], ['fC  pF', ''], ['', 'Gamma 59'], ['5  keV', 'designed room temperature'], ['', ''], ['', 'world power consumption'], ['Research', 'efficient design techniques'], ['Power dissipation', 'steering time circuits'], ['Charge steering', 'high speed circuits'], ['technique', 'op amp op latches'], ['paper', 'op amp'], ['1st op amp circuits', 'single  stage'], ['power', 'current mode improvements'], ['amp power dissipation', 'better  gain'], ['circuits', '180 nm CMOS technology'], ['', 'created performance tools'], ['competent practice standards', 'identified Angoff method'], ['specific chart review', '3  levels'], ['Seventy one child abuse pediatricians', 'social Angoff method'], ['resulting  PHAAT', 'injurious  event'], ['One way analysis', 'significant team level'], ['', 'construct validity'], ['Intrarater reliability evaluations', 'strong  r(s'], ['', ''], ['', 'strong intraclass correlation coefficient'], ['', ''], ['', ''], ['PHAAT', 'physical practice assessment abuse'], ['exosomes', 'genetic  cells'], ['However  roles', 'HBV hepatitis B infection'], ['that', 'active HBV manner'], ['Notably HBV nucleic acids', 'positive CHB exosomes'], ['NK which', 'factor beta treatment'], ['', 'I NK cell stimulation'], ['HBV infection', 'nuclear NK factor'], ['results', 'unappreciated CHB infection'], ['Cellular', ''], ['', 'prehospital abuse screening providers'], ['Checklist We', 'clinical  experience'], ['Next  panel', 'final checklist items'], ['EMS Twenty providers', 'qualitative child interviews'], ['Three  reviewers', 'final  checklist'], ['kappa', 'rater  reliability'], ['correlation', 'chi squared construct validity'], ['final  that', 'trichotomous  scoring'], ['overall  IRR', 'three  raters'], ['kappa', 'substantial  agreement'], ['Internal  consistency', 'overall  0'], ['', ''], ['only  14', 'successfully child simulation'], ['significantly child who', 'reported child abuse'], ['', ''], ['only  task', 'successful child abuse'], ['', ''], ['successful item completion', 'other provider experience'], ['validated  instrument', 'prehospital  training'], ['western blotting technique', 'ray RNA chemiluminescence'], ['chemiluminescence  which', 'traditional ray film'], ['', 'dynamic chemical reaction'], ['Fluorescent detection', 'static CCD state'], ['researchers', 'visible chemiluminescent detection spectrum'], ['Infrared imaging systems', 'infrared  spectrum'], ['Infrared  imaging', 'high linear sensitivity'], ['same target which', 'need'], ['Here  we', 'cardio metabolic cardio methodologies'], ['', ''], ['therapeutic stem cell mechanism', 'wound healing'], ['', ''], ['we', 'therapeutic wound healing'], ['', ''], ['SVF cells', 'related  genes'], ['', ''], ['protein-2 CXCR1 CCR2', 'mesenchymal stem cells'], ['culture', 'substantially wound fibroblasts'], ['Wounds', 'nude Pluronic hydrogel'], ['SVF implantation', 'highly wound closure'], ['transplanted  SVF', 'cutaneous wound closure'], ['', ''], ['SVF', 'chemotactic wound factors'], ['CXC which', 'inflammation infection stress'], ['chemokine', 'liver diseases'], ['Hence  aim', 'heat shock Stimulation'], ['5 Dawley rat that', 'Type I matrix'], ['western blotting analysis', 'isolation shock stresses'], ['SDF-1', 'early rat time'], ['SDF-1 protein', 'isolated  time'], ['', ''], ['mRNA', 'isolated  culture'], ['', ''], ['also  expression', 'different time control'], ['', ''], ['isolation  stresses', 'dependent  manner'], ['that', 'injurious  condition'], ['Background disease pathogenesis', 'bacterial  dysbiosis'], ['', 'periodontal  diseases'], ['', 'direct  pathogen'], ['same  chemokines', 'osteoclast  formation'], ['Previous  reports', 'lymphocyte sexes'], ['chemokine expression', 'osteoclast  formation'], ['Material', 'osteoclast  progenitors'], ['Cells', 'then neutrophil infiltration'], ['ng receptor activator', 'then NF B LPS'], ['Osteoclasts', 'polymerase chain reaction'], ['ResultsIn  response', 'osteoclast chemokine females'], ['ConclusionsFindings', 'bacterial alveolar bone loss'], ['Males', 'key bone chemokines'], ['Thiocyanate', 'carbon nitrogen'], ['It', 'natural  processes'], ['many  removal', 'industrial waste streams'], ['a nitrogen few', 'electron donor'], ['key  enzyme', 'dehydrogenase'], ['group', 'oxidizing sulfide pathway'], ['we', 'described thiocyanate 2'], ['', '3'], ['', ''], ['we', 'also sulfur carbon'], ['thiocyanate dehydrogenase gene', 'contexts Thioalkalivibrio genotypes'], ['first  genotype', 'two type Tv'], ['second  genes', 'eight type Tv'], ['', ''], ['Additionally  we', 'such dissimilatory sulfite reductase'], ['', ''], ['carbon concentrating none', 'known bicarbonate transporters'], ['study', 'industrial waste streams'], ['initial  target', 'sensitive  animals'], ['Adult hens', 'experimental animal OPIDN'], ['However  little', 'chicken'], ['We', 'northern expression blotting'], ['3 cDNA NTE', '379 reading bp'], ['It', '422-nucleotide polyA sequence'], ['', ''], ['chicken', \"552 NTE 5'cDNA bp\"], ['It', 'iniation codon'], ['', ''], [\"3'cDNA\", 'amino acid level'], ['Chicken NTE', 'deduced N terminal sequence'], ['chicken NTE gene', '4'], ['', 'different brain kidney liver'], ['mRNA levels', '24 testis brain'], ['results', 'full length NTE gene'], ['', ''], ['rights', ''], ['linked chicken that', 'female  cells'], ['direct chicken evidence', 'localised chicken embryo'], ['We', 'chicken embryonic expression analysis'], ['embryonic  MHM', 'only  females'], ['sense', 'sense strand'], ['RNA', 'notably heart branchial arch'], ['MHM RNA', 'nucleus'], ['antisense transcript', 'cytoplasmic  cells'], ['antisense transcripts', 'antisense which'], ['This', 'ovarian  females'], ['impairs gonadal expression', 'testis gene'], ['', ''], ['MHM sense', 'biased embryo mortality'], ['MHM', 'embryonic gonadal sex differentiation'], ['', ''], ['rights', ''], ['inducible family proteins', ''], ['present  we', 'reverse polymerase chain reaction'], ['markedly  which', 'antivirus activity'], ['', 'embryonic  organs'], ['', 'Primordial germ 2'], ['high  which', 'gradually  time'], ['interferon- stimulation', 'embryonic fibroblast IFITM10'], ['forced  expression', 'lentiviral  vector'], ['when HeLa cells', 'low G expression buffer'], ['chicken', 'IFITM10 antivirus activity'], ['Twenty chickpea accessions', 'nuclear ribosomal DNA'], ['', ''], ['8S ITS2 regions', 'two Cicer primers'], ['', 'C'], ['', ''], ['reticulatum', '410bp'], ['investigated GC content', '55  %'], ['chain reaction product', 'adenine'], ['BLAST search', 'four ITS-1 C'], ['', ''], ['ITS2', '100 % C'], ['', '99 % C'], ['', ''], ['cooperative chicle which', 'U'], ['', ''], ['', 'chewing contratistas companies'], ['However  project', 'various Great Depression U'], ['', ''], ['companies', 'local  governments'], ['child profiles', 'adult offender populations'], ['meaningful latent class who', 'sexual  abuse'], ['aim', 'acceptance violent myth acceptance offending'], ['Data', 'selected adult male inmates'], ['unique  classes', 'abuse  group'], ['', '4  sample'], ['', ''], ['', ''], ['CAN classes', 'sexual self esteem relationships'], ['unique  nature', 'criminal CAN participants'], ['significance', 'past  research'], ['Potential  contributions', 'treatment strategies'], ['', ''], ['rights', ''], ['', 'state statute'], ['specific reporting failure', 'criminal liability penalties'], ['initial  report', 'criminal prosecutions custody determinations'], ['reporting testimony', 'involved well children'], ['reporting  pediatricians', 'peerless child advocacy'], ['based  ECE', 'developmental child maltreatment'], ['child welfare children', 'home care'], ['child welfare that', 'ECE population'], ['', 'representative United States'], ['', ''], ['0 year olds', 'based  ECE'], ['analyses', 'maltreatment type substantiation'], ['', 'general ECE population'], ['Results', '0 child welfare U'], ['', ''], ['', 'based  ECE'], ['other ECE types', 'based ECE participation'], ['findings', 'recent  U'], ['', ''], ['federal  government', 'young ECE U'], ['', ''], ['when  it', 'services'], ['', ''], ['rights', ''], ['', ''], ['', ''], ['abuse', 'physical  life'], ['true  extent', 'still  Turkey'], ['two ICAST which', 'parent parents'], ['This', 'first  Turkey'], ['First ICAST', 'bilingual  experts'], ['Students', 'trained ICAST researchers'], ['', 'matched  reports'], ['Descriptive  statistics', 'statistical chi comparisons'], ['Turkish  parents', 'effective rebukes children'], ['16  use', 'most  boys'], ['significant  relationship', 'economic  conditions'], ['', ''], ['However  relationship', 'educational  background'], ['', ''], ['children  parents', 'under child maltreatment'], ['parents', 'generally  extent'], ['Possible  approaches', 'political education commitments'], ['Most  victims', 'specific child maltreatment'], ['', 'clinical maltreatment outcomes'], ['total', 'known child study'], ['interviews  information', 'related sociodemographics psychopathology life'], ['Types', 'domestic abuse violence'], ['distinct type maltreatment which', 'sociodemographic outcome variables'], ['participants', 'sexual  abuse'], ['', 'sexual  abuse'], ['', 'sexual  abuse'], ['', ''], ['Members', 'other psychopathology classes'], ['distinct  profiles', 'empirically  sample'], ['Exposure', 'poorer  outcomes'], ['', ''], ['rights', ''], ['Child maltreatment', 'adversely population health'], ['Knowledge', 'child prevention'], ['We', '2443 birth Australians'], ['emotional abuse neglect', 'early  adulthood'], ['Potential risk factors', 'prospectively  childhood'], ['Associations', 'cumulative risk scores'], ['Higher  levels', 'increased child maltreatment'], ['Indicators', 'mixed infant maltreatment'], ['differences', 'risk profiles'], ['economic  disadvantage', 'parental  problems'], ['Risk', 'highest risk groups'], ['that', 'low risk individuals'], ['', ''], ['rights', ''], ['however life little', 'association'], ['related  cognitions', 'social  support'], ['Furthermore age', 'moderator'], ['We', 'structured 8 interview'], ['negative  cognitions', 'past self report questionnaires'], ['related  appraisals', 'social  support'], ['negative  associations', 'dysfunctional  children'], ['protective  function', 'negative  themselves'], ['cognitive  which', 'abusive caregivers friends'], ['', ''], ['rights', ''], ['Child abuse', 'abused health present'], ['vast  amount', 'long  abuse'], ['physical emergency which', 'minimally  rigor'], ['literature review', 'one  forms'], ['in depth analysis', 'literature'], ['comprehensive screening that', 'child abuse'], ['Screening', 'user healthcare system'], ['Child abuse', 'social health Japan'], ['Social  support', 'challenges'], ['aim', 'social  support'], ['sectional  study', 'structured  questionnaire'], ['target population', 'public nursery schools'], ['Bivariate', 'psychological child abuse potential'], ['', '309  mothers'], ['4  %', 'abuse potential child abuse score'], ['mothers', 'abuse potential child abuse score'], ['', 'female parent households'], ['', 'economic  status'], ['', 'low child care support'], ['', 'MSPSS Perceived Social score'], ['', ''], ['', ''], ['Important  predictors', 'low MSPSS score'], ['mothers', 'healthy child abuse'], ['', ''], ['rights', ''], ['current  study', 'implicit Acceptability Movie task'], ['Spanish Parent CAAM', 'misbehavior abuse risk'], ['Spanish Parent CAAM scores', 'such misbehavior misbehavior'], ['Results', 'corporal punishment ban'], ['acute  pain', 'accidental  injuries'], ['abused  reaction', 'challenging  diagnosis'], ['bone child', 'his'], ['abuse cases', 'abuse'], ['control group', 'obvious  abuse'], ['children', 'trauma'], ['analgesic  administration', 'certified pain scale'], ['', 'abused children children'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['We', 'pain assessments'], ['', ''], ['', ''], ['', ''], ['pain expression', 'medical  staff'], ['children', 'traumatic pain event'], ['Paying', 'analgesic  treatment'], ['', ''], ['rights', ''], ['article', 'Rican child youth'], ['who', 'other  types'], ['study', 'different lifetime child maltreatment'], ['', ''], ['', 'Rican youth self youth'], ['Secondary data analyses', 'annual Boricua Youth Study'], ['analytic  sample', 'Rican New York'], ['physical  abuse', 'depressive  symptoms'], ['', ''], ['', ''], ['2  place', 'residence violence'], ['particularly  who', 'child maltreatment'], ['multiple child who', 'mental health problems'], ['', ''], ['rights', ''], ['Background', ''], ['Interpersonal  factors', 'especially childhood women'], ['individual  factors', 'individualized smoking cessation strategies'], ['Attachment insecurity', 'select populations smoking'], ['attachment insecurity', 'plausible childhood adversity'], ['primary care patients', 'adversity attachment insecurity'], ['Statistical  analyses', 'regression'], ['20 childhood %', 'childhood adversity'], ['women attachment anxiety', 'childhood adversity'], ['', ''], ['', ''], ['attachment anxiety', 'current childhood women'], ['', ''], ['', ''], ['current  smoking', 'childhood adversity'], ['', ''], ['', ''], ['Attachment avoidance', 'current  men'], ['', 'women'], ['', ''], ['attachment anxiety', 'current childhood adversity'], ['Childhood adversity', 'cessation women'], ['Research', 'cancer'], ['child abuse', 'higher  adulthood'], ['interrelated  actions', 'abuse'], ['', ''], ['few measure theories', 'abuse'], ['implications', 'issues'], ['that', 'current  shortcomings'], ['carefully abuse measures', 'theoretical  connections'], ['Increasing research efforts', 'ethnic  U'], ['', ''], ['limited  research', 'sexual Latina abuse'], ['Latinos  Latinas', 'research'], ['secondary data analysis', '2401304 CSA reports'], ['descriptive  we', 'Latino Latina CSA'], ['profile', 'analytic sources perpetrator characteristics'], ['Latino Latina who', 'Latina'], ['significant  differences', 'ethnic CSA groups'], ['Findings', 'Latino Latina populations'], ['', ''], ['rights', ''], ['study', 'longitudinal  development'], ['case record study', 'four case record maltreatment'], ['', ''], ['', 'multiple  maltreatment'], ['Next  study', 'observed child maltreatment'], ['different incident children', 'different incident maltreatment'], ['Results', 'Service classification record abstraction'], ['Protective Service classification', 'multiple  maltreatment'], ['Neglect', 'physical  abuse'], ['Some', 'caretaker functioning maltreatment'], ['future practice implication', 'future research directions'], ['', ''], ['abused  they', 'differential  diagnoses'], ['mimic  abuse', 'subsequent  children'], ['', ''], ['common  that', 'physical  children'], ['', 'Ross E'], ['Witch Hunt article', 'social Los Angeles 1980s'], ['child sexual abuse that', 'Southern California'], ['sexual  which', 'day'], ['Psychiatrists', 'child America'], ['who', 'risk'], ['mental  illness', 'methodologic child this'], ['Rather  risk', 'individual  parent'], ['Substance abuse Substance disorder', 'mental  illness'], ['Violence risk', 'rather  static'], ['treated  risk', ''], ['However  families', 'social  support'], ['', 'mandatory reporting obligations'], ['child teachers', 'still  report'], ['report', 'maltreatment'], ['mandatory reporting training', 'ambiguous child maltreatment'], ['further  teachers', 'suspected child victim'], ['when child maltreatment', 'formal  report'], ['White  that', 'ongoing child protection services'], ['White  that', 'different case characteristics'], ['Canadian  children', 'Canadian  children'], ['', '1  case'], ['child protection investigations', 'Canadian child protection communities'], ['unaccounted  that', 'discriminative child protection system'], ['Further  research', 'phenomenon'], ['Numerous data sources', 'early United 1990s'], ['earlier  period', 'higher World War II'], ['study', 'Canadian prevalence population'], ['years household who', '2012 Survey Mental Health'], ['We', 'specific  sex'], ['Findings', 'consistent United States'], ['also  1946', 'relative  1946'], ['evidence', 'more  women'], ['debilitating  it', 'debilitating  which'], ['Continued  monitoring', ''], ['negative  effects', 'zero CSA risk'], ['initial child we', '2011 Guidance Center Japan'], ['maltreatment offender household', 'first logistic regression maltreatment'], ['that', '13 year child'], ['', ''], ['', ''], ['', '40 year offender'], ['', ''], ['', ''], ['', 'childhood'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['45  who', 'child'], ['', ''], ['', ''], ['', 'referral  source'], ['', ''], ['', ''], ['', ''], ['six  we', 'linear prediction 45'], ['', ''], ['', ''], ['child  administrations', 'preventive  recurrence'], ['', ''], ['', 'Elsevier Ltd'], ['Recognizing', 'abusive  injuries'], ['review article', 'current risk children'], ['Physical  abuse', 'intraoral  injuries'], ['chain  protocol', 'chain  evidence'], ['common  who', 'common  children'], ['diagnosis', 'careful  consideration'], ['hepatic  transaminases', 'child'], ['IU transaminase L', 'abdominal  trauma'], ['mental health associations', 'gender'], ['Data', 'Canadian Gender Alcohol'], ['logistic regression models', 'demographic abuse factors'], ['mental  variables', 'CSA  abuse'], ['gender differences', 'associations'], ['', '5  men'], ['CSA', 'off  label'], ['Associations', 'when  depression'], ['', 'significant  associations'], ['Evidence', 'CSA gender abuse'], ['Preventing CSA', 'also substance abuse'], ['', 'Copyright Elsevier Ltd'], ['sponsored  that', 'preventive child protection'], ['Early Preventive Intervention', 'welfare health care infants'], ['program', 'currently  effectiveness'], ['that', 'maternal infant sensitivity'], ['article', 'program'], ['', ''], ['well Pearson correlations', 'statistical program SPSS v'], ['', ''], ['', ''], ['theoretical  knowledge', 'subtle infant communication'], ['maternal  which', 'crucial child abuse'], ['early child who', 'thus  support'], ['three  which', 'regardless  background'], ['emotional conflict divorce toll', 'family unit'], ['away conflict parents', 'away conflict children'], ['lengthy litigation process', 'physical conflict abuse'], ['Child Protective Services', 'high conflict divorce cases'], ['Interest', 'two child maltreatment decades'], ['main  approach', 'self  reports'], ['they', 'unrealistic expectations misattributions'], ['parental parent child that', 'abusive  parenting'], ['we', 'implicit child measures'], ['results', 'measures'], ['research', 'parental parent child maltreating'], ['abusive  parents', 'more  children'], ['Further  research', 'implicit  measures'], ['', ''], ['rights', ''], ['Parental  maltreatment', 'national  it'], ['who', 'psychological  maladjustment'], ['Therefore  variables', 'effective intervention programs'], ['We', 'parental self abuse'], ['middle school who', 'Children Youth Panel Survey'], ['negatively child abuse', 'negatively school adjustment'], ['Further self esteem', 'alone child abuse'], ['findings', 'different child maltreatment types'], ['negative  effects', 'parental peer support'], ['On', 'parental self esteem teachers'], ['study', 'systematically gambling adulthood'], ['It', 'own adult problem children'], ['Multiple database searches', 'defined search gambling'], ['unique  they', 'specifically child maltreatment'], ['that', 'multivariable childhood maltreatment exposure'], ['seven  studies', 'sexual odds abuse'], ['', ''], ['', ''], ['', ''], ['', ''], ['studies', 'positive problem gambling'], ['most studies risks', 'mental health disorders'], ['three  studies', 'considerable physical studies'], ['Child abuse', 'clinical maltreatment assessment'], ['Problem gamblers', 'physically  children'], ['Child welfare professionals', 'when family risk'], ['', ''], ['rights', ''], ['Child maltreatment', 'often  needs'], ['Parental  distress', 'physical  sequelae'], ['relationship  pediatricians', 'important  role'], ['regular  which', 'further child harm'], ['Knowledge', 'potential community families'], ['limited neighborhood context', 'social  connections'], ['1050 Franklin County study', 'social child maltreatment'], ['greater  availability', 'lower child abuse'], ['such child relationship', 'greater child services'], ['increasing  services', 'such child maltreatment prevention'], ['well childhood maltreatment', 'various use disorders'], ['little  research', 'physical  CM'], ['chronic  association', 'CM'], ['2012 CCHS study', 'intimate partner adulthood'], ['logistic regression models', 'demographic risk type'], ['When  controlling', 'severe characteristics CPA'], ['', ''], ['', ''], ['severe  CSA', '2'], ['', ''], ['Controlling', 'particularly diabetes risk CPA'], ['CEIPV', 'significantly  adulthood'], ['CPA', 'risk diabetes'], ['most part associations', 'risk type'], ['severity', 'risk diabetes'], ['intimate partner nonvictims', 'intimate partner violence'], ['other  factors', 'IPV perpetration'], ['1989  study', 'physical IPV perpetration'], ['dating Fifty couples', 'physical CPA IPV'], ['Couples', '10  min'], ['Videos', 'negative  affect'], ['Using', 'greater IPV men'], ['', 'positively IPV men'], ['positive  association', 'negative IPV conflict'], ['BackgroundThere', 'local child protection Japan'], ['MethodsWe', '2011 questionnaire December'], ['Yokohama which', 'ill inpatient children'], ['ResultsA total', 'eight ICH hospitals'], ['84  %', '12months'], ['common  diagnosis', 'computed  tomography'], ['61 injury scene', 'six  cases'], ['We', 'suspected child abuse'], ['Three', 'skeletal skin 14'], ['Thirteen', 'regional child protective services'], ['sociomedical  evaluation', 'systematically child Yokohama'], ['Removing', 'parental  care'], ['', 'reaching  child'], ['', 'generally decision making'], ['making  practitioners', 'child removal'], ['child protection practitioners', 'when  decisions'], ['protective partner relationships', 'further  harm'], ['how  they', 'greater  children'], ['Children', 'other  children'], ['', 'also  research'], ['Research training practices', 'researchers'], ['aim', 'safer research research'], ['increased child researchers', 'research setting'], ['Twenty three Twenty papers', 'literature review'], ['studies', 'different considerations methods disciplines'], ['overarching  themes', '23  papers'], ['child which', 'social  care'], ['training protocols', 'appropriate child abuse referrals'], ['Ethics practices', 'further abuse debate'], ['role', 'children'], ['training', 'child protection Buckley'], ['teachers', 'possible child abuse'], ['schools', 'suspected child abuse cases'], ['cited  reasons', 'individual belief abuse'], ['current  paper', 'consequent child protection issues'], ['current  changes', 'holistic child teachers'], ['', ''], ['child protection victims', 'subsequent youth justice involvement'], ['longitudinal  that', 'relatively  area'], ['study', 'substantiated South experiences'], ['', ''], ['type timing', 'criminal  youth'], ['substantiated  who', 'out  care'], ['greater  that', 'out  care'], ['maltreatment', 'future  area'], ['', ''], ['rights', ''], ['AimChildhood  maltreatment', 'persistent stress response'], ['few axis studies', 'copeptin CM'], ['aim', 'child CM'], ['MethodsThis study', '71 comparison group'], ['CM', 'emotional  neglect'], ['Child psychopathology symptoms', 'Child Behavior Checklist'], ['We', 'immunosorbent serum copeptin assay'], ['ResultsChildren', 'when sex age'], ['total  score', 'CM'], ['We', 'symptoms'], ['Conclusion CM', 'independently age sex'], ['Copeptin', 'new  abuse'], ['current  knowledge', 'young  CSE'], ['public health approach', 'young  CSE'], ['', ''], ['', 'National Bureau'], ['little  investigation', 'high school completion'], ['present  relationship', 'high Childhood Trauma Questionnaire'], ['young Risk Youth who', 'illicit Vancouver Canada'], ['We', 'confounding school variables'], ['combined  models', 'different childhood maltreatment'], ['', 'high  school'], ['physical  neglect', 'high school education'], ['', 'emotional childhood abuse'], ['', ''], ['', ''], ['only  that', 'high school education'], ['cumulative impact assessment', 'high school education'], ['informed  interventions', 'at Nurse Family maltreatment'], ['often  parents', 'often  help'], ['particularly conflict who', 'extraordinary  maladjustment'], ['effective  treatment', 'causality'], ['functioning', 'successful  intervention'], ['We', 'multisystemic Conjoint Therapy families'], ['Methods', 'external  investigations'], ['mental health prevalence', 'interpersonal community family'], ['psychiatric violence who', 'exposure'], ['We', 'current  family'], ['Prevalence', 'violence'], ['Reported  exposures', '27  both'], ['negatively  children', 'FV'], ['Children', 'mental health violence'], ['general  IPE', 'only outcome FV'], ['Degree', 'traumatic stress disorder'], ['classic metaphyseal lesion', 'strongly  infants'], ['traumatic  origins', 'medical  settings'], ['studies', 'traumatic  injuries'], ['primary  objective', 'physical data abuse'], ['120  who', 'child abuse physician'], ['identified sign12 number', 'additional  injuries'], ['Descriptive  analysis', 'traumatic  injuries'], ['', '2890'], ['1  %', 'CML'], ['', '100'], ['', 'additional  fracture'], ['', ''], ['7  %', 'traumatic brain injury'], ['', ''], ['7  %', 'cutaneous  injuries'], ['Oropharyngeal  injuries', '12'], ['', ''], ['Abdominal thoracic injuries', 'also  12'], ['', ''], ['', '95'], ['four  children', 'three  injury'], ['CMLs', 'traumatic  injuries'], ['Identification', 'physical  abuse'], ['Missing', 'devastating  results'], ['Double  read', 'fracture detection'], ['However  yield', 'double  read'], ['', 'accidental  trauma'], ['study', 'two  phases'], ['double  read', 'skeletal  weekday'], ['as read we', '2014  March'], ['second  we', 'first  read'], ['we', 'skeletal  surveys'], ['We', 'skeletal  surveys'], ['difference', 'stratified Mantel Haenszel test'], ['Overall', 'days  3'], ['', ''], ['Double  read', '16  8/178'], ['', ''], ['Seven', 'additional  fractures'], ['initial  read', 'second skull read'], ['', ''], ['', 'skeletal  surveys'], ['', ''], ['', ''], ['significant  change', 'two disagreement study'], ['', ''], ['Double  read', 'positive  fracture'], ['Double  read', 'skeletal  survey'], ['Limiting', 'double  read'], ['', 'CM cocaine detoxification treatment'], ['We', 'healthy reference values'], ['CM- CM history', 'Childhood Trauma Questionnaire'], ['Blood samples', 'second treatment admission'], ['IL-17A ELISA assay', 'plasma cortisol levels'], ['lower cytokines levels', 'Th2 reference values'], ['Cytokines levels', 'gradually detoxification treatment'], ['increased CM levels', 'IL-4 CM+ group'], ['CM+ which', 'negatively crack withdrawal'], ['inflammatory behavior results', 'immunological crack cocaine women'], ['', ''], ['rights', ''], ['sexual  exploitation', 'neglect poverty homelessness'], ['commercial force fraud', 'commercial sex which'], ['article', 'medical identification patients'], ['social  who', 'significant abuse assessment process'], ['current  study', 'in case depth'], ['responses', 'corporal risk interventions'], ['social child abuse which', 'legal  standards'], ['social  workers', 'last child option'], ['that', 'child protective child services'], ['countries', 'child protection services'], ['professional Social judgment', 'less decision making process'], ['negative head effects', 'important  issue'], ['aim', 'primary  PAHT'], ['Markov that', 'high income country'], ['children', 'repeated  consultations'], ['abusers', 'screening'], ['Time horizon', '15  days'], ['Outcomes', 'children'], ['Uncertainty', 'probability distributions'], ['median  number', '100000 % newborns'], ['Screening', '100000 % children'], ['impact', 'programs'], ['model', 'primary  PAHT'], ['psychological  that', 'adulthood'], ['physical  evidences', 'eventually  dentists'], ['', 'systematic DVAC cases'], ['systematic  search', '6 data bases'], ['sectional  articles', 'potential perception DVAC'], ['publication status', 'language time'], ['search', '1'], ['024  18', 'eligibility criteria'], ['knowledge', '39 undergraduation insufficient'], ['', 'most  77'], ['75  %', 'competent  authorities'], ['authorities', '31'], ['', '25  articles'], ['More  attention', 'Forensic  Dentistry'], ['proper  training', 'domestic  violence'], ['', '2016 Elsevier Forensic'], ['rights', ''], ['young child abuse', 'such  fractures'], ['investigations', 'further  harm'], ['child abuse', 'suspected  maltreatment'], ['that', 'further  investigations'], ['article', 'abusive  children'], ['It', 'clinical  practice'], ['psychosocial  phenotype', 'organic bladder pain causes'], ['negative childhood affect', 'psychiatric childhood dysfunctions'], ['acute  who', 'clinical  controls'], ['Standardized  scales', 'potentially  childhood'], ['traumatizing  those', 'IC control group'], ['', 'dissociative control group'], ['two  subgroups', 'urogenital symptom severity'], ['psychosocial BPS phenotype', 'dissociation  proneness'], ['even childhood subgroup', 'urogenital  symptoms'], ['', ''], ['rights', ''], ['primary care who', 'often  maltreatment'], ['study', 'family doctors Milan'], ['', 'child abuse'], ['', 'questionnaires'], ['results', 'judicial child abuse'], ['', 'basilar  manner'], ['half  subjects', 'three child years'], ['one  third', 'scientific child abuse'], ['', 'addition'], ['6  %', 'professional child maltreatment'], ['study', 'proper training programs'], ['where  child', 'unadulterated  scene'], ['However  they', 'protective Child services'], ['', 'prehospital care providers'], ['', 'qualitative head debriefs'], ['Researchers', 'refined  themes'], ['Data collection', 'thematic  saturation'], ['safety which', 'hospital providers'], ['', 'limited  evaluation'], ['Barriers', 'paced caregiver setting'], ['', 'included mandated reporter peers'], ['Prehospital care providers', 'limited vantage topic'], ['increased follow up', 'CAN'], ['Children', 'facial  threat'], ['atypical threat processing', 'psychiatric threat risk'], ['', '19 maltreatment history'], ['Groups', 'IQ socioeconomic status ability'], ['colour Stroop stimuli', 'cognitive  control'], ['who', 'visual association cuneus'], ['group differences', 'classic colour Stroop conditions'], ['negative  associations', 'PTSD  maltreatment'], ['findings', 'maltreated rejection children'], ['previously  PTSD', 'coping  response'], ['atypical  processing', 'future  psychopathology'], ['previous  study', 'early suicidal Zonguldak'], ['aim', 'general childhood trauma'], ['present  study', 'representative Zonguldak province'], ['cluster sampling method', ''], ['written  who', 'demographic Scale Childhood Trauma'], ['ResultsThe lifetime prevalence', 'suicidal ideations'], ['early  it', 'early  trauma'], ['', '6 childhood trauma'], ['', ''], ['emotional  abuse', 'high lifetime suicidal ideations'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Emotional  neglect', 'only lifetime suicidal attempts'], ['', ''], ['', ''], ['', ''], ['', 'Beck Depression Anxiety Inventory'], ['DiscussionEmotional abuse', 'general Zonguldak province'], ['Therefore  clinicians', 'suicidal ideations'], ['physiological  that', 'social  lifespan'], ['joint  effects', 'social  outcomes'], ['We', 'fourth ELBW;2500 life'], ['Social outcome data', 'Canadian birth 1977'], ['avoidant personality who', 'CSA'], ['Birth weight status', 'moderate  CSA'], ['', ''], ['family', ''], ['adverse  effects', 'ELBW survivors'], ['Exposure', 'perinatal  adversity'], ['Individuals', 'social  adulthood'], ['exposed experiences children', 'legal  system'], ['questionnaire', 'social police personnel'], ['several  that', 'effective  work'], ['Routines', 'knowledge professions'], ['widely  conditions', 'sufficient  reports'], ['Results', 'abused  victims'], ['at  children', 'at  risk'], ['child they', 'school age'], ['when child maltreatment', 'when CHC which'], ['Individual', 'qualitative content analysis'], ['keeping', 'nurses'], ['centred  approach', 'interests'], ['where child maltreatment', 'different  ways'], ['Nevertheless  it', 'open  honesty'], ['professional  them', 'next  time'], ['CHC that', 'thereby CHC future'], ['cognitive  that', 'forensic  interviewers'], ['also training interviewers', 'appropriate  interviewing'], ['they', 'actual  field'], ['they', 'conduct'], ['Barriers', 'such  training'], ['medical evaluation rates', 'national child abuse rates'], ['researchers', 'multidisciplinary response team state'], ['paper', 'forensic evaluations thoughts struggles'], ['analysis', 'critical realist content'], ['theme', 'ambivalence'], ['discursive  themes', 'unintended health care evaluations'], ['discursive  elements', 'discursive funding patterns'], ['ImplicatiOns', 'current child abuse'], ['', ''], ['when  FME', 'forensic abuse response work'], ['', ''], ['', 'reactive prevention activities'], ['', ''], ['rights', ''], ['reports', 'interpersonal scale prevalence Netherlands'], ['Using', '4043 youth sport'], ['study', 'retrospectively victim respondents'], ['information', 'common perpetrator profiles'], ['male peer who', 'impromptu  groups'], ['Several  differences', 'interpersonal  violence'], ['incidents', 'sexual perpetrators coach'], ['nuanced  that', 'safeguarding child sport'], ['', ''], ['rights', ''], ['Little', 'Chinese college students'], ['sectional  study', 'Chinese college students'], ['total', '507  survey'], ['prevalence', 'child lowest'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Males', 'more child females'], ['', ''], ['emotional  abuse', 'internet addiction'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['sexual  abuse', 'internet addiction'], ['', ''], ['', ''], ['', ''], ['', 'increased self harm behavior'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Physical  abuse', 'internet addiction'], ['', ''], ['', ''], ['', ''], ['participants', 'higher child abuse'], ['child abuse', 'Chinese college students'], ['Child Protective Services', '700000 United States'], ['risk factors', 'CPS intervention'], ['often CPS that', 'future  practice'], ['We', 'out time CPS placement'], ['Male partners', 'remaining  cases'], ['Data', 'grounded  theory'], ['Mothers', 'variable CPS maltreatment'], ['We', ''], ['child that', 'vulnerable policy children'], ['sexual abuse that', 'actual health development'], ['', 'Child Service Demonstration abuse'], ['We', 'clinical child Taiwan'], ['We', 'medical child 2015'], ['different admission hospitalization abuse', 'different admission hospitalization which'], ['', ''], ['', ''], ['36  incidence', 'old  children'], ['', ''], ['sexual  abuse', 'females'], ['', ''], ['Neglect', ''], ['85  %', 'physical'], ['', ''], ['', ''], ['identifying  setting', ''], ['', '64  neglect'], ['Head neck', 'abused  children'], ['', 'longer  hospitalization'], ['', ''], ['', ''], ['', 'more skin neglect'], ['', ''], ['mortality rate', ''], ['', ''], ['CPMSDC', 'suspected child registry'], ['Cases', 'other head abuse'], ['highly  CPMSDC', 'study period'], ['consequent  injury', 'especially  mortality'], ['important child healthcare they', 'all  children'], ['closer  cooperation', 'forensic child abuse'], ['aim', 'forensic  PCHWs'], ['2013  survey', 'Public Health Service'], ['Forty nine Results Forty percent', '6  months'], ['89  %', 'forensic  physicians'], ['three  respondents', 'forensic  doctor'], ['PCHWs', 'forensic physician consultation rates'], ['More  research', 'forensic  physicians'], ['Childhood maltreatment', 'mental health problems'], ['Adolescents', 'psychiatric risk disorders'], ['multidimensional  that', 'medical  diagnoses'], ['', 'childhood maltreatment'], ['present  we', 'general maltreatment population'], ['We', 'also  QoL'], ['years  400', '67 response %'], ['Maltreatment histories', '335 research adolescents'], ['Previous  exposure', '237  adolescents'], ['Questionnaire', 'Related  Children'], ['general  1017', 'comparison'], ['linear model analyses', 'dependent R life variables'], ['Linear regression', 'adversities'], ['Exposed  adolescents', 'poorer control groups'], ['95 % confidence intervals', 'mean KINDL R subdomains'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['95 % confidence intervals', 'mean score differences'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Number', 'poorer QoL subdomains'], ['Childhood maltreatment', 'poorer QoL score'], ['We', 'QoL  RYC'], ['Childhood maltreatment', 'mental life span'], ['such  disorders', 'first  place'], ['We', 'neurocognitive  domains'], ['where  alterations', 'long term risk'], ['Studies', 'amygdala threat hypervigilance'], ['Studies', 'depressive striatum symptomatology'], ['Studies', 'effortful emotion processing'], ['Finally  studies', 'executive error monitoring'], ['psychiatric overt c', 'psychiatric  symptomatology'], ['neurocognitive  that', 'informed preventative intervention'], ['Such  interventions', 'psychiatric  disorder'], ['which', 'emotional  development'], ['Neglect', 'thus healthcare growth'], ['pediatric  abuse', 'long term consequences'], ['pediatric  dentist', 'child superior child interest'], ['various  which', 'responsible  person'], ['superior  interest', 'life'], ['secondary child principles', 'medical  confidentiality'], ['even  methods', 'civilized  community'], ['aggressive Gene environment behavior', 'independently serotonin transporter'], ['aim', 'healthy child adolescents'], ['group', 'male Child Behavior Checklist'], ['Buccal cells', 'DNA analysis'], ['effects', 'aggressive linear regression model'], ['three way interaction', 'aggressive VNTR behaviors'], ['male  adolescents', 'highest aggression childhood'], ['support aggression', 'synergistic gene environment interactions'], ['Child abuse', 'OOH PC OOH services'], ['aim', 'structured OOH PC services'], ['reporting code', 'consistent  suspicion'], ['children', 'participating year time'], ['checklist', 'electronic patient children'], ['positive  steps', 'reporting code'], ['Additionally  case', 'multidisciplinary child abuse'], ['checklist', '50671  children'], ['2  %', ''], ['multidisciplinary  team', 'positive child 36'], ['Emotional  neglect', 'frequent  abuse'], ['', 'abused children protocol'], ['frequent  care', 'general  practitioner'], ['', 'child abuse'], ['percentage', 'positive  checklists'], ['Validity', 'diagnostic  study'], ['administrative child welfare children', 'residential treatment facilities'], ['question', 'mental health treatment settings'], ['We', 'multiple  systems'], ['years treatment facilities families', '2003'], ['who', 'residential treatment facilities entry'], ['', 'other  factors'], ['Study findings', 'well health being'], ['Child abuse', 'mental health consequences'], ['Fortunately  individuals', 'mental child health'], ['factors', 'mental child impairment'], ['objectives', 'mental child abuse'], ['Data', '2012 Community Health Survey'], ['', ''], ['mental  health', 'mental  disorders'], ['', ''], ['3  %', 'mental child abuse 72'], ['', '4 child abuse history'], ['supportive  that', 'social attachment worth'], ['several relationship level that', 'mental child abuse'], ['identification', 'high risk populations'], ['current  study', 'opioid substitution therapy'], ['Risk Abuse scale', 'internal  reliability'], ['most Random those', 'lower  scores'], ['six factor solution', ''], ['independent  that', 'further  investigation'], ['results', 'potential child abuse potential'], ['subscales', 'convergent  utility'], ['different  sources', 'inconsistent child maltreatment'], ['capitalizes', 'three maltreatmentChild Protection caregivers'], ['sample', 'psychosocial CPS risk'], ['shared  convergence', 'own CPS perspective'], ['shared  variance', 'self child symptoms'], ['Child perspective', 'supervision maltreatment abuse'], ['', 'fully child failure'], ['consistent  information', 'best child risk'], ['evolution', 'social child pediatrics'], ['Pediatric care', 'psychosocial  health'], ['staff responses', 'trauma policy'], ['MethodThe files', 'mental health centres'], ['ResultsThere', 'lesser treatment plans'], ['relevant  which', '25 abuse categories'], ['proportion', 'significantly abuse cases'], ['client', 'abuse  neglect'], ['1  %', 'legal  authorities'], ['People', 'psychotic  disorder'], ['well  people', 'treatment authorities'], ['', ''], ['Child abuse', 'psychiatric risk disorders'], ['Untreated  disorders', 'adulthood'], ['', ''], ['study', 'mental health care CAN'], ['', ''], ['322  children', 'structured health interviews'], ['', ''], ['', 'two  participants'], ['', ''], ['57  %', 'psychiatric  disorder'], ['', ''], ['', ''], ['', ''], ['15  %', ''], ['', ''], ['88  %', 'mental health assessment'], ['', ''], ['provision', 'mental health CAN'], ['improve', 'vulnerable clientele psychiatrists'], ['implementation', 'diagnostic  methods'], ['International  estimates', '25  %'], ['Hardly  data', 'Dutch  figures'], ['aim', 'paediatric child burns'], ['We', 'child burn child abuse'], ['retrospective  study', 'primary burn centre period'], ['Data', 'Dutch Burn Repository R3'], ['medical  records', 'addition'], ['suspected child abuse', '43  children'], ['442 screening questionnaires', ''], ['completed  SPUTOVAMO', 'more  signs'], ['independent  predictors', 'genital child area'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['incidence', 'other child countries'], ['', ''], ['rights', ''], ['Partial  division', 'young  children'], ['We', 'comprehensive nonaccidental trauma'], ['intraparietal branching which', 'intraparietal branching sutures'], ['that', 'cranial  sutures'], ['', ''], ['rights', ''], ['child maltreatment', 'marijuana use'], ['study', 'adolescent adult marijuana use'], ['Analyses', 'Lehigh Longitudinal Study'], ['Measures', 'approval child use'], ['adolescent preschool abuse', 'positively marijuana use'], ['negatively  who', 'marijuana use'], ['adolescent marijuana which', 'positive adult marijuana use'], ['developmental  that', 'ultimately child maltreatment adolescent'], ['sequence', 'vulnerable marijuana individuals'], ['', ''], ['rights', ''], ['one billion one children', 'highest child low-'], ['Sinovuyo Teen programme', 'low resource contexts'], ['objectives', 'behavioural parenting support problems'], ['trial', 'water hygiene programme'], ['Methods  This', '40 South Africa'], ['Settlements', '14-session parenting support programme'], ['primary  outcomes', 'mental parenting health'], ['Concurrent process evaluation', ''], ['Outcomes', 'primary  caregivers'], ['follow  measures', '3 months intervention'], ['this', 'civil research sites'], ['This', 'middle income country'], ['study', 'mediating  pathways'], ['Musculoskeletal  manifestations', 'common emergency department'], ['practicing emergency it', 'serious  injury'], ['Orthopedic  trauma', 'differently  adults'], ['Understanding', 'developmental injury injuries'], ['Children', 'most child maltreatment'], ['presenting  findings', 'fractures long bone fractures'], ['recent  work', 'other fracture detection'], ['Management', 'protective  services'], ['Child abuse', 'emotional  history'], ['children', 'often  property'], ['57000 World Health children', 'year'], ['we', 'past child populations'], ['children', 'mind'], ['Skeletal  indicators', 'nonaccidental  literature'], ['Inflicted  injuries', 'child abuse'], ['metabolic  diseases', 'potential  neglect'], ['recent child homicide', 'child maltreatment'], ['clinical child abuse protocols', 'bioarchaeological child context'], ['', ''], ['', ''], ['', ''], ['', ''], ['growing  sport', 'positive  children'], ['organised  offences', 'trusted  coaches'], ['less  attention', 'physical child athletes'], ['that', '18  Australia'], ['study', 'organised violence overtraining'], ['mixed methods research design', 'young survey adults'], ['a  third', 'physical  violence'], ['which', 'physical  context'], ['Witch Hunt Narrative', 'sexual  abuse'], ['Drawing', 'single  case'], ['false  acquittals', 'sexual  abuse'], ['that', 'productivity'], ['when  abuse', 'sexual  abuse'], ['Third  attorneys', 'temporal  information'], ['', 'Alex A'], ['case', 'wrongful  acquittals'], ['Much', 'public child maltreatment prevention'], ['related policy that', 'individual parenting behaviors'], ['universal  that', 'developmental  process'], ['system', 'highest  risk'], ['only  they', 'issues'], ['commentary', 'collective  children'], ['', 'positive child parents'], ['random household surveys', '18 24 maltreatment range'], ['young  adults', ''], ['', 'full time employment'], ['', 'young  adults'], ['Qatar', 'physical  Palestine'], ['', ''], ['', ''], ['', ''], ['', ''], ['they', 'Palestinian  participants'], ['higher ICAST incidence', 'greater child violence'], ['Suggestions', 'yet child maltreatment questions'], ['', ''], ['rights', ''], ['Recognition', 'physical child safety'], ['however  extent', 'use'], ['study', 'determined  STs'], ['based  survey', '103 abuse program hospitals'], ['survey', 'physical  ST'], ['Respondents', 'ST use'], ['70  most', '70  survey'], ['physical  STs', 'positive length population screen'], ['86  it', 'abuse'], ['Barriers', 'development  ST'], ['most  it', 'abuse'], ['physical uniform which', 'at  children'], ['Traumatic brain injury', 'substantial  children'], ['Posttraumatic  seizures', 'traumatic brain injury'], ['seizures risk factors', ''], ['objective', 'traumatic brain injury'], ['Retrospective cohort study', 'linked Trauma Data Bank'], ['', ''], ['', ''], ['', ''], ['', 'linked Trauma Data Bank'], ['', ''], ['Main outcome', 'International Classification Modification diagnosis codes'], ['Prespecified candidate predictors', 'intracranial type hypoxia hypotension'], ['Posttraumatic seizures', '25'], ['', 'traumatic brain injury'], ['posttraumatic seizures rate', '36'], ['', ''], ['', '4  those'], ['abusive  mechanism', 'posttraumatic  seizures'], ['risk', 'complex  predictors'], ['estimated  odds', 'equal age odds 0'], ['', ''], ['', ''], ['', 'equal odds 0'], ['', ''], ['', ''], ['when  abuse', 'additional  age'], ['infant', '50 39 %'], ['', ''], ['triad', 'posttraumatic age seizures'], ['risk', 'abuse age assault'], ['posttraumatic  seizures', 'even  factors'], ['Many  studies', 'taking psychopathology suicide'], ['Being', 'psychological well being'], ['when  that', 'negative  maltreatment'], ['Self compassion', 'traumatic well events'], ['psychological well who', 'childhood maltreatment'], ['full self mediator', 'partial well mediator'], ['Implications', ''], ['emotional child abuse', 'major South Africa'], ['outcomes', 'help  behaviour'], ['It', 'services'], ['Confidential self report questionnaires', '3515 South Africa'], ['physical  abuse', 'frequent  weekly'], ['', ''], ['', ''], ['', ''], ['', ''], ['6  %', 'confidante abuse disclosure'], ['0  %', 'abuse victims'], ['', '%  help'], ['common  confidantes', ''], ['', 'abuse victims'], ['6  %', 'services'], ['4  %', 'help'], ['', 'formal  health'], ['', '1 community vigilante action'], ['sexual  abuse', 'higher  help'], ['high South knowledge', 'abused services children'], ['fewer  children', 'formal community vigilante action'], ['Urgent action', 'child abuse victims'], ['', 'Northern Sri Lanka'], ['', 'legal child system'], ['retrospective  study', '60-y care conflict'], ['Data', 'based district probation office'], ['hundred twenty Seven hundred cases', 'tertiary care abuse'], ['mean  age', 'children'], ['', ''], ['', ''], ['more  males', 'sexual  abuse'], ['clinical  examination', '15  %'], ['70  victim', 'abuse'], ['Attempted  suicide', 'later school years'], ['problem', 'urgent child victims'], ['Urgent steps', 'affected  areas'], ['particularly  survivors', 'mental  lifespan'], ['', 'ELBW;2500 g ELBW;2500 ages'], ['26  CSA', 'significant  internalizing'], ['', ''], ['', ''], ['', '4'], ['', ''], ['', ''], ['confidence intervals', 'ELBW  those'], ['36  CSA', 'current  3'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['however  this', 'covariates'], ['mental NBW who', 'mental NBW participants'], ['perinatal  who', 'fourth  life'], ['', ''], ['rights', ''], ['sexual  abuse', 'annually United States'], ['primary  obstacle', 'public level risk CSA'], ['We', 'suspected Greater Houston 2009'], ['', 'suspected incidence 5'], ['', ''], ['86  who', 'medical Greater Houston 2009'], ['396 zip children', '396 zip codes'], ['mean  number', 'Houston zip code'], ['62  %', 'three zip sites'], ['Zip codes', 'suspected family poverty CSA'], ['codes level which', 'suspected  CSA'], ['modelling process', 'improved  CSA'], ['socioeconomic  which', 'increased CSA evaluations'], ['Fractures', 'soft tissue bruising'], ['It', 'soft tissue injuries'], ['sign2 years sign2 who', 'pediatric fracture clinic'], ['Statistical  analyses', 'long bone fracture fractures'], ['17  patients', 'accidental  trauma'], ['', 'first  ED'], ['aged', 'years  NAT'], ['', ''], ['multiple  15', 'patients'], ['femoral  fractures', '11'], ['year  all', 'NAT'], ['60  patients', '28  NAT'], ['Age', 'common transverse NAT'], ['abuse exerts', 'mental health outcomes'], ['that', 'association'], ['Here  we', 'psychiatric community adolescents'], ['magnetic resonance imaging', '51  adolescents'], ['', ''], ['19', 'physical  abuse'], ['structured MRI time', 'later  psychopathology'], ['related child differences', 'psychiatric  symptoms'], ['Abuse', 'medial lobe regions'], ['antisocial behavior symptoms', 'generalized anxiety disorder'], ['Thickness', 'antisocial  behavior'], ['cortical  disruptions', 'increased  psychopathology'], ['predictive  biomarkers', 'environmental childhood psychopathology'], ['response', 'adequately child family'], ['well child welfare advocates', 'conventional  tools'], ['CAPTA', 'federal  statute'], ['Authors', 'next reauthorization cycle'], ['CAPTA', 'ongoing child welfare'], ['Dental services professionals', 'often document patients'], ['study', 'adolescent Merida abuse'], ['results', 'percentage bar'], ['frequent  most', 'general dental treatment'], ['It', 'more  child'], ['Attachment theory', 'typical  development'], ['Much', 'well attachment adulthood'], ['developmental parent child relationship', 'crucial  role'], ['that', 'middle measurement gap'], ['aim', 'future research directions'], ['narrative  review', 'current PsychINFO Mendeley'], ['they', 'reviewed language July'], ['39  CAI', 'worthwhile parent child infancy'], ['most  critical', 'coding  system'], ['how  it', 'finally  dimensional'], ['', ''], ['how  victim', 'contextual  children'], ['Reporting System Reporting data', 'two regression preschoolers'], ['significantly United incident', 'significantly United which'], ['who', 'child development outcomes'], ['utilized self report that', 'Appalachian children community'], ['abuse potential child abuse who', 'adaptive household skills'], ['abuse potential child abuse who', 'academic skills subscale'], ['lower family income', 'greater self care skills'], ['who', 'greater communication skills'], ['Parent child dysfunction', 'child development outcomes'], ['educators', 'unique  maltreatment'], ['yet child extent', 'intergenerational  transmission'], ['Disparate findings', 'maltreatment generation'], ['We', 'adolescent type perpetrator mothers'], ['they', '72  %'], ['when  we', 'substantiated  reports'], ['when  mothers', 'multiple childhood maltreatment'], ['', ''], ['rights', ''], ['little child parents', 'negative  professionals'], ['study', 'cognitive  reinforcement'], ['21  who', 'grounded theory approach'], ['outreach analysis', 'negative cognition categories'], ['analysis', 'negative support cognition'], ['child protection analysis', 'anger child protection services'], ['analysis', 'negative  cognition'], ['parents', 'negative  cognition'], ['results', 'child maltreatment cases'], ['', ''], ['', 'Elsevier Ltd'], ['long child drivers', 'association'], ['We', '2443 birth individuals'], ['We', 'demographic abuse factors'], ['attributable child maltreatment that', 'economic  disadvantage'], ['Economic  factors', 'child maltreatment'], ['most  associations', 'noneconomic causal relationships'], ['economic  factors', 'emotional  abuse'], ['Retrospective  perceptions', 'economic child factors'], ['27  %', 'economic child factors'], ['that', 'significant child maltreatment'], ['', ''], ['rights', ''], ['Crime', ''], ['early  exposure', 'serious child adulthood'], ['based child that', 'later child crime'], ['', '18 community U'], ['', ''], ['present  study', 'various child crime'], ['series', 'violent property crime'], ['Structural equation modelings', 'sociodemographic information family income'], ['indirectly property lack', 'child neglect'], ['physical  abuse', 'three  crime'], ['Personality traits', 'significant maltreatment crime link'], ['Preventive  interventions', 'criminal maltreatment victims'], ['', ''], ['rights', ''], ['COI  study', 'based child approach'], ['Costs', 'marginal child outcomes'], ['PAFs', '7 child annum'], ['Sensitivity analysis', 'bound child abuse'], ['best  estimate', 'financial child 2012'], ['cost', '$  5'], ['', ''], ['best  estimate', 'financial child 2012'], ['4 billion', '$  child'], ['', 'targeted support risk'], ['', ''], ['rights', ''], ['', 'U'], ['', ''], ['', ''], ['', ''], ['Family Advocacy Program', 'child safety'], ['that', 'FAP'], ['Thus  objective', 'retrospective  U'], ['', ''], ['medical child who', 'substantiated  2007'], ['old child who', 'medical child maltreatment'], ['Linkage rates', 'substantiated FAP reports'], ['Bivariate', 'substantiated FAP reports'], ['', '5945'], ['3  %', 'substantiated FAP report'], ['Adjusting', 'sexual FAP abuse'], ['', ''], ['', ''], ['', '14'], ['', ''], ['', ''], ['', ''], ['early  care', 'military FAP facilities'], ['', ''], ['', ''], ['', '23'], ['', ''], ['', ''], ['', ''], ['low  rates', 'civilian FAP reporting facilities'], ['', ''], ['rights', ''], ['family that', 'increased  abuse'], ['adolescent government girls', 'total government 1060'], ['Majority', 'adolescence'], ['70 % study subjects', 'one  maltreatment'], ['Physical  abuse', '42'], ['', 'sexual  26'], ['', 'emotional  37'], ['', '9  40'], ['', '1 study subjects'], ['frequent  perpetrator', 'sexual  abuse'], ['physical  mothers', 'physical  abuse'], ['Excessive  arguments', 'study subjects'], ['later child effects', 'relatively  partner'], ['low income association', 'observed depression substance communication'], ['25  %', 'negative  communication'], ['even child wives', 'also  history'], ['partner abuse characteristics', 'abuse history'], ['individual  effects', 'characteristics'], ['Early  victimization', 'psychopathology'], ['disruptions', 'early  victimization'], ['present  study', 'high  victimization'], ['', 'measured  victimization'], ['', ''], ['593  who', 'Child Abuse'], ['directly psychopathology childhood children', 'indirectly  PTS'], ['largely  who', 'early  victimization'], ['study', 'early  victimization'], ['diverse trauma who', 'diverse trauma youth'], ['Educators', 'periodically child abuse'], ['school professionals', 'maltreated  children'], ['which', 'support'], ['Many  educators', 'often school settings'], ['who', 'educational child maltreatment'], ['article', 'reporting practices'], ['when  that', 'training policies'], ['maltreated child that', 'maltreated child cases'], ['however child research', 'Canada'], ['purpose', 'economic maltreatment concern'], ['Secondary  analyses', 'Reported Child Abuse'], ['OIS-2013', 'reported child welfare 2013'], ['chi square chi analyses', 'logistic  maltreatment'], ['9  household', '6 food months'], ['academic  difficulties', 'mental health issues'], ['Controlling', 'substantiated maltreatment investigation'], ['', ''], ['', ''], ['implications', 'future  resilience'], ['Texas Department', 'academic child abuse 2006'], ['9/1/2012 8/31/2014', 'determinations injury physician'], ['8061', '2 DFPS period'], ['Network utilization rates', '7'], ['', '5 San 1'], ['', 'served  counties'], ['Cases', 'older  children'], ['American  children', 'over  referrals'], ['Prevalent risk factors', 'mental illness substance abuse'], ['Network providers', '45  cases'], ['Determinations', 'skeletal quality 121'], ['Insufficient information', '65 case children'], ['child abuse centers', 'different practice regions'], ['findings', 'national risk trends'], ['better case issue', 'further  study'], ['Standard DFPS criteria', 'child abuse study'], ['', ''], ['rights', ''], ['Criminal justice research', 'such gender race'], ['', 'demographic case outcomes'], ['current  study', 'maltreatment child maltreatment cases'], ['Neglect Data we', 'maltreatment child gender'], ['mother perpetrators', 'physical father abuse'], ['gendered  attributions', 'blameworthiness  dangerousness'], ['future  research', 'demographic agency decision making'], ['', ''], ['rights', ''], ['who', 'sensitive parenting behaviors'], ['Participants', 'psychosocial  women'], ['when  children', '1  age'], ['projective  test', 'rated family home'], ['structural equation we', 'interpersonal infant emotion'], ['history', 'facial partner expressions'], ['', ''], ['', 'less parenting time'], ['1 infant history', 'sensitive violence mothers'], ['mothers', 'emotional  connection'], ['other child welfare agencies', 'further child abuse'], ['better  understanding', 'additional recidivism maltreatment'], ['temporary  which', 'increased recidivism risk'], ['previous  study', 'specific maltreatment recidivism'], ['current  it', 'that'], ['', ''], ['above CPS case therapy', 'reduced  recidivism'], ['also  relation', 'cumulative  risk'], ['additional predictor psychotherapy', 'reduced  recidivism'], ['However  Hypothesis', 'temporary  removal'], ['', ''], ['rights', ''], ['criminal justice involvement', 'negative child abuse'], ['However  association', 'criminal justice involvement'], ['paper', 'criminal justice involvement'], ['specific child association', 'specific child which'], ['future multivariate analysis that', 'criminal justice involvement'], ['Implications', 'commonly family parents'], ['', ''], ['rights', ''], ['Child maltreatment', ''], ['associated', 'increased peer adolescence'], ['well Child gender', 'relationships'], ['who', 'physical child age'], ['history', 'physical  assault'], ['relationship', 'boys'], ['findings', 'victimization'], ['', ''], ['rights', ''], ['10 child maltreatment that', 'child maltreatment'], ['maltreating', 'greater HRV reactivity'], ['evidence', 'significance studies'], ['child maltreatment', 'HR baseline activity'], ['', 'allostatic  load'], ['second  set', 'autonomic stress participants'], ['aggregated child study', 'null effect curse'], ['Most  studies', ''], ['Future directions', 'research'], ['social child issue', 'empirical child attention'], ['study', 'family child context'], ['survey', 'two cluster sampling design'], ['Logistic regression analysis', 'psychological risk groups'], ['parent  abuse', 'migrant  adolescents'], ['', ''], ['', 'local  counterparts'], ['economic performance delinquent adversity', 'migrant parent adolescents'], ['child abuse', 'migrant Mainland policy'], ['', ''], ['rights', ''], ['experience', 'low grade adulthood'], ['molecular  mechanisms', 'inflammatory  phenotype'], ['Mitochondria', 'inflammatory inflammasome activation'], ['alterations', 'oxidative maltreatment childhood'], ['We', 'years maltreatment childhood'], ['Exposure', 'dose response relationship'], ['ROS production', 'inflammatory  PBMC'], ['Decreased serum levels', 'increasing child maltreatment experiences'], ['Together  findings', 'inflammatory cell childhood'], ['child warrants', 'physical  health'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['cognitive  difficulties', 'relational  domains'], ['study', 'such child histories'], ['Participants', 'social situations children'], ['predicted  associations', 'relational  domains'], ['distinct  that', 'two  groups'], ['other  second', 'included  children'], ['When group differences', 'poorer variables comparisons'], ['interpersonal  problem', 'neglect  comparisons'], ['regression', 'significantly child neglect'], ['widespread parenting disturbances', 'social child neglect'], ['even abuse child it', 'much  harm'], ['differences', 'alone  abuse'], ['past year I', 'diagnosed Wave I'], ['diagnosed Wave who', 'Wave I'], ['Other  forms', 'youth maltreatment'], ['welfare  professionals', 'new substance dependence disorders'], ['', ''], ['physically  who', 'risk child parents'], ['overall  evidence', 'individual  hypothesis'], ['risk  parents', 'risk  children'], ['difference', 'hypothesized  direction'], ['', ''], ['', ''], ['', ''], ['difference', 'dependent  variables'], ['Further  analysis', 'published p finding'], ['current meta analysis', 'risk  children'], ['magnitude', 'effect'], ['impressions', 'directed  behaviors'], ['impressions', 'abusive parenting behaviors'], ['', 'abuse diagnosis risk factors'], ['questionnaire', 'demographical abuse cases'], ['Descriptive  statistics', ''], ['5 % level', 'statistical  analyses'], ['', ''], ['response rate', ''], ['', ''], ['', 'respondents'], ['frequency', 'Malaysia'], ['Full  agreement', 'dental health care CPA'], ['', '83'], ['reporting', 'legal  Malaysia'], ['8  %', 'such  cases'], ['Lack', 'adequate  history'], ['62  they', 'how child abuse cases'], ['', ''], ['', ''], ['Conclusions', 'suspected risk CPA'], ['only  handful', 'such  cases'], ['Enhancement', 'dental health care CPA'], ['paper', '2 Young Persons Act'], ['children', 'violence'], ['concerned  children', 'violence'], ['violence', 'many  power'], ['More  boys', 'violence'], ['Girls', 'coercive  honour'], ['when gender research', 'parents'], ['2  CYPA', 'crucial  violence'], ['social police who', 'national  curriculum'], ['which', 'narrative  interview'], ['16 Strand B', '21 role play interviews'], ['where role interviewers', 'free  narrative'], ['national  curriculum', 'narrative  participants'], ['Possible  reasons', ''], ['', ''], ['Child protection', 'globalized  world'], ['Ideas', 'religious  contexts'], ['dramatic  societies', 'well being'], ['Children', 'however  risk'], ['They', 'nuclear kinship safety nets'], ['cultural  practices', 'risk'], ['it', 'catastrophic  girls'], ['limited  resources', 'them'], ['vision', 'United Nations Child'], ['especially child abuse it', 'legal  authorities'], ['present  study', 'prior risk assessment'], ['sample', 'identified  pedo-'], ['sexual  preoccupation', 'recent  CAI'], ['sexual  preference', 'early pubescent recent'], ['additional prepubescent paraphilias', 'meaningful  lifetime'], ['Gender preference exclusivity', 'significant  behaviour'], ['what', 'local child thresholds'], ['International Society', 'years Child Abuse'], ['It', 'better child abuse'], ['article', '12 World Perspectives'], ['key  who', 'knowledgeable child protection field'], ['They', 'accurate  information'], ['Countries', 'different income level categories'], ['findings', 'laws prevention'], ['considerable country income programs', 'high income countries'], ['', 'C Elsevier Ltd'], ['however child little', 'interpreting interviewers'], ['investigative  interviews', 'aim'], ['investigative child abuse who', 'regular  basis'], ['Thematic  analysis', 'practice child interview process'], ['recommendations', 'mediated interview process'], ['emotional  abuse', 'important victim factors'], ['case files', 'longitudinal  study'], ['experiencing', 'parental  figure'], ['victim gender victim feelings', 'complicity'], ['Child abuse expectations', 'parental  findings'], ['when  parent', 'timely  CSA'], ['', ''], ['rights', ''], ['worldwide Internet that', 'online  materials'], ['increased  accessibility', 'sexual Internet child exploitation'], ['availability', 'sexual  abuse'], ['time Internet', 'sexual crime abuse'], ['only  exception', 'Internet child offenses'], ['', ''], ['2014  which', 'child definition'], ['article', 'sexual  abuse'], ['It', 'online CP offenders'], ['Treatment', 'such  offenses'], ['Estimating', 'developing prevention strategies'], ['such  data', 'less  Japan'], ['systematic  we', 'clinical lifetime samples'], ['Data', 'published  reports'], ['abstract  review', '120  publications'], ['that', 'selection criteria'], ['range', 'contact females'], ['', ''], ['7  %', 'males'], ['', ''], ['range', 'penetrative  females'], ['', ''], ['', '%  males'], ['', ''], ['', ''], ['number', 'validated  CSA'], ['penetrative  prevalence', 'international contact estimates'], ['Future research', 'sexual abuse Japan'], ['', ''], ['rights', ''], ['population', 'potential child abuse offenders'], ['yet  offense', 'first  offense'], ['widespread outcome application', 'continuous  improvement'], ['primary prevention number', 'sexual  abuse'], ['that', 'association'], ['permanent placement who', 'Child Abuse'], ['', 'physical health transition'], ['when youth youth', 'child protective services records'], ['majority', 'permanent placement instability'], ['ACEs', 'late health childhood'], ['late childhood PTS', 'physical health transition'], ['long term permanency who', 'focused child welfare youth'], ['', ''], ['rights', ''], ['Amendments', 'substantiated child abuse neglect'], ['little  research', 'policies'], ['representative  we', 'developmental  services'], ['', 'years  amendments'], ['', 'U'], ['', ''], ['Hispanic  children', 'least study period'], ['Implications', 'policy'], ['purpose', 'fatal child maltreatment'], ['who', 'prior Neglect Data 2012'], ['foster family preservation results', 'maltreatment'], ['strong  conclusions', 'additional  area'], ['strong wellbeing assessment tools', 'child welfare success'], ['Data', 'state intervention levels'], ['paper', 'Based Achenbach Assessment'], ['we', 'clinical  reliability'], ['We', 'optimal instrument'], ['implementation that', 'successfully child time'], ['', ''], ['rights', ''], ['David Stoesz', 'social child welfare cartel'], ['he', 'American child welfare system'], ['dramatic', 'claims'], ['We', 'social work educators'], ['however brain impact', 'higher order skills'], ['we', 'that'], ['typically  study', 'long term ToM outcomes'], ['poorest ToM outcomes', 'complicated  TBI'], ['Lesion location', 'conative  ToM'], ['affective injury responsiveness', 'conative  ToM'], ['clinicians', 'related level outcome factors'], ['affective  quality', 'paediatric risk TBI'], ['AimTo', 'children'], ['where child professionals', 'children'], ['Frequently  nurses', 'well  abuse'], ['literature', 'potential  role'], ['', 'Integrative Review framework'], ['Medline Web Medline Scopus', '2005'], ['Review studies', 'methodological Skills Appraisal Programme'], ['Data', 'review aims'], ['ResultsInclusion criteria', '60  studies'], ['main  findings', 'vulnerable knowledge families'], ['often  they', 'knowledge area'], ['why  nurses', 'abuse'], ['very  who', 'trust'], ['psychoanalytic mother child incidence', 'such  incest'], ['more  information', 'yet  data'], ['sexual  abuse', 'many  writers'], ['fact', 'maternal  incest'], ['particular  which', 'psychotherapy'], ['two  who', 'sexually  mothers'], ['female  I', 'abused'], ['effective EMS providers', 'pediatric field death'], ['focus  groups', 'urban EMS November'], ['Sixty eight Sixty providers', 'specific  demographics'], ['13  %', 'average  EMS'], ['follow', 'family'], ['EMS family', 'necessary  support'], ['seamless  family', 'ongoing  communication'], ['what', 'family'], ['Exclusion', 'suspected child abuse'], ['emotional follow families', 'emotional  support'], ['effective EMS providers', 'OOH pediatric OOH death'], ['Background living', 'intentionally  poisoning'], ['Present  study', 'unintentional childhood poisoning'], ['referral center', '2013  July'], ['Cases', 'six Tehran Iran'], ['Parents', 'objective childhood poisoning'], ['logistic  regression', 'measured varying confounders'], ['weights', 'inverse  probability'], ['', 'Sixty cases'], ['7  %', 'Methadone'], ['odds ratio', 'logistic un ORs'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['child abuse', 'parental substance abuse'], ['Education', 'methadone poisoning families'], ['Facial  traumas', 'children'], ['arterial  that', 'very  children'], ['ml  total', 'one  age'], ['evaluation', 'sudden  decompensation'], ['primary  repair', 'damaged  tissues'], ['rule', 'debridement'], ['Careful  repair', 'mucocutaneous  lines'], ['Losses', 'directed  cicatrization'], ['Flaps', 'first  reasons'], ['clinical skeleton signs', 'brutal skeleton shock'], ['respective  that', 'respective  complication'], ['Possible children abuse', 'told age injuries'], ['facial ophthalmology wounds', 'under  vision'], ['second  emergency', 'specific floor child'], ['true  it', 'emergency surgery'], ['dental  trauma', 'functional  consequences'], ['usually  scars', 'long  time'], ['risk', 'also  locations'], ['growth', 'initial  location'], ['specialized  managing', 'aesthetic  view'], ['', ''], ['rights', ''], ['relation', 'respiratory tract infections'], ['', 'viral disease ARI'], ['582 Study children', '15  viruses'], ['Correlations', 'CT values'], ['', 'viral Human Coronavirus'], ['', 'viral  load'], ['viral RSV load', 'extra oxygen use'], ['mean CT value', 'multiple Parainfluenza infections'], ['individual  differences', 'significant  findings'], ['', 'viral  virus'], ['', ''], ['', ''], ['rights', ''], ['It', 'perinatal  depression'], ['', 'spiritual  life'], ['Pregnant  women', 'month  childbirth'], ['Psychological  growth', 'Posttraumatic Growth Inventory'], ['', '177  participants'], ['1  %', 'month follow up childbirth'], ['higher  resilience', 'posttraumatic growth others'], ['High  resilience', 'personal  strength'], ['depressive  symptoms', 'greater  life'], ['variables', 'spiritual  change'], ['giving', 'psychological  growth'], ['other hand it', 'response'], ['findings', 'psychological  mothers'], ['interactions', 'depressive onset disorder'], ['how childhood abuse neuroticism', 'general adult population'], ['shortened Life Experiences which', 'shortened Personality Questionnaire Revised'], ['', ''], ['single  regressions', 'data'], ['Childhood abuse neuroticism', 'depressive life symptoms'], ['Childhood abuse', 'structural equation modeling'], ['', 'recall study'], ['study', 'sectional  design'], ['neuroticism', 'negative life events'], ['Childhood abuse', 'depressive  symptoms'], ['individual  differences', 'young child adults'], ['reported  measures', '66 efficacy child adults'], ['higher  who', 'higher  those'], ['who', 'ADHD self symptoms'], ['physical causal abuse', 'later  life'], ['that', 'physical childhood abuse'], ['human rights that', 'cultural gender boundaries'], ['risk', 'disabled  children'], ['It', 'disablist  society'], ['institutional  that', 'everyday  life'], ['Violence', 'individual  professionals'], ['disabled childhood violence these', 'official child abuse'], ['prognostic  who', 'early  disease'], ['study', '2013 Hospital Tehran October'], ['medical  patients', 'statistical  analyses'], ['age', '15  yr'], ['', 'controlled group 2(control group'], ['', 'lower control group'], ['tonic clonic', 'common  seizure'], ['other neurologic disorders', 'refractory control group'], ['who', 'medical  staff'], ['increase', 'Rican  society'], ['article', 'local opinion newspapers'], ['how  visions', 'effective childrens Human Rights'], ['we', 'social family institution'], ['study', 'based Johannesburg South Africa'], ['how focus group they', 'based  home'], ['data', ''], ['Findings', 'accompanying child abuse'], ['based  children', 'resilient  health'], ['highly  polymorphisms', 'obese  children'], ['We', 'early onset children'], ['onset obesity we', 'dependent probe amplification reaction'], ['we', '2305 phenotypic children'], ['obese  we', 'MC4R POMC LEP genes'], ['one SIM1 probe', '52 SIM1 patients'], ['PCR Polymerase chain analysis', 'nucleotide  polymorphism'], ['We', 'extended  cohort'], ['rs3734354  rs3734355', 'index standard deviation score'], ['', 'metabolism blood pressure'], ['obese  we', 'monogenic obesity genes'], ['Nevertheless  we', 'related earlyonset traits'], ['', 'other New children'], ['research which', 'Critical Interpretive Synthesis'], ['2013 Social Services Abstracts', 'Academic ASAP Science'], ['individual  journals', 'also Interpersonal Violence'], ['3323  titles', 'final  synthesis'], ['five evidence characteristics', 'communications interventions'], ['synthesising construct', 'review'], ['evidence', 'public health prevention'], ['review', 'sexual  children'], ['It', 'informed prevention work'], ['Immigrants', 'East 14'], ['', 'total  Canada'], ['sadly North some', 'sexual  abuse'], ['when  who', 'abuse'], ['perpetrators', 'sexual  abuse'], ['they', 'abuse'], ['Asian  children', 'sexual abuse cases'], ['immigrant  children', 'immigrant  children'], ['success', 'significantly vaccine development'], ['pediatric  that', 'pediatric  interest'], ['pneumococcal  vaccines', 'syncytial Streptococcus Staphylococcus detail'], ['Expert Advances', 'future vaccine vaccines'], ['severe  that', 'significantly  children'], ['new  vaccines', 'clinical  children'], ['short attention which', 'classical taste sensitivity adults'], ['aim', 'basic sensitivity schoolers'], ['One hundred One children', ''], ['', ''], ['', 'magic comparison affect'], ['age task', 'verbal  responses'], ['', '0'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['l water dilutions', 'four  levels'], ['Subsets', '20 retest sessions'], ['two success water', 'magic  water'], ['consistently  performances', 'thus level study'], ['average  children', 'selected  tastes'], ['Different sensitivity distributions', 'taste criteria'], ['key  elements', 'appropriate  schoolers'], ['', ''], ['rights', ''], ['demographic characteristics risk', '12 Psychiatric Emergency Services'], ['Bivariate logistic regression analyses', 'pediatric  PES'], ['', ''], ['2  %', 'suicidal thought'], ['ethnic prevalence rates', 'increasingly Whites Latinos'], ['', 'suicidality'], ['263  %', 'mood disorder'], ['', 'psychotic  disorder'], ['', '8  disorder'], ['About  one', 'prior child abuse'], ['Furthermore  patients', 'initial hospital care'], ['study', 'regardless suicide risk'], ['Clinicians', 'psychiatric  crisis'], ['', 'C Elsevier Ltd'], ['aim', 'systematically television viewing'], ['online attention language databases', 'attention language education'], ['that', 'inclusion criteria'], ['relationship', 'television viewing'], ['likely  effects', 'individual characteristics family'], ['Second  features', 'such  outcomes'], ['Specifically  watching', 'academic preschool performance'], ['it', 'short language term'], ['interactions', 'television'], ['systematic  that', 'unique  development'], ['current  generation', 'children'], ['', ''], ['rights', ''], ['underweight  children', 'due  malnutrition'], ['case', 'severe infant underweight'], ['child', 'severe body weight'], ['infant', 'adequate food supply'], ['predisposition', 'disease'], ['well  duration', 'acute food malnutrition'], ['Background', ''], ['genetic  neurogenic', ''], ['main  function', 'metabolism'], ['aim', 'healthy serum vitamin levels'], ['total', 'Sapienza  Rome'], ['', 'allergic skin prick ocular'], ['Serum samples', 'study'], ['Vitamin D dosage', '20  controls'], ['conjunctival scraping', 'VKC'], ['% cyclosporine increase', 'healthy  controls'], ['Moreover  we', 'significant vitamin D disease'], ['children', 'significant vitamin D levels'], ['', 'pediatric 3D population'], ['', '15 experience)reviewed WBMRIs'], ['indications', ''], ['positive  findings', ''], ['third  reader', 'specific gold pathology'], ['Agreement', 'predictive readers STIR'], ['recurrent multifocal chronic recurrent osteomyelitis', ''], ['mean  age', '15  years'], ['Agreement', '0'], ['', ''], ['', ''], ['', '3D  STIR'], ['', ''], ['', ''], ['', '3S  protocol'], ['', '3D  STIR'], ['', '6  3S'], ['', ''], ['2  it', 'reader'], ['', '3D  STIR'], ['', '7  3S'], ['predictive  value', '70 % lymphoma'], ['Sensitivities', '2  protocol'], ['', ''], ['', ''], ['rights', ''], ['Familiarising', 'global child abuse'], ['We', 'first  implementation'], ['We', 'then police children'], ['how tourist seasons', 'police children'], ['children', 'police holidays'], ['how tourist seasons', 'other Cyprus police interviews'], ['We', 'official police testimonies'], ['results', 'Cypriot tourist seasons'], ['', ''], ['cell hematologic B cell who', 'poor line prognosis'], ['promising  who', 'promising  patients'], ['regimens', 'greater T cell expansion'], ['major  toxicity', 'T cell infusions'], ['quick  onset', 'related  mortality'], ['severe  which', 'tocilizumab refractory patients'], ['Other  toxicities', 'T cell neutropenia'], ['that', 'related  toxicities'], ['Studies', 'patient CAR T cells'], ['Long term follow up', 'CAR T therapy'], ['accurate T classifications', 'therapeutic  options'], ['considerations', 'immunologic T cell affinities'], ['international T research they', 'together immunity oncology immunotherapy'], ['new WHO classification', 'immunity vivo imaging'], ['Presentations', 'T cell immunotherapies'], ['packages', 'joint  MTCL'], ['', '23686  genes'], ['chimeric  that', 'nongenomic  alterations'], ['Recently SLC45A3-ELK4 chimera', 'local prostate cancers'], ['Here  we', 'other prostate cancer'], ['coding  we', 'untranslated LNCaP cells'], ['KLK4 cis NAT', 'mediated RT PCR'], ['cDNA transcript', 'multiple KLK4 sense transcript'], ['reporter transcripts', 'trans splicing mechanism'], ['confidence sense confidence three', 'cDNA databases'], ['complex KLK4 that', 'cis sense'], ['neuronal  plasticity', '1 weeks age'], ['reared time cats', 'reared time cats'], ['normal  that', 'older  animals'], ['critical period plasticity that', 'bidirectional  age'], [\"5'RACE  sequencing\", 'gene'], ['', ''], ['Western  blotting', 'visual chimaerin isoform cats'], ['alpha', 'critical  period'], ['Analysis', 'dark alpha chimaerin age'], ['differential  expression', 'frontal  cortex'], ['activating  that', 'corticospinal motor circuits'], ['present  results', 'cortical candidate plasticity'], ['clean power resources', 'power sector'], ['we', 'further research study'], ['review', 'ongoing  conversation'], ['', ''], ['', ''], ['rights', ''], ['Much  attention', 'related CO2 China'], ['explicit  exploration', 'regional CO2 emission volumes'], ['aim', 'accurate cement production'], ['sampling data', 'national level information'], ['process fuel process emissions', '58'], ['', ''], ['', ''], ['', ''], ['volume', 'respectively CO2 2013'], ['discrepancy', 'main production processes'], ['', ''], ['', 'two energy technologies'], ['spatial  distribution', 'mainly NSP process'], ['discrepancy', 'economic distribution China'], ['spatial integration that', 'regional mitigation China'], ['renewable energy sources', 'more  attention'], ['RES', 'rapid  development'], ['However  randomness', 'RES utilization'], ['So  speak', 'large scale RES'], ['However energy storage industry', 'exploration commercialization'], ['This', 'certain  extent'], ['paper', 'energy storage industry'], ['First  it', 'developing energy storage China'], ['Then  paper', 'standard system benefit evaluation'], ['Finally  solutions', 'sound energy storage industry'], ['cDNA self sequences', 'Chinese cherry cultivars'], ['full  length', 'S RNase'], ['normal S(3 m', 'nonfunctional S(4 S(4)-RNase'], ['phylogenetic  analysis', 'S Prunus'], ['', 'earlier  Prunus'], ['Sialic acid', 'mammalian N glycan cells'], ['due inepimerase that', '2-epimerase ManNAc kinase'], ['Sialic acid modification', 'partially cell cells'], ['We', 'polysialic cell surface acid'], ['five cell surface PSA', 'five germ mutants'], ['CMP sialic CST mutations', 'C2 m cells'], ['We', 'Northern CST blotting'], ['C2m9', 'amino missense acids'], ['decreased CST mRNA C2m34', 'putative splice site mutation'], ['partially G256E proteins', 'similar  Golgi'], ['novel missense mutations', 'CST activity'], ['', ''], ['', ''], ['Measuring gene expression', 'valuable gene function'], ['Stably reference genes', 'different gene expression samples'], ['However reference genes', 'Chinese  tallow'], ['185 PDF2 APT TBP', 'sucrose qRT stresses'], ['data', 'common  algorithms'], ['stable experiment genes', 'sucrose experiment stresses'], ['APT GAPDH', 'stable  samples'], ['stability', 'experiments'], ['selected reference genes', 'different chalcone synthase samples'], ['results', 'Chinese gene expression tallow'], ['starter Paocai cultures', '10 degrees C'], ['physicochemical  features', 'industrial  applications'], ['mg  which', 'significantly  control'], ['', ''], ['Low temperature fermentation', 'over Paocai products'], ['Additionally  Paocai', 'denaturing gradient gel electrophoresis'], ['study', 'traditional Paocai products'], ['Vector borne Vector diseases', 'human  health'], ['recent  VBD', 'new disease threats'], ['precise  diagnosis', 'diagnostic  methods'], ['Here  we', 'current  VBD'], ['Chromatin immunoprecipitation', 'used gene expression'], ['which', 'quite  misinterpretation'], ['four Masters students', 'technique'], ['practical  students', 'pairs'], ['They', 'then estrogen receptor it'], ['then DNA target that', 'qPCR'], ['These', ''], ['They', 'two calculation methods'], ['how  technique', 'careful gene results'], ['', 'International Biochemistry'], ['Radiation hardness', 'greatly  production'], ['radiation hardness', 'same  lot'], ['new uniformity test method', 'ionization response comparison'], ['Fusarium seedling blight', 'Fusarium pathogens'], ['We', 'fungal wheat pathogens'], ['disruption', 'diverse knockout Fg'], ['gene family Chs3b', 'Fg expression wheat'], ['Three hairpin RNAi constructs', 'transgenic Fg strains'], ['expression', 'combined type generations'], ['Confocal microscopy', 'transgenic wheat plants'], ['Presence', 'colonizing wheat seedlings'], ['silencing', 'effective field test conditions'], ['asymptomatic  nature', 'current vaccine development'], ['We', 'outer protein variable segments'], ['maximal MOMP VS2/4', 'amino acid sequence'], ['purification tag', ''], ['adjuvant C57BL/6 which', 'live challenge C'], ['', ''], ['Bacterial', 'mediated  responses'], ['Immunized  mice', 'unimmunized control mice'], ['antibody T that', 'recall antigen'], ['Thus MOMP VS2/4', 'less effector pathology'], ['We', 'mucosal chlamydial vaccine'], ['trachomatis genital Chlamydia trachomatis infection', 'reproductive  dysfunction'], ['thus  efforts', 'vaccine'], ['safe  which', 'genital  infection'], ['effective membrane which', 'immune mouse model'], ['current  we', 'added vault adjuvant'], ['immunized PmpG mice', 'histopathologic  C'], ['', ''], ['genital vault vaccine platform', 'genital  infection'], ['specific Chlamydia vault that', 'reproductive tract inflammation'], ['Chlamydia suis infections', 'conjunctivitis pneumonia enteritis'], ['', 'zoonotic  C'], ['suis', ''], ['', ''], ['which', 'chlamydial  infections'], ['', 'C'], ['suis', 'Belgian Chlamydia culture'], ['', 'real time pigs'], ['', 'C'], ['samples', 'Chlamydia trachomatis PCR'], ['Additionally Chlamydia isolates', 'tet(C resistance gene'], ['', ''], ['DNA', 'anatomical  site'], ['None', 'C'], ['', ''], ['Chlamydia suis isolates', 'eight  farms'], ['', ''], ['suis', 'three  farms'], ['', ''], ['suis isolates', 'one  pharyngeal'], ['findings', 'zoonotic  C'], ['suis', 'humans'], ['objective', 'ovarian Chlamys farreri'], ['transcriptomic  analysis', '2500 Illumina platform'], ['174928  42534', 'NR Swiss Prot KOG GO'], ['Results', 'transcriptional transcriptome responses'], ['expressed d genes', '10  libraries'], ['10  majority', 'which'], ['DEGs', 'hormone metabolism'], ['adjacent time point groups', 'coupled G pathway'], ['present  study', 'transcriptomic  C'], ['', 'molecular gonadal maturation'], ['', ''], ['rights', ''], ['13 pilot remediation that', 'Cr(VI'], ['', 'biotic whey injection'], ['molecular biology which', 'overall background treatment'], ['nZVI', 'completely  groundwater'], ['subsequent  application', 'chlorinated  ethenes'], ['spent whey which', 'further remediation site'], ['that', 'dechlorination  reduction'], ['results', 'contaminated whey site'], ['', ''], ['', ''], ['rights', ''], ['PCE  remediation', 'microbial PCE populations'], ['changes', 'prior remediation event'], ['slopes', 'reductive source area'], ['PCE', 'thermal source treatment'], ['thermal treatment cDCE', ''], ['biotic  contribution', 'Dehalococcoides sp'], ['DNA', 'close source area'], ['VC C-13 cDCE', 'downgradient iron plume'], ['interpretation', 'downgradient  plume'], ['chlorinated  effect', 'injection'], ['reductive redox which', 'abiotic  degradation'], ['biogeochemical biology processes', 'chlorinated  ethenes'], ['', ''], ['', ''], ['rights', ''], ['Chloroplast development', 'biological  processes'], ['However  processes', ''], ['genetic chloroplast degree', 'developmental leaf cues'], ['thf1  mutant', 'leaves'], ['new suppressor gene', 'thf1 leaf sot8'], ['nucleotide  mutation', 'partial PRPS9 function'], ['1', 'low photosystem II activity'], ['we', 'specific psrp2 1'], ['knockdown PSRP2 expression', 'leaf variegation'], ['over psrp5 1', 'rRNA processing'], ['processing ribosomal assembly', 'wild type plants'], ['downregulating', 'plastid gene expression'], ['plastid  genome', 'highest copy number'], ['obtaining', 'genetic DNA plant'], ['recent polymerase chain advances', 'plastid  genomes'], ['last  number', 'public sequence 1000'], ['sudden  flood', 'large plant biology'], ['genome  that', 'few  years'], ['new  discoveries', 'molecular  biology'], ['', ''], ['TNF alpha', 'rheumatoid  arthritis'], ['rheumatic drug chloroquine', 'TNF alpha mononuclear phagocytes'], ['We', 'induced cytokine production'], ['', ''], ['IL-6  production', 'ELISA'], ['Levels', 'northern polymerase chain reaction'], ['Synthesis', 'metabolic TNF alpha labelling'], ['Transcription rate', 'run  assay'], ['', ''], ['steady state level', '26-kDa TNF alpha chloroquine'], ['IL-6  release', 'steady state mRNA levels'], ['IL-6  stability', 'IL-1  chloroquine'], ['such TNF they', 'IL-1  beta'], ['', ''], ['soluble TNF alpha it', 'dependent  mechanism'], ['Mammalian cell cultures', 'posttranslational expression processing'], ['which', 'cell proliferation viability'], ['free  conditions', 'recombinant protein production'], ['recombinant protein production', 'early  development'], ['This', 'new cell microenvironment'], ['Chinese  hamster', 'human rhEPO serum-'], ['physiology growth parameters', 'unwanted cell subpopulations'], ['free suspension structure', 'rhEPO'], ['free agitation rate', 'evolutionary operation method'], ['', 'International Union International Biochemistry'], ['Cholangiocarcinoma', ''], ['it', 'recent North decades'], ['prognosis', 'CCA'], ['curative  majority', 'advanced stage resection'], ['therapeutic  approaches', 'molecular  malignancy'], ['review', 'etiologic risk CCA'], ['molecular  pathogenesis', 'mutational  CCA'], ['review', 'diagnostic  CCA'], ['therapeutic  options', ''], ['Cholangiocarcinoma', 'high mortality rate'], ['epithelial mesenchymal transition', 'intrahepatic  spread'], ['genetic gene expression that', 'sarcomatous  CC'], ['Previously  we', 'human CC cell lines'], ['present  we', 'other tumor cell differentiation'], ['We', 'four CC cell lines'], ['deletion mutation', 'sarcomatoid SCK cells'], ['ordinary CC cells', 'Fas  FasL'], ['sarcomatous cDNA that', '18688  genes'], ['247 Choi CK that', '260 Choi CK genes'], ['Northern  blotting', 'differential LDHB UCHL1 ASPH'], ['Immunohistochemistry', 'differential gene proteins'], ['genetic expression alterations', 'sarcomatous CC cells'], ['superior  colliculus', 'other  mammals'], ['We', 'standard choline ChAT'], ['deeper  fibers', 'two  types'], ['ChAT IR cells', 'diverse  morphologies'], ['cholinergic ChAT IR structures', 'parabigeminal microbat brain'], ['TH immunoreactivity', 'cells'], ['density', 'deeper zonal layers'], ['labeled TH IR cells', 'other mammalian SC'], ['cytoarchitectural  results', 'fibers microbat SC'], ['findings', 'visual  systems'], ['Osteosarcoma', 'elderly age group'], ['elderly  patients', 'poorer  adolescents'], ['elderly  we', 'chondroblastic osteosarcoma cell osteosarcoma'], ['immortalized cell line CHOS', '50  passages'], ['cell line', 'functional  analyses'], ['CHOS cells', 'doubling  36h'], ['Cytogenetic  analysis', 'chromosome chromosome'], ['immunofluorescence', 'chondroblastic CHOS cells'], ['CHOS cells', 'more  cisplatin'], ['cell line', 'original  tumor'], ['II aggrecan that', 'original tumor cells'], ['results', 'elderly CHOS cell patients'], ['', ''], ['', 'Wiley Periodicals Inc'], ['', ''], ['important performance parameter', 'great offset voltage'], ['chopping  which', 'l CMOS amplifiers'], ['low pass multiplier', 'modulation noise'], ['circuit', '45 nm CMOS process'], ['harmonic  distortion', 'chopper amplifier'], ['chopper frequency', ''], ['input referred noise', ''], ['average power consumption', ''], ['', ''], ['proposed  technology', 'pleasurable  preference'], ['paper', 'two cutoff frequencies'], ['filter', 'chopping cutoff frequency'], ['frequency compensation network', 'two notch sections'], ['transient  response', 'overshoot  undershoot'], ['Three  circuits', 'techniques'], ['that', 'chopping ripple rejection'], ['integrated radio frequency it', 'operational  amplifiers'], ['first  part', 'chopped input RF systems'], ['final transconductance results', 'first  paragraphs'], ['paper', 'current dc applications'], ['Back  thyristors', 'primary transformer side'], ['Thyristors', 'secondary  transformer'], ['This', 'secondary phase diode transformer'], ['passive  filter', 'primary output voltage'], ['scheme', 'passive power filter'], ['Design guidelines', 'optimum turns ratios'], ['', ''], ['', 'passive  17'], ['5  kVA', 'system performance'], ['comparison', 'state  topologies'], ['paper', '28 nm CMOS technology'], ['folded cascode input which', 'common mode range'], ['It', 'Nested Miller compensation'], ['thus sub threshold opamp', 'specific sub threshold operation'], ['chopper technique', 'offset'], ['circuit', '0'], ['', 'simulated 106dB DC gain'], ['Montecarlo simulations', 'offset  2'], ['', ''], ['Hz', 'noise efficiency 8'], ['axial  which', 'notochord'], ['Notochord', 'nervous chorda system'], ['Therefore  notochord', 'molecular biology research'], ['different  notochord', 'notochordal  tissue'], ['Here  we', 'notochordal  cells'], ['histochemical  methods', '9  11'], ['frozen biology fetuses', 'microtome  slicing'], ['', 'where laser capture microdissection'], ['RNA', 'quantitative  PCR'], ['study', 'different  gestation'], ['Immunohistochemical', 'intervertebral  disc'], ['LCM', 'total RNA RNA'], ['qPCR analysis', 'two housekeeping RNA'], ['LCM', 'qPCR  analysis'], ['early embryo notochord', 'future chordoma development classification'], ['', ''], ['', ''], ['rights', ''], ['Chorioamnionitis', 'microbial  infection'], ['It', 'preterm birth neonatal sepsis'], ['decidua', 'initial  infection'], ['decidual stromal cells', 'microbial  threat'], ['Defining', 'improved cell disease'], ['We', 'special pattern recognition pathogen'], ['likely  play', 'future knowledge research'], ['', ''], ['common  effects', 'immune  system'], ['', ''], ['Rhesus macaque dams', 'forming Ureaplasma parvum'], ['Fetuses', ''], ['We', 'fetal  tissues'], ['', ''], ['', ''], ['parvum', 'amniotic  fluid'], ['', ''], ['systemic microbial invasion', ''], ['Fetal lung inflammation', 'alpha alveolar day'], ['Inflammation', 'fetal  brain'], ['', ''], ['parvum', 'interferon gamma fetus'], ['It', '43 gap junction labor'], ['', ''], ['', ''], ['parvum', 'uterine overt chorioamnionitis'], ['It', '1 T phenotype'], ['Background', 'immunosuppressive  therapy'], ['longitudinal  we', 'patients'], ['mg DEX intravitreal', 'systemic  immunosuppression'], ['Medical history', 'patient'], ['We', 'direct fundus examination'], ['Primary  outcomes', 'functional follow up'], ['Secondary  outcomes', 'last immunosuppression examination'], ['Results  We', 'seven  patients'], ['We', '13 SC implants'], ['visual  acuity', 'two  eyes'], ['two pressure eyes', 'cataract progression'], ['DEX intravitreal DEX implant', '8'], ['', '2'], ['', ''], ['systemic corticosteroid therapy', 'serpiginous treatment whom'], ['more food industry', 'new consumer tendencies'], ['two salt levels', 'two storage temperatures'], ['', 'L'], ['sakei', 'pathogen'], ['Higher  amount', 'L'], ['monocytogenes', 'safer  product'], ['', '7  days'], ['monocytogenes', 'samples'], ['', 'L'], ['monocytogenes', 'logistic salt 1'], ['to  3', '%  L'], ['', 'one  fifth'], ['', ''], ['signifi', 'odds'], ['fi', 'viable  L'], ['when  samples', 'low degrees temperature'], ['general  use', 'meat L'], ['', ''], ['', ''], ['potential  inhibition', 'observed LAB behaviour'], ['amount', 'important  L'], ['growth', 'low salt conservation'], ['local recurrence rate', 'squamous cell cancer'], ['remaining  that', 'new  time'], ['however tumor resection this', 'routine  practice'], ['Purpose', 'free  risk'], ['42  patients', 'free resection 1994'], ['Inclusion criteria', 'postoperative follow treatment'], ['embedded tissue sections', '1 p53 immunohistochemistry'], ['11', '5  years'], ['nine', 'least resection margins'], ['', ''], ['P53 overexpression', 'recurrent  disease'], ['presence', 'free resection survival'], ['', ''], ['Conclusions', 'local resection recurrence'], ['', ''], ['rights', ''], ['We', 'stable colon cancer'], ['total', '401  01/2009'], ['selected MYC/8q STK6/20q', 'short fluorescent fragment'], ['primary end point', 'free  survival'], ['recurrence rate', '4  years'], ['9  %', '31 Stage III patients'], ['', ''], ['4-year  DFS', 'significantly  DCC/18q'], ['', 'ERBB2/17q'], ['', ''], ['Stage loss', 'independent  DFS'], ['combination', 'also hazard 2'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '1  alterations'], ['', ''], ['CNVs', 'significantly MSS colon cancer'], ['physical  exercise', 'chronic  inflammation'], ['inhibitory  effects', 'dextran sulfate sodium'], ['rats', 'subsequently swimming exercise'], ['', ''], ['5  hours', 'caused body weight gain'], ['', '1'], ['', '1  day'], ['Swimming', 'induced myeloperoxidase activity Ly6G(+'], ['nuclear kappa B it', 'interleukin-10  levels'], ['however oxygen it', 'levels total antioxidant capacity'], ['', 'inducing cytochrome c Bax'], ['Overall  results', 'oxidative  stress'], ['T(H)2 airway which', 'chronic  cough'], ['', 'chronic  cough'], ['systematic literature review', '2015 language restriction'], ['that', 'chronic reference cough'], ['data', '3 2 accuracy table'], ['Study quality', 'Diagnostic Accuracy Studies'], ['We', 'original  studies'], ['We', 'thus meta analysis'], ['proportion', '59 ICS %'], ['Sensitivity', '97  %'], ['reported  area', 'about  0'], ['', '0'], ['however  studies', 'lower curve values'], ['None', 'placebo effects'], ['We', 'chronic  cough'], ['Further  studies', 'validated measurement cough'], ['Standardization', 'clinical  evidence'], ['', 'C Elsevier Inc'], ['', 'Allergy Asthma'], ['scientific  article', 'specific  field'], ['cited  articles', 'citation classics'], ['Here  we', 'granulomatous  disease'], ['2016 ISI that', 'several  characteristics'], ['cited  article', '955  citations'], ['citations', ''], ['', ''], ['', ''], ['recent  article', '2011'], ['articles', '36 New England Medicine'], ['Overall  authors', '80 United articles'], ['National Institute', 'corresponding  author'], ['common  type', '67  articles'], ['results', 'first research description'], ['granulomatous  disease', 'live microbial births'], ['many  CGD', 'fatal  childhood'], ['90  %', 'now  adulthood'], ['management', 'unique  challenges'], ['authors', 'current  children'], ['This', 'multidisciplinary  CGD'], ['novel  approach', 'preventive  therapies'], ['', '2016 Allergy Asthma'], ['inherited immunodeficiency that', 'recurrent superoxide generation infections'], ['old  who', 'classic Crohn disease'], ['Suspicion', 'granulomatous  infections'], ['Little', 'chronic United States'], ['study', 'Dominican New York City'], ['SI', 'past self month'], ['physical illness burden', 'diagnosed  conditions'], ['logistic  regressions', 'overall  sex'], ['Adjusted  models', 'chronic illness men'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['association', 'younger  adults'], ['Screening', 'chronic health conditions'], ['chronic kidney impact', 'protective graft transplantation'], ['Recent findings Patients', 'skewed T helper'], ['Naive T cell subsets', 'kidney transplantation'], ['naive TEMRA cells', 'long term graft dysfunction'], ['CD28(null memory cells', 'standard  immunosuppression'], ['T cells', 'also costimulation blockade'], ['CKD', 'differentiation T cell subsets'], ['also cell populations', 'immunosuppressive  regimens'], ['', 'little transplant immunology research'], ['CKD mouse models', 'better  posttransplant'], ['Endothelial  dysfunction', 'chronic kidney disease'], ['Uremic toxins', 'pathogenesis'], ['endothelial progenitor mechanism', 'endothelial progenitor cells'], ['that', 'dependent EPC proliferation'], ['72 p h', 'typically CKD patients'], ['ROS production', 'western blot analysis'], ['mRNA expression levels', 'reverse chain reaction analysis'], ['partially ROS effect', 'alpha chain EPCs'], ['mRNA glutathione expression', 'glutathione peroxidase'], ['antiproliferation effect', 'antioxidant activity'], ['results', 'uremic cardiovascular system'], ['residual stem cell transplantation', 'lymphocytic allo outcome'], ['MethodsWe', 'transplant flow cytometry'], ['11  %', 'refractory  disease'], ['61  %', 'undetectable MRD status'], ['', 'free multivariate survival'], ['only  that', 'overall  survival'], ['', ''], ['undetectable allo SCT', 'transplant  outcome'], ['Chemotherapy', 'marked myeloid results'], ['However  acquisition', 'life multidrug patients'], ['ABC apoptosis transporters', 'main  MDR'], ['Apollon', 'respectively  IAPs'], ['present  we', 'chemotherapy interaction'], ['We', 'human ADM Apollon'], ['expression levels', 'reverse polymerase chain reaction'], ['plasmids', 'K562 ADM Lipofectamine'], ['transfection efficiency', 'fluorescence microscopy'], ['knockdown', 'K562 ADM ADM'], ['intracellular  changes', 'ADM shApollon cells'], ['decreased ADM expression', 'ADM RT PCR'], ['Likewise expression levels', 'shMDR1 Apollon expression'], ['first  downregulation', 'Apollon MDR expression'], ['However reversal mechanism', 'direct  other'], ['who', 'free tyrosine kinase remission'], ['however  feasibility', 'nilotinib'], ['available TFR data', 'molecular  TFR'], ['clinical  TFR', 'achievable CML CP'], ['Imatinib mesylate', 'chronic myeloid leukemia'], ['However  minority', 'impaired  IM'], ['organic  transporter', 'main CML cells'], ['Genetic hOCT1 expression changes', 'IM response'], ['we', 'clinical CML patients'], ['resistant IM genotyping', 'direct hOCT1 exon7'], ['hOCT1 gene', 'when IM responder group'], ['', ''], ['Moreover  sequencing', 'SNP 408V'], ['', '3 base exon'], ['genotype', 'two  patients'], ['mRNA expression', 'clinical CML patients'], ['candidiasis APECED APS I', 'APECED patient APECED Finland'], ['molecular  mechanisms', 'azole resistance'], ['', 'C'], ['albicans', 'decreased APECED 9years'], ['strains', 'multilocus sequence typing'], ['mRNA CDR1/2 expression', 'western Mdr1 blotting'], ['', 'multiple  C'], ['isolates', '5  years'], ['different epidemic strains', 'different  strains'], ['molecular  mechanisms', 'azole CDR1'], ['N740S', 'gain  function'], ['Most  isolates', 'TAC1 point mutations'], ['', 'successful symptoms C'], ['albicans strains', 'APECED patients'], ['Microevolution', 'resistant point isolates'], ['', 'chronic  pain'], ['early life interaction', 'site musculoskeletal pain'], ['sectional  data', '1646 Netherlands Depression'], ['presence', 'Pain Grade Chronic Pain CPG'], ['BDNF', ''], ['age', 'Childhood Trauma Interview'], ['Recent life stress', 'adverse Threatening Events Questionnaire'], ['chronic  differences', 'BDNF gene expression'], ['Higher  levels', 'chronic  pain'], ['', ''], ['interaction effect', 'chronic pain presence'], ['BDNF gene', 'chronic  pain'], ['chronic  it', 'chronic  pain'], ['', 'inflammatory proinflammatory mediators'], ['present  we', 'pancreatic  myofibroblasts'], ['mRNA  expression', 'real polymerase chain reaction'], ['expression', 'immunohistochemical  technique'], ['Intracellular', 'transfected  cells'], ['receptor IL-1RAcP', 'chronic  pancreatitis'], ['Interleukin-36  alpha', 'pancreatic CXCL1 CXCL8 myofibroblasts'], ['Interleukin-36 alpha', 'MyD88 TRAF6 complex'], ['IL-36  alpha', 'nuclear factor kappa B'], ['activated protein kinase inhibitors', 'IL-36 alpha stimulation'], ['IL-36 alpha', 'important autocrine function'], ['salivary  constituents', 'salivary OSCC detection'], ['chronic OSCC salivary levels', 'chronic  periodontitis'], ['objective', 'chronic OSCC OSCC'], ['seven  salivary', 'binding S100 protein'], ['severe degree CPS', 'severe degree smokers'], ['Levels', 'specific chain reaction primers'], ['Results', 'CFX96 Real Time System'], ['', 'fold  patient'], ['control groups', 'Bonferroni corrections'], ['ResultsOnly S100P', 'higher  CPNS'], ['', ''], ['', ''], ['difference', 'S100P OSCC'], ['', ''], ['', '1 specificity CPNS'], ['', ''], ['', ''], ['', 'N1-acetyltransferase ornithine decarboxylase CPS'], ['', ''], ['', 'mRNA histone family OSCC'], ['', ''], ['', ''], ['ConclusionsSalivary S100P mRNA', 'chronic OSCC periodontitis'], ['presence', 'oral cancer detection'], ['Chronic  stress', 'precipitating  depression'], ['basolateral amygdala', 'related  behaviors'], ['disrupted despair which', 'fluoxetine'], ['', 'principal BLA neurons'], ['amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptors', 'increased CP GluR1'], ['We', 'protein kinase protein BLA'], ['', 'molecular basal state fluoxetine'], ['chronic BLA which', 'treatment'], ['depressive  behavior', 'stereotaxic CP injection'], ['depressive  behavior', 'dependent BLA neurons'], ['Furthermore  fluoxetine', 'cytoarchitectural BLA neurons'], ['findings', 'structural BLA neurons'], ['', ''], ['rights', ''], ['Introduction', 'marked paranasal life'], ['CRS patients', 'general sleep population'], ['Sleep disruption', 'cognitive  function'], ['that', 'CRS'], ['Expert studies', 'most CRS patients'], ['main risk factors', 'rhinitis sleep smoking'], ['literature', 'disordered  breathing'], ['', ''], ['', 'apnea CRS patients'], ['sleep that', 'upper  airways'], ['detrimental sleep that', 'major  CRS'], ['elimination', 'diagnostic adult chronic rhinosinusitis'], ['', ''], ['CT symptoms nasal results', 'chronic otolaryngology rhinosinusitis'], ['Clinical  diagnosis', 'facial Rhinosinusitis pain'], ['seventy nine seventy subjects', '40 inclusion criteria'], ['45 RSTF %', '34 sinonasal modality'], ['diagnostic  criteria', '24 sinonasal modality'], ['diagnostic reference criteria', 'significant  37'], ['', '1  65'], ['', 'nonsignificant  79'], ['', '2  70'], ['', ''], ['anxiety psychiatric use', 'objective  CT'], ['diagnostic  criteria', 'chronic  rhinosinusitis'], ['', 'increased concordant sensitivity'], ['diagnostic  criteria', 'primary care syndromes'], ['', 'Evidence4'], ['', ''], ['mild  which', 'affective  state'], ['Affective  state', 'behavioral  cues'], ['study', 'affective sheep vaccination'], ['study', 'conventional control group'], ['stressful  lambs', 'induced judgment bias pessimism'], ['attenuated  vaccine', '1B'], ['Stressed lambs', 'affective judgment bias state'], ['stressed vaccine sheep', 'lower hemoglobin concentrations'], ['Antibody response', 'stressed vaccine sheep'], ['affective  state', 'inflammatory vaccine sheep'], ['animal that', 'emotional  sheep'], ['white matter abnormalities', 'depression'], ['However  study', 'white matter rats'], ['current  study', 'CUS  depression'], ['SPT preference scores', ''], ['successfully CUS animal animals', 'SPT'], ['stereological  methods', 'white matter rats'], ['body weight', 'sucrose CUS rats'], ['', ''], ['', ''], ['total  distance', 'significantly control group'], ['', ''], ['', ''], ['total  diameter', 'significantly control rats'], ['', ''], ['', ''], ['', ''], ['', ''], ['pathophysiology underlying pathophysiology which', 'therapeutic  depression'], ['who', 'alternative  medications'], ['profiles', 'often physician treatment'], ['', 'chronic  urticaria'], ['retrospective chart review', 'academic immunology hospital'], ['twenty six twenty charts', 'alternative  agents'], ['Adverse  effects', '4  omalizumab'], ['Most', 'adverse  dose'], ['proper urticaria laboratory', 'chronic urticaria angioedema'], ['', '2016 Allergy Asthma'], ['Social jet lag', 'social  times'], ['used  formula', 'also sleep workdays'], ['free sleep it', 'free  days'], ['Chronotype', 'long term health'], ['We', 'Finnish adult population'], ['based  data', 'years National Finland'], ['part', '12 morningness months'], ['We', ''], ['', ''], ['', ''], ['7  %', ''], ['ETs', 'greater  depression'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['pulmonary  these', 'multiple  testing'], ['Responses', 'cardiac evening insufficiency'], ['', ''], ['', ''], ['', ''], ['eveningness score', 'cardiac  insufficiency'], ['', ''], ['', ''], ['', ''], ['', ''], ['exploratory  study', 'underlying disease mechanisms'], ['Agroinfiltration', 'chrysanthemum stunt viroid'], ['dimeric antisense Agrobacterium', 'chrysanthemum  leaves'], ['local chain reaction infection', '20  days'], ['CSVd polarities', 'infectivity'], ['agroinfiltration', 'cost CSVd inoculation'], ['', ''], ['', ''], ['rights', ''], ['cDNA  Slctlp2', 'like Spodoptera litura'], ['cDNA', 'molecular  30'], ['6  which', 'catalytic motif GDSGGPL'], ['protein', '5th feeding stages'], ['situ  mRNA', 'predominately  midgut'], ['Expression', 'bacterial  infection'], ['gene 20-hydroxyecdysone', 'expression'], ['expression', 'up Slctlp2 feeding'], ['6th instar it', 'gut'], ['Slctlp2 gene', 'digestive larval development'], ['', ''], ['rights', ''], ['Two dehydrin genes', 'intybus EST database'], ['They', '10 field conditions'], ['CiDHN1', 'amino  acids'], ['rich K which', 'typical  dehydrins'], ['CiDHN2 sequence', 'two Y(2)K(2)-type dehydrin'], ['CiDHN1', ''], ['CiDHN  genes', 'transcript  accumulation'], ['effect', 'CiDHN1  level'], ['CiDHN1 promoter analysis', 'ABA  elements'], ['present  we', 'doped strontium ortho silicates'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'solid state reaction method'], ['crystal structures', 'orthorhombic Pmna space group'], ['chemical compositions', 'ray energy spectroscopy'], ['TL kinetic parameters', 'kinetics peak shape method'], ['clearly  samples', '395  nm'], ['combination', 'CIE chromaticity diagram'], ['phosphors', 'also  object'], ['piezo electricity', 'prepared  phosphor'], ['Cigarette smoke', 'pulmonary  disease'], ['markedly  proliferation', 'present cigarette smoke extract'], ['various  proliferation', 'MTT assay'], ['Furthermore expression levels', 'stimulated polymerase chain reaction'], ['effects', 'C ASMC proliferation'], ['which', 'C  EBP-'], ['simultaneous cell knockdown', 'C cell proliferation'], ['which', 'C  EBP-'], ['findings', 'new novel therapies'], ['Using', 'negative cigarette taxes'], ['We', '2009 YRBS 2011'], ['youths', 'less cigarette 2005'], ['when youth we', 'period'], ['policy makers', 'alternative youth strategies'], ['key  that', 'higher fatty plants'], ['Using', 'developing Cinnamomum longepaniculatum'], ['deduced amino acid sequence', 'high  other'], ['CSAD gene', 'when spinach ferredoxin'], ['gene', 'small gene family'], ['CSAD gene', 'developing  C'], ['', ''], ['results', 'fatty acid C'], ['', ''], ['molecular behavior mechanism', 'effects'], ['related  we', 'situ liver hybridization'], ['however  it', 'Per2  SCN'], ['peripheral  E2', 'expression'], ['', 'biphasic E2 treatment'], ['effects', 'reproductive  periphery'], ['', ''], ['Symptoms', 'specific airway day'], ['midnight worsening', 'frequent  laryngitis'], ['clock epithelium', 'important  roles'], ['present  we', 'specific murine larynx'], ['mutant B16 mice', 'study'], ['We', 'C EBPbeta HNF3beta'], ['strong night expression which', 'suprachiasmatic  mCry1(-/-)mCry2(-/-'], ['mPER1  proteins', 'early expression morning'], ['nuclear  proteins', 'C  rhythms'], ['MUC5b  protein', 'laryngeal submucosal gland'], ['local laryngeal which', 'suprachiasniatic  nucleus'], ['MUC5b  protein', 'circadian submucosal mucous rhythm'], ['rhythmic  expressions', 'specific laryngeal diseases'], ['', ''], ['rights', ''], ['operational  amplifier', 'brief'], ['It', 'current switchable transconductance values'], ['SO  it', 'switched capacitor integrators'], ['added circuit design complexity', ''], ['Optimal switching', 'brief'], ['average power consumption', 'SO  design'], ['', 'switchable show power SNDR'], ['', ''], ['tumor they', 'metastatic  dissemination'], ['lethal  nature', 'such tumor CTCs'], ['morphologic  which', 'secondary tumor development'], ['substantial mesenchymal variations', 'protein place'], ['primary  intravasate', 'secondary tumor development'], ['that', 'metastatic  process'], ['subjects', 'metastatic detection disease melanoma'], ['', ''], ['', ''], ['rights', ''], ['HRQOL  that', 'differentially disease progression'], ['thus  studying', 'individual HRQOL prognostication'], ['', 'elective HRQOL PROMIS cirrhosis'], ['Outpatient cirrhotics', 'PROMIS computerized tools'], ['elective  hospitalization', 'subsequent  enrollment'], ['domains', 'principal component analysis'], ['daily PROMIS domain function', '77 anxiety variability'], ['groups', 'first  hospitalization'], ['encephalopathy % HE', '286  patients'], ['31  %', '47  which'], ['12  %', ''], ['', ''], ['Time', 'first HE HR'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['pain PROMIS group', 'time'], ['', ''], ['', ''], ['', ''], ['HE HR', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Daily function', 'cirrhotic PROMIS patients'], ['Patients', 'acute kidney injury'], ['transmembrane that', 'immune  cirrhosis'], ['Serum Siglec-7', 'acute liver disease'], ['Clinical  characteristics', 'initial Siglec-7 levels'], ['Primary  outcome', '90  days'], ['92', 'primary kidney analysis'], ['26 serum creatinine', 'MELD Stage Liver score'], ['', ''], ['', ''], ['dL  Siglec-7', 'dL  time'], ['', 'high hazard 1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'Siglec-7 AKI'], ['', ''], ['Addition', '90-day serum mortality'], ['', ''], ['', ''], ['', ''], ['', ''], ['Serum Siglec-7', 'hospitalized  cirrhosis'], ['Addition', '90-day  mortality'], ['Platinum drugs', 'antineoplastic  regimens'], ['chemical platinum aspects', 'chemical platinum drugs'], ['first aquation reaction that', 'second RNA molecules'], ['Knowledge', 'cellular RNA biology'], ['based  drugs', 'coding  RNAs'], ['immune  which', 'substantially chemotherapy efficacy'], ['Together platinum drugs', 'fact'], ['Many  aspects', 'existing  compounds'], ['leprosis disease which', 'substantial citrus Colombia'], ['Specific detection methods', 'growing CiLV countries'], ['', 'putative citrus tissues'], ['31 coat which', 'monoclonal  antibodies'], ['monoclonal  antibodies', 'Western  blotting'], ['polyclonal antiserum UF715', 'immunosorbent antibody assay'], ['immunocapture RT PCR', 'specific CiLV C2'], ['standardized TAS ELISA', 'symptomatic citrus leprosis 1:160'], ['CiLV C2', 'growing citrus Colombia'], ['TAS ELISA', 'epidemiological quarantine purposes'], ['IC RT PCR', 'CiLV C2 validation'], ['', ''], ['', ''], ['rights', ''], ['Citrus tristeza virus', 'major  Citrus'], ['', 'broad spectrum CTV'], ['Refinement', 'ten Ctv resistance genes'], ['ten candidate genes', 'susceptible grapefruit varieties'], ['other Poncirus genes', 'transformed Citrus controls'], ['initial plant it', 'subsequent plant lines'], ['100 % sequence identity', 'two promoter varieties'], ['upstream  sequencing', 'instead gene Poncirus'], ['possibility', 'consistent transgenic Citrus trees'], ['MicroRNAs', 'small RNA plants'], ['We', 'available sequence tags'], ['filtering  we', 'five nine Citrus trifoliata'], ['', ''], ['', ''], ['', '430000 EST citrus'], ['we', 'potential citrus species'], ['Eight  miRNAs', 'mediated gene regulation'], ['target which', 'common gene plant'], ['achievement', 'important  miRNAs'], ['microRNA  component', 'recent LMW years'], ['critical  studies', 'high quality LMW RNA'], ['LMW RNA', 'total nucleic acids solutions'], ['steps LMW RNA which', 'negatively  results'], ['4 M which', 'successfully  laboratory'], ['traditional  method', 'high RNA phenol'], ['many  samples', '4  hours'], ['Therefore  this', 'high woody fruit polysaccharide'], ['Using', 'reverse polymerase chain reaction'], ['MicroRNAs', 'small  RNAs'], ['different  identification', 'guided gene regulation'], ['expressed sequence database', 'citrus'], ['However  little', 'citrus'], ['known citrus EST precursors', 'similar precursor Arabidopsis'], ['northern shoot flower some', 'different  tissues'], ['total', '15 citrus miRNAs'], ['transcription that', 'important leaf shoot'], ['other target genes', 'physiological  processes'], ['Four target genes', 'mediated mRNA Poncirus'], ['miRNA regulation it', 'important  citrus'], ['paper', 'universal power input'], ['controller', 'various circuit conversion efficiency'], ['optimal switching timing', 'two power loss distribution'], ['digital signal processor chip', 'digital  platform'], ['300-W laboratory prototype', 'universal dc output feasibility'], ['values', 'full  115-'], ['PF values', 'full  0'], ['', ''], ['current  harmonics', '3 Class D'], ['operational transconductance amplifier', 'large slew rate'], ['proposed slew rate enhancement', 'class AB input'], ['flipped voltage follower cell', 'last class AB operation'], ['90 nm CMOS which', 'same class A OTA'], ['', 'achieved settling 0'], ['conventional class OTAs', 'proposed class AB'], ['', ''], ['', ''], ['we', 'differential  literature'], ['other  CMFB', 'output common mode CMRR'], ['We', 'complementary triode CMFB'], ['', ''], ['triode CMFB', 'proposed submicron CMOS solution'], ['', ''], ['bandwidth', 'sampling frequencies'], ['vibration bandwidth', 'similar load Omega'], ['demand', '200[kHz class D frequencies'], ['demand', 'experiments'], ['present  study', 'American  2014'], ['that', 'times Science Citation Science'], ['We', 'bibliometric Y articles'], ['productive  categories', 'WoS'], ['Science', 'productive University Massachusetts Technology'], ['physicist Edward Witten', 'highest biochemist Marion citations'], ['article', 'highest Tulane 2014'], ['two  that', 'financial  viability'], ['Feed', 'conventional energy producers'], ['CER emission that', 'renewable  investment'], ['how  subsidies', 'financial CDM projects'], ['investment analysis', 'hydropower wind gas projects'], ['Revenues', 'relative electricity sales profitability'], ['CDM', 'high emission reductions'], ['Moreover  conflicts', 'intensive FIT registration'], ['particular project which', 'carbon credit prices'], ['also  Korea', 'issued  CERs'], ['Improving  incentives', 'possible additionality reforms'], ['review', 'translational pathways epigenetics perspective'], ['We', 'translational  research'], ['renal cell carcinoma', '75 gene sporadic'], ['molecular VHL mutant which', 'partially tumor suppressor epigenome'], ['also  it', 'metastatic  cancers'], ['article', 'therapeutic pathways epigenetics strategies'], ['We', 'different drug pathogenesis'], ['paper', 'significant wind power production'], ['second ahead stage', 'real time operation'], ['off peak demands', 'flexibility'], ['Specifically  we', 'ahead demand prices'], ['minimum power outputs', 'account'], ['', 'PG nonmelting flesh'], ['endo PG gene', 'assisted flesh texture'], ['role', 'biochemical endo analyses'], ['Polymorphisms', 'reverse polymerase chain reaction'], ['endo PG protein', 'NMF'], ['levels', 'NMF fruits'], ['reading endo PG frame', 'MF Oro Bolero'], ['us', 'NMF MF phenotypes'], ['NMF phenotype', 'large endo PG gene'], ['Carbohydrates', 'fully plant health'], ['it', 'encoded fluorescent tags'], ['glycan  that', 'metabolically  glycans'], ['techniques', 'catalyzed  labeling'], ['glycan plant that', 'free  techniques'], ['Arabidopsis seedlings', 'N acetylglucosamine acetylgalactosamine L fucose'], ['azido monosaccharides', 'metabolically Arabidopsis seedlings'], ['Control experiments', 'glycan plant cell wall'], ['free labeling reactions', 'incorporated N acetylglucosamine analog'], ['azido monosaccharide analogs', 'normal growth conditions'], ['results', 'direct plant imaging'], ['Overall  we', 'metabolically fluorescent labeling'], ['glycan glycan which', 'wide plant tissues'], ['free click chemistry that', 'uniform  labeling'], ['improved labeling methods', 'enabled monosaccharide Arabidopsis'], ['purpose', 'pluralistic  depression'], ['Thirty nine Thirty clients', 'evidence site approaches'], ['Eighteen', 'face change treatment'], ['they', 'possible  changes'], ['explicit  which', 'research team'], ['data', 'specific priori themes'], ['', 'making therapy therapy'], ['comfortable  challenging', 'techniques'], ['Treatment outcomes', 'helpful perspectives therapy'], ['clients', 'active  treatment'], ['dysfunctional  change', 'reassurance'], ['confounded term issue', 'little  literature'], ['We', '30 Middle Loire River'], ['three term we', 'invertebrate discharge reduction'], ['Hydroclimatic water factors', '65 trait composition'], ['70  %', 'hydroclimatic trait response changes'], ['They', 'adapted  resistance'], ['improved water quality management', 'adverse climate change'], ['based  approach', 'global term change'], ['basic  that', 'all advancement engineering world'], ['electricity power that', 'every  dilapidation'], ['conventional electricity energy which', 'conventional electricity energy electricity'], ['Nigerian  government', 'renewable energy technologies'], ['renewable  which', 'lingering electricity Nigeria'], ['much  individuals', 'renewable  government'], ['paper', 'three case Florence'], ['heating input assumptions', 'thermal HVAC materials'], ['long need opposite', 'long need term'], ['annual energy need', 'periods'], ['Furthermore attention', 'main energy balance'], ['different energy refurbishment that', 'time'], ['', '50000 United States'], ['empiric  research', 'clinical hospital medicine'], ['We', 'clinical  hospitalists'], ['chiefs', 'best hospital hospitalists'], ['Data collection', 'one interview guide'], ['perspectives', 'editing themes'], ['total', '26  hospitalists'], ['50  women', 'physicians'], ['clinical hospital judgment', 'continued  growth'], ['respected  hospitalists', 'clinical hospital medicine'], ['they', 'desired target objective'], ['opportunistic lung function infections', 'patients'], ['We', 'infectious cohort disease'], ['NPSs', 'multiplex polymerase chain reaction'], ['1094  NPSs', '98  23'], ['', '6 mean follow 3'], ['4  interquartile', ''], ['', ''], ['', ''], ['Approximately  half', '97'], ['', '5 tracheobronchitis 56'], ['pneumonia', 'mainly  44'], ['', '4  nine'], ['', ''], ['', '1 LRTID lung mo'], ['', ''], ['', ''], ['nested control analysis AR', 'RVs'], ['Pseudomonas aeruginosa', 'LRTID'], ['CMV  replication', 'URTID'], ['', '3  mo'], ['', 'RVs'], ['', ''], ['', ''], ['we', 'high RV LTRs'], ['LRTID', 'significant lung function abnormalities'], ['Associations', 'P'], ['', 'aeruginosa CMV replication'], ['prospective  study', 'acute allograft rejection'], ['its', 'transformational drug discovery'], ['new  paradigm', 'molecular weight biology'], ['Here  we', 'encoded library technology'], ['potent  that', 'clinical  study'], ['favorable  that', 'high quality drugs'], ['recent  outbreak', '11000 West 2014'], ['clinical virus vaccine trials', 'virus vaccine candidates'], ['vaccines', 'sporadic term outbreaks'], ['first Ebola vaccine candidates', '1  trials'], ['review', 'future Ebola virus vaccines'], ['', 'Copyright Elsevier Inc'], ['rights', ''], ['Breast cancer', 'leading cancer 1'], ['', ''], ['genetic  profile', 'different breast cancer subtypes'], ['molecular  understanding', 'recent breast years'], ['we', 'potential drug resistance treatments'], ['understanding', 'second line therapeutics'], ['Ca2+/H+ which', '1 halophyte S'], ['', ''], ['it', 'only  48'], ['', 'S'], ['', ''], ['Furthermore SsCAX1', 'high transport mutants Ca2'], ['SsCAX1 expression', 'slightly  S'], ['', ''], ['SsCAX1 expression levels', 'CaCl2 protein treatment'], ['', 'Ca2+/H+ salinity'], ['results', 'halophyte S'], ['salsa', 'cytosolic saline condition'], ['mannose  residues', 'furanose 14-dideoxy-14-imino mannitol'], ['enzyme', 'synthesized dolichol glycoproteins'], ['immunological  relationship', 'reticulum alpha mannosidase'], ['antibodies', 'membrane ER alpha mannosidase'], ['cDNA', 'cytosolic alpha RZPD'], ['Comparison', 'cytosolic alpha mannosidase gene'], ['gene', ''], ['', 'major RNA cleavage site'], ['transcription initiation site', '5 ATG RACE'], ['Northern blotting analysis', 'major  3'], ['8  kb', 'tissues'], ['COS cells', 'cytosolic alpha mannosidase activity'], ['enzyme activity', 'DIM'], ['expressed  enzyme', 'final Man8GlcNAc1 isomer C'], ['', ''], ['', ''], ['rights', ''], ['significant liver flukes', 'dismal  prognosis'], ['', ''], ['viverrini', '10 million 10 C'], ['sinensis', '35 million 35 health'], ['two  worms', 'common life cycle genome'], ['derived novel which', 'carcinogenic  exploration'], ['just  handful', 'metabolic  pathway'], ['main  mechanisms', 'possible damage detail'], ['review', 'main  C'], ['', ''], ['', 'carcinogenic contrast pattern'], ['Clopidogrel resistance', 'coronary cardiovascular intervention'], ['Clopidogrel', 'P2RY12 adenosine diphosphate'], ['', 'P2RY12 adverse CVD PCI'], ['ACS', 'prospective cohort study'], ['whole blood samples', 'induced aggregation ratio detection'], ['P2RY12 genotyping', 'polymerase chain reaction'], ['ventricular ejection fraction', 'echocardiography'], ['', 'adverse CVD event'], ['allele frequencies', 'G52 P2RY12'], ['', ''], ['', ''], ['Patients', 'higher clopidogrel resistance'], ['', ''], ['', ''], ['', ''], ['', 'wild type genotype'], ['logistic  regression', 'C34 T'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'higher clopidogrel resistance'], ['', 'Also C34 T'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'PCI CVD factors'], ['P2RY12 polymorphisms C34 T', 'cardiovascular Chinese ACS PCI'], ['current LCL filter', 'connected  inverters'], ['capacitor current', 'back  resonance'], ['computation  modulation', 'poor system robustness'], ['Meanwhile  delays', 'low frequency gains'], ['thus system robustness', 'active damping loop'], ['proposed inverter which', 'sampled switching signals'], ['Therefore noise immunity', 'inverter'], ['Experimental  results', 'proposed phase method'], ['difficult voltage waveform which', 'saturated voltage waveform operation'], ['scheme', 'realizable  references'], ['unsaturated  operation', 'i'], ['', ''], ['converter voltage reference', 'vector modulation hexagon'], ['thereby integrator windup', ''], ['microbial plant decomposition', 'soil fertility'], ['We', 'anoxic soil condition'], ['oxic soil which', 'previous  study'], ['', 'Soil Biol 43:814'], ['We', 'dried rice plant residue'], ['paddy field soil', 'unlabeled callus cells'], ['DNA', 'C-13-enriched density gradient DNA'], ['Then  polymerase', 'bacterial band sequencing community'], ['distinctly  changes', 'community fractionation'], ['negative  bacteria', 'anoxic carbon condition'], ['14  callus', 'bacterial  phase'], ['anoxic soil composition', 'opposite  conditions'], ['However  members', 'anoxic soil conditions'], ['majority', 'anoxic callus conditions'], ['bacterial  members', 'anoxic soil conditions'], ['flow', 'anoxic soil conditions'], ['mutant  strain', 'high throughput C'], ['', ''], ['mutant strain M11', '7'], ['', '30g  glucose'], ['ferulic  which', 'ferulic acid cultures'], ['', '11g  butanol'], ['', ''], ['8g', 'ferulic P2 medium C'], ['beijerinckii M11', 'well  4'], ['', 'butanol'], ['', 'butanol C'], ['beijerinckii M11', ''], ['9g  L', 'ferulic P2 medium'], ['', ''], ['beijerinckii M11', '6'], ['', 'treated carbon source'], ['results', 'that'], ['beijerinckii M11', 'detoxified butanol production'], ['', 'International Union International Biochemistry'], ['Purpose', 'immunocompromised reviewNorovirus hosts'], ['aim', 'immune deficiency diseases'], ['Recent findingsChronic Norovirus infection', 'immune deficiency diseases'], ['causative  it', 'causative  enteropathy'], ['We', 'preventive Norovirus strategies'], ['it', 'newer disease modification'], ['that', 'holistic  studies'], ['This', 'assessment microbiome signatures'], ['solid organ transplant', 'allograft failure'], ['based  guidelines', 'SOT recipients'], ['community onset that', 'diagnostic  yields'], ['cost analysis', '18-month community onset period'], ['stepwise testing model', 'diagnostic test yields'], ['', 'diagnostic  tests'], ['1  %', ''], ['Diagnostic testing', '$ hospital costs'], ['tests', 'false omission rate'], ['significant  difference', 'NV testing'], ['', ''], ['stepwise testing strategy', 'diagnostic  yields'], ['first stage we', 'C'], ['', ''], ['second stage evaluation', 'immunosuppressive immunoassay stool therapy'], ['low  we', 'further hospital stay'], ['difficile health care infection', 'high HO C'], ['', 'significant  diarrhea'], ['We', 'consecutive  C'], ['', 'academic test hospital'], ['electronic patient data tracking', '48 testing h'], ['Outcome measures', 'C'], ['', ''], ['', 'intervention'], ['', ''], ['', '2321  C'], ['difficile test orders', 'laxative  therapy'], ['', ''], ['difficile test utilization', '208'], ['', '8  143'], ['', 'patient  days'], ['', ''], ['CDI incidence rate', '13'], ['', '0  9'], ['', 'patient  days'], ['', ''], ['Oral vancomycin days', '13'], ['', '8  9'], ['', 'patient  days'], ['', ''], ['Clinical complication rates', '869  diarrhea'], ['', ''], ['clinical data tracking', 'effective  C'], ['', 'inflated HO CDI rates'], ['Clostridium kluyveri', 'fermenting  caproate'], ['NADP(+ oxidoreductase which', 'transcriptional  regulator'], ['transcriptional  that', 'transcriptional  units'], ['deduced Rex protein', 'potentially  NAD(H'], ['numerous promoter which', 'carbon synthesis butyrate formation'], ['Rex', 'transcriptional  regulators'], ['specifically target which', 'excess  NAD(+'], ['Rex', 'carbon  C'], ['', 'cellular  ratio'], ['', ''], ['', ''], ['rights', ''], ['load estimation algorithm', 'means cluster analysis'], ['algorithm', 'missing load measurements'], ['Euclidean correlation distances', ''], ['Several case studies', 'smart load meters'], ['time that', '24 h'], ['Canberra distance', 'other distance functions'], ['segmented cluster centres', 'daily cluster centres'], ['Higher accuracy estimates', '16 24 h'], ['developed estimation algorithm', 'better distribution networks'], ['', ''], ['', 'Elsevier Ltd'], ['Bipolar  disorder', 'substantial  overlap'], ['subgroup', 'overlapping  features'], ['study', 'cognitive cluster phenotypes'], ['143  participants', 'nonsocial performance cognition'], ['means cluster analysis', 'diagnostic  groups'], ['functional  capacity', 'functional  patients'], ['two cluster solution', '3  groups'], ['5 SZ patients', '24 BD patients'], ['BD patients', 'cognitive BD domains'], ['cluster participants', 'cognitive  domains'], ['chronic  most', 'assessment'], ['cognitive phenotype that', 'clinical  diagnoses'], ['social Lowe cognition', 'distinct disease disorder'], ['Pleiotrophin', 'healthy adult tissues'], ['many serum PTN', 'lymphocytic  leukemia'], ['We', 'B CLL B mRNA'], ['enzyme PTN protein', 'healthy B adults'], ['We', 'healthy B controls'], ['Interestingly  quantity', 'PTN disease'], ['Moreover suppression', 'PTN leukemia patients'], ['PTN  PTN', 'lymphocytic  leukemia'], ['Existing  perspectives', 'how cluster firms'], ['study', 'Polish  clusters'], ['First  we', 'cluster internationalization'], ['how cluster managers', 'cluster firms'], ['clusters', 'important cluster entities'], ['cluster matures', 'dense internationalization clusters'], ['microeconomic  study', 'holistic internationalization processes'], ['ongoing  deployment', 'numerous electricity consumption data'], ['information', 'effective tariff structures'], ['various clustering methods', 'meaningful  customer'], ['paper', 'finite consumer categorization'], ['superiority', 'present dependency data'], ['CVMM', 'smart metering trial'], ['superior  performance', 'four validity indicators'], ['predictive  performance', 'existing  methods'], ['Further case studies', 'proposed loading method'], ['Cytokines', 'immune  system'], ['how  molecules', 'novel drug therapies'], ['Cytokines', 'therapeutic prog diseases'], ['regulatory  cytokines', 'common cell types'], ['we', 'immunomodula tory drugs'], ['majority', 'untreated IFN control'], ['Correlation analysis', 'significant pairwise cytokines'], ['strongest  correlations', 'IFN gamma'], ['', 'EPO'], ['', ''], ['Cluster analysis', 'robust  clusters'], ['therapeutic  drug', 'cytokines'], ['that', 'nostic biomarker accuracy'], ['', ''], ['rights', ''], ['chronic myeloid introduction', 'estimated mortality CML'], ['positive CML who', 'imatinib'], ['chain reaction testing', 'BCR ABL mutation'], ['new domain mutation that', 'imatinib'], ['', '% imatinib discontinue resistance'], ['90 BCR ABL mutations', 'therapeutic drug impact'], ['aim', 'myeloid leukemia myeloid disease'], ['study design', 'sectional Research 2015'], ['cytogenetic  fluorescence', '17 comparison analysis'], ['chi square chi test', 'experimental  data'], ['', 'significant  ACAs'], ['', ''], ['', ''], ['', ''], ['', '05  study'], ['MMR', 'ABL KD ACAs'], ['we', 'automated analog circuits'], ['optimal transistors', 'based circuit applications'], ['Eight  performances', 'thermal power ratio'], ['program', 'Optimization Toolbox MATLAB Optimization solvers'], ['operational transconductance amplifier', 'standard Spectre circuit TSMC'], ['', ''], ['good  agreement', 'program optimization'], ['paper', 'adaptive squaring circuits'], ['Here tail current', 'auxiliary  circuit'], ['controlled tail which', 'common mode input voltage'], ['', 'common mode rejection ratio'], ['it', 'differential input voltage'], ['currents', 'thus slew rate'], ['', 'Experimental  0'], ['m CMOS technology', 'current rate enhancement increase'], ['design methodology', 'subthreshold stage CMOS region'], ['procedure', 'capacitive silicon loads'], ['presented  we', 'CMOS 0'], ['35-mu m that', 'only  4'], ['', ''], ['10(-3', '200 DC pF'], ['proposed  OTA', 'high  load'], ['Moreover rate enhancer circuit', '200 pF load'], ['Comparison', 'higher improvement 5'], ['paper', 'compact  reliable'], ['powered  which', 'low power consumption'], ['OpAmp', 'standard'], ['18 m CMOS technology', 'open loop gain'], ['correct  functionality', '1'], ['single  supply', 'similar  literature'], ['It', 'rail  input'], ['', '99 mu W'], ['', ''], ['rights', ''], ['paper', 'angular sensor readout circuit'], ['architecture', 'differential voltage output'], ['amplifier', 'operational power output stage'], ['output current', '80 input mA'], ['proposed  circuit', '0'], ['', ''], ['current  flow', '40 sensor ns'], ['automated circuit design which', 'evolutionary Learnable Evolution article'], ['objective  property', 'modified LEM algorithm'], ['such decision that', 'low design space'], ['learning  process', 'high  individuals'], ['learning phase', 'individual evolution evaluations'], ['expert knowledge', 'design space'], ['circuit evaluation', 'HSPICE simulator'], ['order', 'proposed design method'], ['proposed design method', 'operational amplifier circuits'], ['performance', 'evolutionary strategy algorithm'], ['s CMOS image sensor', 'Sigma Delta Sigma paper'], ['two power buffers', 'power inverters'], ['SC switch circuit', 'low Sigma Delta modulator'], ['analysis design optimization', ''], ['based conversion speed', 'area  consumption'], ['proposed CMOS image sensor', '0'], ['', ''], ['pixel conversion gain', ''], ['CMOS image sensor', 'dynamic  range'], ['total power consumption', '60frame s'], ['', ''], ['', ''], ['rights', ''], ['paper', 'low 45-nm CMOS technology'], ['proposed  circuit', 'low voltage operation'], ['proposed Op Amp', 'open loop 74'], ['1 MHz unity gain', '50-degrees Phase Margin'], ['', '10 power 0'], ['', '39 mu +'], ['', ''], ['Simulation results', 'Slew 0'], ['', 'correct output functionality'], ['', 'operational paper amplifiers'], ['it', 'technological'], ['paper', 'novel causal reasoning'], ['design that', 'design step sequence'], ['topological  structures', 'ideal amplifier model'], ['Circuit performance', 'Spectre simulation'], ['certain design which', 'design process'], ['paper', 'amplifier  0'], ['', '2-mu verification approach'], ['operational  amplifier', 'positive feedback paper'], ['positive output differential feedback', 'single output differential amplifier'], ['proposed Op Amp', '0'], ['18 m CMOS process', 'gpdk45 analog design environment'], ['', 'proposed circuit 116'], ['', ''], ['variation', 'minimal power supply circuit'], ['high Op Amp design', 'paper'], ['Proposed  circuit', 'high  linearity'], ['Architecture', 'differential Op pair'], ['proposed Op Amp', '0'], ['18 m CMOS process', 'analog design environment'], ['simulation', '221 mu W power'], ['THD analysis', 'maximum output voltage'], ['low Op Amp design', 'paper'], ['proposed gm enhancement technique', 'sufficient  gain'], ['Op Amp transistors', 'weak inversion region'], ['proposed Op Amp', 'analog design environment'], ['resultant power consumption', '69  simulation'], ['operational op which', 'mixed signal applications'], ['design', 'folded  architecture'], ['amplifier', 'n well CMOS 1'], ['', ''], ['small signal AC gain', 'amplifier'], ['79  dB', ''], ['', 'resistive M load'], ['same gain bandwidth', 'same  load'], ['', '23 phase 54'], ['', ''], ['amplifier', '167 DC uW'], ['referred  noise', ''], ['operational  amplifier', '1 supply V'], ['work', 'standard layout techniques'], ['changing', 'standard layout foundry'], ['circuit', 'TID dose 0'], ['5 rad((Si)/s', '500  krad(Si'], ['circuit', 'accumulated radiation dose'], ['design practices', 'TID detail'], ['', ''], ['rights', ''], ['article', 'ultrasonic echo signal processing'], ['TGC chain', 'amplification attenuation filtering'], ['on oscillator bias circuit', 'on  chip'], ['presented IC concept blocks', '250 nm CMOS process'], ['750 dB which', 'ultrasonic signal frequency range'], ['second  order', '274 filter quality Q'], ['', ''], ['ring  oscillator', '448 tuning 0'], ['', ''], ['where  length', 'received signal strength'], ['presented TGC IC', 'medical  equipment'], ['large scale task', 'analog integrated circuit hand'], ['Optimization', 'wide design parameters'], ['required analog circuit', 'tedious  process'], ['design  processes', 'high  accuracy'], ['integrated  that', 'challenging VLSI design process'], ['two stage comparator', 'P type semiconductor input driver'], ['evolutionary  technique', 'aging particle swarm leader'], ['main  aim', 'better performance circuits'], ['performance parameters', 'optimal MOS transistor sizes'], ['required  functionalities', ''], ['also ALC PSO', 'other power dissipation etc'], ['', 'examples'], ['optimal  designs', 'current mirror load'], ['CRPSO Particle Swarm technique', 'designed MOS circuits'], ['conventional  which', 'multidimensional search space'], ['Integration', 'best velocity solution'], ['based circuit optimization technique', 'premature Differential Evolution'], ['simulation results', 'based haste design conditions'], ['CMOS amplifier analogue CMOS circuits', 'reported power literature'], ['', ''], ['gravitational GSA PSO', 'operational amplifier circuit'], ['PSO', 'evolutionary  suboptimality'], ['based GSA approach', 'amplifier optimal circuits'], ['sizes', 'design performance circuits'], ['specifications performance parameters', 'other GSA PSO'], ['', 'performance parameters'], ['simulation results', 'search artificial analog CMOS circuits'], ['designed MOS circuit', 'best power dissipation etc'], ['', 'reported  literature'], ['design design which', 'manual  tuning'], ['Multiobjective optimization', 'above  difficulties'], ['hybrid optimisation which', 'evolutionary Backtracking Search algorithm'], ['proposed  algorithm', 'amplifier op circuit'], ['simple  that', 'multimodal problems'], ['DE', 'global optimisation problems'], ['sizes', 'proposed BSA circuits'], ['fine tuning it', 'optimal analogue CMOS circuits'], ['obtained', 'artificial analogue CMOS circuits'], ['designed MOS transistor circuit', 'such power dissipation etc'], ['', 'reported  literature'], ['fifth order loop filter', 'operational  amplifiers'], ['analog  SDM', 'digital hearing aid'], ['class D amplifier', 'analog  standard'], ['', ''], ['maximum output power level', 'class D amplifier'], ['', '46'], ['', ''], ['dynamic  range', 'class D amplifier'], ['', ''], ['order analog order SDM', 'shared op amp'], ['', '1'], ['', ''], ['paper', 'operational Miller compensation technique'], ['LtSpice simulation tool', 'different  characteristics'], ['second  which', 'voltage buffer'], ['work', '90 CMOS technology process'], ['double gain which', 'phase 44'], ['8', ''], ['', ''], ['70  degrees', '44'], ['', ''], ['', ''], ['', '830 mu 2'], ['', ''], ['', '06 mu 1'], ['', '486 mu 1'], ['', '90 nm CMOS technology'], ['', 'paper'], ['CMOS variable gain amplifier', 'digital TV tuner applications'], ['proposed  RFVGA', 'gated wideband operation'], ['SFDR', 'also  detail'], ['', '0'], ['RFVGA', 'minimum noise 7'], ['', 'order intercept order 27'], ['', 'average  27'], ['', '8 supply 3'], ['', ''], ['chip core area', ''], ['', ''], ['', ''], ['', ''], ['operational amplifier that', 'electromagnetic  interference'], ['operational CMOS amplifier', 'present  modeling'], ['moreover frequency response', 'operational  amplifier'], ['900 mVpp EMI signal', 'input'], ['operational  amplifier', 'same operating conditions'], ['mathematical  modeling', 'high EMI robustness'], ['ground which', 'integrated  circuits'], ['long  that', 'conductive ground plane'], ['which', 'capacitively voltage buffer'], ['Simulations', 'commercial amplifier devices'], ['critical EMI which', '10  MHz'], ['', 'electromagnetic output pins'], ['operational  amplifier', 'general  purpose'], ['current control model', 'based stage circuit'], ['thoroughly  step', 'details'], ['results', '46 phase degrees'], ['Supply voltage', 'temperature paper'], ['Process variations', 'corner analysis'], ['results', 'schematic Cadence Design System'], ['paper', 'operational sub threshold region'], ['g circuit design', 'scaled transistors currents'], ['architecture', 'efficient mode input way'], ['analytical  which', 'proper  tuning'], ['prototype', 'operational input output standard'], ['', '35 -control loop'], ['amplifier', '597 mu 3'], ['', 'gain bandwidth gain 42'], ['', ''], ['paper', 'various Stage Operational parameters'], ['full CMOS which', '2'], ['', ''], ['', ''], ['paper simulation curves', 'such PM ICMR CMRR'], ['Simulation', 'PSPICE tool'], ['three  design', ''], ['2 stage op amp', 'open rail output swing'], ['which', 'additional  gain'], ['low power DTMOS', 'low power circuits'], ['congenital  CMV', 'congenital  cytomegalovirus'], ['clinical vaccine trials', 'clinical vaccine trials'], ['choriomeningitis Immunology virus', 'congenital CMV infection'], ['', ''], ['', ''], ['', ''], ['combination vaccine', ''], ['', 'optical coherence tomography'], ['Thirteen  eyes', 'corneal polymerase chain study'], ['Slit lamp images', 'corneal posterior structures'], ['Morphological  changes', 'antiviral  treatment'], ['SD OCT images', 'posterior  cornea'], ['protruding  structures', 'quadrangular saw structures'], ['Reflectivity', 'corneal  regions'], ['', ''], ['protruding  structures', 'antiviral intensity treatment'], ['SD OCT examination', 'CMV corneal CMV endotheliitis'], ['', ''], ['central Gansu disease', 'edible  crop'], ['described virus set', 'infected immunoelectron plants'], ['Lily Cucumber mosaic virus', 'serologic Bromoviridae evidences'], ['cytopathologic transmission electron damages', 'infected transmission electron samples'], ['then hybridization data', 'related  virus'], ['Thus  study', 'systemic serologic infections'], ['study', 'viral  future'], ['transformation', 'interesting life cnidarians'], ['which', 'transverse discoidal ephyrae'], ['endogenous Aurelia aurita', 'molecular  biology'], ['', ''], ['environmental  factors', 'process'], ['main  purposes', 'literature A'], ['environmental  that', 'signaling  strobilation'], ['VLSI technology', 'biomedical healthcare diagnosis monitoring'], ['Analog devices', 'very energy decades'], ['CNTFET', 'performance low power devices'], ['we', 'biomedical D converters'], ['based Op Amp', 'biomedical  ADCs'], ['Simulation results', 'based MOSFET circuits'], ['Results', 'power consumption'], ['proposed circuit simulations', 'HSPICE'], ['based  circuits', 'low power applications'], ['paper', 'acoustic field effect phonon'], ['mechanisms', 'device'], ['flicker noise models', 'compact  model'], ['model', 'easily simulation tool ADS'], ['simulation results', 'ballistic Amp model'], ['Hence degradation', 'bandwidth flicker device'], ['Germany', 'CO2 reduction 2020'], ['result ideas', 'political  measures'], ['such  idea', 'fired power plants'], ['possible  impacts', 'energy system'], ['We', 'German energy system impacts'], ['so  we', 'different  scenarios'], ['usual  second', 'coal phase account'], ['third  scenario', 'same coal phase'], ['definitive coal phase', 'additional  CO2'], ['equal CO2 reduction', 'different  strategy'], ['additional  costs', 'evenly  sectors'], ['sensitivities', 'conclusions'], ['consequences', 'several technology portfolio'], ['', ''], ['rights', ''], ['Conversion', 'oil  supply'], ['political  disruptions', 'raw chemical feed stock'], ['Furthermore  it', 'polygeneration i'], ['', ''], ['ratio', 'fluctuating grid requirements'], ['North Rhine committee', 'final chemical April'], ['RWE which', 'related technology decades'], ['economical  reasons', '30  years'], ['', 'Coal plant concepts'], ['Especially  challenges', 'political market goals'], ['', 'alternative annex lignite'], ['Annex', 'CtL CtG plant'], ['here amine scrubbing', 'used Rectisol scrubbing'], ['', 'electrical gasification heating'], ['', ''], ['rights', ''], ['electrochemical  detection', 'phosphate buffer solution'], ['', ''], ['modified  electrode', 'electrochemical  AA'], ['response', 'cyclic pulse voltammetry techniques'], ['resulting  biosensor', 'concentration 6'], ['', '2'], ['', '86437 detection 4'], ['65  M', 'signal  3'], ['Electrochemical  parameters', 'constant electron transfer AA'], ['', ''], ['', ''], ['using', 'low detection limit'], ['', 'International Union International Biochemistry'], ['metal hip replacements', 'inflammatory pseudotumours osteolysis'], ['cellular  mechanisms', 'responses'], ['Cobalt ions', 'bacterial Gram lipopolysaccharide'], ['We', 'inflammatory adhesion molecules'], ['also adhesion molecule expression', 'MonoMac'], ['Co2 +', 'inflammatory  HMEC-1'], ['they', 'small molecule TLR4 antagonist'], ['Increased TLR4-dependent expression', 'endothelial adhesion cells'], ['Furthermore  we', 'endothelial adhesion molecule cells'], ['metalloproteinase-9  we', 'MMP9 Co2'], ['we', 'endothelial  TLR4'], ['We', '-mediated adhesion molecule expression'], ['Finally  sICAM-1', 'further ARMD studies'], ['neural  differences', 'clinical  results'], ['functional cocaine connectivity', 'independent  cohort'], ['Subjects', 'residential treatment programme'], ['Differences', 'functional resting NTSCUs'], ['Survival analysis', 'clinical treatment relapse'], ['cortical  thickness', 'healthy control subjects'], ['anatomical  seeds', 'temporal default mode NTSCUs'], ['Applying', '88 % accuracy'], ['salient salience abnormalities', 'functional cocaine addiction'], ['', 'high cocaine relapse'], ['ObjectiveTo', 'crack users'], ['Materials', 'seventy four age gender'], ['Demographic  variables', ''], ['Subgingival bacterial Subgingival samples', 'real polymerase chain reaction'], ['significant  difference', 'bacterial  groups'], ['However  users', '1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '75th gingivalis Prevotella intermedia'], ['higher crack occurrence', 'bacterial crack factors'], ['Knowledge', 'effective disease management plan'], ['Derbidae', 'growing  seasons'], ['analyses', '16S rRNA phytoplasma'], ['PCR Polymerase chain amplification', 'specific primer phytoplasma'], ['mkurangai Wilson', 'CLYD phytoplasma'], ['Candidatus Phytoplasma', '16SrXX A subgroup'], ['This', \"palmicola'-related  D\"], ['', ''], ['Background  goal', 'physiological  functions'], ['Combination', 'periodontal gene repair'], ['periodontal ligament stem culture', 'transgenic  PDLSCs'], ['Material', 'Bsd  vector'], ['PDLSCs EfnB2-PDLSCs MC3T3-E1', 'osteogenic vector induction'], ['osteogenic  differentiation', 'alkaline polymerase chain phosphatase'], ['Protein expression levels', 'western blot immunoprecipitation'], ['Alizarin  S', 'increased ALP EfnB2-PDLSCs'], ['', 'vector EfnB2-PDLSCs'], ['', ''], ['significantly vector expression', 'significantly  MC3T3-E1'], ['', 'vector MC3T3-E1'], ['EphB4  receptor', 'osteogenic  differentiation'], ['osteogenic  which', 'cell culture'], ['Varying chemical oxygen concentrations', 'microbial fuel cell'], ['1 L COD', 'mg  54'], ['', '90  %'], ['mg Sulphide L', 'high inlet sulphate'], ['Experiments', 'anodic  mV'], ['99 % sulphate removal', 'COD  0'], ['75', 'around  1'], ['', ''], ['sulphur it', 'sulphur MFC'], ['other ICT infrastructures', 'information management'], ['', 'artefact increases adoption'], ['based  that', 'rural water Uganda'], ['based  system', 'transparency accountability'], ['how research engagement', 'based ICT initiatives'], ['alone coeliac approach', 'serological coeliac tests'], ['predictive  value', 'CD'], ['larger  diagnosis', 'diagnostic  centre'], ['270 adult who', 'bowel biopsies antibody 2014'], ['40  %', 'cut off'], ['diagnosis', 'alone transglutaminase antibody method'], ['small bowel biopsy', 'longer  CD'], ['diagnostic  guidelines', 'centre'], ['', ''], ['rights', ''], ['Research', 'especially film evolution'], ['existing  research', 'lesser cluster institutions'], ['theory', 'two  gaps'], ['role', 'theoretical institutions section'], ['phenomena', 'empirical film part'], ['We', 'particular institutions period'], ['reductionist  approach', 'biological chemical processes'], ['thus emergent properties', 'individual  relations'], ['more -omics studies', 'biological graph theory'], ['protein interaction protein protein structure', 'hubs  bottlenecks'], ['system that', 'PPIs'], ['we', 'expression  reconstruction'], ['new  idea', 'expression  application'], ['special  attention', 'topological  analysis'], ['Caffeine  biosynthesis', 'purine S adenosyl methionine'], ['that', 'high sequence homology'], ['genetic  effect', 'PTGS  constructs'], ['Sense antisense repeat constructs', 'caffeine N methyltransferase biosynthesis'], ['silencing  constructs', 'Agrobacterium tumefaciens'], ['Sonication', 'somatic  C'], ['canephora', 'transformants'], ['Molecular analysis', 'coding  genome'], ['Effectiveness', 'targeted RT PCR'], ['silencing  efficiency', 'transgenic alkaloid HPLC'], ['', 'silencing  efficiencies'], ['constructs', 'mainly N methyltransferases'], ['Results', 'caffeine biosynthetic pathway'], ['Further  lowering', 'low survival caffeine'], ['pressurized desalination capability', 'potential'], ['However electricity production', '10  desalination'], ['authors', 'supercritical  CO2'], ['CO2 power technology', 'desalination process'], ['which', 'based CO2 Brayton cycle'], ['low steam turbine section', 'CO2 Brayton cycle'], ['based power conversion system', 'CO2 Brayton cycle'], ['Several S cycle options', 'suggested optimal operating layouts'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['Functional  decline', 'psychotic  disorders'], ['', 'risk mental risk psychosis'], ['early vulnerability markers', 'diagnostic psychosis classification'], ['', ''], ['Structural equation modeling', 'psychotic  disorders'], ['We', 'functional  NSS'], ['intervening  variables', 'general  categories'], ['', ''], ['trimmed  model', 'negative  symptoms'], ['that', 'multiple  paths'], ['indirect  effect', 'NSS'], ['validity', 'ARMS status'], ['', ''], ['starting pathway variables', 'different psychosis risk'], ['social psychosis which', 'early  identification'], ['Several  studies', 'social CHR individuals'], ['psychotic  it', 'younger risk children'], ['25  that', 'social emotion processing perception'], ['Eligible  studies', 'cognition search terms'], ['how  impairment', 'social cognitive impairment'], ['new  that', 'at  populations'], ['Implications', 'treatment'], ['structured  which', 'cognitive  impairment'], ['Thirty eight Thirty individuals', 'again USS posttreatment'], ['USS training', 'high treatment satisfaction ratings'], ['similar  we', 'specific training content'], ['Content gains', 'attributional  mind'], ['baseline  neurocognition', 'cognitive USS Skills measures'], ['USS', 'cognitive  skills'], ['cognition  it', 'lower range cognitive function'], ['Alterations', 'social disorder course'], ['previous  studies', 'inconsistent  results'], ['', 'sibling emotion design'], ['total patients', 'unaffected Facial Recognition Test'], ['Patients', 'other emotion groups'], ['Healthy siblings', 'facial expression recognition'], ['within Cross analyses', 'overall DFAR participants'], ['Within sibling analyses', 'familial DFAR clustering'], ['discordant emotion schizophrenia', 'familial  etiology'], ['traits', 'clinical schizophrenia spectrum disorders'], ['', ''], ['rights', ''], ['', 'IAPT Psychological services'], ['project', 'mild Psychological Wellbeing Practitioners'], ['treatment development guidelines', ''], ['Phase  I', 'manual scale iterations'], ['Phase II', 'mixed feasibility uptake'], ['guided self help', 'guided self help'], ['10/11  who', 'full treatment treatment'], ['Six', 'reliable follow up'], ['Effect sizes', 'extant PWP outcome benchmarks'], ['delivery', 'CAT SH'], ['controlled intensity evaluations', 'low intensity anxiety'], ['current  paper', 'cognitive behaviour Pakistan'], ['it', 'Pakistani  it'], ['research  development', 'paper'], ['social  cognition', 'different information processing'], ['present  study', 'young information processing verbal'], ['', ''], ['', 'explicit  actions'], ['', '1 processing 1'], ['', ''], ['', ''], ['well  who', 'possible  targets'], ['results', 'that'], ['', ''], ['', ''], ['old  children', 'correctly  actions'], ['Experiments', '2  that'], ['2  they', 'statistical  actions'], ['Overall  study', 'social  cognition'], ['It', '3  age'], ['', ''], ['', ''], ['rights', ''], ['that', 'expectation'], ['costly  environment', 'costly  that'], ['novel  who', 'novel  agents'], ['understanding', 'specific  actions'], ['', ''], ['agents', 'future  ones'], ['', ''], ['shortest  it', 'so  future'], ['efficiency agents', 'actions'], ['', ''], ['', ''], ['rights', ''], ['novel group that', 'neutral  behaviors'], ['', ''], ['', 'different  berries'], ['Participants', 'conforming'], ['', ''], ['who', 'more  Glerk'], ['Children', 'negative  age'], ['effects', 'individual group regularities'], ['data', 'stereotyping group enforcement'], ['unique  they', 'unique  which'], ['Comparisons', 'cultural nonhuman language'], ['natural  selection', 'human  evolution'], ['by humans', 'domestic domestication animals'], ['', 'human domestication humans'], ['synthesis', 'future self domestication tests'], ['natural situations speech perception', 'visual  scene'], ['cognitive speech encoding', 'concurrent speech perception'], ['sensory  listeners', 'segmental  time'], ['spectral precursor that', 'spectral precursor sentence'], ['', 'subsequent target word'], ['contextual  cues', 'subsequent target sound perception'], ['main context effect', 'perceived speech signal'], ['cognitive  load', 'visual search task'], ['cognitive  increasing', 'longer target durations'], ['cognitive load effects', 'temporal sampling framework'], ['later  adjustments', 'attention'], ['', ''], ['rights', ''], ['behavioral  approaches', 'cognitive  reactivity'], ['association', 'depression'], ['We', 'specific CR vulnerability depression'], ['study population', '221 Major Depressive Disorder'], ['We', 'demographic data form'], ['participants', 'Leiden Depression'], ['well  CR', 'one way variance'], ['hierarchical linear regression analysis', 'unique  CR'], ['severe group scores', 'logistic regression model'], ['Large group differences', 'rumination  scores'], ['other group differences', 'medium  range'], ['rumination which', 'significant  SRSD'], ['logistic regression model', ''], ['', 'depressed  patients'], ['rumination risk aversion', 'severe  depression'], ['Anxiety disorders', 'mental  adolescence'], ['few emotion studies', 'emotion populations'], ['study', 'cognitive emotion regulation reappraisal'], ['efficacy', 'anxious  youth'], ['', ''], ['', ''], ['', ''], ['', 'psychophysiological  measures'], ['visual  youth', 'Indicators Emotion task'], ['novel  training', 'momentary emotion groups'], ['when  participants', 'emotion task'], ['participants', 'negative anxiety effect'], ['additional group that', 'additional group differences'], ['anxious  youth', 'more emotion regulation effort'], ['training', 'current treatment programs'], ['Psychosocial rehabilitation programs', 'traditional medication therapy'], ['psychosocial  programs', 'cognitive remediation therapy'], ['we', 'cognitive remediation 1990s'], ['We', 'future research directions'], ['We', 'cognitive rehabilitation rehabilitation'], ['', 'various attention types'], ['Future studies', 'cognitive  functions'], ['cognitive  we', 'functional  schizophrenia'], ['', ''], ['', ''], ['rights', ''], ['pilot project', 'social group CET interaction'], ['who', '30 group residents'], ['qualitative  interviews', 'cognitive  tests'], ['Interaction', 'house focus group'], ['six  which', 'formal computer sessions'], ['but computer one', 'group exercises'], ['Observations staff comments', 'social  residents'], ['aspects', 'two  months'], ['formally  it', 'manualized group procedure'], ['feedback effects', 'sustained group community'], ['social  interaction', 'effects'], ['', ''], ['', ''], ['rights', ''], ['cognitive schizophrenia that', 'real world functioning'], ['current  we', 'neurocognitive  training'], ['111  we', 'cognitive training training'], ['Participants', 'social cognition processing'], ['treatment groups', 'functional  capacity'], ['However SCT group participants', 'relative  TCT'], ['even psychosis approaches', 'significant  cognition'], ['functional  form', 'cognitive training approaches'], ['results', 'symptoms'], ['Cognitive remediation programs', 'everyday  outcomes'], ['We', 'cognitive remediation programs'], ['', 'psychotic vocational rehabilitation program'], ['new  that', 'cognitive workplace remediation'], ['groups', '10  weeks'], ['Repeated measures analysis', 'weeks  treatment'], ['Univariate  analysis', 'months work intervention'], ['more ABCR participants', 'challenging  tasks'], ['', ''], ['ABCR effects', 'functional  competence'], ['', 'social  cognition'], ['', ''], ['', ''], ['ABCR participants', ''], ['', ''], ['', 'related ABCR stress'], ['', ''], ['computer -based computer training', 'everyday skill outcomes'], ['Cognitive  challenges', 'social  functioning'], ['challenges', 'social  outcomes'], ['Cognitive remediation', 'cognitive  functions'], ['cognitive  remediation', 'participants'], ['We', 'mental service illnesses'], ['', 'Diagnostic Mental Disorders'], ['', ''], ['', 'cognitive remediation programs'], ['Consensus Cognitive Battery', 'Schizophrenia Syndrome MATRICS'], ['Change', 'reliable change index'], ['Logistic regression analysis', 'cognitive  intervention'], ['Sixty two Sixty percent', 'least MCCB domains'], ['baseline  speed', 'cognitive  remediation'], ['Negative education level factors', 'level shorter education level stay'], ['results', 'good  intervention'], ['Identification', 'cognitive remediation treatment plans'], ['objective', 'Qmci Mild Cognitive screen'], ['', 'geriatric memory loss'], ['Qmci', 'Mini Mental State Examination'], ['Qmci TR', 'impairment borderline age'], ['', ''], ['higher  which', 'adjustment'], ['', ''], ['similar  pattern', 'dementia'], ['Test reliability', 'Qmci TR'], ['Qmci TR', 'Turkish screening population'], ['Evidence', 'social  schizophrenia'], ['Theory', 'social beliefs cognition'], ['', 'adolescent onset schizophrenia'], ['current  study', 'various ToM subcomponents'], ['study', 'affective ToM abilities'], ['Yoni task patients', 'different ToM conditions'], ['AOS patients', 'faux pas scenario'], ['', 'affective disease duration medication'], ['findings', 'ToM tasks'], ['impairment', 'second order ToM'], ['Moreover  deficits', 'symptom disease duration medication'], ['ToM dysfunction', 'adolescent  schizophrenia'], ['cognitive  behavior', 'rapid survival skills'], ['novel', 'wireless sensor networks'], ['ABCC algorithm', 'cluster sensor CWSNs'], ['sensor nodes', 'topological network time'], ['One', 'employing  networks'], ['ABCC algorithm', 'energy networks'], ['cognitive  behaviors', 'wireless sensor networks'], ['Additionally  it', 'optimal parameter settings'], ['Simulation results', 'distributed energy CWSNs'], ['proposed  algorithm', 'other  network'], ['positive  effects', 'long term ART use'], ['Complications', 'long Ugandan adults'], ['We', 'renal data analysis results'], ['Methods', 'above  Uganda'], ['biophysical  measurements', 'social  economic'], ['fasting', 'full counts immunology virology'], ['Plasma samples', 'future  studies'], ['2014  we', '1095  whom'], ['0  %', 'more  9'], ['', ''], ['', ''], ['', 'ART'], ['', ''], ['4  %', 'years  711'], ['9  %', ''], ['6  %', 'ever Tenofovir ART regimen'], ['', 'Inhibitor  regimen'], ['', 'renal  ART'], ['Patients', 'PI density regimen'], ['', ''], ['', ''], ['diastolic  patients', 'p'], ['', ''], ['first line ART', 'renal  function'], ['However integration', 'cardiovascular risk disease'], ['CoLTART cohort', 'long term ART Uganda'], ['human cohort studies', 'intermediate  analyses'], ['Significant  hindrances', 'such  analysis'], ['frequency', 'pediatric plasma participants'], ['', 'freeze thaw inflammatory'], ['Multiple  biomarkers', 'healthy ex individuals'], ['biomarker levels', 'freeze thaw cycles'], ['age', 'stability'], ['quantitative  differences', 'TLR culture ligands'], ['acute protein that', 'multiple freeze thaw cycles'], ['data', 'immunological scale disease'], ['Purpose Keratoconus', 'central  cornea'], ['it', 'collagen type IV'], ['major  protein', 'cornea'], ['Matrix', 'extracellular basement ECM'], ['enzymatic  activity', 'tissue metalloproteinase-1'], ['present  we', 'Iranian population sample'], ['case control study', '140 KC patients'], ['Genotyping', 'rs6609533 polymerase chain reaction'], ['rs55703767G T polymorphism', 'KC'], ['', ''], ['', ''], ['', ''], ['', ''], ['G', 'healthy A individuals'], ['', 'females'], ['', ''], ['', ''], ['', ''], ['', ''], ['allele frequency', 'KC risk KC protection'], ['rs55703767 polymorphism', 'KC'], ['rs6609533  polymorphism', 'increased  KC'], ['indirect impedance measurement techniques', 'particular bioimpedance measurements'], ['new  method', 'operational bioimpedance model resistors'], ['We', 'different fruit samples'], ['Three', 'experimental measurement results'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['IVDD tail model', 'ECM  IVDD'], ['', ''], ['aim', 'ECM IVDD'], ['', 'Background Data'], ['Integrins', 'pathological ECM IVDD'], ['However  role', 'ECM IVDD'], ['', ''], ['three level model', 'four rat weeks'], ['intact disc Co8', 'intact stab coccygeal'], ['', ''], ['significant  degeneration', '9  disc'], ['real polymerase chain reaction', 'Co8 9 Co8 disc'], ['Compression loading', '1 NP cells'], ['one level model', 'severe disc degeneration'], ['1  alpha', ''], ['Similar  activation', 'integrin signaling'], ['', ''], ['Static compression', '1 integrin IVD'], ['other level that', 'compression force'], ['subaponeurotic fluid collection', 'year  age'], ['who', 'natural Sick condition'], ['METHODS Data', 'retrospectively Sick January'], ['Patient age', ''], ['SSFC location', 'characteristics management'], ['yielding', 'English  language'], ['who', 'study period'], ['female  age', '11  months'], ['spontaneously  infants', 'subgaleal hair collections'], ['instrumented  none', 'immediately skin birth'], ['All', '6  cases'], ['months  collections', 'structural  complications'], ['This', 'neurosurgical  center'], ['condition', 'instrumented  delivery'], ['SSFC', 'preceding  trauma'], ['conservative  approach', 'outpatient follow up'], ['on  measurement', 'circuit sensorless converter'], ['on measurement methods', 'low efficiency sensors'], ['gate paper', 'measuring IGBT collector current'], ['circuit', 'on IGBT power emitter'], ['', 'theoretical analysis circuit'], ['circuit', 'dynamic impedance IGBT'], ['', 'state IGBT power emitter'], ['This', 'conventional  detector'], ['adoption', 'large  gain'], ['various  experiments', 'on IGBT collector current'], ['capacitor which', 'voltage uEe'], ['proposed  method', 'IGBT collector current'], ['anabolic fatty acid which', 'colon carcinoma'], ['high  expression', 'molecular colon cancer therapy'], ['molecular colon mechanisms', 'human colon cancer'], ['Cell viability', 'Kit-8 assay'], ['apoptosis rate', 'AnnexinV/ propidium iodide'], ['free fatty acid levels', 'Acid Quantification kit'], ['Western blot analysis', 'target gene'], ['enzymatic  activity', 'human cancer cell line'], ['Emodin', 'higher SW480 SNU C2A'], ['HCT116 protein which', 'elevated protein ubiquitination'], ['Emodin', 'free fatty acids'], ['Emodin', 'time  manner'], ['combined  treatment', 'additive FASN activities'], ['final  product', 'induced FASN viability'], ['emodin', 'phosphatidylinositol3-kinase  Akt'], ['regulated cell growth', 'molecular colon cancer therapy'], ['Changes', 'such  diverticulitis'], ['subtle  changes', 'chronic microbiota diverticulosis'], ['studies', 'healthy biology controls'], ['use', 'intestinal  SUDD'], ['definitive  results', 'available  studies'], ['Most', 'absorbed  antimicrobials'], ['only  1', '4  probiotics'], ['only  2', '11  trials'], ['available  data', 'definite  conclusion'], ['', 'diverticular symptom disease'], ['', 'diagnosis histological CEA TNM staging'], ['', '50  patients'], ['increased  expression', 'tumor tumor samples'], ['', 'when  diagnosis'], ['EGFR gene', 'higher CEA diagnosis'], ['expression', 'clinical TNM remission'], ['therapy', 'existing  therapies'], ['therapeutic  treatment', 'tumors'], ['emitting  diodes', 'lighting automotive lamps communications devices'], ['particular  need', 'research LED lighting'], ['Accurate  prediction', 'solid state lighting field'], ['engineering that', 'normal operating conditions'], ['Prognostics', 'return qualification test analysis'], ['prognostic  that', 'operational LED conditions'], ['methods', 'based filtering particle methods'], ['general  concepts', 'main  methods'], ['fundamental  issues', 'reliability LED LEDs'], ['Finally  challenges', 'prognostic  techniques'], ['Color', 'common surface depth'], ['Understanding', 'molecular surface biology'], ['however  effectiveness', 'such surface visualizations'], ['crowdsourced  that', 'ambient surface occlusion'], ['common visualization design decisions', 'encoded surface colors'], ['color that', 'surface depth'], ['collectively  understanding', 'effective visualization design'], ['striped CPB Leptinotarsa decemlineata', 'global  pest'], ['adverse  insect', 'adverse  toxins'], ['', 'biotechnological biology CPB'], ['modified  potato', 'new  beetle'], ['biotechnological  means', 'alone Colorado potato beetle'], ['control measure', 'remarkable potato adaptability'], ['Nonetheless  potential', 'sustainable CPB management programs'], ['', 'prognostic cancer liver implications'], ['fully  investigated', 'detailed T cell distribution'], ['Patient tissues', '10 tumor border'], ['distinct density patterns', 'malignant T cell tissue'], ['30 mu decrease', 'CD3 T cells'], ['well CD163 macrophages', 'close T cells'], ['data', 'physical  region'], ['Survival analysis', 'direct tumor border'], ['decreased T cells', 'improved mu m survival'], ['detailed  localization', 'clinical T outcome'], ['high resolution analysis', 'clinical T cell responses'], ['spatial T cell investigation', 'new  therapies'], ['', 'colorectal cancer screening'], ['quantitative  PCR', 'pathological duplex TaqMan methods'], ['ITGA6', 'previous stool study'], ['qPCR  methods', 'colorectal TaqMan lesions'], ['ROC curve analysis', 'comparable  0'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'adenomas  cancers'], ['which', 'times control stage'], ['', ''], ['', ''], ['', ''], ['Comparison', 'strong copy ITGA6'], ['ITGA6', 'colorectal TaqMan assays'], ['intergenic noncoding RNAs', 'elevating anticancer therapy'], ['Regulator', 'colorectal  cancer'], ['Radiotherapy', 'preoperative  treatment'], ['considerable  number', 'CRCs'], ['we', 'molecular lincRNA mechanism'], ['Real polymerase chain reaction', 'different tissue samples'], ['Cell viability', 'altered lincRNA expression'], ['direct  impact', 'gain lincRNA strategy'], ['xenograft mouse model', 'CRC treatment'], ['lincRNA ROR', 'CRC cell lines'], ['further  knockdown', 'cell apoptosis'], ['Activity', 'induced CRC therapy'], ['specific  knockdown', 'significant tumor growth'], ['LincRNA ROR', 'potential  CRC'], ['Serrated  polyps', 'human  colorectum'], ['However  identification', 'colorectal  cancers'], ['serrated  polyps', 'serrated precursor pathway'], ['serrated  polyps', 'serrated Health Organization classification'], ['SSA  P', 'colorectal microsatellite instability'], ['proximal interval it', 'mucous  cap'], ['pathologists', 'hyperplastic  polyp'], ['gastroenterologists', 'also postpolypectomy surveillance guidelines'], ['we', 'enhanced endoscopic lesions'], ['People', 'effectively virus replication'], ['defining  cancer', 'high  incidence'], ['aim', 'GI  carcinoma'], ['literature', 'hepatocellular GI carcinoma'], ['only GI little', 'positive treatment patients'], ['More  efforts', 'gap'], ['', ''], ['', ''], ['colorectal  cancer', 'alternative cancer strategies'], ['clinical  imperative', 'clinical surveillance chemoprevention'], ['consensus molecular consensus subtypes', 'molecular  biomarkers'], ['SummaryThe  purpose', 'colonic  neoplasia'], ['Finally  we', 'novel chromatin protection adjuvant'], ['Colorectal cancer', 'common cancer China'], ['Metastatic  dissemination', 'related  mortality'], ['STK31 serine threonine gene', ''], ['It', 'gastrointestinal  cancers'], ['we', 'STK31 CRC patients'], ['STK31 expression level', 'significantly lymph node metastasis'], ['STK31 expression levels', 'significantly RNA level'], ['Surgical  specimens', 'clinicopathological CRC features'], ['Expression', 'real polymerase chain reaction'], ['STK31', 'colorectal  cancer'], ['UNC5C', 'dependence receptor'], ['expression', 'large messenger RNA level'], ['', 'colorectal protein cancer'], ['methylation  expression', 'normal colorectal methylation'], ['Furthermore  relationship', 'methylation protein expression'], ['aberrant  methylation', 'colorectal  cancers'], ['specific chain reaction results', 'UNC5C promoter region'], ['UNC5C methylation', 'colorectal node metastasis cancers'], ['', 'colorectal tissues protein cancers'], ['early node metastasis I', 'advanced node metastasis stage'], ['Furthermore patients', 'Kaplan Meier survival analysis'], ['', ''], ['', ''], ['', ''], ['analysis UNC5C protein expression', 'analysis UNC5C correlation analysis methylation'], ['', ''], ['', ''], ['colorectal  which', 'negatively protein expression'], ['UNC5C', 'colorectal cancers patients'], ['UNC5C', 'further  studies'], ['Background miR-338 3p', 'recently cell differentiation'], ['few  data', 'human colorectal carcinoma'], ['', 'regulative 3p expression mechanisms'], ['total cell RNA', ''], ['3p expression pattern', 'reverse polymerase chain reaction'], ['corresponding protein expression pattern', 'semiquantitative RT PCR'], ['3p expression patterns', 'related CRC factors'], ['Kaplan Meier miR-338 3p', 'overall  patients'], ['PCR', 'human luciferase reporter plasmid'], ['reporter plasmid construct', 'transfected luciferase cells'], ['nontumorous miR-338 value', 'advanced TNM stage'], ['', ''], ['Furthermore miR-338 3p value', 'markedly SW-620 cell line'], ['', ''], ['Low  expression', 'clinical miR-338 covariates'], ['nontumorous SMO protein', 'markedly  CRCs'], ['', ''], ['CRC which', 'reporter plasmid construct'], ['', ''], ['Conclusions nniR-338 3p', 'differentially  CRC'], ['it', 'potential antitumor CRC'], ['integrative  that', 'interpersonal disease epidemiology'], ['development', 'molecular  disease'], ['primary disease aim', 'environmental disease incidence'], ['MPE approach', 'personalized precision prevention'], ['studied MPE approach', 'disease'], ['', 'informative disease biomarkers'], ['further  integration', 'several  MPE'], ['', ''], ['pharmaco MPE immuno MPE', 'etiologic  mechanisms'], ['advent', 'genomic throughput sequencing data'], ['specific disease subgroup', 'public association health'], ['we', 'science precision medicine'], ['chemical  sensor', 'electronic silica wastes'], ['Based Colorimetric Analysis', 'quantitative chemical analysis'], ['', 'two  methods'], ['', ''], ['limit', 'detection  range'], ['Linearity', ''], ['', '0'], ['', 'linear correlation 0'], ['', ''], ['new  sensor', 'up  solution'], ['Ketone  sensor', 'technological silver gold'], ['', ''], ['', ''], ['rights', ''], ['when electricity fluctuating', 'renewable  energies'], ['incorporating', 'stable air energy operation'], ['cooling  heating', 'paper'], ['system', 'engine supplemental heat exchangers'], ['', 'thermodynamic design objectives'], ['', ''], ['overall exergy efficiency', 'combined  system'], ['total product unit cost', 'less  beginning'], ['trade  solution', 'overall exergy 53'], ['', 'total product unit 20'], ['', ''], ['compressor turbine', 'higher exergy efficiency'], ['thermodynamic compression performance', 'gas engine'], ['', ''], ['rights', ''], ['Renewable electricity which', 'greatly  performance'], ['First electricity price', 'called merit order effect'], ['Renewable  which', 'ancillary  services'], ['third  aspect', 'conventional electricity producers'], ['concentrated  it', 'strategic  incumbents'], ['We', 'wholesale  market'], ['significant Coal change', 'renewable Cycle bidding generators'], ['short  effect', 'short  run'], ['Active demand side response', 'significant Great Britain'], ['required power benefits', 'gas supply network'], ['Gas Networks expansion impact', 'electricity time 2050s'], ['results', 'fired electricity peak shaving'], ['reduction', 'meter 90 2050'], ['cost savings', 'around GB power system'], ['DSR', 'crucial gas supply'], ['', ''], ['', 'Elsevier Ltd'], ['Combined modality therapy', 'mainstay thoracic malignancies'], ['integration', 'clinical  oncology'], ['educational cancer meetings', 'state cancer patients'], ['Italian  Association', 'young hypopharynx Italy'], ['meeting', 'latest radiation field'], ['We', 'current  Congress'], ['multimodality approach', 'molecular biology genetics'], ['aspects', 'small cell lung cancer'], ['integration', 'making  therapies'], ['Combination therapy', 'clinical multimodality oncology'], ['Dedicated  meetings', 'young radiation oncology'], ['widespread  overuse', 'human aquaculture health'], ['Alternatively  probiotics', 'aquatic  animals'], ['probiotic  Bacillus', 'MAt32 B'], ['', ''], ['', ''], ['juvenile shrimp vannamei', 'survival disease prevalence'], ['naturally control diets', '6 CFU feed'], ['well  survival', 'treated  groups'], ['infected  shrimp', 'respectively  control'], ['mRNA expression', 'proPO treatment control'], ['LvTo111  gene', 'up treatments control'], ['SOD gene', 'up treatment control'], ['down TGase gene', 'bacillus'], ['', 'conclusion'], ['', 'naturally gene shrimp'], ['This', 'probiotic  A'], ['', 'viral shrimp Litopenaeus vannamei'], ['', ''], ['rights', ''], ['increasing  body', 'pulmonary  health'], ['recently  lung', 'resident  microbiota'], ['lung microbiota', 'immunity epithelial barrier functions'], ['versa  that', 'community composition'], ['Prominent  microbiota', 'pulmonary body health'], ['However  it', 'lung'], ['', 'systemic gut communities'], ['how  microbiota', 'pulmonary  immunity'], ['Energy storage resources', 'attractive demand side flexibility'], ['commercial demand that', 'variable speed heat pumps'], ['proposed  framework', 'thermal electricity prices'], ['thermal  dynamics', 'different room temperature control'], ['consumption  provision', 'contingency wind power generation'], ['Simulation case studies', 'operational ESR penetration constraints'], ['', ''], ['rights', ''], ['Traffic flow', 'making land nature'], ['phenomenon', 'when accessibility factors'], ['case', 'study'], ['municipality', 'commercial traffic consequences'], ['Bojnourd', 'sized North Khorasan province'], ['ultimate  goal', 'commercial route trips'], ['purpose analysis', 'secondary  study'], ['Findings', 'commercial Bojnourd city'], ['Findings', 'strong traffic Bojnourd'], ['that', 'trips'], ['', '2016 Civil Engineers'], ['Identifying', 'parasitized conspecific brood parasitism'], ['Previous  studies', 'mixed egg results'], ['Brood parasitism', 'Common length Coot'], ['Euclidean  distance', 'nest'], ['maximum Euclidean distance values', '-parasitized'], ['', ''], ['', ''], ['split  value', 'recursive Common Coot nests'], ['', ''], ['which', '93'], ['3  %', ''], ['0  %', 'nests'], ['dissimilar  egg', 'only  39'], ['', 'parasitic  eggs'], ['Egg morphology', 'parasitic Common Coot eggs'], ['method', 'observational biology methods'], ['pulmonary  which', 'chronic lung bronchiectasis'], ['Chronic lung disease', 'significant  patients'], ['However  development', 'bacterial lung bronchiectasis'], ['interstitial lung disease', 'frequently pneumonia history'], ['distinction', 'important lung PAD'], ['antibiotic immunoglobulin which', 'bronchiectasis patients'], ['immunological  factors', 'complication'], ['Importantly  ILD', 'more  bronchiectasis'], ['Further  efforts', 'effective diagnosis patients'], ['', '2016 Allergy Asthma'], ['Intergeneric  hybridization', 'common  improvement'], ['presence', 'reported Kr1 genes'], ['transcriptional Fragment Length analysis', 'Line chromosome 5B population'], ['expressed  fragments', 'Kr1 gene'], ['Further  expression', 'northern blotting analysis'], ['Sequence analysis', 'related signal genes'], ['probable  relation', 'other Kr1 gene'], ['common mode circuits', 'common mode feedback'], ['Miller capacitor', 'operational performance degradation'], ['amplifier', 'open loop DC gain'], ['3-GHz unity gain frequency', '65  margin'], ['margin', 'CMFB'], ['paper', 'traditional air conditioning winter'], ['Tests', 'available heat pipe exchanger'], ['experiment', 'cooling heat pipe exchanger'], ['results', ''], ['heat pipe exchanger', 'operating air conditioning system'], ['typical communication base which', 'climatic  China'], ['saving', 'heat pipe exchanger'], ['saving  rate', ''], ['saving  rate', 'Guangzhou'], ['', 'climatic  zones'], ['fitted  correlation', 'outdoor heat pipe temperatures'], ['', ''], ['rights', ''], ['sequential message strategy', 'experimental threestudy findings'], ['current  study', 'positive DITF studies'], ['where  size', 'DITF condition'], ['2  data', 'additional concession observations'], ['third  study', 'published concession DITF'], ['Results', 'positive concession size'], ['', ''], ['', ''], ['', ''], ['Study findings', 'reciprocal DITF effects'], ['polymorphic Candida albicans', 'polymorphic  fungus'], ['It', 'Northern  blotting'], ['method', 'CAI-4 C'], ['that', 'wide decay rates'], ['168  method', 'half  lives'], ['mRNA decay rates', 'orthologous Saccharomyces cerevisiae'], ['procedure', 'broad  C'], ['albicans', 'fungal  species'], ['paper', 'operational op 1'], ['', ''], ['circuits', 'current protection circuit'], ['The', 'SiC power converter applications'], ['comparator', '400 degrees C'], ['op amp', 'common mode 0'], ['60 dc unity', '2'], ['', '400 degrees C'], ['comparator', '550 degrees C'], ['The', 'analog sense 0'], ['', ''], ['unbalanced controller design', 'generated link voltage etc'], ['', 'generator power control'], ['negative sequence compensation scheme', 'magnetizing DFIG'], ['reference currents', 'compensating magnetizing current'], ['rotor side converter', 'thereby  power'], ['grid side converter', 'unity power factor'], ['controlling', 'also dc link currents'], ['effectiveness', 'experimental wind generation 2'], ['3  kW', 'test setup'], ['experimental  results', 'improved laboratory test performance'], ['low dropout regulator', 'low voltage operation'], ['However D LDO', 'inherently limit cycle oscillation'], ['modes', '65-nm CMOS process'], ['LCO reduction technique', 'feedforward power MOS path'], ['technique', 'ripple LCO a'], ['5', 'current  range'], ['dead zone technique', 'negligible circuit complexity'], ['Numerous breast cancer patients', 'cognitive  chemotherapy'], ['cognitive  impairment', 'significantly  life'], ['pilot study', 'adjuvant breast cancer chemotherapy'], ['Fifty four Fifty patients', 'cognitive waitlist condition'], ['They', 'months intervention completion'], ['Outcomes', 'neuropsychological Therapy Cognitive Function'], ['Raw  data', 'repeated age intelligence analysis'], ['effect', 'means'], ['intervention group', 'cognitive waitlist function'], ['verbal  fluency', 'significant  group'], ['', 'cognitive intervention group'], ['cognitive  training', 'cognitive breast cancer patients'], ['follow pilot durations', 'larger pilot sample'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['remaining cell increase', 'minimal cell number'], ['', 'uncontrolled nephron diabetes'], ['molecular  mechanism', 'renal  conditions'], ['deletion', 'contralateral S6 diabetes'], ['wild mice hypertrophic stimuli', 'known ribosomal protein S6K1'], ['elevated basal which', 'hypertrophic  stimuli'], ['Northern  blotting', 'moderate S6K2 mice'], ['renal  mTOR', 'still  mice'], ['10 % it', 'basal rpS6 phosphorylation'], ['mediated mTOR activation', 'selectively  S6K2'], ['ObjectiveClinical  supervision', 'psychologists'], ['specific  training', 'limited NP attention'], ['Reflective  practice', 'foundational Psychology competencies'], ['Reflective  practice', 'clinical decision practice'], ['discussion paper', 'reflective NP supervision'], ['first discussion stage', 'specific supervision requirements'], ['extant  literature', 'NP supervision'], ['reflective  practice', 'based  models'], ['practical  framework', 'reflective  practice'], ['supervisees', 'different  contexts'], ['reflective practice framework', 'professional career span'], ['intraspecific  competition', 'important  depression'], ['inbred  they', 'outbred  ones'], ['intraspecific  competition', 'often  depression'], ['Nicrophorus we', 'resident  brood'], ['males', 'frequently  residents'], ['', 'outbred adult life males'], ['when  it', 'lighter  larvae'], ['previous  that', 'males'], ['outbred  individuals', 'inbred fitness ones'], ['Wind power integration', 'uncertain power nature'], ['then Distribution GENCOs', 'surplus deficit power supply'], ['paper', 'deregulated wind environment'], ['twelve  spots', 'proposed  approach'], ['real time data', 'selected wind spots'], ['imbalance cost', 'charge rate charge rate'], ['30-bus  systems', 'proposed  approach'], ['', ''], ['rights', ''], ['energetically  females', 'physiological  processes'], ['One', 'immune  defence'], ['such  interactions', 'natural  conditions'], ['1day  we', 'reproductive  effort'], ['We', 'reproductive litter effort'], ['before  this', 'reproductive  effort'], ['Mothers', 'reproductive IgG serum effort'], ['We', 'reproductive measured events'], ['individual  females', 'reproductive  effort'], ['when complement mothers', 'reproductive  effort'], ['differential  responses', 'reproductive  effort'], ['females', 'immune  reproduction'], ['positive  association', 'immune litter placenta'], ['positive  association', 'energetic  reproduction'], ['Complement', 'immune  system'], ['It', 'innate  immunity'], ['tight  control', 'immune  homeostasis'], ['Factor H', 'where self markers'], ['', ''], ['glycan  structures', 'host surfaces'], ['that', 'related macular degeneration'], ['', 'addition'], ['', ''], ['', ''], ['', ''], ['altered  self', 'immune factor response'], ['Here  we', 'infectious factor diseases'], ['Immunology', 'immune  systems'], ['', 'scientific  career'], ['seminal  that', 'molecular  level'], ['killer quest', 'immune killer system'], ['interstitial poly Perforin-1', 'Perforin-2 cell date'], ['three killing systems', 'survival'], ['experimental complement activation', 'different  diseases'], ['that', 'complement disease'], ['alternative  pathway', 'directly lectin diseases'], ['syndrome  it', 'other  glomerulonephritis'], ['that', 'given complement disease'], ['currently complement investigators', 'clinic'], ['We', '0'], ['', 'ultralow power 0'], ['', ''], ['two stage that', 'complementary input stage'], ['coupled output stage', 'additional chip area'], ['Hence  it', 'capacitive op load'], ['dc gain', 'common mode input 0'], ['', '25 supply 0'], ['', ''], ['DC gains', 'common mode input 50'], ['unitygain  frequency', ''], ['0  kHz', '40 phase pF'], ['power consumption', 'bias circuits'], ['', 'd  Xd-1'], ['succinct  proof', 'different  sides'], ['We', 'original  Lagrange'], ['approach', 'definite  improvements'], ['modified Lagrange which', 'most degrees d'], ['', ''], ['rights', ''], ['Metal hydrides', 'flourishing hydrogen economy'], ['recent  studies', 'thermal energy storage plants'], ['review', 'physical structures thermodynamic NiH4](4'], ['synthesized  derivatives', 'complex transition metal hydrides'], ['', ''], ['', ''], ['rights', ''], ['physical  it', 'special  it'], ['natural  it', 'analogous  physics'], ['', 'theoretical  physics'], ['Part', 'daunting living organisms'], ['many  attempts', 'simplicity'], ['we', 'unifying  concept'], ['', 'healthy  population'], ['Patients', 'collected kidney stone database'], ['immune hepatitis patients', 'autoimmune case group'], ['Control group', 'kidney stones'], ['Patients', 'randomly case complexity'], ['Sixty two Sixty patients', '21  cases'], ['', 'age gender mass groups'], ['', 'positioning PCNL accesses'], ['Complication rate', 'case group'], ['', '1  14'], ['', ''], ['major  complications', 'Clavien score'], ['', '8  2'], ['', ''], ['', ''], ['', '19 case 4'], ['', ''], ['', ''], ['', 'hemoglobin level'], ['', ''], ['', ''], ['', ''], ['', '8  4'], ['', ''], ['', 'significantly case group'], ['Immunocompromised  patients', '2'], ['', 'increased  complications'], ['', ''], ['', ''], ['', ''], ['', 'increased blood transfusion'], ['', ''], ['', ''], ['', ''], ['', 'free hospital stay'], ['Immunocompromised  patients', 'such  PCNL'], ['', 'high OP accuracy'], ['differential input circuit', 'systematic offset rejection amplifier'], ['systematic offset voltages', ''], ['Soybean oil', 'important Streptomyces kitasatoensis'], ['different  surfactants', '85 soybean oil utilization'], ['all', 'kitasamycin biosynthesis'], ['', ''], ['g L SDS', '12 control treatment'], ['', ''], ['surfactant', ''], ['consumption rate lipase activity', 'organic kitasamycin biosynthesis'], ['butyric acid concentration', 'containing  acetylation'], ['', 'Additionally oil S'], ['kitasatoensis', ''], ['where fermentation surfactant', 'primarily fermentation process'], ['', 'International Union International Biochemistry'], ['', ''], ['paper', 'overdrive circuit design'], ['Macromodels', 'good amplifier convergence'], ['Also  macromodels', 'double power supply'], ['macromodel', 'sound effect design'], ['Output waveform', 'double power supply'], ['output', 'set  model'], ['macromodel', 'overdrive circuit design'], ['digital controller solutions', 'them'], ['digital  controller', 'continuous conduction mode'], ['', 'due  ADC'], ['', 'adverse control performance'], ['nonlinearities', 'digital  controller'], ['order', 'more  implementation'], ['nonlinearities', 'cycle oscillations'], ['overall phase margin', 'thus  instability'], ['asymptotically  nonlinearities', ''], ['MATLAB Simulink environment', 'issues'], ['unrelated  lymphomas', 'same  tissue'], ['incidence', 'tumors'], ['ones', 'peripheral T cell lymphoma'], ['We', 'mixed cellularity type'], ['We', 'histological  cases'], ['Immunostaining', 'paraffin sections'], ['PTCL cells', 'five  cases'], ['Hodgkin', 'five Reed EBER'], ['IGH immunoglobulin genes', 'whole paraffin sections'], ['We', 'one laser case'], ['HL', 'CD8-positive  PTCL'], ['Clinicians', 'CL'], ['reinforced  polymers', 'mechanical weight corrosion'], ['end  regulations', 'directly  composites'], ['that', 'useful airline industry'], ['work', 'recycling processes restrictions'], ['CFRP recycling that', 'structural  composite'], ['less sparse that', 'Nyquist sampling'], ['computational  complexity', 'real  applications'], ['orthogonal matching they', 'less processing time'], ['stage signal reconstruction algorithm', 'work'], ['It', 'former  work'], ['estimated  these', 'forward  stages'], ['respectively  which', 'iteration'], ['natural DD FBP', 'other success rate'], ['Sequential  estimation', 'wide sub Nyquist attention'], ['However estimation methods', 'off  targets'], ['regardless  targets', 'grids'], ['sequentially delay estimation', 'beamspace direction spectrum estimation problem'], ['spatial spectrum estimation techniques', 'high  delay'], ['existing grid conditions', 'on  targets'], ['Theoretical analyses', 'proposed  scheme'], ['complex level optimization that', 'complex level optimization problems'], ['state  approach', 'mixed integer linear programs'], ['scheduling horizon increases', 'consideration'], ['we', 'strategic nodal electricity markets'], ['mixed integer that', 'huge computation time'], ['when MILP we', 'computation time approach increases'], ['paper', 'embedded  systems'], ['which', 'Least control applications'], ['developed  method', 'current  motor'], ['method', 'correct sample device'], ['zero sequence which', 'harmonic sinusoidal modulation'], ['also  addition', 'harmonic motor current'], ['above  method', '4D24SEC pulse width THD'], ['zero sequence injection', '4D24SEC  PWM'], ['zero sequence signal', 'quite  DZIPWM'], ['4D24SEC  implementation', '4D24SEC  PWM'], ['computational  efficiency', 'programmable gate array platform'], ['paper', 'computational split phase effort'], ['small noncoding that', 'transcriptional gene expression'], ['based  interaction', 'functional miRNAs miRNAs'], ['we', 'endogenous host mammalian one'], ['functional sequence we', 'web software'], ['selected plant we', 'exogenous intracellular interaction networks'], ['when protein mimic', 'line G2 cell line cells'], ['friendly web access', 'website'], ['', ''], ['', ''], ['', ''], ['coding  that', 'posttranscriptional gene level'], ['They', 'abiotic  stress'], ['However  this', 'important bio radiation'], ['responsive expressions patterns', 'gamma IR stress'], ['responsive radiation stress', 'genomic  approaches'], ['Here  we', 'miRNAs  36'], ['PCR polymerase chain analysis', 'selected gamma IR stress'], ['37  miRNAs', '149 pathways DNA repair'], ['predicted  miRNAs', 'regulatory IR Tradescantia'], ['Altogether  results', 'molecular plant gamma'], ['that', 'different  research'], ['active  that', 'potential'], ['we', 'immune protein system'], ['system', 'such B cells'], ['it', 'immune  study'], ['Distinct scenarios', 'mathematical  model'], ['we', 'yellow  fever'], ['simulations', 'available  literature'], ['model', 'such  dengue'], ['Young  children', 'intracranial skull injury'], ['Using', 'fracture  performance'], ['', 'abusive head trauma'], ['This', '3-D skull reconstruction'], ['reference standard', ''], ['studies', 'second interobserver reliability'], ['seventy seven seventy children', ''], ['Sixty two', 'skull  radiography'], ['CT', '87 97 skull fracture'], ['', 'plain  radiographs'], ['', ''], ['Kappa', ''], ['', 'radiologist  CTs'], ['', ''], ['', 'skull radiographs'], ['CT', '3-D skull fractures'], ['skull radiographs', 'diagnostic  value'], ['increasing  levels', 'significant law enforcement agencies'], ['CSA  they', 'on child abuse'], ['such paedophile they', 'known CSA media'], ['new child abuse that', 'network'], ['intelligent forensics that', 'unseen CSA investigators'], ['Additionally  research', 'European enforcement cybercrime countries'], ['iCOP software that', 'forensic P2P network environment'], ['system', 'same P2P client'], ['hands CSA case trials', 'investigative law enforcement workflows'], ['', ''], ['', 'Elsevier Ltd'], ['', 'particular engineering education'], ['physical  that', 'mathematical  algorithms'], ['Furthermore computer it', 'many engineering production'], ['However  focus', 'real  measurement'], ['experimental  stands', 'many university laboratories'], ['that', 'electrical  systems'], ['use', 'large university practice'], ['real block system it', 'basic Operational Amplifier circuits'], ['result', ''], ['behavioural  therapy', 'significant  use'], ['feasible cCBT less', 'Veterans'], ['VA Veterans', 'based  programme'], ['focus  groups', 'supported engagement depression'], ['VA PSS', 'well  support'], ['Veteran  preferences', 'technical PSS progress'], ['also  Veterans', 'real  problems'], ['findings', 'peer support depression'], ['digital  we', '90 East 2013'], ['We', 'near media contacts'], ['especially network who', 'limited  mobility'], ['digital  they', 'new  ones'], ['real  that', 'digital  media'], ['Older  adults', 'digital  companionship'], ['They', 'also  ties'], ['more  Skype', 'close family ties'], ['rather  that', 'existing  ties'], ['social  that', 'older  adults'], ['COMT O genotype', 'adverse vulnerability environment'], ['', 'aggressive COMT behavior'], ['COMT Val158Met polymorphism', '1783  individuals'], ['three way interaction', 'aggressive parent child behavior'], ['when  they', 'positive Met carriers'], ['that', 'aggressive  behavior'], ['novel  they', 'independent  samples'], ['', ''], ['Previous  studies', 'genetic  variants'], ['', ''], ['', 'well  being'], ['how  genes', 'well  being'], ['individual  differences', '445  questionnaires'], ['individuals', 'greater Met gratitude'], ['dispositional  gratitude', 'being genotype symptoms'], ['results', 'genetic  factors'], ['sample size', 'results'], ['study', 'dopaminergic COMT Va1158Met happiness'], ['Solar Tower Technology', 'solar  radiation'], ['called volumetric air receiver', 'concentrated  heat'], ['air which', 'recirculated  air'], ['radiation', 'permeable  material'], ['larger  amount', 'closed heat receiver'], ['heated  air', 'conventional steam turbine system'], ['cellular metal honeycomb structure', 'open volumetric receiver'], ['It', 'flat metal foils'], ['which', 'primarily engine exhaust gases'], ['number', 'turbulence linear honeycomb flow'], ['Firstly  set', 'solar laboratory scale thermal'], ['results', 'theoretical  predictions'], ['promising  materials', '500 Solar Tower Julich'], ['state  which', 'main Solar Tower'], ['Next', 'overall lifetime technology'], ['', ''], ['rights', ''], ['High concentration photovoltaics', 'effective utility scale'], ['conventional multiphysics that', 'conventional multiphysics effect'], ['Modelling', 'further market penetration'], ['multiphysics modelling procedure', 'high concentration work'], ['It', 'electrical spectral model'], ['high concentration photovoltaic that', 'thoroughly  geometry'], ['experimental  results', 'good  2'], ['', 'maximum power point'], ['overall performance it', 'solar  electricity'], ['It', 'high concentration photovoltaic modules'], ['', ''], ['rights', ''], ['One', 'thermophysical Heat Transfer Fluids'], ['enhancement', 'technology'], ['Ag nanoparticles', 'eutectic diphenyl oxide'], ['base fluid', 'solar power plants'], ['nanofluids', '6 base fluid'], ['Thus  use', 'overall CSP plants'], ['varying nanoparticle properties', 'heat  conductivity'], ['dynamic  calculations', 'molecular  level'], ['heat conductivity values', 'experimental  tendency'], ['base fluid oxygen atoms', 'important  role'], ['which', 'thermal  properties'], ['', ''], ['rights', ''], ['conceptual  that', 'potable water electricity'], ['We', 'potable water electricity'], ['relative  positions', 'key  parameters'], ['', ''], ['RO energy net', 'power  potential'], ['We', 'mathematical RO PRO'], ['When RO unit', 'PRO unit'], ['permeate potable rate', 'rival  sequence'], ['other salt potential', 'RO  units'], ['', ''], ['', ''], ['rights', ''], ['FRP  composites', 'highly service structures'], ['that', 'FRP laboratory joints'], ['generalized deterioration database', 'environmental bond conditions'], ['existing test reporting', 'full load displacement behavior'], ['experimental  study', 'aqueous carbon conditions'], ['investigation', 'sulfuric acid pH'], ['', 'acid  rain'], ['sulfuric acid attack', 'most  bond'], ['Then  using', 'environmental bond exposure'], ['', '2017 Civil Engineers'], ['ToM preschool who', 'developing brain peers'], ['longitudinal  findings', 'well ToM abilities'], ['who', '6 ToM desires'], ['orthopedic  83', 'typically  children'], ['3  groups', 'demographic  characteristics'], ['mTBI group', '6 months injury'], ['correlations', 'injury characteristics'], ['', 'ToM performance'], ['specific brain that', 'long preschool children'], ['parameter underlying disease it', 'also host physiology'], ['higher  individuals', 'crowded  environment'], ['However  health', 'environmental  conditions'], ['often info which', 'also  offspring'], ['All', 'presumed host density'], ['we', 'consecutive host parasite generations'], ['chemical signals', 'parental phenotypic generations'], ['when life history signal', 'density'], ['', 'infected  exposure'], ['how density host they', 'disease'], ['subsequent  influence', 'instead  infection'], ['findings', 'complex infection disease'], ['We', 'genotype transmission interactions'], ['high  others', 'negative  correlation'], ['efforts', 'recent power conversion years'], ['majority', 'thermal power stress'], ['basic failure precursor', 'recent power literature'], ['sensing which', 'measurement off unit'], ['paper', 'on voltage power resistance'], ['same pole that', 'control purposes'], ['however boost it', 'continuous condition mode'], ['proposed  algorithm', 'dc  converter'], ['paper', 'well generation microgrid'], ['financial  risk', 'value  criterion'], ['proposed  approach', 'mixed linear programming framework'], ['model', 'financial scheduling risk'], ['impacts', 'connected operation modes'], ['total convergence behavior', 'out  analysis'], ['Early life stress', 'lasting stress response life'], ['associated exhibit mechanism', 'effect'], ['social Maternal MS', 'early rodent studies'], ['mice', 'place preference place CPP'], ['MS SI experience', 'male adult mice'], ['We', 'ventral nucleus accumbens'], ['lower protein expression', '2 D2 groups'], ['protein levels', 'male  mice'], ['MS Dl we', 'Drd1a promoter region'], ['female  which', 'epigenetic promoter region'], ['', ''], ['', ''], ['rights', ''], ['predictive control that', 'power factor correction'], ['line current', 'current  controller'], ['current  controller', 'additional  circuits'], ['predictive control method', 'PI current control method'], ['proposed  algorithm', 'predictive optimal duty control'], ['advantages', 'current PFC converters'], ['We', 'proposed  1'], ['', ''], ['human papilloma that', 'external  genitalia'], ['urinary  involvement', 'urinary immunosuppression'], ['old  woman', 'renal  transplantation'], ['She', 'urethral  lesions'], ['', 'also sessile warty TUR'], ['postoperative  course', ''], ['lesions', ''], ['real polymerase chain reaction', 'HPV type'], ['uncommon  involvement', 'urethra'], ['case', '45 bladder condyloma'], ['TUR', 'preferred urinary bladder'], ['conference didactic conference lectures', 'based  presentations'], ['longer  lectures', 'decreased  information'], ['authors', '6-year emergency period'], ['authors', '6 EM years'], ['authors', 'American Academy Academic Emergency Medicine'], ['', 'four lecture conferences'], ['', 'educational fire sessions'], ['', 'mean  lecture'], ['analysis', 'mean lecture length'], ['findings', 'medical education conference planning'], ['Expectation', 'other  environment'], ['likely  qualities', 'evidence'], ['associative learning that', 'indirect  evidence'], ['human twenty we', 'prefrontal decision cortex'], ['Value', 'regardless hand confidence'], ['However  value', 'ventromedial agent area'], ['pattern', 'cognitive posterior anterior'], ['Task behavior', 'social decision contexts'], ['tendency', 'subsequent  conformity'], ['', ''], ['tendency', 'temporoparietal self junction'], ['findings', 'social value others'], ['bilinguals', 'simple flanker task'], ['young  adults', 'flanker  task'], ['', 'flanker reaction effect'], ['however  which', 'previous trial monolinguals'], ['finding', 'response  interval'], ['Study', 'shorter  study'], ['behavioral SCE differences', 'previous reaction time Studies'], ['bilinguals', 'current trial monolinguals'], ['', ''], ['', ''], ['rights', ''], ['congenital Chagas disease', 'congenital Chagas nonendemicity'], ['vertical screening lack', 'common  laboratories'], ['aims', 'cost Trypanosoma cruzi T'], ['', ''], ['passive IgG none', '12  months'], ['', 'sensitive  chemiluminescent'], ['infected antibody decline', 'only treatment initiation'], ['', 'congenital  T'], ['fewer  that', 'significant cost savings'], ['protocol', 'parasitological  test'], ['9  positive', '12  confirmation'], ['simultaneous  vaccination', 'protection'], ['We', 'human length mice'], ['Immunization  vector', 'adjuvanted neutralizing subunit'], ['Immunization', 'robust T cell responses'], ['combined pp65 vectors', 'individual monovalent formulations'], ['pp65  Freund', 'recombinant  gB'], ['vectors', 'gB bivalent formulation'], ['Combined  vaccination', 'maternal GPCMV subunit'], ['bivalent vaccine', 'monovalent pup vaccines'], ['', 'humoral GPCMV model'], ['clinical  trials', 'vectored HCMV vaccines'], ['Cytomegalovirus', 'developed  0'], ['', ''], ['', 'live  births'], ['substantial  it', 'neurodevelopmental hearing children'], ['often CMV majority', 'birth  programs'], ['Other', 'mother  transmission'], ['congenital  field', 'few  years'], ['high throughput treatment', 'long term hearing'], ['review', 'antiviral laboratory therapy'], ['It', 'congenital CMV disease'], ['Erythropoietin', 'pulmonary  vasculature'], ['EPO', 'retinoic acid'], ['direct retinoid pathway', 'CDH  model'], ['synthesis', 'rat CDH'], ['Pregnant  rats', 'gestational  day'], ['Fetuses', 'control'], ['real RT performedto', 'fetal  liver'], ['We', 'fetal EPO lung'], ['relative  expression', 'significantly CDH controls'], ['', ''], ['', ''], ['results', 'RT PCR analysis'], ['significant  changes', 'fetal CDH controls'], ['suppressed CDH which', 'pulmonary CDH rat model'], ['', ''], ['Super majorities', 'scholarly  attention'], ['Legislative  we', 'increasing  polarization'], ['that', 'likely interbranch veto'], ['positive agenda control', '1994 vote election'], ['presidents', 'reputational signing statements'], ['bipartisan  institution', 'bipartisan  alliances'], ['strategic  activity', 'presidential veto bargaining'], ['virtually judgment error', 'much conjunction fallacy'], ['insofar process errors', 'deliberative  reasoning'], ['conjunction errors', 'effortful  thought'], ['Predictions', 'dual override failure'], ['when  participants', 'one  sided'], ['participants', 'errors'], ['cardiac', 'cardiac tissue growth myocytes'], ['pathophysiological fibroblast effects', 'cardiac  myocytes'], ['we', 'rat neonatal rat cardiomyocytes'], ['Cardiac  myocytes', 'full cell surface area'], ['induced amino acid hypertrophy', 'Northern  blotting'], ['CTGF treatment', 'p38 MAPK JNK'], ['mediated cell inhibition', 'cardiac MAP hypertrophy'], ['CTGF', 'cardiac  myocytes'], ['', ''], ['rights', ''], ['neuroimaging  studies', 'affective cognition states'], ['also brain we', '2 covariance sites'], ['opercular  correlation', 'thickness'], ['structural covariance analysis', 'socio cognitive socio phenotypes'], ['prefrontal  empathy', 'anterior insula networks'], ['Findings', 'recruitment generalizability'], ['', 'double  empathy'], ['structural  substrates', 'specific  se'], ['Human brain asymmetries', ''], ['Intriguingly  number', 'brain lifespan'], ['Recent  studies', 'human white matter brain'], ['period  that', 'human  brain'], ['present  study', 'healthy  adolescents'], ['white graph theory', 'hemispheric  networks'], ['2 network degree', 'young  adults'], ['young  adults', 'parasylvian nodal area'], ['social brain that', 'period'], ['Adverse  conditions', 'neonatal  period'], ['study connectomics', 'early brain adolescence'], ['who', 'perinatal  neurodevelopment'], ['Three  cohorts', 'years growth age'], ['connections which', 'axonal pruning process'], ['similar  pattern', 'total connection strength'], ['Associations', 'functional IUGR children'], ['aim', 'conotruncal  defects'], ['Two  polymorphisms', '259 CTDs patients'], ['association', 'SNP TGF-2'], ['frequency', 'significantly control subjects'], ['', '7  40'], ['', ''], ['', ''], ['', ''], ['TGF-2 gene polymorphisms', 'genetic  CTDs'], ['', ''], ['aim', 'cognitive night performance'], ['', ''], ['30 control room CROs', 'last day shift'], ['continuous performance test', 'cognitive  performance'], ['Karolinska sleepiness scale', 'sleepiness'], ['', ''], ['correct  responses', 'working response memory'], ['intentional  errors', 'shift work'], ['', ''], ['CNS', 'significant reaction time'], ['', ''], ['', ''], ['hazardous petrochemical which', 'appropriate  alertness'], ['', 'rotating CRO safety'], ['high success rate', 'developing management India'], ['clinical  that', 'partly  outcomes'], ['Patients', 'rehabilitative oncology pediatric outcomes'], ['Indian Society', 'contemporary consensus medulloblastoma'], ['optional  recommendations', 'follow risk medulloblastoma'], ['current  document', 'curative intent medulloblastoma'], ['specific  guidelines', 'related health care country'], ['optimal use', 'numerous warming mitigation land'], ['goal', 'global warming contribution'], ['', 'different life cycle biomass'], ['Optimal solutions', 'environmental linear programming'], ['utilizing', 'global warming mitigation'], ['purpose combustion', 'promising  technologies'], ['coal  oil', 'still energy system'], ['renewable transport diversion', 'beneficial  uses'], ['natural biofuel gas', 'domestic energy crops cultivation'], ['', ''], ['rights', ''], ['low level that', 'peripheral self control'], ['extent people', 'high level knowledge'], ['initial  individuals', 'dieting promotes self domain'], ['individual  differences', 'control success outcomes'], ['', ''], ['body mass who', 'goals'], ['end self they', 'end self extent'], ['Theoretical  implications', 'findings'], ['aim', 'constructed fuel wetlands'], ['life cycle assessment', 'based anode MFC'], ['systems', '1500 population p'], ['', ''], ['They', 'effluent  quality'], ['treatment CWs', 'conventional CW system'], ['functional  unit', '1  wastewater'], ['LCA', 'CML IA baseline method'], ['three  scenarios', 'environmental Abiotic Depletion Potential'], ['environmental impact impact', 'based anode MFC'], ['It', 'friendly  materials'], ['', ''], ['', 'based anode MFCs'], ['friendly anode which', '20 system %'], ['system', ''], ['', 'conventional CW system'], ['', ''], ['', ''], ['rights', ''], ['back  which', 'nonfatal  construction'], ['Ergonomic studies', 'general LBD risk assessments'], ['directly roof they', 'slanted roof surfaces'], ['paper', 'related laboratory assessment'], ['configurable wood platform', 'rooftop'], ['indicators', 'different signal recording settings'], ['', ''], ['different roof slopes', 'directions'], ['results', 'unfavorable LBD conditions'], ['', ''], ['where pitch work', 'particular  attention'], ['Such  information', 'nonfatal construction jobsites'], ['', '2017 Civil Engineers'], ['other  drugs', 'still  development'], ['Nevertheless  collecting', 'biological  activities'], ['molecular biology techniques', 'recombinant Escherichia coli'], ['which', 'misfolded  proteins'], ['that', 'protein expression solubility'], ['SUMO', 'very Ulp1 protease'], ['However  removing', 'SUMO'], ['expression', 'SUMO'], ['expression Ulp1', 'interest  purification'], ['strategy', 'new Bothrops insularis snake'], ['viable  that', 'viable  proteins'], ['important  this', 'domestic  sector'], ['water savings', 'ways'], ['focus', 'domestic consumer water'], ['study', 'different India South Africa'], ['technical socio questions', 'water household study'], ['individual  washing', 'dishes'], ['running', 'domestic water usage'], ['66  Argentina', 'conscious tap subcontinent'], ['Based', 'voted  Internet'], ['Research Scholars', 'little consumer sponsorship'], ['professional sponsorship which', 'ultimately  team'], ['research purpose', 'professional cycling fans'], ['professional cycling sponsor', 'partnership'], ['yet  fans', 'Euskaltel'], ['corporate sponsor they', 'Basque Euskaltel cycling'], ['how term support', 'negative  sentiment'], ['study', 'particularly sponsorship termination'], ['especially term sponsorship fans', 'time'], ['Green energy', 'environmental research damage'], ['willingness', 'green  consumers'], ['Such  willingness', 'green  energy'], ['so  it', 'green  energy'], ['present  study', 'perceived value value'], ['second  order', 'conditional  value'], ['attempt', 'present originality study'], ['scale', 'green  energy'], ['that', 'green  energy'], ['green  consumers', 'emotional  considerations'], ['mass energy that', 'financial  incentives'], ['Researchers', 'other consumer behaviour'], ['', ''], ['rights', ''], ['social  infections', 'social  which'], ['main populations that', 'network'], ['new data sources', 'molecular HIV prevention'], ['We', 'potential HIV transmission network'], ['existing  we', 'HIV epidemiology'], ['combination that', 'statistical data framework'], ['', ''], ['rights', ''], ['present  study', 'contaminated washing technique'], ['sandy soil samples', 'thermal electricity power plant'], ['sandy  soil', 'dry 20 soil'], ['industrial  wastewater', '30 contamination days'], ['study results', 'optimum water content'], ['considerable unit decrease', 'internal  soil'], ['proposed remediation technique', 'sandy soil soils'], ['results', 'internal cohesion friction'], ['slight  increase', 'contaminated soil samples'], ['removal efficiencies', 'soil'], ['', ''], ['', ''], ['', ''], ['87 soil samples', '40 10 %'], ['driven  that', 'physical  judgments'], ['important  feature', 'suitable  contrast'], ['optimal balance', 'two  other'], ['reached', 'contrast'], ['such color which', 'theoretical  predictions'], ['', 'concurrent cognition judgment'], ['perceptual  that', 'alternative  theories'], ['', ''], ['rights', ''], ['specific decision function', 'cognitive  control'], ['related brain they', 'novel gambling task'], ['virtual  payoffs', 'one  other'], ['reward participants', 'which'], ['results', 'action selection'], ['paper', 'digital mode converters'], ['increased DAC shuffling scheme', 'weighted  averaging'], ['Analysis', 'mathematical transistor level simulations'], ['input offset cancellation scheme', 'simulation results'], ['current  practice', 'load power systems'], ['paper', 'marginal electricity pricing'], ['binary commitment variables', 'optimal values'], ['We', 'continuous time ED problem'], ['marginal  price', 'marginal electricity price'], ['numerical  results', 'varying power systems'], ['approach', 'Sigma Delta CT Sigma paper'], ['', 'electronic  balance'], ['general  idea', 'compensated load cell'], ['pulsewidth differential which', 'Sigma Delta modulator'], ['composite  that', 'two  sinc(N'], ['simulations', 'white Gaussian Simulink'], ['electronic  balance', 'nonautomatic weighing instruments'], ['L plant R', 'current voltage source converters'], ['most LCL filter', 'most  which'], ['VSC working effects', 'equivalent series resistance'], ['plant inductance', 'rated LCL interface conditions'], ['parameters', 'plant time'], ['', ''], ['', 'controlled plant VSCs'], ['current reference controller', 'synchronous reference frame'], ['inductance that', 'current  controllers'], ['Experimental  results', 'approach'], ['impulse  that', 'flat design dc'], ['low frequency phase', 'lead plant dynamics'], ['compensating  filter', 'closed loop response'], ['second order instantiation', 'two design parameters'], ['expression levels', 'RNA quantitation'], ['expression levels', 'two control ischemia'], ['novel expression levels', 'forebrain mouse ischemia'], ['GeneChip Mu6500 we', '24 ischemia reperfusion'], ['stable  we', 'restricted  1'], ['', '5-fold expression threshold'], ['statistical  we', '10 GeneChip data'], ['criterion GAPDH beta genes', '10 control genes'], ['present  findings', 'forebrain control ischemia'], ['use', 'modern energy economy'], ['nuclear power trend', 'based control systems'], ['cyberphysical  security', 'critical  NPPs'], ['we', 'physical  security'], ['We', 'cyber  attacks'], ['We', 'quantitatively intrusion probability'], ['proposed  framework', 'also cybersecurity regulations'], ['We', 'physical  attacks'], ['Finally  we', 'three  metrics'], ['', ''], ['', ''], ['proposed  cyberframework', 'steady state probabilities'], ['residential electricity consumers', 'actively demand response'], ['Dynamic pricing schemes', 'sufficiently consumption management'], ['intelligent HEMS algorithm', 'smart  household'], ['Electric vehicle', 'electric water HEMS'], ['They', 'controllable storage capability'], ['intensive  which', 'dispatchable  source'], ['penetration', 'considerably  future'], ['algorithm', 'PV energy storage system'], ['Simulation results', 'different DR effectiveness'], ['Case studies', 'real  measurements'], ['household', 'controllable PV generation inputs'], ['daily household energy cost', ''], ['', ''], ['', 'different pricing schemes'], ['', ''], ['', ''], ['rights', ''], ['mechanical cord modeling', 'spinal cord injury'], ['We', 'spinal cord injuries'], ['Graded contusion lesions', 'nine impact NHPs'], ['Protocols', 'spinal canal cord'], ['operative  MRI', 'histological lesion measures'], ['behavioral parameters lesion relationships', 'previous  rat'], ['univariate outcome we', 'multivariate cervical SCI syndrome'], ['Impacts', 'digital energy control'], ['', ''], ['', ''], ['model', 'candidate translational candidate therapies'], ['low cost platform', 'convective polymerase chain care'], ['thermal  processor', 'electrical  power'], ['different temperature which', 'controlled domain temperature cycling'], ['one acid dipstick assay', 'instead amplification instrumentation'], ['utility', 'diagnostic H1N1 1'], ['', '35  min'], ['developed  system', 'centralized laboratory facilities'], ['', ''], ['', ''], ['rights', ''], ['where sampling rate', 'fundamental control frequency'], ['new control scheme', 'harmonic control frequencies'], ['proposed control scheme', 'conventional  RC'], ['repetitive  controller', 'less data memory'], ['Dynamic  response', ''], ['stability', 'method'], ['Experimental  results', 'single control scheme'], ['Entomopathogenic  fungi', 'friendly insect mycoinsecticides'], ['genomic insect pathogenic features', 'evolutionary  insect'], ['that', 'fungal insect virulence'], ['fungal resistance knowledge', 'effective pest field'], ['Relative', 'insect interactive insect models'], ['cement production process', 'numerous process line'], ['specific power consumption', 'average peak 9'], ['', ''], ['', 'electric  0'], ['high kWh that', 'competitive profit advantage'], ['generation', 'national electricity power grid'], ['plant', '3'], ['', 'electrical  power'], ['This', 'net  2'], ['', '15 recovery plant %'], ['This', '33 case study plant'], ['paper', 'power generating plant'], ['designed steam plant', 'payback  2'], ['', ''], ['Vector Control Local Vector that', 'electronic  systems'], ['controller', 'stationary reference frames'], ['performance', 'current clamp minimisation'], ['dead- LVC beat', 'current  controllers'], ['paper', 'AGD power semiconductor devices'], ['sequential optimization that', 'next switching edge'], ['overvoltage peaks', '200 turn V'], ['Demand response', 'recent power system'], ['successful  implementation', 'appropriate policy technology'], ['main distribution stakeholders', 'heterogeneous home agents'], ['HA', 'electricity load demand'], ['real price prediction model', 'HA'], ['optimal control', 'real time pricing'], ['peak power ratio', 'proposed electricity algorithms'], ['HA', 'intelligent DR policies'], ['emerging  that', 'DR'], ['study', 'infrared brain spectroscopy'], ['brain activity', 'frontoparietal  regions'], ['We', 'cooperative lover friend'], ['frontal  which', 'also task performance'], ['analyses', 'different lover cooperation'], ['', 'romantic study lovers'], ['', ''], ['', ''], ['neural  mechanisms', 'detail'], ['We', 'cichlid fish Astatotilapia burtoni'], ['male  neighbor', 'perceived territory intruder'], ['', 'other hand partner'], ['index', 'preoptic dopaminergic neurons'], ['', 'mammalian neighbor hippocampus'], ['neural activity patterns', 'behavioral territory role'], ['', ''], ['rights', ''], ['agricultural Belgorod article', 'extant  studies'], ['such  cooperatives', 'widely  Belgorod'], ['top  cooperatives', 'driven  cooperatives'], ['intentional  coordination', 'such  effects'], ['three  explanations', 'three  which'], ['social  effects', 'in  synchrony'], ['effects', 'rhythmic intervening variable'], ['threshold amount', 'coordination'], ['classes', 'rhythmic  cooperation'], ['intentional  degree', 'cooperation'], ['social  that', 'social  effects'], ['why  coordination', 'social  behaviors'], ['COPD patients', 'more  others'], ['Mechanisms', 'susceptibility'], ['immune  responses', 'frequent  COPD'], ['Peripheral blood mononuclear cells', 'frequent COPD exacerbators'], ['parameter flow cytometry', 'infrequently COPD patients'], ['24 COPD patients', 'SD  76'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['3)%', ''], ['PBMCs', 'infrequent memory exacerbators'], ['', ''], ['', ''], ['', ''], ['observation', 'absolute  CD4'], ['', ''], ['', ''], ['', ''], ['PBMCs', 'HLA DR IE COPD patients'], ['', ''], ['', ''], ['', ''], ['Differences', 'frequent COPD phenotype'], ['differences', 'central memory cells'], ['Nutrients', 'significant  bone'], ['that', 'attention'], ['three trace that', 'inadequate copper iron'], ['role', 'recent  attention'], ['containing bone which', 'collagen fibril crosslinking'], ['deficient  states', 'bone pathology'], ['Selenium deficiency', 'indirect  bone'], ['when cartilage presence', 'pathology'], ['when knowledge each', 'three trace animals'], ['fungal immunomodulatory protein', 'allergy fip gsi gene'], ['we', 'fip gsi G'], ['', 'FIPs gsi'], ['fungal pBfip gsi', 'fip gsi G'], ['sinense', 'C'], ['', ''], ['PCR blotting analysis', 'exogenous fip C'], ['', ''], ['fip gsi gene', 'C'], ['', ''], ['yield', 'kg-1 fresh mg kg-1 mycelia'], ['such blood activity', 'red blood vitro'], ['', 'fip G'], ['sinense', 'successfully  C'], ['cinerea', 'bioactive FIP gsi protein'], ['This', 'first  C'], ['heterologous FIP gsi it', 'large scale protein'], ['Effective  methods', 'human alveolar parasite'], ['Little', 'commercial test E'], ['', 'PCR Polymerase Chain kits'], ['different Zymo R', 'Fast Macherey E'], ['multilocularis eggs', 'foxes'], ['faecal  samples', '600'], ['multilocularis eggs', 'times DNA extraction kits'], ['extracted DNA sample', 'three PCR protocols'], ['', ''], ['', ''], ['', 'QuantiTect'], ['', 'molecular  E'], ['multilocularis eggs', 'DNA MiniPrep Faecal DNA QuantiTect'], ['', 'analytical PCR examinations'], ['present  it', 'molecular PCR E'], ['', 'faecal multilocularis samples'], ['', ''], ['', ''], ['rights', ''], ['paper', 'Coptic United Egypt'], ['it', 'Coptic minority status'], ['strategic unity they', 'strategic unity those'], ['understanding', 'diaspora activists'], ['international  they', 'Egyptian  authorities'], ['diaspora that', 'significant diaspora minority'], ['early  diagnosis', 'increasingly incidence cancer'], ['SCCA', 'human  serum'], ['Thus  immunoassay', 'early  SCCA'], ['electrochemical immunosensor herein', 'squamous cell carcinoma antigen'], ['ceric dioxide nanocubes', 'signal platinum amplification'], ['electrochemical  property', 'current hydrogen peroxide'], ['D Au which', 'glassy antibodies carriers'], ['NPs', 'fg detection SCCA'], ['immunosensor', 'high  selectivity'], ['potential human serum application', 'clinical tumor markers'], ['Rabbit cells', 'corneal transplant experiments'], ['corneal cell that', 'proliferative gene transfer'], ['endothelial  cells', 'conventional  methods'], ['reverse expression profiles', 'vivo corneal vivo endothelium'], ['ultrastructure', 'cells'], ['similar pump RCECs', 'Ussing chamber system'], ['soft colony formation iRCECs', 'soft colony formation assay'], ['rabbit corneal cells', 'endothelial research studies'], ['', ''], ['ACE  gene', '2 hypertension cardiovascular diabetes'], ['aim', 'Indian coronary artery population'], ['total', 'D ACE polymorphism'], ['mean  age', 'CAD patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Anthropometric', 'higher CAD patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['We', 'lowest BMI values'], ['Dyslipidemia', 'highly control subjects'], ['Genotypic data', 'higher control subjects'], ['', ''], ['significant  difference', 'CAD patients'], ['DD genotype', '1'], ['8', 'Asian  Indians'], ['', ''], ['', ''], ['', ''], ['', ''], ['frequency', 'significantly CAD patients'], ['', ''], ['when CAD data', 'ACE gene'], ['DD genotype', 'Indian ACE population'], ['Background', 'cardiovascular OP procedures'], ['coronary artery CR', 'myocardial  care'], ['retrospective  analysis', '2000 OP CR June'], ['a  quarter', '1 OP CR'], ['24 management who', 'ECG ischemia'], ['', ''], ['84 management %', 'directly CR staff detection'], ['more ECG patients', 'coronary ECG ischemia'], ['most  patients', 'medical management finding'], ['Diagnostic quality ECG CR', 'population'], ['patients', 'IVIG Kawasaki disease'], ['gamma RIIA expression', 'KD patients'], ['how Fc gamma receptors', 'KD patients'], ['gamma RIIB methylation levels', 'four HumanMethylation27 BeadChip'], ['We', '10 control fevers'], ['We', 'real time RT Fc'], ['', ''], ['RIIB expression levels', 'well luciferase RIIA'], ['We', 'gamma IVIG treatment'], ['gamma RIIA', 'luciferase assay'], ['gamma expression levels', 'susceptibility CAL formation'], ['resistant  that', 'treatment  period'], ['mRNA expression ratio', 'considerably KD CAL'], ['increased KD that', 'IVIG treatment'], ['RIIA expression', 'KD patients'], ['expression ratio', 'CAL formation'], ['significant  contribution', 'recent material years'], ['today  control', ''], ['environmental  issues', 'thus  treatments'], ['where  organisms', 'extreme  conditions'], ['molecular  it', 'today biocorrosion phenomenon'], ['relevant  involvement', 'oxidative sulfur techniques'], ['enzymes', 'environmental  conditions'], ['CPR  genes', 'conterminous Cunninghamella elegans'], ['We', 'mammalian steroid PAHs'], ['cytochrome P-450 reductase', 'cortexolone'], ['cytochrome CPR genes', 'steroids'], ['expression', 'CPR gene'], ['', 'controls'], ['gene expression', 'enzymatic activity levels'], ['Cognitive  empathy', 'cortex  insula'], ['cortical  thickness', 'cognitive  empathy'], ['cortical  thickness', 'poorer  population'], ['dwelling  individuals', 'empathy self task'], ['We', 'between t variance'], ['Next  we', 'empathy INS SMA groups'], ['Individuals', 'cortical INS SMA TPJ'], ['impaired  cognitive', 'measures'], ['', 'controls'], ['', 'cortical IFC aMCC'], ['', ''], ['Individuals', 'cognitive  empathy'], ['cortical  thickness', 'cognitive schizophrenia group'], ['other  that', 'empathy  schizophrenia'], ['', ''], ['', ''], ['rights', ''], ['Epileptiform discharges', 'neural field theory'], ['isolated  that', 'neural  populations'], ['like  waveforms', 'deafferented EEG cortex'], ['model', 'acute time states'], ['intact corticothalamic which', 'limit cycle dynamics'], ['results', 'deafferented  cats'], ['Secreted  phosphoprotein', 'primate macaque rodents'], ['SPP1 expression', 'corticospinal  systems'], ['present  we', 'spinal somatosensory M1'], ['SPP1-positive pyramidal number', 'M1'], ['spinal  SPP1', 'positive lamina IX'], ['We', 'lateral motor neurons'], ['When SPP1 expression', 'spinal ALS ALS'], ['SPP1 expression', 'spinal ALS patients'], ['reduced motor projection expression', 'ALS'], ['Virtually  nothing', 'avian gene species'], ['Here  we', 'partial chicken GR'], ['partial', 'full chicken genome'], ['Chicken GR', 'vertebrate genome classes'], ['GR', 'chicken chromosomes'], ['RT PCR RT GR', 'many  tissues'], ['demonstrates', 'embryonic GR gene days'], ['Plasma levels', 'same  period'], ['This', 'embryonic MR gene species'], ['', ''], ['rights', ''], ['Pregnant  victims', 'more childhood preterm'], ['mechanisms', 'relationship'], ['momentary pilot stress', 'gestational maltreatment length'], ['35  %', 'study'], ['Women', '34 weeks gestation'], ['two  women', 'corresponding salivary cortisol samples'], ['Gestational length', 'medical chart review'], ['Higher  reports', 'gestational  length'], ['High  stress', 'higher maltreatment maltreatment'], ['Results', 'increased childhood maltreatment victims'], ['pituitary axis dysregulation', 'advanced  that'], ['aim', 'healthy diurnal cortisol controls'], ['mild MRC dyspnoea grade', 'mild dyspnoea breathlessness'], ['Measures', 'breathlessness stress'], ['diurnal cortisol slope', 'transformed collection time'], ['Mean DCS', 'ANCOVA'], ['Individual  slopes', 'four  categories'], ['mean age DCS', 'mild  breathlessness'], ['', ''], ['', ''], ['', 'moderate cortisol 23'], ['', 'healthy  controls'], ['which', 'significantly  DCS'], ['', ''], ['', ''], ['moderate axis dysregulation', 'functional  breathlessness'], ['', ''], ['rights', ''], ['Two  genes', 'individually Escherichia coli'], ['', 'E'], ['', ''], ['', ''], ['protein products', 'methionine adenosyltransferase'], ['ATCC13032  MetK', 'S adenosyl l methionine'], ['enzyme activity', 'l methionine'], ['SDS SAM2', 'C'], ['', ''], ['codon it', 'well l SAM'], ['Finally  SAM2-C', 'individually  E'], ['SAM2-C', ''], ['optimum  activity', 'pH'], ['degrees C degrees SAM2-C', 'different l methionine'], ['SAM2-C', 'C'], ['', 'SAM'], ['', 'International Union International Biochemistry'], ['Borne Mission e', 'Borne Mission LSPE'], ['', ''], ['', 'P'], ['', ''], ['', 'primordial Cosmic Microwave Background'], ['microwave telescopes', 'equivalent nK range'], ['detector', 'signal readout'], ['front end which', 'squid  it'], ['squid  output', 'CMOS operational noise CMOS amplifier'], ['Equivalent input noise density', ''], ['nV  Hz', '2  MHz'], ['devices', 'liquid CMOS nitrogen'], ['squid', 'slow control system'], ['digital  interface', 'control computer'], ['Predicting', 'natural phenotypic them'], ['', 'immune parasites defense'], ['Theory', 'related trade traits'], ['Empirical  studies', 'directional  selection'], ['examined host resource that', 'empirical trade studies'], ['individually Lymnaea stagnalis we', 'antibacterial defense traits hemolymph'], ['We', 'snail food supply'], ['six  we', 'two fitness components snails'], ['antibacterial  activity', 'directional  selection'], ['Selection', 'mainly  survival'], ['form', 'present parasite community'], ['current  investment', 'reproductive  success'], ['recent  evidence', 'immune  insects'], ['copulatory  activity', 'sympatric splendens populations'], ['splendens', 'superior  competitor'], ['', ''], ['also  which', 'common  damselflies'], ['Copulation activity', 'C'], ['splendens', 'allopatric  populations'], ['', 'sympatric populations C'], ['more gut we', 'number  encapsulation'], ['infected  which', 'reproductive  investment'], ['smart meter they', 'different rate schedule'], ['objective', 'different wind resources'], ['hourly wind speed use', 'representative  location'], ['annual household electricity cost', 'traditional meter rates'], ['6 wind turbine system', 'annual  grid'], ['rate structures electricity generation systems', 'economically  region'], ['', ''], ['rights', ''], ['absence', 'commonly herpes simplex virus'], ['multiple  authors', 'old protein HIV'], ['Adoption', 'patient HSV care'], ['Little', 'cost approach'], ['decision analysis model', 'HSV CSF'], ['Estimates', 'largest United States'], ['200 HSV patients', 'truly HSV CNS infection'], ['prior  none', 'deferred HSV encephalitis'], ['Adoption', '$ 127 million'], ['model calculations', 'random HSV assumptions'], ['adoption', 'effective HSV PCR approach'], ['Renewable  energies', 'fossil CO2 emissions fuels'], ['renewable  energies', 'efficiently EU carbon 2050'], ['dynamic optimisation that', 'forest fossil fuel sectors'], ['results', 'Euro ton 2050'], ['current electricity which', '8'], ['', '2 emissions target'], ['average  cost', 'as forest carbon sequestration'], ['forest carbon they', 'continued government support'], ['', ''], ['rights', ''], ['Salinity', 'environmental plant growth'], ['H+-PPase gene TsVP', 'mosaic virus 35S promoter'], ['sense', 'cotton genome'], ['', 'wild type plants'], ['plants', 'wild type plants'], ['Overexpressing TsVP', 'shoot  growth'], ['transgenic  plants', 'wild type plants'], ['transgenic  accumulation', 'toxic  effects'], ['water which', 'overexpressing salt cotton'], ['increasing  number', 'regulatory plant development'], ['Here  we', 'wild fiber initiation'], ['related RACE miRNAs', 'transcriptional regulation auxin'], ['paper', 'regulatory fiber initiation responses'], ['36 novel miRNAs', 'known  78'], ['complex  subunit', 'miRNA splicing targets'], ['study', 'regulatory cotton fiber initiation'], ['rich  that', 'important plant growth development'], ['Y', 'Y proline proline proline'], ['quantitative RT PCR it', 'dpa  fibers'], ['Gossypium genome', 'PCR'], ['staining', 'other  tissues'], ['GhH6L', 'plasma cytoplasm'], ['', 'functional  cotton'], ['textile they', 'textile industry'], ['Enzymes', 'textile chemical processing'], ['bio proteases', 'wool category'], ['', 'reduced temperature properties'], ['Advances', 'friendly enzymes option'], ['such  which', 'useful  cases'], ['process', 'enzymes'], ['review', 'enzymatic textile chemical processing'], ['paper', 'textile chemical industry'], ['', ''], ['rights', ''], ['Cotton', 'high polyphenolics polysaccharides'], ['Genomics', 'large molecular biology DNA'], ['efficient genomic DNA which', 'excellent leaf purity'], ['enzymatic  PCR', 'end genomic end studies'], ['one', '100  day'], ['genomic  DNA', 'transgenic event selection'], ['Understanding', 'pathogenic managing diseases'], ['defoliating  pathotype', 'one clonal lineage'], ['clear  association', '1 clonal lineages'], ['1 effector that', 'resistance gene'], ['single clonal which', 'V'], ['dahliae', 'horizontal gene plants'], ['', '195  V'], ['1 clonal isolates', 'only lineage 2A'], ['Conversely 2A isolates', 'race'], ['nucleotide  sequences', 'other 2A V'], ['dahliae race', '1  GenBank'], ['identical Ave1 race', 'once  V'], ['', ''], ['established D pathotype', 'only lineage 1A'], ['cotton', 'low lineage tomato'], ['banking reform', 'both  ownership'], ['', 'Imita'], ['universal  banks', 'corporate  years'], ['new  centers', 'Italian phone capitalism'], ['We', 'sectoral  differences'], ['local  banks', 'industries'], ['paper', 'counterfactual  thinking'], ['four  which', 'link'], ['individual  individuals', 'potential  lies'], ['others', 'which'], ['behaviotiral  people', 'counterfactual  thoughts'], ['imagination', 'important  lies'], ['We', 'counterfactual  thinking'], ['', ''], ['', ''], ['rights', ''], ['Pfaffian  circuits', 'polynomial # P'], ['Much  work', 'machinery'], ['circuits', ''], ['We', 'planarity condition'], ['one SWAP gate', 'restricted  graphs'], ['Pfaffian  gates', 'hyperplane'], ['', ''], ['rights', ''], ['Witricity  that', 'integrated planar coil strips'], ['80 resonator mm', 'transmitter'], ['devices', 'prior vector network analyzer'], ['current  results', '30 mm distance range'], ['more unit which', '30 mm range'], ['coupled  which', 'coupled  devices'], ['5  %', '30 mm devices'], ['lateral  misalignment', 'proposed  device'], ['neural probe system', 'two measurement unit'], ['wireless transceiver measurements', 'electronic transceiver components'], ['varicap diode', 'reflective delay line'], ['', ''], ['3 nH inductor', 'high impedance matching effect'], ['overall impedance perturbations', 'electrical time pulses'], ['Good  linearity', 'electrical  pulses'], ['modeling matching simulations', 'experimental device results'], ['', ''], ['', ''], ['rights', ''], ['Integration', 'important research undergraduates'], ['undergraduate research experiences', 'driven instructor lead experiences'], ['impact', 'National Science Foundation'], ['state  CUREs', 'practical  guide'], ['', 'International Biochemistry'], ['article', 'ultimate court children'], ['article', 'focus  initiative'], ['Twelve  jurisdictions', 'middle court locations'], ['discussion', 'qualitative case time'], ['Family Court initiative', 'family law matters'], ['how  rules', 'parental child rights'], ['We', 'wide court improvement initiative'], ['court that', 'other  jurisdictions'], ['zoonotic bacterium Coxiella that', 'acute  disease'], ['series', 'Portuguese University 2014'], ['cases', 'epidemiological  history'], ['Diagnosis', 'only  2'], ['Serological  tests', 'initial  disease'], ['Molecular biology methods', 'timely polymerase chain diagnosis'], ['', ''], ['', 'environmental dispersion metals'], ['Cr  contamination', 'major health biota'], ['recent  chromium', 'less  attention'], ['review', 'molecular defense metal'], ['Recent  advances', 'such genomics herein'], ['precursor', 'mainly yolk protein shrimp'], ['However  little', 'Vg crabs'], ['present  we', 'commercial Portunus aquaculture'], ['open reading that', '2560 amino acid residues'], ['deduced amino acid sequence', 'known crustacean Vgs'], ['potential cleavage sites', 'deduced Vg precursor'], ['SDS PAGE blotting analysis', 'major  polypeptides'], ['Vg', 'mainly vitellogensis females'], ['Vg transcript', 'reverse chain reaction analysis'], ['', ''], ['fights', ''], ['based pathogen identification', 'particularly skull base fungi'], ['We', 'debilitating antifungal illness'], ['clinical  rationale', 'long term antifungal therapy'], ['fungal Ibis disease', 'biochemical  assays'], ['discussion', 'fungal  disease'], ['We', 'future skull base osteomyelitis'], ['hypothalamic hormone oxytocin', 'major  behavior'], ['Quality', 'hypothalamic childhood craniopharyngioma lesions'], ['sectional  we', '10 craniopharyngioma patients'], ['', 'mammillary grade II bodies'], ['Emotional  tasks', 'emotion portrayals corpus'], ['patients', 'detectable  administration'], ['Nasal administration', 'increased oxytocin saliva'], ['oxytocin administration craniopharyngioma patients', 'hypothalamic craniopharyngioma areas'], ['positive craniopharyngioma patients', 'negative  emotions'], ['Oxytocin', 'anterior hypothalamic area'], ['Further  studies', 'larger  cohorts'], ['eastern oyster Crassostrea virginica', 'eastern United States'], ['they', 'estuary northwest system'], ['', 'numerical reef model'], ['Water quality parameters', '2007 oyster July'], ['numerical Pensacola which', 'ontogenetic larval distribution'], ['when oyster recruitment', 'empirically  bay'], ['contemporaneous oyster model', 'salient Pensacola Bay'], ['modeled model outcomes', 'field caution'], ['Larval supply', 'successful  recruitment'], ['transfer', 'identified oyster reef restoration'], ['Finally  exports', 'Gulf oyster metapopulation'], ['Systemic  inflammation', 'marker  mechanism'], ['relationship', 'common trauma exposure'], ['We', 'physical World Trade September'], ['We', 'routine community disaster'], ['C Reactive marker', 'potential symptoms age risks'], ['CRP', 'PTSD  severity'], ['', 'depression'], ['', 'anxiety'], ['', ''], ['CRP', 'positively  p'], ['', ''], ['', 'cognitions symptom mood'], ['', ''], ['', ''], ['systemic stress which', 'confounding  variables'], ['results', 'traumatic stress pathology'], ['', ''], ['', 'Elsevier Ltd'], ['', 'testicular germ toxicity'], ['mouse line', 'Cre reporter loxP'], ['mouse line', 'oral glycol monomethyl gavage'], ['green fluorescence intensity', 'molecular vivo imaging techniques'], ['testicular GFP expression', 'mice'], ['GFP', 'spermatocytes germ cell spermatocytes'], ['green fluorescent intensity', '34  days'], ['testicular  sections', 'secondary  spermatocytes'], ['observations', 'testicular testis histopathology'], ['application', 'reproductive germ toxicity'], ['Inadequate  regulation', 'unequal  wealth'], ['spatial  States', 'spatial  development'], ['spatial planning that', 'preventive land plan'], ['systems', 'public development projects'], ['models', 'institutional planning technologies'], ['', 'economic crisis life'], ['recombinant virulence that', 'molecular biology toolbox'], ['new Cas9 that', 'defined recipient genome'], ['novel  approach', 'pathogenic mould Aspergillus fumigatus'], ['various  that', 'Cas9 enzyme'], ['Validation', 'selected candidate A'], ['screening  approaches', 'genetic gene families'], ['Palindromic  technology', 'biomedical gene function'], ['recently  technology', 'human Barth syndrome heart'], ['9 genome editing', 'large model vivo'], ['CRISPR Cas9 gene editing', 'tumor deficiency immunotherapy'], ['Furthermore  technology', 'large molecules scale'], ['CRISPR  Cas9', 'specific disease transplantation'], ['use', 'human  diseases'], ['', ''], ['', 'Elsevier B'], ['', ''], ['This', 'BY NC license'], ['', 'org  nc'], ['', ''], ['emergence', 'technological mass spectrometry'], ['advancements', 'structural throughput biology'], ['MS exchange MS', 'biomolecular structures functions'], ['particular  we', 'cellular CRISPR Cas systems'], ['two silica that', 'namely  CR'], ['cell death', 'A549 lung epithelial cells'], ['cytotoxicity assays', 'molecular A549 cells'], ['dimensional gel electrophoresis data', 'cell death'], ['', ''], ['', ''], ['', ''], ['FSCN1 HNRNPAB FSCN1 pathways', 'two silica particles'], ['Reverse chain reaction data', 'proteomic  findings'], ['physical  extent', 'biological surface effects'], ['physical  attributes', 'cellular particulate toxicity'], ['toxicoproteomic  analyses', 'traditional cytotoxicity endpoints'], ['', 'Canada'], ['', 'John Wiley'], ['critical conduction mode', 'current power waveform'], ['on PFC converter', 'letter'], ['simple analog divider circuit', 'primary CRM flyback'], ['experiment results', 'proposed control scheme'], ['digital steering navigation', 'GI type capsule tract'], ['fluid resistance torsion moment', 'insufficient GI fluid'], ['online GI measurement', 'fluid resistance torsion moment'], ['fluid resistance torsion moment', 'magnetic  moment'], ['when  it', 'shaped  tiles'], ['contact driving performance', 'dynamic GI pressure'], ['purpose', 'alternative freedom transformation'], ['such  limits', 'political  contexts'], ['limits', 'critical  pedagogues'], ['', 'SC  K'], ['new necrosis factor inflammatories', 'long necrosis factor treatment'], ['different IBD compounds', 'different  pathway'], ['literature search', 'different  pathway'], ['First  authors', 'different IL-17 agents'], ['Second  they', 'different  pathway'], ['safety they', 'also immunogenicity pregnancy'], ['monoclonal  targeting', 'IL-17  pathway'], ['Biomarkers', 'personalized  medicine'], ['reported  lot', 'future  years'], ['potential crop that', 'billions  dollars'], ['key', 'plant disease causal'], ['Polymerase chain reaction', 'based  diagnostics'], ['last  development', 'simple plant disease diagnostics'], ['', '200 LAMP which'], ['LAMP assays', 'fungal plant diseases'], ['Here  we', 'various detection chemistries'], ['We', 'when LAMP assays'], ['they', 'laboratory'], ['review', 'plant disease diagnostics'], ['where Hong mothers', 'personal domain child'], ['scenarios', 'essential  self'], ['when emotion mothers', 'personal  choices'], ['Evaluations', 'shaming'], ['when  acts', 'personal  reasons'], ['when shaming events', 'pragmatic shaming choices'], ['Positive  emotions', 'Chinese  children'], ['Crustaceans', 'single neuron behavior'], ['However  lack', 'molecular model systems'], ['we', 'two decapod crustaceans'], ['seven hundred sixty six', 'seventy C'], ['', ''], ['', 'respectively  9489'], ['transcripts genes', 'nervous system function'], ['genes', 'glutamate transmitter receptor receptors'], ['crustacean model systems', 'nervous system function'], ['new  member', 'Chinese shrimp Fenneropenaeus 3'], ['full length cDNA', '130 amino acids'], ['deduced  peptide', '113 amino acids'], ['molecular  mass', 'mature  peptide'], ['', ''], ['It', 'isoelectric  8'], ['', ''], ['deduced amino acids sequence', 'Penaeus  setferus'], ['situ Crustin gene', 'exclusively  tissues'], ['Crustin', '6 microbe infection'], ['level', '72 h challenge'], ['when  shrimps', 'bacterial  pathogen'], ['astronomical multipixel we', 'channel field effect transistor'], ['cryogenic  we', 'four power supplies'], ['amplifiers', '4'], ['', 'open loop 2000'], ['gain bandwidth gain product', '6 mu W'], ['referred voltage noise', 'performance evaluations'], ['', '1  Hz'], ['', '10  kHz'], ['power spectrum density', '10  kHz'], ['', ''], ['rights', ''], ['paper', '45MVA(33 ASG Power Systems'], ['which', '275/33 kV U'], ['', ''], ['', '38  %'], ['magnetic  which', 'reduced  size'], ['Magnetic  saturation', 'magnesium diboride magnesium magnets'], ['interaction', 'power grid'], ['Details', 'also  paper'], ['mental  status', 'altered meningitis mentation'], ['clinical  we', 'CSF cytokines characteristics CSF chemokines'], ['30  patients', 'cryptococcal antigen titers'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'GCS'], ['mental  status', 'rather Cryptococcus burden'], ['Cryptosporidium', 'important diarrhoeal illness'], ['environmental  that', 'relatively  Africa'], ['African  parasites', 'negatively child growth'], ['Malnutrition  status', 'African  countries'], ['zoonotic transmission that', 'further  investigation'], ['available  drug', 'nitazoxanide  individuals'], ['emerging  resistance', 'clinical  utility'], ['Climate change', 'also water sources'], ['ordinated  commitments', 'together health parasites'], ['Structural  properties', 'therapeutic basis drug'], ['structure', '09 computer calculation software'], ['lowest energy value', 'optimized crystal values'], ['results', 'mentioned  methods'], ['Also  type', 'computational constituent methods'], ['experimental  spectrum', 'polar isomer solvents'], ['sigma amount', 'molecular solvents H2O CH3CN'], ['well solvents H2O CH3CN', 'DFT PBEPBE 6'], ['', ''], ['', ''], ['rights', ''], ['genetic  that', 'vertebrate  hosts'], ['Arterivirus', 'viral life cycle'], ['Here  we', 'arteritis syndrome virus'], ['structures', 'compact  domains'], ['EAV they', 'human Nidovirales order'], ['charged NendoU groove', 'catalytic  nidoviruses'], ['remarkably nsp11 family oligomerization', 'nsp11 family proteins'], ['structures', 'molecular NendoU mechanism'], ['reproductive syndrome virus', 'major arterivirus family'], ['leading swine pathogen', 'young  pigs'], ['quick drug spread', 'animals'], ['PRRSV', 'annually United States'], ['', '5 Europe'], ['we', 'nonstructural  protein'], ['nsp11', 'infected immunity system'], ['three  structures', 'deadly protein viruses'], ['that', 'melanocytes'], ['which', 'resistant tumor initiation cells'], ['Cancer stem cells', 'unique cell surface'], ['CSCs', 'molecular  CSCs'], ['They', 'specific signaling cascades'], ['CSCs', 'host system'], ['when  patient', 'metastasis'], ['conventional oncology treatments', 'only tumor mass'], ['Thus  targeting', 'traditional cancer therapy'], ['traditional  therapies', 'therapeutic  melanoma'], ['only photovoltaic modules', '20 field conditions'], ['performance degradation', 'financial  viability'], ['Performance degradation', 'such installation site'], ['harsh degradation effects study', 'desert environment'], ['c modules that', 'environmental  conditions'], ['evaluation', 'usually curve field measurements'], ['', ''], ['rights', ''], ['Analysis', 'open reading genome'], ['further  which', 'putative coat protein'], ['Polymerase chain using', 'single DNA band'], ['', ''], ['product', 'purified Escherichia coli'], ['Western ORF3 protein', 'Western  blotting'], ['positively  antiserum', 'CsNIV coat protein'], ['14 peptide that', 'ORF3 CsNIV'], ['expression', 'infected cDNA cells'], ['however CsNIV clones', 'only ORF3 region'], ['Northern  blotting', 'single  2'], ['5-kb  ORF3', 'together  ORF4'], ['', ''], ['', ''], ['rights', ''], ['rare blood that', 'key cancer metastasis'], ['Investigation', 'major cancer types'], ['Gastric cancer', 'especially East China'], ['', 'gastric cancer patients'], ['', 'gastric cancer biomarkers'], ['review', 'gastric  CTCs'], ['Introduction', 'oncogenic tumour type'], ['We', 'patient specimens cell lines'], ['CTGF  expression', 'real time PCR'], ['We', 'reverse CTGF protein diversity'], ['short CTGF that', 'cellular  growth'], ['mRNA ALL cell that', 'terminal  domain'], ['primary  patient', 'canonical  CTGF'], ['alternative  transcripts', 'predicted CTGF size'], ['short CTGF splice variant', 'positive cell B'], ['only CT domain', 'B ALL tumorigenesis'], ['', ''], ['rights', ''], ['20  years', 'fascinating CTLA-4 biology'], ['negative T cell absence', 'lymphoproliferative  disease'], ['cell extrinsic cell CTLA-4', 'one  cell'], ['CTLA-4', 'suppressive T activity'], ['CTLA-4-positive cell cells', 'naive T cells'], ['Notably  CTLA-4', 'costimulatory  endocytosis'], ['identification', 'immune Treg system'], ['', ''], ['CTLA-4', 'follicular T cell differentiation'], ['German Immunology I', 'own CTLA-4 field'], ['autoimmune CTLA-4 it', 'important  pathway'], ['', '2017 Immunological Societies'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['normal nucleic CLRs', 'cholesteatoma'], ['Altered  expression', 'immune pattern recognition cholesteatoma'], ['study', 'normal  cholesteatoma'], ['Cholesteatoma specimens', 'acquired  cholesteatoma'], ['levels', 'Reverse ossicle destruction'], ['12 member mRNAs', 'destroyed control skin ossicles'], ['levels', 'initial cholesteatoma specimens'], ['', ''], ['level', 'mild hearing loss'], ['', ''], ['', ''], ['Lectin', 'immune  crustacean'], ['Knowledge', 'immune regulation system'], ['novel type lectin gene', 'cDNA ends cDNA PCR'], ['full length cDNA', '287 amino acids'], ['deduced amino acid sequence', '19 amino acids'], ['like C type which', '78 % other'], ['CRD1', 'Japanese % lamprey'], ['acids which', 'relatively type lectin CRDs'], ['binding  I', 'Fclectin'], ['2 QPD E NP', 'galactose type sugars'], ['Fclectin', 'C type lectin'], ['Transcripts', 'situ  hybridization'], ['variation', 'capillary RT PCR'], ['LPS stimulation', 'cultured  vitro'], ['Expression profiles', 'greatly bacteria LPS'], ['stated  data', 'innate disease control'], ['', ''], ['rights', ''], ['core features', 'other  distress'], ['Using', 'young community adults'], ['', ''], ['', ''], ['03', 'Callous Unemotional Traits'], ['magnetic resonance imaging data', 'facial  expressions'], ['dependent blood oxygenation responses', 'right anterior cingulate amygdala'], ['CU traits', 'noncriminal  population'], ['It', 'when CU traits'], ['', ''], ['', 'Elsevier Ltd'], ['This', 'open NC ND license'], ['lysozyme', 'spatial conformation enzyme kinetics'], ['sensitive  determination', 'wide  fields'], ['we', 'responsive Cu@Au nanoparticles'], ['Colorimetric detection', 'low detection costs'], ['strategy it', 'irregular Cu@Au spherical'], ['Consequently  phenomenon', 'catalytic H2O2-TMB system'], ['accurate  which', 'molecular Cu@Au NP recognition'], ['modified Cu Au NPs', 'ultrasensitive detection 60'], ['2b protein', 'solanaceous pathogenicity disease'], ['mutant CMV Delta which', 'mutant Fny CMV'], ['', ''], ['glutinosa seedlings', 'structural photosynthetic chloroplast'], ['wild type Fny CMV', 'structure mosaic leaf chloroplasts'], ['However host seedlings', 'slight mosaic symptom'], ['photosynthetic  rates', 'structure chlorophyll chloroplasts'], ['low photosynthetic rates', 'chloroplast morphology'], ['Northern virulence', 'systemic CMV progeny leaves'], ['expression', 'genomic accumulation I'], ['level', 'subgenomic CP protein'], ['CB7 strain', 'genomic RT templates'], ['RNAI', 'genomic CNW RNAs'], ['Infectious RNA transcripts', 'CMV N'], ['necrosis symptom that', 'typical mosaic symptoms'], ['genetic CNW determinant', 'necrosis RNA2'], ['infectious  clones', 'respectively Overlapping PCR'], ['chimeric 2b gene', 'necrotic CMV CB7 pathotype'], ['Northern blotting analysis', 'genomic host plants'], ['necrotic  phenotype', 'N'], ['glutinosa', 'genomic  RNAs'], ['developmental flower that', 'directly fruit cucumber'], ['regulatory  mechanisms', 'potential flower process'], ['RNA Seq that', 'gynoecious cucumber plants'], ['Results', 'decreased shoot tips'], ['dramatically transcription treatment', 'potential sex cucumber'], ['floral homeotic gene GA', 'independent cucumber sex process'], ['results', 'male flower cucumber'], ['GA', 'probably sex process'], ['modulated cucumber sex pathway', 'modulated cucumber sex determination'], ['We', 'ectopic gene expression'], ['Agroinfiltration', 'foreign  plants'], ['vitro transformation techniques agroinfiltration', 'mature plant tissues'], ['cucurbits', 'mature cucurbit tissues'], ['research', 'mature Luffa cylindrica L'], ['luffa', 'transiently Agrobacterium tumefaciens'], ['We', 'efficiently beta glucuronidase'], ['GUS activity', '24 leaf bacteria'], ['transiently GUS gene', 'agroinfiltrated EDTA leaves'], ['luffa leaves', 'physiological plant expression cucurbits'], ['Mosquitoes', 'widely insecticide treatments'], ['intensive  application', 'many Culex pipiens mosquitoes'], ['resistance us', 'different gene L1014F Cx'], ['pipiens', 'three  Morocco'], ['Mosquito adults', 'different  Morocco'], ['susceptibility tests', 'collected  larvae'], ['Specimens', 'diagnostic microsatellite CQ11'], ['Identified mosquitoes', 'then PCR assay'], ['21  %', 'tested lambda cyhalothrin'], ['43  %', 'Cx'], ['', ''], ['', '5  Cx'], ['', ''], ['416  specimens', 'L1014F kdr mutation'], ['L1014F mutation', 'different  Cx'], ['', 'different  sites'], ['frequency', 'L1014F Cx'], ['hybrid  it', 'Cx'], ['', ''], ['presence', 'significantly lambda Cx'], ['', ''], ['', ''], ['', ''], ['', 'lambda Cx'], ['pipiens populations', 'largely L1014F kdr mutation'], ['frequencies', 'natural Culex pipiens Morocco'], ['findings', 'potential mosquito arboviruses'], ['purpose', 'major graduate studies program'], ['Graduate student education', 'core York Botanical Garden'], ['program', 'major University Cornell University'], ['125 year Garden', '300  216'], ['', ''], ['', ''], ['economic  program', 'modern plant diversity'], ['program', '93  81'], ['', ''], ['Fordham which', 'first  graduates'], ['', 'genome DNA evolution'], ['Technological  advances', 'economic botany research'], ['125(th  hallmark', 'better plant diversity'], ['primary  goal', 'cultural  Chinese'], ['', ''], ['', 'adolescent misconduct behaviors'], ['', '395  U'], ['', ''], ['255  parents', 'study'], ['participant', 'adolescent misconduct wrongness'], ['misconduct behaviors', 'three  themes'], ['Results', 'adolescent misconduct behaviors'], ['more drug China', 'more weapon offenses'], ['cultural  differences', 'further  culture'], ['Chinese  adolescents', 'more  U'], ['', ''], ['adolescent misconduct behaviors', 'conventional school violations'], ['However  it', ''], ['', ''], ['Chinese misconduct parents', 'adolescent misconduct categories'], ['', 'pregnant Group B women'], ['We', 'infected polymerase chain women'], ['', 'Rio de Janeiro'], ['negative  ratios', 'culture'], ['pregnant  women', 'inclusion criteria'], ['later index 336', 'analyses'], ['GBS colonization rate', ''], ['', ''], ['Sensitivity', 'GeneXpert GBS assay'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['predictive  values', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['where GBS culture', 'reasonable GBS settings'], ['diversity', 'real polymerase chain reaction'], ['Results', 'early sampling time'], ['', '7days Lactococcus lactis'], ['05  quantities', ''], ['', ''], ['', '14days Weissella sp'], ['bands', '21st  day'], ['', ''], ['maturation', 'Lc'], ['lactis', 'Weissella sp'], ['', 'intensity'], ['', 'Finally Weissella sp'], ['', ''], ['50x10(7  copiesL(-1', 'Lc'], ['', ''], ['', '56days'], ['pickling  process', 'Lc'], ['lactis', 'Lc'], ['', ''], ['', 'finally Weissella sp'], ['major limiting factor', 'physiological  plants'], ['Salinity', 'cellular oxygen components'], ['tolerance', 'injurious plant effects'], ['reverse polymerase chain reaction', 'antioxidant  genes'], ['', ''], ['', 'Cuminum cyminum L'], ['', 'mM 100 NaCl'], ['Enzymatic  activities', 'three  antioxidants'], ['parameters protein content', ''], ['which', 'higher NaCl proline'], ['', 'higher dismutase ascorbate peroxidase'], ['same  condition', 'SOD mRNA level'], ['Protein content', 'other 50 concentrations'], ['200 salt mM', 'parameters'], ['it', 'details'], ['', 'antioxidant system efficiency'], ['DNA methyltransferases', 'neurodegenerative  disorders'], ['small  that', 'neurodegenerative blood brain diseases'], ['small compound RG108', 'study'], ['effects', 'neuronal Adh cell line'], ['nontoxic  concentration', 'WST-1 assay'], ['Subsequently  cells', '50nM nerve growth factor'], ['Cell differentiations', 'real cell analyzer system'], ['outgrowth', 'beta PC-12 Adh cells'], ['III expression levels', 'real polymerase chain reaction'], ['', '50nM PC-12Adh NGF'], ['Curcumin NGF combination', 'more cell curcumin'], ['curcumin  combination', 'GAP43 expression levels'], ['conclusion curcumin', 'PC-12Adh neurite NGF'], ['natural DNMT1 inhibitors', 'neurodegenerative disorders treatment'], ['underlying  mechanisms', 'hepatoprotective  curcumin'], ['aim', 'BDL)-fibrotic rat model'], ['Wistar', 'mg sham+Cur kg'], ['mRNA expression levels', 'real polymerase chain reaction'], ['Curcumin treatment', 'hepatic cell enzymes'], ['Moreover  increase', 'back curcumin treatment'], ['', ''], ['also  escalation', 'serum antioxidant markers'], ['', ''], ['', 'treated BDL rats'], ['', ''], ['Curcumin', 'serum Racl Racl BDL'], ['', ''], ['rights', ''], ['three stage amplifiers', 'capacitive  loads'], ['total compensation capacitor', 'current speed feedback amplifier'], ['dominant  poles', 'capacitive  loads'], ['it', 'more silicon area'], ['where HCCCA amplifier prototype', 'only compensation 0'], ['', ''], ['It', '1'], ['', ''], ['', '80 mu W 1'], ['', ''], ['small performance metrics', 'literature'], ['worldwide China Japan Italy', 'largest  region'], ['', 'important utility others'], ['current control that', 'international grid standards'], ['RPGS', 'highly grid interconnection operations'], ['paper', 'three phase grid RPGSs'], ['current  control', 'advantages'], ['Performance comparison', 'several  controllers'], ['', ''], ['rights', ''], ['controlled dc dc converters', 'digital signal controller'], ['main energy management goal', 'bus voltage regulation'], ['safe  operation', 'system'], ['selected  converter', 'ripple efficiency output'], ['it', 'different master control'], ['Simulation', '1200-W dc bus'], ['current  controller', 'voltage source paper'], ['control structure', 'programmable gate array chip'], ['small signal bandwidth', 'modulation period'], ['small modulation which', 'current signal oversampling rate'], ['uninterruptible power supplies', 'renewable laboratory battery chargers'], ['work', 'current control sources'], ['proposed control system', 'dynamic power converter response'], ['Additionally control system', 'defined  precision'], ['estimation algorithm', 'controlled  current'], ['algorithm', 'controlled control dynamics'], ['use', 'erratic  comparisons'], ['Then estimator gains', 'typical root pulse'], ['proposed control system', 'programmable gate array'], ['', 'overflow point account'], ['Experimental  results', 'proposed laboratory prototype'], ['current voltage source converters', 'paper'], ['hysteresis current hysteresis it', 'digital analog converters'], ['current error processing algorithm', 'constant switching frequency'], ['Overall  it', 'related analog hysteresis problems'], ['programmable gate array which', 'computation conversion delays'], ['intended application areas', 'distributed laboratory battery testers'], ['current  controller', 'steady PMSM Servo System'], ['current design proceeding', 'current order ADRC loop'], ['improved control method', 'delay effects'], ['current  regulation', 'high  performance'], ['Simulation', 'proposed  method'], ['paper', 'polynomial Steady State Error'], ['proposed  rectifier', 'controlled induction motor input'], ['input', 'apart bus voltage regulation'], ['current  controllers', 'different loading conditions'], ['good disturbance that', 'current  controller'], ['control algorithm', 'significant reference performance'], ['paper', 'passive immittance elements'], ['feasibility', 'two  CFOAs'], ['proposed  topologies', 'negative inductance- resistance conductances'], ['functionality', 'available AD844 CFOA'], ['experimental  results', 'theoretical  calculations'], ['paper', 'resistance capacitance multipliers'], ['circuit', 'operational  amplifiers'], ['functionality', 'ADS Advanced Design software'], ['simulation results', 'theoretical  calculations'], ['versatile system we', 'original  realization'], ['further  transpose', 'MCFOA'], ['Thus voltage mode we', 'same mode MCFOAs'], ['', ''], ['tunable notch bandpass highpass', ''], ['filters', 'feedback operational feedback amplifier'], ['one', 'feedback operational feedback amplifier'], ['summing  amplifiers', 'voltage mode realizations'], ['Experimental  results', 'feedback operational feedback amplifier'], ['results', 'proposed  circuits'], ['paper', 'new memristor emulator'], ['memristor emulator', 'off  components'], ['well linear oscillations', 'single  resistor'], ['proposed  circuit', 'chaotic laboratory oscillators'], ['oscillators new sinusoidal oscillators structures', 'type'], ['Three  catalogues', '17 oscillator circuits'], ['Some', 'orthogonal  oscillation'], ['orthogonal  it', 'Barkhausen criterion'], ['specific oscillator leading', 'orthogonal  oscillation'], ['Experimental  results', 'AD844 CFOA'], ['paper', 'cascode operational radio frequency application'], ['respectively  which', 'circuit'], ['common source transistor', 'common gate transistor'], ['cascoding', 'less output complexity'], ['current gate mirror', 'paper'], ['proposed  circuit', '45 nanometer CMOS technology'], ['simulated  results', 'DC 63'], ['62 dB unity', '2'], ['70  GHz', 'V phase 59'], ['5 degrees power supply', 'operational  amplifier'], ['4 power consumption', ''], ['', ''], ['circuit specification', 'radio frequency application'], ['balanced output signal that', 'basic building block'], ['OFCC', 'current voltage circuits'], ['advantages', 'balanced output signal generator'], ['Firstly  it', 'matched  resistors'], ['differential  it', 'current  outputs'], ['proposed CMBG circuit', 'current  conveyor'], ['proposed  CMBG', ''], ['experimental  results', 'basic building blocks'], ['current sensor technique', 'full bridge inverters'], ['', 'single switching cycle'], ['inductor', 'selectively feedback other'], ['paper', 'closed loop output impedance'], ['proposed  SCST', 'uninterruptible power supply'], ['paper', 'regulation current line regulation mirror'], ['bandgap reference that', 'well HR resistor'], ['current line mirror', 'negative  feedback'], ['', 'current  0'], ['35 m CMOS process', 'ppm temperature 0'], ['line regulation', '0'], ['', '5 supply 3'], ['', '5'], ['', ''], ['paper', 'common supply rails'], ['amplifier', 'nested Miller frequency compensation'], ['chopping mu V', 'chopping offset voltage'], ['chopping output amplifier', 'notch filter'], ['CMRR', 'common input voltage 80V'], ['stability', '20V loop V'], ['common sense CM', 'independent power supply rail'], ['proposed  circuit', 'differential input voltages'], ['that', 'typical  accuracy'], ['proposed  architecture', 'standard'], ['25 m BCD technology', 'simulations'], ['paper', 'controlled DC buck converters'], ['circuit', 'high sigma delta accuracy'], ['acquisition delay', 'achievable loop bandwidth'], ['inductor', 'switching converter'], ['output', 'experimental  0'], ['', '165 buck mu'], ['Current  sensors', 'electromagnetic PCB level'], ['literature', 'possible frequency range'], ['such  filters', 'parasitic  interconnects'], ['EMI', 'temporary operation failures'], ['paper', 'offset chopper OTAs'], ['Analyses', 'direct test chip'], ['Voltage Controlled', 'Electrical Bio Impedance Spectroscopy'], ['circuit', '130 nm CMOS 1'], ['', ''], ['proposed Howland Current Source', 'Biased Complementary Folded Cascode'], ['current peak amplitude', '10'], ['', ''], ['specifications', '1 MHz frequency'], ['main  results', ''], ['5 k Omega', '1'], ['', 'lower amplitude 0'], ['', '10 load Omega'], ['performance', 'EBS CCD applications'], ['design', 'electrical bio impedance spectroscopy'], ['circuit', '130 nm CMOS 1'], ['', ''], ['current  source', 'folded  cascode'], ['current peak amplitude', '10 mu A'], ['specifications', '1 MHz frequency'], ['main  results', ''], ['', 'vertical bar load 1'], ['', 'lower amplitude 0'], ['', 'vertical load bar'], ['experimental  result', 'maximum  linearity'], ['', 'full  scale'], ['performance', 'EBS CCD applications'], ['article', 'operational bandpass amplifier'], ['connected feedback that', 'connected feedback filter'], ['undergraduate  which', 'electronic shadow filter'], ['Experimental  results', 'operational  amplifier'], ['paper', 'negative immittance functions'], ['proposed  circuit', 'operational  amplifiers'], ['functionality', 'ADS Advanced Design software'], ['simulation results', 'theoretical lossless inductance calculations'], ['paper', 'low  frequency'], ['active device performance parameters', 'parasitic input output amplifier'], ['numerical  simulations', 'CFOAs'], ['dynamic  behavior', 'CFOA'], ['Afterwards  SNFS', 'linear PWL CFOAs'], ['SNFS  latter', 'such PWL approaches'], ['', ''], ['rights', ''], ['paper', 'operational bandpass shadow amplifier'], ['proposed  circuit', 'controlled center frequency'], ['Experimental  results', 'AD844 CFOA'], ['paper', 'direct methanol fuel cell'], ['ECM', 'operational amplifier diodes'], ['current voltage profiles', 'current COMSOL model'], ['Afterward  influences', 'passive oxygen DMFC'], ['ECM', 'good  DMFC'], ['simulated  application', 'circuit ECM'], ['simulated  result', ''], ['it', 'real  applications'], ['paper', 'controlled dc dc converter'], ['transient  it', 'conventional output voltage'], ['modifying process', 'transient  state'], ['feedforward  control', 'steady state error'], ['current  paper', 'current sensing methods'], ['output current sensing method', 'current sensing resistor'], ['transient response performance', 'case'], ['when sensing efficiency', 'current sensing method'], ['alkaline laboratory students', 'type kinetic enzyme'], ['Students', 'also DNA purification digestion'], ['', 'mutant techniques enzymes'], ['that', 'traditional textbook biochemical concepts'], ['Students', 'journal quantitative'], ['', 'International Biochemistry'], ['', ''], ['hybrids', 'diverse  genome'], ['globally  industry', 'growing  wood'], ['various propagation approaches', 'vitro  view'], ['it', 'commercial  foplantations'], ['however propagation researchers', 'vitro growth propagules'], ['exogenous  supply', 'plant growth protocols'], ['present  review', 'published species explants'], ['advancements', 'accurately Eucalyptus propagation'], ['', 'recent  E'], ['grandis genome sequence', 'eucalypt genomics metabolomics'], ['Collectively  developments', 'valuable  eucalypts'], ['European Society', 'clinical diagnosis markers'], ['new  definition', 'large  patients'], ['objective', 'primary  hypogammaglobulinemia'], ['', 'primary DEFI hypogammaglobulinemia'], ['351  patients', 'CVID'], ['new  ESID', '18  patients'], ['severe  6', 'major T cell defect'], ['We', 'severe T cell defect'], ['criteria', 'overall CVID 67'], ['', ''], ['', ''], ['', 'combined  immunodeficiency'], ['new ESID definition', 'severe T cell defect'], ['2015  that', 'more T cell LOCID'], ['population', 'specific  care'], ['', '2016 Allergy Asthma'], ['Leukocyte populations', 'menstrual  cycle'], ['cell', 'steroid receptors'], ['14 C which', 'up secretory cycle'], ['We', 'northern  blotting'], ['where  it', 'only secretory cycle'], ['progesterone response elements', 'relative translation start site'], ['These', 'constructs electrophoretic mobility shift assays'], ['deletion  mutation', '40 progesterone %'], ['CXCL14', 'cell vitro'], ['human  it', 'epithelial uNK glands'], ['Metastasis', 'human colorectal cancer patients'], ['However  contribution', 'tumor metastasis'], ['Herein  we', 'colorectal chemokine ELISA array'], ['Immunohistochemistry', 'colorectal cancer patients'], ['Human HCT116 cell lines', 'vitro shCXCR2 lentivirus study'], ['Immunoblot immunofluorescence', 'morphological  cells'], ['we', 'nude tumor vivo'], ['CXCL5', 'colorectal cancer patients'], ['CXCL5', 'instead tumor mesenchyme'], ['Additionally  overexpression', 'CXCR2-dependent beta catenin manner'], ['silencing', 'CXCR2-enhanced cell vitro'], ['elevated  expression', 'intrasplenic injection model'], ['findings support', 'colorectal cancer patients'], ['estimated  state', 'running power systems'], ['accuracy', 'due meter attacks'], ['FDI data attacks', 'estimated  state'], ['Continuous  works', 'recent power years'], ['survey', 'major FDI attacks'], ['Specifically  we', 'associated electricity market view'], ['Then system we', 'FDI attacks'], ['We', 'above FDI attacks impacts'], ['frequency domain approach', 'digital SISO systems'], ['noise gain', 'subject phase margin constraint'], ['repeated pole which', 'linear  equations'], ['PID+filter controls', 'limiting case'], ['Researchers', 'protective  cyberharassment'], ['such  factor', 'electronic technology use'], ['Little  attention', 'parental mediation strategies'], ['', ''], ['restrictive  viewing', 'cyberharassment'], ['', ''], ['how  gender', 'associations'], ['present  study', 'parental mediation strategies'], ['focus', '8th United States'], ['when  relationship', 'more  boys'], ['findings', 'cyberharassment  involvement'], ['', ''], ['rights', ''], ['Type', 'major intracellular cAMP'], ['', 'inflammatory liver diseases'], ['significant  body', 'different liver cancer'], ['present  study', 'human hepatoma HepG2 cells'], ['Treatment', 'time cell growth'], ['that', '50 cell cycle experiments'], ['', ''], ['5 mu M', 'Western blot analysis'], ['Changes', 'also cyclin treatments'], ['inhibitors', 'caspase-3/7 activity'], ['HepG2 cell they', 'hepatocellular  carcinoma'], ['', ''], ['aim', 'lymphoblastic telomerase leukemia'], ['total', 'CDKN2B methylation CDKN2B activity'], ['present  that', '31 CDKN2B diagnosis'], ['1  41', 'CDKN2B methylation'], ['', ''], ['However CDKN2B methylation', 'ITP controls'], ['mean  level', 'telomerase activity'], ['', ''], ['TPG  which', 'significantly  2'], ['', ''], ['', '27 ITP controls'], ['', ''], ['mean  levels', 'telomerase'], ['', ''], ['', ''], ['', ''], ['', '43 CDKN2B methylation'], ['therefore  children', 'increased  telomerase'], ['increased telomerase activity', 'increased childhood ALL'], ['', ''], ['', 'methylated  CDKN2B'], ['', 'unmethylated  CDKN2B'], ['46  %', 'increased telomerase activity'], ['present  hypermethylation', 'upregulated telomerase activity'], ['', ''], ['subepithelial  myofibroblasts', 'inflammatory cytokines PGE2'], ['Sphingosine-1-phosphate', 'cyclooxygenase-2 cell expression'], ['present  we', 'COX-2 SEMFs'], ['Primary SEMFs', 'specific marker proteins'], ['Expression', '1 RT PCR analysis'], ['COX-2 expression', 'Western PGE2 blotting'], ['mRNA stability', 'Northern  blotting'], ['S1P', 'increased PGE2 SEMFs'], ['actions', 'induced COX-2 expression'], ['hand  PKC', 'induced COX-2 expression'], ['induced COX-2 expression', 'p38  activation'], ['S1P', 'COX-2 expression'], ['S1P addition', 'mRNA stability'], ['', 'increased mRNA stability'], ['that', 'intestinal  inflammation'], ['Purpose Overexpression', 'transformed  cells'], ['', 'epithelial growth factor cells'], ['A549 human lung adenocarcinoma which', 'A549 human lung adenocarcinoma cells'], ['COX-2 protein', 'TGF beta'], ['We', 'also RNA interference'], ['protein expression', 'significantly TGF beta'], ['induced TGF beta inhibition', 'mRNA COX-2 stability'], ['also TGF beta', 'destabilizing mRNA expression'], ['that', 'pivotal TGF beta'], ['Smad3', 'dependent TGF beta'], ['results', 'Smad3 A549 cells'], ['PG  biosynthesis', 'key inflammation tumorigenesis development'], ['also  regulation', 'transcriptional cell levels'], ['assays COX-2 we', 'chapter'], ['Emphasis', 'two  points'], ['Firstly COX-2 reporter assays', 'blotting western blotting measurement'], ['Secondly  one', 'experimental reporter purposes'], ['DNA alkylating DNA which', 'various chemotherapy cancer'], ['It', 'immunomodulatory  agent'], ['activation protein alpha', 'associated tumor microenvironment'], ['tumor stromal tumor antigen', 'immune tumor microenvironment'], ['study', 'tumor FAP alpha'], ['CY administration', 'splenic CD8(+)T spleen'], ['immunosuppressive tumor tissues CXCL-12', 'immunosuppressive tumor tissues cytokines'], ['Meanwhile CY combination', 'further tumor stromal factors'], ['vaccinated  mice', '80 survival time'], ['Thus  combination', 'new cancer therapies'], ['retinoic acid metabolizing enzyme', 'vertebrate embryo development'], ['Cyp26a1', 'subtracted hybridization analysis'], ['However  role', 'rat embryo implantation'], ['expression', 'hybridization western hybridization blotting'], ['dUTP nick end Hoechst', 'dUTP nick end labeling'], ['related  proteins', 'western  blotting'], ['Cyp26a1', 'remarkable peri implantation increase'], ['', '4 implantation phase'], ['', ''], ['', 'pregnancy'], ['CYP26A1', 'epithelium luminal epithelium'], ['level', 'artificial CYP26A1 decidualization'], ['', 'control'], ['Forced Cyp26a1 overexpression', 'p53  P'], ['', ''], ['', '05  FasL'], ['', 'nuclear  antigen'], ['05  proteins', ''], ['Cyp26a1', 'spatiotemporally embryo implantation'], ['Overexpression', 'down cell p53'], ['Clopidogrel', 'acute antiplatelet coronary'], ['adequate antiplatelet patients', 'ischemic  events'], ['partly  they', 'poor platelet treatment'], ['loss P450 polymorphisms', 'European impedance population'], ['study', 'ischemic  stroke'], ['Platelet aggregation', 'impedance aggregometry'], ['loss  polymorphisms', 'length polymorphism technique'], ['clinical  data', ''], ['Results', '19 clopidogrel therapy'], ['distribution', 'CYP2C19 polymorphisms'], ['1  %', 'patients'], ['7  %', 'patients'], ['3  heterozygotes', '10  patients'], ['where infarction patients', 'infarction arterial infarction hypertension'], ['prevalence', 'Western clopidogrel populations'], ['Clopidogrel response', 'significantly CYP2C19 polymorphisms'], ['concomitant  use', 'synergic platelet drugs'], ['Asian  populations', 'Caucasian allele populations'], ['10 CYP2D6 enzyme variant', 'clinical  practice'], ['10 CYP2D6 enzyme alleles', 'Asian  populations'], ['total', 'Chinese polymerase chain reaction'], ['1/*10  10/*10', '5/*10 probe drug'], ['Metabolic  ratios', 'h plasma sample type'], ['urinary plasma', 'successively salivary CYP2D6'], ['', ''], ['homozygous metabolizer 10/*10', 'heterozygous CYP2D6 enzyme CYP2D6'], ['Urinary plasma', ''], ['normal metabolizer group', 'detailed  classification'], ['activity score system', 'single phenotype group'], ['Single point plasma samples', 'clinical phenotyping convenience'], ['cytochrome P450 monooxygenases', 'detoxifying insect populations'], ['Spodoptera litura', 'wide  insecticides'], ['novel P450 gene CYP321B1', 'S'], ['', ''], ['function', 'chlorpyrifos beta cypermethrin'], ['open reading frame', '495 amino acid residues'], ['larval CYP321B1 expression', 'fat instar body'], ['expression', '15 beta %'], ['Addition', 'chlorpyrifos beta S'], ['', 'PBO  detoxification'], ['mediated  silencing', 'further  25'], ['', ''], ['fifth instar larvae', 'respectively LC50 dose levels'], ['CYP321B1', 'chlorpyrifos beta S'], ['', ''], ['levels', 'susceptible Helicoverpa strain'], ['Here  we', 'specific HDS H'], ['', ''], ['Comparison', 'HDFR CYP6B7 HDS'], ['', 'genomic  HDFR'], ['Northern blotting analysis', 'HDFR  H'], ['armigera', '5-fold  HDS'], ['however  it', 'pupae  stages'], ['cytochrome P450 CYP6B7', 'HDFR insecticide fenvalerate H'], ['', 'amino fenvalerate H'], ['', 'China'], ['lifelong latent little', 'farmed koi China'], ['We', 'southern CyHV-3 infection'], ['CyHV-3 DNA', 'asymptomatic blood koi'], ['5  samples', 'prior CyHV-3 infections'], ['koi', 'CyHV-3 infections'], ['Two  genotypes', 'dependent cystatin gene wheat'], ['', ''], ['Three  members', 'cystatin gene family'], ['Analysis', 'different wheat cystatin'], ['functional signature domains', 'actively protease inhibition capability'], ['quantitative  levels', 'western ELISA techniques'], ['however expression level', 'resistant cystatin gene HD'], ['contrary WC1 expression', 'gradually S stage'], ['western WC1 family', 'other gene families'], ['further WC1 protein', 'susceptible S2 genotype'], ['low  level', 'KB infection'], ['results', 'dependent cystatin gene KB'], ['', 'molecular cysteine protease 11'], ['5  kDa', 'hydrophobic column chromatographies'], ['strongly plant cysteine protease', 'K  5'], ['', ''], ['105 amino acid that', 'Sarcophaga peregrina'], ['12  which', 'MsCPI  segments'], ['recombinant Escherichia protein', 'such cathepsins B'], ['', ''], ['', ''], ['', ''], ['', 'chymotrypsin subtilisin pepsin'], ['', ''], ['rights', ''], ['oomycete Phytophthora capsici', 'important plant production'], ['asexual  reproduction', 'rapid  field'], ['global proteomics study', 'asexual life P'], ['', ''], ['', ''], ['', 'biochemical  processes'], ['total', 'qualitative  proteomics'], ['transcript  abundance', 'real polymerase chain reaction'], ['Seventy three Seventy proteins', 'different  mycelium'], ['proteins', 'cellular building growth'], ['early infection stage', 'primarily energy production'], ['data', 'better  P'], ['', 'developmental disease control'], ['2 repeat domain gene', 'mitochondrial RNA metabolism'], ['mice', 'catalytic cytochrome complex'], ['reduction', 'ventricular fibro fatty tissue'], ['reduction', 'processed ND5-CYTB transcript'], ['PTCD2 protein', 'mitochondrial DNA'], ['This', 'possible heart failure'], ['Previous  studies', 'increased atrazine exposure'], ['1678 reading which', '559 amino acid residues'], ['Alignments', 'other insect CYP4 genes'], ['1200 CYP4 gene', 'late instar larvae'], ['', 'over  C'], ['tentans', 'aquatic atrazine organisms'], ['', ''], ['rights', ''], ['new cytochrome P450 CYP4G25', 'subtractive cDNA hybridization'], ['cDNA sequence', '557 amino acid residues'], ['putative motif that', 'P450 cytochromes'], ['', 'predominant  pharate'], ['Northern blotting analysis', 'diapause larval development'], ['CYP4G25', 'strongly  pharate'], ['', ''], ['rights', ''], ['novel cytochrome P450 CYP4x1', 'CYP4A C family'], ['human  cDNAs', 'putative cytochrome P450 proteins'], ['Molecular modelling', 'binding CYP4 family'], ['Expression', 'northern EST blotting'], ['hepatic  levels', 'phenobarbital PPAR alpha-/- mice'], ['quantitation', '10 Cyp4x1 protein'], ['microsomal Cyp4x1', ''], ['Immunohistochemical  localization', 'specific Cyp4x1 staining'], ['data', 'important  brain'], ['CYP1B1', 'congenital P450 glaucoma'], ['mechanism', 'PCG phenotype'], ['Previously  investigators', 'situ hybridization techniques'], ['additional  investigators', 'Northern adult blotting'], ['study', 'fetal  eyes'], ['fetal  eyes', 'appropriate  controls'], ['intensity', 'quantitative  techniques'], ['', 'ciliary  epithelium'], ['intense  IR', 'ciliary  epithelium'], ['IR', 'corneal  epithelium'], ['However  IR', 'trabecular  samples'], ['general  immunolabeling', 'when adult eyes'], ['IR', 'fetal  development'], ['IR', 'trabecular  meshwork'], ['abnormalities', 'ciliary  epithelium'], ['', ''], ['rights', ''], ['expression patterns', 'epithelial  neoplasms'], ['aims', 'small cell lung cancer'], ['mRNA  expression', 'Northern CK14 CK15 blotting'], ['Protein expression', 'tissue microarrays'], ['CKs', 'airway epithelial airway cells'], ['expression pattern', 'CKs'], ['Regarding', 'squamous cell adenocarcinomas'], ['', ''], ['', ''], ['higher  expression', 'lower  grading'], ['', ''], ['', ''], ['increased  expression', 'ADC'], ['', ''], ['CK7 CK14 CK17', 'diagnostic  NSCLC'], ['', ''], ['', ''], ['etiologic  agent', 'cardiovascular  disease'], ['', 'However  S'], ['mutans', 'cardiovascular  disease'], ['aim', 'cytokine S'], ['', 'binding -like HAECs'], ['Cytokine production', 'real reaction flow cytometry'], ['involvement', 'invaded RNA interference'], ['', 'invasion S'], ['mutans strains', 'antibiotic protection assays'], ['', 'six  S'], ['mutans', 'interleukin-6 interleukin-8 chemoattractant protein-1 HAECs'], ['', ''], ['mutans', 'mRNA  HAECs'], ['Streptococcus mutans Xc', 'TLR2 protein HAECs'], ['', 'TLR2  S'], ['mutans Xc', 'interleukin-6 interleukin-8'], ['', 'invasive Cytokine S'], ['mutans', 'cardiovascular intracellular disease'], ['1 TNFR1 CD120a', 'transplanted TNF cells'], ['TNFR2  pTNFR2', 'xenograft rejection'], ['We', 'rapid cDNA ends'], ['We', 'functional expression roles'], ['We', 'fourth pTNFR2 Delta modifications'], ['mRNA  transcripts', 'northern  blotting'], ['Quantitative RT PCR', 'cells pTNFR2 tissues'], ['full  receptor', 'endothelial pig TNF'], ['bound pTNFR2 Delta E4', 'contrary'], ['binds pig', 'human pig TNF cytokine'], ['soluble pTNFR2 Delta E4', 'based  assay'], ['pTNFR2', 'soluble xenograft setting'], ['other pTNFR2 that', 'immune  xenografts'], ['', 'implant macrophage activation invitro'], ['Ti titanium zirconium', 'different surface treatments'], ['Surface roughness energy', ''], ['Primary murine macrophages', 'old tissue culture polystyrene'], ['mRNA', 'quantitative polymerase chain culture'], ['protein levels', 'culture'], ['Results Quantitatively Results microroughness', 'surfaces'], ['modSLA  that', 'TiZr'], ['high SLA surfaces', ''], ['Cells', 'low energy surfaces'], ['effect', 'when Ti SLA'], ['Macrophages', 'inflammatory TiZr cytokines'], ['combination', 'inflammatory factor release'], ['bioactive plant food compounds', 'periodontal  disease'], ['we', 'tight junction integrity'], ['effects', 'monocytes signaling macrophages'], ['', 'factor gene P'], ['gingivalis', 'real time PCR'], ['fluorescence assay', 'P'], ['', 'gingival keratinocyte monolayer'], ['Tight junction integrity', 'electrical gingival resistance'], ['', 'MMP P'], ['stimulated  macrophages', 'ELISA'], ['3xB monocyte cell line', 'NF B activation'], ['Gelatin degradation', 'fluorogenic  assay'], ['ResultsBlack tea TFs', 'major virulence P'], ['', 'gingival keratinocytes'], ['treatment', 'tight junction P'], ['', ''], ['IL-6 tumor chemokine', '8 MMP-3 P'], ['', 'stimulated  P'], ['mediated NF B', 'signaling pathway'], ['black tea TFs', 'gelatin MMP-9'], ['black tea TFs', 'periodontal  disease'], ['leading skin incidence', 'past  decades'], ['available treatment options', 'clinical  research'], ['Melanoma', 'immunotherapeutic  melanoma'], ['recent  utilizing', 'advanced  melanoma'], ['overview', 'emerging cytokine details'], ['study', 'based  melanoma'], ['', ''], ['', ''], ['rights', ''], ['systematic meta that', 'healthy  controls'], ['PubMed MEDLINE EMBASE', 'PsycINFO May'], ['Effect sizes', 'random effects models'], ['ResultEighty two ResultEighty studies', '2798 inclusion criteria'], ['2 interferon gamma levels', 'MDD'], ['', ''], ['', ''], ['IL-17 growth beta', 'significantly  HCs'], ['Heterogeneity', ''], ['', ''], ['7  sources', 'heterogeneity'], ['', ''], ['', ''], ['ConclusionOur results', 'cytokine chemokine MDD'], ['Future studies', 'immune biosignature cells'], ['Objective', 'immunosuppressive pleiotropic activities'], ['promoter region polymorphism', 'expression  cytokine'], ['nucleotide  polymorphisms', 'squamous cell carcinoma'], ['We', 'Indian PCR method'], ['Allele', '95 % confidence intervals'], ['genotype  distribution', 'significantly genotype AC'], ['', ''], ['', ''], ['', ''], ['', 'CC'], ['', ''], ['', ''], ['', ''], ['', ''], ['-592 C alleles', 'significantly OSCC cases'], ['', ''], ['', ''], ['', ''], ['', ''], ['-592 C polymorphism', 'reduced  OSCC'], ['OSCC group', 'greater control group'], ['', ''], ['rights', ''], ['MC  migration', 'mesangiocapillary  glomerulonephritis'], ['vitro  investigations', 'central multidomain MC'], ['major necrosis factor that', 'major necrosis factor genes'], ['Transcriptional  induction', 'Western polymerase chain blotting'], ['PTN', 'confluent MC cultures'], ['', 'associated migration PTN'], ['PTN protein', 'conditioned  MCs'], ['removed  localization', 'extracellular cell matrix'], ['rapidly  that', 'rapidly  cells'], ['result', 'currently  investigation'], ['transcriptional  reprogramming', 'human polarization spectrum'], ['Lipids', 'cellular protein membranes'], ['changes', 'immune responses phagocytosis'], ['human membrane monocyte', 'different  donors'], ['fluid mass spectrometry which', 'fatty acid composition'], ['enzymatic polarization lipid', 'molecules'], ['Thromboxane A2 production', 'specific M1 polarization'], ['alterations', 'cellular activation states'], ['', ''], ['rights', ''], ['such leprosy who', 'inflammatory  proteins'], ['immunological  shift', 'periodontal Porphyromonas disease'], ['ObjectiveTo', 'vitro Mycobacterium tuberculosis'], ['leprae lysates', 'immune  P'], ['', 'experimental  immunology'], ['Material', 'bacterial blood mononuclear M'], ['', ''], ['', ''], ['', ''], ['we', 'immunosorbent  assay'], ['', '1 ResultsEarly M'], ['', ''], ['same  cells', 'oral pathogen P'], ['', ''], ['immunological  that', 'present  PD'], ['presence', 'past health populations'], ['Matrix metalloproteinases', 'tissue'], ['novel cytokine', 'inflammatory MMP expression'], ['We', 'signaling MMP-1 pathways'], ['HCF', 'recombinant  human'], ['MMP-1 expression', 'MAPK protein kinase assays'], ['Signal transduction pathways', 'interfering  RNA'], ['IL-17', 'promoter reporter HCF'], ['response', 'TNF alpha'], ['IL-17-stimulated I collagenase activity', 'mediated MMP-1 knockdown'], ['', 'negative signaling proteins'], ['Inhibition', 'C IL-17-stimulated MMP-1 expression'], ['MAPK  activation', 'IL-17-mediated transcription factor activation'], ['C EBP IL-17', 'myocardial  remodeling'], ['necrosis factor alpha', 'nuclear vivo canine model'], ['anesthetized  dogs', '3 coronary hours'], ['Dogs', 'soluble TNF inhibitor'], ['', 'intravenously  occlusion'], ['blotting ICAM-1 protein expression', 'Western  blotting'], ['kappa B activation', 'electrophoretlic mobility shift assays'], ['INF  RISK', 'collateral saline control flow'], ['', 'INF mean RISK'], ['', ''], ['', ''], ['', ''], ['', ''], ['MPO activity ICAM-1', 'etanercept kappa B group'], ['TNF inhibitor', 'myocardial ischemia reperfusion'], ['TNF a', 'postischemic  inflammation'], ['', 'topical  ganciclovir'], ['', 'referral Brussels Belgium'], ['', 'positive polymerase chain reaction'], ['We', 'clinical CMV anterior uveitis'], ['Patients', 'pretreatment follow 13'], ['', ''], ['', '78 posttreatment follow 42'], ['', ''], ['', ''], ['', ''], ['3  %', 'clinical Posner Schlossman syndrome'], ['7  %', 'heterochromic keratic iridocyclitis'], ['', 'visual presentation acuity'], ['', ''], ['patients', 'mean  41'], ['', ''], ['', ''], ['', '5 follow patients'], ['glaucoma', 'needed glaucoma surgery'], ['', ''], ['final  VA', ''], ['', ''], ['', ''], ['5  %', 'final  0'], ['', '1'], ['Patients', 'recurrences year posttreatment'], ['', ''], ['', 'pretreatment  period'], ['', ''], ['', ''], ['', ''], ['mean  time', '4'], ['', 'months  12'], ['', 'months  treatment'], ['', ''], ['patients', '0'], ['topical  ganciclovir', 'central  time'], ['However  glaucoma', ''], ['', ''], ['Systemic  reactivations', 'immune care deficiency'], ['clinical  relevance', 'events'], ['', ''], ['we', 'tertiary care Netherlands'], ['who', 'known ICU immunodeficiency'], ['We', 'weekly polymerase chain plasma'], ['', ''], ['329  we', '68 viremia patients'], ['Viremia', 'HHV-6 HSV1 60'], ['34  patients', 'concurrent viremia events'], ['Crude mortality', 'remaining  patients'], ['', ''], ['CMV  reactivations', 'increased  mortality'], ['', ''], ['', ''], ['', ''], ['', ''], ['Herpesvirus reactivations', 'prior shock immunodeficiency'], ['Concurrent  reactivations', 'independently  mortality'], ['Viruses', 'immunocompromised  patients'], ['diagnostic  it', 'infections'], ['present  study', 'immunocompromised  patients'], ['total', 'MPCR months culture'], ['Patients', 'pathogens'], ['', ''], ['', ''], ['', 'Category i'], ['', ''], ['', ''], ['MPCR', 'causative  59'], ['culture', 'only  37'], ['', '8  patients'], ['etiological  agent', '32 Klebsiella cytomegalovirus'], ['Numbers', 'category'], ['', ''], ['', ''], ['', ''], ['', ''], ['Mortality', 'mixed Category infections'], ['sensitive  which', 'immunocompromised  patients'], ['transcriptional  patterns', 'sterile mustard Brassica juncea'], ['', '2 stem mustard CMS'], ['open reading frame hereafter', 'mitochondrial nad2 CMS'], ['novel orfB gene', '5 Arabidopsis B'], ['', '5 CMS Brassica juncea'], ['Three  copies', 'single maintainer line'], ['maintainer which', 'specific  CMS'], ['Meanwhile  expression', 'maintainer line'], ['thus nad2 gene', 'associated orfB CMS'], ['that', 'partial nad2 gene'], ['Such  alterations', 'male NADH sterility'], ['', 'EGR-1 tumor IR'], ['PC3  cells', '2 gamma Gy'], ['surviving  cells', ''], ['sensitivity', 'DOX colony formation assay'], ['RT polymerase chain analysis', 'radioresistant cells'], ['interfering RNA system', 'resistant EGR-1 cells'], ['possible  EGR-1', 'radiosensitivity'], ['FI', 'tumor cells'], ['interactive expression EGR-1 gene', 'treated  cells'], ['', 'other DAB2IP overexpression'], ['B inhibitor BAY11 7082', 'resistant  radiosensitivity'], ['Conventionally FI', 'acquired  vitro'], ['targeted drug design', 'induced tumor patients'], ['Tomato', 'ornamental Dahlia Japan'], ['plant that', 'free  plants'], ['distribution', 'transcriptional polymerase chain reaction'], ['infected compound it', 'lamina'], ['tissue blot immunoassays', 'especially leaf blade'], ['In detection rate', 'vegetative growth stage'], ['uneven  distribution', 'bulb'], ['well  rachis', 'compound dahlias'], ['study', 'uneven dahlia plants'], ['Metabolic impairs changes', 'embryonic  development'], ['metabolic insulin concentrations', 'energy balance diabetes'], ['Still  insulin', 'developmental  offspring'], ['investigated', 'developmental rates embryo quality'], ['', 'maturation 10'], ['1 mu gmL(-1', 'free blastocyst control'], ['', ''], ['', ''], ['', ''], ['', '3  23'], ['', ''], ['', ''], ['', '8 cell control'], ['', ''], ['Transcriptome analysis', 'quantitative polymerase chain reaction'], ['maturation', 'specific gene expression perturbations'], ['combined  supplement', 'milk feed intake'], ['supplementation', 'milk milk component synthesis'], ['', 'Thus transcriptome liver'], ['multiparous Holstein dairy cows', '305-day milk production'], ['', '5 block saline'], ['', '10 vitamin vitamins'], ['experimental  period', '9 calving lactation'], ['Liver', 'mammary dairy 64'], ['Samples', 'hepatic  tissues'], ['mammary  expression', 'vitamin supplements'], ['Gene ontology', 'molecular  biology'], ['Panther', 'online gene function classification'], ['It', '63 Function Biological Process'], ['Most', 'developmental metabolic process inflammation'], ['developmental protein process', 'mammary  gland'], ['Out', '25  qPCR'], ['metabolic  processes', 'lactating dairy cows'], ['vitamin supplements', 'early liver lactation'], ['RT  results', 'fermented dairy microorganisms'], ['experimental set ups', 'technological Lactococcus environments'], ['sufficient SLAB DNA', 'cellular  integrity'], ['first  order', 'free RT qPCR results'], ['Importantly  interference', 'negative nucleic samples'], ['DNA mRNA', 'molecular  quantifications'], ['Therefore  results', 'molecular dairy matrices'], ['', ''], ['rights', ''], ['', 'watershed river resilience'], ['125 New dams', 'ecological  rationales'], ['local restoration who', 'dammed  landscapes'], ['comparative case study we', 'six New England'], ['Each', 'institutional removal conditions'], ['these', 'local removal process'], ['where  removals', 'cases'], ['that', 'institutional  power'], ['scientific Matter Particle which', 'dark  space'], ['bismuth germanium which', 'tube  dynodes'], ['key Specific Integrated components', 'PMT signals'], ['onboard calibration circuit', 'VA160'], ['It', '12-bit Analog Converter'], ['which', 'input range'], ['It', 'trigger FEEs'], ['calibration circuit', 'environmental Flight DAMPE'], ['calibration circuit', 'periodically  space'], ['We', 'fast zebrafish Danio'], ['', '26/27 degrees C'], ['Fast muscle fibres', '31 degrees C ET'], ['31 C ET', '22 degrees C ET'], ['Further  growth', 'only fibre hypertrophy'], ['Microarray experiments', 'whole life cycle'], ['expression', 'independent time M(+'], ['regulated  miRNAs', 'together M- 34'], ['', ''], ['abundant  categories', 'regulated contractile proteins'], ['', ''], ['', ''], ['regulated  transcripts', 'M(-  phenotype'], ['', ''], ['', ''], ['like complement protein', '1  cd9l'], ['that', 'specifically nascent myofibres'], ['regulated  miRNAs', 'seven miRBase Targets version'], ['', ''], ['', ''], ['uk  which', 'four  miRNAs'], ['five', 'mRNA targets'], ['miRNAs', 'M- genes'], ['', ''], ['Finding', 'natural O products'], ['Daphnetin', 'potent COMT inhibitors'], ['Here  potential', 'human liver cytosol'], ['', ''], ['Daphnetin', 'dependent dopamine O manner'], ['', 'IC50 daphnetin'], ['', 'similar  0'], ['', ''], ['', 'similar  24'], ['3 mu M', 'little HLC concentrations'], ['Further kinetic analysis', 'K daphnetin'], ['', ''], ['', ''], ['Other  metabolites', 'negligible  COMT'], ['', 'vitro IV 24'], ['when COMT they', 'daphnetin'], ['', ''], ['inhibiting activity daphnetin', 'new COMT inhibitors'], ['much  attention', 'primarily  COMT'], ['acrokeratosis relationship', '2  entities'], ['yet  they', 'other  fashion'], ['authors', 'crusted dorsal neck'], ['Histological  evaluation', 'like  AKV'], ['Forehead biopsy', 'acantholytic  DD'], ['Polymerase chain reaction', 'like  papule'], ['Cytoplasmic  expression', 'capsid  hypergranulosis'], ['presence', 'productive HPV infection'], ['', 'significant  DGIs'], ['DGIs', 'viral  attacks'], ['common leaf that', 'various mosaic viruses'], ['We', 'infected Nicotiana tabacum leaves'], ['less  LGTs', 'less  virus'], ['DGIs', 'higher plant defence'], ['reduced ascorbic that', 'even control plants'], ['ethylene defence genes', 'viral DGIs infection'], ['accumulation', 'much  LGTs'], ['accumulation', 'interfering  LGTs'], ['leaf that', 'enhanced defence responses'], ['operational  amplifier', 'boosted Darlington technique'], ['proposed  Opamp', 'high capacitor compensation technique'], ['It', 'rail power +'], ['amplifier', 'high power gain'], ['89dB  bandwidth', ''], ['slew rate', ''], ['', ''], ['circuit', 'gpdk45 nm technology'], ['MHC histocompatibility genes', 'immunological  individuals'], ['', 'tailed gene phascogales'], ['only DAB PCR', 'initial muscle DAB'], ['fragments', '98 DAB gene koala'], ['Multiple sequence alignment', 'individual Class II total'], ['Genomic DNA', 'phascogale scat samples'], ['tailed  phascogales', 'MHC  population'], ['industrial  millions', 'power grid refineries petrochemical plants'], ['managing  they', 'managing  data'], ['much', 'special plant operator'], ['based data mining that', 'industrial alarm data'], ['method', 'historical alarm events'], ['graph analytics that', 'critical  events'], ['proposed  method', 'world power generation station'], ['how  research', 'past  years'], ['', 'major data research'], ['average data publication', 'larger citation field'], ['We', 'related DAC publications'], ['study', 'together citation datasets'], ['results', 'openly  data'], ['brief', 'deregulated electricity markets'], ['We', 'constrained queue delay'], ['', 'fast workload arrival distribution'], ['offline DSRP which', 'proposed performance method'], ['Finally  we', 'real  workloads'], ['sensitivity', 'real data perturbation'], ['that', 'wholesale electricity prices'], ['static operating that', 'future  time'], ['then linear sensitivity that', 'look data dispatch'], ['matrix', 'look forecast horizon'], ['results', '14-bus  system'], ['sustainable energy systems', 'making  processes'], ['article', 'LC energy systems'], ['used criteria data sources', 'MCDA energy systems'], ['Moreover DEA approaches', 'available energy sustainability'], ['central  focus', 'oriented  energy'], ['potentials', 'wide DEA models'], ['methodological energy scenario framework', 'dynamic sustainability DEA'], ['DEA concept', 'sustainable energy future'], ['', ''], ['rights', ''], ['paper', 'Italian manufacturing firms'], ['We', 'first bootstrap stage'], ['We', 'well sector outliers'], ['obtained efficiency scores', 'truncated Maximum Simar'], ['technical workplace aspects', 'negative debt effect'], ['labor contracts effect', 'negative  effect'], ['', ''], ['', ''], ['rights', ''], ['secondary peri aim', 'dental data mining methods'], ['Material', 'internal plaque connection'], ['Real polymerase chain reaction', '23  pathogens'], ['predictive  models', 'C4'], ['', 'experimental decision sites'], ['final  sample', 'implant peri implantitis'], ['Total', 'healthy pathogen controls'], ['peri  pocket', 'microbiologic  82'], ['', ''], ['', ''], ['', '5  accuracy'], ['microbiological  profile', 'implantitis  controls'], ['implant peri method', 'complex  infections'], ['recent electricity crisis', 'widening  demand'], ['future  demand', 'efficient  electricity'], ['efficient electricity demand forecasting', 'crucial  tools'], ['forecasting technique', 'proper decision policy'], ['DE vector optimization', 'hoc Friedman test'], ['empirical  results', 'other candidate 0'], ['', ''], ['proposed  model', 'annual electricity consumptions'], ['', ''], ['', ''], ['rights', ''], ['object', 'digital  control'], ['embedded systems time intervals', 'control discipline'], ['common  cyclic', 'common  use'], ['fundamental theory models', 'dispatching control disciplines'], ['Mathematical  relationships', 'switches'], ['parameters', 'embedded data systems'], ['real time which', 'real time market'], ['day forecast errors which', 'separate trading scheme'], ['unified trading that', 'day ahead trading scheme'], ['model', 'real time market'], ['', 'behaved particle swarm algorithm'], ['Finally  impacts', 'proposed trading model'], ['Existing  methods', 'two DC categories'], ['However loop gains', 'totally  other'], ['two loop accuracy', 'simulation'], ['forward  that', 'open loop ASDM'], ['Spread spectrum', 'many  circuits'], ['where performance spreading', 'lowest performance circuit'], ['result', 'different EMI victim models'], ['proposed  analysis', 'resonant converter class'], ['paper', 'wide input voltage'], ['based function controller', 'digital signal processor'], ['proposed output load controller', 'output'], ['Experimental  results', 'conventional PID controller'], ['paper', 'unbalanced load condition'], ['key  novelty', 'simple line frequency approach'], ['four LC filter', 'single ac conversion stage'], ['based control algorithm', 'unbalanced coupling loads'], ['behavior', 'qZS operating network'], ['Furthermore  effect', 'inductor current inductor constraint'], ['verify', 'balanced approach loads'], ['current DC power arc', 'applications'], ['switching DC DC converter', 'recovery turn energy recovery snubber'], ['Circulating currents', 'primary novel control algorithm'], ['', 'experimental  4'], ['5kW DC DC converter', 'switching 100kHz'], ['weighted controller structure', 'large signal operations'], ['local linear compensators', 'single controller structure'], ['local linear compensator', 'wide operating point variations'], ['easily linear compensation that', 'analog control circuitries'], ['alone DC DC converter', 'simulation DC converter results'], ['power feeding system', 'recent  years'], ['dynamically  stability', 'dc dc converter'], ['paper', 'small output capacitance'], ['proposed  method', 'logarithm load current'], ['when output capacitance', 'high  stability'], ['Stability', 'stable dc bus'], ['paper', 'high output capacitance'], ['integral  which', 'load current'], ['stability analysis', 'Bode diagrams'], ['even output capacitance', 'conventional  method'], ['Simulation', 'experimental  concept'], ['paper', 'real time microcontroller unit'], ['pulse width modulation which', 'low cost joystick'], ['Voltage regulators', 'correct DC batteries'], ['digital drive controller', 'good user driving'], ['reference modified PID which', 'controlled dc dc converters'], ['various energy network types', 'stable control operation'], ['they', 'heavily  system'], ['complicated control it', 'circuit converters'], ['simple  design', 'stable power converters'], ['black  it', 'complicated input output modelling'], ['overcompensation phenomenon', 'transient  response'], ['neural network control', 'conventional PID control'], ['output voltage', 'output voltage'], ['simple duration design', 'transient network response'], ['proposed  method', 'conventional PID control'], ['purpose', 'current dc dc converter'], ['reactor current', 'small signal analysis'], ['They', 'large amplitude operation'], ['tendency', 'transient analysis results'], ['gradual  response', 'dc dc converter'], ['proposed  method', 'current mode digital'], ['SOSM control approach', 'synchronous dc dc converters'], ['synchronous dc dc converters', 'integral control loop'], ['SOSM controller', 'transient parameter uncertainties'], ['Fast  transients', 'one controller parameter'], ['Furthermore hysteresis method', 'switching frequency'], ['proposed  approach', 'experimental  1'], ['', ''], ['static dc dc that', 'input voltage'], ['sensorless model control', 'output voltage'], ['transient  response', 'output voltage'], ['transient improvement which', 'transient bias state'], ['transient improvement that', 'transient circuit condition'], ['', ''], ['', ''], ['', ''], ['digital Fast controller', '65-nm CMOS process'], ['low dropout regulator', 'step NMOS power CP'], ['clock tripler', 'Fast RAP control'], ['transient linear response', 'adaptive  scheme'], ['light load efficiency', 'response time'], ['When  CP', '90  80'], ['small  ripples', 'only dropout 4'], ['1 % efficiency', ''], ['', ''], ['output ripple', '20 load mA'], ['paper', 'controlled dc dc converters'], ['Power supplies', 'electronic communication them'], ['required  they', 'power supplies'], ['superior control which', 'transient output voltage'], ['neural  network', 'transient output state'], ['gradually training procedure', 'neural  network'], ['also time which', 'transient control characteristics'], ['repetitive  training', 'transient duration characteristics'], ['presented  method', 'conventional PID control'], ['aim', 'current dc dc converter'], ['real  it', 'arbitrary overcurrent limitation mode'], ['It', 'renewable energy system'], ['effectiveness', 'simulated  results'], ['purpose', '380 Vdc system'], ['soft start operation', 'start dc dc converters'], ['soft dc dc converter', 'light load condition'], ['Therefore  it', 'desired power output'], ['start control speed', 'flexibly load condition'], ['approximated load which', 'experiment advance'], ['soft start control method', 'simulations'], ['proposed  method', 'conventional start one'], ['paper', 'ISOP output connection'], ['work', 'input input voltages'], ['decoupled control scheme', 'control strategy'], ['experimental  setup', 'constructive parameter account'], ['Dc dc converters', 'nonlinear  dynamics'], ['controlled  converters', 'known limit cycle oscillations'], ['controlled  origin', 'asymmetric duty cycle'], ['study', 'responsible converter system it'], ['challenges', 'free system SGO'], ['potential  oscillation', 'SGO immune SGO designs'], ['Simulation', 'experimental  claims'], ['study', 'controlled DC DC converter'], ['reduced state Kalman filter', 'low output resolution'], ['different prototype which', 'digital signal processor'], ['proposed scheme eliminates', 'cycle oscillation'], ['LHO loop technique', 'multiple start up'], ['presented  technique', 'small clock blocks'], ['It', 'low silicon power'], ['presented  technique', 'pulse width modulation'], ['Experimental  results', 'simpler LHO technique'], ['study', 'signal imperfect modelling'], ['regulation DC DC margins', 'determined operating conditions'], ['proposed  approach', 'dynamic instability converter'], ['adaptive DC DC controller', 'system identification degree pole placement'], ['experimental  setup', 'adaptive micro controller'], ['experimental  results', 'different operating points'], ['Centralised electricity systems', 'improved power grid'], ['', 'effective energy storage electromobility'], ['electric charger stations loads', 'resonant converter building block'], ['latter', 'available DC nanogrid'], ['Proposed power system', 'conventional voltage source converter'], ['proposed  analyses', 'core  element'], ['', ''], ['', ''], ['paper', 'controlled power loads'], ['load converters', 'damped LC filters'], ['dynamic  behavior', 'conventional averaging techniques'], ['However dc power systems', 'widely transportation applications'], ['stability analysis', 'intrinsic system model'], ['impacts', 'discrete time method'], ['active  stabilizer', 'dynamic stability margin'], ['theoretical  observations', 'experimentally laboratory hardware prototype'], ['Deficits', 'neurological  disorders'], ['underlying  mechanism', ''], ['loss', 'social dopamine system'], ['receptor D1 agonist', 'short term plasticity'], ['genetic  that', 'social autism spectrum disorders'], ['', ''], ['', ''], ['rights', ''], ['Soil salinity', 'environmental plant growth'], ['1 DEAD box that', 'salt exposure'], ['overexpression', 'virus salinity tolerance'], ['AvDH1 gene', 'cotton genome'], ['growth', 'saline field trial'], ['Transgenic  cotton', 'when growth chamber'], ['membrane which', 'plant survival rates'], ['transgenic cotton lines', 'high soil salinity levels'], ['transgenic  cotton', 'promising saline fields'], ['paper', 'dead time effect compensation'], ['proposed  solution', 'analog  converters'], ['instants', 'PWM pulsewidth strategy'], ['it', 'dead voltage time'], ['voltage error', 'next reference voltage'], ['proposed  solution', 'voltage source inverters'], ['experimental research studies', 'clamped  55-'], ['results', 'experimental  paper'], ['lit  film', 'human  death'], ['existential  article', 'dead'], ['nature', 'high profile child deaths'], ['child that', 'official  accounts'], ['social  they', 'information'], ['Workers', 'defined situations time pressures'], ['which', 'better  understanding'], ['prefrontal  cortex', 'past  goals'], ['nonmatch  that', 'monkey H interaction'], ['that', 'object goal'], ['other object goal it', 'subsequent  trial'], ['neurons', 'previous goal position'], ['future  we', 'human agent future goal'], ['other  one', 'agent choice'], ['Parkinson disease', 'motor  symptoms'], ['Nonmotor symptoms', 'frontostriatal substantia circuits'], ['we', 'social cognition PD'], ['We', 'additional  citations'], ['only  18', 'search criteria'], ['different health that', 'emotional face recognition'], ['Studies', 'executive  function'], ['Patients', 'earliest  disease'], ['ability', 'cognitive  functions'], ['deep brain stimulator', 'power data transmission'], ['in  controller', 'stimulation parameters'], ['stimulator', 'four control channels'], ['controlled voltage cancellation rectifier', 'supply stimulator'], ['monolithic  stimulator', 'SMIC'], ['', ''], ['23  mm(2', '180 mu W'], ['published  design', 'stimulated  current'], ['', 'low voltage supply'], ['', ''], ['', ''], ['Literature studies', 'deep Transcranial Magnetic Stimulation'], ['when  it', 'clinical  studies'], ['study', 'clinical figure of-8 experiments'], ['when figure they', 'focal H1 coil'], ['deeper brain it', 'frontal penetration lobe'], ['work', 'experimental brain treatments'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['Narratives', 'social  values'], ['how  brain', 'listener  narratives'], ['response', 'values'], ['that', 'particularly  receivers'], ['Protected  values', 'social decision cognition'], ['Here  we', 'protected  narratives'], ['fMRI we', '20 million 20 weblogs'], ['Reading', 'prefrontal temporo cortices'], ['protected value value', 'intensive  material'], ['strength', 'protected  values'], ['Communication', 'optimal cognitive optimal processing'], ['Functional  relationships', 'spontaneous activity patterns'], ['relationships', 'regional  connectivity'], ['functional connectivity consequences', 'distributed connectivity changes'], ['Here  we', 'healthy comparison individuals'], ['', 'undamaged DN nodes'], ['specific  changes', 'DN  networks'], ['findings', 'functionally  mPFC'], ['Rather  they', 'functional  interactions'], ['lesions', 'large scale systems'], ['', 'fixing plant cells rhizobia'], ['nad1 Medicago truncatula mutant', 'reverse genetics methods'], ['mutant  phenotype', 'cell biology approaches'], ['sequencing  technique', 'mutant  nodules'], ['immediately plant rhizobia', 'symbiotic infection nodules'], ['associated  responses', 'nad1 nodules'], ['specifically Morus transcript', 'highly  nodules'], ['NAD1', 'endoplasmic transmembrane reticulum'], ['data', 'rhizobial  nodulation'], ['BackgroundThere', 'implantitis power therapy'], ['Removal', 'naturally tissue healing'], ['', 'high power laser procedures'], ['precise  mechanisms', 'effects'], ['work', 'capable wound healing'], ['Material', 'low nm doses'], ['real polymerase chain reaction', 'western  blotting'], ['growth signaling', 'small molecule inhibitors'], ['ResultsWe', 'oral keratinocyte cell line'], ['TGF-1 that', 'HBD-2 expression'], ['two  arms', 'mediated HBD-2 expression'], ['induced  both', 'surgical laser applications'], ['Moreover  use', 'peri dose laser disease'], ['defensive  behaviors', 'eliciting threat stimuli'], ['Threat scenarios', 'additional scenario studies'], ['human  studies', 'two threat threats'], ['Stabilometric studies', 'sway'], ['', ''], ['escapable flight gun', 'away  subject'], ['Relationships', 'anxious threat individuals'], ['Enhanced  rumination', 'particularly risk women'], ['this', 'defensive  behavior'], ['', 'C Elsevier Ltd'], ['diabetic iron chelator DN', 'diabetic iron chelator nephropathy'], ['180', 'mg DN deferiprone'], ['DN group', 'mg vena caudalis'], ['duration', 'deferiprone treatment'], ['Histopathological  changes', 'hematoxylin eosin'], ['cyclo oxygenase TIMP)-1 cyclo COX)-2', 'reverse polymerase chain reaction'], ['deferiprone treatment', 'collagenous inflammation rats'], ['B MCP-1 which', 'DN'], ['mechanism', 'deferiprone MMP-9'], ['Decreased', 'significantly DN deferiprone'], ['oxidative stress which', 'MCP-1 MMP-9 TIMP-1 COX-2'], ['young  adults', 'significant United challenges'], ['DACA Childhood protections', 'mental  health'], ['We', '18 health needs'], ['Participants', 'belonging health support'], ['DACA', 'greater adult responsibilities'], ['Thus immigration policies', 'expected  ways'], ['Research', 'better health needs'], ['MHWB implications', 'services'], ['Overpopulation', 'common  deforestation'], ['good  governance', 'environmental population degradation'], ['bottom  we', 'top  approach'], ['state', 'rural electrification access'], ['also  it', 'more population growth'], ['based energy it', 'based  deforestation'], ['global  initiatives', 'universal land electricity'], ['', ''], ['rights', ''], ['Wiener processes', 'two degradation decades'], ['process degradation that', 'correlated measurement considerations'], ['constructed  methodology', 'cases'], ['simple  method', 'transformed process degradation model'], ['Then model parameters', 'maximum likelihood estimation'], ['probability distribution function', 'hitting measurement time'], ['percentiles', 'performance degradation'], ['comprehensive simulation study', 'proposed degradation model'], ['real  applications', 'carbon film metal'], ['constructed  approach', 'reasonable  result'], ['', ''], ['rights', ''], ['extraction  techniques', 'sufficient  bones'], ['mitochondrial DNA mitochondrial analysis', 'ultimate  identification'], ['six bone samples', 'human  remains'], ['DNA', 'Real polymerase chain reaction'], ['amplified PCR Amplification products', 'autosomal STR typing'], ['', 'DNA 0'], ['04 ng', 'complete STR profiles'], ['MtDNA control region', ''], ['especially bone which', 'degraded DNA content'], ['large  family', 'Y segment S segment'], ['K we', 'vascular Pfam00257 dehydrin plants'], ['amino acid type', 'other  positions'], ['central Y segment tyrosine', 'aromatic amino acids'], ['S segment', 'conserved LHR sequence'], ['where GXGGRRKK X', 'two  motifs'], ['abiotic  others', 'dehydration stress'], ['thyroid gland', 'even selenium deficiency'], ['which', 'high thyroid hormone biosynthesis'], ['blotting selenoprotein P', 'germinal  thyroids'], ['Selenoprotein', 'marginally cell types'], ['mRNA', 'normal thyroid cancer controls'], ['GPx3', 'thyroidal  0'], ['i', 'loosely colloidal thyroglobulin'], ['findings', 'possible  H2O2'], ['Particularly  GPx3', 'present storage colloid'], ['lipopolysaccharide helper T cell', 'asthma'], ['low LPS levels', 'Th2 responses'], ['we', 'Th2 Lee et al'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'immune Kim system'], ['1045  system', 'IL-4 Th2 activities'], ['time delays', 'nonlinear LPS H'], ['extended reaction diffusion model', 'heterogeneous  microenvironment'], ['', ''], ['Deficiencies', 'phenotypic  consequences'], ['adversely honey bee they', 'natural  selection'], ['', ''], ['We', 'indolizidine alkaloid vtvo'], ['', ''], ['AmLAM', 'other  animals'], ['', 'only Dietary saccharides'], ['Interestingly  abundance', 'treated fatty individuals'], ['like  symptoms', 'pupal larval metamorphosis'], ['', ''], ['We', 'toxicity colony level impacts'], ['developmental  heterochrony', 'impaired LAM expression'], ['more  flexibility', 'task allocation'], ['transmissible gastroenteritis virus', 'associated  piglets'], ['TGEV ORF3 gene', 'three field 2015'], ['Eight TGEV ORF3 sequences', 'study'], ['eight TGEV ORF3 genes', 'Miller cluster'], ['closely CH SH', 'Miller M60'], ['results', 'Chinese field TGEV'], ['Furthermore  we', 'three CH TGEV'], ['results', 'underlying evolution coronaviruses'], ['Modification', 'various partners cancer'], ['current  expression', 'aforementioned lung genes'], ['133p53 length isoforms', '17 lung carcinoma specimens'], ['RNA expression analysis', 'reference gene'], ['Detection', 'western  blotting'], ['Significant  overexpression', 'cancerous  tissues'], ['full length p53', 'significant MDM-2 increase'], ['expression', 'cancerous p21 specimens'], ['133p53 p21 expression levels', 'parallel'], ['p21 protein', 'cancerous  tissues'], ['Delta mRNA levels', 'useful lung cancer'], ['133p53 lung transcripts', 'transcriptional cell cycle'], ['that', 'active power topology'], ['proposed  architecture', 'active modulator topology'], ['that', 'active transfer function'], ['return  DAC', 'pulse delay sensitivity'], ['simple  features', 'higher frequency operation'], ['130 prototype modulator', 'active  0'], ['', ''], ['', 'mW  1'], ['', ''], ['It', 'peak  60'], ['15  MHz', '780 sampling MHz'], ['figure', 'modulator'], ['paper', 'SC SC integrator function'], ['method', 'high technology test vehicle'], ['solution', 'positive SC feedback'], ['current power consumption', 'current dc adder'], ['Power reduction', 'first feed amplifier'], ['low  swing', 'active slew rate linearity'], ['', 'active CMOS 0'], ['1 test chip', 'peak signal dB peak 88'], ['', 'peak signal dB peak 88'], ['', '106  73'], ['', 'fJ conv 176'], ['paper', 'low power radio'], ['DSM', 'operational power consumption'], ['Furthermore 4-bit quantizer', 'high sampling frequency'], ['asynchronous approximation register which', 'used flash architecture'], ['DSM', '65 nm CMOS process'], ['Simulation results', '500 kHz signal bandwidth'], ['DSM', '800 mV power supply'], ['advanced metering which', 'tremendous demand response resources'], ['Demand response', 'entire electricity sector'], ['However  China', 'developed demand response'], ['Institutional  barriers', 'competitive demand response'], ['free demand response resources', 'leveled power field'], ['', ''], ['', ''], ['rights', ''], ['where power value', 'power system'], ['shifting capacity which', 'multiple  services'], ['different power system resources', 'power system operators'], ['Additionally policy makers', 'different capacity remuneration mechanisms'], ['demand side', 'specific capacity resource'], ['resource', 'thermal storage heating space'], ['Ireland', 'test case'], ['shifting  devices', 'thus capacity value'], ['given DR values', 'operational occupancy profile impacts'], ['results', 'shifting demand response resources'], ['', ''], ['rights', ''], ['We', 'individual pricing households'], ['that', 'individual DR loads'], ['DR', 'generated tax reduction grid'], ['net metering pricing scheme', 'rated PV 4'], ['', ''], ['use', 'tax reduction household'], ['kWp  installation', 'larger  households'], ['Furthermore tax reduction scheme', 'DR'], ['same Appliance DR', 'low PV installation'], ['', ''], ['rights', ''], ['when supply shortage', 'extreme weather conditions'], ['solicit  aids', 'active system reliability'], ['benefits', 'works demand cases'], ['Systematic  analyses', 'based system reliability'], ['case study', 'significant DR programs'], ['unique  merits', 'improving  approaches'], ['Furthermore  we', 'fundamental DR functions'], ['Values', 'various DR programs'], ['', 'recent power industry years'], ['', ''], ['rights', ''], ['less grid capacity', 'smart grid environment'], ['smart demand response that', 'renewable  barriers'], ['', 'different demand programmes'], ['barriers', 'Netherlands'], ['direct load they', 'market players'], ['', ''], ['', 'John Wiley'], ['where end user', 'flexible demand demands'], ['individual  user', 'overall system way'], ['approach', 'traditional DSM approaches'], ['knowledge', 'advanced metering infrastructure'], ['where DSM trial data', 'residential  end'], ['', 'depressive symptoms burden'], ['Ninety six Ninety caregivers', 'simplified  psychoeducation'], ['participant', '2-month  home'], ['finding  participants', 'SIM PE SIM d'], ['', ''], ['', ''], ['They', 'when STD PE participants'], ['', ''], ['Self efficacy', 'upsetting treatment effects'], ['Finding', 'depressive Alzheimer caregivers'], ['cognitive  impairments', 'Lewy bodies'], ['visuoconstructive  memory', 'visuoconstructive  dysfunction'], ['cognitive  profile', 'poorly  date'], ['We', '37 prodromal DLB'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['They', 'neuropsychological test processing'], ['HCs patients', 'visual Sample-48 items'], ['', ''], ['', 'Selective Reminding Test'], ['', ''], ['', ''], ['002  scores', 'also  patients'], ['Assessment', 'lower  HCs'], ['assessment', 'mixed  results'], ['Indeed  patients', 'lower language tests'], ['', '022 tool use'], ['', 'meaningless  gesture'], ['', ''], ['', ''], ['Visuoconstruction', 'also  patients'], ['visuoperceptual  abilities', 'groups'], ['Finally  theory', 'mind HCs'], ['emotion recognition abilities', ''], ['study', 'prodromal  DLB'], ['results', 'executive  function'], ['However  we', 'prodromal DLB memory'], ['psychiatric  autopsy', 'Lewy bodies'], ['frontotemporal  he', 'core DLB'], ['limbic  he', '75  years'], ['following  features', 'DLB'], ['behavioral  disturbances', 'temporal locus region'], ['conventionally  symptoms', 'pathological  brain'], ['It', 'clinical  setting'], ['Dementia', 'ageing  society'], ['', 'sharp treatment strategies'], ['It', ''], ['certain  lacunae', 'molecular treatment dementia'], ['neurotrophic factor receptor exploitation', 'clinical  use'], ['well sex that', 'practise'], ['', 'dwelling family dementia'], ['self rating Felt', 'emotional care caregiver'], ['We', 'single factor CC'], ['We', 'caregiver care receiver pairs'], ['Logistic regression', 'tested FEERS items'], ['main  contributors', 'own care receiver'], ['distressed  caregivers', 'care receiver'], ['When  offering', 'perceived family member'], ['program', 'more leisure time'], ['ITER experimental ITER reactor', 'commercial  plant'], ['important reliability availability cost', 'strongly power aspects'], ['conceptual Work Package design', 'European research institutes'], ['innovative  solutions', 'mainly beam source neutralizer'], ['synchronous tuning fork gyroscope', 'digital processing technology'], ['integral  demodulator', 'axis output signal'], ['high precision output', 'gyroscope'], ['synchronous integrator which', 'theoretical  analysis'], ['other demodulation SID', 'better noise harmonics'], ['also  which', 'gyroscope'], ['corresponding array digital experiment', 'programmable array digital circuit'], ['SID algorithm', 'good control performance'], ['bias instability', 'tested  gyroscope'], ['', 'random  0'], ['degrees root h', '60 measurement +'], ['', 'adaptive  immunity'], ['how  they', 'tumor'], ['role  which', 'tumor  immunity'], ['different  that', 'associated  DCs'], ['Both', 'optimized tumor cancer'], ['CD8(+ cytotoxicT which', 'tumor  immunity'], ['Emerging  evidence', 'key receptor immunity'], ['how  D3R', 'tumor DCs immunity'], ['D3R deficiency', 'tumor  immunity'], ['D3R inhibition', 'presentation  activation'], ['D3R', 'tumor  immunity'], ['', ''], ['', ''], ['rights', ''], ['We', 'soft matter DNA nanoparticles'], ['incorporation', 'modified uniform size'], ['single self assembly micelles', 'CpG  motifs'], ['immunological  effects', 'comprehensive animal experiments'], ['conjugated  which', 'stimulatory up molecule'], ['', ''], ['rights', ''], ['Dendritic  cells', 'based cancer vaccines'], ['Critical  parameters', 'secreted CD80 CID83 interleukin-12p70'], ['However  level', 'based DC therapy'], ['We', 'immature  DCs'], ['12  miRNAs', 'two DC phenotypes'], ['four hsa miR-125a-5p', 'real polymerase chain reaction'], ['matured  DCs', 'differentiated  DCs'], ['quantitative  evaluation', 'potentially DC vaccines'], ['', '2010 American Histocompatibility'], ['', 'Elsevier Inc'], ['rights', ''], ['', 'dengue virus Pakistan'], ['retrospective  study', '2012 University Hospital December'], ['Test', 'immunosorbent dengue assay'], ['SPSS', '17 data analysis'], ['Overall', 'dengue  virus'], ['', 'them'], ['7  %', ''], ['', 'them'], ['66  %', '2012'], ['', '28  2013'], ['', '56  2014'], ['', '49  2015'], ['', 'nonstructural protein-1 antigen'], ['4401(76  samples', '1332(23 polymerase chain reaction'], ['trend', 'positive antigen testing'], ['', '6 immunoglobulin M'], ['', '4 polymerase chain reaction'], ['', 'dengue immunoglobulin M testing'], ['upsurge', 'important tourism May'], ['Investigations', 'outbreak'], ['average  number', '2  years'], ['435  patients', 'positive polymerase chain reaction'], ['94 cases/1000 it', 'different  villages'], ['virus', ''], ['Havelock which', 'nautical South miles'], ['occurrence areas', 'neglected  diseases'], ['Dengue', 'scientific  challenge'], ['Combining bibliometrics', 'dengue network analysis research'], ['aim', 'scientific  research'], ['METHODS  We', 'scientific research landscape'], ['results', 'central collaboration network'], ['MAIN findings', 'well policy researchers'], ['scientific community policy paper', 'public dengue strategies'], ['Background', 'highly  hosts'], ['However  we', 'mutualistic  DV'], ['we', 'molecular  HaDV2'], ['HaDV2', 'genus  Iteradensovirus'], ['genus sequence identity', 'amino VP NS1'], ['NS1  proteins', 'shorter N terminal sequences'], ['', 'about  2'], ['VP proteins', 'Northern Blot'], ['NS1 Western Blot analysis', '78  kDa'], ['Finally  localization', 'Fluorescent Protein Green Fluorescent labelling'], ['HaDV2', 'subfamily  Densovirinae'], ['Dental  teams', 'over child 40years'], ['paediatric child who', 'such  cases'], ['further  research', 'existing  gap'], ['', '% Dental Surgeons'], ['surgical  technique', 'grafted term areas'], ['frozen  grafts', 'immunologically bone host'], ['Six  male', 'systemic diseases surgery'], ['patients', 'human tissue bank'], ['patients', 'months blood procedure'], ['HLA HLA(human leukocyte antibodies', 'such PRA Class I'], ['Reactive  individuals', 'median fluorescence intensity'], ['two  patients', 'one HLA class II'], ['patients', '3 HLA class which'], ['23  6', '3 HLA class these'], ['specificities', 'average  fluorescence'], ['lifting  procedures', 'immunological allogeneic sensitization'], ['mesenchymal stem that', 'promising tissue engineering'], ['dental stem that', 'dental  tissues'], ['we', 'dental pulp stem cells'], ['dental stem cells', 'quantitative polymerase chain reaction'], ['Additionally  we', 'dental stem cells'], ['GED-1 ratio c which', 'hDPSCs'], ['Immunostaining', 'similar c passages'], ['majority', 'M cell cycle'], ['study', 'stemness differentiation fate'], ['different  behaviors', 'clinical treatment variations'], ['where South crop', 'often  irrigation'], ['Fusarium', 'growing South Africa'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['semitectum', 'which'], ['', ''], ['', ''], ['', ''], ['', ''], ['semitectum', 'previously South Africa'], ['Fusarium graminearum', 'seven  locations'], ['more polymerase chain isolates', 'nivalenol'], ['irrigated South which', 'rain fed conditions'], ['Rotations', 'fungal  inoculum'], ['resistant wheat lines', 'agronomic disease severity losses'], ['invention', 'genetic polymerase chain oncogenes'], ['current time which', 'current time version'], ['we', 'key dPCR i'], ['', ''], ['', 'still lab development'], ['We', 'biomedical  applications'], ['Finally  we', 'future  dPCR'], ['genetic  that', 'living  organisms'], ['However  process', 'internal DNA strands'], ['they', 'certain  time'], ['Thankfully cells', 'original DNA state'], ['8-oxoguanine DNA they', 'other repair enzymes'], ['progress', 'operating challenges'], ['article', 'molecular DNA glycosylase care'], ['', ''], ['', ''], ['rights', ''], ['MCR control operations', 'conventional control room'], ['same MCR operations', 'team decisions'], ['Therefore  assessing', 'human reliability analysis'], ['we', 'present  study'], ['that', 'analytical control dependencies'], ['Second', 'fuzzy logic approach'], ['uncertain  it', 'clear reasoning reasoning'], ['Therefore  traceability', 'proposed  method'], ['Third  we', 'proposed case approach'], ['that', 'sensitivity model'], ['', ''], ['', ''], ['rights', ''], ['', 'increased  depression'], ['phenomenology', 'childhood'], ['However  participants', 'clinical  services'], ['aim', 'mental health difficulties'], ['consecutive  N=100', 'mental health England'], ['Young  people', 'diagnostic self report anxiety'], ['half', 'depressive  disorder'], ['key  symptoms', 'depression'], ['Suicidal ideation', 'other  studies'], ['Caregiver', 'adolescent  depression'], ['Caregivers', 'fewer  themselves'], ['ConclusionsThese  data', 'mental health children'], ['how  sample', 'other  countries'], ['', 'high risk adolescents'], ['who', 'inadequate  antidepressants'], ['adjunctive time that', 'depressive release UK'], ['Research design', 'antidepressant Practice Research Datalink'], ['Patients', 'bipolar disorder schizophrenia'], ['', 'adjunct outcome antipsychotics'], ['', '224353  depression'], ['6  %', 'antipsychotic  therapy'], ['Overall  incidence', 'antipsychotic  initiation'], ['', 'patient  years'], ['', ''], ['', ''], ['initiation', 'antipsychotic  prescribing'], ['', '7  29'], ['atypical  antipsychotics', ''], ['', '1  49'], ['7  %', ''], ['who', 'antipsychotics'], ['4  %', ''], ['', ''], ['median  age', ''], ['Antipsychotics', 'UK primary UK care'], ['choice', 'preferred treatment choice'], ['severe  patients', 'such  hospitals'], ['even  authorization', 'depressive treatment disorder'], ['oxidative health stress', 'inextricably  pathophysiology'], ['Coenzyme Q10', 'inflammatory neuro properties'], ['CoQ10', 'down regulation hippocampal 23-dioxygenase'], ['like  behavior', 'light cycle etc'], ['Male Wistar rats', 'five  groups'], ['', ''], ['', ''], ['CoQ10 effects', 'behavioral  tests'], ['CoQ10', 'open field test'], ['oxidant  effect', 'glutathione catalase levels'], ['CoQ10', 'beta necrosis factor alpha'], ['It', 'hippocampal hippocampal tryptophan'], ['CoQ10', 'fibrillary acidic CUMS group'], ['CoQ10', 'like  CUMS'], ['This', 'Kynurenine/ serotonin pathway'], ['Collaborative Care', 'primary NICE Guidance'], ['However  uptake', 'UK'], ['review', 'Collaborative Care'], ['barriers', 'primary Collaborative care'], ['review', '18 Collaborative settings'], ['framework analysis', 'Collaborative Care definition'], ['The', 'organisational  integration'], ['', 'personal role qualities'], ['papers', 'selected  studies'], ['', 'little  which'], ['six quality that', 'further  barriers'], ['preferred  way', 'approach'], ['mental health risk', ''], ['when care medications', 'clinical decision support systems'], ['descriptive  study', 'Care Survey Medical Care 2010'], ['medication', 'mental health risk'], ['Adjusted  odds', 'computerized medication warnings'], ['when care practice medications', 'primary care practice visits'], ['', '1  2'], ['when  medications', 'mental medication disease contraindication'], ['that', 'contraindication'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'only health warnings'], ['', ''], ['', ''], ['when  medications', 'mental health risk'], ['Presence', 'mental health risks'], ['positioned warning systems', 'at health information patients'], ['', ''], ['rights', ''], ['ObjectiveTo', 'negative  information'], ['MethodCohort who', 'depressive  symptoms'], ['Positive  recall', 'computerised time points task'], ['Depressive  symptoms', 'four Beck Depression Inventory'], ['Analyses', 'multilevel models'], ['ResultsConcurrently  we', 'depressive  0'], ['', ''], ['', '-0'], ['', ''], ['association', 'confounders'], ['', 'negative  recall'], ['', ''], ['', '0'], ['', ''], ['positive  recall', 'depressive vice versa'], ['even  recall', 'negative  information'], ['negative  that', 'negative  events'], ['', 'older Veterans Taiwan'], ['871  participants', 'multimorbidity stool incontinence history'], ['', ''], ['', ''], ['years  males', '222(25'], ['past  91', 'past  year'], ['recurrent  they', 'Barthel stool trend'], ['', ''], ['GDS-5', 'single  falls'], ['', ''], ['', ''], ['', ''], ['', 'single  fallers'], ['', ''], ['', ''], ['', ''], ['', 'recurrent  fallers'], ['', 'recurrent  fallers'], ['', ''], ['', ''], ['', ''], ['', ''], ['Urinary incontinence', 'older retirement communities'], ['urinary  incontinence', 'recurrent  falls'], ['Intervention study', 'urinary  incontinence'], ['', ''], ['', ''], ['rights', ''], ['Sleep problems', 'systemic lupus erythematosus'], ['', '2 sleep SLE'], ['Patients', 'three rheumatology Japan'], ['Outcome Study Short Form-12', 'Outcome Tool'], ['Fluctuations', '2-week sleep interval'], ['We', 'multiple sleep quality'], ['205  who', 'survey'], ['9  %', 'poor sleep quality'], ['largest  fluctuation', 'sleep night'], ['pain  vitality', 'poor  sleep'], ['clinical  subscales', ''], ['majority', 'poor sleep quality'], ['specific QoL scale', 'poor SLE patients'], ['Symptom management', 'key sleep quality'], ['novel  model', 'pituitary adrenal axis'], ['responsible endocrine it', 'depression'], ['existence uniqueness', 'attracting trapping region'], ['model', 'healthy  subjects'], ['sensitivity analysis', 'physiological  parameters'], ['approximated parameter version', 'reduced parameter model'], ['thus  parameters', 'gland functions'], ['whereby hypothesis it', 'individual treatment protocols'], ['Finally  method', 'effective  treatment'], ['', ''], ['rights', ''], ['that', 'TRYCAT depression somatoform disorder'], ['aim', 'physio TRYCAT symptoms'], ['We', 'prenatal Postnatal Depression Scale'], ['We', 'pregnant  25'], ['', 'prenatal anthranilic depression'], ['large  part', 'most IgA PMS'], ['IgA responses', 'picolinic anthranilic xanthurenic'], ['', ''], ['5  %', 'positively quinolinic acid'], ['derived TRYCAT pathway activation', 'depression anxiety symptoms'], ['somatic  symptoms', 'immune inflammatory pathophysiology'], ['Induction', 'more physio symptoms'], ['depressive  disorder', 'disrupted partners family'], ['problems', 'clinical illness influence recovery'], ['who', 'social  partners'], ['other  faces', 'opposite  location'], ['groups', 'invalid gaze cueing faces'], ['Following', 'task faces'], ['social  appraisal', 'depressed  participants'], ['who', 'social trust partners'], ['Depression', 'adverse  life'], ['treatment', 'better  outcomes'], ['We', 'untreated  differs'], ['multicenter cohort that', '24 US hospitals'], ['Research coordinators', 'Health Questionnaire-9 index AMI admission'], ['Depression', 'PHQ-9  score'], ['as discharge diagnosis none', 'medical PHQ score'], ['One year mortality', 'untreated demographics AMI severity'], ['', ''], ['7  patients', 'PHQ-9 depression'], ['4  %', ''], ['1-year mortality that', '1-year mortality rates'], ['', '1  6'], ['', ''], ['', ''], ['', ''], ['', ''], ['528  patients', '1-year  depression'], ['', '8  6'], ['', ''], ['', ''], ['', ''], ['', ''], ['long term association', 'untreated  depression'], ['Simultaneous  relief', 'body'], ['derived isoflavone puerarin', 'comorbid depression'], ['We', 'spared nerve injury'], ['SNI surgery mice', '8  days'], ['like Frey filament test', 'mechanical  stimulation'], ['effectively SNI citalopram', 'depressant  activity'], ['contrast ibuprofen', 'induced  depression'], ['BDNF  citalopram', 'prolonged BDNF stimulation'], ['puerarin', 'induced ERK CREB'], ['Puerarin', 'novel lead depression'], ['', 'physical temporomandibular functioning'], ['case control study', '126  subjects'], ['chronic  who', 'clinical  practice'], ['chronic tension type 63', 'tension type headache'], ['clinical  diagnosis', 'International Headache'], ['Axis II criteria', 'Chronic Pain Scale'], ['logistic regression analysis', 'high SCL scales'], ['TMD pain', 'chronic TMD pain intensity'], ['presence', 'severe SCL DEP'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['study', 'severe TMD depression'], ['370 Child Bor', 'Collishaw Journal Child Psychology'], ['', 'Australian New Psychiatry'], ['least  referral', 'adolescents'], ['', 'General Psychiatry'], ['', ''], ['worrying  statistics', 'therapeutic  nihilism'], ['Extant  controversy', 'particular  trends'], ['high profile publications', 'adolescent  depression'], ['', ''], ['', ''], ['', ''], ['epidemiological  that', 'depressed  adolescents'], ['how life events', 'depression'], ['positive life that', 'depression'], ['where mediation gratitude', 'decreased life depression'], ['different adult who', 'five  timepoints'], ['each', '3 months time'], ['Increases', '3 personality months'], ['positive  emotions', 'positive life events'], ['We', 'positive life depression'], ['findings', 'depression remission'], ['score', 'initial EPDS 11'], ['This', '200 EPDS score'], ['utilization', 'eight  delivery'], ['Logistic regression', 'confounders'], ['Women', 'medical EPDS 11'], ['', ''], ['', ''], ['', ''], ['Pregnant  women', 'perinatal  period'], ['subset', 'prenatal  care'], ['Interventions', 'future  research'], ['when  women', 'increased  depression'], ['', 'significant postpartum depression'], ['', 'maternal parenting behavior'], ['', ''], ['negative', '6 months postpartum'], ['6-month home dyads', 'interactional tasks difficulties'], ['Mothers', 'standardized childhood abuse instruments'], ['parenting self report ant', 'parenting  impairment'], ['interactive  who', 'interactive  those'], ['', ''], ['', ''], ['Childhood maltreatment', 'parenting risk'], ['third sample that', 'also  parenting'], ['', ''], ['', ''], ['', 'psychiatric self interviews'], ['salient  that', 'parenting analysis'], ['however optimal application', 'depression screening risk'], ['current  study', 'putative risk factors'], ['observational cohort study', 'negative EPDS screen'], ['', ''], ['', ''], ['primary  outcome', ''], ['receiver sensitivity specificity', 'receiver operating characteristics'], ['', ''], ['8  %', 'postpartum depression'], ['', 'EPDS cut EPDS 8'], ['improved(AUC', '0'], ['', '0'], ['when  antepartum', 'depressive  pregnancy'], ['', 'low EPDS cohort'], ['predictive postpartum value', 'postpartum screening'], ['study', 'outpatient psychiatric research clinic'], ['45 adult participants', 'weekly  imbPST'], ['primary outcome measure', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['such  patients', 'depressive NTC condition'], ['Participants', 'moderate BDI 21'], ['', ''], ['', 'mild  depression'], ['', ''], ['', 'weekly  imbPST'], ['', 'weekly  sessions'], ['', ''], ['', ''], ['', ''], ['NTC participants', 'significant BDI II scores'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['significant depression none', 'NTC criterion'], ['imbPST participants', 'first system usability session'], ['', ''], ['usability scores', 'last  session'], ['', ''], ['', ''], ['easily depression treatment that', 'administered  fashion'], ['demographic characteristics family', 'elderly Norte Brazil'], ['depressive  symptoms', 'elderly  61'], ['abbreviated Geriatric Depression version', 'Services Rating Scale'], ['social relations those', 'depressive  symptoms'], ['', ''], ['elderly  adults', 'integrative community therapy'], ['they', 'low family problem'], ['', 'health services'], ['', ''], ['results', 'depressive health symptoms'], ['disturbance', 'residual  depression'], ['present  analyses', 'mental health clinics'], ['MethodSixty three MethodSixty adolescents', 'adolescent IPT depression'], ['Participants', 'interpersonal DSM functioning'], ['Measures', '12 treatment follow up'], ['Hierarchical linear modeling', 'depression'], ['ResultsOngoing sleep disturbance', 'worse depression clinician'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'interpersonal  treatment'], ['', ''], ['', ''], ['', ''], ['Treatment condition', 'sleep disturbance'], ['', ''], ['14  p', ''], ['patients', 'depressed study sleep adolescents'], ['Sleep disturbance', 'slower  depression'], ['sleep disturbance', 'depressed treatment development adolescents'], ['depressive  disorder', 'daily mood life'], ['daily  that', 'positive  depression'], ['depressed Sixty patients', 'consecutive stress days'], ['usual event this', 'positive  affect'], ['problem  coping', ''], ['why  people', 'negative  affect'], ['findings', 'predominant therapy resilience'], ['few  studies', 'medication class'], ['initial  pharmacotherapies', 'subsequent treatment augmentation'], ['18 US who', 'new  2009'], ['logistic Propensity regression', 'initial treatment augmentation'], ['Risk adjustors', 'provider type insurance'], ['class', 'independent care provider interest'], ['Main outcome', 'monotherapy'], ['Thirty four Thirty percent', 'treatment augmentation'], ['initial generation treatment', 'other  classes'], ['', ''], ['', ''], ['', ''], ['result', 'propensity score adjustment'], ['', ''], ['', ''], ['', 'other generation pharmacotherapy'], ['significant  predictor', 'treatment augmentation'], ['Mental health specialists', 'more  generalists'], ['', ''], ['', ''], ['', ''], ['type', 'antidepressant treatment augmentation'], ['Second generation antipsychotics', 'other  classes'], ['disease which', 'depressive  depression'], ['that', 'disease activity'], ['current  study', 'cognitive disease activity'], ['116 IBD that', 'different self waves'], ['Correlation analyses', ''], ['main  result', 'depressed IBD mood'], ['', ''], ['', 'depressive  symptoms'], ['rather  it', 'cognitive  fusion'], ['', ''], ['', ''], ['that', 'depressed IBD mood'], ['regulation processes patients', 'difficult  experiences'], ['inclusion', 'psychological IBD patients'], ['Further  implications', ''], ['depressive salivary flow symptoms', 'salivary flow rate'], ['', 'environmental  factors'], ['We', 'depressive  outcome'], ['three step regression', 'environmental  factors'], ['We', 'twin sex pairs'], ['coefficients', 'environmental  factors'], ['', 'environmental Furthermore factors'], ['We', '448  twins'], ['', 'depressive DZ symptoms'], ['', 'depressive twin pairs symptoms'], ['SFR', 'individual  analyses'], ['association', 'genetic  males'], ['association', 'important  hyposalivation'], ['', 'adolescents'], ['ongoing mood symptoms', 'maturational  process'], ['Trajectory analyses', 'clinical trajectory time'], ['We', 'between trajectory 15'], ['We', 'relevant  articles'], ['common class membership', 'biological risk factors'], ['depressive  symptoms', 'concurrent  health'], ['Findings', 'clinical  practice'], ['gut microbiota', 'depressive brain disorder'], ['conceptual  aspects', 'further  elucidation'], ['habitual  diet', 'behavioural  effects'], ['Sprague Dawley rats', 'five fat weeks'], ['', '34 swim %'], ['probiotic  treatment', 'stimulated TNF alpha'], ['transcript Crh r1 HFD', 'levels'], ['probiotics', 'neuroprotective  agent'], ['findings', 'potential treatment MDD'], ['Importantly  efficacy', 'pattern  MDD'], ['system microbial metabolism', 'context'], ['Importantly  study', 'depressed  patients'], ['', ''], ['rights', ''], ['generation that', 'original power limit'], ['owners', 'more power uprates'], ['other  that', 'reactor power'], ['careful investment decisions', 'technological  plants'], ['locked  loops', 'connected power systems'], ['paper', 'derivative phase elements'], ['quadrature signal generator', 'same  parameters'], ['PLL', 'based  QSG'], ['that', 'generalized  integrator'], ['when grid frequency', 'high  performance'], ['paper', 'frequency domain time behavior'], ['also PLL method', 'digital control system'], ['proposed  PLL', 'harmonic  rejection'], ['Identification', 'improved  cultures'], ['negative  results', 'cultures'], ['addition identification', '1  day'], ['real PCR methods', 'collected PCR products'], ['unique  results', 'skin hair onychomycosis'], ['samples', 'possible  species'], ['oral extent which', 'oral extent dermatophytes'], ['benefits', 'especially laboratory manipulations'], ['immunocompetent  it', 'systemic  disease'], ['effective  treatment', 'fungus'], ['aim', 'experimental skin N'], ['', ''], ['c mice', 'different  infection'], ['', ''], ['67 strain HUPE115669', '49  %'], ['Neoscytalidium dimidiatum', 'subcutaneous epidermal injection'], ['8 15 8 inoculation', 'different  infection'], ['', 'cutaneous infection N'], ['dimidiatum', '15 skin 29'], ['inflammatory haematoxylin it', 'T'], ['', ''], ['intradermal  route', 'skin N'], ['', ''], ['animal model', 'cutaneous  N'], ['dimidiatum', 'emerging aetiology immunology mycosis'], ['isolation', 'long  time'], ['commonly  isolated', 'based reference identification'], ['44  isolated', '24  Hatay'], ['isolates', 'DiversiLab System'], ['genotyping', 'different rep PCR'], ['agreement', 'rep PCR'], ['', '8  41'], ['four  which', 'PCR'], ['strains', 'identical Clone B region'], ['conclusion rep PCR', 'complex Trichophyton isolates'], ['similarity', 'different rep PCR'], ['putative  that', 'PacC transcription regulators'], ['', 'promoter T'], [\"5'-GCCAAG-3 PacC transcription\", 'alkaline growth conditions'], ['', 'enhanced expression T'], ['rubrum pacC gene', 'Northern blotting analysis'], ['also  disruption', 'sole nail nutrition'], ['', ''], ['', 'dermatophyte'], ['molecular  which', 'protein PacC'], ['', 'immune skin hosts'], ['mediated  immunity', 'immune T dermatophytes'], ['most  studies', 'Th1 pathway'], ['key mucosal fungal elements', 'Th17 dermatophytes'], ['Stimulation', 'presenting C type cells'], ['Th17 cells', 'affected antimicrobial peptides'], ['Th1 which', 'also  pathway'], ['t(11;22)(p13;q12 EWSR1-WT1 fusion which', 'regulatory  activity'], ['immunohistochemically  it', 'neural  markers'], ['reverse RT which', 'desmoplastic  stroma'], ['when  occurring', 'nonclassical location morphology'], ['clinical RT PCR', 'prognostic  implications'], ['important destination it', 'particularly experience experiences'], ['questions', 'little tourism scholarship'], ['when tourism experience', 'satisfaction'], ['based  experiment', '480  respondents'], ['generated  messages', 'generated  messages'], ['experience', 'unsatisfied  tourists'], ['', ''], ['rights', ''], ['X Ray Free Electron Laser', 'peak currents pulse duration'], ['electron bunches', 'accelerating radio cavity'], ['', 'higher repetition 4'], ['5  Mhz', ''], ['Charge variations', 'dependent photoemission process'], ['', 'digital Telecommunication Computing Architecture'], ['4  standard', 'successfully  FLASH'], ['input which', 'optical photo cathode laser'], ['Pockels cell', 'thus laser polarizer'], ['modulation', 'fast bunch train'], ['first measurement results', 'detailed  system'], ['', 'pregnant delivery room'], ['prospective  study', 'unknown university July'], ['diagnostic  accuracy', 'two reference method'], ['534  patients', ''], ['', 'CO  1'], ['', 'diagnostic  criterion'], ['1  patients', 'positive ELISA result'], ['rapid  three', 'positive  test'], ['', ''], ['', 'S CO 2'], ['', 'cutoff'], ['7  patients', 'positive ELISA result'], ['rapid  one', 'negative  test'], ['', ''], ['', 'S  1'], ['more', 'RNA PCR'], ['rapid  test', 'fourth generation ELISA'], ['rapid  testing', 'unknown HIV status'], ['purpose', 'naturally  shellfish'], ['fecal  that', 'electron viruses'], ['isothermal polymerase coding that', 'RNA amplicons'], ['oligonucleotide  that', 'I genogroup noroviruses'], ['expected  band', 'nonspecific  band'], ['specific  signal', 'many  repeats'], ['', 'fecal  which'], ['3  %', 'GII'], ['belonged', 'NASBA'], ['Target RNA concentrations', 'fecal  NASBA'], ['When  assay', 'artificially nucleic acid'], ['', ''], ['potential  use', 'different Guangzhou which'], ['76  %', '128  19'], ['6  %', 'GII'], ['4  %', 'GI'], ['assay', 'high  specificity'], ['synchronous drive motors', 'high  velocity'], ['detent force', 'mechanical  resonance'], ['paper', 'design PMLSM method'], ['permanent frequency magnets', 'high order harmonic components'], ['skewed linearization observer', 'order harmonic order components'], ['digital discretization method', 'estimated  errors'], ['estimated detent force', 'feedforward control way'], ['properly  convergence', 'Lyapunov stability theory'], ['effectiveness', 'theoretical  analysis'], ['psychiatric  who', 'self interruption'], ['We', '2009 Katsushika Maternity December'], ['regardless  who', 'psychiatric  specialists'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '16  %'], ['continuation', 'depressive  disorders'], ['determinism', ''], ['Incompatibilism', ''], ['often  compatibilism', 'social  cognition'], ['often  patterns', 'implicit  compatibilism'], ['paper', 'such  patterns'], ['central  tendencies', 'moral responsibility accountability'], ['', ''], ['', 'moral  accountability'], ['', ''], ['', 'negative  outcomes'], ['paper', 'simulated  circuit'], ['aim', 'computer simulation it'], ['most  influence', 'numerical integration simulation'], ['possibility', 'chaotic systems simulation'], ['Multiple mutation Fc', 'monoclonal antibody therapeutics'], ['biophysical  which', 'poor aggregation manufacturability'], ['2 colloidal sets', 'half receptor life'], ['significantly  we', 'poorer aggregation profiles'], ['new TM that', 'thermostability'], ['novel  combination', 'mediated TM cytotoxicity'], ['engineering approach', 'biological Fc activity'], ['', ''], ['', 'Elsevier Inc'], ['rights', ''], ['high  percentage', 'first  life'], ['aim', 'human life models'], ['We', 'thorough  literature'], ['Early life stress', 'medium  term'], ['cognitive  domains', 'main neurotransmission systems'], ['experimental  it', 'thus life intervention'], ['Developmental Dyslexia', 'neurodevelopmental  acquisition'], ['thereby  one', 'even preschool years'], ['DD', 'disorder'], ['we', 'impaired learning disability'], ['set', 'younger touch children'], ['edible Shiitake that', 'nutritional  value'], ['number', 'dikaryotic  primordium'], ['serial  analysis', 'dikaryotic gene expression L'], ['', 'molecular fruit body development'], ['in  house', 'dikaryotic  primordium'], ['specific expression set', 'fruit body development'], ['different  genes', 'intracellular  trafficking'], ['findings', 'fruit body development'], ['Northern SAGE SAGE', 'highly transcriptome analysis'], ['this', 'first SAGE mushroom'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['glucocorticoids', 'developing  intestine'], ['previous microarray studies', 'Dex  mice'], ['Now  we', 'cellular  transcripts'], ['Mouse pups', 'Dex'], ['Robotic  based', 'labeled  riboprobes'], ['Transcripts', 'Ndrg1 Sgk1 Fos'], ['ISH', 'cellular  expression'], ['epithelial villus Ndrg1', 'upper  crypt'], ['remaining  transcript', 'strongly muscle layers'], ['only muscle Fos', '9 muscle layers'], ['', 'Northern ISH blotting'], ['quantitative cell ISH', 'valuable hormone tissue'], ['it', 'intravenous  administration'], ['We', 'procedural intranasal dexmedetomidine'], ['controlled  that', 'various trial registries'], ['who', 'interventional  procedures'], ['', '18'], ['dexmedetomidine', 'criteria'], ['rate score blood effects', 'primary sedation outcome'], ['Risk ratio', 'dichotomous % confidence outcomes'], ['Main meta analysis', '11  RCTs'], ['SMD', 'sedative intranasal dexmedetomidine'], ['', ''], ['', ''], ['58', 'unsatisfactory patient outcome'], ['', ''], ['', 'dichotomous intranasal saline'], ['SMD', 'sedative intranasal dexmedetomidine'], ['', ''], ['', ''], ['69  %', 'continuous  outcomes'], ['M H', ''], ['', ''], ['', 'dichotomous per os benzodiazepines'], ['respiratory  it', 'delayed  effects'], ['', ''], ['rights', ''], ['Dexmedetomidine', 'sympatholytic sparing properties'], ['study', 'regulated protein kinase'], ['Animals', 'onetime  doses'], ['histone protein levels', 'various dopamine dexmedetomidine'], ['messenger RNA expression', 'real polymerase chain reaction'], ['Dexmedetomidine administration', 'ERK1/2 phosphorylation H3 acetylation'], ['inhibitor', 'histones H3 acetylation'], ['that', 'signal  2-adrenoceptor'], ['dopamine which', 'neuroprotective  dexmedetomidine'], ['Advances', 'neonatal heart surgery'], ['high survival rate', 'neuropsychological  morbidities'], ['Dextro transposition', 'neurodevelopmental heart outcomes'], ['Landmark studies', 'neurodevelopmental  D'], ['', 'spatial processing speed'], ['they', 'such hyperactivity disorder depression'], ['aim', 'arterial switch operation'], ['We', 'adolescent adult outcomes'], ['Finally  we', 'future adult neuropsychology field'], ['alternative  that', 'outcomes'], ['based  model', 'subsynchronous output resonance'], ['high frequency resonance', 'weak DFIG network'], ['paper', 'thus DFIG HFR'], ['influences', 'rotor speed variation'], ['Two resonances phenomena', ''], ['', ''], ['', 'parallel DFIG system'], ['impedance', 'experimental DFIG results'], ['TID  pathogenesis', 'primary  prevention'], ['immune  that', 'later control neonates'], ['study', '1:2 case control matching'], ['individuals', '2002'], ['Cases', 'National Patient Register'], ['active  leptin', 'R myeloid technology'], ['We', 'possible  confounders'], ['1  we', 'also HLA DQ'], ['total', 'statistical  analyses'], ['Adiponectin', 'later  models'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'positively  model'], ['', ''], ['', ''], ['', ''], ['respectively  results', 'same  model'], ['immunological  signatures', '18  years'], ['', ''], ['rights', ''], ['Background', 'directly diabetes periodontitis'], ['Therefore  aim', '2 MMP-9 DM'], ['Material  biopsies', '2 SChP diabetes'], ['', ''], ['MMP-9 TIMP-1', 'real polymerase chain reaction'], ['ResultsThe MMP-8 expression', 'ChP group'], ['', ''], ['DMChP group', 'when SChP group'], ['', ''], ['MMP-1 TIMP-2 ratios', 'ChP DMChP groups'], ['', ''], ['DMChP group', 'mRNA ChP group'], ['', ''], ['MMP-8 TIMP-2 ratio', 'SChP group'], ['', ''], ['MMP  which', 'related matrix periodontitis'], ['Recent  studies', '1 prolongs diabetes'], ['that', 'possibly  treatment'], ['metabolic  background', '2-year follow up'], ['Patients', 'up 10(6)/kg b'], ['', ''], ['', 'expanded  CD3(+)CD4(+)CD25(high)CD127(-)Tregs'], ['patients', 'years  inclusion'], ['beta cell function', 'untreated c peptide controls'], ['Increased  levels', 'naive  CD62L(+)CD45RA(-)Tregs'], ['IL1', 'untreated TNF group'], ['survival', 'other  lymphocytes'], ['increasing proinflammatory which', 'administered  Tregs'], ['therapeutic  cells', 'highly  IL2'], ['therapy', 'earlier  T1DM'], ['Sleep problems', 'poor  diet'], ['Comprehensive  management', 'good lifestyle habits'], ['persons', 'glycaemic sleep control'], ['handling proteins', 'pivotal  cardiomyopathy'], ['However  little', 'diabetic insulin treatment'], ['lean  littermates', '19  weeks'], ['Ins', '6  life'], ['Gene expression', 'northern  blotting'], ['Ca2', 'ventricular 45Ca homogenates'], ['neonatal  cardiomyocytes', 'insulin glucose'], ['mRNA  expression', 'Taqman PCR'], ['Furthermore effects', '5 heart tissue insulin'], ['', 'western blot phosphorylations wortmannin'], ['SERCA levels', 'control'], ['', ''], ['', ''], ['', ''], ['', ''], ['', '#  control'], ['', ''], ['', '#  p'], ['', ''], ['PLB', 'significantly  ZDF'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'control'], ['', 'control'], ['SERCA PLB Ins', 'enhanced  SR'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'Ca2  expression'], ['', 'direct  cardiomyocytes'], ['long term treatment', 'SERCA relaxation time'], ['Akt', 'significantly  insulin'], ['effect', 'wortmannin'], ['SERCA PLB insulin', 'directly SERCA expression'], ['results', 'Akt cardiac SERCA2a'], ['', 'renal pressure failure'], ['therapeutic diabetes strategies', 'general diabetes population'], ['We', 'clinical  clinicaltrials'], ['gov', 'new  DKD'], ['promising  that', 'polyol protein kinase hexosamine'], ['One', 'extracellular matrix accumulation'], ['interesting  therapies', 'diabetic  nephropathy'], ['', ''], ['beta 1-Akt beta I', 'mesangial  cells'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['matrix accumulation', 'diabetic  nephropathy'], ['HG)-induced transactivation I', 'mesangial PI3K PKC cells'], ['', 'classic PKC isoforms'], ['induced  I', 'MC'], ['Primary rat MC', 'osmotic  control'], ['Western  I', 'Northern  blotting'], ['Diabetes', 'streptozotocin'], ['HG treatment', '1 Y783 activation'], ['Mannitol', 'effect'], ['gamma 1 Y783 phosphorylation', 'diabetic  rats'], ['HG', '1 coimmuno precipitation'], ['1 EGFR kinase it', 'inactive EGFR inhibitor EGFR'], ['Phosphoinositide-3-OH kinase inhibition', 'also PLC gamma'], ['induced Akt S473 phosphorylation', '1 PLC gamma inhibitor'], ['induced interference I', 'induced interference collagen'], ['subsequent beta 1-Akt I', 'MC'], ['1', 'diabetic  nephropathy'], ['metformin', 'renal  damage'], ['present  we', 'protective kidney podocytes'], ['high fat diet', 'low T2DM rats'], ['Diabetic  rats', '300 kg 8weeks'], ['blood samples', 'different  indices'], ['transmission electron microscopy', 'morphological  changes'], ['real polymerase chain reaction', 'nephrin mRNA expression'], ['renal  expression', 'dependently metformin treatment'], ['kidney podocytes', 'renal nephrin expression'], ['', 'proliferative diabetic retinopathy'], ['study', 'diabetic retinopathy diabetic patients'], ['expression', 'real polymerase chain reaction'], ['serum content', 'damage retina'], ['', 'retinopathy  groups'], ['', ''], ['serum miR-126', 'diagnostic  PDR'], ['It', '0'], ['', '81'], ['', ''], ['', 'healthy % ROC'], ['', '84'], ['', ''], ['', 'healthy % controls'], ['diagnostic  threshold', '8'], ['', 'NPDR'], ['When  content', '5'], ['possibility', 'PDR'], ['Serum miR-126', 'endothelial  injury'], ['', ''], ['Diabetic retinopathy', 'leading vision loss'], ['Previous  studies', 'diabetic retinopathy progression'], ['study', 'diabetic rat retinopathy'], ['', ''], ['Brown Norway rats', 'administered  diabetes'], ['', '4 post streptozotocin administration'], ['Systemic drug concentration', 'mass spectrometry'], ['Visual  function', 'visual  acuity'], ['presence', 'visual  acuity'], ['transcription', 'real polymerase chain reaction'], ['', ''], ['weeks vision loss', 'dependent  CLT-005'], ['therapeutic  effect', 'inflammatory  retina'], ['', ''], ['Stat3  inhibition', 'diabetic vision retinopathy'], ['allergic  diseases', 'inflammatory  conditions'], ['clinical  manifestation', 'threatening  episodes'], ['Often  patients', 'decreased disease activity'], ['that', 'better  diagnostics'], ['therapeutic drug that', 'currently  evaluation'], ['clinical  which', 'European  Allergy'], ['Trichinellosis', 'cooked swine meat'], ['Several  studies', 'trichinellosis'], ['Trichinella spiralis antibodies', 'infection'], ['', '45 kDa T'], ['spiralis antigen', ''], ['rats', '45 kDa T'], ['', '500 7 T'], ['', '500  T'], ['spiralis', 'two post routes'], ['humoral  response', 'confocal IgA IgM'], ['detection', 'increasing qRT popularity'], ['different  steps', 'result'], ['aim', 'well RNA extraction methods'], ['oral  which', '1 PRRSV isolate'], ['2 PCR that', '15  sensitivity'], ['', 'lowest  dilution'], ['TRIzol extraction methods', 'equivalent virus concentrations'], ['PRRSV NA PRRSV reagents', 'better  p'], ['', ''], ['I', 'PCR'], ['', ''], ['', ''], ['rights', ''], ['Equine herpesvirus type', '-stranded DNA horses'], ['It', 'genus Herpesviridae family'], ['respiratory disorders abortions', 'neurological equine herpesvirus myeloencephalopathy'], ['infection', 'fetal  membranes'], ['where blood virus', 'peripheral blood leukocytes'], ['however  assays', 'fast  EHV-1'], ['Advances', 'viral genome loads'], ['One', 'main molluscs pathogens'], ['Disease agent transfer', 'major disease outbreaks'], ['European Union', 'European  countries'], ['good  diagnosis', 'appropriate  it'], ['response  strategies', 'molluscs'], ['histological  techniques', 'diagnosis'], ['molecular  techniques', 'also disease programs'], ['that', 'early  infection'], ['cell infection', 'cell host'], ['situ  reliability', 'situ  hybridization'], ['specific cancer molecules', 'biological  fluids'], ['We', 'healthy prostate cancer males'], ['based  methods', 'identified prostate cancer biomarkers'], ['level', 'healthy prostate cancer males'], ['characteristic  curve', '16  0'], ['88  sensitivity', '94 % specificity'], ['combination', '68 % sensitivity'], ['promising  biomarkers', 'good mass antibodies'], ['urinary exosomal proteins', 'clinical mass use'], ['', ''], ['', ''], ['rights', ''], ['purpose', 'then diagnostics treatment'], ['Recent Bacterial meningitis', 'recent  years'], ['molecular time diagnostics', 'similar time period'], ['viral  meningitis', 'developments'], ['', ''], ['many  cases', 'viral  aetiology'], ['which', 'clinical herpes simplex trial'], ['Summary Viruses', 'bacterial  disease'], ['', 'viral aetiology age'], ['Molecular diagnostics', 'unnecessary antibiotics hospitalization'], ['Further  research', 'longer term sequelae'], ['chronic transplant entity', 'diagnostic  delays'], ['Transplant clinicians', 'early  detection'], ['positive transplant NV', 'Johns 2013'], ['Factors', 'random forest analysis'], ['who', 'positive stool RT PCRs'], ['Symptoms', 'diarrhea'], ['Acute kidney injury', '21  6months'], ['Median  duration', 'diarrheal symptoms'], ['4  patients', 'improvement'], ['incompatible kidney transplant status', 'longer diarrhea durations'], ['Treatments', '74  immunosuppression'], ['deaths', 'NV'], ['NV', 'chronic transplant recipients'], ['incompatible kidney transplant', 'longer symptom duration'], ['acute  which', 'often  diagnosed'], ['acute  diarrhea', '5  age'], ['', 'acute  diarrhea'], ['Samples', 'bacterial  etiologies'], ['Rotavirus', 'immunochromatographic  tests'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'specific polymerase chain reaction'], ['Escherichia coli', ''], ['', '07  Rotavirus'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Concurrent infections', 'two  130'], ['84  %', 'old  children'], ['', '2 years age 34'], ['', ''], ['overall  result', 'three detection infections'], ['', ''], ['', ''], ['', 'acute childhood diarrhea'], ['severe  that', 'experimental  infections'], ['We', 'PSD95 microRNA antibody'], ['majority', 'forebrain pyramidal homogenate'], ['synaptic  that', 'whole  tissue'], ['synaptic microRNA precursors', 'predominantly  PSDs'], ['', 'corresponding  mature'], ['microRNAs', 'dendritic  spines'], ['synaptic  stimulation', 'microRNA  synapse'], ['', 'rat dental follicle cells'], ['PCR array analysis', 'mineral induction'], ['further  experiments', 'DEC osteogenesis'], ['DKK3', 'reverse polymerase chain reaction'], ['short hairpin RNA', 'lentiviral DKK3 expression'], ['ALP activity assay', 'DKK3-shRNA DECs'], ['osteogenic  differentiation', 'RT gPCR'], ['TCP hydroxyapatiteiP tricalcium scaffolds', 'combined hematoxylin eosin'], ['DKK3 expression', 'rat DECs'], ['', '2 control cells'], ['implanted  section', 'HA TCP scaffolds'], ['osteogenic  differentiation', 'conversely DEC osteogenesis'], ['bewildering  complexity', 'cytopathological mitochondrial mechanisms'], ['phenotypic outcomes', 'regardless  which'], ['discoideum mitochondrial gene', 'disruption'], ['disruption', 'other mitochondrial defects'], ['These', 'liquid  medium'], ['phagocytic nutrient processes', 'phagocytic nutrient uptake'], ['diseased Dictyostelium strains', 'healthy Legionella pneumophila'], ['diseased  strains', 'wild type Dictyostelium strain'], ['regardless mitochondrial gene', 'generalized mitochondrial gene expression'], ['phenotypic outcomes', 'sensing mitochondrial chaperonin'], ['', ''], ['rights', ''], ['Dielectric  actuators', 'microrobotic  applications'], ['that', 'small conversion size'], ['high conversion ratio that', 'voltage driving stage'], ['current  interface', 'current modulation control stage'], ['half bridge converter', 'driving dielectric signal driving actuators'], ['', ''], ['3  g', 'microrobotic kV applications'], ['reduced graphene nanosheets', 'low electricity storage applications'], ['PDOPA', 'mild  conditions'], ['presence', 'also PDOPA PVDF'], ['', 'low PVDF frequencies'], ['PDOPA interface layers', 'dielectric loss mechanisms'], ['PDOPA', 'dielectric interface permittivity'], ['work', '120 contactless permittivity GHz'], ['It', '240 nm SiGe GHz'], ['on  system', 'external PLL operation'], ['subsequent  buffer', '120 output GHz'], ['Additionally  IC', 'direct readout ability'], ['120 GHz LNA', '17 DC output chip'], ['It', 'phase shift measurement'], ['phase system', '907'], ['', ''], ['Diencephalic  defects', 'neurological  diseases'], ['retinoic acid retinoic signaling', 'neural diencephalic development'], ['significant diencephalic RA', 'signaling'], ['characterized TACC1 that', 'specific acid response RA'], ['which', 'transcriptional RA target genes'], ['dependent  that', 'RAR beta'], ['Gcn5(hat diencephalic mutants', 'developing RA diencephalon'], ['specific RA that', 'forebrain diencephalic development'], ['Pectinolytic  bacteria', 'soft rot Europe'], ['', ''], ['solani', 'frequently potato blackleg'], ['', ''], ['solani strains', 'severe potato D'], ['', 'higher  temperature'], ['They', 'lower inoculum levels'], ['presented  we', 'fifteen phenotypic D'], ['also Poland we', 'three  D'], ['dianthicola', ''], ['comparison', 'cellulolytic activities siderophore production'], ['', ''], ['solani strains', 'tested cell temperatures'], ['observation', 'higher Polish D'], ['solani', 'soft  rot'], ['', 'addition D'], ['solani strains', 'tested laboratory D'], ['dianthicola', ''], ['collected  results', ''], ['repetitive REP they', 'cellulolytic potato tuber tissue'], ['paper', 'motor flatness PMSM'], ['differential flatness estimation', ''], ['two state observers', 'voltage drop'], ['It', 'PMSM drive system'], ['flatness  we', 'simple  dynamics'], ['high operating dynamics', 'disturbance rejection'], ['proposed hardware system', 'laboratory controller DSll04 platform'], ['', 'excellent motor drive cycles'], ['Exposure', 'placental tissue softening'], ['mRNA differential display strategy', 'disorder'], ['Watermelon fruit', '20 degrees C'], ['', ''], ['2 mu g', 'anchored oligo dT primers'], ['High stringency PCR', 'oligo dT primers'], ['expressed % bands', '6 % gel'], ['Confirmation', 'northern  blotting'], ['78 mRNA genes', 'differentially  which'], ['BLAST search results', 'enzymes plant defense exonucleases'], ['1  6d', 'corresponding expression genes'], ['data', 'oxidative up enzymes'], ['', ''], ['', ''], ['rights', ''], ['five lung cancer', 'related  deaths'], ['squamous cell carcinoma', 'lung cancer West'], ['We', 'Asian lung Indians'], ['subtracted cDNA libraries', 'expressed  tumors'], ['Differential expression', 'Northern blot analysis'], ['DNA', 'confirmed GenBank Blast searches'], ['RNA expression levels', '10 RT NSCLC'], ['expressed gene cDNA fragments', 'LSCC'], ['expressed  genes', 'cycle transcription proliferation apoptosis'], ['inhibitor', 'differentially DNA LSCC'], ['Identification', 'novel anticancer therapy'], ['', ''], ['rights', ''], ['discriminative  number', 'effective  behavior'], ['special education who', 'delayed matching task'], ['intervention', 'matching sample observation trials'], ['compound matching', 'verified sample stimuli'], ['Nineteen  participants', 'substantially matching them'], ['10 sessions accuracy', ''], ['accurate DOR performance', 'most  participants'], ['DOR training', 'observing  behavior'], ['paper', 'submodule tracking control level'], ['DPP power that', 'little power converters'], ['Design', 'communication  efficiency'], ['Isolated dc converter prototypes', 'proposed control method'], ['', 'experimental extraction 99'], ['12  %', '30 submodule mismatch'], ['', 'DPP % architecture'], ['alternate risk that', 'alleged maltreatment perpetrator'], ['how  DR', 'prior CPS research'], ['NCANDS DR implementation', 'demographic  neglect'], ['2010  investigations', '2010  data'], ['', 'likely DR counties'], ['current  difference', 'significantly DR counties'], ['Child race', 'substantiation decisions'], ['269  rate', 'three DR implementation'], ['However substantiation rates', 'DR implementation'], ['differences', 'DR  DR'], ['findings', 'large scale policy changes'], ['', ''], ['rights', ''], ['operational cascode amplifier', 'small voltage transfer function'], ['pole unity gain frequency', 'design equations'], ['Then analysis result', 'low power op 0'], ['', ''], ['', ''], ['', 'molecular  acclimation'], ['SSH degrees libraries', 'trifoliate  orange'], ['', 'expressed sequence libraries'], ['91  ESTs', 'known sequence functions'], ['They', 'catalytic activity binding protein'], ['Expression analysis', 'differential polymerase chain screening'], ['further  they', 'low temperature treatment'], ['physiological oxygen species processes', 'low temperature stress'], ['candidate that', 'cold stress tolerance'], ['', ''], ['', ''], ['rights', ''], ['Work', 'least horsemeat 2013'], ['', 'high animal species foods'], ['article', 'current analysis standardisation'], ['It', 'biology origin working Germany'], ['depressive anxiety disorders', ''], ['Research', 'mood volume disorders'], ['studies', 'depressed  individuals'], ['study', 'depressed matter individuals'], ['unmedicated  39', 'morbid anxiety disorder diagnosis'], ['tractography methods', 'uncinate  fasciculus'], ['Diffusion connectometry', 'white matter health'], ['Correlations', 'biological  measures'], ['Tractography', 'depressed amygdala groups'], ['diffusion connectometry analysis', 'anisotropy  groups'], ['', 'based  measures'], ['structural group connectivity', 'morbid anxiety disorder'], ['anxiety that', 'underlying  networks'], ['', ''], ['rights', ''], ['structural brain connections', 'brain traits'], ['behavioral  they', 'autistic brain traits'], ['We', 'young  adults'], ['', ''], ['', ''], ['autistic Autism Spectrum we', 'Shapes Clips task'], ['We', 'autistic UF age traits'], ['Autistic  traits', 'left FA ILF'], ['other  relationships', 'FA values'], ['that', 'clinical  diagnoses'], ['mid  technologies', 'mid  2000s'], ['underlying  factors', 'technological innovation change'], ['how energy policy', 'decision  making'], ['We', 'mixed method approach'], ['First  we', 'basic coal injection'], ['We', 'individual  firm'], ['individual  they', 'technologies'], ['Economics', 'foremost  EET'], ['certain  company', 'capital EET'], ['economically  company', 'capital EET'], ['induced  prices', 'recent  TRT'], ['We', 'limited cases policy intervention'], ['Technical  risks', 'marginal imperfect cases'], ['specific  factors', 'selected  EET'], ['operational  amplifier', 'based op approximation'], ['high  gain', 'multiple gain stages'], ['proposed algorithmic scheme', 'multiple driving paths'], ['designed op amp', '10-bit pipeline 0'], ['', ''], ['designed op amp', '60 pipeline dB'], ['average peak DAC', 'DAV DC DC converter'], ['DAV control algorithm', 'detail'], ['equivalent series resistance', 'output capacitor'], ['controlled', 'controlled time domain simulation'], ['DAV control', 'steady  accuracy'], ['controlled buck converter', 'whole duty ratio'], ['load transient DAV control', 'lower load variation'], ['inspired  circuits', 'alternative logic gates'], ['we', 'complex computing circuits'], ['memristive threshold logic gates', 'modern Fourier microprocessors'], ['however CMOS logic they', 'higher power logic'], ['Loudspeakers line arrays', 'real reproduction sound environments'], ['', ''], ['theaters', 'linear directivity source'], ['sound  field', 'mechanical signal processing movements'], ['approach', 'computational complexity reduction'], ['full  investigation', 'digital line arrays'], ['', ''], ['rights', ''], ['study', 'dithered PWM control'], ['Constraints', 'available PV system'], ['PWM dithering', 'average PWM resolution'], ['control that', 'fast tracking speed'], ['practical  that', 'solar PV applications'], ['experimental ripple correlation that', 'basic hardware requirements'], ['rapid prototyping methodology', 'digital  paper'], ['main  application', 'microgrid inverter controllers'], ['current width control', 'global  optimization'], ['digital layer control', 'different layer implementations'], ['However  developing', 'signal hardware processors'], ['configurable DSP functions', 'efficiently optimal application'], ['Furthermore  paper', 'codesigned time controllers'], ['case study', 'experimental test verification'], ['article', 'high precision materials processing'], ['digital control system', 'key servo servo'], ['Two  ways', 'digital CAN protocol'], ['benefits', 'high data transmission standardization'], ['precise  delivery', 'such delivery system etc'], ['One', 'such  application'], ['day petroleum it', 'customer'], ['digital control valve', 'such delivery systems'], ['', 'digital control valve'], ['fluid control delivery', 'accuracy'], ['continuous domain models', 'previous  studies'], ['which', 'extreme approximation situations'], ['discrete time model', 'three PWM boost rectifier'], ['three PWM boost which', 'control performance'], ['approach  Based', 'digital Laplace domain'], ['discrete time model', 'state space average'], ['', 'single rotation transformation'], ['Laplace that', 'time delay modulation effect'], ['discrete time model', 'small signal model'], ['digital control location', 'open loop transfer system'], ['RHP  zero', 'also sampling period'], ['Furthermore corner frequency', 'mainly sampling period'], ['accounting', 'three phase PWM rectifier'], ['accurately system stability', 'critical  stable'], ['model', 'three phase PWM'], ['simple  method', 'digital power switching converter'], ['', 'feasible time delay restrictions'], ['It', 'insightful system performance'], ['', 'predictive power converters'], ['predictive  control', 'possible cost objectives'], ['control technique', 'dynamic  response'], ['However MPC method implementation', 'real time implementation'], ['real time implementation', 'direct matrix converter'], ['fully  need', 'digital signal processors'], ['proposed  scheme', 'parallel computation FPGAs'], ['controlled  plant', 'slow disturbance sensor'], ['intrinsic  difficulties', 'human machine etc'], ['paper', 'sampled Nyquist frequency'], ['inter sample disturbances', 'fully  sampling'], ['proposed control scheme', 'several stability assurance'], ['motion control that', 'advanced manufacturing systems'], ['', ''], ['', ''], ['rights', ''], ['new control structure', 'maximum wind regime'], ['extractable reference it', 'extractable reference condition'], ['This', 'fed induction generator'], ['presented  structure', 'active power tracking algorithms'], ['simulations', 'discrete backstepping technique'], ['current  control', 'adaptive slope paper'], ['PPCC', 'adaptive operation regions'], ['current ratio feed which', 'current ratio feed forward'], ['addition parts', 'external resolution ramp components'], ['performance', '260 V rms'], ['digital system we', 'current PR loop'], ['Then  we', 'digital design method'], ['discrete PR which', 'sampling calculation delay'], ['', 'steady state error'], ['11-kVA DVR prototype', ''], ['proposed control strategy', 'dynamic response performance'], ['frequency  converters', 'entire eGaN control'], ['adaptive driving scheme', 'efficiently input voltage range'], ['state space model', 'different gate drive signals'], ['high time resolution circuit', 'high speed buffers'], ['', 'entire input voltage range'], ['30-MHz VHF SR flyback', 'printed circuit board'], ['measured  efficiency', '80'], ['', ''], ['proposed  solution', '72'], ['', 'conventional  75'], ['', '1  2'], ['', ''], ['paper', 'novel power converter architecture'], ['surface  number', 'comfortable healing therapies'], ['hybrid mode power converter', 'capacitor  topologies'], ['flyback', 'galvanic battery isolation'], ['efficient SC stage', 'pulse slew stimulus'], ['SC', 'discharging  circuits'], ['regulation', 'current SC CS'], ['digital  controller', 'patient  protection'], ['experimental  prototype', 'bodied output individuals'], ['new output stage', 'known slew solutions'], ['faster slew rate pulses', 'portable ES applications'], ['', 'green supply wireless transmission'], ['agricultural  which', 'different application scenarios'], ['repeated  it', 'such  advantages'], ['advantages', 'MP control applications'], ['MP  system', 'zero order hold'], ['paper', 'different output NMP SHIs'], ['new  SHIs', 'square  pulse'], ['Numerical simulations', 'sample DT parameters'], ['smaller sampling that', 'proposed MP DT ZOH'], ['cover system identification', 'then pseudorandom loop'], ['resistor capacitor filter', 'unmodeled actuator dynamics'], ['proposed SHI scheme', 'actuator modeling error'], ['MP properties', 'three DT SHIs'], ['forward triangle SHI', 'small sampling periods'], ['efficient frequency response which', 'closed loop system'], ['algorithm', 'additional power stage hardware'], ['periodic frequency which', 'power converter'], ['conventional host which', 'sensitive power converters'], ['fixed point implementation', 'widespread  technique'], ['control transfer function', 'online frequency response'], ['algorithm', 'intelligent cost function estimation'], ['correlation', 'modeled plant transfer function'], ['dual core approach', 'switching frequency converters'], ['LCL filters', 'connected  inverters'], ['how time delay', 'connected LCL filters'], ['connected time that', 'current  feedback'], ['ranges', 'continuous s domain'], ['proper time delay', 'GCF loop'], ['different  conclusions', 'previous GCF studies'], ['delay addition method', 'GCF'], ['then  that', 'adequate stability margins'], ['dependent stability study', 'simulation'], ['chaotic  behaviour', 'simple chaos map'], ['chaotic  nature', '20 micro chaos years'], ['strange  attractors', 'desired  system'], ['control error', 'local  neighbourhoods'], ['present  we', 'several control methods'], ['Digital  stabilization', 'like linear oscillations'], ['vibrations', 'chaotic  sampling'], ['existence', 'Smale horseshoe'], ['dimensional micro chaos map', ''], ['', ''], ['it', 'finite  maps'], ['small voltage regulator', 'switched capacitor converter technology'], ['Voltage regulation', 'digital pulse density modulation'], ['It', 'zero disturbance types'], ['', 'entire operation range'], ['operation', 'over voltage load'], ['Simple design guidelines', 'voltage regulation experiments'], ['discrete time control schemes', 'discrete sliding mode technique'], ['first  controller', 'equivalent control method'], ['twisting sliding mode dynamics', 'integral  action'], ['measurable rotor fluxes', 'two  observers'], ['second observer design', 'sliding mode technique'], ['simulation study', 'discrete time control techniques'], ['robust  performance', 'external loop perturbations'], ['other control strategies', 'accuracy'], ['good  performance', 'proposed  strategy'], ['adaptive rotor flux observer', 'paper'], ['observer', 'current inverter sensors'], ['observer', 'sensored  observer'], ['rotor which', 'rotor temperature'], ['Computer simulation results', 'proposed  method'], ['paper', 'PFC controller power function'], ['key  topology', 'conventional  stage'], ['', 'one stage PFC circuits'], ['digital  controller', 'low cost PFC'], ['experimental  results', 'proposed  circuit'], ['modulated  controller', 'PIM digital redesign method'], ['output which', 'LLC converter'], ['performances', 'extensive  simulations'], ['currently  which', 'computational  requirements'], ['paper', 'magnetic silicon steel sheets'], ['new measurement system', 'wide silicon steel frequency'], ['novel system level model', 'paper'], ['digital  structure', 'whole delay system'], ['IF sigma delta which', 'consumption'], ['digital charge voltage which', 'better  stability'], ['ADCs', '102'], ['', '10 kHz bandwidth'], ['how drive noise', 'digital driving signals'], ['final  result', 'whole  gyroscope'], ['transient energy transfer response', 'possible output voltage deviation'], ['CPM time optimal solutions', 'current  stress'], ['controller', 'two  phases'], ['discharging state process', 'steady state value'], ['second  voltage', 'second  phase'], ['current valley which', 'tuning  procedure'], ['operation', '100-W 100-kHz switching frequency'], ['programmable deviation system', 'to  1'], ['', 'smaller component stress'], ['design', '10 frequency MHz'], ['proposed  DPWM', '11 duty cycle 17'], ['', '10 mu kHz'], ['', '10  MHz'], ['proposed  DPWM', 'low power consumption'], ['operating  clock', 'on relaxation oscillator'], ['integrated  circuit', '0'], ['proposed  DPWM', 'entire operating range'], ['nonideal  effects', 'NIBB noninverting buck converter'], ['step step phenomenon', 'unpredictable output voltage ripple'], ['two  results', 'entire power system'], ['brief', 'controlled NIBB converter'], ['proposed  technique', 'digital mode transition controller'], ['Moreover  technique', 'accurate output voltage'], ['based output voltage', 'transition region'], ['observed input voltage', 'Li ion battery'], ['', ''], ['5  V', ''], ['3  which', 'systems audio systems'], ['switching frequency', ''], ['technical  we', 'discrete time leader system'], ['distributed  observer', 'also system matrix'], ['Then matrix we', 'estimated feedforward control gain'], ['Finally  we', 'distributed control observer'], ['aim', 'current input voltage fluctuation'], ['quick power feeding response', 'also voltage fluctuation'], ['transient  response', 'digital mode PID control'], ['convergence time', '50 output %'], ['Phase shift modulation', 'resonant dc ac'], ['analog modulation PSM', 'digital  controllers'], ['discrete  time', 'small signal nature'], ['such width delay', 'well converter operating point'], ['paper', 'sampled phase shift modulators'], ['Second  it', 'closed loop compensation'], ['Theoretical findings', 'simulation'], ['PV mode controller which', 'real PV module'], ['portable PV simulator prototype', 'current voltage source load'], ['look PV which', 'measured output voltage'], ['Equivalent Method approach', 'linearized PV arrays characteristics'], ['PV simulator', 'real PV module'], ['experimental  results', 'source voltage loads'], ['last  century', 'overwhelming engineering field'], ['recent  us', 'simply  website'], ['that', 'aforementioned  question'], ['paper', 'state power operations'], ['they', 'benefit'], ['hardware resources', 'digital signal processor implementations'], ['digital implementation scheme', 'overall execution system'], ['entire control algorithm', 'low pass filter'], ['on chip FPGA which', 'other  applications'], ['entire  algorithm', 'Xilinx'], ['', 'proposed ISE system'], ['coded  algorithm', 'state state operating conditions'], ['paper', 'equivalent series resistance'], ['SOSM control', 'steady state operation'], ['Experimental  results', '2'], ['', ''], ['', ''], ['', ''], ['5  V', ''], ['new generator control unit', 'variable AC power system'], ['Control algorithms', 'conditioning process'], ['paper', 'final RMS calculation scheme'], ['Test results', 'dynamic performance performance'], ['paper', 'wide frequency bands'], ['recent novel that', 'new servo technologies'], ['Kucera parameterization scheme', 'local frequency regions'], ['waterbed that', 'fundamental feedback control'], ['Finally  simulation', 'experimental precision control'], ['', ''], ['rights', ''], ['paper', 'digital signal processors'], ['proposed system control architecture', 'six master converter'], ['master controller', 'serial energy bus'], ['slave controller', 'capacitors arm'], ['Intercommunication', 'inter integrated circuit bus'], ['Experiments', 'architecture'], ['controllers  processors', 'connected signal processing'], ['', ''], ['', ''], ['', ''], ['', ''], ['unit that', 'unit delays'], ['PLL Phase Locked system', '50 unit delays'], ['', ''], ['', 'orthogonal voltage system'], ['thus  number', 'Delay PLL implementation'], ['process', 'required control delays'], ['Hence Virtual Unit Delay', 'digital Delay PLL system'], ['varying control performance', 'varying grid way'], ['proposed  VUD', 'controlled Delay PLL system'], ['Experimental  results', 'proposal'], ['planet', 'urbanized  world'], ['urban  agglomerations', 'urban information systems'], ['', 'urban city century'], ['', 'advanced service citizens'], ['digital  technology', 'smart planning cities'], ['paper', 'urban strategy framework'], ['currently  that', 'urban accessibility congestion safety'], ['finally  potential', 'recent smartphone data systems'], ['paper', 'urban policy inter systems'], ['', ''], ['rights', ''], ['Various  versions', 'effectiveness control view'], ['', 'presented  stimuli'], ['results', 'classical  variance'], ['visual  activity', 'examined eye tracking system'], ['Quantitative PCR(qPCR', 'important pathogen detection'], ['qPCR DNA extraction which', 'false patient care'], ['wider  establishment', 'clinical quantification context'], ['accurate  methods', 'certified reference materials'], ['Digital PCR(dPCR', 'already nucleic acids'], ['actual performance it', 'adequate measurement uncertainties'], ['four  laboratories', 'common reference material'], ['Using', 'consecutive virus experiments'], ['Furthermore discrepancies', 'main DNA variability'], ['dPCR', 'metrological reference framework'], ['Digital PCR', 'rare nucleic acids'], ['complicated  which', 'extensive  application'], ['paper', 'simple self partition format'], ['chip', '10000 reaction compartments'], ['', ''], ['glass sandwich configuration', 'nonspecific water protein'], ['attached PDMS chip', 'high dPCR analysis'], ['We', 'genomic cell line H1975'], ['small copy number which', 'quantitative  PCR'], ['', 'widespread platform dPCR'], ['', ''], ['', ''], ['rights', ''], ['optical modulator driver', '0'], ['', 'digital input line'], ['Measurements', '58 output return GHz'], ['swing', 'on energy detector'], ['circuit', 'internal data calibration'], ['', ''], ['active  area', ''], ['', '92  +'], ['', ''], ['industrial Digital PID', 'many  stages'], ['paper', 'active PID 0'], ['', ''], ['PID', 'second Operational Transconductance generation'], ['results', 'three frequency response'], ['digital envelope modulator', 'frequency power paper'], ['class D power that', 'class D power amplifiers'], ['previous analog requirements', 'static power dissipation'], ['controlled power opamp', 'previous power work'], ['it', 'hybrid envelope modulators'], ['digital  processor', 'complementary oxide semiconductor technology'], ['overall power consumption', 'digital  1'], ['', ''], ['digital class AB', 'complete envelope modulator architecture'], ['overall  efficiency', '5-MHz input signal'], ['', ''], ['', 'multidisciplinary  technology'], ['', 'synchronous hardware basis'], ['electronic  systems', 'permanent  mechanism'], ['we', 'digital theory research motor'], ['effectiveness', 'motion brushless control engineering applications'], ['novel control that', 'digital state transitions'], ['', 'digital attenuation state'], ['This', 'possible signal overshoot'], ['digital control it', 'digital RF performance'], ['proposed  technique', '6-bit'], ['reduced overshoot DSA', 'commercial'], ['', 'SOI  process'], ['technique', 'than  0'], ['', ''], ['electronic control technology', 'electronic  device'], ['switching power supply', 'electronic  equipment'], ['quality', 'electronic  equipment'], ['Digital control technology', 'new power electronics'], ['Digital control', 'temperature convenient'], ['paper', 'digital system system'], ['DAC Analog circuit', 'paper'], ['circuit', '1997 International Test Conference'], ['Golden  circuits', 'two CMOS Operational faults'], ['assembled fault detection procedure', 'detectable faults HSPICE'], ['type', 'faulty  circuit'], ['within grape which', 'biological  condition'], ['performing', 'especially vine mortality'], ['recurrent vine patterns', 'electrical survey conductivity'], ['6 planting map', '2015-Pleiades panchromatic band'], ['Within field terroir units', 'EM38 data'], ['within terroir units', 'past soil management 1940s'], ['Missing vines frequency', 'N organic C contents'], ['temporal  assessment', 'sustainable grape production'], ['', ''], ['', 'Elsevier B'], ['', ''], ['This', 'open CC BY license'], ['innovative  variable', 'high voltage power supply'], ['It', 'maximum output 0'], ['', ''], ['It', 'linear supply rejection 58dB'], ['also analog which', 'output voltage'], ['Theorists', 'inevitable post capitalism'], ['capitalist  they', 'capitalist  labour'], ['digital case we', 'assumptions'], ['corporate  players', 'technical network ecosystems'], ['strategies', 'oligopolistic market competition'], ['basic labour process rationalization', 'competitive  strategies'], ['We', 'capitalist  labour'], ['locked  which', 'frequency  ADPLLs'], ['single  band', 'DCO'], ['new  which', 'wide control unit'], ['dual band DCO', 'digital control bits'], ['band  DCO', 'wider  frequencies'], ['wide gap width', 'dual band DCO'], ['designer', 'direct  frequencies'], ['So  we', 'trade power'], ['we', 'low frequency applications'], ['proposed  designs', 'critical DCO coarse'], ['delay linearity factors', 'combined control unit'], ['simulations', '128-bit input coarse codes'], ['simulation  results', 'dual band 14'], ['8 ps jitter', '134  1'], ['', 'wide overlap mode'], ['7 ps jitter', '184'], ['', '61  1'], ['', ''], ['designs', 'standard ADPLL designs'], ['Dignity therapy', 'psychological  life'], ['Little', 'effect'], ['', 'threatening dignity diseases'], ['Systematic  review', ''], ['Three  authors', 'Appraisal Skills Programme'], ['Data', 'study objectives'], ['Data PubMed', 'Cochrane Library'], ['years', 'dignity therapy January'], ['Dignity therapy', 'search term'], ['Studies', 'threatening  diseases'], ['', '121  studies'], ['Quality', 'studies'], ['Results', 'different effectiveness satisfaction diseases'], ['randomized control trials', 'psychological dignity distress'], ['One', 'anxiety  time'], ['other', 'post dignity depression'], ['Nonrandomized studies', 'existential  measurements'], ['it', 'end  experience'], ['dignity therapy', ''], ['controlled  trial', 'anxiety DT scores'], ['Other design studies', 'end  experience'], ['high  level', 'most distress therapy'], ['', ''], ['continuous ambulatory peritoneal patients', 'peritoneal  fibrosis'], ['1 growth TGF', 'peritoneal interleukin-1 fibrosis'], ['Diltiazem', 'frequently  hypertension'], ['objectives', 'signalling  induction'], ['', ''], ['Human PMCs', 'human  omentum'], ['Collagen synthesis', 'precipitated  collagen'], ['expression', 'northern TGF blotting'], ['production', 'human TGF immunoassay'], ['changes', 'intracellular fluorescence spectrophotometry'], ['Western  blotting', 'activated protein proteins'], ['', ''], ['We', 'diltiazem'], ['2  mM', 'dependent collagen basis'], ['', ''], ['', 'human  protein'], ['', ''], ['ng IL-1 ml', 'also IL-1 beta-'], ['Intracellular calcium levels', 'diltiazem'], ['p38 MAPK diltiazem', 'phenomenon'], ['', ''], ['Diltiazem', 'human collagen PMCs'], ['signalling  transduction', 'instead intracellular calcium'], ['diltiazem', 'further vivo studies'], ['based dimensionality reduction methods', 'such image classification'], ['which', 'dramatically input methods'], ['we', 'based dimensionality reduction methods'], ['LC GODR', 'joint projection framework'], ['Therefore  graph', 'adaptively dimensionality reduction'], ['proposed algorithm distinct', 'other dimensionality reduction methods'], ['effective updating scheme', 'proposed LC GODR'], ['Extensive  experiments', 'five image algorithm'], ['experimental  results', 'that'], ['', ''], ['', ''], ['rights', ''], ['Dimethyl sulfoxide', 'several  literature'], ['It', 'abnormal collagen tissue'], ['', 'scar  rabbits'], ['male albino rabbits', 'four  groups'], ['punch', 'biopsy  animal'], ['Following', 'DMSO triamcinolone groups'], ['therapeutic  agent', 'control  groups'], ['last ear samples', 'real gene expression analyses'], ['epithelium', 'sham group'], ['Connective tissue thickness', 'control DMSO'], ['TRA groups', 'control'], ['III immunoreactivity level', 'other sham groups'], ['type I III immunoreactivity ratios', 'DMSO group'], ['alignment', 'DMSO sham'], ['gene expression levels', 'sham group'], ['mRNA expression levels', 'almost  groups'], ['mRNA expression levels', 'control TRA groups'], ['intralesional  administration', 'hypertrophic scar formation'], ['', 'Reconstructive British Surgeons'], ['', 'Elsevier Ltd'], ['rights', ''], ['Differential gene expression profile', 'Dimocarpus longan Lour'], ['', 'simulated acid pH'], ['', ''], ['', ''], ['6', 'differential polymerase chain reaction'], ['mRNA differential display conditions', 'acid rain stress'], ['potential encoding products', '81 Theobroma cacao'], ['fragment', 'acid longan rain'], ['', 'Fresh  longan'], ['', 'browning'], ['Aril breakdown', 'quality storage fruit'], ['molecular expression patterns', 'XET room temperature'], ['aril breakdown index', '4 degrees C'], ['accumulations', 'differential aril breakdown'], ['early Dl EXP3', 'later aril breakdown'], ['However  expression', '4 degrees C'], ['when longan fruit', '12 storage period'], ['Dl EXPs', 'closely longan fruit'], ['forming  strain', 'when Monilinia fructicola'], ['same  strain', 'other fruit pathogens'], ['Optical electron microscopy', ''], ['fermentans', 'peach apple tissue'], ['subtractive hybridization approach', 'pathogenic  P'], ['', 'P'], ['24 hours growth', 'hours peach fruit'], ['reverse Northern Blotting which', 'significantly apple tissue'], ['compared', 'dimorphic yeast Candida albicans'], ['relationship', 'genes dimorphism'], ['humans', 'particular  others'], ['Wild  canids', 'European  dog'], ['we', 'behavioural assessment tool'], ['sample', 'modern  dogs'], ['Overall  number', 'demographic breed breeds'], ['Dingoes', 'modern  dogs'], ['Dingoes', 'ancient animal dogs'], ['dingoes', 'domesticated  dogs'], ['primitive breed behaviour', 'earlier selection pressures'], ['', ''], ['', ''], ['rights', ''], ['Karenia brevis', 'human tide brevetoxins'], ['PKS gene cluster', 'PKS'], ['eight PKS transcripts', 'K'], ['', 'high cDNA library screening'], ['30  which', '50 PKS transcripts'], ['one  transcript', 'carrier protein'], ['Transcript  lengths', 'northern sequence blotting'], ['', 'phylogenetic  K'], ['brevis KS domains', 'protist  type'], ['catalytic II domain', 'individual  protein'], ['results', 'toxic PKS dinoflagellate'], ['', 'Elsevier GmbH'], ['marine  they', 'in  group'], ['We', 'morphological dinoflagellate evolution'], ['results', 'thecate athecate ones'], ['cellulosic  we', 'cell division'], ['dinoflagellates', 'Mesozoic  strata'], ['living  dinoflagellates', 'metabolically  plastids'], ['evolutionary  origin', 'plastidic tetrapyrrole biosynthesis'], ['evolutionary  which', 'like  proteins'], ['Two Keggin type polyoxometalates', 'mushroom tyrosinase inhibitors'], ['strongly inhibition mechanisms', 'strongly diphenolase tyrosinase'], ['half inhibition concentration values', ''], ['', ''], ['', ''], ['Lineweaver Burk HGly)(3)PW12O40', 'uncompetitive K IS=0'], ['046mmol  HGly)(4)SiW12O40', 'noncompetitive K IS=2'], ['', ''], ['study', 'medicine  preservation'], ['', 'International Union International Biochemistry'], ['genomic DNA fragment', 'diploid potato IVP101'], ['', ''], ['Nucleotide sequencing', '115-bp DNA intron'], ['deduced PINII-2x protein', 'signal  peptide'], ['PINII-2x gene', 'tetraploid proteinase inhibitor II'], ['mRNA', 'potato leaves'], ['respectively rice I', 'ubiquitin  promoter'], ['two  constructs', 'japonica rice cv'], ['', ''], ['PCR blotting analysis', 'transgenic PINII-2x gene'], ['Northern blotting analysis', 'transgenic rice plants'], ['average Chilo suppressalis weight', '61 control plants'], ['PINII-2x gene', 'effective insect resistance'], ['little regime attention', 'potential  them'], ['paper', 'direct  democracy'], ['possibilities', 'unpopular decision institutions'], ['regime', 'legitimacy'], ['national  analysis', 'European transition democracies'], ['It', 'secondary country level surveys'], ['social  that', 'rapid  detection'], ['direct  gaze', 'memory tasks'], ['', ''], ['', ''], ['direct  gaze', 'cognitive  processes'], ['', ''], ['', ''], ['direct  gaze', 'concurrent memory tasks'], ['where change detection participants', 'small  agents'], ['when  agents', 'directly  them'], ['disruptive  effect', ''], ['Prolonged presentation', 'sustained change detection performance'], ['present  study', 'when working gaze'], ['NGDI Gas Direct engines', 'pollutant engine emissions'], ['jet structure', 'optimal mixture formation'], ['Here jet characteristics', ''], ['natural gas jet', 'hole Schlieren photography'], ['effects', 'macroscopic jet characteristics'], ['New  correlations', 'tip speed'], ['reducing', 'axial injection penetration'], ['Moreover linear relation', 'toinjected gas density ratio'], ['', ''], ['rights', ''], ['different  one', 'perceptual  experiences'], ['we', 'low edges colors'], ['content', 'perceptual  emotions'], ['argument', 'social core cognition'], ['we', 'perceptual  belief'], ['perceptual  experiences', 'yet  experience'], ['person', 'field'], ['perceptual  experiences', 'cognitive pattern penetration'], ['cheater  detection', 'social  exchange'], ['memory', 'cheaters'], ['when  who', 'when  partner'], ['two studies participants', 'sequential dilemma cheaters'], ['Alternating', 'facial game blocks cooperators'], ['experiments', 'facial congruence cheaters'], ['regardless  partners', 'cheater detection hypothesis'], ['Low level Radio Frequency', 'digital Radio Frequency'], ['controller', 'QWR linear accelerator'], ['cavities', 'condition'], ['medium beta cavities', '160  MHz'], ['RF controller', 'different  cavities'], ['RF signals', 'RF ADCs'], ['programmable gate which', 'control loop'], ['phase  quadrature', 'hence power cavities'], ['digital control that', 'direct RF signal'], ['undersampling  control', 'digital Complex Phase Modulator'], ['FPGA', 'new RF controller'], ['problem', 'uniform linear array'], ['ESPRIT  algorithm', 'half array wavelength'], ['NC which', 'NC signals'], ['which', 'computational  cost'], ['conventional GESPRIT it', 'due NC property'], ['proposed  algorithms', 'well NC phase'], ['effectiveness', 'following simulation results'], ['Canine dirofilarioses', 'climatic  factors'], ['Dirofilaria', 'clinical heartworm implication'], ['', 'last  D'], ['', 'zoonotic  potential'], ['epidemiological  surveys', 'D'], ['', ''], ['', ''], ['present case report', 'natural  D'], ['', ''], ['', 'western male Romania'], ['clinical  diagnosis', 'kidney failure'], ['parasites', 'PCR'], ['this', 'ectopic  D'], ['', 'ocular  Romania'], ['clinical  findings', 'D'], ['', 'histopathological  lesions'], ['Further  investigations', 'pathogenic  D'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['sexual  CSE', 'young  disabilities'], ['specifically  little', 'best  group'], ['UK which', 'young  disabilities'], ['who', 'CSE'], ['paper', 'young government people'], ['', ''], ['rights', ''], ['Children', 'how teachers parents'], ['older disclosure children', 'similar performance achievement'], ['younger achievement children', 'preferential performance disclosure'], ['One hundred thirty children', '3 classroom performance information'], ['high achieving who', 'high achieving peer'], ['however  children', 'low age peer'], ['social  that', 'possible  help'], ['', ''], ['continuous time which', 'zero order hold device'], ['system that', 'continuous time system'], ['simple time difference', 'two integration gain'], ['certain gain that', 'discretized  system'], ['smaller error one', 'linear approximation'], ['Simulations', 'forward difference methods'], ['continuous time which', 'forward difference model'], ['', 'malnutrition animal populations defence'], ['We', 'immune condition defence'], ['we', 'total plasma proteins'], ['', 'female Soay sheep'], ['individual plasma that', 'overwinter survival'], ['older  individuals', 'high protein nutritional plane'], ['findings', 'wild animal populations'], ['efficacy', 'health systems'], ['chronic heart who', 'advanced health care services'], ['1360 label patients', 'randomly disease management'], ['Disease management', 'patient weight blood pressure'], ['Patients', 'primary care practitioners'], ['composite  endpoint', 'first heart failure cause'], ['Secondary  endpoints', 'related follow up'], ['Intention  comparisons', 'patient  data'], ['', 'follow up'], ['', '9 disease management'], ['1  %', 'primary endpoint event'], ['primary endpoint event', 'study'], ['', ''], ['', '0  management'], ['', ''], ['', 'usual  care'], ['', ''], ['', '1'], ['', ''], ['Hospital admissions', '70 heart failure'], ['Patients', 'lower follow up'], ['composite  it', 'related  life'], ['chronic heart who', 'universal health care'], ['associated protein kinases', 'recently  Arabidopsis'], ['novel  Oryza', 'WAK'], ['deduced amino acid sequence', '27'], ['', '6 % Arabidopsis'], ['OsWAK1', 'recently transcription rice'], ['OsRFP1', 'strongly kinase OsWAK1'], ['OsWAK1', ''], ['fusion protein', 'cell surface'], ['further  OsWAK1', 'cell wall'], ['Magnaporthe oryzae', 'compatible blast fungus'], ['OsWAK1', 'mechanical wounding ABA'], ['OsWAK1', 'novel plant defense'], ['transgenic rice lines', 'compatible  race'], ['However OsWAK1 expression', 'normal growth conditions'], ['novel  RLK', 'important plant disease resistance'], ['cognitive  process', 'evaluative disease aspect'], ['Regarding', 'cultural  research'], ['hetero perception', 'adaptive self significance'], ['human  properties', 'emotional  disease'], ['that', 'perceptual  elucidation'], ['Spanish  enfermedad', 'Indo European Indo languages'], ['different  words', 'evil suffering states'], ['', 'revised  cultures'], ['Viral  vaccines', 'domestic animal populations'], ['often  it', 'sufficient  population'], ['old  method', 'major vaccine revolution'], ['genetic  engineering', 'transmissible  vaccine'], ['Unfortunately  releasing', 'oral polio vaccine'], ['weakly  that', 'evolutionary  reversion'], ['Here  we', 'transmissible  vaccines'], ['vaccines', 'infectious eradication efforts'], ['transmissible  vaccines', 'infectious animal humans'], ['Lymphocyte  ratio', 'survival cancer'], ['relationship', 'LMR  cancer'], ['We', 'nonmetastatic rectal cancer'], ['rectal  who', 'curative  January'], ['LMR', 'absolute monocyte counts'], ['cut  value', 'median  value'], ['', '2 value groups'], ['total', 'rectal  study'], ['median follow up time', 'patients'], ['cut  value', 'LMR'], ['patients', '2  groups'], ['', ''], ['univariate  LMR', 'overall  survival'], ['', ''], ['', ''], ['', ''], ['', ''], ['also  LMR', 'significantly  DFS'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'node metastasis LMR'], ['', 'nonmetastatic rectal cancer patients'], ['output stability', 'high speed rotor system'], ['paper', 'suspended displacement motor'], ['third  probe', 'temperature drift'], ['operational measuring amplifier', 'one  probes'], ['Then  scheme', 'auxiliary temperature probe'], ['detailed operating procedure', 'temperature drift ratio'], ['Finally  terms', 'final displacement sensor'], ['Experimental  results', 'proposed motor test solution'], ['', ''], ['Omacetaxine mepesuccinate', 'two tyrosine kinase inhibitors'], ['', ''], ['objective', 'single faeces 1'], ['', 'subcutaneous cancer patients'], ['', ''], ['High chromatography mass spectrometry', 'off metabolite identification'], ['', ''], ['six  metabolites', 'omacetaxine'], ['reactions', '13-dioxole hydrolysis pyrocatechol ring'], ['Unchanged  omacetaxine', 'related  plasma'], ['', \"together  4'-DMHHT\"], ['pyrocatechol metabolite', 'omacetaxine M534'], ['', ''], ['Omacetaxine', 'renal  metabolites'], ['metabolites', 'materially  omacetaxine'], ['paper', 'Canadian child welfare system'], ['study', 'Canadian child welfare system'], ['Asian child maltreatment ethnicity', 'child demographics'], ['Canadian  children', 'Canadian child welfare children'], ['', 'Canadian  population'], ['', ''], ['', 'Canadian  population'], ['Child welfare involvement', 'Canadian  children'], ['three disparity indexes', 'domestic child maltreatment violence'], ['Disproportionality', ''], ['variation', 'racial child welfare research'], ['methodological  considerations', 'Canadian child welfare populations'], ['', ''], ['rights', ''], ['DEF energy which', 'natural power systems'], ['', ''], ['transient state that', 'actual PMU data'], ['PMU data processing', 'actual PMU data'], ['effectiveness', 'two Electricity Coordination Council'], ['study', 'specific oscillation mode'], ['', ''], ['rights', ''], ['Plunging water jets', 'such simplicity energy efficiency'], ['Specifically  these', 'interfacial gas water'], ['however oxygenation capacity', 'limited turbulent attention'], ['flow characteristics', 'standard flow depth'], ['Two  equations', 'plunging turbulent flow'], ['dynamic  behavior', 'two flow visualization'], ['', '2017 Civil Engineers'], ['magnetic resonance it', 'midrange wireless charging'], ['Here functions', 'wireless charging system'], ['', 'sensing  hardware'], ['', ''], ['frequency power source', 'multiple antenna functions'], ['due sensing range', 'fixed Q antenna'], ['controllable area effectiveness', 'theoretical  analysis'], ['effective  area', 'antenna g antenna d'], ['', ''], ['', ''], ['current energy system', 'renewable energy consideration'], ['reference year', 'present energy structure'], ['which', 'further energy constructions'], ['well CO2 emissions', 'natural gas CHP'], ['preliminary  feasibility', 'excess electricity production'], ['20 wind energy fraction', ''], ['flexible  techniques', 'grid stabilities'], ['excess  production', '60 energy %'], ['', ''], ['rights', ''], ['Recent years installation', 'environmental tariff system'], ['static var compensator', 'distribution system'], ['SVC', 'voltage'], ['SVC', 'existing ratio control transformer'], ['existing voltage controller', ''], ['RBF basis network', 'radial basis function'], ['method', 'conventional performance method'], ['advantage', 'existing SVC setup method'], ['study', 'middle income Latino'], ['', ''], ['', ''], ['judgments', 'societal  fairness'], ['multipart  interviews', 'conceptions'], ['', ''], ['', ''], ['Overall  adolescents', 'actual  U'], ['', ''], ['', 'egalitarian wealth distribution'], ['societal fairness judgments', 'academic  plans'], ['adolescents', 'academic fairness plans'], ['older  adolescents', 'preferred wealth inequality'], ['cooling system model', 'district'], ['Mathematical  models', 'cooling energy system'], ['measures', 'unequal pumping station'], ['quick  that', 'quick  combinations'], ['optimum  that', 'lowest electricity consumption'], ['flow rate water flow head', 'chilled pumping district'], ['booster pumping stations', 'main pumping station'], ['effects', 'cooling energy system'], ['that', 'cooling energy system'], ['utilization level', 'similar climate zones'], ['study', 'thermal energy storages'], ['Energy needs', 'case area'], ['solar energy heat', 'thermal tank winter'], ['60  %', 'self sufficiency heat scenarios'], ['carbon dioxide emissions', 'business  situation'], ['', ''], ['rights', ''], ['Ensemble weather predictions', 'dynamic heat load uncertainties'], ['These', 'dependent risk e'], ['', ''], ['', 'supply'], ['it', 'close electricity markets'], ['autoregressive forecast model', 'new weather prediction concept'], ['study performance', 'complex forecast models'], ['total  uncertainty', 'constant model uncertainty'], ['latter', 'ensemble  spread'], ['total forecast uncertainty', 'consequence'], ['forecast model', 'three heat exchanger stations'], ['Applying', 'current supply operation'], ['Improving', 'further heat ground'], ['potential  benefit', 'smaller pumping capacities'], ['', ''], ['rights', ''], ['increasingly power devices', 'lower power losses'], ['high precision which', 'programmable gate array'], ['modulated frequency dither', 'DPWM resolution'], ['low frequency which', 'output filter controller design'], ['optimal dither technique', 'DPWM power converters'], ['concepts', 'first  paper'], ['dither  period', 'six switching periods'], ['proposed  optimal', 'lowest order harmonics'], ['experimental  results', 'proposed buck technique'], ['', 'adverse pregnancy outcome'], ['circadian  preference', 'previous sleep studies'], ['evening type women', 'Finnish SLEEP Birth Cohort'], ['Chronotype', 'shortened morningness eveningness questionnaire'], ['Pregnant evening type women', 'more sleep troubles'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'even sleep deprivation'], ['They', 'higher Epworth Sleepiness Scale'], ['', ''], ['', ''], ['', 'also  pregnancy'], ['', 'general  health'], ['', 'morning type women'], ['They', 'more sleep childhood'], ['', ''], ['', ''], ['', ''], ['', 'morning type women'], ['eveningness', 'unhealthy life pregnancy'], ['deferred lifetime which', 'comparable career nations'], ['less  it', 'less  attention'], ['Companies', 'working duties job time'], ['All', ''], ['indefinite  nature', 'many employment problems'], ['job contents', 'which'], ['that', 'shift'], ['bidirectional LC which', 'current inductance tracking'], ['LCL filter', 'grid'], ['injected grid current', 'harmonic LCL filter capacitor'], ['paper', 'grid current grid harmonics'], ['control  reduction', 'current  harmonics'], ['39th voltage rejection which', 'weak grid connection'], ['Experimental  results', 'digital  control'], ['present  study', 'assumptive Nrf2-ARE neuroprotection'], ['weight drop model', 'TBI'], ['ICR mice', 'experimental  groups'], ['NBP', 'mg  intraperitoneal'], ['', ''], ['', '1  TBI'], ['administration', 'neurological brain water content'], ['Furthermore  level', 'NBP treatment group'], ['NBP', '1 antioxidant enzyme SOD'], ['NBP', 'western blot immunofluorescence'], ['Additionally  it', 'western  blot'], ['NBP administration', 'potentially Nrf2-ARE pathway'], ['present  study', 'emerging bone field'], ['Ameloblasts', 'ill  vivo'], ['primary model cultures', 'recently rat vitro'], ['Dlx3  probe', ''], ['', ''], ['human Dlx3 sense RNA', 'Northern maxillo blotting'], ['Immunolabeling', 'situ Theiler stage E'], ['', 'birth'], ['differentiated  it', 'odontoblast  polarization'], ['endochondral formation Dlx3 protein', 'prehypertrophic inetaphyseal periosteum'], ['real time PCR studies', 'closely Ihh variations'], ['', 'membranous preosteoblasts osteoblasts'], ['functional transcription factor', 'entire matrix skeleton'], ['', ''], ['rights', ''], ['purpose', 'TDO pulp syndrome'], ['NC novel mutant cells', 'recombinant  lentiviruses'], ['proliferation rates', 'CCK8 assay'], ['assay mineralization ability', 'Alizarin red Alizarin staining'], ['Odontogenic  markers', 'real polymerase chain reaction'], ['DMP-1', 'Western DSPP blotting'], ['novel mutant DLX3', 'wild type DLX3'], ['novel mutant novel DLX3', 'odontogenic  genes'], ['results', 'Western  blotting'], ['novel mutant DLX3', 'wild type DLX3'], ['novel  mutation', 'TDO syndrome'], ['', ''], ['rights', ''], ['human  gene', 'tumorigenesis brain defense'], ['SRCR receptor which', 'bacterial  pathogens'], ['repetitive  number', 'genetic  polymorphism'], ['Here  we', 'porcine DMBTI mRNA'], ['We', '4'], ['kb porcine cDNA sequence', 'seminal vesicle RNA'], ['porcine DMBT1 cDNA', 'open reading 4050'], ['transcript', 'calculated amino 147'], ['', ''], ['human  it', 'four terminal SRCR domains'], ['Northern  blotting', 'similar  4'], ['7  kb', 'tissues'], ['Analysis', 'secreted  variants'], ['porcine', '54 chromosome 14q28-q29'], ['genomic BAC clone', '3 terminal SRCR domains'], ['', 'interspecific transmembrane exon'], ['porcine DMBT1 gene', 'coding human DMBT1 exons'], ['', ''], ['', ''], ['rights', ''], ['Penaeid shrimps', 'Egyptian capture fisheries'], ['such species that', 'economic  value'], ['Egyptian capture Penaeus', 'Metapenaeus monoceros'], ['Morphological  clues', 'species'], ['Furthermore  DNA', '16S polymerase chain reaction'], ['New  barcodes', 'morphological GenBank identification'], ['discrepancies', 'Genbank database'], ['closest  that', 'previously  GenBank'], ['fundamental  which', 'studied shrimp species'], ['study', 'growing shrimp Egypt'], ['it', 'also Mediterranean supreme Egypt'], ['', ''], ['', ''], ['rights', ''], ['Gold nanoparticles', 'visual nucleic acid readout'], ['major  challenge', 'ultrasensitive  simplicity'], ['conventional  strategy', 'modified gold nanoparticle probes'], ['ultrasensitive DNA assay platform', 'modified gold nanoparticles'], ['binding  mechanism', 'free magnesium ions'], ['poly(ethylene  glycol', 'induced magnesium pyrophosphate'], ['similar  phenomenon', 'containing  nanomaterials'], ['isothermal amplification it', 'positive target DNA target'], ['This', 'isothermal DNA assay amplification'], ['commercial  methods', 'agricultural biogas plant'], ['two biogas plants', 'devoted  biomass'], ['diverse  that', 'commercial  fields'], ['ability', 'high  importance'], ['Important  parameters', 'recovered  DNA'], ['higher  amount', 'more  degradation'], ['DNA purity', 'PCR amplificability'], ['two  methods', 'DNA'], ['such  addition', 'DNA'], ['eukaryotic  methods', 'prokaryotic  DNA'], ['digestion analysis', 'prokaryotic ribosomal library'], ['We', 'free novel DNA intercalators'], ['stranded ds DNA', 'mass SPR sensor surface'], ['binding thiol that', 'assembled gold substrate'], ['instead pyrenyl group', 'adjacent pyrene groups'], ['molar concentration ratio', 'mixed SPR sensor ratios'], ['Finally  we', 'pure purification process'], ['free  biosensor', 'quantitatively ds accordance'], ['', ''], ['', ''], ['rights', ''], ['Stress', 'dependent suicidal behavior'], ['pituitary adrenal axis', 'common  disorder'], ['involvement', 'additional  depression'], ['underlying gene that', 'depression'], ['epigenetic  modifications', 'serious suicidal ideation'], ['associated  Brain', '5 Hormone Binding Protein'], ['transcript  levels', 'same  PBMC'], ['NR3C1 gene promoters', 'significantly suicidal ideation'], ['promoter hypermethylation', 'observed MDD patients'], ['secondary analysis methylation', 'serious suicidal ideation'], ['MDD', 'small sample size'], ['suicidal  which', 'patient  population'], ['', ''], ['rights', ''], ['Childhood maltreatment', 'mental risk health'], ['different  forms', 'epigenetic  signatures'], ['68 city %', 'one  maltreatment'], ['', 'major childhood maltreatment'], ['strongest  many', 'psychiatric  disorders'], ['', ''], ['', 'biological methylation processes'], ['', ''], ['physical  abuse', 'neural cardiovascular development'], ['stringent  set', 'high confidence associations'], ['Together findings', 'molecular childhood maltreatment'], ['high  it', 'epigenetic maltreatment types'], ['Furthermore  studies', 'identified maltreatment exposure'], ['', ''], ['rights', ''], ['epigenetic gene that', 'virtually cell types'], ['higher  it', 'homeostatic cell phenotype'], ['where  it', 'neoplastic  tissues'], ['experimental  evidence', 'dynamic paradigms methylation processes'], ['stochastic  that', 'age'], ['various  factors', 'intercellular methylation patterns viz'], ['', ''], ['how biology heterogeneity', 'clonal evolution'], ['how basal bimodal methylome', 'didactic  overview'], ['gene', 'cancerous  phenotypes'], ['Lastly  we', 'heterogeneous methylation assessment methylation'], ['', 'C Elsevier Ltd'], ['Astrocytomas', ''], ['They', 'high grade lesions'], ['Here  we', 'potential astrocytoma progression'], ['we', 'based expression patters'], ['19  genes', ''], ['possible  we', 'poor expression survival'], ['five  genes', 'single gene signatures'], ['double strand NEIL3', 'highly glioblastoma cells'], ['high grade EXO1', 'reactive oxygen species'], ['Thereby  we', 'therapeutic tumor targets'], ['mTOR that', 'aging  process'], ['mutant hormone receptor gene', 'associated protein A'], ['lower mTOR signals', 'related  diseases'], ['PAPPA KO mice', 'DNA repair O-6-methylguanine DNA methyltransferase'], ['Furthermore  we', 'transcriptional NDRG1 protein mechanisms'], ['transcriptional  regulator', 'lived mTORC1 mice'], ['specific CCR4-NOT modulation', 'aging  process'], ['Cellular  sensing', 'early virus infections'], ['how GMP AMP cells', 'incoming DNA genomes'], ['antiviral interferon I', 'antiviral interferon type'], ['facilitate', 'wide sensors adaptor proteins'], ['induced STING we', 'antiviral evasion pathway'], ['fresh water resources', 'effluent  land'], ['', 'better mitigation strategies'], ['3  tracers', 'study'], ['experiment  groundwater', 'pond domestic oxidation pond effluent'], ['selected DNA tracers', 'temporal mass moments'], ['intact dsDNA tracers', 'less Br tracer'], ['dsDNA tracers', 'larger  pores'], ['Effluent tracking experiments', 'quantitative polymerase chain reaction'], ['DNA tracer', '3-orders detection limit'], ['it', 'greater  distances'], ['further  studies', 'environmental  conditions'], ['multiple DNA tracers', 'spatial contamination sources'], ['', ''], ['', ''], ['rights', ''], ['molecular  analysis', 'methodological  results'], ['real time PCR', 'often  sensitivity'], ['Nevertheless  implementation', 'higher authenticity costs'], ['', 'degraded mitochondrial DNA samples'], ['proposed  method', 'short mitochondrial DNA'], ['standard  curve', 'samples'], ['proposed  method', 'ancient  bone'], ['DNA inhibitory DNA substances', ''], ['proposed  method', 'inhibitory  substances'], ['DNA analysis', 'modified  organisms'], ['often DNA which', 'consequently PCR analysis'], ['PCR we', 'novel DNA fragmentation'], ['real time PCR that', '200 400 base pairs'], ['indicator value DNA fragmentation which', 'real time PCR assays'], ['Finally  we', 'processed GMO detection'], ['', ''], ['rights', ''], ['far goat milk ingredients', 'labels'], ['study', 'reliable product consumers'], ['', ''], ['rights', ''], ['aim', 'molecular polymerase chain reaction'], ['Cyt b Cyt gene', 'target gene'], ['Amplicon size', 'beef lamb'], ['specific  set', '24 PCR run'], ['detection limit', '1 meat species'], ['PCR method', '1 meat adulteration'], ['stability', 'processed  meats'], ['direct  PCR', 'mixed  meats'], ['developed  assay', 'on meat site'], ['', ''], ['rights', ''], ['dependent  activator', 'regulatory hepatitis B virus'], ['HBV  mechanism', ''], ['e  secretion', 'Southern DNA replicative blotting'], ['Western  blotting', 'staining'], ['B NF activity', 'dual immunofluorescence assay'], ['antiviral  effects', 'secreted  cytokines'], ['Viral protein secretion', '57  %'], ['level', '67 HBV %'], ['', ''], ['associated  DNA', 'expressing Huh7 cells'], ['kappa B DAI', 'antiviral Huh7 cells'], ['HBV B alpha activity', 'DAI'], ['IRF3', 'cytokines'], ['inhibitory HBV effect', 'NF kappa cytokines'], ['', ''], ['rights', ''], ['LAMP facile that', 'simple amplification targets'], ['inner  primer', 'next  amplification'], ['signal  precursor', 'larger target DNA amplification'], ['formed quadruplex hemin that', 'direct colorimetric assay'], ['', ''], ['pg genomic pg DNA', 'cascade signal amplification gels'], ['colorimetric  strategy', 'visual DNA LAMP'], ['method', 'point  detection'], ['', ''], ['', ''], ['rights', ''], ['', 'human placenta preeclampsia'], ['We', 'pregnant PE women'], ['western reaction blot', 'placenta tissue detection'], ['expressions', 'when NP ones'], ['', ''], ['Hypomethylation', 'significant PE placentas'], ['', ''], ['methylation level', 'significantly  -97'], ['', 'normal PE placentas'], ['', ''], ['epigenetic PE mechanism', 'PE'], ['', ''], ['rights', ''], ['Cellular  stressors', 'eukaryotic ribosomal cells'], ['treatment tumor RNA degradation', 'complete tumor destruction'], ['underlying drug mechanisms', 'drug response'], ['SKBR3 cancer cell lines', 'several cytotoxic chemotherapy drugs'], ['RNA', 'resistant drug exposure'], ['Disruption', 'capillary  electrophoresis'], ['Northern  blotting', '28S degradation bands'], ['Apoptosis activation', 'binding caspase-3 activation'], ['link', 'caspase-3 inhibitor'], ['chemotherapy drugs', 'similar RNA disruption patterns'], ['Docetaxel treatment', 'resistant RNA disruption'], ['two RNA disruption bands', '28S  rRNA'], ['concurrent RNA inhibition', 'significantly RNA disruption'], ['RNA disruption', 'different drug response'], ['link', 'apoptosis'], ['Evaluation', 'novel chemotherapy vivo'], ['We', 'scientific microlevel activities'], ['doctoral  perception', 'social  productivity'], ['reviewed  we', 'greater impact 4'], ['', 'authored  articles'], ['face  we', 'molecular biology Ph'], ['', ''], ['', 'selected Japan Singapore'], ['Additional productivity data', 'online bibliometric databases'], ['component  analyses', 'semantic differential which'], ['results', '4 MMI PCs'], ['influenced publication we', 'Poisson regression'], ['who', 'high  NFA'], ['scientific training environment findings', 'important mentoring science'], ['', 'International Biochemistry'], ['best drug DH', 'previous  reaction'], ['Accidental exposures', 'sensitized  patients'], ['Preventable prescription errors', ''], ['They', 'poor drug reaction'], ['essential  doctor', 'therapeutic  decision'], ['European Network', 'general drug allergy documentation'], ['medical discharge evaluation', 'adequate  patient'], ['who', 'away  home'], ['detailed culprit information', 'issuer'], ['It', 'full allergy workup'], ['', 'based alert documentation'], ['hormone oxytocin', 'important attachment humans'], ['Recent  research', 'psychological intranasal humans'], ['few  studies', 'behavioural  species'], ['important  application', 'common attachment dogs'], ['what', 'human separation literature'], ['Reasoning', 'such  environment'], ['domestic  dogs', 'physical target objects'], ['1  dogs', 'then  doors'], ['Dogs', 'two  doors'], ['already  doors', 'only  themselves'], ['dogs', 'light  door'], ['inferential  reasoning', 'own  objects'], ['', 'C Elsevier B'], ['', ''], ['Babesiosis', 'protozoal  Babesia'], ['', 'mammals'], ['important tick borne which', 'livestock productions reproductions'], ['', 'domestic meta 1998'], ['Nine  databases', 'five  English'], ['940  corresponding', 'different qualifying criteria'], ['overall  prevalence', 'domestic  herbivores'], ['results', 'highest Khorasan Razavi'], ['', ''], ['', '2  Mazandaran'], ['', ''], ['', ''], ['infection', 'western  country'], ['data', 'health farm animals'], ['', 'minor sex identification'], ['', ''], ['', ''], ['where Hasbro patients', 'outpatient emergency department'], ['', '18 DMST August'], ['self  that', 'high DMST involvement'], ['Children', '81  DMST'], ['Childhood maltreatment Childhood dysfunction', '41 substance abuse patients'], ['Children', 'medical  problems'], ['26/41', 'parent home placement guardian'], ['Children', 'medical  needs'], ['increased  awareness', 'victim identification'], ['', 'different de Janeiro Brazil'], ['This', '270 Conflict Tactics parents'], ['Prevalence', ''], ['', 'psychological  aggression'], ['', 'physical  96'], ['that', 'psychological  aggression'], ['who', 'psychological  aggression'], ['', ''], ['Children', 'increased family disabilities'], ['', 'greater child families'], ['exact emergency that', 'court'], ['aim', 'potential  violence'], ['', 'literature cases opinions'], ['attending injury physician', 'violence'], ['documentation', 'clinician'], ['Particular  importance', 'exact photo injuries'], ['Commonly  physicians', 'medicolegal  situations'], ['Continuing  education', 'proper wound documentation'], ['Cooperation', 'clinicians'], ['research', 'domestic violence England'], ['disclosures', 'regularly report recommendations'], ['routinely  voices', 'account'], ['how  views', 'cultural child welfare'], ['unrelenting  influence', 'most  cases'], ['Rather  safeguarding', 'overall child fathers'], ['', 'Elsevier Ltd'], ['rights', ''], ['Exposure', 'behavioural health impact'], ['Health care professionals', 'best multiagency response'], ['whole  that', 'DVA survivors'], ['We', 'professional child involvement'], ['interventions', 'socialworkers'], ['Twenty one', 'inclusion criteria'], ['', ''], ['Training interventions', 'DVA knowledge competence'], ['results', 'after  surveys'], ['Results', 'primary health care'], ['Implications', 'policy'], ['', ''], ['', 'John Wiley'], ['present  study', '228 Lake County Illinois'], ['violent behavior survival patterns', 'origin violence exposure'], ['who', 'Violent  offenders'], ['', ''], ['who', 'violence'], ['frequently  who', 'violence'], ['significant  findings', 'typology'], ['policy  implications', ''], ['', ''], ['rights', ''], ['dengue  virus', 'tropical  diseases'], ['viral  which', 'original  conformation'], ['dengue disease which', 'antiviral  diagnostics'], ['magnetic spin vector', 'magnetic spin vector'], ['magnetic spin paper', 'magnetic spin components'], ['double error compensation method', 'relative linear polarization'], ['effectively  which', 'accurate capsule environment'], ['global vice authentication', 'most  DNA'], ['highly  targets', 'food processing'], ['first  we', 'processed mitochondrial foods'], ['boiling', 'cooking conditions'], ['71 % beef curries', 'beef burgers'], ['assay', '0'], ['', 'admixed % products'], ['', ''], ['rights', ''], ['controlled food challenge', 'diagnostic food allergy'], ['foods', 'centers'], ['Sensory evaluation techniques', 'such triangle DBPCFC'], ['197 triangle volunteers', '2-phase triangle which'], ['phase participants', 'odd active-1 one'], ['that', 'phase'], ['much  participants', 'recipes'], ['white  recipe', 'phase'], ['9  %', 'odd  sample'], ['', ''], ['Milk', '2 hazelnut foods'], ['7  %', 'odd  sample'], ['', ''], ['Median VAS scores', '3  6'], ['', '9'], ['', ''], ['We', 'sensory hazelnut DBPCFC'], ['validated  recipes', 'most  participants'], ['paper', 'fed induction machines'], ['angular  speed', 'varying  systems'], ['objective', 'specified operating range'], ['continuous time transformation', 'discrete time controller'], ['Experimental  results', 'mechanical stator voltage dips'], ['such  skills', 'particularly Down fear'], ['photo matching task emotion recognition', 'four Down syndrome conditions'], ['', ''], ['', ''], ['emotion labelling', 'recognition accuracy'], ['Down recognition', 'developing label use'], ['Implications', 'interventions'], ['Solar  energy', 'sustainable society energy way'], ['', 'solar  energy'], ['However  issues', 'electrical  example'], ['One', 'solar PV cells'], ['high energy photon', 'lower  energy'], ['Trough downconversion', 'solar  cells'], ['', 'solar downconversion cells'], ['Here  we', 'main  materials'], ['specific  attention', 'short cancer diagnosis'], ['Chitosan', 'several  techniques'], ['aptamer', 'targeted Prostate cancer cells'], ['PC-3 cells', 'binding flow cytometry'], ['binding  affinity', 'initial  library'], ['40  %', '15  days'], ['Cytotoxicity', 'MTT assay'], ['specifically LNCaP it', 'negative PC-3 control'], ['Apt MCS DOX', 'lethal LNCaP cells'], ['results', 'cancerous  cells'], ['currently  which', 'immune  system'], ['Combination', 'synergistic  effect'], ['CD4(+ T cell that', 'blocking  antibody'], ['Furthermore doxorubicin', 'inflammatory  cytokines'], ['Finally B cells', 'increased bladder cancer CD86-expression'], ['doxorubicin', 'presenting B patients'], ['Development', 'tailored  chemotherapy'], ['', 'C Elsevier Inc'], ['Facile', 'environmental  issues'], ['13-dipolar electron cycloaddition', 'triazole click bridge'], ['it', 'optical  properties'], ['TTO', 'strong  methanol'], ['', 'organic  solvents'], ['', 'selective methanol identification'], ['Notably  TTO', 'excellently detection limit'], ['7 volume which', 'practical promise applications'], ['', ''], ['', ''], ['rights', ''], ['specific  method', 'DPO rotavirus norovirus system'], ['reverse polymerase chain reaction', '96%-100 Green PCR %'], ['high  sensitivity', 'enteric virus infections'], ['', ''], ['', ''], ['rights', ''], ['several  strategies', 'end'], ['titanium surface', 'blasted  surface'], ['aim', 'dental Mesenchymal Stem pulp'], ['treatment', 'environmental ROS mitochondria'], ['PCR titanium data', 'osteoconductive OGI treatment'], ['mesenchymal stem cells', 'osteogenic OGI activities'], ['', ''], ['', ''], ['rights', ''], ['Duck plaque virus', 'family Herpesviridae'], ['attenuated  vaccine', 'only DPV infection'], ['ineffectiveness', 'major field condition'], ['DPV', 'molecular  poultry'], ['present  we', 'physical  conditions'], ['DPV', '65 degrees degrees'], ['salt concentrations', 'significantly  DPV'], ['study', 'optimum DPV viability'], ['', '2016 Biological Standardization'], ['', 'Elsevier Ltd'], ['rights', ''], ['digital  control', 'conventional analog methods'], ['pulse width blocks', 'high conversion ratio applications'], ['it', 'deep submicron CMOS technologies'], ['work', 'line components'], ['also line voltage that', 'low voltage supply'], ['48V:7V  application', ''], ['Development', 'several exchange units'], ['Carrying', 'final  stage'], ['very  developers', 'studied  objects'], ['casual  character', 'changing  population'], ['Authors', 'studied exchange system'], ['hardware it', 'on  parameters'], ['authors', 'electric consequence performance quality'], ['Biofilm detachment', 'secondary water distribution systems'], ['', 'stainless steel compound study'], ['Real polymerase chain reaction', '454  bacteria'], ['pipe material', 'greatly  biofilm'], ['strong  those', 'GCIPs'], ['frequency', 'different metal pipes'], ['Thus  resistance', 'also pipe material'], ['shear  stress', 'different pipe types'], ['results', 'technical  DWDS'], ['Vehicle driveability', 'longitudinal  vibrations'], ['track which', 'such  behaviour'], ['when design iteration', 'very  time'], ['main vehicle that', 'torsional  driver'], ['dual  mass', 'flywheel'], ['dynamic  model', 'modal  analysis'], ['Objective indexes', 'possible powertrain parameters'], ['compound talents', 'overall minority secretary major'], ['major training plan', 'cultural communication training program'], ['too  curriculum', 'teachers'], ['paper', 'intelligent talent training'], ['', 'secretary major secretary courses'], ['secondary effect evaluation which', 'secretary major training model'], ['Bactrian camels Camelus one', 'humped dromedarius Camelus dromedarius'], ['three  species', 'extreme temperatures dehydration'], ['People', 'harsh milk meat centuries'], ['', 'however research Pakistan'], ['neurodegenerative Prion it', 'Pakistan date'], ['which', 'neurodegenerative  animals'], ['prions', 'transmissible spongiform encephalopathies'], ['we', 'dromedary Prion protein Pakistan'], ['Material Genes', 'cellular  mechanisms'], ['Genomic DNA', 'enrolled blood Nucleospin((R'], ['Genomic DNA', 'specific primer pair'], ['Prion protein gene', 'seven province Pakistan'], ['required fragment size', 'Sanger Sequencing'], ['sequences', 'phylogenetic Codon Code analysis'], ['mammalian  that', 'different  clades'], ['We', '99'], ['', 'nucleotide Dromedary camels'], ['Bactrian codon that', 'causative protein gene camels'], ['Neighbor Joining Neighbor method', 'phylogenetic bootstrap tree'], ['study', 'different camel breeds'], ['deletion', 'previously PrP allelic breeds'], ['more  investigations', 'genetic  camels'], ['next  that', 'neurodegenerative Prion disorders'], ['small noncoding RNAs', 'intronic  D'], ['', 'comparative genomics method'], ['combinated  which', \"2'-O rRNA antisense D\"], ['', '28S  C2673'], ['predicted  precursors', 'loop structure known'], ['two miRNAs genes', 'Northern RNA blotting'], ['conserved  that', '500  bp'], ['', 'transcriptional gene processing'], ['foreign  gene', 'cotton genome'], ['transgenic membrane plants', 'wild type plants'], ['shoot  growth', 'osmotic drought WT'], ['higher chlorophyll content', 'less cell membrane WT'], ['We', 'transgenic amino plants'], ['average seed cotton yields', 'flowering drought stage'], ['average seed cotton yields', '% WT counterparts'], ['study', 'arid semiarid regions'], ['nationwide substance use that', 'nonviolent  felonies'], ['incarceration approach', 'minor substance dependency'], ['drug courts', 'demographic law enforcement trends'], ['where drug courts', 'nation'], ['Exosomes', 'mammalian body fluids'], ['Exosomes', 'distant cell cell cells'], ['several lipids which', 'important disease biomarkers'], ['Moreover exosomes', 'conventional delivery systems'], ['increasing  attention', 'various target tissues'], ['interfering  which', 'available delivery strategies'], ['review', 'recent  drugs'], ['Theory', 'sociocognitive  thoughts'], ['substance alterations', 'social  disorders'], ['brain structures', 'drug use conditions'], ['We', 'systematic drug use conditions'], ['electronic MEDLINE that', 'actual drug use'], ['147  14', 'review eligibility criteria'], ['drugs', 'particularly ToM use'], ['impairments', 'clinical  functions'], ['drug use which', 'further  investigation'], ['', 'inflammatory bowel disease'], ['Recent findingsWe that', 'nervous system gut'], ['We', 'therapeutic  IBD'], ['Further  we', 'therapeutic  targets'], ['like  2', 'small molecule IBD'], ['SummaryNutritional immunology drug development research', 'more  cures'], ['Protein protein interactions', 'all  cell'], ['large  fraction', 'based peptide therapeutics'], ['Peptides', ''], ['They', 'also chemical synthesis'], ['significant  challenges', 'therapeutic  agents'], ['peptide peptides', 'enzymatic cell degradation'], ['we', 'pharmacokinetic motif limitations'], ['Pancreatic  cancer', 'available  treatments'], ['presence', 'metastatic  disease'], ['Here  we', 'pancreatic cell line PANC-1'], ['We', 'SP PANC-1 cells'], ['PANC-1 SP cells', 'metastatic gemcitabine treatment'], ['like  phenotypes', 'enhanced ABCG2 Oct4'], ['derived antioxidant garcinol', 'anticancer properties'], ['garcinol treatment', 'Mcl-1 PANC-1 SP EZH2'], ['importantly garcinol treatment', 'several garcinol treatment'], ['Thus PANC-1 SP cells', 'pancreatic  CSCs'], ['', 'International Union International Biochemistry'], ['Purpose Endometrial cancer incidence', 'major North women'], ['We', 'active  interest'], ['invasive lymph node staging', 'invasive  diagnosis'], ['Progress', 'future trial design'], ['Molecular  characterization', 'active treatment research'], ['adjuvant treatment strategy', 'related  toxicity'], ['targeted drug therapies', 'hormonal  therapy'], ['', 'predictive  biomarkers'], ['understanding', 'specific  therapies'], ['precise  role', 'clinical discovery care'], ['PurposeTo', 'dry eye patients'], ['92  who', 'Sacred Heart August'], ['25(OH)D  levels', ''], ['Subjects', '25(OH)D  levels'], ['Eye discomfort', 'ocular surface disease index'], ['staining Tear score', ''], ['age', ''], ['', ''], ['', ''], ['25(OH)D  level', ''], ['', ''], ['', ''], ['tear  secretion', '25(OH)D  levels'], ['', ''], ['', ''], ['', ''], ['', ''], ['tear  secretion', 'sufficient  group'], ['', ''], ['', ''], ['Fluorescein staining Fluorescein scores', 'three OSDI groups'], ['ConclusionTear break ConclusionTear secretion', 'vitamin D levels'], ['Vitamin D status', 'dry eye syndrome'], ['SPMSG cycle voltage drive', 'synchronous cycle voltage generator'], ['', 'electric energy storage system'], ['current control scheme', 'desired generating performance'], ['current D control', 'conventional space vector modulation'], ['simplification', 'self  PMSG'], ['current  control', 'winding feedback controller'], ['computation time', 'current control scheme'], ['processing times', 'conventional  control'], ['Moreover dc link voltage', 'proposed  OCVR'], ['method', 'voltage controller design'], ['two parameter designing procedure', 'feedback controller'], ['system stability', 'addition'], ['waveforms', 'dynamic SPMSG drive'], ['reduction', 'switching calculation results'], ['paper', 'sinusoidal pulse width modulation'], ['transformerless UPS', 'well ac reference voltage'], ['proposed control law', 'current inductance levels'], ['Thus distortion', 'current inductor core size'], ['However  circulating', 'common power factor corrector'], ['circulating', 'output voltages'], ['Experimental  results', 'proposed control approach'], ['three phase inverters', 'active power injection'], ['It', 'frame transformation'], ['However D Sigma control', 'namely grid connection'], ['', 'similar correction PF 0'], ['', ''], ['', ''], ['Moreover switching sequences', 'increasing firmware programming'], ['', 'digital D control'], ['', 'general parameter form'], ['switching  sequences', 'also grid connectionmode'], ['derivation which', 'control law'], ['bidirectional 10-kVA inverter', 'improvement'], ['paper', 'modular multilevel converter'], ['multilevel  converters', 'back  back'], ['digital D control', 'current module capacitor voltage'], ['digital D control', 'active power factor correction'], ['power balance combination', 'ac arm'], ['According', 'digital capacitor voltage balancing'], ['low limitation factor', 'cell voltage regulation'], ['then control laws', 'current voltage detail'], ['obtained', '54 kW analysis'], ['generalized symptom criteria', 'further  evaluation'], ['current  study', 'representative Singapore community sample'], ['', '6166 Singapore 18'], ['', ''], ['', 'mental  disorders'], ['Associated  symptoms', 'autonomic GAD diagnosis'], ['associated  symptoms', 'adequate  specificity'], ['inability', 'associated symptoms criteria'], ['relationship', 'overlapping  GAD'], ['high quality output voltage', 'special UPS applications'], ['Several control schemes', 'three phase inverter'], ['paper', 'predictive control control'], ['It', 'possible switching inverter'], ['switching that', 'next sampling instant'], ['results', 'proposed control scheme'], ['experimental  results', 'realistic HIL conditions'], ['PFC Power Factor converter', 'paper'], ['integrated  topology', 'number control switches'], ['proposed  converter', 'hence control control'], ['Sub harmonic Sub which', 'current  controller'], ['performance', 'converter'], ['proposed  scheme', 'digital signal processor'], ['performance', 'different  load'], ['50 Hz AC', '100 kHz switching frequency'], ['integrated PFC converter', 'harmonic Class C'], ['Viruses', 'infectious virus particles'], ['members', 'direct RNA evidence'], ['Here  we', 'mammalian RNA cells'], ['data', 'further Bluetongue virus'], ['Formation', 'electrophoretic mobility shift assay'], ['complex virus recovery', 'complete RNA packaging'], ['reverse genetics system', 'antiviral Reoviridae molecules'], ['false  smut', 'growing Ustilaginoidea areas'], ['Mycoviruses', 'little  U'], ['', ''], ['ds banding patterns', 'wild type U'], ['', 'geographical  China'], ['presence', 'unusually  U'], ['198  elements', 'more  mycoviruses'], ['unclassified virens RNA which', 'probably tolerance Partitiviridae'], ['infected  strains', 'apparent  symptoms'], ['UvRV1', 'frequently  U'], ['similarly  bands', 'similar  sequence'], ['mycoviruses', 'U'], ['virens', 'China'], ['', ''], ['', ''], ['rights', ''], ['DAB  converter', 'distributed power systems'], ['inherent  nonlinearity', 'serious stability problem'], ['controlled loop control', 'controlled output voltage'], ['accurately  study', 'discrete DAB converter'], ['model', 'digital control delay'], ['proportional stability boundary', 'proportional DAB controller'], ['also  ESR', 'great output system'], ['Finally  simulation', 'theoretical  analysis'], ['independent  one', 'which'], ['study', 'dual character concepts'], ['normative  dimension', 'basic role role'], ['basic  function', 'social  role'], ['normative  dimension', 'relevant  itself'], ['basic  information', 'dependent  others'], ['Neuroscience  investigations', 'marker  hypothesis'], ['neural  which', 'other  reasoning'], ['when  emotion', 'cognitive  judgment'], ['infusion models', 'social  cognition'], ['single channel supply product', 'retail  channels'], ['new  channel', ''], ['Moreover  we', 'decentralized supply chain system'], ['supply chain performance', 'new  channel'], ['Moreover  we', 'different quality sensitivity price'], ['', ''], ['', ''], ['rights', ''], ['hepatotropic  that', 'human liver disease'], ['similar liver disease', 'also Hepatitis A virus'], ['many  types', 'hepatotropic  urine'], ['enter', 'urine'], ['potential  we', 'days replication infection'], ['Immunohistochemistry', 'viral  kidney'], ['Double  staining', 'cell immune expression cytokines'], ['Histopathology', 'standard HE staining'], ['study viruses', 'renal  tubules'], ['which', 'transient cytokine storms'], ['scattered  infection', 'persistently host urine'], ['deletion', 'persistent cytokine survival'], ['review', 'molecular  perspective'], ['molecular transcriptome that', 'treatment'], ['molecular  it', 'inherent  disease'], ['', 'epigenetic transcription modifiers'], ['Studies', 'complex tumor development'], ['multifaceted  that', 'spatiotemporal tumor evolution'], ['development', 'novel  treatment'], ['', ''], ['Anaplasma', ''], ['which', 'tropical tick areas'], ['Theileria', 'Anaplasma sheep'], ['two primer sets', 'specifically  Theileria'], ['18S Anaplasma', ''], ['', ''], ['Genomic  DNA', 'tenfold primer sets'], ['related primer hematoparasites', 'negative  templates'], ['single detection results', 'PCR methods'], ['two primer this', 'generated  298-bp'], ['', ''], ['', ''], ['detection limit', 'assay'], ['', 'other  hematoparasites'], ['developed  duplex', 'PCR detection'], ['', 'published PCR methods'], ['that', 'simultaneously  Theileria'], ['Anaplasma', ''], ['', 'sheep'], ['epidemiological  it', 'mixed  pathogens'], ['', ''], ['rights', ''], ['temporal  pole', 'social  cognition'], ['general  hub', 'socioemotional  information'], ['26  participants', 'evoking film scanning'], ['sad  half', 'sad  music'], ['In', 'empathic role concern'], ['temporal fusiform which', 'additional  TP'], ['Bayesian model comparison', 'contextual FG information'], ['backward  projections', 'emotional  music'], ['findings', 'visual integration demands'], ['Time domain simulations', 'severe industry standards'], ['commercial software packages', 'large scale model'], ['stochastic  behavior', 'real security time'], ['paper', 'commercial application programming interfaces'], ['HPC performance techniques', 'commercial package TSAT'], ['synchronous generator it', 'sufficient  accuracy'], ['ambient  coolant', 'available colder months'], ['changes', 'round electricity generation'], ['cycle pressure ratio', 'major isentropic turbine'], ['that', 'new expansion concept'], ['comprehensive  analysis', 'firstly  which'], ['it', 'round electricity generation'], ['However  improvement', 'variable expansion ratios'], ['Furthermore  improvement', 'heat recuperator'], ['expanders', 'constant pressure inlet'], ['increase', 'such pressure expanders'], ['discharging  temperature', 'thermal heat efficiency'], ['', 'higher heat recuperator'], ['Dysfibrinogenemia', 'molecular blood coagulation fibrinogen'], ['Here  we', 'new  case'], ['old  female', 'normal fibrinogen antigen level'], ['We', 'genetic DNA mutation'], ['kinetics', 'linking polyacrylamide gel electrophoresis'], ['DNA sequencing', 'heterozygous alpha chain'], ['Fibrin polymerization', 'final lag turbidity'], ['rate', 'fibrinopeptide  patient'], ['mass spectrometry analysis', 'mutant fibrinogen circulation'], ['Electron graphs', 'abnormal fibrin clots'], ['Fibrin cross linking', ''], ['Sodium', 'western polyacrylamide gel difference'], ['We', 'fibrinopeptide  region'], ['functional  abnormalities', 'delayed  cleavage'], ['Receptor Potential Vanilloid', 'nociceptive neurons integrators'], ['They', 'regulated rat manner'], ['TRPV1', 'peritoneal endometriosis TRPA1'], ['severe laparoscopic dysmenorrhoea', 'moderate  pain'], ['protein expressions', 'quantitative endometrium curettage'], ['Results', 'clinical pain intensity'], ['TRPV1 receptors', 'human  mRNA'], ['TRPV1 immunopositivities', 'stroma  layers'], ['upregulated mRNA levels', 'deep endometriosis patients'], ['Histological  scoring', 'deep endometriosis samples'], ['Besides  we', 'deep infiltrating endometriosis'], ['TRPV1 immunoreactivities', 'ectopic epithelial dyspareunia'], ['Epithelial', 'dyschezia TRPV1 severity'], ['We', 'human TRPV1 channels'], ['upregulations', 'pathophysiological pain disease'], ['Dystonia musculorum', 'recessive  mice'], ['Homozygous  animals', 'severe neuro coordination'], ['dt  strains', 'spontaneous  mutants'], ['They', 'Bullous  Pemphigoid'], ['BPAG1', 'plakin cytolinker proteins'], ['BPAG1', 'specific  isoform'], ['neurological  phenotype', 'nervous dt Alb system'], ['goal', 'homozygous dt Alb mice'], ['biological dt Alb lesion', 'coding deletion region'], ['it', ''], ['BPAG1 segments', 'Northern dt Alb blotting'], ['Western  blotting', 'full dt Alb brain'], ['5 dt Alb it', 'standard dt Alb PCR'], ['', ''], ['', ''], ['rights', ''], ['Genetic  findings', 'etiologic  dystonic'], ['precise sequencing role', 'molecular  pathogenesis'], ['Also  role', 'sporadic risk dystonias'], ['complex  that', 'disease risk'], ['0157  H7', 'thus food safety'], ['that', '0157 RNA seq'], ['', '223  E'], ['', '110  E'], ['0157  H7', 'upregulated  E'], ['', ''], ['whole', 'resistance process'], ['', 'E'], ['lysine  decarboxylation', 'neutral  E'], ['', 'death'], ['which', 'low  environment'], ['oxidation acid which', 'E'], ['', ''], ['', ''], ['rights', ''], ['related foodborne illnesses', 'public health world'], ['study', 'E'], ['', '375 chicken meat parts'], ['samples', 'southeast  Turkey'], ['They', 'immunomagnetic  separation'], ['study', 'stx(2 hlyA PCR'], ['', ''], ['coli O157 prevalence', 'chicken meat parts'], ['', ''], ['', 'E'], ['coli O157 isolates', 'rfbE(O157'], ['', ''], ['genes breast which', 'important virulence disease'], ['translational  that', 'eukaryotic  cells'], ['role', 'functional  two'], ['phosphorylation', 'protein phosphorylation'], ['Here  we', 'molecular  level'], ['ubiquitination  ubiquitination', 'emphatic  scaffolding'], ['further  advances', 'molecular system level understanding'], ['two  they', 'many  store'], ['', ''], ['rights', ''], ['Junior Members', '35 EAACI allergy'], ['Junior Member collaboration', 'related Junior activities'], ['collaboration', 'such Junior Journal'], ['collaboration', 'critical  review'], ['', 'solid breast cancer'], ['Aim', 'adjuvant breast chemotherapy'], ['171  patients', 'early stage breast adenocarcinomas'], ['Immunoradiometric  assays', 'adjuvant blood chemotherapy'], ['presence', 'timereverse polymerase chain reaction'], ['IGFBP-3 serum levels', 'well node status oestrogen'], ['Log rank test', 'possible IGFBP-3 serum levels'], ['adjuvant IGFBP-3 serum levels', '0361  <'], ['significant p values', '<'], ['', ''], ['IGF-1 serum levels', 'initiation'], ['', 'completion'], ['', 'adjuvant  chemotherapy'], ['IGFBP-3 serum levels', 'detectable  CTCs'], ['', '='], ['', 'adjuvant  chemotherapy'], ['', 'clinical DFI OS'], ['', ''], ['', ''], ['', ''], ['', ''], ['serum initiation', 'early stage breast cancer'], ['', ''], ['rights', ''], ['comprehensive  that', 'nurturing care children'], ['program goals', 'actively  mission'], ['complex  that', 'home visitation'], ['preventative Early Head interventions', 'Early Head families'], ['study', 'active  engagement'], ['Semistructured interviews', '10  EHS'], ['when  program', 'developmental  milestones'], ['Barriers', 'parental  values'], ['other  that', 'similar  engagement'], ['early  it', 'resilience mechanism'], ['amygdala  activity', 'depressed life event adults'], ['healthy Twenty participants', 'resonance imaging resonance ELS'], ['who', 'ELS'], ['amygdala  reactivity', 'depressive  symptoms'], ['Amygdala reactivity', 'sad memory recall'], ['consistent emotion preservation', 'enhancing stress depression'], ['rest which', 'residual endemic areas'], ['protective mosquito bites', 'outdoor  use'], ['previous  that', 'outdoor biting mosquitoes'], ['infectious  people', 'early bed evening'], ['study', 'Valley Ulanga District'], ['outdoor biting malaria vectors', 'outdoor mosquito biting 23'], ['Treated  baskets', '89 Anopheles arabiensis %'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['they', 'outdoor Culex spp'], ['', '66  RR'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['when malaria people', 'such verandas bars'], ['Additional  research', 'outdoor mosquito borne pathogens'], ['one', 'psychosocial  challenges'], ['importantly  they', 'functional  life'], ['biological  that', 'dysfunction'], ['prefrontal  structure', 'early phase psychosis cohort'], ['Analyses', 'metacognitive  ability'], ['early phase which', 'cognitive  illness'], ['standardized household which', 'SDGs'], ['local volunteer enumerators', 'urban population slums'], ['results', 'contemporaneous Kenya water'], ['significant  differences', 'statistically  0'], ['particular DHS values', 'urban  slums'], ['therefore citizen surveys', 'more  poor'], ['', 'standardized household surveys'], ['This', 'important Data Revolution'], ['suggestions', 'improved population estimates'], ['', ''], ['rights', ''], ['that', 'frequently weight loss'], ['Two  groups', 'perspective self evaluations'], ['two  groups', 'priori body interest'], ['cluster', 'less friend evaluations'], ['more  anxiety', 'social self evaluations'], ['differences', 'anxiety shape AN'], ['exploration', 'early brain trajectory'], ['neural  differences', 'predictive  value'], ['Utilization', 'sustained weight AN'], ['', ''], ['rights', ''], ['2544 Ebola Virus deaths', 'Guinea'], ['human EVD outbreak application', 'times'], ['Guinea which', 'surveillance'], ['safe burial requirements', 'Case case'], ['PCR Polymerase Chain results', 'infection'], ['properly  disease', 'early  stage'], ['high border health she', 'bus journey'], ['oral swab sample', 'retrospective  testing'], ['characteristic symptomatology 5', '3  weeks'], ['', 'regardless laboratory results'], ['Social mobilization', 'lasting disease epidemics'], ['scientific  insights', 'technical  response'], ['immunology  research', 'future  epidemics'], ['scientific  contributions', 'real  time'], ['fluid  sharing', 'data'], ['how  science', 'infectious  emergencies'], ['article', 'themed  issue'], ['Ebolaviruses', 'extreme  humans'], ['majority', 'hemorrhagic Ebola virus humans'], ['EVD', 'available case fatality EVD'], ['molecular  biology', 'antiviral  therapeutics'], ['several  which', 'full length GP'], ['additional entry ebolavirus functions', 'complex  virus'], ['Here  we', 'viral ebolavirus pathogenesis'], ['Infection', 'latent B lymphocytes'], ['virus', 'viral  transactivators'], ['Zta', 'gene expression'], ['EBV DNA array', 'various EBV Conditions'], ['complete  set', 'induced Akata cells'], ['In', 'latent virus replication'], ['Secondly gene expression', 'induced Raji cells'], ['Several  genes', 'possible novel genes'], ['epithelial Raji NA', 'siRNA strategy'], ['array data', 'blotting RT PCR'], ['information', 'lytic gene expression'], ['', ''], ['rights', ''], ['Unaccustomed  exercise', 'strength loss soreness'], ['repeated exercise appearance', 'repeated bout effect'], ['50 Wanfang database', '50 PubMed MEDLINE'], ['molecular regulation network diagram', 'molecular immunology mechanisms'], ['ectopic thyroid cancer', 'domestic ectopic thyroid report'], ['metastatic thyroid I', 'orthotopic thyroid cancer'], ['', ''], ['', ''], ['', ''], ['004', 'highly ectopic thyroid cancer'], ['', ''], ['', ''], ['', ''], ['001', 'orthotopic thyroid cancer'], ['', ''], ['016', 'metastatic thyroid cancer'], ['signaling crossing which', 'three thyroid cancers'], ['', ''], ['', ''], ['PI3 K', 'Akt mTOR MAPK'], ['PI3 K gene', 'starting thyroid cancers'], ['different thyroid cancers', 'signaling  pathways'], ['metastatic thyroid cancer', 'high  expression'], ['', 'practical power manner'], ['Hard  tools', 'obligation'], ['full custom which', 'research  domain'], ['that', 'used  software'], ['forensic medicine that', 'sensitive  nature'], ['Examples', 'domestic suicide violence'], ['direct  which', 'society'], ['students', 'medical  education'], ['students  who', 'especially  cases'], ['appropriately risks they', 'professional  careers'], ['However  risk', 'educational  programme'], ['We', 'medical medicine curricula'], ['', '2016 Elsevier Forensic'], ['rights', ''], ['power', 'comparative  education'], ['local history that', 'new  history'], ['collective  that', 'textbook mobility'], ['present  research', 'specific et Metiers Paris'], ['them', 'professional museum gestures'], ['used imaging that', 'low  cost'], ['Ag AgCl metal electrodes', 'electrical brain activity'], ['multiple  they', 'adjacent skin electrodes'], ['Potential Sensor Electric Potential device', 'operational auto amplifier'], ['EPS', ''], ['absence', '10 EPS Hz'], ['comprehensive  study', 'commercial EEG system'], ['similar  signals', 'free cross 0'], ['', 'EPS'], ['existing  studies', 'commercial EEG system'], ['EPS', 'reduced setup sensor'], ['scalability', 'dense EPS array'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['related  movements', 'allocentric  someone'], ['egocentric  perspective', 'allocentric  perspective'], ['recent  studies', 'egocentric  movements'], ['direct parietal evidence', 'other  differentiation'], ['current  study', 'other IPL differentiation'], ['we', 'egocentric hands movement perspective'], ['Electroencephalography', 'immediately movement tACS'], ['tACS', 'causal movement self-'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['Increased  attention', 'statistical intervention studies'], ['precise meta which', 'precise meta impact'], ['educational policy decisions', 'these'], ['which', 'restricted  circumstances'], ['governments', 'instead research design manipulations'], ['public  policy', 'danger'], ['that', 'class recitation activities'], ['We', 'clicker discussion questions'], ['Learning gains', 'key biochemistry course exams'], ['Long term retention', 'comprehensive  students'], ['using', 'short student term'], ['Similar  results', 'moderate arts enrollments'], ['', 'International Biochemistry'], ['natural killer receptors', 'human pattern immunology'], ['inflammatory  they', 'end  line'], ['them', 'fine tune tissue homeostasis'], ['advanced performance evaluation that', 'new evaluation requirements'], ['thermal power industry', 'specific emissions reduction targets'], ['operational electricity it', 'also electricity demand'], ['environmental electricity production it', 'environmental emissions abatement regulations'], ['environmental effectiveness measure', 'thermal power industry'], ['developed effectiveness measurements', 'thermal power 2006'], ['efficiency', 'environmental electricity production system'], ['operational performance changes', 'global Malmquist productivity index'], ['significant study policies', 'expected power effects'], ['However emissions reduction targets', 'thermal power industry'], ['', ''], ['rights', ''], ['We', '2 module design AM1'], ['', ''], ['Device physics calculations', 'wide design space'], ['realistic material us', 'optical contact resistance losses'], ['short circuit that', '90  ideal'], ['electrically  we', 'new optimal bandgap combinations'], ['where series resistance subcells', 'lumped series resistance ensembles'], ['when  subcells', 'optical  confinement'], ['Distributing', 'conventional V cell technology'], ['derived', 'physiological  properties'], ['study', 'II)-induced endoglin vivo'], ['Cardiac Wistar rats', 'Ang II'], ['time PCR activity assay', 'blotting  Northern'], ['Ang II', 'significantly control cells'], ['', '100 Ang II induction'], ['induced  endoglin', 'electrophoretic mobility shift assay'], ['EGCG', 'AP-1 endoglin promoter binding'], ['Finally  EGCG', 'confocal endoglin microscopy'], ['', 'myocardial fibrosis 53'], ['', ''], ['', 'hemodynamic friction monitor'], ['suppressive endoglin effect', 'JNK'], ['ZP zona which', 'vertebrate  species'], ['ZP otocephalans', 'growing  oocyte'], ['which', 'earlier  Euteleostei'], ['partial amino acid sequences', 'egg envelope'], ['eel egg envelope', 'four ZPC homologues'], ['ZP that', 'vertebrate ZP proteins'], ['fish ZP proteins', 'originally transmembrane evolution'], ['RT all', 'eZP liver'], ['which', 'liver'], ['then  site', 'evolutionary  Euteleostei'], ['19 noncoding that', 'transcriptionally gene organisms'], ['various  role', '300  age'], ['we', 'high throughput sequencing'], ['', 'high egg production chickens'], ['', '11'], ['known  miRNAs', 'hormone biosynthesis hormone synapse'], ['Additionally expression profiling', 'real polymerase chain reaction'], ['high egg miRNAs', 'reproductive  chicken'], ['regulated gga miR-200a-3p-', 'related  pathways'], ['This', 'further  confirmation'], ['related  knowledge', 'actors'], ['they', 'adaptive decision capacity'], ['empirical network data', '31 response %'], ['even  it', 'i network i'], ['', ''], ['', 'certain alter groups'], ['', ''], ['', ''], ['social forest networks', 'minimal climate change'], ['infrequent  timing', 'knowledge sharing'], ['forest owners', 'advisory forestry services'], ['', ''], ['owner associations companies', 'clear climate adaptation'], ['Peers', 'actual forest property'], ['research', 'island developing island state'], ['extended  model', 'unified  technology'], ['247 performance expectancy', 'behavioural  intention'], ['Computer self efficacy', 'behavioural  intention'], ['further  trustworthiness', 'inversely  resistance'], ['developing  states', 'critical e Government users'], ['design  quality', 'thereby  resistance'], ['', ''], ['rights', ''], ['e ticketing', 'government policies'], ['', 'government official government hours'], ['important  that', 'behavior'], ['how e Gov experience', 'behavior'], ['how  users', 'e Gov services'], ['where e Gov services', 'early  stage'], ['citizens', 'traditional government it'], ['study', 'technological government perspective'], ['implications', 'competent e Gov services'], ['', ''], ['rights', ''], ['experimental Lyme arthritis', 'impaired Borrelia burgdorferi'], ['present  we', 'further 5-LOX B'], ['', ''], ['derived  macrophages', '5-LOX-/-  B'], ['', 'spirochete internali zation'], ['BMDM', 'efficiently affinity B'], ['', ''], ['low LTB4 receptor BLT2', 'phagocytic  5-LOX-/-'], ['', 'inhibited LTB4-stimulated BLT2'], ['this', 'phagocytic  defect'], ['high affinity ligand', 'specific murine macrophages'], ['macrophage BLT2', 'BLT1'], ['physiological  that', 'cellular  functions'], ['inflammatory  activation', 'regulated receptor potential vanilloid'], ['that', 'Gq GPCR pathway'], ['we', 'heterologous calcium system'], ['robust  that', 'exogenous TRPV1 stimuli'], ['Moreover  we', 'regulated PKC response'], ['acting', 'TRPV1'], ['requirement', 'neuronal TRPV1 inflammation'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Activation', '1 PKC phosphorylation'], ['paper', 'harmonic ac power systems'], ['DG state space inverter', 'current control loops'], ['Based', 'two inverter fed system'], ['based stability analysis', 'harmonic power system'], ['how  system', 'harmonic  instability'], ['Based', 'harmonic instability analysis'], ['experimental  results', 'theoretical  analyses'], ['We', 'specific expression probe'], ['NIT', 'close  isoforms'], ['DIA results', 'treated MT E'], ['', 'dry Cd controls'], ['single  exposure', 'dry I NIT'], ['response', 'I  month'], ['Clear  differences', 'dry Cd soil'], ['where  metals', 'chloragogenous  gut'], ['work', 'that'], ['NIT', 'when gene expression response'], ['Further  experiments', 'contaminated soil toxicity assessments'], ['', ''], ['rights', ''], ['NIT manure Eisenia', 'cadmium'], ['NIT', 'Northern expression blotting'], ['highly Zn body concentration', 'highly  worms'], ['Zn', 'dry Cd soil'], ['Exposure', 'cytosolic NIT levels'], ['worms', 'also Cd toxicity'], ['binding MT Zn', 'binding MT isoform'], ['medium  expression', 'high  exposure'], ['Several  hypotheses', 'best earthworm species'], ['Further  experiments', 'now earthworm species'], ['', ''], ['rights', ''], ['OC  exposure', 'vertebrate  species'], ['immune OC function', 'round Urobatis mainland'], ['Proliferation', 'blood splenic blood leukocytes'], ['Percent phagocytosis', 'ingested fluorescent E'], ['', 'BioParticles'], ['', 'whole cell blood'], ['higher Sigma PCB', 'splenic mainland population'], ['environmental  variables', 'observed  effects'], ['', ''], ['rights', ''], ['digital  that', 'piezoelectric  patches'], ['now transfer that', 'analog  circuits'], ['pole method', 'piezoelectric transfer shunting'], ['', 'low subwavelength 0'], ['', ''], ['physical  mechanism', 'flexural group bandgaps'], ['analog shunting which', 'one  one'], ['large vibration transmission insulations', 'low frequency ranges'], ['elder  which', 'serious  consequences'], ['diagnostic emergency care radiologists', 'geriatric injury victims'], ['little  literature', 'elder abuse identification'], ['We', 'elder  abuse'], ['high energy that', 'acute  injuries'], ['Specific  injuries', 'diaphyseal  fracture'], ['We', 'elder differential diagnoses'], ['Physical  activity', 'psychological anxiety vitality'], ['study', 'depressive nursing life'], ['We', 'pretest posttest study'], ['lasting Physical Activity Program', 'four walking week'], ['', 'significant Physical Activity Program'], ['eight  subscales', 'experimental  group'], ['', ''], ['physical activity program', 'elderly  individuals'], ['', ''], ['', ''], ['rights', ''], ['are', 'cognitive research methodologies'], ['cognitive  reserve', 'context'], ['current  study', 'rigorous cognitive methodology'], ['older Fifty adults', '50  surgery'], ['healthy Forty controls', 'equivalent age interval'], ['Cognition cognitive reserve', ''], ['based  methods', 'cognitive  testing'], ['TJR patients', 'TMT B TMT controls'], ['Cognitive reserve', 'TJR TMT B patients'], ['higher  who', 'greatest  decline'], ['rigorous  which', 'practice effects'], ['Cognitive reserve', 'only TJR sample'], ['However  role', 'compromised  patients'], ['some', 'flicker unbalances power systems'], ['time  loads', 'parameters'], ['electric arc which', 'distortions voltage unbalances'], ['prediction  control', 'industrial  plant'], ['digital  control', 'reactive  power'], ['proposed  TSC', 'voltage power factor'], ['reactive TSC performance', 'natural time delay'], ['pass harmonic filter', 'current capacitor TSC'], ['suggested  TSC', '2 power EAFs'], ['modeling', 'proposed  TSC'], ['unified series that', 'frequently power supply'], ['behaviour', 'voltage voltage conditions'], ['presented  algorithms', 'locked loop circuit'], ['harmonic  currents', 'electrical power system'], ['control algorithms', 'digital control them'], ['', 'acquired UPQC performance'], ['main  voltages', 'proposed  UPQC'], ['Simulation', 'transient state conditions'], ['generalised  integrator', 'wide  applications'], ['approximation', 'two integrator RI'], ['However  it', 'resonant frequency discretisation'], ['accurate  realisation', 'trigonometric frequency variation'], ['', 'resonant frequency deviation'], ['additional logic elements', 'resonant frequency location'], ['This', 'lesser phase RI'], ['effect', 'proper calculation time'], ['appropriate  choice', 'continuous phase response time'], ['accuracy', 'current frequency controller'], ['paper', 'electric elevator drive'], ['information', 'digital control systems'], ['tangible  example', 'mechanical position systems'], ['tasks', 'experimental time testing'], ['load demand estimation', 'economic power industry'], ['Forecasting  movements', 'strategic load planning'], ['fluctuations', 'weekly term operations'], ['hybrid electricity load that', 'Vector Regression Vector algorithms'], ['proposed EMD SVR method', 'denoising training data'], ['proposed  algorithm', 'specific Intrinsic Mode denoising'], ['Experimental  results', 'different feature vectors'], ['It', 'denoised electricity load forecasting'], ['', ''], ['rights', ''], ['environmental  issues', 'increasing  attention'], ['160  which', 'everyday  use'], ['long distance EV vehicles', 'recharging  stations'], ['', 'rapid EV charge chargers'], ['which', 'call loss condition'], ['appropriate  number', 'when EV infrastructure'], ['Therefore  number', 'station'], ['mathematical  model', 'widespread charge station'], ['', 'fossil air fuels'], ['medium duty diesel engine', 'urban driving conditions'], ['performance parameters', 'conventional fuel consumption'], ['Five  scenarios', 'present viability value'], ['environmental CO2 emissions', 'EV'], ['', 'times diesel vehicle'], ['viability', 'high exchange rates'], ['payback  period', '13  operation'], ['', ''], ['rights', ''], ['electric  it', 'essential application load electricity'], ['estimation accuracy', 'dynamic fusion estimation load'], ['estimation necessity', 'redundant  modeling'], ['parameters', 'genetic algorithm offline'], ['based state observer technique', 'aforementioned  models'], ['concept', 'fusion estimation'], ['certain  which', 'Bayes'], ['4  Batteries', 'different load method'], ['estimation accuracy', 'fusion'], ['', ''], ['rights', ''], ['increasing  demand', 'future energy systems'], ['comprehensive electricity knowledge', 'characteristics'], ['analysis', 'crucial load task'], ['electric mobility studies', 'comprehensive EV purpose'], ['we', 'detail'], ['how EV load they', 'management'], ['We', 'conducted EV studies'], ['resulting charging load profiles', 'other EV studies'], ['', 'future energy systems'], ['', ''], ['rights', ''], ['paper', 'power systems power cost'], ['', 'price taking price approach'], ['smart charging adoption', 'marginal pricing rule'], ['we', 'vehicular electricity consumption flow'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'vehicular shock rarefaction wave'], ['road conditions', 'shock electricity wave'], ['', ''], ['when traffic flow', 'small electricity perturbation'], ['', ''], ['when road conditions', 'oscillation'], ['paper', 'when  models'], ['mixed research methodology', ''], ['how  performance', 'high teaching proficiency'], ['Four  lecturers', 'mechanical engineering study'], ['Achievement tests', 'introductory  electronics'], ['higher teaching students', 'lower teaching expertise'], ['three taxonomy results', 'three  levels'], ['routine knowledge taxonomy both', 'interpretation level'], ['linear accuracy', 'actual  value'], ['Electrical  impedance', 'high output impedance'], ['idealities', 'operational op performance'], ['impedance spectra', 'output current'], ['User specifications', ''], ['biological  loads', 'simulations'], ['input op which', 'best performance circuit'], ['open loop gain corner', 'higher output circuit'], ['algorithm', 'such cancer tissue characterisation'], ['operational  amplifier', 'which'], ['high slew which', 'high slew rate'], ['OPAMP', 'digital  circuitry'], ['also stimulation stimulator', 'also stimulation order'], ['', 'clock needs'], ['stimulator', '0'], ['', ''], ['stimulator', 'only  0'], ['056 % charge mismatch', '32 mu s'], ['Gap junctions', 'synaptic  neurons'], ['', 'electrical  synapses'], ['Electrical  synapses', 'proper channels adhesion function'], ['components', 'differentially  junction'], ['molecular  complexity', 'functional  diversity'], ['', ''], ['middle income countries', 'sized energy cities'], ['', 'urban energy forms'], ['annual household electricity consumption', 'two  density'], ['dense  city', 'higher transport energy consumption'], ['key  factor', 'dense  city'], ['This', 'urban policy Thailand'], ['China', 'miraculous  development'], ['study', 'secondary electricity China'], ['paper', 'theoretical Vector Autoregressive'], ['macroeconomic  results', 'unidirectional Gross Domestic 2000'], ['only GDP Granger', 'electricity 2014'], ['conclusions', 'impulse response function'], ['study', 'economic electricity development'], ['World Trade trend', 'economic  transformation'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['', ''], ['', 'latent class models'], ['method groups that', 'better  comparison'], ['where  elements', 'unique  technology'], ['Second  classes', ''], ['classification', 'seminal  papers'], ['We', 'different electricity specifications'], ['we', 'approximately  78'], ['', 'small  7'], ['', ''], ['', ''], ['Moreover  most', 'small classes categories'], ['We', 'residual detector classes'], ['work', 'homogeneous latent class reference'], ['increasing  limitations', 'available utilization resources'], ['that', 'investment'], ['study', 'specific time period'], ['This', 'daily energy costs'], ['influences', 'different  scenarios'], ['effects', 'transmission line capacity'], ['scenarios', '30-bus IEEE network'], ['possible  specifications', 'selected plant cost functions'], ['transmission it', '21  years'], ['Singapore', 'BAU greenhouse 2020'], ['Carbon dioxide', '4 electricity generation 2020'], ['we', 'EnergyPLAN electricity generation 2020'], ['2020 emissions reduction trajectory', 'BAU 2020'], ['three APS scenarios', '2020 electricity generation sector'], ['that', 'measures'], ['Vulnerabilities', 'fuel mix emission reduction 2020'], ['', ''], ['rights', ''], ['Currently  privatized', 'vertically electricity Taiwan'], ['political electricity market', 'unique  characteristics'], ['social market welfare', 'fairness responsibility'], ['We', 'operational model planning'], ['', 'three phase pricing method'], ['proposed pricing method', 'following policy goals'], ['', 'reasonable power price allocations'], ['', 'electric grid operation'], ['', 'power plants'], ['', 'renewable energy use'], ['Countries', 'greener energy markets'], ['Energy  Package', 'green house gases'], ['implemented market policy', 'account'], ['herein  we', 'necessary CO2 losses'], ['we', 'hourly  2013'], ['indeed electricity losses', 'average CO2 emissions system'], ['combined  impact', 'CO2 technologies'], ['policy recommendations', 'CO2 emissions'], ['Mexican electricity which', 'closed reform industry'], ['independent system we', 'two modeling strategies'], ['first  we', 'Mexican price cap networks'], ['second  we', 'planned power flow model'], ['which', 'Mexican transmission planning authorities'], ['PRODESEN plan', ''], ['We', 'renewable power competition'], ['uncertainties', 'production'], ['system who', 'corresponding market prices'], ['conventional  generators', 'renewable supply function competition'], ['intermittent market generation', 'system'], ['intermittent market competition', 'overall price efficiency'], ['based  subsidies', 'renewable  energy'], ['Kenyan electricity price signs', 'persistence'], ['when energy which', 'major  debate'], ['electricity prices', 'permanent unit shocks'], ['long run relationships', 'fractional  cointegration'], ['series', 'fractionally electricity prices'], ['', ''], ['rights', ''], ['retail  they', 'retail  electricity'], ['rate', 'compensation'], ['centralized intermittent generation', 'pollution  externalities'], ['w', 'alternative  conditions'], ['considerably industry conditions', ''], ['Furthermore  requirement', 'distributional  effects'], ['generally  referring', 'mounting policy world'], ['different electricity it', 'economic  problem'], ['electricity security', 'European Union European EU'], ['work', 'closer EU electricity security'], ['this', 'electricity policy'], ['', 'electricity security sectors'], ['', 'analytic electricity security EU'], ['', 'proposed grid design initiatives'], ['paper', 'increasing storage facilities'], ['However  it', 'bulk storage storage'], ['largely wind generation', 'wind generation'], ['problem', 'high  variance'], ['It', 'secure energy supplies'], ['new capacity setting', 'new capacity market'], ['challenges', 'European electricity suppliers'], ['Innovative business models', 'financial electricity viability'], ['novel Integrated Energy that', 'industrial  customers'], ['We', 'similar market Europe'], ['', ''], ['rights', ''], ['paper', 'integrated electricity traders'], ['ANN power which', 'clustering power algorithm'], ['integrated  model', 'further risk provisions'], ['integrated  model', 'day electricity markets'], ['UC', 'wholesale electricity Greece'], ['model', 'forecasting model'], ['integrated  model', 'high forecasting confidence'], ['integrated  model', 'useful price traders'], ['', ''], ['rights', ''], ['paper', 'main electricity performance'], ['empirical  analysis', '30 OECD period'], ['regulatory  reforms', 'higher labor sector'], ['liberalised  level', 'subsequently electricity performance'], ['when Renewable Energy Sources', 'account'], ['last  share', 'major power grid'], ['crucial building block', 'renewable grid level'], ['we', 'intermittent energy storage'], ['explicitly time which', 'energy markets'], ['storage representation', 'asymmetrical conversion power'], ['when price prices', 'also price market'], ['easily decision that', 'readily  practice'], ['numerical  study', 'sophisticated Dynamic Programming literature'], ['', ''], ['rights', ''], ['Resources scarcity', ''], ['Wastewater', 'fertilizing water nutrients'], ['current wastewater treatment technologies', 'cost wastewater recovery'], ['It', 'sustainable energy manner'], ['innovative  technology', 'then electricity energy'], ['less energy MFCs', 'existing  technologies'], ['Multiform wastewaters', 'other processing units'], ['low power density', 'then scale development'], ['Therefore  paper', 'objectively wastewater treatment'], ['Moreover  integration', 'other contaminants removal'], ['primary  challenges', 'future scaling wastewater'], ['sonar power amplifier', 'underwater paper'], ['It', 'SPWM Pulse Width sonar'], ['method', 'high frequency inverters'], ['low digital signal controller', 'Controlled Full Bridge Circuit'], ['inputs', 'digital  controller'], ['CFBC power which', 'unwanted harmonics output'], ['power filter', 'acoustic transducer underwater'], ['voltage', 'same control loop system'], ['digital Mode Power control', 'ranging Mode Power sonar'], ['Salient  results', ''], ['paper', 'MWCNT)-modified Escherichia coli'], ['', 'polymerase chain reaction'], ['aureus', 'biosensor'], ['capture probe', 'specifically  E'], ['it', 'stranded  nanomaterial'], ['wrapped  MWCNTs', 'disposable DNA hybridization'], ['Electrochemical  behaviors', 'modified Raman spectroscopy'], ['selective DNA hybridization', 'about guanine oxidation 1'], ['', 'DPV'], ['Numerous  factors', 'such concentration hybridization etc'], ['designed DNA sensor', 'well  E'], ['', '20 min detection 0'], ['', '30 sample volume'], ['Electrochemical  immunosensors', 'rapid food pathogens'], ['recent  advances', 'area'], ['new  that', 'working electrode surfaces'], ['Many  advances', 'often  other'], ['use', 'superior sensor sensitivity'], ['then  they', 'practical  applications'], ['platform', 'optical read out'], ['Electrolytic  current', 'emitting  diode'], ['several  variants', 'transducing circuitry'], ['circuit', 'high transducing device'], ['', 'detection'], ['', ''], ['readable', 'direct mu H2O2'], ['whole transducing system', 'off  <'], ['', 'experimental  production'], ['system', 'alternative linear range'], ['that', 'operational  amplifier'], ['', ''], ['rights', ''], ['Electrochemistry', 'electrochemical PAH degradation remediation'], ['Pyrene', 'doped diamond electrode'], ['', '1'], ['', ''], ['', ''], ['Pd H-2H- quinones', 'investigated oxidation PAHs'], ['oxygenated PAH which', 'high  environment'], ['benzo[a]pyrene quinone all', 'mammalian  metabolism'], ['good  correlation', 'also UV irradiation experiments'], ['', 'higher  2'], ['capability', 'remediation technique'], ['', ''], ['rights', ''], ['ObjectiveElectroconvulsive  therapy', 'cognitive  death'], ['we', 'systematic mortality analysis'], ['MethodThe study', 'Systematic Reviews'], ['related mortality rate', 'total ECT treatments'], ['studies', '180 inclusion criteria'], ['Sixteen  cases', 'related mortality 2'], ['', '000  treatments'], ['', ''], ['', ''], ['nine  that', 'related  death'], ['related mortality rate', '2'], ['', '100 000 100 treatments'], ['recent  analysis', 'surgical mortality 3'], ['', '100'], ['death', 'ECT'], ['novel driving method', 'electromagnetic  paper'], ['hardware', 'schematic  diagram'], ['corresponding operating principle', 'digital control chip'], ['pulse duty cycle pulse', '100  %'], ['dynamic response it', 'frequency switching control'], ['proposed driving method', 'paper'], ['biological  transformations', 'free electron radicals'], ['based spectroscopy radicals', 'biological  mechanisms'], ['Redox processes', 'radical  formation'], ['many O-2-reactive they', 'protective  role'], ['like Trp clusters', 'two copper nitrite reductases'], ['two domain muticopper oxidases', 'active  site'], ['reactive oxygen species', 'O-2 reduction'], ['many application models', 'neural network field'], ['neural network models', 'operational  amplifier'], ['It', 'connecting  network'], ['we', 'multiple hold circuits'], ['connecting  weights', 'input voltage'], ['It', 'connection coefficient'], ['model', 'electronic  circuits'], ['short learning model', 'flexible  learning'], ['However  structure', 'one  input'], ['We', 'unit'], ['Moreover  we', 'deep learning model'], ['', ''], ['', 'Elsevier B'], ['', ''], ['many application models', 'neural network field'], ['neural network models', 'operational  amplifier'], ['It', 'connecting  network'], ['we', 'multiple hold circuits'], ['connecting  weights', 'input voltage'], ['It', 'connection coefficient'], ['model', 'electronic  circuits'], ['short learning model', 'flexible  learning'], ['However  structure', 'model'], ['We', 'unit'], ['Moreover  we', 'deep learning model'], ['useful  that', 'electronic commerce systems'], ['Consequently  it', 'remarkably  business'], ['topic', 'past  decade'], ['many  methods', 'task'], ['higher  which', 'real time system'], ['Hence  we', 'recommended item recommendation accuracy'], ['defined  recommendations', 'defined  which'], ['MovieLens methods', 'computational prediction complexity'], ['performance', 'long term storage'], ['which', 'accelerated  test'], ['white noise', 'different performance degradation'], ['zero  drift', 'operational noise amplifier'], ['resistances', 'long test storage'], ['feasible  demand', 'valued performance specifications'], ['which', 'complex analog systems'], ['hybrid  metaheuristic', 'prominent design specifications'], ['', ''], ['', 'subject design conditions'], ['Here  convergence', 'optimum  solution'], ['Experimental  results', 'hybrid optimization quality'], ['underlying Electronic Design circuitry', 'chip'], ['', 'employing analog circuit design'], ['heuristic', 'defined river formation specifications'], ['Here search strategy', 'operational amplifier circuit'], ['Experimental  results', 'standard optimization techniques'], ['electrostatic  discharges', 'combustible  air'], ['prevention', 'essential  explosions'], ['electrostatic  discharges', 'various chemical plants'], ['incidents', ''], ['Spark', 'leaking steam pipe'], ['', ''], ['Spark', 'charging  solid'], ['', ''], ['solid  which', 'powder'], ['', ''], ['pneumatic brush which', 'electric process operator'], ['', ''], ['electrostatic brush which', 'hydrocarbon'], ['it', 'industrial  facilities'], ['electrostatic safety which', 'repetition'], ['', 'C Elsevier B'], ['', ''], ['Enzyme', 'molecular  biology'], ['that', 'easily  errors'], ['Robotics', 'obvious  advantages'], ['based 3D that', 'conventional  ELISA'], ['ELISA', 'fluid sandwich transfer'], ['results', 'robotics pillar ELISA'], ['human leukocyte antigen G', 'like immunology tumor receptors'], ['distinct mRNA one', 'detectable sandwich ELISA'], ['Therefore G ELISAs', 'noninvasive diagnosis system'], ['data', 'conventional body IB'], ['optimized ELISA which', 'IP IB analysis'], ['G amniotic levels', 'clearly  term'], ['we', 'conventional ELISA system'], ['Elongation factor', 'many bacteria fungi animals'], ['1 SeEF-1 cDNA', '1 elongation exigua'], ['This', 'molecular amino 24'], ['', '04  4'], ['', ''], ['Malpighian tubules', 'brain epidermis'], ['SeEF-1 beta', 'developmental  stages'], ['', 'SeEF-1 beta'], ['36  which', 'three control groups'], ['when EF-1 beta', ''], ['SeEF-1 beta', 'key  S'], ['', ''], ['Single phase inverters', 'renewable energy grid'], ['', 'single phase inverter'], ['paper', 'TMS320F28335 Texas chip'], ['pulse sampling width', 'pulses'], ['embedded software design', 'single phase inverter'], ['scale single phase inverter system', 'neural network microcontroller'], ['microcontroller', 'challenging hardware experiment conditions'], ['us', 'other  people'], ['It', 'social  relationships'], ['exactly  people', 'them'], ['present  paper', 'visuospatial perspective taking'], ['Visuospatial perspective taking', 'physical  person'], ['when  people', 'perceived  closeness'], ['1067  participants', 'taking  task'], ['visual  which', 'embodied  simulation'], ['angular  participants', 'task'], ['', '4 target person'], ['embodied task transformation', 'only task trials'], ['', ''], ['', 'angular  disparities'], ['Implications', 'perspective  research'], ['embryonic  implantation', 'competent  blastocysts'], ['key let-7a expression profiles', 'peri implantation'], ['expression', 'situ  hybridization'], ['effect', 'situ let-7a hybridization'], ['expression level', 'gestation day'], ['', ''], ['', 'oil g'], ['', ''], ['', ''], ['', ''], ['', ''], ['Let-7a', 'glandular  epithelia'], ['expression', 'delayed  implantation'], ['Treatment', 'significantly let-7a expression'], ['active  let-7a', 'endometrial  decidualization'], ['', ''], ['Somatic  embryogenesis', 'breeding woody species'], ['It', 'such Pinus radiata'], ['One  approach', 'descriptive  study'], ['MALDI TOF MS analysis', 'Pinus radiata D'], ['4 cell that', 'environmental initiation stage'], ['139 Swiss Prot 25', 'somatic initiation embryogenesis'], ['two  proteins', 'high initiation rates'], ['60  %', 'metabolic  process'], ['study', 'ofthe breeding programmes'], ['complex  that', 'surface ectoderm'], ['eyelids they', 'postnatally  mouse'], ['', 'such TGF- Activin B'], ['growth factors', 'ERK cascade'], ['Several  mechanisms', 'Wnt/-catenin eyelid fusion'], ['Eyelid opening', 'Smad signaling system'], ['genetic  disorders', 'molecular  pathways'], ['DAEF  technique', 'switched mode power converters'], ['conventional DAEF topology', 'only  ports'], ['It', 'definitely Common Mode'], ['novel DAEF topology', 'paper'], ['It', 'well prevent CM'], ['traditional time model', 'system behavior'], ['paper', 'precise DAEF system'], ['model', 'digital control system'], ['model', 'accurately filter DAEF'], ['proposed  DAEF', 'effectively CM EMI'], ['precise  model', 'system filter performance'], ['Emotion recognition impairments', 'bipolar  disorder'], ['This', 'different emotion disorders'], ['featural BD patients', 'only  latter'], ['impairments', 'facial emotion cohorts'], ['Twenty eight Twenty individuals', 'featural face processing strategies'], ['Sz patients', 'whole face condition'], ['BD patients', 'whole face condition'], ['facial  configural', 'emotion Sz'], ['This', 'emotion disorders'], ['negative  they', 'significant  comfort'], ['present  we', 'based  interaction'], ['', 'long term study'], ['two  partners', 'randomly  target'], ['target', 'negative  valance'], ['she', 'regulatory  strategy'], ['', ''], ['', 'regulatory emotion partner'], ['', ''], ['', ''], ['outside  perspective', 'intrapersonal emotion regulation'], ['emotional  empathy', 'interpersonal emotion regulation'], ['regulatory  that', 'distress'], ['larger depression sample', 'potential moderating effect'], ['results', 'cognitive  distress'], ['behavioral  that', 'psychopathology'], ['', ''], ['rights', ''], ['neural  substrate', 'also smile smile'], ['hypothesis', 'standard laboratory settings'], ['where  difficulties', 'focal electroencephalogram epilepsy'], ['stimulation', 'facial anterior cingulate expression'], ['depicting video actors', 'neutral  expression'], ['findings', 'social  cognition'], ['study', 'facial party expressions'], ['HS HN accuracies', 'respective pitch Hellos'], ['SN detection accuracy', 'sad pitch Hellos'], ['which', 'evolutionary  perspective'], ['negative  correlation', 'empathy HS detection discrimination'], ['whereby Autism Spectrum nature', 'emotional prosody processing'], ['Here  we', 'novel lifelike behavioral'], ['', 'behavioral prosody recognition task'], ['', 'basic STS controls'], ['Moreover  coupling', 'basic ASD group'], ['', 'brain activity'], ['Brain activity', 'strongly ASD participants'], ['coupling', 'strongly control group'], ['results', 'emotional prosody ASD'], ['differences', 'social  communication'], ['when  people', 'misfortunes'], ['when  misfortune', 'human  warmth'], ['Two  experiments', 'two  warmth'], ['', ''], ['sociability', 'distinct driving schadenfreude'], ['when  misfortune', 'individual lacking morality'], ['Study', 'only  morality'], ['higher  misfortunes', 'higher  schadenfreude'], ['morality', 'basic person perception'], ['', ''], ['', 'schadenfreude'], ['already  patients', 'facial emotion perception'], ['moderating  effect', 'perceptual emotion attribution'], ['study', 'emotional sentence schizophrenia'], ['Twenty one schizophrenia patients', 'grammatical  person'], ['First  patients', 'only emotion attribution task'], ['Second  patients', 'irrespective  emotions'], ['Lastly', 'prefrontal sentences attribution cortex'], ['functional  abnormality', 'social cognition schizophrenia'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['adults', 'social Tourette cognition'], ['therefore  patients', 'human  eyes'], ['', ''], ['standard Eyes which', 'novel comparison age'], ['', ''], ['reduced temporo parietal activity', 'inferior parietal cortex'], ['Age judgement', 'temporal medial mentalizing'], ['interaction', 'frontal  gyrus'], ['', 'global  urge'], ['', ''], ['recognizing', 'reduced brain agency'], ['when state mentalizing', 'mental state patients'], ['social findings which', 'tic  expression'], ['children', 'mental  abuse'], ['deficit hyperactivity disorder', 'neurodevelopmental  children'], ['children', 'more child controls'], ['104 case control who', 'disruptive behavior disorders'], ['approval', 'families'], ['children', 'physical  96'], ['', ''], ['', 'significant  controls'], ['', ''], ['6  they', 'physical  neglect'], ['', 'healthy  children'], ['', 'witnessing family violence'], ['', ''], ['', 'sexual  abuse'], ['', ''], ['', ''], ['education  programs', 'results'], ['', ''], ['rights', ''], ['research', 'young communication abuse'], ['minors', 'protective care maltreatment'], ['relation', 'social  communication'], ['lack', 'social  communication'], ['study', 'affective  empathy'], ['scarce  ability', 'social  interactions'], ['emotional intervention which', 'social  communication'], ['deleterious  effects', 'physiological school outcomes'], ['However school relationship', 'potential  relationship'], ['three  studies', 'emotional school dysregulation'], ['emerging school burnout', 'well school burnout'], ['Specifically  relationship', 'dispositional self control'], ['Findings', 'emerging school adults'], ['self control', 'damaging ameliorating school effects'], ['Limitations', 'future  research'], ['', ''], ['rights', ''], ['that', 'threat  signals'], ['combatants', 'atypical  EP'], ['Available reintegration programs', 'communities'], ['However  they', 'emotional  regulation'], ['Social Cognitive which', 'social Social Reintegration skills'], ['', 'mean  37'], ['29  men', 'armed  study'], ['', 'conventional reintegration intervention'], ['groups', '12 training period'], ['comprehensive  which', 'Behavioral  instruments'], ['prior  intervention', 'groups'], ['groups', 'baseline'], ['combatants', 'conventional reintegration intervention'], ['first  that', 'such SCT intervention'], ['We', 'social reintegration strategies'], ['Recognition', 'basic emotion faces'], ['choices', 'context'], ['response we', 'visual  scenes'], ['Responses', 'social  emotions'], ['scoring that', 'five  TBI'], ['', 'significant response faces'], ['', 'scenes'], ['labels', 'one  photo'], ['Results', 'affect choice TBI'], ['Relative', 'higher population suicide'], ['Suicide risk', 'criminal  offenders'], ['disordered  individuals', 'high risk group'], ['neurobehavioral risk correlates', 'psychotic suicidal disorders'], ['four brain i', 'psychotic community disorders'], ['Established suicide risk variables', 'social brain cognition'], ['Relative', 'empathic suicide accuracy'], ['Empathic  accuracy', 'other risk variables'], ['brain  correlates', 'incremental suicide risk'], ['right hemisphere lesions', 'emotional partner money'], ['when  they', 'partner win'], ['percentage', 'negatively rating losses'], ['concept', 'cognitive  psychologists'], ['conflicting  some', 'social  one'], ['utility', 'simulation'], ['this', ''], ['how  others', 'epistemological  role'], ['This', 'simulationism'], ['likely  empathy', 'likely  which'], ['certain  empathy', 'certain  which'], ['social  I', 'transparent fellow feeling'], ['Inferring', 'clinical  schizophrenia'], ['current  study', '16  schizophrenia'], ['frontal schizophrenia those', 'healthy UHR groups'], ['', 'significant schizophrenia group'], ['', 'social brain emotion'], ['UHR  groups', 'when hypo IFG beliefs'], ['findings', 'clinical  psychosis'], ['Empathy', 'pain'], ['unintentional  that', 'contrary'], ['wherein pain identification participants', 'prime target experiences'], ['underlying PIT empathy', 'Unintentional target stimuli'], ['', 'Experiment'], ['slow response deadline', 'Intentional  Empathy'], ['', 'Experiment'], ['perspective taking', ''], ['Intentional  Empathy', 'targets'], ['outcome information effects', 'PIT'], ['rather  effects', 'semantic  priming'], ['high  empathy', 'maladaptive  altruism'], ['Theoretical  applications', 'modeling empathy'], ['prosocial outcomes', 'maximizing  impulses'], ['We', 'prefrontal burst areas'], ['We', 'MT control area'], ['unsupervised Dictator they', 'anonymously  themselves'], ['prefrontal  subjects', 'MT  V5'], ['specifically cTBS DLPFC', 'low SES players'], ['costly  they', 'different  ways'], ['contextual  DMPFC', 'tonic  control'], ['when prosocial decisions', 'strategic  reputation'], ['', ''], ['social  that', 'social  interaction'], ['flexible  that', 'neuronal  networks'], ['', ''], ['mental  who', 'psychosocial rehabilitation programme'], ['', ''], ['sample', 'psychosocial rehabilitation programme'], ['interpersonal reactivity index', 'subject'], ['', ''], ['experimental Eyes group', 'lower control group'], ['', ''], ['', ''], ['significant  differences', 'other  variables'], ['', ''], ['Persons', 'generalised  empathy'], ['they', 'normal  population'], ['Load demand forecasting', 'electric  utilities'], ['deep learning approach', 'work'], ['load demand series', 'intrinsic mode functions'], ['extracted Boltzmann tendencies', 'IMFs'], ['Finally prediction results', 'aggregated load demand'], ['data sets', 'based DBN approach'], ['Simulation results', 'nine forecasting methods'], ['', ''], ['', ''], ['rights', ''], ['strategic  they', 'necessary  strategies'], ['Accordingly  it', 'strategies'], ['they', 'managerial'], ['We', 'strategic performance measurement roles'], ['that', 'managerial project roles'], ['', 'Hormozgan Cement Company'], ['who', 'performance value'], ['therefore  employees', 'proper  method'], ['illicit child drugs', 'child maltreatment'], ['However  relationship', 'empirical child attention'], ['72 employment who', 'protective substance abuse'], ['Child maltreatment potential', 'self  employment'], ['association', 'personal child abuse significance'], ['results', 'social  desirability'], ['Employment satisfaction', 'other employment factors'], ['gainful  that', 'gainful  employment'], ['Happiness', 'biological testing self participants'], ['Future directions', 'vocational assistance population'], ['paper', 'later employment life'], ['disadvantaged  who', 'homelessness'], ['estimation approach', 'potential adult employment'], ['first  children', 'first  time'], ['relationship', 'related childhood homelessness'], ['however childhood homelessness', 'male employment rates'], ['integration', 'nanoliter scale droplets'], ['multibarrel system', 'programmable droplet emulsions'], ['capillary  method', 'dispersed droplet phase'], ['Individual  phases', 'neighboring droplet generators'], ['dimensional multibarrel system', 'conventional microfluidic droplet generators'], ['7-barrel capillary ability', 'higher order emulsions'], ['', ''], ['', ''], ['rights', ''], ['We', 'odontogenic rat tumors'], ['further Apin gene', 'various tissue EO'], ['RT expression', 'nasal  epididymis'], ['protein sequences', 'mammal rat mouse genomes'], ['Apin', 'highly fish birds'], ['transfected  Apin', 'linked  glycosylation'], ['rodent incisors Apin', 'secretory maturation stage'], ['Intense  labeling', 'well enamel matrix'], ['epithelial  which', 'tooth surface'], ['active cell tooth presence', 'physiological  roles'], ['aetiological  spectrum', 'acute encephalitis'], ['infectious Sri which', 'Asian  population'], ['sectional  study', 'tertiary care Colombo'], ['Cerebrospinal fluid', 'encephalitogenic  viruses'], ['nucleic acid amplification', 'antibody viruses'], ['reduction neutralization test', 'West Nile virus'], ['age', '73  years'], ['', ''], ['', 'female  1'], ['', ''], ['viral  aetiology', 'only  27'], ['', ''], ['These', 'dengue  virus'], ['', ''], ['', ''], ['', ''], ['None', 'herpes simplex viruses'], ['Screening', 'bacterial  patients'], ['', 'viral  aetiologies'], ['7  which', 'viral  aetiology'], ['viral  aetiology', 'a  encephalitis'], ['Dengue virus', 'majority'], ['Glycan  conversion', 'homogeneous bio glycoform'], ['key product undergoes which', 'practical  enzyme'], ['We', 'like M mutant activity'], ['M N175H mutant', 'like activity N175Q'], ['natural donor N175H', 'sialoglycosylated RNase B'], ['alternative glycoengineering which', 'laborious donor substrate'], ['', 'International Union International Biochemistry'], ['', ''], ['Osteoclasts', 'primary  bone'], ['different tissue which', 'skeletal bone growth'], ['present  that', 'growing bone rats'], ['rats', '21 saline days'], ['femur', 'light  scanning'], ['expression', 'real polymerase chain reaction'], ['little ALN area', 'little ALN group'], ['positive ETN they', 'positive ETN group'], ['expression', '2 ossification bisphosphonates'], ['ALN', 'RANK'], ['results', 'related bone genes'], ['IntroductionWomen', 'endometrial  cancer'], ['Insulin resistance', 'pertinent  conditions'], ['aim', 'binding serum lipid profiles'], ['Material', 'sectional University Hospital UK'], ['34  participants', 'group'], ['endometrial  biopsies', 'participants'], ['real polymerase chain reaction', 'element binding protein-1 gene'], ['', 'ovary mass syndrome'], ['', ''], ['', ''], ['', ''], ['62kg', ''], ['Women', 'mean body mass index'], ['', ''], ['', ''], ['regulatory protein-1 gene expression', 'syndrome cancer controls'], ['', ''], ['regulatory protein-1 gene expression', 'positively body mass index'], ['', ''], ['', ''], ['', ''], ['ovary  this', 'ovary  syndrome'], ['positive  correlations', 'endometrial mass cancer'], ['', ''], ['', ''], ['', ''], ['', ''], ['regulatory protein-1 gene expression', 'syndrome  cancer'], ['', ''], ['', ''], ['regulatory binding protein-1 gene', 'endometrial gene expression'], ['', ''], ['regulatory protein-1 gene expression', 'ovary serum syndrome'], ['endoparasitoid  wasp', 'like Meteorus particles'], ['', 'lepidopteran host oviposition'], ['associated  factors', 'immune host defense'], ['conventional venom gland that', '5 cDNA regions'], ['expressed sequence tags', '228 cDNA clusters'], ['One hundred', 'GO Blast2GO analyses'], ['', 'major  M'], ['parasitoid wasp it', 'polydnaviruses'], ['Twenty  clusters', 'further  analyses'], ['12 chain reaction factors', 'reverse chain reaction analyses'], ['RNA interference targets', 'five gene factors'], ['five  factors', 'two  MpVLP'], ['deficient', 'inhibitory host hemocyte vitro'], ['that', 'plant disease'], ['hosts', 'pathogens'], ['other animals host that', 'also foodborne pathogens'], ['laboratory', 'wild corn relatives'], ['four H7 Listeria', 'dual Pseudomonas culture'], ['Two Paenibacillus polymyxa endophytes', 'deleterious  agar'], ['Using', 'antibacterial polymyxin action'], ['Polymyxin production', 'immunosorbent  assay'], ['modern Zea Zea', 'ssp parviglumis'], ['modern  we', 'pathogens food spoilage agents'], ['Taxol', 'human  cancers'], ['', 'northern Iranian Taxus Iran'], ['molecular screening approach', 'endophytic  exon'], ['', 'key taxol production pathway'], ['We', 'producing chain reaction fungi'], ['produced batch taxol', 'standard performance liquid taxanes'], ['six  fungi', 'taxol'], ['highest  level', 'baccatin'], ['', 'isolated Cladosporium sp'], ['', ''], ['fungal  taxols', 'commercial MTT taxol'], ['fungal  taxols', 'human cancer cell line'], ['expression', 'standard  taxols'], ['using', 'other  methods'], ['small  RNAs', 'biological  processes'], ['greater  availability', 'regulatory throughput molecules'], ['where  millions', 'individual  sequences'], ['other  procedures', 'northern  blotting'], ['Here  we', 'Solexa Illumina technology'], ['Improving', 'crucial islet graft survival'], ['are', 'isolated EC islet'], ['traditional  method', 'low EC vitro'], ['study', 'coated islet graft'], ['fibrous  scaffold', 'EC islets'], ['8 PGA %', 'significantly control group'], ['', '7 days culture'], ['Stimulation index', '7 ECs coating'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['growth factor growth level', '7 days culture'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['three growth microenvironment islet', '14 ECs coating'], ['vivo PGA', 'coated control group'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['angiogenesis', 'mean microvessel density'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'reverse chain reaction analysis'], ['efficiency', 'successfully PGA scaffold'], ['method', 'isolated function vivo'], ['endothelial  lipase', 'lipoprotein  metabolism'], ['human lipid we', 'normal plasma HDL rabbits'], ['EL tissue Northern', 'situ RT PCR hybridization'], ['We', 'plasma HDL levels'], ['rEL mRNA', 'related kidney bone marrow'], ['heritable  hyperlipidemic', 'normal plasma rabbits'], ['plasma HDL levels', 'hepatic plasma rEL rEL'], ['Injection', 'specific antisense plasma'], ['rEL mRNA', 'WHHL  rabbits'], ['rEL', 'such cholesterol metabolism'], ['EL', 'important plasma HDL rabbits'], ['present  we', 'cell invasion'], ['ET I', 'ET cells'], ['markedly  which', 'when  MMP-9'], ['Furthermore inhibition', 'central differentiation proliferation'], ['gelatinase inhibition', 'successful osteosarcoma cell osteosarcoma'], ['Leptin', 'appetite  weight'], ['plasma leptin levels', 'positively body weight'], ['ET-1  overexpression', 'insulin resistance'], ['study', 'Northern muscle blotting'], ['effect', 'mediated cell proliferation'], ['significant I-125]-ET-1 which', 'significant I-125]-ET-1 binding'], ['M)-treated ET cells', 'to  2'], ['', 'controls'], ['', 'to  2'], ['', 'leptin'], ['', 'ERK inhibitor PD-98059'], ['5  M', 'induced  I-125-ET-1'], ['M)-stimulated cell proliferation', 'maximal  controls'], ['leptin', 'dependent ETAR manner'], ['effect', 'ET-1-stimulated cell proliferation'], ['findings', 'associated ET hypertension'], ['', 'cardiac  hypertrophy'], ['We', 'intracellular calcium transient'], ['calcium transient', 'fura-2'], ['', 'prolonged calcium transient decay'], ['', 'transient  decay'], ['when  sodium', 'bath solution'], ['ET-1-induced  prolongation', 'sodium calcium exchanger'], ['ET-1-treated  decrease', 'BQ-788'], ['Moreover pretreatment', 'reduced SERCA2 gene expression'], ['Real RT PCR analysis', 'abundant receptor gene cardiomyocytes'], ['', 'transient intracellular decay'], ['Specific  inhibition', 'cardiac ETA performance'], ['Leprosy', 'immune  response'], ['Endothelium', 'infected cell tissues'], ['objective', 'possible  M'], ['', 'endothelial expression cytokines'], ['skin biopsy skin samples', 'monoclonal ICAM-1 ICAM-2 VCAM-1'], ['Immunostaining', 'endothelial tuberculoid leprosy'], ['', ''], ['', 'lepromatous  samples'], ['', ''], ['mm(2  ICAM-2', 'endothelial  tuberculoid'], ['', ''], ['', ''], ['', ''], ['', ''], ['VCAM-1-immunostained', '18'], ['', ''], ['', 'mm(2 tuberculoid leprosy'], ['', ''], ['', 'lepromatous  leprosy'], ['VLA-4', '22'], ['', ''], ['', '38 tuberculoid leprosy'], ['', ''], ['', 'lepromatous  leprosy'], ['larger ICAM-1 that', 'inflamed  tissue'], ['', ''], ['rights', ''], ['paper', 'subjective electricity heating oil'], ['energy prices', 'well  being'], ['sizes', 'well  being'], ['Effects', 'lowest income quartile'], ['required energy expenditures', 'times'], ['greater fuel poverty', 'well energy being'], ['Energy saving', 'due climate changes'], ['However  perception', 'still concept stage'], ['yet  they', 'given energy bill'], ['', 'integral energy savings'], ['Notably  gap', 'smart technology technology'], ['Singapore', 'smart energy consumption'], ['paper', 'smart Singapore energy'], ['Areas', 'smart energy homes'], ['three case studies', 'existing  solutions'], ['UK government', '80 carbon 2050'], ['use', 'secure energy future'], ['where reduction measures', 'most energy consumption'], ['paper', 'research energy fields'], ['these', 'typical  household'], ['typical UK house design', 'aided floor design'], ['house design', 'payback  8'], ['', ''], ['', ''], ['Climatic  conditions', 'primary energy heating'], ['', 'strict  efficiency'], ['predictive energy savings', 'partly efficiency behavior'], ['We', 'residential water sector'], ['regression analysis', 'four characteristics market aspects'], ['two stage interpolation that', 'Least t Squares'], ['results', 'demand forecasting'], ['space', 'different gas regions'], ['heating gas demand', 'positive  elasticity'], ['We', 'rebound  effect'], ['when gas price', 'moderate income magnitude'], ['', ''], ['rights', ''], ['paper', 'oil OECD member countries'], ['We', 'annual panel data 2011'], ['real prices size', 'oil stock demand'], ['run elasticity coefficients', 'short run parameters'], ['demand', 'short  run'], ['energy demand', 'energy prices'], ['economic market size', 'significantly energy consumption'], ['when market development indicators', 'solely energy price'], ['empirical  findings', 'further demand management policies'], ['using durables consumers', 'new energy appliance'], ['We', 'also imperfect competition'], ['average energy consumption', 'period'], ['%  what', 'competitive  market'], ['small market power', 'actually energy use'], ['', ''], ['', ''], ['rights', ''], ['program administrator', 'potential performance improvements'], ['saved  programs', 'participants'], ['', 'total savings U'], ['', ''], ['utility efficiency we', '$  0'], ['', 'favorably energy supply costs'], ['Programs', '$  0'], ['', '$ kW 0'], ['', 'nonresidential kW programs'], ['', '$ Lighting 0'], ['', 'residential savings market'], ['common program administrators', 'average  half'], ['standardized  reporting', 'efficiency programs'], ['Differing  definitions', 'savings program results'], ['Reducing', 'planners'], ['study', 'external power supply'], ['interface circuit', 'two  stages'], ['first stage voltage doubler', 'considerably output voltage'], ['traditional offset which', 'low power consumption'], ['harvested  which', 'zero input current'], ['which', 'power consumption'], ['validity', '65 nm CMOS process'], ['minimum input voltage', 'down  0'], ['3  V', ''], ['', '6 DC output 75'], ['maximum power efficiency', ''], ['', '2 DC output 40'], ['4 mu A', ''], ['', ''], ['power loss', 'entire interface circuit'], ['65 op amp', 'only  2'], ['', ''], ['cell electric Fuel cell vehicles', 'chemical motor'], ['when fuel cell cars', 'on fuel cell power'], ['renewable power generation', 'vehicle  power'], ['which', 'refilling  station'], ['operational  costs', 'way'], ['traveling fuel cell schedules', 'fuel cell vehicles'], ['operational  costs', 'renewable energy generation'], ['finally case study', 'designed  system'], ['', ''], ['', 'Elsevier Ltd'], ['', 'electricity expenses'], ['energy management system', 'simultaneously energy cost'], ['that', 'energy consumption'], ['monetary  expense', 'varying pricing model'], ['home gateway', 'efficiently electricity price peak'], ['scheduling  approach', '24-h turbine PV period'], ['', ''], ['rights', ''], ['photovoltaic energy station system', 'work'], ['Power converters', 'autonomous source vehicle'], ['Efficient  regulation', 'DC bus voltage'], ['Energy management', 'digital Matlab calculations'], ['mathematical  formulation', 'local  stability'], ['Gains', 'two transfer function'], ['analysis', 'Routh Hurwitz'], ['Simulation evidence results', 'performance improvement'], ['Downhill conveyors', 'potential conveyor belt systems'], ['energy', 'regenerative  drives'], ['generic energy that', 'downhill conveyors'], ['three case study that', 'time  tariff'], ['savings  that', 'internal downhill conveyor grid'], ['CBS', '1984 energy configuration'], ['Analysis', 'three life cycle cost'], ['use', 'variable energy CBSs'], ['that', 'profitable case study consideration'], ['PBPs', 'annual discount rate'], ['optimal energy that', '5  years'], ['paper', 'based Aalborg University Denmark'], ['MGRL', 'comprehensive  microgrids'], ['structure', 'facilities configurations'], ['complete control system', 'secondary control control'], ['secondary  management', 'central  controller'], ['software  schemes', ''], ['Several example case studies', 'storage system control'], ['Experimental  results', 'whole  system'], ['Pacific white shrimp Litopenaeusvannamei', 'inland salinity salinity'], ['much research progress', 'low  salinity'], ['recent  findings', 'low shrimp salinity'], ['white  shrimp', 'high  pathogens'], ['15 20 % carbohydrate', 'low cine alanine salinity'], ['further  studies', 'further  finding'], ['Future research', 'physiological salinity change'], ['dietary  requirements', 'low amino acids salinity'], ['always  which', 'real energy services'], ['we', 'substitution relations definition'], ['asymmetric cost share paper', 'fossil energy consumption RE'], ['unrelated time series RE', 'electricity generation estimated'], ['RE', ''], ['power generation sector', 'generally energy saving'], ['we', 'total customer view'], ['both', 'peak  use'], ['monthly base cost', 'thus load control'], ['well energy arbitrage', 'ToU'], ['ESS operation', 'KCI tariff'], ['we', 'real  environment'], ['approach', 'significantly peak 49'], ['', 'total  10'], ['8  that', 'uncertainty'], ['we', 'proposed battery degradation techniques'], ['fully  vehicles', 'photovoltaic energy system'], ['Nevertheless charging management problem', 'local RES generation'], ['paper', 'intermittent EV charging'], ['real charging optimization scheme', 'charging power priorities'], ['proposed  approach', 'operational PVS charging'], ['it', 'multiple  services'], ['feature', 'many power systems'], ['', 'unpriced cost classification'], ['storage developers', 'priced  services'], ['', 'former case storage market'], ['asset', 'unpriced services ratebase'], ['regulatory  design', 'inefficient storage investment'], ['third  that', 'priced  services'], ['', 'regulatory end use'], ['We', 'efficiently storage capacity rights'], ['revenues', 'marginal market bids'], ['', 'large energy role'], ['This', 'weather patterns'], ['renewable energy system', 'decoupling  demand'], ['paper', 'potential  flexibility'], ['first', 'border energy interconnection'], ['', ''], ['', 'different instance heat'], ['they', 'extent'], ['two energy that', 'Northern'], ['developmental  that', 'sector  interconnectivity'], ['increasing  level', 'border transmission interconnectivity'], ['sector system interconnection', 'best system performance'], ['', 'main  aspects'], ['second', 'two  archetypes'], ['', ''], ['rights', ''], ['alleviate', 'important energy utilization'], ['traditional power system', 'coupled energy flow analysis'], ['GEF analysis which', 'electricity heat electricity subsystems'], ['First  models', 'natural gas ESI'], ['equivalent gas method', 'different control modes'], ['Newton Raphson algorithm', 'connected power ESI'], ['Finally  validity', 'practical flow cases'], ['EU dependence', 'total electricity generation'], ['dependence', 'significant EU energy system'], ['', 'potential gas supply interruptions'], ['', 'electricity paper EU-28'], ['where gas supply routes', 'yearly gas Europe'], ['interruption', '12 electricity prices'], ['heavily  Spain', '18 electricity result'], ['gas storages', 'gas storage infrastructure'], ['This', '6 power Europe'], ['gas  which', 'when energy whole'], ['', ''], ['rights', ''], ['basic physics Beaudreau', 'led energy mid-1970s'], ['high use growth rates', 'drastically OECD productivity'], ['considerable  doubt', 'view'], ['real energy prices', 'pre-1973  levels'], ['related speed factors', 'hence productivity slowdown'], ['further  increases', 'late  1960s'], ['', ''], ['rights', ''], ['nuclear  plants', '21 UK electricity'], ['reliable carbon future', 'dioxide emissions targets'], ['', 'long % term'], ['modular  reactors', '300  unit'], ['burn safety they', 'nuclear power plants'], ['Moreover  proliferation', 'such  thorium'], ['paper', 'nuclear electricity deployment'], ['Concerns', 'nuclear power production capability'], ['modular legislation route', 'nuclear reactor power'], ['two  decades', 'oriented electricity sector reforms'], ['reforms', 'structure market mechanisms'], ['However  passage', 'developing  countries'], ['paper', 'empirical electricity sector future'], ['Overall  reforms', 'technical  sector'], ['macroeconomic  benefits', 'reforms'], ['Also  gains', 'institutional  weaknesses'], ['that', 'economic  access'], ['when  poor', 'electricity'], ['New technologies', 'institutional capacity reforms'], ['payas service computing you', 'service  features'], ['distributed  which', 'scalable virtualization service'], ['high generation core bandwidth', 'distributed generation core characteristics'], ['However concern', 'high electricity bills'], ['we', 'dynamic Optical Cloud cases'], ['online  we', 'dynamic EPOCN problem'], ['aware routing algorithm', 'based routing algorithm'], ['traffic matrix', 'advance'], ['We', 'ESSA datacenter networks'], ['NP  we', 'exact Integer Linear problem'], ['We', 'proposed energy consumption'], ['', ''], ['', ''], ['rights', ''], ['significant  attention', 'global climate change'], ['that', 'precious production commodities'], ['resolution', 'renewable energy technologies'], ['renewable energy integration', 'sustainability concerns'], ['renewable energy integration studies', 'integrated energy water infrastructure'], ['Many', 'economic dispatch simulation'], ['economic  that', 'water power'], ['paper', 'corresponding unit commitment problem'], ['It', 'several case Singapore'], ['renewable  energy', 'simultaneously CO2 emissions'], ['production  constraints', 'production cost levels'], ['', ''], ['rights', ''], ['thin  films', 'limited paper microfluidic settings'], ['pH sensing platform', 'acrylonitrile butadiene styrene'], ['GO graphene which', 'excellent  stability'], ['IrO2  film', 'observable grain cracks'], ['IrO2-RGO  electrode', 'ionic response oxygen'], ['signal', 'operational input amplifier'], ['electrochemical paper sensors', 'pH glass electrode'], ['construction', 'uniquely structure function relationship'], ['3D  structures', 'exclusively computer screen'], ['real  information', 'stereoscopic vision touch'], ['tangible  models', 'conceptual hypothesis biomolecules'], ['Recent  advances', 'molecular 3D printing representations'], ['However  optimization', 'detailed  guidance'], ['3D cost that', 'filament fabrication technology'], ['Various insect species', 'genomic  years'], ['Thus  researchers', 'genomic  invertebrates'], ['which', 'functional  analyses'], ['we', 'public bench databases'], ['Enolase', 'glycolytic  organisms'], ['We', 'silkworm Bombyx mori'], ['RNA Hidden Markov we', 'functional  B'], ['', ''], ['BmEno1', 'other metal species'], ['However  BmEno2', 'key amino acid'], ['BmEno2', 'lepidopteran  clusters'], ['BmEno1', 'study'], ['BmEno2', 'ovary  ganglion'], ['BmEnoC', 'weakly  testis'], ['thus testis BmEnoC', 'specific  spermiogenesis'], ['We', 'dry bench silkworm'], ['', ''], ['BmEno2', 'specific  functions'], ['strategy', 'public  databases'], ['bacterial  strains', '16S rRNA gene comparisons'], ['They', 'concatenated sequence similarities'], ['', 'related Ensifer glycinis'], ['', ''], ['', ''], ['Phylogeny', 'nodulating  E'], ['', ''], ['', ''], ['Astragalus it', 'ineffective Leucaena leucocephala'], ['18:0 fatty 20:0', 'related  strains'], ['', 'carbon source pH'], ['intolerance', 'related type species'], ['genome  size', 'CCBAU 251167(T'], ['2  Mbp', 'DNA G+C 59'], ['', ''], ['', ''], ['', ''], ['', '29645(T type strain'], ['', 'GmbH'], ['rights', ''], ['CTX)-resistant  coliforms', 'commercial  samples'], ['78  number', '1'], ['', '46  samples'], ['', 'Standardization methods'], ['Escherichia', '36 19 36 samples'], ['', 'resistant coliforms K'], ['', ''], ['', ''], ['cloacae complex', '8 1 8 samples'], ['', ''], ['', ''], ['complex  isolates', 'third generation cephalosporins'], ['', ''], ['', ''], ['pneumoniae isolates', 'extended beta lactamase genes'], ['', ''], ['pneumoniae', ''], ['complex cluster IV isolate', 'determining amino acid GyrA'], ['', ''], ['complex  isolates', 'mediated fosfomycin resistance gene'], ['possible heating spread', 'opportunistic resistance pepper'], ['Therefore  it', 'hygienic cultivation harvesting'], ['Most  studies', 'immunocompromised  patients'], ['', 'healthy  people'], ['', 'immunocompetent Pahang Malaysia'], ['indigenous  that', 'interior Peninsular Malaysia'], ['They', ''], ['7  %', '76 poverty line'], ['', ''], ['poor housing conditions', 'unhygienic illiteracy people'], ['Stool samples', 'small ribosomal RNA gene'], ['', ''], ['bieneusi', '8  individuals'], ['', ''], ['infection', 'commonly  females'], ['', ''], ['', ''], ['', ''], ['infected Orang Asli', '44  years'], ['Diarrhea', 'one  case'], ['', '5  species'], ['findings', 'clearly  E'], ['bieneusi', ''], ['antiparasitic  therapy', 'E'], ['', ''], ['findings', 'similar disease communities'], ['', ''], ['rights', ''], ['BackgroundHuman', 'acute South Africa'], ['', 'molecular EV 2009'], ['Patients MethodsStudy samples', 'polymerase chain reaction'], ['', ''], ['2  %', 'SARI  enterovirus'], ['EV D68', 'EV which'], ['ConclusionsEV D68', 'pathogenic South strains'], ['Dermatologic  findings', 'viral  infection'], ['HSV Zika that', 'cutaneous  neonate'], ['Recent polymerase chain reaction', 'neonatal  prognosis'], ['suppressive  therapy', 'delayed  diagnosis'], ['Food  Administration', 'varicella'], ['Centers', 'severe varicella infection'], ['compound', 'controlled  pleconaril'], ['strain', 'clinical enterovirus sepsis'], ['erythematous palmoplantar rash', '3 human infection'], ['Zika virus infection', 'nonspecific  macular'], ['maternal travel requesting', 'early  diagnosis'], ['others', 'systemic  illness'], ['Recognizing', 'viral  illnesses'], ['Enterovirus', 'common picornavirus clinics'], ['Early  study', 'mainly pathogen culture'], ['Recent  progress', 'molecular pathogen diagnosis'], ['study', 'clinical EV genotyping'], ['94  children', '37  controls'], ['Fluorescent RT PCR', 'positive CT values'], ['primary  screening', 'positive VP4 fragments'], ['37 control 69', 'aseptic EV RNA expression'], ['47 VP1 samples', '53 VP1 segment'], ['Sequencing', 'viral % strain'], ['Fluorescent RT PCR', 'nervous infection efficiency'], ['combined  genotyping', 'further EV typing'], ['EE  literature', 'especially policy circles'], ['comparative EE literature', 'systematically  time'], ['we', 'future  EE'], ['associated  which', 'antibodies'], ['goal', 'circulating HIV-1 strains'], ['various immunization that', 'neutralizing  antibodies'], ['based design that', 'standing HIV-1 vaccine problem'], ['efficient frequency power that', 'peak power ratio'], ['multilevel multiphase buck converter', 'envelope ET'], ['presented multiphase buck converter', 'node duty cycles'], ['multilevel', 'simple power stage'], ['However  complexity', 'digital power control'], ['Detailed  discussion', 'proposed envelope amplifier'], ['minimum driver that', 'envelope slew rate'], ['modified  that', 'modified  control'], ['Finally  prototype', 'nonlinear class F amplifier'], ['when power it', 'constant  voltage'], ['adjacent channel power ratio', ''], ['obtained  results', '5 predistortion technique'], ['assisted supply modulator', 'paper'], ['envelope', 'power amplifiers'], ['controlled linear power amplifier', 'switching modulator'], ['proposed  structure', '0'], ['', ''], ['results', 'two efficiency architectures'], ['It', 'WiMAX  6'], ['', '7 dB 26'], ['8', 'average output 73'], ['5  %', 'proposed  design'], ['', ''], ['', ''], ['rights', ''], ['Purpose Knowledge', 'agricultural  systems'], ['Consideration', 'scientific life cycle decision'], ['aims', 'agricultural production scenarios'], ['burdens', 'LCA methodology'], ['chosen', 'loose cherry tomatoes'], ['study', 'quantitative Monte Carlo simulation'], ['Three  scenarios', ''], ['flows', 'several product sections'], ['climate', 'depletion Recipe USEtox'], ['structure auxiliary equipment', 'environmental cherry tomato production'], ['greatest  impact', 'irrigation fertilizers'], ['GH', 'higher  eutrophication'], ['', '60  100'], ['', '4  GH'], ['LCA', 'environmental Mediterranean area'], ['study', 'environmental  impacts'], ['SAD gene family', 'three  members'], ['Expression', 'soluble Pichia proteins'], ['Purified SAD A', 'antibody rabbits'], ['which', 'two  dimers'], ['SAD genes', 'northern UV blotting'], ['accumulation', 'prolonged UV B irradiation'], ['', ''], ['rights', ''], ['Lignin', 'renewable  nature'], ['Here  we', 'chemical hydrolysis lignin'], ['EHL', 'magnetic self nanospheres'], ['DLS light fourier', 'infrared  spectroscopy'], ['layer pi pi which', '190 size nm'], ['-dropping EHL concentration', 'average  nanospheres'], ['average  diameters', '30  days'], ['structural  features', 'significant preparation process'], ['High preparation temperature', 'volatile  solvent'], ['average  diameter', 'dropping  water'], ['proposed EHL nanospheres', 'based  carrier'], ['', ''], ['', ''], ['rights', ''], ['study', 'Korean lawn grass'], ['3 bp leader which', 'molecular amino acid 41'], ['', ''], ['gene', 'Korean lawn grass genome'], ['binding phosphoenol which', 'aromatic shikimate pathway'], ['Northern blotting zjEPSPS', 'hours  0'], ['', 'wild  samples'], ['higher EPSP synthase activity', 'glyphosate  treatment'], ['featured zjEPSPS gene', 'adoptable management options'], ['students', 'reaction rate'], ['Students', 'catalytic  event'], ['reaction students', 'catalyzed reaction rate'], ['exam activity', 'targeted learning outcomes'], ['Michaelis Menten activity', 'catalyzed reaction rate'], ['Therefore  it', 'initial Michaelis Menten kinetics'], ['', 'International Biochemistry'], ['integrated', 'wearable power sensors'], ['Kinetic models', 'ELBC oxidase performance'], ['', 'maximum power output'], ['ELBC', 'wearable  sensors'], ['anode', 'cyclic  CV'], ['coefficient', 'lactate  refill'], ['', 'Elsevier Ltd'], ['respiratory type chest that', 'corticosteroid  therapy'], ['frequency', 'blood tissue eosinophilia'], ['objective', 'appropriate chest it'], ['153  who', 'Brigham'], ['who', 'cardiac chest treatments'], ['other chest cases', 'suspected chest detail'], ['', 'chest  ischemia'], ['', 'high aspirin reduction'], ['almost  all', 'significant  eosinophilia'], ['chest  pain', 'antianginal  therapy'], ['associated coronary artery which', 'high dose aspirin'], ['early chest treatment', 'corticosteroids'], ['', '2016 Allergy Asthma'], ['', 'gastrointestinal  esophagus'], ['criteria', 'esophageal tissue samples'], ['', 'white  two'], ['one  four', 'luminal EoEM compression'], ['EoEM', 'elevated s IgE'], ['Histology', 'high power field values'], ['', ''], ['', ''], ['', 'epithelium'], ['', ''], ['', 'conventional  epithelium'], ['', ''], ['', 'subepithelium'], ['', ''], ['', 'muscularis propria'], ['Presence', 'downward papillae EoE'], ['', 'EoE'], ['which', 'esophageal EoE EoGDs'], ['Ependymomas', 'pediatric brain tumors'], ['2016 classification pathology', 'localization'], ['total  removal', 'one  looks'], ['role', 'randomized  studies'], ['front line chemotherapy', 'infants'], ['Inclusion', 'ependymoma II protocol'], ['further  inclusion', 'irradiation I II'], ['better  understanding', 'first line patients'], ['Glaucoma', 'higher age groups'], ['patient  age', 'glaucoma'], ['important  results', 'visual  glaucoma'], ['prevalence', 'age'], ['Aging  processes', 'intraocular outflow pressure'], ['ganglion cell axons', 'eye'], ['dependent glia cell mitochondria', 'immune system glaucoma'], ['Patient age', 'prescribed  therapy'], ['main risk which', 'disease'], ['additional  factors', 'glaucoma'], ['young  who', 'major  transmission'], ['Oral CMV shedding', '9 chain reaction months'], ['Three  phases', 'oral  shedding'], ['Viral  expansion', '3  days'], ['viral transition phase load', '6 transition phase weeks'], ['life  shedding', 'infant'], ['oral CMV expansion', 'within reproduction number'], ['immune  that', '44  %'], ['oral CMV shedding', 'viral  expansion'], ['RET proto oncogene', 'Germline  Transfection'], ['distribution', 'RET populations'], ['RET results', 'other  populations'], ['1583  who', 'three RET gene September'], ['Sanger which', 'exons'], ['Mutations', 'ARUP database'], ['RET mutations', 'unrelated  families'], ['', '13  36'], ['1  %', 'codon'], ['', '1  codon'], ['', '620  one'], ['', '8  codon'], ['', '634  one'], ['', '8  codon'], ['', '8  codon'], ['', '8  codon'], ['', '8  codon'], ['', '9  codon'], ['12  p', '611  mutations'], ['', ''], ['distribution', 'other RET populations'], ['Mutations', 'reported  mutations'], ['This', 'possible founder p'], ['', ''], ['further  studies', 'mutational  Denmark'], ['Objectives Sleep problems', 'third  trimester'], ['Previous  studies', 'clinical  groups'], ['We', 'associated pregnancy pregnancy'], ['Methods  We', 'general mother child population'], ['We', 'parametric  questionnaires'], ['Results  We', 'three sleep duration pregnancy'], ['6  %', ''], ['Factors', 'decreasing  trajectory'], ['', ''], ['', ''], ['', 'gestational  age'], ['', ''], ['', ''], ['', ''], ['Sleep duration', 'insomniac symptoms'], ['', ''], ['', 'coefficient  trimester'], ['', ''], ['', ''], ['Restless legs syndrome', 'increasing sleep duration'], ['', ''], ['', ''], ['', ''], ['', ''], ['cesarean  section', 'decreasing  trajectory'], ['Proportion', 'decreasing trajectory group'], ['Birth weight z score', 'increasing trajectory group'], ['specific risk that', 'pregnancy'], ['Taking', 'maternal  health'], ['environmental  signals', 'gene expression'], ['environmental offspring epigenetics', 'new  life'], ['social  it', 'political  dimensions'], ['how commonsense assumptions', 'maternal design care'], ['experiments', 'maternal research trends agency'], ['we', 'environmental knowledge epigenetics'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Features', 'epilepsy spectrum disorder'], ['', ''], ['key phenotypic traits', 'PWE  controls'], ['We', 'ASD controls'], ['epilepsy onset age duration', 'FER'], ['77 Thirty %', 'systematic database search'], ['Analyses', 'reduced  controls'], ['', 'reduced ASD relatives'], ['', ''], ['ToM', 'ASD relatives'], ['weak  associations', 'FER'], ['findings', 'intellectual ASD disability'], ['', ''], ['rights', ''], ['genetic  that', 'severe  seizures'], ['', ''], ['', ''], ['SCN1A sodium channel', 'gated  type'], ['drugs', 'adequately DS patients'], ['clinical  data', '5-hydroxytryptamine drug fenfluramine'], ['zebrafish  that', 'DS'], ['agonists  antagonists', 'abnormal scn1a mutants'], ['antagonist LY ketanserin', 'so LY 310762'], ['when  it', 'sigma(1)-agonist  PRE'], ['study', 'sigma(1  FA'], ['We', 'further  neurotransmitters'], ['', ''], ['g aminobutyric acid', 'FA treatment'], ['neurological  effect', 'therapeutic  compound'], ['epileptiform  activity', 'also 5-HT2C sigma(1'], ['pharmacological  that', 'DS'], ['hermaphroditic  that', 'natural sex change'], ['female  groupers', '42 alpha days'], ['PIN oxide gene', 'cDNA ends polymerase chain reaction'], ['open reading that', '89 amino acids'], ['PCR transcription PIN', 'male  gonads'], ['PIN gene', 'muscle tissue'], ['Western RT transcription', 'gradually  male'], ['female  expression', 'sex proceeds'], ['precise sex role', 'process'], ['', ''], ['rights', ''], ['default mode network', 'episodic  retrieval'], ['many  hypotheses', 'effects'], ['statistically DMN DMN', 'equally rest retrieval'], ['we', 'within rest design'], ['We', 'three pattern conditions'], ['Similarity', 'total  variance'], ['temporal  regions', 'temporal  DMN'], ['', ''], ['temporal cortex cortex', 'preferentially  rest'], ['DMN connectivity', ''], ['emerging  DMN', 'cognitive  demands'], ['', ''], ['', ''], ['Basement membranes', 'epithelial  invasion'], ['expression', 'EMT cancer progression'], ['transcription factor we', 'full 43A laminins'], ['Northern blotting immunofluorescence', '43B 43A SNA cells'], ['4 laminin mRNA', 'laminin-411'], ['Chromatin immunoprecipitation', '4 laminin genes'], ['Immunofluorescence', '43B 43A cells'], ['potently  adhesion', 'laminin-411'], ['', 'extracellular matrix proteins'], ['laminin-411 which', 'directly  Snail'], ['Concomitant  changes', 'binding  receptors'], ['tumor cells', 'invasive  behavior'], ['MicroRNAs', 'transcriptional cleavage gene'], ['EBV Epstein Barr infection', 'coding  e'], ['', ''], ['', 'miR-21  miR-155'], ['MiR-146a', 'innate  immunity'], ['encoded latent membrane protein', '1 NF kappa B'], ['LMP1', 'miR-146a B response elements'], ['LMP1-mutant  deficient', 'kappa B promoter'], ['which', 'standard NF kappa B95'], ['', ''], ['LMP1-deficient P3HR1 mutant', 'less  miR-146a'], ['low LMP1 levels', 'III BL cells'], ['Expression', 'miR-146a P3HR1 levels'], ['miR-146a', 'Sarcoma Herpes virus'], ['induction', 'immune host cell'], ['Increase', 'huge power plants'], ['recent  trends', 'political operating issues'], ['severe stability fault', 'critical  lines'], ['special protection scheme', 'cascading scale effect'], ['enormous SPS cost', 'power outage'], ['paper', 'Korea electric power system'], ['First  characteristic', 'SPS'], ['proper  capacity', 'equal tripping generators'], ['new control method', 'full  utilization'], ['Finally  effectiveness', 'Korea electric power system'], ['major histocompatibility complex I', 'major histocompatibility complex class'], ['ectopic trophoblast', 'immune equine chorionic responses'], ['Immunologic  memory', 'experimental  system'], ['immune survival time', 'subsequent  transplants'], ['male skin grafts', 'multiple syngeneic mice'], ['Eight  mares', 'spaced trophoblast transplants'], ['grafts', 'same histocompatibility antigen exposure'], ['histocompatibility complex histocompatibility I', ''], ['Cytotoxic antibody production', 'immune  transplants'], ['Detection', 'transplant lifespan'], ['', 'immunologic transplant memory'], ['secondary ectopic trophoblast transplants', 'immune  recipients'], ['Mechanisms', 'immune  responses'], ['relatively equine it', 'devastating  horses'], ['', 'reported EHM donkeys'], ['study', '2011  December'], ['incidence', 'EHM June'], ['EHM', 'clinical  paralysis'], ['main  age', '10  years'], ['', ''], ['7  %', 'more  males'], ['incidence', 'affected EHV-1 isolates'], ['results', 'affected  equines'], ['9  %', 'ORF30 genotype'], ['variant', 'one  donkey'], ['isolates', 'geographical  group'], ['fatal  it', 'species'], ['', 'proper management adaptations'], ['it', 'also  donkeys'], ['stressful  that', 'immune  responses'], ['', 'various cancer immunotherapy'], ['Specific  conditions', 'malignant myeloid cells'], ['integrated Unfolded Protein which', 'environmental cell conditions'], ['However  UPR', 'unresolved ER stress'], ['Three  branches', 'requiring  enzyme'], ['we', 'specific tumor development growth'], ['sustained ER stress responses', 'immune  tumors'], ['immunosuppressive  that', 'infiltrating myeloid cells'], ['ErbB2  antibodies', 'functional ErbB2-overexpressing tumors'], ['monoclonal antibody yield', 'mg flask cultures'], ['inefficient  we', 'full length scFv P'], ['', 'low  level'], ['Codon optimization', '3- expression 6'], ['further  increase', 'mainly translation efficiency'], ['scFv expression', 'pH'], ['', ''], ['', '72 h methanol induction'], ['', 'one affinity chromatography'], ['yield', ''], ['A21', 'especially ErbB2-targeted immunotherapy'], ['', ''], ['rights', ''], ['encodes', 'several  populations'], ['', 'Han Chinese Han population'], ['case control study', 'healthy  men'], ['medical  history', ''], ['ED  severity', 'IIEF-5 Erectile score'], ['polymerase chain reaction', 'three Sanger NOS3'], ['IIEF-5 scores', 'different  sildenafil'], ['frequencies', 'matched control group'], ['', ''], ['', 'alleles'], ['', ''], ['', ''], ['', ''], ['', ''], ['015', 'significantly NOS3 ED'], ['increased  risk', 'earlier risk genotype carriers'], ['', ''], ['', ''], ['Patients', 'risk IIEF-5 genotype'], ['', ''], ['', '12'], ['', ''], ['', ''], ['', ''], ['influence', 'T-786C G894 sildenafil'], ['detectable  effect', 'Han Chinese Han population'], ['Han Chinese Han which', 'limited  study'], ['results', 'Han Chinese Han population'], ['paper', 'sequences analysis'], ['', 'plain control panels'], ['panels', 'digital clock speedometers'], ['Subjects', 'appropriate  button'], ['females', 'covert attention men'], ['Moreover  article', 'examined control outcomes'], ['Chinese mitten crab', 'cultivated Chinese 2015'], ['explore', 'meta transcriptomic HPND'], ['Comparison analyses', 'diseased  crabs'], ['Bacteroidetes Proteobacteria', '93  %'], ['striking  shift', 'microbial  HPND'], ['Tenericutes', 'diseased  crabs'], ['82  prevalence', 'healthy  crabs'], ['', ''], ['prevalence', 'significantly  HPND'], ['', '49  HPND'], ['', ''], ['also  prevalence', 'HPND'], ['', '70  disease'], ['', ''], ['bacterial  family', 'polymerase chain reaction'], ['', 'diseased  crabs'], ['HPND', 'clearly  HPND'], ['CHH  family', 'significant Y crustaceans'], ['', 'complete cDNA MIH'], ['DQ341280', 'Chinese Eriocheir 5'], ['full length cDNA', 'mature amino peptide'], ['deduced amino acid sequence', 'typical CHH domain'], ['Transcripts', 'Northern Ers MIH blotting'], ['production', 'recombinant Escherichia coli'], ['', ''], ['two peptide fragments', 'deduced Ers MIH'], ['', 'E'], ['mediated sinensis suppression', 'rErs ecdysteroidogenesis'], ['Accumulation', 'dependent  0'], ['ecdysteroid secretion', 'significantly  0'], ['8-Br cGMP concentration', 'ecdysteroid  releasing'], ['study', 'molt cycle regulation'], ['', ''], ['rights', ''], ['', ''], ['lipid  that', 'coupled  receptors'], ['', 'human cancer cell lines'], ['', ''], ['Receptor expression', 'Northern RT blotting'], ['Cellular  responses', 'proliferation assays phosphoprotein'], ['', ''], ['', 'cell lines LPA'], ['LNCaP', 'LPA'], ['only  EGF', 'LNCaP'], ['PC-3 Akt', 'EGF LPA'], ['constitutively  EGF', 'further  phosphorylation'], ['FAK', 'LNCaP'], ['', 'different cell lines'], ['lipid  mediators', 'LNCaP'], ['Du145 S1P', 'cellular  LPA'], ['', ''], ['when Erk Akt', 'signal cancer cell lines'], ['Other  responses', 'cellular PLD outcomes'], ['', ''], ['', ''], ['Bacteriorhodopsin', 'technology  studies'], ['extensively bacteriorhodopsin studies', 'present  measurements'], ['Further  impacts', 'photoelectric  measurements'], ['we', 'dry bacteriorhodopsin sensor'], ['information', 'when photocurrent measurements'], ['ships nuclear command system', 'visual information interface'], ['paper studies', 'visual cognition theory'], ['design which', 'operation information processes'], ['HERA failure identification we', 'complex information interface'], ['Erythema nodosum leprosum', 'lepromatous leprosy patients'], ['It', 'economic leprosy patients'], ['understanding', 'ENL'], ['immunological T cells that', 'ENL'], ['Searches', 'PubMed'], ['Studies', 'published  ENL'], ['eligible  studies', 'systematic  review'], ['mediated  presence', 'ICs'], ['Increased  levels', 'necessarily tumor necrosis initiation'], ['multiple  studies', 'peripheral  ENL'], ['Microarray data', 'new  ENL'], ['Studies', 'different laboratory techniques'], ['standardized  approach', 'issues'], ['ENL', 'immune  system'], ['clinical  descriptions', 'greater genomics epigenomics condition'], ['Congenital  causes', 'molecular  them'], ['', 'large oxygen place'], ['aim', 'diagnostic  disorders'], ['current  we', 'expert France'], ['we', 'international oxygen database'], ['specialized  hemoglobins', 'increasingly oxygen clinicians'], ['Phenotypic  it', '5  years'], ['87 oxygen %', 'phenotypic techniques'], ['direct  measure', 'poor Hemox apparatus'], ['high oxygen it', 'further  investigations'], ['molecular biology it', 'definitely  diagnosis'], ['It', 'first laboratory practice'], ['Rheumatoid  arthritis', 'inflammatory RA pathogenesis'], ['IL)-18', 'positive  RA'], ['1 erythroid differentiation which', 'DBA/1J animal mice'], ['Treatment', 'collagen IgG IgG1 CIA'], ['expression', 'affected rErdr1-treated mice'], ['Erdr1  treatment', 'synovial fibroblast migration'], ['', 'various cell types'], ['rErdr1  treatment', 'therapeutic  RA'], ['Testing', 'integral treatment decisions'], ['procedures', 'false  outcomes'], ['review', 'such erythropoietin receptor'], ['where bone it', 'red blood cell Epo'], ['cancer EpoR', 'endothelial tumor cells'], ['immunohistochemistry  Northern', 'Western  assays'], ['review', 'methods'], ['such cell surface results', 'current receptor biology'], ['present  study', 'ESCC cell progression'], ['mRNA expression levels', 'reverse polymerase chain reaction'], ['expression levels', 'factors'], ['carcinoma tissues expression levels', 'significantly organ group'], ['HOTAIR expression levels', 'differentiated  cancer'], ['cadherin protein expression levels', 'para carcinoma tissues'], ['significantly protein expression levels', 'significantly organ group'], ['HOTAIR mRNA expression levels', 'cadherin expression levels'], ['mRNA expression levels', 'catenin mRNA expression levels'], ['related  detection', 'early  diagnosis'], ['formerly phylogroup that', 'multidrug resistance'], ['87 multilocus that', 'typical  uidA'], ['', 'specific beta glucuronidase'], ['95 % confidence interval', '100 % sensitivity'], ['distant  that', 'purified template DNA'], ['Thus  novel', 'diagnostic  PCR'], ['coli', 'STc648'], ['Escherichia coli', 'sole carbon source'], ['', 'single rbsDACBK operon'], ['ribose affinity RbsD', 'd ribose'], ['type transcription which', 'downstream ribose operon'], ['present rbs operon', 'only  RbsR'], ['however  we', 'nucleotide rbs metabolism'], ['RbsR', 'nucleotide salvage synthesis'], ['RbsR', 'purine de novo nucleotides'], ['Matrix metalloproteinases', 'carcinoma cell invasion'], ['epithelial  association', 'MMPs'], ['ESE-1', 'transcriptional cell MMP-9'], ['HSC-3', 'oral SCC lines'], ['expression', 'situ  hybridization'], ['assay gelatin zymography', 'gelatinolytic ESE-1 transfectants'], ['Luciferase assays', 'transcriptional MMP-9 promoter ESE-1'], ['invasive  MMP-9', 'oral SCC tissues'], ['ESE-1', '92 kDa gelatinolytic transfection'], ['ESE-1', 'negative MMP-9 ESE-1'], ['ESE-1', 'transcriptional  MMP-9'], ['overall survival rate', ''], ['Traditional  treatment', 'new  treatments'], ['cancer type', 'normal  tissue'], ['immune  which', 'immune  surveillance'], ['review', 'therapeutic immunotherapy EC'], ['Radiotherapy', 'squamous cell carcinoma'], ['However tumor cells', 'thereby treatment efficacy'], ['ESCC cells', 'associated  biomarkers'], ['Eca109  cells', '60  Gy'], ['MTT', 'radiation biology cells'], ['Cell cycle distributions', 'flow cytometry'], ['polymerase chain reaction', 'epithelial mesenchymal transition'], ['Eca109R60/2Gy  cells', 'parental clone cells'], ['Eca109R60/2Gy cells', 'increased S phase'], ['Additionally apoptosis rate', 'parental  cells'], ['significantly cadherin levels', 'Eca109  cells'], ['radioresistance', 'EMT'], ['Early  diagnosis', 'important cell prognosis'], ['transcript antisense RNA', 'oncogenic HOXC ESCC'], ['serum HOTAIR', 'ESCC'], ['we', 'real polymerase chain reaction'], ['serum HOTAIR', 'TNM stage'], ['', 'serum HOTAIR'], ['', ''], ['', 'healthy ESCC controls'], ['', ''], ['', ''], ['', ''], ['ROC curve analysis', 'ROC curve ROC 0'], ['', ''], ['', '0'], ['', ''], ['', ''], ['Also HOTAIR expression level', 'preoperative  specimens'], ['', 'significant Pearson correlation analysis'], ['first serum HOTAIR', 'potential  ESCC'], ['MMR MutL homolog', 'genomic  integrity'], ['Methylation', 'numerous glioblastoma colorectal ovarian'], ['present MLH1 promoter methylation', 'squamous cell carcinoma'], ['embedded ESCC tissues', 'male  patients'], ['MLH1 promoter methylation', 'specific chain reaction approach'], ['Kaplan Meier survival curves', 'overall MLH1 promoter ESCC'], ['Cox regression analysis', 'crude hazard ratios'], ['MLH1 promoter methylation', '53/87'], ['', 'male  ESCC'], ['MLH1 promoter hypermethylation', 'poorer  ESCC'], ['', ''], ['MLH1 promoter hypermethylation', 'male  ESCC'], ['', ''], ['', ''], ['', ''], ['Therefore MLH1 promoter hypermethylation', 'male  ESCC'], ['brown Nilaparvata lugens', 'major  Asia'], ['', 'Extensive  insecticides'], ['lugens', 'frequent control field'], ['aim', 'present field N'], ['', 'various South insecticides'], ['We', 'transferases detoxifying GSTs'], ['Moderate  levels', 'field thiamethoxam'], ['', ''], ['92', ''], ['', ''], ['', ''], ['', ''], ['09', 'low  imidacloprid'], ['', ''], ['', '70  etofenoprox'], ['', ''], ['', ''], ['EST activities', 'field populations'], ['', '3'], ['susceptible  ratios', '1'], ['', '3'], ['', ''], ['', '1'], ['', ''], ['EST activity', 'resistance'], ['', ''], ['', ''], ['high selection pressure', 'multiple insect growth failures'], ['results', 'effective IPM BPH'], ['work', 'Pseudomonas aeruginosa crude complexes'], ['CECs', 'different corn substrates'], ['', 'best  rhamnolipids'], ['', 'mN % surface m'], ['g  L', '30 degrees ESB'], ['fermented  bagasse', 'potential  energy'], ['findings', 'P'], ['', ''], ['cerevisiae', 'fermented  bagasse'], ['', ''], ['rights', ''], ['Responsible  conduct', 'undergraduate Western Australia'], ['undergraduate  lecture', 'responsible  research'], ['Third year student groups', 'human  research'], ['Academic  staff', 'discussions'], ['Students', 'interactive capstone Honours movie'], ['survey', 'student  perceptions'], ['Data', 'Strongly  Agree'], ['RCLR', 'further % area'], ['Free entry comments', 'constructive  improvement'], ['RCLR modules', 'valuable pharmacology undergraduate curriculum'], ['approach', 'specific science undergraduate topics'], ['', 'International Biochemistry'], ['Witch Hunt Narrative', 'moral  issues'], ['society', 'sexual  children'], ['moral  concerns', 'key child abuse cases'], ['article', 'institutional research interest'], ['whistle it', 'ethical  wrongdoing'], ['child welfare law professionals', 'sexual abuse victims perpetrators'], ['Adding', 'significantly mobility transfer'], ['RNA that', 'different denaturation conditions'], ['We', 'heterologous DNA probes'], ['fluorescent intensity', 'previously amount denaturation time'], ['g mL EtBr', 'heterologous DNA probes'], ['heterologous blot concentration', '30  mu'], ['only  that', 'also  probe'], ['based  work', 'gender  SG'], ['', ''], ['', ''], ['study', 'mental  health'], ['', 'representative Adolescent Health 1306'], ['', '4 SG minority whom'], ['3  %', ''], ['status minority ethnicity', 'mental  distress'], ['Generally  speaking', 'Zealand European New Zealand students'], ['double minority students', 'communities New Zealand'], ['paper', 'contemporary  China'], ['It', 'authoritarian economy systems'], ['western xibu da paper', 'ethnicity streetlight imagery provision'], ['It', 'also  period'], ['ethnic minority concentration', 'western  provinces'], ['autonomous  provinces', '10-year minority period'], ['counties', 'opposite  trend'], ['political  control', 'Chinese state implements'], ['', ''], ['', 'Elsevier Ltd'], ['Matrix metalloproteinase', 'malignant  tumors'], ['type IV that', 'membrane type'], ['MT1-MMP', 'critical tumor progression'], ['We', 'malignant melanoma cell melanoma'], ['expression', 'Northern melanoma blotting'], ['expression level', 'vitro  invasion'], ['when  E1AF', 'RNA interference'], ['E1AF', 'up MT1-MMP expression'], ['', ''], ['', ''], ['', 'S'], ['salsa', 'saline  environments'], ['increased  growth', 'cellular water sodium'], ['', ''], ['salsa', 'salt leaves'], ['Thus  plant', 'vacuoles'], ['proton that', 'increased sodium vacuole'], ['we', 'inorganic membrane S'], ['', ''], ['SsVP cDNA', '764 amino acids'], ['SsVP', 'leaves'], ['activities', 'NaCl type stresses'], ['Overexpression', 'transgenic drought Arabidopsis'], ['Jackals', 'phylogenetic  wolf'], ['Thus  they', 'diverse transmission routes'], ['Recently  populations', 'Eurasian Western Europe'], ['aim', 'domestic Romania Czech dogs'], ['PCR DNA amplifications', '70  Hepatozoon'], ['', 'individual Leishmania infantum'], ['Phylogenetic  analyses', 'sequenced 18S rDNA H'], ['', ''], ['18S  sequences', 'golden Theileria jackals'], ['single  animal', 'PCR Dolj L'], ['', 'also ITS1 5'], ['', ''], ['Apparently  expanding', 'new Central Europe'], ['', 'Theileria annae'], ['canis', 'further  parasites'], ['', 'Also  L'], ['infantum', 'attention'], ['that', 'analogous North America'], ['article', 'European state levels'], ['empirical member state preferences', 'Court'], ['greater  attention', 'political ECJ jurisprudence'], ['individual  decisions', 'expansive case law fashion'], ['judicial  it', 'European state policy making'], ['temporal  which', 'identifiable  beginnings'], ['functions', 'two  boundaries'], ['beginnings', 'more causal power'], ['lay  additions', 'previous  affairs'], ['beginning  advantage', 'annual  seasons'], ['when  they', 'historical  movements'], ['what', 'conclusions'], ['beginning  advantage', 'historical  importance'], ['', ''], ['', ''], ['rights', ''], ['conglomerate layer', 'several Donying periods'], ['It', 'difficult sedimentation geologists'], ['paper', 'astronomical turbidity study'], ['conglomerate we', 'same formation period'], ['stratigraphy cycle', 'MSC1 eccentricity 189'], ['', ''], ['', ''], ['Milankovitch theory', 'petrographic  analysis'], ['stratum', 'four IV grade sequences'], ['information', 'significant Milankovitch wave log'], ['we', 'further conglomerate detail'], ['', ''], ['', ''], ['complete  sequence', 'inferential  aggression'], ['neural brain activity', 'real  life'], ['critical  that', 'nonhostile  behavior'], ['nonaggressive Thirty individuals', 'study'], ['hostile N400 that', 'nonaggressive  individuals'], ['nonhostile  which', 'attributional  bias'], ['Expectancy Violation paradigm', 'hostile  others'], ['', ''], ['', ''], ['', ''], ['', ''], ['mental event construal', 'syntactic  structure'], ['This', 'well causation event participants'], ['', 'Less  syntax'], ['event that', 'six count studies'], ['durative  events', 'transitive mass frame'], ['Durative  verbs', 'semantic duration estimates'], ['syntactic  structure', 'systematically  event'], ['', ''], ['', 'Elsevier Inc'], ['triggered  control', 'certain control performance'], ['majority', 'proposed regulation problems'], ['triggering  condition', 'guaranteed  paper'], ['quadratic control design problem', 'LMI optimization problem'], ['Comparisons', 'proposed  strategy'], ['effective  approach', 'early child maltreatment prevention'], ['they', 'different  foci'], ['article', 'based  Teachers'], ['qualitative model feedback', 'braided pilot curriculum'], ['implementation  that', 'comprehensive  maltreatment'], ['vocal  communication', 'many nonhuman features'], ['combinatorial  that', 'pragmatic  inference'], ['ancestors', 'similar  communication'], ['common  many', 'distinctive  features'], ['conflicting  situation', 'contemporary  biology'], ['', ''], ['scientific  that', 'different  way'], ['concepts', ''], ['urgently  contradictions', ''], ['two stage comparator', 'colliding bodies optimization'], ['internal control algorithm', 'internal control parameter'], ['main  objective', 'better performance circuits'], ['based design design', 'desired  specifications'], ['required  functionalities', ''], ['based  approach', 'other power dissipation etc'], ['', 'examples'], ['', ''], ['Recurrent gene fusions', 'clear salivary gland'], ['We', 'pathologic ATF1 entities'], ['Tumors', 'equal sex distribution'], ['2  1', ''], ['Histologically  tumors', 'like myxoid background'], ['except  1', 'unique sunburst amianthoid fibers'], ['Immunohistochemically tumors', 'epithelial membrane antigen'], ['perirectal RNA which', 'situ polymerase chain reaction'], ['second  case', 'similar meningeal tumor'], ['remaining  cases', '2 EWSR1-CREB1 1'], ['we', 'intracranial myxoid mesenchymal locations'], ['myxoid none', 'novel  entity'], ['paper', 'synchronous power system'], ['electromotive state that', 'electromotive state variable'], ['mathematical  model', 'measurable  variables'], ['Furthermore control law', 'also voltage regulation'], ['digital control performance', 'synchronous power system'], ['Experimental  results', 'PSS2A transmission stabilizer'], ['experimental  results', 'conventional PI voltage controller'], ['proposed  stabilizer', 'well generator stability limit'], ['', ''], ['', ''], ['rights', ''], ['optimized', 'numerical semiconductor microcavity'], ['Exciton polaritons', 'strongly  excitons'], ['They', 'potential  applications'], ['numerical  modeling', 'differential  evolution'], ['we', 'efficient Runge Kutta computations'], ['algorithms', 'parallel vector instructions'], ['EPCGP which', 'theoretical exciton polaritons'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['html Program', 'University Belfast N'], ['', ''], ['', 'distributed test data etc'], ['', ''], ['', 'distributed test data etc'], ['', ''], ['', 'OpenMP extensions'], ['', 'AMD  processors'], ['', ''], ['code', 'single run Classification'], ['', ''], ['exciton polariton superfluid', 'high exciton polaritons spin'], ['They', 'integrated  circuits'], ['This', 'out semiconductor microcavity'], ['standard  GP', 'frameworks'], ['Finding', 'theoretical exciton polaritons'], ['Runge Kutta method', 'differential exciton polariton superfluids'], ['method', 'exciton polariton equations'], ['C++ programs', 'fully computer hardware'], ['', '100 ps parameters'], ['', ''], ['rights', ''], ['Interest', 'intermediate  psychopathology'], ['central  question', 'executive response speed'], ['conceptual  models', 'diagnostic  hierarchy'], ['641  age', 'executive function processing speed'], ['internalizing', 'differentially  EF'], ['antisocial deficit hyperactivity substance', 'disorders'], ['Speed', 'overall severity model'], ['most response speed', 'psychopathology liability'], ['Results', 'general  psychopathology'], ['Bangor Gambling Task', '20 BGT trials'], ['This', 'healthy brain controls'], ['study', 'also task performance'], ['thirty nine thirty controls', 'working memory working function'], ['total BGT groups', \"cut  impaired'performance\"], ['three  survivors', 'cluster'], ['only  age', 'overall BGT performance'], ['based decision number', 'clinical  BGT'], ['exendin-4 difference', 'microRNA target gene'], ['three  groups', '4 dose group dosage'], ['', ''], ['pancreatic  tissue', 'morphology biology analysis'], ['specimen', 'locked acid array system'], ['real fluorescent quantitative PCR', 'microRNA screen significant'], ['gradually islet frame', 'control group D'], ['islet hypertrophy', 'pancreas'], ['down  miRNA-1', 'which'], ['target genes', 'microRNA apoptosis glucose metabolism'], ['expression', 'pancreatic NOD rats'], ['expression file', 'pancreatic NOD rat exendin-4'], ['differential  expression', 'NOD pancreatic NOD trauma'], ['4 NOD mice', 'pancreatic tissue size'], ['This', 'pancreatic diabetes prevention'], ['recent resistance exercise', 'considerably host immunobiology'], ['systematic  process', 'resistance exercise'], ['systematic  review', 'acute leukocyte counts'], ['systematic literature search', 'electronic date 1989'], ['eligibility criteria', 'acute leukocyte counts'], ['Specific exclusion criteria', ''], ['Risk', 'PEDro scale'], ['', 'present narrative review'], ['single  bout', 'acute monocytosis neutrophilia'], ['reviewed  literature', 'sufficient time blood'], ['researchers', 'temporal blood effects'], ['acute neutrophilia monocytosis', 'low dose resistance exercise'], ['induced cell trafficking changes', 'metabolic  factors'], ['Physical  aptitude', 'induced lymphocyte trafficking responses'], ['', '2016 Immunological Societies'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['different  forms', 'immune  function'], ['how  exercise', 'cancer treatment'], ['beneficial  effects', 'patient cancer immunotherapy'], ['We', 'male varying fitness'], ['Subjects', 'separate cycling visits'], ['Leukocytes', '50 collection sample'], ['We', 'dependent exercise intensity'], ['natural killer cells', 'greatest  5'], ['immediately maximal granulocytes', '3 maximal exercise'], ['', ''], ['intense endurance exercise', 'attenuated  leukocytosis'], ['elevated T cells', 'death-1  PD-1'], ['several  presence', 'related fitness parameters'], ['leukocytes subsets', 'peripheral  exercise'], ['compositional  differences', 'various fitness parameters'], ['', 'important splenic T lymphocytes'], ['Swiss Male mice', 'randomly control group'], ['EG mice', '3  months'], ['Lymphocytes', 'intracellular Fura-2(AM'], ['combination', 'succinimidyl ester cell proliferation'], ['-regulating genes', 'quantitative polymerase chain reaction'], ['Results', 'significantly  CG'], ['', ''], ['Ca2+](i  transients', 'EG phytohemagglutinin concanavalin <'], ['', ''], ['However  differences', 'thapsigargin'], ['', ''], ['T cells', 'induced proliferation CG'], ['', ''], ['', ''], ['', 'such STIM1 Cav2'], ['ORAI1 MCU TRPM5', 'significantly  P'], ['', ''], ['', ''], ['moderate  exercise', 'Ca2 murine splenic lymphocytes'], ['', 'such cell proliferation'], ['downregulation', 'elevated intracellular Ca2'], ['based generation energy system', 'water electricity heating cooling'], ['exergetic  analysis', 'proposed  system'], ['', 'important  variables'], ['', ''], ['electrical production unit cost', 'total unit products'], ['energy  efficiencies', 'about multigeneration 34'], ['', ''], ['', ''], ['total unit cost', 'approximately  23'], ['', ''], ['', '185 degrees C'], ['', 'C Elsevier Ltd'], ['Life Cycle Assessment', 'energy systems'], ['unified life this', 'main Life Cycle Assessment'], ['Input Output analysis', 'national Input Output economies'], ['national  MIOT', 'hence Input Output model'], ['renewable  exergy', 'appropriate performance ELCA'], ['introduced  model', 'Italian power context'], ['renewable  exergy', 'analyzed  construction'], ['', ''], ['', ''], ['net  that', 'renewable resources requirements'], ['joint  application', '7938 electricity toe'], ['', ''], ['rights', ''], ['related  that', 'fibrillar  body'], ['exfoliation which', 'common  blindness'], ['Recent  developments', 'inherited genetics cell disease'], ['review', 'future pathogenesis identifies research'], ['', 'C Elsevier Ltd'], ['Exosomes', 'intercellular  communication'], ['recently  us', 'deeper RNA transcriptomes'], ['we', 'exosomal epithelial cell proteins'], ['derived cancer which', 'derived  exosomes'], ['next generation sequencing technology', 'coding  exosomes'], ['available  we', 'coding  RNAs'], ['', 'abundant hsa libraries'], ['expression levels', 'reverse polymerase chain reaction'], ['result', 'gastric  cancer'], ['also novel microRNA they', 'also novel microRNA candidates'], ['research', 'differential RNA exosomes'], ['BACKGROUNDStereotactic body radiation therapy', 'dose radiation treatments'], ['concerns', 'related  toxicity'], ['authors', 'related prostate SBRT'], ['consecutive  men', 'institutional prostate protocol'], ['HRQOL Cancer Index data', '5  years'], ['EPIC-26', '5  domains'], ['primary  endpoint', 'EPIC-26 multidomain decline'], ['high risk disease', '20 androgen deprivation therapy'], ['', 'to  patients'], ['', 'baseline bowel HRQOL'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'independently multidomain decline'], ['%', 'such cancer disease'], ['long multidomain majority', 'significant multidomain treatment'], ['other comorbid that', 'overall  HRQOL'], ['', ''], ['', ''], ['', 'global term life'], ['poor bowel function', 'increased multidomain decline'], ['alpha expansin alpha gene', 'raspberry'], ['Expression', 'ripening raspberry fruits'], ['level', 'later fruit stages'], ['expression', 'closely raspberry fruits'], ['propane-1-carboxylic acid synthase that', 'limiting ethylene production'], ['Transcript  accumulation', 'later  fruit'], ['ethylene', 'RiEXPA1 raspberry fruit'], ['results', 'climacteric RiACS1 fruits'], ['', ''], ['rights', ''], ['rather  who', 'victim sensitivity'], ['labeled person that', 'negative  expectations'], ['findings', 'different personality psychology'], ['explicit support weight predictions', 'perceptual  weight'], ['weight', 'learned  weight'], ['multiple  that', 'specific  way'], ['updating', 'focused lifting attention'], ['where size participants', 'full  attention'], ['weight we', 'inverted size weight objects'], ['when  mode', 'inverted  illusion'], ['inverted lifting forces', 'objects'], ['focused  attention', 'when object weight'], ['', ''], ['', ''], ['rights', ''], ['digital  set', 'admissible control actions'], ['Coupled', 'attractive control formalism'], ['However  design', 'admissible control sets'], ['driven  method', 'nonlinear output systems'], ['design', 'nonlinear support vector machines'], ['used MC SVM algorithms', 'driven Q EMPC'], ['Extensive  testing', 'proposed 5-D methodology'], ['concept', 'positive  life'], ['highly maternity that', 'ill childbirth health'], ['well  research', 'such stress anxiety'], ['primary  aim', 'developed Well questionnaire'], ['cohort study', 'being hospital measures'], ['exploratory factor analysis', 'same WiP time'], ['overall  alpha', 'WiP'], ['', ''], ['two WiP factors', 'positive  Cronbach'], ['', ''], ['', ''], ['overall WiP score', 'being scale scales'], ['', ''], ['', ''], ['how well being', 'important life stage'], ['psychometric  data', 'WiP questionnaire'], ['women', 'well  being'], ['potent plant we', 'stable medicine herb motherwort'], ['in protein', 'fungi'], ['Then cDNA encoding LJAMP2', 'rapid amino acid sequence'], ['', 'specific lipid transfer proteins'], ['like  gene', 'seeds'], ['Overexpression', 'visible plant growth'], ['data', 'antifungal disease plants'], ['10  isoforms', 'various fatty tissues'], ['FABP  we', 'external FABP standards'], ['', 'individual FABP tissue'], ['three  12', 'particular  tissue'], ['single FABP isoform', 'certain  level'], ['results', 'FABP  mammals'], ['Superoxide', 'oxidative  plants'], ['SODs', 'prosthetic Zn metals'], ['We', 'rapid cDNA ends'], ['ThCSD  gene', '456 reading bp'], ['152-amino acid polypeptide', 'molecular  15'], ['', 'pI  5'], ['', ''], ['Recombinant ThCSD Recombinant protein', 'native Escherichia gel'], ['sodium ThCSD', 'sodium azide'], ['ThCSD', 'roots'], ['when  plants', 'when UVB light'], ['ThCSD', 'environmental  conditions'], ['functional  that', 'pigment melanocytes'], ['aim', 'native duck ducks'], ['34  individuals', '12 duck polymorphisms'], ['nucleotide  polymorphisms', 'coding acid changes'], ['four  SNPs', 'seven duck breeds'], ['exact  test', 'possible MCIR gene polymorphisms'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Arg217Cys', 'deduced  genotypes'], ['', ''], ['', 'plumage color phenotypes'], ['highest Nageswari duck which', 'black  phenotype'], ['identified  polymorphisms', 'Asian duck breeds'], ['Extended spectrum beta bacteria', 'several  carbapenems'], ['however  that', 'clinical  setting'], ['we', 'oncology immunology care unit'], ['ESBL E ESBL outbreak', 'molecular microbiology techniques'], ['We', 'molecular microbiology typing strain'], ['typical  prevalence', 'ESBL E unit'], ['', 'month'], ['', 'week'], ['prevalence', 'target research period'], ['', 'month'], ['', 'week'], ['', '19  isolates'], ['', ''], ['four control that', 'inpatient  hospital'], ['', 'field gel K'], ['pneumoniae', 'one control strain'], ['', 'ESBL K'], ['strains', 'other control SHV'], ['result', 'direct DNA sequencing'], ['', 'K'], ['pneumoniae', 'PFGE ESBL E'], ['coli', 'individual ESBL gene patterns'], ['pattern', 'more antimicrobial K'], ['', 'E'], ['', ''], ['Typing', 'various PCR organisms'], ['two  outbreaks', 'same transmission unit'], ['clinical  transmissibility', 'strain'], ['patient  transmission', 'individual ESBL strain'], ['antisocial behavior problems theory', 'empirical research literature'], ['why application limits maltreatment', 'best behavior association'], ['purpose', 'intervening child welfare services'], ['life course', 'social learning perspective'], ['', 'conceptual child welfare model'], ['policy  implications', 'welfare workers administrators'], ['', ''], ['rights', ''], ['', 'structural ADAMTS features'], ['long spacer which', 'six N glycosylation sites'], ['linked matrix binding carbohydrate', '20  mass'], ['', ''], ['', 'northern mouse liver blotting'], ['', 'third mouse embryogenesis gestation'], ['mRNA', 'skeletal muscle liver bronchial'], ['Immunohistochemical  localization', 'mRNA expression'], ['myogenic  precursors', 'myogenic  differentiation'], ['', 'coordinately muscle differentiation'], ['Furthermore activation', 'also determinant Adamtsl2'], ['mRNA', 'integral  myogenesis'], ['', ''], ['', ''], ['', 'Matrix Biology'], ['rights', ''], ['detection', 'regulatory plant functions'], ['It', 'nascent operation field'], ['18 plant miRNAs', 'reverse polymerase chain reaction'], ['values', 'standard qRT concentrations'], ['Sixteen miRNAs', 'human  juice'], ['CT values', 'standard linear curves'], ['high basal 6', 'physiological absorption 0'], ['', '04  1'], ['', ''], ['Northern  blotting', 'qRT PCR results'], ['Critical  issues', 'such RNA extraction'], ['', ''], ['', 'Elsevier Inc'], ['This', 'open NC ND license'], ['Evolution', 'lymphatic  spread'], ['mechanisms', 'metastatic lymph niche'], ['We', 'sentinel lymph node'], ['Importantly  phenotype', 'prior nodal metastasis'], ['Herein  we', 'specific  DCs'], ['DCs', 'treated MIP-1 DCs'], ['S100A8 protein which', 'similar melanoma EVs'], ['similar  EVs', 'afferent lymphatic fluid ex vivo'], ['DC maturation', 'draining  patients'], ['Extracellular vesicles', 'inter tumor growth'], ['multiple  that', 'distant mesenchymal organs'], ['derived  exosomes', 'detached cancer cells'], ['we', 'multiple  metastasis'], ['Future research directions', 'biological cancer diagnosis prognosis'], ['significant cell they', 'significant cell communication'], ['Extraskeletal myxoid chondrosarcoma', 'high tissue metastases'], ['clinical sequencing we', 'actionable  mutations'], ['We', 'reported EMC patients'], ['six  patients', 'clinical sequencing research study'], ['normal  samples', 'normal tumor transcriptome'], ['expression levels', 'KDR PDGFRA KIT RET FLT1'], ['genomic  abnormalities', 'patient  tumors'], ['RET expression', 'other  liposarcoma'], ['', ''], ['folate receptor', 'two  patients'], ['mutational  profile', 'pathognomonic  translocation'], ['clinical  significance', 'RET EMC'], ['molecular  that', 'clinical  setting'], ['neuropsychological motor battery', 'such  purposes'], ['We', 'healthy attentional abilities participants'], ['healthy  subjects', 'cognitive Digit Sequencing efficiency'], ['usability Depression Inventory questionnaire', 'anxiety'], ['Significant  correlations', 'working memory abilities'], ['poor  correlations', 'FAB'], ['Usability aspects', 'working memory abilities'], ['cognitive  participants', 'independently  motor'], ['Further  studies', 'motor verbal motor impairments'], ['epigenetic  which', 'increased tyrosine phosphorylation'], ['possible feedback mechanism', 'gastric  cancer'], ['705 EZH2 expression', 'normal  IHC'], ['EZH2', 'western GC cell blot'], ['p STAT3 protein', 'western  blotting'], ['EZH2 expression', 'electrophoretic mobility shift assay'], ['EZH2 expression', 'factor COX regression'], ['EZH2 expression', 'GC cells'], ['STAT3 signaling', 'EZH2 GC'], ['', ''], ['transcriptional  factor', 'relative promoter region'], ['STAT3', 'poor  survival'], ['', ''], ['Patients', 'worse p others'], ['', 'advanced TNM staging'], ['', ''], ['siSTAT3  A', 'apoptotic  cells'], ['It', 'GC treatment'], ['EZH2 inhibitor', 'novel GC treatment'], ['EZH2 expression', 'GC patients'], ['new  that', 'groups'], ['metal that', 'phosphate 2016'], ['putative AlF30 which', 'transition state'], ['interpretation', 'molecular phosphate biology'], ['Review', 'comprehensive  uses'], ['binding fatty protein', 'gut Branchiostoma belcheri'], ['It', 'approximately amino 15'], ['', ''], ['vertebrate fatty it', 'vertebrate  FABPs'], ['lower hind it', 'also  endostyle'], ['hepatic  caecum', 'later 2-day larvae'], ['hepatic I caecum', 'vertebrate  liver'], ['older gender recognition which', 'similar  affordances'], ['facial  gender', 'particular gender discrimination'], ['issues', 'controlled memory attention'], ['those', 'attentional expression decisions'], ['stimulus attributes', 'attentional  control'], ['Individuals', 'facial affect recognition'], ['how  impairments', 'overall  TBI'], ['worse  performance', 'social  functioning'], ['Forty seven Forty individuals', 'social QoL mood'], ['TBI group', 'significantly  FEIT'], ['who', 'poorer  QoL'], ['who', 'greater  fatigue'], ['facial emotion which', 'genetic  liability'], ['impairment', 'generalized  dysfunction'], ['', 'genetic emotion liability'], ['27 degree controls', 'emotional resonance faces'], ['emotion age relatives', 'intact  performance'], ['Patients', 'prefrontal  cortex'], ['prefrontal  region', 'social recruitment patients'], ['greater  deactivation', 'similar age discrimination'], ['common  patterns', 'facial emotion recognition'], ['intact brain activation', 'genetic  behaviour'], ['compensatory mode network that', 'intact  performance'], ['emotional  which', 'others'], ['social  little', 'developmental  process'], ['infants', 'emotional  expressions'], ['old corrugator they', 'visual  emotions'], ['unimodal emotion stimuli', 'neutral  vocalization'], ['500 stimulus which', 'facial  mimicry'], ['unimodal emotion stimuli', 'corresponding  muscles'], ['emotional  information', 'five  age'], ['resistant virulence environment', 'resistant resistance serotypes'], ['current  study', 'recreational Versova Mahim Mumbai'], ['38  isolates', '22 virulence factors'], ['isolates', 'O91 R O101 which'], ['', ''], ['', ''], ['1  %', 'remarkable  diversity'], ['95  %', 'isolates'], ['', 'sensitive  E'], ['extended cephalosporin resistance', 'other  antibiotics'], ['isolates', 'high risk contamination'], ['encoding  stx1', 'enterohaemorrhagic  E'], ['', ''], ['', 'specific enterotoxigenic E'], ['', 'pathogenic  serotypes'], ['Thus government authorities', 'coastal health waters'], ['type III polyketide synthase', 'corresponding Fallopia multiflora'], ['', ''], ['length  cDNA', 'long amino acid protein'], ['different III PKS genes', 'cloned Polygonum cuspidatum'], ['it', 'like stilbene enzymes'], ['Southern  blotting', 'four FmPKS genome'], ['FmPKS', 'important  biosynthesis'], ['thoughts', 'false belief understanding'], ['why belief difference', 'false belief understanding'], ['language', 'false belief relation'], ['Participants', 'olds'], ['False belief understanding', 'significantly behavior emotions'], ['Family income', 'multiple belief mediation'], ['study', 'false belief understanding'], ['', ''], ['rights', ''], ['second  infants', 'false  agents'], ['prior  studies', 'physical  objects'], ['old  infants', 'emotional  displays'], ['other', 'two  objects'], ['she', 'merely  properties'], ['agent', 'empty'], ['first  infants', 'second causal beliefs'], ['robust  that', 'based  responses'], ['', ''], ['', ''], ['rights', ''], ['adenomatous  polyposis', 'colorectal Man cancer'], ['FAP', 'retinal epithelium dental disorders'], ['It', 'adenomatous polyposis coli'], ['present  study', 'Chinese  FAP'], ['Polymerase chain reaction', 'coding APC family'], ['nonsense mutation', 'APC pedigree'], ['15 APC which', 'premature amino acid'], ['', ''], ['truncated  protein', '1853 amino acids'], ['present  study', 'germline APC gene'], ['Prophylactic  proctocolectomy', 'possible  mutation'], ['which', 'associated survival mortality'], ['genetic  factors', 'also lung cancer'], ['family history', 'lung smokers'], ['review', 'familial lung cancer'], ['development', 'environmental family members'], ['Familial lung cancer', 'well lung cancer'], ['addition studies', 'early lung therapy'], ['review', 'familial familial lung cancer'], ['research', 'cardiac intensivee care surgery'], ['research', ''], ['comprised', 'cardiac surgery ICU'], ['hours nursing patients', '2nd  days'], ['control group', 'routine  information'], ['Demographic variables', 'anxiety family patients'], ['Demographic  variables', '2 stress intervention'], ['mean  score', 'significantly control group'], ['', ''], ['Anxiety levels', 'intervention'], ['significant  difference', '2nd ICU day'], ['', 'significant 3rd ICU day'], ['', ''], ['nursing supportive nursing which', 'cardiac anxiety levels'], ['', ''], ['', ''], ['sets', 'quantitative minority masculinities'], ['current 18 study', 'parental gender childhood'], ['', 'one  sample'], ['raised', 'disciplinary  actions'], ['multivariable  study', 'educational gender attainment'], ['recent  substance', 'multivariable  models'], ['psychological  number', 'disciplinary  childhood'], ['attempts', 'sexual minority men'], ['relationship', 'sexual minority men'], ['13 Child children', 'other  voice'], ['one  directive', 'domestic  information'], ['area', ''], ['arguments', 'sex education'], ['author', 'online  settings'], ['advent', 'intimate networking citizenship'], ['online fan which', 'sexual Harry issues'], ['imaginary abuse publications who', 'sexual  scenarios'], ['Hence  children', 'young child pornography'], ['they', 'fictional  scenarios'], ['sexual  thoughts', 'sexual  offending'], ['they', 'what'], ['', 'sexual  men'], ['SO adult men', '6081 community men'], ['', 'Sexual Computerized Experiences'], ['sexual  thoughts', 'coercive  themes'], ['emotional emotions states', 'consent consent'], ['Type', 'sexual  thought'], ['consensual  type', 'more SO group'], ['sexual  thoughts', 'sexual risk clinicians'], ['other  person', 'enduring  consent'], ['Exploring', 'targeted risk treatment'], ['', 'Sexual International Medicine'], ['', 'Elsevier Inc'], ['rights', ''], ['epileptic  encephalopathy', 'epilepsy  phenotypes'], ['technological  advances', 'rapidly  EOEE'], ['Genes', 'cellular structure transcription EOEE'], ['which', 'epilepsy tRNA phenotype'], ['Here  we', 'homozygous  c'], ['G309S missense that', 'Korean phenylalanyl tRNA families'], ['intractable  that', '3  months'], ['Seizure types', 'infantile  spasms'], ['relentless seizure onset', 'patients'], ['etiologic  investigation', 'specific brain etiology'], ['positive  FARS2', 'genetic  EOEE'], ['', ''], ['', ''], ['rights', ''], ['Representatives', 'economic trematode family losses'], ['Fascioloides magna', 'wild liver ungulates'], ['', 'molecular  F'], ['magna', ''], ['Therefore  objective', 'genome  F'], ['', 'other mtDNA dataset'], ['', ''], ['mt genome sequence', ''], ['', 'gene F'], ['magna mt genome', 'Fasciola spp'], ['trnE', 'coding  F'], ['', ''], ['', 'Phylogenetic  F'], ['intergeneric  differences', 'genera Fascioloides'], ['', ''], ['', ''], ['', 'F'], ['mt genome sequence', 'molecular family markers'], ['Fasciolosis', 'grazing borne trematode animals'], ['molecular  basis', 'new vaccine candidates'], ['present  study', 'synthesised vaccine F'], ['', ''], ['B T which', 'F'], ['', 'novel vaccine F'], ['adjuvant adaptation vaccination they', 'experimentally  F'], ['', ''], ['Spleen RNA', 'standardised  protocols'], ['then expression signal', ''], ['Pathway Analysis tool', 'molecular interaction networks'], ['Mice', 'experimental survival rates'], ['It', '820  genes'], ['', ''], ['', '7'], ['', ''], ['functional  study', 'CXC chemokine CXC receptor'], ['data', 'molecular  F'], ['murine which', 'future vaccine candidates'], ['Activated B cells', 'other cytokine production'], ['autoimmune B cell deficiencies', 'poor  prognosis'], ['B cells', 'tuberculosis'], ['cell mRNA expression', '2 diagnosis treatment'], ['CD38 FASLG expression', 'healthy TB controls'], ['changes', 'reduced TB diagnosis'], ['', 'significant TB cases'], ['6 APRIL FASLG IL5RA', 'TB cases'], ['increase', 'TB treatment'], ['B cells', 'protective  M'], ['', ''], ['successful TB expression', 'potentially treatment response'], ['students', 'such Protein Liquid Chromatography'], ['laboratory exercise', 'different ion proteins'], ['how protein conformations', 'different  conditions'], ['', ''], ['', ''], ['Students', 'eluting IEX chromatography'], ['other', 'flow'], ['experimental sample that', 'fundamental structure protein purification'], ['', 'International Biochemistry'], ['paper', 'current crystal oscillator'], ['proposed XTAL driver', 'three  mode'], ['Fast settling mode', 'settling time'], ['reduce', 'internal noise booster'], ['', 'simulated start up 4'], ['', '19403MHz XTAL 0'], ['18um  CMOS', '80  800us'], ['Retention mode', 'total power consumption'], ['Peak  detection', ''], ['stand by', 'XTAL driver'], ['HVT signal', 'down'], ['It', 'power consumption'], ['EMI reduction mode', 'output spur noise'], ['pseudorandom number generator', 'random  -10dB'], ['mode', 'Digital Control block'], ['100 ppm operation', '60  degrees'], ['boosted  technique', ''], ['gain booster', 'high cascode gain'], ['opamp', '0'], ['', 'open unity gain 4'], ['', '75  1'], ['6pF', ''], ['opamp', 'settling  time'], ['', ''], ['proposed  opamp', 'pipelined  ADC'], ['who', 'arachidonic docosahexaenoic C20:4n6'], ['amount', 'immune  function'], ['FADS fatty acid polymorphisms', 'adequate ARA status'], ['ARA levels', 'red infant formula'], ['Methods', 'controlled  study'], ['Infants', '10 mg docosahexaenoic weeks'], ['Fatty acid composition', 'red cells activation FADS1'], ['Lymphocyte ARA', '25-ARA formula 0-'], ['', '34-ARA formula group'], ['', 'highest plasma ARA ARA'], ['who', 'ARA'], ['ARA level', 'minor ARA FADS'], ['Dietary ARA', '18:0/18:2 B cell phospholipids'], ['intake', 'to cell ARA genotypes'], ['Biotechnological  production', 'recent chemical years'], ['Fatty alcohols', 'acyl acyl reductase'], ['we', 'mediated Agrobacterium transformation'], ['efficiency', 'transformation'], ['fatty alcohols', 'transgenic hairy root lines'], ['tested arachidyl alcohol', 'tested lines stearyl alcohol'], ['total fatty amount', '2  %'], ['', 'transgenic hairy root 0'], ['', '2'], ['', 'dry fatty weight'], ['low  activity', 'selected hairy root lines'], ['this', 'first hairy root cultures'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'fatty liver'], ['transcription PCR', 'Xupu white Xupu conditions'], ['up fatty it', '83 % identity'], ['471 amino which', '95 selenium binding rat'], ['function', 'published  information'], ['tissue expression expression', 'tested geese SELENBP1 tissues'], ['overfeeding', 'mRNA expression geese'], ['medium fault currents', 'generations'], ['Uncertainties', 'system protection problems'], ['current limiting capability', 'increasing system protection'], ['', 'current system protection'], ['based  method', 'current fault currents'], ['results', 'based impedance selection method'], ['based fault accommodation technique', 'general quantization paper'], ['Only output signal', 'direct  measurement'], ['simulation study', 'theoretical tank developments'], ['', ''], ['paper', 'asymmetrical time voltage faults'], ['main  objective', 'asymmetrical DC faults'], ['compensator', 'discrete DC side dynamics'], ['current oscillating component', 'negative dq axes currents'], ['current  references', 'asymptotically harmonics grid'], ['Simulation results', 'severe fault conditions'], ['', ''], ['rights', ''], ['Background', 'individual diagnosis level'], ['we', 'neuropsychological PET brain findings'], ['', ''], ['', ''], ['variant lv PPA', ''], ['neuropsychological  information', 'FDG PET baseline'], ['', 'follow 27'], ['', ''], ['55  months', 'clinical  progression'], ['Brain metabolism', 'single subject level'], ['metabolic FDG PET assessment', 'underlying language networks'], ['dysfunctional  patterns', 'specific dementia conditions'], ['metabolic nfv pattern', 'progressive supranuclear palsy'], ['lv PPA sv who', 'bilateral follow baseline'], ['wise FDG PET imaging', 'specific dementia condition'], ['study', 'possible endo phenotypes'], ['Recalling', 'powerful  affect'], ['positive  which', 'negative down affect'], ['', 'positive  mood'], ['Participants', 'less depression strategy'], ['elevated  fear', 'related mood repair'], ['sad mood induction', 'autobiographical  memories'], ['Subjective  measures', 'mood induction'], ['greater  fear', 'positive  memories'], ['positive  which', 'positive  affect'], ['findings', 'potential affect regulation'], ['heat  dispatch', 'integrated energy systems'], ['district heating which', 'electricity control center'], ['privacy communication it', 'detailed  ECC'], ['new DHS which', 'thermal  inertia'], ['greedy  method', 'linear programming problems'], ['new  models', 'central DHS operation constraints'], ['', ''], ['', ''], ['modified  models', 'current dispatch programs'], ['Case studies', 'method'], ['conservativeness', 'decoupled energy dispatch'], ['', ''], ['rights', ''], ['Biotreatment', 'degraded feather feed'], ['present  we', 'based Calcutta Wetland Area'], ['molecular weight keratinolytic protease', 'degrading DCUW strain'], ['Moreover utilization', 'degraded feather hydrolysis'], ['keratinolytic  protease', '8'], ['5', 'C'], ['PMSF', 'enzyme'], ['purified  enzyme', '80 SDS PAGE'], ['broad range substrate that', 'collagen fibrin BAPNA'], ['protease', 'northern blotting techniques'], ['This', 'extracellular feather B'], ['', 'cereus organisms'], ['Real  numbermodeling', 'SoC hardware description validation'], ['driven piecewise linear', 'functional  models'], ['which', 'iteration'], ['calibration error which', 'when output accuracy'], ['next limit cycle that', 'discrete time event simulator'], ['efficiently  user', 'simpler component models'], ['performance', 'operational filter amplifier'], ['', 'fixed time step transceiver'], ['connected grid voltage feedforward', 'usually side AC current'], ['However suppression effect', 'grid voltage distortion'], ['time delay', 'voltage filtering voltage circuits'], ['leading time delay correction', 'feedforward voltage'], ['leading  step', 'digital phase frequency control'], ['further  performance', 'converter output current'], ['validity', 'simulation experiment results'], ['feasible investment them', 'traditional energy sources'], ['feed  tariffs', 'produced power electricity'], ['tariff models', 'common southeast Europe'], ['paper', 'preferential southeast Europe'], ['significant RES capacity others', 'still planning stage'], ['amount', 'same  technology'], ['comprehensive  review', 'current technology projects region'], ['MMPI)-2 Restructured that', 'pretrial  trial'], ['Symptoms Second which', 'cognitive  impairment'], ['Results', 'curve'], ['', ''], ['72', 'moderate Memory criterion'], ['most  who', 'less  TOMM'], ['significant IST who', 'lower cutoff manual'], ['alternate cutoff scores', 'psychiatric IST defendants'], ['only TOMM RBS', 'significantly  model'], ['Implications', 'psychiatric  settings'], ['We', 'urinary  incontinence'], ['paper', 'alone floor exercise MUI'], ['Women', 'validated bladder diary'], ['Controls', 'incontinence symptoms'], ['participants', 'vaginal DNA analysis'], ['central  lab', 'PCR bacterial16S ribosomal RNA'], ['composition', '1 amplicon controls'], ['126  MUI', '80 % power'], ['', ''], ['Specimen collection', ''], ['DNA', 'subsequent  evaluation'], ['Methods papers', 'particularly control populations'], ['We', 'urogenital microbiome MUI'], ['Low temperature NH3-SCR', 'stationary  sources'], ['catalytic  activity', 'further SO2 improvement'], ['FeMnOx', 'low temperature region'], ['exhibit', 'FeMnOx'], ['reduction', 'fast surface SCR'], ['', 'comparative SO2 resistance FeMnOx'], ['latter', 'improved pore volume'], ['that', 'containing  Ce(12'], ['more  which', 'less metal sulphates'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['solid  that', 'ovarian  graft'], ['doublecortin tyrosine transcripts', 'ovarian NB tissue'], ['Analyses', '2015 Clermont Ferrand'], ['ovarian  tissues', 'increasing RT qPCR'], ['DCX transcripts', 'small tumor cells'], ['PHOX2B', 'ovarian  fragment'], ['PHOX2B levels', '10 NB cells'], ['study', 'ovarian disease tissue'], ['Only  PHOX2B', 'ovarian NB tissue'], ['who', 'oncological  risk'], ['', 'mouse development viability'], ['', ''], ['', ''], ['', 'C57BL/6'], ['129X1 SvJ strains', 'studies'], ['Expression', 'early Dkkl1 vivo'], ['Dkkl1 RNA expression', 'Northern blotting hybridization'], ['vitro  assays', 'functional  Dkkl1'], ['developing  product', 'mature  sperm'], ['Dkkl1', 'trophectoderm placental lineage'], ['Surprisingly  embryos', 'fertile DKKL1 adults'], ['that', 'severely type vitro'], ['defect', 'wild type sperm'], ['Dkkl1', 'directly zona pellucida'], ['well Dkkl1 delay', 'other preimplantation development'], ['vitro fertilization that', 'infertility'], ['strongly vitro effect', 'vivo'], ['', ''], ['', 'Reproductive Medicine'], ['', ''], ['Conditionally  transformed', 'cardiac cell biology'], ['We', 'sensitive SV40 strain'], ['resulting cell lines', 'TAg  permissive'], ['fetal growth which', 'permissive  serum'], ['transformed myocyte phenotype', 'Western polymerase chain reaction'], ['Cell lines', 'atrial natriuretic peptide'], ['sarcomeric  actin', 'approximately  38'], ['well  who', 'human  myocytes'], ['cell lines', 'cardiac muscle cells'], ['Fibroblast growth factor', 'cortical  development'], ['effect', 'FGF2'], ['We', 'embryonic neuron day'], ['', ''], ['', ''], ['1 coil that', 'FGF2 up stimulation'], ['Northern  blots', 'adult RT brains'], ['situ  ccpl', 'cortical dorsal E15'], ['', ''], ['', 'Furthermore expression E13'], ['', ''], ['5', 'early  phase'], ['expressed ccpl protein', 'cortical cell neurons'], ['', ''], ['', ''], ['rights', ''], ['scheduling  system', 'remote fault diagnosis'], ['remote  equipment', ''], ['railway scheduling station', 'future railway communication'], ['paper', 'dispatching processing system'], ['use', 'recent mono fiber years'], ['paper', 'short  fibers'], ['aim', 'reinforced  concretes'], ['This', 'cementitious steel composites'], ['Different  types', 'hybrid fiber type'], ['physical  properties', 'resultant  composites'], ['hybrid  forms', 'such mono fiber reinforcement'], ['', ''], ['rights', ''], ['mechanisms underlying fibrillation potentials', ''], ['expression', 'gated sodium Nav1'], ['5', 'such  potentials'], ['Muscle samples', 'various time denervation'], ['', ''], ['', 'northern messenger blotting'], ['when fibrillation potentials', 'second  denervation'], ['cardiac sodium those', 'contralateral muscle action potentials'], ['', 'Nav1'], ['', 'skeletal fibrillation muscle'], ['We', 'skeletal muscle denervation'], ['', '2012 Clinical Neurophysiology'], ['', 'Elsevier Ireland Ltd'], ['rights', ''], ['Research', 'molecular  biology'], ['Periapical surgery', 'complete wound bone'], ['endodontic  procedures', 'current pulp therapy procedures'], ['regenerative  potential', 'platelets'], ['rich  fibrin', 'promising healing bone induction'], ['which', 'diverse growth dentistry'], ['paper', 'endodontic  therapy'], ['', ''], ['different  mechanism', 'effect'], ['Various growth factors', 'wound healing'], ['', 'importantly fibroblast cells'], ['aim', 'A'], ['', 'mouse embryonic fibroblast cells'], ['We', 'different fibroblast A'], ['', '12  h'], ['', 'Fibroblast A'], ['v treatment', 'control'], ['expression', 'immunosorbent time gene'], ['We', 'that'], ['1  genes', 'particular  time'], ['results', 'that'], ['v', 'time fibroblast vitro'], ['mechanism', 'physical  lesion'], ['', ''], ['rights', ''], ['Human  skin', 'morphological body site'], ['spatial epidermal distinction', 'dermal  components'], ['that', 'abundantly palmoplantar skin'], ['first  Northern', 'dermal skin tissues'], ['whole  mount', 'developmental mouse embryos'], ['respectively beta mRNAs', 'abundantly trunk skin fibroblasts'], ['FN', 'both plamoplantar skin'], ['FN', 'mouse embryos'], ['FN', 'spatially body sites'], ['distinct  expression', 'cutaneous hair germ'], ['paucity', 'oral skin phenotypes'], ['how dance movement psychotherapy', 'psychotherapeutic  process'], ['second  we', 'fatigue anxiety depression'], ['primitive  who', 'psychological  pain'], ['data', 'simple regression model'], ['', 'many study highlights Others'], ['results', 'fibromyalgia'], ['patients', 'pain'], ['when  it', 'therapeutic  alliance'], ['study', 'osteosarcoma progression'], ['invasive cell subclones', 'immunohistochemistry'], ['functional  we', 'invasive osteosarcoma cell potential'], ['small pLVX fibulin-4', 'invasive  subclones'], ['effects', 'biological vivo assays'], ['fibulin-4 expression', 'low lymph node metastasis'], ['Fibulin-4', 'invasive cell subclones'], ['Fibulin-4', 'AKT mTOR pathway'], ['fibulin-4', 'future osteosarcoma studies'], ['heterogeneous cell pathogenesis', 'genetic  events'], ['combined modality that', 'unpredictable  results'], ['who', 'locoregional  recurrences'], ['that', 'therapeutic surveillance strategies'], ['only HPV status', 'oropharyngeal treatment site'], ['human telomerase which', 'potential cancer risk'], ['review', 'clinical  HNSCC'], ['passive phase shifter', 'ISM Industrial band'], ['patterned  shielding', 'on inductor quality factor'], ['transistor switches', 'body source connection'], ['minimum phase error', '32  states'], ['5  degrees', ''], ['', ''], ['measured insertion loss', ''], ['60 return loss', '57  GHz'], ['total chip size', ''], ['', 'mW DC power consumption'], ['fluid dynamics simulations', 'high repetition rate operation'], ['hydrodynamic  motions', 'finite volume calculation'], ['large gas interaction pressure', 'photoelectric energy absorption'], ['Concurrent outward heat conduction', 'slower time scale'], ['trailing  pulses', 'additional gas particles'], ['competing  mechanisms', 'pulse  cycle'], ['hydrodynamic  evolution', 'equivalent wave power'], ['filarial', ''], ['Dennis Atmosoedjono Oemijati', 'lymphatic  tropics'], ['pahangi', 'zoonotic  Malaysia'], ['', ''], ['', 'Palmieri Pulnomo Brugia'], ['', 'Asia Sri Lanka'], ['However  origin', 'Wuchereria Brugia clade'], ['filarial  we', 'common Tupaia glis Diard'], ['We', 'filarial Peninsular parasites'], ['we', 'partial c oxidase subunit'], ['ITS1 transcribed region', 'recombinant pGEM T sequencing'], ['Malayfilaria sofiani', 'Mat Udin'], ['', ''], ['', ''], ['', ''], ['', 'common Pasu Kelantan Malaysia'], ['', 'new cox1 gene species'], ['bancrofti', ''], ['', ''], ['new  species', 'monophyletic  W'], ['bancrofti', ''], ['adult parasites', 'common lymph treeshrews'], ['described  species', 'closely Wuchereria spp'], ['Brugia', ''], ['', 'morphological  characteristics'], ['species', 'W'], ['bancrofti', ''], ['', 'genus  level'], ['We', 'new  species'], ['', ''], ['thin barium films', 'microstructure ink composition'], ['Inkjet printing', 'functional  materials'], ['complex  technique', 'highly  microelectronics'], ['common  way', 'dense degrees structure'], ['final phase composition', 'substrate'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['', 'realized delay sensitivity filter'], ['grounded impedance which', 'operational  amplifier'], ['sensitivity measure', 'continuous filter pair design'], ['It', 'analytic pole frequency expression'], ['tuning', 'only  resistors'], ['underlying  that', 'financial  strain'], ['financial  strain', 'depressive smoking symptoms'], ['dependent  variables', 'negative mood abstinence expectancies'], ['Participants', 'adult daily adult smokers'], ['', ''], ['353 % female', 'psychological smoking cessation study'], ['depressive  symptoms', 'negative mood abstinence expectancies'], ['smoking interventions', 'therapeutic  depression'], ['', ''], ['rights', ''], ['', 'natural food resources'], ['Productive  resources', 'financial asset classes'], ['financial asset interactions', 'less community attention'], ['rural  that', 'unease'], ['multidimensional  that', 'various  ways'], ['emerging  paper', 'recent agri food system'], ['paper', '0'], ['', 'Internet sensor nodes'], ['leakage', 'FinFET 0'], ['4-V threshold voltage', ''], ['stabilized DD V topology', 'nested Miller compensation'], ['near V amplifier', 'second  gain'], ['fabricated op amp', '1-MHz CM voltage range'], ['growing computing demand', 'such power consumption'], ['power dissipation power current', 'portable power systems'], ['when  device', 'inactive  mode'], ['new circuit technique', 'low power state paper'], ['approach', 'also retention mode'], ['electrical op characteristics', 'circuit 0'], ['', ''], ['simulated DC gain', ''], ['', 'active  mode'], ['operational amplifier performance traits', '45 nm scale'], ['Here  effect', '45 nm technology regime'], ['low power enhancement', 'slew rate'], ['simulation results', ''], ['operating  voltages', 'digital control equipment'], ['abnormal control which', 'mainly  lightning'], ['lightning surges', 'effective lightning protection methodologies'], ['', 'incoming power plants'], ['insulated lightning surge we', 'measured surge validation'], ['induced transmission line which', 'applied AC voltages'], ['substantial price amount', 'financial data mining techniques'], ['such trading decisions', 'anchoring  effect'], ['study', 'first passage process'], ['power law scaling', 'anomalous anchoring effect'], ['microscopic price fluctuations', 'long stock market'], ['microscopic  trends', 'macroscopic stock markets'], ['', ''], ['', ''], ['rights', ''], ['Most  studies', 'few episode predictors'], ['study', 'psychosocial  functioning'], ['total', 'early psychosis treatment department'], ['psychopathological  subdomains', 'psychosocial symptoms functioning'], ['cognitive  factors', 'cognitive component battery'], ['backward regression models', 'psychosocial  functioning'], ['three  neurocognitive', 'largely  psychopathology'], ['strongest  associations', 'cognitive  factors'], ['Higher  levels', 'verbal processing speed'], ['Together  factors', '39'], ['', 'psychosocial  functioning'], ['impaired  neurocognition', 'first episode psychosis'], ['None', 'psychosocial  functioning'], ['Sn DT compound atoms', 'poly silicon crystals'], ['atoms', 'functional principles theory'], ['results', 'analysis'], ['thin  surface', 'fifth  layer'], ['Second C', 'arrived film growth'], ['atoms', 'atomic equilibrium configurations'], ['', 'increasing surface C'], ['C formation energies', 'increasing surface C'], ['that', 'thin  film'], ['experimental  that', 'associated  fields'], ['study', 'based laboratory experiments'], ['three Biochemistry that', 'sequentially  autonomy'], ['Organizational autonomy support Procedural', 'gradually  laboratory'], ['students', 'tightly worksheet directions'], ['group lab students', 'different  autonomy'], ['Thus  approach', 'also  experiments'], ['', ''], ['n-3 Fatty acids', 'MCP-1 rat mesangial cells'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['1 CC that', 'renal  disease'], ['MCP-1', 'glomerular  vivo'], ['Interventions', 'experimental MCP-1 models'], ['inflammatory n-3 fatty basis', 'which'], ['We', 'inflammatory MCP-1 injury'], ['equimolar acids docosahexaenoic concentrations', 'fatty acids controls'], ['MCP-1  expression', 'transient MCP-1 transfection'], ['involvement', 'MEK inhibitor'], ['DHA', 'MCP-1 MCP-1 gene'], ['nuclear NF kappa both', 'MCP-1  expression'], ['kappa B', 'MCP-1  DHA'], ['DHA', 'stimulated MCP-1 ERK'], ['such  effects', 'renal fish disease'], ['Shi Hang Belt', 'Yangtze Mesozoic tectonic blocks'], ['It', 'dynamic formation mechanism'], ['dynamic  process', ''], ['', 'onset South China Block'], ['AFT fission thermochronology', 'Hunan Province'], ['Twenty three Twenty samples', '23'], ['', ''], ['', '45'], ['', ''], ['', ''], ['', 'older  ages'], ['', ''], ['', ''], ['', ''], ['other  ages', 'less Chenzhou Linwu fault'], ['measured  rocks', 'different onset 23Ma'], ['cooling  pattern', 'fold thrust feature'], ['dynamic South China which', 'early Pacific Cenozoic'], ['far field effect', 'Shi Hang Belt'], ['paper', 'circuit performance design'], ['pairing design norator', 'supporting  components'], ['', 'current  components'], ['current fixator norator that', 'given  design'], ['proposed  methodology', 'common emitter amplifier'], ['binding  protein', 'FKBPs'], ['Altered expression', 'several  malignancies'], ['', 'gastric  cancer'], ['FKBP14 expression levels', 'quantitative polymerase chain reaction'], ['Cell proliferation', 'Cell assay'], ['cell adhesion', 'cell adhesion'], ['Protein expression', 'western blot analysis'], ['FKBP14  expression', 'normal cancer tissues'], ['which', 'cellular proliferation adhesion'], ['transition beta catenin Snail1', 'FKBP14 cancer silenced'], ['', 'gastric proliferation carcinogenesis'], ['FKBP14', 'gastric diagnosis cancer'], ['synonym mutation Ttc7(fsn we', 'previous  study'], ['genomic Ttc7 deletion', 'repeat-2B TTC7 protein'], ['9  both', 'other Ttc7 gene'], ['Ttc7 mRNA', '11  muscle'], ['Ttc7(fsn hea Ttc7(fsn mutations', 'flaky skin mutation'], ['in microfiber interferometer', 'compact MI temperature'], ['MI MI', 'about extinction 12'], ['', 'spectral  1'], ['', '9  1545'], ['longer MI MI heat', 'copper wire'], ['thus  measurement', 'current'], ['sensor', 'temperature 33'], ['', 'than  0'], ['', 'current  1'], ['', 'electricity generation distribution grids'], ['Careful  characterization', 'derived cause effect product'], ['we', 'proven health benefits'], ['research history', '70 biology medicine years'], ['Analysis', 'magnetic fingerprinting techniques'], ['early  recognition', 'cellular  mechanisms'], ['8 weeks which', 'healthy health humans'], ['Changes', 'inflammatory gene benefit'], ['scientific  evidence', 'molecular health humans'], ['genomic RNA mechanism', 'genomic RNA which'], ['membranous  which', 'viral endoplasmic reticulum NS1'], ['RC)-associated replication which', 'RC components'], ['authentic RC -associated vesicles', 'infectious WNV cDNA'], ['heterologous NS polyproteins', 'abnormal  vesicles'], ['which', 'immature RNA vesicles'], ['specific  structures', 'viral RNA replication'], ['global genus that', 'neurological  infants'], ['available New World that', 'significant  transmission'], ['novel  ZIKV', '2015 Puerto Rico'], ['infectious clone virus', 'human wildtype ZIKV'], ['transmission mosquitoes', 'similar AG129 mice'], ['infectious clone system', 'development diagnostics vector competence'], ['mosquito borne that', 'congenital Guillain Barre fetuses'], ['ZIKV', ''], ['molecular  determinants', 'phenotypes'], ['researchers', 'antiviral ZIKV drugs'], ['Here  we', 'recent Puerto Rico'], ['infectious  clone', 'critical ZIKV infection'], ['Geometric  modeling', 'computational  biophysics'], ['intersecting cusps that', 'molecular  modeling'], ['flexibility  which', 'geometric B factor representation'], ['FRI rigidity surfaces', 'geometric  singularities'], ['We', 'electrostatic Poisson -Boltzmann analysis'], ['approaches', '21  proteins'], ['results', 'established  methods'], ['curvature  which', 'concave protein surfaces'], ['electrostatic  potential', 'potential ligand binding sites'], ['', ''], ['', ''], ['rights', ''], ['paper', 'robotic pressure applications'], ['ROC', 'resistive pressure variations'], ['digital  circuits', 'on ring reference'], ['130 nm RFCMOS prototype', '159 power 27'], ['', '2 mu VDD'], ['digital  ROC', 'wide measurement sensitivity'], ['', ''], ['', ''], ['', ''], ['', 'contact detection contact evaluation'], ['read  time', 'human 1 touch'], ['Flexible Hybrid Electronics', 'flexible silicon systems'], ['New static New tests', 'systems'], ['Dynamic  radius', '180 PET substrate'], ['1 f noise reduction', 'folded  cascode'], ['significantly operation enhance', 'noise performance'], ['Also  technique', 'larger margin degeneration'], ['amplifiers', '0'], ['18 m CMOS technology', 'theoretical simulation analyses'], ['Proposed design methodology', '1 power consumption'], ['concerns', 'rotatable wheel table'], ['means', 'relative  part'], ['presented', 'welding automobile system'], ['design', 'digital Weld Hold control'], ['work', 'Interleaving fuel cell applications'], ['paper', 'four fuel cell applications'], ['FIBC', 'ripple power losses'], ['where  minimizing', 'current  ripple'], ['Actually  approach', 'digital control reconfiguration'], ['Relevant  aspects', 'controlled  paper'], ['cell populations', 'unprecedented  detail'], ['dimensional  which', 'automated analysis methods'], ['', 'downstream cell analysis'], ['Here  we', 'dimensional performance flow'], ['We', 'manual reference standard'], ['Several  methods', 'shift PhenoGraph Rclusterpp'], ['fast  method', 'standard data laptop'], ['results', 'new CyTOF data'], ['scripts', 'GitHub'], ['FR FCM comparisons', 'clustering methods reference data sets'], ['', ''], ['', 'Wiley Periodicals Inc'], ['', 'ISAC'], ['transcriptomic cell that', 'primary  immunodeficiency'], ['recent multiparameter tissue which', 'affected  tissue'], ['instead earth metal tags', 'single  cell'], ['Mass cytomety', 'primary immunodeficiency defects'], ['Protein epitopes', 'mixed cell populations'], ['Multiplexed epitope imaging', '3D tissue microenvironment'], ['SummaryMass cytometry', 'primary multiplexed epitope immunodeficiencies'], ['ability', 'therapeutic disease interventions'], ['Angiosperms', 'extant seed plants'], ['gymnosperms', 'flowering FLOWERING angiosperms'], ['released gymnosperm we', 'phylogenetic gene reconstruction'], ['Expression patterns', 'heterologous gymnosperm FT like'], ['ancient gene duplication', 'FT seed genes'], ['gymnosperm TFL1-like genes', 'common growth rhythm'], ['When  both', 'like  genes'], ['gymnosperms', 'like  genes'], ['gene  duplications', 'significantly PEBP gene family'], ['expression patterns', 'functional gene family'], ['specific  recombinases', 'synthetic  biology'], ['We', 'weak ribosome binding site'], ['', ''], ['', ''], ['rights', ''], ['NFTPV  devices', 'PV emitter electricity'], ['large energy conversion portion', 'band gap'], ['that', 'room temperature'], ['', ''], ['', 'several vacuum nanometers'], ['Scattering theory', 'grating radiation energy emitter'], ['grating ridge that', 'available fabrication technologies'], ['power output', '40  29'], ['', '9  32'], ['', 'flat tungsten emitter'], ['Reasons', 'close band gap'], ['grating  structures', 'thermal  nanoscale'], ['Formation Tarim Basin', 'diagenesis basin approach'], ['suite', 'optical scanning electron microscope'], ['workflow', 'diagenetic hydrocarbon charge'], ['diagenetic  events', 'early emplacement micro quartz'], ['diagenetic  event', 'quartz cementation'], ['Kaolinite', 'diagenetic hydrocarbon charge'], ['second calcite episodes', '6 hydrocarbon Ma'], ['timing', 'diagenetic formation minerals'], ['integrated  analysis', 'effective hydrocarbon charge'], ['', ''], ['', ''], ['rights', ''], ['quantitative grain fluorescence', 'clastic hydrocarbon reservoirs'], ['threshold', 'accurately hydrocarbon accumulation history'], ['However  absence', 'carbonate cutoff application'], ['natural outcrop samples', 'oil inclusions formation etc'], ['hydrocarbon', 'gotten Basin eastern threshold'], ['carbonate fluorescence index threshold', 'clastic extract intensity reservoir'], ['quantitative grain fluorescence', 'gas paleo oil tectonism'], ['carbonate  which', 'future petroleum exploration'], ['design', 'responsive novel characteristics'], ['abundance we', 'codoped SN luminophore'], ['incorporation', 'significant fluorescence intensity GQ'], ['', ''], ['simple  method', 'GQD fluorescence enhancement'], ['validity', 'environmental water samples'], ['', ''], ['', ''], ['rights', ''], ['digital control method', 'side sensing observer'], ['isolated Flyback converter', 'method'], ['measured  signal', 'drain source switch'], ['signal constraint problem controller', 'duty cycle ratio'], ['advantages', 'minimal  overshoot'], ['experimental  it', 'effectively feedstuff additives'], ['We', 'transgenic Stylosanthes guianensis cv'], ['', ''], ['northern  production', 'western VP1 blotting'], ['level', 'expressed  protein'], ['', ''], ['', ''], ['that', 'structural  VP1'], ['transgenic feedstuff that', 'systemic antibody animals'], ['results', 'based feedstuff additives'], ['Previous  research', 'subjective value network'], ['overlap  we', 'human resonance brain'], ['we', 'significant activation SVN'], ['overlapping  subregions', 'functional  subnetwork'], ['We', 'prefrontal  cortex'], ['functional  dPCC', 'networks'], ['subjective  we', 'self mind findings'], ['', 'unipolar multivariate depression'], ['Purposes', 'depressive  symptoms'], ['independent  subsets', '180 BiDirect depression'], ['Functional  connectivity', 'known resting state'], ['Support vector machines', 'well classifiers subgroup'], ['Model parameters', ''], ['independent  subset', 'successful  models'], ['Classification accuracies', 'heterogeneous  45'], ['', '56'], ['', ''], ['', ''], ['', 'significantly depression 60'], ['', ''], ['', 'independent  validation'], ['', 'realistic depression population'], ['Future research', 'important symptom factor'], ['present  study', 'visual  saliency'], ['old  infants', 'social anime AC'], ['22-channel behaviors', 'time'], ['when medial infants', 'Peek AC'], ['when  infants', 'Peek human'], ['when Peek Boo', 'human'], ['Peek Boo conditions', 'measure'], ['salient  which', 'more  attentions'], ['focused default mode which', 'old  infants'], ['Foamy  viruses', 'human immunodeficiency murine leukemia'], ['N terminal region', 'capsid particle Env'], ['critical  residues', 'primate  FVs'], ['Mutagenesis', 'viral Env leader protein'], ['also Gag assembly', 'specific  interaction'], ['wild type Gag', 'mostly virus capsids'], ['proteolytic  processing', 'completely particle budding'], ['competent Pol encapsidation', 'genomic Gag processing'], ['unable  it', 'package Gag processing'], ['Conclusions', 'viral terminal Gag assembly'], ['Discussion', 'recent prototype FV'], ['Mobile  technologies', 'public information management'], ['largely  budget', 'largely  managers'], ['police they', 'performance'], ['Tablet PCs', 'Sexual Child Abuse Units'], ['interpretive task research', 'improved police performance'], ['police tasks data', 'Tablet PCs'], ['improved  performance', 'reduced costs transparency teamwork'], ['findings', 'mobile police technologies'], ['environmental  which', 'national defense aviation aerospace'], ['FOG', 'important accuracy indicator'], ['conventional  turntable', 'environmental  conditions'], ['physical  effects', 'new factor performance paper'], ['operational modulation signal', 'operational amplifier which'], ['operational amplifier circuit', 'superimposed Y FOG'], ['test system', 'sawtooth factor performance test'], ['effect', 'angular voltage turntable'], ['so correction method', 'angular parameter velocity'], ['turntable performance test results', 'two  methods'], ['turntable', 'ambient  conditions'], ['operational  that', 'two stage op amp'], ['proposed  design', 'GPDK'], ['', ''], ['This op amp', 'common mode range'], ['common mode level', 'voltage'], ['op which', 'LDO applications'], ['', '1'], ['8  V', 'DC 72'], ['', 'phase 62'], ['4636  degree', '13'], ['33  MHz', 'power 0'], ['', 'mW  72'], ['', ''], ['area', 'approximately  8897'], ['', ''], ['amplifier capacitor technique', 'pipelined  ACDC'], ['amplifier', 'positive cascode feedback'], ['', 'operational  0'], ['35um CMOS process', '75 power 0'], ['', '75  1'], ['', ''], ['', 'simulation 1'], ['configuration', 'MSample s 2'], ['', 'analog power 1'], ['', ''], ['that', 'maturing rat testis'], ['strong rat signal', 'molecular weight signals'], ['situ  Ttc29', 'primarily  spermatocytes'], ['We', 'hypophysectomized Ttc29 rats'], ['5 Ttc29 expression', '7  weeks'], ['chorionic hypophysectomy Ttc29 expression', 'stimulating  hormone'], ['Ttc29', 'axonemal sperm flagella'], ['axonemal dynein expression', 'stimulating  hormone'], ['primary  foods', 'illegal  additives'], ['TPB  model', 'extremely food choices'], ['perceived background factors', 'public TPB additives'], ['original  that', 'additives'], ['important risk that', 'additives'], ['attention', 'perceived scandal additives'], ['perceived  risk', 'such scandal news'], ['', ''], ['rights', ''], ['diagnosis', 'immunologic  symptoms'], ['oral food challenge', '391  children'], ['', ''], ['suspected  milk', 'IgE)-[pmediated OFC outcome'], ['OFC', '391  children'], ['skin reactions', 'negative OFC result'], ['localized skin reactions', 'more milk challenge'], ['', 'respiratory tract symptoms'], ['', 'more wheat challenge'], ['14  %', 'immediate  i'], ['', ''], ['adrenalin', 'reaction'], ['related OFC reactions', 'suspected wheat age'], ['accuracy', 'one OFC challenges'], ['study', 'maltreatment neglect'], ['Adolescent NSCAW the', '2010 National Child'], ['received CPS services', 'of child investigation'], ['multiple maltreatment families', 'shorter CPS neglect'], ['small  percentage', 'future CPS investigation'], ['', ''], ['rights', ''], ['mediated food that', 'shock'], ['clinical pathophysiology outcomes', 'pathophysiology diagnosis'], ['consensus document', 'international Allergy Asthma'], ['These', 'based  FPIES'], ['Research', 'future prevalence FPIES'], ['more  evidence', ''], ['Recent  attention', 'eventual food system'], ['Cooperative Extension Educators', 'local United needs'], ['better  understanding', 'food systems'], ['who', 'resources change'], ['available  who', 'them'], ['', 'food system change'], ['market centric market that', 'vulnerable  consumers'], ['who', 'policy'], ['new change agents that', 'food system problems'], ['diverse food system they', 'transformational  work'], ['public health it', 'life  prevalence'], ['National Institute', 'clinical food allergy'], ['emerging peanut allergy', 'containing  infancy'], ['patient Infectious Diseases', 'specifically peanut allergy'], ['addendum', 'wide health care providers'], ['Topics', 'containing health care home'], ['addendum guidelines', 'background recommendation'], ['Guidelines', 'various peanut allergy'], ['', 'Allergy Asthma'], ['State statutes', 'three  issues'], ['three child states', 'psychological  maltreatment'], ['that', 'negatively  conflict'], ['review', 'Lissner Medal'], ['It', 'cranial Michigan State University'], ['Cranial  fractures', 'forensic pediatric trauma courts'], ['forensic  anthropologists', 'basic  testimony'], ['following', 'cranial bone fracture'], ['human  studies', 'immature porcine model'], ['cranial bone studies', 'resultant bone fracture pattern'], ['studies', 'falling parietal heads'], ['head', 'different impact energy'], ['linear fractures', 'focal surface impacts'], ['results', 'machine learning'], ['interface', 'medical examiner offices'], ['Fracture Printing that', 'cranial bone fracture'], ['Rapid  advances', 'entomological Generation matrixes'], ['other  those', 'forensic crime investigations'], ['postmortem which', 'morphological life cycle stage'], ['when  identification', 'species'], ['who', 'unknown  causes'], ['human  DNA', 'gastrointestinal  tract'], ['such DNA Quantification Kit', 'genetic Applied profile'], ['', ''], ['rights', ''], ['children', 'hysteria'], ['Author Ross Cheit', 'original witch hunt label'], ['he', 'what'], ['today  who', 'negative  children'], ['writer', 'high witch hunt narrative'], ['unwarranted witch hunt assertions', 'negative  credibility'], ['ultimately  who', 'sexual  abuse'], ['We', 'Witch Hunt Cheit'], ['most', 'ritual child abuse 1980s'], ['we', 'witch hunt'], ['scholarly  we', '10 witch hunt'], ['ritual child abuse they', 'ritual child abuse criteria'], ['most  defendants', 'ritual abuse cases'], ['many  TWHN', 'contrary  hypotheses'], ['TWHN', 'scholarly  information'], ['Scholars', 'caution'], ['forensic  medicine', 'custodial traffic medicine'], ['forensic  practitioner', 'also undertaking autopsies'], ['20  discipline', 'importantly specialist nurses'], ['user', 'financial  pressure'], ['governments', 'qualified  tasks'], ['This', 'crossroads'], ['discipline', 'academic convince world'], ['greater  that', 'expensive  personnel'], ['establishment', 'meaningful  research'], ['failure', 'subsequent skills justice'], ['', '2017 Elsevier Forensic'], ['rights', ''], ['Retinal hemosiderin deposition', 'elapsed  trauma'], ['male  infant', 'acute  deterioration'], ['Examination', 'abusive head trauma'], ['he', 'right  femur'], ['patient', 'unsuccessful  resuscitation'], ['Ophthalmopathological investigation', 'retina  eyes'], ['Retinal hemosiderin deposition', '8  AHT'], ['case report', 'prior hemosiderin death'], ['Implications', 'retinal hemosiderin AHT'], ['files', 'physical child children'], ['Fatal cases', 'younger  subjects'], ['leading  death', 'extracranial  injuries'], ['Eyes', 'cases'], ['Spinal  cord', 'mostly thoracic area'], ['previous  injuries', 'cases'], ['', 'significant age groups'], ['Subjects', 'internal  injuries'], ['association', 'highly child abuse'], ['suspected postmortem examination', 'investigative  reports'], ['introduction colonoscopy', 'therapeutic  tool'], ['safe  complications', 'safe  procedure'], ['most  dreaded', 'complications'], ['it', 'significant  complications'], ['high risk which', 'bowel bacteria'], ['we', 'healthy bowel adult'], ['international bowel none', 'molecular biology analysis'], ['Skull fracture characteristics', 'such impact abuse'], ['However correlations', 'loading infant'], ['computational  model', 'skull impacts'], ['fractures', 'based element elimination strategy'], ['Simulation results', 'qualitatively porcine heads'], ['simplified  model', 'initial fracture propagation'], ['fracture  characteristics', 'human infant cadaveric'], ['parameters', 'fracture  patterns'], ['jagged  shapes', 'strain skull'], ['international  prevalence', 'high  detection'], ['Herein  we', 'high LCGreen Plus((R'], ['iii target reproducibility', 'different reliabilitysample days'], ['microscopic  analysts', 'high  species'], ['verification methodology', 'digital implementation aspects'], ['verification that', 'digital control uncertainty'], ['digital controller DSVerifier', 'closed loop system'], ['proposed  methodology', 'fragile control literature'], ['robust fragility which', 'due FWL effects'], ['work', 'hybrid control system'], ['thermal linear we', 'digital  thermostat'], ['', 'degree  variation'], ['called  constraint', 'ineluctably thermostat performance'], ['temporal causality constraints', 'consistent  analysis'], ['We', 'physical  variables'], ['Catalytic  oxidation', 'hazardous air ones'], ['limited  information', 'especially service efficiency'], ['method  evidence', 'real application conditions'], ['limitations', 'industrial building applications'], ['full scale chamber which', 'realistic  conditions'], ['Formaldehyde', 'low approach levels'], ['small scale column tests', 'practical screening method'], ['', ''], ['', ''], ['rights', ''], ['', 'myopic collagen sclera'], ['old guinea pigs', 'normal form deprivation myopia'], ['then FDM changes', 'refractive  power'], ['Immunohistochemistry', 'emmetropia collagen I'], ['refractive FDM power', 'gradually  2'], ['', ''], ['', '0  -1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '6  4wk'], ['', 'myopia'], ['axial  length', '5'], ['', ''], ['', '39  6'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '4  4wk'], ['', ''], ['mRNA  expression', 'control groups'], ['reduction', ''], ['Furthermore correlation', 'myopic down sclera'], ['1 TGF signaling', 'myopia'], ['Trinidad', 'developing  0'], ['', 'economic % challenges'], ['It', 'producer electricity'], ['distributive justice that', 'fiscal  prudence'], ['value', 'paper'], ['global subsidy intractability that', 'environmental  reform'], ['Second  framework', 'former politicians policy makers'], ['developmental justice goals', 'heavily  subsidy'], ['results', 'fossil fuel reserves'], ['control system', 'spectral interference spectrometer'], ['key control scheme', 'moving mirror spectrometer'], ['closed loop control', 'current PI control'], ['scan peak current', 'scan  mirror'], ['', '5  acceleration'], ['relative  error', 'uniform  section'], ['digital control strategy', 'significantly control system'], ['', 'C  GmbH'], ['rights', ''], ['mechanism', 'nonlinear quadrant paper'], ['four stability condition', 'four quadrant converter'], ['describing saturation frequency', 'nonlinear  oscillation'], ['simulation  results', 'analyses'], ['paper', 'automatic control systems'], ['digital  structure', 'VHDL standard'], ['graphical  interface', 'monitoring'], ['DC encoder', 'real Java time'], ['push', 'pull buck regulator'], ['pull Voltage switches', 'buck pre regulation'], ['Pulse width modulation', 'only buck stage'], ['buck inductor current', 'current mode control'], ['', 'closed 20W 100V'], ['buck push', 'pull analog control PSIM'], ['digital SIMCOUPLER which', 'digital  MATLAB'], ['Further hardware implementation', 'two  platforms'], ['digital converter converter', 'open loop operation'], ['cysteine they', 'different  conditions'], ['function', 'directly  receptors'], ['immune infection autoimmunity components', 'general infection autoimmunity situation'], ['However  role', 'inflammation'], ['we', 'published postfracture studies'], ['Strawberry', 'climacteric  fruits'], ['Hormonal regulation', 'gene strawberries'], ['high throughput analyses', 'date'], ['role', 'regulatory strawberry fruit'], ['actually strawberry we', 'fruits'], ['We', 'temporal  expression'], ['First group', 'initial development stages'], ['second  group', 'final  processes'], ['Each', 'hormonal sub regulation'], ['main  that', 'development  process'], ['Auxins', 'crucial timeA genes'], ['ABA', 'vast  ripening'], ['physiological  rule', 'hormones'], ['also  ethylene', 'prominent  processes'], ['CGG repeat expansion', 'intellectual X disability'], ['199 FM alleles', 'related ataxia syndrome'], ['Here  we', 'cerebellar matter pathology'], ['he', 'expanded blood alleles'], ['microdeletion', 'complete CGG cells'], ['methylation CGG results', 'concurrent  FXS'], ['demonstrated  presence', 'early FM cerebellar'], ['who', 'detailed laboratory testing'], ['', ''], ['2011 tornado interest', 'developing tornado damage'], ['study', 'light wood building winds'], ['system level performance', 'wall load foundation'], ['', 'less  attention'], ['wood shear herein', 'combined wall failure shear'], ['building archetype', 'observed building practice'], ['Fragilities', 'vertical load path system'], ['independent Monte simulation', 'system reliability analysis'], ['', '2017 Civil Engineers'], ['crystallizable  fragment', 'immune effector system'], ['that', 'immune  response'], ['structural  characterization', 'therapeutic Fc protein agents'], ['binding Furthermore peptides', 'therapeutic  antibodies'], ['numerous Fc protein others', 'Fc protein complexes'], ['improved Fc protein approaches', 'such  cases'], ['structural bioinformatics approach', 'Fc protein complexes'], ['loosely  corresponding', 'initial docking search'], ['Rescoring', 'unrestrained test docking'], ['well Fc protein that', 'Fc'], ['Objective  study', 'aortic valve replacement'], ['65  who', '2008 valve October'], ['mean  age', 'operation'], ['patients', '30  days'], ['Functional Independence which', 'six  domains'], ['total Independence Measure score', 'unaffected  group'], ['', ''], ['preoperative Independence Measure score', 'unaffected  group'], ['', ''], ['postoperative care hospitalization', 'unaffected  16'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '23'], ['', ''], ['Functional Independence Measure', 'operative valve morbidity'], ['Vaccine development', 'extracellular aquaculture industry'], ['contrast infections', 'intracellular  pathogens'], ['', ''], ['disease', 'fish'], ['Francisellosis', 'high  host'], ['we', 'bacterial vaccine F'], ['', ''], ['', ''], ['Bacterial  MVs', 'such  molecules'], ['MVs', 'cultured  F'], ['', ''], ['mass MVs', 'outer OmpA ClpB'], ['electron we', 'F'], ['', ''], ['orientalis', 'myelomonocytic  vitro'], ['Immunization', 'F'], ['', ''], ['orientalis', 'lethal  F'], ['', ''], ['', ''], ['mRNA expression levels', 'real time PCR'], ['Expression', 'tnfa il1b'], ['ighm', 'immunogenic  F'], ['', ''], ['', ''], ['measure', 'damped electrode solution oscillation'], ['active  inductance', 'operational  amplifier'], ['second order oscillation system', 'active  test'], ['active  inductance', 'low measurement frequency'], ['negative  resistor', 'oscillation parameter estimation'], ['oscillation  signal', 'square wave voltage excitation'], ['instantaneous  capacitance', 'nonlinear impedance measurement'], ['operational  availability', 'available  resistors'], ['impedance nonlinearity', 'different sinusoidal excitation methods'], ['proposed  method', 'square wave period'], ['that', 'social  interactions'], ['substantial  amount', 'intentional  states'], ['', ''], ['theory', 'exteroceptive  e'], ['', ''], ['', ''], ['', ''], ['', ''], ['pivotal  role', 'internal  states'], ['that', 'human  brain'], ['another', 'internal energy states'], ['interoceptive predictions that', 'mind'], ['', ''], ['', 'Elsevier Inc'], ['VLC light system', 'lighting'], ['It', 'much  attenuation'], ['easily  it', 'good VLC receiver'], ['solar  cell', 'Rx devices'], ['Hence  it', 'IoT  networks'], ['highly  it', 'VLC data rate'], ['solar Manchester Rx', 'VLC'], ['times wandering increase', 'data rate'], ['Freedom', 'political  philosophy'], ['freedom', 'distributive  justice'], ['concern', 'public  policy'], ['most  theorists', 'proper  time'], ['now  we', 'future  freedom'], ['none', 'candidate time'], ['sufficientarian  none', 'various  freedom'], ['distributive  that', 'personal  freedom'], ['smart grid it', 'stable  operation'], ['impedance method', 'connected inverter systems'], ['impedance method', 'frequency domain'], ['However frequency characteristics', 'only analog control systems'], ['new frequency analysis method', 'digital control paper'], ['digitally LCL type results', 'Saber simulator'], ['Finally  they', 'based  system'], ['', ''], ['Background ObjectivesVariant genes', 'red epitope cell'], ['study', 'D D epitope profile'], ['weak serology blood RHD', 'SNP typing platform'], ['D antibody kits', 'D epitope profiles'], ['97 type samples', 'RHD variants'], ['2 RHD*weak type', '75  donors'], ['22  samples', 'different RHD variants'], ['One  donor', 'novel'], ['', 'one D epitope'], ['5 15 17', 'partial D epitope profile'], ['Australian donor that', 'future genotyping strategies'], ['study', 'early well adulthood'], ['random  sample', 'named well peers'], ['response rate', ''], ['resulting', '782  cases'], ['We', 'structural equation trust'], ['well  being', 'measurement part'], ['structural  part', 'late  adolescence'], ['well  being', '23  age'], ['lower sex difference', 'trust'], ['young model fit causation', 'young well women'], ['Subsequent  analysis', 'young  women'], ['young  people', 'same adult populations'], ['who', 'low friendship time'], ['Background Friendships', 'intellectual  disability'], ['contact', 'friendship'], ['case study approach', 'intellectual term disability'], ['Qualitative  methods', 'participant data observation'], ['relationship', 'working disability support organisation'], ['Individualised  role', 'positive  friendship'], ['Conclusions Friendships', 'long term outcomes'], ['Wood frogs', 'wild mass populations'], ['caught FV3 adults', 'fatal  10(4'], ['', 'pfu  0'], ['', ''], ['', ''], ['Mild lesions', '2 bone dpi'], ['Severe lesions', 'mucosae tissue lymphoid tubules'], ['liver skin', 'liver kidney'], ['4 IHC labeling', 'multiple  tissues'], ['poor week samples', 'healthy  frogs'], ['social avoidance that', 'Autism Spectrum Disorder'], ['MRI studies', 'social WS cognition'], ['unique Syndrome Brain that', 'quantitatively WS PFC cytoarchitecture'], ['We', 'matched area WS'], ['V WS VI', 'statistical  BA'], ['higher  difference', 'higher  TD'], ['Neuron density', '4  WS'], ['cortical  areas', 'WS prefrontal WS areas'], ['Neuron density', 'also  ASD'], ['PFC', 'sociobehavioral  alterations'], ['Autism', ''], ['', '2016 Wiley Periodicals Inc'], ['nervous Anterior which', 'genetic folate metabolism'], ['case control study', 'Northeast Indian Northeast population'], ['80 AE controls', 'length polymorphism technique'], ['MTHFR', 'significantly AE risk'], ['', ''], ['', ''], ['MTHFR', '677C-1298C/677T-1298A'], ['', ''], ['', 'progressive  manner'], ['pA', 'disease susceptibility'], ['Children', 'increased rs2236225 GG'], ['', ''], ['', ''], ['Children', 'elevated rs1801133 CT risk'], ['', ''], ['', ''], ['MTHFD1 polymorphism', 'progressive MTHFR manner'], ['', ''], ['', ''], ['data', 'gene gene AE'], ['Together haplotypes MTHFD1', 'progressive  manner'], ['>  C', 'possible  regions'], ['', ''], ['Psychiatric  symptoms', 'clinical  patients'], ['Purpose', 'psychiatric  FTD'], ['research', 'psychiatric database FTD'], ['search strategy', 'the'], ['Pathophysiology', 'other  dementia'], ['drugs', 'serotonergic Alzheimer patients'], ['Data', 'psychiatric  FTD'], ['observational  studies', 'effective  FTD'], ['Frontotemporal  dementia', 'devastating  ways'], ['article', 'commonly Alzheimer disease'], ['structural  we', 'semantic brain dementia'], ['they', 'semantic  dementia'], ['semantic ToM memory', 'semantic ToM dementia'], ['results', 'affective  representations'], ['affective ToM deficit', 'processing  impairment'], ['cognitive ToM performances', 'prefrontal  regions'], ['Intrinsic connectivity analyses', 'cortical  regions'], ['also  that', 'semantic cognitive dementia'], ['disturbed ToM that', 'abilities'], ['experimental  study', 'axial RC compression'], ['longitudinal FRP load', 'longitudinal steel rebars'], ['axial RC contribution', 'axial steel load'], ['axial RC stress', 'gradually  deformation'], ['Significant  interactions', 'longitudinal steel rebars'], ['interaction', 'theoretical steel modeling'], ['', ''], ['rights', ''], ['present  study', 'unconditional frustration intolerance beliefs'], ['Participants', 'University Lahore Pakistan'], ['They', '387 Self Esteem Society'], ['', '2001a General Health Questionnaire'], ['', ''], ['results', 'unconditional frustration intolerance beliefs'], ['unconditional self that', 'educational  growth'], ['Fucoidan', 'biological anticancer activity'], ['Recently  fucoidan', 'metastatic cancer cells'], ['Increasing research attention', 'based  nanomedicine'], ['However  application', 'chitosan anticancer drug 6'], ['', ''], ['responsive  properties', 'dynamic light scattering'], ['', ''], ['', ''], ['5', 'anticancer nanoparticles'], ['charge conversion release properties', 'metastatic cancer cell line'], ['', ''], ['rights', ''], ['based thermoelectric generators', 'waste heat'], ['Utilization', 'heavy duty work'], ['alternator', ''], ['generated fuel electricity', 'electrical  loads'], ['original  alternator', 'certain  conditions'], ['', ''], ['smaller  alternator', 'together  TEG'], ['', ''], ['', ''], ['overall  performance', 'simulation analysis'], ['fuel former', 'better  results'], ['properly fuel economy', ''], ['simulation results', 'solid  future'], ['shield  machine', 'congested ground surface areas'], ['paper', 'first URUP tunneling China'], ['shield  machine', 'partially ground surface'], ['paper', 'induced grouting process'], ['regardless load factor approach', 'fair volume loss'], ['expanding displacement field', 'several  locations'], ['Pressure measurements', 'dependent grouting process'], ['that', 'Mode Logic Mode world'], ['Doing', 'low power consumption'], ['outstanding  properties', 'CMOS technology parameters'], ['layout Monte Carlo simulations', 'robust fabrication idealities'], ['layout Monte results', ''], ['37  mW', 'power'], ['current  gain', 'abovementioned  layout'], ['43  mW', 'power'], ['results', 'proposed  technology'], ['paper', 'input Ring 1'], ['45  GHz', ''], ['two frequency which', 'digital mode bit'], ['Switching', 'run delay time'], ['reconfigurable delay element', 'current code tails'], ['Power consumption profile', 'steady  regime'], ['fully  which', 'jitter high performance applications'], ['proposed  DCO', 'CMOS standard'], ['', ''], ['', ''], ['frequency power consumption', 'lower  band'], ['', '2  505'], ['', ''], ['', '455  MHz'], ['', '04  505'], ['1  MHz', 'upper  1'], ['', '39  1'], ['', ''], ['', '7  1'], ['', ''], ['', '48  1'], ['', ''], ['', 'analytical frequency bands'], ['Monte Carlo Monte test', 'acceptable frequency tolerance'], ['other problem behavior', 'multiple  conditions'], ['problem behavior', 'automatic  reinforcement'], ['current  study', 'sensory analysis extinction'], ['self injury', 'physical  participant'], ['based self that', 'successfully  settings'], ['Multiferroic  materials', 'memory  sensors'], ['we', 'magnetic  microwave'], ['', ''], ['', ''], ['', ''], ['', ''], ['ferromagnetic  components', 'standard magnetization equation'], ['ferromagnetic  saturation', 'paramagnetic  BFO'], ['', ''], ['', ''], ['', ''], ['', 'enormously cycloid spin'], ['magnetoelectric voltage coefficient', 'BFO'], ['', ''], ['it', 'BLFMO'], ['', ''], ['', ''], ['', 'magnetic BFO BLFMO properties'], ['', ''], ['', ''], ['rights', ''], ['Similarity search', 'current  databases'], ['6500  papers', 'Science'], ['recent  research', 'early  stage'], ['functional  which', 'account'], ['main  concern', 'existing  topic'], ['', ''], ['', ''], ['rights', ''], ['electrical  stimulation', 'spinal cord injury'], ['However  most', 'controlled feedback bladder'], ['us', 'nerve bladder'], ['proposed  stimulator', 'digital  analog'], ['anodic control which', 'anodic control signals'], ['high output which', 'load'], ['amplitude  frequency', 'pulse stimulating sequences'], ['we', 'neural  recording'], ['especially feedback which', 'previous  studies'], ['neural  stimulating', 'bladder control TSMC'], ['', ''], ['proposed  stimulator', 'low headroom 0'], ['168  V', '2'], ['', '1 mu Hz'], ['', 'referred recording 3'], ['', '62 mu 3'], ['', 'low power 7'], ['2 mu W', '61'], ['', '300  5'], ['', ''], ['circuit analysis', 'proposed  designs'], ['given plant that', 'biochemical  stimuli'], ['time polymerase chain microarray', 'other RNA which'], ['questions', 'solitary expression atlas'], ['tolerant plant genes', 'developmental plant parts'], ['transcriptome', 'downstream target genes'], ['Marker information', 'improved  varieties'], ['Fortunately  data', 'ample transcriptome utilization'], ['transcriptome  which', 'special gene microarray'], ['regulatory gene which', 'improved plant varieties'], ['Psychopathological  symptoms', 'psychosocial  functioning'], ['However  nature', 'still  scrutiny'], ['We', 'previous premorbid adjustment year'], ['We', 'cognitive premorbid adjustment performance'], ['healthy Sixty volunteers', 'controls'], ['aforementioned  variables', 'psychosocial  functioning'], ['significantly  most', 'psychopathological  dimensions'], ['negative  symptoms', '47  variance'], ['negative  symptoms', 'cognitive  adjustment'], ['', ''], ['', ''], ['rights', ''], ['Cognitive Assessment Interview', 'daily  activities'], ['We', 'psychosocial CAI psychosis'], ['FEP episode who', 'neuropsychological  battery'], ['Patients', 'clinical  assessment'], ['37  controls', 'neuropsychological normalization purposes'], ['CAI Sp scores', 'FEP  patients'], ['FEP we', 'significant  correlations'], ['Most  associations', 'clinical  symptoms'], ['Sp rater scores', 'DAS S symptoms'], ['CAI Sp', 'FEP  patients'], ['functional illness disturbances', 'cognitive  impairments'], ['', ''], ['', ''], ['rights', ''], ['paper', 'two step perturbation method'], ['shells', 'also temperature account'], ['in boundary conditions', 'in  plane'], ['governing  equations', 'neutral surface concept'], ['explicit  expressions', 'transverse perturbation method'], ['numerical  comparisons', 'research solution method'], ['bending foundation', 'shells'], ['', ''], ['rights', ''], ['that', 'functional  decline'], ['potential  that', 'high risk patients'], ['total', 'clinical Melbourne measures'], ['We', 'correlational Functioning Assessment regression'], ['Performance', 'concurrent jokes role'], ['', ''], ['', ''], ['', ''], ['', ''], ['it', 'negative  symptoms'], ['Social functioning', 'social cognition tasks'], ['only  test', 'high risk sample'], ['longitudinal  research', 'high risk group'], ['cognitive  that', 'high risk individuals'], ['uses', 'partially  personality'], ['Brief Life Orientation Test', 'Beck Depression Inventory'], ['Openness', 'complex  RC'], ['', ''], ['', ''], ['', ''], ['', 'conventional  UC'], ['', ''], ['pop  extraversion', 'positively  preferences'], ['', ''], ['', ''], ['link', 'prominent extraversion trait'], ['relationship', 'to RC music experience'], ['Trait neuroticism', 'emotional depression music'], ['negative music affect', 'emotional  music'], ['Perturbations', 'later health life'], ['much  research', 'two  archaea'], ['5 28 5 150', 'real time PCR'], ['Sequences', 'collected meconium samples'], ['early  diversification', 'formula milk'], ['which', 'three  life'], ['3  which', 'relative genera Bifidobacterium'], ['Generally  depletion', 'when VD infants'], ['other  factors', 'observed antibiotics patterns'], ['previous CSD which', 'only  bacteria'], ['This', 'gastrointestinal  tract'], ['P  Sucrose', 'Trichoderma  roots'], ['we', 'fungal  cells'], ['Several bioinformatics tools', 'sucrose Trichoderma 8'], ['Gene expression profiles', 'Northern  blotting'], ['Biochemical  studies', 'fungal  TvSut'], ['TvSut', 'sucrose  plants'], ['when  sucrose', 'symbiotic  association'], ['', 'T'], ['sucrose H+ that', 'early root colonization'], ['results', 'beneficial  associations'], ['fungal  that', 'symbiotic  association'], ['Pathogenic  isolates', 'pathogenic plant wilts'], ['genetic biocontrol basis', 'biocontrol mechanisms'], ['aim', 'biocontrol F'], ['mutant strain which', 'protective  capacity'], ['when  conidia', 'tomato cell cultures'], ['total', 'regulated  protective'], ['plant  that', 'putative  functions'], ['plant those', 'plant stresses'], ['NADP(H ATP synthase', 'Northern RPM1-interacting blotting'], ['large  proportion', 'protective  F'], ['', ''], ['', ''], ['rights', ''], ['Fusarium head blight', 'high yield losses'], ['Fusarium species', 'also Golestan Iran'], ['41  F', '41  24'], ['graminearum', 'stricto'], ['', ''], ['six', ''], ['proliferatum', ''], ['culmorum', 'three  F'], ['', ''], ['', 'one meridionale F'], ['asiaticum', ''], ['NIV  genotype', '3-acetyl  deoxynivalenol'], ['Production', 'autoclaved GC MS'], ['', 'mean Fusarium spp'], ['', ''], ['Fusarium isolates', 'mainly  cellulase'], ['Lipase pectinase activities', 'less  quantities'], ['', 'F'], ['', 'F'], ['maximum  which', 'high  wheat'], ['', 'other hand wheat'], ['Virulence', 'producing  isolates'], ['virulence factors', 'considerable  pathogen'], ['This', 'first Fusarium spp'], ['', 'growing FHB Iran'], ['', 'Fusarium oxysporum f'], ['', ''], ['fragariae', ''], ['commercial strawberry it', 'commercial strawberry production'], ['Reliable chemical control', 'Fusarium wilt disease'], ['', ''], ['oxysporum', 'genetic  F'], ['', ''], ['', ''], ['', ''], ['genetic  diversity', 'strawberry pathogen'], ['110  pathogens', 'namely South Korea'], ['isolates', 'F'], ['', ''], ['', ''], ['', ''], ['PCR RFLP PCR analyses', 'four restriction HhaI'], ['', 'three tubulin gene region'], ['genetic cultivation method diversity', 'cultivated  region'], ['IntroductionDetection', 'refined  leukemia'], ['nested', 'transcription PCR'], ['MethodsWe', 'parallel fusion reactions'], ['method', 'known fusion transcripts'], ['real time PCR method', 'detected fusion genes'], ['Intra assay reproducibility', 'frequent  0'], ['', '41  0'], ['74 interassay reproducibility', '1'], ['', '62  2'], ['', 'separate  experiments'], ['lowest detection limit', '1'], ['Validation', 'nested RT PCR'], ['method', 'diagnostic fusion leukemia'], ['use', 'residual  disease'], ['Prostate Apoptosis Response', 'proapoptotic prostate cancer activity'], ['Particularly SAC domain', 'normal cancer cells'], ['large scale production', 'still  concern'], ['Here  we', 'transgenic Nicotiana cv'], ['', 'recombinant promoter M24'], ['Transgene integration', 'Real time assays'], ['recombinant SACPar-4-GFP it', 'as  0'], ['', 'soluble  protein'], ['targeting', 'plant recombinant plant bacterial'], ['Deglycosylation analysis', 'targeted SAC Par-4-GFP'], ['MU apoptosis induction assays', 'multiple cancer cell lines'], ['Additionally  treatment', 'significantly prostate cancer model'], ['SAC Par-4', 'new  era'], ['BACKGROUNDNovel fusion transcripts', 'common chromosomal cancers'], ['current  authors', 'new colon cancers'], ['TopHat Fusion', 'new colon cancers'], ['5  member', 'genomic chromosomal rearrangement'], ['Next  expression', 'normal colon epithelia'], ['RESULTSThe authors', 'normal FT epithelia'], ['unexpectedly  it', '1 KLHL29 chromosome'], ['germline  which', 'population 0'], ['40', 'cancer development'], ['validated', 'KLHL29 gene insertion'], ['NR5A2-KLH29FT expression levels', 'colonic colon epithelia'], ['', 'potential tumor type'], ['CONCLUSIONSNR5A2-KLHL29FT', 'KLHL29 locus'], ['NR5A2-KLHL29FT', 'colon cancer'], ['transchromosomal that', 'current assembly algorithms'], ['', ''], ['', ''], ['group fusion member', 'instead chromosome rearrangement'], ['expression', 'potential colon cancer'], ['Mushroom production', 'solid state fermentation world'], ['success', 'how control temperature humidity'], ['paper', 'mentioned production rate'], ['other  collection', 'MATLAB software'], ['', 'product quality'], ['standard deviation variance', 'digital  controlling'], ['controlling  system', 'lowest  fluctuation'], ['fuzzy graph controlling', 'better  process'], ['digital control system downtime', 'fuzzy control system'], ['', ''], ['rights', ''], ['paper', 'dynamic Fuzzy Logic Controller'], ['system', 'agricultural  land'], ['', ''], ['canals', 'low  irrigation'], ['second water reservoir controller', 'set water canal'], ['', 'real system HMI'], ['MATLAB which', 'OPC gateway'], ['based system communication', 'PLC water level meter'], ['data', 'pumping station'], ['system', 'manual selection switch'], ['proposed  that', 'nonlinear  plants'], ['superior  that', 'lower  level'], ['flight it', 'individual  controllers'], ['hierarchical control strategy', 'simple t student test'], ['we', 'fuzzy control approach'], ['genetic control algorithm', 'fuzzy optimal fashion'], ['', ''], ['', ''], ['rights', ''], ['Galactose  metabolism', 'structural GAL proteins'], ['cells', 'severe growth defects'], ['Hsp90', 'possibly Gal defects'], ['Hsp90', 'environmental cell cues'], ['Yeast cells', 'filamentous  galactose'], ['Hsp90 Hsp90 which', 'cell pathways'], ['Hsp90 client proteins', 'filamentous cell morphology growth'], ['phenomenon', 'cellular  constraint'], ['why GAL pathway', 'yeast species'], ['inborn  error', 'first von Ruess'], ['100  years', 'underlying  condition'], ['Initial  studies', 'clinical  disease'], ['However  discovery', 'enzymatic  pathway'], ['defects', '1-phosphate  galactosemia'], ['affected  enzyme', 'other  III'], ['', '1970s molecular biology galactosemia'], ['chromosomal  locations', 'three DNA genes'], ['studies', 'biochemical  studies'], ['enzymatic  impairment', 'often  misfolding'], ['Cellular organism studies', 'oxidative GALE stress'], ['Thus  it', 'affected intermediates proteins'], ['', ''], ['', ''], ['rights', ''], ['', 'Lactobacillus rhamnosus'], ['', 'open reading Lact'], ['rhamnosus TCELL-1', ''], ['order', 'ORFs'], ['major lacTEGF galKETRM transcripts', 'gene cluster'], ['transcription', 'independently gal lactose'], ['blotting primer experiments', 'lacTp ORFs galK'], ['enzymatic GalK expression', 'galactose repression mechanism'], ['', 'Lact'], ['galactose  metabolism', 'Leloir pathway'], ['work', 'important sugar Lact'], ['', ''], ['We', 'vitro  0'], ['', ''], ['', ''], ['', ''], ['', 'cerebral cortex rats'], ['tocopherol ascorbic acid', 'parameters'], ['Results', '3'], ['mM', 'hippocampus cerebral rats'], ['', 'cerebral cortex 5'], ['', ''], ['mM', 'TBA RS carbonyl 10'], ['mM', 'AChE activity'], ['', 'cerebellum 5'], ['', ''], ['mM', 'TBA RS SOD'], ['', 'hippocampus 5'], ['', ''], ['mM', 'TBA RS TBA 10'], ['mM', 'GSH Px'], ['Data', 'greater  5'], ['galactose', 'also cholinesterase activity'], ['oxidative AChE that', 'galactose'], ['therapeutic  which', 'appropriate  galactose'], ['We', 'central Digital Sky Survey'], ['previous size mass which', 'stellar mass relations'], ['central  galaxies', 'more quiescent population'], ['forming  we', 'small  mass'], ['we', 'stellar mass galaxies'], ['We', 'larger mass surface radii'], ['when  they', 'forming  groups'], ['low  all', 'outer  galaxies'], ['Functionalized  nanoparticles', 'modern  imaging'], ['We', 'ductal target adenocarcinoma'], ['Promising targets', 'normal cancer precursor tissues'], ['Molecular  probes', 'binding t galectins'], ['Affinity constants', 'synthesized microscale thermophoresis'], ['binding  which', 'over t PA PDAC'], ['t PA peptide-1', 'biodegradable iron oxide nanoparticles'], ['polylactic co glycolic obtaining', 'already drug delivery applications'], ['binding  efficacy', '90 flow cytometry'], ['efficacy', 'pancreatic tumor 1'], ['', ''], ['vectorized t NPs', 'injected staining NPs'], ['Post mortem NP deposition', 'histopathology tissue sections'], ['targeted  NPs', 'fast murine tumor models'], ['PEG tPA pep1Lac', 'pancreatic NPs tumor'], ['analogue digital analogue circuit', 'optical ring resonators'], ['approach', '2800 chip 0'], ['', ''], ['Therefore  it', 'optical switch matrices'], ['analogue power dissipation', '7  %'], ['recent  practice', 'large game attention'], ['Popular  discussion', 'behavioral profitability goal outcomes'], ['empirical  that', 'such  expectations'], ['paper', 'group game mechanic'], ['implementation  group', '1  year'], ['gamified  group', 'full  year'], ['users', 'active transactions way'], ['', ''], ['rights', ''], ['Gamification', 'increasing business education'], ['wide support potential', 'tourism industry'], ['Gamification', 'well brand destination'], ['first  paper', 'specific tourism fields'], ['game design that', 'meaningful  gamification'], ['innovative  concept', 'tourism marketing'], ['Implications', 'tourism marketing'], ['', ''], ['rights', ''], ['Human delta T cells', 'stressed T cell cells'], ['molecular  determinants', 'recognition'], ['Here  we', 'various tumor cell V'], ['', ''], ['antigenic TCRs annexin A2', 'direct  V'], ['8Vd3 TCR', 'dependent oxygen manner'], ['other T cell clones', 'peripheral blood mononuclear cells'], ['oxidative delta T that', 'adaptive stress surveillance'], ['paper', 'Nitride structure transistors'], ['Static characterization results', 'gate driver circuits'], ['current Common propagation', 'digital control circuits'], ['conductive CM noise', 'digital control circuits'], ['lateral structure GaN which', 'lateral power loop design'], ['current overvoltage less', 'lateral power loop design'], ['designed EMI noise that', 'propagation path control'], ['paper', 'interconnected Great Britain'], ['systems', 'different supply outlooks'], ['heavily gas GB', 'gas  interactions'], ['realistic unit commitment', 'economic gas supply network'], ['Extreme weather events', 'low supply network stress'], ['Decreased wind profiles', 'domestic gas demand'], ['high gas network stress', 'localised generating units'], ['Additionally entry node congestion', 'short run generators'], ['Gds storage', 'significantly electricity supply'], ['', ''], ['', 'Elsevier Ltd'], ['objective', 'assisted gas turbine system'], ['Parabolic trough collectors', 'friendly gas system'], ['collector field which', 'lower electricity production'], ['parametrically  it', 'second  part'], ['objective optimization optimization', 'inversed electricity production'], ['1050 collector modules', '0'], ['', 'equal electricity 14'], ['', ''], ['optimum  solution', '64 % fuel 2'], ['', 'produced % electricity'], ['system', 'steady Engineering Equator Solver'], ['', ''], ['comparative  analysis', 'long  literature'], ['natural gas demand', 'industrial  sector'], ['paper', 'gap'], ['It', 'Spanish manufacturing 1995'], ['homogenous  estimators', 'purpose'], ['spurious price elasticity', 'significantly gas the'], ['', ''], ['', ''], ['price elasticity', 'electricity demand'], ['statistically income elasticities', 'statistically  0'], ['', '0'], ['', ''], ['preferred  estimation', 'natural gas demand'], ['', ''], ['rights', ''], ['thermal  treatment', 'mass thermodynamic equilibrium'], ['average MSW composition', 'ton waste gasification facility'], ['combustion', 'pyrolysis stoichiometric auto oxygen'], ['cases', 'electricity'], ['thermal oxygen gasification', 'most  electricity'], ['oxygen plasma gasification', 'net  amount'], ['', '1 day scale'], ['calorific  value', 'internal combustion engine'], ['amount', 'higher process efficiencies'], ['auto thermal oxygen process', ''], ['cost', 'however oxygen picture'], ['lower  market', 'lower  what'], ['derived electricity syngas', 'natural chemical waste gas'], ['detailed  that', 'global tar process'], ['research work', 'fluidized bed reactors'], ['model', 'homogeneous oxidation aromatization'], ['it', 'cracking tar species'], ['model', 'global tar process'], ['', ''], ['rights', ''], ['coding  RNAs', 'regulatory  cancers'], ['lung adenocarcinoma transcript', 'human  cancers'], ['main  objective', 'gastric expression cancer'], ['clinicopathological MALAT1 prognosis', 'gastric carcinoma patients'], ['protein expressions', 'western blot analysis'], ['Luciferase reporter assay', 'MALAT1'], ['we', 'local lymph node metastasis'], ['Patients', 'shorter MALAT1 survival'], ['MALAT1', 'cells GC'], ['MALAT1', 'sponging HMGB2 expression'], ['critical GC which', 'gastric  cancer'], ['gastric  adenocarcinoma', 'worldwide  et'], ['', ''], ['Epidemiol', '2002 Gastric Cancer et'], ['', ''], ['', ''], ['', ''], ['', 'International Cancer'], ['impact gastric impact neoplasms', 'important imaging modalities'], ['varied  many', 'similar imaging features'], ['radiologist', 'diagnostic  considerations'], ['3  5', 'together  exon'], ['circular  RNAs', 'human  diseases'], ['However  little', 'gastric  cancer'], ['we', 'gastric cancer patients'], ['time cancer cell quantitative', 'reverse polymerase chain reaction'], ['potential  relationship', 'hsa_circ_0001895 expression levels'], ['characteristic  curve', 'diagnostic  hsa_circ_0001895'], ['', 'gastric epithelial GES-1 cells'], ['healthy control it', 'only  69'], ['', 'precancerous cancer lesions'], ['Moreover hsa_circ_0001895 expression levels', 'embryonic antigen expression'], ['hsa_circ_0001895', 'clinical prognosis prediction'], ['molecular  subtyping', 'molecular Epstein Barr features'], ['we', 'gastric EBV carcinoma'], ['EBV genes component H1 ratios', 'conventional polymerase chain method'], ['14  sensitivity', 'detection'], ['', ''], ['', ''], ['significantly EBV DNA', 'EBVaGC surgery'], ['free EBV DNA', 'little  prognosis'], ['repeated EBV ratio', 'tumor progression tumor recurrence'], ['results', 'well treatment EBVaGC'], ['O GlcNAcylation', 'nuclear monosaccharide proteins'], ['O GlcNAcylation', 'dynamically O GlcNAc transferase'], ['O GlcNAcylation', 'human  cancers'], ['exact  role', 'tumor progression'], ['O GlcNAcylation', 'gastric  cancer'], ['First cell models', 'specific inhibitor Thiamet OGT'], ['O GlcNAcylation', 'gastric cancer cells'], ['O GlcNAcylation', 'cellular colony formation vitro'], ['Akt1 activity', 'elevated O GlcNAcylation'], ['enhanced cell invasion', 'K inhibitor LY294002'], ['Akt1 it', 'still  shRNA'], ['Akt1 overexpression', 'induced cell invasion'], ['PI3K  Akt', 'pathway'], ['', 'International Union International Biochemistry'], ['', ''], ['diagnostic  markers', 'clinical  practice'], ['which', 'new tumor diagnosis'], ['UCA1 CEBPA AS1', 'gastric cancer tissues'], ['plasma level', 'normal cancer controls'], ['characteristic  we', 'plasma 0'], ['921', 'individual CEBPA levels'], ['gastric cancer plasma most', 'healthy control plasma samples'], ['gene expression profiles', 'tumor microarray analysis'], ['gastric polymerase chain 5', 'gastric cancer plasma'], ['certain  lncRNAs', 'gastric cancer cancer'], ['combination', 'gastric cancer patients'], ['', 'MKN45 gastric cancer cells'], ['growth rate', 'only CCK-8 assay'], ['mRNA expression levels', 'reverse polymerase chain reaction'], ['Growth', 'dependent MKN45 manner'], ['', ''], ['inhibitory  effect', 'dependent  PDTC'], ['', ''], ['mRNA  expression', 'only  PDTC'], ['suppressive  effect', 'when  cisplatin'], ['', ''], ['respect', 'only  cisplatin'], ['', ''], ['similar  tendency', 'corresponding immunofluorescence analysis'], ['', ''], ['MKN45 gastric cancer disturbance', 'gastric treatment cancer'], ['7 protocadherin that', 'human  cancers'], ['However expression function', 'gastric  cancer'], ['we', 'realtime polymerase chain reaction'], ['clinicopathological  prognosis', 'clinicopathological  characteristics'], ['tetrazolium))and transwell assays', 'gastric cancer cell lines'], ['real polymerase chain reaction', 'epithelial mesenchymal transition markers'], ['7  expression', 'gastric lymph node metastasis'], ['Low  expression', 'significantly  classification'], ['', ''], ['', ''], ['', ''], ['', ''], ['down  regulation', 'migration cancer cell abilities'], ['', ''], ['cadherin  expression', '7 cancer depletion'], ['protocadherin', 'cadherin cell inhibition'], ['Protocadherin', 'gastric  cancer'], ['gastroenteropancreatic  tumors', 'embryological  gut'], ['incidence', 'probably  imaging'], ['recent  advances', 'therapeutic  patients'], ['which', 'recently tumor growth'], ['neuroendocrine rapamycin role', 'nonpancreatic'], ['treatment', 'multidisciplinary  approach'], ['management', 'surgical  surveillance'], ['However  treatment', 'directed tumor growth'], ['article', 'future  approaches'], ['Gastroesophageal  malignancies', 'diagnosed  cancers'], ['effective  treatments', 'malignancies'], ['targeted  therapies', 'minimal disease group'], ['new GE it', 'significant  malignancies'], ['', 'genomic drug resistance'], ['Several growth factor receptors', 'prominent GE cancer cell'], ['monoclonal growth factor that', 'later  therapy'], ['review', 'molecular GE biology'], ['development', 'significant tumor molecular profiles'], ['molecular disease we', 'improved GE cancers'], ['stromal  tumors', 'digestive  1'], ['1  cases/100000', ''], ['group', 'pathological Spanish tumors'], ['10 mm-35 that', 'parietal  growth'], ['Histologically  they', 'expansive  growth'], ['Mitotic activity', 'high  cellularity'], ['commonly tyrosine kinases GISTs', 'BRAF SDH genes'], ['method', 'direct amplification products'], ['always  region', 'detection method'], ['stromal  tumors', '90 proto oncogenes cases'], ['mutations', 'prognostic multikinase impact'], ['Here  we', 'routinely Molecular Cancer Diagnosis'], ['patients', 'present University study'], ['KIT PDGFRA', '600 Sanger sequencing'], ['KIT', 'PDGFRA 71'], ['', ''], ['', '2  cases'], ['different  13', 'different  which'], ['18  mutations', 'bowel  localizations'], ['mutation', 'KRAS'], ['Molecular studies', 'GISTs'], ['study', 'new  KIT'], ['first  significance', 'such DNA repair carcinogens'], ['tested', 'first target objects'], ['less  person', 'measure'], ['Less  differentiation', 'high interest condition'], ['developing  children', 'when object themselves'], ['Biological  functions', 'globo series glycosphingolipids'], ['mRNA globo series expression', 'genes'], ['Distribution', 'products'], ['Gb4 CD77 both', '348 amino acids'], ['Gb3 CD77 synthase gene', 'other  tissues'], ['Gb4  synthase', 'kidney liver skin'], ['Gb3  CD77', 'converting  enzyme'], ['it', 'coincidental white CD10'], ['It', 'aside alveolar hair'], ['Gb4', 'proximal alveolar Gb3'], ['it', 'central choroids liver'], ['expression patterns', 'almost  exception'], ['results', 'functional globo series glycolipids'], ['low noise Op Amp', 'paper'], ['high Op Amp', 'large capacitor gain'], ['we', 'three stage Op Amp'], ['designed  circuit', '78'], ['4  which', 'two  stage'], ['', 'various slew rate etc'], ['', 'larger GBW PM'], ['We', 'input common mode range'], ['Improvement', 'then L results'], ['', 'Gain Bandwidth Gain 176'], ['60 Phase degrees', 'power dissipation'], ['Op Amp', '180 nm CMOS technology'], ['simultaneously  they', 'different  tissues'], ['They', 'Northern gene blotting'], ['various gene what', 'beta tubulin expression'], ['nine beta tubulin genes', 'maize'], ['multiple tub some', 'biological  plant'], ['This', 'different maize beta development'], ['following  work', 'gene differential expression'], ['Based oil microarray data', 'immature seedling ears'], ['', 'different tubulin tissues'], ['specific beta tubulins', 'developmental  stages'], ['immature  tub2', 'transcript  abundances'], ['similar expression which', 'transcriptional  regulation'], ['transcript  abundance', 'seedling  shoots'], ['tub3', 'first maize endosperm'], ['chapter', 'important tubulin gene work'], ['Sertoli  cells', 'spermatogonial stem spermatozoa'], ['neurotrophic cell which', 'SSC self renewal'], ['how stem cell factor', 'stem cell niche'], ['previous  studies', 'ultimately sperm cell output'], ['we', 'canonical cells pathway'], ['which', 'thus Gdnf cAMP'], ['Sertoli NOTCH ligand cells', 'negative feedback regulation'], ['beta keratins', 'adhesive gecko lizards'], ['amino  sequences', 'gecko mRNAs'], ['Specific  oligonucleotides', 'gecko beta keratin cDNA sequences'], ['coding  sequences', 'rich glycine 16'], ['', '169 amino acids'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['central  region', 'beta keratin beta filaments'], ['It', 'avian core scale'], ['RTPCR polymerase chain analysis', 'normal gene epidermis'], ['', 'oberhautchen  cells'], ['Expression', 'adhesive RT PCR'], ['proteins', 'multigene  family'], ['genes', 'avian beta keratins'], ['enolase2  gene', 'specific  enolase'], ['present  we', 'about Gekko 2'], ['', 'Northern Gekko blotting'], ['1305  which', 'amino acid protein'], ['brain spinal brain it', 'other  tissues'], ['spinal cord it', 'seventh days experiment'], ['recombinant  plasmid', 'fused NSE protein'], ['purified NSE protein', 'polyclonal  antisera'], ['titer', 'than  ELISA'], ['prepared  antibody', 'recombinant NSE protein'], ['positive  signals', 'brain'], ['study', 'polyclonal Gekko japonicus'], ['Tuberculous Meningitis', 'EPTB Extrapulmonary cases'], ['Most  guidelines', 'molecular Polymerase Chain Reaction'], ['However  sensitivity', 'CSF sample'], ['present  we', 'peripheral TBM cases'], ['based system total', 'prospectively Medical January'], ['Mycobacterium tuberculosis', 'clinical Medical Research TBM'], ['Clinical  characteristics', 'categorical  variables'], ['', ''], ['', ''], ['statistical  analysis', 'MedCalc software version'], ['', ''], ['80  which', 'culture'], ['', ''], ['peripheral PCR assay', 'three TBM stages'], ['Positivity', '50 MTB %'], ['Increased positivity rates', 'mycobacterial TBM severity'], ['repeated CSF collection', 'good TBM severity'], ['', 'present  hypothesis'], ['Northern blotting analysis', 'complex state sample'], ['gel RNA', 'gel which'], ['more  that', 'subsequent  detection'], ['Northern  blotting', 'inexpensive  artefacts'], ['Recent  developments', 'laborious nuclease protection experiments'], ['women', 'empathic  men'], ['opposite pareidolia sex', 'humans'], ['', 'erotic incongruent behavior pictures'], ['Sex differences', 'based attachment response'], ['human  faces', 'male University students'], ['Stimuli', 'facial  expression'], ['whole  women', 'positive  men'], ['Furthermore  they', 'arousal evaluation'], ['facial expression women', 'faces  men'], ['', 'opposite'], ['', 'facial sex age'], ['facial  that', 'evolutionary  psychobiology'], ['', ''], ['people', 'health professionals'], ['study', 'transitioning transgender people'], ['online  that', 'personal gender congruence anxiety'], ['ResultsAlthough results', 'structural equation dissatisfaction'], ['personal  hardiness', 'gender congruence self health'], ['Australian health this', 'mental health outcomes'], ['personal  hardiness', 'important  transitioning'], ['greater  emphasis', 'personal transgender people'], ['rapid  advances', 'innovative data acquisition interpretation'], ['many  processes', 'molecular  biology'], ['Identification', 'such  processes'], ['work', 'prokaryotic protein coding genomes'], ['proposed  algorithm', 'genomic mapping analysis'], ['MRC  peaks', 'coding  regions'], ['proposed  algorithm', 'prokaryotic genome sequences'], ['Bayesian  classifiers', 'proposed  algorithm'], ['algorithm', 'such gene detection GLIMMER'], ['This', 'genomic sequence analysis'], ['', ''], ['rights', ''], ['Cas  pathway', 'biological  research'], ['Modifications', 'eukaryotic gene cells'], ['important  that', 'important  experiments'], ['CRISPR Cas that', 'eukaryotes'], ['how  system', 'biological gene pathways'], ['', '2017 American Bone'], ['', 'mRNA  data'], ['', ''], ['calculation', 'single gene technologies'], ['we', 'established gene expression measurements'], ['', ''], ['standard normalization strategies', 'stage osteoarthritic cartilage samples'], ['different normalization procedures', 'well gene expression levels'], ['normalization procedures', 'absolute volcano plots'], ['P values', 'fold normalization changes'], ['commonly housekeeping genes', 'different  specimens'], ['gene expression analysis', 'cDNA qPCR'], ['much normalization strategies', 'gene analysis'], ['', ''], ['', 'regulated  genes'], ['Different normalization approaches', 'large P genes'], ['Thus  it', 'individual expression data appropriateness'], ['use', 'final microarray study results'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['sessile seedlings herein', 'sessile Hb oak'], ['cellular  expression', 'situ  hybridization'], ['encoded  protein', '51 Arabidopsis class'], ['QpHb1', 'strongly  roots'], ['situ sessile transcripts', 'cortical protoxylem cell cells'], ['transcript hypoxia level', 'flood tolerant root submergence'], ['gene', 'hypoxia'], ['Much  effort', 'actual expression K'], ['pneumoniae', ''], ['expression levels', 'different carbon K'], ['', ''], ['induction repression ratio', 'extremely  K'], ['', ''], ['basal level', 'lacZ 396'], ['5U  which', ''], ['5-fold  higher', 'induced  K'], ['', ''], ['constitutive carbon Pbud', 'different carbon sources'], ['set', 'engineered gene K'], ['', 'based  medium'], ['', 'International Union International Biochemistry'], ['Lung cancer', 'men'], ['promising lung survival', 'advanced lung cancer cancers'], ['normal  immortalized', 'normal  NHBE'], ['that', 'early  intervention'], ['six', 'normal cDNA array'], ['Downregulated genes', 'binding proteins proteins'], ['functions', 'upregulated  gene'], ['Similar  expression', 'Northern cancer cell blotting'], ['differential  expression', 'human lung tumors'], ['expressed  genes', 'binding  proteins'], ['transformed carcinogenesis expression', 'different  carcinogenesis'], ['vitro carcinogenesis cell system', 'early lung chemoprevention'], ['necrotrophic foliar that', 'latent  period'], ['pesticide reduction policies', 'varietal  resistance'], ['qualitative resistance genes', 'gene wheat relationship'], ['study', 'compatible  Z'], ['molecular  that', 'early symptomless colonization'], ['western  expression', 'presymptomatic qRT infection'], ['Production', 'Z'], ['', 'experimental  replicates'], ['', 'compatible  responses'], ['environmental plant conditions', 'early  Z'], ['', 'complex  pathosystem'], ['nitrate ammonium Oryza', 'L'], ['', ''], ['function', 'transcriptional stress regulation'], ['fed  leaves', 'more  cysteine'], ['ammonium fed ammonium', 'rice leaves'], [\"namely 5'-phosphosulfate reductase\", 'ammonium treatment'], ['total  content', 'serine asparagine glutamine'], ['amino  acids', 'central ammonium nutrition'], ['Increasing  evidence', 'oestrous embryo survival cattle'], ['We', 'binding bovine endometrium'], ['Heifers', '8  ovulation'], ['4  animals', 'HC plasma progesterone concentrations'], ['exogenous  progesterone', 'low  progesterone'], ['8 gene expression', 'Northern  blotting'], ['Increasing progesterone concentrations', 'PGR  expression'], ['dependent  effects', '4 progesterone Days'], ['responsive  changes', 'uterine embryo development'], ['transcript  levels', 'corresponding protein levels'], ['Here  we', 'corresponding mRNA transcriptomics'], ['RTP factor independent', 'significantly RNA levels'], ['RTP ratio', 'hundred mRNA others'], ['protein copy numbers', 'attractive  genomics'], ['reverse transcription PCR', 'high accuracy sensitivity'], ['However  reliability', 'expressed reference genes'], ['Amorphophallus', 'high konjac corm'], ['crop', 'traditional food years'], ['', 'validated reference Amorphophallus'], ['usually reference genes', 'other candidate reference genes'], ['putative  sequences', 'degenerate prirners'], ['expression stability', 'abiotic  A'], ['', ''], ['', ''], ['distinct  algorithms', 'candidate reference genes'], ['EF1-a EIF4A H3', 'best heat Amorphophallus'], ['Furthermore  EF1-a', 'waterlogged reference conditions'], ['EF1-a EIF4A', 'sets'], ['small shock protein which', 'Amorphophallus'], ['various stress we', 'biological gene expression'], ['results', 'further RT Amorphophallus'], ['hepatic stellate which', 'inflammatory matrix tissue'], ['study', 'transcriptional TNF HSCs'], ['human HSC line', 'present  study'], ['blotting gene promoter assays', 'expression MMP-1 transcription'], ['Deletional', 'necessary TNF alpha inducibility'], ['shift mobility assays', 'transcriptional TNF alpha responsiveness'], ['', 'dependent mRNA manner'], ['time course experiment', 'rapid TNF alpha treatment'], ['binding  bp', 'transcriptional TNF site'], ['transcriptional  regulation', 'p50 kappa B'], ['gene expression', 'human NF kappa HSCs'], ['', 'Microbe Signalling Organisation'], ['aim', 'exciting microbiology research'], ['meeting', 'further Royal Edinburgh'], ['other poster that', 'energetic  meeting'], ['Harnessing', 'exciting lung cancer therapy'], ['checkpoint blockade which', 'immune  tumor'], ['1 death antibodies', '25 lung cancer'], ['immune  system', 'lung tumor'], ['individual lung tumor', 'specific  that'], ['high mutation them', 'immune  therapies'], ['immune lung cancer system', 'immune vaccine tumor'], ['skeletal glucose insulin', 'activity skeletal delta activity muscle'], ['purpose', 'delta protein availability'], ['Studies', 'differentiated cell myotubes'], ['delta protein levels', 'blotting RT PCR'], ['Insulin stimulation', 'whole cell lysates'], ['effect', 'delta protein degradation'], ['Insulin', '15 PKC min'], ['Pretreatment', 'induced delta protein levels'], ['also  insulin', 'effect PKC delta transcription'], ['signaling MAP mechanisms', 'PKC delta'], ['PKC delta insulin', '5  min'], ['skeletal PKC delta', 'early response insulin'], ['', ''], ['rights', ''], ['Gene trapping', 'novel  functions'], ['It', 'trapped  function'], ['mesodermal we', 'adenoviral Pax1 Brachyury'], ['', 'first transcription screening'], ['Northern  expressions', 'trapped transcription factors'], ['Expression patterns', 'neural HPI tube'], ['Wtap mutant Furthermore Wtap mice', 'trapped mesendoderm formation'], ['trapped ES clones', 'effectively transcription factors'], ['', ''], ['rights', ''], ['Few  studies', 'epistatic gene x schizophrenia'], ['simultaneous  disruption', 'different phenotypic gene'], ['NRG1 heterozygotes', 'selected brain areas'], ['Single gene DISC1 mutants', 'associated ErbB4 microRNA'], ['disruption', 'hypothalamic vasopressin gene expression'], ['findings', 'associated DNA genes'], ['tolerant  Oryza', 'L'], ['', 'down genotype stress'], ['DNA polymorphism', 'stressed DD gels'], ['partial', 'differential moisture gel'], ['corresponding', 'high water deficit stress'], ['partial DNA cDNA', 'D1 protein'], ['', 'severe childhood abuse'], ['Methods Depressive symptoms', 'adult primary care attendees'], ['nine plasticity allelic load', 'nine  genes'], ['mixed  models', 'severe childhood abuse'], ['higher  PAL', 'lower symptom history'], ['Importantly  interaction', 'important  covariates'], ['', ''], ['antidepressant  use', '5  observation'], ['Conclusions', 'worse childhood manner'], ['Measures', 'environmental trait influences'], ['environmental  challenges', 'cognitive intelligence abilities'], ['big intelligence hypothesis brains', 'labile group mates'], ['We', 'social intelligence cognition'], ['Behavioural  data', 'cognitive  abilities'], ['other hyaena hyaenas', 'social intelligence hypothesis'], ['domain general domain intelligence', 'social selection domain'], ['general intelligence evolves', 'strictly selection demands'], ['it', 'experimental  data'], ['autocorrelational  structure', 'learning experiment'], ['intelligent barley that', 'constant  experiment'], ['human  factor', 'interest'], ['that', 'possible modeling strategy'], ['Alternative modeling strategies', 'confirmatory data analysis'], ['', ''], ['rights', ''], ['areas', 'pressing air pollution problems'], ['Measures', 'thermal emission wind'], ['Social welfare emission', 'modern power system operations'], ['paper', 'renewable scheduling production'], ['objective scheduling model', 'above  objectives'], ['Wind power uncertainty', 'dispatchable  model'], ['outcomes', 'illustrative  example'], ['model EM results', '28 wind spillage'], ['optimal generation scheduling', 'model MT'], ['work', 'renewable welfare production'], ['', ''], ['rights', ''], ['HTS temperature generators', 'much research attention'], ['brushless HTS exciters', 'HTS generators'], ['large wind power we', 'brushless wind power exciter'], ['brushless HTS exciter', 'generator'], ['All', '2 G wire'], ['cooling  test', '30 test K'], ['detailed  results', 'HTS detail'], ['complete  model', 'thermal  electricity'], ['current  densities', 'thermionic  data'], ['genetic algorithm optimisations', 'power which'], ['result', 'maximum power 1'], ['', 'Maximum  7'], ['69  %', 'thermal  power'], ['future simulation developments', 'positively device performance'], ['', ''], ['rights', ''], ['Meiosis', 'sexual life eukaryotes'], ['several model most', 'evolutionary  interpretations'], ['we', 'weird  features'], ['meiotic life arrests', 'meiotic asymmetry meiotic recombination'], ['evolutionary  significance', 'features'], ['why  sex', 'eukaryotes'], ['article', 'sexual  reproduction'], ['Modern  biotechnology', 'increasing  society'], ['Development', 'high school bioscience classrooms'], ['study', 'two school decades'], ['surprisingly  knowledge', 'current  students'], ['most  students', 'biotechnology'], ['current biotechnology who', 'Advanced Biology'], ['current  who', 'AB'], ['students', 'agricultural  biotechnology'], ['', 'AB'], ['', 'medical  biotechnology'], ['current  students', 'former  students'], ['high school curriculum', 'GE  plants'], ['also  attitude', 'moral GE belief'], ['high school teachers', 'near university future'], ['', 'International Biochemistry'], ['', 'coronary heart disease'], ['', ''], ['222  patients', 'coronary heart disease'], ['patients', 'cardiologic Kharkiv city hospital'], ['which', 'basic Internal Medicine'], ['', 'National Medical Ukraine'], ['comparison group', 'normal body weight'], ['healthy  persons', 'control group'], ['Groups', 'age'], ['study', 'oncological organs digestion diseases'], ['', ''], ['that', '42'], ['', ''], ['A  A', 'G  15'], ['', ''], ['14  %', ''], ['allele which', '36'], ['', ''], ['', ''], ['A Genotypes A', 'G  47'], ['', ''], ['', ''], ['74  %', 'CHD'], ['', '71  patients'], ['98  %', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Comparison leptin alleles', 'reliable genotypes polymorphism alleles'], ['allele G', 'CHD'], ['G  G', ''], ['', '% control group'], ['Allele A', ''], ['', '% control CHD'], ['', ''], ['Arg223Gln leptin polymorphism', 'detected leptin gene'], ['', ''], ['', ''], ['Arg223Gln leptin polymorphism', 'obesity'], ['pulse  productivity', 'hence  production'], ['genetic  diversity', 'such Vicia Mucuna Moghania'], ['National Bureau', 'genetic nodal India'], ['pulse Vigna umbellata Vigna', 'Viceasp'], ['', ''], ['', 'other  world'], ['Several  pests', 'exotic quarantine germplasm'], ['situ base collection', '61  pulses'], ['germplasm', 'pulse reference crops'], ['total', 'potential  donors'], ['Core  cores', 'bean mungbean lentil moth bean'], ['Wild  species', 'cultivated  species'], ['Application', 'pulse gene crops'], ['Taiwanese nonsecretor phenotype', 'Taiwanese blood group which'], ['when  epidemic', 'norovirus infection'], ['old  who', 'confirmed norovirus infections'], ['Controls', 'healthy  age'], ['norovirus genotype', 'VP1 gene'], ['Lewis antigen', 'FUT3 ABO genes'], ['total', '147 case control pairs'], ['', ''], ['4 Sydney strain', 'major  78'], ['', '3  cases'], ['Lewis  genotypes', 'commonly  controls'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Lewis  genotypes', 'increased norovirus infections'], ['', ''], ['', ''], ['', ''], ['', ''], ['weak secretor genotype', 'severe norovirus GII'], ['4  Sydney', 'Taiwan'], ['aim', 'intervertabral gene disc'], ['effect', 'current vivo rabbit model'], ['total', 'three New Zealand groups'], ['guided  puncture', 'intervertebral disc degeneration'], ['lentiviral  vector', 'nucleus pulposus'], ['significant  difference', 'two  groups'], ['', ''], ['punctured control difference', 'punctured control groups'], ['', ''], ['Overall  results', 'intervertebral  discs'], ['present animal study', 'disc degeneration'], ['Gene editing', 'molecular biology field'], ['genetic  modifications', 'many  years'], ['where stem it', 'them'], ['advent', 'genetic transfer will'], ['entire  landscape', 'palindromic effector repeats'], ['altered  that', 'altered  animal'], ['increasingly  which', 'consumers'], ['aim', 'modified time feed'], ['research materials', 'animal years'], ['applied research methods', 'modified DNA plants'], ['Cascade methods', 'quantitative GMO content'], ['20042015 research total', '1435  GMOs'], ['positive  result', '559  cases'], ['positive  samples', 'modified  soybeans'], ['20142015  increase', 'positive GM rape samples'], ['GM maize', 'positive  samples'], ['', ''], ['', 'legislative GMO threshold'], ['9  %', 'than GM 0'], ['9 % GMO', ''], ['soybean plant', 'feed Poland'], ['GM reasons', 'third  countries'], ['feed situation', 'Polish MON810 fields'], ['proportion', 'other EU countries'], ['source', 'Polish feed protein'], ['namely pUC RICE5', 'GM  rice'], ['pUC RICE5', 'endogenous reference gene'], ['qualitative PCR assay approach', '10 rice haploid genomes'], ['square regression coefficients', '0'], ['', '1'], ['', ''], ['standard  deviation', 'standard deviation 0'], ['', '0'], ['', ''], ['', '10  0'], ['', ''], ['it', 'five GM rice events'], ['', ''], ['rights', ''], ['ebb', 'genetic  paradigm'], ['review', 'craniofacial tooth genetics'], ['Findings Contemporary studies', 'genomic  eras'], ['Emerging  data', 'dentofacial  abnormalities'], ['here MSX1 mutation', 'evolving tooth theme'], ['', ''], ['different  mutations', 'dentofacial phenotypic severity'], ['molecular  that', 'genotype phenotype correlation'], ['past  century', 'clinical  dentistry'], ['overarching  theme', '2016 Toxicologic Responses'], ['how toxicity knowledge', 'prospective drug development'], ['influence', 'epigenetic toxicologic risk'], ['presentations', 'genetic toxicologic populations'], ['TNF alpha TNF polymorphism', 'several  populations'], ['', 'Indian  population'], ['', 'psoriatic TNF patients'], ['74 Psoriasis age', 'healthy  individuals'], ['Patients', 'R'], ['', ''], ['', '2014 Kolar Karnataka March'], ['TNF polymorphism', 'PCR RFLP PCR method'], ['frequency', 'TNF alpha -308A'], ['', '4  psoriatic'], ['', 'psoriatic  individuals'], ['difference', ''], ['', ''], ['TNF alpha polymorphism', 'psoriatic South patients'], ['aim', 'MCP-1  RA'], ['healthy EULAR subjects', 'controls'], ['A G polymorphism', '162'], ['', '6 RA 63'], ['', ''], ['', ''], ['', ''], ['', ''], ['associations', 'heterozygotes'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['gene polymorphism', 'RA'], ['dietary isoflavone genistein', 'particular blood pressure'], ['biological  action', 'Least cell signalling'], ['far  most', 'molecular  endothelium'], ['', 'transcriptional  2'], ['endothelial mu M we', 'atherogenic cDNA array stimulus'], ['alteration', 'individual RT PCR'], ['Gen', 'related receptor a'], ['Furthermore Gen', '165 growth factor types'], ['achievable  levels', 'angiogenic blood endothelium'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['DNA sequences', 'molecular  genetics'], ['classical cis splicing', 'introns'], ['findings', 'both intron trans G'], ['transcriptome', 'systematic diplomonad questions'], ['', ''], ['I', 'transcriptornic  G'], ['', 'spliced Spironucleus introns'], ['previously  trans', 'G'], ['', 'good  sensitivity'], ['', ''], ['Scrutiny', 'spliced  G'], ['', 'p68 helicase S'], ['', ''], ['p68 intron', 'high core G'], ['spliced  introns', 'molecular  mechanism'], ['', ''], ['results', 'both trails genes'], ['Future work', 'intriguing  phenomenon'], ['Cas9  system', 'diverse immunity species'], ['CRISPR Cas9 system', 'recent genome years'], ['short guide RNA which', 'less effector nucleases'], ['where species it', 'CRISPR  Cas9'], ['technology', 'molecular cancer research'], ['we', 'CRISPR Cas9 targeting plasmids'], ['We', 'molecular  technology'], ['', 'Copyright Elsevier B'], ['', ''], ['rights', ''], ['Volvariella volvacea', 'low temperature resistance'], ['efficient  strains', 'low  temperature'], ['', 'edible temperature fungus'], ['strains', 'low genome shuffling'], ['', 'optimum  V'], ['strain', 'protoplast  regeneration'], ['70%-80  which', 'forward  mutation'], ['', '16  V'], ['beam UV irradiation', 'beam UV irradiation'], ['mutated  protoplasts', 'low temperature resistance'], ['low temperature testing', 'genetic VF1 stability'], ['respectively degrees which', 'resistant storage strain'], ['Genome shuffling', 'low temperature V'], ['', 'desirable  strains'], ['this', 'optimized genome phenotype'], ['', 'International Union International Biochemistry'], ['Genome sequences', 'molecular  biology'], ['sequences', 'scientific sequence databases'], ['sequence repositories', 'INSDC GenBank world'], ['many validation criteria', 'database'], ['job', 'partners'], ['well tool who', 'process'], ['transcriptional  that', 'cell differentiation'], ['where  material', 'regulatory  tissues'], ['regulatory sex we', 'fetal DNaseI H3K27ac'], ['active  enhancers', 'enriched  genes'], ['Sequence analysis', 'Sertoli cell differentiation'], ['we', 'transgenic Sertoli cells'], ['sex determination sex that', 'sexual  development'], ['molecular biology that', 'evolutionary  taxa'], ['which', 'otherwise  PCR'], ['This', 'large  tissues'], ['snail Achatina which', 'large  mucus'], ['we', '16S biology rDNA'], ['yield', 'genomic  DNA'], ['Indian sub which', 'phylogenetic starting affinities'], ['biochemical  basis', 'protein structures'], ['', 'genetic information impact'], ['We', 'common  phenotypes'], ['activities', 'phenotype testing protein structure'], ['however  activities', 'observable  phenotype'], ['activities', 'student capabilities'], ['complete  sequence', 'direct structure protein structure'], ['', 'International Biochemistry'], ['new  that', 'past plant science decade'], ['Essentially DNA microarrays', 'northern biology blotting'], ['single DNA microarrays', 'single  experiment'], ['however model plant microarray', 'major weed species'], ['prepared', 'related gene species'], ['now  time', 'weed science research'], ['Questions', 'well microarray approach'], ['Additionally gene expression profiling', 'biological competition allelopathy weeds'], ['dimensional  mutations', 'nervous system MS'], ['key myelin that', 'MS'], ['genomic  analysis', 'genomic MS DNA'], ['Quantification', 'mutant MS patients'], ['seek', 'mutant MS patients'], ['Thus  we', 'mutated MS patients'], ['13', 'mutant PLP1 peptides'], ['Interestingly  we', 'MS antibody controls'], ['results', 'human  MS'], ['study', 'human  diseases'], ['High grade osteosarcomas', 'malignant  bone'], ['localized extremity tumors', 'high grade osteosarcomas'], ['prognosis', 'metastatic  disease'], ['Outcome', 'three  decades'], ['selected genomics which', 'therapeutic childhood osteosarcoma'], ['Characterizing', 'pneumococcal  epidemiology'], ['Probing', 'wide IgG pangenome'], ['binding  which', 'pneumococcal surface proteins'], ['ABTs', 'extensive synthesis machinery adhesins'], ['positive  this', 'functional  recombination'], ['rapid  variation', 'rich PsrP glycoprotein'], ['antigenic core profiles', 'core genome'], ['antigens', 'similar antigen profiles'], ['substantial  variation', 'only  epitopes'], ['pneumococcal  that', 'functional  constraint'], ['endogenous  that', 'gene plants'], ['however Triticum miRNAs', 'however Oryza wheat'], ['computational EST sequences', 'in prediction miRNAs'], ['study', '79  candidates'], ['prediction accuracy', '79  candidates'], ['59 wheat ESTs', 'putative  targets'], ['fecal  specimens', 'acute Hospital Central Kenya'], ['positive  specimens', 'G RT genotypes'], ['RVA', '429/1546'], ['', ''], ['RVA infections', '17 age months'], ['infections', 'seasonal  year'], ['28  %', 'predominant  G9P[8'], ['yearly  genotypes', 'major  2012'], ['African  strains', 'nucleotide  P[6'], ['results', 'basic vaccine introduction'], ['', ''], ['passive source which', 'geological ground investigation'], ['geophysical  it', 'geophysical  methods'], ['', 'large scale deployment'], ['low cost geophone', 'large scale microtremor survey'], ['First  it', 'microtremor survey'], ['Second  it', 'operational  amplifier'], ['Third  it', 'external  module'], ['fourth  it', 'low software code'], ['optimized  geophone', 'large scale microtremor survey'], ['purpose', 'research'], ['600  g', ''], ['', ''], ['entire  system', '2000  RMB'], ['optimized  geophone', 'microtremor  O'], ['', ''], ['geological  geophone', 'geological  conditions'], ['results', 'geological survey data'], ['existing microtremor survey it', 'large scale survey'], ['optimized  geophone', 'rapidly detector arrays'], ['large  it', 'three velocity area'], ['microtremor  survey', 'broad application prospects'], ['much Part D less', 'rural Part D residents'], ['study', 'available plan information'], ['65 adults who', 'Part survey'], ['We', 'health Part characteristics'], ['FindingsOverall  half', 'very Part D knowledge'], ['lower  they', 'decision making process'], ['lower  they', 'lower  plan'], ['rural Part residents', 'reduced Internet availability'], ['Furthermore confidence', 'making Part D program'], ['Osmoprimed seeds', 'pGlcT proteins'], ['Osmopriming', 'together RBR proteins'], ['heat  seeds', 'low  temperature'], ['when  seeds', 'unfavorable  conditions'], ['objectives', 'primed seed seeds'], ['redried  seeds', '9 fluorescent daylight 16'], ['Osmopriming', '31 A degrees C'], ['several sugar transport this', 'metabolic  germination'], ['such cell proteins', 'thermal  stress'], ['heat  seeds', 'increased adenosine triphosphate'], ['herein', 'osmopriming heat shock treatment'], ['colour web page similarity', 'attention banner stage'], ['eye tracking device', 'psychological brand attitudes'], ['using', 'similar fixation time'], ['longer fixation time', 'positive banner advertisement'], ['results', 'relevant e commerce'], ['essential graphics researchers', 'molecules'], ['mouse  that', 'mouse  control'], ['interactive software suitability', 'molecular  graphics'], ['Here  we', 'mobile interaction device'], ['used  functions', 'zooming  translation'], ['task performances', 'mouse  method'], ['However  it', 'such school classes'], ['PyMOL  mControl', 'new user experiences'], ['software', ''], ['', 'International Biochemistry'], ['', 'developing  countries'], ['incidence food insecurity', 'incidence food food'], ['study', 'mental Upper West Ghana'], ['We', 'sectional Insecurity Access Scale'], ['results', 'severely food insecure'], ['', ''], ['', ''], ['', ''], ['', 'secure  households'], ['female household heads', 'mental  distress'], ['', ''], ['', 'male  counterparts'], ['findings', 'Ghanaian food context'], ['', ''], ['rights', ''], ['Flow cytometry', 'viral detection particles'], ['giant  viruses', 'hence flow them'], ['Recently  we', 'high flow cytometry'], ['Consequently  isolating', 'same  sample'], ['faster  it', 'pure minority population'], ['robust sorting which', 'giant virus supernatants'], ['We', 'artificial flow cytometry mixtures'], ['Purity control', 'electron microscopy'], ['viral sorting we', 'end point dilution'], ['growing  we', 'Cedratvirus'], ['sorting  assay', 'new flow virometry'], ['', ''], ['', 'intense  sunlight'], ['where violaxanthin de epoxidase', 'excessive photosynthesis light'], ['We', '2'], ['GVDE gene which', 'circadian box'], ['GVDE promoter', 'green  tissues'], ['GUS beta activity', 'high GVDE light'], ['abiotic hormones growth which', 'acid salicylic sodium glycol'], ['Interestingly GUS activities', 'term  h'], ['Analysis', 'functional flank -210'], ['transcription', 'endogenous circadian clock'], ['region', 'basic promoter activity'], ['novel  promoter', 'first GVDE study'], ['We', 'circadian promoter rhythms'], ['ObjectivesTo', 'surgical gene expression wounding'], ['MethodsTen volunteers', 'one  palate'], ['later  biopsies', 'healing  gingiva'], ['Tissue samples', 'gene expression'], ['enrichment pathway analysis', ''], ['hundred  genes', 'differentially healing gingiva'], ['399  genes', 'previously  gingiva'], ['decreased CTHRC1 7-FC', 'expression'], ['time  PCR', 'selective mRNA genes'], ['enrichment analysis', 'biological  pathways'], ['Immunohistochemistry', 'normal MUC21 CTHRC1 gingiva'], ['comprehensive  analysis', 'molecular wound mechanisms'], ['present  results', 'other gingival wound injury'], ['ability', 'oncolytic  therapy'], ['Here  we', 'gastrointestinal stromal tumors'], ['Interaction', 'transferase pull S transferase immunoprecipitation'], ['Effects', 'FAM96A cancer cells'], ['like  cells', 'reverse chain reaction immunohistochemistry'], ['stably murine ICC transduced', 'immunocompromised  mice'], ['FAM96A', 'mitochondrial apoptosis'], ['FAM96A  protein', 'independent patient cohorts'], ['FAM96A  expression', 'tumorigenic ICC SCs'], ['', 'increased apoptosis tumorigenicity'], ['apoptotic tumor that', 'GIST tumorigenesis'], ['where tumor cell escape', 'acquired  apoptosis'], ['Here  protein', 'most activating GISTs'], ['FAM96A  expression', 'cells tumor apoptosis'], ['xenograft models tumor growth', 'FAM96A  expression'], ['Hence', 'suppressive  GISTs'], ['Knowledge', 'novel GIST therapies'], ['Treatment', 'gene therapy'], ['use', 'nonphysiological gene disease'], ['Genes', 'conventional  drugs'], ['They', 'longer  action'], ['Genes', 'naked DNA cells'], ['enormous  progress', 'cell/  tissue'], ['eye', 'ideal gene therapy'], ['easily  it', ''], ['', 'congenital  amaurosis'], ['However  number', 'systemic eye diseases'], ['', ''], ['such  number', 'near  future'], ['long term gene drug', 'daily  applications'], ['Here  we', 'retinal ganglion neurodegeneration'], ['Glioblastoma', 'short brain duration'], ['Acquiring', 'therapeutic  strategies'], ['', 'human Gab cancer'], ['GAB2', 'therapeutic glioma invasion intervention'], ['how  it', 'novel  therapy'], [\"microRNA miR)-197 expression 3'-UTR\", 'miR-197'], ['Northern  blotting', 'current polymerase chain study'], ['involvement', 'disease'], ['present  miR-197', 'glioblastoma cells'], ['only expression levels', 'also glioma severity'], ['addition overexpression', 'glioblastoma cells'], ['Therefore restoration', 'other  glioblastoma'], ['serine threonine pathway', 'common glioblastoma cells'], ['Downstream factors', 'cellular cell proliferation migration'], ['block', 'transcriptional  level'], ['aim', 'AKT pathway'], ['interfering RNA transfection', 'Northern  blotting'], ['Down regulation', 'U251 cells'], ['furthermore c expression', 'also  AKT'], ['', 'thus AKT tumorigenesis'], ['We', 'downstream transcription factors'], ['understanding', 'tailored AKT gliomas'], ['Aberrant  expression', 'downstream  proteins'], ['however cell role', 'glioma'], ['purpose', 'regulatory  glioma'], ['We', 'miR-1202 glioma tissues'], ['miR-1202 cell expression', 'inversely  Rab1A'], ['luciferase we', 'novel  miR-1202'], ['', 'promoted cell proliferation'], ['Similarly  silencing', 'endoplasmic reticulum stress'], ['miR-1202', 'endoplasmic glioma cells'], ['results', 'therapeutic glioma patients'], ['Prolonged translation arrest', 'cerebral CA1 ischemia'], ['regulatory brain ischemia', 'ribosome molecular ribosome biology'], ['Here  we', 'global rat brain'], ['Proteomics', 'mRNA 10min condition'], ['Notably HuB HuC', 'NIC CA1'], ['associated  mRNAs', '46'], ['1  %', 'uridine  CA3'], ['', '7  CA1'], ['ischemic  this', 'selective contributing vulnerability'], ['Data', 'ProteomeXchange identifier PXD004078'], ['who', 'mental health services'], ['fragmented service delivery models', 'mental health treatment gap'], ['how health systems', 'future priority research'], ['sound  disorders', 'low resource community'], ['Stigma', 'service uptake'], ['Prevention', 'mental health research'], ['Research implementation studies', 'policies'], ['Summary Four priority areas', 'based health interventions'], ['mRNA  that', 'ligand binding'], ['molybdenum  which', 'metabolic redox enzymes'], ['candidate', 'class'], ['mRNA encodes', 'moaA Moco'], ['RNA binding carbon storage CsrA', 'vivo'], ['regulatory  CsrA', 'central carbon metabolism'], ['mobility shift CsrA', 'high  moaA'], ['chromosomal lacZ reporter CsrA', 'indicative translation control'], ['Deletion', 'two CsrA binding'], ['CsrA binding', 'moaA RNA structure'], ['which', 'different  factors'], ['we', 'additional  examples'], ['', ''], ['rights', ''], ['TLR4  pathway', 'nephropathy proinflammatory cytokines'], ['PPAR gamma PPAR agonists', 'inflammatory  TLR4'], ['However  interaction', 'fully PPAR vivo'], ['TLR4 pathway', 'experimental  rats'], ['Bovine gamma globulin', 'IgAN  model'], ['TLR4 Pio rats', 'y agonist pioglitazone'], ['creatinine blood nitrogen', 'biochemical  analyzer'], ['IgA deposition', 'glomeruli'], ['Real polymerase chain reaction', 'renal protein tissues'], ['Results', 'mean'], ['Differences', 'one way variance'], ['experimental  rats', 'higher  ACR'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['obvious IgA deposition', 'serum hypercellularity beta'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'IL-1  beta'], ['biochemical  parameters', 'pathological TAK242 group'], ['', 'IgAN(Pio Pio group'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['inflammation', 'rat models'], ['Moreover  pioglitazone', 'IgAN'], ['Stem cell factor', 'many tissue remodelling'], ['growth factor', 'later tissue fibrosis'], ['NTN', 'glomerular basement membrane antibodies'], ['Animals', '30  group'], ['kidneys', 'c kit mast cell fibrosis'], ['Changes', 'Western mRNA blotting'], ['', 'tubular c compartments'], ['Mast cells', 'barely rat sections'], ['Double  immunostaining', 'SCF CD34'], ['Immunostainable SCF protein', 'positive proteinuria glomerulosclerosis score'], ['glomerular  SCF', 'tubular  atrophy'], ['Increased SCF immunostain', 'Northern  blotting'], ['19-kDa  which', 'study'], ['results', 'remodelling NTN kidney'], ['Upregulation', 'proteolytic protein KL cleavage'], ['immunohistochemical  staining', 'fibrotic NTN processes'], ['', ''], ['', ''], ['predictive -induced assays', 'lymphoblastic  leukemia'], ['aim', 'dexamethasone(Dex)induced caspase ALL'], ['B line CCRF CEM', 'B cell line RS(4;11'], ['involvement', 'flow cytometry immunocytochemistry'], ['Apoptosis', 'annexin V'], ['Caspase activity', 'fluorometric  assay'], ['Results Dex', 'apoptotic Delta psi m'], ['induced  apoptosis', 'early  caspases'], ['Inhibition', 'Bak Delta psi m'], ['induced  apoptosis', 'Bax'], ['', 'Bcl-2 clown p=0'], ['', ''], ['', ''], ['Furthermore vivo Dex sensitivity', 'early treatment polychemotherapy'], ['', ''], ['differential  regulation', 'primary ALL cells'], ['consumption', 'common equine mortality'], ['even  horses', 'increased carbohydrate load'], ['We', 'small brush border response'], ['Expression', 'Northern blotting QPCR'], ['rates SGLT1 protein', 'enriched mRNA forage'], ['Activity', 'diet'], ['SGLT1 expression', '2-month  period'], ['', ''], ['', 'known  composition'], ['SGLT1 expression', 'duodenum'], ['', 'ileum'], ['study', 'dietary  horse'], ['Reciprocal  signalling', 'balanced pathogen homeostasis'], ['expression repertoire changes', 'infected Dermacentor variabilis'], ['GSTs', 'cellular stress host'], ['We', 'full length D'], ['', ''], ['class theta class delta DvGST2', 'same  family'], ['DvGST1 expression transcripts', 'also DvGST2 ovaries'], ['DvGST transcripts', 'up tick feeding'], ['Challenge', 'naive coli ticks'], ['addition', 'common food industry'], ['', 'processed meat products'], ['method', '9'], ['', '8 soybean DNA'], ['', 'thermal soybean treatments'], ['normalised  approach', 'also  0'], ['w pork which', 'processed meat products'], ['Soybean', 'cooked  0'], ['3  samples', 'undeclared labelling soybean'], ['', ''], ['rights', ''], ['important energy source', 'many bacteria fungi'], ['', 'first glycogen S'], ['', ''], ['SpoexGS cDNA', 'molecular amino 76'], ['', '19  5'], ['', ''], ['2946 reading which', 'approximately  96'], ['', '63  6'], ['', ''], ['SpoexGS', 'Malpighian tubules S'], ['', ''], ['Expression patterns', 'developmental  stages'], ['transcript starvation conditions expression', 'increasing starvation time'], ['mRNA levels', 'starvation  groups'], ['Treatment', '12 control group'], ['findings', 'potential glycogen synthase'], ['', ''], ['specific  variant', 'rat testis cDNA expression'], ['nucleotide  cDNA', 'substantial  GAPDS'], ['Northern  blotting', 'rat tissue 1'], ['', 'skeletal brain seminal vesicle'], ['postnatal testis which', 'round  spermatids'], ['isolated spermatogenic cell RNA', 'condensing Gapds gene'], ['Gapds expression', 'only rat testis XIII'], ['reliable human comparisons', 'toxicant screening'], ['thermophilic Thielavia terrestris', 'Pichia pastoris'], ['CBH7B', 'molecular amino acid 51'], ['', ''], ['7  glycosyl', 'binding  module'], ['Purified', 'catalytic  pH'], ['55', '50 degrees C'], ['enzyme', 'when reaction mixture'], ['%  alkaline', 'empty fruit bunch'], ['infrared Fourier spectroscopy', 'OPEFB CBH7B'], ['Scanning electron microscopy', 'nonsupplemented OPEFB control'], ['Therefore  CBH7B', 'hydrolyzing lignocellulosic biomass'], ['', 'International Union International Biochemistry'], ['Interleukin-13', 'human type-1 diabetes'], ['conventional expression systems', 'recombinant  efficiency'], ['transgenic  plants', 'human expression IL-13'], ['DNA constructs', 'tobacco plants'], ['Transcriptional  expression', 'reverse polymerase chain reaction'], ['hIL-13 protein', 'high expression 0'], ['', 'soluble  leaves'], ['multiple  forms', 'linked  oligomerization'], ['rhIL-13', 'unglycosylated  proteolysis'], ['stability', 'fluid  digestion'], ['TF-1 cell rhIL-13', 'authentic hIL-13 protein'], ['transgenic  plants', 'based expression production'], ['transgenic  plants', 'such type-1 diabetes'], ['Gnathostomiasis', 'zoonotic  Gnathostoma'], ['molecular  biology', 'public  problems'], ['purpose', 'mt Gnathostoma nipponicum'], ['', 'other Gnathostoma species'], ['mt genome sequences', 'subsequent primer walking'], ['', 'complete mt G'], ['', ''], ['', ''], ['Both', 'coding mt genes'], ['gene order', 'transcription G'], ['', ''], ['', ''], ['sequence difference', 'entire mt 14'], ['', '4  18'], ['', '2  G'], ['', ''], ['', ''], ['', ''], ['doloresi', 'Japan'], ['Phylogenetic  analyses', '12 amino acid PCGs'], ['', ''], ['', 'distinctive  Gnathostoma'], ['nipponicum', 'closely Gnathostoma sp'], ['', 'G'], ['', ''], ['novel  which', 'molecular Gnathostoma spp'], ['', ''], ['', ''], ['rights', ''], ['Caseins', 'widely dairy products'], ['Isoelectric', 'isoelectric dairy points'], ['discrimination', 'indigenous dairy goats'], ['indigenous kappa casein which', 'positive kappa casein results'], ['such kappa casein information', 'indigenous dairy goats'], ['indigenous dairy goats', 'kappa casein genie'], ['polymorphic  sites', ''], ['isoelectric kappa casein it', 'ewe peptide'], ['6', 'problematic point mutations'], ['genetic  IEF', 'genetic  results'], ['goat', 'problematic  genotypes'], ['frequency', 'genotypes'], ['', ''], ['', 'indigenous  breeds'], ['such  genotypes', 'Greek goat breeds'], ['new dairy goat method', 'Greek dairy goat products'], ['contagious Animal that', 'economic  losses'], ['It', 'capricolum subspecies capripneumoniae'], ['fifteen Al Ahsa Dammam', 'ten Al Kharj study'], ['total', 'typical lung CCPP'], ['clinical  signs', '40 degrees C'], ['Necropsied animals', 'fibrinous  pleuropneumonia'], ['', ''], ['', ''], ['', ''], ['3 Mycoplasma isolates', ''], ['Biochemically  isolates', 'glucose'], ['Sixty seven', '16S Mycoplasma mycoides rRNA'], ['chain reaction screening', 'specific  M'], ['', ''], ['capripneumoniae', '55  isolates'], ['', ''], ['', ''], ['', ''], ['', ''], ['rights', ''], ['environmental  water', 'wide Hg attention'], ['Here  we', 'catalyzed gold amalgam'], ['catalyzed organic reaction', 'catalytic  AuNPs'], ['detection limit', 'Hg species'], ['1  which', 'orders  U'], ['', ''], ['', 'drinking water'], ['high  selectivity', 'specific gold amalgam'], ['based tap water assay', 'low  environment'], ['Nanocarrier  design', 'respiratory tract disorders'], ['dendritic  that', 'allergic  diseases'], ['surface charges', 'dendritic cell surface receptor'], ['human epithelial tissue barrier', 'aerosolized'], ['PVA NH2', 'highest flow cytometry'], ['only PVA NH2', 'higher apoptosis levels'], ['DC SIGN', 'AuNPs surface charge'], ['results', 'complex lung cell model'], ['findings', 'immune  nanocarriers'], ['Gorham Stout disease', 'excessive bone tissue'], ['etiology', 'all  world'], ['however  histopathology', 'gold standard'], ['condition', 'clinical  case'], ['old  who', 'infectious origin suspicion'], ['radiographic histopathology she', 'GSD'], ['standardized  we', 'osteoclastogenic lymphangiogenesis GSD'], ['new  studies', 'new  treatment'], ['small  that', 'important plant development'], ['stages', 'secondary wall thickening'], ['We', 'seven initiation elongation'], ['conserved  families', 'small RNA sequencing'], ['real polymerase chain analyses', 'dynamic fiber development'], ['38  targets', 'five degradome sequencing'], ['specific  miRNAs', '1 fiber development'], ['Histochemical  analyses', 'ovule  development'], ['mature fiber miRNA156/157', 'essential fiber elongation'], ['however G mechanisms', 'striped  hamster'], ['real polymerase chain reaction', 'different hypothalamus seasons'], ['different KiSS-1 expression mode', 'seasonal GPR54 expression hypothalamus'], ['GPR54 expression profile', 'reproductive  activity'], ['4  that', 'KiSS-1'], ['regardless  that', 'different  seasons'], ['expressions', 'striped  hamsters'], ['how  GPR54', 'seasonal  influence'], ['', 'biological knockout mouse gene'], ['artificial chromosome retrieval methods', 'targeting vector'], ['Gpr128 knockout mouse model', '129 BL6 background'], ['mice', 'standard laboratory chow diet'], ['phenotypes', 'molecular  analyses'], ['reverse', 'Northern tissue mRNA'], ['Beginning', '4 wk body weights'], ['blood  samples', 'fecal quantity organ blood'], ['Trendelenburg preparation', '8  wk'], ['mRNA', 'intestinal  tissues'], ['Targeted  deletion', 'small wave intestine'], ['24  wk', 'Gpr128(-/-  mice'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['frequency', 'peristaltic  Gpr128(-/-'], ['8  frequency', '3  cmH2O'], ['', ''], ['', '3 peristalsis/15 2'], ['', ''], ['5 WT P', '7 WT intestine'], ['', ''], ['32  frequency', '2  cmH(2)O'], ['', ''], ['', ''], ['', ''], ['8 WT frequency', 'contraction'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'WT'], ['', 'WT'], ['', 'slow wave Gpr128(-/-'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['1  8)', 'also WT intestine'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['We', 'intestinal animal model'], ['', ''], ['', ''], ['rights', ''], ['we', 'Physical Yale University'], ['sophisticated  who', 'biological  problems'], ['also training program we', 'development'], ['hands student peer that', 'interdisciplinary  research'], ['cohesive program all', 'applicable  careers'], ['curriculum', 'several graduate Ph'], ['', ''], ['', 'engineering home sciences'], ['ranging recruiting activities', 'graduate Yale'], ['institution level that', 'new graduate program'], ['how  who', 'own  institutions'], ['', 'C Wiley Periodicals Inc'], ['', 'International Biochemistry'], ['randomized control results', 'discrepancies'], ['Therefore  we', 'six meta trials'], ['incidence', 'significantly ATG arms'], ['', ''], ['', ''], ['however  incidence', 'cytomegalovirus'], ['', ''], ['neutrophil engraftment', ''], ['', ''], ['conclusion rabbit ATG', 'delayed virus engraftment'], ['Studies', 'prophylactic  regimens'], ['Graft  disease', 'severe stem cell cases'], ['skin', 'acute  GVHD'], ['review', 'basic  condition'], ['aim', 'producing Escherichia China'], ['', 'producing  E'], ['coli  isolates', 'mediated fosfomycin resistance genes'], ['Clonal relatedness', 'field gel electrophoresis'], ['genetic  environment', 'polymerase chain reaction'], ['Plasmids', 'conjugation experiments'], ['', ''], ['', ''], ['coli  isolates', 'study'], ['gene', 'strains'], ['sequence isolates', ''], ['new  combinations', 'first IS26-ISEcp1-bla(CTX time'], ['Conjugation experiments', 'single  plasmid'], ['', 'incompatibility group'], ['A-:B plasmids', 'E'], ['coli', 'different  provinces'], ['results', 'producing  E'], ['', 'clonal China'], ['transmission', 'different chicken China'], ['Plasminogen', 'broad plasma spectrum'], ['Plasmin activity', 'direct  metalloproteinases'], ['Infected tooth root canals', 'fluid  components'], ['bacterial  biofilms', 'hematogenously  bacteria'], ['We', 'initial  bacteria'], ['', ''], ['', ''], ['', ''], ['', ''], ['gordonii', 'dental root canals'], ['', ''], ['', ''], ['sanguinis', 'situ rRNA hybridization'], ['', ''], ['', 'particular naeslundii L S'], ['gordonii', 'coated  surfaces'], ['', ''], ['faecalis', 'plasminogen'], ['96  streptococci', 'time'], ['', 'streptococcal  strains'], ['these', 'coated control surfaces'], ['specificity', 'binding epsilon aminocaproic acid'], ['Plasminogen', 'particular plasma streptococci'], ['binding', 'distant  organs'], ['', ''], ['rights', ''], ['cratering  experiments', 'granular crater shape'], ['granular glass beads former', 'where friction coefficient repose'], ['crater', 'slope'], ['Furthermore crater floor', 'asymmetric downslope profile'], ['subsequent downslope which', 'crater floor'], ['asymmetric ejecta dispersal', 'Z model'], ['topographic  we', 'increasing I theta'], ['when glass we', 'theta tan theta(r'], ['scaled depth length which', 'different  targets'], ['nearly  many', 'depth length ratios'], ['also formation process', 'effective friction coefficient'], ['', ''], ['rights', ''], ['BackgroundThe incidence', 'immunosuppressive  therapy'], ['diagnosis', 'cutaneous NTM infection'], ['MethodsWe', 'panmycobacterial paraffin blocks'], ['immunocompromised  patients', 'cutaneous  lesions'], ['histopathology', 'granulomatous abscesses transepidermal necrosis'], ['immunocompromised  patients', 'little granuloma formation'], ['31  culture', '13  cases'], ['ConclusionThe', 'clinical NTM correlation'], ['we', 'cutaneous NTM infection'], ['present  study', 'human granulosa cells'], ['serum  we', '102 oocyte retrieval'], ['luteinized  cells', '5  follicles'], ['IL-18  concentration', 'polymerase chain reaction'], ['results', 'median  serum'], ['', ''], ['', ''], ['', 'significantly  FF'], ['', ''], ['', ''], ['', ''], ['', ''], ['receptor', 'GCs'], ['presence', 'ovarian  function'], ['however  mechanisms', 'antibiotic  alternative'], ['present  study', 'weaned piglet colistin'], ['Piglets', 'kitasamycin control colistin'], ['28 gut chyme', 'intestinal tissue microbiota'], ['treated  piglets', 'better growth performance'], ['', 'intestinal  permeability'], ['abundant  OTUs', 'Firmicutes'], ['proanthocyanidins treatment', 'bacterial  composition'], ['butyric  which', 'GPR41'], ['dietary  proanthocyanidins', 'increasing barrier occludin'], ['proanthocyanidins', 'oxidative gut microbes'], ['Isolation', 'reverse polymerase chain reaction'], ['presence', 'inaccurate  results'], ['wide  which', 'RNA isolation'], ['we', 'total Vitisvinifera L'], ['best  that', 'purity'], ['methods', ''], ['RNA quality', 'nanodrop agarose gel electrophoresis'], ['combined  which', 'time isolation GYSVd-1'], ['when graphene it', 'large graphene kidney'], ['lethal gene which', 'stress'], ['', 'dependent graphene oxide mice'], ['Balb C mice', 'mg kg body nanoplatelets'], ['graphene nanoplatelets', 'kidney BAX tissues'], ['', ''], ['nanoparticles', 'kidney BCL2 gene tissues'], ['', ''], ['Graphene', 'significantly  groups'], ['', ''], ['', ''], ['', 'group'], ['', ''], ['', 'Also control group'], ['', ''], ['', ''], ['', 'groups'], ['', ''], ['', 'C Elsevier B'], ['', ''], ['which', 'wearable living devices'], ['Flexible triboelectric generators', 'wearable output power electronics'], ['it', 'large output power 10'], ['which', ''], ['', ''], ['as  it', 'excellent cycling behavior'], ['corresponding  mechanism', 'electrode  FTTG'], ['emitting  diodes', 'flexible  devices'], ['How  preserve', 'graphene structure field'], ['methacryloxyethyltrimethyl ammonium kind', 'covalently graphene oxide'], ['modified  graphene', 'DMC rGO PVA composites'], ['structure', 'ray diffraction analysis'], ['graphene', 'covalently structure approach'], ['hydroxyl  groups', 'DMC'], ['DMC rGO PVA composites', 'low DMC rGO loading'], ['simple modification approach', 'graphene polymer composites'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['We', 'two sample differences'], ['dyadic sample hypothesis', 'two sample window'], ['independently  we', 'spatial Markov windows'], ['we', 'local  differences'], ['two sample difference', 'small  data'], ['then flow cytometry it', 'local  differences'], ['we', 'two sample difference'], ['We', 'scanning  inference'], ['Chemical fertilizers', 'especially plant biomass livestock'], ['microbial soil ammonia which', 'central  fertilization'], ['3 P additions', 'Qinghai Tibetan Qinghai Plateau'], ['oxidizing amoA archaea', 'amended  soil'], ['AOB', 'first urea amendment'], ['short AOB community composition', 'more urea amendment'], ['3 N fertilizer', 'such Qinghai Tibet Plateau'], ['public health researches', 'disaster'], ['epidemiologic Miyagi region', 'most  GEJE'], ['vulnerable  that', 'future  disaster'], ['Long term follow up', 'various health diseases'], ['', ''], ['', ''], ['Furthermore  building', 'social  survivors'], ['emerging cohort disasters', 'helpful novel indices'], ['constant  that', 'new data needs'], ['objectives', 'discussed serum MMP levels'], ['MMP9  levels', '2013 Heart Center January'], ['influence', 'serum MMP2'], ['aortic configuration hypertension factors', 'possibly serum MMP levels'], ['relation', 'correlation ranks'], ['Serum MMP2 levels', ''], ['Correlation', 'hyperlipidaemia'], ['', ''], ['', 'hyperlipidaemia;rho'], ['', ''], ['', 'patients'], ['Serum MMP9 levels', 'greater  variation'], ['Serum MMP9 levels', 'significantly  hyperlipidaemia'], ['', ''], ['distinct correlation patterns', 'future  studies'], ['relation', 'MMP9'], ['biological  roles', 'plants'], ['novel  that', 'rhodanese  domain'], ['terminal transit purification', 'rhodanese  vitro'], ['native Chlamydomonas protein', '27 M chloroplasts'], ['Chlamydomonas that', '34-kDa 30 protein'], ['strains', 'reminiscent chloroplast translation mutants'], ['northern RT effect', 'transcript RT PCR'], ['it', 'chloroplast translation'], ['Green planning', 'less construction construction'], ['how  communication', 'green  implementation'], ['successful school communicating', 'construction project'], ['paper', 'completed sustainability design projects'], ['high performance sustainability that', 'designs'], ['responses', 'positive  impacts'], ['when  project', 'occupancy'], ['Successful  implementation', 'healthier working environment'], ['', 'built  environment'], ['', ''], ['', ''], ['', ''], ['', 'such  technologies'], ['how  public', 'such  technologies'], ['understanding', 'widespread  use'], ['such  perception', 'product acceptance'], ['contribution', 'paper'], ['First  it', 'sustainable Feliz technologies'], ['sustainable design technology', 'misunderstandings'], ['', '2016 Civil Engineers'], ['animal gremlin-1', 'bone morphogenetic bone osteogenesis'], ['However  impact', 'derived mesenchymal stem cells'], ['aim', 'derived mesenchymal stem cells'], ['interfering  RNA', 'human protein MSCs'], ['mRNA expression levels', 'human polymerase chain MSCs'], ['gremlin-1 suppression', 'human MSC metabolism'], ['expression levels', 'significantly gremlin-1 inhibition'], ['enzymatic ALP activity', 'gremlin-1-inhibited  group'], ['BMP-2-inducing gremlin-1 inhibition', 'calcium deposits'], ['human cell suppression', 'human cell BMP-2'], ['Most  individuals', 'frank  illness'], ['Nevertheless  many', 'clinical  outcomes'], ['white brain UHR', 'long term follow up'], ['functional resonance outcome', '9'], ['', ''], ['Primary  analysis', 'functional matter outcome'], ['findings', 'mental  state'], ['Similar  regions', 'negative follow up'], ['baseline grey matter densities', 'Functioning Global score'], ['', 'positive grey matter followup'], ['novel  those', 'mental transition state'], ['Replication', 'functional  outcome'], ['immune  which', 'endogenous  factors'], ['social  context', 'haematological group living parameters'], ['potential causal relationship', 'scientific  attention'], ['following sex age', 'condition'], ['', ''], ['', 'relevant periods ambient temperature'], ['Blood samples', 'relevant  seasons'], ['Results  We', 'haematological  parameters'], ['unpaired mating individuals', 'paired  fall'], ['H L ratio', 'unsuccessful L ones'], ['absolute  number', 'dependent  way'], ['Discussion Haematology', 'wild  vertebrates'], ['social  they', 'individual stress load'], ['PV battery storage systems', 'traditional electricity service'], ['We', 'net system emissions'], ['double  price', 'higher emissions benefit'], ['', ''], ['rights', ''], ['Power grid interconnection', 'renewable Northeast Mongolia'], ['paper', 'solar power exports'], ['author', 'linear programming problem'], ['analysis', 'electric NEA regions'], ['Mongolian  renewables', 'significant CO2 NEA'], ['', 'fired  generation'], ['huge  investments', 'boundary electricity supply cost'], ['relevant planning organizations', 'economic  implementation'], ['paper', 'economic Democratic Korea'], ['total system availability', 'massive NEA Mongolia'], ['', ''], ['', 'Elsevier Ltd'], ['systematic design method', 'nonlinear grid paper'], ['Equations', 'chaotic grid attractors'], ['5  4', 'chaotic grid method'], ['chaotic  circuit', 'operational  amplifiers'], ['circuit', 'three  integrators'], ['parameters', 'chaotic grid attractors'], ['circuit', 'chaotic grid attractors'], ['central  frequency', 'frequency characteristic frequency CFOA'], ['designed  circuit', ''], ['method', 'feedback operational feedback amplifier'], ['nonlinear  circuit', 'CFOA'], ['relevant circuit parameters', ''], ['central  frequency', 'characteristic circuit CFOA'], ['power distribution grid', 'distributed power generation devices'], ['grid impedance', 'even harmonic system'], ['Therefore  study', 'high impedance paper'], ['where phase effects', 'digital output impedance account'], ['phased compensation control strategy', 'connected phase inverters'], ['implementation  design', 'phased compensation control method'], ['dynamic control scheme', 'also experiment results'], ['', 'connected generation system'], ['it', 'connected impedance stability'], ['Phase Locked design approach', 'PLL regulator parameters'], ['negative impedance model', 'harmonic  linearization'], ['experimental output impedance which', 'theoretical  analysis'], ['based analysis method', 'connected interaction system'], ['Predictive Power Control', 'Active Front End'], ['vectorper sampling interval character', 'big control variables'], ['work', 'implementable DMV FPGA'], ['proposed control scheme', 'classical  DMPPC'], ['control performance', 'proposed DMV MPPC scheme'], ['One', 'new construct Grit'], ['emergence', 'positive  outcomes'], ['little  attention', 'related  outcomes'], ['present  paper', 'Five Factor personality'], ['constructs', '170 worldng adults'], ['Grit', 'focal FFM outcomes'], ['Consequently  relevance', 'caution'], ['More  research', 'various personnel performance'], ['', ''], ['rights', ''], ['far  spaces', 'metric  geometry'], ['recent  lot', 'computational Gromov Hausdorff distance'], ['two  shapes', 'certain  invariances'], ['which', 'metric Gromov Hausdorff shapes'], ['computational  complexity', 'Gromov Hausdorff distance'], ['standard complexity theoretic assumptions', 'polynomial Gromov Hausdorff time'], ['metric  which', 'major  instance'], ['approximation which', 'corresponding parameter parameters'], ['regulatory  that', 'distally target genes'], ['many  that', 'genomic  analyses'], ['active  enhancers', 'enhancer RNAs'], ['seq', 'powerful nascent enhancer transcription'], ['unique  pattern', 'underlying transcription factors'], ['Here  we', 'processing  alignment'], ['known factor binding that', 'active  enhancers'], ['Furthermore  we', 'genomic target gene expression'], ['further  that', 'genomic  assays'], ['user', 'specific cell enhancers'], ['two inductor resistors', 'operational inductor amplifier'], ['proposed  GISs', 'such  AD844s'], ['Also  they', 'passive component matching conditions'], ['lossless  one', 'floating  capacitor'], ['proposed  number', 'simulation'], ['negative inductance simulator', 'passive transresistance elements'], ['based OTRA realization', 'operational inductance amplifier'], ['proposed  circuit', 'theoretical  results'], ['cancellation', 'proposed inductance simulator'], ['that', 'worldwide  attention'], ['', 'future groundwater vulnerability'], ['extra land use patterns', 'future groundwater scenarios'], ['vulnerability classes', 'future  scenarios'], ['Hunan province', 'high groundwater pollution future'], ['depth  table', 'future Hunan province'], ['Decision makers', 'early groundwater resources'], ['related receptor gamma t', 'tract lymphoid tissues'], ['ILC3', 'significant NCR+ plasticity'], ['Recent  advances', 'intestinal tissue microenvironment'], ['we', 'ILC3 homeostasis subsets'], ['that', 'one  lives'], ['invisible group genre', 'productive  ways'], ['so  focus', 'them'], ['Two  women', 'particular  attention'], ['first', 'Romantic Elizabeth journalist'], ['second', 'Mary Anne Disraeli'], ['how group biography', 'inherent  foreground'], ['such group resistance', 'potential'], ['Social  groups', 'social  survival'], ['', 'considerable group development'], ['', 'functional group neuroimaging'], ['participants', 'out amygdala group'], ['Moreover  we', 'amygdala brain fusiform'], ['', 'relevant group cues'], ['motivational  significance', 'important group development'], ['operation', 'human blood blood'], ['various  which', 'transmitted  diseases'], ['blood screening process', 'two  phases'], ['Linked', 'specific Sorbent antibodies'], ['second  phase', 'initial ELISA phase'], ['Thousands', 'central blood bank'], ['screening scheme', 'testing costs'], ['blood unit', 'expiration date'], ['residual testing that', 'future blood use'], ['controller', 'well operations management problem'], ['He', 'too testing reliability'], ['new testing we', 'Recycled Incomplete Identification Procedure'], ['which', 'subgroups'], ['We', 'explicit cost procedure'], ['it', 'several  ELISA'], ['', ''], ['', ''], ['rights', ''], ['aim', 'based National Children'], ['therapy outcomes', 'CORE OM tool'], ['Clients', '19 mean 41'], ['', ''], ['Clients', 'different childhood locations'], ['CORE domains improvements', 'therapy'], ['age improvements', 'community inmates'], ['community adult that', 'emotional childhood abuse'], ['moral  that', 'religiously  believers'], ['little  what', 'divide'], ['Moral foundations theory', 'opposing resolution directions'], ['Individual  differences', 'neuroanatomical conflict differences'], ['Examining  neuroanatomy', 'influential  theories'], ['whole  brain', 'conflict detection conflict system'], ['belief', 'reduced conflict detection'], ['', ''], ['', ''], ['rights', ''], ['large  amount', 'embryo'], ['vitro  markers', 'implantation failure'], ['We', 'clinical implantation pregnancy'], ['immediately  IVF', 'real polymerase chain reaction'], ['We', 'higher gene expression'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'clinical pregnancy patients'], ['areas', 'implantation context'], ['', ''], ['', '-inhibin'], ['-glycan expression transcripts', 'lower secretory phase IVF'], ['aim', 'juvenile beluga Huso huso'], ['', ''], ['20 triplicate groups', 'medicinal control herbs'], ['Feed conversion ratio', 'significant condition differences'], ['', 'herbal  diets'], ['Significant  differences', 'dietary blood treatments'], ['AST serum alanine levels', 'supplemented diet control'], ['Innate', 'other Safflower fed groups'], ['', ''], ['medicinal  herbs', 'Persian  sturgeon'], ['', ''], ['rights', ''], ['marrow stromal cells', 'tyrosine kinase inhibitor'], ['', 'certain  CML'], ['Little', 'resistant Ph+ ALL'], ['', 'resistant SUP B15'], ['Next  proliferation', 'Cell Counting Kit-8'], ['quantitative polymerase chain reaction', 'associated flow genes'], ['present  study', 'resistant Ph+ ALL'], ['hBMSCs', 'resistant Ph+ ALL'], ['This', 'cell cycle'], ['also  expression', 'C D1'], ['apoptotic BCL XS', 'X 3'], ['associated beta catenin cadherin', 'associated oncogene genes'], ['ciated drug resistance expression', 'associated protein kinase'], ['hBMSCs', 'aforementioned Ph+ mechanisms'], ['Therefore  targeting', 'resistant Ph+ ALL'], ['', 'talk genome cell'], ['prior DNA which', 'transcriptomic  data'], ['method', 'simple  yield'], ['real time PCR', 'SDS Northern PAGE'], ['buffers', 'functional  cell'], ['whereby  it', 'disulfide acidic'], ['homolog', 'bioinformatic guinea methods'], ['open reading frame', 'about  25'], ['', ''], ['structure', 'six  introns'], ['gpGILT  all', 'linked glycosylation sites'], ['tertiary  structures', 'same mouse template'], ['phylogenetic  gpGILT', 'closely  68'], ['', ''], ['constitutive  expression', 'real polymerase chain reaction'], ['12 up h', 'innate GILT immunity'], ['', 'recombinant  E'], ['coli', 'acidic antigen processing'], ['results', 'immunological laboratory guinea pig'], ['', ''], ['rights', ''], ['aim', 'Malawian microbiota infants'], ['microbiota changes', 'study infants'], ['Malawian  infants', '6-month intervention period'], ['Infants', 'supplementary control food'], ['Infants', '6 soy protein age'], ['Fecal  bifidobacteria', 'real chain reaction method'], ['', '6-month study period'], ['', 'total  bacteria'], ['', ''], ['', ''], ['', 'lower B infantis'], ['', ''], ['', ''], ['', ''], ['', '6  age'], ['dietary  supplementation', 'Bifidobacterium study infants'], ['bifidobacterial  diversity', 'observed microbiota time'], ['Up regulation', 'adaptive cancer chemotherapy'], ['two  K', 'C'], ['However  capability', 'up cancer cells'], ['study', 'colorectal adenocarcinoma cells'], ['mechanisms', 'inductive  effect'], ['inductive  effect', 'reverse polymerase chain reaction'], ['reactive oxygen species production', '2'], ['protein content', 'western blot analysis'], ['GK OC', 'mu M Caco-2 cells'], ['presence', 'inductive mRNA level'], ['Moreover MAPK inhibitors', 'p38 GK ISO'], ['findings', 'three p compounds'], ['GK', 'mRNA c Jun level'], ['benzophenones', 'MDR transcription level'], ['molecular  mechanisms', 'mediated  pathway'], ['', 'GmbH'], ['rights', ''], ['paper', 'two transversal resistance'], ['two circuit port', 'ideal'], ['', 'unidirectional circuit diagram'], ['numerical simulation PSpice', 'equal transfer conductance'], ['we', 'Gyrodactylus brachymystacis rainbow trout'], ['circular  genomes', 'other Gyrodactylus species'], ['Comparative  analyses', 'nucleotide ribosomal RNA genus'], ['secondary  group', 'genetic  markers'], ['herein', 'phylogenetic pathogen lineage'], ['excretory secretory which', 'antigenic  function'], ['However  little', 'immunomodulatory host cell'], ['present study gene', 'excretory secretory protein'], ['recombinant  protein', 'soluble Escherichia coli'], ['Binding activity', 'nitric oxide rHcES-24'], ['rHcES-24', 'PBMCs'], ['interaction', 'dependent cell manner'], ['However  treatment', 'PBMC IFN gamma production'], ['rHcES-24', 'regulatory goat PBMCs'], ['Degradation', 'cellular gene homeostasis'], ['that', 'different target specificities'], ['exo- RNase J', 'growth'], ['', 'RNase H'], ['we', 'next generation RNA'], ['strong  depletion', 'steady state levels'], ['open reading frames', 'more  2-fold'], ['coding  RNAs', 'less RNase J depletion'], ['Northern  blotting', 'coding  results'], ['Globally  data', 'RNase H'], ['pylori', 'cellular  RNAs'], ['changing  biodiversity', 'infectious disease risk'], ['which', 'considerable win win conservation'], ['dilution effect', ''], ['pathogen transmission that', 'scaled host model'], ['declining  biodiversity', 'infectious endemic prevalence'], ['how host competence', 'body size'], ['Dilution effects', 'dependent  pathogens'], ['host competence', 'bodied  species'], ['dependent host competency', 'only  effect'], ['models', 'habitat biodiversity disease loss'], ['type', 'when driving disease habitat'], ['article', 'themed Conservation biodiversity'], ['less', 'physical  activity'], ['vigorous intensity exercise intervention', 'depressed  adults'], ['intervention', '12-week intervention groups'], ['Mixed  models', 'sedentary MVPA time'], ['light activity time', 'intervention groups'], ['light exercise intervention group', 'MVPA minutes'], ['', ''], ['', ''], ['time', 'MVPA'], ['', ''], ['', ''], ['', 'activity bouts'], ['', ''], ['', ''], ['', ''], ['moderate exercise intervention group', 'MVPA bouts'], ['', ''], ['', ''], ['', 'sedentary  interruptions'], ['', ''], ['', ''], ['', ''], ['changes', 'vigorous exercise intervention group'], ['sedentary  change', 'sedentary  time'], ['light MVPA this', 'vigorous exercise intervention group'], ['', ''], ['', 'Elsevier Ltd'], ['medical  that', 'human bacteria protozoa diseases'], ['bacterial  flora', 'developmental gradient gel electrophoresis'], ['distinct DGGE bands', 'PCR DGGE method'], ['they', 'Bacillus cereus'], ['', ''], ['Our', 'that'], ['', ''], ['aeruginosa  isolates', 'H'], ['', 'developmental flava stages'], ['zoonotic  pathogens', 'H'], ['', 'Henan province China'], ['this', 'bacterial  H'], ['', 'flava China'], ['effect', 'HSCT polyomavirus recipients'], ['We', 'HSCT  recipients'], ['Polyomavirus', 'PCR polymerase chain urine'], ['risk factors', 'BK virus'], ['kidney  functions', 'infected  patients'], ['virus JC virus', 'HSCT simian recipients'], ['HCMV infection', 'independent JC virus infection'], ['transplants', 'more BK virus infection'], ['', ''], ['Liver function', 'uninfected JC subjects'], ['We', 'especially HCMV infection'], ['JC virus infection', ''], ['We', 'physiological Uta health'], ['Blood samples', 'Arizona southern Utah'], ['Hemoparasites', '22  individuals'], ['', '2 % Arizona'], ['', '1  Utah'], ['ectoparasites', '51  individuals'], ['', '3 % Arizona'], ['', '1  Utah'], ['', '11  both'], ['Hemoparasites', 'three  states'], ['Immunocompetence', 'hemoparasites'], ['condition glucocorticoid levels', 'reproductive  status'], ['parasitic  infection', 'usually  parasites'], ['red blood cells', 'RBC IgG alloantibodies'], ['HDFN', 'K  -c-'], ['thereby Fc receptor which', 'HDFN disease severity'], ['Here  we', 'prospective Fc tail immunisation'], ['-K show that', 'pronounced IgG D'], ['low K Fc fucosylation', 'fetal  anaemia'], ['IgG Fc glycosylation', 'RBC  antigen'], ['features', 'needing  treatment'], ['', ''], ['tree which', 'medicinal  importance'], ['Roots', 'traditionally folk medicines'], ['Different Agrobacterium LBA', 'hairy  plant'], ['Hairy root initiation', '30  infection'], ['Optimum transformation frequency', 'ATCC15834 leaf strain'], ['Infection time', '10 transformation min'], ['', 'solid woody plant callus'], ['Whole  shoots', '65  %'], ['Induction', '4 stem cultivation'], ['strains transformation efficiency', 'A4'], ['', ''], ['', '4  cultivation'], ['Transformation frequency', 'explants'], ['', 'hairy  S'], ['anacardium', 'half strength liquid medium'], ['slender hairy which', 'original  explants'], ['Visible  growth', '3 liquid months'], ['Polymerase chain reaction', 'positive transformation events'], ['paper', 'compact precision positioner'], ['moving  that', 'total  1'], ['52  kg', 'single  frame'], ['positioner', 'permanent magnet matrix'], ['Three Hall effect sensors', 'vertical laser distance displacement'], ['Time Application Interface', 'real time control'], ['MIMO  model', 'positioner'], ['LQG  controllers', 'horizontal  positioning'], ['experimental  results', 'dynamic  positioner'], ['time robust disturbance attenuation problem', 'uncertain energy paper'], ['specific disturbance attenuation type', 'control rule'], ['robust disturbance attenuation problem', 'special disturbance attenuation problem'], ['discrete time counterpart', 'L-2 gain'], ['Finally  solution', 'sufficient time condition'], ['discrete time design', 'considered energy system'], ['new  method', 'general energy functions'], ['discrete time design method', 'double pendulum system'], ['Simulation results', 'discrete  paper'], ['explicit design solution', 'nonlinear  systems'], ['field', 'unsolvable surgery problems'], ['30 hand transplantation', 'refined research indications'], ['many  lessons', 'successful hand transplantation'], ['', 'American Hand'], ['rights', ''], ['', ''], ['compensated bandgap reference', 'low temperature paper'], ['curvature  compensation', 'dependent resistor ratios'], ['which', 'high MOSFET threshold transistors'], ['design', '65-nm CMOS 1'], ['', ''], ['output reference voltage', '550  0'], ['', '80 degrees C'], ['that', 'supply rejection ratio'], ['', '1  kHz'], ['effect', 'mismatch'], ['', ''], ['proposed  BGR', 'line 0'], ['', 'total power 20'], ['', ''], ['genomic  that', 'regulatory  molecules'], ['It', 'autoimmune  diseases'], ['50  it', 'intensively  mice'], ['recent macaque species', 'precise Sanger sequencing'], ['special Macaque we', 'human polymorphism haplotype structure'], ['alignment', 'molecular reference biology'], ['When  problem', 'reads execution time'], ['we', 'perfect  sequencing'], ['existing  solutions', 'exact memory footprint matching'], ['human reference aligns', 'such GPU SOAP3'], ['new reference that', 'sequenced  data'], ['optimal  management', 'appropriate hepatitis B treatment'], ['', 'chronic HBV St'], ['we', 'DNA HBV detection'], ['DNA  HBV', 'Real Polymerase Chain strips'], ['We', 'identical  methods'], ['frequent  genotype', ''], ['probably  virus', 'treatment'], ['accurate cost we', 'chronic infected management cases'], ['Recently  performance', 'increasing engine attention'], ['research', 'after operating system'], ['combustion mode', 'ignitable Top Dead combustion'], ['experimental  investigation', 'heavy duty engine'], ['R one', 'dual fuel detail'], ['R g', 'better operating paper'], ['HCII', 'same  time'], ['THC  emissions', 'Diesel Oxidation Catalyst'], ['Then HCII strategy', 'after Euro V device'], ['fuel consumption', 'dual fuel strategy'], ['', ''], ['rights', ''], ['HCMV Human infections', 'epithelial  tissue'], ['Animal model', 'living sacculus rabbits'], ['specimens', 'hours  infection'], ['virus', 'RT PCR'], ['Severe inflammation damage', 'infected  tissue'], ['viral  protein', 'high lamina immunohistochemistry'], ['', ''], ['lymphocytes', 'viral infection groups'], ['HCMV', 'ligated intestine loop inoculation'], ['present  study', 'intestinal HCMV pathogenesis study'], ['rabbit model', 'immune HCMV infection'], ['rapid  advances', 'gradually Herpesviridae genome'], ['UL83 antisense strand', 'clinical  isolates'], ['Three cDNA clones', 'late HCMV cDNA library'], ['UL83 antisense transcripts', 'rapid cDNA ends'], ['UL83asts', '3  ends'], ['open reading frames', 'UL83asts'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Hepatitis C virus', 'microRNA HCV homeostasis'], ['C terminal', 'like nucleic vitro'], ['specificity', 'HCV pathogenesis'], ['transmission electron microscopy', 'cellular nucleic microRNAs'], ['C124', 'self  folding'], ['12 nucleic assembly', 'mainly charge neutralization'], ['assembly', 'nucleic acids'], ['fluorescence correlation C124', 'unspecific nucleic NLPs'], ['charge neutralization', 'like HCV core protein'], ['cellular  which', 'infectious host particles'], ['reciprocally histone acetyltransferases', 'translational  modification'], ['HDACs', 'immune  cells'], ['specific  function', 'individual  HDACs'], ['nervous expression profile', 'T cells'], ['here  HDAC4', 'multiple T cell lineages'], ['lack', 'thymus lymphoid organs'], ['conventional T cells', 'significant cytokine production'], ['steady  HDAC4', 'conventional T cells'], ['damage response failure', 'damaging  treatments'], ['We', 'standard damage response therapy'], ['Twenty  patients', 'squamous cell head'], ['treatment', 'concomitant docetaxel chemoradiotherapy'], ['therapeutic  response', '18F]FDG  PET'], ['normal gene expressions', 'real polymerase chain reaction'], ['down regulation', '2 up cases'], ['1 REV1 case', 'REV1 RT'], ['overexpression', 'independent tumor relapse'], ['altered WRN overexpression', 'altered REV1 predicts RT'], ['', 'oropharyngeal HPV-16 cancer'], ['HPV-16 infection', 'larynx  cavity'], ['We', 'HPV-16  Head'], ['HPV-16 infection', '185 HNSCC samples'], ['Associations', 'exact  test'], ['Survival analysis', 'Cox regression analysis'], ['OS', 'longer  HPV-16'], ['', ''], ['positive  tumors', 'negative  tumors'], ['positive  patients', 'better  survival'], ['status', 'prognostic  HNSCC'], ['Addition', 'better HNSCC patients'], ['squamous cell incidence', 'other  subsites'], ['Human papillomavirus', 'significant risk OPSCC'], ['socioeconomic education which', 'classical  OPSCC'], ['neck metastases', ''], ['better  response', 'staging  approaches'], ['Clinical  trials', 'acute treatment efficacy'], ['review', 'new disease entity'], ['abusive head trauma', 'blunt  impact'], ['1 Evidence it', 'leading child abuse'], ['Clinical  presentation', 'injuries'], ['other  that', 'accidental cancer metabolic diseases'], ['medical  development', 'treatment strategies'], ['', 'able treatment outcomes'], ['clinical  studies', 'future'], ['Purpose Headache', 'sellar  region'], ['still  headache', 'actually  tumor'], ['underlying  headache', 'prospective study design'], ['twelve One patients', 'months  surgery'], ['Patients', 'self handheld computer'], ['Clinical  variables', 'inventories'], ['53 Fifty patients', '44  questionnaires'], ['four  patients', 'pituitary thunderclap headache'], ['diverse headache types', 'other  patients'], ['Untreated gonadotroph deficiency', 'clinical  headache'], ['Presence', 'significantly  surgery'], ['pituitary Conclusion we', 'significant headache neurosurgery'], ['Headache', 'sufficient tumor removal'], ['new health care', 'general pharmacy profession'], ['lasting health behavior that', 'overall well being'], ['care implementation that', 'better  lifestyle'], ['especially health who', 'chronically medication adherence'], ['', ''], ['', 'psychotropic  medications'], ['', ''], ['', ''], ['nursing', 'health coaching models'], ['nurse coaching', 'American Nurse Association'], ['', '1 million 1 U'], ['', ''], ['A', 'also nurse coaching'], ['pharmacy profession', 'related health coaching'], ['How health pharmacists', 'health practice'], ['', ''], ['rights', ''], ['Health care providers', 'central child abuse'], ['positive parenting which', 'intentional childhood injuries'], ['based injury prevention that', 'tailored prevention print children'], ['informant  interviews', 'communication caregivers'], ['Cognitive response testing', '20 priority materials'], ['Interviews', 'thematic coding methods'], ['health care providers', 'very  messages'], ['abuse', 'RISE health care setting'], ['well  graphics', 'RISE Up programme'], ['Conclusions', 'greater childhood injury impact'], ['Providers', 'favourably communication strategy'], ['Low  engagement', 'prenatal birth outcomes'], ['Multiple  factors', 'engagement'], ['', 'prenatally southwest 2010'], ['secondary  outcome', 'home visit frequency'], ['maternal  covariates', 'then ZIP code'], ['', 'individual model agency'], ['', 'ZIP code violence rates'], ['', '837  women'], ['3  %', ''], ['4  %', 'expected  visits'], ['first  model', 'early  agency'], ['however agency volume', ''], ['', 'early model violence enrolment'], ['', ''], ['interaction term', 'maternal  race'], ['', ''], ['effect', 'white community women'], ['', ''], ['', 'black  women'], ['', ''], ['', ''], ['intercept multilevel models teenagers', 'early  AOR'], ['', ''], ['', ''], ['', ''], ['', ''], ['home visiting Prenatal home engagement', 'multiple programme implementation'], ['', 'reported caregiver wellbeing'], ['negative evidence appraisals', 'evidence which'], ['', 'intellectual health disability'], ['Informal  carers', '2199 English Households'], ['estimating equations', 'psychological physical health health'], ['', 'reduced  life'], ['poorer health health', 'poorer health status'], ['higher  risk', 'sized caregiver groups'], ['Carers', 'caring  load'], ['factors', 'well  being'], ['negative  appraisal', 'English population representative data'], ['long caregiving caregivers', 'negative  wellbeing'], ['Support', 'two  factors'], ['well  consequences', 'old  age'], ['purpose', 'future scoping research'], ['We', 'old health age'], ['128  items', '15 scoping review'], ['Papers', 'two population groups'], ['evidence', 'social  isolation'], ['recent  trend', 'social  isolation'], ['Depression', 'well cardiovascular being'], ['two  studies', 'detrimental  health'], ['further  investigation', ''], ['We', 'at sub interventions'], ['Future research', 'loneliness risk health'], ['study', 'different Healthy Eating Index'], ['healthy  participants', 'randomly  September'], ['anthropometric  measurements', ''], ['dietary  recall', 'individuals'], ['Diet quality', 'HEI-2005 HEI-2010 scores'], ['HEI-2010 scores', 'individuals'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Significant  differences', 'mean HEI-2005'], ['', ''], ['HEI-2005 score', 'poorer mean HEI-2010 scores'], ['highest  HEI-2005', 'overweight education groups'], ['', ''], ['positively Diet qualities', 'age gender education'], ['HEI-2010 changes', 'healthy food group'], ['HEI-2010', 'more food HEI-2005'], ['HEI-2010', 'precise diet quality'], ['spiritual well being', 'heart failure'], ['However  consistent', 'limited HF patient attention'], ['aim', 'psychospiritual HF patients'], ['based  intervention', 'pretest pilot study design'], ['convenience sample', 'prestudy Illness Therapy Spiritual'], ['Research staff', 'semistructured program completers'], ['Interviews', 'conventional content analysis'], ['82 % age', 'poststudy intervention questionnaires'], ['intervention', 'modules'], ['religion', 'which'], ['who', 'increased  QOL'], ['', 'depressive  symptoms'], ['less  Meaning', 'Life'], ['', ''], ['based  program', 'coping  QOL'], ['they', 'HF'], ['Future research', 'revised  intervention'], ['Air pollution', 'recent  years'], ['China', 'recently air pollution'], ['Remediation', 'important air pollution'], ['industrial Guangdong China', 'industrial  protection'], ['benefits', 'heat supplier'], ['Furthermore  paper', 'early dispute measure dispute'], ['possible  solutions', 'problems'], ['', ''], ['rights', ''], ['gain', 'fat beet armyworm'], ['SexHSP70 SexHSP74', '685 amino 5'], ['', ''], ['', ''], ['', ''], ['three  mRNAs', 'gut body spermary'], ['SexHSP70', 'developmental  stages'], ['three SexHSP transcripts', 'initial instar larvae'], ['heat shock SexHSP70', 'also recovery stage'], ['SexHSP74', 'short term heat shock'], ['long term shocking', 'long recovery stage'], ['', 'Elsevier Inc'], ['heat shock which', 'protein stress'], ['HSFI', 'two  exon'], ['cold  exposure', 'osgHSFla'], ['isoforms', 'mainly  eyes'], ['Expression', 'development'], ['C', 'osgHSF1 isoforms expression'], ['Exposure', '12 osgHSF1 h'], ['GF-1 cells', 'HSF1 reduced virus infection'], ['osgHSF1', 'molecular virus temperatures'], ['', ''], ['rights', ''], ['common  existence', 'unprecedented heat transfer level'], ['hot temperature which', 'thermal heat exchangers'], ['corresponding energy flow models', 'individual heat exchangers'], ['', ''], ['thermo electrical analogy which', 'heat transfer system'], ['we', 'thermal management system'], ['overall system constraints', 'intermediate Kirchhoffs variables'], ['optimization equations', 'theoretically Lagrange multiplier method'], ['directly heat capacity which', 'energy conservation'], ['energy flow model', 'heat transfer systems'], ['', ''], ['rights', ''], ['we', 'novel passenger car'], ['heat exchanger', 'therefore exhaust vehicle'], ['Thermoelectric generators', 'hot temperature TEG'], ['heat transfer', 'TEG'], ['Two  configurations', 'various exhaust flow rates'], ['power capacity', 'overall heat transfer system'], ['power capacity', 'temperature exhaust system'], ['power', '90 exhaust gas'], ['', 'TEG 66'], ['7  %', 'overall heat transfer 33'], ['', ''], ['', ''], ['rights', ''], ['Physical  treatments', 'treated  product'], ['present  review', 'consistent disease control'], ['review', 'biotic  diseases'], ['physical  tools', 'postharvest  pathogens'], ['physiological  phenomenon', 'physiological  which'], ['also  limitations', 'commercial persistence application'], ['', ''], ['', ''], ['rights', ''], ['induced  corrosion', 'local heat exchanger refinery'], ['failure', 'halfway carbon steel shell'], ['ultrasonic  survey', 'ruptured % wall zone'], ['', 'internal shell compartment'], ['dissolved  solids', 'condensate dropout sample'], ['satisfactorily post heat failure', 'affected  zone'], ['chain reaction polymerase chain analysis', 'moderate operating numbers'], ['', ''], ['', ''], ['colonization', 'substantial heat exchanger shell'], ['localized wall thinning', 'original pressure retention wall'], ['', ''], ['rights', ''], ['Transformation', 'molecular heat shock decades'], ['unexpected heat shock', 'essential transformation process'], ['observation', 'DNAs UV cells'], ['heat shock approach', 'especially ice machine'], ['Sunflower leaf spot', 'biotic sunflower production'], ['', 'biochemical  A'], ['helianthi', 'sunflower'], ['Differential activation', 'increased host plant resistance'], ['active  role', 'native PAGE analysis'], ['dependent  induction', 'resistant pathogen inoculation'], ['three  peroxidase', '24 interaction inoculation'], ['', 'resistant time intervals'], ['Molecular expression', 'resistant cDNA interaction'], ['peroxidase isoforms', 'A'], ['helianthi', 'transcript disease resistance'], ['', 'main Helicobacter pylori'], ['infection management', 'antibiotic  resistances'], ['phenomenon', 'conventional regimen effectiveness'], ['bacterial point which', 'especially  clarithromycin'], ['international  guidelines', 'high eradication rates'], ['', ''], ['', ''], ['These', 'large  tablets'], ['only  who', 'major  disorders'], ['inhibitory resistance concentrations', 'resistant  mutants'], ['susceptibility tests', 'line  treatment'], ['susceptibility guided susceptibility therapy', 'empiric meta analyses'], ['Conventional susceptibility test', 'culture'], ['However  method', 'related hetero resistances'], ['free Polymerase chain techniques', 'specific point mutations'], ['need', 'important  spread'], ['further  step', 'fecal point samples'], ['Few  studies', 'gastric clarithromycin biopsies'], ['now  they', 'controversial  findings'], ['novel PCR method', 'preliminary stool experience'], ['', 'able  H'], ['pylori', 'antibiotics'], ['kinds', 'clinical  application'], ['further  studies', 'solid  considerations'], ['molecular  tests', 'compliance time infection management'], ['potential  risk', 'large  scale'], ['', 'Helicobacter pylori'], ['pylori', 'infectious treatment diseases'], ['molecular  approaches', 'routine places H'], ['pylori treatment', 'based eradication treatment'], ['efficacy', 'multiple  resistance'], ['levofloxacin which', 'many  countries'], ['Mutations', 'antimicrobial  H'], ['different  mechanisms', 'antibiotic  resistance'], ['Determining', 'new  H'], ['', 'antimicrobial resistance'], ['treatment', 'empirical antimicrobial treatment'], ['based susceptibility which', 'usually treatment failure'], ['management', 'steadily antimicrobial resistance'], ['binding  protein', 'evolutionarily  plants'], ['', '85 bollworm Helicoverpa armigera'], ['where Bombyx mori it', 'highly Bombyx mori midgut'], ['HACBP', 'predominantly  midgut'], ['HaACBP', '12 h ecdysis'], ['HaACBP', 'columnar cells'], ['Northern  HaACBP', 'probably nutrition absorption'], ['HaACBP expression', 'larval molting'], ['how  helminths', 'human  immunity'], ['we', 'how self Trichuris'], ['trichiura', 'intestinal adult mucosal'], ['Colonic mucosal biopsies', 'T'], ['', 'mebendazole treatment'], ['Unexpectedly  volunteer', 'Campylobacter T'], ['trichiura this', 'infectious  control'], ['Trichuris trichiura colonization', 'quantitative polymerase chain reaction'], ['We', 'systemic  T'], ['', ''], ['Plasma eosinophils', 'Th2-dominated T cells'], ['together findings helminths', 'human  immunity'], ['study', 'statewide  adolescence'], ['diverse  that', 'parenting questions'], ['University Child Development Resources', 'age adolescence'], ['Overall  staff', '6 Parenting Assistance data'], ['they', 'also  warmline'], ['that', 'parental parent adolescence'], ['telephone assistance lines', 'when parenting issues'], ['other program administrators', 'when  nature'], ['feeding  trial', 'juvenile sturgeon Acipenser baerii'], ['', ''], ['', ''], ['3  g', 'experimental basal L'], ['', '8  weeks'], ['immune  responses', 'significantly lysozyme fish'], ['', 'other plantarum groups'], ['', ''], ['Furthermore fish', 'various  L'], ['plantarum', 'white control group'], ['', ''], ['feeding fish', 'S'], ['', 'disease resistance'], ['', 'S'], ['iniae challenge', 'probiotic'], ['results', 'dietary  L'], ['plantarum', 'immune Siberian sturgeon juvenile'], ['thus stem hematopoiesis', 'developmental cell lineage commitment'], ['hematopoietic  which', 'permissive blood manner'], ['', 'compromised B cell absence'], ['precise  role', 'B cell debate'], ['present  we', 'simultaneously B cell FL'], ['therefore  IL-7', 'B cell lineage'], ['Further  analysis', 'Ly6D(+)CD135(+)CD127(+)CD19(- survival progenitors'], ['Aging', 'signal anemia myeloid transcription'], ['previous Stat5 deletion', 'ITD+ myeloid expansion'], ['long Lin term', 'hematopoietic stem cells'], ['Single polymerase chain reaction', 'lineage  hematopoiesis'], ['dominant  populations', 'associated cell cycle genes'], ['expressing  majority', 'genes'], ['Stat5 mRNA levels', 'several  genes'], ['inflammatory  results', 'mechanistic Stat5 expression'], ['early  beginnings', 'hereditary stem cell diseases'], ['This', 'malignant disease eradication'], ['latter', 'graft stem cell graft'], ['insights', 'related donor donors'], ['other stem cell sources', 'clinical blood stem routine'], ['older  patients', 'allogeneic GvL'], ['nowadays allogeneic HSCT', 'cellular  toxicity'], ['chapter', 'current  developments'], ['role', 'HSC maintenance'], ['Il2(-/-  mice', 'defective HSC hematopoiesis'], ['lympho  myelopoiesis', 'Il2(-/-'], ['cell axis', 'HSC maintenance'], ['Lack', 'activated bone marrow'], ['successfully HSC mice', 'even Treg cells'], ['IFN gamma IFN treatment', 'hematopoiesis'], ['diagnosis', 'early  diagnosis'], ['primary  HLH', 'definitive cell cure'], ['Flow cytometric screening tests', 'genetic  HLH'], ['primary  which', 'primary  genes'], ['', 'Immunology Ammann'], ['', ''], ['', ''], ['', ''], ['', ''], ['primary cell phenotype assessment', 'T cell HLH'], ['Furthermore phenotypic analysis', 'primary  HLH'], ['serious drug that', 'high platelet thrombosis'], ['IgG  that', 'factor-4  PF4'], ['', 'platelet crosslink Fc activation'], ['procoagulant tissue which', 'prothrombotic  state'], ['immune  it', 'independent T mechanisms'], ['memory which', 'independent  mechanism'], ['immunobiological  that', 'immune heparin HIT'], ['immune  that', 'HIT'], ['genetic multistep diagnosis', 'increasingly  attentions'], ['aim', 'hepatic blood mononuclear metastasis'], ['hepatic carcinoma samples', 'different  metastasis'], ['JUN IL8', 'real polymerase chain reaction'], ['JUN IL8', 'hepatic  metastasis'], ['work', 'clinical metastasis future'], ['transporting  polypeptide', 'functional hepatitis B virus'], ['objective', 'Moroccan HBV infection patients'], ['allelic Ser267Phe variant', 'serological HBV markers'], ['we', 'wild type groups'], ['polymorphism', 'Moroccan HBV infection patients'], ['S267F variant', 'chronic HBV infection status'], ['aim', 'currently Microbiology Legnano'], ['1002  HIV1', 'simultaneously  systems'], ['Western HBV DNA', 'discordant HIV samples'], ['well viremia levels', 'treatment'], ['HBsAg  HCV', 'routine  series'], ['', ''], ['', ''], ['', '100  samples'], ['molecular  biology', 'positive  sample'], ['Measure', 'respectively K 0'], ['', ''], ['', ''], ['', ''], ['R XL system', 'VITROS laboratory system'], ['', ''], ['HBV Hepatitis B infection', 'hepatocellular risk carcinoma'], ['like HCC 2', 'also tumor progression'], ['However  interaction', 'HCC progression'], ['potential HCC mechanisms', 'related HCC cells'], ['expression', 'different HCC cell lines'], ['', ''], ['', 'time reverse polymerase chain reaction'], ['Cellular invasion cytokine productions', 'also TLR2-silencing HepG2'], ['', ''], ['', '15 HBsAg stimulation'], ['mRNA  levels', 'significantly  HepG2'], ['', ''], ['', '15 HepG2 cells'], ['HBsAg simulation', 'proinflammatory cytokine HepG2'], ['', ''], ['15  process', 'TLR2 silence'], ['However  transfection', 'alone tumor cells'], ['Moreover HBsAg', 'kappa B p50'], ['', 'induced p HepG2'], ['', ''], ['', ''], ['conclusion HBsAg stimulation', 'related HCC cells'], ['MyD88 NF kappa B', 'cytokine production'], ['interaction', 'related  HCC'], ['Longan County', 'endemic hepatitis B virus'], ['derived  vaccine', '1987'], ['sectional  survey', 'long term vaccine'], ['derived 0 1', 'derived HB ages'], ['Serological HBV markers', 'previous survey data'], ['Overall  prevalence', 'hepatitis B surface participants'], ['', ''], ['who', '24  h'], ['who', 'first  dose'], ['rate  effectiveness', 'yearly  immunization'], ['mean  concentration', 'positive  participants'], ['this', 'immunization'], ['', '2'], ['0  %', 'HB  levels'], ['derived  administration', '24 HB birth'], ['HBs  levels', '18  years'], ['Furthermore studies', 'derived HB vaccine'], ['18  that', 'transcriptional gene regulation'], ['Hepatitis B virus', 'high liver cirrhosis'], ['mammalian  viruses', 'cellular  miRNAs'], ['However  interactions', 'HBV'], ['Methods  microarray', 'expressing cell line HepG2'], ['', ''], ['', ''], ['miRanda program', 'targets'], ['flow cytometric assay', 'human leukocyte antigen'], ['Eighteen  miRNAs', 'two cell lines'], ['up  seven', 'down  HepG2'], ['', ''], ['', ''], ['down  which', 'microarray analysis'], ['some  targets', 'mRNA expression'], ['gene', 'down HLA A'], ['cellular  which', 'related liver diseases'], ['HBV Hepatitis B infection', ''], ['HBV', 'acute  hepatitis'], ['2 billion 2 people', 'HBV'], ['advances', 'effective HBV infection'], ['recent  discoveries', 'novel HBV cure'], ['derivative', 'natural hepatitis B vivo'], ['HBV replication cycle', 'HepG2'], ['', ''], ['', 'qRT  PCR'], ['HBV protein expression', 'Western  blotting'], ['core protein', 'RNA immunoprecipitation'], ['infected vivo ducks', 'HBV vivo DHBV'], ['', ''], ['', '15  d'], ['', 'intracellular HBV HepG2'], ['', ''], ['', '15 IC50 1'], ['L  compound', 'IC50 50'], ['', ''], ['Furthermore  NZ-4', 'ADV HBV mutants'], ['L  concentration', 'deficient  HepG2'], ['', ''], ['', ''], ['', 'infected DHBV DNA ducks'], ['NZ-4', 'deficient HBV capsids'], ['Such  mechanism', 'therapeutic HBV infection'], ['Vasculitis', 'extrahepatic  HCV'], ['it', 'pathogenic serum factor'], ['attribution', 'immunology microbiology'], ['HCV', 'different  mechanisms'], ['clinical  picture', 'hepatic  manifestations'], ['It', 'increased  lymphoma'], ['pathology', ''], ['that', '2014'], ['Management', 'clinical  presentation'], ['It', 'severe  disease'], ['two  types', 'Egyptian mass HCV'], ['', '2016 Elsevier B'], ['', ''], ['', 'Cairo University'], ['Hepatitis E virus', 'oral  route'], ['HEV', 'large  world'], ['case fatality rate', 'induced  0'], ['', 'pregnant  women'], ['infecting  humans', 'four  genotypes'], ['3  those', 'known animal reservoirs'], ['vitro HEV virions functions', 'HEV immunity HEV pathogenesis'], ['further  investigation', 'species tropism vaccine efficacy'], ['review', 'enigmatic  virus'], ['wild cell culture systems', 'virus'], ['recent  report', 'human rat cells'], ['human rat HEV', 'genetic HepG2 group'], ['associated  that', 'sucrose  1'], ['', ''], ['', 'g  1'], ['', ''], ['', ''], ['Northern blotting analysis', 'genomic  7'], ['', 'kb  2'], ['', 'infected  cells'], ['subgenomic  RNA', 'conserved  GAAUAACA'], ['establishment', 'functional HEV proteins'], ['Further  investigation', 'zoonotic  HEV'], ['', ''], ['', ''], ['rights', ''], ['Hepatocellular  carcinoma', 'viral hepatitis infection'], ['inflammatory secretion predominate', 'particularly disease progression'], ['10  monokine', 'inducible C receptor'], ['', 'prognostic treatment outcome'], ['', 'important cancer immunology'], ['production', 'HCC cell lines'], ['immune gene that', 'patient chemokine gene'], ['intratumoral alpha IFN which', 'enhanced cancer cell death'], ['protumorigenic macrophage blocking', 'B cell HCC'], ['neutralizing Grp78 ER antibody', 'adjuvant HCC cisplatin treatment'], ['Hepatocellular  carcinoma', 'human  cancers'], ['coding  RNAs', 'several  cancers'], ['associated RNA colon transcript', 'hepatocellular carcinoma tissues'], ['1 expression level', 'positively tumor volume'], ['', 'Cancer stage'], ['', 'hepatocellular carcinoma patients'], ['associated colon transcript', '1 miR-490 3p'], ['associated colon transcript', 'hepatocellular carcinoma cells'], ['associated colon transcript', 'hepatocellular cell vitro'], ['regulatory  pathway', 'hepatocellular  carcinoma'], ['1 colon expression', 'hepatocellular  carcinoma'], ['Limited  efficacy', 'thus combination therapy'], ['Interleukin-6', 'immune  cancers'], ['IL-6  blockade', 'L1 checkpoint HCC'], ['sources', 'modulating HCC models'], ['IL-6 PD HCC', 'mice'], ['IL-6', 'cancer associated tumor HCC'], ['IL-6 expression CAFs', 'suppressive HCC cells'], ['IL-6 expression CAFs', 'immune T cell checkpoints'], ['IL-6  blockade', 'HCC tumor model'], ['targeted  inhibition', 'potential PD Ll HCC'], ['', 'Elsevier Inc'], ['major  that', 'poor  HCC'], ['growing Hippo kinase signaling', 'many  cancers'], ['However  upstream', 'Hippo HCC'], ['lncRNA we', 'novel lncRNA'], ['expression', 'HCCLM3 MHCC97L cells'], ['Furthermore  we', ''], ['', 'real polymerase chain reaction'], ['', ''], ['using', 'rapid cDNA ends'], ['', 'biological  function'], ['we', 'loss  vivo'], ['', ''], ['134', 'blotting microarray analyses'], ['ISH assay', 'that'], ['134  expression', 'adjacent  tissues'], ['134  expression', 'patient  prognosis'], ['Furthermore  we', 'full length transcript'], ['134', \"3'-RACE  analysis\"], ['', ''], ['134', 'cell proliferation knockdown'], ['134', 'opposite  results'], ['Furthermore  we', 'that'], ['', 'nuclear aa export'], ['Moreover  we', 'that'], ['134', 'mediated target YAP'], ['', ''], ['134  LATS1', 'embedded  ISH'], ['study', 'that'], ['134', 'YAPS127 carcinoma phosphorylation'], ['use', 'promising Hippo kinase'], ['Hepatocellular  carcinoma', 'related  death'], ['active  it', 'misleading  scenario'], ['Western  we', 'molecular  pathways'], ['however fibroblast growth factor', 'Asian Notch population'], ['variations', 'known  HCC'], ['different  patterns', 'clinical trial design'], ['rate', 'HCC trials'], ['', ''], ['rights', ''], ['4  member', 'hepatocellular stem carcinoma'], ['Oct4', 'Huh7 cell line'], ['present  study', 'Oct4-dependent genomics Huh7'], ['', ''], ['Arrays', 'quantitative polymerase chain reaction'], ['fold  change', 'self  renew'], ['1 BHLH transcription cadherin', '1 BHLH transcription Oct4'], ['nuclear beta catenin aggregation', 'HCC cell lines'], ['catenin  WNT', 'epithelial mesenchymal transition'], ['present  findings', 'important  HCC'], ['', 'hepatocellular Signal carcinoma'], ['Deregulation', 'cellular  HCC'], ['STAT3', 'HCC cells'], ['cell lines HepG2', 'Hep3B pcDNA3'], ['respectively  treated', 'mammalian  STAT3'], ['HK2 expressions', 'real polymerase chain reaction'], ['level', 'glucose consumption'], ['results', 'HepG2  pcDNA3'], ['1(+)-EGFP STAT3', 'STAT3 protein expression consumption'], ['', 'significantly glucose consumption'], ['', 'significantly glucose consumption'], ['Treatment', 'HK2  expression'], ['HCC STAT3', 'therapeutic HK2 HCC'], ['oncogenic  that', 'sphingosine-1-phosphate'], ['Sphk1', 'human cancer cells'], ['However  role', 'hepatocellular  carcinoma'], ['Therefore  expression', 'embedded HCC immunohistochemistry'], ['expression', 'normal HCC tissue'], ['', ''], ['expression', 'significantly size tumor stage'], ['', ''], ['patients', 'high Sphk1 expression'], ['Furthermore Sphk1-specific', 'hepatoblastoma G2'], ['based transcription activation system', 'live cell L02'], ['expression Cell expression', 'transfected blot cells'], ['first  Sphk1', 'tumor progression'], ['Sphk1', 'independent prognosis HCC'], ['TNM  classification', 'solid  tumors'], ['clinical  outcome', 'same TNM stage'], ['many  efforts', 'prognostic  parameters'], ['Indeed  analyses', 'prognostic cancer Immunoscore'], ['we', 'hepatocellular T carcinoma'], ['hepatocellular  who', 'colorectal tumor cancer'], ['USP39  gene', 'hepatocellular SMMC-7721 carcinoma'], ['USP39 gene USP39 sequences', 'lentiviral  vector'], ['recombinant pEGFP plasmids', 'cells'], ['Knockdown efficiency', 'transcription quantitative transcription PCR'], ['impact', 'formation flow cytometry'], ['impact', 'nude SMMC-7721 mice'], ['Western  blotting', 'SMMC-7721 cell growth'], ['Recombinant  sequences', 'SMMC-7721 cells'], ['inhibited SMMC-7721 upregulation', 'tumor cells'], ['USP39 knockdown', 'induced SMMC-7721 cells'], ['knockdown', 'nude transcription factor'], ['1 cyclin A', '1 cyclin protein'], ['knockdown', 'mRNA M FoxM1'], ['initially  it', 'other  organs'], ['However  role', 'lung carcinogenesis'], ['we', 'transgenic lung mice'], ['g body weight diethylnitrosamine', '15  age'], ['incidence', 'HGF TG'], ['HGF overexpression', 'induced lung carcinogenesis'], ['Seventy six Seventy percent', '48 lung weeks'], ['incidence', 'TG WT mice'], ['', ''], ['mean  diameter', 'TG WT mice'], ['', ''], ['northern blotting analyses', 'tumorous TG lesions'], ['blotting  analyses', 'increased c Met'], ['HGF c Met', 'signaling pathway'], ['c Met signaling pathway', 'vital lung carcinogenesis'], ['Changes', 'organic transport anions'], ['changes', 'hepatobiliary contrast agent gadoxetate'], ['enhanced  MRI', 'advanced  fibrosis'], ['compartmental  analysis', 'efflux sinusoidal backflux rates'], ['expression', 'reverse polymerase chain reaction'], ['backflux rate', 'gadoxetate'], ['', ''], ['', ''], ['', ''], ['Significant  correlations', 'influx'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['changes', 'enhanced liver MRI'], ['aEuro cent Expression', 'advanced liver fibrosis'], ['cent Kinetic parameters', 'enhanced hepatocyte transporter expression'], ['Hepatocyte transport function', 'enhanced  MRI'], ['cent Compartmental aEuro cent analysis', 'advanced liver fibrosis'], ['pheochromocytoma cell cell translocation gene', 'BTG Tob protein family'], ['study', 'different BTG2 progression'], ['partial  we', 'cultured hepatocyte system'], ['expression levels', 'PC3 RT PCR'], ['Meanwhile  expression', 'situ tissue hybridization'], ['partial  hepatectomy', 'hours  operation'], ['molecular  HPO', 'proliferation'], ['BTG2 mRNA Positive BTG2 expression', '71'], ['', 'normal HCC tissues'], ['mainly HCC expression', 'differentiation'], ['human  HPO', 'PC3 BTG2 gene'], ['highly HCC expression', 'cell differentiation'], ['PC3  BTG2', 'important  processes'], ['', ''], ['produced  that', 'systemic iron homeostasis'], ['iron deficiency anemia', 'iron overload'], ['We', 'hypoxic transcription hepcidin'], ['real blotting PCR', 'various reporter conditions'], ['reduced hepcidin levels', 'down gene promoter activity'], ['effect', 'even interleukin-6 treatment'], ['dependent  oxygenases', 'high HIF-1-independent manner'], ['modulation', 'related oxygenase disorders'], ['', '2008 European Liver'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['HER2 antibody trastuzumab', 'breast cancers'], ['key  that', 'trastuzumab treatment'], ['Here  we', 'CDK2 Rb breast cancer cells'], ['dramatically kinase activity', 'CDK4'], ['that', 'Northern mechanisms blotting'], ['', 'little E protein level'], ['Overexpression', 'molecular weight trastuzumab'], ['Levels', 'cyclin trastuzumab'], ['Rb that', 'CDK6 cyclin A'], ['trastuzumab', 'binding histone H4'], ['Blockade', 'similar PI3 K genes'], ['HER2 PI3 K that', 'histone cell cycle'], ['', ''], ['Men', 'undesirable side effects'], ['definitive  recommendations', 'promising  results'], ['pilot study', 'moderate PSA rise rate'], ['', ''], ['controlled parallel trial', 'conventional imaging methods'], ['Patients', '12 treatment weeks'], ['primary  endpoints', 'secondary EORTC QLQ C30'], ['Data', 'intervention PSA doubling periods'], ['', ''], ['phytotherapeutic  intervention', 'active  arms'], ['intervention collection methods', 'participants'], ['statistical  difference', 'clinical pilot study'], ['active treatment group', 'significant log PSA'], ['', ''], ['5 placebo group', 'log PSA'], ['', ''], ['', ''], ['', ''], ['powered  study', 'recurrent prostate cancer'], ['', ''], ['Hereditary fever syndromes', 'inflammatory  infection'], ['Advances', 'new gene immunity'], ['key  role', 'rapid cytokine blocking therapies'], ['This', 'inflammatory cytokine networks'], ['aim', 'specific cytokine signatures'], ['molecular  HFS', 'intrinsic beta activation disorders'], ['review', 'updated  HFS'], ['', ''], ['rights', ''], ['host shutoff UL41', '1 herpes simplex virus'], ['swine virus', 'also RNase activity'], ['However  mechanism', 'vhs'], ['RNA degradation profile', '1 simplex virus vhs'], ['Notably  presence', 'internal ribosome entry site'], ['simple PrV vhs', 'multiple  intermediates'], ['various PrV vhs', '3 RNase activity'], ['translation eIF4H', 'capped PrV RNA'], ['Nonetheless  proteins', 'rabbit reticular lysate system'], ['translation initiation machinery', 'nuclease PrV vhs'], ['However  process', 'targeting  pattern'], ['', 'Solanaceae Nolana L'], ['', ''], ['two  that', 'anatomical  characteristics'], ['However  they', 'cytogenetic  perspective'], ['', 'situ fluorescent probes'], ['5S rDNA loci', 'seeds'], ['species', 'chromosome number'], ['most  chromosomes', 'submetacentric  N'], ['', ''], ['CMA DAPI banding technique', 'metacentric chromosome species'], ['FISH technique', 'one  Nolana'], ['', 'CMA(+)/DAPI(- 26S loci bands'], ['Three Sclerophylax species', '5S  S'], ['adnatifolia', 'three'], ['rDNA loci', 'same  N'], ['', ''], ['two x=12 number', 'closest chromosome relatives'], ['hybrid  nanostructures', 'evolved  properties'], ['GO alpha Fe2O3@GO', 'heterogeneous Fenton system'], ['H2O2 alpha system', 'wide  range'], ['that', 'classical  Degussa'], ['', 'alpha Fe2O3'], ['unique  which', 'charged electron MB'], ['High  efficiencies', 'estradiol Orange E2'], ['reactive oxygen species', 'radical quenching methods'], ['phenyl which', 'MS  MS'], ['reduction', 'increasing irradiation time'], ['results', 'conventional photo Fenton reaction'], ['', ''], ['', ''], ['rights', ''], ['', 'traumatic heterotopic ossification'], ['total', 'experimental Sprague Dawley groups'], ['Anatomy', 'postoperative sample days'], ['Hematoxylin', 'local  tissues'], ['MMP-9 MMP-2 MMP-9 levels', 'polymerase chain reaction'], ['Radiological  investigation', '5  HO'], ['incidence', 'experimental control group'], ['serum MMP-9 levels', '5 control group'], ['MMP-9 gene expression', '3 control group'], ['TIMP-1 gene expression levels', 'markedly time point'], ['Thus  increase', 'inflammatory brain HO'], ['pathological  elevation', 'extracellular osteoblast precursor HO'], ['MMP-9', 'predictive  HO'], ['longest  that', 'gene therapy'], ['key  that', 'viral  infection'], ['However  role', 'HFV infection'], ['we', '293 distribution volcano picture'], ['mRNAs  which', '293 T cells'], ['differentially  lncRNAs', 'real polymerase chain reaction'], ['production receptor interaction', 'functional  lncRNAs'], ['acting fas ENST00000354838', 'acting IL18 manner'], ['Overall  results', 'wider host vector'], ['grid  concept', 'hydrokinetic  work'], ['electronics hydropower characteristics strategies', 'complete  module'], ['dynamic  simulation', 'KSG'], ['It', 'single grid tie connection'], ['control  stages', 'hydrokinetic  microturbine'], ['technical  results', 'future investment KSGs'], ['paper', 'large iTesla project'], ['It', 'operational stability analysis'], ['results', '11 stability indicators'], ['commercial  tools', 'plug  architecture'], ['case study', '8000  scenarios'], ['Performance data', '10 000 task timings'], ['generated decision trees', 'functional DSA platform'], ['invention', 'tissue architecture'], ['', 'situ protein interactions'], ['Microscopy', 'key  pathways'], ['Multiple  approaches', 'single  cells'], ['also activity us', 'cellular  health'], ['however  methods', 'pros'], ['Therefore  one', 'suitable  methods'], ['Herein  we', 'well  use'], ['study', 'inflammatory bowel diseases'], ['mice', 'normal lamina diet'], ['producing  cells', ''], ['HSD', 'associated lymphoid organ'], ['T  HSD', 'suppressive Treg cells'], ['induced  response', 'treated  mice'], ['HSD', 'intestinal Treg cells'], ['mice HSD', 'intestinal  IBD'], ['digital  control', 'embedded Synchronous systems'], ['paper', 'high PMSM digital control'], ['study', 'decoupling inverse Park transformation'], ['proposed  decoupling', 'discrete  delay'], ['voltage', 'three Modulation PWM converter'], ['rotor', 'q delay'], ['when  ratio', 'electrical output frequency'], ['electric  motor', 'voltage vector'], ['efficiency', 'time simulation'], ['auxiliary sensor node power', 'mixed signal sensor components'], ['', 'isolated ac dc'], ['two chip architecture', 'current mode control'], ['current  loops', 'side  HS'], ['IC', 'transistor  circuits'], ['LS IC', '20 communication interface'], ['architecture', 'simulated  85'], ['12  size', 'current mode operation'], ['State UHV BCD technologies', 'poor Silicon junction'], ['paper', 'fast DSP core'], ['current PWM sensing', 'charger'], ['DSC controller', 'adaptive slope compensation'], ['current  DSC', 'such load capacitor'], ['This', 'conventional HV sensor'], ['load voltage we', 'digital grade HV algorithm'], ['work', 'operational  amplifier'], ['OPAs', 'industrial conditioning applications'], ['signal conditioning circuits', 'always HV domain'], ['as HV which', 'based  transistors'], ['input input ranges', 'key HV applications'], ['We', 'rail HV issues'], ['proposed  design', '0'], ['', ''], ['core area', ''], ['', ''], ['', ''], ['DC gain', 'proposed rail HV OPA'], ['', ''], ['rail HV OPA', '30  0'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['multivariate location problem', ''], ['familiar  method', 'problem'], ['normal Hotelling test', 'normal  distributions'], ['Unfortunately  distributions', 'finite Hotelling test'], ['medical Hotelling test', 'medical  situations'], ['sided sample that', 'interpoint  observations'], ['Five  modifications', 'original  test'], ['problem', 'power computation'], ['two', 'original interpoint test'], ['complex dependence which', 'molecular  biology'], ['magnetic resonance imaging', 'case control study'], ['Higher  education', 'social  mobility'], ['recently  attention', 'social  mobility'], ['social mobility journeys', 'particularly  analysis'], ['paper', 'medical status school'], ['how  participants', 'professional  identities'], ['Students', 'different  themselves'], ['imposters', 'privileged  medicine'], ['such  language', 'middle class origin'], ['middle class difference', 'medical  profession'], ['averaged modeling method', 'current buck boost control'], ['order', 'averaged inductor model'], ['', ''], ['dynamical buck boost which', 'averaged  model'], ['corresponding bifurcation point', 'locus poles'], ['fast scale occurrence', 'slow scale bifurcation'], ['oriented  which', 'unified  framework'], ['ObjectivesMicroRNA-155', 'T cell differentiation'], ['It', 'also HIV infection'], ['miR-155', 'infected T cell individuals'], ['', ''], ['', ''], ['MethodsWe', 'antiretroviral  therapy'], ['MiR-155 levels', 'reverse polymerase chain reaction'], ['immune activation exhaustion', '1 flow cytometry'], ['ResultsThe levels', 'HIV-1-infected CD8 T patients'], ['', ''], ['Nonresponders', 'lower T CD4(+)CD127(+'], ['', ''], ['We', 'HIV-1-infected T patients'], ['', ''], ['miR-155  levels', 'HIV-1-infected T cell activation'], ['Therefore  miR-155', 'immune HIV-1 infection'], ['linear  PGA', 'level shifter BLE paper'], ['merits', 'proposed  PGA'], ['It', '0'], ['', '18 m CMOS 1'], ['', 'high capacitor 2'], ['V  s', ''], ['OIP3', 'constant gain loop'], ['Proposed  PGA', 'gain 2dB'], ['THD', '72'], ['when  PGA', '1'], ['', ''], ['times they', 'strict  assumptions'], ['where time series determination', 'past  observations'], ['high order FTS model', 'time series forecasting'], ['Specifically optimal lengths', 'intervals'], ['monotonic  quantifiers', 'weighted  aggregation'], ['Simultaneously  weights', 'logical relationship prediction'], ['known time numbers', 'recently New South models'], ['developed  model', 'fuzzy  features'], ['', ''], ['', ''], ['rights', ''], ['Time delays', 'industrial  practice'], ['Time delays', 'mainly mass energy'], ['many time delay', 'low order systems'], ['One', 'lower time delay'], ['high order that', 'second time delay'], ['controller algorithms', 'LQ Smith predictor'], ['LQ criterion', 'pole assignment principle'], ['algorithms', 'cylinder atmospheric cylinder tanks'], ['social cognition domain', 'social  dysfunction'], ['symptoms', 'illness'], ['first degree studies', 'social emotion population'], ['study', 'healthy affect ages'], ['hypothesised FHR children', 'relative recognition controls'], ['facial recognition accuracy scores', 'social  groups'], ['study', 'facial FHR children'], ['asymptomatic FHR it', 'developmental stage predating symptoms'], ['Further  findings', 'early emotion recognition'], ['Improved  characterisation', 'early FHR intervention'], ['miRNAs', 'key gene plants'], ['nt RNA molecules', 'translational  suppression'], ['expression', 'miRNAs'], ['expression pattern', 'critical  clues'], ['previously  families', 'paralogous  loci'], ['different  members', 'identical  miRNAs'], ['This', 'individual  genes'], ['several  that', 'other data validation'], ['purposes', 'high intensity interval training'], ['', ''], ['', ''], ['3  years', 'eight exercise HILT'], ['back squat exercises', 'four  exhaustion'], ['Serum samples', 'HIIE Conc Post Conc'], ['comparison', 'ANOVA Bonferroni hoc'], ['Interleukin-6', 'moment effect'], ['', ''], ['only HIIE tendency', 'HIIE'], ['', ''], ['', ''], ['MCP-1', 'condition moment'], ['Interleuldn-10', 'moment  effects'], ['', ''], ['', ''], ['', ''], ['', ''], ['Conc', 'significantly  HIIE'], ['interaction', 'probably  Conc'], ['', ''], ['', ''], ['', ''], ['', ''], ['addition maintenance', 'immune  function'], ['eight cytokines weeks', 'concurrent training exercise'], ['', ''], ['rights', ''], ['nine  men', 'two skin lesions'], ['nine  men', 'deserted  house'], ['diagnosis', 'mycological  analysis'], ['', 'presumed  H'], ['', ''], ['how  contamination', 'place'], ['', ''], ['rights', ''], ['Indoplanorbis exustus', 'responsible cattle schistosomiasis'], ['freshwater snail', 'eastwards Southeast Asia southwards'], ['veterinary  importance', 'geographical distribution patterns'], ['South India South that', 'South India South areas'], ['phylogenetic  inference', 'genetic  clades'], ['', ''], ['nominal  species', 'cryptic  species'], ['species group', 'Early  Miocene'], ['cladogenetic  events', 'climatic Plio oscillations'], ['coverage', 'single Indo Australian clade'], ['Contrary', 'biogeographical colonisation constraints'], ['demographic mismatch that', 'anthropogenic  activities'], ['main  findings', 'digenetic  trematodes'], ['phylogeographical  patterns', 'meaningful range parasites'], ['It', 'public  issues'], ['', 'serological hepatitis markers'], ['consisted', 'Paulo State Brazil'], ['who', 'clinical hepatitis B tests'], ['Patients', 'serological microparticle enzyme immunoassay'], ['Clinical  variables', 'lamivudine aminotransferase level tenofovir'], ['positive  we', '105'], ['', 'chronic hepatitis B'], ['patients', 'six  20'], ['', ''], ['patients', 'antiretroviral follow up'], ['e  antigen', 'first  assessment'], ['Clearance', 'subsequent B surface antigen'], ['positive  patients', '57 serologic marker'], ['', 'clinical  follow'], ['5  who', 'presented hepatitis marker'], ['', 'serological therapy markers'], ['frequent  monitoring', 'serum markers'], ['HIV)-infected Human Immunodeficiency men', 'ED Human Immunodeficiency Virus'], ['authors', 'observational  study'], ['ED', 'emotional Hospital Anxiety'], ['Median  age', ''], ['HIV diagnosis', ''], ['', ''], ['', ''], ['92  %', 'antiretroviral  treatment'], ['8  %', 'viral  load'], ['prevalence', 'ED'], ['', ''], ['ED', '30'], ['', '%  19'], ['', '%  6'], ['', '1  2'], ['', ''], ['ED medications', '19  men'], ['longer  HIV', 'containing protease regimen'], ['lower CD4 cell count', 'concomitant  conditions'], ['that', 'HAD multivariate total'], ['', 'infected  men'], ['Age', 'fundamental  presence'], ['', 'former Soviet Union'], ['most  attention', 'male  migrants'], ['study', 'left household survey Armenia'], ['extramarital  wives', 'extramarital  sex'], ['higher HIV differences', 'extramarital  sex'], ['Finally  difference', 'consistent condom husbands'], ['Armenian gender they', 'male  migration'], ['Implications', 'HIV risks'], ['related  shame', 'older  HIV'], ['related  shame', 'HRQoL well 299'], ['depression', 'related  shame'], ['related  shame', 'older  PLHIV'], ['Few  studies', 'antiretroviral drug children'], ['objective', 'first PDR children'], ['', 'Cox proportional hazards models'], ['models', 'clinical cART start'], ['88  %', '476  children'], ['interquartile range interquartile age', 'cART initiation median'], ['', ''], ['', ''], ['', '297 CD4 cells'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['virus', 'prescribed  drugs'], ['cumulative Kaplan Meier estimate', 'virological  failure'], ['', ''], ['', ''], ['', ''], ['Cumulative  risk', 'active  cART'], ['', ''], ['', ''], ['', '19'], ['', ''], ['', ''], ['', ''], ['', ''], ['multivariable analysis age', 'additional  year'], ['', ''], ['', ''], ['', ''], ['', ''], ['PDR', 'first  cART'], ['additional treatment which', 'PDR time'], ['Lack', 'virological age failure'], ['RT H C domains', 'RT inhibitors'], ['However  impact', 'B subtypes'], ['', 'region HIV-1 subtype C'], ['Viral RNA', 'genomic reaction DNA sequencing'], ['Two novel mutations M357R', 'failing HIV-1C patients'], ['viral treatment E529D', 'HIV-1 subtype B'], ['novel that', 'specific  predominance'], ['limited child it', 'limited child which'], ['structured  that', 'infected  depression'], ['Caregivers', 'complex poverty stigma'], ['how  child', 'sick  children'], ['integrated caregiver that', 'affected  families'], ['linked E74-like factor', 'important T cell functions'], ['However  molecules', 'HIV-1 disease progression'], ['we', 'healthy FOXO3 controls'], ['Moreover FOXO3 expression', 'viral  load'], ['increased T cell activation', 'typical  progressors'], ['fewer Naive T cells', 'low HIV infection CD4(+'], ['vitro xIAP expression', 'healthy cell receptor stimulation'], ['T cell activation', 'FOXO3 IRF4'], ['results', 'therapeutic HIV-1 disease progression'], ['Longitudinal opioid prescription use', 'infected  patients'], ['based trajectory modeling', 'UNC CFAR Clinical Cohort participants'], ['Three  trajectories', 'female HIV sex'], ['opioid  prescription', 'episodic HIV users'], ['CXCR4-using  HIV-1', 'derived T cell interleukin(IL)-4'], ['cellular  which', 'IL-4-stimulated  CD38(-'], ['RNF125  TRAC-1', 'peripheral blood mononuclear cells'], ['RNFI25  TRAC-1', 'important ubiquitin protein ligase'], ['down E3 ligase activity', 'down  activity'], ['blotting RNFl25 TRAC-1 function', 'viral transcription step'], ['RNFI25  TRAC-1', 'ubiquitin proteasome pathway'], ['', ''], ['rights', ''], ['HLA B*13:83', 'nucleotide  positions'], ['HLA B*52:01:27', 'nucleotide  position'], ['', 'nucleotide HLA C*01:109N position'], ['induced  who', 'immunoadjuvant  therapies'], ['functional gold it', 'immune cell challenge'], ['We', 'new tumor necrosis lipopolysaccharide'], ['', 'medical immunology center'], ['septic shock patients', ''], ['', 'whole flow 2'], ['', 'wash centrifuge procedure'], ['tremendous  that', 'more  patients'], ['when  results', 'fluorescence intensity'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'positive  cells'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['iTNF expression', 'DR expression HLA DR patients'], ['preliminary  results', 'septic shock patients'], ['They', 'intensive care unit conditions'], ['This', 'personalized response medicine'], ['antigens', 'various autoimmune diseases'], ['Here  we', 'certain HLA DRB1 alleles'], ['04:02 HLA that', 'same sequence region'], ['other  that', '74 DR beta RA'], ['convincing  explanation', 'antagonistic  effect'], ['70 DR beta epitope', 'other antigen presentation'], ['successful  failure', 'such  abortion'], ['T cell responses', 'thus tolerance induction'], ['immune modulatory which', 'pregnancy'], ['Here  we', 'pregnant MDSCs women'], ['like HLA ILT4-expression', 'GR pregnancy'], ['Stimulation', '3 myeloid cells'], ['Effects', 'MDSC ILT4'], ['results', 'fetal HLA tolerance'], ['Modulating MDSC function', 'immunological pregnancy complications'], ['Gastric  cancer', 'related  mortality'], ['underlying  which', 'fundamental tumor development'], ['discovered differentiation inducer', 'gastric  cancer'], ['FACS levels', 'sequential cell HMBA'], ['GSK-3 beta', 'regulating Ad Akt infection'], ['investigate', 'CDK2 kinase assays immunoprecipitation'], ['northern  blotting', 'functional  HMBA'], ['HMBA', 'gastric epithelial cell differentiation'], ['G0 G1 arrest', 'gastric cancer differentiation'], ['Moreover  treatment', 'GSK-3 nucleus'], ['p27Kip1 which', 'GSK-3 beta'], ['this', 'GSK-3 beta inhibition'], ['herein', 'gastric epithelial cell differentiation'], ['Vitamin', 'key carbohydrate metabolism'], ['Mammals', 'crucial de novo synthesis'], ['here Plasmodium falciparum', 'vitamin biosynthesis pathway'], ['plasmodial  pathway', 'vitamin biosynthetic enzymes'], ['Recombinant PfThiM', '12 mu HMP'], ['Furthermore  ability', 'negative complementation E'], ['', ''], ['Northern blood which', 'vitamin B-1 biosynthesis enzymes'], ['However cultivation', 'minimal  HMP'], ['human  malaria', 'P'], ['vitamin  which', 'external thiamine precursors'], ['clinical neutrophil significance', 'malignancies'], ['study', 'CD62L(high  head'], ['state tumor which', 'cancer prognoses'], ['Tumor biopsies', 'untreated HNSCC patients'], ['Neutrophil subsets', 'flow cytometry'], ['Isolated  granulocytes', 'immune  functions'], ['CD16(high  subset', 'high  CD11b'], ['subset', 'tumor  derived'], ['', 'subset  transition'], ['CD16(high  neutrophils', 'induced FaDu cancer cells'], ['CD16(high tumor neutrophils', 'neutrophil extracellular neutrophil traps'], ['Furthermore  neutrophils', 'increased survival rate'], ['clinical  neutrophil', 'increased HNSCC patients'], ['clinical cancer link', 'diverse cancer immunology'], ['clinical  neutrophil', 'head'], ['Patients', 'healthy  controls'], ['increased  neutrophils', 'increased  survival'], ['tumoral  neutrophil', 'HNSCC'], ['care workers interventions', 'respiratory health diseases'], ['controlled Twenty studies', 'environmental  interventions'], ['effectiveness', 'detailed health tables'], ['Limitations', 'studies'], ['Overall  review', 'appropriate health environment'], ['case  approach', 'achievable home interventions'], ['review', 'future care workers action'], ['', '2016 Allergy Asthma'], ['who', 'training  risks'], ['current state study', 'system- client substance use'], ['overall  management', 'risk areas'], ['greater home visitor knowledge', 'extensive risk domains'], ['Implications', 'based behavioral health training'], ['study', 'protective  services'], ['2598  who', 'initial CPS July'], ['Assessment Form Family Assessment families', 'following  HBPS'], ['chi square chi analyses', 'demographic multivariate characteristics'], ['need', 'needs'], ['concrete  need', 'clinical parenting services'], ['contrast caregivers', 'educational living services'], ['relatively  match', 'respective  services'], ['We', 'additional prevention services'], ['', 'Elsevier Ltd'], ['aim', 'sexual place time population'], ['This', 'electronic Link Embase Science'], ['complementary  search', 'public  U'], ['', ''], ['', 'selected reference articles'], ['We', '20 HIV prevalence rates'], ['9829  15', 'descriptive inclusion summary'], ['Of', 'sexual  exploitation'], ['15', ''], ['HIV prevalence', '0 Cochabamba 37'], ['', '4  St'], ['', ''], ['', '20 Kolkata India'], ['HIV infection', 'sexual  exploitation'], ['Measures', 'ethical health governments'], ['causes', 'homelessness'], ['paper', 'homeless Traumatic Brain Injuries'], ['Respondents', 'traumatic  childhoods'], ['7  %', 'drug  dependence'], ['6  %', 'psychological  child'], ['Seventy six Seventy percent', 'one  TBI'], ['', '4  consciousness'], ['Nineteen  percent', 'foster  children'], ['2  %', 'primary  caregiver'], ['they', 'much  children'], ['5  %', 'children'], ['Santa Clara County', 'unsheltered  nation'], ['Leaders', 'homeless community people'], ['gender', 'judicial  sentencing'], ['we', 'larger gender society'], ['sample', '303 college students'], ['8 % female', 'social  sciences'], ['Participants', 'Portuguese  newspapers'], ['half', 'intimate partner homicide'], ['sex', 'orthogonally  crime'], ['gender', 'mental  disorders'], ['intimate partner homicide', 'addition'], ['results', 'retributive  punishment'], ['how gender norms', 'punitive  population'], ['Glomerulonephritis', ''], ['Accumulation', 'pathobiological matrix GN'], ['that', 'GN'], ['Honokiol', 'inflammatory inflammation models'], ['we', 'first Thy1 nephritis'], ['Thy1 nephritis', 'rat Thy1 antibodies'], ['Nephritic  rats', 'randomly  honokiol'], ['5mg  kg', 'various time points'], ['Glomerular histology', ''], ['Western  blotting', 'proliferation'], ['Adhesion molecules chemokine', 'Northern matrix gene blotting'], ['nephritic  rats', 'glomerular  cellularity'], ['nuclear  antigen', 'nephritic  honokiol'], ['Honokiol', 'nephritic mRNA rats'], ['honokiol', 'proliferative  GN'], ['barley stripe mosaic particles', 'infected Hordeum vulgare'], ['specific alpha each', 'specific alpha particle'], ['Partial  sequence', 'Egyptian stripe mosaic virus'], ['known CV17 generation', 'phylogenetic  trees'], ['thus BSMV alpha', 'separate  clusters'], ['especially BSMV they', 'distinct  cluster'], ['', 'pure BSMV AE1 virus'], ['infected  tissue', 'specific alpha probe'], ['triple coat gene', 'block'], ['distinct  which', 'evolutionary Hordeivirus group'], ['Horizontal gene transfer', 'key  evolution'], ['increasing genome HGT', 'evolutionary  innovation'], ['Here  we', 'exogenous Tobacco etch genome'], ['One', 'many AlkB organisms'], ['that', 'existing Cucumber mosaic virus'], ['We', 'viral virus fitness'], ['AlkB domain', 'wild type levels'], ['Conversely 2b gene', 'viral  fitness'], ['when  RNA', 'HC Pro'], ['observations', 'evolutionary  functions'], ['Current  evidence', 'mood  disorders'], ['We', 'prior mood disorder'], ['Methods', 'linear mixed effect models'], ['95  %', '84 % p'], ['', '022  PPD'], ['previous  relationship', 'larger pregnancy sample'], ['', ''], ['rights', ''], ['domestic  animals', 'social  domestication'], ['being', 'similar  humans'], ['few  that', 'knowledge humans'], ['that', 'only  caretakers'], ['where  food', 'knowledge'], ['horses', 'visual  signals'], ['where  caretakers', 'food'], ['horses', 'communicative knowledge state'], ['C reactive C protein', 'atherosclerotic amyloid lesions'], ['structural conformation that', 'phosphocholine  groups'], ['', 'containing conformation substances'], ['reactive oxygen that', 'also ligand recognition CRP'], ['Controlled H2O2 treatment', 'PCh binding PCh CRP'], ['H2O2-treated ligand binding CRP', 'dependent factor manner'], ['binding', 'binding  CRP'], ['H2O2', 'structure ligand CRP'], ['ligand recognition function', 'inflammatory  microenvironment'], ['inflammatory  microenvironment', 'pathogenic  sites'], ['Aggressive  behavior', 'social information processing'], ['theories', 'ambiguous  stimuli'], ['', ''], ['enhanced  others', 'emotional  expressions'], ['', 'aggressive  populations'], ['aim', 'reported processing aggression'], ['stimulus', 'categorization'], ['2  we', 'happy categorization blends'], ['1  Experiment', 'fearful VO group'], ['Importantly  deficit', 'reported  VO'], ['current  study', 'heightened  anger'], ['deficit', 'social information processing'], ['study', 'dual behavior children'], ['Thus study goal', 'adolescent drug use'], ['sample', 'autonomous care Galicia'], ['who', 'dual family violence victimization'], ['Hosts', 'different avoidance resistance'], ['tremendous defense that', 'other life history traits'], ['Trade offs', 'also avoidance resistance'], ['Here  we', 'natural fluke Diplostomum pseudospathaceum'], ['We', 'salmonid defense them'], ['We', 'specific  resistance'], ['Further  we', 'trade resistance'], ['relative defense importance', 'environmental  components'], ['Overall  study', 'when host parasite interactions'], ['', ''], ['Nasal colonization', 'modifier T cell immunity'], ['Likewise T cell signals', 'innate  defense'], ['', ''], ['Whole  blood', 'viable  S'], ['', ''], ['1 cytokine expression', 'relevant promoter haplotypes'], ['', ''], ['carriers', 'more interferon gamma'], ['', ''], ['', 'IL-17A mRNA ratio'], ['', ''], ['', '93  IL-17A'], ['', ''], ['', ''], ['', ''], ['', '35 IFN gamma'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'IL-17A mRNA ratio'], ['', ''], ['', 'human hBD-3 skin'], ['', ''], ['', ''], ['low  ratio', 'persistent  S'], ['aureus nasal colonization', 'potential hBD-3 link'], ['vital  which', 'several  diseases'], ['protein interaction network', 'such biology interactions'], ['protein protein interaction', 'challenging druggability issues'], ['several  studies', 'better protein protein complexes'], ['recent  studies', 'new drug discovery process'], ['approach', 'such protein protein interactions'], ['', ''], ['', 'Elsevier B'], ['', ''], ['', 'King Saud University'], ['This', 'open access the'], ['', 'org  nc'], ['', ''], ['Housekeeping genes', 'northern blotting RT etc'], ['genes', 'constitutive  genes'], ['expression', 'experimental stage condition'], ['histological  data', 'embryonic  development'], ['present  we', 'situ RT PCR'], ['GAPDH', 'high cell levels'], ['Strikingly expression levels', 'very  organs'], ['two  genes', 'vascular expression system'], ['GAPDH', 'lower beta arteries'], ['strongly  it', 'cardiac muscle cells'], ['Researchers', 'when gene expression experiments'], ['Sexual  differences', 'hepatic cytochrome P450'], ['Expression', 'numerous housekeeping results'], ['internal  controls', ''], ['We', 'used housekeeping genes'], ['We', 'male RT rats'], ['unconventional housekeeping that', 'male factor-1 rats'], ['glyceraldehyde-3-phosphate which', 'glyceraldehyde-3-phosphate dehydrogenase'], ['other  genes', ''], ['', 'male  rats'], ['five dehydrogenase beta actin', 'pituitary  ablation'], ['expression levels', 'normalizing housekeeping controls'], ['', ''], ['often Howland that', 'current  systems'], ['Theoretical  determination', 'overall  circuits'], ['paper', 'simple output measurements'], ['results', 'practical  circuit'], ['cut  frequency', 'other  THS3201'], ['biological gene that', 'directly cell growth'], ['Human polynucleotide I', \"3'-5 exoribonuclease degrades\"], ['present  study', 'human melanoma cells'], ['microarray analysis', 'differentially melanoma hPNPase(old-35'], ['down p27(kip1)by which', 'human IFN beta treatment'], ['mature  miR-221', 'hPNPase(old-35'], ['', 'hPNPase(old-35 IFN beta action'], ['Moreover  we', 'enzymatic miRNA degradation'], ['Targeted  overexpression', 'such  melanoma'], ['reproductive syndrome virus', 'greatest swine industry'], ['M protein', 'structural  PRRSV'], ['cellular  that', 'M protein'], ['that', 'monoclonal PRRSV antibody'], ['expressed  proteins', 'LC MS LC MS'], ['screened  proteins', 'Gene Ontology'], ['cellular  proteins', 'M IP'], ['HuN4-F112 infection group', '10 control group'], ['M which', 'high LC confidence'], ['identified  proteins', 'subcellular  locations'], ['Functional  analysis', 'infectious protein disease'], ['nuclear T interact', 'confocal M analyses'], ['interactome  data', 'cellular M PRRSV'], ['interactome', 'virus swine future'], ['Dysregulated  expression', 'human  papillomavirus'], ['', 'automated RNA18 technology'], ['p16 immunohistochemistry', 'related DNA ISH anogenital'], ['total', 'intraepithelial  lesions'], ['HRRISH DNA ISH', 'embedded p16 sections'], ['RNA ISH', 'low risk HPV types'], ['RNA', 'automated DNA ISH systems'], ['HR HPV PCR', 'embedded  punches'], ['HR RISH', 'Z97 % Z97 PCR+and'], ['HR RISH', '81  CIN1'], ['Furthermore  subset', 'invalid HR RISH'], ['reactive cervix sample', ''], ['HR RISH', 'robust HPV pathobiology'], ['Performance', 'reactive  cases'], ['Decentralized energy supply', 'continuously energy prices'], ['study', 'renewable energy supply costs'], ['We', 'three case studies'], ['systems', 'annual energy 8'], ['', 'annualized  investments'], ['internal return rate', 'HRES investments'], ['', ''], ['work', 'industrial research supply'], ['model', 'decentralized supply facilities'], ['', 'C Elsevier Ltd'], ['Heat shock factor', 'physiological shock transcription stress'], ['induced  expression', 'knock gene array'], ['Northern G promoter', 'transcriptional G CSF EMSA'], ['transcription  secretion', 'G HSF1'], ['enhancer binding heat shock element', 'G CSF'], ['binding  capability', 'heat shock'], ['However  HSF1', 'binding G CSF promoter'], ['transcriptional  activity', 'dependent NF manner'], ['HSF1', 'NF IL6-binding NF element'], ['cloned Crassostrea gigas amplification', 'RACE  techniques'], ['full  length', '620 amino acids'], ['HSP70 cDNA', 'deduced amino acid sequence'], ['HSP70 gene', 'extreme  98'], ['', '9  C'], ['', ''], ['Northern  blotting', 'middle HSP70 layers'], ['samples', 'signal HSP70 mRNA transcript'], ['middle  which', 'massive Gamak bay'], ['HSV Herpes simplex infections', 'significant mortality children'], ['study', 'HSV acyclovir meningitis'], ['total', 'preimplementation HSV PCR groups'], ['real CSF samples', 'sample  assay'], ['CSF samples', 'HSV'], ['60  %', 'acyclovir'], ['test', 'postimplementation 14'], ['', ''], ['', '6  9'], ['', ''], ['', ''], ['', ''], ['PCR results', '4 specimen collection'], ['mean  time', 'acyclovir discontinuation'], ['1 h', 'postimplementation group'], ['', '14  h'], ['', ''], ['median  duration', 'significantly postimplementation group'], ['', '2  14'], ['', ''], ['', ''], ['implementation', 'unnecessary acyclovir therapy'], ['', 'related pigment molecules'], ['RPE cell line', 'injured  model'], ['cells', 'HtrA1 expression'], ['Subsequent  expression', 'real polymerase chain reaction'], ['Changes', 'well Bax Caspase-3'], ['HtrA1', 'blue light irradiation'], ['Knockdown', 'ARPE-19 proliferation cells'], ['', ''], ['Bax', 'significantly protein levels'], ['', ''], ['Bcl-2 expression', 'ARPE-19  cells'], ['', ''], ['Silence', 'injured proliferation model'], ['ARPE-19  cells', 'up Bcl-2 expression'], ['cellular titanium that', 'calcium immersion ion implantation'], ['different titanium surfaces', 'RBM hydroxyapatite grit'], ['surface characteristics', 'SEM ray diffraction'], ['mesenchymal stem cells', 'different  surfaces'], ['Initial cell attachment', 'SEM MTT assay'], ['Real polymerase chain reaction', 'osteoblastic gene expression'], ['', ''], ['', 'alkaline RUNX2 phosphatase'], ['Surface analysis', 'ion implantation'], ['magnesium ions', 'deeper calcium ions'], ['calcium', 'initial cell attachment'], ['Investigation', 'significant cell groups'], ['implanted  expression', 'implanted  surface'], ['conclusion ion implantation', 'surface topography'], ['Calcium magnesium', 'cellular  attachment'], ['review', 'contemporary  glycosylation'], ['Biologic variants', 'menstrual cycle conception gestation'], ['', ''], ['', 'Obstetrics'], ['', 'clinical  biochemistry'], ['Recent  knowledge', 'hyperglycosylated hCG hCG'], ['biologic  variants', 'well beta infertility'], ['', ''], ['prognostic polymerase chain value', 'hCMV polymerase chain infection'], ['', ''], ['retrospective  study', 'Cytomegalovirus Infection Database'], ['', ''], ['', ''], ['lumbar  puncture', 'PCR  result'], ['Clinical characteristics neuroimaging abnormalities', 'audiological  groups'], ['', ''], ['total', '136  study'], ['', 'positive CSF PCR'], ['', 'negative  results'], ['Seventeen  patients', 'positive  52'], ['', 'negative  group'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['8  %', 'positive CSF PCR'], ['', 'viral neuroimaging load'], ['Sensorineural hearing loss', 'positive PCR result'], ['', ''], ['', ''], ['', ''], ['association', '6  age'], ['', ''], ['positive hCMV PCR result', 'symptomatic  birth'], ['neuroimaging  plasma', '6  months'], ['PCR', 'prognostic  cCMV'], ['HCMV UL31 gene UL30', 'complementary UL32 strand'], ['UL32 transcription', 'gene region'], ['Northern cDNA screening', 'RACE PCR'], ['eight  transcripts', 'late HCMV infection'], ['3  coterminus', 'predicted UL30 gene'], ['', ''], ['transcript', 'predicted UL32 gene'], ['Other  transcripts', 'UL30 gene region'], ['', 'three UL32 transcription unit'], ['transcription', 'UL31'], ['coterminal  transcripts', 'UL30-UL32 gene region'], ['', 'human cyclic endometrium'], ['', ''], ['', 'Anatomy'], ['-5 mRNA expression', 'endometrial epithelial cells'], ['Transcript  size', 'Northern  blotting'], ['LGR-7 protein expression', 'immunohistochemistry'], ['mRNA', 'individual expression women'], ['LGR-7 immunostaining', 'midproliferative  phase'], ['stromal  cells', 'functional basal LGR-7'], ['unknown  which', 'possibly fertility control'], ['endometrial cell which', 'human  endometrium'], ['', ''], ['Seasonal influenza', 'elderly  patients'], ['aim', 'well risk mortality'], ['', ''], ['descriptive  study', '31 General University April'], ['', ''], ['total', '219 study period'], ['1  %', ''], ['Most flu episodes', 'influenza A'], ['', ''], ['Patients', 'glomerular filtration rate'], ['', ''], ['', ''], ['', ''], ['', '22  9'], ['', ''], ['', 'cardiac  insufficiency'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'adjusted odds 9'], ['', ''], ['', ''], ['who', 'long term care facility'], ['', ''], ['', '06  hyperlactataemia'], ['', ''], ['', ''], ['', ''], ['', ''], ['Seasonal influenza', 'general  hospital'], ['HLA  system', 'various  vaccines'], ['study', 'HBs hepatitis infancy'], ['297  children', 'primary booster immunization'], ['mIU  ml', 'long term responders'], ['Ten  alleles', 'specific polymerase chain primers'], ['HLA 0401', 'HLA DQB1'], ['', 'higher hypo responder 7'], ['', 'long term responder group'], ['', ''], ['', ''], ['however  difference', 'statistical Bonferroni correction'], ['', ''], ['two HLA DQB1 alleles', 'non-  responders'], ['None', 'long term antibody infantile'], ['', ''], ['rights', ''], ['sensitive sandwich immunoassay', 'multiwalled carbon APTES'], ['increased surface area', 'LCN2 capture antibodies'], ['bound LCN2 MTPs', 'when  0'], ['', ''], ['', ''], ['IA', '0'], ['', 'mL(-1  0'], ['', ''], ['assay', 'immunosorbent assay kit'], ['', ''], ['', ''], ['rights', ''], ['ABC  transporters', 'epithelial expression barriers'], ['present  work', 'five ABC efflux proteins'], ['', ''], ['', '2650 cell line'], ['Western blot analysis', '2650 polymerase chain reaction'], ['functionality', 'respective accumulation substrates'], ['mRNA  expression', 'corresponding cell culture models'], ['functional  expression', 'first MRP transport time'], ['1 intranasal administration', 'future  developments'], ['specimens', 'vitro MRP1 MRP2'], ['2650 cell culture models', 'particular nasal application'], ['novel  approach', 'specific transcription factors'], ['essential cell they', 'long cell renewal capacity'], ['', 'ethical  issues'], ['aim', 'reprogramming reagent transfection vectors'], ['Obtained', 'molecular  biology'], ['Distinct colonies', 'day'], ['presence', 'alkaline iPSCs phosphatase'], ['embryoid  they', 'AP 60'], ['Oct4 Sox2', 'significantly expression comparison'], ['', ''], ['biological analysis they', 'regenerative  medicine'], ['reliable foodborne disease that', 'small  food'], ['Con which', 'sensitive detection HuNoV'], ['spans Asp16', 'nine mCon HuNoV'], ['Mn2 Ca2 region', 'observed virus protein interaction'], ['significantly mCon MCR', 'major Con HuNoV'], ['', ''], ['results', 'rapid Con A genogroups'], ['method', 'short concentration time'], ['HuNov', '90 A PAB application'], ['method', 'pH  values'], ['', ''], ['', ''], ['virus transmission method', 'viral  infections'], ['', ''], ['rights', ''], ['4  which', 'various  cancers'], ['important  role', 'squamous cell carcinomas'], ['Here  we', 'Western blot analysis'], ['associated cell cycle which', 'cellular transcription proliferation'], ['TEAD4 expression', 'tumoral OSCC patients'], ['knockdown OSCC cells', 'dependent CDK inhibitors'], ['TEAD4-YAP  complex', 'related  genes'], ['TEAD4', 'therapeutic  OSCCs'], ['', ''], ['rights', ''], ['HPV Human infection', 'cervical  cancer'], ['', 'cervical epidemiology cancer'], ['isothermal  amplification', '23 HPV genotypes'], ['sequences', 'HPV genome'], ['fluorescent dye calcein', 'reaction'], ['reaction', '40 degrees minutes'], ['positive  reaction', 'color green'], ['fluorescence curve diagram', 'time quantitative time instrument'], ['cervical swab samples', 'different HPV specificity'], ['results', 'other HPV genotypes'], ['serial  dilution', '23 L1 gene sensitivity'], ['Different HPV subtypes', 'different detection capability'], ['sensitivity', 'different LAMP 1'], ['', '4'], ['', 'reaction'], ['assay', 'clinical dot samples'], ['', ''], ['', ''], ['', 'positive  LAMP'], ['', ''], ['', '8 HR HPV'], ['agreement', 'LAMP'], ['', ''], ['', 'HPV positivity'], ['', ''], ['', 'HR HPV positivity'], ['colorimetric LAMP assay', 'limited HPV hospitals'], ['positive  tumors', 'aggressive  therapy'], ['purpose', 'squamous cell carcinoma lines'], ['alternate  transcripts', 'reverse polymerase chain reaction'], ['', 'viral host genes'], ['Cellular gene expression', 'viral integration sites'], ['positive cell lines', 'viral E7 oncogenesis'], ['HNSCC cell lines', 'intergenic UM integration'], ['positive cell that', 'positive cell tumors'], ['HPV integration', 'driven  tumors'], ['', ''], ['', ''], ['which', 'human  papillomavirus'], ['however Notch role', 'cervical  cancer'], ['', 'cervical  cancer'], ['cervical cancer samples', 'abnormal Notch pathway'], ['different Numb isoforms', 'cervical cancer cells'], ['alternative Numb which', 'cervical cancer cells'], ['activated Notch signaling', 'cervical Numb splicing'], ['Thus Numb splice variants', 'cervical cancer genesis'], ['high risk HPV16/18', 'etiological  head'], ['we', 'related  cancers'], ['article', 'histopathology molecular demography histopathology biology'], ['that', 'Rev Man'], ['', ''], ['positive  tumors', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'strongly  oropharynx'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['related  tumors', 'more p16 overexpression'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'negative  tumors'], ['patients', 'reduced  death'], ['', ''], ['', ''], ['', ''], ['related HN tumors', 'traditional  tumors'], ['etiological  relationship', 'future diagnosis prevention patients'], ['', ''], ['Objectives', 'squamous cell carcinoma'], ['HPV', 'benign lymphoid hypertrophy'], ['We', 'oropharyngeal sleep tissue'], ['', 'chart review'], ['old  who', 'single  January'], ['adequate  HPV6', 'embedded tissue blocks'], ['logistic Student t regression', 'HPV hypopnea groups'], ['99  cases', 'six  HPV6'], ['BMI AHI age', 'HPV  groups'], ['multivariate analysis', 'variable'], ['HPV', 'significant  OSA'], ['None', 'oropharyngeal OSA patients'], ['', ''], ['it', 'developing  fetus'], ['however B19 knowledge', 'B19  pregnancy'], ['present  study', 'G BeWo trophoblasts'], ['Briefly BeWo trophoblasts', 'purified B19-VP1u B19-VP2'], ['Subsequently  expression', 'apoptotic flow cytometry ELISA'], ['expression levels', 'B19-VP2 control group'], ['only rabbit CD29', 'B19-VP1u  IgG'], ['apoptotic protein cytochrome peptidase', 'B19-NS1 BeWo IgG'], ['antibodies', 'pathological  pregnancy'], ['findings', 'underlying B19 pregnancy'], ['Potassium channels', 'sensitive intracellular ATP'], ['kinetics  channels', 'distinct  types'], ['mechanical ATP which', 'bone resorption'], ['So  we', 'periodontal channel ligaments'], ['human PDL cells', 'third  molar'], ['experiments human PDL fibroblasts', '3'], ['', ''], ['inside patch clamp recordings', 'voltage clamp mode'], ['Reverse polymerase chain reaction', 'channel subunits'], ['wise  comparisons', 'Paired t test'], ['', ''], ['05', ''], ['We', 'mRNA  Kir6'], ['', ''], ['', '2 human PDL cells'], ['inward K+ rectification', 'free bath solution'], ['reversal potential', '140 bath solution'], ['single channel currents', '5 bath solution'], ['However  currents', '100 mu M glibenclamide'], ['human PDL cells', 'ATP channels Sur2B'], ['', ''], ['which', 'ATP'], ['', ''], ['rights', ''], ['renal cell carcinoma', 'high treatment modalities'], ['Therefore  investigation', 'biologic treatment strategies'], ['127  genes', 'initially gene expression HRCCs'], ['subset', 'Northern  blotting'], ['Unexpectedly caveolin-1 Unexpectedly gene', 'up HRCC tissues'], ['metastatic  SN12CPM6', 'more  SN12C'], ['Caveolin-1 gene', 'slightly DXR treatment'], ['which', 'kidney tumor metastasis'], ['cancer drug incidence', 'pulmonary SCID nodules'], ['', ''], ['together  caveolin-1', 'eventually lung metastasis'], ['schools', 'human resources management'], ['Specifically  HRM', 'increased involvement teachers'], ['how HRM HRM', 'positive  teacher'], ['HRM systems', 'A'], ['this', 'performance'], ['HRM they', 'HRM way'], ['administration', 'nephrotoxic side cisplatin'], ['MSC)-derived Mesenchymal stem exosomes', 'therapeutic tissue injury'], ['derived  exosomes', 'renal hucMSC vivo'], ['NRK-52E  cells', '8 cisplatin h'], ['Cells', 'immunosorbent apoptosis assay'], ['we', 'acute injury rat models'], ['', '0'], ['5 h hucMSC Ex', 'renal  capsule'], ['rapamycin', 'hucMSC Ex'], ['animals', 'days cisplatin injection'], ['tubular  apoptosis', ''], ['hucMSC Ex', 'epithelial mitochondrial vitro'], ['hucMSC Ex', 'related NRK-52E cells'], ['renal hucMSC effects', 'autophagy animals'], ['activation', 'effectively hucMSC cisplatin'], ['Therefore  treatment', 'therapeutic hucMSC cisplatin'], ['Ulinastatin', 'endothelial necrosis factor alpha'], ['study', 'therapeutic sepsis patients'], ['TNF alpha', ''], ['hy926', 'inflammation model'], ['Horseradish peroxidase permeability assays', 'epithelial voltmeter EA'], ['', ''], ['Immunocytochemistry', 'endothelial F permeability'], ['MYPT1 p MYPT1', 'real polymerase chain reaction'], ['', 'electrical TNF EA'], ['permeability', 'cells'], ['', ''], ['VE cadherin', 'additional stress cells'], ['Ulinastatin treatment', 'phenomena'], ['western  expression', 'TNF alpha TNF P'], ['however  ulinastatin', 'two  proteins'], ['', 'normal TNF EA'], ['', 'endothelial TNF alpha treatment'], ['', ''], ['Ulinastatin', 'endothelial TNF alpha'], ['inhibitory  effect', 'RhoA  pathway'], ['', ''], ['', ''], ['rights', ''], ['Helminths', 'chronic host defense infections'], ['macrophages', 'immune pathogen invasion'], ['They', 'distinct  phenotypes'], ['present  paper', 'excretory THP-1 macrophages'], ['Monocytes', 'living  parasite'], ['HD', 'human THP-1 macrophages'], ['Macrophages', 'reduced parasite cytokines'], ['', ''], ['', ''], ['', ''], ['CxCL10 s expression', 'ESP stimulation'], ['when  macrophages', 'living  parasites'], ['ERK1/2 AMPKa1', '1/2/3 S473 Hsp60'], ['immunosuppressive  properties', 'lower  levels'], ['presence', 'M1 M2 macrophage phenotypes'], ['human  this', 'immune  cestodiasis'], ['BLT mouse model', 'human  immunology'], ['fetal thymus that', 'mice'], ['restriction', 'HLA  haplotypes'], ['critical  we', 'established BLT mice'], ['SCID recipient we', '8 BLT weeks'], ['proBLT  mice', 'primary BLT donor mouse'], ['such HLA A2 that', 'A2-restricted human T cell immunotherapies'], ['proBLT  mice', 'immune cell gene therapy'], ['method', 'preclinical research tool'], ['Small Hydropower Projects', 'ecological  impacts'], ['We', 'local Western respondents'], ['Primary interview data', 'assured  impacts'], ['We', 'human elephant interactions'], ['assurances', 'electricity  generation'], ['most  respondents', 'adverse  impacts'], ['We', 'human elephant conflict'], ['policies', 'SHPs'], ['Affective  Theory', 'specific  own'], ['Previous  studies', 'affective Eyes RMET'], ['Results', 'early  HD'], ['cognitive  impairments', 'poor RMET test'], ['affective ToM ability', 'cognitive ToM impairment'], ['We', '15 HD patients'], ['groups', 'education'], ['ability', 'normal HD population'], ['percentage', 'correct  responses'], ['Furthermore  impairment', 'visuospatial  task'], ['RMET', 'cognitive HD status'], ['which', 'cognitive  abilities'], ['when others patients', 'cognitive  decline'], ['Purinergic  signaling', 'vascular aggregation cell proliferation'], ['well purine enzymes', 'nucleoside  metabolism'], ['Recent  studies', 'physiological  conditions'], ['comprehensive  analysis', 'metabolic  attention'], ['', 'nucleoside diphosphate kinase'], ['attempt', 'exo hydrolytic exo ones'], ['We', 'kinase nucleotidase families'], ['genes', 'HUVEC NDPK1 cells'], ['data', 'ATP exo phosphotransferases activity'], ['described  enzymes', 'venous signal vasculature'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['paper', 'programmable HVAC controllers'], ['HVAC air systems', 'ambient optimal characteristics'], ['paper', 'simplified  system'], ['Further  it', 'also  same'], ['programmable  which', 'it'], ['pharmaceutical case who', 'currently  system'], ['main  purpose', 'real time data'], ['operational pseudo which', 'ray sensor array'], ['power hybrid ADC', 'good trade accuracy'], ['two  stages', 'same analog area'], ['test chip', '0'], ['', ''], ['hybrid  ADC', 'power 218'], ['', ''], ['effective  number', 'bits'], ['', ''], ['operational pseudo which', 'focal plane array detector'], ['stage hybrid stage ADC', 'good trade accuracy'], ['two  stages', 'same analog area'], ['charge effectiveness', 'theoretical  analysis'], ['test chip', '0'], ['', ''], ['hybrid  ADC', 'power 218'], ['', ''], ['effective  number', 'bits'], ['', ''], ['paper', 'on voltage control'], ['OLTC tap positions', 'discrete SE view'], ['Estimation', 'formidable  challenge'], ['proposed  methodology', 'discrete state variables'], ['hybrid particle swarm optimization', 'solution'], ['method', 'standard  IEEE'], ['proposed  algorithm', 'accurately bus voltage magnitudes'], ['accurate  which', 'overall  electricity'], ['current  increase', 'electric electricity generation grids'], ['Solutions', 'stable energy electricity'], ['paper', 'fast energy storage systems'], ['hybrid  plant', 'additional air liquefaction combustion'], ['hybrid  plants', 'fast control services'], ['ideal energy storage technology', 'low power costs'], ['energy carrier', 'compressed air energy storage'], ['compressed  air', 'significant  costs'], ['Air Energy Storage', 'large volumetric energy storage'], ['R simulation software', 'trip  efficiencies'], ['proposed  configurations', 'near power future'], ['', ''], ['rights', ''], ['grid electricity generation', 'conventional energy resources'], ['main  purpose', 'small Punjab Pakistan'], ['electric load data', 'irrigation  needs'], ['Hybrid Optimization Model', 'biomass hybrid configuration'], ['solar irradiance data', 'available HOMER analysis'], ['then HOMER results', 'further sensitivity analysis'], ['Sensitivity parameter', 'solar sensitivity analysis'], ['system', 'present  energy'], ['', ''], ['rights', ''], ['paper', 'distributed execution resources'], ['It', 'continuous time plant'], ['It', 'disabled Electrical people'], ['It', 'digital control livings'], ['whole  system', 'wireless  components'], ['real  implementation', 'functional  requirements'], ['simulation tool', 'joint control loops'], ['low sustainability which', 'many  projects'], ['study', 'diesel Tsumkwe Namibia'], ['It', 'public field studies institutions'], ['it', 'economic electrification program'], ['HOMER', 'TM  analysis'], ['it', 'existing growth potentials'], ['progressive tariff system', 'low energy matrix'], ['Adoption', 'prior energy efficiency costs'], ['African  challenges', 'African  countries'], ['', ''], ['rights', ''], ['', 'efficient resources necessitate manner'], ['Electrocatalytic water splitting', 'powerful  technologies'], ['development', 'flexible water electrolysis devices'], ['review', 'electrocatalytic  performance'], ['water splitting reaction', 'such solution ions'], ['Quantitative understanding', 'electrocatalytic electrolysis systems'], ['electrolyte', 'indirectly concentration overpotential'], ['review', 'photo)electrochemical water splitting reactions'], ['endothelial cell which', 'initial  atherosclerosis'], ['real polymerase chain reaction', 'related reference studies'], ['objective', 'endothelial hydrogen peroxide'], ['expressed reference genes', 'qRT PCR H2O2'], ['stable RPLP0 GAPDH', 'NormFinder'], ['expression stability', 'statistical reference program'], ['TFRC RPLP0 GAPDH', 'oxidative stress study'], ['electrochemical  reactor', 'bipolar hydrogen plates'], ['large electrode fabrication method', 'large area electrodes'], ['Scanning electron microscopy', 'spectroscopy particle electrodes'], ['particle electrodes', 'electrode material layer'], ['electrochemical  reactor', 'positive metal electrodes'], ['stack', 'current hydrogen production 95'], ['', 'electrical hydrogen evolution 259'], ['', '1 W 0'], ['', ''], ['', 'current  densities'], ['also charging which', 'hydrogen production efficiency'], ['further design modifications', 'heat device'], ['', 'C Elsevier Ltd'], ['oxidative Claus decomposition', 'low H2S ratio'], ['', ''], ['', ''], ['kinetic model', 'experimental  data'], ['results', 'higher  temperatures'], ['yield  selectivity', 'experimental  values'], ['sensitivity analysis', 'lower kinetic temperatures'], ['', ''], ['rights', ''], ['Flow Induced Motions', 'particularly Vortex Induced lift'], ['Aquatic Clean Converter', 'synergistic MHK electricity'], ['distributed surface roughness', 'efficiency'], ['two  cylinders', 'center  1'], ['', ''], ['', ''], ['57  diameters', 'damping ratio'], ['', ''], ['', 'Reynolds number'], ['Renewable Energy enables', 'closed control loop'], ['oscillatory response energy envelope', 'optimal power'], ['experiments', 'Surface Water Free Surface Michigan'], ['harness  power', '2'], ['', ''], ['single  efficiency', 'two  2'], ['', ''], ['', 'single  cylinder'], ['MHK power', '100 downstream cylinder'], ['MHK power', 'lesser downstream interaction'], ['VIVACE', 'slow  0'], ['', 'upper flow velocity'], ['high spring Stiffness', 'harnessed  power'], ['optimal', 'softer power increases'], ['', ''], ['rights', ''], ['Omeprazole', 'gastro intestinal gastro disorders'], ['worldwide  omeprazole', 'urban  wastewaters'], ['human urinary metabolites', 'abiotic transformation environment'], ['', 'environmental water treatment plants'], ['relevance', 'simulated photodegradation irradiation'], ['different water lake matrix', 'investigated  compound'], ['photodegradation process', 'aquatic  environment'], ['TPs', 'high resolution mass spectrometry'], ['four', 'also hydrolysis TPs'], ['solar  photolysis', 'aqueous  solutions'], ['systematic  investigation', '8 screening analysis'], ['findings', 'parent compound parent wastewaters'], ['further concentration attention', 'metabolites  fPs'], ['', ''], ['', ''], ['rights', ''], ['important  impact', 'hydroelectric power dams'], ['Circulation Model General Circulation projections', 'two emissions scenarios'], ['detailed  that', 'dynamics reservoir bathymetry'], ['inclusion', 'simulated hydropower climate'], ['Simulation results', 'high emissions GCM'], ['most  prominent', 'southern Europe northern Africa'], ['hydropower production', 'high emissions scenario'], ['current Balkans countries', 'national electricity country'], ['', 'new power generation facilities'], ['', ''], ['', ''], ['rights', ''], ['solar  which', 'catalytic  triiodide'], ['widely NiSe2 we', 'NiSe2  DSSCs'], ['HED CE', 'iodine ED NiSe2'], ['', 'solar conversion 8'], ['24  %', '7'], ['', 'significant ED NiSe2(7'], ['', ''], ['HED method', 'solar CE energy'], ['', ''], ['', ''], ['rights', ''], ['Hydroidfest', '23 Bodega Bay CA'], ['meeting', 'other North world'], ['scientific  topics', 'immunology symbiosis'], ['Thanks', 'numerous technologies disciplines'], ['powerful  that', 'repeatedly  meeting'], ['that', 'ensuing  discussions'], ['', ''], ['', 'allergic hymenoptera stings'], ['', ''], ['observational  study', 'ascertained Liguria VIT'], ['structured  questionnaire', 'allergic  reactions'], ['These', 'first  VIT'], ['', ''], ['One hundred', 'complete data set'], ['', '32'], ['allergic  reaction', 'work activities'], ['', '31'], ['2  %', 'occupational  activity'], ['grades', 'first VIT sting'], ['', ''], ['', ''], ['findings', 'high hymenoptera stings'], ['diagnostic  which', 'proven  HVA'], ['separation', 'aliphatic chemical industry'], ['Pervaporation', 'low energy consumption'], ['However  formation', 'aliphatic study mixtures'], ['which', 'driven assembly method'], ['emulsion  membranes', 'TEM SEM'], ['crosslinking  density', 'also NMR system'], ['membranes', 'aliphatic  pervaporation'], ['pervaporation separation index', 'composite  solvent'], ['3-fold', 'toluene heptane mixtures'], ['composite  membranes', 'comprehensive pervaporation performance'], ['facile  strategy', 'aliphatic  industry'], ['', ''], ['', ''], ['rights', ''], ['infrared  response', 'based  photodetectors'], ['We', 'infrared femtosecond laser irradiation'], ['fabricated PN photodiodes', 'electromagnetic photoresponse spectral spectrum'], ['onset  energies', 'known silicon band gap'], ['technique', 'based broadband detectors'], ['', ''], ['', ''], ['rights', ''], ['prominent  that', 'diabetes'], ['Hyperglycemia', 'malignant cancer cells'], ['Clinical  studies', 'different  cancers'], ['poorly glucose metabolism', 'inflammatory  markers'], ['', ''], ['interleukin', 'immune cancer cells'], ['uncontrolled proinflammatory responses', 'immune  overactivation'], ['immune tumor microenvironment', 'associated tumor biology'], ['paper', 'hyperglycemic  conditions'], ['Then  authors', 'well prostate liver inflammation'], ['authors', 'associated  cancers'], ['', ''], ['rights', ''], ['diseases', 'immune  function'], ['Technical advancements', 'genetic RNA PIDs'], ['present  review', 'clinical differential diagnosis'], ['present', 'low IgG IgA'], ['other serum immunoglobulins', 'age'], ['Mechanistically  disorders', 'immunoglobulin'], ['genetic stability CSR', 'mismatch repair'], ['defects', 'laboratory HIGM'], ['review', 'congenital  HIGM'], ['when OMIM annotated', 'pathogenesis'], ['therapeutic  options', 'available  condition'], ['', '2016 Allergy Asthma'], ['PurposeTo', 'rodent heart'], ['Alterations', 'acute contractile Ca2'], ['however  changes', 'myocardial  damage'], ['RF  pulses', 'injected  hyperpolarized'], ['3D imaging which', 'mediated label HCO3-'], ['', '4'], ['', ''], ['5  resolution', 'vivo rodent heart'], ['technique', 'cardiac dobutamine infusion'], ['ResultsThe intracellular', ''], ['', ''], ['', '6'], ['', ''], ['', 'continuous -adrenergic stimulation'], ['ConclusionsVolumetric maps', 'hyperpolarized  1-C-13]pyruvate'], ['new  method', 'ischemic  heart'], ['', ''], ['', 'Wiley Periodicals Inc'], ['', 'Magnetic Medicine'], ['original use work', 'use medium'], ['Two  person', 'two brain process'], ['Finally  we', 'mental  illness'], ['latter', 'transcultural  psychiatry'], ['Combination therapy', 'higher trough infliximab'], ['role', 'concurrent adalimumab trough levels'], ['We', 'scheduled maintenance therapy'], ['inflammatory maintenance who', 'adalimumab trough January'], ['Drug level', 'solid phase assay'], ['Pairwise comparison', 'immune modulator therapy'], ['79  patients', ''], ['', ''], ['1  %', 'weekly  dosing'], ['9  %', 'alternate  weeks'], ['Median adalimumab trough levels', 'clinical  remission'], ['', ''], ['', ''], ['', '6'], ['', ''], ['', ''], ['', ''], ['g  g', 'lower adalimumab trough levels'], ['', ''], ['', 'faecal  calprotectin'], ['', ''], ['', ''], ['this', 'statistical  significance'], ['', ''], ['Median adalimumab trough levels', 'concurrent  immunomodulators'], ['', ''], ['', ''], ['', 'concurrent  immunomodulator'], ['', ''], ['', ''], ['', ''], ['', ''], ['Adalimumab trough levels', 'concurrent maintenance therapy'], ['', 'elevated adalimumab trough calprotectin'], ['paper', 'digital control circuit'], ['current output which', 'transmission lines'], ['presented edge boosting method', 'DDR(Double Data Rate'], ['', 'conducted power supply pins'], ['operational  amplifier', 'first OP case'], ['ICEM  model', 'theoretical OP study'], ['curve fitting method', 'physical structure OPA694'], ['experimental  test', 'conducted sine wave noise'], ['common simulation susceptibility criterion', 'immunity measurement'], ['ICEM DPI model', 'perfectly 200MHz frequency range'], ['coordinate data components', 'data'], ['Most', 'fourth order moment'], ['Skewness', 'less order attention'], ['Gaussian  which', 'asymmetric  data'], ['which', 'typical color images'], ['', ''], ['rights', ''], ['structure', 'seismic subsurface melt experiments'], ['aerial rift elevation', 'broadband seismic broadband arrays'], ['We', 'spreading Rayleigh wave Iceland'], ['high resolution model', 'branched  Iceland'], ['10  km', 'strong shear wave velocities'], ['', 'active  rifts'], ['Slow  velocities', 'neo volcanic neo zones'], ['where magmatic rate', 'melt supply'], ['lowest velocity cores', 'central Eastern Volcanic volcano'], ['This', 'shallow melt rift'], ['strongest velocity contrasts', '10 20 10 rifts'], ['here  ridge', 'Eastern Volcanic Zone'], ['', ''], ['', 'Elsevier B'], ['', ''], ['Collodion baby', 'neonatal  period'], ['It', 'clinical  picture'], ['it', 'dry  Ichthyosis'], ['prenatal biology diagnosis', 'genetic  counselling'], ['which', 'first infant life'], ['whereby  mutations', 'ICN'], ['FRMD7-S', 'neuronal  differentiation'], ['skipping FRMD7 which', 'northern NT2 blotting'], ['bone morphogenetic protein-2', 'quantitative  PCR'], ['expression', 'neuronal NT2 cells'], ['FRMD7_SV2', 'neuronal  development'], ['Interstitial lung diseases', 'radiological lung features'], ['', 'fibrotic disease progression'], ['immune fibrosing overactivity', 'fibrosis'], ['However  subgroup', 'similarly lung IPF'], ['It', 'molecular IPF ILDs pathways'], ['One', 'individual lung progression'], ['we', 'autoimmune  features'], ['installed  capacity', 'cooling energy heating'], ['paper', 'CCHP dispatch power'], ['security constraints', 'optimal dispatch model'], ['natural pipeline flow equation', 'natural gas pipelines'], ['objective  function', 'total operation IES'], ['Then  model', 'MILP computation efficiency'], ['Numerical case studies', 'proposed wind power integration'], ['', ''], ['rights', ''], ['associated IFIT1 expression', 'previous SLE studies'], ['Therefore  we', 'pathological IFIT1 changes'], ['MRL lpr mice', 'present c study'], ['Quantitative analysis', 'protein Complement C3'], ['HE', 'renal TEM tissue'], ['Significant  elevation', 'same lpr age'], ['Staining', 'cellular basement membrane thickening'], ['optical  density', 'inversely F actin Nephrin'], ['summary IFIT1 expression', 'glomerular podocytes filtration'], ['proper gate control strategy', 'insulated gate bipolar efficient'], ['key back control issues', 'back control strategy'], ['paper', 'high power IGBT'], ['It', 'electromagnetic voltage transient'], ['collector', 'real  time'], ['detected analog signal', 'digital  board'], ['algorithm', 'forward gate drive resistance'], ['control stability', 'result'], ['detection  process', 'only  nanoseconds'], ['proposed control method', 'high  reliability'], ['Experimental  results', 'back digital control method'], ['CCS carbon technologies', 'global  warming'], ['paper', 'short term future'], ['different power generation technologies', 'CCS'], ['Process simulation', 'commercial CCS system'], ['', '9 % USC'], ['', '7 % IGCC'], ['ready  USC', 'levelized electricity 38'], ['', 'lower  43'], ['IGCC', 'CO2-free 59'], ['', '63'], ['', 'USC'], ['commercial scale applications', 'levelized CCS electricity'], ['', ''], ['kind', 'key  parameters'], ['', ''], ['fuel', 'international CCS technologies'], ['Therefore sensitivity analysis', 'economic  plant'], ['', ''], ['rights', ''], ['Lymphocyte differentiation', 'foreign effector substances'], ['cellular  it', 'lifelong effector immunity'], ['binding transcription that', 'cellular specialization expansion'], ['promoting transcription factors', 'basic  immunology'], ['mechanisms', 'immune cell base'], ['Here  I', 'earliest lymphocyte homeostasis'], ['member', 'angiogenic  effects'], ['', 'regulatory mouse models'], ['IL-27', 'human cancer cells'], ['IFN gamma', 'ovarian cancer cells'], ['smaller concordant number', 'concordant cytokines'], ['regulated  proteins', 'IFN gamma'], ['functional  analysis', 'viral protein levels'], ['I', 'low tumor expression'], ['IL-27', 'homozygous B2 M gene'], ['broad IFN which', 'common STAT1 pathway'], ['data', 'immune  regulation'], ['Accumulated  data', 'many modulatory colitis'], ['critical  modulator', 'adaptive  autoimmunity'], ['induced  which', 'Th2 Treg switch'], ['novel  IL-33', 'induced primes colitis'], ['polarized  effect', 'increased Th2-type cytokines'], ['', 'IL-33-treated TNBS colitis'], ['adoptive  transfer', 'treated disease mice'], ['induced  which', 'closely AAM polarization'], ['that', 'mainly T cells'], ['IL-7', 'immune cell arrest'], ['far  it', 'direct  cancer'], ['review', 'neoplasia'], ['problem', 'special image encryption scheme'], ['Image encryption scheme', 'network order Henon system'], ['initial  conditions', 'order Henon mapping'], ['chaotic  Y', 'CNN system'], ['last cipher image', 'random sequence Y'], ['simulation algorithm', 'information entropy information correlation'], ['IC  which', 'voltage circuit ROIC'], ['which', 'fixed pattern noise'], ['variable gain amplifier', 'high voltage sensitivity'], ['output characteristic', 'proposed  device'], ['mV  K', ''], ['', ''], ['HSPICE chip', 'Microelectronics Corporation Japan'], ['simulation', 'close measurement results'], ['what', 'Fritz tension'], ['disconnect', 'audible'], ['imagery rescripting', ''], ['psychological meta that', 'aversive  memories'], ['Relevant  publications', 'Medline Science'], ['social anxiety disorder', 'dysmorphic  disorder'], ['ImRs', '4'], ['', ''], ['ImRs', 'overall follow sample'], ['', ''], ['', ''], ['comparison', 'large effect size'], ['', 'posttreatment'], ['Finally  effects', 'aversive comorbid imagery'], ['post  findings', 'controlled  trials'], ['ImRs', 'small  session'], ['', ''], ['rights', ''], ['fictional  morality', 'fictional  which'], ['much  one', 'self report scale'], ['1  we', 'related Imaginative Resistance structure'], ['', 'large  sample'], ['2  we', 'imaginative  IRS'], ['IRS scores', 'related  measures'], ['results', 'future  research'], ['', ''], ['rights', ''], ['Phagocytes', 'acute  inflammation'], ['This', 'associated tissue pathology'], ['Imaging flow cytometry', 'morphometric cell analysis tools'], ['integrative  that', 'acute phagocyte inflammation'], ['We', 'cellular quantitative markers'], ['characterization', 'other animal models'], ['However  it', 'apoptotic inflammation control cells'], ['', 'C Elsevier Inc'], ['Regulation', 'distinct  stages'], ['Previous  research', 'core transcription vivo'], ['individual  TFs', 'single gene cell'], ['Direct  observation', 'ideal copy problem'], ['Research', 'molecular imaging transcription'], ['advanced cell imaging', 'fixed transcription cells'], ['hit transcription that', 'vitro biochemistry analysis'], ['key  question', 'single  cells'], ['technical  advancements', 'single copy vivo'], ['review article', 'recent  challenges'], ['', ''], ['rights', ''], ['proportion', 'classes'], ['Classification performance', 'existing class distribution imbalance'], ['minority which', 'minority classes'], ['ensemble classification method', 'imbalance classification problem'], ['classification rule', 'random boosting scheme'], ['experimental  RHSBoost', 'attractive imbalance data'], ['', ''], ['', ''], ['rights', ''], ['yet migration which', 'coping  strategies'], ['2009 Community Health Survey', 'high life stress'], ['Separate  models', 'comparative  purposes'], ['results', 'socioeconomic life stress'], ['areal  effect', 'CMA life immigrants'], ['When  comparing', 'high life immigrants'], ['partially  immigrants', 'recent  arrivals'], ['areal  effect', 'individual stress predictors'], ['classical chemical which', 'usually  byproducts'], ['why  enzymes', 'analytical  chemistry'], ['', 'physiological  conditions'], ['long  it', 'activity'], ['correctly  enzymes', 'more  denaturation'], ['approach', 'particular Immobilized Enzyme microfluidic'], ['various  types', 'mu IMERs'], ['Particular  attention', 'capillary immobilization format'], ['', ''], ['', ''], ['rights', ''], ['driven stewardship program', 'ideal body weight'], ['primary  objective', 'medical stewardship center'], ['This', '2013  December'], ['patients', 'defined study period'], ['assessed', 'driven medication approval'], ['primary end point', 'indication weight'], ['Secondary end points', 'IVIG guideline nonadherence'], ['total', '418 study time frame'], ['top  indications', 'bone marrow transplantation'], ['', ''], ['', '8  thrombocytopenia'], ['', ''], ['', '12  patients'], ['9  %', 'IVIG prescribing guideline'], ['', ''], ['5  %', 'prescribed  indication'], ['9  %', 'nonadherent  guideline'], ['total', '26033 study period'], ['IVIG stewardship program', 'medical guideline center'], ['', ''], ['zootechnical  wellness', 'several tract tissues'], ['potential OTC toxicity', 'human food chain supply'], ['', 'such literature toxicity'], ['', ''], ['Here  we', 'precipitation blot analysis'], ['', ''], ['peripheral blood mononuclear cells', 'vitro lysine OTC'], ['changes', 'increased  Interferon'], ['', ''], ['data', 'human  PI3MC'], ['OTC presence', 'human animal health'], ['Harnessing', 'new cancer therapy'], ['sipuleucel T Yervoy CTLA-', 'research cancer immunotherapy'], ['clinical  trials', 'metastatic antigen cancer'], ['Current  success', 'cancer antigens'], ['engineered T cell immunotherapy', 'solid  cancer'], ['NY ESO-1', 'solid  cancer'], ['50 checkpoint blockade %', 'cancer therapy'], ['advent', 'broader cancer patients'], ['we', 'derived cancer immunotherapy'], ['immune  ITP', 'immune  thrombocytopenia'], ['present  we', 'peripheral ITP patients'], ['Platelet autoantibodies', 'GPIb MAIPA method'], ['regulating  effect', 'Th agomir'], ['expression', 'miR-146a ITP controls'], ['cells', 'significantly ITP controls'], ['expression levels', 'negatively Th17 cells'], ['expression', 'positively Treg cells'], ['significant  correlation', 'miRNAs  expression'], ['miR-146a  expression', 'ITP patients'], ['Moreover  miR-146a', 'ITP vitro'], ['related ITP miR-146a', 'Tregs differentiation'], ['', 'immune  axis'], ['longer blood brain barrier', 'CD39 adenosine CD73'], ['that', 'systemic lupus erythematosus'], ['specialized  that', 'specialized  structure'], ['Two  examples', 'intracellular Hu Yo encephalitis'], ['multiple T cell paradigm', 'particularly aquaporin Thl'], ['neurologic  we', 'immune  cells'], ['', ''], ['rights', ''], ['symbiotic  that', 'immune  tolerance'], ['where  balance', 'ecological  relationships'], ['which', 'now  communities'], ['ontological  basis', 'profound  change'], ['biological metaphysics undergirding philosophy', 'ecological  dialectics'], ['mature CD56dn NK cells', 'TFR success'], ['major  goal', 'immune TFR success'], ['immune  system', 'parasitic  diseases'], ['Immunological  mechanisms', 'mediated  disease'], ['Immunological  variation', 'defense mechanisms'], ['particular  that', 'immune  function'], ['SNPs', 'asthma periodontal diabetic retinopathy psoriasis'], ['related  alterations', 'immune  system'], ['large  differences', 'widely influenza virus studied'], ['mechanism', 'infectious disease models'], ['immune  system', 'induced  infection'], ['adaptive pattern recognition immunity', 'clear  infection'], ['that', 'eukaryotic cell death programs'], ['which', 'other host pathogens'], ['Mitochondria', 'immune  pathogens'], ['innate sensing that', 'sterile  conditions'], ['Several  lines', 'molecular  inflammation'], ['Mitochondrial function', 'inflammatory  inflammasomes'], ['mitochondria', 'metabolic  reprogramming'], ['', ''], ['rights', ''], ['intracellular that', 'mammalian  cells'], ['peptides', 'nuclear  proteins'], ['Proteasome inhibition', 'human cell lines'], ['functional peptide significance', 'intracellular peptide profile'], ['expression', 'labeling spray mass spectrometry'], ['VGSELIQKY', 'regulatory 19S subunit'], ['HeLa that', 'interferon control cells'], ['EL28', 'chymotrypsin trypsin'], ['penetrating  EL28', 'CD8 T cells'], ['penetrating peptide construct', 'high antibody responder mice'], ['intracellular  that', 'interferon gamma activity'], ['functional  identification', 'limited  cells'], ['', ''], ['', ''], ['rights', ''], ['aim', 'prophylactic Salmonella Typhimurium infection'], ['Methods', 'vitro Thirty criteria'], ['Pediococcus pentosaceus', 'probiotic Salmonella infection'], ['', 'intragastric  Ped'], ['', '10(6 Salmonella Salm'], ['Typhimurium', 'clinical weight Salmonella'], ['Pediococcus pentosaceus', 'small TNF intestine'], ['usual  criteria', 'functional  properties'], ['probiotic  strain', 'Ped'], ['#  40', 'experimental  mice'], ['prophylactic  effectiveness', 'precise health claims'], ['Flow cytometry', 'such size 0'], ['', 'several  diameter'], ['forward sideward it', 'respective  structures'], ['Using', '1)-loaded pollen 0'], ['', 'inhalable particulate matter'], ['', ''], ['extracellular  traps', 'infectious neutrophil stimuli'], ['component', 'immune disease autoimmunity'], ['protocol', 'simple microplate fluorescence assay'], ['Blood', 'conventional venipuncture techniques'], ['Neutrophils', 'dog blood'], ['', 'such well plate phorbol-12-myristate-13-acetate'], ['DNA release', 'impermeable nucleic acid dye'], ['assay', 'alternative cell methods'], ['which', 'cellular proliferation migration'], ['therefore energy studying', 'overall  cells'], ['extracellular flux analyzer', 'many cell types'], ['comprehensive  protocol', 'particularly  lymphocytes'], ['fragile  that', 'poorly ex vivo conditions'], ['subsets', 'low cell numbers'], ['that', 'difficulties'], ['that', 'extracellular flux analyzer'], ['metabolic  activities', 'different cell densities'], ['thus cell it', 'immune  cells'], ['activated cell sorting', 'specific flow cytometry'], ['researchers', 'other cell cells'], ['MCS cell FACS', 'more flow cytometry'], ['simultaneously cell which', 'experiments'], ['it', 'functional vivo settings'], ['protocol', 'functional bone pDC'], ['spatial T cell that', 'western flow blotting'], ['quantification', 'high flow affinity'], ['adequate  handling', 'necessary culture fluorescence'], ['we', 'naive GD2 ganglioside CD4(+'], ['GM2 gene analysis experiments', 'low input RNA kits'], ['Autoimmune  diseases', 'immunological self tolerance'], ['Regulatory T cells', 'immunologic self tolerance'], ['Tregs', 'peripheral cell blood'], ['functional  which', 'autoimmune  diseases'], ['Here  we', 'Ag)-specific iPSCs'], ['', ''], ['', ''], ['method', 'then Notch 1'], ['', 'specific Ag stimulation'], ['method', 'autoimmune murine model'], ['induced AIA)bearing mice', 'joint bone loss'], ['immune  that', 'specific  autoimmunity'], ['Many  approaches', 'different T cell development'], ['However  studies', 'cellular mouse systems'], ['genetic  approach', 'primary helper T cells'], ['relative  it', 'molecular  biology'], ['multiple  genes', 'readily helper T action'], ['We', 'different helper subsets'], ['Finally  use', 'uncovering T cell development'], ['ribosomal spacer', 'resolving genotyping S'], ['that', 'routine  purposes'], ['miniaturized electrophoresis system', 'best resolution data evaluation'], ['here electrophoresis assignment', 'genotype'], ['they', 'standard PCR machine'], ['PCR cycling', 'prolonged  ramping'], ['MLST DNA what', 'high  throughput'], ['', 'Furthermore bovine S'], ['aureus', 'as spa MLST'], ['PCR data base', '141  genotypes'], ['method', 'highly gene pattern S'], ['aureus', 'bovine mastitis'], ['', ''], ['aureus', 'large herds Switzerland'], ['other  genotypes', 'individual  cows'], ['Genotyping', 'pathogenic RS S'], ['', 'veterinary  medicine'], ['high  goal', 'easily RS S'], ['', 'other  laboratories'], ['Dendritic  cells', 'thereby cell immunity'], ['major  function', 'adaptive T lymphocytes'], ['Therefore  DCs', 'lymph infection'], ['derived DC vaccination DCs', 'vitro DC vaccination strategies'], ['cells', 'dendritic physiology cells'], ['stimulating granulocytemacrophage factor', 'healthy GM donors'], ['how  monocytes', 'mononuclear cell density gradient centrifugation'], ['Human monocytes', '5  incubation'], ['Lymphocyte proliferation', 'useful  immunomodulatory'], ['', ''], ['', ''], ['blastogenic cell volume', 'division'], ['It', 'several T lymphocyte stimulation'], ['Here  we', 'automated cell counter'], ['Various', 'cellular population population'], ['direct cell that', 'mitogens  vitro'], ['Breakdown', 'multiple blood brain sclerosis'], ['process', 'main brain BBB'], ['However  consequences', 'such T cells'], ['that', 'MBMEC T time'], ['use', 'electrical EC monolayer resistance'], ['naive T cells', 'EC monolayer Ccl'], ['', 'continuous EC monolayer fashion'], ['different T cell it', 'pharmacological cell EC reagents'], ['technique', 'vitro T cell transmigration'], ['it', 'physiological BBB conditions'], ['functional  which', 'such host defense'], ['immune  serum', 'functional  readouts'], ['readily  that', 'immune host B cells'], ['B cell subsets', 'conjugated flow cytometry'], ['naive  cells', 'culture'], ['that', 'singlecell blotting level'], ['ELISpot assay', 'large blood samples'], ['peripheral B employment', 'IgM IgG ASCs'], ['pMHC I pMHC tetramers', 'invaluable  CD8(+'], ['labeled I tetramers', 'CD8(+ vitro stimulation'], ['color I tetramer staining', 'CD8(+ stage memory phenotype'], ['especially T cells', 'AIDS'], ['Experimental  infection', 'cellular AIDS virus'], ['considerable  progress', 'animal model'], ['Here  we', 'CD8(+ rhesus macaques'], ['simultaneous T cell which', 'specific T cell vaccination'], ['biomedical nonhuman methodology', 'multiple disease settings'], ['Regulatory T cells', 'autoimmune self diseases'], ['Clinical  approaches', 'first  outcomes'], ['number', 'induced Treg Tregs'], ['date', 'specific protein Tregs'], ['induced  protocols', 'human  cells'], ['protocol', 'only retinoic acid parallel'], ['It', 'also flow cytometry'], ['protocols', 'certain FOXP3-regulatory factors'], ['iTregs', 'molecular Treg induction'], ['large cell that', 'large cell numbers'], ['limitation', 'relative FOXP3 nTregs'], ['suppressive  iTregs', 'suppressive retinoic activity'], ['use', 'appropriate  controls'], ['Bacterial  biofilms', 'metabolic cooperation competition'], ['study', 'environmental science food production'], ['few  studies', 'partially  them'], ['Most', 'epithelial biofilm cells'], ['often vivo technology', 'three hyphal networks'], ['we', 'fungal hyphal colonies'], ['we', 'LSCM electron microscopy'], ['report', 'microorganism cultures'], ['external  which', 'also pathogens allergens'], ['immune  system', 'inhaled  antigens'], ['dendritic  cells', 'inflammatory  response'], ['more  studies', 'healthy lung tissue individuals'], ['healthy lung tissue that', 'endobronchial  biopsies'], ['small  biopsies', 'advanced flow cytometric analysis'], ['outlined  protocols', 'low state DCs'], ['methods', 'immune mucosal lung tissue'], ['where  bronchoscopy', 'pulmonary  disease'], ['number', 'immortalized cell lines'], ['We', 'powerful B LCLs'], ['method', 'little blood cell 0'], ['immortalized cell which', '100 % success rate'], ['method', 'clinical  samples'], ['Reporter mice', 'targeted  genes'], ['protocol', 'new reporter mouse model'], ['where  it', 'inflammation'], ['Reporter systems', 'other  vivo'], ['', 'then  vitro'], ['which', 'drug  it'], ['they', 'so  vivo'], ['fluorescent protein', 'producing  vivo'], ['Fluorescent producers', 'then flow cytometry'], ['artificial  that', 'gene'], ['engineered  chromosome', 'then mouse genome'], ['Homeostatic reporter expression', 'spleen flow cytometry analysis'], ['Colitis', 'transfer T expression'], ['then lymph they', 'small lamina intestine'], ['good IL-22 it', 'knock  procedures'], ['stimulation', 'invertebrate  immunity'], ['pathogenic  particles', 'immune  effectors'], ['here melanization Anopheles', 'here melanization mosquito'], ['melanization response', 'dark  melanin'], ['response mosquitoes', 'microcapillary glass tubes'], ['24  mosquitoes', 'beads'], ['degree', 'image analysis software'], ['Beads', 'immune  response'], ['injections', 'such life fecundity'], ['directly host parasite it', 'interesting  immunity'], ['well T lymphocytes', 'several cardiovascular diseases(12345'], ['hypertension', 'experimental T hypertension(6'], ['several  that', 'vascular  vasoconstriction'], ['cardiovascular  it', 'present T cell tissues'], ['transcription they', 'surface cytokines'], ['flow cytometry', 'invaluable  tissues'], ['Here  we', 'induced angiotensin hypertension'], ['following  steps', 'single stimulation fixation permeabilization'], ['fundamental  principles', 'proper flow cytometric controls'], ['Monoclonal  antibodies', 'widely  biomedicine'], ['Nevertheless  generation', 'complicated  alternatives'], ['aim', 'monoclonal hybridoma technology'], ['technology', 'two  steps'], ['Step', 'such antibody molecules'], ['generated hybridoma cells', 'monoclonal culture supernatant'], ['supernatants', 'immunosorbent antigen specificity'], ['appropriate cell cells', 'large antibody amounts'], ['purification', 'routinely affinity chromatography'], ['antibody molecule', 'final test application'], ['high  antibody', 'desired test system'], ['full thickness skin transplantation', 'alloimmune vivo response'], ['', 'widely transplantation research'], ['it', 'microsurgical  techniques'], ['Moreover graft rejection', 'direct  inspection'], ['secondary skin transplantation', 'specific transplant tolerance'], ['complications', 'respiratory anesthesia procedure'], ['Graft failure', 'inappropriate graft bandage'], ['we', 'successful thickness skin procedure'], ['Neutrophils', 'phagocytic  pathogens'], ['They', 'constitutively  apoptosis'], ['inflammatory  they', 'potent antimicrobial killing'], ['uncontrolled  they', 'surrounding  tissues'], ['however neutrophil versatility', 'plasticity  functions'], ['derived  which', 'stimulating growth factor'], ['therefore neutrophil they', 'largely neutrophil size'], ['neutrophils G phi', 'long  culture'], ['They', 'monocytic lineage markers'], ['They', 'opsonized  zymosan'], ['G phi', 'low density lipoprotein'], ['cultured  they', 'reactive oxygen species'], ['Additionally  phagocytes', 'coated light chain autophagy'], ['phagocytosis', 'development'], ['We', 'phagocytic  identification'], ['protocol', 'further G significance'], ['different gamma Fc', 'research  settings'], ['assay', 'whole blood mononuclear blood'], ['MMA', 'human  investigations'], ['monocytes', 'Fc'], ['', ''], ['gamma that', 'immune  responses'], ['red blood cells', 'subsequently Fc gamma monocytes'], ['', 'extravascular  hemolysis'], ['mediated vivo process', 'different  the'], ['clinical candidate that', 'engaging Fc drugs'], ['which', 'mammalian research ethics blood'], ['adequate MMA results', '24-h turnover time'], ['Cells', 'surrounding  media'], ['also  that', 'same  EVs'], ['that', 'them'], ['viruses', 'bulk  analysis'], ['high throughput that', 'regular flow cytometers'], ['Viruses', 'magnetic  surface'], ['captured  virions', 'other surface antigens'], ['resultant  complexes', 'conventional flow fluorescence'], ['method', 'small  vitro'], ['Here  we', 'extracellular Dengue bloodstream'], ['cells', 'usually  <'], ['', '05  lymphocytes'], ['researchers', 'rare  phenotype'], ['that', 'differentiated  daughters'], ['obvious  approach', 'activated cell sorting'], ['However  utility', 'electronic cell sorting'], ['magnetic B that', 'large starting cell populations'], ['method', 'such vivo antigen autoimmunity'], ['Human CD8', 'important tumor control'], ['expressed T cell receptor', 'derived leukocyte peptides'], ['However  we', 'sub optimally tumor antigens'], ['targeted  that', 'shortcomings'], ['molecular  understanding', ''], ['we', 'how  TCRs'], ['methods', 'pHLA T multimers'], ['how  modifications', 'cell antigen recognition'], ['findings', 'new cancer therapies'], ['intestine', 'immune lamina cells'], ['All', 'intestinal antimicrobial host defense'], ['Therefore  identifying', 'vitro  setting'], ['vitro  studies', 'normal crypt organoid intestine'], ['how organ culture system', 'host defense responses'], ['representative  we', 'exogenous IL-1 beta'], ['antimicrobial effector molecules', 'efficiently organ vitro'], ['approach', 'immune  responses'], ['Fluorescence correlation spectroscopy', 'temporal  resolution'], ['FCS', 'labeled cell membrane'], ['technique', 'steady plasma state'], ['', ''], ['', 'actual measurement time'], ['that', 'endogenous  proteins'], ['straightforward  method', 'primary cell membrane lymphocytes'], ['commonly  acquisition', 'commonly  observations'], ['photostable fluorescent that', 'extensively  measurements'], ['diffusing  which', 'common cell membranes'], ['analysis procedure', 'generated autocorrelation curves'], ['FCS it', 'molecular diffusion rates'], ['Human noroviruses', 'epidemic  gastroenteritis'], ['most  infections', 'important norovirus outbreaks'], ['We', 'hard macrofoam surfaces'], ['', 'antistatic virus recovery'], ['', ''], ['', '700 toilet seat cm(2'], ['protocol', 'viral spin columns'], ['', 'total'], ['where norovirus gastroenteritis', 'RT qPCR'], ['', '29'], ['', ''], ['it', 'also remediation strategies'], ['specific  restriction', 'biological development gene viruses'], ['however  they', 'many virus attenuation'], ['many exhibit size that', 'genetic targeting methods'], ['coding  that', 'complementary messenger degradation'], ['microRNA  signatures', 'many  biomarkers'], ['specific  that', 'specific  cells'], ['', 'viral gene expression'], ['that', 'corresponding  microRNAs'], ['targeted  that', 'vitro'], ['however replication modification', 'different virus titration viruses'], ['immune  system', 'first  defense'], ['Better  knowledge', 'different  HIV'], ['T cells', 'gamma T cell chains'], ['known cytotoxic T that', 'alpha beta TCRs'], ['GD T cells', 'specific  epithelium'], ['GD T cells', 'surveillance infectious tumor surveillance disease'], ['Here  we', 'intraepithelial GD T lymphocytes'], ['We', 'endocervical HIV Infection Study'], ['clinical mucosal vulnerability', 'vaginal  microbicides'], ['addition knowledge', 'infectious GD diseases'], ['antibiotic  understanding', 'resulting  host'], ['Antibiotics', 'often microbial community composition'], ['Many  diseases', 'disrupted bowel microbiota'], ['complex  interplay', 'tractable host microbiome interactions'], ['freshwater vertebrate freshwater fish', 'microbial host community'], ['Methods', 'osmotic gut motility'], ['techniques', 'rapid host phenotypes'], ['High throughput screening', 'biochemical chemical reactions'], ['innovative drug which', 'resurgent  HTS'], ['oncology field', 'related immunomodulatory complications'], ['Here  we', 'new immunomodulatory compounds'], ['transgenic Nur77 promoter', 'T cell receptor stimulation'], ['target assay', 'biological  responses'], ['4398 target which', 'potential immunomodulatory activities'], ['drug discovery programs', 'prior vivo validation studies'], ['they', 'inflammatory  fashion'], ['ability', 'therapeutic  target'], ['We', 'small modeling molecules'], ['IRF5D', 'tight skin mouse'], ['K d', 'recombinant  IRF5'], ['', ''], ['', 'binding biolayer interferometry experiments'], ['EC  proliferation', 'increasing  IRF5D'], ['Tsk/+ mice', '21 d d'], ['IRF5  expressions', 'IRF5D  treatment'], ['Endothelial  function', 'IRF5D treatment'], ['', 'factor IRF5 nucleus'], ['Translocation', 'cardiac extracellular matrices'], ['IRF5D treatment', 'positive IRF5D treatment'], ['important  IRF5', 'Tsk/+ mice'], ['liver', 'systemic  inflammation'], ['', 'acute phase reactants'], ['Experimental  tools', 'chronic kidney disease'], ['isolated  hepatocytes', 'acute phase response'], ['high technique reproducibility', 'easily screening approach'], ['primary murine we', 'inflammatory  ELISA'], ['NK cell cytotoxicity', 'outside NK cell function'], ['However  accuracy', 'experimental NK manipulation'], ['that', 'minimum'], ['4 time that', 'intense  exercise'], ['First NK cells', 'one CD56 milliliter'], ['sorted NK cells', 'reagent  antibodies'], ['They', 'accurate NK cell blood'], ['1 imaging flow that', 'such  doublets'], ['workflow', 'human  samples'], ['available research teams', 'several time integrity'], ['Lipid analysis', 'broad layer lipids'], ['', 'lipids'], ['', ''], ['', 'cellular host processes'], ['Here  we', 'high performance liquid chromatography'], ['aim', 'neutrophil extracellular traps'], ['NET release', 'host defense host'], ['human  neutrophils', 'lipid M beta cells'], ['beta CD treatment', 'significant cholesterol cell'], ['same beta CD treatment', 'immunofluorescence microscopy'], ['here  we', 'detailed lipid NETs'], ['neutralizing  that', 'drugs'], ['simple  that', 'monoclonal linear antibody'], ['Here  authors', 'neutralizing virus coat mAb'], ['technique', 'synthetic polyvinylidene fluoride'], ['minimum antigenic region', '6-mer peptide epitope'], ['alanine scanning mutagenesis', 'binding amino acid epitope'], ['residues', 'critical peptide conformation regulation'], ['identified epitope peptide', 'functional diffraction therapeutics'], ['important  feature', 'rapidly pathogen Staphylococcus antibiotics'], ['Genomic studies', 'that'], ['horizontal gene transfer', 'critical  S'], ['', ''], ['', 'full  S'], ['natural  which', 'recently  bacterium'], ['three  that', 'vitro  S'], ['', ''], ['Streptogramin phenotype', 'Lincosamides Oxazolidinones Pleuromutilins'], ['', 'which'], ['aureus', 'spreading surveillance future'], ['immune macrophages that', 'other  inflammation'], ['humoral  mechanisms', 'therapeutic  potential'], ['inflammatory  pathway', 'potent  manner'], ['that', 'vagus  pathway'], ['methodology', 'such heart rate variability'], ['now  it', 'laboratory'], ['goal', 'potential  CAP'], ['earlier  we', 'enzymatic metabolism properties'], ['inflammatory time sacrifice', 'purposes'], ['', ''], ['', 'inflammatory  responses'], ['vagus nerve which', 'inflammatory  responses'], ['Additionally  we', 'mechanistic  spleen'], ['Systemic lupus erythematosus', 'autoimmune  immunopathogenesis'], ['regulatory T cells', 'T protection'], ['Recently  we', 'characteristic forkhead box protein'], ['Studies', 'RORt(+)FoxP3(+ T regs'], ['functional  nature', 'name biT(regs'], ['biT(reg  effects', 'RORt'], ['We', 'therapeutic RORt activation'], ['analyses', 'organ pattern autoimmunity'], ['specific  ablation', 'pulmonary RORt vasculitis'], ['secretion', 'fl  mice'], ['Furthermore T regs', 'specific  RORt'], ['', 'dependent  manner'], ['study', 'therapeutic  strategies'], ['MHCII processing pathway', 'CD4 presents cells'], ['CD4 glycopeptide structures', 'cases'], ['Here  we', 'only melanoma cell lines'], ['we', 'different  glycoforms'], ['complex  glycopeptides', 'regions'], ['bonded MI This', 'novel tumor immunoevasion'], ['p38 protein mediates', 'environmental  stress'], ['p38  isoforms', 'adaptive  immunity'], ['p38 Murine T isoform', 'elevated cell isoform'], ['T cells', 'simultaneously lymphoid atrophy'], ['naive T cells', 'appropriate inducing conditions'], ['Pharmacological  inhibition', 'therapeutic signaling applications'], ['Acute  pancreatitis', 'systemic inflammatory response'], ['inflammatory  response', 'acute  pancreatitis'], ['mild  presenting', 'three symptom onset'], ['Peripheral  blood', 'healthy cytokine controls'], ['Th1/ Bead Array assay', 'FCAP Array software'], ['3 IL17A levels', 'significant  day'], ['IFN gamma', 'time points'], ['inflammatory  cytokines', 'T day'], ['which', 'significantly time points'], ['systemic  inflammation', 'Th1  response'], ['cutaneous  leishmaniasis', 'healing  CL'], ['Th1 T cells', 'important  disease'], ['molecular  that', 'Th1  NHCL'], ['observational  study', 'five  groups'], ['first  groups', 'healing comprise CL'], ['recovered  who', 'CL'], ['who', 'fourth endemic group'], ['hyperendemic none', 'CL'], ['aim', 'other NHCL groups'], ['leishmanin skin test', 'Leishmania infection'], ['', 'peripheral blood mononuclear ELISA'], ['C IL-17a gene expression', 'flow cytometry'], ['IL-12B mutation analysis', ''], ['IL-12B  which', 'persistent  CL'], ['expected  results', 'NHCL'], ['study', 'ethical  committee'], ['final  results', 'reviewed  journals'], ['Advances', 'uncommon practice disorders'], ['We', 'associated killer cell albinism'], ['Advances', 'secondary light hypogammaglobulinemias'], ['primary  outcomes', 'hematopoietic stem cell transplantation'], ['syncytial  virus', 'particularly  children'], ['Much  information', 'vitro animal studies'], ['Here  we', 'infected literature humans'], ['strong RSV which', 'interleukin-8 disease IL-'], ['Dendritic  cells', 'presenting  cell'], ['systemic T cell lymphopenia', 'viral T cell clearance'], ['RSV IgG', 'reinfection'], ['stimulating  factors', 'protective antibody generation'], ['Gamma interferon', 'protective IFN role'], ['particularly  chemokines', 'immune IFN pathogenesis'], ['harmful T cells', 'protective IFN roles'], ['These', 'therapeutic RSV infection'], ['We', 'biochemical  species'], ['experimentally  that', 'negatively impact phenomenon'], ['generic  properties', 'biochemical  adaptation'], ['surprisingly  antagonism', 'independently ligand concentration'], ['Thus  antagonism', 'necessary by phenotype'], ['where antagonism strength', 'detection threshold'], ['where  antagonism', 'simpler  models'], ['phenotypic spandrel', 'immune decision TCRs'], ['Vaccination', 'medical  procedure'], ['now  that', 'empirical  Pasteur'], ['that', 'pertinent  scourges'], ['we', 'biology  research'], ['ability', 'immune cell surface receptors'], ['immune surface receptor cell', 'stem cell'], ['VDJ recombination that', 'young  adult'], ['We', 'dramatic  diversity'], ['statistical recombination we', 'immune time system'], ['also  us', 'statistical VDJ recombination process'], ['nearly  analysis', 'proper TCR receptor protein'], ['laboratory it', 'repertoire'], ['immune PD system', 'small molecule drugs'], ['respond', 'immunooncology drugs'], ['', ''], ['', ''], ['third immuno oncology drugs', 'inhibitory II compounds'], ['', ''], ['TIM-3', ''], ['', ''], ['CD40', ''], ['monoclonal  that', 'such checkpoint CTLA-4'], ['novel cancer therapy', 'immunologic  brakes'], ['however cell toxicity', 'clinical  trials'], ['numerous agent questions', 'patient dose schedule populations'], ['', 'new novel immunotherapy'], ['Here  we', 'evolving  field'], ['', ''], ['rights', ''], ['development', 'human immuno PCR antibodies'], ['sensitivity', 'same  antigen'], ['', 'cutaneous lymphoma lymphomas'], ['IP cell antigen that', 'cutaneous T cell lymphoma'], ['Therefore  we', 'possible lymphoma cells'], ['We', 'paired  specimens'], ['median', '12  case'], ['We', 'differential loss increase'], ['We', 'consecutive  biopsies'], ['gain', '7'], ['', '8  3'], ['', 'increased  4'], ['', '2  8'], ['', ''], ['Molecular analysis', '100 TCR patients'], ['', 'histopathologic IP features'], ['IP shifts', 'antigens'], ['IP shifts', 'clinical T cell correlates'], ['PCGD antigen modulation', 'pathogenesis'], ['neoplasm  studies', 'clonal identity'], ['assay', 'molecular biology fields'], ['severely  it', 'high throughput analysis'], ['Here  we', 'fast immunoprecipitation reaction'], ['FLIP', 'agarose fluorescent beads'], ['here  FLIP', 'high throughput analysis'], ['We', 'unknown IP procedures'], ['parallel  analysis', 'two  procedures'], ['unpurified hybridoma we', 'easy FLIP signals'], ['new  FLIP', 'high throughput IP'], ['', 'increased cells death'], ['immune  which', 'permanent  pathogens'], ['complement activity concentrations', 'great  tits'], ['sectional  birds', 'three  lives'], ['Three', 'immune  age'], ['However  shape', 'immune response parameters'], ['when  birds', 'early  life'], ['young  levels', 'increasing  age'], ['nitric oxide concentrations', 'age'], ['observed  differences', 'innate  immunity'], ['Unraveling', 'innate  immunity'], ['', ''], ['rights', ''], ['Treatment', 'multidisciplinary surgery radiotherapy'], ['Traditionally  patients', 'metastatic combination chemotherapies'], ['complete response responses', 'good response palliation'], ['field', '20 cancer years'], ['target cancer cells', 'immune  system'], ['ability', 'conventional cytotoxic chemotherapy'], ['small  number', 'durable  years'], ['we', 'genitourinary immunotherapy malignancies'], ['We', 'single immunotherapy combination'], ['attractive immunotherapy it', 'often tumor cells'], ['associated I MHC which', 'p53-specific T cells'], ['Interestingly  it', 'transduced T cells'], ['mutational cell antitumor we', 'A2(+)/p53(- p53 cells'], ['p53-specific T we', 'determined p53 expression intracellular'], ['We', 'mutant cell cycle dynamics'], ['selected p53 mutations', 'measured p53 protein levels'], ['Thus p53', 'when cancer p53'], ['ac impedance spectroscopy measurements', 'balancing impedance bridge'], ['top  analyzers', 'industrial field applications'], ['paper', 'balancing precision measurement bridge'], ['methods', 'balancing  bridge'], ['overall  design', 'digital  detail'], ['system', 'basic measurement 0'], ['', '20 Hz-2 MHz'], ['low measurement it', 'industrial field applications'], ['system', 'starter PTC thermistor'], ['Current  sources', 'health monitoring device'], ['current  source', 'high  accuracy'], ['typical measurement it', 'stray M capacitances'], ['Generalized impedance converters', 'stray impedance capacitances'], ['we', 'grounded  loads'], ['we', 'bandwidth Howland AD8021'], ['better  accuracy', '1  MHz'], ['operational circuit configuration', 'than  0'], ['', 'low  frequencies'], ['', ''], ['rights', ''], ['aim', 'high glucose concentrations'], ['effects', 'high osteoblast functions'], ['NMSLA MC3T3-E1 surface', 'normal  serum'], ['surface characteristics', 'electron microscopy'], ['Cell proliferation', 'MTT assay'], ['ALP  activity', 'alkaline  phosphatase'], ['Real polymerase chain reaction', 'osteogenic expression genes'], ['NMSLA', '7 time serums'], ['Cells', 'higher ALP activities'], ['2  I', 'notably SLA surface'], ['high  glucose', 'decreased  osteoblast'], ['structured titanium surface', 'diabetic  serum'], ['aim', 'implant bacteria microflora'], ['Twenty  implants', 'implant abutment connection'], ['implant  microflora', '30 paper s'], ['Real Polymerase chain time', '9 bacteria periodontal pathogens'], ['bacterial  count', ''], ['', ''], ['19', '1  2'], ['', ''], ['significant  differences', 'Group'], ['', ''], ['', ''], ['bacterial  colonization', 'high peri implantitis'], ['bacterial  colonization', 'lower peri implantitis'], ['clinical  parameters', '1 peri Group'], ['', ''], ['360 days implants', 'cemented peri connection'], ['present  study', 'binding protein eIF4E1'], ['which', 'restricted mRNA cap fashion'], ['25 kDa form', 'ovariectomized  animals'], ['23 kDa variant', 'early  implantation'], ['23 kDa form', 'eIF4E  proteins'], ['It', '21 N terminus'], ['progesterone', '23 beta kDa'], ['G', 'also  eIF4A'], ['1 4E G', 'binding  site'], ['where 4E BP1', 'altered eIF4E/4E BP1 conditions'], ['translational PABP initiation', 'particularly conceptus implantation'], ['Implicit  evaluations', 'associative attitude processes'], ['They', 'reflective  processes'], ['present  research', 'implicit rape case'], ['', ''], ['', ''], ['', 'rape case'], ['', ''], ['rape myth acceptance', 'explicit rape case'], ['', 'implicit Moreover evaluation'], ['explicit  effect', 'low  cognition'], ['', ''], ['who', 'effortful  processing'], ['discussion', 'decision  making'], ['article', 'alternative  field'], ['implicit theory that', 'literature'], ['certain  that', 'child molester cognition'], ['less  who', 'less  those'], ['scale', 'other reliability instruments'], ['predictive curve power', 'sexual  chance'], ['SWCH it', 'offending  schema'], ['', ''], ['hepatocyte', 'clear cell carcinoma'], ['HNF1 beta we', 'nuclear receptor Importin alpha'], ['beta(KKMRRNR235)-K-229 deletion sequence', 'nuclear  localisation'], ['We', 'biophysical Importin 2'], ['', '4 Importin alpha'], ['nuclear HNF1 interaction', 'nuclear import pathway'], ['', '2016 Molecular Biology'], ['', 'Elsevier Inc'], ['local  farmers', 'local seed conditions'], ['invaluable maize germplasm', 'rural  risk'], ['efficient  diversity', 'landrace populations'], ['minimum  that', 'situ  germplasm'], ['rare Puebla State that', 'native landrace crops'], ['based  strategy', 'molecular DNA biology'], ['continuous  monitoring', 'landrace populations'], ['methodology', 'traditional  cultivars'], ['Corneal  immunoimaging', 'immune resolution cells'], ['approach', 'slit lamp examination'], ['we', 'bedside ocular immunology research'], ['central murine us', 'ocular surface diseases'], ['biomarker', 'high interobserver agreement'], ['analyses', 'negative DC density'], ['corneal  nerves', 'directly  cornea'], ['Inbreeding', 'often  offspring'], ['inbred  individuals', 'outbred  conspecifics'], ['intestinal parasite loads', 'locus pedigree inbreeding heterozygosity'], ['however  correlation', 'when  f'], ['Such  findings', 'genetic effects burdens'], ['Indeed  we', 'certain parasite load'], ['multiple test they', 'future  strength'], ['banded  heterozygosity', 'better pedigree f'], ['inbreeding', 'wide facilitates linkage heterozygosity'], ['Finally  f', 'gastrointestinal  parasites'], ['heterozygous  individuals', 'banded parasite mongoose'], ['hot water energy consumption', '16 household heating 2013'], ['improvement', 'multifamily family buildings'], ['currently  lost', 'building solutions'], ['most  publications', 'detailed building data'], ['heat recovery potential', 'specific  inhabitant'], ['method', 'in heat recovery systems'], ['', 'load building specificities'], ['methods', 'residential optimisation buildings'], ['water heat recovery', '63 fuel %'], ['integrated  approach', 'single family houses'], ['', 'inhabitant heat recovery'], ['more water heat results', 'geographical building scope'], ['proposed  method', 'detailed heat recovery systems'], ['', 'C Elsevier Ltd'], ['purpose', '60 childhood abuse criminality'], ['Overall sample inmates', 'mental health problems'], ['common child neglect', 'emotional  abuse'], ['siblings', 'mental health problems'], ['Neuroimaging techniques', 'human brain health'], ['ultimate  goal', 'individualized brain imaging predictions'], ['generalized  that', 'multiple  modalities'], ['multiple regression which', 'based prediction methods'], ['gray resting DTI', 'cognitive regression scores'], ['', ''], ['', 'positive syndrome r'], ['7785', 'negative  r'], ['', ''], ['Moreover brain areas', 'potential parietal neuromarkers'], ['', 'clinical prediction measures'], ['current  results', 'decision brain imaging making'], ['', ''], ['rights', ''], ['Induced pluripotent stem cells', 'regenerative drug medicine'], ['However methods', 'skeletal  purposes'], ['Here  we', 'independent iPSC lines'], ['2 fibroblast growth we', '36 cell populations'], ['cells', 'medium  formulation'], ['We', 'hexanucleotide repeat expansions'], ['derived', '120 differentiation vitro'], ['study', 'lateral  sclerosis'], ['electronic  interface', 'inductive  sensors'], ['proposed  circuit', ''], ['circuit', 'internal  CFOA'], ['', 'Sinusoidal 122'], ['1  MHz', 'AD844 inductance'], ['', 'peak output voltage'], ['Industrial waste heat', 'future energy demands'], ['Depending', 'different temperature levels'], ['waste heat', 'different waste countries'], ['top  analyses', 'other waste heat countries'], ['bottom  approach', 'industrial waste heat Germany'], ['', 'German production companies'], ['81000 data sets', 'industrial waste heat'], ['German waste heat volume', 'industrial fuel consumption'], ['missing  share', 'data'], ['Exogenous oxytocin administration', 'human primate adults'], ['Risk factors', 'however  infancy'], ['when  plasticity', 'negative  outcomes'], ['oxytocin', 'social  adults'], ['we', 'cognitive  skills'], ['', ''], ['', 'briefly  information'], ['', ''], ['', 'reared macaque monkeys'], ['effects', 'males'], ['socially  oxytocin', 'only working males'], ['biased autism spectrum oxytocin', 'potential  treatment'], ['first  oxytocin', 'infant cognitive infant abilities'], ['behavioral  effects', 'sexually sex differences'], ['Oxytocin effects', 'other  sex'], ['screening  instruments', 'primary health care'], ['aim', 'emotional Cyprus Greece'], ['total', 'three screening application'], ['nine item screening tool', 'physical  abuse'], ['screening tool', 'three health countries'], ['they', 'questions'], ['questions', 'clinical  family'], ['', ''], ['screening tool', 'international face clinicians'], ['Individual  differences', 'such Autism Spectrum Disorder'], ['First Year Inventory', '12-month ASD diagnosis'], ['early  that', 'cognitive  development'], ['theoretical  we', 'based Social Attention'], ['database', 'completed  items'], ['consistency item distribution', 'confirmatory factor analysis'], ['Data analyses', '3  years'], ['behavioral FYI attention that', 'cognitive  skills'], ['elaborate  that', 'basic  method'], ['months  46', 'study'], ['basic method mothers', 'global  meal'], ['how  infants', 'when  meal'], ['positive  spoon', 'initial  spoons'], ['They', 'global  meal'], ['methods', 'familiar age range'], ['basic  method', 'difference'], ['elaborate  method', 'basic  method'], ['negative age behaviours', 'positive  behaviours'], ['elaborate  method', 'first  spoons'], ['', ''], ['rights', ''], ['directed  speech', 'prosodic voice features'], ['prosodic  features', 'positive infant affect'], ['present  set', 'two infant life'], ['results', 'better infant outcomes'], ['association', 'linguistic  outcomes'], ['insufficient  number', 'infant emotion expression'], ['Many  limitations', 'natural infant observations'], ['results', 'parental IDS competences'], ['so  contribution', 'influential  IDS'], ['', ''], ['rights', ''], ['Overall  analysis', 'high  morbidity'], ['we', 'inflammatory A549 cells'], ['Western blot analysis', 'inflammatory A549 cells'], ['knockdown', 'inflammatory cytokine activity'], ['Wnt factor kappa B', 'pathways'], ['FAK', 'therapeutic  disease'], ['young service system who', 'abuse'], ['young  who', 'abuse'], ['future  directions', 'literature'], ['human  papillomaviruses', 'cervical health women'], ['', 'potential prevention vaccination'], ['reviews', 'online Disease Control'], ['current Evidence knowledge', 'genital  men'], ['', 'genital anatomic lesions'], ['This', 'benign vaccination programs'], ['Patient  review', 'potential prevention vaccination'], ['', 'genital anatomic lesions'], ['', '2016 European Urology'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['Unravelling', 'molecular plant science'], ['Bacteria', 'own host benefit'], ['bacterial  manipulation', 'affected symptom plants'], ['Determining', 'microbiological host research'], ['bacterial  it', 'function'], ['straightforward  approach', 'Y2H  screen'], ['binding  that', 'sufficiently silico algorithm'], ['It', 'expressed host proteins'], ['causative  agent', 'phytoplasma'], ['protocol', 'molecular Y2H screen'], ['commonly  that', 'Y2H cost'], ['protocol', 'standard lab techniques'], ['demand', 'identified  microbes'], ['microbiology laboratory', 'infectious drug therapy'], ['infectious  it', 'cell tissue level'], ['ID it', 'well  microbiology'], ['Expertise', 'morphological  identification'], ['Moreover ID pathologists', 'situ  hybridization'], ['increasing  frequency', 'infectious pathology diseases'], ['this', 'cancer tumor tissue therapies'], ['we', 'surgical ID pathology'], ['intention', 'best ID pathology'], ['Infertility', 'social  issues'], ['', 'cervical Staphylococcus aureus'], ['majority', 'patients'], ['present  study', 'S'], ['', 'northwest  Iran'], ['', 'sterile vagina speculum'], ['performance', 'antibiotic methicillin resistance S'], ['', ''], ['urogenital  tracts', 'S'], ['', ''], ['', 'respectively  which'], ['5  patients', 'fungi'], ['', ''], ['Antibiotic susceptibility results', 'high  isolates'], ['results mecA sequences', '7'], ['encoding', 'clinical  strains'], ['', 'S'], ['aureus', 'infertile  women'], ['Therefore  it', 'thoroughly infertility infection'], ['when  biomaterial', 'human  body'], ['more  biomaterials', 'such contrast agents'], ['molecular mechanisms patterns', 'vast  phenomena'], ['conformational protein they', '3D ECM development'], ['especially biomaterials science', 'immune  system'], ['intraocular lens opacification leukocyte', 'intravascular incontinence stents'], ['induced NLRP3 this', 'clinical biocompatibility outcomes'], ['Inflammation', 'related macular degeneration'], ['Wogonin', 'inflammatory Scutellaria effects'], ['pharmacological  effects', 'AMD'], ['ARPE-19  cells', '50 mu LPS'], ['Transepithelial electrical resistance analysis', 'induced mu M changes'], ['RT immunofluorescence analyses', 'polymerase chain reaction'], ['nitric TNF alpha', 'wogonin'], ['wogonin', 'ARPE-19  cells'], ['novel  treatment', 'potential NF AMD'], ['patient tumor that', 'real life population'], ['MethodsWe', 'high sensitivity electrochemiluminescent assays'], ['Psychiatric  symptoms', 'Studies Depression Scale'], ['ResultsPlasma SAA', 'diagnostic out patients'], ['multiple scale that', 'related  items'], ['ConclusionsSAA', 'naturalistic patient setting'], ['glial  association', 'inflammatory mood disorders'], ['immune system adaptation', 'perinatal  depression'], ['inflammation markers', 'eight weeks postpartum'], ['', 'depressive postnatal depression scale'], ['', ''], ['', ''], ['', ''], ['228  controls', 'associated extension assay markers'], ['summary inflammation variable', ''], ['net Logistic regression analyses', ''], ['Forty markers', 'depressive symptoms postpartum'], ['difference', 'otherwise Bonferroni correction'], ['summary inflammation variable', 'depressive symptoms postpartum'], ['protein level findings', 'available methylation data'], ['explorative  approach', 'previously symptoms literature'], ['results', 'biological summary inflammation future'], ['', ''], ['', 'Elsevier Ltd'], ['Purpose', 'uveitis clinic population'], ['', ''], ['infectious uveitis who', 'medical National records'], ['macular  eye', 'neovascular Prevalence Research Group'], ['expected  number', 'large EDPRG estimates'], ['Results  We', 'infectious  uveitis'], ['0  %', 'gradable fundus photos'], ['Average  age', ''], ['', ''], ['5years', 'race  ethnicity'], ['Large  drusen', 'four  patients'], ['', ''], ['', '6'], ['', ''], ['patients', 'late  AMD'], ['large  which', 'age'], ['', ''], ['', '0'], ['', 'whole  cohort'], ['', ''], ['', '0'], ['', 'Hispanic  whites'], ['', ''], ['', '1'], ['', 'Hispanic  blacks'], ['Large drusen prevalence', 'Hispanic age whites'], ['racial  distribution', 'possible US population AMD'], ['systematic  study', 'greater  findings'], ['Kyrieleis retinal Purpose Kyrieleis periarteritis', 'intraocular  eye'], ['nine  cases', 'available  literature'], ['We', 'multimodal imaging findings'], ['Methods Charts', 'uveitis referral world'], ['Follow up', '12months'], ['arteritis', '25  study'], ['Nineteen  patients', ''], ['cytomegalovirus', 'toxoplasmosis retinochoroiditis'], ['angiography fundus autofluorescence', 'green  25/25'], ['OCT coherence scans', 'segmental Kyrieleis arteritis'], ['green  angiography', 'early  hypofluorescence'], ['increased SD OCT scans', 'segmental vessel wall'], ['quasi histologic Kyrieleis plaques', 'inflammatory  endothelium'], ['', 'neonatal prematurity morbidity'], ['different preterm that', 'inflammatory  response'], ['bacteria', 'immunological  factors'], ['us', 'underlying pathophysiologic processes'], ['', 'immunosuppressive  placenta'], ['derived  exosomes', 'immune  tolerance'], ['associated  that', 'common proinflammatory organs'], ['', 'menstrual inflammation cycle'], ['immune  fluctuations', 'conception'], ['', ''], ['', ''], ['sexually  women', 'most cytokine expression'], ['serum cytokines', 'reactive luteal protein'], ['Participants self', 'intercourse  study'], ['', ''], ['', 'naturally premenopausal women'], ['', ''], ['', 'total INF inflammation'], ['active  women', 'abstinent  women'], ['active women abstinent women', 'menstrual  CRP'], ['', 'IFN-7 midcycle IL-4'], ['inflammatory  that', 'subsequently midcycle inflammation'], ['', 'Reproductive Medicine'], ['therapeutic blood cell it', 'therapeutic blood cell arsenal'], ['clinical  manifestations', 'principally  nature'], ['general  feature', 'essentially  alloimmunization'], ['platelets blood that', 'inflammatory  mediators'], ['only  one', 'clear  role'], ['Inflammation', 'harmful  agents'], ['reaction', 'vascular  tissues'], ['inflammatory  response', 'evolutionary  process'], ['main  which', 'cellular blood elements'], ['phenomena', 'damaged defense areas'], ['interrelated  which', 'inflammatory  response'], ['', 'pathological dystrophy necrobiosis'], ['', 'physiological exudation phagocytosis'], ['Simultaneity', 'inflammatory  processes'], ['well influenza predictors', 'viral  shedding'], ['ObjectivesWe', 'confirmed Hutterite colony influenza'], ['MethodsA cohort study', 'Alberta Canada'], ['Flocked nasal swabs', 'symptomatic influenza influenza'], ['Samples', 'positive influenza samples'], ['viral shedding presence', 'viral  load'], ['younger  age', 'viral  AUC'], ['inapparent  infection', 'viral shedding duration'], ['ConclusionsPatterns', 'viral age sex symptoms'], ['Predictor variables', 'influenza subtype'], ['H9N2 Influenza subtype', 'economic  losses'], ['New mutations', 'directly  humans'], ['Effective surveillance tools', 'potential  species'], ['We', 'PCR H9N2 virus'], ['assay', 'virus'], ['specific  aptamers', 'high stringency protocol'], ['Next  panel', 'selected H9N2 virus'], ['aptamer', 'sensitive  sandwich'], ['3-log increase', 'low virus particles'], ['test', 'economic  regions'], ['', ''], ['', ''], ['rights', ''], ['Caregivers', 'loved constraints one'], ['sectional  study', 'associated Udupi District'], ['convenience sampling technique', '171 SPSS version'], ['', ''], ['Majority', 'caregivers'], ['', 'mean  38'], ['', ''], ['', ''], ['', ''], ['3 % caregivers', ''], ['2  %', 'biological  CLWHA'], ['Mild caregiver burden', 'Zarit Burden 84'], ['8  %', 'psychological General Health 49'], ['', ''], ['Relationship', 'relatives caregiver foster'], ['', ''], ['', 'child'], ['Alcohol', ''], ['', 'children'], ['', 'psychological  distress'], ['caregiver burden', 'psychological  CLWHA'], ['Psychological  problems', 'infected ART centres'], ['which', 'attentional  bias'], ['emotional  it', 'emotional  reactivity'], ['growing  number', 'active  groups'], ['VS  ABM', 'heightened training control anxiety'], ['bias interpretation bias', ''], ['Primary  outcomes', 'three months follow up'], ['stronger control who', 'more training sessions'], ['overall training reduction', 'emotional  resilience'], ['training', ''], ['online  ABM', 'heightened  symptoms'], ['', ''], ['', 'Elsevier Ltd'], ['infrared  thermometer', 'order'], ['contact body measurement', 'voice body temperature'], ['measurement error', 'acquisition'], ['5 C voice broadcast', 'liquid  temperature'], ['Infrastructure services', 'human  development'], ['drivers', 'global service scale'], ['paper', 'global water sanitation electricity'], ['panel we', 'key infrastructure services'], ['per  GDP', 'comparable income levels'], ['Much', 'population density'], ['Access levels', 'urban sanitation electricity'], ['', ''], ['rights', ''], ['major RNA element', '514  L1-mRNA'], ['Northern  we', 'major L1 DNA element'], ['', 'steady state mRNA'], ['efficient down regulation', 'undetectable  mRNA'], ['the down regulation', '5  element'], ['half  element', 'normal Fluc mRNA'], ['When  element', 'detectable state level'], ['RNA I', 'element'], ['inhibitory  mRNA', 'mediated mRNA maturation'], ['few prison researchers', 'gender relationship'], ['representative state we', 'prior inmate maladjustment'], ['violent  effect', 'depressive child symptoms'], ['effects', 'prior prison maladjustment'], ['Based', 'well findings nonstranger maladjustment'], ['aim', 'various crime substance abuse'], ['study', 'female  inmates'], ['findings', 'male childhood inmates'], ['female  inmates', 'male health inmates'], ['female  inmates', 'male family history inmates'], ['siblings', 'male substance inmates'], ['We', 'findings'], ['Growing  evidence', 'presenting  cells'], ['APCs', 'tolerogenic  immunology'], ['', 'prominent modulatory APCs'], ['MS T cell patients', '24 fingolimod months'], ['Impact', 'phagocytotic cytokine vitro'], ['CD8 T cell proliferation', 'also  vitro'], ['Fingolimod', 'peripheral slanDC count CD1'], ['T cell count', 'treated  time'], ['CD86', 'fingolimod'], ['S1P', 'inflammatory  vitro'], ['Fingolimod', 'phagocytic  slanDCs'], ['fingolimod slanDCs', 'treated T cell patients'], ['inflammatory  which', 'dependent T cell activation'], ['Phagocytosis', 'macrophages'], ['extracellular subcellular which', 'final  phagocytosis'], ['lysosomal  infection', 'lysosomal  functions'], ['we', 'quantitative murine RAW'], ['different  Listeria', 'L'], ['', ''], ['', '193 glycosylation proteins'], ['distinct  which', 'toll receptor activation inflammation'], ['significant  changes', 'glycosylation'], ['changes', 'whole cell level'], ['Thus  study', 'unique macrophage activation'], ['purpose', 'transplantation allograft rejection'], ['Recent  findings', 'intestinal lymphoid transplantation'], ['host responses', 'inflammatory bowel diseases'], ['more  making', 'intestinal transplant patients'], ['microbiome lymphoid cells', 'ongoing  research'], ['intercellular  that', 'embryonic  development'], ['gap junction proteins', 'Drosophila'], ['Here  we', 'novel band formation stage'], ['one Bm inx4', 'four copy exons'], ['structural  similarities', 'extracellular innexin family loops'], ['other Bm inx4', 'known Dm inx4'], ['situ Bm inx2', 'nervous  embryogenesis'], ['Bm inx4', 'larval band formation stages'], ['functional  that', 'neuronal  B'], ['', ''], ['', 'Elsevier Ltd'], ['Recent  work', 'toxic gene responses'], ['present  we', 'induced rat toxicity'], ['genomic  we', 'hepatic mRNA translation'], ['deiodinase type that', 'canonical  pathways'], ['reduced  protein', 'increased  dose'], ['translational  repression', 'reduced liver damage'], ['induced  hepatotoxicity', 'localized thyroid hormone liver'], ['mRNA  which', 'decreased D3 production'], ['important  liver', 'pituitary energy thyroid'], ['free quantum dots', 'molecular biology level'], ['InP ZnS QDs', 'systematically multispectroscopic approaches'], ['InP ZnS QDs', 'intrinsic static mode'], ['binding  site', 'mainly subdomain HSA'], ['thermodynamic parameters', 'electrostatic ZnS interactions'], ['CdSe ZnS which', 'biological ZnS HSA'], ['results', 'human toxicity health'], ['', ''], ['', ''], ['rights', ''], ['Inpp5f v3', 'distal mouse chromosome'], ['It', 'imprinted  mouse'], ['we', 'spatiotemporal mouse development'], ['one  transcript', ''], ['7  kb', 'Inpp5f brain'], ['signals', 'embryonic  day'], ['', ''], ['', ''], ['time PCR QRT expression', 'gradually Inpp5f E11'], ['', 'E17'], ['', 'E17'], ['5', 'then  E18'], ['', 'brain development'], ['Inpp5f v3 gene', 'embryonic cortex development'], ['', ''], ['expression', 'situ olfactory hybridization'], ['results', 'mainly postnatal day'], ['Inpp5f v3', 'specifically mouse brain'], ['successfully Bactrocera dorsalis mechanisms', 'peptides'], ['homolog', 'NF kappa transcription factor B'], ['', ''], ['open reading that', '1013 amino acids'], ['it', 'transcription activator proteins'], ['BdRelish', 'fat transcription body'], ['Staphylococcus aureas', 'significantly  BdRelish'], ['', 'markedly antimicrobial peptides'], ['Individuals', 'faster control groups'], ['Therefore  BdRelish', 'invading  bacteria'], ['bug Rhodnius prolixus', 'interesting lipid metabolism'], ['publication', 'future biology experiments'], ['preliminary  analysis', 'lipid metabolism'], ['Here  we', 'different fatty acid metabolism'], ['', ''], ['prolixus genome', 'neutral lipase lipases'], ['expression profiles', 'genes'], ['We', 'nine A2 genes'], ['gene that', 'synthase elongase desaturase'], ['second  that', 'ubiquitously  organs'], ['Finally  genes', 'acid beta oxidation'], ['results', 'possible disease transmission'], ['', ''], ['', ''], ['rights', ''], ['Mythimna separata walker', '300  food'], ['', 'rarely sequence M'], ['separata', 'molecular insect species'], ['we', 'transcriptome  M'], ['', ''], ['45227 bioinformatics unigenes', 'homologous annotation 65'], ['', ''], ['lepidopteran  insects', 'transcriptome  data'], ['', 'insecticide  M'], ['15  families', 'related  proteins'], ['transcriptome  17', 'selected  unigenes'], ['Expressions', 'insecticide gut resistance'], ['study', 'transcriptome  M'], ['separata', 'other Noctuidae family insects'], ['emerging  adults', 'social networking likes'], ['ASETs', 'pulse ray metallization'], ['We', 'induced laser ASETs'], ['shapes', 'two  methods'], ['this', 'heavy  ions'], ['pulsed x rays', 'single event effects'], ['increasing  share', 'important energy systems'], ['synergies', 'integrated energy system'], ['electricity network operation constraints', 'networks'], ['purpose', 'daily operation constraints'], ['objective optimization algorithm', 'optimal daily operation IES'], ['Simulation studies', 'electricity network gas network'], ['', 'C Elsevier Ltd'], ['IPB  system', 'simultaneous degradation nutrient removal'], ['mathematical  model', 'IPB system'], ['external flow outputs', 'nutrient removal electricity generation'], ['determination', 'unknown sensitivity analysis'], ['Satisfactory model fitting', 'square root 5'], ['', ''], ['', 'varied COD input'], ['other COD flow rate', 'current  generation'], ['optimal condition', '150 flow 0'], ['', ''], ['IPB model', 'electrochemical  reactions'], ['', ''], ['rights', ''], ['Solar  energy', 'conventional energy consumption'], ['comprehensive  utilization', 'undoubtedly  interest'], ['present optimization model', 'cold plateau areas'], ['case study', 'developed Lhasa model'], ['solar photovoltaic systems', 'solar energy resources'], ['sensitivity analysis', 'economical electricity performance'], ['life cycle assessment', 'optimization system'], ['', ''], ['rights', ''], ['it', 'classroom laboratory instruction'], ['how  experimentation', 'knowledge'], ['semester long research project', 'lecture  course'], ['project', 'uncharacterized test genes'], ['students', 'critical content course'], ['test student questions', 'student project'], ['', 'International Biochemistry'], ['few  studies', 'key health care'], ['', 'leading IM USA'], ['structured  interviews', 'mixed method approach'], ['elements', 'academic research activities'], ['key  elements', 'centered team care'], ['cultural IM which', 'engagement IM framework'], ['that', 'stakeholders'], ['conceptual  framework', 'efficient patient care'], ['C Elsevier rights', 'important  plasmatocytes'], ['mental  they', 'thereby  IA'], ['Nonetheless  IA', 'open reality evidence'], ['Such  variations', 'multiple communion agency analysis'], ['', ''], ['', 'dispositional  warmth'], ['when  agency', 'EEE account'], ['mothers', 'alcohol health ID'], ['children', 'studied child mothers'], ['children', 'mental illness ID'], ['study', 'based  1999'], ['national Medical Birth codes', 'medical  ID'], ['children', 'seven  age'], ['2749', 'ID'], ['Children', 'mental health problems'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'early  childhood'], ['They', 'due  falls'], ['', ''], ['', ''], ['', ''], ['largest  risk', 'trauma'], ['', ''], ['', ''], ['', ''], ['conclusion children', 'increased injuries violence'], ['based  children', 'best  care'], ['', ''], ['', 'Elsevier Ltd'], ['paper', 'obtained information effect'], ['basic information which', 'mechatronic system designing'], ['they', 'mechatronic  system'], ['Conformity degree', 'current control efficiency'], ['set', 'possible control states'], ['allowable control which', 'favorable system states'], ['it', 'probabilistic system states'], ['fulfilled  it', 'mechatronic system designing'], ['Interconnected electricity networks', 'far  electricity'], ['These', 'fossil House Gas fuels'], ['Supergrids', 'renewable interconnection technologies'], ['', 'appropriate  interconnections'], ['which', 'wider  Supergrids'], ['paper', 'robust  framework'], ['', 'initial candidate countries'], ['4  uncertainties', 'whole life appraisal approach'], ['greatest cost risks', 'regulatory energy policy'], ['desirable interconnection option', 'France'], ['', ''], ['rights', ''], ['paper', 'capacitive MEMS sensors'], ['pulse inverter which', 'parasitic  capacitance'], ['high pass filter', 'noise sources'], ['circuit', 'digital control signals'], ['circuit', 'higher  sensitivity'], ['sensitivity', 'circuit'], ['', '3'], ['', 'controlling  parameters'], ['dynamic sensing range', 'controlling  parameters'], ['interface circuit', 'United Microelectronics Corporation'], ['', ''], ['It', 'active  0'], ['17  mm(2', ''], ['based pressure sensor', 'digestive interface tract'], ['sensitivity', '101  kPa'], ['paper', 'force feedback sigma delta loop'], ['electrostatic feedback technique', 'feedback signals'], ['low capacitance detection circuit', 'operational f amplifier'], ['interface', 'standard'], ['5 m CMOS process', ''], ['chip', '250 sampling kHz'], ['average noise floor', '-115  1'], ['', ''], ['measured  resolution', 'accelerometer system'], ['nonlinearity', ''], ['', ''], ['proposed sigma delta interface', 'good  performance'], ['common pollen borne that', 'many Prunus species'], ['strains', 'adverse  effects'], ['', ''], ['many mosaic strains', 'sweet  cherry'], ['even symptomless strains', 'such Gisela T'], ['', ''], ['', ''], ['Using', 'IR Agrobacterium EHA105'], ['This', 'transgenic  Gi7'], ['Regenerated  plants', 'normal  phenotype'], ['presence', 'Southern PNRSV blot'], ['Northern  blotting', 'transgenic  events'], ['transgenic  lines', 'then  PNRSV'], ['transgenic  Gi7', 'ELISA assays'], ['transgenic Gi7 plants', 'serious virus infection symptoms'], ['still PNRSV it', 'still PNRSV infection'], ['transgenic  Gi6', 'ELISA assays'], ['cherry which', 'modified virus fruits'], ['number', 'diabetic glucose complications'], ['We', 'better  adipocytes'], ['capping signal sequence trap', 'white adipose tissue'], ['Profiles', 'northern  blotting'], ['cDNA fragment', 'stimulated gene search'], ['ISG12b', 'white adipose tissue'], ['Interferon', 'also preadipocyte cell vitro'], ['level', 'mature  preadipocytes'], ['369bp  upstream', '5593bp upstream region'], ['ISG12b', 'adipose  interferon'], ['concept', 'important partner research'], ['violence', 'subsequent  generations'], ['public  perceptions', 'legal  IPV'], ['Data', 'nationwide South Korea'], ['ZIP  which', 'skewed count variables'], ['ZIP us', 'IPV'], ['child abuse experience', 'IPV'], ['more child aware', 'less  IPV'], ['Witnessing IPV', 'increased  IPV'], ['domestic  IPV', 'domestic  violence'], ['We', '1418 child relationship participants'], ['emotional parent child age', 'emotional parent child G2'], ['', 'same parent child questionnaire'], ['Emotional  warmth', 'demographic  generations'], ['transmission', 'emotional  acceptance'], ['intergenerational  transmission', 'women'], ['findings', 'long parenting generations'], ['level electrical calibration laboratory', 'satisfactory  results'], ['instrument', 'small measurement it'], ['ILC', 'one hundred measurement points'], ['ILC', 'secondary measurement capabilities laboratory'], ['Attention', 'two laboratories measurements'], ['calibrator', 'fixed  8'], ['', 'multimeter  ILC'], ['', ''], ['rights', ''], ['paper', 'current dc dc sensor'], ['current dc information', 'width  modulation'], ['current phase currents', 'single PWM cycle'], ['current  controller', 'current  phase'], ['proposed sensor strategy', 'current sensing sensors'], ['effectiveness', 'automotive battery charging application'], ['multilevel DC DC converters', 'low filter size'], ['high voltage output that', 'galvanic  isolation'], ['series connection', 'higher voltage application'], ['new  it', 'also input capacitors'], ['fundamental operating relationships', 'circuit'], ['paper', 'practical application examples'], ['paper', 'independent input capacitors'], ['IL-1beta  beta', 'important histocompatibility pregnancy'], ['antigen RT1-A antigen', 'Western  blotting'], ['IL-1beta treatment', 'early  pregnancy'], ['', 'significantly pregnancy placenta'], ['early pregnancy RT1-DM protein', 'luminal basalis outer epithelium'], ['mid pregnancy RT1-DM', 'trophoblastic labyrinthine layers'], ['exogenous  IL-1beta', 'corresponding  pregnancy'], ['', 'macular IL -13 degeneration'], ['IL -13 levels', 'immunosorbent AMD assay'], ['ng mL IL', '12  24'], ['cell proliferaton', 'MTS method'], ['mRNA  levels', 'real polymerase chain reaction'], ['expression', 'endothelial growth ELISA'], ['IL -13 levels', 'significantly  control'], ['', ''], ['', '27'], ['', ''], ['', ''], ['', ''], ['', 'ARPE-19 cell proliferation'], ['', 'ARPE-19  cell'], ['', ''], ['', '1'], ['', ''], ['', ''], ['ZO-1', ''], ['', ''], ['', '0'], ['', ''], ['', ''], ['ng mL IL', '48h'], ['protein expression', 'same  tendency'], ['', ''], ['', ''], ['IL -13', 'significantly TNF a'], ['', ''], ['', ''], ['', ''], ['', ''], ['level', 'significantly TGF 34'], ['', ''], ['', '57'], ['', ''], ['', 'pg  24h'], ['', '61'], ['', ''], ['', '86'], ['', ''], ['', 'pg  48h'], ['', ''], ['IL', 'treatment'], ['ARPE-19 cell proliferation', 'AMD'], ['extensive abuse history', 'other  populations'], ['study', 'high childhood abuse'], ['', ''], ['C reactive birth outcomes', 'respectively blood interleukin-6'], ['', 'second Results trimester'], ['', ''], ['low  depression', 'low abuse severity'], ['Abuse', 'gestational  birth'], ['', ''], ['such  those', 'gestational  birth'], ['Cortisol', 'gestational  birth'], ['', ''], ['', ''], ['pregnant Latina it', 'abused  adolescents'], ['Cortisol', 'gestational  birth'], ['Multiple  adversities', 'intergenerational birth health'], ['high  IL)-9', 'Th9  subset'], ['many  contribution', 'allergic  rhinitis'], ['first Th9 cells', 'mouse AR'], ['We', 'IL-9 T cell antibodies'], ['IL-9  Abs', 'intranasally  BALB'], ['We', 'rubbing motion sneezing'], ['', 'Il-9 protein PU'], ['', ''], ['', 'mRNA nasal mucosa'], ['', 'Th2 Treg response'], ['IL-9 IL-9 Ab treatment', 'therapeutic  AR'], ['Wind power generation', 'renewable energy sources'], ['wind power generation', 'other power generators'], ['coal weather generators', 'other weather instance'], ['associated  costs', 'simulations'], ['We', 'Danish wind power generation'], ['short term costs', 'wind power generation'], ['', ''], ['rights', ''], ['paper', 'full combustion load'], ['electric  grids', 'classical  fuels'], ['heat recovery system', 'Organic Rankine Cycle'], ['novel  method', 'partial EG loads'], ['based  systems', 'full EG load'], ['total surface those', 'boiler zone'], ['', ''], ['', ''], ['case', 'partial EG load'], ['thermal  efficiency', 'thermal ICE operating'], ['', 'eta(ICE  Hits'], ['', '6'], ['', ''], ['', ''], ['', '100 EG %'], ['', ''], ['three  cereals', 'monetary  value'], ['crops DNA extraction', 'high protein grains'], ['advanced  techniques', 'pure  DNA'], ['majority', 'molecular weight DNA'], ['we', 'minor Zea modifications'], ['two hybrids M10', '1 Mericon extraction'], ['Genes', 'thousand tandem 18S'], ['8S 26S units', ''], ['evolutionary  regions', 'genetic  diversity'], ['then  PCR', 'specific  gene'], ['PCR products', 'agarose  gel'], ['modified Mericon extraction method', 'affordable DNA cost'], ['Background', 'traumatic child protection professionals'], ['', 'secondary trauma responses'], ['', 'two UK police forces'], ['Participants', 'secondary stress trauma'], ['normally  results', 'correlation t test regression'], ['higher study who', 'higher study investigators'], ['', 'other  studies'], ['additional risk support', 'ICAI risk STS'], ['recent  that', 'traditional  openness'], ['such  paper', 'digital  control'], ['', 'endogenous space preferences'], ['even motivation latter', 'extrinsic motivation equilibrium'], ['actually  results', 'great Internet regulation'], ['Interpersonal  space', 'nonverbal  affiliation'], ['we', 'interpersonal  space'], ['controlled  we', 'familiar distance friend'], ['participants', 'closer toa stranger'], ['overall distancing effect', 'friend'], ['friend that', 'mentalizing  system'], ['when  stranger', 'participants'], ['effect', 'greatly  protagonist'], ['social salience OT', 'social  context'], ['', ''], ['rights', ''], ['problem', 'stochastic interchange generation'], ['interchange scheduling technique', 'expected operating cost'], ['equivalent  that', 'social  welfare'], ['proposed  technique', 'marginal optimal interchange operators'], ['Several  extensions', 'proposed  technique'], ['paper', 'medium voltage vacuum contactor'], ['Such  development', 'mechatronic  approach'], ['', ''], ['', 'digital control unit'], ['preliminary modeling design', 'coordinated  simulations'], ['prototype', 'design procedure'], ['underlying  pathophysiology', 'spinal  disorders'], ['mechanical  loading', 'major  IDD'], ['aim', 'novel rabbit model'], ['Rabbits', 'intradiscal lumbar spine'], ['Radiograph', 'weeks disc degeneration'], ['disc specimens', 'quantitative polymerase chain reaction'], ['MRI results', '14-week study period'], ['significantly expression levels', 'experimental control group'], ['', ''], ['Histological examination', 'fibrotic nucleus pulposus'], ['degenerative rabbit lumbar which', 'novel animal humans'], ['Background', 'epithelial T cells'], ['We', 'epithelial cell lines'], ['human colon epithelial cells', 'real polymerase chain reaction'], ['NF)-kappa B2 mutant B', 'nuclear B2 mutant factor'], ['expression INF gamma', 'delayed  kinetics'], ['', 'three cell lines'], ['CXCL10 promoter induction', 'IL-1 IFN gamma'], ['cellular kappa B beta', 'major IFN CXCL10'], ['immune  that', 'such barrier skin'], ['Expulsion', 'often host infection'], ['However  role', 'mast  infections'], ['Mast cells', 'mast worm expulsion'], ['', 'Immunology Sorobetea'], ['', ''], ['', ''], ['', ''], ['', ''], ['mast  cells', 'intestinal mast cell permeability'], ['we', 'mast cell health'], ['AE adult epithelial cells', 'larval epithelial apoptosis'], ['They', 'adult epithelium'], ['Thyroid hormone', 'various Notch receptor'], ['we', 'situ polymerase chain hybridization'], ['they', 'specific  manner'], ['Particularly  Hairy1', 'specifically AE cells'], ['Notch', 'c secretase inhibitor'], ['intestinal stem cell marker', 'GSI treatment'], ['Notch signaling', 'intestinal Hairy remodeling'], ['organ culture that', 'absorptive secretory cells'], ['findings', 'vertebrate stem development'], ['postnatal  development', 'border lactase rodents'], ['This', 'phenomenon humans'], ['present  effect', 'intestinal rat pups'], ['Lactase levels', 'enzyme analysis'], ['mRNA levels encoding lactase', 'Northern  blotting'], ['', '4  days'], ['lactase activity', 'old rat intestine'], ['However cortisone administration', 'P'], ['', 'lactase conditions'], ['Western blot analysis', 'treated protein animals'], ['However  intensity', 'treated lactase controls'], ['mRNA levels encoding lactase', '6'], ['mRNA transcript', 'rats'], ['mRNA levels encoding lactase', 'injected  controls'], ['Microvillus', 'saline'], ['', ''], ['', ''], ['treated', 'significant lactase activity'], ['luminal  which', 'maturational adult rat intestine'], ['study', '1 month postnatal'], ['also  relationships', 'depressive  symptoms'], ['prospective cohort that', '1  childbirth'], ['Japanese Infant Bonding version', 'depressive pregnancy bonding pregnancy'], ['Structural equation modeling', 'four  variables'], ['final path model', 'good  data'], ['1 month IPV', '1 month postnatal'], ['associations', 'depressive month symptoms'], ['results', 'prenatal health settings'], ['interventions', 'depressive bonding childbirth'], ['Intimate partner violence', 'PTSD stress depression'], ['current  study', 'mental health IPV'], ['PTSD  symptoms', 'Revised IES R'], ['Depression symptoms', 'administered Interview Schedule IV'], ['Anxiety symptoms', 'administered ADIS IV'], ['40  %', '55 % meeting GAD'], ['self report measure', 'diagnostic measure concordance'], ['high IES R', 'PTSD'], ['BAI', 'poor IV GAD section'], ['multiple assessment modalities', 'when  IPV'], ['Intimate partner violence', 'public United States'], ['Children', 'physical  safety'], ['unique  physicians', 'various family victims'], ['Screening', 'national Emergency Physicians'], ['Effective screening protocols', 'local community resources'], ['Intracerebral  hemorrhage', 'ening  stroke'], ['marrow mesenchymal stem cells', 'beneficial  ICH'], ['neuroprotection', 'conditioned  CM'], ['associated neurite which', 'therapeutic  ICH'], ['underlying BMSC mechanisms', 'direct BMSC addition'], ['brain water content', 'present polymerase chain study'], ['BMSC CM both', 'neurological  functions'], ['', 'significant tumor necrosis factor'], ['kinase protein expression levels', 'GAP-43'], ['present  treatment', 'direct rat ICH'], ['mediated  neuroprotection', 'well ERK-1/2 phosphorylation'], ['signaling  pathway', 'neurological BMSC diseases'], ['subarachnoid that', 'young  children'], ['children', 'subdural  trauma'], ['clinically  finding', 'protection law enforcement investigations'], ['1 24 1 who', '6 CT feet'], ['SAS', ''], ['Enlarged  SAS', '4 CT scans'], ['head circumference percentile', 'head circumference'], ['relationship', 'intracranial bivariate analysis'], ['RESULTS', '4  mm'], ['mean patient age', ''], ['', ''], ['', ''], ['', ''], ['9  %', 'subarachnoid  subpial'], ['', ''], ['', ''], ['', ''], ['', ''], ['Enlarged  SAS', 'epidural  hemorrhage'], ['however HC percentile', 'independently  ICH'], ['CONCLUSIONS Enlarged SAS', 'other  ICHs'], ['BEH', 'accidental  trauma'], ['objective', 'before levonorgestrel intrauterine system'], ['Study Women', 'solid organ transplant patients'], ['blood', 'endometrial LNG IUS insertion'], ['repeat serum', 'uterine  lavage'], ['Cytokine levels', 'inflammatory  biomarkers'], ['Immunohistochemistry staining', 'endometrial macrophage levels'], ['nonparametric  that', 'two marker groups'], ['Sixteen  participants', 'study'], ['', 'soluble IUD insertion'], ['', 'healthy IUD women'], ['', 'endometrial device insertion'], ['pilot study', 'uterine transplant patient population'], ['Findings', 'inflammatory transplant recipients'], ['larger  that', 'patient  population'], ['', ''], ['', 'Elsevier Inc'], ['development', 'substantially cell immunology'], ['prolonged  periods', 'acquired image sequence'], ['that', '2PM drift offset acquisition'], ['We', 'real data acquisition'], ['us', '100  lymphoid'], ['it', 'live imaging data acquisition'], ['', ''], ['', ''], ['rights', ''], ['present  work', 'tapetal cell layer'], ['', ''], ['that', 'orf316 hairpin orfH522'], ['constructs', 'independently  tobacco'], ['restorer  cassettes', 'hybrid tobacco seeds'], ['plants', 'restorer cassette'], ['Hybrid plants', 'normal pollen capsules'], ['interrupted', 'higher RNA restorer construct'], ['hybrid Segregation plants', 'di hybrid di ratio'], ['transitive  silencing', 'more orfH522 transcripts'], ['natural feed which', 'positive  production'], ['Inulin', ''], ['mechanism', 'avian inulin body'], ['many  authors', 'positive host organism'], ['', 'pathogenic inulin microbes'], ['provoked  changes', 'intestinal absorption poultry'], ['also  inulin', 'systemic  minerals'], ['often inulin effectiveness', 'strongly  administration'], ['lobular  carcinoma', 'genetic molecular biology'], ['', 'biological  LCIS'], ['presence', 'clinicopathologic tumor parameters'], ['254  cases', 'ILC'], ['Clinicopathologic  parameters', '254 ILC cases'], ['patient', 'clinicopathologic ILC parameters'], ['pure  ILC', '147  LCIS'], ['', ''], ['32  cases', 'axillary lymph node metastases'], ['108  micrometastasis', '5 N1 N2 cases'], ['involvement', 'less P 0'], ['', ''], ['', ''], ['presence', 'pure  ILC'], ['', ''], ['', 'pure ILC cases'], ['', ''], ['50 ILC years', 'pure  ILC'], ['', ''], ['coexisting', 'pure  ILC'], ['', 'pure ILC+LCIS ILC'], ['biological  this', 'certain tumor ILC'], ['inverse  problem', 'orthogonal Wiener class'], ['valued  version', '1992'], ['Hankel Wiener class that', 'inverse problem'], ['also  solution', 'also  case'], ['where  functions', 'solution'], ['', ''], ['rights', ''], ['voltage digital hysteresis voltage control', 'half bridge inverters'], ['slow switching it', 'hysteresis method'], ['current band which', 'fast system parameters'], ['desired hysteresis band', 'constant switching value'], ['Simulation results', 'proposed control cases'], ['model', 'output filter'], ['parameters', 'nominal output inductance'], ['Input Single control systems', 'rectifier RC load'], ['However  design', 'actual inverter parameters'], ['it', 'automated source inverter parameters'], ['breadboard verification', ''], ['Voltage inverters', 'frequency electrical frequency systems'], ['usually modulation that', 'gating  switches'], ['modulation block', 'directly  controller'], ['such  control', 'electrical  system'], ['paper', 'such  configuration'], ['analysis', 'fundamental  frequencies'], ['Also  dependence', 'harmonic commutation losses'], ['findings', 'regardless control parameters'], ['Some', 'them'], ['procedure', 'phases'], ['', '2016 International Simulation'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['', 'alone loop control inverter'], ['then load voltage', 'linear Kalman filter algorithm'], ['double loop which', 'transient state performance'], ['controller parameters', 'required stability margin'], ['Furthermore  controllability', 'digital control estimators'], ['Simulation', 'proposed VA estimation'], ['skeletal muscle damage', 'chloride channel expression'], ['PKC protein kinase which', 'channel'], ['intracellular resting calcium', ''], ['Similar  alterations', 'higher statin myotoxicity'], ['we', 'western blot analysis'], ['restCa', 'histological muscle sections'], ['results', 'aged adult animals'], ['observed  changes', 'MEF2 ClC-1 expression changes'], ['activity', 'aged  rats'], ['', 'glycolytic muscle metabolism'], ['worsening', 'aged  animals'], ['strong  reduction', 'induced muscle elderly'], ['', ''], ['rights', ''], ['eutectic  solvents', 'ionic  liquids'], ['core that', 'e'], ['', ''], ['high vapor DESs', 'low starting materials'], ['they', 'various  sectors'], ['applications', 'medical  fields'], ['various safety concern', 'mixtures'], ['first  they', 'safe  mixtures'], ['only  they', 'negligible toxicity profiles'], ['it', 'based  research'], ['First  it', 'ample toxicity profiles'], ['that', 'biotechnological  applications'], ['', ''], ['rights', ''], ['Flowers', 'reproductive  plants'], ['shapes colours', 'reproductive insect success'], ['process', 'Ipomoea study'], ['', 'cytology cell chemistry'], ['results', 'already mitochondrial membrane degradation'], ['stage genomic stage DNA', 'random  degradation'], ['However  judging', 'early flower senescence stage'], ['it', 'withering flower corolla'], ['We', 'safely corolla I'], ['programmed cell that', 'flowering  stage'], ['temporal  which', 'high  pollination'], ['Intimate partner violence', '36 Saharan population'], ['African  countries', 'highest'], ['we', 'ecological sub theory'], ['journal which', 'high  implementation'], ['Western  poverty', 'past child abuse'], ['Low  education', 'also  women'], ['partner abuse', 'violence prevention'], ['more North which', 'focused  approaches'], ['HIV others', 'reduced violence men'], ['programs', 'Saharan  Africa'], ['emerging  disease', 'immunosorbent Costa Rica'], ['Onion plants', 'elongated  lesions'], ['partial  sequences', 'North New Zealand'], ['essay', 'radical Irish Free journal'], ['Honesty', 'socialist  republican'], ['', 'longstanding  women'], ['political  leadership', 'news agenda'], ['what', 'domestic Free audiences'], ['Free which', 'wider Free State society'], ['that', 'particular  breadline'], ['However  radicalism', 'Irish Free State journalism'], ['Iron deficiency', ''], ['neuronal myelination dopamine presence', 'neurofunctional iron deficiency effects'], ['scarce  effects', 'human  adults'], ['Resting', 'functional resonance connectivity'], ['Default Mode Network', 'social state cognition'], ['four core regions', 'consistently  DMN'], ['Therefore  investigate', 'functional term brain'], ['We', 'young state brain adults'], ['31  that', 'follow  infancy'], ['deficient  17', 'mean  21'], ['', ''], ['', ''], ['8  %', ''], ['data', 'statistical  DMN'], ['left posterior cingulate they', 'right DMN PCC'], ['Differences', 'anemic attention networks'], ['preliminary  results', 'young  adults'], ['nutritional  problem', 'common  adulthood'], ['', 'deficient sugar rats'], ['6  wk', 'northern blotting technique'], ['Hemoglobin', 'anemic iron rats'], ['', 'transepithelial  sodium'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'significantly control group'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'respectively  <'], ['', ''], ['transepithelial  transport', 'groups'], ['', 'anemic SGLT1 intermediate'], ['', ''], ['', '659  1'], ['', ''], ['AU  segments', 'significantly  values'], ['', ''], ['', ''], ['', ''], ['', ''], ['significant  difference', 'proximal GLUT2 mRNA segments'], ['Iron deficiency', 'small SGLT1 rats'], ['', ''], ['rights', ''], ['arsenate removal that', 'external electricity supply'], ['where  it', 'electricity'], ['possibility', 'liter fuel cell stack'], ['electrolyte species', ''], ['arsenate  Na2SO4', 'current  density'], ['power use', 'arsenate iron hydroxide'], ['dominant iron hydroxide', 'Raman spectroscopy'], ['four air fuel cell', 'maximum power density'], ['', ''], ['rights', ''], ['microbiological production quality', 'climatic irrigation water Brazil'], ['study', 'generic  E'], ['', 'E'], ['', 'produced Southern Brazil'], ['We', 'potential  samples'], ['longitudinal  study', '2014  August'], ['results', 'generic  E'], ['', 'coli  84'], ['', ''], ['', 'important irrigation lettuces'], ['significant  differences', 'E'], ['', 'different surface water sources'], ['climatic  conditions', 'high  E'], ['', ''], ['', 'highest  E'], ['coil', 'warmest irrigation year'], ['', ''], ['only water 4', 'culture media'], ['', ''], ['rights', ''], ['BackgroundIrritability', 'increased  anger'], ['current attention study', 'based  sample'], ['MethodsWe', '6  Development'], ['CBCL  that', 'temper tantrums'], ['dot probe task', 'angry attention stimuli'], ['Multiple regression analysis', 'demographic  variables'], ['score matching analysis', 'demographic causal variables'], ['ResultsIrritability', 'related attention cues'], ['associations', 'internalizing hyperactivity symptoms'], ['association', 'demographic  symptoms'], ['ConclusionsIrritability', 'biased  information'], ['further  it', 'possible treatment implications'], ['genetic  surroundings', 'further UK UK'], ['faecal  specimens', 'international practice travel'], ['', ''], ['deficient  that', 'double disc synergy test'], ['molecular  environments', 'DNA sequencing gene'], ['', ''], ['96 CTX M %', 'clone ST131'], ['', '24 bp ISEcp1'], ['different  promoters', 'different cephalosporin resistance'], ['', ''], ['truncated  which', 'overseas population mobility'], ['Islamic State', 'western terror thousands'], ['Many  executions', 'future media attacks'], ['We', 'reported adult Israelis'], ['potential  which', 'general anxiety depression'], ['positive  relationship', 'ISIS anxiety'], ['well sleep difficulties', 'such  anxiety'], ['', ''], ['rights', ''], ['genes', 'psychrotrophic bacterium Pseudomonas psychrophila'], ['Open reading frames', '741 amino acids'], ['deduced amino acid sequences', 'other genus Pseudomonas'], [\"5'-terminal  they\", \"5'-terminal  mRNAs\"], ['', 'monomer- IDH C'], ['slight  inductions', 'low  P'], ['', ''], ['Both', 'monomer- dimer C'], ['', ''], ['', 'Glu55 P'], ['psychrophila monomeric psychrophila which', 'monomeric residue C'], ['', ''], ['optimum  residue', 'mesophilic  P'], ['', ''], ['same  policy', 'same  importance'], ['little  attention', 'presidential multiparty systems'], ['presidential  candidates', 'other party parties'], ['small  candidates', 'mainstream issue ownership advantage'], ['two  parties', 'only mainstream party'], ['political  communication', 'also party parties'], ['Itraconazole', 'human  cancers'], ['study', 'gastric cancer cells'], ['CCK-8 assay', 'gastric cancer cells'], ['dual polymerase chain luciferase', 'reverse polymerase chain reaction'], ['Tumor xenograft models', 'gastric cancer vivo'], ['Itraconazole', 'gastric cancer cells'], ['', 'significantly cancer cells'], ['Furthermore  itraconazole', 'gastric cancer cells'], ['Hh', 'gastric cancer samples'], ['expression', 'transcriptional finger transcription itraconazole'], ['also  itraconazole', 'Gli1'], ['oral  itraconazole', 'chemotherapeutic antitumor agent'], ['gastric  itraconazole', 'gastric Gli1 expression'], ['human  role', 'intrauterine growth restriction'], ['We', 'PHLDA2 MEST mRNA IUGR'], ['', ''], ['imprinting PHLDA2 protein', 'villous IUGR placentae'], ['We', 'IUGR Affymetrix U133A microarrays'], ['imprinted  genes', 'false discovery 0'], ['', 'decreased IUGR placentae'], ['mRNA', 'IUGR cases'], ['We', 'Northern IUGR blotting'], ['imprinted microarray data', 'differentially family solute IUGR'], ['', ''], ['Ixodidae adult Dermacentor ticks', 'Thaya Czech 1995'], ['10  homogenates', 'free  mice'], ['spleens', 'liver glucose blood blood'], ['Sixty four Sixty pools', 'F'], ['minimum infection rate', ''], ['', ''], ['', '3064 male D'], ['reticulatus', ''], ['', ''], ['respectively  MIRs', '0'], ['', ''], ['', ''], ['bacterial  load', 'infected  0'], ['', '5'], ['', ''], ['', 'tularensis tick'], ['', ''], ['', '220000  cells'], ['infectious  cells', '24  ticks'], ['', '3  ticks'], ['', 'infected  ticks'], ['', 'D'], ['', 'presence  F'], ['tularensis', 'valuable  tularaemia'], ['JAK Janus which', 'cytokine  factor'], ['Analysis', 'auto- TYK2 immunity'], ['TYK2-deficient patients', 'cellular signalling functions'], ['wide association studies', 'autoimmune  diseases'], ['cytokine signalling TYK2', 'tumour surveillance'], ['leukaemic  TYK2', 'leukaemic  diseases'], ['Here  we', 'intrinsic  carcinogenesis'], ['we', 'inactive tumour rejection'], ['', ''], ['', 'Elsevier Ltd'], ['biological  characteristics', 'similar laboratory mice'], ['Moreover', 'such immunology endocrinology'], ['aim', 'in carcass analysis'], ['Japanese  quails', 'different ova oviducts'], ['five  quails', 'direct standoff imaging technique'], ['It', 'white  follicles'], ['', 'yellow  follicles'], ['ovulatory  follicles', 'also development oviducts'], ['productive breeding which', 'efficient laboratory procedures'], ['associated JC nephropathy', 'renal JC dysfunction'], ['We', 'definitive disease entity'], ['renal transplant recipient', 'years JC transplantation'], ['Immunosuppressive  agents', 'renal  function'], ['We', 'rare  entity'], ['shaping  that', 'traditional  flexibility'], ['machining  quality', 'unique  phenomenon'], ['', ''], ['anode', 'high nozzle travel rate'], ['paper', 'optimum rate parameter window'], ['anodic  behavior', 'electrochemical impedance spectroscopy'], ['dependent  mechanism', 'corrosion anodic interface structure'], ['full electricity quantity', 'uniform dissolution state'], ['parameter Q', 'anodic  behavior'], ['model', 'machined  profile'], ['nozzle travel rate', 'present parameter work'], ['', ''], ['rights', ''], ['recent years using', 'organizational  context'], ['they', 'potential self organizations'], ['study', 'various business Turkey'], ['leadership perceptions', 'self monitoring'], ['results', 'leadership perception'], ['measured N170 they', 'virtual reality paradigm'], ['it', 'computer program'], ['', 'joint trial target'], ['50 congruent character', 'different  location'], ['', 'congruent gaze responses'], ['P350 effect', 'agent condition'], ['occipitotemporal N170 responses', 'congruent gaze shifts'], ['approximately gaze mechanisms', 'perceptual  gaze'], ['social  that', 'social  interactions'], ['paper', 'photovoltaic energy storage device'], ['wind electricity market powers', 'main  submission'], ['problem', 'stochastic programming problem'], ['first energy deviation', 'second stage problem'], ['Energy storage', 'conveniently market prices'], ['Iberian ahead electricity comparison', 'joint  operations'], ['', ''], ['rights', ''], ['Tunneling', 'good field effect scalability'], ['However  they', 'ambipolar  conductivity'], ['we', 'hetero gate hetero dielectric'], ['approach', 'low drain voltages'], ['proposed  structure', 'I 8'], ['', 'mu m mu 1'], ['', ''], ['length', 'performance k gate device'], ['', 'courts child abuse'], ['Dependency proceedings', 'ongoing state agency'], ['court proceedings', 'culminating twenty trial'], ['they', 'justice'], ['', 'significant  attention'], ['electrochemical impedance which', 'printed carbon transducer'], ['target detection', 'covalently SPCEs surface'], ['morphology  properties', 'FT IR electron microscopy'], ['devised  aptasensor', 'dynamic  range'], ['', '600  linearity'], ['', '75  detection'], ['', 'S N KANA'], ['developed  aptasensor', 'competitive  analogues'], ['practical aptasensor performance', 'acceptable recovery 96'], ['', ''], ['', ''], ['56  n=3', 'milk samples'], ['', ''], ['', ''], ['rights', ''], ['Seed germination', 'critical plants life cycle'], ['stages', 'such  light'], ['family', 'biological release germination regulation'], ['KARs', 'high transduction pathways'], ['KARs', 'acid abscisic IAA'], ['Interestingly KARs', 'different seed species'], ['potential shade avoidance which', 'more plant molecular biology'], ['KARs', 'especially  IAA'], ['updated  we', 'current plant growth'], ['Further  crosstalk', 'shade responses'], ['future  challenges', 'KAR research field'], ['Ganoderma lingzhi', 'medicinal  mushroom'], ['MicroRNAs', 'biological  processes'], ['we', 'first  G'], ['', ''], ['candidate  miRNAs', 'first  G'], ['', ''], ['target genes', 'largest  proportion'], ['high  abundance', 'qRT expression PCR'], ['This', 'comprehensive  G'], ['which', 'further miRNA G'], ['', ''], ['', 'Elsevier B'], ['', ''], ['', 'Mycological Japan'], ['ciliary kinesin motor that', 'primary Hedgehog pathway cilium'], ['normal T cells', 'primary  cilia'], ['Kif7-deficient  Kif7-deficiency', 'DP thymocyte progenitor cell'], ['', 'selectively CD8 lineage'], ['Kif7-deficient T cells', 'when radiation vitro'], ['Kif7-deficient Hh thymocytes', 'Hedgehog signal'], ['', 'thymic epithelial cells'], ['NK cell activity', 'like killer cell receptors'], ['Diversity', 'disease outcome'], ['Sepsis development', 'immune  response'], ['critical  that', 'sepsis'], ['Male  patients', '14  years'], ['DNA samples', 'specific chain reaction primers'], ['frequencies', 'when sepsis controls'], ['', '23  55'], ['', ''], ['', '49  51'], ['', ''], ['', ''], ['', 'respectively Bonferroni correction'], ['activating', 'protective KIR sepsis'], ['', '2017 American Histocompatibility'], ['', 'Elsevier Inc'], ['rights', ''], ['conserved RNA that', 'DNA repair cell cycle progression'], ['promoting  function', 'Kin17'], ['', 'small cells lung cancer'], ['Elevated protein expression', 'benign lung lesion tissue'], ['Kin17 overexpression', 'patient lymph node prognosis'], ['knockdown', 'NSCLC cells'], ['knockdown', 'matrix metalloproteinase'], ['present  Kin17', 'benign lung lesion'], ['upregulation', 'important NSCLC cells'], ['Kin17', 'therapeutic  NSCLC'], ['Genetic  factors', 'environmental  stimuli'], ['major histocompatibility I', 'killing function'], ['aim', 'Iranian sclerosis population'], ['specific HLA I', '19 KIR genes'], ['DNA', 'specific sequence primer method'], ['4  genotypes', 'sclerosis  disease'], ['confounding  effects', 'two  combinations'], ['common MDD CIDI PHQ9', 'gold standard gold measure'], ['32  %', 'Spanish preference participants'], ['', 'higher  sensitivity'], ['', ''], ['', 'MDD CIDI SF items'], ['', ''], ['', ''], ['CIDI SF measures', 'depressive  symptomatology'], ['Implications', 'cultural  depression'], ['purpose', 'induced scald injury'], ['partial  which', 'child abuse'], ['further  parents', 'chronic  constipation'], ['induced  that', 'literature'], ['Diapers', 'induced risk dermatitis'], ['Surprisingly  dose', 'burn injury'], ['physicians', 'dermatitis mimicking buttocks'], ['Parents', 'over  children'], ['ionic  toxicity', 'aquatic alkyl chain organisms'], ['We', '1-alkyl-3-methylimidazolium  nitrate'], ['We', 'high performance liquid chromatography'], ['', 'present  study'], ['investigated reference ILs', 'water'], ['lethal  concentration', 'acute  zebrafish'], ['toxic  IL', ''], ['LC(50)s', 'similar  values'], ['ILs', 'aquatic alkyl chain organisms'], ['present  study', 'future  ILs'], ['growing  demand', 'optimal  vehicle'], ['depletion', 'electrified vehicle industry'], ['goal', 'abiotic depletion impact'], ['study', 'also Life Cycle Assessment'], ['LCA', 'seven impact methods'], ['energetic resources consumption', 'lastly mineral resources'], ['consumption', 'total life impact'], ['', 'impact method'], ['', ''], ['', ''], ['rights', ''], ['Purpose Application', 'innovative ground water treatment'], ['bottom valent which', 'strong reducing agents'], ['green sodium that', 'natural  products'], ['alternative  methods', 'sustainable  processes'], ['', 'critical synthesis nZVI'], ['economic  evaluation', 'different electricity production'], ['green synthesis method', 'first  scenario'], ['', 'traditional  synthesis'], ['extraction which', 'closely electricity production'], ['critical  that', 'sodium borohydride'], ['traditional synthesis method', 'green  synthesis'], ['green synthesis method', 'traditional  synthesis'], ['Lead', 'much Flint water crisis'], ['Pb', 'deleterious health humans'], ['discussion paper', 'environmental United States'], ['It', 'strong  WLLs'], ['', 'more water chemistry'], ['', 'regulatory Flint water crisis'], ['paper', 'well tap water'], ['increased  paper', 'L'], ['', ''], ['This', 'public health impacts'], ['important water we', 'health decision health making'], ['', ''], ['', ''], ['rights', ''], ['Eliminating', 'three phase photovoltaic'], ['current  elimination', 'four leg PV inverter'], ['', 'common leakage current'], ['based modulation methods', ''], ['new modulation strategy', 'current mode reduction'], ['different modulation methods', 'digital control platform'], ['experimental  results', 'proposed  solution'], ['human', 'important default mode network'], ['functional parcellation organization', 'exact  DMN'], ['spontaneous  fluctuations', 'behavioral  level'], ['revealed', 'task'], ['Here  they', 'seven coactivation subregions'], ['three  subregions', 'angular  gyrus'], ['three posterior subregions', 'semantic  processing'], ['functional  LIPL', 'functional  LIPL'], ['functional rest that', 'task processing'], ['', ''], ['clinical  anatomy', 'practical medicolegal questions'], ['surgery  modifications', 'personal child injury'], ['anatomical  methods', 'comprehensive  analysis'], ['rigorous  interpretation', 'forensic evaluation contexts'], ['', ''], ['', ''], ['', ''], ['', ''], ['negative soil that', 'leguminous  plants'], ['taxonomy', 'molecular biology techniques'], ['isolation', 'rhizobial plant species'], ['Here  we', 'edible  legumes'], ['bacterial  that', 'common  bean'], ['one  that', 'faba bean'], ['two  that', 'soybean Bradyrhizobium fredii'], ['that', 'common faba bean'], ['how  we', 'important  bacteria'], ['rhizobial  that', 'nutritional  future'], ['secreted  vesicles', 'protein virulence factors'], ['', 'capable recipient cell phenotype'], ['they', 'bystander cells'], ['exosomes', 'indeed Leishmania donovani'], ['We', 'short RNA sequences'], ['Exosomes', 'intact RNA RNase'], ['exosome RNA cargo', 'cell vitro'], ['exosomal majority', 'such RNA rRNA'], ['depth analysis', 'regulatory RNA functions'], ['Northern  blotting', 'small  exosomes'], ['novel  which', 'total cell RNA'], ['we', 'coding  L'], ['', 'L'], ['donovani', ''], ['leishmania exosomes', 'coding  RNAs'], ['where  they', 'host cell interactions'], ['', 'exosomal RNA L'], ['', ''], ['braziliensis', 'exosomal RNA leishmania'], ['small RNA which', 'therapeutic  approaches'], ['arthropod borne arthropod that', '2 million 2 people'], ['aims', 'endemic Leishmania Turkey'], ['where  cases', 'human  leishmaniasis'], ['five Paraphlebotomus Larroussius Adlerius', 'five  villages'], ['', 'abundant Phlebotomus tobbi'], ['LeishmaniaDNA', 'P'], ['', ''], ['', 'polymerase chain reaction'], ['LeishmaniaDNA', 'Phlebotomus L'], ['', 'Sergentomyia spp'], ['', 'real time PCR'], ['', 'caught  P'], ['', ''], ['2  %', 'engorged  specimens'], ['neglectus', 'important vector L'], ['', 'Aydn  province'], ['Transmission', 'endemic Czech Republic'], ['likely breeding dog', 'definitive laboratory diagnosis'], ['second generation offsprings', 'transplacental polymerase chain transmission'], ['obvious  vectors', 'also  areas'], ['', 'C Elsevier B'], ['', ''], ['serine tyrosine kinase which', 'tumor progression'], ['purpose', 'therapeutic thyroid cancer'], ['ELISA assay', 'protein serum'], ['Immunohistochemistry', 'polymerase chain LMTK3'], ['Flow cytometry', 'cell cycle'], ['terminal nick end labeling', 'cell apoptosis'], ['LMTK3 level', 'pathological lymph node metastasis'], ['LMTK3 level', 'benign thyroid tumor patients'], ['', ''], ['protein', 'benign thyroid tumors'], ['', 'retarded SW579 cells'], ['addition downregulation', 'SW579 cells'], ['findings', 'partly SW579 cells'], ['It', 'therapeutic thyroid cancer'], ['2 serum lipid polymorphisms', 'primary simvastatin hyperlipidemia'], ['We', 'primary response hyperlipidemia'], ['They', 'simvastatin'], ['Fasting serum lipids', '4  treatment'], ['Genotyping', 'fragment length polymorphism'], ['More  patients', 'bad response group'], ['', ''], ['patients', 'high QR baseline'], ['', 'good  responders'], ['consecutive  days', 'larger RR triglycerides'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'bad QR responders'], ['Bonferroni results', 'Bonferroni correction'], ['LEPR Q223R polymorphism', 'primary LEP hyperlipidemia'], ['Leprosy', 'infectious Mycobacterium leprae'], ['', 'diagnosed WHO 2014'], ['clinical  that', 'infected  individuals'], ['forms', 'tuberculoid M'], ['also  that', 'M'], ['', 'lepromatous leprae M'], ['regulatory  that', 'M'], ['leprae replication', 'bacterial  dissemination'], ['clinical  forms', 'immune  biases'], ['neurological  that', 'chronic  disabilities'], ['immune  that', 'clinical  leprosy'], ['injury acute disease muscle pain', 'bleeding disorders'], ['inflammatory  we', 'inflammation mouse model'], ['treatment', 'inflammatory tissue damage'], ['TNF alpha', 'immunosorbent  assay'], ['chemicals', 'kinase N terminal kinase'], ['inflammatory NF kappa B', 'epithelial protein mice'], ['increasing  use', 'human techniques Leptospira leptospirosis'], ['', 'different Leptospira isolates'], ['biological blood culture material', 'leptospires'], ['', ''], ['rights', ''], ['Lesch Nyhan syndrome', 'purine  Xq26'], ['', ''], ['', ''], ['', ''], ['', 'diagnostic  triad'], ['', ''], ['signs', 'genetic novel LNS'], ['2 % patients', 'neurological  SIB'], ['old  who', 'LNS'], ['boy', 'SIB  i'], ['', ''], ['he', 'venous sinus LNS'], ['', 'human treatment ineffectiveness'], ['cancers', 'numerous  chemotherapy'], ['serves', 'key leukaemia cells'], ['present  study', 'sensitive drug resistance'], ['cell proliferating activity', 'commercial testing kits'], ['AKT473/308 mammalian p AKT473/308 target', 'transcription quantitative polymerase chain reaction'], ['lactate glucose accumulation', 'lactate kinase activities'], ['K562 ADM cells', 'more HK II'], ['Notably  inhibition', 'potently anticancer agent'], ['K562 ADM which', 'directly glucose consumption'], ['glycolytic  this', 'signalling pathway'], ['Therefore  inhibition', 'relapsed multidrug leukaemia'], ['', 'acute  erythroleukemia'], ['results', '2014 cytogenetics molecular biology'], ['Flow cytometry analysis', ''], ['', ''], ['', ''], ['', ''], ['4  %', 'highly  AEL'], ['', '148'], ['8 AEL patients', '27  148'], ['common 5 one', '35'], ['', 'abnormal  17'], ['', ''], ['CEBPA mutation ratio', 'AEL patients'], ['', '0  NPM1as'], ['', ''], ['induced remission rate', 'AEL'], ['', '6  33'], ['', '3  MDSM6'], ['overall  survival', 'male'], ['', ''], ['overall survival time', 'significantly chemotherapy group'], ['', ''], ['old  group', 'second  place'], ['Patients', 'varying granulocyte erythrocyte'], ['Periodic acid Shiff reaction', 'erythroblast ortho AEL'], ['AEL', 'poor stem cell prognosis'], ['probabilistic  that', 'endogenous input parameters'], ['approach', 'nuclear power project'], ['correlation', 'significant model outcome'], ['', 'mean input leverages'], ['Moreover  paper', 'external  detail'], ['economic gas power viability', 'nuclear  project'], ['', ''], ['rights', ''], ['Analysis', 'novel tumor suppression'], ['Northern Tusc3 gene expression', 'such  cerebrum'], ['3 protein expression', 'molecular  size'], ['situ protein localization', 'such Leydig cells'], ['TUSC3', 'normal prostate development'], ['that', 'existential certainty security'], ['that', 'namely  inequality'], ['empirical  yield', 'questions'], ['We', '360000  participants'], ['ideological meta asymmetries', 'subjective reflection self threat'], ['', 'public demography opinion'], ['political self efficacy party', 'power'], ['some', 'political belief psychology'], ['when style it', 'when  them'], ['energetic  integration', 'renewable  energy'], ['Part', 'photovoltaic  panels'], ['massive  use', 'storable overproduction energy'], ['PtG  technology', 'then carbon dioxide'], ['economic Cycle Assessment', 'anaerobic sludge valorization'], ['Process studies', 'available equipment technologies'], ['biogas', 'annual electricity PtG'], ['longer operation time', 'methanation biogas'], ['Reduction', 'production costs'], ['technological  improvements', 'overall cost reduction'], ['continuous  PtG', 'significantly GHG emissions'], ['endpoint impact', 'much fossil energy'], ['Future development', 'renewable CO2 technology'], ['', 'C Elsevier Ltd'], ['wide intensity that', 'such  cornea'], ['industry safety standards', 'critical arc flash safety'], ['Accurate  measurement', 'first eye protection'], ['light measurement devices', 'detecting cadmium sulfide'], ['However response times', 'initial arc flash'], ['brightness', 'traditional light measurement devices'], ['CIE luminosity function which', 'ambient light conditions'], ['paper', 'traditional light measurement approaches'], ['design', 'human arc eyes'], ['results', 'arc eyes'], ['use', 'biological laser immunology'], ['Microperforation', 'genetic  engineering'], ['microwelding', 'genetic laser outfit'], ['specific  regions', 'whole  chromosomes'], ['Handling', 'diseased  cells'], ['optical microbeams heart tweezers', 'heartbeat'], ['Finally laser microbeams', 'living cancer'], ['Conversion', 'sustainable electricity production'], ['lignocellulosic biomass', 'high fuel efficiency'], ['microbial fuel novel', 'such polyoxo metalates'], ['efficiency  output', 'practical temperature fuel applications'], ['fuel that', 'low  temperatures'], ['specifically  we', 'fueled progress MFCs'], ['interesting  researches', 'also efficiency principles'], ['promising fuel it', 'promising fuel cells'], ['However power density', 'commercial  applications'], ['Improving', 'fermentable cell output power'], ['however exergy it', 'low  efficiency'], ['More  research', 'fundamental process mechanisms'], ['Expression profiling', 'somatic  embryogenesis'], ['qRT PCR', 'dynamic data reliability'], ['This', 'first miRNA expression Lilium'], ['', ''], ['', ''], ['', ''], ['coding reference candidates', 'two SE lilies'], ['Four normalization algorithms', 'also reference candidates'], ['', 'Lilium pumilum DC'], ['', ''], ['lpu U6', 'lpu miR408b'], ['', 'Lilium davidii var'], ['greater  half', 'best lda miR159a'], ['Further expression miR529', 'reference lilies'], ['', 'same Lilium genus'], ['This', 'other reference plants'], ['Many', 'common Charles ancestor'], ['Sir Richard Owen', 'focused middle man'], ['ensuing  decades', 'further tetrapod limbs'], ['what', 'natural year selection'], ['understanding', 'evolutionary limb size'], ['that', 'diverse  limbs'], ['article', 'morphological genomics diversity'], ['typical Limonium recretohalophyte', 'significant saline land'], ['Understanding', 'efficient salt gland L'], ['bicolor transformation which', 'report'], ['Leaf explants', 'selectable B resistance marker'], ['', '96'], ['9  %', 'Murashige  4'], ['', ''], ['acid M alpha roots', 'MS medium'], ['', ''], ['tissue culture system', 'mediated  L'], ['', ''], ['cultivated  explants', 'old  Agrobacterium'], ['', ''], ['4  explants', 'continued Agrobacterium growth'], ['transformation frequency', 'GUS gene'], ['', ''], ['Quantitative PCR', 'further GUS L'], ['', ''], ['This', 'based transformation L'], ['', ''], ['system', 'salt gland development'], ['intergenic noncoding RNAs', 'molecular  glioma'], ['Here  we', 'biological linc glioma'], ['current  we', 'normal glioma tissues'], ['Level', 'advanced tumor stage'], ['knockdown', 'tumor vivo'], ['mechanistic  studies', 'partially pathway activity'], ['linc OIP5', 'molecular  glioma'], ['', 'C Elsevier B'], ['', ''], ['QCD change algorithm', 'power system'], ['statistics', 'linearized power flow network'], ['transient voltage phase which', 'phasor measurement units'], ['adaptive  algorithm', 'composite hypothesis testing problem'], ['other outage detection algorithms', 'previously  literature'], ['Case studies', '118-bus test system'], ['digital work that', 'DC DC system'], ['algorithms', 'SoC design identification Chip'], ['identification process', 'actual  converter'], ['feedforward optimal which', 'discontinuous conduction mode'], ['proposed LQR controller', 'two  improvements'], ['zero tracking control inverse', 'minimum phase system'], ['proposed control strategy', 'autonomously mode detector'], ['proposed mode detector', 'greatly operating modes'], ['proposed  controller', 'boost converter'], ['proposed  controller', 'conventional LQR controller'], ['lipoprotein lipase that', 'HDL metabolism'], ['EL', 'endothelial  cells'], ['We', 'regulatory EL macrophages'], ['Macrophages', 'lipopolysaccharide  LPS'], ['expression', 'northern  blotting'], ['DiI LDL', 'low density lipoprotein'], ['LPS', 'oxidative EL mRNA macrophages'], ['LPS', 'like EL receptor'], ['LPS treatment', 'significantly EL+/+ mice'], ['Simvastatin', 'induced EL expression'], ['EL expression', 'macrophages'], ['Simvastatin', 'up  macrophages'], ['Thus  findings', 'atherogenic lipoprotein statins'], ['Sphingosine-1-phosphate', 'secondary lymphoid tissues'], ['S1P concentration', 'erythrocytes'], ['S1P release', 'dependent  transporter'], ['we', 'rapid S1P analog'], ['S1P', 'dependent  manner'], ['which', 'S1P erythrocytes'], ['Moreover  release', 'competitively intracellular S1P'], ['erythrocyte', 'NBD S1P'], ['We', 'lipid sample preparation assay'], ['Furthermore  we', 'successfully assay 0'], ['', ''], ['method', 'conventional S1P transporter fluorometers'], ['nonoleaginous yeast Saccharomyces that', 'eukaryotic  cells'], ['tools', 'genetic  manipulation'], ['function', 'biosynthetic  steps'], ['phosphatidic acid that', 'yeasts'], ['metabolic engineering that', 'microbial  lipids'], ['', ''], ['single cell TAG', 'final  processes'], ['same  comparison', 'fundamental  differences'], ['', ''], ['', 'oleaginous lipid Y'], ['', ''], ['These', 'more  Y'], ['where  biochemistry', 'oleaginicity'], ['Changes', 'gene expression'], ['that', 'key chromatin structure'], ['cholesterol', 'potential chromatin architecture'], ['molecular  mechanisms', 'chromatin structure'], ['nucleosome  cholesterol', 'nucleosome'], ['cholesterol', 'binding chromatin sites'], ['fascinating  processes', 'hydrophobic carapace molecules'], ['Interestingly  most', 'lipocalin'], ['that', 'system cDNA Macrobrachium'], ['We', 'spatial Northern Blotting analysis'], ['gene', 'faintly adipose hepatopancreas'], ['However  signal', 'other muscle gill'], ['maximal  level', 'just  molt'], ['', 'Elsevier Inc'], ['Important  insights', 'last oil water decade'], ['driving  interest', 'emulsified obesity lipids'], ['article', 'vitro  lipolysis'], ['where protein polysaccharide proteins', 'main  stabilizers'], ['mechanisms', 'critical lipids digestion'], ['', ''], ['rights', ''], ['Previous  studies', 'various animal models'], ['underlying  mechanism', 'ischemia reperfusion injury'], ['present  study', 'heme oxygenase-1 heme treatment'], ['epithelial  cells', 'H zinc protoporphyrin PPAR'], ['', ''], ['', 'mRNA expression PPAR'], ['HO-1', 'western polymerase chain reaction'], ['Binding  activity', 'chromatin immunoprecipitation'], ['Nrf2', 'electrophoretic mobility shift assay'], ['', 'glutamyl transpeptidase leucine aminopeptidase'], ['', 'mRNA expression PPAR'], ['', ''], ['', ''], ['MAPK pathway which', 'LXA(4)-induced  PPAR'], ['', ''], ['', 'H r injury'], ['', 'Nrf2 PPAR translocation'], ['', 'PPAR'], ['', 'LXA(4)-induced HO-1 expression'], ['protection', 'H R PPAR'], ['', 'nuclear HO-1 ARE'], ['Therefore  renoprotection', 'Nrf2-ARE HO-1 pathway'], ['mutation testing', 'small cell lung cancer'], ['digital polymerase chain which', 'invasive target diagnostic'], ['Here  we', '21 T790 exon'], ['activating  mutations', '21 EGFR TKI treatment'], ['Results', 'reference genomic detection assay'], ['', ''], ['sensitivity', 'corresponding mutation tumors'], ['', ''], ['', ''], ['7  %', 'previous  studies'], ['T790 M', '43 EGFR TKI treatment'], ['based dPCR assay', 'clinical EGFR settings'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['use', 'liquid  attention'], ['purpose', '3-phosphate telomerase reverse larynx'], ['', ''], ['We', '2 hypopharyngeal cancer'], ['blood sample', 'surgical  tumor'], ['We', 'real polymerase chain reaction'], ['', ''], ['surgery', 'diagnostic  value'], ['Detection', 'glottic  tumors'], ['', 'subsequent  recurrence'], ['', ''], ['', 'subsequent  recurrence'], ['', ''], ['', ''], ['free  survival', 'negative plasma samples'], ['', 'healthy plasma subjects'], ['', ''], ['', ''], ['', 'clinically  laryngeal'], ['', ''], ['PTC self heating EVs', 'low PTC power'], ['comparative heating experiments', ''], ['discharge capability', 'external discharge power'], ['further heating studies', 'heated temperature distribution pack'], ['heat generation rate', 'PTC materials'], ['numerically temperature heating', 'good  uniformity'], ['self heating method', 'low  temperature'], ['clearly  development', 'only fish immunologists'], ['insufficient  efficacy', 'inadequate vaccine design'], ['we', 'farmed fish species'], ['human vaccine we', 'recent fish mucosal immunology'], ['Finally  we', 'potentially aquaculture fish species'], ['', ''], ['', 'Elsevier Ltd'], ['', 'catalyzes carcinogenesis'], ['Little', 'hepatocellular  carcinoma'], ['We', 'paired  HCC'], ['48 Shanghai sets', 'specimens'], ['findings', 'reverse chain reaction analysis'], ['CHKA messenger RNA', 'polymerase chain reaction'], ['CHKA', '3 HCC cell lines'], ['Cells', 'wound healing migration'], ['Cells', 'tail mice'], ['Immunoprecipitation', 'immunofluorescence CHKA'], ['increased nontumor expression', 'CHKA loci'], ['survival times survival tumors', 'low  CHKA'], ['more HCC that', 'CHKA'], ['CHKA', 'mechanistic rapamycin complex'], ['HCC cells', 'metastatic xenograft inhibitors'], ['We', 'reduced survival patients'], ['Overexpression', 'mechanistic rapamycin complex'], ['coding  RNAs', 'liver disease'], ['Increased cyclooxygenase-2 Increased levels', 'also liver cirrhosis'], ['present  correlations', 'expression levels mRNA expression levels'], ['Liver fibrosis', 'carbon 2months'], ['histopathological  evaluation', 'hematoxylin'], ['Hepatic  expression', 'reverse polymerase chain reaction'], ['fibrotic control areas', 'times 2 M group'], ['LncRNA upregulation', 'cirrhotic  liver'], ['mRNA expression levels', 'fibrotic RNA expression area'], ['mRNA expression', 'positively lncRNA COX-2 expression'], ['expression', 'COX-2 liver fibrosis'], ['LncRNA COX-2', 'therapeutic liver fibrosis'], ['Background', 'long transplant patients'], ['MHC histocompatibility molecules', 'immune transplant recipients'], ['gene transfer', 'encoded  antigen'], ['alloantigen gene transfer', 'graft acceptance'], ['AAV MHC I', 'BALB c mice'], ['treated  mice', 'adenoviral term vector'], ['mice', '40 islet recipients'], ['mediated  expression', 'suppressive T properties'], ['generated  Tregs', 'pancreatic islet grafts'], ['specific Treg which', 'fully allogeneic graft'], ['Liver gene transfer', 'specific vivo tolerance'], ['Lay liver', 'immune  tolerance'], ['we', 'allogeneic transplantation'], ['first  the', 'regulatory T lymphocytes'], ['Tregs', 'pancreatic  animals'], ['Allogeneic transplantation', 'main end stage organs'], ['still graft treatments', 'serious side effects'], ['present  findings', 'specific vivo CD8(+'], ['', '2016 European Liver'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['Recent  years', 'natural community healthcare disease'], ['modifying  agents', 'promising bile acid results'], ['drug obeticholic drug acid', 'refractory line PBC'], ['International cohort studies', 'personalised disease progression'], ['Major  challenges', 'second line therapies'], ['tumor microenvironment', 'primary tumor formation'], ['cellular  components', 'tumor tumor therapy'], ['hepatic stellate which', 'immune tumor responses'], ['we', 'primary liver tumors'], ['therapeutic  approaches', 'immune liver cancer patients'], ['', 'Elsevier Inc'], ['Tec tyrosine kinase', 'differentially regenerating liver'], ['purpose', 'potential hepatocyte proliferation'], ['thirds kinase gene hepatectomy', 'representational difference analysis'], ['Tissue distribution', 'northern polymerase chain reaction'], ['Full rat Tec cDNA', ''], ['highest  Tec', 'fetal  livers'], ['expression level', 'neonatal  livers'], ['Similar  results', 'western blotting analyzes'], ['thus  Tec', 'hepatocyte proliferation'], ['Tec expression', 'rat livers'], ['increase', 'partial Tec hepatectomy'], ['growth factor', 'primary rat hepatocytes'], ['Tec gene expression', 'starved cell line HepG2'], ['Stimulation', 'dramatic Tec cells'], ['early response that', 'hepatocyte proliferation'], ['aim', 'metalloproteinase-8 liver transplantation'], ['Periodontal pocket depth', ''], ['Subgingival biofilm samples', 'common periodontal pathogens'], ['GCF Gingival crevicular samples', '2 scoring >'], ['following', 'statistical  analysis'], ['', '110  study'], ['Periodontal findings', 'significantly  groups'], ['higher  prevalence', 'Campylobacter group'], ['', ''], ['', '0 postLTx group'], ['more  patients', '1  group'], ['', ''], ['Furthermore aMMP-8 concentrations', 'preLTx  group'], ['', ''], ['Additionally aMMP-8 concentration', 'mild  periodontitis'], ['', ''], ['LTx', 'bacterial  LTx'], ['Determination', 'wrong  results'], ['synchronous  rectifier', 'two counter implementation'], ['on body diode time', 'well body diode conduction'], ['One', 'ripple switching detection'], ['ripple  which', 'high frequency LLC converters'], ['simple  implementation', 'few controller resources'], ['adaptive SR driving method', 'extra  cost'], ['', 'closed loop details'], ['Experimental  results', '500kHz 60MHz MCU'], ['small piecewise PI regulation', 'simulation'], ['many  that', 'controlled regulation regulators'], ['load factor', ''], ['objective', 'such step load transient'], ['which', 'transcriptional gene levels'], ['More  lncRNAs', 'other  diseases'], ['Previously  we', 'remodeling splicing regulation'], ['Application', 'technological  lncRNAs'], ['major  tools', 'RIP RNA purification'], ['we', 'lncRNAs lncRNA protein interactions'], ['Long noncoding RNAs', 'sporadic colorectal cancer'], ['', 'early stage colon cancer'], ['MSI  status', 'multiplex  PCR'], ['expression', 'microarrays'], ['expressed  lncRNAs', 'real polymerase chain reaction'], ['67  CC', 'MSI H'], ['1804  mRNAs', 'early stage CC'], ['expressed  mRNAs', 'angiogenesis apoptotic differentiation'], ['lncRNA  networks', 'expression  degrees'], ['2  lncRNAs', 'CC'], ['5', 'distant TNM population'], ['Differentially  lncRNAs', 'clinical pMMR CC'], ['years brightening that', 'global heat flow'], ['We', '70 Gemini 2013'], ['high  cadence', 'wavelength Loki Patera'], ['', ''], ['2006  model', 'three magma events'], ['particular  we', 'lava thermal lava data'], ['preferred  models', 'overturn front propagation 1'], ['', ''], ['', '1500 day m(2)/s'], ['time intervals', '540-day Rathbun et al'], ['', 'prior  2001'], ['fits', 'thermal  0'], ['', ''], ['', 'best  0'], ['average  that', ''], ['opposite clockwise what', 'past brightening events'], ['bright  phase', 'well propagating patera'], ['raised magma sea', 'raised topographic which'], ['', ''], ['rights', ''], ['sensitive medicine that', 'complex  infrastructure'], ['current detection technologies', 'own  limits'], ['plant molecular plant method', 'already species identification'], ['we', 'specific  L'], ['', 'internal transcribed spacer'], ['We', 'commercial  L'], ['', ''], ['HRM', 'L'], ['', 'common  adulterants'], ['HRM', 'fast  L'], ['', 'herbal  products'], ['HRM approach', 'herbal  authentication'], ['last  China', 'other water sectors'], ['efficient  management', 'projects'], ['experience', 'little  literature'], ['how  risks', 'which'], ['how  they', 'five PPP stages'], ['interrelationship', 'PPP stages'], ['questionnaire it', 'quantitative'], ['how  impacts', 'project stages'], ['Some', 'five PPP stages'], ['dynamic PPP water which', 'when risk mitigation strategies'], ['', '2017 Civil Engineers'], ['skin', 'interstitial  reservoir'], ['', 'tissue age inflammation'], ['This', 'inflammatory cell capacity'], ['how  NaCl', 'immune  cells'], ['how  salt', 'inflammatory T cell potential'], ['Na+  availability', 'novel  immunity'], ['Na+  levels', 'autoimmune  diseases'], ['that', 'substantial  response'], ['sources', 'electronic  factors'], ['electronic performance latter', 'optical  system'], ['electrical study analysis', 'geometric  errors'], ['component tolerances variations signal frequency', 'digital amplifier converter'], ['it', 'negligible results section'], ['reliance', 'sales states'], ['study', 'economic county 1990'], ['results', 'especially manufacturing industry'], ['Further  findings', 'possible  spillover'], ['manufacturing  industries', 'business activity'], ['more  people', 'personal  privacy'], ['TTP', 'single  failure'], ['alleviate', 'collaborative k anonymity'], ['users', 'anonymous range communication group'], ['user', 'other k users'], ['However  schemes', 'continuous  ones'], ['mobile  we', 'short query CaQBE'], ['then  caches', 'continuous  service'], ['collaborative user selection', 'passive impersonation attack'], ['', 'active  adversaries'], ['Finally security analysis', 'further  performance'], ['PTSD  who', 'posttraumatic control trauma cognitions'], ['Fifty  women', 'natal Depression Scale Control'], ['12  %', 'PTSD  partial'], ['Sixty two Sixty percent', '54 General Health Questionnaire-28'], ['who', 'depressive comparison group'], ['groups', 'control'], ['who', 'negative  self'], ['Posttraumatic  which', 'PTSD  morbidity'], ['Locus', 'psychological  outcomes'], ['negative  cognitions', 'trauma characteristics'], ['Women', 'psychiatric  symptoms'], ['how  they', 'negatively  themselves'], ['This', 'PTSD  symptoms'], ['we', 'bag image model'], ['several image modifications', 'literature'], ['variants', 'final classification step'], ['coding Fisher vector encoding', 'hard vector quantization'], ['little  attention', 'local  features'], ['we', 'popular classification Caltech-101'], ['novel keypoint detection that', 'computational keypoint sampling cost'], ['', ''], ['rights', ''], ['1788 New volume', 'Pierce London'], ['article traces', 'such plate series'], ['It', 'common guides poetry'], ['collective  lives', 'collective  which'], ['Social  attachment', ''], ['people', 'loneliness'], ['Loneliness', 'multiple adult factors'], ['However  little', 'schizophrenia'], ['58 control subjects', 'revised UCLA Loneliness scale'], ['Social cognition', 'self report questionnaire'], ['Social trait perception', 'facial  task'], ['medical  diagnoses', 'inpatients'], ['greater loneliness patients', 'greater loneliness controls'], ['loneliness', 'social self report cognition'], ['loneliness scores', 'drug abuse dependence hypertension'], ['Patients', 'social  isolation'], ['Loneliness', 'psychological  controls'], ['particularly  it', 'metabolic  population'], ['coding  RNAs', 'biological  processes'], ['Alterations', 'tumor formation progression'], ['several LET role', 'gastric  cancer'], ['aim', 'gastric cancer development'], ['expression levels', 'reverse polymerase chain reaction'], ['LET expression', 'gastric qPCR assay analysis'], ['Furthermore  impact', 'cell counting'], ['expression level', 'normal cell tissues'], ['Restoration', 'significantly cell vitro'], ['LET', 'gastric tumor cancer'], ['LET', 'gastric  cancer'], ['HSO LED which', 'on  implementation'], ['output voltage', 'SC boost converter output'], ['high power density', 'a SC converter system'], ['boost converter', 'output voltage'], ['introduced boost SC HSO', 'peak voltage switches'], ['Experimental  results', '3'], ['', '7  V'], ['introduced boost HSO converter', 'same power processing efficiency'], ['hemicellulose  which', 'cellular cell wall relaxation'], ['then expression profiles', 'different development stages'], ['I', 'rapid cDNA methods'], ['three  DIXET', 'different fruit growth'], ['Accumulation', 'fruit developmental fruit stage'], ['whole fruit development it', 'rapid aril growth stage'], ['longan DIXET1', 'primarily aril growth'], ['only  TDZ', '12  treatment'], ['36 h DIXET-3', 'whole  fruit'], ['56  NAA', 'NAA treatment'], ['', 'addition'], ['expression patterns', 'different tissue specificity'], ['different growth which', 'different growth stage'], ['', 'Elsevier Ireland Ltd'], ['', ''], ['', ''], ['', 'oil  components'], ['Genetic  approaches', 'ongoing soya bean breeding'], ['former', 'primary vegetable world'], ['primary  usage', 'human  consumption'], ['thereby soya bean we', 'steelhead soya bean trout'], ['marine aquafeed that', 'harvested Omega-3 fatty flesh'], ['genetic  that', 'added ketocarotenoid crop'], ['systematic  introduction', 'derived novel events'], ['Oxidative  stress', 'defence  damage'], ['Theoretically supplementation', 'functional antioxidant decline'], ['Yet supplementation trials', 'minimal animal success'], ['similarly vitamin C', 'oxidant  vivo'], ['widely vitamin self', 'healthy stress retard lifespan'], ['effect', 'significant energy metabolism'], ['oxidative  damage', 'supplemented  mice'], ['18  months', 'radical Mn superoxide dismutase'], ['additional down regulation', 'treated vitamin group'], ['positive vitamin benefits', 'oxidative protection damage'], ['', ''], ['rights', ''], ['important  that', 'longitudinal shape variation'], ['', 'longitudinal object configuration'], ['However  simplify', 'sphere regression type paper'], ['instances', 'great  baselines'], ['Euclidean risk function', 'smoothing smoother manner'], ['proper analysis objects', 'time'], ['proposed  models', 'real life datasets'], ['Little', 'midlife women'], ['study', 'milder follow up'], ['Black  women', '42 Nation Pittsburgh site'], ['Psychiatric  interviews', 'psychiatric  depression'], ['We', 'depressive depression disorder'], ['We', 'other MDD three'], ['', 'major lifetime depression'], ['', ''], ['', 'previous life year'], ['', ''], ['', 'other  three'], ['Persistent recurrent group', 'more family depression'], ['', 'current sleep problems'], ['', 'Single Episode MDD group'], ['', 'Small  minD'], ['maltreatment family depression history', ''], ['Persistent recurrent depression course', 'midlife'], ['current sleep problems', 'pernicious depression course'], ['', ''], ['', ''], ['rights', ''], ['quality', 'different substitute care'], ['study', 'foster child Nigeria'], ['wrong  they', 'own  countries'], ['study', 'residential Positive Relationship Scale'], ['child abuse measure', 'single  score'], ['subsequent  analysis', 'other child abuse'], ['even  abuse', 'settings'], ['child children', 'more  age'], ['', 'significant care abuse'], ['foster child carer relationships', 'residential  establishments'], ['Membrane type1 matrix metalloproteinase', 'matrix cell surface'], ['It', 'cell proenzyme'], ['soluble  form', 'loose arthroplasty endoprostheses'], ['aim', 'other activation state'], ['northern  blotting', 'one  transcript'], ['which', 'active C terminal site'], ['Cell ELISA', 'giant plasma proenzyme'], ['proteolytic sMT1-MMP TIMP-2 complex', 'interstitial  collagenase'], ['production mechanism', 'cell complex'], ['low dropout regulator', 'low D process'], ['tradeoff', 'transient response applications'], ['fine tuning technique', 'burst trade off'], ['under  overshoot', 'steady xi state'], ['limit cycle oscillation', 'negligible forward compensation power'], ['proposed D LDO', '60 mV voltage undershoot'], ['', 'steady mode-1 state'], ['LDO  regulator', '0'], ['13 m CMOS which', 'input 1'], ['', 'regulated output 1'], ['', '1 Spice circuit simulator'], ['operational Op Amp', 'error amplifier'], ['based Artificial Bee optimizer', 'other Op Amp'], ['approach', 'linear sub micron devices'], ['supply rejection ratio', '0 load mA'], ['', '1  KHz'], ['', '10  MHz'], ['', 'line mu regulations'], ['CYCIAE-100  cyclotron', 'beam Facility project'], ['cyclotron RF system', 'half wavelength cavities'], ['accelerating  voltages', 'LLRF control'], ['hybrid LLRF system', 'dee voltage stabilization'], ['analog subsystems designs', 'down conversion tuning control'], ['digital  system', 'Finite State Machine'], ['digital  parts', 'LLRF control'], ['brief system hardware introduction', '100 cyclotron LLRF system'], ['also  most', 'digital  parts'], ['', ''], ['', ''], ['rights', ''], ['avian Newcastle influenza', 'complicating Newcastle disease'], ['samples', 'infectious laryngotracheitis virus'], ['18/48  flocks', 'hemagglutinating  agents'], ['3  flocks', '17  AIV'], ['neuraminidase  all', 'LPAI H9N2 subtype'], ['F they', 'virulent type'], ['PCR results', 'etiological  agents'], ['', 'positive  flocks'], ['detection rate', 'sextuple  infections'], ['exacerbated  that', 'otherwise  field'], ['paper', 'low frequency identification tags'], ['inner  blocks', 'elementary stages rectifier'], ['AB bias', 'adaptive biasing form'], ['completely sampling voltage which', 'low power dissipation'], ['regulator output voltage', ''], ['07 output ripple', ''], ['', ''], ['value', 'supply rejection ratio'], ['', ''], ['', ''], ['', ''], ['111 W power consumption', '20 K omega load'], ['simulation', 'Cadence 0'], ['operational m CMOS frequency', ''], ['layout', 'proposed  regulator'], ['', ''], ['integrated CMOS circuit', '4  K'], ['application', 'astronomical readout observations'], ['We', 'operational FD SOI technique'], ['Ge BIB Ge which', '200  m'], ['first  we', 'Ge BIB 4'], ['', ''], ['result', 'cryogenic  ROICs'], ['Temperature', 'domestic  temperate'], ['previous  attempts', '10 degrees C'], ['alternative  that', 'such time reactors'], ['Batch reactors', '8 degrees C'], ['specific treatment rates', 'methanogenesis'], ['methanogenic degrees C', 'methanogenic  8'], ['', ''], ['', ''], ['putative hydrolysis rates', ''], ['', ''], ['', ''], ['', ''], ['Hydrolysis', 'sensitive  methanogenesis'], ['', ''], ['', ''], ['times  we', 'same  temperatures'], ['low wastewater that', 'Directive COD standards'], ['satisfactory cell concentrations', ''], ['', 'C Elsevier Ltd'], ['low  temperatures', 'related gene expressions'], ['', 'perennial  ryegrass'], ['accession', ''], ['It', 'present CBF proteins'], ['Southern  analysis', 'perennial ryegrass accessions'], ['differential promoter regions', 'putative promoter regions'], ['RT PCR LpCBF3', 'highest  1'], ['', 'cold  treatment'], ['downstream  gene', 'cold ryegrass treatment'], ['cold COR gene', 'perennial ryegrass accessions'], ['Cold treatment', 'perennial ryegrass accessions'], ['transgenic  overexpression', 'like 35S plants'], ['TAGAP activation Rho polymorphisms', 'celiac disease'], ['Therefore  we', 'relevant celiac disease'], ['PubMed databases', '2016 LPP rs1464510'], ['meta analysis', '7 LPP rs1464510'], ['minor  allele', 'carried odds 1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['respectively  which', 'increased celiac disease 10'], ['', ''], ['', ''], ['estimated  lambdas', ''], ['', ''], ['dominant  model', 'gene effects'], ['robust  polymorphisms', 'potential celiac European'], ['Prospective  studies', 'pathogenic celiac disease'], ['case control study', 'Chinese A379V population'], ['94 AP patients', 'case group'], ['score standard AP patients', 'MAP  group'], ['48 SAP patients', 'MODS MODS group'], ['who', 'physical control group'], ['A2 LP levels', 'immunosorbent  assay'], ['rs13989  polymorphisms', 'fragment length polymorphism'], ['', 'significant AP group'], ['SAP group', 'MODS group'], ['', ''], ['A G G C haploids', 'AP susceptibility'], ['A allele gene', 'independent risk AP'], ['', ''], ['gene polymorphisms V279F', 'AP'], ['epigenetic  that', 'transcription chromosomal structure'], ['Here  we', 'essential zeste PRC2'], ['Immuno precipitation GST assay', 'proteins'], ['MCF-7 cells', 'the'], ['western RT blot', 'real polymerase chain reaction'], ['MS analysis', 'proteins'], ['quantitative ChIP analysis', ''], ['LSD1', 'histone MCF-7 cells'], ['LSD1', 'common  genes'], ['LSD1', 'protein expression'], ['LSD1', 'EZH2 pathway'], ['LSD1', 'histone IRF9 gene locus'], ['proteomic interferon pathway', 'proteomic  approaches'], ['promoter which', 'key interferon pathway'], ['coordination', 'stimulated lock genes'], ['', 'C Elsevier Masson SAS'], ['exotic  options', 'standard volatility problem'], ['how  framework', 'three interest components'], ['Craig Sneyd finite difference which', 'still grid nodes'], ['blow', 'economic Lucilia importance'], ['skin', 'severe animal disease'], ['', 'considerable  L'], ['well biology it', 'well biology hosts'], ['recent blow which', 'molecular host level'], ['genomic  resource', 'fundamental research future'], ['present  article', 'L'], ['treatment prevention L cuprina genome', 'new  myiasis'], ['', ''], ['rights', ''], ['objective', 'human lung cancer cells'], ['We', 'recombinant AQP3 AQP3'], ['recombinant  expression', 'RT PCR'], ['assay flow cytometry', 'XVVLC-05 cycle process cells'], ['Then  activity', 'gelatin zymography'], ['Tumor formation', 'nude vivo mice'], ['XWLC-05 cell cycle', 'cell apoptosis'], ['activity', 'remarkably RNAi group'], ['AQP3 RNAi', 'nude tumor growth'], ['inhibition', 'XWLC-05 lung cancer MMP2'], ['', ''], ['rights', ''], ['poorly lung making', 'successful  therapies'], ['crucial  they', 'specific intracellular pathways'], ['Intersectin-1s', 'pulmonary multidomain adaptor diseases'], ['date', 'LC'], ['A549 LC stable', 'molecular myc biology'], ['microscopy mouse metastasis assays', 'microscopy xenograft tumor'], ['prevalent  protein', 'significantly human LC cells'], ['ITSN-1s protein level', 'LC cell proliferation'], ['immunodeficient  mice', 'metastatic A549 cells'], ['also  restoring', 'enhanced Eps8 oncoprotein'], ['unproductive  assembly', 'small GTPase Rac1'], ['Impaired Rac1 activation', 'decreased LC cell migration'], ['induced Eps8 ubiquitination', 'metastatic LC cells'], ['peripartum lung', 'physiologic gas exchange'], ['Protein synthesis', 'environmental  stresses'], ['translational control mechanisms', 'perinatal  lung'], ['56 ribosomal 56', 'sharp Postnatal Day'], ['phospho-56 staining', 'large  airways'], ['large eIF4 which', 'P1'], ['specific P1 association', 'large  polysomes'], ['RT PCR', '2 protein phosphatase'], ['gene  changes', 'polysome  abundance'], ['that', 'biochemical synthesis processing approaches'], ['where body storage it', 'subsequently  alveolus'], ['Surfactant phospholipid', 'molecular surfactant phospholipid species'], ['analytical  techniques', 'surfactant  metabolism'], ['Refinements', 'molecular phospholipid detail'], ['combination', 'molecular surfactant phospholipid'], ['it', 'clinical  studies'], ['how surfactant application', 'human surfactant subjects'], ['', 'GmbH'], ['rights', ''], ['', ''], ['LN', 'severe  SLE'], ['invasive  biomarkers', 'proliferative  LN'], ['', ''], ['We', 'renal SLE flares'], ['Healthy  controls', 'glomerular  diseases'], ['Modular  repertoire', 'microarray PCR'], ['', ''], ['', 'modular module M5'], ['15', 'strongly SLE LN'], ['', ''], ['15  activity', '17  %'], ['', ''], ['15', 'moderately CS dose'], ['', ''], ['15  activity', 'when  treatment'], ['', ''], ['higher CS it', 'also quiescent patients'], ['quiescent those', 'higher  M5'], ['', ''], ['', ''], ['15  activation', 'glomerular  diseases'], ['', ''], ['15  activation', 'present  LN'], ['', ''], ['Modular neutrophil signature', 'LN treatment'], ['Systemic lupus erythematosus', 'genetic  underpinnings'], ['review', 'clearer  therapeutics'], ['100  genes', 'defined lupus phenotypes'], ['traditional  which', 'traditional  therapies'], ['diagnostic  toolbox', 'new gene expression signatures'], ['This', 'clinical lupus SLE'], ['stability issue', 'forward Euler approximate model'], ['considered control law', 'disconnected level sets'], ['Lyapunov function', 'forward Euler approximate model'], [\"continuous time Lur'e system\", 'proposed digital control law'], ['relevance', 'numerical  example'], ['We', 'pregnant mare serum gonadotropin'], ['mRNA levels', 'pretreatment rat Day'], ['5  levels', '3-fold control levels'], ['cultured  uterus', 'cAMP  medium'], ['receptor proteins', 'epithelial  endometrium'], ['functional  LHRs', 'immature hCG treatment'], ['LH', 'ovulation'], ['study', 'LHR'], ['binding  that', 'many  tomato'], ['similar  genes', 'allergen Lyc 1'], ['', ''], ['', ''], ['aim', 'transgenic RNA interference'], ['Northern gene blotting', 'immunoblotting skin prick testing'], ['remaining profilin accumulation', '10-fold untransformed controls'], ['decrease', 'allergenic skin prick tests'], ['most  patients', 'widely tomato individuals'], ['1-diminished tomato RNAi', 'reduced  food'], ['simultaneous  silencing', 'multiple hypoallergenic tomatoes'], ['allergenic  concept', 'novel allergen avoidance'], ['Isolation', 'secondary tree cells'], ['efficient RNA extraction which', 'high lychee tree'], ['utilized EDTA LSS', 'successfully RNase activities'], ['ionic  strength', '2 M NaCl'], ['secondary  metabolites', 'deoxidized sodium condition'], ['RACE blotting RNA', 'subsequent gene expression analysis'], ['method', 'other plant species'], ['protocol', 'recalcitrant plant tissues'], ['generally  known', 'inflammatory  lycopene'], ['', 'inflammation'], ['human colorectal cancer cells', '10 20 10 lycopene'], ['MTT assay', 'cell proliferation'], ['Western  blotting', 'nuclear factor kappa B'], ['Real polymerase chain reaction', 'tumor necrosis factor'], ['Concentrations', 'immunosorbent  assays'], ['mRNA expression', 'dependent TNF manner'], ['', ''], ['', 'lycopene concentration'], ['', ''], ['protein expressions', 'significantly lycopene concertation'], ['', ''], ['JNK which', 'human colorectal cancer cells'], ['GLU GLU AFP', 'tomato cv'], ['', 'mediated Micro method'], ['Transformants', 'staining  PCR'], ['blotting  analysis', 'transcription level'], ['three  copies', 'nuclear  genome'], ['transgenic tomato lines', 'nontransgenic dose effect'], ['alfAFP  genes', 'synergistical  R'], ['', ''], ['independent  lines', 'further disease studies'], ['red chicken little', 'different  compartments'], ['present  role', 'LPS chicken stimulation'], ['capillary', 'chicken'], ['sheathed addressin cell which', 'endothelial  chicken'], ['LPS', 'sheathed  chicken'], ['rout', 'red white pulp'], ['mRNA  levels', '1 LPS stimulation'], ['mechanism', 'linked protein kinase B'], ['firstly lymphocyte homing', 'induced  inflammation'], ['possible  lymphocyte', 'infectious  disease'], ['review', 'major lymphoma predisposition'], ['We', 'mechanisms'], ['mediated lymphoma we', 'depth'], ['We', 'critical lymphoma risk assessment'], ['Clinical  application', 'personal risk assessment'], ['Lastly  we', 'well lymphoma lymphoma'], ['anomalous  distribution', 'adhesive cell surface adhesion'], ['', 'M'], ['genome sequence analysis', 'subfamily  M'], ['extensively  function', 'proteins'], ['review', 'M'], ['', 'host cell'], ['particular  effort', 'several PGRS protein M'], ['', 'host pathogen interactions'], ['Effect', 'calcium phagocytosis'], ['Furthermore FnBP', 'immune  response'], ['', ''], ['tuberculosis entry mechanism', 'new novel M'], ['tuberculosis FnBP', 'selective  therapeutics'], ['', 'International Union International Biochemistry'], ['', ''], ['emerging  that', 'lung diseases'], ['Recent  findings', 'designated abscessus bolletii'], ['We', 'English language subspecies'], ['human  infections', 'environmental  M'], ['abscessus', 'reservoir'], ['Basic research', 'other gene bacteria'], ['', 'bacteriological  M'], ['abscessus', 'molecular  biology'], ['Genotypic phenotypic testing', 'macrolide  clarithromycin'], ['Genotyping methods', 'common  source'], ['outcomes', ''], ['', ''], ['abscessus', 'clinical  research'], ['well host pathogen interactions', 'ecology  routes'], ['human  it', 'effective  regimens'], ['secreted tumor that', 'many tumor metastasis'], ['We', 'gastric Mac-2BP cancer'], ['negative cell which', 'parental SW13 cell'], ['induced Mac-2BP expression', 'RT PCR'], ['flow cytometric Mac-2BP protein', 'mock  control'], ['overexpressed  hTERT', 'specific'], ['Mac-2BP expression', ''], ['Mac-2BP levels', 'Northern blot analysis'], ['Mac-2BP protein', 'normal tumor tissues'], ['Mac-2BP', 'healthy cancer donors'], ['elevated serum Mac-2BP level', 'distant tumor metastasis'], ['', ''], ['', ''], ['Mac-2BP', ''], ['it', 'metastatic stomach cancers'], ['', ''], ['Several simian adenoviruses', 'zoonotic disease transmission'], ['Here  we', 'fecal polymerase chain samples'], ['', 'fecal  samples'], ['', '87  monkeys'], ['7  %', 'AdV  infection'], ['infected  individuals', ''], ['Phylogenetic  analysis', 'AdV  genotypes'], ['Chinese Macaca which', 'supporting  evidence'], ['Affective  coldness', 'main  Machiavellianism'], ['affective  blunting', 'negative  distress'], ['We', 'neuropsychological emotion level'], ['emotional  Machiavellianism', 'mindedness  instability'], ['evocative reappraisal pictures', 'different Affective Picture contexts'], ['They', 'new  title'], ['', ''], ['', 'labeled  ones'], ['task performance Machiavellians', 'increased emotion amygdala'], ['Machiavellian  individuals', 'social  situations'], ['temporal  Machiavellians', 'emotional  stimuli'], ['intense  that', 'environmental  changes'], ['cognitive  processes', 'behavior'], ['flexibility approach', 'rational emotion thinking'], ['resistive memory devices', 'neuromorphic  systems'], ['that', 'resistive  synapses'], ['integrate neuron that', 'resistive mode synapses'], ['proposed  design', '0'], ['', ''], ['Measurements', 'associative  learning'], ['neuron circuit', 'small  0'], ['', 'energy efficiency 9'], ['', ''], ['correct coding region identification', 'molecular biology field'], ['problem', 'conservative messenger RNA'], ['Therefore  it', 'computational Translation Initiation Sites'], ['', 'inductive Support Vector Machine'], ['much  attention', 'such Support Vector Machine'], ['well  amount', 'labeled  ones'], ['rapidly Genome that', 'new  organisms'], ['Consequently  work', 'inductive TIS method'], ['transductive  inference', 'inductive F TIS'], ['Additionally  it', 'smaller False ISVM'], ['Rattus Mus musculus Homo', 'Drosophila melanogaster'], ['transductive  method', 'also F ISVM'], ['ISVM  approaches', 'available web interface'], ['approaches', 'satisfactory Miner NetStart results'], ['results', 'ISVM'], ['application', 'specially F measure'], ['which', 'identified study databases'], ['symbolic  macromodel', 'SC  work'], ['model', 'behavioral time domain'], ['symbolic  adjustment', 'directly transistor level need'], ['proposed modeling methodology', 'operational SC amplifiers'], ['step response waveforms', 'about level simulation 20x'], ['paper', 'operational compressor circuit design'], ['macromodel', 'singlepower  supply'], ['output waveforms', 'double power supply'], ['output voltages', 'larger input 200mV'], ['other output voltages', 'whole  region'], ['that', 'single compressor circuits'], ['electrostatic  forces', 'macromolecular  interactions'], ['However  calculating', 'shaped  water'], ['DelPhi that', 'electrostatic biomolecular systems'], ['', 'triquadratic interpolation methods'], ['corresponding  errors', '4  grids'], ['DelPhiForce', 'three protein protein complexes'], ['mutual  orientations', 'partners'], ['VMD', 'additional protein protein binding'], ['DelPhiForce', 'DelPhi http://compbio'], ['', ''], ['', ''], ['', ''], ['', ''], ['Mucosal immunity', 'aberrant  inflammation'], ['innate chemokine receptor CX3CR1', 'strategically gut epithelial barrier'], ['however  role', 'blown  inflammation'], ['we', 'acute dextran sulphate colitis'], ['KO mice', 'colonic WT macrophages'], ['expression', 'higher KO production'], ['intestinal CX3CR1 that', 'damage'], ['', 'C  GmbH'], ['rights', ''], ['works', 'European Richard modernism'], ['influence', 'symbolist  them'], ['conservative  that', 'scholarly  literature'], ['he', 'classical  Wagner'], ['political  that', 'back motivic Beethoven'], ['Magnesium silicide', 'mid temperature range'], ['However  synthesizing', 'inhomogenous processing stoichiometry'], ['alternative  method', 'pure nano crystalline Bi'], ['', ''], ['', 'spark SPS'], ['Mg2Si EDS', 'homogeneity'], ['superior power factor', '550 degrees C'], ['', ''], ['', ''], ['rights', ''], ['psychiatric  that', 'poor stroke patients'], ['aim', 'Chinese serum magnesium patients'], ['hundred nine stroke patients', 'study'], ['Depressive  symptoms', '3 Rating stroke'], ['Based', 'depressive DSM IV PSD'], ['Serum magnesium levels', 'colorimetric  admission'], ['Multivariate analyses', 'logistic regression models'], ['serum magnesium levels', 'also  control'], ['', 'fifty nine fifty patients'], ['2  %', 'PSD'], ['serum magnesium levels', 'normal PSD subjects'], ['', ''], ['Indeed  patients', 'lower serum magnesium levels'], ['PSD  patients', 'admission'], ['increased  risk', 'serum magnesium levels'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Low serum magnesium levels', '3  stroke'], ['combination', 'such colloidal PCR'], ['present  work', 'potential PCR components'], ['Several  types', 'Transmission Electron Microscopy'], ['Colloidal stability', 'PCR thermo cycling'], ['stabilized  MIONs', 'best PCR room'], ['Citrate', 'comparable PCR concentration'], ['1 mg inhibition', '0'], ['', ''], ['PCR', 'critical reaction components'], ['', ''], ['', ''], ['rights', ''], ['Early  integration', 'mining minerals processing sites'], ['how  integration', 'magnetic modelling separator'], ['magnetic separator unit model', 'mineralogical sustainability indicators'], ['overall  sustainability', 'developed grade iron model'], ['use', 'ore study'], ['measures', 'separation sustainability indicator ratings'], ['magnetic separator sustainability indicators', ''], ['indicator', 'weighting importance'], ['11 reliability Carbon dioxide', 'mineralogical feed ore'], ['therefore ore values', 'different feed ore grades'], ['WSM Sum methods', 'particular ore feed'], ['Results', 'mineralogical feed attributes'], ['results', 'single sustainability indicators'], ['', ''], ['rights', ''], ['single molecule that', 'numerous  physics'], ['magnetic  number', 'original  strengths'], ['molecular biology solutions', 'possible  applications'], ['multiple  DNAs', 'remarkable  macromolecules'], ['several tweezers that', 'versatility'], ['on  that', 'microfluidic  circuits'], ['We', 'fabricated  devices'], ['We', 'valve valve'], ['We', 'reversibly valve channels'], ['We', 'microfabricated flow rate 0'], ['', ''], ['', 'best valve closure'], ['fabrication', 'small polymer microfabrication size'], ['valve structures', 'diagnostic flow devices'], ['', ''], ['limited  studies', 'natural  transmission'], ['insect that', 'specific polymerase chain primers'], ['', 'similar  1'], ['DNA fragment', 'major leafhopper species viz'], ['', 'symptomatic variety CoS'], ['', 'BLASTn 1'], ['symptomatic sugarcane leafhoppers', 'reported Candidatus Phytoplasma oryzae'], ['', 'SCGS rRNA M'], ['', ''], ['', ''], ['indicus phytoplasma strains', 'phylogenetic  Ca'], ['', ''], ['', ''], ['Transmission tests', 'further population sampling that'], ['', ''], ['unimaculata', 'healthy sugarcane plants'], ['leafhopper  species', 'SCGS  phytoplasma'], ['however maize changes', 'cold maize stress'], ['line W9816', 'chilling abundance protein stress'], ['quantitative  proteomic', 'study'], ['173  DAPS', 'chilling  stress'], ['108  DAPS', '99 KEGG pathways'], ['iTRAQ results', ''], ['adaptive  response', 'overall protein ROS'], ['important  maize', 'chilling  stress'], ['major  challenge', 'chilling maize stress'], ['extensive  researches', 'chilling transcriptomics molecular maize'], ['adaptive  response', 'overall protein species enzymes'], ['important  maize', 'chilling  stress'], ['biological ion that', 'chilling stress response'], ['', ''], ['', ''], ['rights', ''], ['immunologic  studies', 'major serotonin depression'], ['aim', 'depressive blood mononuclear disorder'], ['5-HT3A receptor mRNA expressions', 'free MDD patients'], ['mRNA expressions', 'real time quantitative PCR'], ['study', 'clinical Rating Scale-17 items'], ['mRNA  expression', 'healthy MDD controls'], ['', ''], ['', ''], ['MDD patients', 'expression  scores'], ['', ''], ['', ''], ['', ''], ['', ''], ['depressed  patients', 'healthy  subjects'], ['mRNA  levels', 'MDD illness'], ['clinical  symptoms', 'childhood psychopathology'], ['aim', 'gray childhood MDD'], ['Differences', 'magnetic resonance imaging'], ['further MDD comparisons', '11 child abuse'], ['healthy MDD patient group', 'occipital  cuneus'], ['patient group', 'cerebellar cortices putamina vermis'], ['MDD patient subgroup', 'postcentral  abuse'], ['findings', 'subcortical  MDD'], ['possible  reduction', 'orbitofrontal body perception'], ['MH class II receptors', 'immune  systems'], ['function', 'CD4  cells'], ['Variation', 'various  diseases'], ['Very  little', 'teleost class II date'], ['we', 'polyclonal expression genes'], ['class II alpha', 'rainbow trout'], ['class II beta', ''], ['Northern  expression', '5 degrees C'], ['2 degrees C downregulation', 'Northern protein blotting'], ['important  role', 'cold water disease'], ['', 'negative Plasmodium falciparum'], ['technical mitochondrial DNA sequence', 'PCR Plasmodium'], ['specific  primers', 'c oxidase P'], ['', ''], ['', ''], ['clinical  which', 'thick blood smears'], ['amplified PCR segments', 'results'], ['positive  64', 'P'], ['', ''], ['Nine  samples', ''], ['vivax mono infection', '3 co P'], ['falciparum gametes', 'P'], ['', 'PCR amplification'], ['Sensitivity', ''], ['Results', 'PCR method'], ['Malaria', 'continued world health illness'], ['World Health Organization', 'suspected  malaria'], ['where  HIV', 'especially  populations'], ['8 Bamenda we', 'bright field microscopy'], ['Peripheral blood samples', 'suspected  GS'], ['nested PCR assay', 'two gold methods'], ['', ''], ['ninety nine hundred ninety samples', 'final  analysis'], ['Of', 'PCR'], ['', 'mean  19'], ['', ''], ['', '99  GS'], ['mean  NPV', ''], ['', ''], ['', '28  GS'], ['Sensitivity', ''], ['67  %', 'groups'], ['', ''], ['', '21  GS'], ['diagnostic skill which', 'FM'], ['frequency', 'clinical  suspicions'], ['malaria that', 'less  FM'], ['PPV', 'limited cost environments'], ['physician  education', 'overtreatment'], ['larger  study', 'available  RDTs'], ['Four  species', 'vivax Khanh Phu commune'], ['latter  species', 'wild macaque region'], ['three transmission we', 'same  region'], ['specific  we', '3 pfg377 pvs25 P'], ['', ''], ['', ''], ['', ''], ['knowlesi', ''], ['specific  mRNA', '47  P'], ['', ''], ['', ''], ['', ''], ['', ''], ['70  that', 'P'], ['human malaria mosquitoes', 'P'], ['', 'human  infections'], ['Malaria', 'million Plasmodium deaths'], ['Pf life cycle', 'morphological  transformations'], ['where blood they', 'sexual  gametocytes'], ['symptoms', 'asexual blood stage parasites'], ['Flow cytometry methods', 'live  DNA'], ['imaging flow we', 'parasite blood stages'], ['technique', 'Pf iRBCs cultures'], ['morphological  we', 'robust parasitemia profile'], ['new  method', 'research screen assays'], ['', ''], ['rights', ''], ['Sensitive  methods', 'low endemicity malaria'], ['PCR techniques', 'molecular nucleic methods'], ['However  most', 'epidemiological  studies'], ['developed  capture', 'high screening purposes'], ['where malaria elimination', 'sight'], ['parasite CLIP PCR', 'northeastern  Myanmar'], ['100 mu RNA', 'dried blood filter paper'], ['sensitivity', 'conventional  light'], ['Pvs25 gene', 'gametocyte samples'], ['Light microscopy', 'only Plasmodium 1'], ['19  %', 'parasites'], ['CLIP PCR', 'better Plasmodium 1'], ['', '89  population'], ['nested  which', 'P'], ['', 'vivax falciparum 2'], ['', '39  residents'], ['nested RT PCR targeting', 'as  187'], ['', '61 Plasmodium P'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['large  proportion', 'asymptomatic  individuals'], ['', 'molecular parasite detection'], ['molecular  which', 'smaller RNA input'], ['where  malaria', 'still  south'], ['pregnant  who', 'Vapi Salavan Provincial Hospital'], ['Peripheral  malaria', 'diagnostic  tests'], ['maternal birth anaemia', 'low birth weight'], ['', '12/204  5'], ['', ''], ['', ''], ['9', 'TBS'], ['History', 'higher  MiP'], ['', ''], ['', ''], ['', ''], ['two falciparum submicroscopic infections', 'delivery'], ['', ''], ['', ''], ['', 'Vapi District'], ['86 bed %', 'week food median'], ['94  half', 'anaemia'], ['24  %', 'women'], ['Factors', 'higher  LBW'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Factors', 'maternal Lao Theung ethnicity'], ['prevalence', 'population'], ['vivax  which', 'national  Laos'], ['', ''], ['performance', 'low endemicity settings'], ['', ''], ['qualitative polymerase chain PCR', 'reference standards'], ['positive  we', 'epidemiological  factors'], ['', ''], ['', '1353  patients'], ['', 'positive  185'], ['2  %', 'negative  testing'], ['', 'predictive sensitivity RDTs'], ['', ''], ['', ''], ['', ''], ['', ''], ['100 mu which', '75'], ['', 'negative  results'], ['sensitivity specificity sensitivity PPV', 'PCR detectable PCR infections'], ['', ''], ['', ''], ['', ''], ['', ''], ['Deletions', 'pfhrp2'], ['recent malaria health facility', 'testing characteristics'], ['', ''], ['low transmission we', 'symptomatic density subjects'], ['PPV', 'further  investigation'], ['point  diagnostic', 'malaria elimination efforts'], ['effective malaria vaccine', 'research  efforts'], ['This', 'pathogenic blood stage infection'], ['attractive vaccine they', 'immune system attack'], ['We', 'clinical vaccine models'], ['PE vaccines', 'broad  infection'], ['recent  innovations', 'synergistic vaccine approach'], ['preclinical  assays', 'further malaria infection effort'], ['Emergence', 'future malaria malaria'], ['Therefore  objective', 'insecticide Anopheles mosquito'], ['international profile citation journals', 'insecticide  resistance'], ['Scopus search which', 'relevant  data'], ['Keywords', 'available  topic'], ['duration', '1996'], ['', 'original research articles'], ['37  %', ''], ['average  number', 'article'], ['', ''], ['linear regression analysis', ''], ['', 'extra pyrethroid resistance'], ['total', 'retrieved  articles'], ['United Kingdom', 'first United America'], ['productive  countries', 'African  countries'], ['UK', 'relative link 46'], ['total', 'retrieved institution/ articles'], ['active institution/ organization', 'Tropical Medicine'], ['Retrieved articles', 'peer  journals'], ['that', 'most  topic'], ['', ''], ['active South two', 'UK'], ['Three', 'cited Molecular Biology journal'], ['least pyrethroid two', 'DDT resistance'], ['Publications', 'past malaria decade'], ['International collaborations', 'endemic malaria'], ['Molecular biology', 'emerging  problems'], ['genus  Malassezia', 'human commensal skin'], ['yeasts', 'parenteral nutrition catheters'], ['Very  little', 'Malassezia epidemiology'], ['This', 'mainly  species'], ['Currently  identification', 'morphological  characteristics'], ['they', 'certainty'], ['aim', 'flight mass spectrometry'], ['isolates', 'French university hospitals'], ['strain', 'transcribed spacer sequencing'], ['', 'six Forty species'], ['', ''], ['', ''], ['', ''], ['', ''], ['pachydermatis', 'MALDI TOF database'], ['other  strains', ''], ['strains', 'log >'], ['', 'criteria'], ['Repeatability', '10 log score %'], ['new Malassezia database', 'fast Malassezia species'], ['Implementation', 'better Malassezia epidemiology'], ['sterile  line', 'mediated Arabidopsis transformation'], ['bacterium', 'plasmid 1'], ['male sterility latter', 'CaMV 35S promoter'], ['all', 'male PCR extent'], ['MNX which', 'higher  degree'], ['also  transgenes', 'transgenic  generation'], ['sterile  plants', 'deeper pollen lobes'], ['pollen mother abortion', 'polar amitosis chromosomes'], ['study', 'important  crops'], ['Maleic acid', 'industrial food additives'], ['intentional food it', 'human maleic health'], ['However  influence', 'human maleic health'], ['', 'nervous system human'], ['aim', 'neuronal maleic cells'], ['transcriptome  profiling', 'human maleic health'], ['Gene expression profiles', '24 mu h'], ['dependent  manners', 'further enrichment analysis'], ['expression profile', 'quantitative polymerase chain reaction'], ['Specific fluorescence probes', 'neuronal maleic cells'], ['total', 'upregulated maleic acid'], ['DNA binding DNA binding', 'neuronal maleic acid'], ['Maleic acid exposure', 'dependent  manner'], ['levels', 'also maleic acid'], ['exposure', 'transcriptional maleic levels'], ['study', 'neuronal maleic acid'], ['It', 'experimental silico toxicogenomics'], ['proposed  approach', 'human  health'], ['when child one', 'childhood'], ['', 'widespread intervention Canada'], ['', ''], ['mixed mistreatment we', 'generational  trauma'], ['paper', 'innovative practice perspectives'], ['', ''], ['', 'Elsevier Masson SAS'], ['rights', ''], ['alpha Farnesene', 'natural apple fruit'], ['Oxidation products', 'superficial  apple'], ['encoding', 'farnesyl apple fruit'], ['', ''], ['GenBank AFS-1 sequences', 'deduced amino acid sequence'], ['Southern  blotting', 'one  apple'], ['10  apples', 'cold room temperature'], ['Expression', 'AFS DPA'], ['biosynthetic  that', 'cellular  factors'], ['Analysis', 'molecular stress nucleolus'], ['Here  we', 'mammalian rRNA cells'], ['We', 'large rRNA RNAs'], ['multiple ratio that', 'rRNA processing steps'], ['effects', 'mandated maltreatment reporting laws'], ['better  objectives', 'mandated reporting law change'], ['We', 'county level U'], ['', ''], ['National Child Abuse', 'concurrent maltreatment child'], ['universal clergy reporting which', 'even  child'], ['Universal reporting', 'psychological clergy reporting reports'], ['physical abuse neglect', 'psychological  reports'], ['that', 'pronounced clergy reporting laws'], ['changing', 'meaningfully child maltreatment identification'], ['', ''], ['rights', ''], ['new  evolution', 'similar phenotypic traits'], ['molecular  biology', 'new  habitat'], ['collectively mangrove trees', 'dramatic  examples'], ['high salinity hypoxia', 'genomic  features'], ['Here  we', 'genomic  mangroves'], ['CCS method', 'ancestral  character'], ['400  that', 'nonmangrove relatives'], ['embryo which', 'new  habitat'], ['transcriptional  that', 'oxidative stress response'], ['Transcription', 'typically self iron'], ['pathogen Mannheimia attempt', 'transcriptional  M'], ['', ''], ['Northern blotting RT PCR', 'primer that'], ['distinct  two', 'upstream fldA gene'], ['third  promoter', 'tricistronic  message'], ['real PCR experiments', 'current Fur regulation M'], ['haemolytica fur transcription', 'stationary iron phase'], ['', ''], ['', ''], ['rights', ''], ['mannosylerythritol lipids', 'emulsifying  properties'], ['MEL', 'MEL A'], ['Burman design surface methodology', 'culture nutrients'], ['optimal medium', 'g L yeast extract'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['yield', 'MELs'], ['', ''], ['', ''], ['unstructured kinetic model', 'mycelial growth MEL utilization'], ['work', 'fungus MEL A'], ['Optimization', 'mannosylerythritol lipid recovery'], ['Importantly  we', 'mannosylerythritol lipid production'], ['', ''], ['rights', ''], ['Nowadays  introduction', 'such manufacturing Industry'], ['', 'Cyber China'], ['effective supply demand', 'common manufacturing issues'], ['academic research concept', 'manufacturing service SDM paper'], ['based  architecture', 'statistical strategies analysis'], ['SDMSim', 'related manufacturing service researchers'], ['', ''], ['rights', ''], ['', 'operational pixel matrices'], ['Monte Carlo simulations', 'global parameter variation'], ['paper', 'quantized Markov jump output'], ['such system outputs', 'transmission'], ['Attention', 'unknown transition probabilities'], ['exact  information', 'transition probabilities matrix'], ['quantization error', 'bounded model transformation'], ['filtering error system', 'stochastically attenuation performance index'], ['Finally simulation results', 'proposed  results'], ['', ''], ['', ''], ['rights', ''], ['audience', 'communicative  interactions'], ['human  primates', 'given audience time'], ['vocal  behaviour', 'multiple audience decisions'], ['virtual  each', 'vocal  behaviour'], ['signalling  paradigm', 'communicative  decisions'], ['making  strategies', 'immediate communication network'], ['', 'similar Hellas 4'], ['', ''], ['', 'fracture scarps grabens'], ['numerous lobate scarps', 'Late Amenthes Rupes'], ['we', 'prominent lobate scarps'], ['We', '38  uncertainty'], ['low  surface', 'similar heat flow Mars'], ['upper circum Hellas that', 'whole  crust'], ['', ''], ['rights', ''], ['Marsupials', 'immune  protection'], ['marsupial complement expression', 'specific complement proteins'], ['We', 'tailed liver phascogale'], ['Conservation', 'translated phascogale C3 CFP'], ['Gene expression', 'old liver animals'], ['Average complement expression', 'own complement system'], ['pouch  results', 'average C1r MASP2'], ['average complement expression', 'significantly  adulthood'], ['', ''], ['rights', ''], ['present  study', 'clinical degree variables'], ['18  FDR', 'healthy  controls'], ['capacity', 'false Social Cognition'], ['which', 'neurocognitive  performance'], ['ToM deficits', 'cognitive trait deficit'], ['Further  research', 'such ToM assessment MASC'], ['Understanding', 'molecular biology purpose'], ['which', 'proteomic  studies'], ['Here  we', 'mass desorption electrospray ionization'], ['Preparation', 'spatial DESI analytes'], ['we', 'schizophrenia postmortem brains'], ['results', 'molecular MS disease'], ['', ''], ['', ''], ['rights', ''], ['', 'real time PCR'], ['assay', 'different bovine lactation'], ['fresh quarter milk that', 'PCR'], ['standard  protocol', 'clinical mastitis cases'], ['sterile  DNA', 'sterile  water'], ['performance comparison', 'mid dairy lactation'], ['Bacterial culture results', 'PC'], ['', ''], ['that', 'current  Strep'], ['', ''], ['', ''], ['PCR', '86'], ['', '8  87'], ['', '7  Strep'], ['', ''], ['', ''], ['', ''], ['', 'respectively  Staph'], ['', ''], ['', ''], ['extracts', 'relative  79'], ['', '2  86'], ['', '8  Strep'], ['', 'uberis 92'], ['', '9  96'], ['', '4  Staph'], ['', 'unidentified PCR inhibitors'], ['', 'Strep'], ['relative  specificity', 'mid  lactation'], ['estimates', 'to cutoff cycle 34'], ['77  it', 'test sensitivity'], ['', ''], ['assay', 'specifically  Strep'], ['', ''], ['', ''], ['', 'early  lactation'], ['home', 'young income children'], ['CBT  home', 'CBT  depression'], ['Booster sessions', '3 CBT months'], ['Participants', 'prior randomization intervention'], ['Parent child interaction', '6  months'], ['Intent  analyses', 'improved  coping'], ['positive  impacts', 'selected  children'], ['Maternal  characteristics', 'intervention'], ['lower  those', 'more intervention sessions'], ['Mothers', 'favorable post intervention outcomes'], ['more  work', 'young income children'], ['immune  response', 'key influenza infection'], ['where  individuals', 'acute  infection'], ['possible  which', 'infected epitope cell'], ['memory', 'second  infection'], ['thyristor matrix converter', 'predictive  control'], ['standard  MPC', 'overall  system'], ['19683 switching states', 'this'], ['result', 'drastic commutation frequency'], ['', 'still thyristor matrix converter'], ['contribution', 'predictive control problems'], ['result', 'problematic working areas'], ['', 'harmonic  distortion'], ['impaired trophoblast invasion', 'fetal fibrin compromise'], ['modulation', 'impaired HELLP syndrome'], ['Total RNA', 'gestational HELLP age'], ['mRNA  expression', 'Northern plasminogen activator blotting'], ['Protein expression', 'Western plasminogen activator ELISA'], ['syndrome mRNA TIMP-1', 'syndrome mRNA MMP-2'], ['MMP-9', 'groups'], ['Protein expression', 'proteolytic  factors'], ['control this', 'protein level'], ['Mature landfill leachate', 'high  ammonia'], ['partial nitrification Anammox', 'mature landfill leachate'], ['', 'ammonia conversion 99'], ['', ''], ['', 'TN removal 99'], ['1  %', 'influent  1950'], ['Full  utilization', 'significant SNAD process'], ['nitrogen removal contribution', 'nitrogen'], ['', '1  Anammox'], ['', '6  dehitrification'], ['first operation DOM', 'excess NO3 denitrification'], ['oxidizing  which', '12'], ['', ''], ['', 'total  bacteria'], ['', 'SNAD process wastewater'], ['', ''], ['', ''], ['rights', ''], ['cumulative genocide that', 'uncertain  future'], ['Little', 'mental  population'], ['cumulative  it', '102 Southeast Florida'], ['social  determinants', 'particularly alcohol men'], ['early  screening', 'early  treatment'], ['review', 'ancient Maya skeletons'], ['how  work', 'methodological war Maya'], ['how  results', 'recent  Maya'], ['potential  that', 'anthropological  questions'], ['emergence', 'drug drug resistances'], ['recently  we', 'mcr-1-carrying gut microbiota'], ['complex  scenario', 'healthy swine populations'], ['1026  pieces', 'different pig farms'], ['coli  isolates', 'mcr-1 gene'], ['locus  sequence', 'positive novel Sequence strains'], ['6  four', 'which'], ['promoter', 'similar  activity'], ['complex  dissemination', 'various ST E'], ['', 'healthy Southern China'], ['IL-24  receptor', '11 cytokine receptor family'], ['receptor expression', 'cancer cell lines'], ['information', 'clinical gene therapy'], ['skin total skin RNA', 'RT PCR'], ['northern liver cell receptors', 'northern liver cell mda-7'], ['BEL-7402 Hep3B HepG2', 'PLC  IL-22R'], ['Only  HepG2', 'IL-22R IL-20R2 receptor complex'], ['', 'heterodimeric  receptors'], ['Huh-7 QGY-7701', 'receptor'], ['receptors', 'seldom cancer cell lines'], ['suppressive  that', 'human  cancer'], ['MDSCs', 'key cancer immunotherapy'], ['ceramide', 'mammalian cell apoptosis'], ['we', 'molecular  MDSCs'], ['Treatment', 'significantly MDSC vivo'], ['LCL521', 'ceramide  level'], ['LCL521-induced MDSC death', 'necroptosis  mechanism'], ['LCL521 treatment', 'autophagic vesicles heterolysosomes'], ['concomitant  inhibition', 'LCL521-induced cell death'], ['interrupted ER that', 'MDSC death'], ['Therefore ceramidase inhibitor', 'based cancer immunotherapy'], ['improve', 'induced selection ARPI'], ['Improved  understanding', 'effective t NEPC'], ['MEAF6 gene MEAF6 that', 'prostate cell cancers'], ['MEAF6 1 MEAF6 splicing', 'neuronal splicing factor SRRM4'], ['', 'independent cell growth invasion'], ['MEAF6 1 MEAF6 actions', 'ID1  genes'], ['rather proliferation that', 'neuroendocrine  phenotypes'], ['', 'markets biochemical networks transportation science'], ['Prior  works', 'relatively equilibrium uncertainties'], ['we', 'mean field states'], ['We', 'Brownian  motion'], ['First  we', 'robust field games'], ['Second  we', 'exhaustible  resource'], ['dimension', 'mean field process'], ['Measurement', 'key bone mass'], ['This', 'bone diseases'], ['bone which', 'digital sensors amplifiers converters'], ['it', 'small bone mass'], ['measurement', 'minimum bone mass'], ['Strain gauge sensors', 'interconnected bone mass'], ['minimum  it', 'original  strain'], ['it', 'when analog signal'], ['Hence voltage signal', 'strain'], ['operational analog signal', 'comparator circuit'], ['operational  amplifier', 'CMOS Mentor graphics'], ['long system power consumption', 'long  strain'], ['Thus  analysis', 'orthopedic  diseases'], ['are', 'schizophrenia'], ['healthy  controls', 'social  cognition'], ['older  age', 'dynamic emotion patients'], ['older  age', 'better decipher hints'], ['mental state attribution that', 'visual  stimuli'], ['Findings', 'age  patients'], ['Findings', 'social  cognition'], ['Meat adulteration', 'public  health'], ['mammalian PCR that', 'meat products'], ['method', 'nuclear  gene'], ['specificity heterogeneity', 'copy myostatin'], ['Additionally  we', 'method'], ['myostatin', 'mammalian  species'], ['limit', 'animal genomic animal DNA'], ['001 % meat ingredient', 'animal genomic animal DNA'], ['', ''], ['blind  biases', 'measured  values'], ['real time PCR method', 'different reference gene'], ['', ''], ['rights', ''], ['', ''], ['Secondary  damages', 'days'], ['Secondary  damages', 'mainly ion channels'], ['However  studies', 'intact sodium neurons'], ['Mixed  cultures', 'mechanical mouse cortical vitro'], ['Expression', 'real polymerase chain reaction'], ['conditioned  medium', 'inflammatory  VGSCs'], ['Spike behaviors', 'whole patch clamp recordings'], ['Mechanical  injury', '24 growth injury'], ['', 'neuronal  membranes'], ['completely  currents', 'dependent  manner'], ['neuronal cell which', '6  h'], ['', 'spike  threshold'], ['combined  effect', 'intact  neurons'], ['BDNF', 'intact VGSC neurons'], ['Rett syndrome', 'mostly MECP2 gene'], ['mice', 'neuronal  excitability'], ['augmenting', 'like GABA mice'], ['sustained  which', 'neuronal  RTT'], ['Methods', 'extrasynaptic agonist 4567-tetrahydroisoxazolo[54-c]pyridin-3-ol hydrochloride'], ['Low dose THIP', 'neonatal  lactation'], ['when breathing motor mice', 'breathing motor function'], ['Changes', 'neuronal biosynthesis enzyme electrophysiology'], ['breathing abnormalities', 'social MECP2-null mice'], ['beneficial  effects', 'neuronal biosynthesis enzyme expression'], ['THIP treatment', 'perhaps  RTT'], ['One', 'thermal salt methods'], ['thermal  energy', 'such gas turbine'], ['solid oxide fuel GT', 'multiple effect desalination system'], ['Combination', 'individual exhaust systems'], ['optimal system costs', 'important design parameters'], ['', ''], ['operational  temperature', 'levelized exergy electricity'], ['Implementing GA optimization', '57 exergy 63'], ['5  %', 'levelized  0'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['aberrant Mediator expression', 'tumourigenesis'], ['Med19', 'breast cancer'], ['3 factor subunit CBFA2T3', 'human cancer cell lines'], ['cancer cell proliferation', 'CCK8 lentivirus infection'], ['expression', 'reverse polymerase chain reaction'], ['correlation', '25 human breast cancer'], ['cell proliferation', 'significantly Med19 vitro'], ['which', 'CBFA2T3'], ['ectopic  expression', 'Hs578 HEB expression'], ['effect', 'CBFA2T3 overexpression'], ['negative  correlation', 'Western breast cancer tissue'], ['cancer cell effect', 'CBFA2T3'], ['provide', 'therapeutic breast cancer therapy'], ['Vertical  integration', 'widely school biochemistry'], ['peer learning model', 'medical school biochemistry course'], ['medical  students', 'first year biochemistry students'], ['Students', 'well  session'], ['basic  it', 'clinical  medicine'], ['now understanding biochemistry', 'clinical  medicine'], ['senior student facilitators', 'more  sessions'], ['they', 'teaching skills'], ['novel  combination', 'other  institutions'], ['', 'International Biochemistry'], ['Children', 'clinical child presentations'], ['Atypical  signs', 'medical child abuse'], ['medical child abuse', 'medical  complexity'], ['medical  diagnosis', 'significant  children'], ['purpose', 'medical health students'], ['Jefferson Scale', 'medical University Religion students'], ['mental health Religiosity', 'life'], ['more  attention', 'further health findings'], ['Patients', 'such anxiety fatigue'], ['optimal training prescription', 'symptoms'], ['We', 'small cell lung'], ['cross  study', 'advanced GI chemotherapy'], ['Patients', '6  weeks'], ['Psychological', 'physical intervention period'], ['Nineteen  patients', 'interventions'], ['Comparing interventions', 'anxiety  scores'], ['However SET treatment', 'perceived  strength'], ['', ''], ['', ''], ['interventions', 'certain  symptoms'], ['', ''], ['', ''], ['', ''], ['beneficial  effects', 'second exercise interval'], ['QG', 'psychological cancer patients'], ['However  SET', 'greater exercise symptoms'], ['warrants', 'second exercise intervention'], ['however macrophages modulates mechanism', 'macrophages'], ['Herewe', 'lung injury lung mice'], ['Treatment', 'induced neutrophil mice'], ['TSG6', 'thereby kappa B activation'], ['TSG6', 'inflammatory CD206 macrophages'], ['shift', 'suppressed transcription factors STAT1'], ['LPS', 'autocrine  macrophages'], ['TLR4 NF kappa B', 'secondary TSG6 suppression'], ['Ischemia reperfusion injury', 'subsequent blood tissues'], ['', 'main pressure ulcers'], ['cascade', 'immune IR injury'], ['clamping skin studies', 'intravital imaging studies'], ['where mouse ear we', 'immune multiphoton intravital imaging'], ['paper', 'moving switching current'], ['well vacuum circuit they', 'application'], ['solution', 'breaker functional breaker parameters'], ['frequently  they', 'distinct  entities'], ['', 'PTC  origin'], ['', 'PTC MTC patients'], ['', ''], ['3  %', 'familial RET germline tissues'], ['', '22'], ['sporadic  cases', 'three tissue components'], ['', 'MTC component 10/22'], ['4  patients', '7  22'], ['8  %', 'somatic M918 T mutation'], ['2  %', 'H RAS gene'], ['', 'additional  case'], ['6 H RAS', ''], ['', '1 PTC 24'], ['2  patients', '1 V600E BRAF 24'], ['', '2 H RAS 24'], ['remaining PTC cases', 'somatic  mutation'], ['one  MTC', 'RET mutation'], ['None', 'tumors'], ['this', 'RET BRAF RAS oncogene PTC'], ['activating  mutations', 'simultaneous  occurrence'], ['Resistance', 'poor  outcomes'], ['present  study', 'human cancer cells'], ['PCR  analysis', 'cis diamminedichloroplatinum cisplatin cis II'], ['genes', 'RNA  CDDP'], ['When  genes', 'CDDP'], ['administration', 'enhanced mefenamic CDDP'], ['family', 'human cancer cells'], ['Thus  use', 'clinical anticancer drug resistance'], ['responsive  that', 'megaloblastic  anemia'], ['', 'immune MTHFD1 deficiency'], ['methods', 'affected  siblings'], ['Routine laboratory', 'before folinic acid supplementation'], ['3 MTHFD1 that', 'mother'], ['suggestive  we', 'exome sequence depth exons'], ['13  that', 'father'], ['Routine laboratory data', 'poor  vaccines'], ['', 'healthy  volunteers'], ['Treatment', 'prophylactic folinic therapies'], ['Exome sequencing', 'combined novel immunodeficiency'], ['precision therapy', 'primary  immunodeficiency'], ['', '2016 Allergy Asthma'], ['wherein germ cells', 'primordial haploid gametes'], ['we', 'specific gene Gcse'], ['major  that', 'Gcse length'], ['Gcse s', 'only adult testes'], ['female development Gcse l', 'embryonic  day'], ['', 'ovulated  eggs'], ['However Gcse s signals', 'fertilized adult ovary'], ['', 'late pachytene spermatocytes'], ['However Gcse s transcripts', 'round  spermatids'], ['Furthermore  expression', 'subcellular GCSE L cells'], ['GCSE L', 'late pachytene spermatocytes'], ['meiosis GCSE L', 'spermatozoa'], ['GCSE L colocalizes', 'Golgi apparatus'], ['However GCSE S proteins', 'only  spermatids'], ['GCSE proteins', 'acrosome spermiogenesis'], ['particular family relationships', 'genetic  sharing'], ['genetic skin which', 'molecular skin traits'], ['dermatologic  that', 'twin family cohort'], ['We', 'twin  pairs'], ['Variance component method', 'genetic  heritability'], ['Heritability', 'index sebum secretion'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'respectively  factors'], ['genetics', 'mild sebum secretion'], ['Sebum secretion', 'shared family members'], ['findings', 'biologic  studies'], ['Proopiomelanocortin', '1  melanogenesis'], ['levels', 'possible melanocortin vitiligo'], ['study', 'vitiligo  patients'], ['Skin biopsies', 'real polymerase chain reaction'], ['lesional  they', 'lesional  controls'], ['', 'lesional  patients'], ['other  we', 'lesional  patients'], ['melanocortin system', 'end disease'], ['testis  antigens', 'healthy germ tissue'], ['aim', 'TMEM31 CT melanoma'], ['pattern', 'human chain reaction analysis'], ['TMEM31 protein expression', 'metastatic immunohistochemistry analysis'], ['TMEM31', 'weakly  placenta'], ['protein expression', '120/190'], ['', ''], ['intensity', 'primary  melanoma'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['expression', 'primary melanoma samples'], ['', ''], ['', ''], ['', ''], ['', ''], ['novel CT that', 'immunotherapeutic melanoma melanoma'], ['Cucurbit viruses', 'economic  China'], ['growing sample which', 'largest melon China'], ['MWMV watermelon mosaic Tomato', 'wilt  virus'], ['We', 'like melon symptoms'], ['', '94'], ['5  %', 'least  viruses'], ['WMV', ''], ['WMV CMV', '77'], ['', ''], ['', ''], ['1  %', 'significantly melon cultivars'], ['Other  viruses', 'sample'], ['number', 'multiple  infections'], ['', 'double  infection'], ['', 'closely  WMV'], ['', ''], ['Statistical  analysis', 'multiple  infections'], ['genetic purifying selection', 'population'], ['amplifier  that', 'operational memory sharing'], ['two phase clock amplifier', 'two  circuits'], ['small  amplifiers', 'other  circuit'], ['amplifier  arrangement', 'split mode'], ['S  circuits', 'proposed memory effect cancellation'], ['simulations', 'least memory 14'], ['', 'split  mode'], ['', '32 combination 0'], ['', 'proposed P input technique'], ['new  circuit', 'floating  memristor'], ['circuit', 'analog feedback converters'], ['circuit', 'similar  circuits'], ['application', 'proposed memristor circuit'], ['Experimental  results', ''], ['nano that', 'last switching state'], ['interesting memristor characteristics', 'potential  applications'], ['problem', 'cost fabrication nanoscale device'], ['only  way', 'memristor'], ['I V behaviors', 'actual model device'], ['new  approach', 'CMOS memristor application'], ['interfacing  circuit', 'SPICE memristor model'], ['interfacing  circuit', 'operational memristor amplifier'], ['interfacing  circuit', 'very memristor application studies'], ['floating memristance simulator circuit', 'current  conveyors'], ['which', 'circuit characteristics'], ['hardware', 'available simulator components'], ['Theoretical  derivations', 'PSPICE simulation'], ['Performance', 'simple example circuits'], ['proposed simulator circuit', 'loop  features'], ['maximum frequency values', 'passive element values'], ['Simulator circuit', '40 frequency kHz'], ['Memristor', 'fundamental circuit 1971'], ['significant memristor it', 'growing  rate'], ['thanks analog circuit which', 'passive circuit elements'], ['practical  which', 'real world circuit design'], ['based memristor design', 'paper'], ['operational  amplifier', 'also power implementation'], ['Memristor design', 'active  CMOS'], ['', '18 m process symmetric'], ['25 V supply', ''], ['memristor', 'second  order'], ['based band pass filter', 'real electroencephalogram data processing'], ['design', 'low power frequencies'], ['paper', 'new memristor emulator circuit'], ['circuit', 'continuous transconductance memresistance'], ['available memristor which', 'binary memresistance levels'], ['current impedance driving', 'low impedance input'], ['functionality', 'less multivibrator circuit'], ['obtained  results', ''], ['', 'GmbH'], ['rights', ''], ['submandibular duct portion', 'preferentially  puberty'], ['molecular  mechanisms', ''], ['transcription JunD', 'striated GCT duct'], ['nuclear  protein', 'thereby tumor suppressor activity'], ['Northern', 'Western  blotting'], ['Immunoreactivity', 'intercalated SD cells'], ['GCT cells', 'menin'], ['levels', 'repeated  males'], ['cells', '48 GCT hrs'], ['patterns', 'quite  JunD'], ['Furthermore coimmunoprecipitation analysis', 'menin vivo'], ['JunD menin complex', 'dependent mouse SMG'], ['', ''], ['meningococcal  disease', '7 US university 2013'], ['Neisseria meningitidis', 'nasopharyngeal  carriage'], ['MenB H binding vaccine', 'college outbreak'], ['We', 'meningococcal MenB FHbp carriage'], ['', ''], ['sectional  surveys', 'FHbp vaccination campaigns'], ['Questionnaires', 'oropharyngeal  students'], ['Specimens', 'real polymerase chain reaction'], ['Adjusted prevalence ratios', 'generalized estimating equations'], ['', ''], ['4  %', 'rt PCR'], ['outbreak strain', 'second  surveys'], ['carriage reduction', 'more MenB FHbp doses'], ['noncarriers', 'remained  carriers'], ['1 MenB FHbp', '2  doses'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'meningococcal  carriage'], ['', ''], ['stable MenB FHbp', 'meningococcal  carriage'], ['This', 'close vaccination outbreaks'], ['study', 'mental video games applications'], ['', 'external depression symptoms'], ['internal causality language', 'higher game games'], ['spent', 'external causality language'], ['effectiveness', 'mental health apps'], ['', ''], ['rights', ''], ['article', 'mental health parents'], ['Chinese  government', 'only child families'], ['even  we', 'demographic  characteristics'], ['effects', 'significantly  children'], ['social security system', 'especially population China'], ['mental health that', 'greatly  HIV'], ['objective', 'positive British Columbia Canada'], ['who', 'health services health study'], ['behavioral health care utilization', 'HIV BC AIDS'], ['We', 'mental health population'], ['', 'mental health disorder diagnosis'], ['65  disorders', 'mental health conditions'], ['mental health disorder', 'overall  functioning'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'higher stigma score'], ['', ''], ['', ''], ['', ''], ['Participants', 'sexual health assault'], ['', ''], ['', ''], ['', 'case management services'], ['', ''], ['', ''], ['', ''], ['mental health disorder diagnosis', 'sexual  violence'], ['Understanding', 'serious decision making'], ['Scientists', 'future climate systems'], ['scientists', 'other climate aims'], ['Often  predictions', 'human policy support'], ['poor  appreciation', 'computational system models'], ['mental  system', 'when policy choices'], ['system', 'general  future'], ['mismatch', 'potentially policy support'], ['prefrontal  cortex', 'mental brain states'], ['precise  function', 'network'], ['recently  dmPFC', 'high level abstract'], ['', ''], ['', 'high  construal'], ['light seed', 'root'], ['how  metaphors', 'such  beliefs'], ['suddenly  that', 'gendered  male'], ['metaphors', 'idea genius'], ['', 'prevailing gender seed'], ['opposite  pattern', 'male  inventors'], ['Saharan trypanosomosis control tsetse', 'Saharan trypanosomosis control Africa'], ['trypanosome infection it', 'vector'], ['We', 'controlled laboratory conditions'], ['Publications', 'Science'], ['screened PRISMA total', '72  studies'], ['microscopic  examination', 'main dissection analysis'], ['random meta analysis', 'molecular gold standard'], ['pooled  prevalence', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'field survey laboratory experiment data'], ['country', 'significantly trypanosome tsetse'], ['low  information', 'specificity'], ['how risk variation', 'real risk factors'], ['diagnostic  prevalence', 'high trypanosome throughput'], ['formation', 'different  genes'], ['patient  it', 'targeted  intervention'], ['review', 'interventional  strategies'], ['Cancer cells', 'site extravasation micrometastasis formation'], ['', 'major  importance'], ['HGF Wnt signaling S100A4', 'metastatic  process'], ['gene', 'therapeutic  intervention'], ['90 cancer it', 'underlying  mechanisms'], ['This', 'prognostic  markers'], ['', ''], ['', ''], ['diabetic drug metformin', 'anticancer effects'], ['Sonic  signaling', 'gastric  cancer'], ['present  metformin', 'gastric cancer cells'], ['gastric cancer cells', 'different  durations'], ['mRNA  levels', 'western polymerase chain analyses'], ['effects', 'activated protein kinase'], ['protein', 'time cell manner'], ['Metformin', 'gene SMO Gli-2'], ['induced  depletion', 'gastric cancer cells'], ['signaling', 'inhibitory Shh pathway'], ['Methamphetamine', 'several neurotoxic mechanisms'], ['effects', 'mitochondrial biogenesis'], ['So  we', 'GDNF substantia rat'], ['', '14  days'], ['days MA we', 'PGC1 TFAM GDNF SN'], ['Furthermore  we', 'acidic tyrosine immunohistochemistry'], ['We', 'immediately MA discontinuation'], ['We', '1 Iba1 striatum'], ['mRNA time levels', '1 MA SN'], ['that', 'such mitochondrial SN'], ['mechanisms', 'nigrostriatal TH immunoreactivity pathway'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['stellar chemical we', 'solar  neighbourhood'], ['three  branches', 'evolutionary  which'], ['stellar  that', 'distinct  origin'], ['intermediate  that', 'statistical  significance'], ['empirical star formation rate', 'thin  disc'], ['We', 'solar disc neighbourhood'], ['method', 'evolutionary chemical tagging trees'], ['common  that', 'solar neighbourhood stars'], ['Adipose  dysfunction', 'cardiovascular  disease'], ['activation', 'pathological  settings'], ['present  study', 'endothelial  function'], ['effects', 'western blot analysis'], ['polymerase chain reaction', 'western protein expression levels'], ['ELISA assay', 'TNF alpha'], ['PA Palmitic stimulation', 'adipocytokine  PVAT'], ['inflammatory adiponectin expression', 'inflammatory necrosis factor alpha'], ['interfering modulatory MTX', 'dependent  manner'], ['endothelial  treatment', 'nitric rat aorta'], ['present  MTX', 'endothelial adipocytokine dysfunction'], ['data', 'cardiovascular  diseases'], ['Cervical  cancer', 'human papilloma virus infection'], ['cancer metastasis suppressor', 'several DNA promoter cancers'], ['study', 'cervical papilloma epithelium'], ['We', 'specific polymerase chain reaction'], ['expression', 'cancerous BRMS1 lesions'], ['Methylation', 'BRMS1 37'], ['5  %', 'human papilloma virus'], ['', 'pathological  histology'], ['', ''], ['Methylation', 'cervical cancer cells'], ['where papilloma staining', 'malignant papilloma tissues'], ['', 'differentiated cancer blasts'], ['BRMS1 promoter methylation', 'further papilloma investigation'], ['yeast researcher genus', 'developmental biology genetics ecology'], ['Metschnikowia', 'modern animal phagocytosis'], ['monophyletic  which', 'few Candida species'], ['two  which', 'Metschnikowia'], ['200 ascus formation', 'chlamydospores'], ['adaptive  value', 'such  features'], ['genetic  studies', 'model species'], ['plant insect others', 'aquatic parasite theory'], ['globally  others', 'extreme  endemism'], ['Many  species', 'known  habitats'], ['', ''], ['important iron dipeptide that', 'other  microorganisms'], ['incapable culture kinship', 'group'], ['', ''], ['future  study', '20-years de los 2014'], ['normal  LPG', 'one'], ['lowest  share', 'LPG expenditure'], ['policy makers', 'efficient  reforms'], ['Neoantigen', 'specific tumor oncogenesis'], ['immune  responsiveness', 'clinical tumor immunotherapies'], ['MHC I', 'CD8 T cells'], ['improved  understanding', 'restricted MHC class antigens'], ['limited tumor comprehension', 'clinical  practice'], ['review', 'clinical tumor immunotherapy'], ['', ''], ['', ''], ['rights', ''], ['fundamental  that', 'water sea environments'], ['European  eel', 'molecular osmoregulatory plasticity'], ['life cycle', 'back Sargasso reproduction'], ['anatomical  changes', 'successful  SW'], ['aim', 'gene SW'], ['Tissues', 'FW SW transfer'], ['subtractive  hybridization', 'expressed  genes'], ['expressed kidney clones', 'unique  sequences'], ['clones', 'remaining  sequences'], ['results', 'Northern microarray blotting'], ['functional  roles', 'normally  ion'], ['lateral Gene expression hypothalamus', 'Mus  musculus'], ['1 zinc binding which', 'dark mRNA phase'], ['lipid peak metabolism', 'circadian  astrocytes'], ['Rhythmically  expressed', 'previous meta analysis'], ['Genes', 'fabp7'], ['guanosine  that', 'dexras1 G 16'], ['Northern  blotting', 'diurnal mRNA genes'], ['suprachiasmatic arcuate nucleus', 'mediated  signaling'], ['rich carboxyl terminal which', 'discrete  hypothalamus'], ['regulatory  role', 'diurnal activity rhythms'], ['results', 'circadian gene processes'], ['', 'Elsevier IBRO'], ['present carbohydrate polymer', 'oxidative  aniline'], ['conductive  this', 'heavy bioreduction metals'], ['infrared  polyaniline', 'cellulose surface'], ['tensile  stress', '23  modulus'], ['current  density', 'required  Cr'], ['system', '99 % 1'], ['', '5  pH'], ['Kinetic experiment studies', 'constant  rate'], ['', ''], ['', ''], ['conductive  MC', 'bioelectrochemical  processes'], ['experimental  results', 'bioelectrochemical  systems'], ['', 'C Elsevier Ltd'], ['Metagenomics', 'microbial community composition function'], ['It', 'molecular microbiology ecology statistics'], ['complex  that', 'microbial  communities'], ['even ore that', 'roots'], ['Knowledge', 'human health agriculture'], ['article', 'technical DNA sequencing methods'], ['native family that', 'degraded  revegetation'], ['electrochemical  systems', 'attracting wastewater treatment'], ['catalytic anode that', 'electricity'], ['Microorganisms', 'respectively  exoelectrogens'], ['it', 'important  performance'], ['mini  we', 'different BESs application'], ['effects', 'operational microbiome development'], ['Further  discussion', 'molecular microbial community analysis'], ['EET extracellular electron mechanism', 'electroactive  biofilms'], ['review', 'operational exo electrogens activities'], ['', ''], ['rights', ''], ['that', 'wells'], ['increasing', 'internal char resistance'], ['PVA hydrogel separator', 'molecular electricity generation'], ['optimal parameters', 'anode 1'], ['', '1 separator cm'], ['continuous flow the', 'markedly  benzene'], ['95  %', '38 mW m(-2'], ['MFC', '120  maintenance'], ['', ''], ['rights', ''], ['Anolyte acidification', 'free microbial fuel cells'], ['H+ hydroxyl that', 'running anodic cycles'], ['alkaline  intervention', 'electroactive Geobacter sp'], ['', 'KCl AER MFC'], ['pH', 'alkaline KCl intervention'], ['maximum power density', 'KCl AER 307'], ['', ''], ['', '542'], ['', ''], ['', 'lower PBS MFC'], ['', ''], ['', ''], ['coulombic  efficiency', 'KCl AER 54'], ['', '1  61'], ['2  which', 'very PBS MFC'], ['', ''], ['alkaline  intervention', 'free  MFCs'], ['', ''], ['', ''], ['rights', ''], ['occurrence intracellular reduction', 'EAB'], ['', 'tentatively Stenotrophomonas sp'], ['Cr(III fluorescent probe', 'inevitably  EAB'], ['More  Cr(VI', 'total MFC 45'], ['', ''], ['', ''], ['', ''], ['', '4  ions'], ['', ''], ['', ''], ['', ''], ['', 'other chromium 18'], ['', ''], ['', ''], ['', ''], ['', 'intracellular total intracellular chromium'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['cathode', 'functionally MFC biocathodes'], ['', ''], ['', ''], ['rights', ''], ['microbial fuel cell', 'simultaneous  anode'], ['aerated biofilm which', 'aerated  membrane'], ['', 'maximum power 4'], ['', ''], ['12 W m(-3', 'current  4'], ['', ''], ['', ''], ['open removal rates', '9'], ['', ''], ['', ''], ['', ''], ['respectively  which', 'electrochemical  denitrification'], ['chambers', 'coulombic  40'], ['', ''], ['', ''], ['', ''], ['', ''], ['electroconductivity MABR', 'thus aeration SND'], ['Overall EAM MFC', 'COD N 2'], ['', ''], ['', ''], ['', ''], ['', ''], ['rights', ''], ['Microbial fuel cells', 'sustainable wastewater treatment'], ['', 'catalyzed electron reduction'], ['contaminants', 'also electron anode'], ['previous  studies', 'thorough cathodic electron acceptors'], ['Oxygen', 'oxidation potential oxidation availability'], ['Recent  studies', 'different cathode areas'], ['aim', 'various electron MFCs'], ['review', 'select electron acceptors'], ['', ''], ['', ''], ['electrochemical  strategy', 'Pt cathode C'], ['dramatically  which', 'powerful LEV detection'], ['ray Fourier transform', 'fully FePO4 NPs'], ['', '3 concentration 0'], ['pg  L', 'excellent concentration 0'], ['', ''], ['temporary  effect', 'back  normal'], ['It', 'continuous electricity running'], ['detection mechanism', 'functional quantum chemical theory'], ['carbon graphene', 'carbon nanotubes'], ['Microbial fuel cell', 'modified anode cathode'], ['substrate', 'microbial fuel cell'], ['optimum output voltage', 'microbial fuel cell'], ['prepared  nanomaterials', ''], ['increasing  concern', 'electrical energy recovery'], ['conventional HCSW MFC', 'single bio energy step'], ['', ''], ['review', '3 electricity substrates'], ['major  drawback', 'simple power substrates'], ['HCSW hydrolysis', 'major  MFCs'], ['optimization', 'fuel'], ['', ''], ['Excess  consumption', 'environmental  pollution'], ['Current  developments', 'several bioenergy advantages'], ['new bio which', 'rising  energy'], ['Microalgae', 'added products synthesis'], ['review', 'unwanted power nutrients'], ['review', 'different microalgae MFCs'], ['technological microalgae MFC bottlenecks', 'microalgae MFC system'], ['', ''], ['rights', ''], ['additional  procedure', 'nitrogen'], ['flat FA that', 'hydraulic retention 2'], ['', ''], ['effluent chemical oxygen COD', '85 chemical oxygen %'], ['', ''], ['', ''], ['', ''], ['', ''], ['greatest  removals', 'first  unit'], ['', 'kg N TN removal rate'], ['domestic  it', 'minimal power output'], ['', 'first  unit'], ['abiotic ammonia loss', 'supplied  1'], ['biological nitrogen removal', 'dominant FA MFCs'], ['like  strains', 'like  denitrification'], ['like  strains', 'metabolic nitrogen anode'], ['FA MFC system', 'sustainable wastewater treatment'], ['', ''], ['', ''], ['rights', ''], ['', 'genera  i'], ['', ''], ['Advenella aminophilus', 'microbial cell performance'], ['', 'different cathode side'], ['', 'oxidation -0'], ['', 'Ag  AgCI'], ['281  V', 'H2S'], ['', 'microbial  community'], ['detrimental power density', 'aqKMnO(4'], ['', ''], ['Solution resistance', 'aqKMnO(4)(60 ohm'], ['', ''], ['', ''], ['10  which', 'highest power aqKMnO(4'], ['Buffering', '40  ohm'], ['', ''], ['8  W', 'aqueous  pH'], ['', ''], ['developed  consortium', 'simultaneous electricity generation'], ['', ''], ['', ''], ['rights', ''], ['better energy understanding', 'anodic  communities'], ['taxonomic  structure', 'primary clarifier overflow'], ['microbial community dynamics', 'phylogenetic  microarrays'], ['when voltage output', ''], ['other  genus', 'still voltage stabilization'], ['genus', 'minor fluorescence biofilm'], ['days  voltage', '20  operation'], ['chambered Microbial Fuel Cells', 'fruit  residues'], ['carbon fiber cathodes', 'ceramic Nafion membranes'], ['performances', 'potentiostatic NaCI water growth'], ['TMFCs', ''], ['', ''], ['pH amendment', ''], ['environmental  TMFCs', 'cathodic Power surface'], ['COD removal', '28-day  period'], ['', 'well Nafion membrane'], ['scale  estimation', 'anaerobic digestion plants'], ['global TMFC they', 'anaerobic digestion technologies'], ['', ''], ['rights', ''], ['Microbial fuel cells', 'metabolic step bacteria'], ['new  they', 'biodegradable waste materials'], ['microbial  kinetics', 'commercial construction technology'], ['new  which', 'achievable power density'], ['', 'effective  materials'], ['paper', 'recent novel MFCs'], ['particular  it', 'emerging anode nanomaterials'], ['also  some', 'next generation MFC systems'], ['hurdles', 'commercial MFC technology'], ['future  directions', 'MFC anodes'], ['', 'MFC fuel technology'], ['microorganisms', 'organic  source'], ['', ''], ['that', 'limited  settings'], ['Nevertheless  requirement', 'active feeding system'], ['Here  we', 'exoelectrogenic fuel bacteria'], ['MFC', 'photosynthetic  bacteria'], ['that', 'few  hours'], ['current', 'photosynthetic  bacteria'], ['miniaturization', 'short start up time'], ['advantages', 'general micropower generation'], ['', ''], ['', ''], ['rights', ''], ['carbon brush', 'microbial fuel cells'], ['Two  types', 'electrical carbon resistivity'], ['', ''], ['05 mu Omega m', ''], ['based carbon fibers', 'microbial brush anodes'], ['based carbon brush anodes', 'higher power density'], ['nitric power density', 'based  29'], ['', ''], ['7  %', '816'], ['', 'based carbon brush'], ['based carbon fibers', 'extensive anode MFCs'], ['', ''], ['', ''], ['rights', ''], ['exoelectrogenic  belonging', 'Citrobacter freundii'], ['strain', 'current  843'], ['', ''], ['', 'three electrode configuration'], ['electricity generation performance', 'maximum power 1233'], ['', 'also formate acetate strain'], ['Data', 'electroacfive c type C'], ['', ''], ['', 'when ITO situ'], ['anaerobic strains LZ-1', 'microbial  electrochemistry'], ['polar production process compounds', 'gases anions'], ['Disposal', 'strict  legislations'], ['producing  countries', 'effective  treatment'], ['physical  methods', 'dissolved hydrocarbon compounds'], ['Coupling', 'clean fuel water'], ['suitability', 'present  Work'], ['simple  design', 'different Pt cathodic catalyst'], ['results', 'membraneless chemical cathode'], ['3 mW it', 'PW MFCs'], ['complete hydrocarbon degradation', 'fed cycle'], ['', ''], ['', ''], ['anaerobic  biocathode', 'acetate fed MFCs'], ['aerobic sulfur which', 'hypersaline  environment'], ['', 'practical PW biodegradation process'], ['electrochemical  parameters', 'industrial Tafel PW'], ['', ''], ['rights', ''], ['how gut brain we', 'neurological  health'], ['recent  workshop', 'combined brain areas'], ['article', 'disciplinary Brain Health'], ['Mammalian  evolution', 'micro macro millennia'], ['presence', 'colonizing  species'], ['we', 'mammalian bacteria viruses intestine'], ['Furthermore  we', 'inflammatory bowel disease'], ['Finally  we', 'therapeutic design applications'], ['', ''], ['', 'Elsevier B'], ['', ''], ['This', 'BY NC license'], ['', 'org  nc'], ['', ''], ['young age it', 'leading  setting'], ['predisposed  who', 'environmental  factors'], ['new  which', 'review'], ['We', 'published  MS'], ['regulatory B they', 'prevention'], ['mainly case control that', 'bacterial  communities'], ['Multiple  evidence', 'EAE'], ['therapeutic  knowledge', 'us'], ['', ''], ['', 'Elsevier Espana S'], ['', ''], ['', ''], ['', 'particular  microbes'], ['', 'analogously  humans'], ['particular Bifidobacterium that', 'alone murine intestine'], ['', 'SFB B'], ['adolescentis', 'attendant gut inflammation'], ['', ''], ['adolescentis', 'alternative cell accumulation'], ['', 'B'], ['adolescentis', 'K BxN mouse model'], ['that', 'intestinal cell accumulation'], ['several  which', 'haemochorial  placenta'], ['', ''], ['mice', 'humans'], ['', ''], ['Zealand white New Zealand which', 'TG  TG'], ['TG  construct', 'previously Beauty transposon system'], ['different  methods', 'TG gene rabbits'], ['peripheral blood mononuclear cells', 'TG flow cytometry'], ['also histology sections', 'robust Venus protein expression'], ['In', 'specific tissue QPCR'], ['data', 'TG cell gestation'], ['ultimate  goal', 'artificial  pancreas'], ['Such  devices', 'least actuator module'], ['artificial  modules', 'artificial  organs'], ['we', 'BioCapacitor principle'], ['dehydrogenase', 'miniaturized enzyme anode'], ['enzyme fuel cell', '100 charge pump'], ['voltage', '330 charge 3'], ['1  V', '100 mu F capacitor'], ['charge pump circuit', 'low power microcontroller'], ['17  that', 'LED'], ['sole energy source', 'artificial  pancreas'], ['Cell capturing', 'frequently immunology diagnostics'], ['new  methods', 'microfluidic platform'], ['', 'sample cost volumes'], ['two  methods', 'label cell separation'], ['traditional  method', 'purified target cells'], ['free  method', 'physical target integrity'], ['industrial scale it', 'rapid research development'], ['capturing  methods', 'broad life science'], ['We', 'lab fuel devices'], ['laminar ion which', 'virtual  membrane'], ['array prototype', 'continuous fuel anolyte'], ['flow region microorganisms', 'organic  anodes'], ['protons', 'liquid cathodic streams'], ['where  they', 'protons'], ['', ''], ['', ''], ['array', 'maximum power 60'], ['kg(2  which', 'approximately flow MFC 4'], ['series', 'on power generation'], ['', ''], ['', ''], ['rights', ''], ['integration', 'clinical food safety'], ['Such  tools', 'limited  settings'], ['nucleic acid sequence', 'sensitive detection protocols'], ['integration', 'thermal target sequence amplification'], ['review', 'isothermal microfluidic devices'], ['greatly  implementation', 'limited amplification settings'], ['Possibilities', 'digital droplet amplification'], ['article', 'exponential  enrichment'], ['electrokinetically amplification product', 'fluid affinity flow'], ['hybrid  approach', 'prior affinity selection'], ['based  reactions', 'offline SELEX procedures'], ['microfluidic approach', '10 K h'], ['Microglia', 'neuronal  injury'], ['Recent  studies', 'reciprocal  microglia'], ['study microglia', 'embryonic cortical neurons'], ['We', 'differential semaphorin receptors'], ['result', 'transcription PCR transcription blotting'], ['when  Sema3A', 'stressed  neurons'], ['Using', 'stressed adult neurons'], ['whereby  neurons', 'activated  microglia'], ['Hybrid  microgrids', 'developing  countries'], ['dispatch which', 'recently operation costs'], ['we', 'load'], ['application', 'forecast cost microgrid'], ['We', 'intermittent operation strategy generation'], ['', ''], ['rights', ''], ['Microinsurance', 'important  shocks'], ['voluntary  demand', 'useful risk management tool'], ['', 'theoretical paper insurance'], ['lack', 'important price puzzle'], ['', ''], ['rights', ''], ['polymeric micron that', 'patient skin compliance'], ['human MN delivery', 'cancer vaccines'], ['We', 'ultrathin conformal coatings'], ['immune polyelectrolyte multilayers', 'intradermal MN substrates'], ['iPEMs', 'automated  fashion'], ['prepared', 'g cancer vaccine cm(2'], ['iPEM cargo', 'dendritic T coculture'], ['', 'subsequent booster MN application'], ['new tumor vaccine that', 'checkpoint blockade'], ['Cadmium  accumulation', 'subsequent food chain'], ['Cd transport aiming', 'rice growth'], ['thorough  understanding', 'efficient Cd rice'], ['we', 'agronomic practices bioremediation'], ['findings', 'human Cd beings'], ['', ''], ['rights', ''], ['', 'widely receptor agonist presentation'], ['inflammatory  that', 'inflammatory  properties'], ['properties', 'adjuvant  mechanisms'], ['Here  we', 'immune silica silane'], ['silica silane shell', 'immune polymer cells'], ['method', 'different  compositions'], ['method', 'controlled agonist loading'], ['known  this', 'immune agonist activity'], ['Very  little', 'normal tissues tumors'], ['Here  we', 'real processing patterns'], ['RNA', 'human  tissues'], ['certain cell precursor', 'precursor'], ['cell processing', 'cancer cell lines'], ['Northern  we', 'miRNAs'], ['', ''], ['situ hybridization precursors', 'nucleus'], ['We', 'cell types'], ['large  number', 'mature'], ['nt  that', 'gene expression'], ['MiRNAs', 'such growth development differentiation'], ['human expression level', 'major  mankind'], ['detection  analysis', 'correlated gene drugs'], ['hybridization nucleic which', 'isothermal rolling circle amplification'], ['new  techniques', 'labeled  probe'], ['detection', 'detection trends'], ['small noncoding that', 'cellular gene transcripts'], ['miRNAs', 'cellular expression processes'], ['cancer tumors', 'healthy  tissues'], ['normal  that', 'microRNA  regulation'], ['miR-145  that', 'regulatory cancer microRNAs'], ['psiCHECK-145 T vector', 'four Renilla luciferase gene'], ['Renilla luciferase activity', 'high control condition'], ['Additionally  overexpression', 'psiCHECK-145 T vector'], ['target sequences', 'breast normal cell line'], ['', 'International Union International Biochemistry'], ['Ovarian  cancer', 'gynecological United States'], ['continued  morbidity', 'invasive  mechanisms'], ['aberrant  some', 'oncogenic suppressor properties'], ['miR-205', 'tumorigenesis'], ['Presently  we', 'ovarian  cancer'], ['real polymerase chain reaction', 'ovary transcription samples'], ['effect', 'luciferase reporter assay'], ['effect', 'transwell invasion assay'], ['ovarian  it', 'ovarian cancer cell lines'], ['directly  which', 'ovarian cancer tissue'], ['miR-205', 'inhibitory cell invasion'], ['Matrix Metalloproteinases', 'important cancer invasion'], ['TCF21', 'ovarian cancer cell invasion'], ['transfection', 'ovarian cancer cells'], ['miR-205', 'ovarian  TCF21'], ['ovarian cancer which', 'ovarian cancer treatment'], ['genetic  which', 'tumor suppressor genes'], ['expression', 'pancreatic  cancer'], ['we', 'pancreatic cancer cells'], ['levels', 'Western  blotting'], ['pancreatic tumor models', 'nu nu mice'], ['disparate  level', 'well Panc-1 cells'], ['Knockdown', 'miR-22 miR-143 let-7i'], ['1  expression', 'miR-22 Capan-2 PTEN'], ['', ''], ['Knockdown', 'significantly Panc-1 tumor growth'], ['contrast knockdown', '1 Capan-2 tumor growth'], ['molecular gene expression mechanisms', 'pancreatic cancer subclasses'], ['study', 'personalized  therapy'], ['', ''], ['rights', ''], ['aim', 'factor-1 transcription factors'], ['K562 cells', 'overexpression plasmid'], ['negative  control', 'groups'], ['cells', 'normoxia'], ['Expression', 'quantitative miR-574 PCR'], ['protein expression', 'western blot analysis'], ['', 'other overexpression groups'], ['Differences', ''], ['', ''], ['level', 'negative control group'], ['', ''], ['however interference level', 'normoxic overexpression conditions'], ['', 'normoxic interference conditions'], ['NF E2 mRNA', 'reversely  GATA-2'], ['levels', 'negative NF normoxia'], ['overexpression GATA-1', 'reverse  association'], ['', 'interference normoxia'], ['Differences', ''], ['', ''], ['GATA-1 GATA-2', 'mRNA transcription levels'], ['therefore GATA l', 'hypoxic K562 condition'], ['entirely  HIF-1', 'regulatory  hypoxia'], ['MicroRNAs', 'biological cell development'], ['full expression patterns', 'other  vertebrates'], ['we', 'experimental chicken analyses'], ['Detailed expression patterns', 'Northern  embryogenesis'], ['Twenty clusters', 'linked expression miRNAs'], ['results', 'structural miRNA vertebrates'], ['', ''], ['', ''], ['rights', ''], ['coding  that', 'transcriptional gene level'], ['Information', 'turmeric  miRNAs'], ['present  we', 'high silico analysis'], ['We', '97 novel candidate miRNAs'], ['Selected miRNAs', 'stem loop RT PCR'], ['targets', 'identified plant growth'], ['Expression pattern', 'stem loop PCR'], ['turmeric  which', 'spice gene crop'], ['coding  that', 'transcriptionally gene expression'], ['complex passenger strand', 'complex  RISC'], ['genetic  variation', ''], ['MIR1 MIR133B that', '10  variants'], ['variant', 'miR-133a-5p passenger RISC'], ['Genomic DNA fragments', '79C HeLa cells'], ['79 T allele', 'weak  miR-133a-5p'], ['79C allele', 'miR-133a-3p'], ['', 'miR-133a-5p  levels'], ['levels', 'miR-133a-5p'], ['3  ends', '2  predominant'], ['a 5p few', 'common'], ['different target profiles', 'humans'], ['miR-133a-5p that', 'miR-133a-5p strand'], ['', 'clear cell carcinoma'], ['We', 'human expression mature'], ['Northern microarray blotting', 'selected  miRNAs'], ['RCCC  48', 'significant NT difference'], ['MiRNAs', 'higher NT tissue'], ['chip results', 'northern blot analysis'], ['study', 'diagnostic  RCCC'], ['', 'Copyright Elsevier Ltd'], ['rights', ''], ['nt noncoding that', 'biological cell differentiation proliferation'], ['study', 'emerging life science'], ['detection', 'first miRNA exploration'], ['Several  methodologies', 'successfully PCR microRNA miRNA'], ['review', 'existing microRNA arrays'], ['MicroRNAs', 'fine gene regulation'], ['Antisense oligonucleotides', 'therapeutic  function'], ['miR  ONs', 'LNA nucleic DNA'], ['Northern  blotting', ''], ['miR detection which', 'miR miRNA binding'], ['standard RNA that', 'cellular  the'], ['increase', 'purified RNA extract'], ['miR-122', 'miR  the'], ['technical  issues', 'miR  ONs'], ['MicroRNAs', 'vertebrate brain homogeneity'], ['miRNA miR-124', 'nervous  system'], ['We', 'neural Oryzias development'], ['five candidate genes', 'nucleotide medaka precursor length'], ['they', 'functional stem loop structures'], ['mature  miR-124', 'two days fertilization'], ['We', 'direct tract binding miR-124'], [\"3'UTR Ptbp1 contains\", 'binding target miR-124'], ['miR-124 target silences', 'vivo'], ['neural medaka miR-124 homologs', 'other  vertebrates'], ['small  that', 'cellular  pathways'], ['', 'translational protein repression'], ['Northern  we', 'wild  type'], ['different LPS LDL', 'other expression miRNAs'], ['', 'C transcription miR-155'], ['comprehensive data we', 'hierarchical  DCs'], ['', '2014 European Biochemical Societies'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['regulatory  that', 'complementary  target'], ['miRNAs', 'tumor oncogenes'], ['181', 'miR-128'], ['Expression', 'different polymerase chain malignancy'], ['glioma 181b', 'normal brain tissue'], ['higher tumor levels', 'high grade gliomas'], ['study', 'different  malignancy'], ['molecular pathways miRNAs', 'also brain tumors'], ['microRNAs', 'cellular proliferation apoptosis'], ['', 'certain lung colorectal'], ['clear expression level', 'distant  metastasis'], ['However  function', 'renal cell carcinoma'], ['paired RCC tissues', 'reverse polymerase chain reaction'], ['effect', 'also RCC MTT'], ['Furthermore  function', 'wound scratch'], ['Flow cytometry', 'also cell apoptosis'], ['normal kidney cell which', 'other  cancer'], ['miR-30b', 'RCC'], ['present  study', 'proliferation migration invasion'], ['Further  studies', 'potential target RCC'], ['Aberrant  expression', 'miRNA expression cancer'], ['Drosha Dicer proteins', 'key miRNA processing'], ['', 'mature processing miRNAs'], ['Here  we', 'Argonaute  proteins'], ['we', 'Ago2 cotransfection'], ['', 'regulatory brain development synchrony'], ['MicroRNAs', 'regulatory  system'], ['recent  evolution', 'specialized  functions'], ['Here  we', 'primate  neurons'], ['neural neuroblastoma cell we', 'northern  blotting'], ['We', 'miR-1290  levels'], ['miR-1290  overexpression', 'neuronal cell phenotypes'], ['crucial cell cycle proteins', 'aberrantly expression level'], ['miR-1290', 'differentiated  state'], ['coding  that', 'transcriptional  regulation'], ['target genes', 'such development metabolism'], ['', ''], ['important grain miRNAs', 'plant'], ['secondary sequence total', 'new  miRNAs'], ['miRNAs', '11  families'], ['identified analysis server miRNAs', '68 target genes'], ['RNA they', 'transcriptional  Panicum'], ['we', 'miRNAs'], ['that', 'specific disease areas'], ['this', 'rheumatoid  arthritis'], ['clinical  results', 'refractory RA patients'], ['circulating  microRNAs', 'potential RA patients'], ['expression profiles', 'responder plasma microarrays'], ['that', 'differentially nonresponder group'], ['differential  they', 'reverse polymerase chain reaction'], ['miRNAs miR-495 3p', 'significantly nonresponder group'], ['characteristic Receiver analysis', 'diagnostic  potential'], ['miRNAs', 'clinical RA validation'], ['', 'invasive  biomarkers'], ['aim', 'invasive liver disease technique'], ['changes', 'human hepatocarcinoma cell line'], ['results', 'benign selenoprotein P groups'], ['best  cutoff', 'benign carcinoma groups'], ['', ''], ['', ''], ['changes', 'target protein'], ['Hence serum microRNA-7', 'hepatocellular selenoprotein carcinoma'], ['selenium', 'hepatocellular anticancer microRNA-7'], ['review', 'small noncoding RNA'], ['RNA molecules', 'RNA interference'], ['It', 'conservative sequences tissue specificity'], ['techniques', 'situ analysis reporter analysis'], ['targeted  therapy', 'microRNA virus molecules liposomes'], ['PI3K  AKT', 'signaling growth factor-1 receptor'], ['PI3K cell lung AKT', 'signaling pathway'], ['Real polymerase chain reaction', 'small lung cancer patients'], ['binding messenger RNA levels', 'low microRNA-125b tumors'], ['free  survival', 'p53-mutated type patients'], ['binding growth effect', 'type cells'], ['increase', 'p53-mutated cell cells'], ['microRNA-125b level', 'poor lung cancer outcomes'], ['Colorectal carcinoma', 'increasing  incidence'], ['Further  understanding', 'therapeutic underlying strategies'], ['molecular  mechanisms', 'miR-155  CRC'], ['present  study', 'possible CRC cells'], ['miR-155', 'normal colon tissue samples'], ['inhibition', 'signaling CRC cell pathway'], ['miR-155 suppression', 'also animal model'], ['novel  which', 'Wnt/-catenin pathway'], ['Furthermore patients', 'reduced survival rates'], ['miR-155', 'HBP1-associated Wnt/-catenin mechanism'], ['Therefore  miR-155', 'therapeutic  CRC'], ['we', 'bladder cancer'], ['Real polymerase chain reaction', 'expression miR-294'], ['Western  blot', 'PI3K  AKT'], ['assay transwell', 'respectively cancer cell line'], ['J82 T24', 'significantly bladder epithelium cells'], ['significantly T24 they', 'significantly miR-294 inhibitor transfection'], ['Moreover miR-294 suppression', 'apoptotic T24 cells'], ['treated T24 it', 'empty miR-294 control'], ['Overexpression', 'PI3K T24 AKT'], ['miR-294 expression', 'positively T24 cells'], ['Moreover miR-294 suppression', 'T24 cisplatin'], ['also  miR-294', 'JAK T24 cells'], ['', 'regulatory cell proliferation migration'], ['2  which', 'cell self renewal'], ['direct  regulator', 'greatly Sox-2 osteosarcoma'], ['reverse polymerase chain reaction', 'expression osteospheres'], ['miR-34a b', 'like  cells'], ['short miR-34a shSox-2', 'soft transformation agar'], ['epigenetic  expression', 'osteosphere stem cell formation'], ['inhibitory  role', 'tumorigenic renewal capacity vitro'], ['findings', 'therapeutic  miR-34a'], ['', ''], ['numbers', '16 2050'], ['we', 'detectable  AD'], ['cellular  changes', 'inflammatory cell cycle'], ['miRNAs', 'cellular gene regulation'], ['also  microRNAs', 'translational gene expression'], ['that', 'AD transgenic mouse AD'], ['', ''], ['rights', ''], ['MicroRNAs', 'small  RNAs'], ['gene that', 'specific mRNA transcription'], ['Mature  miRNAs', '22  length'], ['They', 'biological cancer progression'], ['Cellular expression levels', 'genetic gene disorders'], ['Methods', 'northern polymerase chain reaction'], ['review', 'electrochemical  microRNA'], ['', ''], ['', ''], ['rights', ''], ['Nervous necrosis one', 'economic aquaculture industry'], ['morecular  mechanisms', 'NNV'], ['expression profiles', 'deep sequencing technique'], ['total', 'miRDeep2 novel software'], ['Compared', '3 DE h'], ['expression profiles', 'deep  sequencing'], ['target genes', 'apoptotic process proteolysis process'], ['over  expression', 'four  RGNNV'], ['data', 'effective RGNNV infection'], ['', ''], ['rights', ''], ['ago mammalian plethora', 'than  2500'], ['dysregulation', 'complex cancer diabetes'], ['1 RNA diabetes', 'diverse RNA type'], ['pivotal beta cell interplay', 'animal beta cell disease'], ['major  players', 'prognostic system type'], ['chronic  which', 'endoscopically  mucosa'], ['inflammatory bowel which', 'physicians'], ['MC', 'available  treatment'], ['We', 'lymphocytic CAPES topic'], ['most  studies', 'particularly  pathophysiology'], ['further  studies', 'long  term'], ['long term effects', 'mechanical energy conversion processes'], ['parameter  data', 'different  ownerships'], ['which', 'multiple distribution MTs'], ['dynamic distribution that', 'MTs'], ['three stage identification method', 'mechanical system saturation'], ['fast simulation methodology', 'multiple distribution network'], ['Finally  model', 'promising 37-node test results'], ['', ''], ['rights', ''], ['life cycle assessment', 'zinc oxide facile microwave technique'], ['Key synthesis parameters', '710 degrees W'], ['effect', 'environmental  nanostructures'], ['nanostructures', 'ray electron microscopy'], ['Crystalline site', ''], ['', '110 W microwave power'], ['', '310  W'], ['', '710  W'], ['110 surface area', '110 surface W'], ['', '310  W'], ['', '710  W'], ['60  it', ''], ['', '150 degrees C'], ['', '220 degrees C'], ['environmental  weaknesses', 'dependent electricity source'], ['710 synthesis temperatures', '27  %'], ['electricity mix', '25  %'], ['', ''], ['', ''], ['rights', ''], ['monogenic  that', 'gated  Ca(V)2'], ['', ''], ['that', 'increased spreading depression'], ['Here  we', 'molecular FHM1 R192Q CSD'], ['Gene expression profiles', 'serial gene expression sequencing'], ['data', 'wild  mice'], ['up FHM1 R192Q that', 'inflammatory  signalling'], ['inflammatory  signature', 'relevant mouse migraine'], ['present  study', 'annual growth 17'], ['', '37 % citation 8'], ['', 'collaborative publication 9'], ['', 'global publication 2'], ['', ''], ['productive  countries', '75'], ['', 'global publications 2006'], ['15  organizations', '15  31'], ['', ''], ['', ''], ['', ''], ['', 'Indian % citation output'], ['Medicine', 'largest  publications'], ['', '90 pharmacology toxicology'], ['', ''], ['', ''], ['', ''], ['', '97  2006'], ['15 migraine journals', '32'], ['', '64 % output'], ['cited  papers', 'average  149'], ['', ''], ['', 'more healthcare area'], ['', 'human glioma cells'], ['malignant polymerase chain findings', 'human glioma cell lines'], ['3 cDNA plasmid', 'U87MG'], ['simple scratch test', 'motility changes'], ['Morphological  changes', 'light  microscopy'], ['doubling times', 'different glioma cell motilities'], ['14 3-beta', 'highly U87MG cells'], ['actin', ''], ['U87-YA-3 cell motility', 'parental U87MG cells'], ['doubling  times', 'transfected  cells'], ['3-beta  expression', 'migratory glioma cell abilities'], ['3 3-beta U87MG which', 'therapeutic  glioma'], ['hence gene that', 'cancer progression'], ['coding  RNAs', 'thus prostate disease'], ['novel  gene', 'key cancer progression'], ['MIEN1', 'normal  cells'], ['regulation', 'better  strategies'], ['that', 'silico algorithms'], ['validation', 'situ miRNA tissues'], ['other  regulation', 'other  molecules'], ['functional  effects', 'cell invasion clonal'], ['', \"MIEN1 3'UTR oligomiRs\"], ['hsa  miR-940', 'normal cancer MIEN1'], ['normal prostate miR-940', 'negligible  tumors'], ['MIEN1', 'downstream alters MIEN1 effectors'], ['migratory  potential', 'mesenchymal growth transition'], ['results', 'diagnostic prostate cancer'], ['empirical  research', 'differently  men'], ['', 'acculturation age stressors'], ['Gender differences', 'total  migrants'], ['Results', 'global migration background'], ['perceived  loss', 'more  women'], ['guilt feelings', 'Turkish migration men'], ['', ''], ['Gender differences', 'migration  research'], ['functionalized metal organic frameworks', 'such catalysis CO2'], ['large BET surface m(2)/g', 'free  conditions'], ['obtained  material', 'catalytic Henry reaction'], ['', ''], ['', ''], ['rights', ''], ['Few  studies', 'cognitive  MCI'], ['We', '145 function hippocampal MCI'], ['Patients', 'Test Automated Battery'], ['Hippocampal volume', '42 CSF tau'], ['sustained attention tasks', 'higher CSF tau'], ['Memory tasks', 'daily biomarkers memory performance'], ['biomarkers', 'early incipient AD'], ['', ''], ['rights', ''], ['Background Respiratory illnesses', 'medical  military'], ['', 'military attrition training'], ['male Methods Thirty recruits', '12 Army Training training'], ['', ''], ['4 km run time', 'aerobic  fitness'], ['Saliva', 'full blood counts'], ['recruit', 'mood profile'], ['Significant  salivary', 'military training period'], ['leucocyte count', '28  %'], ['neutrophil percentage', '13  %'], ['lymphocyte %', '17  %'], ['lymphocyte ratio', '22  %'], ['eosinophil%', '71  %'], ['', ''], ['monocyte%', '68  Mid'], ['', '30  End'], ['IL-6', '39  Mid'], ['', '61  End'], ['', ''], ['4 km RT', 'URTS  duration'], ['', ''], ['', '1-min 2'], ['4 km RT', 'risk'], ['', 'average  3'], ['', ''], ['high URTS RT', 'high URTS duration'], ['01', '45 attrition %'], ['higher URTS which', 'high attrition Army'], ['aerobic  fitness', 'military attrition training'], ['Traceability', 'important food foods'], ['they', 'various product names'], ['Recently  this', 'adulteration'], ['real time which', 'dairy products'], ['different  cheeses', 'such cow sheep'], ['', 'study'], ['67  %', '100 % cow milk'], ['1333 sheep milk', '1333  goat'], ['one  sample', '100 % sheep milk'], ['', 'goat cheese samples'], ['100 % sheep milk', '100 % cow milk'], ['linear relationship', 'fatty acids cheeses'], ['', ''], ['', ''], ['rights', ''], ['capacitive load amplifier', 'small gain paper'], ['coupled  structure', 'effective output stage transconductance'], ['', 'standard'], ['', 'm CMOS 0'], ['proposed mu amplifier', '1'], ['', '17 phase 74'], ['', 'capacitive  9'], ['', ''], ['average slew rate', ''], ['', ''], ['on compensation capacitor', 'on  chip'], ['', ''], ['active chip area', ''], ['', ''], ['which', 'inducible Leucaena factors'], ['mimosine  inhibits', 'like MC3T3-E1 cells'], ['', 'IL-6 protein kinase A'], ['present  effects', 'like MC3T3-E1 cells'], ['concentrations', 'relevant ELISA kits'], ['OPG  mRNA', 'reverse polymerase chain reaction'], ['p38 MAP JNK', 'western  blotting'], ['Mimosine', 'significantly expression IL-6'], ['however expression it', 'IL-6  release'], ['Furthermore  mimosine', 'p38 MAP kinase'], ['normoxic HIF inducers', 'IL-6 OPG osteoblasts'], ['', 'social  cognition'], ['how  we', 'social concept MENTALISTIC AGENT'], ['Recent  developments', 'new  questions'], ['rudimentary  learning', 'important MENTALISTIC AGENT concept'], ['MENTALISTIC AGENT', ''], ['why  concept', 'particular  traits'], ['Smokers', 'alternative  cessation'], ['which', 'recently smoking cessation intervention'], ['review synthesizes', 'MM smoking cessation'], ['electronic  databases', 'nicotine smoking cessation cravings'], ['independent  reviewers', 'included study level studies'], ['Meta analyses', 'random effects models'], ['quality', 'GRADE approach'], ['Ten  RCTs', 'inclusion criteria'], ['Intervention duration intensity', ''], ['Studies', 'interactive program learning'], ['one  RCT', 'statistical power power'], ['Publication bias', ''], ['mindfulness  meditation', 'relative comparator groups'], ['small  number', 'adjunctive interventions interventions'], ['adverse  events', ''], ['MM', 'significantly tobacco use'], ['powered  RCTs', 'existing study studies'], ['', ''], ['rights', ''], ['however  discussions', 'basic  settings'], ['current  research', 'new trait mindfulness'], ['within end state they', 'judgment'], ['created  scale', 'three  studies'], ['positive trait it', 'emotional mortality salience'], ['End state mindfulness', 'many  aspects'], ['', ''], ['rights', ''], ['study', 'coping African Americans'], ['American college students', 'racial strategy preference'], ['higher  degree', 'coping socialization strategies'], ['mindful  observation', 'positively  minority'], ['regulatory  strategies', 'negative African Americans'], ['mindfulness African Americans', 'related  stressors'], ['', 'Mindfulness reappraisal Theory'], ['stressful  events', 'psychological  which'], ['we', 'based community intervention'], ['', 'previous state week'], ['Support', 'long state MBI'], ['positive feedback structure', 'upward  spiral'], ['therapeutic  factors', 'positive  MBIs'], ['change', 'active Cancer intervention'], ['', ''], ['Expressive Group Therapy', 'mood life'], ['secondary  analysis', 'distressed breast cancer survivors'], ['intervention questionnaire who', 'MBCR'], ['MBCR participants', 'social SET participants'], ['social  support', 'partially mood symptoms'], ['mediation analyses', 'variables'], ['more  changes', 'mindfulness'], ['This', 'social  MBCR'], ['Mindreading', 'social thoughts world'], ['predominantly children groups', 'NT ceiling adults'], ['We', 'mentalizing emotion perception facets'], ['We', 'highlighting NT adult cohorts'], ['multidimensional  approaches', 'upper construct ability'], ['paper', 'analytical element method'], ['virtual  backfilling', 'granular mining materials'], ['Normal', 'sidewall model friction'], ['DEM', 'high model backfill'], ['that', 'analytical  solutions'], ['analyses', 'spatial contact forces'], ['DEM', 'closely particle scale'], ['engineers', 'possible mining backfill'], ['', '2016 Civil Engineers'], ['Rural electrification rates', 'central grid expansion'], ['central mini grids', 'economic  growth'], ['private  investment', 'virtually  India'], ['grids', 'central grid connection'], ['prospective  entrepreneur', 'subsequently electricity area'], ['that', 'already  grid'], ['precisely grid discoms', 'economic electricity cost'], ['threat', 'mini grid India'], ['issues', 'called holdup organizations'], ['', 'regulatory state level grids'], ['We', 'policies  future'], ['', ''], ['rights', ''], ['causal child evidence', 'relationship'], ['We', 'minimum child maltreatment rates'], ['increases', 'neglect child reports'], ['1  increase', 'significant  9'], ['', 'neglect % reports'], ['6  effect', 'adolescents'], ['We', 'minimum wage race'], ['findings', 'specifications'], ['that', 'working  welfare'], ['', ''], ['rights', ''], ['who', 'computed head head'], ['Scalp', 'intracranial  injury'], ['edema  caregiver', 'scalp'], ['We', 'further  setting'], ['24  months', '24 head trauma'], ['Cases', '2014 study May'], ['Seventy six Results Seventy patients', 'patient  study'], ['mean  age', 'presentation'], ['', ''], ['patients', 'nonaccidental Child Protection Team'], ['epidural skull which', 'patient  encounters'], ['78  patient', 'further NAT evaluation'], ['neurologic  all', 'nonfocal neurologic discharge'], ['patient', 'delayed neurologic decline'], ['', 'required  surgery'], ['minor  who', 'surgical neurologic decline'], ['workup', 'safely CT setting'], ['Myocardial  ischemic', '1  laboratory'], ['Male Wistar rats', '5 3 ligation'], ['protein', 'Situ quantitative RT hybridization'], ['Expression', '6  h'], ['protein signals', 'infarcted  zone'], ['myogenic  cells', 'H2O2'], ['Mipu1', 'myogenic ischemia reperfusion'], ['Background', 'metabolic fatty acid synthesis'], ['that', 'liver'], ['aim', 'transcript promoter region'], ['RT PCR RT RACE', 'binding transacting sites'], ['Reporter gene assays', 'HNF4 vitro'], ['HNF4 alpha', 'miR-122 promoter'], ['', 'regulatory miR-122 vivo'], ['miR-122', 'distal upstream promoter species'], ['transcriptional promoter that', 'nuclear miR-122 factor'], ['HNF4 alpha', 'conserved DR I element'], ['conserved miR-122 activation', 'further PGC1 alpha'], ['HNF4 alpha', 'miR-122 Huh7 cells'], ['HNF4 alpha', 'key miR-122 liver'], ['', '2011 European Liver'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['small noncoding function', 'proper cell growth'], ['regulatory  they', 'pathological nerve cells'], ['growth', 'vitro cell line model'], ['expression pattern', 'situ glioma cell localization'], ['effect', 'human MTS assay TUNEL'], ['identification', 'dual luciferase activity assay'], ['We', 'differential  1'], ['', ''], ['Up regulation', 'inhibited U343 ATRA'], ['', 'induced glioma apoptosis'], ['Bcl-2 modifying miR-125b', \"3'-untranslated Bmf\"], ['overexpression', 'induced sensitizes apoptosis'], ['important  miR-125b', 'cell apoptosis'], ['', ''], ['', ''], ['nucleotides RNA that', 'target genes'], ['that', 'Salmonella infection'], ['bioinformatics strategies', 'genomic  sequence'], ['Here  we', 'commercially Salmonella pigs'], ['Salmonella infection nine', 'yet  pig'], ['expression', 'northern  blotting'], ['natal miR-27b all', 'days Salmonella inoculation'], ['predicted  targets', 'three luciferase reporter assays'], ['miR-27b', 'IFNG'], ['findings', 'Salmonella infection'], ['commercial breed it', 'genetic salmonella infection pigs'], ['Malignant astrocytomas', ''], ['which', 'conventional  therapy'], ['small  that', \"specific 3'-untranslated region\"], ['molecular  disruption', 'important  astrocytomas'], ['some', 'astrocytoma patients'], ['we', 'different astrocytoma tissues'], ['levels', 'human T98 G astrocyte'], ['Furthermore  levels', 'pathological  astrocytomas'], ['also  TROVE2', 'novel luciferase reporter system'], ['Furthermore expression levels', 'pathological  stages'], ['Finally  levels', 'negatively astrocytoma tissues'], ['data', 'human  astrocytomas'], ['Aberrant  levels', 'colorectal  cancer'], ['aim', 'colorectal cancer diagnosis'], ['We', '117 serum patients'], ['miR-622', 'colorectal  cancer'], ['colorectal control miR-622', 'frequently  patients'], ['AUC', 'miR-139 3p'], ['', '96'], ['', '6  97'], ['', ''], ['Serum miR-139 3p level', 'early stage CRCs'], ['Detectable serum miR-622', '87'], ['', '5  63'], ['CRC sensitivity', 'late stage patients'], ['', ''], ['We', 'based blood CEA biomarkers'], ['', 'median CRC patients'], ['ng  ml', 'significantly  control'], ['', ''], ['AUC value', 'diagnosing CRC patients'], ['', ''], ['positive tumor level', 'male'], ['Collectively miR-139 3p', 'colorectal cancer detection'], ['nervous  which', 'aggressive surgery chemotherapy'], ['stranded RNA which', 'human cancer hepatocellular carcinoma'], ['that', 'formally glioma development'], ['relatively  little', 'endothelial glioma progression'], ['miR-140 5p expression', 'real polymerase chain reaction'], ['miR-140 5p', 'glioma cell vitro'], ['messenger RNA', 'western blot assay'], ['', 'endothelial growth factor A'], ['endothelial growth factor', 'matrix metalloproteinase-2 matrix vivo'], ['neoangiogenesis  that', 'neoangiogenesis  mechanisms'], ['We', 'real cell time'], ['Survival curver', 'transwell analysis kits'], ['tissues', 'high CRC TLR2'], ['Targeting TLR2', 'markedly CRC cells'], ['that', 'primarily CRC TLR2'], ['expression', 'CRC cell vivo'], ['miR-143', 'human CRC cells'], ['knowledge', 'clinical miR-143 CRC'], ['AIM', 'gastric  cancer'], ['levels', 'gastric cancer cells'], ['real polymerase chain reaction', 'CD44'], ['luciferase reporter assay', 'western CD44 expression'], ['', 'gastric cancer cells'], ['gastric cancer that', 'highly cancer stem cells'], ['miR-145', \"directly CD44 3'-untranslated region\"], [\"CD44 3'-UTR CD44 interactions\", 'silencing  effects'], [\"CD44 3'-UTR CD44 interactions\", 'stimulatory  effect'], ['Enforced CD44 expression', 'gastric cancer cells'], ['Furthermore  inhibition', 'significantly cancer CD44'], ['miR-145 targeting', 'gastric chemo cancer'], ['secure', 'efficient life span control'], ['signaling  which', 'cytokine genes'], ['inflammatory response information', 'functional  apoptosis'], ['deep murine expression', 'Northern  blotting'], ['that', 'induced  miR-155'], ['primary macrophage activation', 'expression mRNA reduction'], ['Endogenous  CASP-3', 'activated CASP-3 macrophages'], ['induced silencing miRISC', 'ARGONAUTE'], ['specific antagomir transfection', 'activated CASP-3 mRNA macrophages'], ['vitro translation assays', 'CASP-3 reporter mRNA destabilization'], ['induced  miR-155', 'down  regulation'], ['we', 'activated mRNA RAW'], ['7  macrophages', 'crucial  inflammation'], ['aim', 'underlying cancer mechanisms'], ['miR-200c', 'namely colony formation cells'], ['expression levels', 'reverse polymerase chain reaction'], ['miR-200c', 'increased cell proliferation'], ['3 transcription mRNAs', 'cadherin cadherin vimentin p14'], ['results', 'direct cancer and'], ['MicroRNA-498', 'many  carcinomas'], ['signaling modulates carcinogenesis', ''], ['molecular  pathogenesis', 'squamous cell carcinoma'], ['we', 'clinicopathological  ESCC'], ['Expression', 'real polymerase chain reaction'], ['vitro  effects', 'cellular  miR-498'], ['Western  blot', 'interacting immunofluorescence ESCC'], ['miR-498  expression', 'esophageal  tissues'], ['', ''], ['Patients', 'miR-498  expression'], ['Overexpression', 'when colony control'], ['', 'KLF6 transcriptional KLF6 ESCC'], ['addition miR-498 addition overexpression', 'reduced cancer cell growth'], ['conclude', 'FOXO1 KLF6 signaling pathway'], ['changes', 'well  ESCC'], ['', ''], ['rights', ''], ['coding  that', 'translational gene repression'], ['various  role', 'gastric miR-584 cancer'], ['we', 'miR-584 GC'], ['expression', 'real polymerase chain reaction'], ['incorporation colony formation assays', 'mouse tumorigenicity model'], ['Cell apoptosis', 'vitro vivo TUNEL'], ['Luciferase reporter assays', 'miR-584 5p'], ['GC cell apoptosis', 'GC cell proliferation'], ['Luciferase reporter assays', 'direct miR-584 5p'], ['effects', 'WWP1 overexpression'], ['effects', 'miR-584 5p WWP1-shRNA'], ['miR-584 expression levels', 'negatively GC tissues'], ['miR-584 5p', 'TGF beta signaling WWP1'], ['together  results', 'human miR-584 GC'], ['small cell lung cancer', '80 lung cancer cases'], ['MicroRNAs', 'important cancer development'], ['miR-615 3p', 'lung cancer'], ['overexpression', 'reverse polymerase chain reaction'], ['ectopic miR-615 expression', 'H1299 cell lines'], ['that', 'negative control sequence'], ['miR-615 3p overexpression', 'H1299 cell NC'], ['ectopic  expression', '3 cancer cell lines'], ['that miR-615 3p functions', 'therapeutic tumor NSCLC'], ['nucleotide length that', 'gene regulation'], ['', 'miRNA expression levels'], ['fully  it', 'small expression molecules'], ['Northern  which', 'detection methods'], ['method', 'low  sensitivity'], ['This', 'detection methods'], ['detection methods', 'solid solution solution'], ['Northern throughput they', 'vivo use'], ['however  they', 'high throughput settings'], ['', 'electrochemical assays etc'], ['', 'much miRNA detection'], ['current  detection', 'new  methods'], ['future  detection', 'methods'], ['little', 'esophageal  cancer'], ['we', 'situ cancer cell hybridization'], ['Let-7 g miR-21', '2 cell lines'], ['transient  transfection', 'beta(2 miR-16 expression'], ['miR-16 2', 'esophageal disease adenocarcinoma'], ['miR-16  expression', 'esophageal cancer patients'], ['miR-16 2 miR-16 miR-30e', 'squamous cell carcinoma patients'], ['prognostic miR-16 biomarkers', 'esophageal  adenocarcinoma'], ['role', 'further  study'], ['other  families', 'rapid expression patterns'], ['Here  we', 'total RNA samples'], ['method', 'Northern amplification blotting'], ['method', 'different  organisms'], ['microRNAs', 'environmental  adaptation'], ['recent  miRNAs', 'functional  importance'], ['specific  which', 'modulated gene expression'], ['available identification software', 'plants'], ['particularly  which', 'repetitive  genome'], ['scripts  method', 'such crop Triticum'], ['Herein  we', 'increased miRNA identification plants'], ['Recent  updates', 'positive  predictions'], ['It', 'transposable  elements'], ['SUmirPredictor', 'high confidence plant'], ['microRNAs', 'important gene expression'], ['eukaryotic  function', 'vast  molecules'], ['it', 'spatial expression patterns'], ['it', 'routine gene expression studies'], ['we', 'mature  miRNAs'], ['Total RNA', 'total  templates'], ['expression', 'mature  method'], ['two polymerase chain assay', 'Northern  blotting'], ['RT PCR', 'convenient  miRNAs'], ['MicroRNAs', 'eukaryotic gene cells'], ['However  RNAs', 'same  bacteria'], ['size  which', 'deep Streptococcus mutans'], ['Bioinformatic  analysis', '900  individual'], ['cellular  content', 'quantitative RT PCR'], ['biological  role', 'RNA S'], ['which', 'dental  caries'], ['when quantification they', 'normal  conditions'], ['various  methods', 'coding  RNAs'], ['methods', 'extension northern blotting microarray transcription'], ['Here  we', 'mature time PCR miRNAs'], ['which', 'primer time PCR probe'], ['assay', 'two cancer cell lines'], ['assay', 'coding  RNAs'], ['Renal  fibrosis', 'extracellular tubulointerstitial fibroblast matrix'], ['miR-21', 'growth'], ['however tissue it', 'SphK S1P miR-21'], ['SphK S1P signaling', 'TGF-'], ['first  miR-21', 'qRT  PCR'], ['61 muscle actin', 'specific  TECs'], ['ELISA', 'S1P qRT TECs'], ['S1P production', 'SphK1'], ['upregulation', 'exogenous  S1P'], ['Blocking', 'also  miR-21'], ['miR-21  overexpression', 'epithelial ECM SphK1'], ['study', 'renal  fibrosis'], ['interpersonal  interactions', 'made  actions'], ['', 'iterative perception action loop'], ['single macaque which', 'sensory response properties'], ['mirror  neurons', 'human mirror system'], ['current  review', 'focused mirror neuron origin'], ['particular  we', 'mirror  actions'], ['changing task demands', 'frontal control networks'], ['', ''], ['', 'Elsevier Ltd'], ['This', 'BY NC license'], ['', 'org  nc'], ['', ''], ['amygdala', 'crucial salience detection'], ['', 'emotional voice processing'], ['However  relationship', ''], ['healthy syllables who', 'trait anxiety'], ['amplitudes', 'implicit amygdala fear'], ['left amygdala association', 'implicit amygdala fear'], ['amygdala  reactivity', 'emotional  MMN'], ['', 'explicit saliency perception'], ['', ''], ['', ''], ['metabolic  reprogramming', 'key tumor development'], ['', 'glycolytic growth tumors'], ['known Warburg which', 'clinical glucose analogs'], ['Recent Glucose utilization', 'carbon tumors'], ['new  studies', 'glycolytic tumor phosphorylation'], ['which', 'antioxidant chain response'], ['dependent cancer cells', 'glutamine  acids'], ['diversity', 'clinical carbon diagnosis'], ['Metabolic', 'such proliferation survival migration'], ['induced mitochondrial metabolism', 'tumor microenvironment components'], ['associated  fibroblasts', 'neoplastic  cells'], ['They', 'thus cancer treatments'], ['Future Characterizing', 'better treatment resistance'], ['exclusively powerhouse mitochondria', 'most cell biology'], ['human research which', 'underlying mitochondrial dysfunction'], ['synaptic brain release that', 'physiological  systems'], ['mitopathogenic  mechanisms', 'medical oncology neurology immunology'], ['Increasing  knowledge', 'various diagnosis therapy medicine'], ['specific mitochondrial that', 'likely modem medicine'], ['', ''], ['', 'Elsevier B'], ['', ''], ['Tat arginine pathways', 'well  bacteria'], ['all plant mitochondrial these', 'all plant mitochondrial date'], ['functional  that', 'plant Arabidopsis thaliana'], ['plants', 'potentially mitochondrial biogenesis'], ['Manganese superoxide dismutase', 'oxidative defense stress'], ['molecular  us', 'immune  system'], ['novel manganese superoxide dismutase', 'cDNA ends cDNA PCR'], ['full length cDNA', '220 amino acids'], ['deduced amino acid sequence', '20 amino acids'], ['Sequence comparison', 'F'], ['giant freshwater prawn Macrobrachium', 'blue Callinectes sapidus'], ['mMnSOD  transcripts', 'Northern organ intestine blotting'], ['mMnSOD', 'artificial spot syndrome virus'], ['fusion protein', 'vitro'], ['two peptide fragments', 'corresponding  M'], ['mMnSOD enzyme activity', 'recombinant  protein'], ['', ''], ['rights', ''], ['ventricular  hypertrophy', 'important organ damage hypertension'], ['genetic  factors', 'important  LVH'], ['aim', 'Chinese  hypertensives'], ['mutational  screening', 'Chinese PLA General Hospital'], ['Specific  mutations', 'mitochondria'], ['Changes', 'specific  RNA'], ['Rates', '5300 av oxygraph'], ['Sequence analysis', '4401 A4401 tRNA(Met'], ['noncoding region mutation', 'mitochondrial'], ['reduction', 'steady state mutation'], ['novel  mutation', 'Chinese control patients'], ['', 'Chinese mitochondrial hypertensives'], ['protein', 'myocardial  infarction'], ['relevant  induction', 'similar  benefits'], ['AAV9  vectors', 'coronary  ligation'], ['Hearts', 'Western chain reaction histology'], ['delivery', 'transgenic  mice'], ['acute  it', 'transgenics'], ['', 'global zone wall hypertrophy'], ['local LV trends', 'LV volume'], ['ligation', 'structural border benefits'], ['chronic infarct size', 'translational gene efforts'], ['however  consideration', 'transgene  delivery'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '1972'], ['rheumatic  they', 'good steroid prognosis'], ['MCTD', 'distinct  disease'], ['initially  described', 'well  features'], ['MCTD', ''], ['new literature observations', 'MCTD'], ['term', 'rheumatic  disease'], ['generic MS that', 'practice'], ['use', 'thus method practitioners'], ['NINES New Energy which', 'new energy system'], ['involved', 'method approach client approach'], ['evaluation', 'transferable  lessons'], ['emerge', 'OR MS methods'], ['future  which', 'mixed  method'], ['', ''], ['rights', ''], ['integrated width that', 'switched DC power supplies'], ['that', 'capability temperature dependency'], ['analog  which', 'digital PID input'], ['', '8-bit 0'], ['m CMOS process', 'only switching 96'], ['', '25 mu 1'], ['', '8 V 0'], ['', 'overlapping SMPS power devices'], ['', ''], ['', ''], ['rights', ''], ['Geotrichum candidum', 'soft  cheeses'], ['NUP116 URA1 URA3 which', '67 sequence G'], ['candidum strains', ''], ['but  two', 'milk cheese'], ['findings', 'specialized European G'], ['candidum', ''], ['we', 'like repeat G'], ['related dairy which', 'MLST'], ['Overall  findings', 'environmental  isolates'], ['regional  specificity', 'dairy G'], ['candidum strains', ''], ['present  study', 'dairy  G'], ['previous  that', 'cheese species'], ['', ''], ['Humans', 'social  partners'], ['human  targets', 'however  humans'], ['behaviour', 'attachment'], ['Here  we', 'mobile  attachment'], ['stress which', 'behavioural  level'], ['related  which', 'related  stimuli'], ['We', 'emotional Stroop test'], ['Additionally  we', 'assess mobile attachment'], ['', 'mobile stress attachment'], ['other  mobile', ''], ['', 'relevant  mobile'], ['which', 'social  attachment'], ['This', 'evolutionary attachment structures'], ['', ''], ['rights', ''], ['aim', 'known validation tests'], ['that', 'four order model'], ['selected model adequacy it', 'different tracking performances selections'], ['proposed  solution', 'identification time solutions'], ['Performance', 'significantly time delays'], ['time  delays', ''], ['new voltage which', 'present control cycle'], ['dead  which', 'selected load current'], ['types', 'delays'], ['known  solutions', 'hardware software implementations'], ['Introduction power electronics', 'clear  way'], ['This', 'linear model predictions'], ['paper', 'current voltage source inverters'], ['based voltage which', 'dead time compensation'], ['main  points', 'extensive  simulation'], ['paper', 'neutral type control system'], ['reduced order which', 'dimensional  system'], ['Sufficient  condition', 'asymptotic error system'], ['projection which', 'subject complementary linearization algorithm'], ['', 'special results model i'], ['', ''], ['', ''], ['numerical simulation example', 'proposed controller design approach'], ['Rice stripe tenuivirus', 'Asian strand RNA countries'], ['viral  particle', 'nucleocapsid  protein'], ['how RSV NP', 'genomic particle assembly'], ['polar amino acids', 'predicted RNase digestion'], ['RSV NP', 'pentamers hexamers heptamers'], ['oligomer  formation', 'terminal amino NP'], ['wild  type', 'less  RNA'], ['findings', 'genomic RSV RNA'], ['It', 'quantitatively target practice'], ['We', 'one OR simulation'], ['that', 'such input dioxins'], ['Gene promoters', 'essentially AGCT string'], ['paper', 'configuration'], ['we', 'uniform probability strings'], ['uniform', 'previous time series'], ['', ''], ['69', 'more  model'], ['based  study', 'molecular  biology'], ['Petrochemical plants', 'piping'], ['typically process which', 'fuel gas cooling water'], ['Utilities', 'significant operating plant'], ['Therefore reduction', 'utilities'], ['which', 'often  optimisation'], ['potential  benefits', 'generation utility areas'], ['main  objectives', 'dual cooling water system'], ['continuous input which', 'control  solutions'], ['cost  consumption', 'predictive  control'], ['additional Regulatory benefit', 'control optimisation techniques'], ['additional  capital', 'necessarily  techniques'], ['', ''], ['rights', ''], ['key  that', 'recycling intention'], ['subjective  that', 'intention'], ['study', 'conceptual Planned gap'], ['study', '246 Hong Kong'], ['Findings', 'that'], ['', ''], ['experiential  attitude', 'subjective recycling intention'], ['subjective  norm', 'motivating recycling behaviors'], ['experiential  who', 'limited recycling behaviors'], ['Policy implications', 'findings'], ['Limitations', 'study research direction'], ['', ''], ['rights', ''], ['DNA methylation CpG', 'centromere histone string'], ['aim', 'Mycobacterium aoium subsp'], ['', 'conventional polymerase chain tests'], ['total', '121 Pernambuco Brazil'], ['MAP DNA', '20  samples'], ['', '34  samples'], ['', '1  qPCR'], ['MAP DNA', '6 animal farms'], ['where PCR sensitivity', 'conventional  qPCR'], ['', ''], ['Thus IS900 region', 'bovine milk Pernambuco'], ['this', 'first Northeast Brazil'], ['also qPCR technique', 'conventional milk samples'], ['', 'C Elsevier Editora Ltda'], ['present  study', 'Cryptosporidium Brazil'], ['total', '11 Sao Paulo'], ['', 'gene Cryptosporidium sp'], ['DNA', '21'], ['', '7  foals'], ['HSP70 nPCR amplicons', 'fecal  samples'], ['PCR amplification', 'C parvum genotypes'], ['Interestingly  we', 'human parasite C'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['Methylation', 'transcriptional cytosine silencing'], ['biological cytosine functions', 'enzymatic cytosine 5mC'], ['number', 'biological  systems'], ['some', 'functional cell roles'], ['Here  we', 'modified  cytosine'], ['method', 'experimental protein lineage contexts'], ['canonical  set', 'wide protein functionality'], ['Nevertheless  set', 'potential protein applications'], ['incorporation', 'noncanonical amino scope'], ['', 'noncanonical amino acids'], ['that', 'canonical  ones'], ['usually amino codon', 'canonical amino acid'], ['genetic code expansion', 'given amino protein'], ['genetic  code', 'translational  system'], ['translation machinery', 'prescribed amino i'], ['', ''], ['occurrences', 'noncanonical amino one'], ['incorporation', 'physical protein properties'], ['often expression they', 'endogenous vivo protein production'], ['', 'noncanonical amino proteins'], ['noncanonical acid L canavanine', 'noncanonical L amino'], ['It', 'inherent vivo expression'], ['Additionally  protocol', 'mass spectral analysis'], ['L lysine', 'lower L hydroxy efficiency'], ['long  endogenous', 'vitro translation it'], ['recent  development', 'large scale metagenomic'], ['genetic enzyme screening that', 'dimethylphenol phenol'], ['genetic screening system', 'different BRENDA database'], ['', 'maximum flow cytometry signals'], ['developed screening which', 'flow cytometry sorter'], ['phenolic  substrates', 'different beta enzymes'], ['metagenomic enzyme activities', 'further gene identification'], ['novel extraction which', '2 separation min'], ['blood specimen', 'briefly separation membrane'], ['', 'genomic separation membrane'], ['wherein PCR inhibitors', 'absorbent blotting pad'], ['membrane', 'further PCR purification'], ['simple  method', 'inexpensive laboratory supplies'], ['early infant that', 'genetic  targets'], ['Imaging', 'real cell time'], ['2D  which', 'cellular  microenvironment'], ['method', '3D hydrogel environment'], ['yields', 'probe activation range'], ['cyclic adenosine levels', 'material type herein'], ['2D FRET method', 'additional  work'], ['already  utilizing', '3D FRET microenvironment'], ['It', 'engineered 3D microtissues'], ['Additionally  it', 'pulsed fluorescence illumination'], ['versatile  that', 'mutations gene fusions'], ['Standard RNAseq', 'mRNA RNA RNAs'], ['RNAseq  capture', 'selected desktop sequencer'], ['transiently  that', 'traditional RNAseq methods'], ['Here  we', 'multiplex desktop sequencer'], ['computational analysis which', 'nucleotide gene expression variants'], ['targeted transcript sequencing', 'expression gene fusions'], ['ribonucleoprotein that', 'aberrant chromosomal fusion'], ['Telomere length', 'alternative  telomeres'], ['', ''], ['elegans', 'multicellular model telomere'], ['Visualization', 'repetitive  telomeres'], ['quantitative restriction fragment methods', 'averaged  length'], ['', 'individual  cells'], ['Here  we', 'representative  C'], ['', 'situ  hybridization'], ['situ  that', 'noticeable  morphology'], ['labeled nucleic we', 'repetitive  C'], ['', ''], ['such cell that', 'proper cell cytoskeletal structures'], ['given  that', 'particularly  proteins'], ['cellular protein morphology', 'cellular  processes'], ['Transient depletion rescue experiments', 'powerful analyzeprotein functions'], ['However  reintroduction', 'physiological target level'], ['method termed method that', 'normal  actin'], ['HeLa cells', \"3'UTR siRNA region\"], ['tagged BAG3 proteins', 'recombinant transfection reagents'], ['Adenofection', 'physiological stress response'], ['effect', 'stressinducible protein homeostasis'], ['cell transduction we', 'mitotic cell progression'], ['Adenofection', 'functional myoblast myotubes'], ['biological structure function that', 'cytoskeletal  dynamics'], ['FRET)-based studies', 'increasingly  GPCR'], ['research group', 'agonist Ga stimulation'], ['Here  we', '2-adrenergic C terminus 100'], ['ER FRET acceptor K', 'systematic affinity strength modulation'], ['protocol', 'assay execution data analysis'], ['experimental  design', 'also proteinprotein ligands'], ['protocol', 'reproducible  execution'], ['Green fluorescent variants', 'vesicular living cells'], ['lysosome  which', 'endocytic cargo pathway'], ['sensitive  that', 'acidic  environments'], ['', 'vacuole cargo proteins lumen'], ['Thus quenching', 'endocytic  pathway'], ['paper', 'based flow cytometry'], ['Caspases', 'proteolytic cell activity'], ['available technologies apoptosis', 'levels'], ['Caspases', 'few cell minutes'], ['same  caspases', 'enzymatic  levels'], ['Studies', 'ultimate cell vivo'], ['permanently  that', 'whole caspase animals'], ['green fluorescent that', 'caspase past'], ['caspase  dependent', 'apoptotic adult fly'], ['This', 'ovary malpighian tubules ducts'], ['lived biosensor activity', 'days caspase activation'], ['biosensor', 'live caspase animals'], ['Structural  interactions', 'cellular mitochondrial signaling'], ['75 GRP75)/inositol 145triphosphate receptor', 'dependent anion channel'], ['simple  method', 'endogenous ER mitochondria cells'], ['Similarly  MAMs', 'suitable protein overexpression'], ['Here  we', 'outer MAM interface'], ['Similar', 'cyclophilin IP3R1 antibodies'], ['other imaging it', 'multiple condition testing'], ['Therefore  use', 'pathological ER mitochondria contexts'], ['consecutive  cryosections', 'skeletal gene muscle'], ['skeletal buffer volumes', 'low RNA yield'], ['30 mu m sections', 'mechanically buffer penetration'], ['it', 'cryostat'], ['pooled muscle method', 'skeletal  muscles'], ['Furthermore  technique', 'matched  analyses'], ['', ''], ['skeletal gene measurements', 'multiple animal applications'], ['Optogenetic  tools', 'signaling  pathways'], ['popular cell tools', 'vitro cell experiments'], ['flow cytometer', 'single cell resolution'], ['However  it', 'widely  optogenetics'], ['that', 'optogenetics'], ['device', 'specific flow cytometric measurements'], ['It', 'common flow cytometers'], ['we', 'real Dronpa time'], ['protocol', 'possible  experiments'], ['importantly  it', 'optogenetic  tools'], ['protein complexes', 'cellular  homeostasis'], ['how protein proteins', 'pathways'], ['how protein interaction misregulation', 'disease pathogenesis'], ['several  approaches', 'such tandem affinity purification'], ['scale proteomic pathway scale strategies', 'stable cell line generation'], ['Here  we', 'stable protein subcellular localization'], ['approach', 'proteomic cell analyses'], ['Xenopus', 'first Gurdon et al'], ['', 'widely  discovery'], ['oocyte', 'endogenous ion channels(4'], ['expression system', 'gated ion channels'], ['expression  receptors', 'electrophysiological solution experiments'], ['procedures', 'ones'], ['denuded collagenase oocytes', 'ovary collagenase RT'], ['diverse membrane proteins', 'system'], ['methods', 'gated ion channels'], ['small center which', 'cellular mammals bacteria'], ['', 'single cell level'], ['physiological  effects', 'actual center radical'], ['that', 'single center dot'], ['center dot center that', 'hence center dot need'], ['Here  we', 'different center dot chemical'], ['3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N methyl-1-propanamine 3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N NOC-7', 'inorganic donor sodium nitroprusside'], ['green indicator fura-2', 'endothelial center dot cells'], ['geNOps', 'experimental center dot setups'], ['Live cell imaging', 'HEK angiotensin II'], ['HEK cells', 'green fluorescent protein'], ['Lysosomes', 'red fluorescent dye'], ['Live cell images', '3D Ang II time'], ['Live cell imaging', 'tagged membrane receptors'], ['subcellular  localization', 'receptors'], ['Images', 'rapid vesicle movement'], ['faster  number', 'photons'], ['Compromises', 'also imaging speed'], ['Significant  applications', 'live protein protein name'], ['last  decades', 'scientific RNA level'], ['branch', 'transcriptional  regulation'], ['revolutionary  perspective', 'specific state species'], ['fleeing Northern Blot assay', 'immediate RNA expression'], ['It', 'easily RNA biology'], ['Here  we', 'cultured adult cells'], ['use', 'isolated  cells'], ['use', 'ligninolytic fungi Trametes micropollutants'], ['few  studies', 'sterile  conditions'], ['inoculated  fungus', 'other  bioreactor'], ['fungal  treatments', 'reverse wastewater treatment plant'], ['setup', 'parallel  T'], ['which', 'control'], ['main  objective', 'microbial PhAC bioreactors'], ['biochemical fatty acids analysis', 'PLFA gradient gel electrophoresis'], ['only  which', 'inoculated  fungi'], ['', ''], ['Trichoderma', 'asperellum  T'], ['', 'ROC treatment'], ['also wastewater origin', 'microbial  T'], ['', ''], ['', ''], ['', ''], ['', ''], ['rights', ''], ['bacterial  design', 'periodontal  disease'], ['', ''], ['3 mean age', 'ligating  brackets'], ['Saliva', 'bonding'], ['One  sample', '30'], ['analysis', 'DNA DNA hybridization'], ['data', 'parametric  test'], ['significant  increase', 'analyzed  species'], ['ligating  brackets', 'orange incidence complexes'], ['', 'different bracket design'], ['levels', 'significant Campylobacter differences'], ['highest  values', 'R R bracket'], ['bracket design', 'periodontal  disease'], ['additional  studies', 'orthodontic  treatment'], ['dynamic  alteration', 'soft  tissues'], ['different  types', 'bacterial  adherence'], ['Bracket design', 'orthodontic  treatment'], ['serine threonine that', 'hematological  malignancies'], ['Few  studies', 'especially prostate cancer'], ['aim', 'prostate cancer'], ['Material  We', 'prostatic prostate hyperplasia'], ['Western RNA blot', 'different cell lines'], ['mRNA expression', 'prostatic hyperplasia tissue'], ['', ''], ['Accordingly protein level expression', 'significantly control cells'], ['expression status', 'stage antigen Gleason metastasis'], ['High  expression', 'significantly survival surgery'], ['important prostate we', 'valuable  Chinese'], ['Microparasites', 'important Pacific salmonids'], ['impacts', 'wild salmon populations'], ['We', '45 microparasite taxa'], ['20 microparasite four', 'previously Fraser River'], ['positive blood plasma associations', 'physiological Ceratonova morbidity'], ['We', 'previous British Columbia'], ['better  underlyingmechanisms', 'cardiovascular  disease'], ['Findings Molecular imaging', 'molecular vivo imaging'], ['Molecular probes', 'such cell death inflammation'], ['that', 'traditional imaging systems'], ['molecular  imaging', 'important precision medicine'], ['physicians', 'near  future'], ['scientific  that', 'pathology biostatistics bioinformatics'], ['underlying  objective', 'prevention population health'], ['breast lung breast methodology', 'most  diseases'], ['Recent  successes', 'behavioral disease subtype'], ['Central  challenges', 'educational  field'], ['new  series', 'Boston MA'], ['Herein  we', '17 International MPE countries'], ['Special  topics', 'immunology health disparity research'], ['meeting series', 'scientific  fields'], ['Autopsy  histology', 'surgical  pathology'], ['molecular  biology', 'diagnostic  armamentarium'], ['pathology molecular biology techniques', 'therapeutic  targets'], ['Molecular pathology', 'based  discipline'], ['Traditional  pathology', 'molecular tumor therapy'], ['that', 'histopathology pathology autopsies'], ['molecular biology which', 'fast  pace'], ['parallel sequencing that', 'parallel sequencing sequencing'], ['analytical  steps', 'such DNA extraction'], ['steps', 'laboratory information systems'], ['much  histology', 'situ  quantification'], ['Expert review', 'molecular  pathology'], ['vision', 'technological  changes'], ['aim', 'air biomass sources'], ['working  combination', 'molecular  methods'], ['study', 'main fuel source'], ['studied bioaerosol particles', 'directly storage places'], ['Simultaneously swab samples', 'microbial work contamination'], ['microbial  isolates', 'polymorphic polymerase chain methods'], ['mean  concentrations', 'studied biomass workplaces'], ['', ''], ['', ''], ['', ''], ['', ''], ['number', 'high  1'], ['', ''], ['', ''], ['', 'genus  Bacillus'], ['', 'genus  Bacillus'], ['', ''], ['', ''], ['4  Staphylococcus', 'RAPD PCR method'], ['Based', 'air protective biomass air mask'], ['xylosus strains', 'air mask'], ['biomass', 'primary power plant workplaces'], ['associated  bacteria', 'routine  activities'], ['correctly hand workers', 'key prevention strategy'], ['based  methods', 'occupational  environment'], ['Such  methods', 'infectious  workplaces'], ['Biomineralogy', ''], ['biological  that', 'mineral'], ['broad  that', 'mineralogists materials scientists'], ['only  expert', 'expert'], ['biological  insight', 'mineral'], ['rich  diversity', 'mineralised  structures'], ['now  strategy', 'molecular  biologist'], ['evo devo', 'future gastropod shell formation'], ['', ''], ['rights', ''], ['', 'related Monascus aurantiacus'], ['trace cDNA amplification kit', \"3'-RACE length products\"], ['This yp05 gene', 'fungal manganese superoxide BLASTp'], ['transcription', 'Northern Monascus blotting'], ['only Monascus citrinin', 'only Monascus strains'], ['transcription', 'red biosynthesis pigments'], ['psychological research that', 'assumption'], ['people', 'moral  history'], ['1  people', 'moral  history'], ['', ''], ['', ''], ['alternative  judgments', 'stolen  money'], ['they', 'positive  act'], ['actual  people', 'tainted  money'], ['that', 'effectively  origins'], ['old  girl', 'back  arms'], ['local  conclusion', 'marks'], ['three  marks', 'three  days'], ['where child abuse', 'forensic skin cases'], ['guide', 'Mongolian  spots'], ['', 'human immunodeficiency cocaine'], ['', ''], ['tenofovir', 'electrochemical impedance spectroscopy'], ['cultureware CC', 'HIV infection Coc drug'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'developed CC chip'], ['HIV infection progression', 'specific cell electrophysiology'], ['work', 'timely HIV diagnosis'], ['presented  study', 'dendritic CNS cells'], ['', ''], ['', ''], ['rights', ''], ['numerical  that', 'electrical  neurons'], ['stochastic Monte Carlo that', 'different cell membrane'], ['Gating channels', 'first Hodgkin Huxley stage'], ['We', 'steady state currents'], ['model', 'thus  ion'], ['alone shot noise', 'also excitation appearance'], ['dynamic G that', 'healthy  brain'], ['subtle  changes', 'down membrane cytoskeleton'], ['called Ising which', '3-dimensional phase space'], ['further  it', 'dependent ion channels'], ['Finally  we', 'major  depression'], ['mechanisms', 'adult mental health general health'], ['analytical  assumptions', 'social  epidemiology'], ['aim', 'differential CSES childhood abuse'], ['Furthermore  we', 'mediated recall effects'], ['assumptions', 'when causal diagram'], ['Poisson regression models', 'psychological % childhood'], ['Mediation analysis', 'mental health general health'], ['Exposure', 'two time points'], ['Mediation', 'sectional  data'], ['Psychological  abuse', '714 women p'], ['', ''], ['27  %', 'differential recall bias'], ['total exposure effects', 'same exposure time'], ['Consequently  proportion', 'mediated  effects'], ['then recall results', 'sectional  that'], ['', 'empathic Dopamine misfortune'], ['Va1158Met polymorphism', 'empathic  dispositions'], ['who', 'empathic Interpersonal Reactivity Index'], ['results', 'moral  harm'], ['Val Val which', 'Met Met genotypes'], ['also  individuals', 'empathic Val misfortune'], ['findings', 'social COMT cognition'], ['', ''], ['rights', ''], ['cognitive  skills', 'developmental  conditions'], ['However  lack', 'direct  skills'], ['study', 'developmental  task'], ['visual Reasoning Aptitude Level', 'healthy So participants'], ['findings', 'early group adolescence'], ['related  that', 'clinical MR populations'], ['findings', 'appropriate So childhood'], ['temporal brain that', 'significant  childhood'], ['such brain lesions', 'sociobehavioural  problems'], ['little  attention', 'focal  EBI'], ['present  performance', 'sociobehavioural parent problems'], ['Patients', 'general decision cognition'], ['parents', 'sociobehavioural  problems'], ['focal  EBI', 'sociobehavioural  problems'], ['', ''], ['', ''], ['unintentional  assessments', 'everyday  life'], ['that', 'moral  evaluations'], ['multinomial Moral Categorization that', 'multiple component processes'], ['These', 'directional target actions'], ['Speeded response deadlines', 'Intentional Judgment'], ['Unintentional Judgment', 'negative transgression primes'], ['Intentional Judgment', 'behavioral  control'], ['who', 'gay marriage primes'], ['negative  primes', 'moral  identity'], ['Theoretical  applications', 'moral  psychology'], ['', ''], ['', ''], ['rights', ''], ['Recent  research', 'multiple  sclerosis'], ['impairments', 'moral  judgment'], ['MS patients', 'moral  judgment'], ['', ''], ['', 'third party acts'], ['moral MS judgments', 'specific  acts'], ['', ''], ['more  responses', 'theirs'], ['elevated  levels', 'occurring  effects'], ['greater appropriateness judgments', 'affective  empathy'], ['current  results', 'possible MS patients'], ['', 'functionally Moltierella vivo'], ['transcriptional polymerase chain reaction', 'open Mortierella isabellina'], ['Plasmids pEMICL12', 'it'], ['pEMICL12', 'Escherichia coli'], ['coll', 'CaCl2 IPTG'], ['pTMICL12', 'acetate IN galactose'], ['Northern blotting method', 'transcriptional  S'], ['cerevisiae', 'IN VSc1'], ['Recombinant plasmids pEMICL12', 'successfully  E'], ['', ''], ['', 'appropriate  method'], ['it', 'acid desaturase E'], ['', ''], ['active Delta(12)-fatty acid which', '17'], ['', ''], ['', 'respectively GC MS vivo'], ['', 'M'], ['', 'isabellina D12D E'], ['', ''], ['cerevisiae', ''], ['', ''], ['rights', ''], ['integrated bandgap reference which', 'current mode structure'], ['sophisticated bandgap reference', '0'], ['it', '125 degrees C'], ['', '1'], ['voltage', 'power'], ['5 mu W', '57 DC frequency'], ['', ''], ['125 bandgap reference', 'successfully nm lab'], ['operational  amplifier', 'paper'], ['here  which', '1microamp input bias 0'], ['nonconventional MOS input', 'bias'], ['sub threshold designer', 'low input bias current'], ['It', 'low  voltage'], ['dynamic power range', 'low power dissipation'], ['when MOS transistors', 'moderate  inversion'], ['', 'power low voltage op 0'], ['op amp', 'low power voltage'], ['operating', 'moderate  version'], ['lower voltage operation', 'lower power dissipation'], ['proposed op amp', 'single op amp'], ['input stage', 'differential NMOS pair'], ['Opa they', 'basic Analogue Electronic Circuits'], ['linear that', 'subtract conditioning integration'], ['molecular  biology', 'well flower species'], ['We', 'different moso bamboo'], ['We', 'three KEGG analysis'], ['insitu  hybridization', 'different flower development stages'], ['PheDof1 PheMADS14', 'floral moso bamboo'], ['research paves', 'molecular moso bamboo flowering'], ['negative  thinking', 'maternal mother infant relations'], ['depressive mother infant symptoms', 'negative mother infant bonding'], ['Therefore  we', 'longitudinal infant study'], ['overall  level', 'months mother infant birth'], ['Furthermore differences', 'negative  bonding'], ['overall  levels', 'depressive  symptoms'], ['negative  pregnancy', 'depressive  symptoms'], ['Observers', 'complex  information'], ['Rather  impressions', 'often  motives'], ['negative  they', 'ingroup members'], ['Here  we', 'biased impression formation'], ['Participants', 'social  targets'], ['Following', 'outgroup ingroup targets'], ['tendency', 'negative junction targets'], ['negative ingroup they', 'less ingroup impressions'], ['effortless perceivers', 'desired  conclusions'], ['automatic motor that', 'brute causal responses'], ['picture', 'automatic motor processes'], ['learned motor that', 'brute causal fashion'], ['Rather motor control', ''], ['I', 'recent skill Stanley'], ['196 Inst Philos which', 'low level phenomena'], ['skilled motor accounts', 'skilled motor control'], ['motor control', 'personal level intentions'], ['final  I', 'above optimal control features'], ['drive control which', 'only feedback signal'], ['characteristic waveform which', 'reconstructed motor line currents'], ['torque  which', 'single sensor drives'], ['where performance obtaining', 'stable  response'], ['proposed control algorithm', 'digital signal processor'], ['Speech  impairments', 'lateral  sclerosis'], ['However  knowledge', 'social  communication'], ['', 'healthy ALS controls'], ['Methods', '24 Trobe Communication Questionnaire'], ['Participants', 'informant  LCQ'], ['Demographic  information', ''], ['Informant  ratings', 'conversational ALS controls'], ['ALS participants', 'informant control group'], ['LCQ scores', 'functional  variables'], ['Social  communication', 'difficulties'], ['clinical  speech', 'informant report format'], ['Mott  cells', 'retained secretory product'], ['Originally  they', 'sometimes  hypergammaglobulinemia'], ['Few  descriptions', 'avian Mott literature'], ['purpose', 'three poultry species'], ['Transmission electron micrographs', 'light microscopic cell light images'], ['marrow', 'SPF chickens ducks'], ['positive Mott samples', 'commonly  leukocytosis'], ['Atypical  granulocytes', 'regularly Mott cells'], ['circulating Mott cells', 'indicative stress dyscrasia'], ['Moreover Mott cells', 'H  ratios'], ['defective  observations', 'hematology immunology pathology'], ['effect', 'frequent liver function'], ['Thus  effects', 'female mouse liver'], ['dehydrogenase fatty acid GAPDH', 'proteomics reverse polymerase chain reaction'], ['activities', 'GSTs glutathione CAT'], ['oxidative  damage', 'protein carbonylation'], ['Liver histology', 'light'], ['FAS +30 FAS levels', 'CAIII'], ['+20 mRNA it', 'CAT'], ['3 liver protein carbonylation', 'lipid +55 %'], ['3 PFD CD', 'SGOT'], ['3 PFD CD', 'hepatic pattern damage'], ['dietary amino acid deprivation', 'precancerous  conditions'], ['BACKGROUND', 'Mesenchymal liver fibrosis'], ['However  little', 'fibrotic  MSCs'], ['secretome proteins', 'time mass spectrometry'], ['intraperitoneal mice', 'then  secretomes'], ['Liver tissues', 'histology gene expression patterns'], ['1 growth TGF', 'HSC stellate lines'], ['Liver tissues', '16 liver immunohistochemistry'], ['smooth alpha muscle', 'smooth alpha ACTA2'], ['TGF beta TGF proteins', 'pathways'], ['significantly SMAD2 phosphorylation', 'greater  hpUCMSCs'], ['32  that', 'mediated  HSCs'], ['8 globule EGF MFGE8', 'primary  HSCs'], ['MFGE8', 'umbilical cord teeth'], ['', 'extracellular matrix deposition'], ['injection', 'fibrotic hpUCMSC mice'], ['Levels', 'cirrhotic liver controls'], ['strongly TGF beta', 'extracellular liver mice'], ['Mice', 'common  ancestor'], ['human drug they', 'human drug development'], ['this', 'beneficial targets humans'], ['large  differences', 'immune protein mice'], ['related response substrains', 'genetic response drift'], ['how shares differences', 'mouse disease'], ['Direct eye contact', 'interpersonal  interactions'], ['direct eye contact', 'observer'], ['present  we', 'behavioral  enhancements'], ['how hand process', 'eye contact'], ['two hand participants', 'hand opening hand movements'], ['direct eye gaze', 'subject'], ['findings', 'induced motor facilitation'], ['when movement observation', 'averted eye gaze'], ['eye contact', 'social  behavior'], ['Furthermore  findings', 'relevant mirror motor actions'], ['occlusive  that', 'internal carotid artery'], ['occurrence', 'genetic Moyamoya factors'], ['60 Moyamoya etiology', '60 Moyamoya years'], ['review', 'pathogenic Moyamoya disease'], ['how cell functions', 'genes'], ['medical faculty modules', 'Physiological Sciences GI'], ['fundamentally  what', 'Physiological  Sciences'], ['It', 'good PhD studies'], ['first  that', 'physiological research sciences'], ['recipients', 'confident  learner'], ['unique  that', 'comparable  examples'], ['such Physiological they', 'basic health sciences'], ['students', 'imagination'], ['Hence  students', 'creative  energy'], ['We', 'embryonic mouse adulthood'], ['Mpped1', 'developing  telencephalon'], ['Postnatally  expression', 'embryonic dorsal telencephalon'], ['Mpped1  expression', 'hippocampal CA1 region'], ['cortical patchy patterns', 'cortical beta catenin'], ['', ''], ['', ''], ['current  we', 'intrarenal osmolality gradient'], ['steady MRI experiments', 'two chain reaction rats'], ['significant  decline', 'increased urea transport transcription'], ['urea', 'diabetic urea concentration control'], ['', ''], ['', '2016 Magnetic Medicine'], ['We', 'human cancer cell lines'], ['presumptive signal transduction which', 'lung cancer metastasis'], ['amplification', 'reverse transcription PCR'], ['Northern  blotting', 'TARSH cDNA probes'], ['TARSH  we', 'human cancer cell lines'], ['encoding cDNA which', 'human  lung'], ['', 'human hybridization analysis lung'], ['expression', 'remarkably cancer cell lines'], ['TARSH  expression', 'neoplastic lung tissue'], ['TARSH', 'molecular lung human'], ['Transcription export complex', 'nuclear export factor'], ['TREX-2 complex', 'Sac3 which'], ['similar  Cdc31', '710  805'], ['like TREX-2 repeats', 'also Cdc31 S'], ['cerevisiae complex', ''], ['density visible', '100  kDa'], ['putative Sac3 N helices', 'also  4'], ['', 'ray angstrom resolution crystallography'], ['Summary We', 'structural expression S'], ['previously  M-', 'spatial CID orientation'], ['', '2016 Molecular Biology'], ['', 'Elsevier Inc'], ['molecular  that', 'synaptic  efficacy'], ['Development', 'learning'], ['entire network that', 'local protein synthesis'], ['data revolution', 'computational  patterns'], ['how data synapses', 'neuronal  circuits'], ['seminal  that', 'synaptic  activity'], ['we', 'computational RNA data'], ['few', ''], ['new protein that', 'difficult  field'], ['Finally  we', 'big data approaches'], ['Prophylactic  vaccines', 'strong  adjuvant'], ['immunological  readouts', 'species'], ['we', 'based strain model'], ['evaluation', 'intradermal  injection'], ['immunostimulation', 'up mRNA vaccine'], ['', 'TLR8 mRNA humans'], ['', 'immune mice system'], ['also mRNA that', 'vitro vivo mouse models'], ['resistant Staphylococcus aureus', 'hospitals'], ['public health it', 'contaminate foodborne illness'], ['study', 'southern dairy 2008'], ['', '484  S'], ['strains', ''], ['3  %', 'PVL Panton Valentine biofilm'], ['recovered  STs', ''], ['', '5  ST398'], ['', ''], ['isolates', 'SCCmec type V'], ['', ''], ['', 'one  isolate'], ['5  SCCmec', ''], ['', ''], ['two seg strains', 'seh gene'], ['', 'encoding  genes'], ['icaD genes', 'icaA'], ['', ''], ['thus health it', 'microbiological food risk'], ['', ''], ['', 'Elsevier Ltd'], ['This', 'open NC ND license'], ['Background', 'major tumor head'], ['MSC display', 'immune  cells'], ['Conversion', 'immune  cells'], ['present  study', 'malignant adenosine tissue'], ['HNSCC MSC', 'tumor tissue'], ['Differentiation properties', 'flow cytometry'], ['active  CD39', 'luminescence'], ['Suppressive  activity', 'isolated T cells'], ['Plasticity', 'conditioned tumor media'], ['Differentiation', 'chondrogenic  cMSC'], ['corresponding  which', 'decreased mass spectrometry'], ['T cells', 'exogenous  ADO'], ['conditioned  medium', 'down ADO production'], ['We', 'exogenous  ADO'], ['patients', 'excessive  inflammation'], ['', 'C  GmbH'], ['rights', ''], ['standard  development', 'biotechnological protein expression potential'], ['such  systems', 'metabolic  capacity'], ['that', 'promoter metallothionein'], ['antigen culture which', 'purification proteolysis'], ['We', 'HEK293FT HeLa'], ['We', 'different transfection agents'], ['hPSA production', 'green fluorescent protein fluorescence'], ['expression', 'immunosorbent polyacrylamide gel electrophoresis'], ['BHK-21 cell CuSO4', 'highest hPSA production rates'], ['BHK-21  cells', '100 mu M CuSO4'], ['inducible expression system', 'molecular  biology'], ['', 'menstrual mu opioid cycle'], ['', 'reverse polymerase chain reaction'], ['', ''], ['', 'opioid drug use'], ['Endometrial  samples', 'menstrual cycle phases'], ['', 'menstrual MOR cycle'], ['expression', 'human MOR endometrium'], ['MOR expression', 'proliferative secretory'], ['Lower  values', 'maximum  ovulation'], ['Small  variations', 'endometrial  compartment'], ['presence', 'human reproduction endometrium'], ['', 'Reproductive Medicine'], ['mirror neuron system', 'social  cognition'], ['confirmation emotion evidence', 'emotion classification'], ['study', 'facial mu expressions'], ['mu suppression', 'facial  expressions'], ['Nineteen  participants', 'facial emotion word'], ['Mu activity', 'inverse stimulus conditions'], ['Subtractive  logic', 'specific  interest'], ['recognising faces', 'thereby  hypothesis'], ['effects', 'further motor hypotheses'], ['study', 'facial convergent expressions'], ['Theories', 'artwork'], ['', ''], ['brush marks', 'sensorimotor cortex'], ['aim', 'visual sensorimotor processes'], ['Twenty eight Twenty participants', 'different line triangle house'], ['Central mu activity', '8 Hz EEG band'], ['', 'electrode hyp5hesis mu handmade'], ['', ''], ['', ''], ['occipital alpha activity', 'computer  graphics'], ['', ''], ['stronger mu suppression', 'generated  graphics'], ['', ''], ['', ''], ['action individuals', 'responsive mirror neuron system'], ['', ''], ['', ''], ['rights', ''], ['Mucin glycan', 'primary mucin functions'], ['1 blood which', 'core'], ['profound mucin which', 'gene'], ['epithelial  gene', 'primarily mucus secretory tissues'], ['human genome gene', 'three  exons'], ['Northern I probe', 'proximal transcription initiation site'], ['', 'regulatory scanning -291/-282'], ['Further promoter activity', 'trans retinoic acid'], ['Thus promoter region', 'hC2GnT M ATRA'], ['regulatory  elements', 'specific mucus hypersecretory diseases'], ['TNF necrosis antibodies', 'inflammatory bowel diseases'], ['molecular  mechanism', 'still  debate'], ['Apart', 'central modulating features'], ['TNF  antibodies', 'vitro'], ['Furthermore TNF agent etanercept', 'inflammatory disease diseases'], ['we', 'immune TNF neutralization apoptosis'], ['We', 'soluble  IBD'], ['that', 'intestinal medicine therapy'], ['', ''], ['', 'Publishing Group Inc'], ['rights', ''], ['Mucosal surfaces', 'interaction commensal'], ['forming mucin that', 'goblet cells'], ['bound  that', 'functions'], ['diverse transmembrane that', 'few  characteristics'], ['tight mesh that', 'harmful  conditions'], ['transmembrane that', 'cell interactions differentiation'], ['Transmembrane mucins', 'also development adenocarcinomas'], ['damaged transmembrane functions', 'survival advantage'], ['review', 'multifunctional transmembrane proteins'], ['', ''], ['', ''], ['Cartilage injuries', 'common musculoskeletal disorders'], ['number', 'current tissue engineering methods'], ['Recent  advances', 'various cartilage injuries'], ['study', 'multiwalled carbon nanotubes'], ['nanostructural  scaffold', 'enhanced vapor deposition technique'], ['Articular cartilage specimens', 'adolescent collagenase digestion'], ['scaffolds', 'scanning electron microscopy'], ['seeded  constructs', 'SEM'], ['Chondrocytes', 'MWCNT surfaces'], ['one  week', 'plastic flask'], ['cytoplasmic  that', 'MWCNTs'], ['nanotubes', 'nanostructured cell surface'], ['good  that', 'cartilage tissue'], ['them', 'cultures'], ['they', 'deeper  resources'], ['We', 'multicultural identity patterns'], ['personal well who', 'them'], ['we', 'simultaneously identity plurality'], ['filling visualization model', 'especially tree visualization'], ['graphic  that', 'based graph visualizations'], ['edge crossing', 'naturally space filling approach'], ['filling  concept', 'multidimensional  visualization'], ['visual display clutter', 'evenly display plate'], ['problem', 'particular  visualization'], ['we', 'multidimensional data visualization'], ['main  contributions', 'multidimensional space visualization'], ['', ''], ['100  %', 'well data patterns'], ['we', 'parallel linear correlations'], ['less  time', 'when data patterns'], ['', ''], ['rights', ''], ['dissemination', 'worldwide patient care'], ['We', '21st resistance mechanisms'], ['stochastic  that', 'again  future'], ['multifunctional  platform', 'Pirani vacuum gauge temperature'], ['It', 'on tungsten chip'], ['platform', 'oxide  semiconductor'], ['tungsten plug', 'specially serpentine heater'], ['microhotplate', '340 nm gap'], ['operational  amplifier', 'bias microhotplate'], ['platform', 'different  sensors'], ['first  one', 'Pirani vacuum 10(5'], ['second  one', '70 degrees C'], ['thermal conductivity gas which', 'constant gas pressure'], ['sensitive fabrication platform', 'gas concentration'], ['smart energy that', 'Smart Energy Framework'], ['large scale introduction', 'forecasted power day'], ['proper control deviation', 'network overloads'], ['that', 'local  information'], ['control strategy', 'distribution account'], ['We', 'predictive example simulation control'], ['Lagrangian Eulerian Arbitrary Lagrangian method', 'severe surface deformation'], ['single  which', 'grid refinement process'], ['less  attention', 'geometric remapping problems'], ['basic polyhedron idea', 'used  Grandy'], ['', ''], ['new  algorithm', 'incremental segment plane intersections'], ['', 'Jia et al'], ['new  method', 'when polyhedron intersections'], ['thoroughly geometry integrity', 'new  algorithm'], ['also polyhedron subdivision which', 'various convex convex'], ['volume conversation', 'exactly MMALE simulation'], ['', ''], ['rights', ''], ['molecular  imaging', ''], ['Improving', 'human  medicine'], ['Moreover  possibility', 'old imaging clinic'], ['Cardiology neurology immunology', 'molecular  imaging'], ['tomography positron emission tomography', 'human animal disease'], ['above imaging techniques', 'molecular animal disease'], ['clinical  translatability', 'possible  application'], ['ability', 'necessary  experiment'], ['Merging molecular Merging probes', 'best imaging results'], ['study', 'aged mood veterans'], ['who', '2007 Pittsburgh Healthcare December'], ['Most  veterans', 'chronic organ disease'], ['', '3  which'], ['1  %', 'depressive  disorder'], ['5  %', 'anxiety disorder'], ['7  %', 'depression'], ['mood disorder', 'chronic organ disease'], ['marital  status', 'significant mood disorder'], ['findings', 'chronic health care veterans'], ['clinical  it', 'microbial antimicrobial resistance'], ['compromised cell which', 'compromised cell cells'], ['Recent  advances', 'single cell level'], ['review', 'physical antimicrobial treatments'], ['counting', 'given antimicrobial treatment'], ['combination', 'microbial antimicrobial treatments'], ['work', 'phase fuel cell applications'], ['paper', '2 boost 4MIBC'], ['', 'ripple power losses'], ['where  minimizing', 'current  ripple'], ['Actually  approach', 'digital control reconfiguration'], ['Relevant  aspects', '2 design modeling paper'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['Branch', 'objective optimization problem'], ['it', 'implicit tree search'], ['objective  we', 'Kiziltan'], ['objective  branch', ''], ['situation', 'objective  optimization'], ['bound  which', 'classic  Villarreal'], ['it', 'fully  2007'], ['paper', 'objective concepts algorithms'], ['mainly optimization who', 'continuous zero variables'], ['aiming', 'efficient  solutions'], ['', ''], ['', ''], ['rights', ''], ['', 'bandwidth  delay'], ['negative rail impact', 'low switching inverter'], ['sampling delay', 'multiple sampling method'], ['Test results', 'proposed  method'], ['objective', 'multiple  sclerosis'], ['prospective  study', 'healthy progressive HS'], ['subjects', 'neuropsychological emotion recognition questionnaires'], ['', ''], ['3  %', 'one SC test'], ['impaired SC tests', 'three  phenotypes'], ['Mean scores', 'test Eyes Mind'], ['ANOVA analyses', 'lower awareness RRMS'], ['ToM performance', ''], ['executive  functions', 'episodic memory scores'], ['SC impairment', 'impaired MS patients'], ['', '50 ToM performance'], ['Emotional  awareness', 'progressive  MS'], ['Natalizumab', 'multiple disease sclerosis'], ['Natalizumab', 'immune blood brain barrier'], ['This', 'immune cell blood'], ['sVCAM-1 serum concentrations', 'treated MS patients'], ['mRNA sVCAM-1 serum expression', 'treated RRMS patients'], ['whole blood expression', 'treated MS patients'], ['Five  genes', 'treated validation group'], ['Decreased serum concentrations', 'sensitive MS disease activity'], ['decreased  expression', 'treated activation MS'], ['', ''], ['', ''], ['rights', ''], ['Glycosylation alterations', 'multiple animal sclerosis'], ['immunoglobulin G galactosylation', 'multiple  sclerosis'], ['Immunoglobulin G', 'inflammatory  disease'], ['based  assay', 'potential immunoglobulin G'], ['Results', 'cerebrospinal control patients'], ['immunoglobulin G galactosylation', 'multiple sclerosis patients'], ['Furthermore  modification', 'multiple  sclerosis'], ['such galactosyl change', 'viral brain inflammation'], ['molecular  marker', 'multiple treatment sclerosis'], ['Circulating microparticles', 'potential blood brain barrier'], ['how flow fingolimod', 'endothelial microparticles production'], ['endothelial cell microparticle numbers', 'endothelial  microparticles'], ['Fingolimod', 'endothelial microparticle vitro'], ['endothelial B cell which', 'MS'], ['molecular imaging techniques', 'multiple  sclerosis'], ['increased MS disease monitoring', 'therapeutic  targets'], ['Diverse imaging modalities', 'better precision medicine'], ['magnetic resonance imaging', 'golden MS research'], ['PET positron emission imaging', 'disease progression treatment response'], ['specific astrogliosis cytokine which', 'specific imaging purposes'], ['inflammation  activation', 'MS'], ['complex  which', 'successful disease treatment'], ['PET', 'early precision MS'], ['we', 'experimental MS research'], ['paper', 'Continuous Delay Differential Equations'], ['discrete state space model', 'impulse response CFDDE'], ['Discrete Delay Difference Equation', 'discrete block companion form'], ['Continuous Delay Differential Equation', 'bilinear approximation method'], ['time Delayed Control Law', 'discrete state space model'], ['', 'bilinear approximation method'], ['delayed  observers', 'developed  DIDCL'], ['illustrative  example', 'proposed  method'], ['', ''], ['rights', ''], ['Genomic  DNA', 'dynamically chromatin fibers'], ['3D  configuration', 'transcriptional  regulation'], ['Noncoding RNA', '3D  chromatin'], ['molecular ChIA which', 'paired end tags'], ['Here  we', 'standard ChIA PET'], ['cultured Carassius auratus fish', 'myxosporeans'], ['', ''], ['', ''], ['Here  we', '4 PCR myxosporeans'], ['specific  primers', '28S rDNA T'], ['', ''], ['', '8S M'], ['', ''], ['', '18S rDNA M'], ['', ''], ['4 primer sets', 'myxosporean  species'], ['Detection limits', 'multiplex PCR assay'], ['', ''], ['', ''], ['', ''], ['', '8  T'], ['', ''], ['', ''], ['', ''], ['', ''], ['Following', 'microscopic PCR examination'], ['multiplex PCR assay', '4 gibel carp'], ['PCR protocols', 'single  sheep'], ['FMDV sheeppox virus', 'orf procedure'], ['single acid extraction protocol', 'simultaneous  RNA'], ['two step which', 'viral RNA cDNA'], ['it', 'six  reaction'], ['assay', 'various  specimens'], ['multiplex forty PCR', 'highly  identification'], ['multiplex  PCR', 'DNA  reaction'], ['', ''], ['', ''], ['rights', ''], ['RT)-polymerase chain reaction', 'developed gastroenteritis assay'], ['clinical  which', 'January'], ['10  types', 'based  assays'], ['viral  parameters', 'viral age type'], ['frequency', 'mixed  infections'], ['positive genogroup II noroviruses', 'common  virus'], ['7  %', 'group A rotaviruses'], ['', ''], ['', ''], ['who', 'patients'], ['based  assays', 'specific gastroenteritis gastroenteritis'], ['', ''], ['present  we', 'intrinsic cancer growth noises'], ['like  phenomenon', 'first cell growth noises'], ['like time it', 'effectively cancer system'], ['tumor it', 'additive noise intensity'], ['multiplicative noise intensity', 'inhibition'], ['large cancer it', 'positive time delay'], ['', ''], ['rights', ''], ['well  existence', 'many control systems'], ['than  two', 'minimum  phase'], ['zero sampling period', 'nonlinear sample hold cascade'], ['such GSHF that', 'resulting  model'], ['two  GSHFs', 'continuous time plant'], ['also intersample behavior', 'zero stability dynamics'], ['results', 'nonlinear  cases'], ['paper', 'well  regions'], ['entry', 'conventional energy sources'], ['policy measures', 'electricity prices'], ['recent  controversy', 'regional distribution effects'], ['price input output models', 'regional value chains'], ['generation', 'distributive household income effects'], ['However  investment', 'positive  households'], ['', ''], ['', ''], ['rights', ''], ['many  works', 'chaotic circuit attractors'], ['high Lyapunov which', 'chaotic  unpredictability'], ['same MLE values', 'different  way'], ['', ''], ['', 'entropy  values'], ['way  we', 'high  MLE'], ['evolutionary  which', 'feasible  solutions'], ['Second associated entropy', 'feasible  solution'], ['experimental  results', 'chaotic  oscillator'], ['MLE', 'scrolls'], ['us', 'useful signal processing applications'], ['However  it', 'nonlinear  circuits'], ['way  investigation', 'available  AD844'], ['SNLF  we', '100 frequency kHz'], ['frequency limitations', 'based SNLF AD844'], ['electronic technology which', 'experimental theory teaching'], ['analog analysis', 'ideal teaching effect'], ['paper', 'developed linear augmentation'], ['Special  attention', 'chaotic engineering responses'], ['effectiveness', 'soft impact oscillator'], ['transient control which', 'broad engineering problems'], ['', ''], ['', ''], ['rights', ''], ['paper', 'continuous delta sigma modulators'], ['design procedure', 'stage'], ['', 'power efficiency'], ['65 op amp', 'mW power consumption'], ['paper', 'indirect capacitor feedforward compensation'], ['proposed  OPA', 'TSMC'], ['2 V CMOS process', '330 gain bandwidth product'], ['', ''], ['', 'mW power 1'], ['', ''], ['walled nano films', 'cholesterol oxidase study'], ['preparation process', 'electrochemical electron microscopy'], ['electrocatalytic cholesterol biosensor', 'excellent linear 2'], ['', ''], ['mu M', 'detection 0'], ['', 'high  109'], ['', '5 response Sec'], ['Moreover reproducibility stability', 'biosensor'], ['', 'International Union International Biochemistry'], ['', ''], ['reared time cats', 'cat visual cat cortex'], ['', ''], ['visual  that', 'older  animals'], ['northern polymerase chain that', 'mammalian  C'], ['unc  gene', 'visual period cortex'], ['', ''], ['visual Munc13 which', 'gene manipulation analysis'], ['Munc13 3 Munc13 protein', 'mice'], ['', 'visual  3'], ['', ''], ['', 'visual  9'], ['', ''], ['Analysis', 'dark protein age'], ['bidirectional  regulation', 'frontal  cortex'], ['Bidirectional  regulation', 'Munc13 family members'], ['glutamatergic vesicle work', 'synaptic  plasticity'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['dependent  changes', 'resident gene expression'], ['We', 'real time quantitative PCR'], ['genes', 'differentially  mutants'], ['synaptic  genes', ''], ['most neuropeptide genes', 'higher control cortex'], ['differentially  genes', 'receptors'], ['Differential expression', 'time quantitative PCR analysis'], ['situ  difference', 'specific neuropeptide mutant'], ['differential  expression', 'neuropeptides'], ['data', 'secreted  products'], ['Southern Mini Gel System', 'Southern Northem RNA Mupide'], ['We', 'conventional gel methods'], ['also  reduction', 'harmful gel running buffer'], ['DNA blotting us', 'small  RNA'], ['', ''], ['rights', ''], ['Rickettsiosis', 'infectious  travelers'], ['such  eschar', 'such  rash'], ['Definite  diagnosis', 'often convalescent disease'], ['acute phase diagnosis', 'real polymerase chain serum'], ['polymerase chain reaction', 'rickettsial  travelers'], ['Striated  muscles', 'metabolic activity levels'], ['continuous contractile which', 'long  function'], ['skeletal  muscles', 'different longissimus exercise'], ['three  that', 'energy metabolism'], ['histochemical  studies', 'fibre type composition'], ['Oxidative  capacity', 'dehydrogenase isocitrate activities'], ['activated growth hormone subunits', 'Northern  blotting'], ['Heart', 'oxidative muscle fibres'], ['Longissimus muscle', 'glycolytic  fibres'], ['GLUT', 'major energy source'], ['4  glucose', 'oxidative energy muscle'], ['4  expression', 'glycogen exercise'], ['which', 'large energy demand'], ['strongly muscle I', 'muscle'], ['growth which', 'glycolytic insulin muscles'], ['abundant  tissue', 'movement'], ['skeletal stem muscle', 'therapeutic  clinic'], ['It', 'skeletal  muscle'], ['precise genome which', 'skeletal muscle development regeneration'], ['recent  that', 'muscle development stem cell function'], ['', '2016 Great Britain'], ['', 'John Wiley'], ['objective', 'dermal Muse melanocytes'], ['human Oct4 Sox2 cells', 'immunofluorescence'], ['expression levels', 'reverse polymerase chain reaction'], ['', 'Muse differentiation'], ['outer root sheath', 'dermal  papillae'], ['which', '3 flow cytometry antibody'], ['Western expression levels', 'dermal Muse fibroblasts'], ['derived Muse melanocytes', 'specific marker HMB45'], ['scalp dermal scalp which', 'self vitro'], ['', 'little  research'], ['young science learning', 'portable  museums'], ['', 'such information learning'], ['It', 'traditional  museums'], ['didactic technologies museums pedagogies', 'digital leisure use'], ['purpose', 'long term care Taiwan'], ['study', 'two research subjects'], ['Subjects', 'experimental  group'], ['', '24 Kagayashiki music weeks'], ['Subjects', 'comparison activities'], ['two KMC groups', 'mental state examination'], ['two Cornell groups', 'significant Behavior Rating Scale'], ['findings', 'elderly depression anxiety'], ['effective music intervention', 'clinical  settings'], ['We', 'clinical  practice'], ['MethodsTwo hundred fifty child', 'final Northern analyses'], ['Follow up', '13weeks  postrandomisation'], ['Primary  outcome', 'System Rating 13weeks'], ['Secondary  outcomes', 'functioning self esteem depression'], ['ResultsThere', 'adjusted child mean'], ['', ''], ['', '6'], ['', ''], ['', 'guardian SSIS'], ['', ''], ['', '3'], ['', ''], ['', ''], ['13 child SSIS communication', '13 intervention group'], ['', ''], ['', '10'], ['', ''], ['', ''], ['', ''], ['', '5'], ['', ''], ['', ''], ['significantly depression scores', 'significantly  week'], ['', 'social  week'], ['findings', 'further practice study'], ['', ''], ['Evidence', 'medicine hospice patients'], ['a patient few', 'family members'], ['primary  purpose', 'palliative music medicine'], ['Patient', 'reported music therapist change'], ['Patients', 'music therapy sessions'], ['One family member', 'restlessness comfort level life'], ['effect', 'music therapy patient'], ['Recommendations', 'patient music therapy'], ['family member patient dyads', 'study'], ['100  %', 'further music therapy patient'], ['Patients', 'depression distress mood scores'], ['Family members', 'positive music themselves'], ['', 'better family members'], ['Understanding', 'molecular biology disease genetics'], ['where Daphnia selection', 'MA Daphnia conditions'], ['experiments', 'obligate asexual progenitor clone'], ['bioinformatic  we', 'nucleotide mutation 2'], ['', ''], ['', ''], ['', '70  generation'], ['', 'overall  4'], ['82  10(-5', '2 deletion kb'], ['MA  we', 'deleterious purifying mutations'], ['MA  we', 'selection'], ['positive  selection', 'clonal  population'], ['1 Human MutT MTH1', 'distinct triphos cancer'], ['present  expression', 'various breast cancer vivo'], ['protein levels', 'reverse polymerase chain reaction'], ['effect', 'cell line mice'], ['toxicity', 'nude MTH1 mice'], ['mRNA MTH1 levels', 'cancerous breast cancer control'], ['apparent  differences', 'molecular breast cancer'], ['MTH1 overexpression', 'patient age tumor size'], ['', 'dependent cancer manner'], ['results', 'distinct breast cancer'], ['adverse xenograft effects', 'blood biochemistry kidney function'], ['present  MTH1', 'patient age tumor size'], ['Inhibition', '2posi tive 2posi vivo'], ['further MTH1 studies', 'clinical MTH1 inhibitors'], ['Myasthenia gravis', 'neuromuscular  transmission'], ['postsynaptic  membrane', 'postsynaptic  muscle'], ['', 'pathophysiological  disease'], ['PubMed searches', 'thymoma terms treatment'], ['Additionally  we', 'current  immunopathology'], ['neuromuscular target which', 'refined disease subgroups'], ['who', 'first line therapy'], ['long term drug therapy', ''], ['Mycobacterium avium complex', 'public health importance'], ['group', 'aquatic amoeba bioffirns'], ['microbial risk assessment', 'mycobacterial dose response disease'], ['relevant  species', 'human water biofilms'], ['', ''], ['', ''], ['', ''], ['', ''], ['critical  review', 'susceptible MAC risk assessment'], ['data sets', 'dosing vivo experiments'], ['exponential dose response models', 'relevant infection liver infection'], ['physical  tests', 'clinical  M'], ['', ''], ['intracellulare  differentiating', 'environmental MAC sources'], ['framework', 'susceptible dose response population'], ['', ''], ['rights', ''], ['Tuberculosis', 'global health burdens'], ['mycobacterial Lactococcus antigens', 'immune  mice'], ['host cell we', 'immunity'], ['mycobacterial PHA PHA', 'MBB mouse model'], ['organism nonpathogenic Mycobacterium smegmatis', 'immobilized mycobacterial antigens surface'], ['PhaA acetoacetyl reductase', 'PHA E'], ['', 'Mycobacterium shuttle trans'], ['specific PHA which', 'immobilized PHA antigens'], ['', ''], ['smegmatis vector control', 'buffered mouse immunology saline'], ['We', 'immune mycobacterial antigens'], ['IMPORTANCE Tuberculosis', 'global health burdens'], ['we', 'immune mycobacterial antigens'], ['human host pathogen host', 'important  role'], ['selection', 'primary MTB review'], ['We', 'main drug resistance'], ['genetic  that', 'TB drug resistance'], ['We', 'interesting TB research'], ['', ''], ['', ''], ['', 'International Chemotherapy'], ['rights', ''], ['probable  scenario', 'second vaccine candidate'], ['Bacille Calmette Bacille ESAT-6', 'DDA adjuvant'], ['specific T cells', 'specific serum IgG CD4(+'], ['recombinant boost ESAT-6', 'immune T response'], ['', 'immune ESAT-6 fusion response'], ['Ag85B', 'immune ESAT-6 response'], ['present  study', 'protective ESAT-6 fusion efficacy'], ['Tuberculosis', 'negative disease patients'], ['current  study', 'pulmonary tuberculosis patients'], ['total', '2014 tuberculosis June'], ['sample', 'microscopy  culture'], ['onLowenstein Jensen L J)was', 'gold standard'], ['', 'smear'], ['81  %', ''], ['19  %', ''], ['thegold standardL culture', '37'], ['positive  positivity', 'MTB  RIF'], ['', ''], ['predictive sensitivity value', 'MTB  RIF'], ['', ''], ['', ''], ['', ''], ['', ''], ['sensitivity specificity', 'GeneXpert MTB/ RIF'], ['', ''], ['', ''], ['', ''], ['corresponding accuracy values', 'smear  positive'], ['', ''], ['', ''], ['', ''], ['', ''], ['MTB RIF assay', 'negative Mycobacterium patients'], ['', ''], ['rights', ''], ['Mycoplasma ovipneumoniae', 'main  sheep'], ['disease', 'great sheep husbandry'], ['Current  methodologies', 'complicated  expensive'], ['different base number', 'conserved  sequence'], ['fluorescence enhancement', 'copies detection 1'], ['', ''], ['MnO2 microsphere Cy5-ssDNA biosensor', 'biochemical  application'], ['', ''], ['', ''], ['rights', ''], ['Magnaporthe oryzae chrysovirus', 'causal fungus Magnaporthe oryzae'], ['heterologous  expression', 'cytological yeasts Saccharomyces cerevisiae'], ['viral  we', 'conidial virus M'], ['', 'suppressive  effects'], ['MoCV1-A ORF4 protein', 'conidial Pichia M'], ['', ''], ['ORF4 protein sequence', 'mycoviral  proteins'], ['', ''], ['', '1 Chrysoviridae family'], ['210  aa', 'MoCV1-A ORF4'], ['Indeed yeast transformants', 'length MoCV1-A ORF4 protein'], ['mycovirus', 'fungal rice blast M'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['tumor microenvironment', 'stromal cancer cells'], ['critical  component', 'different tumor factors'], ['MDSCs', 'immune effector cells'], ['increased  presence', 'immunotherapeutic tumor progression strategies'], ['current  that', 'MDSC expansion'], ['clinical  that', 'cancer therapies'], ['derived suppressor cells', 'pathological T cell sites'], ['tumor which', 'consequently tumor progression'], ['detailed  study', 'relationship'], ['surprisingly Lewis lung IL-17', 'immunosuppressive  MDSCs'], ['Additionally  effect', 'even  tumors'], ['thereafter antitumor immunity', 'suppressive  MDSCs'], ['Therefore  findings', 'downstream signaling MDSCs'], ['recent  myocardium', 'different  etiologies'], ['important heart it', 'immune  system'], ['immunological  activity', 'elderly  mice'], ['myocardial  impairment', 'draining lymph nodes'], ['deficient T cells', 'myocardial  inflammation'], ['adoptive T cells', 'irrelevant med sites'], ['myocardial  aging', 'immunological  factors'], ['immune  responses', 'clear tissue damage'], ['myocardial T which', 'elderly  population'], ['CVB3)-induced Coxsackievirus myocarditis', 'cardiac heart function'], ['abovementioned  findings', 'viral cardioprotective myocarditis'], ['Monocytes', 'myocardial tissue inflammation'], ['present  study', 'CVB3-induced  myocarditis'], ['One C57BL/6 mice', 'molecular cytometry analysis'], ['inflammatory  those', 'spleen'], ['inflammatory  monocytes', 'treated CVB3 mice'], ['splenic MSC application', 'myelopoietic CVB3 mice'], ['derived factor-1 RNA expression', 'systemic CVB3 MSC mice'], ['MSC application', 'cardiac disease progression'], ['Fibroblasts', 'physiological tissue repair'], ['that', 'elderly senescent people'], ['senescent process', 'fibroblast aging'], ['senescent effect', 'fibroblasts'], ['changes', 'functional  fibroblasts'], ['changes', 'activated cell sorting lectins'], ['contributors', 'real polymerase chain reaction'], ['1 growth stimulation', 'EP fibroblasts'], ['changes', 'alpha O benzyl'], ['decrease', 'LP fibroblasts'], ['reduction', 'cellular proliferation senescence'], ['sialylation', 'myofibroblast  differentiation'], ['lipid which', 'myofibroblast  sialylation'], ['myofibroblast  differentiation', 'sialidase inhibitor'], ['Desialylation', 'myofibroblast TGF differentiation'], ['Thus  regulation', 'elderly skin people'], ['', ''], ['purpose', 'scleral myopia vivo'], ['', ''], ['TIMP-2 expression', 'polymerase chain reaction'], ['vitro TIMP-2 inhibition', 'activity plate assay'], ['Tree shrews', 'deprived form eye'], ['scleral  tissue', '12 collagen degradation'], ['', ''], ['development', '5 form deprivation'], ['', ''], ['activation', 'to  20'], ['', 'reduced myopia development'], ['', 'vitreous chamber elongation'], ['', ''], ['TIMP-2 treatment', 'treated collagen eyes'], ['', 'similar control eyes'], ['', ''], ['reduced  which', 'degradative  sclera'], ['replenishment', 'scleral collagen degradation'], ['round cell liposarcoma', 'typical chromosomal translocations'], ['genetic  alteration', 'specific tumor entity'], ['', 'four adult fat tissue'], ['cdk4 cyclin D2', 'microarray analysis'], ['Immunohistochemistry', 'different  tumors'], ['localization', '25 tumor cases'], ['results', 'myxoid round cell liposarcoma'], ['cyclin finding', 'tumor type'], ['increase', 'intratumoral plexiform blood vessels'], ['round cell findings', 'especially c myc'], ['green Myzus persicae Sulzer', ''], ['time qRT PCR', 'gene expression M'], ['', ''], ['real expression levels', 'reliable reference genes'], ['However  date', 'available reference genes'], ['we', 'nine candidate reference M'], ['', 'experimental  conditions'], ['tested candidate genes', 'alternative  methods'], ['18s Actin', 'stable reference M'], ['ribosomal protein L27', 'abiotic reference studies'], ['finding', 'real qRT PCR M'], ['persicae', 'further  M'], ['', 'RNA interference'], ['15 motor interference paradigms', 'action execution'], ['automatic  that', 'confounding  factors'], ['furthermore  number', 'neural imitation inhibition'], ['However fMRI studies', 'low level motor'], ['current EEG we', 'cognitive  mechanisms'], ['We', 'biological motor preparation'], ['interference effect', 'low level perception'], ['Moreover  we', 'autistic  behavior'], ['Representing', 'current greenhouse research'], ['study', 'A gene copy numbers'], ['experimental  observation', 'chromatographic N2O method'], ['AOA gene copy numbers', 'real polymerase chain reaction'], ['rain fed potato field', ''], ['', ''], ['', ''], ['N2O emissions', 'significantly fertilisation 19'], ['A', '15 volumetric water %'], ['Crop rotation', 'appreciably N2O 34'], ['', '52'], ['', 'fed potato fields'], ['N2O emissions', 'fed potato fields'], ['research', 'dry farmland fields'], ['abiotic  which', 'productivity storage plants'], ['current SNAC4 changes', 'abiotic tomato conditions'], ['SNAC4 9 gene expression profiles', 'ABA pathways'], ['all', 'significant proline content'], ['MDA', 'treated  seedlings'], ['collectively SNAC4 9', 'proline ABA systems'], ['environmental NAC genes', 'postharvest tomato plants'], ['aim', 'immunodominant coli Bacillus subtilis'], ['immune  system', 'bacterial  diseases'], ['Antibacterial  peptides', 'therapeutic snake agents'], ['Identification', 'western blot analysis'], ['Identified  proteins', 'preparative Electro elution'], ['', 'clinical step S'], ['', ''], ['', ''], ['', ''], ['', 'negative broth microdilution'], ['', 'same Ampicillin Penicillin conditions'], ['immunodominant  proteins', 'positive  bacteria'], ['', ''], ['that', ''], ['However  they', 'negative  bacteria'], ['', ''], ['', ''], ['Gram  that', 'slight  two'], ['immunodominant  proteins', 'positive antimicrobial bacteria'], ['', ''], ['', 'negative  bacteria'], ['', ''], ['that', ''], ['Being', 'proven electron transfer light'], ['nano anatase', 'greatly spinach growth'], ['molecular  mechanisms', 'nano anatase'], ['respectively messenger effects', 'bulk  TiO2'], ['Accordingly protein expression', '40  control'], ['activity', 'to  2'], ['bulk  treatment', 'significant  effects'], ['molecular anatase treatment results', 'photosynthetic carbon reaction'], ['thin POMANI)-Mn3O4 nanocomposites', 'glass substrate'], ['nanocomposite films', '75 degrees C'], ['cut', 'degrees  C'], ['Synthesised', 'thermal structure stability'], ['Delta which', 'range'], ['', ''], ['', ''], ['Further  linearization', 'operational OP AMP'], ['based temperature sensors', 'high  sensitivity'], ['', ''], ['rights', ''], ['inorganic nano materials', 'optoelectronic devices sensors'], ['covalently  PMA', 'phosphomolybdic nano which'], ['nanocomposites', '45 % MWNTs'], ['preparation processes', 'Fourier transform'], ['nano SiO(2)BenV nano particles', 'MWNTP4VP@nano SiO(2)BenV triad nano cores'], ['Cyclic voltammo grams', 'potential redox range'], ['8', 'Ag SiO(2)BenV(2+)MWNTP4VP@nano SiO(2)BenV(+center dot'], ['three  couples', 'potential PMA polynary range'], ['', ''], ['8  V', 'successive electron transfer PMA'], ['polynary  composites', 'electrocatalytic  bromate'], ['', ''], ['', ''], ['rights', ''], ['renewable bio macromolecule', 'much research community'], ['detailed  herein', 'magnetite titanium dioxide nanoparticles'], ['aim', 'photocatalytic hydrogen generation'], ['Fe3O4  NP', 'Well  NFC'], ['NFC@Fe3O4@TNP nanocomposites', 'photocatalytic NFC TNP sample'], ['superparamagnetic  they', 'fifteen  cycles'], ['', 'C Elsevier B'], ['', ''], ['Gas sensors', 'much  nanoscience'], ['', 'enhanced gas sensing properties'], ['ZnO In2O3 nano heterostructures', 'vapor deposition process'], ['gas sensor', 'low operating temperature'], ['In2O3 In2O3 nano exhibit', 'ideal power exponent'], ['significantly  response', 'long term stability'], ['unique surface depletion properties', 'ZnO gas sensing In2O3'], ['study', 'novel gas sensing performances'], ['', ''], ['', ''], ['rights', ''], ['easily immunomodulatory they', 'presenting  cells'], ['They', 'sustained target sites'], ['now vivo those', 'rational  vaccines'], ['exciting DNA which', 'infectious  diseases'], ['biodegradable nano methods', 'invasive presenting cells routes'], ['recent  change', 'new cancer therapy'], ['loaded  nanoparticles', 'more tumor sites'], ['Nanoparticles', 'new  cancer'], ['nanoparticles', 'important tumor cell invasion'], ['We', 'chitosan tumor cells'], ['chitosan nanoparticles', 'significantly cell invasion'], ['Rheumatic heart disease', 'respiratory Group route'], ['these', 'antibiotics'], ['attractive intranasal it', 'natural IgG immunity'], ['Nanoparticles', 'glycolic vaccine acid'], ['encapsulation', 'presenting LCP-1 cells'], ['immunogenicity', 'based intranasal administration'], ['systemic antibody IgG titres', 'coated  nanoparticles'], ['encapsulated PLGA NPs', 'different GAS strains'], ['based lipopeptide delivery', 'friendly mucosal IgA response'], ['', ''], ['', ''], ['rights', ''], ['Optical  methods', 'highly  nanomaterials'], ['that', 'several  micrometres'], ['near field that', '100 diffraction nm'], ['free  manipulation', 'sub-100-nm time nanoparticles'], ['that', 'single sub-100-nm objects'], ['dimensional  manipulations', 'well plasmid DNA molecule'], ['Backscattering', 'similar enhancement 30'], ['demonstrated  approach', 'single biomolecule studies'], ['conventional C AV', 'systemic Naja naja venom'], ['effective  dose', 'induced C mice'], ['', ''], ['', ''], ['systemic heart toxicity', 'lower C AV'], ['C AV', 'forming  N'], ['', 'naja AV'], ['potency', 'available protein NPs'], ['', 'International Union International Biochemistry'], ['', ''], ['', 'molecular force biology'], ['important amyloid beta which', 'etiological  disease'], ['However  knowledge', 'single molecule level'], ['longitudinal metal beta', '42  AFM'], ['role', 'molecular beta force'], ['specific force F i', '42 control +'], ['unbinding', 'metal cations'], ['substoichiometric copper cations', '3  days'], ['metal cations', 'aggregating  beta'], ['exploitation', 'molecular  scale'], ['Nanotechnology', 'medical energy production etc'], ['nanotechnology Researchers', 'atomic  scale'], ['many  governments', 'nanotechnology  research'], ['', 'various review fields'], ['It', 'also  it'], ['more  attention', 'oil  reservoirs'], ['Nanpu Sag', 'oil  reservoirs'], ['CEC contact angle measurements', 'ultrasonic microscope observations testing'], ['physico chemical effects', 'instability'], ['major mineral constituents', 'investigated  shales'], ['clay mineral contents', '25'], ['', '33  52'], ['03  %', 'quartz 20'], ['', '03  46'], ['', ''], ['large  amounts', 'illite  smectite'], ['210 mmol shales', '210 mmol kg(-1'], ['water  water', 'capillary  effect'], ['acoustic  which', 'strength'], ['shale hydration effect', 'acoustic travel cohesion'], ['', 'fluid clay hydration inhibitor'], ['Phytoene  synthase', 'many color species'], ['binary pCAMBIA1301 which', 'phytoene synthase gene'], ['Effects', 'transformation'], ['6  inoculation', 'transient GUS expression'], ['addition', 'transient GUS expression'], ['Transformants', 'MS medium'], ['acetic alpha acid', ''], ['1', 'bar'], ['', 'gus PCR gene'], ['One  copies', 'Southern blotting analyses'], ['transcription', 'transgenic  plants'], ['method', 'genetic Narcissus transformation'], ['Differences', 'substantially  events'], ['functional MRI we', 'different  ways'], ['higher mirror neuron who', 'opposing  interpretation'], ['Furthermore  difference', 'two  narrative'], ['together  who', 'same  views'], ['leisure reading', 'cognitive  abilities'], ['Researchers', 'so  mind'], ['we', 'lifetime reading mind'], ['Consistent', 'cognitive nonfiction reading'], ['However  effects', 'magnitude'], ['effect', 'studies'], ['We', 'also gender publication moderators'], ['However  none', 'significance'], ['results', 'meta causal mechanisms'], ['Nattokinase', 'potential thrombosis diseases'], ['subtilis NK we', 'several  methods'], ['We', 'two tandem promoters'], ['efficacies', 'northern activity SDS analyses'], ['altering', '136 NK %'], ['production', 'significantly  literatures'], ['Similar  results', 'SDS PAGE'], ['engineered  promoter', '249 beta %'], ['two tandem promoters', 'marginal  NK'], ['-10  element', 'heterologous  B'], ['', ''], ['transcribed', 'genomic  vertebrates'], ['impact', 'gene regulation'], ['antisense RNAs', '48 hours postfertilization'], ['we', 'various Xenopus oocytes'], ['cytoplasm combination', 'cytoplasm RNAs'], ['antisense transcripts', '4  h'], ['homologous  transcript', 'processing'], ['nuclear reporter RNA', 'nuclear  sense'], ['short Xenopus RNAs', 'Northern  blotting'], ['that', 'coexpression antisense transcripts'], ['orientation', 'short  RNAs'], ['48  hpf', 'Xenopus oocytes'], ['findings', 'widespread antisense transcription'], ['genes', 'directions'], ['many antisense RNAs', 'coding RNA duplex'], ['RNA  Northern', 'anti sense transcript'], ['However  applications', 'substantial  data'], ['Thus  we', 'complicated  RNAs'], ['We', 'single S1 sense'], ['known Xist antisense chicken', '1 elongation factor method'], ['respectively  which', 'possible  cases'], ['method', 'transcriptional  pairs'], ['it', 'regulatory throughput RNAs'], ['method', 'single  gene'], ['NKp46 which', 'NK ncr1 ncr2'], ['classically  that', 'cytotoxicity tumor cells'], ['new  findings', 'alternative  NCRs'], ['ligand matters', 'distinct NK cells'], ['various heparan sulfate which', 'extracellular heparan sulfate proteoglycans'], ['NCRs', 'receptor ligand interactions'], ['predominant  expression', 'inhibitory  NKp44'], ['selective  expression', 'significantly cancer infection'], ['better  understanding', 'human ligand health'], ['We', 'natural pipeline congestion'], ['first  stage', 'ahead optimization scheduling'], ['', ''], ['second  stage', 'real time scenarios'], ['We', 'natural gas supply conditions'], ['First  we', 'potential gas pipeline congestion'], ['natural  which', 'ramping  events'], ['natural gas supply', 'natural gas transmission bottlenecks'], ['fired ISO units', 'early  mornings'], ['Natural killer cells', 'immune NK system'], ['that', 'immune  cells'], ['Indeed NK cells', 'damaged tumor cells'], ['limited  expression', 'somatic  recombination'], ['NK cells', 'immune  cells'], ['particular NK cells', 'repeated  stimulus'], ['mechanisms', 'T NK lymphocytes'], ['significant  phenotypic', 'functional NK cell differentiation'], ['existing immunology which', 'immune  cells'], ['like NK cells', 'particular NK cell memory'], ['natural  that', 'scientific  tasks'], ['comparative  strategy', 'mental  disorders'], ['I', 'clinical person psychopathology'], ['trilateral  strategy', 'schizophrenia debate'], ['CD30 molecule', 'embryonal CD30 antigen stages'], ['We', 'positive cryptae results'], ['dynamic  that', 'constantly  life'], ['they', 'anucleate  cell'], ['cells', 'CD30 antigen'], ['We', 'monoclonal NCL CD30'], ['Northern blotting analysis', ''], ['positive  reaction', 'skin appendages'], ['Northern  blots', 'positive control cell line'], ['new  field', 'clinical -omics diagnostics'], ['breadth', 'daunting  information'], ['review', 'common miR research strategies'], ['This', 'surrounding miR technology'], ['attentional processing resources', 'rigid processing way'], ['NFC', 'distributed  attention'], ['High NFC individuals', 'rather  parallel'], ['additional  they', 'attentional  task'], ['Low NFC individuals', 'other  parallel'], ['', ''], ['they', 'attentional  shifts'], ['we', 'main  task'], ['task performance eyes', ''], ['NFC', 'additional  task'], ['It', 'more  task'], ['effects', 'easy  condition'], ['paper', 'directly NFC levels'], ['', ''], ['rights', ''], ['Negative  symptoms', 'core  schizophrenia'], ['functional  management', 'unmet  need'], ['Improvements', 'effective characterization assessment interventions'], ['five  constructs', 'negative  symptoms'], ['', ''], ['psychotic medication symptoms', 'blunted anhedonia avolition'], ['we', 'available assessment correlates'], ['further  boundaries', 'small symptom dimension rewards'], ['', ''], ['however  what', 'child'], ['', ''], ['authors', 'dental  neglect'], ['They', 'such health care children'], ['They', 'suspected  neglect'], ['', ''], ['what', 'confusion'], ['dental  professionals', 'moral  neglect'], ['practice practitioner', 'advocate'], ['', ''], ['Clinicians', 'child neglect'], ['digital data treatment registry', 'additional health status'], ['', ''], ['', 'dental  incidence'], ['neglect', 'depression'], ['We', 'maltreated  children'], ['maternal gene expression which', 'early  MSEW'], ['depression phenotype data', 'secondary swimming analyses'], ['when adult they', 'adult male adult mice'], ['ID3 GRIN1', 'behavioral TPPP gene EPM'], ['results', 'early life stress'], ['', 'C Elsevier B'], ['', ''], ['Parenting behaviors', 'individual  family'], ['Ecological systems theory', 'multiple child ways'], ['When  challenges', 'within systems child abuse'], ['complex level interactions', 'ecological parenting behaviors'], ['Structural equation modeling', 'WIC Franklin County Ohio'], ['Living', 'lower poverty neighborhoods'], ['individual poverty status', 'nonpoor child neighborhood'], ['', ''], ['rights', ''], ['important  that', 'children'], ['three community variables', 'child maltreatment behaviors'], ['social community participation', 'child maltreatment'], ['mediating  variable', ''], ['psychological child associations', 'internal  control'], ['', ''], ['rights', ''], ['coding  sequence', 'RACE DNA reactions'], ['reading  frame', '220 amino acid residues'], ['This', 'aspartate superoxide protein'], ['cloned Mn SOD gene', 'mitochondrial transit peptides'], ['It', 'three copy introns'], ['expression level', 'infective stage larvae'], ['dominant  transcript', 'infective adult worms'], ['information', 'adenophorean superoxide nematodes'], ['neoliberal  direction', '2012 Vulnerable Children'], ['document', 'risky child protection families'], ['soon Kahui which', 'Maori child abuse'], ['how  media', 'neoliberal citizen subjectivity'], ['death', 'all  involved'], ['ill  neonates', 'United States'], ['infants', 'medical  stabilization'], ['hundreds', 'year United States'], ['resuscitative  neonates', 'resuscitative  measures'], ['knowledge  preparation', 'tragic  situations'], ['We', 'neonatal  death'], ['Cutaneous  inflammation', 'affected dorsal root ganglia'], ['specific  mechanisms', 'behavioral afferent development'], ['Recent  studies', 'potential pain modulation'], ['affects', 'neonates'], ['young skin we', 'spinal cord preparation'], ['inflammation', 'affected GH skin'], ['Furthermore pretreatment', 'mechanical nociceptor function'], ['1 growth GH', 'transcriptional DRG vivo'], ['selective  knockdown', 'similar GH pretreatment'], ['GH', 'possibly painlike DRG'], ['Renal cell carcinoma', 'common kidney malignancies'], ['upgraded  comprehension', 'innovative antitumor therapies'], ['adverse  events', 'pathway inhibitor pathway therapy'], ['Relevant  studies', 'PubMed'], ['', ''], ['who', 'VEGF  therapy'], ['total', 'systematic  review'], ['incidence', '17 grade 49'], ['', ''], ['Proteinuria', '% creatinine 65'], ['', '6  patients'], ['adverse  events', 'sometimes treatment discontinuation'], ['however  one', 'main  patients'], ['also side effects', 'antiangiogenic agents'], ['netrin-1', 'vital bone metabolism'], ['which', 'osteoclast  differentiation'], ['However  role', 'osteoblast differentiation'], ['we', 'osteoblasts'], ['reverse netrin generation', 'plasmids cell assay'], ['', 'osteoblast acid netrin-1 expression'], ['Gene expression', 'down netrin-1 treatment'], ['also osteoblast differentiation', 'recombinant bone morphogenetic netrin-1'], ['Forced  expression', 'alkaline phosphatase expression'], ['which', 'netrin osteoblasts'], ['Moreover phosphatase expression', 'two  receptors'], ['Netrin-1', 'osteoblast differentiation'], ['', 'biological  entities'], ['', ''], ['transcripts', 'proteins'], ['Network representation', 'frequently  molecules'], ['several network properties', 'molecular  biology'], ['where  scientists', 'one drug time'], ['frequently network nodes', 'preclinical  date'], ['how network biology', 'small molecule inhibitors'], ['types', 'such side chemotherapy'], ['Global  analysis', 'rapid  medicine'], ['it', 'major diagnosis diseases'], ['article', 'aperiodic data sampling'], ['varying sampling which', 'several Control Theory'], ['Systems', 'varying time parameters'], ['goal', 'structural stability analysis problem'], ['we', 'unified  manner'], ['when converse stability relations', 'other  detail'], ['aperiodic domain they', 'constructive stability conditions'], ['that', 'possible  improvement'], ['emerging research directions', 'such sampling sequences'], ['', ''], ['rights', ''], ['Large  networks', 'molecular network biology'], ['limited  number', 'task'], ['high performance that', 'large level networks'], ['SNAP functionality', 'implementational performance benchmarks'], ['dynamic graph nodes', 'time'], ['SNAP', 'of  edges'], ['structural graphs properties', 'regular  nodes'], ['fully  they', 'low  cost'], ['SNAP', 'well source Python'], ['real world we', 'real world which'], ['collection', 'widely graph analytics algorithms'], ['Neural tube defects', 'abnormal  development'], ['molecular  mechanisms', 'neural tube defect induction'], ['', 'neural tube defects'], ['neural development study', 'Chinese Military Medical January'], ['pregnant adult Kunming mice', 'retinoic acid group'], ['gene microarray', 'Incyte database'], ['Retinoic acid', 'normal control group'], ['Total RNA', 'E retinoic acid day'], ['', ''], ['', ''], ['two  Northern', 'cDNA microarray'], ['', 'normal control group'], ['intact  closure', 'normal days E10'], ['', ''], ['', ''], ['surface', 'spine'], ['', 'retinoic acid days'], ['', ''], ['', ''], ['Morphological  malformations', 'abnormal  metencephalon'], ['changes', 'different  days'], ['', ''], ['', ''], ['These', '1 Csf3r Apoa-4'], ['also Cdk5 expression', 'day E11'], ['', ''], ['results', 'Northern microarray blotting'], ['Psmc6 Rb', 'neural tube defects'], ['it', 'formally Internet addiction'], ['behavioral  which', 'human machine interaction'], ['We', 'social  interaction'], ['', ''], ['that', 'preclinical  modeling'], ['when Internet this', 'real hikikomori phenomenon'], ['', ''], ['', 'own  room'], ['neuro developmental adolescence IA', 'everyday  life'], ['social IA adolescents', 'familial anger conflicts'], ['clinical  conditions', 'social anxiety disorders'], ['paper', 'nosographic  label'], ['pathogenetic  which', 'preclinical  modeling'], ['', ''], ['rights', ''], ['neurotrophic tyrosine kinase receptor', 'poor  neuroblastoma'], ['BDNF activation', 'chemo  phosphoinositide-3-kinase'], ['we', 'BDNF  NB'], ['expressing NB cell line', ''], ['Boyden chamber migration', 'TB3 cells'], ['tumor xenograft model', 'NB vivo'], ['Inhibitors', 'K MAPK Akt'], ['Western  blotting', 'Akt P Erk'], ['expressing cells BDNF treatment', 'significantly gap closing'], ['', 'significantly wound healing cells'], ['', ''], ['', 'Boyden chamber migration'], ['distant  metastases', 'expressing xenograft tumors'], ['', ''], ['', 'induced Akt P Erk'], ['BDNF  TrkB', 'potential NB metastasis'], ['Treatment', 'high risk neuroblastoma'], ['50  %', 'late risk toxicities'], ['new  that', 'adverse risk events'], ['New  strategies', 'radiotherapy targeted cytotoxics biologics immunotherapy'], ['clinical  trials', 'novel  treatments'], ['clinical precision medicine that', 'somatic  mutations'], ['Expert  Advances', 'cellular phase pathways'], ['chemotherapeutic  treatments', 'current  strategies'], ['who', 'rapidly  diagnosis'], ['Neurocognition', 'potential  relationship'], ['schizophrenia study', 'functional UHR individuals'], ['Ultrahigh risk participants', 'neurocognitive Brief Schizophrenia'], ['Social skills', 'High Negative Symptoms'], ['one  instrument', 'social  functioning'], ['neurocognition', 'measures'], ['Negative  symptoms', 'five  measures'], ['We', 'social  neurocognition'], ['Negative  symptoms', 'longitudinal UHR studies'], ['This', 'functional UHR individuals'], ['', 'neurocognitive  DSM-5'], ['We', 'relative International Working MCI'], ['based  sample', '1644  adults'], ['diagnostic  criteria', 'cognitive  performance'], ['expert who', 'complex  cases'], ['algorithm', 'DSM-5 major DSM-5 curve'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'mild  NCD'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'when expert diagnosis'], ['Expert diagnosis', 'relative DSM IV'], ['Additional  cases', 'IADL DSM IV dementia'], ['DSM-5 mild NCD', '19 % diagnosis'], ['additional  cases', 'social MCI cognition'], ['NCD criteria', 'psychometric  population'], ['additional DSM-5 criteria', 'categorization'], ['Cell fate determination', 'loop helix transcription factors'], ['expression', 'two transcription factor neurogenesis'], ['KO cell culture NeuroD2', 'loss  approaches'], ['however  they', 'NSCL2 transcription'], ['binding  ability', 'NSCL1 induction'], ['epistatic  we', 'situ hybridization RT PCR'], ['expression', 'double KO mice'], ['However  expression', 'single  KO'], ['NeuroD1', 'upstream NSCL2 mice'], ['', 'regulatory  vivo'], ['', ''], ['rights', ''], ['neurodegenerative  diseases', 'insoluble  proteins'], ['molecular protein which', 'neuropathological differential diagnosis'], ['associated protein that', 'collectively fibrillary tauopathies'], ['how  tau', 'neurodegenerative  disorders'], ['research', 'new cell nucleus'], ['biological concepts tau', 'neuronal  networks'], ['it', 'genome  stability'], ['large  which', 'large  tau'], ['present  review', 'two  parts'], ['First  we', 'physiological cell functions'], ['which', 'disease progressive basal degeneration disease'], ['', ''], ['rights', ''], ['Neurodegenerative  diseases', 'neurocognitive  dysfunctions'], ['intensive  immunotherapy', 'channelopathy mitochondrial dysfunctions'], ['hippocampal atrophy which', 'neurodegeneration'], ['traumatic brain injury', 'neurodegeneration'], ['However  onset', 'later'], ['Simultaneously  discrimination', 'existing brain literature'], ['traumatic brain that', 'neurodegenerative  pathways'], ['immune  system', 'physiological  stimuli'], ['epigenetic  mode', 'ageing  condition'], ['Here  we', 'hippocampal cross regions'], ['Frontal alpha asymmetry', 'affective  style'], ['specific frontal alpha effects', 'activity approach withdrawal motivation'], ['present  study', 'positive alpha anxiety'], ['handed Thirty females', 'active control group'], ['asymmetry group', 'right alpha site'], ['', 'negative  affect'], ['', 'training'], ['specific  modulation', 'positive  symptoms'], ['findings', 'clinical alpha asymmetry settings'], ['', ''], ['rights', ''], ['importance', 'physiological  states'], ['so  need', 'molecular analysis techniques'], ['Current imaging technologies', 'health neuroimmune immunology'], ['immense  they', 'immense  CNS'], ['innovative  which', 'acute neuroimmune responses'], ['Therefore  review', 'medical neuroimmune research'], ['', ''], ['rights', ''], ['impulsive stage who', 'attention deficient hyperactivity disorder'], ['juvenile susceptibility any', 'age group'], ['Adult rats', '5 20 kg day'], ['Juvenile rats', '0 dose 5'], ['toxicological  assessments', 'relevant study FDA'], ['related  elevation', 'age groups'], ['Organ weight changes', 'liver adrenal gland'], ['Decreases', 'sufficient adult exposure'], ['', 'decreased body weights'], ['reproductive  changes', 'hormonal species reproduction'], ['', 'two age groups'], ['finishing swine operation', '30 case fatality %'], ['clinical  onset', 'environmental paresis stimuli'], ['Tissues', 'diagnostic  investigation'], ['Histopathologic examination', 'viral neuron satellitosis infection'], ['Bacterial pathogens', 'affected  pigs'], ['Samples', 'pseudorabies virus'], ['Immunohistochemistry', 'reproductive virus porcine circovirus'], ['Porcine sapelovirus', 'nested enterovirus porcine teschovirus'], ['Next generation sequencing', 'other cord pathogens'], ['Sapelovirus mRNA', 'situ nerve hybridization'], ['PSV', 'reported amino acid Korea'], ['This', 'severe United pigs'], ['Addictive  disorders', 'significant health disability'], ['current  interventions', ''], ['that', 'neural self circuits'], ['developments', 'magnetic brain stimulation'], ['only  us', 'impaired brain circuits'], ['long term safety', 'interventions'], ['Here  we', 'future progress field'], ['recent  advances', 'optical  neuroscience'], ['engineering biology light', 'single  cells'], ['Here  we', 'neuronal  structures'], ['Stroke', 'leading  US'], ['', 'cerebral  disability'], ['limited  success', 'preclinical  compounds'], ['well  that', 'complex signaling cascade'], ['immune antagonists clomethiazole regulators', 'current  progress'], ['recent  studies', 'more glyburide uric options'], ['use', 'further  development'], ['past  trials', 'future trial therapies'], ['', 'dopaminergic bradykinesia rigidity'], ['identification', 'fixed fluorescent cells'], ['Here  we', '3 VM weeks'], ['We', 'TH Tyrosine promoter'], ['Individual  neurons', 'glass micropipettes'], ['Next  we', 'single RNA Seq libraries(12345'], ['subsequent  analysis', 'gene expression'], ['We', 'dopaminergic midbrain cultures'], ['live TH eGFP that', 'live TH eGFP cells'], ['techniques', 'neuroscience  biology'], ['that', 'environment'], ['reverse polymerase chain reaction', 'mold phosphate pH'], ['', ''], ['differential  expressions', 'Northern  N'], ['', 'loss preg gene'], ['orotate ubiquinone C which', 'molecular  N'], ['', ''], ['mucin overexpression', 'important  process'], ['However  mechanism', 'bacterial mucus infection'], ['then cell cells', 'real polymerase chain reaction'], ['Nox I', 'cells'], ['Then  we', 'selective ELISA kit'], ['H2O2 production', 'dependent  manner'], ['upregulated protein DMTU', 'high  expression'], ['', 'mRNA level p'], ['', 'western grey blot'], ['', 'immunohistochemical protein level'], ['Moreover I', 'H2O2 p'], ['', 'high  expression'], ['', 'mRNA level p'], ['', 'immunohistochemical protein level'], ['NE induced TGF alpha any', 'selective  p'], ['', ''], ['', 'up MUC5AC production'], ['kinase C protein kinase oxidase', 'biliary epithelial cells'], ['abundant  leukocyte', 'immune  cancer'], ['neutrophils', 'dual cancer development'], ['', 'neutrophils increase'], ['advanced  we', 'different maturity tumor cytotoxicity'], ['important sub population', 'granulocytic suppressor cells'], ['Differencing G MDSC', 'granulocytic  populations'], ['Herein  we', 'far G MDSC'], ['We', 'different surface markers populations'], ['Lastly  we', 'full  cancer'], ['', 'C  GmbH'], ['rights', ''], ['', '38'], ['6 million 6 mortalities', 'liver cancer'], ['therapeutic  are', 'poor liver cancer'], ['comprehensive liver that', 'cancer molecular biology'], ['', 'interferon- liver cancer'], ['recombinant DNA plasmid', 'exogenous  genes'], ['orange ethidium bromide staining', 'recombinant DNA plasmid'], ['old C57BL/6 mice', 'hepatoma bearing mouse model'], ['Mice tumor tissue', 'immunohistochemistry electron microscopy'], ['recombinant DNA vaccine', 'induced mitochondrial vitro'], ['paper', 'operational step response experiment'], ['measure data', 'system parameters'], ['iterative estimation algorithm', 'output error criterion'], ['estimated circuit we', 'estimated circuit model'], ['Moreover  we', 'operational amplifier circuit'], ['proposed  method', 'operational amplifier circuit system'], ['are', 'BCC'], ['We', 'TCR T cell BCC'], ['V', 'skin resident T cells'], ['We', 'random J gene usage'], ['Lack', 'specific TIL BCC'], ['analysis', 'biological  decades'], ['', 'high throughput expression microarrays'], ['high throughput expression data', 'single base resolution'], ['that', 'essential precision medicine'], ['development', 'parallel generation sequencing'], ['further  improvements', 'applications'], ['that', 'parallel sequencing instrument'], ['barcoded bisulfite specificity', 'same  strands'], ['which', 'all  interest'], ['tiny  amounts', 'DNA'], ['here  BiSeqS', 'wild type molecules'], ['pituitary endocrine thyroid', 'parathyroid adrenal testicular ovarian'], ['tools', 'scientific  community'], ['Endocrine cancers', 'considerable health etiology'], ['even  that', 'disease'], ['Microarray data', 'therapeutic endocrine treatments'], ['next generation sequencing many', 'clinical drug targets'], ['', ''], ['comprehensive  review', 'related generation sequencing cancers'], ['that', 'genetic endocrine tumors'], ['We', 'clinical endocrine challenges'], ['mediated genes activation', 'relative  genes'], ['decoy ODNs', 'tumor growth'], ['First B decoy oligodeoxynucleotides', 'c myc gene'], ['Then supression effects', 'five MTT assay'], ['Apoptosis', 'cytometric chromosome DNA analysis'], ['Thirdly suppression effects', 'nude NF kappa mice'], ['NF kappa B', 'SKOV-3 lipofectamineTM2000'], ['Expression levels', 'northern c blotting'], ['DNA protein interactions', 'electrophoretic mobility shift assay'], ['Treatment', 'especial cancer cell vivo'], ['Induction', 'DNA gel electrophoresis'], ['Activity', 'transfected control decoy'], ['endogenous caspase-8 transcripts', 'endogenous c myc gene'], ['EMSA', 'specific kappa B protein'], ['kappa B activation', 'ovarian  carcinomas'], ['Inhibitors', 'desired target genes'], ['ODNs', 'human  malignancies'], ['development', 'much water attention'], ['nitrogen', 'hydrogen evolving hydrogen catalysts'], ['ZnNb2O6 g C3N4 heterostructures', 'photocatalytic charge hydrogen'], ['CN mole ratio', 'important  production'], ['5%NGQDs Zn/7CN sample', 'higher hydrogen evolution 340'], ['', ''], ['heterojunction photocatalytic heterojunction which', 'efficient charge separation'], ['photocatalytic  mechanism', 'NGQDs ZnNb2O6 g C3N4'], ['work', 'driven hydrogen evolution reaction'], ['', 'C Elsevier B'], ['', ''], ['where  microorganisms', 'decisive  role'], ['', 'scientific processes knowledge'], ['new enology direction', 'monitored  fermentations'], ['', 'economic context returns'], ['analytical term that', 'based enology trend'], ['actually  it', 'microbial  diversity'], ['associated  microbiota', 'also health grapevine'], ['recent  works', 'sensory associated wines'], ['entire wine making we', 'ecological microbiome vine health'], ['These', 'critical precision enology practices'], ['metagenomic  techniques', 'food industry'], ['review', 'next generation sequencing pipelines'], ['new  directions', 'wine research'], ['research', 'Certificate energy usage'], ['monthly energy consumption', 'mechanical power meters'], ['Intrusive Appliance Load which', 'pertinent power consumption'], ['real time feedback feature', 'such cost NIALM algorithms'], ['System', 'SoC  challenge'], ['important Programmable Gate which', 'high performance system'], ['Therefore  we', 'real FPGA acceleration'], ['', ''], ['rights', ''], ['nicotine exerts', 'reward'], ['differential  that', 'neurophysiological  properties'], ['Computer simulations', 'individual reward attention nicotine'], ['nigral dopaminergic that', 'thalamocortical filtering mechanism'], ['nicotine', 'mental  flexibility'], ['', 'particularly deficit hyperactivity disorder'], ['why  patients', 'when  nicotine'], ['', ''], ['', ''], ['rights', ''], ['conserved gene that', 'synaptic  neurotransmission'], ['nAChR subunits perform', 'Drosophila melanogaster'], ['', '10  D'], ['only  three', '7 escape response'], ['Other  subunits', 'several  insecticides'], ['allele', '1  insecticides'], ['ends  gene', 'genetic phenotypic background'], ['this', 'nAChR  insecticides'], ['1  function', 'courtship sleep longevity'], ['signaling', 'previously mating D'], ['nAChR  subunit', ''], ['biological fitness that', 'neonicotinoid  resistance'], ['economic  development', 'entire  Earth'], ['such  forecasts', 'national  scale'], ['we', 'per pixel 2000'], ['statistical Holt we', 'urban pixel level China'], ['lit  population', 'nighttime  GDP'], ['forecast  GDP', 'demographic National data'], ['Finally  we', 'potential  disaggregation'], ['', ''], ['', 'acute iodide administration'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['-Iodide', 'important thyroid activity'], ['acute thyroid hormone which', 'TGF thyroid'], ['alterations', 'hours Wolff Chaikoff effect'], ['mRNA perchlorate treatment', 'them'], ['Rats', 'treatment'], ['03  %', 'NaI'], ['', '30 24 h'], ['set', 'equimolar  doses'], ['mRNA content', 'poly(A cDNA test'], ['mRNA abundance tail length', 'significantly iodide treatment'], ['that', 'modifications'], ['NIS mRNA translation', 'NIS mRNA which'], ['new iodide exerts', 'autoregulatory  thyroid'], ['Nitrate cycling', 'soil systems'], ['Excessive  application', 'great research attention'], ['Sorption', 'environmentally nitrate fixation'], ['biochars', 'sorption'], ['well biomass compositions', 'potential nitrate fixation'], ['Increased  sorption', 'increasing pyrolysis biomass'], ['groups  charges', 'well nitrate sorption'], ['surface area', 'controlling nitrate sorption'], ['coating', 'nitrate tannic sorption'], ['nitrate  sorption', 'organic  matter'], ['Nitrate sorption', 'engineered particles clay particles'], ['Soil particles', 'high  biochars'], ['biochars', 'massive nitrate application'], ['Nitrogen fixation', 'carefully biochar feedstocks'], ['', ''], ['', ''], ['rights', ''], ['which', 'public  health'], ['concentrated reject that', 'economic  disposal'], ['inert nitrogen that', 'inert nitrogen gas'], ['attention', 'metallic reduction anodes'], ['values', 'larger  scales'], ['development', 'few ammonium technologies'], ['overview', 'future  research'], ['', ''], ['', ''], ['rights', ''], ['Nitrobenzene', 'different  products'], ['Moreover  it', ''], ['Therefore  detection', 'more  sensor'], ['article', 'modified Ni nitrobenzene'], ['GRGO', 'reducing caffeic agent'], ['pi pi', 'RGO'], ['magnetic resonance Fourier', 'infrared  spectroscopy'], ['structural  morphology', 'prepared scanning electron microscope'], ['electrochemical  studies', 'CV  technique'], ['DPV studies', 'proposed linearity sensor'], ['', '878 mu 1'], ['mu  cm(-2', 'detection'], ['', ''], ['GRGO Ni TPP', 'good  NB'], ['real sample analysis', 'various water samples'], ['', ''], ['rights', ''], ['study', 'coastal enzyme activity'], ['Sediment', 'different N rates'], ['NAG N beta activities', 'N addition'], ['C  limitation', 'N input'], ['Besides N input', 'fungal  sediment'], ['increased  phenolics', 'exacerbated N changes'], ['treated C which', 'bacterial  abundance'], ['high  trend', 'higher C PHO'], ['thus C storage', 'more  future'], ['', ''], ['rights', ''], ['Ammonia', 'vital commodity fertilisers'], ['such  ammonia', 'centralized  facilities'], ['smaller  devices', 'local  consumption'], ['enabling  it', 'any  demand'], ['which', 'then  cathode'], ['water latter', 'renewables'], ['ammonia NH3', 'minimal cost facilities'], ['we', 'seminal ammonia production field'], ['different  that', 'remaining  ammonia'], ['', ''], ['', ''], ['rights', ''], ['recent radiation advances', 'targeted NSCLC therapies'], ['particular  class', 'elusive cancer cure'], ['review', 'available  NSCLC'], ['We', 'patient  life'], ['maternal  adaption', 'semiallogeneic decidualization'], ['Remodeling', 'dendritic T deciduas'], ['unique  population', 'maternal NK adaptation'], ['immune transplantation system', 'transplantation assumption'], ['tendency', ''], ['immune  system', 'maternal NK cells'], ['immune  response', 'uterine NK cells'], ['lytic Chediak Higashi granules', 'severe target cell immunodeficiency'], ['Correction', 'hematopoietic stem cell therapy'], ['We', 'IL-2 cord blood them'], ['strong  defect', 'IL-2 IFN gamma treatment'], ['thus cell contact IL-2', 'general cell effector functions'], ['NK cell cytotoxicity', 'IL-2  treatment'], ['IL-2', 'lytic CHS patient'], ['', '2016 Immunological Societies'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['Dysregulation', 'solid  tumors'], ['However  status', 'clinical acute myeloid leukemia'], ['transcript  level', '126 myeloid leukemia patients'], ['Clinical  significance', 'low NKD1 expression'], ['messenger RNA level', 'acute myeloid leukemia controls'], ['', ''], ['', 'p karyotypic >'], ['', ''], ['significant  difference', 'complete remission rate'], ['patients', 'M3 acute myeloid leukemia'], ['', ''], ['', ''], ['', ''], ['low NKD1 expression', 'acute myeloid leukemia patients'], ['', ''], ['', ''], ['prognostic  value', 'acute myeloid leukemia patients'], ['', ''], ['', ''], ['increased induction chemotherapy', 'acute myeloid leukemia patients'], ['', ''], ['NKD1  expression', 'acute myeloid leukemia'], ['dependent', 'cognitive  functions'], ['', 'associated chronic NMDAR hypofunction'], ['', ''], ['', 'prefrontal  circuits'], ['pharmacological fMRI study', 'positive crossover pictures'], ['irrespective', 'prefrontal emotion activity'], ['ketamine', 'negative  stimuli'], ['network level ketamine', 'negative orbitofrontal stimuli'], ['', '5 memory days'], ['ketamine', 'emotional memory formation'], ['pattern', 'previously  schizophrenia'], ['Skeletal  surveys', 'suspected  abuse'], ['however WB application', 'child abuse pediatrics'], ['that', 'suspected child abuse'], ['', ''], ['rights', ''], ['article', 'clinical presentation evaluation'], ['accidental  trauma', 'pediatric  population'], ['vulnerable  radiologist', 'suspected  abuse'], ['review', 'clinical emergency medicine'], ['radiologic spine imaging', 'injured head child'], ['illustrated  depictions', 'induced  injuries'], ['abusive  who', 'themselves'], ['', 'so fatty liver diseases'], ['Methods  Rats', 'high cordyceps sinensis'], ['total  cholesterol', 'Northern luciferin blotting'], ['Liver histopathology', ''], ['rats', 'gradual ATP level'], ['advanced liver disease', 'high fat diet'], ['Up regulation', 'high fat week'], ['', 'high liver level'], ['Conclusion NAFLD rat models', ''], ['rats', 'beneficial  exposure'], ['Cordyceps sinensis', 'protective  progression'], ['One', 'thereby metabolism energy homeostasis'], ['inhibiting', 'NSAID'], ['Alternative NSAID', 'adverse COX II effects'], ['prophylactic  premedication', 'recurrent  pain'], ['intake', 'NSAID'], ['NSAID  who', '5 mg desloratadine'], ['17 H-1-antihistamine patients', 'weak COX I COX'], ['2  patients', '400 mg ibuprofen'], ['800 mg ibuprofen', '400 mg ibuprofen'], ['strong COX I inhibitor', 'minutes mg intake'], ['', '2016 Allergy Asthma'], ['decline', 'ecological  mechanisms'], ['high altitude effect', 'environmental  biodiversity'], ['Studies', 'relatively altitude ponds'], ['', 'different variability lakes'], ['high altitude waterbodies species', 'aquatic altitude gradient'], ['consuming species chironomids', 'regular  surveys'], ['present  we', 'special 1100-m altitude chironomids'], ['58  taxa', 'study ponds'], ['mean chironomid diversity', '13 chironomid taxa'], ['invertebrate  richness', 'negative altitude chironomid response'], ['opposite Chironominae trend', 'Diamesinae'], ['aggressive  that', 'high recurrence metastasis'], ['Dysregulation', 'several tumor cancers'], ['coding  that', 'real polymerase chain reaction'], ['Out', 'tobacco chewing history'], ['coding RNA profile', 'Genome Atlas database'], ['Linc regulator', 'strong tumor recurrence'], ['first cell we', 'undifferentiated RNA tumors'], ['together  study', 'therapeutic linc RoR response'], ['long noncoding RNAs', 'date'], ['sequencing  we', 'Northern mitochondrial blotting'], ['encoded mitochondrial proteins', 'RNA expression'], ['three RNase P protein', '1  transcripts'], ['intermolecular  abundance', 'functional mitochondrial gene expression'], ['Collecting', 'public health prevalence investigation'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'child abuse'], ['', ''], ['', ''], ['that', 'sensitive  questions'], ['alternative', 'sensitive response triangular questions'], ['techniques', 'anonymity'], ['who', 'techniques'], ['researchers', 'reliable  information'], ['randomized response which', 'face  reproductivity'], ['randomized response covariate', 'randomized response which'], ['well noncompliance probabilities', 'sensitive  characteristic'], ['proposed  techniques', 'sensitive  probabilities'], ['real  example', 'premarital university methodologies'], ['Infrared  thermography', 'various  materials'], ['technique', 'surface test material'], ['signal video schemes', 'various  fields'], ['', 'coded  excitations'], ['paper', 'active  thermography'], ['developed  technique', 'compressed side pulse'], ['defect detection capabilities', 'blind plastic defects'], ['investigation', 'spatial  ratio'], ['theory', 'possible Turing algorithms'], ['digital  computers', 'classical  UTMs'], ['deterministic computer UTMs', 'classical  UTMs'], ['previously  construction', 'previously  NUTM'], ['Here  we', 'physical  NUTM'], ['previous DNA computing computation', 'simple  operations'], ['design', 'computational P time'], ['Thue rewriting Thue step', 'novel polymerase chain reactions'], ['arbitrary Thue classes', 'Thue rule'], ['where  it', 'classical  UTMs'], ['NUTMto trade which', 'theoretical computer science'], ['It', 'practical Richard bottom'], ['electronic  computers', 'tiny  energy'], ['employing', 'pseudo exponential transconductance amplifier'], ['proposed transconductance amplifier', 'digital CMOS technology'], ['dependent transconductance which', 'input digital code'], ['proposed  DAC', 'nm standard CMOS technology'], ['squared simulation value', 'fitted  0'], ['', '999  process'], ['presented  DAC', 'worst mu case'], ['Digital  control', 'recent power years'], ['induced limit cycle which', 'induced limit cycle oscillations'], ['we', 'actively limit cycles'], ['how  system', 'duty cycle levels'], ['limit cycle which', 'system'], ['', ''], ['Oscillators', 'molecular  systems'], ['Artificial  oscillators', 'biological  computation'], ['nucleic biochemical reaction we', 'oscillatory  solutions'], ['network', 'three bacteriophage cells'], ['oscillations', 'realistic reaction rates'], ['zero  dynamics', 'many control problems'], ['continuous time system', 'minimum  phase'], ['zero  dynamics', 'resulting  model'], ['zero  conditions', 'desired  model'], ['known  notion', 'zero linear dynamics'], ['', 'remote energy harvesting sensors'], ['better vibration energy they', 'broader vibration spectrum'], ['nonlinear energy that', 'internal frequency bandwidth'], ['bandwidth', 'fixed  magnets'], ['harvester', 'fixed cantilever magnet'], ['it', 'mechanical  amplifier'], ['mathematical  model', 'movable cantilever magnet'], ['perturbation method', 'analytical  solutions'], ['effects', 'various frequency responses'], ['long shooting technique', 'analytical  results'], ['results', 'electrical  bandwidth'], ['', ''], ['rights', ''], ['recent  development', 'various  structures'], ['graphene sheet which', 'physical  properties'], ['Magnetic field effects', 'scientific  community'], ['nonlocal  we', 'viscoelastic nanoplate medium'], ['We', 'viscoelastic Kirchhoffs plate nanoplates'], ['Closed form solutions', 'supported  nanoplates'], ['results', 'numerical  method'], ['numerical  examples', 'natural  VOMNPS'], ['study', 'nanoelectromechanical graphene sheets'], ['', ''], ['rights', ''], ['Most  research', 'visual  cues'], ['social  that', 'visual  cues'], ['one  cue', 'other cue it'], ['', 'German Germany job appearance'], ['accents', 'strong  categorization'], ['incongruent  targets', 'extremely congruent targets'], ['accents', 'most  targets'], ['bringing', 'underlying impression formation'], ['multiple  access', '5 research G'], ['two  users', 'decode  relay'], ['We', 'fading outage channels'], ['Closed form expressions', 'outage users'], ['Approximate outage capacity', 'high ratio regime'], ['cooperative  NOMA', 'cooperative outage probability'], ['tightness', 'proposed  protocol'], ['early  detection', 'critical  prognosis'], ['microRNAs expression profiling', 'small cell lung cancer'], ['Relative  expression', 'small lung cancer cases'], ['informed  consent', 'enrolled  individuals'], ['Ethical  Committees', '1964  Helsinki'], ['small lung cancer miR-10b', 'small lung cancer lavage'], ['Overexpression', 'clinical  cancer'], ['oncomir ROC curve miR-1', 'lavage tumor miR-10b'], ['', ''], ['', ''], ['', ''], ['788 AUC values', 'small cancerfree subjects'], ['free lung cancer which', 'small cell lung cancer'], ['', ''], ['rights', ''], ['we', 'Han Chinese Han population'], ['> G variant', 'fragment length polymorphism'], ['Allele G', 'increased  NSCLC'], ['Moreover  individuals', 'AA genotype carriers'], ['> rs1550117 G', 'significantly  age'], ['consistently allele G', 'significantly DNMT3A transcription'], ['transcription repressor which', 'decreased allele DNMT3A'], ['Collectively  results', 'dual NSCLC tumorigenesis'], ['', 'small cell lung cancer'], ['very  prognosis', 'advanced  disease'], ['immune  system', 'cancer self'], ['Novel immunotherapies', 'effective  disease'], ['immune checkpoint NSCLC', 'likely action data agents'], ['we', 'small cell lung cancer'], ['small lung cancer carcinoma', '151 lung patients'], ['neurotrophic antisense expression levels', 'reverse polymerase chain reaction'], ['Clinical  relevance', 'neurotrophic antisense expression level'], ['potential', 'small cell lung cancer'], ['neurotrophic factor antisense', 'forced  overexpression'], ['effects', 'vitro 3-(45-dimethylthiazol-2-yl)-25-diphenyl tetrazolium assays'], ['neurotrophic factor antisense', 'late stage carcinomas'], ['neurotrophic factor antisense downregulation', 'overall lymph node survival'], ['', 'small lung cancer proliferation'], ['neurotrophic factor antisense', 'potential lung cancer prognosis'], ['Overexpressing', 'small cancer tumor growth'], ['Radiation treatment', 'major lung cancer'], ['majority', 'inevitably treatment failure'], ['Therefore  identification', 'other novel cancer'], ['present  we', 'sensitive cell line HCC827'], ['array multiple array miRNAs', 'resistant  cells'], ['resistant thioredoxin reductase', 'novel  miR-124'], ['knockdown', 'reactive radiation treatment'], ['multiple  miRNAs', 'resistant mediates radiation expression'], ['present  study', 'therapeutic lung cancer'], ['small cell lung cancer', 'few treatment options'], ['molecular  it', 'molecular  way'], ['uncontrolled cancer cell proliferation', 'NSCLC'], ['that', 'advanced cancer progression'], ['', 'targeted treatments treatment NSCLC'], ['major  advances', 'small cell lung cancer'], ['new  that', 'directly cell survival'], ['ablative dose radiotherapy', 'metastatic  disease'], ['GOECP  SEOR', 'advanced stage metastatic'], ['robotic Robotic Timber fabrication', 'full scale dimensions'], ['robotic  that', 'digital nonstandard timber structures'], ['architectural  morphologies', 'differentiated  material'], ['where timber focus', 'generic  space'], ['design building information', 'entire building process'], ['paper', 'earliest fabrication design'], ['thus design that', 'constructive  repertoire'], ['', ''], ['', ''], ['rights', ''], ['', '510-methylenetetrahydrofolate  reductase'], ['producing  alterations', 'cleft folate palate'], ['We', 'combined parent trio samples'], ['Subjects', '121 case parent cases'], ['allele genotype result', 'allele transmission trios'], ['samples', ''], ['Maternal genotype effect', 'additionally log linear method'], ['', ''], ['', ''], ['', ''], ['69', 'case control sample'], ['However triad sample', 'significant  association'], ['', ''], ['', ''], ['which', 'combined  OR'], ['', ''], ['', ''], ['', ''], ['Maternal  genotype', 'also  phenotype'], ['', ''], ['Chilean  results', 'offspring MTHFR c'], ['T variant', 'Chilean  population'], ['immune  that', 'bovine livestock'], ['Little  information', 'South Africa'], ['diversity', 'South Africa'], ['known NTM species', 'keeping Mycobacterial genes'], ['following  which', 'potential Mycobacterium tuberculosis animals'], ['', '601 Mycobacterium avium subsp'], ['', ''], ['', ''], ['', ''], ['', ''], ['GR-2007', 'potential Mycobacterium animals'], ['immune tuberculin that', 'immunology'], ['', ''], ['bolletti', '102  isolates'], ['Other NTM species', 'pathological  changes'], ['certain South role', 'certain disease M'], ['', 'bTB'], ['Noroviruses', 'acute  humans'], ['', 'molecular time RT noroviruses'], ['real RT PCR which', 'real RT PCR assays'], ['higher norovirus they', 'DNA standard GII DNA controls'], ['Assay B', 'highest  genogroups'], ['reactivity', 'GI noroviruses rotavirus'], ['fecal detection samples', 'detection GI'], ['Cq  value', 'statistical assays significance'], ['', ''], ['real RT PCR assays', 'GI'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['study', 'DNA standard DNA controls'], ['Sewage samples', 'human norovirus populations'], ['statistical  relationship', 'clinical  sewage'], ['we', '2013  2016'], ['correlation  analysis', 'reported gastroenteritis cases'], ['Norovirus genotypes', 'also stool samples'], ['correlation  analysis', 'peak coefficient'], ['variation', 'gastroenteritis cases'], ['which', '13 stool 2'], ['', ''], ['4', 'frequently sample GII'], ['', ''], ['Phylogenetic  analysis', 'GII'], ['2014  lineage', '2012 study season'], ['', 'GI'], ['2015 sewage monitoring', 'GI'], ['', 'previous  season'], ['monitoring', 'human epidemic populations'], ['IMPORTANCE  We', '3-year study period'], ['Sewage sample analysis', 'human norovirus populations'], ['We', 'closely  GII'], ['2014  lineage', 'clinical study cases'], ['similar  pattern', 'GI'], ['cases', 'previous  season'], ['monitoring', 'molecular  noroviruses'], ['Applying', 'enteric  ecology'], ['immunochromatographic  assay', '771 stool gastroenteritis'], ['R gold QUICK', 'overall  72'], ['', '8  99'], ['', ''], ['Xpert GENE PCR Norovirus', 'mostly R RIDA'], ['negative stool result', 'definitively  norovirus'], ['', ''], ['rights', ''], ['Silver nanoparticles', 'medical spectrum antimicrobial applications'], ['Initially  efficacy', 'feline  calicivirus'], ['norovirus surrogates', 'then cell culture assays'], ['AgNP  ions', 'dependent  2'], ['', ''], ['PHBV  films', 'PHBV18 PHBV3 films'], ['when MNV titers', '0'], ['', ''], ['smooth EDAX analysis', 'PHBV3 PHBV18 layer'], ['first  suitability', 'antiviral AgNP surfaces'], ['', ''], ['rights', ''], ['Northern blot that', 'locked nucleic acids'], ['Northern blot detection', \"5'-P-32-end LNA mixmer label\"], ['nucleotide  which', 'unique length cells'], ['Northern blot analysis', 'radioactive nylon probes'], ['Earlier  efforts', 'short RNA detection'], ['We', 'northern electrophoresis step'], ['herein  we', 'several  recommendations'], ['protocol', 'microRNA length lengths'], ['medium selectivity notch filter', ''], ['active RC filter', 'passive  components'], ['floating  resistors', 'independent Q factor'], ['amplifier pole frequency', 'positive feedback configuration'], ['filter', 'proposed Q factor configuration'], ['passive parameter which', 'single pole model'], ['PSpice simulations', 'theoretical  analysis'], ['', 'exact liver fibrosis'], ['We', 'concanavalin A'], ['blood mononuclear cells', 'modeled  rats'], ['', '24 TGF h'], ['beta signaling', 'real polymerase chain reaction'], ['beta proteins', 'western  blotting'], ['beta signaling', 'model'], ['Administration', 'Notch signal model'], ['DAPT', 'such TGF beta TGF'], ['also protein expression', 'pathway'], ['beta signaling', 'liver fibrosis'], ['which', 'TGF signaling'], ['MITE  families', 'genome Camponotus floridanus'], ['They', ''], ['', 'entire  genome'], ['most insertion members', 'host genome'], ['association', 'noncoding  C'], ['floridanus', ''], ['autonomous  partner', 'also  C'], ['', ''], ['autonomous  element', 'animals'], ['phylogenetic  TECs', 'classic CACTA transposon'], ['Finally transposition mechanism', 'host genome evolution'], ['rapid  development', 'basic satellite system'], ['charged  most', 'particles'], ['bulk  recombination', 'electrons'], ['gain degradation', 'bipolar  circuits'], ['therefore electron radiation it', 'different electron radiation conditions'], ['tested  devices', 'commercial Texas Instruments'], ['operational NPN input amplifiers', 'different radiation damage effect'], ['Experiment', 'Co-60 gamma ray'], ['total radiation experiments', 'Co-60 Xinjiang Technical physics'], ['accumulated test dose', 'test samples'], ['high temperature annealings', 'different dose biases'], ['Result', 'that'], ['more  that', '1'], ['', 'same Gy(Si)/s energy'], ['same electron beam former', 'more displacement latter'], ['different radiation sensibility', 'same electron energy'], ['electric  field', 'trapped  charge'], ['', 'initial  value'], ['result', ''], ['1 MeV electron radiation', 'operational ionization amplifier'], ['aim', 'pulmonary bleomycin A5'], ['', 'which'], ['sinensis effect', ''], ['interstitial pulmonary fibrosis model', 'male bleomycin A5'], ['Then  rats', '18 treatment A'], ['', '='], ['Control', 'equal  saline'], ['Hematoxylin staining', 'pulmonary  fibrosis'], ['Collagen content', 'hydroxyproline assay'], ['kappa B NF kappa activity', 'electrophoretic mobility shift assay'], ['beta growth factor expression', 'immunosorbent protein assay'], ['results', 'pulmonary  A'], ['sinensis', 'significantly model group'], ['', 'A'], ['also  content', 'TGF beta mRNA'], ['results', 'that'], ['sinensis', 'possibly TGF beta expression'], ['Requiring', 'on aquaculture pathogens'], ['Taura syndrome one', 'several penaeid shrimp species'], ['NASBA amplicons', 'specific gel primer'], ['Detection TSV that', 'based TSV detection OIE'], ['TSV NASBA RNA', 'target  signals'], ['', 'alternative NASBA amplicons'], ['Taken', 'on  TSV'], ['nucleobase  that', 'molecular DNA biology'], ['ultraviolet  irradiation', 'accurate quantum chemistry calculations'], ['main relaxation pathways', 'ground state intersystem crossing'], ['ground state relaxation', 'predominant gas phase'], ['We', 'excited state dynamics simulations'], ['ultrafast ISC which', 'mostly  the'], ['article', 'condensed gas interfaces'], ['Nucleophosmin', 'closely cancer chemoresistance'], ['However  interaction', 'oxaliplatin resistance'], ['', 'gastric cancer cell oxaliplatin'], ['clinical expression levels', 'gastric cancer cells'], ['However  expression', 'gastric cancer cells'], ['cell sensitivity', 'simultaneously NPM expression'], ['significantly Her-2 which', 'simultaneously  NPM'], ['gastric  trastuzumab', 'gastric cancer cells'], ['coach coach athlete relationship', 'knowledge'], ['knowledge', 'long weight control eating'], ['organisational  change', 'Artistic dieticians'], ['coaching life histories', 'three knowledge gymnasts'], ['findings', 'illustrative  themes'], ['personal  knowledge', 'regardless weight generation'], ['introduction', 'healthier  practices'], ['Reflections', 'continued elite gymnastics'], ['postnatal  period', 'immune docosahexaenoic development'], ['objective', 'immune  function'], ['Sprague Dawley rats', 'adequate  lactation'], ['', ''], ['suckled  pups', 'randomly mucosal OT challenge'], ['5  pups', 'systemic  immunization'], ['immune d function', 'factorial d which'], ['Feeding dams DHA', 'higher concanavalin LPS'], ['', 'control pups'], ['', 'specific plasma immunoglobulin'], ['', ''], ['that', 'P'], ['', ''], ['immune IFN feeding', 'inflammatory  response'], ['Providing', 'female rat offspring'], ['staggering  prevalence', 'exorbitant health care resources'], ['sectional  study', 'nonobese obesity risk factors'], ['drug dependency', 'nonobese'], ['Psychopathy', 'lower  BMI'], ['decision health deficits', 'abuse traumatic brain injury'], ['Adjusting', 'sexual  abuse'], ['Females', 'sexual  abuse'], ['heat metabolism', 'still ob debate'], ['We', '10 C57BI/6 background group'], ['', 'interscapular euthanasia analysis'], ['ob ob group', '1 alpha protein'], ['36 binding protein', 'binding insulin signaling'], ['ob ob group', 'increased gene inflammation'], ['ob ob mice', 'reduced acid synthesis mobilization'], ['', 'also gene inflammation'], ['lack', 'ob ob mice'], ['', 'C  GmbH'], ['rights', ''], ['psychodynamic  improvement', 'decrease'], ['sample', 'psychological service clinic'], ['OR functioning', 'relational Relations narratives'], ['Psychotherapy Process Scale', 'early psychotherapy treatment'], ['rater agreement', 'excellent  range'], ['', 'psychodynamic effect therapy'], ['early  number', 'psychotherapy sessions'], ['reliable  change', 'global  OR'], ['overall symptoms OR', 'outcome'], ['Limitations', 'clinical research practice'], ['', ''], ['still  association', 'clinical OC individuals'], ['other perception personality', 'clinical adult population'], ['337  who', 'other perception personality traits'], ['Confirmatory factor analyses', ''], ['factor  ideation', 'factor  ideation'], ['results', 'other OC perception'], ['Understanding', 'prevention  policies'], ['', ''], ['perception', 'social nursing obstetrics'], ['learning university we', 'intervention'], ['', ''], ['', 'parents'], ['', ''], ['', 'year  delivery'], ['', ''], ['Problem areas', 'social  stress'], ['when  professionals', 'tangible  support'], ['conversations', 'stress'], ['Relating', 'positive support experiences'], ['Justness', 'important  topics'], ['', ''], ['attendance', 'professional hospital attitudes'], ['stigmatizing well network', 'great  importance'], ['maternal resource mortality', 'United States'], ['Caring', 'physiological  pregnancy'], ['Optimization', 'Scientific Maternal Cardiac Arrest'], ['Current  recommendations', 'cardiac airway arrest'], ['', 'Electricity dams'], ['', ''], ['hydrokinetic  electricity', 'renewable  U'], ['', ''], ['', ''], ['study', 'hydrokinetic power turbines'], ['control algorithm', 'induction electric machine model'], ['moored  simulation', 'electromechanical generator model'], ['three phase sinusoidal that', 'asynchronous  generator'], ['speed control', 'simplified voltage source inverter'], ['real  which', 'PWM width technique'], ['developed rpm fluctuations', 'developed  algorithms'], ['', 'significant wave height'], ['', 'significant wave height'], ['TNF receptor', 'neoplastic TNF diseases'], ['G TNF genes', 'Serbian  patients'], ['Genotyping', 'reaction length polymorphism analysis'], ['significant  difference', 'genotype  SNPs'], ['', ''], ['TNF variant', 'eightfold KCOT risk'], ['', ''], ['', ''], ['', ''], ['carriers', 'fourfold KCOT risk'], ['', ''], ['', ''], ['', ''], ['', ''], ['two  polymorphisms', 'Serbian KCOT population'], ['article', 'autonomous multiport circuit'], ['autonomous I p', 'equivalent highimpedance circuit'], ['ideally DDA it', 'zero  value'], ['conditions', 'low V io temperatures'], ['small V drift', 'small V io'], ['Large Wind Parks', 'residential  districts'], ['offshore  WPs', 'other legislation uses'], ['', ''], ['aim', 'ecological  Crete'], ['It', 'coastal area context'], ['areas', 'strictly  EU'], ['Three  steps', 'regional Western Crete'], ['', ''], ['rights', ''], ['Improvement', 'specialized oilseed rape'], ['special  feature', 'extended symptomless latency'], ['when crop maturity it', 'natural  senescence'], ['genotypic Verticillium disease it', 'ripening  plant'], ['qPCR  which', 'quantitative  V'], ['', 'field conditions'], ['', 'two tubulin V'], ['longisporum genome', ''], ['tubulin primers', 'high  V'], ['primers', 'fungal stem quantification'], ['', 'symptomatic fg plants'], ['best  discrimination', 'senescent stem tissues'], ['Field screening data', 'thus cultivar V'], ['', 'improved elite OSR Verticillium'], ['Older  adults', 'negative  information'], ['when emotion regulation', ''], ['sad  we', 'different mood state changes'], ['attentional mood that', 'attentional  engagement'], ['older  adults', 'randomly  stressor'], ['Before', 'nervous mood state calm'], ['tracking  participants', 'emotional  stimuli'], ['Changes', 'attentional disengagement strategies'], ['who', 'happy positivity faces'], ['tension who', 'sad mood faces'], ['partially  it', 'nervous  mood'], ['older  adults', 'positivity attention'], ['', ''], ['sad  effect', 'stressors'], ['', ''], ['rights', ''], ['aim', 'diet  variables'], ['Dietary patterns', 'cluster  men'], ['', ''], ['', ''], ['', ''], ['', 'older  adults'], ['Cluster analyses', 'dietary  gender'], ['dietary  clusters', 'variables cognitive variables function'], ['dietary  clusters', 'sociodemographic'], ['ready  meals', 'slight  depression'], ['Results', 'effective consideration prevention'], ['', ''], ['', ''], ['rights', ''], ['sarcoma', 'resected  radiotherapy'], ['Oligosarcoma', 'sarcomatous  components'], ['targeted  those', 'radiotherapy'], ['Moreover cases', 'resected  oligodendroglioma'], ['fluorescent', 'first 1p/19q tumor'], ['Additionally  immunohistochemistry', '1 isocitrate tumors'], ['together  findings', 'monoclonal tumor origin'], ['Consequently  case', 'resected  glioma'], ['Olive  flounder', 'marine China Korea'], ['Controlling', 'sustainable aquaculture production systems'], ['Therefore  investigation', 'great gonadal aquaculture'], ['Furthermore identification', 'regulatory expression mechanism'], ['olive  which', '6'], ['', ''], ['', '24 GB ovary'], ['then olive reads', 'gene'], ['expressed  genes', 'FPKM values'], ['biased  genes', ''], ['fertilization GO spermatogenesis', 'biased germ genes'], ['embryonic  morphogenesis', 'biased aromatase genes'], ['nucleotide  polymorphisms', '32993  transcriptome'], ['work', 'future molecular biology species'], ['Advanced chemical remediation strategies', 'olive mill wastewater'], ['', 'solar photocatalysis coagulation OMW'], ['organic pollutants abatement grade', 'available  today'], ['Special  attention', 'industrial effect scale'], ['latest  advances', 'mixed sunlight others'], ['Solutions', 'by treatment processes'], ['associated costs comparison', 'different  processes'], ['', ''], ['', ''], ['rights', ''], ['inner Rio de waters', 'human sewage decades'], ['EV  rotavirus', 'contaminated surface waters'], ['', '2016 Summer event'], ['monthly  collections', 'different de Janeiro Brazil'], ['Total coliform counting', 'quantitative polymerase chain reaction'], ['Analyses', 'infectious virus particles'], ['results', '95'], ['9  %', 'one water virus'], ['', 'individually  water'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['viral  loads', 'gc  10(6'], ['', 'main C D F'], ['90  %', 'infectious HAdV C'], ['where Olympic rowing', 'Olympic athletes tourists'], ['', ''], ['', ''], ['rights', ''], ['disruptive  cancers', 'tremendously  patient'], ['conventional  treatment', 'genomic  reality'], ['type', 'other  illnesses'], ['related  developing', 'complicated  problem'], ['One  solution', 'existing silico modeling'], ['However  optimization', 'dimensional computer printing'], ['limitless  that', 'previously manufacturing facilities'], ['Companies', '3D home use'], ['scantily  application', 'digital chemical control'], ['This', '3D chemical reagents'], ['', 'printed drug seizures'], ['biologic materials tissues', ''], ['green  materials', 'recently  environment'], ['sulfur N S CDs', 'green ginkgo materials'], ['synthesized carbon dots', 'nitrogen  elements'], ['fluorescence intensities', 'and carbon strength'], ['green N S CDs', 'optical fluorescent properties'], ['', ''], ['', ''], ['rights', ''], ['molecular  beacon', 'one KRAS gene stoichiometry'], ['exogenous  element', 'signal  transduction'], ['', 'two target quenchers'], ['This', 'enhanced fluorescence signal'], ['KRAS gene', 'dynamic  0'], ['nM', 'molecular detection beacons'], ['Moreover point mutations', 'target'], ['potential  application', 'real SW620 cell'], ['genetic biology DHMB', 'homogenous sensing systems'], ['sufficient electricity which', 'energy crops'], ['farm', 'two  models'], ['', 'abandoned self sufficiency crops'], ['farm', 'maximum farm unit 100'], ['different  each', 'certain  demand'], ['such  food', 'case study'], ['establishment', 'abandoned food security'], ['FSSR', '9  %'], ['estimated bioethanol potential', ''], ['', ''], ['', ''], ['Additionally  surplus', '61  GWh'], ['simultaneous  evaluation', 'yields'], ['therefore self policies', 'further  evaluation'], ['strategy', 'online Oregon State University'], ['free drawing cards', 'educational Metabolic Melodies'], ['', 'International Biochemistry'], ['online  interventions', 'low distress uptake'], ['Few  predictors', 'particularly  cancer'], ['study', 'related  distress'], ['Participants', 'curative  intent'], ['frequency duration activity analyses', 'medical  uptake'], ['study', 'active  type'], ['Uptake', 'ovarian'], ['', '8  melanoma'], ['', ''], ['Adherence', 'older  age'], ['Baseline distress levels', 'adherence'], ['High  adherers', 'low emotion adherers'], ['Uptake', 'online age gender'], ['uptake', 'related  distress'], ['sustained media internet', 'academic  occurrence'], ['well Gerry who', 'thus  McCann'], ['previous group research', 'online group conduct'], ['method  approach', 'online  commentary'], ['language', 'McCann group group'], ['previous  which', 'social personality disorder'], ['implications', 'future  research'], ['', ''], ['rights', ''], ['which', 'developmental  human'], ['purpose', 'oral mouse oocytes apoptosis'], ['study immature study oocytes', 'experimental mouse groups'], ['that', 'normal  saline'], ['experimental  groups', '50 100 mu l DEHP'], ['mu  M', ''], ['experimental  groups', '50 100'], ['mu  M', ''], ['Fertilization', 'embryonic  OMM'], ['Apoptosis', 'V FITC Cell Apoptosis Kit'], ['mRNA levels', 'Pou5f1 oocytes'], ['Finally  mouse', 'acridine ethidium viability'], ['2-cells embryo formation stage', 'dependent  manner'], ['Annexin V', 'treated  control'], ['expression Ccna1', 'treated mouse control'], ['total cell count', 'treated mouse controls'], ['meiotic mouse phthalates', 'reproductive risk health'], ['induced Ccna1 transcription level', 'treated  oocytes'], ['Phytophthora capsici', 'pectate crop lyase'], ['Here  we', 'virulent lyase P'], ['capsici', 'SD33'], ['Pcpel1', '21 amino acids'], ['predicted  protein', 'molecular  43'], ['', 'pI 6'], ['', ''], ['1 polysaccharide lyase that', 'pectate lyase activity'], ['', 'differential mass yeast'], ['', 'strongly blotting analysis P'], ['', 'host infection'], ['disassembly parasite interaction', 'cell wall'], ['Phytophthora species', 'natural  ecosystems'], ['root', 'hemibiothrophic oomycete Phytophthora parasitica'], ['two Citrus rootstocks', 'susceptible citrus P'], ['them', 'suitable plant defense mechanisms'], ['Gene expression analysis', 'particular  PCR'], ['Hence  it', 'appropriate expression normalization'], ['several candidate reference set', 'best  P'], ['', ''], ['We', 'five candidate reference database'], ['GeNorm', 'best reference genes'], ['We', 'RT qPCR P'], ['F EGIDH', 'more  C'], ['', ''], ['excellent  normalizers', 'regardless pathogen attack'], ['opal microwave resonance FeNi3', 'opal microwave resonance Fe3Ni2'], ['which', 'transmission resonance coefficients'], ['Electromagnetic  properties', 'millimeter frequency range'], ['Special  attention', 'magnetic  nanocomposites'], ['Frequency dependences', 'resonance features'], ['Spectra', 'resonance'], ['magnetic  antiresonance', ''], ['structure', 'nanocomposites'], ['', ''], ['', ''], ['rights', ''], ['low  voltage', 'current Process source'], ['design methodology', 'current Opamp source'], ['spice  simulations', '90 nm 0'], ['', ''], ['results', 'current source Opamp'], ['proposed  Opamp', 'better  80'], ['', '54 power uW'], ['Negative feedback technique', 'important analog circuit design'], ['high gain op amp', 'intrinsic  gain'], ['using', 'high power efficiency'], ['drain conductance', 'complementary cascode input'], ['bias current', 'input transistors'], ['', 'common gate input'], ['bias', 'hence input transistors'], ['proposed  circuit', '65 nm CMOS process'], ['input NMOS', ''], ['30 gain bandwidth noise', 'conventional  topology'], ['main replica which', 'conventional replica amp techniques'], ['proposed replica amplifier', 'main error amplifier'], ['main replica amplifier', 'main error amplifier'], ['amplifies', 'higher output voltage swing'], ['proposed  amplifier', 'same gain 15'], ['', 'times supply 1'], ['', 'closed telescopic opamp'], ['', 'new channel challenges'], ['alternative device structures', 'FinFET'], ['hence IC we', '90 nm MoS'], ['These', 'Gain Bandwidth rate'], ['many  we', 'comparison  i'], ['', ''], ['', 'Section paper'], ['operational  amplifiers', 'electronic  circuits'], ['multistage which', 'on  applications'], ['proposed  circuit', 'differential CMOS technology'], ['circuit', 'low power 1'], ['', '180 nm technology'], ['paper', 'single event transients'], ['First  we', 'scientific SPICE literature'], ['several  strategies', 'integrated  circuits'], ['Finally simulation results', 'other data researchers'], ['expensive  paper', 'academic research universities'], ['accurate  design', '180 Tanner EDA tools'], ['proposed  architecture', 'feedback model'], ['70 degree phase margin', '79'], ['', 'consuming  3'], ['Even order harmonics', 'quantizer loop structures'], ['multiple stage ring which', '100 KHz rang'], ['Remarkable power dissipation', 'overall  circuit'], ['1 f noise', 'architecture'], ['rail differential amplifier', 'input stage'], ['common power it', '22 mu current'], ['1 output THD', ''], ['', ''], ['Oscillation test methodology', 'signal CMOS circuits'], ['paper', 'high fault coverage'], ['bridging  faults', ''], ['1 test technique', 'negligible fault area'], ['operational  amplifier', 'minimum input stage standard'], ['', ''], ['', 'constant input transistors'], ['', ''], ['', ''], ['complementary differential pairs', 'PMOS input transistors'], ['Monte Carlo simulation', 'mismatch insensitivity'], ['common mode voltage', '+'], ['', '27 degrees C'], ['120 degrees variation', '120 degrees C'], ['', ''], ['', 'Furthermore  g(m'], ['m  cases', ''], ['', ''], ['', ''], ['introduced  circuit', 'regardless input pair'], ['', ''], ['rights', ''], ['indirect feedback which', 'capacitive load applications'], ['it', 'outer feedback amplifier'], ['capacitive  it', 'extra phase margin'], ['prototype', '28 Cadence Virtuoso'], ['Simulations', 'unity gain 741'], ['', '57  1'], ['', '38 phase margin degree'], ['phase margin gain', '150 temperature C'], ['article', 'integrated radiation experiments'], ['high accuracy support', 'measurements'], ['conducted amplifier disturbance', 'DPI measurement'], ['Correlation', 'output voltage'], ['integrated spectrum that', '65 nm CMOS technology'], ['', '2'], ['linearized  OTAs', 'to IIP3 6'], ['', 'filter band edge'], ['spectrum sensor', '22 blocker -100MHz'], ['system', '36'], ['', ''], ['', '1'], ['', ''], ['virtual programming which', 'operational  amplifiers'], ['first  order', 'high  pass'], ['results', 'two  papers'], ['first  one', 'active  filters'], ['different  values', 'numerical op filter'], ['effect', 'Bode characteristic frequency response filter'], ['vertical log frequency', 'horizontal log axis'], ['ideal Open it', 'also  chart'], ['values', 'numerical Frequency Cut control'], ['validity', 'simulation theory'], ['modular  it', 'education training courses'], ['slew rate verification', 'operational  amplifier'], ['methods', 'SPICE Analog Devices'], ['opamp design that', 'low power consumption'], ['architecture', 'nm bulk CMOS technology'], ['chip', 'high gain 2'], ['03  GHz', 'only power 2'], ['', ''], ['sophisticated  technologies', 'BiCMOS'], ['opamp', 'real time ability'], ['Low All', 'active  Filters'], ['It', 'higher frequency response'], ['optimizers', ''], ['nodal signal analysis', 'form'], ['different  examples', 'approach'], ['operational amplifier filter', 'higher  order'], ['three Nelder Mead', 'worst  result'], ['Processing', 'virtual LabVIEW development environment'], ['results', 'operational  amplifier'], ['Formulas', 'operational model parameters calculations'], ['analog circuit reliability', 'very circuit system'], ['online testing system', 'operational  amplifier'], ['system', 'electrical test test(DUT'], ['which', 'data acquisition system'], ['values', 'Pc'], ['heat temperature', 'heat source'], ['Finally  life', 'mathematical  methods'], ['proposed  method', 'operational life amplifier'], ['having', 'classical Widlar architecture'], ['differential input stage', 'classical compensation 0'], ['', 'occupied chip area'], ['', 'P SPICE 0'], ['25 V supply', 'reported  designs'], ['operational  amplifier', 'gain bandwidth gain 1'], ['', '< chip 400'], ['square triangular wave generator', 'also sinusoidal oscillations'], ['triangular sinusoidal oscillator', 'same  resistance'], ['new sinusoidal oscillator', 'one  resistor'], ['that', 'different  regimes'], ['work', 'operational  amplifiers'], ['defined  procedure', 'operational  amplifiers'], ['', '0'], ['compensated stage amplifier', '0'], ['complementary oxide semiconductor process', ''], ['op amp', 'gain bandwidth gain 18kHz'], ['active  area', '0'], ['', ''], ['designed subthreshold op amps', 'electronic  systems'], ['op amps', 'better speed power'], ['', ''], ['paper', 'virtual function design'], ['real analog signals', 'simulated Op Amp circuits'], ['proposed  system', 'different Op Amp configurations'], ['minimal  modifications', 'inverting subtraction differential'], ['that', 'electrical  components'], ['related Op components', 'diagram'], ['Voltage signals', 'signal DAQ module'], ['parameters', 'easily  software'], ['parameter values', 'virtual DAQ instruments'], ['output signal values', 'applied circuit test'], ['paper', 'high speed response'], ['It', 'input differential input OA'], ['', 'common static DS'], ['', 'V mu S'], ['operational conjugate that', 'current buffer Miller compensation'], ['complex conjugate poles', 'first frequency compensation introduction'], ['that', 'second order system'], ['This', 'based frequency compensation'], ['current buffer that', 'nulling phase resistor'], ['paper', 'previously tracking Nenadovic'], ['', 'proc'], ['', 'ICECS'], ['accuracy', 'received tracking signal'], ['operational  amplifier', 'precise gain control'], ['operational  amplifier', 'signal  0'], ['', '20 body temperature'], ['low A C', '300 supply 2'], ['', ''], ['130 A degrees C', 'temperature range'], ['10  mV', 'signal  amplitudes'], ['4  %', '1  kHz'], ['', 'bandwidth loop 4'], ['8  MHz', ''], ['operational  amplifier', '250 SiGe BiCMOS 0'], ['', ''], ['Frequency compensation', 'final transfer function'], ['process', 'selected compensation scheme'], ['we', 'active feedback Miller compensation'], ['standard feedback we', 'closed op amp'], ['graphical design procedures', 'three op amps'], ['we', 'three stage op standard'], ['', ''], ['layout op amp', 'low unity gain 1'], ['', 'total bias 1'], ['', ''], ['published op amp', 'comparable  art'], ['', ''], ['logistics', 'offshore wind farms'], ['operational  expenditure', '9'], ['5', '57 wind %'], ['These', 'offshore wind systems'], ['cost  measures', 'cultural  differences'], ['based office who', 'cost reduction efforts'], ['paper', 'wide cost reduction initiatives'], ['business case', 'also % night'], ['rail linear input range', 'weak inversion region'], ['regenerative feedback loop', 'bulk  transconductance'], ['SC CM SC which', '42 loop 70'], ['', ''], ['It', '9'], ['24  kHz', '64 quiescent 0'], ['', '15 pF load'], ['proposed  OTA', 'total harmonic 52'], ['', '200 Hz frequency'], ['increased gain GBW', 'reduced output nonlinearity'], ['Cadence Virtuoso environment', 'proposed CMOS process circuit'], ['less child welfare who', 'other  drugs'], ['previous  studies', 'MAT child permanency population'], ['START  model', 'occurring substance use'], ['MAT who', 'MAT those'], ['', 'opioid START program'], ['2  %', 'MAT'], ['who', 'more  MAT'], ['additional regression months', 'children'], ['address', 'well workforce court personnel'], ['', ''], ['rights', ''], ['PurposeThe purpose', 'opioid International overdoses'], ['MethodsData', 'Kaiser Permanente Northwest'], ['Diagnostic  data', 'electronic Oregon Washington'], ['', ''], ['', ''], ['', ''], ['', 'adverse opioids codes'], ['', ''], ['', ''], ['', 'indicative  overdoses'], ['', ''], ['respiratory  depression', 'chart audits'], ['adverse effects codes', 'low  overdoses'], ['4  %', '127  charts'], ['codes', 'electronic health years'], ['available  241/2100', 'available  information'], ['285', 'opioid  overdoses'], ['Thus  PPV', ''], ['adverse  effects', '1849  events'], ['', ''], ['ConclusionsOpioid poisoning codes', 'opioid overdose overdose'], ['Further  research', 'sensitivity specificity'], ['', ''], ['II ion sensor', 'multimode fibre multimode chitosan'], ['diameter', 'tapered fibre region'], ['it', 'clad  silica'], ['sensing it', 'unique metal agent'], ['II  this', 'spectrophotometer'], ['that', 'different  0'], ['', ''], ['absorbance', 'lead  ion'], ['average  sensitivity', '40'], ['', ''], ['II ion it', 'prior sensing layer'], ['stranded Genome phages', 'biochemical biology methods'], ['We', 'single molecule experimentation'], ['this', 'optical RNA tweezers'], ['phi', 'tripartite  genome'], ['negative  strands', 'preformed  procapsid'], ['We', '6 molecule PC'], ['slow  which', 'secondary  the'], ['mean packaging velocity', ''], ['', ''], ['nm  packaging', '4'], ['', 'fast packaging phase'], ['continuously linear control control', 'i'], ['', ''], ['piecewise time cost', 'piecewise time interval'], ['sampled data controls', 'permanent  control'], ['second data control one', 'dynamic programming principle'], ['we', 'quadratic data problems'], ['', ''], ['rights', ''], ['dispatchable storage which', 'connected  modes'], ['traditional optimization techniques', 'last power decade'], ['One', 'technical  regard'], ['operation optimization OPF', 'undeniable power system'], ['', 'smart distribution grids'], ['main OPF approaches', 'objective functions constraints'], ['computational case study networks', 'publication methods'], ['basic  challenges', 'smart OPF grids'], ['when  it', 'sustainable water development'], ['engineering  it', 'living  standards'], ['aim', 'special optimization renewables'], ['which', 'dynamic water harvesting simulations'], ['developed  model', 'urban optimization districts'], ['It', 'economic energy viewpoint'], ['reliability', 'electric environment load'], ['levelized  cost', '0'], ['', ''], ['', ''], ['maximum harvesting system reliability', 'built environment area distribution'], ['levelized  cost', '$ network water tariff'], ['', ''], ['rights', ''], ['new  method', 'piezoelectric  transformers'], ['implemented  method', 'analog control systems'], ['', 'piezoelectric voltage gain'], ['additional time delay', 'oscillating  loop'], ['Delay control setpoints', '417  kHz'], ['control loop', 'resonant frequency cycle'], ['operation principle', 'self paper'], ['experimental  results', ''], ['optical  that', 'molecular  biology'], ['It', 'optical  light'], ['technique', 'mammalian opsin neurons'], ['use', 'human  detail'], ['paper', 'neural causal networks'], ['mixed electricity which', 'bilateral pool producers'], ['revenue', 'which'], ['only term markets', 'successfully term auction'], ['global optimization solvers', 'which'], ['numerical  results', 'satisfactory  results'], ['medium  term', 'mixed  market'], ['advantages', 'bilateral term contracts'], ['', ''], ['', ''], ['rights', ''], ['unidirectional crane scheduling problem', 'more  attention'], ['we', 'mixed integer programming formulation'], ['Next  we', 'even solution plans'], ['numerical  experiments', 'three risk aversion'], ['', ''], ['', ''], ['rights', ''], ['Oral  cancer', 'malignant  head'], ['cancer', 'last  decades'], ['Moreover  incidence', 'young  people'], ['molecular  mechanisms', 'oral  tumors'], ['accurate  that', 'early target treatments'], ['possibly  that', 'side survival'], ['we', 'early diagnosis treatment'], ['pursuit', 'oral mortality carcinogenesis'], ['molecular  biology', 'promising  patients'], ['AP-1 factor activator family', 'modern  therapeutics'], ['role', 'oral  cancers'], ['south east we', 'oral  carcinogenesis'], ['western blotting immunohistochemistry', 'oral FosB precancer'], ['Constitutive  activation', 'upregulated cancer cases'], ['c Fos c JunD', 'prevalent cancer tissues'], ['together Fos proteins', 'oral kappa B cancers'], ['Thus  study', 'oral  carcinogenesis'], ['', 'oral population cavity'], ['heritable gene that', 'underlying DNA sequence'], ['cells', 'genes'], ['Epigenetic  change', 'several  age'], ['environment', 'epigenetic  change'], ['changes', 'later  generations'], ['biological  that', 'human  disease'], ['Epigenetics', 'molecular  biology'], ['we', 'evolution genetics'], ['environmental  factors', 'genetic  expression'], ['Epithelial  cells', 'inflammatory damage mediators'], ['EOM', 'cellular biology research'], ['Usually  EOM', 'painful  process'], ['we', 'oral scraping mucosa'], ['Papanicolaou staining', 'epithelial EOM scraping'], ['EOM', 'successfully murine feeder layer'], ['EOM', 'morphology viability'], ['EOM', 'genetic studies diagnosis'], ['like  factor', 'endothelial polymerase chain template'], ['like  it', 'low  levels'], ['migration epithelialmesen which', 'cell carcinoma cell cells'], ['that', ''], ['Expression Omnibus which', 'OSCC'], ['expression', 'then  immunohistochemistry'], ['highest KLF7 expression', 'further  analysis'], ['Subsequently  cells', 'reduced CAL27 KLF7'], ['Transwell migration', 'then wound healing cells'], ['protein expression levels', 'transcription quantitative transcription PCR'], ['tissue which', 'cytoplasmic OSCC cells'], ['sh HN13 OE which', 'sh HN13 OE cells'], ['Expression', 'sh HN13 EMT status'], ['present KLF7 overexpression', 'migratory lymph snail'], ['innovative cell strategies', 'molecular  mechanisms'], ['bioinformatic  we', 'signaling mRNA pathway'], ['which', 'inflammatory gene response'], ['Validated miRNAs', 'regulatory  network'], ['regulatory Protein protein genes', 'interacting  pathway'], ['universal  miRNAs', 'inflammation'], ['miRNA-19a  b', 'inflammatory  OSCC'], ['deregulated mRNA which', 'diagnostic  OSCC'], ['', ''], ['', ''], ['rights', ''], ['numbers', 'later pluripotent passage'], ['we', 'mediated carcinoma method'], ['RT polymerase chain immunofluorescence', 'embryoid bodies'], ['Reprogrammed H103', 'clear feeder layer'], ['Reprogrammed Rep H376', 'disorganized ESCs morphology'], ['Oct4 Sox2', '5 Rep 10'], ['10 H376 Nanog level', 'parental  cells'], ['Rep H103', 'three germ layers markers'], ['Rep H103', 'differentiation adipocytes'], ['which', 'stage iPSC OSCC'], ['APETALA2', 'plant floral plant development'], ['we', 'multitepal orchid Cymbidium ensifolium'], ['length  encoding', 'complementary Erycina miR172'], ['accumulation', 'putative CeAP2-like miR172'], ['CeAP2-like', 'low type gynostemium'], ['accumulation', 'abnormal CeAP2-like gynostemium'], ['A C that', 'floral organ fate'], ['multitepal genes', 'wild  type'], ['balance', 'floral  C'], ['', ''], ['study', 'floral orchid C'], ['', ''], ['when Picker Routing items', 'storage locations'], ['total picking length', 'picker tours'], ['items', 'picking order'], ['problem', 'Picker Routing Problem'], ['two routing problem', 'when Order Batching Problem'], ['Instead order pickers', 'when routing warehouse'], ['corresponding picker tours', 'easily  order'], ['block  layouts', ''], ['picker which', 'far  optimal'], ['local search benefits', 'integrated Picker Routing way'], ['numerical  it', 'substantial solution quality'], ['Background  Differences', '70 stage %'], ['rats', 'hours 24 Hx'], ['1 Oatp1 Oatp2', 'Northern  blotting'], ['liver function tests', ''], ['Postoperative survival rates', '70  %'], ['mRNA  expression', '70 % %'], ['values', '70 % Hx'], ['', ''], ['Mrp2 expression', '70 % %'], ['mRNA  expression', 'similar % extent'], ['Total serum bilirubin', '90 hepatectomy %'], ['Alteration', 'acute liver failure'], ['Organic Rankine Cycles', 'low temperature heat sources'], ['', ''], ['', 'biomass heat recovery applications'], ['Dynamic  simulations', 'economic  performance'], ['geothermal ORC power dynamics', 'measured  data'], ['model', 'two shell side'], ['negative step function', 'source flow rate'], ['', 'well simulation cases'], ['liquid  level', 'challenging  quantity'], ['better  agreement', 'entire volume flow simulation'], ['discrepancies', 'fluid heat transfer this'], ['suggestions', 'simulations'], ['industrial  processes', 'excess  product'], ['Recovering', 'energy use efficiency'], ['excess  heat', 'heating purposes'], ['', ''], ['', 'district heating electricity'], ['applied  technology', '90 degrees C'], ['few  studies', 'commissioned ORC systems'], ['paper', 'industrial Flanders Belgium'], ['purpose', 'specific policy account'], ['diverse  costs', 'economic Europe Belgium'], ['sensitivity analysis', 'results'], ['analysis', 'investment expenses'], ['financial  support', 'government'], ['Finally sensitivity analysis', 'financial ORC projects'], ['financial heat electricity support', 'certain heat electricity conditions'], ['Reducing', 'investment conditions'], ['', ''], ['rights', ''], ['delayed  neurotoxicity', 'central distal axonapathy'], ['severe  disease', 'single  dose'], ['leghorn layer hens', 'DFP'], ['mg  kg', 'dimethyl  sulfoxide'], ['Control groups', 'vehicle propylene glycol'], ['', 'dimethyl  sulfoxide'], ['10 2 tissues', 'quickly midbrain cerebellum protein'], ['fractionation SDS PAGE', 'differential PKA CREB'], ['nuclear PKA fraction', 'same 8 h'], ['change', 'soluble time points'], ['nuclear  fraction', 'time point'], ['p CREB', 'nuclear p fraction'], ['at  points', 'at  time'], ['Similarly  set', 'western protein expression analysis'], ['complex  immunohistochemistry', 'neuronal beta CNS'], ['cytoskeletal  damage', 'earlier p CREB findings'], ['', 'differential PKA CREB'], ['p CREB', 'nervous initiation system'], ['', ''], ['rights', ''], ['Organophosphorus  compounds', 'many  pesticides'], ['compounds', 'humans'], ['enzymatic  cleavage', 'more organophosphorus consideration'], ['Several  studies', 'different signal peptides'], ['', 'extracellular  E'], ['', 'codon signal E'], ['', ''], ['culture medium', '4 induction time'], ['extracellular  secretion', 'also SDS PAGE'], ['effects', 'extracellular growth OPH'], ['secretion', 'highly culture conditions'], ['recombinant  OPH', 'extracellular  medium'], ['secretion system', 'high OPs compounds'], ['', 'International Union International Biochemistry'], ['', ''], ['', 'major Rabdosia rubescens'], ['Hara', 'dietary  supplement'], ['tumour  little', 'angiogenesis'], ['tumour  activity', 'angiogenesis'], ['antiangiogenesis effect', 'endothelial tube formation cells'], ['embryonic  vasculogenesis', 'Tg'], ['endothelial growth factor', 'reverse polymerase chain reaction'], ['Furthermore inhibition effects', 'xenograft zebrafish tumour model'], ['Angiogenesis', 'differentiation'], ['Importantly  proteins', 'dimensional electrophoresis mass spectrometry'], ['oridonin', 'migration invasion proliferation migration formation'], ['Oridonin', 'embryonic  development'], ['TP53 expression', 'VEGFR3 zebrafish'], ['Moreover oridonin', 'strong tumour vivo'], ['differentially  17', 'up  28'], ['4  Claudin', 'closely tumour growth'], ['tumour which', 'mainly oridonin antiangiogenic effects'], ['1  Claudin', 'main  mechanism'], ['Scrub typhus', 'febrile Asia Pacific region'], ['clinical  manifestation', 'early  diagnosis'], ['We', 'diagnostic  tools'], ['Here  we', 'TaqMan time PCR probes'], ['', 'early scrub typhus'], ['lower detection limit', '10  reaction'], ['We', 'internal DNA quality'], ['confirmed scrub who', '4-fold  IgG'], ['PCR assay result', '52  86'], ['', ''], ['', '94'], ['', ''], ['scrub typhus patients', '100  %'], ['', ''], ['test', 'single blood samples'], ['real time PCR assay', 'here scrub typhus'], ['Combining PCR', 'acute febrile illness'], ['eastern article', 'ethnic  settings'], ['political  that', 'economic study area'], ['that', 'focus group discussions'], ['that', 'people'], ['last  decade', 'limited cell alcohol'], ['subset', 'squamous human papillomavirus infection'], ['oral laryngeal which', 'oral cavity hypopharyngeal nasopharyngeal'], ['HPV', 'improved chemoradiation therapy'], ['improved associated SCC efforts', 'clinical  research'], ['review', 'important  HPV'], ['We', 'new  disease'], ['', 'Elsevier B'], ['', ''], ['Trehalose', 'many plants bacteria fungi'], ['', 'trehalose-6-phosphate Catantops pinguis'], ['CpiTPS cDNA sequence', 'molecular reading 91'], ['', '13 pI 6'], ['', ''], ['mRNA RT PCR expression', 'posterior brain trachea C'], ['', ''], ['Northern  blotting', 'first instar larvae'], ['CpiTPS', 'key  C'], ['', ''], ['> Oryza meyeriana Baill', 'Xanthomonas oryzae'], ['', ''], ['However  genes', 'strong  resistance'], ['', 'differentially  O'], ['', 'Xoo infection'], ['Oryza meyeriana plants', 'inoculated pathogenicity driver'], ['responsible cell wall which', 'pathogen invasion'], ['', 'such metabolism cells'], ['48 Xoo it', 'later  responses'], ['study', 'molecular  O'], ['', 'new resistance candidate genes'], ['different stress plant', 'cycle'], ['reference which', 'uniform  organism'], ['RNA isolation', 'real polymerase chain reaction'], ['ACT11  ubiquitin', '10 soil vegetative'], ['different  that', 'particular reference study'], ['we', 'different  methods'], ['UBC E2', 'reference samples'], ['eIF-4 alpha', 'lower stability values'], ['selected reference use', 'erroneous  results'], ['finger protein Oryza', 'L'], ['', 'abiotic  stresses'], ['gene', 'namely salinity drought'], ['Phylogenetic  analysis', 'diverse plant species'], ['Southern blot analysis', 'multiple copy gene'], ['steady state levels', 'OsZFP salinity drought'], ['finger protein gene', 'His2-type RT PCR'], ['expression', 'constitutively  leaves'], ['Northern  blotting', 'low  temperature'], ['OsZFP', 'important transcription factor'], ['', ''], ['', 'worldwide OA Spain'], ['', ''], ['influence', '431  Kellgren'], ['Progression', 'higher follow up'], ['proportional hazard models', 'radiographic knee OA progression'], ['1603 Meta Analyses guidelines', 'individual  studies'], ['sensitivity analysis', 'results'], ['', ''], ['CHECK subjects', 'radiographic knee OA progression'], ['', ''], ['', ''], ['', ''], ['', ''], ['When  JT', 'same  trend'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['05', 'radiographic knee OA progression'], ['', 'T meta HR'], ['', ''], ['', ''], ['', ''], ['', 'JT  HR'], ['', ''], ['', ''], ['', ''], ['', ''], ['results', ''], ['', ''], ['', 'radiographic OA progression'], ['mtDNA  polymorphisms', 'genetic disease progression'], ['chondral  types', 'high  patients'], ['aim', 'osteochondral tissue biomimetic'], ['HA doped crystals', 'organic  scaffold'], ['scaffold  structure', 'linking  agent'], ['developed  scaffold', 'then physico chemical characteristics'], ['structure', 'integrated adhesion layers'], ['vitro cell culture studies', 'human mesenchymal stem chondrocytes'], ['Moreover  an', '4 vivo points'], ['chondral  layers', 'able hMSCs attachment'], ['Moreover  association', 'extracellular  matrix'], ['osteochondral  hMSCs', 'osteochondral  depth'], ['scaffold', '4 neo angiogenesis weeks'], ['great tissue it', 'chondral  regeneration'], ['', ''], ['', ''], ['rights', ''], ['public health that', 'children'], ['inherited  that', 'skeletal  fractures'], ['molecular child testing', 'COL1A1  genes'], ['total', 'molecular  OI'], ['5  both', 'clinically  diagnosis'], ['when maltreatment concerns', 'pathogenic  variants'], ['radiographic child studies', 'metabolic  fracture'], ['clinical child findings', 'low  yield'], ['careful  review', 'genetic evaluation alterations'], ['', ''], ['Patients', 'cancer year survival therapies'], ['', ''], ['targeted chemotherapy It', 'intratumoral lung cancer'], ['osteopontin', 'critical tumor progression'], ['present  review', 'potential OPN inconsistencies'], ['article', 'therapeutic cancer target'], ['', 'C Elsevier Ltd'], ['Background', 'superfamily necrosis factor atherosclerosis'], ['how OPG gene polymorphisms', 'vascular  stenosis'], ['We', 'LAA artery stroke'], ['LAA stroke patients', 'vascular signals stenosis'], ['rs3102735 gene polymorphism', 'polymerase chain reaction'], ['microembolic  signals', '72 stroke onset'], ['severity', 'Institutes Stroke Scale'], ['CC  genotypes', 'significantly control group'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'negative  patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '6 NIHSS Score'], ['', ''], ['rs3102735 gene polymorphism', 'vascular stroke stenosis'], ['', ''], ['', ''], ['rights', ''], ['Osteosarcoma', 'common  bone'], ['where  it', 'aggressive  phenotype'], ['long noncoding that', 'malignancies'], ['few  studies', 'expression ANRIL'], ['We', 'real polymerase chain reaction'], ['nucleotide mobility shift assay', 'direct ANRIL promoter region'], ['based  knockdown', 'molecular HIF-1 ANRIL'], ['expression', 'normal  tissues'], ['hypoxia', 'ANRIL osteosarcoma cells'], ['HIF-1 alpha', 'putative upstream ANRIL'], ['mediated HIF-1 alpha suppression', 'hypoxic ANRIL conditions'], ['hypoxia ANRIL', 'cell apoptosis'], ['HIF-1 alpha', 'hypoxic  conditions'], ['ANRIL', 'aggressive  osteosarcoma'], ['Osteosarcoma', 'common bone children'], ['class', 'routinely  OS'], ['well  miR)-150', 'OS'], ['levels', 'reverse polymerase chain reaction'], ['expression levels', 'three OS cell lines'], ['Cell proliferation migration', 'miR-150'], ['potential  targets', 'western blot analyses'], ['miR-150', 'OS  lines'], ['overexpression', 'inversely cell proliferation migration'], ['also  miR-150', 'negatively OS cell lines'], ['miR-150', 'directly  ROCK1'], ['conclusion miR-150', 'tumor ROCK1'], ['interaction', 'OS'], ['Furthermore miR-150', 'therapeutic  OS'], ['molecular MG-63 cell miR-22', 'biological  process'], ['real polymerase chain reaction', 'RT miR-22'], ['MG-63 cell line', 'miR-22 overexpression'], ['infected  cells', 'negative  control'], ['MTT assay', 'cell viability'], ['cell cycle', 'western flow blotting'], ['miRNA level', 'significantly MG-63 osteoblasts'], ['', ''], ['MG-63 cells', 'blank proliferation vector'], ['overexpression', 'elevated flow cytometry Bcl-2'], ['Furthermore  results', 'mimic G1 group'], ['', ''], ['67  %', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['miR-22', 'G0 cell cycle arrest'], ['Thus  miR-22', 'novel  osteosarcoma'], ['WRKY rice that', 'following  treatments'], ['WRKY  which', 'acetic ortholog Arabidopsis'], ['35S::OsWRKY08 stress recombinant', 'Arabidopsis'], ['transgenic  Arabidopsis', 'primary root development'], ['abiotic  genes', 'transgenic  plants'], ['OsWRKY08', 'independent signaling pathway'], ['Oral  tolerance', 'immune gut immunity'], ['Experimental  models', 'specific antibody titer'], ['high aryl hydrocarbon AhR)-ligand', 'mice'], ['AhR', 'immune gut epithelial cells'], ['We', 'deficient  OT'], ['complete AhR deficiency', 'oral  antigen'], ['OT destabilization', 'significant  IL10'], ['', 'gut tissue'], ['deficient mouse we', 'immune cell context'], ['findings', 'important gut immune functions'], ['RFC  amplifier', 'extra  cascode'], ['added  transistors', 'automatically slewing phase'], ['negative slew rates', 'small signal operation'], ['results', '90 nm CMOS 2'], ['', 'conventional RFC structure'], ['operates', 'weak inversion region'], ['proposed  configuration', 'recycling structure compensation path'], ['higher  DC', 'adversely unity gain performance'], ['presented  OTA', '0'], ['18 m CMOS technology', 'theoretical simulation analyses'], ['proposed  amplifier', '104'], ['', ''], ['', ''], ['6 power consumption', ''], ['that', 'usual term treatment problems'], ['behavioral depression peer characteristics', 'multiple Predictor demographic'], ['Participants', ''], ['', 'inner city area'], ['characteristics', 'one year follow up'], ['baseline symptom Youth', 'clinical  gains'], ['Higher  levels', 'better psychopathology outcomes'], ['change', 'delinquent peer delinquency acts'], ['Implications', 'routine treatment care'], ['CP Escherichia coli isolates', 'Taiwanese university hospital'], ['Genetic  relatedness', 'PFGE'], ['beta Lactamases', 'PCR'], ['Outer membrane proteins', 'SDS PAGE'], ['Cloning  experiments', 'carbapenem susceptibility'], ['nine NS isolates', 'lactamase IMP-8-type combination'], ['decrease', 'cloned ompC gene'], ['PFGE', 'nine  isolates'], ['patients', 'five spectrum isolation'], ['study', 'decreased  E'], ['coli', 'different drug resistance clones'], ['', 'ovarian chemokine receptor cancer'], ['Human ovarian cancer OVCAR-3 cells', 'short hairpin RNA'], ['effect', 'reverse polymerase chain reaction'], ['effects', 'apoptotic tetrazolium bromide assay'], ['addition expression levels', 'western blot analysis'], ['mRNA expression levels', 'blank OVCAR-3 groups'], ['', ''], ['cell proliferation', 'induced OVCAR-3 cells'], ['', ''], ['miR-9', 'regulated expression kinase'], ['miR-9', 'SDF-1 CXCR4 pathway'], ['MicroRNAs', 'endogenous cancer development'], ['human  role', 'ovarian  cancer'], ['3AO', 'reverse polymerase chain reaction'], ['cell apoptosis', 'putative target APAFI'], ['Expression', 'ovarian cancer tissues'], ['Patients', 'free miR-221 expression survival'], ['', ''], ['', 'low miR-221 expression'], ['APAF1 protein expression', 'tumor cell apoptosis'], ['APAF1 gene', 'induced cell vitro'], ['miR-221-APAF1', 'ovarian  cancer'], ['', 'fifth treatment Spain'], ['aim', 'clinical  practice'], ['often  that', 'modeled  overimitation'], ['social account overimitation', 'social affiliation motives'], ['', ''], ['', 'social  demonstrator'], ['', 'cognitive causal relevance'], ['', ''], ['components', 'outcome'], ['social William cognition', 'helpful test overimitation'], ['tracking  we', 'typically  children'], ['children', 'irrelevant  ASD'], ['findings', 'motivational  overimitation'], ['', ''], ['', ''], ['rights', ''], ['Microsporidia', 'reduced intracellular genomes'], ['presence', 'adjacent gene genes'], ['phenomenon', 'strongly gene density'], ['how  pool', 'given  locus'], ['we', 'fluorescence RACE PCR procedures'], ['we', '6 actin A'], ['', 'previously EST sequences'], ['Overall  we', 'most  A'], ['untranslated  regions', 'downstream  gene'], ['35  %', 'several RACE sites'], ['Finally  we', 'very  A'], ['locustae', ''], ['transcripts', 'microsporidian mRNA species'], ['', 'renewable  energy'], ['', ''], ['it', 'more grid scale'], ['renewable  energy', 'financial  utilities'], ['unique  form', 'dominated  systems'], ['renewable  energy', 'oversupply  conditions'], ['economic  model', 'financial  U'], ['', ''], ['Pacific Northwest', 'growing wind power generation'], ['', 'excess transmission markets'], ['oversupply  losses', 'future electricity prices'], ['transmission cost', 'associated  losses'], ['', ''], ['rights', ''], ['Ovis ammon darwini', 'domestic World Conservation destruction'], ['Study', 'endangered biology species'], ['Mitochondrial genome', 'very ecology systematics'], ['', 'complete mitochondrial genome O'], ['', ''], ['next generation sequencing which', 'tRNAs 2 genes'], ['Base composition', 'genome'], ['', ''], ['', ''], ['', ''], ['', 'A  61'], ['', ''], ['Phylogenetic  analysis', 'systematic  O'], ['', ''], ['darwini', 'more  O'], ['', ''], ['', ''], ['', ''], ['', 'O'], ['', ''], ['darwini', 'genetic  O'], ['', ''], ['two  understanding', 'body rights'], ['Experiment', 'owned  objects'], ['Experiment', 'simpler  112'], ['Findings', 'two  theory'], ['First', 'physical  contact'], ['related  changes', 'body rights'], ['crucial  behaviors', 'property'], ['', ''], ['rights', ''], ['ubiquitous  property', 'countries corporations families'], ['when  property', 'complexities'], ['6  children', '540 group ownership'], ['certain  objects', 'individual  people'], ['3  children', 'group ownership'], ['where  agents', 'property'], ['individual  members', 'owned  property'], ['5  children', 'group ownership'], ['6 group members', 'more group resources'], ['how  children', 'group ownership groups'], ['Selenium', 'oxidative antioxidant stress'], ['it', 'organic pacu fed selenium'], ['', ''], ['', ''], ['', ''], ['analyzed selenium concentrations', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '65  days'], ['', 'Dietary Se 1'], ['RBC blood cell hematocrit', 'corpuscular  volume'], ['', 'pacu 1'], ['yeast  kg', 'immune trade systems'], ['', 'such Se 1'], ['respiratory burst WBC', 'RBC'], ['', ''], ['thrombocyte', 'RBC HTC'], ['findings', 'immune immunomodulators administration'], ['dietary selenium that', 'dietary selenium pacu'], ['', ''], ['', ''], ['rights', ''], ['Oxygen reduction reaction', 'such metal air batteries'], ['two  pathway', 'electron  pathway'], ['We', 'alkaline ring disk medium'], ['', ''], ['they', 'two  pathway'], ['activity', 'lower H2O2 it'], ['different research we', 'reasonable loading catalyst'], ['', ''], ['', ''], ['rights', ''], ['Low oxygen pressure', 'pathological cancer development'], ['main  family', 'pathological HIF prolyl conditions'], ['entire HIF transcription cascade', 'seventh  inflammation'], ['proteins influence tumor', 'immune differentiation vessel normalization'], ['where  hypoxia', 'inflammatory  response'], ['', ''], ['intrinsic  inhibition', 'reg cell induction'], ['Interestingly  this', 'local  lung'], ['we', 'prospective HIF pathway pitfalls'], ['responses', 'substantially  males'], ['controlled  study', 'hormonal  contraception'], ['Participants', 'such  chasing'], ['shapes', ''], ['this', 'neural  activation'], ['social  processing', 'neural  oxytocin'], ['emotional  functioning', 'important anorexia nervosa'], ['', 'emotional intranasal processing'], ['', 'present intranasal AN'], ['present  which', 'over  design'], ['participants', 'one placebo other'], ['when  they', 'humorous film clips'], ['intranasal oxytocin', 'AN comparison groups'], ['AN group', 'negative film clips'], ['effects', 'individual  differences'], ['firm  conclusions', 'oxytocin'], ['steady  people', 'emotionally  stimuli'], ['It', 'emotional by domestication'], ['emotional oxytocin it', 'socio communicative skills'], ['intranasal oxytocin', 'pointing object choice gesture'], ['We', 'above  findings'], ['above  oxytocin', 'positive dog events'], ['', 'pathological emotions development'], ['psychiatric  symptoms', 'positive  symptoms'], ['negative  symptoms', 'positive  symptoms'], ['negative  which', 'social  deficits'], ['', 'intranasal OT IN OT'], ['null Bayes We', 'primary  studies'], ['oxytocin', 'negative  symptoms'], ['symptom oxytocin', 'negative  symptoms'], ['estimates', 'analyses'], ['IN OT', 'effective  schizophrenia'], ['', ''], ['rights', ''], ['formation', 'marine  bivalves'], ['Ocean acidification', 'largely shell formation'], ['enzymes', 'such phenol periostracum'], ['present  we', 'early larval shell biogenesis'], ['631-amino acid that', 'signal  peptide'], ['Ca tyrA1 transcription', 'D veliger larvae'], ['expression', 'saddle electron scanning microscope'], ['treatment group', 'primary Ca tyrA1 shell'], ['vital Crassostrea that', 'ocean acidification'], ['', ''], ['rights', ''], ['active  saRNA)-p21-saRNA-322', 'p21 gene expression'], ['2 colorectal cancer', 'situ p21-saRNA-322 delivery'], ['goal', 'colorectal  cancer'], ['', 'HCT-116 cancer cell p21-saRNA-322'], ['expression', 'Western polymerase chain reaction'], ['furthermore colorectal tumor mode', 'tumor suppressing tumor vivo'], ['colorectal cancer cell expression', 'dramatically p21-saRNA-322 transfection'], ['Transfection', 'apoptosis cell cycle G(0)/G(1'], ['proliferation effect reduction', 'treated  cells'], ['p21-saRNA-322 treatment', 'significantly p21 vivo'], ['p21-saRNA-322-induceded up regulation', 'colorectal  cancer'], ['P23k', '23 barley seeds'], ['present  study', 'major Triticeae crops barley'], ['low copy number', '3 Aegilops accessions'], ['P23k gene', 'further tandem chromosomes'], ['wheat P23k', '3D bread wheat'], ['few P23k accumulation', 'hexaploid wheat accessions'], ['where ancestral P23k', 'homoeologous  chromosome'], ['ancestral Hordeum P23k', '3D wheat lineage'], ['Mast cells', 'allergic  reactions'], ['activation results', 'such secretory granules'], ['dependent  hypersensitivity', 'also UDP process'], ['we', 'mast cell line'], ['Additionally  TMPS', 'stable P2Y14 receptor'], ['use', 'mast cell activation'], ['Ependymomas', '12 brain children'], ['management', 'significant  outcomes'], ['complete  resection', 'prior conformal radiotherapy'], ['chemotherapeutic  regimen', 'clinical  benefit'], ['Predicting', 'robust disease histopathology'], ['cell failure', 'targeted animal therapies'], ['', 'therapeutic years insights'], ['histopathological  these', 'clinical  outcomes'], ['three anatomic which', 'supratentorial'], ['', 'clinical PF characteristics'], ['shifting treatment that', 'paediatric  ependymoma'], ['', ''], ['rights', ''], ['sexual  abuse', ''], ['medical  history', 'cases'], ['forensic  history', 'forensic  examination'], ['medical  history', 'forensic  evaluation'], ['when  child', 'assessment'], ['retrospective  review', 'paediatric Paediatric Medical 2014'], ['data', 'squared spread STATA'], ['medical  history', 'increasing  child'], ['medical  practitioner', 'only  police'], ['child', 'medical  events'], ['', 'parents caregivers events'], ['study', 'additional  information'], ['', 'physical  abuse'], ['', '2017 Elsevier Forensic'], ['rights', ''], ['definitive  treatment', 'diaphyseal  fractures'], ['Modalities', 'lesser  impact'], ['Current  evidence', 'most Orthopedic Surgeons'], ['authors', 'up age group'], ['current  we', 'major trauma centre'], ['violent occupationfear humiliationquell', 'political  agency'], ['article', 'violent  sensorium'], ['that', 'political  depression'], ['Theoretically  I', 'critical  fear'], ['affective feara register', 'political  oppression'], ['detection', 'complex  diseases'], ['', 'diagnostic sensing purposes'], ['molecular P that', 'multiple reporter polymerization template'], ['', 'additional DNA P probes'], ['hybridized  targets', 'unique strand displacement amplification'], ['enzymatic  amplification', '100 linear response 75'], ['This', 'one DNA probe'], ['new DNA that', 'molecular biology research'], ['Palythoa caribaeorum', 'protein  substances'], ['complex  that', 'lipophilic  areas'], ['effect', 'head'], ['transporting subumit GAPDH', 'clonogenic- enzyme inhibitor assays'], ['SCID xenograft mice', 'tumor regression'], ['data', 'One Way Annova'], ['toxic  effects', 'tumor 1'], ['', '3'], ['', 'normal  cells'], ['tumor PTX', 'primarily plasma membrane'], ['carcinoma which', 'MAPK)/JNK HNSCC cell PTX'], ['ng tumor regression', 'control animals'], ['further  which', 'head'], ['Intergroup conflict', 'cooperative  nature'], ['humans chimpanzee societies', 'violent intergroup conflicts'], ['group individuals', 'intergroup conflict'], ['social trust evidence', 'natural  settings'], ['noninvasive  we', 'wild intergroup chimpanzees'], ['chimpanzees', 'immediately intergroup controls'], ['elevated hormone levels', 'social intragroup interactions'], ['oxytocinergic  system', 'likely intergroup conflict'], ['complement system', 'immune  system'], ['first  it', 'humoral  immunity'], ['Disorders', 'aberrant exocrine complement'], ['key complement which', 'local  inflammation'], ['inflammatory pancreas complement which', 'day'], ['review', 'experimental exocrine data'], ['Participation', 'well tumor immunology'], ['Therapeutic  strategies', 'clinical  setting'], ['Cell division cycle', 'human Rho cancers'], ['However  expression', 'pancreatic  cancer'], ['present  study', 'cellular expression PC'], ['Western polymerase chain blotting', 'pancreatic CDC42 carcinoma'], ['differential  expression', 'qRT PC PCR'], ['correlation', 'CDC42 expression'], ['Finally  CDC42', 'both  vitro'], ['results', 'Western tumor blotting'], ['PanC-1 CDC42 expression', 'qRT HPDE6-C7 PCR'], ['High CDC42 expression', '69'], ['2  %', 'significantly tumor differentiation'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['CDC42 expression', 'independent PC patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['CDC42', 'PanC-1  vitro'], ['CDC42', 'prognostic  PC'], ['aim', 'ductal cell adenocarcinoma'], ['100  who', 'adjuvant  2007'], ['1 ribonucleotide reductase subunits', 'high expression tertiles'], ['median survival times', 'moderate expression hENT1'], ['', ''], ['', ''], ['', ''], ['', '10'], ['', ''], ['', 'low  RRM1'], ['', '11'], ['', ''], ['', ''], ['proportional hazards model', 'low  hENT1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'moderate  RRM1'], ['', ''], ['', ''], ['', 'prognostic  factors'], ['hENT genes', 'adjuvant PDAC gemcitabine'], ['We', 'pancreatic  cancer'], ['real polymerase chain reaction', 'pancreatic cancer cell lines'], ['Pancreatic cancer cell lines', 'lentiviral  transduction'], ['mechanistic  effects', 'pancreatic fluorouracil chemosensitivity vivo'], ['interacting', 'dual luciferase activity assay'], ['pancreatic cancer development', 'downregulated  cells'], ['MiR-181d', 'pancreatic cancer cell lines'], ['miR-181d  downregulation', 'pancreatic cancer vivo'], ['NKAIN2', 'pancreatic  cancer'], ['mediated NKAIN2 knockdown', 'pancreatic cancer development'], ['MiR-181d', 'pancreatic  cancer'], ['Inhibiting miR-181d', 'inverse cancer NKAIN2'], ['KRAS mutational KRAS status', 'uncertain endoscopic ultrasound'], ['where turnaround patient', 'ideally turnaround centre'], ['KRAS Mutation Test', 'molecular  expertise'], ['Idylla test', 'FFPE  sections'], ['FFPE  sample', 'aspirate DNA cartridge'], ['Sanger', 'clinicopathological end points'], ['Results Idylla', 'valid  49/52'], ['2  %', '2h'], ['total', '2 KRAS exon'], ['Idylla KRAS test', '100 % specificity'], ['', 'higher Sanger sequencing'], ['', '3  ASLNAqPCR'], ['', ''], ['clinical KRAS sensitivity', '61'], ['9  %', '454-NGS'], ['', ''], ['first  that', 'pancreatic Idylla KRAS cancer'], ['particular  system', 'cytological KRAS evaluation'], ['Pancreatic  cancer', '5 year survival %'], ['15  %', 'radical  surgery'], ['Evidence', 'R1 R0 resection'], ['Adjuvant chemoradiotherapy', 'positive  margins'], ['pancreatic  cancer', 'limited  extension'], ['tumors', 'positive  margins'], ['Neoadjuvant treatment', 'best R0 resection'], ['new chemotherapy treatment schemes', 'overall nab gemcitabine'], ['Progress', 'near cancer future'], ['related  diseases', 'induced  humans'], ['few  compounds', 'clinical  studies'], ['new scaffold 1H indene-(1356)-tetrol', 'different  scaffold'], ['explore', 'molecular docking studies'], ['rigid C_12 C_24', 'further  analysis'], ['three  inhibitors', 'inhibitory molecular dynamics simulations'], ['structural  fragments', 'binding  other'], ['different core that', 'different core scaffold'], ['', 'International Union International Biochemistry'], ['', ''], ['tropical physico chemical changes', 'several nova proteins'], ['', 'differential display RT PCR'], ['Seventy transcript', 'northern papaya blotting'], ['17', 'putatively homology search'], ['like RNase L protein', 'UDP glucosyltransferase'], ['', 'regulated  genes'], ['fragments', 'further pulp studies'], ['case', 'papayas'], ['', ''], ['', ''], ['rights', ''], ['competent control organisms', 'able animal origin products'], ['', 'official  methods'], ['', ''], ['light microscopy', 'short Polymerase Chain time'], ['combination', 'able particle selectivity'], ['', ''], ['spectroscopic  method', 'Discriminant Analysis'], ['such customs it', 'drastically  analysis'], ['', 'C Elsevier Ltd'], ['Viral  infections', 'respiratory age asthma'], ['respiratory syncytial virus influenza virus', 'little parainfluenza viruses'], ['stranded paramyxovirus that', 'respiratory  individuals'], ['mild  disease', 'severe tract croup'], ['Moreover hPIV infection', 'chronic  asthma'], ['we', 'chronic airway disorders'], ['Method', 'parametric wafer map creation'], ['technique', 'fast wafer batch'], ['operational op amp', 'parametric defects map'], ['opportunity', 'technological  route'], ['Avian  paramyxoviruses', 'avian  world'], ['Avian  paramyxoviruses', 'huge  it'], ['different  serotypes', 'date'], ['Avian  paramyxoviruses', 'genus  Avulavirus'], ['Newcastle disease virus', 'characterized APMV serotypes'], ['genome  sequence', 'twelve APMV serotypes'], ['recent  APMV-1', 'oncolytic vaccine animals'], ['based  vaccine', 'modular DNA replication'], ['other APMV understanding', 'molecular biology tools'], ['paranoia mind someone', 'even thinking feeling mind'], ['We', 'better mind paranoia'], ['We', 'subclinical mind sample'], ['Participants', 'schizotypy mind perception'], ['well mind perception', 'partially  paranoia'], ['increased  paranoia', 'less mind people'], ['mind perception', 'partially  paranoia'], ['', 'social mind functioning'], ['simple  solution', 'important  role'], ['parareal  which', 'parallel  computation'], ['algorithm', 'large G propagator'], ['T Delta 2', 'T Delta J'], ['explicit G propagator', 'parallel convergence analysis'], ['sharp convergence which', 'coefficient mesh ratio matrix'], ['extension', 'periodic  conditions'], ['numerical  experiments', 'theoretical  results'], ['', ''], ['rights', ''], ['cellular  identity', 'innate lymphoid cell type'], ['however responses tumor we', 'parasitic Th9 infections'], ['developing health we', 'therapeutic T helper use'], ['Viannia  braziliensis', 'tegumentary  Americas'], ['molecular  diversity', 'clinical endemic Brazil'], ['Pentavalent antimonials', 'severe side effects'], ['', 'Rio de Janeiro Brazil'], ['', ''], ['metastasis  infections', 'parasites'], ['use', 'clinical tissue management'], ['parasite load', 'small ribosomal RNA gene'], ['Results  data', 'mucous disease progression'], ['Parasite load', 'primary  ones'], ['sequential  relapses', 'immune system infection'], ['Therefore parasite burden', 'good disease progression'], ['', ''], ['', 'Infectious International Diseases'], ['twelve class that', 'different host world'], ['life cycles', 'other  nematodes'], ['recent  characterization', 'molecular  biology'], ['present  we', 'Trichinella spiralis'], ['pseudospiralis', 'transcriptomic data sets'], ['how  variation', 'unique Trichinella morphology biology'], ['Furthermore  we', 'undescribed N terminal domain'], ['present  findings', 'specific nematode intervention'], ['Importantly  the', 'structural silico modeling investigation'], ['gastrointestinal  that', 'similar  ways'], ['Importantly  Hg', 'Arctic  regions'], ['parasitic  infections', 'reproduction'], ['blood', 'prior Hg breeding'], ['nest survival return rates', 'Hg treatment'], ['reproduction', 'parasite placebo treatment'], ['parasites', 'poor  condition'], ['', 'Copyright Elsevier B'], ['', ''], ['rights', ''], ['disease', 'chronic wasting ruminants'], ['Hallmark symptoms', 'small weight intestine'], ['MAP', 'persistent  host'], ['that', 'widespread  inflammation'], ['we', 'MAP associated MAP lesions'], ['lesion classification scheme', 'healthy control animals'], ['results', 'bacterial lesion pathology'], ['T cell abundance', 'increasing lesion severity'], ['associated  genes', 'increasing lesion severity'], ['that', 'clinical  disease'], ['', ''], ['', ''], ['rights', ''], ['parental  attributions', 'disciplinary  actions'], ['parental  attributions', 'daily  stressors'], ['', ''], ['', 'own child maltreatment'], ['Mothers', 'own child maltreatment'], ['parental  attributions', 'parenting stress'], ['risk', 'parental child attributions'], ['', ''], ['rights', ''], ['public health they', 'dysfunctional parenting discipline'], ['depressive  symptoms', 'dysfunctional child maltreatment discipline'], ['234  who', 'due child maltreatment'], ['Referrals', 'school medical child welfare personnel'], ['', ''], ['average  age', 'children'], ['', ''], ['depressive  symptoms', 'over  hostility'], ['three  relations', 'parental  stress'], ['documented  relations', 'depressive parenting pathology'], ['Family structure', 'static child maltreatment literature'], ['particular effects types', 'maternal child abuse'], ['', 'theoretical child maltreatment literature'], ['transitions', 'maternal child abuse'], ['frequency', 'closely relationship transitions'], ['largely  presence', 'nonbiological child abuse'], ['Background Parenting', 'sound service policy'], ['purpose', 'other  disability'], ['Survey', 'suitable Disability survey'], ['Results', ''], ['41  %', '17000  ID'], ['Parents', '1 capital disability'], ['findings', 'regional  Australia'], ['Depressive  symptoms', 'significant  life'], ['present  study', 'demented PD patients'], ['right posterior cingulate region', 'supplementary motor area'], ['Furthermore  presence', 'left anterior cingulate'], ['negative  correlation', 'depressive symptoms scores'], ['subcortical  structures', 'significant  correlations'], ['depressive  symptoms', 'cortical thalamus volume thinning'], ['present  study', 'early PD disease'], ['', ''], ['rights', ''], ['Sleep disturbance', 'negatively  life'], ['how dopamine agonists', 'particularly sleep parameters'], ['goal', 'polysomnographic PD methods'], ['total', '25 nocturnal sleep impairment'], ['stable rotigotine therapy', 'polysomnographic questionnaire methods'], ['Parkinsonism depression anxiety', 'also questionnaire assessments'], ['daytime motor performance depression', 'subjective  life'], ['sleep latency', 'rotigotine sleep treatment'], ['polysomnographic  analysis', 'rotigotine  treatment'], ['observation', 'sleep disturbances'], ['paper', 'ubiquitous Participatory participation'], ['societal  processes', 'political  context'], ['clear PD that', 'alternative design narratives'], ['counterfactual  we', 'political  PD'], ['pluralistic design that', 'only  future'], ['We', 'participatory  architecture'], ['advent', 'increasingly research fields'], ['awareness', 'nanoscale  submicron'], ['appealing  possibility', 'functional  food'], ['common  techniques', 'light  scattering'], ['basic  principles', 'such Stokes Einstein'], ['aim', 'commonly food NTA'], ['different  that', 'individual food contamination'], ['comparison', 'also light techniques'], ['increasing  interest', 'conscious food managing approach'], ['', ''], ['rights', ''], ['Ambient particulate matter', 'exposed  subjects'], ['aim', 'urban candidate PM2'], ['', ''], ['', ''], ['5', '18 diesel exhaust exposure'], ['IL-1  alpha', 'EGF receptor'], ['increased  expression', 'epithelial RT cells'], ['', 'treated GRO alpha'], ['', 'two protein genes'], ['aqueous amphiregulin extracts', 'GRO alpha release'], ['', 'epithelial  cells'], ['5', 'chemoattraction process'], ['renewable  they', 'thermal comfort levels'], ['However design construction', 'critical  challenges'], ['considerable load reductions', 'modern  houses'], ['climates', 'two energy reasons'], ['where heating energy requirements', 'generally colder climates'], ['renewable energy resources', 'tropical  climates'], ['paper', 'tropical  Mauritius'], ['baseline  model', 'Mauritian DesignBuilder software'], ['passive building design many', 'vernacular  architecture'], ['application', 'positive  energy'], ['resulting electricity consumption', '24'], ['', '14'], ['', ''], ['', ''], ['2 kW photovoltaic system', 'annual electricity house'], ['aim', 'microbiological  pastrami'], ['where Kayseri pastrami', 'pastrami retail Kayseri Turkey'], ['Sliced cutting board', 'possible knife surface contamination'], ['Samples', 'coli Enterobacteriaceae Staphylococcus aureus'], ['pastrami samples', 'reducing Clostridium spp'], ['', ''], ['8 pastrami samples', 'TVC'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['gondii positivity', 'pastrami samples'], ['knife surface swabs', 'TVC level'], ['', ''], ['', ''], ['', 'total  coliforms'], ['', ''], ['6  %', 'target value'], ['', ''], ['pastrami', 'contact surfaces'], ['More  emphasis', 'hygienic pastrami sale'], ['retail  inspections', 'public  health'], ['', 'Public Health'], ['', 'Elsevier Ltd'], ['rights', ''], ['', ''], ['molecular  biology', ''], ['Here  we', 'wide  P'], ['', 'next generation sequencing technology'], ['present  we', '108996 RNA sequencing data'], ['', 'NR database'], ['assembled  transcriptome', 'high  quality'], ['Gene expression levels', 'leaf'], ['', 'metabolic patchouli P'], ['three  genes', 'significantly  leaves'], ['', 'essential oil P'], ['cablin', 'PA  production'], ['more  PA', 'more  P'], ['', ''], ['', 'P'], ['cabin', 'genetic Pogostemon engineering'], ['Infected  organisms', 'per  fitness'], ['well  researchers', 'mechanisms  animals'], ['research', 'explicitly host transmission'], ['behavioral fitness which', 'enhancing fitness infection'], ['Here  we', 'vertebrate  animals'], ['Inflammatory  responses', 'specific oxygen tolerance'], ['behavioral  which', 'normal  behaviors'], ['specific  tolerance', 'infectious  diseases'], ['We', 'intimately animal animals'], ['', ''], ['rights', ''], ['statistical  tools', 'early alliance development outcome'], ['however  methods', 'later  ones'], ['systematic treatment examinations', 'theoretical treatment attention'], ['We', '166 alliance psychotherapy'], ['Three  patterns', 'repaired alliance rupture'], ['unrepaired rupture pattern', 'later alliance treatment'], ['unrepaired rupture pattern', 'better  outcomes'], ['early alliance development patterns', 'treatment process'], ['ubiquitous  which', 'humans'], ['Diagnosis', 'respiratory  samples'], ['New assays', 'resistant  infections'], ['manuscript', 'Pneumocystis pneumonia'], ['', 'radiological  microbiological'], ['', ''], ['microbiological PCR beta Glucan', ''], ['Recommendations', 'prophylactic  management'], ['diagnosis', 'far  optimal'], ['99  testing', 'disease'], ['lower  sensitivity', 'application'], ['Newer diagnostics', 'clinical respiratory pressure'], ['testing', 'resistant  PcP'], ['microbial  which', 'fixed plant growth plants'], ['aromatic Oryza sativa', 'tropical rice condition'], ['it', 'active  diazotrophs'], ['', 'aromatic polymerase chain reaction'], ['Azospirillum brasilence', 'positive dot blot'], ['None', 'ARA A'], ['', ''], ['local alighnment search tool', 'BLAST stutzeri Klebsiella sp'], ['Klebsiella pneumoniae', ''], ['B10 B12', 'cereus Enterobacter sp'], ['', ''], ['', '16S rDNA sequencing'], ['they', 'firmicutes'], ['Multiple sequence alignment', 'less NifH isolates'], ['Moreover restriction digestion', 'small Mspl diazotrophs'], ['results', 'LARR cropping system'], ['continuous  application', 'LARR cropping system'], ['', ''], ['', ''], ['rights', ''], ['Molecular  diagnosis', 'mainly  PCR'], ['most PCR laboratory', 'most PCR methods'], ['multicenter  we', 'calibrated Toxoplasmosis 0'], ['', ''], ['suspensions', 'DNA extraction manufacturer'], ['other placenta 95', 'proven  toxoplasmosis'], ['ELITe MGB assay', '2/3 concentration laboratories'], ['Additionally  combination', 'low parasite concentrations'], ['', 'parasite  ml'], ['clinical  specificity', 'commercial  assay'], ['sensitivity', '100 placenta %'], ['rich EXTRAblood kit', 'rich MGB samples'], ['fourth  pillar', 'surgery radiation'], ['immune checkpoint inhibitors', 'immune  responses'], ['clinical  trials', 'new cancer immunology'], ['However  failure', 'new combination therapies'], ['Here  we', 'clinical  use'], ['immune  system', 'foreign self reactivity'], ['T lymphocytes', 'immune  signals'], ['autoreactive thymic fraction', 'self reactive self autoimmunity'], ['immune  system', 'regulatory T cells'], ['cell  that', 'cognate antigens'], ['1 B7-DC CD273', 'peripheral T cells'], ['PD L1 L2 pathway', 'antiviral T effector immunity'], ['Therapeutic  targeting', 'viral T cell pathogens'], ['Here  we', 'events T effector cells'], ['key food allergy studies', 'allergenic  foods'], ['Early LEAP On', 'food allergy prevention'], ['first  peanut', 'home'], ['medical  assessment', 'eczema egg allergy'], ['Here  we', 'Canadian Clinical practitioners'], ['macromolecular  structure', 'interfacial  activity'], ['We', 'major building blocks'], ['following  role', 'molecular protein weight'], ['how  modification', 'desired emulsification properties'], ['molecular g I', 'well  emulsifier'], ['', 'low extraction 2'], ['', ''], ['', 'monoprotic  acid'], ['', ''], ['HCl', ''], ['proposed  set', 'interfacial extraction functionality'], ['', ''], ['rights', ''], ['Traumatic  stressors', 'interpersonal child children'], ['study', 'interpersonal  age'], ['Revised IPT exposure', 'Revised Conflict Tactics Scale'], ['follow up child', 'age'], ['We', 'logistic IPT regression'], ['structural equation we', 'adverse life events'], ['Effect modification', 'sex'], ['Mothers', 'high school education'], ['', 'maternal regression models boys'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['chronic equation IPT', 'active  pregnancy'], ['', ''], ['active  asthma', 'asthma'], ['', ''], ['indirect  effect', 'path'], ['', ''], ['', ''], ['Associations', 'most  boys'], ['history', 'chronic  boys'], ['association', 'maternal  pregnancy'], ['Background', 'immune breast milk infants'], ['thus breast differences', 'lactoferrin stool newborns'], ['safety', 'neonatal growth pattern'], ['66  women', 'probiotic  33'], ['1 breast level', 'one stool life'], ['Antropometrical  evaluation', 'gastrointestinal  newborns'], ['mean  beta', 'mature breast milk'], ['mothers', 'probiotic control group'], ['maternal  supplementation', 'infantile  infants'], ['', 'functional sIgA infants'], ['dilated  little', 'pediatric IDC hearts'], ['We', 'failing adult hearts'], ['Pediatric  hearts', 'histologically  fibrosis'], ['important polymerase chain that', 'fibrosis'], ['We', 'specific MMP-9 tissue metalloproteinase'], ['also  that', '1 receptor TIMP-1'], ['Finally microRNAs c', 'significantly pediatric IDC patients'], ['Pediatric IDC patients', 'molecular adult heart'], ['unique gene expression pattern', 'pediatric  heart'], ['Childhood obesity prevention', 'children'], ['efficacy parent preschool child that', 'healthy  growth'], ['Methods  We', 'controlled  trial'], ['Parenting self efficacy', 'PSOC-5 Parenting scale'], ['', ''], ['depressive  symptoms', 'Studies Depression Epidemiological Studies scale'], ['Child outcomes', 'activity media meals'], ['We', 'other linear covariates'], ['sample', '601 parent child pairs'], ['Median child age', ''], ['', ''], ['', ''], ['BMI body mass percentile', ''], ['', ''], ['', ''], ['6  %', 'children'], ['Median parent age', ''], ['', ''], ['', ''], ['22  %', 'depression'], ['25 Parenting self IQR', 'depressive  symptoms'], ['', ''], ['', ''], ['higher parenting self efficacy', 'fewer  TV'], ['', ''], ['', 'depressive child sleep duration'], ['', ''], ['Parenting self efficacy', 'physical  activity'], ['depressive child symptoms', 'protective child sleep duration'], ['700000  children', 'year United States'], ['accidental  trauma', 'sentinel  injuries'], ['recurrent  which', 'higher mortality rate'], ['purpose', 'based NAT screening tools'], ['multidisciplinary specialty that', 'acute care setting'], ['', ''], ['rights', ''], ['Pediatric  burns', 'common  5'], ['', ''], ['', '8  abuse'], ['goal', 'North Texas area'], ['Methods', 'maintained  patients'], ['Patients', 'burn  analysis'], ['', 'pediatric burn admissions'], ['3  %', 'abuse'], ['Children', 'non accidental non injuries'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Scald', 'common  injury'], ['inflicted  89', 'inflicted  burns'], ['', ''], ['', ''], ['', ''], ['', ''], ['logistic  regression', 'significant feet abuse'], ['Victims', 'worse  mortality'], ['', ''], ['', ''], ['', ''], ['', ''], ['size abuse', 'significant  mortality'], ['', ''], ['', ''], ['particular  those', 'bilateral buttocks suspicion'], ['Burns', 'worse  stay'], ['', 'C Elsevier Ltd'], ['therapeutic care interventions', 'physical cancer disease'], ['Mental health issues', 'sizable cancer survivors'], ['key  determinants', 'preconception life adulthood'], ['diverse  that', 'developing  childhood'], ['review', 'level life course childhood'], ['key  determinants', 'various life trajectory'], ['pedophilic  disorder', ''], ['mental  son', 'sexual  partner'], ['previously sex association', 'female child abusers'], ['to  half', 'squamous cell carcinomas'], ['warty  basaloid', 'common basaloid HPV'], ['lymphoepithelioma  carcinomas', ''], ['Here  we', 'penile  HPV'], ['Twelve  cases', \"international d'Oncologia Barcelona Spain\"], ['HPV mRNA detection', 'cases'], ['full tumor staining', 'utilized  p16(INK4a'], ['chain reaction analysis', 'SPF10-DEIA LiPA(25'], ['ages', '92  years'], ['tumor', 'commonly  glans'], ['microscopic  finding', 'inflammatory lymphocytes plasma cells'], ['Tumors', 'trabecular sheets pattern'], ['Cells', ''], ['Keratinization', ''], ['Nuclei', 'prominent  nucleoli'], ['Mitoses', ''], ['Tumor necrosis', ''], ['Deep  invasion', 'corpora cavernosa'], ['mRNA detection', '9  cases'], ['prevalent  genotype', ''], ['Other  genotypes', '58  33'], ['Medullary carcinomas', 'older grade individuals'], ['More  studies', 'penile  neoplasm'], ['Peptide', 'molecular biology applications'], ['that', 'directly solubility solution'], ['that', 'radioiodinatable  tyrosine'], ['organic  that', 'reverse phase HPLC'], ['prosthetic  group', 'solid phase resin'], ['presence', 'single HPLC run'], ['resultant I-125-labeled PNA it', 'Northern Lcn2 blotting'], ['', ''], ['rights', ''], ['histocompatibility complex histocompatibility multimers', 'single flow cytometry'], ['labeling reagents', 'weak T cell receptor'], ['based tetramer they', 'self tumor reactive clones'], ['in  production', 'typical biology research laboratory'], ['Here  we', 'conventional tetramer preparation'], ['We', 'reactive T cells'], ['We', 'mediated antigen presentation'], ['current  study', 'different  perfectionists'], ['total', '276 perfectionism conscientiousness neuroticism'], ['Latent Profile Analysis', 'distinct latent perfectionists'], ['maladaptive life perfectionists', 'highest  meaning'], ['Findings', 'perfectionists'], ['', ''], ['rights', ''], ['model', 'fuzzy c FCM'], ['similar FCM companies', 'clusters'], ['', 'effective reliability index'], ['', 'external PBR companies'], ['proposed  model', 'Iran'], ['results', 'AHP score PRS'], ['', ''], ['rights', ''], ['', 'perihilar E3 ubiquitin cholangiocarcinoma'], ['expression', 'Western PHCC cell blot'], ['Immunohistochemistry', 'clinicopathological  PHCC'], ['Univariate  analysis', 'PHCC risk patients'], ['Wound healing', 'PHCC metastasis'], ['EMT Furthermore markers', 'CUL4A  knockdown'], ['relationship', 'also IHC assay'], ['Finally  role', 'Western blot Transwell'], ['CUL4A  overexpression', 'PHCC cell lines'], ['Clinicopathological  analysis', 'CUL4A differentiation T PHCC'], ['CUL4A  expression', 'poor PHCC patients'], ['well N TNM N', 'CUL4A TNM expression'], ['Further  multivariate', 'prognostic regression PHCC'], ['Moreover  silencing', 'dramatically PHCC cell metastasis'], ['CUL4A  overexpression', 'processes'], ['Mechanistically ZEB1', 'EMT'], ['prognostic  it', 'ZEB1 expression'], ['CUL4A', 'therapeutic  PHCC'], ['', ''], ['aim', 'pathogenic zirconium species'], ['', ''], ['An', 'sterile Ti SLA'], ['essential cetyl pyridinium oils', 'mechanical cetyl peridinium disruption'], ['Viable  bacteria', 'quantitative propidium monoazide'], ['generalized lineal model', 'bacterial Fusobacterium surface'], ['', ''], ['exposure', 'species Ti SLA'], ['which', '2  A'], ['', 'P'], ['', '3 Ti F'], ['nucleatum', ''], ['antimicrobial Ti application', 'mechanical  disruption'], ['', ''], ['', ''], ['', ''], ['', ''], ['nucleatum', 'bacterial multispecies communities'], ['', 'Dental Materials'], ['', 'Elsevier Ltd'], ['rights', ''], ['filamentous  that', 'bacterial host adhesion'], ['Two Porphyromonas gingivalis', 'oral  cavity'], ['fimbrial  forms', 'limited polymerization mechanisms'], ['Here  authors', 'fimbrial accessory proteins'], ['Mfa5', 'accessory cell surface'], ['IX secretion which', 'outer Bacteroidetes membrane'], ['relationship', 'mediated terminal signal secretion'], ['expressing  strain', 'accessory mfa5 disruption proteins'], ['porU mutants', 'intracellular  Mfa5'], ['outer  which', 'subsequent  fibers'], ['findings', 'novel polymerization P'], ['', ''], ['Regeneration', 'periodontal  attachment'], ['Human periodontal ligament stem cells', 'periodontal cell tissues'], ['However  subpopulations', 'cementogenic differentiation lineages'], ['Thus  we', 'cementogenic vitamin PDLSCs'], ['CEMP1 cementum expression', 'original  pool'], ['osteogenic markers bone sialoprotein', 'differentiation medium differentiation CAP'], ['CAP', 'VC treatment'], ['Transplantation', 'bone mineral vivo'], ['ectopic  CAP', 'fibrous mineral tissues'], ['cementogenic  VC', 'periodontal lineage regeneration'], ['inflammatory  drugs', 'pseudo inflammatory pseudo reactions'], ['particular  effects', 'periodontal NSAID meloxicam'], ['We', 'cellular side reactions'], ['21 cone beam', 'left tooth molars'], ['', 'mg meloxicam kg'], ['we', 'cm(2 ligament meloxicam'], ['', 'gastric marker tolerance'], ['we', 'mediated  osteoclastogenesis'], ['', 'orthodontic movement therapy'], ['prophylactic tolerance which', 'further  investigation'], ['Correct  diagnosis', 'optimal skin testing'], ['Cross reactivity studies', 'cefazolin hypersensitivity'], ['application', 'mg skin test sensitivity'], ['', 'second  cefazolin'], ['total', '20 skin mg'], ['Patients', 'graded drug reactivity'], ['27  who', 'negative skin testing'], ['alternative control culprit', 'perioperative  anaphylaxis'], ['amoxicillin', 'monobactams'], ['alternative cefazolin hypersensitivity', 'alternative  cephalosporin'], ['Increasing cefazolin concentration', 'mg skin diagnosis'], ['cefazolin hypersensitivity', 'other b lactam antibiotics'], ['', '2016 Allergy Asthma'], ['lack', 'peripheral artery disease'], ['Addressing', 'molecular  disease'], ['We', 'symptomatic PAD patients'], ['Plaque material', 'directional femoral atherectomy'], ['RNA', 'reverse polymerase chain reaction'], ['We', '2 Bcl2 21'], ['We', 'CD68 5p miR424 5p'], ['remaining  patients', 'intermediate plaque characteristics'], ['specific Notch that', 'PAD progression'], ['term peritoneal dialysis', 'ultrafiltration failure'], ['which', 'various  UFF'], ['present  study', 'mesothelial rat cells'], ['RPMCs', 'different  PDS'], ['gene expression levels', 'reverse chain reaction analysis'], ['PPAR gamma', 'western blot analysis'], ['Interleukin', 'ELISA'], ['RPMCs', '4'], ['', '72 % h'], ['secretion', 'rosiglitazone'], ['use', 'completely gamma inhibitor rosiglitazone'], ['PDS exposure', 'inflammatory  RPMCs'], ['further  investigations', 'underlying  mechanism'], ['Purpose', 'cold CT abscesses'], ['29  age', '16 75 16 years'], ['TB infection', 'bacilli polymerase chain reaction'], ['', ''], ['4  %', 'perihepatic  space'], ['', 'subphrenic  space'], ['', 'subphrenic  space'], ['', 'pelvic  cavity'], ['', 'perihepatic  space'], ['', ''], ['abscess  contents', '10'], ['', '61'], ['', ''], ['', ''], ['', ''], ['', 'other TB organs'], ['5  %', ''], ['TB infection', 'peritoneal TB PCR fluid'], ['', ''], ['5  %', 'recent TB ascites'], ['cold Peritoneal abscesses', 'other TB organs'], ['bacterial  cells', 'geological Arctic time'], ['permafrost  it', 'increased  pathogenicity'], ['Mycoplasmas', 'immune host organism'], ['us', 'Arctic permafrost'], ['other Pleistocene Ice it', 'mycoplasmal  permafrost'], ['DNA fragments', 'human animal insect'], ['ubiquitous mycoplasma Acholeplasma laidlawii', 'three  metagenomes'], ['It', 'metabolic  A'], ['', 'Mollicutes'], ['LaMnO3', 'new electrode supercapacitors'], ['electronic transport ability', 'application'], ['active electron which', 'potential  drop'], ['', 'work'], ['9MnO3 films', 'simple deposition method'], ['It', 'room temperature La0'], ['9MnO3', 'times  parent'], ['driven oxygen enhancement', 'oriented  La0'], ['', ''], ['existence', 'La deficiency'], ['9MnO3 compound', 'oxygen content'], ['strain', 'ambient oxygen stoichiometry conditions'], ['Following', 'practical process application'], ['important research that', 'cost reduction targets'], ['well uncertainty that', 'greatest cost improvement'], ['We', 'hybrid perovskite photovoltaic modules'], ['$ perovskite module uncertainty', '$ cadmium telluride basis'], ['incumbent power conversion efficiency', '20  years'], ['18 power conversion lifetime', 'levelized electricity targets'], ['', ''], ['crucial  which', 'various energy tumors'], ['study', 'hepatocellular gamma coactivator-1 carcinoma'], ['changes', 'reverse polymerase chain reaction'], ['human cell line overexpression', 'alpha complementary cell line HepG2'], ['morphological  changes', 'optical  microscopy'], ['Cellular  apoptosis', 'Hoechst'], ['expression levels', '21400  microarray'], ['activated coactivator-1 alpha expression', 'normal liver tissues'], ['immature L02 cells morphology', 'cancerous  tendency'], ['Apoptosis', 'activated gamma coactivator-1 alpha'], ['Microarray analysis', 'consistent  results'], ['activated gamma coactivator-1 alpha', 'hepatocellular  carcinoma'], ['', 'ACO Fuping Janshi persimmon'], ['fruit', ''], ['20 ethylene release rate', 'Northern blotting analysis'], ['then ethylene treatment', 'two  genes'], ['existed', 'inhibitory ACO effect'], ['enhanced  effect', 'fruit stalk'], ['other DKACS2 gene', 'four  propylene'], ['much', 'social person perception categories'], ['', ''], ['social  categories', 'smaller  subcategories'], ['', ''], ['that', 'perceived  typicality'], ['subcategory labels', 'perceived  others'], ['1  participants', 'Black  men'], ['2  we', 'Black image classification members'], ['representations', 'Black  subtypes'], ['Similarly  representations', 'White White subtypes'], ['current  experiments', 'further superordinate category'], ['Implications', 'stereotype maintenance'], ['', ''], ['rights', ''], ['that', 'goals'], ['Deliberate', 'imagined goal attainment'], ['', 'imagined well attainment'], ['that', 'goals'], ['allergic  which', 'various  cytokines'], ['Previous  studies', 'immune  asthma'], ['neurotrophic  II', 'physiological  activity'], ['mRNA  levels', 'inducing  anxiety'], ['Psychopathological  variables', 'cytokine neurotrophin stress'], ['aim', 'asthmatics'], ['total', 'asthmatic  study'], ['RPE Perceived Scale', 'subjects'], ['BDNFII gene', 'real polymerase chain reaction'], ['Different  levels', 'healthy  study'], ['IL-15', 'bronchial  asthma'], ['depression level', 'BDNFII  expression'], ['neurotrophin', 'temperament variable'], ['BDNFII', 'asthmatic  patients'], ['BDNFII', 'stress'], ['hypothesis', 'functional  models'], ['obtained  data', 'selected  asthmatics'], ['day  we', 'concrete  means'], ['us', 'social  environment'], ['Nevertheless', 'also environment perspective'], ['us', 'people actions'], ['when  actions', ''], ['exploratory  we', 'different verb categories'], ['second  pronouns', 'action  verbs'], ['', ''], ['', 'object'], ['', ''], ['', 'object'], ['', ''], ['', ''], ['grasping  they', 'linguistic  stimuli'], ['further motor act', 'earlier action verbs'], ['Thus influence perspective we', 'motor chain verbs'], ['German  it', 'salient  Italian'], ['language', 'embodied language processing'], ['Pertussis infection', 'unvaccinated  infants'], ['case control study', 'unvaccinated breast pertussis'], ['healthy polymerase chain controls', 'ultrasound screening'], ['Vaccinated  infants', ''], ['clinical  information', ''], ['effect', 'multivariable  analysis'], ['Breast milk', 'blood patients'], ['IgA  binding', 'other breast milk'], ['IgG', 'pertussis serum'], ['We', '296  patients'], ['Exclusive  breastfeeding', 'artificial  feeding'], ['', ''], ['', ''], ['', ''], ['Children', 'higher  pertussis'], ['', ''], ['', ''], ['', ''], ['IgA', 'pertussis cases'], ['', 'optical  controls'], ['', ''], ['bacterial', 'B'], ['pertussis', 'breast cases'], ['', '35  controls'], ['', ''], ['', 'bacterial  B'], ['pertussis', 'other  pathogens'], ['correlation', 'serum IgG'], ['numerous  it', 'pertussis'], ['Alternative  strategies', 'unvaccinated  pertussis'], ['significant  increase', 'urban  areas'], ['Using', 'concrete  noise'], ['standard  materials', 'pervious  concrete'], ['many  researchers', 'pervious eco concrete'], ['partial cockle replacement', 'pervious  concrete'], ['which', '6'], ['30  mm', '75 25 6'], ['', ''], ['', '75  shells'], ['specimens', 'fog room'], ['compressive  range', '28  days'], ['angular  shape', 'high void content'], ['maximum  increase', '75 void 6'], ['30  mm', '28  days'], ['KS  concrete', 'silent road pavement'], ['therefore  use', 'pervious concrete pavement'], ['', ''], ['rights', ''], ['presence', 'pesticide food'], ['Exposure', 'first food contaminants'], ['present  study', 'gastrointestinal gut tract'], ['three  reactors', 'human  adults'], ['Three time points', '15 CPF oil administration'], ['CPF', 'gut microbiota'], ['It', 'culturable Enterobacteria Bacteroides'], ['fermentative clostridia which', 'bifidobacterial clostridia counts'], ['iii  changes', 'short chain fatty acids'], ['', ''], ['frequent  it', 'frequent  France'], ['cancer', ''], ['', 'invasive diagnosis efficacy'], ['We', 'clinical imaging trial'], ['', ''], ['systematic  review', 'clinical prostate application'], ['', ''], ['Several PET tracers', 'low prostate cancer'], ['marketing tracers', 'several  limitations'], ['NaF', 'only bone metastasis'], ['furthermore prostate sensitivity', 'initial lymph disease'], ['', 'initial PSMA recurrences'], ['', ''], ['accurate  knowledge', 'metabolic  imagery'], ['new  tracers', 'prostate cancer'], ['indication', 'them'], ['', ''], ['rights', ''], ['long day plant', 'light period stress'], ['subtractive  hybridization', 'short light periods'], ['expressed  transcripts', 'positive  clones'], ['cellular  component', 'metabolic  metabolism'], ['quality', '14 transcription genes'], ['spatial qRT PCR they', 'premature flower abortion'], ['inconsistent expression pattern', 'novel flower bud abortion'], ['data', 'enhanced photoperiod stress tolerance'], ['', 'C Elsevier B'], ['', ''], ['rights', ''], ['P which', 'systemic lupus erythematosus'], ['we', 'Chinese Guangxi population'], ['genotypes', 'healthy SLE Guangxi'], ['Direct sequencing method', 'results'], ['TT genotype', 'adjusted CC 1'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['allele T', 'recessive  effect'], ['', ''], ['', ''], ['', ''], ['', ''], ['analyses', 'ae40 years ae40 subjects'], ['C', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['MDR1 rs1128503 polymorphisms', 'Chinese Guangxi population'], ['based cathode catalysts', 'microbial fuel cells'], ['catalysts', 'organic support precursors'], ['LSV Linear Sweep curves', '0'], ['', ''], ['', 'RRDE ORR characteristics'], ['us', 'reaction kinetics'], ['metallic gas diffusion', 'metallic  pellet'], ['highest power densities that', '200 mu Wcm(-2'], ['', 'Pt cathode'], ['better Fe AC', 'Pt'], ['larger  amounts', 'worse  performance'], ['', ''], ['', 'Elsevier B'], ['', ''], ['Phaeodactylum tricornutum', 'used diatom biology'], ['We', 'P'], ['specific literature that', 'interactively search queries'], ['bibliome', 'genome scale computation models'], ['', 'P'], ['tricornutum', 'literature P'], ['', 'independent  articles'], ['We', 'physiological biology studies'], ['that', 'P'], ['tricornutum', 'ecotoxicology bibliome'], ['1124 -20 %', 'additional  notes'], ['easily  that', 'individual  researchers'], ['HTML tool', 'algal  species'], ['', ''], ['', ''], ['rights', ''], ['Phagocyte function', 'further neutrophil preeclampsia'], ['cause', 'declined  function'], ['Decreased phagocyte function', 'high trophoblast preeclampsia'], ['aim', 'neutrophil granulocytes'], ['Methods', 'preeclamptic plasma pregnant'], ['cells', 'immunofluorescent zymosan molecules'], ['when nonpregnant cells', 'pregnant plasma women'], ['decreased phagocyte function', 'maternal  circulation'], ['cognitive  enhancement', 'academic  performance'], ['how  users', 'positive student experiences'], ['', ''], ['cognitive  that', 'PCE use'], ['students', 'relevant PCE use'], ['', ''], ['', ''], ['54 % females', 'reported PCE substances'], ['Three user groups', 'namely  users'], ['', 'dietary  supplements'], ['', 'dietary  supplements'], ['', ''], ['Multivariate analysis', 'anticipated PCE use'], ['significant  differences', 'academic  burnout'], ['university students', 'independent student experiences'], ['assisted performance enhancement mindset', 'PCE substances'], ['II genes', 'neoplastic  carcinogens'], ['novel  antioxidant', 'endothelial heme injury'], ['purpose', 'endothelial II cells'], ['selected glutathione which', 'nuclear  translocation'], ['observed II gene induction', 'cellular activity glutathione'], ['GSH  which', 'mRNA phase II genes'], ['Nrf2 gene attenuation', 'partial HO-1 JNK'], ['', ''], ['rights', ''], ['Repetitive control strategies', 'industrial voltage source applications'], ['paper', 'islanded  microgrids'], ['', 'overall control system'], ['', ''], ['delay', 'performance deterioration control performance instability'], ['quantificational  analysis', 'existing literature works'], ['paper', 'repetitive system stability'], ['controller performance', 'proposed  method'], ['proposed  method', 'repetitive control scheme'], ['active diode bridge synchronization', 'modern bridgeless topologies'], ['rebuilding Sensorless algorithms', 'current estimation error'], ['digital PLL algorithm', 'synchronous reference frame'], ['It', 'programmable gate parallelism'], ['orthogonal line signal', 'central unity frequency'], ['performance', 'same  device'], ['Simulations', 'different line transients'], ['dynamical  that', 'dissipative  system'], ['system', 'other  two'], ['electronic  circuit', 'two resistors scrolls'], ['macromolecular crystallography P13 beamline', 'user mid-2013'], ['P13', 'energy 17'], ['', 'experimental phase determination'], ['Baez focusing patrick Baez system', 'experimental focus situations'], ['', '4 Data keV'], ['beamline photon', 'low helium path'], ['', 'high  energies'], ['4  10(11', '17'], ['', 'atomic data resolution'], ['', ''], ['', 'about  8'], ['photons', '11  keV'], ['Automated sample mounting', '160 sample samples'], ['close sample laboratory', '150 atom users'], ['beta pattern recognition GBP', '2-macroglobulin protection crustaceans'], ['related protein protein analyses', 'prophneoloxidase pathway'], ['hence ProPO cascade we', 'structural ProPO pathway proteins'], ['PPIs', 'silico approach'], ['triggering it', 'modeled protein complex synthesis'], ['findings', 'immune ProPO computation'], ['we', 'experimental ProPO cascade proteins'], ['', 'International Union International Biochemistry'], ['', ''], ['gated Na V antagonist', 'isolated rat neurohypophysis'], ['phenytoin', 'producing neuroendocrine tumors'], ['We', 'small cancer cell line'], ['Cells', 'fifth bovine passage'], ['new sandwich levels', 'reverse polymerase chain reaction'], ['g  mL', 'copeptin 48 h'], ['same concentration levels', 'Lu-165  cells'], ['mEq sodium L', 'AVP  levels'], ['', '10 sodium mEq'], ['Phenytoin', '20 sodium mEq'], ['', 'tested Na V'], ['3', 'Lu-165  cells'], ['However phenytoin', ''], ['', '10 sodium mEq'], ['cells', 'AVP release'], ['Phenytoin', 'neuroendocrine NaV tumors'], ['better policy article', 'systematic reviewed literature'], ['review', 'protection policy responses'], ['diverse  that', 'quality appraisal tool'], ['findings', 'child maltreatment child protection Philippines'], ['It', 'such child institutions'], ['study', 'mobile Microbial Fuel urine'], ['new  that', 'power density losses'], ['simply  using', 'modern day smartphone'], ['charging circuitry', '38 battery capacity'], ['mobile phone which', 'neat charge urine'], ['', ''], ['', 'Elsevier Ltd'], ['This', 'open CC BY license'], ['subcellular pathways that', 'essential membrane lipids'], ['final plant oil composition', 'triacylglycerol'], ['One  reason', 'acid modification lipid metabolic network'], ['where lipid metabolic uncertainty', 'seed oil biosynthesis'], ['Special Plant Lipid Biology', 'Kent D'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['objective', 'serous phospholipase carcinoma'], ['PLD1 PLD2 isoform expression', 'time reverse polymerase chain reaction'], ['Expression levels', 'clinicopathological  chemoresponse'], ['anatomic PLD2 levels', 'positively  P'], ['', 'effusions'], ['messenger RNA PLD2 messenger expression', 'ovary  metastases'], ['', ''], ['Higher  levels', '125  diagnosis'], ['higher PLD2 levels', 'unfavorable  chemotherapy'], ['', ''], ['studied  that', 'phospholipase  survival'], ['present  study', 'first PLD cancer'], ['', ''], ['rights', ''], ['applications', 'microbial power generation'], ['phosphorylation', 'UV'], ['composite  membrane', 'Scanning Electron Microscopy'], ['conductivity water uptake', 'prepared ion exchange membrane'], ['', ''], ['', ''], ['power density', ''], ['', 'composite  membrane'], ['maximum Cu++ removal', ''], ['', '2  63'], ['', '2 Ultrex CMI'], ['prepared  membrane', 'vital copper wastewater'], ['', ''], ['', ''], ['rights', ''], ['Phototropin1', 'dependent kinase activation'], ['conformational  changes', 'kinase domain'], ['Here  we', 'angle x ray scattering'], ['fragment', 'photoreversible SAXS 42'], ['', '9  dark'], ['', '8 BL irradiation'], ['twisted SAXS that', 'twisted SAXS arrangement'], ['molecular  shape', 'slightly  dark'], ['dependent kinase change', 'relative LOV2 dimer'], ['important  residue', 'structural kinase domain'], ['interface', 'adjoining  LOV2'], ['Photobiomodulation', 'low energy densities'], ['controversial  outcomes', 'promising  effects'], ['detailed osteoblast cells', '635 energy 0'], ['', ''], ['red propidium staining', 'reverse type I ALPL'], ['studied energy doses', '48 osteoblast viability'], ['Similarly laser irradiation', 'ALP activity'], ['results', 'osteoblast RT PCR markers'], ['clearly laser treatment', 'clinical bone tissue level'], ['photocatalyst', 'past light years'], ['that', 'important  details'], ['functional  theory', 'index stoichiometric index BiOI'], ['relaxation', 'low index BiOI surfaces'], ['Thus surface energies', 'BiOl'], ['001 conduction which', 'excited  carriers'], ['dangling  bonds', 'broken Bi O bonds'], ['dangling bond atoms', 'square  nano'], ['lowest energy it', 'lowest energy BiOl'], ['', ''], ['dangling bonds density', 'only surface energy'], ['also  which', 'Wulff construction'], ['photocatalytic  that', 'based BiOI future'], ['', ''], ['', ''], ['rights', ''], ['dimensional bimetallic nanowires', 'light absorption work'], ['Recently metal nanowires', 'especially plasmon resonance effects'], ['Moreover Ni bimetallic nanowires', 'recent monometallic works'], ['metallic Schottky that', 'Cu Ni TiO2 network topology'], ['heterostructured  photocatalyst', 'photocatalytic step hydrolysis performance'], ['Cu Ni NWs', 'dimensional TiO2 matrix'], ['photocatalytic  performance', 'significantly TCN TiO2'], ['Acetaldehyde', 'continuous TCN feeding'], ['3 Cu Ni NWs', '20  UV'], ['electron -hole pairs', 'significantly  TCN'], ['Finally  mechanism', 'above TiO2 analyses'], ['', ''], ['', ''], ['rights', ''], ['synthesis  modification', 'photocatalytic TiO2 field'], ['two TiO2 factors', 'phOtocatalytic TiO2 crystals'], ['when surface F ions', 'photo oxidation probe reactions'], ['We', 'photogenerated hole migration'], ['001 holes which', 'significantly photo oxidation activity'], ['synergistic  effect', '101  facets'], ['finding', 'exposed charge facets'], ['', ''], ['', ''], ['rights', ''], ['photocatalytic Fenton reactor', '5 dye Reactive electricity'], ['', 'development fuel system'], ['Therefore  PFC', 'instead Fenton system'], ['effect', 'azo PFC'], ['maximum power output', 'hybrid Fenton system'], ['higher degradation efficiency', 'hybrid PFC system'], ['', ''], ['', ''], ['rights', ''], ['photochromic  materials', 'recent  years'], ['photochromic powder material', 'solid state method'], ['surface color', 'alternatively purple UV'], ['Diffuse reflectance spectra', 'photochromic  properties'], ['optimal', ''], ['', ''], ['Several cycles measurements', 'high photochromism performance'], ['critical photochromism role', 'charge traps'], ['schematic  diagram', 'photochromic  mechanism'], ['', ''], ['', ''], ['rights', ''], ['that', 'photodynamic cancer cells'], ['Here  we', 'reducible disulfide bonds'], ['conjugate', 'controllable s PpIX stability'], ['quenching s sPpIX which', 'inactive s PpIX state'], ['', 'significant fluorescent emission'], ['stable s PpIX NPs', 'light irradiation treatment'], ['s PpIX NPs', 'normal photodynamic tissues'], ['', ''], ['rights', ''], ['vital  which', 'overall  health'], ['expensive  that', 'various  parameters'], ['However  instruments', ''], ['Hence  it', 'military bedside camps'], ['modular  which', 'physiological  parameters'], ['common MicroController which', 'associated  firmware'], ['general computing system', 'such USB UART bridge'], ['controller', 'computer'], ['JavaScript', 'open source software'], ['which', 'incoming  data'], ['data we', 'serial text files'], ['we', 'namely heart photoplethysmography'], ['switchable  system', 'various blood pressure ECG'], ['', 'computer screen'], ['Psoriasis', 'T helper'], ['study', 'narrow band ultraviolet B'], ['serum levels', 'control NBUVB'], ['NBUVB levels', 'healthy  controls'], ['Area Severity Score', 'Surface Area disease'], ['', 'psoriasis psoriasis patients'], ['', ''], ['', ''], ['', ''], ['serum levels', 'strongly  disease'], ['NBUVB decline', 'controls'], ['', ''], ['23', 'when control group'], ['', ''], ['', ''], ['', '23 serum psoriasis'], ['', 'psoriasis levels controls'], ['study', 'possible T cytokines'], ['', 'many system aspects'], ['paper', 'hybrid structure energy flow'], ['also light system', 'outdoor  conditions'], ['movable  system', 'external power supply'], ['system', 'two  technologies'], ['second output power part', 'thermal  energy'], ['separate  parts', 'respectively control circuits'], ['system', 'kWh electric kWh energy'], ['', 'normal working conditions'], ['efficiency', 'hybrid PVT system'], ['revised  that', 'paper'], ['hybrid PVT system', 'remote electricity areas'], ['It', 'also PVT system'], ['different  levels', 'geographical energy system 2020'], ['Energy system models', 'high technology detail'], ['potential  costs', 'geographic time place'], ['case we', 'potential wind power'], ['', 'regional wind PV'], ['However  they', 'modelled cost other'], ['mainly  differences', 'summer days'], ['solar  availability', 'PV installations'], ['We', 'regional JRC EU disaggregation'], ['disaggregating wind regions', 'lower electricity wind'], ['', ''], ['', 'Elsevier Ltd'], ['Photovoltaic arrays', 'renewable  energy'], ['photovoltaic', 'environmental  conditions'], ['Finding', 'good control results'], ['However  solutions', 'set  effort'], ['RL reinforcement that', 'prior power knowledge'], ['RL algorithm', 'photovoltaic  sources'], ['proposed RLMPPT control method', 'set PV time'], ['evaluate', 'conventional control method Perturb'], ['Results', 'prior optimal knowledge'], ['', ''], ['rights', ''], ['paper', 'minimum Levelized Energy'], ['GD', 'battery hydrogen system'], ['relationship', 'devices'], ['GD', 'solar  insolation'], ['empirical GD formula', 'different  Japan'], ['proposed GD calculation', 'conventional year weather simplicity'], ['optimal capacity', 'objective GD LCE'], ['', ''], ['rights', ''], ['Risk analysis', 'solar  projects'], ['paper measures', 'iii energy yield irradiance'], ['large electricity they', 'variable market rates'], ['international  comparison', 'results'], ['CPV systems which', 'negotiated system suppliers'], ['Uncertainty', '17  %'], ['Uncertainty', 'most  3'], ['', ''], ['two  system', 'two  play'], ['', ''], ['rights', ''], ['new  specialty', 'oriented child abuse studies'], ['Abuse Pediatrics NetWork', 'medical child research'], ['practical research we', 'such topic a'], ['', ''], ['Research questions', 'Ray E'], ['Helfer Society', 'topic areas'], ['topic areas', 'in  person'], ['topics', 'highest  diagnosis'], ['agenda', 'maltreatment medical child maltreatment research'], ['', ''], ['rights', ''], ['Cognitive  deficits', 'schizophrenia  options'], ['comprehensive  evaluation', 'date'], ['We', 'cognitive exercise schizophrenia'], ['Studies', 'electronic  April'], ['Meta analyses', 'pooled effect sizes'], ['We', '385 outcome schizophrenia'], ['Exercise', 'global  cognition'], ['', ''], ['', ''], ['', ''], ['', 'statistical  heterogeneity'], ['7  which', 'controlled  trials'], ['', ''], ['', ''], ['greater  amounts', 'global  cognition'], ['', ''], ['', ''], ['which', 'physical activity professionals'], ['', ''], ['', ''], ['Exercise', 'working  memory'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Effects', 'visual processing memory'], ['exercise', 'higher  exercise'], ['Given', 'supervised health schizophrenia'], ['physical  indices', 'disordered  breathing'], ['', ''], ['', ''], ['', ''], ['', ''], ['9 kg m(-2', '6 intensity days'], ['', ''], ['', 'prior laboratory PSG'], ['vigorous intensity activity', 'MVPA'], ['Indices', 'timing'], ['sedentary MVPA analyses', 'daily wake time'], ['Binary logistic Binary regression', 'sedentary AHI MVPA'], ['', 'sedentary  time'], ['', ''], ['', ''], ['9  day', 'greater  AHI'], ['', 'mild  SDB'], ['', 'high  MVPA'], ['min  day', 'low  MVPA'], ['', ''], ['', 'AHI model P'], ['', 'mild  SDB'], ['', 'other  groups'], ['other sleep measures', 'sedentary time MVPA'], ['Sedentary time', 'SDB'], ['lower SDB severity', 'future  exploration'], ['vast  majority', 'physical child abuse'], ['intimate partner that', 'high risk group'], ['Elements', 'negative child behavior'], ['methodological  study', 'analog child abuse risk'], ['Contrary', 'independently child abuse men'], ['anger poorer anger empathy', 'further child abuse risk'], ['how  factors', 'varying child abuse risk'], ['', ''], ['rights', ''], ['cognitive processes characteristic', 'personal parent child vulnerabilities'], ['study', 'expectant multimethod partners'], ['domestic substance resiliencies', 'social partner relationship efficacy'], ['greater  attitudes', 'elevated compliance PCA'], ['', 'empathy approval attitudes'], ['Findings', 'notable  distinctions'], ['how  findings', 'prevention programs'], ['neighbor are', 'real life setting'], ['question', 'child community'], ['study', 'Chinese school Shanghai'], ['Results', 'physical neighbor father'], ['legal  punishment', 'physical neighbor help'], ['ecological  which', 'different  sources'], ['results', 'legal child abuse'], ['', ''], ['rights', ''], ['modern physician knowledge', 'modern  way'], ['Physician  recertification', 'long time span'], ['maintenance', 'ongoing knowledge basis'], ['continuous assessment that', 'innovative question formats'], ['article', 'new American Allergy'], ['new test center focus', 'firmly core competencies'], ['ABAI', 'clinical program assessment'], ['Periodic  surveys', 'public program trust'], ['', '2016 Allergy Asthma'], ['isolated', '1 ex vivo hr'], ['innovative  that', 'high genome transplantation'], ['various  pharmaceuticals', 'perfusion'], ['kidney', 'biology biochemical biology analysis'], ['paper', 'surgical mouse kidneys'], ['perfusion data', 'molecular nephron readout'], ['mRNA differential display technique', 'Habanero pepper'], ['expression', 'oomycete Phytophthora capsici L'], ['single primer gene', 'oligonucleotide primer combinations'], ['quantitative  accumulation', 'multiple  transcripts'], ['which', 'hours P capsici'], ['systemic adult levels', 'salicylic methyl jasmonate'], ['P capsici', 'enzymatic defence activity'], ['', ''], ['', ''], ['', 'similar  kinetics'], ['activity', 'specific host defence response'], ['', ''], ['rights', ''], ['new recipient which', 'new  environments'], ['gene transfer', 'appreciable  frequency'], ['Here  we', 'eukaryotic Phytophthora species'], ['blotting Phytophthora genes', 'early cyst pathogen'], ['Analysis', 'recent gene duplications'], ['Bioinformatic analyses', 'eukaryotic  groups'], ['where cutinase genes', 'degrading land microbes'], ['actinobacterial gene transfer', 'important  virulence'], ['findings', 'important virulence plant'], ['', ''], ['', ''], ['lights', ''], ['PID controller', 'automotive aerospace process control'], ['Recently  FPGA', 'digital control algorithm systems'], ['Integral Derivative Proportional Integral controller', 'incremental  PID'], ['PID control language', 'software programs'], ['Simulation results', 'proposed  method'], ['Piezoelectric bending actuators', 'few  millimeters'], ['Therefore  actuators', 'wide  applications'], ['200 output which', '200 output V'], ['paper', 'high voltage output'], ['model', 'piezobending Matlab Simulink amplifiers'], ['simulation results', 'high voltage piezoactuator'], ['influence', 'operational actuator current'], ['high investigations results', 'paper'], ['', ''], ['rights', ''], ['paper', 'piezoelectric  actuators'], ['Piezoelectric  actuator', 'laser beam power laser techniques'], ['nonlinearities', 'closed loop set ups'], ['thus  nonlinearities', 'piezo'], ['high Piezoelectric Actuators', 'Fabry Perot interferometer'], ['hysteresis attenuation technique', 'scientific control specification'], ['such  APA', 'reflective mirror plate'], ['3 nm hysteresis', 'positioning  accuracy'], ['hybrid amplifier circuit', 'operational  APA'], ['steady state noise', ''], ['hybrid patent application', '2015 number N'], ['', 'piezoelectric paper actuators'], ['discussed  driver', 'mainly flyback converter'], ['variable P which', 'piezoelectric DC actuator'], ['supply voltage', 'input signal'], ['power conversion efficiency', '30  %'], ['advantageous  features', 'high slew rate'], ['', ''], ['transcriptional  that', 'clonal cell rodents'], ['We', 'Northern porcine FoxO1 blotting'], ['deduced amino acids', 'corresponding  human'], ['aa it', 'transcriptional Tyr phosphorylation vivo'], ['IMpRH we', 'FoxO1 gene'], ['data', 'further FoxO1 gene'], ['0  it', 'porcine primary preadipocyte differentiation'], ['however FoxO1 protein', 'dependent  manner'], ['FoxO1', 'porcine preadipocyte IGF-1'], ['Maturation', 'successful fertilization embryo growth'], ['events', 'cumulus cells'], ['migration', 'molecular  level'], ['study', 'developmental porcine oocytes vitro'], ['brilliant cresyl blue', 'vitro  maturation'], ['', 'Affymetrix((R'], ['1 expression profile', '12258 porcine transcripts'], ['nine cell migration that', 'nine cell migration mechanisms'], ['genes', 'IVM expression analysis'], ['important  mechanisms', 'biological VEGFA KIT'], ['selected microarray assays', 'real polymerase chain reaction'], ['We', 'such protein microtubules'], ['they', 'maturational porcine oocytes'], ['However migration potency', 'porcine vitro'], ['such INSR TPM1', 'vitro porcine culture'], ['also  that', 'regenerative  future'], ['CCN proteins', 'tissue regeneration'], ['primary chondroprogenitor cell that', 'viral  vector'], ['We', 'human gamma agonist retinoblastoma'], ['effects', '33258 MTT assay'], ['related protein levels', 'western  blot'], ['Inflammationary factors analysis', 'western  blot'], ['nuclear reporter gene transcription', 'B luciferase assay'], ['c nude c animals', 'antitumor vivo'], ['pioglitazone', 'Y79 vitro'], ['pioglitazone', 'related kappa B signal'], ['pioglitazone', 'significant side effects'], ['human cell growth', 'thus tumor vivo'], ['', 'digital calibration 1'], ['analog stage converter', 'paper'], ['Capacitor mismatch', 'proposed calibration method'], ['capacitor mismatch', 'finite OPAMP 1'], ['bit stage pipeline ADC', 'ideal FFT effects'], ['small power capacitor', 'then  space'], ['', '10  bit'], ['8 bit circuit performance', '0'], ['', ''], ['Circuit measurement result', 'signal  51'], ['11 dB calibration', '1 sample MHz'], ['', ''], ['design', 'operational Miller OP'], ['low power pipeline ADC', 'standard'], ['', '18um CMOS 3'], ['', ''], ['ADC', '8bits  resolution'], ['analog  converter', 'analog  digital'], ['', ''], ['redundant  stages', 'digital op amp requirements'], ['', 'MATLAB Simulation Simulink'], ['8 V CMOS', ''], ['pipelined  ADC', 'mW SINAD/80 dB 1'], ['8 V supply FoM', ''], ['', ''], ['main  aspects', 'analog power converters'], ['', 'main  1'], ['redundant  ADC', 'redundant  pipeline'], ['Examples', 'pipelined power reduction mechanisms'], ['', ''], ['Piperaceae', 'used  world'], ['differentially Piper which', 'valuable  crop'], ['SSH Subtractive technique', 'subtracted Piper nigrum'], ['tester population', 'leaf root'], ['efficiency', 'housekeeping gene actin'], ['30 sequence %', 'type-2 gene'], ['predominance', 'Real Time PCR analyses'], ['possible type-2 homologues', 'specific Piper nigrum'], ['2005 Global Assessment Scale', 'abusive relationship patterns'], ['sample', '47  months'], ['Sixty four Sixty dyads', 'already violence problems'], ['caregiver child interactions', 'appropriate child age'], ['PIR GAS', 'abusive Child Abuse'], ['', ''], ['', ''], ['', 'disciplinary  practices'], ['PIR GAS ratings', 'abusive PIR GAS'], ['Interrater reliability', 'moderate PIR excellent'], ['such  3R', 'infant  abuse'], ['coding  that', 'mostly germ line cells'], ['However  presence', 'whitespotted bamboo shark liver'], ['previous shark piRNAs', 'small Solexa technology'], ['piRNAs', 'shark liver'], ['We', 'Northern liver blotting'], ['further  six', 'piRNABank'], ['actual  expression', 'four novel PCR'], ['total', '10 target miRanda'], ['five  piRNAs', 'eighteen GO annotations'], ['identified  piRNAs', 'specific inflammation differentiation'], ['manuscript', 'whitespotted bamboo shark liver'], ['findings', 'therapeutic liver damage'], ['', ''], ['', ''], ['rights', ''], ['food development', 'processed  foods'], ['LNA nucleic probes', 'R pistachio Green'], ['specific pistachio allergen', 'different pistachio varieties'], ['probe real LNA probe PCR', 'mg  pistachio'], ['pressure', 'based LNA qPCR'], ['nevertheless  effect', 'thermal  pressure'], ['applicability', 'commercial ELISA kit'], ['', ''], ['rights', ''], ['PKI55 protein', 'specific kinase C inhibitor'], ['previously  PKI55', 'poorly feedback inhibition'], ['expression', 'PKI55'], ['Northern RT it', 'highly brain tissue'], ['AP1 consensus we', 'proteins'], ['Box  I', 'preferentially  Box'], ['interaction', 'consequently PKI55 PKC'], ['', ''], ['rights', ''], ['homonymous zinc finger that', 'multiple cell cycle pathways'], ['molecular  protein', 'diverse PLAGL1 processes'], ['we', 'pathological  processes'], ['total  environment', 'linking  which'], ['global population increases', 'environmental climate pollution'], ['case', 'especially  China'], ['Land', 'human  survival'], ['How  increase', 'sustainable agriculture development'], ['potential pre- which', 'arable  land'], ['many  results', 'practical  efficiency'], ['molecular use types interactions', 'lithosphere  atmosphere'], ['', ''], ['', ''], ['rights', ''], ['Infectious plant diseases', 'such viruses viroids phytoplasma'], ['plant pathogen infections', 'economic crop losses'], ['Plant pathogen detection', 'first country boarders'], ['immunological  techniques', 'immunosorbent  assays'], ['PCR polymerase chain RTPCR', 'also pathogen identification'], ['complex  instruments', 'in  analysis'], ['', 'high plant care'], ['we', 'biosensing plant pathogen antibody'], ['', 'biosensing  pathogens'], ['', ''], ['bacteria', 'care'], ['Plastic', 'on sensing detection'], ['Beside devices', 'also  review'], ['atherosclerotic  plaques', 'cannabinoid receptor type'], ['immune  which', 'inflamed  plaques'], ['We', 'atherosclerotic CB2-specific lesions'], ['differential gene expression', 'quantitative polymerase chain reaction'], ['CB2 expression levels', 'vitro  autoradiography'], ['appropriate animal we', 'induced CB2 vivo'], ['CB2', 'various time points'], ['Retrospectively  carotids', 'histopathology gene expression analysis'], ['normal  12', 'vulnerable  plaques'], ['latter  group', 'matrix metalloproteinase family'], ['CB2', 'atherosclerotic CD68 expression levels'], ['Specific', 'predominantly  plaques'], ['KO mice', 'atherosclerotic accumulation plaques'], ['elevated KO mice', 'vulnerable  plaques'], ['human plaque which', 'novel  imaging'], ['CB2-specific radiotracer', 'vulnerable ApoE KO plaques'], ['Elsevier rights', ''], ['tractability', 'cellular yeast life'], ['advent', 'controlled yeast manner'], ['new  family', 'yeast shuttle vectors'], ['plasmids', 'exogenous auxotrophy marker marker'], ['', 'desired marker locus'], ['transcriptional  unit', 'two  constructs'], ['cassettes', 'dimer red fluorescent protein'], ['tagging cassettes', 'desired marker cassette locus'], ['we', 'budding  yeast'], ['pSK41', 'conjugative Staphylococcus aureus'], ['coding antisense that', 'mRNA leader region'], ['enzymatic  probing', 'secondary  RNAI'], ['two stem loop structures', 'SLRNAI inhibition'], ['Northern rep mRNA', 'mediated  vivo'], ['together  observations', 'new replication control mechanism'], ['', ''], ['rights', ''], ['Plasmodium parasites', 'mosquito vector'], ['', 'environmental insect changes'], ['', ''], ['temperature', 'mobile parasite survival'], ['Oxidative  stress', 'integrated stress response'], ['ISR', 'Plasmodium survival'], ['in mosquito midgut we', 'reactive dismutase activity'], ['Additionally  we', 'cellular stress markers'], ['', ''], ['reverse polymerase chain processes', 'probably Plasmodium berghei ookinetes'], ['genus  which', 'Anopheles mosquitoes'], ['Plasmodium vivax', 'important  P'], ['', ''], ['we', 'two  P'], ['', 'Ad Aotus monkeys'], ['prime plasmid boost', 'then blood stage challenge'], ['alone antigen antigens', 'smallest parasitemia curve'], ['prechallenge MSP142 antibody titers', 'decreased parasite burden'], ['significant  proportion', 'immunized  anemia'], ['', 'conclusion'], ['5  vaccine', 'further Aotus development'], ['Pf Plasmodium parasites', 'final  vaccination'], ['injectable malaria vaccine', 'long Pf strain'], ['Here  we', 'open PfSPZ 9'], ['PfSPZ', 'i'], ['', ''], ['', 'naive  adults'], ['', 'nonvaccinated 35 controls'], ['', ''], ['underwent repeat CHMI', 'final  immunization'], ['Five', 'nonvaccinated 36 controls'], ['cell  responses', 'vaccine recipients'], ['Cytokine production', 'homologous T NF54'], ['specific T cell responses', 'subsequent  immunizations'], ['durable  protection', 'homologous PfSPZ Vaccine'], ['protective  efficacy', 'additional vaccine immunizations'], ['Alloimmunization', 'neonatal alloimmune thrombocytopenia'], ['aim', 'histological platelet alloimmunization'], ['study', 'matched Rhone Alpes region'], ['Clinical  findings', 'FNAIT case'], ['Two  pathologists', 'FNAIT  case'], ['features', 'inflammatory  lesions'], ['Differences', 'two chi square'], ['FNAIT', 'chronic  chorioamnionitis'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['more control differences', 'more control group'], ['FNAIT', 'significantly CC BCV'], ['inflammatory  reaction', 'maternofetal  interface'], ['HPA alloimmunization', 'graft  disease'], ['', ''], ['rights', ''], ['Immunization', 'clinical platelet complications'], ['detection', 'mediated platelet thrombocytopenias'], ['platelet alloantigen frequencies', 'ethnic antiplatelet groups'], ['importance', 'clinical transfusion China'], ['HPA genotyping which', 'clinic alloimmune platelet environments'], ['Research', 'ethnic Chinese world'], ['Production', 'Chinese risk population'], ['Advances', 'Chinese alloimmune platelet population'], ['', 'Elsevier Inc'], ['Phospholipase D', 'apoptosis'], ['direct  evidence', 'apoptosis'], ['recently  apoptosis', 'HI  injury'], ['apoptosis', 'PLD signal transduction'], ['invasive cancer cell line', 'when serum growth factors'], ['cerebral HI treatment', 'faulty PLD expression'], ['PLD1 activity', 'down  apoptosis'], ['Northern  blotting', 'focal cerebral HI'], ['results', ''], ['', ''], ['9 kb transcripts', 'previous PLD ischemia'], ['days  HI', 'transient PLD2 phenomenon'], ['PLD2 that', 'apoptosis'], ['hypothetic  role', 'apoptosis'], ['Energy management strategies', 'electric fuel vehicles'], ['conventional  EMSs', 'uphill battery terrains'], ['optimal control strategy', 'road grade information'], ['target state', 'GPS GIS system'], ['Furthermore  trajectory', 'uphill  charge'], ['genetic  algorithm', 'CD mode'], ['charge  mode', 'uphill CS terrain'], ['Finally simulation model', 'MATLAB Simulink platform'], ['proposed control strategy', 'better fuel economy'], ['Application', 'much point attention'], ['However  effects', 'crude  oil'], ['monodispersed PMSQ microspheres', 'two step solgel route'], ['Then  effect', 'crude flow oils'], ['PMSQ microspheres', 'single oil spheres'], ['two PMSQ microspheres', 'crude wax appearance temperature'], ['improving  efficiency', 'greatly PMSQ microspheres'], ['also PMSQ microspheres', 'asphaltenes'], ['However PMSQ microspheres', 'two oil samples'], ['spacial hindrance which', 'thus flow oil'], ['mechanism', 'new generation flow nano'], ['', ''], ['rights', ''], ['Pc Pneumocystis adhesion', 'well Pneumocystis pneumonia'], ['like Pc surface molecule', 'major Pc surface glycoprotein'], ['Recent  data', 'important Candida spp'], ['', 'polystyrene biofilm formation'], ['transcription factor', 'available Pc genome database'], ['single Pc gene', 'organism'], ['BLASTP analysis', '41 Saccharomyces cerevisiae'], ['Northern  blotting', 'greatest  pH'], ['', ''], ['', 'fungal biofilm milieu'], ['Western  blot', 'cyst Pc life forms'], ['deficient yeast Pcflo8', 'invasive flo8 Delta cells'], ['Furthermore  Pcflo8', 'functional Flo8 transcription factor'], ['PcFlo8', 'organism adhesion'], ['inflammatory  that', 'pulmonary animal fibrosis'], ['molecular heat shock chaperone', 'human growth vitro'], ['well type II fibroblasts', 'pulmonary animal bleomycin'], ['present  study', 'human A549 vitro'], ['expression', 'Northern TGF blotting'], ['expression', 'immunocytochemical fibronectin staining'], ['1 collagen type I', 'significantly A549 process'], ['Pirfenidone', 'also TGF beta'], ['alveolar epithelial which', 'reduced lung fibrosis'], ['Furthermore  pirfenidone', 'epithelial mesenchymal transition'], ['Variable  ventilation', 'acute respiratory distress syndrome'], ['variable  ventilation', 'pneumonia'], ['tidal airway pressures', 'bacterial alveolar barrier bloodstream'], ['We', 'experimental cell pneumonia'], ['Thirty two Wistar rats', 'randomly Pseudomonas aeruginosa'], ['24-h  animals', 'controlled mean VT'], ['', ''], ['tidal  volume', '30  %'], ['Additional  animals', 'NV  controls'], ['', 'oxygenation  VCV'], ['', 'decreased IL)-6 VCV'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'surfactant protein D 2'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'perivascular VCV edema'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '<'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['CFU  counts', ''], ['', ''], ['', ''], ['NV VV', 'expression amphiregulin'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Angiopoietin-2 expression', 'NV animals'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'bacterial lung translocation'], ['Podcasts', 'very  areas'], ['higher  they', 'teaching  processes'], ['study', 'University Geology Portugal'], ['It', 'pedagogical  technology'], ['informative  podcasts', 'feedback'], ['audio  episodes', 'short summaries study guidelines'], ['Students', 'other  courses'], ['', 'personal devices podcasts'], ['student acceptance', 'other teaching courses'], ['pedagogical  approach', 'centered podcasts producers'], ['', 'International Biochemistry'], ['Electrochemical Impedance Spectroscopy', 'biomedical  applications'], ['We', 'biomolecular EIS measurement detection'], ['times blood glucose use', 'lower  detection'], ['EIS technique', 'low  concentration'], ['test which', 'real  impedance'], ['circuit', 'single  standard'], ['', ''], ['2 frequency measurement', 'excellent simulation agreement'], ['Advances', 'assays acid amplification care'], ['rapid  assays', 'such microscopes photomultiplier tubes'], ['we', 'microfluidic nucleic acid device'], ['commercial  we', 'operational cost lenses'], ['Temperature regulation', 'printed board fabrication methods'], ['fabrications', 'poor  settings'], ['Intentional childhood poisoning', 'high child morbidity'], ['Patients', 'main  illness'], ['limited  clinicians', 'high  diagnoses'], ['Transformation', 'negative plant growth'], ['defective  PAP', 'only  host'], ['defective PAP gene', 'mediated Phytolacca method'], ['PacPAP', 'transgenic expression plants'], ['identification', 'artificial cucumber mosaic virus'], ['', 'transgenic  plants'], ['wilt  PacPAP', 'Fusarium oxysporum fsp'], ['', ''], ['work', 'resistant cucumber breeding resource'], ['whole bio cathode process', 'cathode bioelectrochemical bio cathode system'], ['', 'polar  study'], ['active electron biofilm', 'aromatic  pollutants'], ['acclimated  bioanodes', 'nitroaromatic  nitrobenzene'], ['established  biocathode', 'open circuit controls'], ['Several  microbes', 'bidirectional biocathode communities'], ['well ARB Geobacter', 'backward electron NB'], ['study', 'coexisting electron wastewaters'], ['', ''], ['', ''], ['rights', ''], ['RNA', 'natural defense viruses'], ['RNA', 'suppressor proteins'], ['P0 proteins', 'SSP'], ['local  that', 'infiltration Nicotiana benthamiana plants'], ['infectious cDNA that', 'N'], ['infiltration P0 protein', 'viral suppression genome'], ['other P0 protein', 'systemic silencing signals'], ['P0 protein', 'interfering  RNAs'], ['study', 'blue CLRDV infection'], ['', ''], ['', ''], ['rights', ''], ['risk', 'virus food'], ['pediatric  who', 'Chiang Mai 2010'], ['', 'pediatric stool 0'], ['61  %', '1300'], ['mixed  infection', 'eight  cases'], ['PV strains', 'partial VP1 sequences'], ['present  two', 'Sabin vaccine'], ['data', 'acute Chiang Mai Thailand'], ['', ''], ['who', 'conservative  world'], ['recently  research', 'early  life'], ['that', 'ideological  positions'], ['present  we', 'social processing cognition'], ['', 'political process ideology'], ['', ''], ['', 'implicit  order'], ['existential', 'school conformity children'], ['one  parent', 'child'], ['unique  associations', 'namely  dominance'], ['', ''], ['', ''], ['', ''], ['', ''], ['more epistemic needs', 'more  SDO'], ['relational  conformity', 'increasing  SDO'], ['relatively  links', 'strong suggesting ideology'], ['Limitations', ''], ['digital control that', 'object'], ['Elementary simplifications', 'Markov  processes'], ['initial Markov process which', 'selected  links'], ['Formulae', 'linked  states'], ['selected time that', 'polling procedure'], ['chapter', 'oligo(T  capture'], ['method', 'magnetic capture particles'], ['4 cell lysis which', 'endogenous  RNases'], ['', 'oligo(dT LNA technology'], ['northern RT PCR', 'northern blotting analysis'], ['PARP ADP ribosylation they', 'PARP ADP ribosylation that'], ['field', 'considerably DNA damage late'], ['This', 'specific ADP substrates'], ['methodological genomics cell that', 'new  field'], ['recent DNA that', 'viral ADP infections'], ['promising  PARPs', 'therapeutically  disease'], ['we', 'future  field'], ['Polymeric  carriers', 'ubiquitously encapsulation cargo'], ['many  polymers', 'immune  signals'], ['However  extent', 'intrinsic immunogenicity degradation'], ['poly(beta amino that', 'similar degradation rates'], ['dendritic  cells', 'low MW fragments'], ['contrast particles', 'classical DC activation example'], ['', 'physicochemical degradation activation example'], ['when  MW', '1500  Da'], ['that', 'immune  vaccine'], ['', ''], ['simple', 'different  disciplines'], ['electrochemical  synthesis', 'gold composite'], ['wherein  AuNPs', 'electrode  surface'], ['prepared  materials', 'physicochemical  methods'], ['modified  electrode', 'modified electro oxidation electrodes'], ['pulse  voltammetry', 'CC'], ['DPV response', '0'], ['', '175'], ['', '5 detection 0'], ['', ''], ['modified  electrode', 'interfering  isomers'], ['sensor', 'excellent  water'], ['Insulin resistance', 'ovary  syndrome'], ['Quercetin', 'such  diabetes'], ['However  quercetin', 'PCOS'], ['study', 'underlying PCOS rat mechanism'], ['PCOS rat model', 'subcutaneous  dehydroepiandrosterone'], ['estrous  cycle', 'treated  rats'], ['Serum inflammatory cytokines', 'immunosorbent  assay'], ['ovarian  expression', 'blot real polymerase chain reaction'], ['nuclear  translocation', 'also NF immunofluorescence'], ['resistant quercetin treatment', 'resistant PCOS model'], ['', ''], ['Quercetin', '1 tumor necrosis factor'], ['Quercetin', 'resistant PCOS rat model'], ['expression', 'ovarian density tissue'], ['Quercetin', 'therapeutic  PCOS'], ['underlying  mechanism', 'ovarian PCOS rat model'], ['', 'herb Polygonum hydropiper'], ['two response surface methodology', 'dissolution protein content'], ['significant PB factors', 'flavonoid protein content'], ['two  RSMs', 'two response variables'], ['mutual  corroboration', 'experimental  design'], ['validation experiment', 'flavonoid dissolution 94'], ['', '00 protein 18'], ['20  %', '21'], ['', ''], ['', '10  control'], ['present  study', 'two stage RSM'], ['', 'International Union International Biochemistry'], ['', ''], ['morphologies', 'polyketone polyamide-6 blends'], ['composition dependence', 'well Kwei equation'], ['intermolecular  interaction', 'two melting point depression'], ['isothermal crystallization kinetics', 'Avrami approach'], ['linear  increase', 'compositions'], ['spherulites', 'identical growth rates'], ['gradually polyamide-6 number', 'blends'], ['We', 'free PCR amplification'], ['microfluidic PCR that', 'optical fiber SPR bimetallic'], ['device', 'only Salmonella spp'], ['', 'subsequent fiber sensor part'], ['resolvable DNA that', '15th  cycle'], ['integrated  device', 'DNA amplification DNA instrument'], ['reusability', 'genetic  analysis'], ['', ''], ['', ''], ['rights', ''], ['polymerase chain reaction', 'molecular biology research'], ['However  presence', 'generally  technique'], ['Recently  use', 'very  PCR'], ['most', 'experimental PCR strategy'], ['PEI)-entrapped PEG Au each', 'different gold contents'], ['role', 'GC PCR PCR'], ['results', 'possible PCR enhancement'], ['round PCR improvement', 'electrostatic PEG Au interactions'], ['', 'rich system thermal conduction'], ['important  findings', 'particularly PCR biology'], ['essential DNA sequencing which', 'molecular biology research'], ['analogues', 'labeled PCR conditions'], ['report', 'LC MS Gel techniques'], ['analyses', 'oligonucleotide Therminator DNA polymerase'], ['', 'prNTP amine polymerase'], ['Hence  prNTPs', 'dyes nucleobase structure'], ['', ''], ['rights', ''], ['', 'slow hydrolysis bacteria'], ['low  which', 'mixed  culture'], ['Therefore  links', 'PS  process'], ['', 'TS sequencing batch ratio'], ['5', 'activated sludge system'], ['apparent NOT N concentration', 'effluent'], ['change', 'activated cycle sludge'], ['', 'PS TS 0'], ['ammonium utilization rate', ''], ['q PCR results', 'PS TS 0'], ['5', ''], ['', ''], ['', ''], ['', ''], ['', 'PS TS 0'], ['However  abundance', 'total  bacteria'], ['', 'former  latter'], ['microcolony', 'PS TS ratio'], ['paper', 'biological wastewater treatment systems'], ['', ''], ['rights', ''], ['DNA vaccine', 'molecular generation vaccine biology'], ['It', 'viral  infection'], ['significant  addressing', 'better  carriers'], ['review', 'nanoscale DNA vaccine'], ['multilevel DNA vaccine that', 'DNA vaccination'], ['nuclear export disorder', 'miRNAs'], ['aberrant  expression', 'certain  cancers'], ['', 'TC  development'], ['we', 'normal cancer tissues'], ['XPO5 we', '1230  controls'], ['Finally luciferase assays', 'XPO5'], ['RNA message levels', 'normal cancer tissues'], ['', ''], ['noble SNP rs11077', 'functional  region'], ['also XPO5 rs11077', 'GT TT P=0'], ['', ''], ['', ''], ['', ''], ['', ''], ['adverse  influence', 'mainly  age'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'M1'], ['', ''], ['following luciferase test', 'critical XPO5 expression'], ['Furthermore patients', 'lower XPO5 expression level'], ['SNP', 'Chinese  population'], ['', 'chronic  diseases'], ['', ''], ['', 'inflammatory  action'], ['great  variety', 'general teas population'], ['reduces', 'cardiovascular  disease'], ['maternal  ingestion', 'ductal  constriction'], ['Fetuses', 'minimal pulsatility substances'], ['entirely  it', 'inflammatory  pathway'], ['dual  behavior', 'dietary  gestation'], ['', 'inflammatory  drugs'], ['translation control', 'physiological gene conditions'], ['relevance', 'solid tissue RNA samples'], ['tissue samples', 'NP40-lysis RNAse inhibitors'], ['sucrose  RNA', 'fraction'], ['problem  that', 'polyA(+'], ['different  components', 'reverse  transcription'], ['nonspecific RNAse inhibitor', 'efficient RNA reaction'], ['Heparin', 'successfully RT PCR reactions'], ['amenable tissue Northern', 'RT PCR analyses'], ['incarcerated life women', 'sexual  assault'], ['We', 'polyvictimization'], ['', ''], ['', 'healthrelated  outcomes'], ['', ''], ['well prevalence rates', 'significantly  women'], ['incarcerated problems drug it', 'incarcerated alcohol women'], ['low  levels', 'incarcerated  women'], ['Porcine CFL2b gene', 'myofibrillar muscle pig'], ['porcine', 'cloning length RACE'], ['full  length', 'C2C12 cells'], ['cells', 'stably  G418'], ['We', 'C2C12 cells'], ['dramatically control level', 'slow  mRNA'], ['Northern', 'skeletal  muscles'], ['', 'nucleotide CFL2b shares'], ['', ''], ['', '9 CFL2b human'], ['', '166 pig shares'], ['', '1 % human'], ['porcine CFL2b', 'muscle fiber MyHC'], ['like virus P1', 'viral  genome'], ['we', 'viral  genes'], ['RNAs', 'northern porcine kidney blotting'], ['specific  RNAs', ''], ['viral  ORFs', 'viral 6 strand'], ['proteins', 'amino P1 ORF1'], ['We', 'viral P1-infected cells'], ['Porcine deltacoronavirus', 'neonatal  piglets'], ['detailed IFN mechanisms', 'interferon beta'], ['like  protease', 'diminished NF PDCoV'], ['PDCoV nsp5 cleavage site', 'common nsp5 cleavage coronaviruses'], ['Furthermore  cleavage', 'IFN response'], ['together  findings', 'immune IFN deltacoronaviruses'], ['which', 'economic pork industry'], ['Inactivated PEDV vaccine', 'key  PEDV'], ['this', 'virus  development'], ['we', 'epithelial strain cells'], ['better Vero titer', 'IEC cultures'], ['', ''], ['', '1  passage'], ['viral S mutations', 'attenuation'], ['survival', '5th  passage'], ['use', 'molecular  virus'], ['farm fomites', 'farm personnel'], ['study', 'experimental biosecurity setting'], ['PEDV RNA', 'reverse polymerase chain reaction'], ['Virus', '19 RNA dpi'], ['Sentinel  pigs', 'first INF group'], ['first days post trial', '24 days post movement'], ['Viral RNA', 'protective LB personnel'], ['however MB transmission', 'virus'], ['swabs', 'HB study personnel'], ['indirect PEDV transmission', 'modeled  conditions'], ['Biosecurity procedures', 'effective PEDV pigs'], ['reproductive  syndrome', 'first  1994'], ['commercial  PRRS', 'live  vaccine'], ['', ''], ['2 Joseph Missouri PRRSV', 'old  1996'], ['objective', 'recent  isolates'], ['', '5 challenge virus'], ['Regardless', 'effectively lung lesions'], ['interferon gamma secreting cells', 'immune PRRSV viremia'], ['', 'immunological PRRS responses'], ['PRRS MLV', '35 million 35 pigs'], ['', ''], ['rights', ''], ['Porcine rotavirus', 'dehydrating  piglets'], ['immunosorbent antigen assay', 'polyclonal group A antibodies'], ['detection limit', 'reverse RT 10(2'], ['', ''], ['', 'conventional RT PCR'], ['sensitivity', 'relative RT qPCR'], ['', 'strong  agreement'], ['', 'two  techniques'], ['Total detection rate', 'conventional RT PCR'], ['', ''], ['', ''], ['', 'significant  difference'], ['Moreover AC ELISA', 'virus transmissible gastroenteritis virus'], ['highly  which', 'preventive porcine farms'], ['new  class', 'much building attention'], ['design', 'good  porosity'], ['', 'porous formaldehyde dimethyl polymer'], ['Moreover amine groups', 'synthetic modification method'], ['porous polymer POP NH2', 'aqueous  solution'], ['q(max  evaluated', 'Langmuir model'], ['', ''], ['easily coordination which', 'efficient  adsorption'], ['generated POP NH2', 'significant adsorption efficiency'], ['potential POP NH2', 'aqueous metal solution'], ['', ''], ['', ''], ['rights', ''], ['developed  which', 'promising feedback delay'], ['most', 'nonlinear  controller'], ['we', 'degree position system'], ['analysis', 'act differential controller'], ['performed  investigation', 'also deadbeat delay'], ['unbounded  which', 'unbounded  stability'], ['we', 'digital position control'], ['system', 'lumped  spring'], ['two  cases', 'collocated'], ['Stability analysis', 'continuous'], ['discrete time approach', 'real  applications'], ['therefore time it', 'constant control system'], ['stability charts', 'sampling time'], ['differences', 'robust parameter variations'], ['emotional action control', 'such conflict irony'], ['emotional conflict processing', 'positive  emotion'], ['', ''], ['', ''], ['2 EEG we', 'cognitive conflict processing'], ['Participants', 'visual stimulus dimension'], ['positive  target', 'emotional conflict processing'], ['emotional conflict costs', 'neutral  targets'], ['we', 'cognitive conflict processing'], ['P200 conflict effect', 'neutral  targets'], ['emotion', 'differently conflict type'], ['This', 'executive  control'], ['positive  emotions', 'critical mood adolescence'], ['This', 'endophenotypic mood disorder onset'], ['present  study', '11 outpatient age'], ['joy', 'increased  depression'], ['Low  levels', 'uniquely  mania'], ['Results', 'age ethnicity gender'], ['findings', 'manic mood symptom adolescence'], ['', 'adolescent emotion development'], ['Research', 'mental  onset'], ['introduction', 'diagnostic breakthrough DSM5'], ['It', 'clinical  psychology'], ['study', 'complex  psychopathology'], ['positive  emotions', 'human research psychopathology'], ['which', 'folded Op amp structure'], ['new  technique', 'open Op linearity'], ['proposed  structure', 'typical HSPICE 0'], ['', ''], ['', 'estimated HSPICE simulation improvements'], ['Traditionally  treatments', 'positive  resources'], ['study', 'behavioral psychology therapy'], ['clinical  trial', 'major DSM IV depression'], ['Participants', '10-session  47'], ['interventions', 'well  being'], ['', 'main  outcomes'], ['', ''], ['', 'depressive  symptoms'], ['', ''], ['', 'positive  life'], ['', 'depressed  PPI'], ['this', 'treatment patients'], ['Posner Schlossman which', 'ocular  hypertension'], ['intraocular  pressure', 'glaucoma  medications'], ['', 'intraocular Posner Schlossman pressure'], ['33 case series who', 'medication'], ['clinical  factors', 'surgical  groups'], ['surgical  group', 'endothelial  cell'], ['', ''], ['', ''], ['', 'positive  cytomegalovirus'], ['', 'surgical  group'], ['Eighteen', 'high CEC reduction ratio'], ['', 'required glaucoma surgery'], ['PSS patients', 'such glaucoma surgery'], ['intraocular anterior that', 'secondary  glaucoma'], ['rare  disease', 'aged cytomegalovirus males'], ['Diagnosis', 'infectious  cause'], ['systemic  therapy', 'topical  treatment'], ['We', 'current treatment options'], ['', ''], ['rights', ''], ['that', 'social  factors'], ['article', 'northeastern United States'], ['educational  experiences', 'academic street development'], ['current  each', 'face  interview'], ['higher education program', 'key research participants'], ['personal  agency', 'future crime avoidance'], ['pathological  mechanisms', '15  mothers'], ['Ovariectomized adult mice', 'simulated  pregnancy'], ['binding protein phosphor neurosteroidogenesis', 'late EW EW'], ['like  behaviors', 'late EW mice'], ['phosphor CREB', 'late EW mice'], ['treatment', 'like phosphor CREB'], ['nNOS inhibitor', 'reduced HSP mice'], ['steroidogenic  StAR', 'late EW mice'], ['sigma-1 receptor', 'early EW mice'], ['pharmacological  blockade', 'like NO CREB'], ['late EW which', 'sigma'], ['TrkB receptor activator', 'early EW mice'], ['activation', 'increasing CREB activities'], ['study', 'depressive severity symptoms'], ['183 postpartum who', 'longitudinal childhood mother'], ['Participants', 'depressive symptom severity'], ['results', 'identified CM severity'], ['interaction', 'interpersonal CM severity'], ['final  model', '29 PDS scores'], ['study', 'surviving childhood women'], ['income', 'when family support'], ['this', 'at  mothers'], ['Postpartum depression', 'new  mothers'], ['adverse life events', 'increased  PPD'], ['Immigrant  women', 'general  population'], ['prevalence', '10 Pakistani 7'], ['6  %', ''], ['Somali  people', 'Western  background'], ['study', 'Somali  literature'], ['aim', 'greater Oslo region'], ['sectional  survey', 'new Oslo region'], ['Data', 'administrated  questionnaires'], ['PPD', 'possible Postnatal Depression PPD'], ['', '49  study'], ['', '39  respondents'], ['7  %', 'possible  PPD'], ['associated  factors', 'economical  problems'], ['prevalence', 'associated  caution'], ['associated  factors', 'enough  associations'], ['However  some', 'Western  society'], ['Postpartum depression', 'reproductive  age'], ['public  it', 'maternal  morbidity'], ['When postpartum depression', 'depressive  disorder'], ['Many  studies', 'bipolar  disorder'], ['article', 'mixed disorder features'], ['safety', 'antidepressant  pregnancy'], ['accurate postpartum identification', 'proper  treatment'], ['controlled postpartum trials', 'conflicting  results'], ['paucity', 'depressive  disorder'], ['controlled depression trials', 'postpartum bipolar postpartum depression'], ['magnitude', 'independent coronary artery disease'], ['', 'standardized fatty test meal'], ['We', 'endothelial cell adhesion cells'], ['adherence', 'monocyte adhesion'], ['Incubation', 'intercellular surface selectin'], ['increased  amounts', 'postprandial ICAM-1 LDL'], ['adhesion', 'postabsorptive  LDL'], ['We', 'increased novo protein monocytes'], ['upregulation', 'postprandial  lipemia'], ['', ''], ['rights', ''], ['Transcriptional Gene which', 'annual Austin Texas'], ['molecular  biology', 'such  drought'], ['related  technologies', 'transcriptional gene level'], ['interacting  RNAs', \"fully 2'-O 3'-termini\"], [\"3'-nucleotide which\", 'destabilization'], ['we', \"2'-O  piRNAs\"], ['early  treatments', 'traumatic stress children'], ['natural month recovery', 'still  trauma'], ['trials', 'PTSD  i'], ['', ''], ['', ''], ['', 'PTSD waiting 10weeks'], ['more  participants', '95 % difference'], ['', ''], ['', ''], ['CT PTSD', 'PTSD report questionnaire depression'], ['CT PTSD', '12-month 6- posttreatment'], ['Beneficial  effects', 'cognitive CT PTSD'], ['CT PTSD', 'low  dropout'], ['ConclusionsThis trial', 'early CT youth'], ['Moreover  trial', 'particularly WL functioning'], ['larger  attention', 'recruitment issues'], ['ObjectiveTo', 'epidemiological Australian partners'], ['twice  partners', '2012'], ['also  who', 'children'], ['Statistical  analysis', '95 % confidence families'], ['PTSD  diagnoses', 'trauma exposure trauma PTSD'], ['other partner PTSD', 'other  sons'], ['Veteran  depression', 'veteran alcohol PTSD'], ['PTSD', 'specifically Vietnam veteran sons'], ['Posttraumatic stress disorder', ''], ['different  effects', 'PTSD'], ['We', 'systematic meta question'], ['We', 'electronic  August'], ['Additional  articles', 'personal reference collections'], ['Combined sample size', 'controlled rTMS groups'], ['LF  rTMS', 'total  score'], ['total  score', 'SMD'], ['', ''], ['', ''], ['', ''], ['', 'SMD'], ['', ''], ['', ''], ['', ''], ['HF  rTMS', 'following  results'], ['', 'total  SMD'], ['', ''], ['', ''], ['', ''], ['', 'experiencing  SMD'], ['', ''], ['', ''], ['', ''], ['', 'SMD'], ['', ''], ['', ''], ['', ''], ['', 'SMD'], ['', ''], ['', ''], ['', ''], ['', 'SMD'], ['', ''], ['', ''], ['', ''], ['', 'SMD'], ['', ''], ['', ''], ['', ''], ['Therefore  HF', 'PTSD LF symptoms'], ['limited LF rTMS', 'overall  PTSD'], ['HF rTMS', 'main  PTSD'], ['additional  research', 'findings'], ['', ''], ['rights', ''], ['early life trauma', 'posttraumatic stress disorder'], ['goal', 'abuse PTSD childhood abuse symptoms'], ['Subjects', 'urban  hospital'], ['Psychotic  disorders', 'PTSD Traumatic Events Inventory'], ['child abuse', 'psychotic lifetime trauma load'], ['numbing  symptoms', 'demographic  variables'], ['bootstrapping  we', 'early child life'], ['continued  research', 'such  models'], ['Identifying', 'successful treatment interventions'], ['', ''], ['', 'Elsevier Ltd'], ['neuronal  synchronization', 'synaptic chain excitation'], ['synchronous epileptiform activity', 'synaptic  transmission'], ['seizure  we', 'realistic K+ ions'], ['detailed  modeling', 'ionic  dynamics'], ['lasting extracellular which', 'pathological  discharges'], ['effect', 'synaptic  network'], ['results', 'nonsynaptic  transition'], ['present review work', 'ceramic temperature materials'], ['technology developments', 'containing gases solids'], ['special  attention', 'basic operation principles'], ['existing  problems', 'analysis'], ['', ''], ['', ''], ['rights', ''], ['Electrochemical  biosensing', 'bacterial  contaminants'], ['electrochemical  which', 'potentiometric  amperometric'], ['several  researchers', 'based  potentiostats'], ['advances', 'low power paper'], ['', 'cost detection environment'], ['current sensor value', 'electrochemical redox system'], ['which', 'operational amplifier core'], ['appropriate circuit design', 'various amperometric front account'], ['bare custom CMOS which', 'electronic paper components'], ['two CMOS amplifier circuit', 'ams'], ['IC', 'project wafer manufacturing run'], ['simulated  results', '2'], ['4  MHz', 'common mode rejection 70'], ['', 'dB  0'], ['154  which', 'analytical  values'], ['Accurate  identification', 'agricultural control production'], ['aim', 'Potato potato'], ['', 'Natal South Africa'], ['Potato leaf samples', 'different  district'], ['Initial  detection', 'triple antibody ELISA'], ['positive  samples', 'specific PVY serotypes O'], ['cv Samsun plants', 'positive  samples'], ['Symptoms', '4-week tobacco period'], ['They', 'veinal PVYN PVY(N)Wilga'], ['Reverse polymerase chain reaction', 'four PVY areas'], ['Strains PVYN', ''], ['second  part', 'full A4 KD2 Msinga'], ['', 'total tobacco leaves'], ['cv Samsun cv that', 'next PVY NGS'], ['125 end 125bp', 'paired end chemistry'], ['de novo assembly', 'generated  reads'], ['resulting  contigs', 'PVY genomes'], ['recombinant PVY sequences', 'following  strains'], ['Recombination events', 'RDP4 software'], ['SneP3', 'PVY N group'], ['Recombination analyses', 'recombinant Msinga district'], ['widespread  presence', 'growing scale livelihood'], ['', ''], ['rights', ''], ['', 'multiWatt frequency range'], ['', '1'], ['output amplitude', 'digital input words'], ['amplifier', 'common gate mode'], ['power supply voltages', '15  V'], ['load resistance', 'bandwidth output matching networks'], ['W Output efficiencies', '50  bandwidth'], ['electronic  load', 'current power source testing'], ['electronic  which', 'electronic  load'], ['compared power control result', 'electronic power transistor load'], ['keyboard', 'interactive man interface'], ['operational feedback it', 'current'], ['voltage follower', 'differential  voltage'], ['Moreover overcurrent protection function', 'robustness'], ['electronic  converters', 'different system events'], ['which', 'real system time'], ['based dc dc', 'boost converter'], ['sliding control manifold', 'digital memory hardware'], ['dynamic  that', 'many  system'], ['', ''], ['rights', ''], ['large power which', 'interprovincial power transmission'], ['fuel mix', 'provincial power transmission'], ['Provincial CO2 emissions', 'based consumption perspective'], ['total CO2 emissions', 'total power sector'], ['embodied  emissions', '94  2007'], ['general transfer pathway', 'long range power transmission'], ['disparities', 'CO2 provinces'], ['based  emissions', '%  production'], ['study', 'most CO2 period'], ['', ''], ['', ''], ['rights', ''], ['simple cycle control strategy', 'boost PFC converter'], ['duty cycle', 'current output cycle'], ['operating  principles', 'control detail'], ['high power factor', 'proposed control strategy'], ['results', ''], ['Continuous AC DC converters', 'medium output power'], ['reactive input power', 'second DC link voltage'], ['speed', 'distorted input current'], ['wherein voltage estimation integrator', 'second order frequency'], ['approach', 'harmonic input current'], ['also  it', 'DC costs'], ['authors', 'current feedforward loop'], ['current  corrector', 'wide load range'], ['effectiveness', 'proposed control simulation'], ['study', 'current shaping loop'], ['', 'such wind power systems'], ['small wind power system', 'proposed PFC control'], ['achieved power factor', '99'], ['', ''], ['predictive control strategy', 'dynamic power factor response'], ['converter circuit values', 'next switching advance'], ['optimized duty cycle', 'dynamic PFC converter'], ['single phase boost', 'field programmable gate array'], ['digital control strategy', 'dynamic PFC converter'], ['PFC power factor converter', 'many  applications'], ['', 'continuous conduction mode'], ['light load converter', 'discontinuous conduction mode'], ['current  which', 'low power factor'], ['Moreover  effect', 'input current'], ['paper', 'current duty ratio controller'], ['increase', 'boost PFC converter'], ['paper', 'portable power generator'], ['design', '0'], ['low dc dc', 'switching power capability'], ['4 output we', '95 power 300'], ['control stage', 'analogto- digital control losses'], ['converter', '98 tracking %'], ['detailed  study', 'calculated inductor results'], ['article', 'active voltage source'], ['coupling DC transformer', 'electrical power grid'], ['control that', 'compensation voltage algorithm'], ['topology  strategy', 'active simulation software'], ['Experimental  results', 'international IEEE Standard'], ['article', 'switched power supply'], ['proposed  technique', 'offline dc dc converter'], ['new  it', 'overall design process'], ['High  penetration', 'renewable variability uncertainty'], ['widely optimal scheduling', 'FR'], ['stochastic scheduling that', 'simultaneously energy production'], ['single security model', 'reduced load curtailment'], ['proposed  model', '2030-GB  effectiveness'], ['impact', 'installed wind VOLL'], ['combination', 'renewable energy sources'], ['conversion', 'often  electrification'], ['high  finding', 'positive business case'], ['study', 'FC ELY flexibility'], ['potential', 'secondary control Germany'], ['', 'purpose year'], ['squared  errors', 'forecast errors'], ['different bidding strategies', 'SCR account'], ['applications', ''], ['However  profitability', 'highly  configuration'], ['', ''], ['rights', ''], ['paper', 'operational Logic Controller design'], ['mathematical  realization', 'function'], ['operational amplifier that', 'acquired circuit background'], ['We', 'Prader Willi syndrome'], ['genetic language comprehension modality', 'executive  functions'], ['latter', 'social recognition face norms'], ['Results', 'relevant brain imaging cognition'], ['importance', 'small numbers replication'], ['', ''], ['rights', ''], ['Pragmatics', 'peripheral language evolution research'], ['This', ''], ['aims', 'field'], ['transcriptional repeat protein that', 'anterior prolactin promoter rats'], ['PREB', 'adipose  tissue'], ['PREB', '3T3L1 adiponectin preadipocytes'], ['aim', 'adipose  vivo'], ['that', 'PREB'], ['Insulin resistance', 'transgenic  glucose'], ['Adiponectin expression', 'western blot analysis'], ['expression levels', '2(ADIPOR2 adiponectin qPCR'], ['Results Glucose', 'transgenic insulin mice'], ['Serum adiponectin', ''], ['adipose  which', 'transgenic ADIPOR2 mice'], ['activated receptor r', '10-day feeding period'], ['PREB', 'adiponectin gene vivo'], ['early parent infant interaction', 'crucial  that'], ['Infants', 'developmental time needs'], ['social care which', 'pregnant decision women'], ['case study', 'care pathway'], ['mother', 'six post months'], ['birth risk assessment process', 'further  evaluation'], ['current sensing applications', 'paper'], ['proposed  structure', 'common supply rail'], ['Furthermore  solution', 'entire operating voltages'], ['proposed  circuit', 'typical  0'], ['25 CMOS BCD technology', 'simulations'], ['Decision support methodologies', 'operational decision problems'], ['Special  attention', 'efficient decision field'], ['weed integration', 'automatic weed recognition procedures'], ['objective', 'operational decision support precision'], ['it', 'appropriate weed technology'], ['potential  gains', 'increased cost precision'], ['however conditioning reward role', 'declarative  encoding'], ['', 'current probability experience'], ['unimodal probability PE', 'prior  evidence'], ['We', 'previous scene item scene'], ['two foil items', 'same target item'], ['new  pairing', 'prior  PE'], ['inconsistent  priors', 'new  pairing'], ['sensory  evidence', 'better  memory'], ['PE hypotheses', 'experiments'], ['PIMMS Multiple Memory framework', 'full  results'], ['', ''], ['', 'Elsevier Inc'], ['This', 'open CC BY license'], ['occurrence', 'clinical spectrum challenge'], ['computational psychiatry that', 'predictive  coding'], ['symptoms', 'bottom prediction errors'], ['Likewise  autism', 'similar  perturbations'], ['theoretical  overlap', 'overlapping  symptomatology'], ['Experimental  evidence', 'meaningful  disorders'], ['additional  hallucinations', 'distinct  process'], ['Predictive  control', 'widely power electronics'], ['further  developments', 'still energy investigation'], ['principles', 'predictive  control'], ['two control strategies', 'flexible power supply'], ['They', 'PV energy systems'], ['active laboratory prototype powers', 'state  performance'], ['penetration level', 'renewable energy systems'], ['pathological  conditions', 'such  preeclampsia'], ['NKG)2D killer receptor', 'killer  preeclampsia'], ['they', 'important  pregnancy'], ['present trophoblast cell which', 'closely  preeclampsia'], ['present ULBP1 expression levels', 'pregnant polymerase chain reaction'], ['effects', 'SVneo uNK cells'], ['protein expression levels', 'ULBP1'], ['', 'normal  controls'], ['NKG2D uNK that', 'extravillous uNK cells'], ['biological uNK which', 'trophoblast invasion'], ['brain behavior which', 'patient  care'], ['', 'frontal lobe epilepsy'], ['objective', 'frontal lobe epilepsy'], ['relationship', 'dispositional  FLE'], ['study', 'experimental  paradigm'], ['Sixty patients', 'Sheikh Zayed'], ['healthy  individuals', 'control subjects'], ['Participants', 'interpersonal reactivity index'], ['Following  they', 'drawing test switching experiment'], ['Patients', 'weaker  PCF'], ['', ''], ['', 'healthy control subjects'], ['Patients', 'healthy control subjects'], ['', 'affective  empathy'], ['Cognitive', 'potential  PCF'], ['Cognitive  empathy', 'cortical  FLE'], ['cognitive  empathy', 'efficient  PCF'], ['how IPV associations', 'sex'], ['291  we', 'within IPV relationship'], ['us', 'correlated  data'], ['', 'income relationship duration'], ['64  %', 'IPV'], ['', ''], ['', ''], ['', ''], ['', ''], ['', '001 IPV group'], ['', 'perceived IPV profile'], ['', ''], ['anxiety equity depression', 'significant sex interaction'], ['', ''], ['psychological  couples', 'healthiest  characteristics'], ['Females', 'high  risk'], ['Couple level interventions', 'young IPV behaviors'], ['', ''], ['purpose', '20 teen U'], ['', ''], ['', 'young adult females'], ['total', '5972 Adult Health'], ['sexual orientation identity', ''], ['multivariate regression models', 'sexual victimization history'], ['sexual bisexual women', 'heterosexual teen pregnancy'], ['', ''], ['', ''], ['association', 'sexual risk behaviors'], ['Bisexuals', '18 teen pregnancy'], ['', ''], ['', ''], ['', ''], ['lesbian  women', 'less teen pregnancy'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'final  models'], ['extant  we', 'sexual risk taking'], ['particularly  bisexuals', 'young  women'], ['', '2016 Adolescent Health'], ['rights', ''], ['psychosocial risk that', 'other birth stress'], ['Better  understanding', 'maternal risk outcomes'], ['objective', 'subsequent term birth pregnancy'], ['Analyses', 'Canadian birth cohort'], ['Data', 'administered study entry'], ['Pregnancy anxiety', 'prenatal study visits'], ['Results', 'previous 3D pregnancy'], ['prior pregnancy miscarriage', 'first pregnancy trimester'], ['Prior  stillbirth', 'third pregnancy trimester'], ['elective  abortion', 'third pregnancy anxiety trimester'], ['outcomes', 'conceptual pregnancy anxiety'], ['', 'mental  disorders'], ['Models', 'neurological  development'], ['biological  that', 'biological  factors'], ['aetiological  model', ''], ['discussion', 'mental risk disorder'], ['Maternal anxiety disorder', 'neonatal parenting outcome'], ['Available  evidence', 'early  attachment'], ['Transgenerational  mechanisms', 'early  risk'], ['Maternal anxiety', 'mental risk health'], ['Development', 'important risk reduction strategies'], ['early  identification', 'preventive  interventions'], ['maternal  history', 'pregnancy childhood obesity'], ['when years they', 'Childhood Trauma Questionnaire'], ['CTQ score', 'severe  maltreatment'], ['mental  health', 'maternal Trait Anxiety Inventory'], ['', ''], ['', ''], ['', '75th percentile 75th women'], ['', ''], ['', ''], ['', ''], ['Risk', 'gestational weight gain'], ['', ''], ['', ''], ['', 'anxious CTQ women'], ['association', 'anxious  women'], ['', ''], ['', ''], ['', ''], ['Prenatal depression', 'maltreatment  gain'], ['Factors', 'pregnancy  obesity'], ['', 'CD8(+ T cells'], ['asmemory T cells', 'maternal  health'], ['associated  antigens', 'normal adult tissues'], ['elicited', 'placenta tumor antigen'], ['type H2b fetuses', 'OVA'], ['specific T cells', '24  weeks'], ['cells', 'bred  females'], ['G7-OVA thymoma cells', 'virgin type growth'], ['virgin  progression', 'wild  type'], ['CD8(+ T cell that', 'delayed OVAexpressing pregnancy'], ['data', 'placenta tumor antigens'], ['specific T which', 'same cancer antigen'], ['risk', 'generations'], ['old  children', 'increased  asthma'], ['1551  Babies', 'prospective pregnancy cohort'], ['24  she', 'medical  diagnoses'], ['Symptoms', '24 months postpartum'], ['Unadjusted  models', 'more  asthma'], ['', '4  4'], ['', ''], ['', ''], ['', '6  9'], ['', ''], ['', ''], ['Maternal  symptoms', 'maternal  CA'], ['Maternal  symptoms', 'maternal  CA'], ['old  symptoms', 'maternal  variables'], ['serum drug concentrations', 'prognostic withdrawal symptoms'], ['observational monocenter cohort study', 'psychotropic  drugs'], ['logistic  regression', 'multivariate analysis'], ['', '186  22'], ['6  %', 'neonatology ward'], ['', '5  withdrawal'], ['', 'therapeutic psychotropic medication'], ['0  %', 'withdrawal symptoms'], ['', 'undetectable odds 3'], ['', ''], ['', ''], ['', 'odds 20'], ['', ''], ['', ''], ['', 'withdrawal symptoms'], ['Therapeutic  concentrations', 'undetectable drug concentrations'], ['measurement', 'clinical withdrawal symptoms'], ['immune  system', 'paternal  which'], ['embryo feto unit', 'harmful defense reactions'], ['Indeed  this', 'seminal  plasma'], ['pregnancy complications', 'premature lab mouse models'], ['also  what', 'women'], ['female  mouse', 'human  female'], ['Nevertheless  it', 'human mouse studies'], ['uterine  that', 'talk'], ['Issues', 'immune system cells'], ['visual processing skills', 'influence  performance'], ['multi element processing', 'decoding sight reading'], ['reading One children', 'MEP naming speed'], ['Early reading level', 'first  grade'], ['low frequency words', 'short reading high-'], ['Results', 'low frequency words'], ['reading  MEP', 'decoding  skill'], ['reading  MEP', 'future  reading'], ['', ''], ['rights', ''], ['concerns', 'psychiatric treatment patients'], ['', 'large university hospital department'], ['', 'psychiatric Hospital Risskov Denmark'], ['Information', '25-item survey form'], ['p value', 'squared  test'], ['05', ''], ['study', '41 pilot patients'], ['1 month total', '90 age years'], ['', ''], ['One hundred eighty patients', 'pharmacological psychotropic therapy'], ['Ninety seven', '49  psychotherapy'], ['', 'physical  therapy'], ['', 'pharmacological  therapy'], ['26 Fifty patients', 'monotherapy'], ['Mean number', 'treatment patient'], ['', 'patients'], ['', 'inpatients'], ['', 'settings department categories'], ['psychotropic  medication', 'applied  treatment'], ['Psychiatric  disorders', 'Great  Recession'], ['psychotropic  who', 'administrative  data'], ['psychotropic  who', '12  months'], ['who', 'economic propensity score matching'], ['one drug difference', 'only  males'], ['Females subjects', 'respectively males subjects'], ['who', 'job'], ['', ''], ['', ''], ['', 'psychotropic drugs females'], ['variance style pressure sensor', ''], ['fault', 'basis'], ['bridge output signal', 'amplifier detection signal'], ['when changeless input signal', 'drift failure'], ['change laws', 'them'], ['different  failure', 'works'], ['such fault evaluation', 'such fault location'], ['value', 'true fault fault'], ['renewable salinity which', 'large  scale'], ['we', 'economic power viability'], ['conclusively operating that', 'conclusively operating conditions'], ['state PRO we', 'US$  1'], ['', '$  0'], ['', 'reverse osmosis brine'], ['', '2 MW production system'], ['18  water', '$ wind 0'], ['', ''], ['We', 'membrane structural membrane parameter'], ['latter  method', 'more membrane permeability coefficient'], ['', ''], ['', ''], ['rights', ''], ['Child Welfare that', 'national child abuse'], ['present  study', '2008  amendment'], ['aim', 'such  incidents'], ['focal  who', 'caregivers'], ['Conflict Tactic which', 'Straus et al'], ['', ''], ['occurrence rate', 'CPPM'], ['', '3 income poverty region'], ['who', 'more  siblings'], ['implications', 'further  research'], ['prevalence', 'male  infertility'], ['prevalence', 'psychological depression symptoms'], ['', ''], ['', ''], ['', 'current Mental Health Inventory-5'], ['Differences', 'psychological age symptoms'], ['Clinical  factors', 'depressive risk symptoms'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['infertility duration', 'high anxiety 3'], ['', ''], ['', ''], ['', ''], ['', ''], ['clinical  conditions', 'psychological risk symptoms'], ['reproductive  who', 'psychological  distress'], ['haemoparasitic  diseases', 'where host pathogen'], ['livestock some', 'public  health'], ['primary  aim', '1727 blood Turkey'], ['PCR polymerase chain tests', 'specific polymerase chain reaction'], ['DNA samples', 'specific Theileria sp'], ['', ''], ['', ''], ['', ''], ['luwenshuni Babesia', 'Anaplasma ovis'], ['RLB', 'known Theileria Babesia Anaplasma'], ['diagnostic  sensitivity', 'single  species'], ['', ''], ['43  %', 'specific  PCR'], ['', 'Theileria sp'], ['', ''], ['', ''], ['uilenbergi', 'first Babesia motasi B'], ['', ''], ['separata', 'molecular  methods'], ['high  prevalence', 'PCR  that'], ['', ''], ['42  %', 'multiple  species'], ['80  %', 'mixed  T'], ['', ''], ['', ''], ['RLB approach', 'such Theileria sp'], ['', ''], ['', ''], ['', ''], ['', ''], ['pathogens', 'highly  Turkey'], ['diagnostic  sensitivity', 'generally  RLB'], ['latter  approach', 'mixed species infections'], ['use', 'infected pathogen hosts'], ['Burgeoning  research', '3  life'], ['Early  exposure', 'developmental health childhood'], ['Scientists', 'young  brain'], ['functioning parent child that', 'parenting'], ['Capitalizing', 'young well children'], ['', 'public health prevention framework'], ['Primary prevention programs', 'such home visiting'], ['Secondary prevention models', 'maternal risk depression'], ['Tertiary programs', 'therapeutic parent child dyad'], ['Empirical  knowledge', 'young child welfare services'], ['focused child that', 'struggling preventative families'], ['particularly  that', 'neglect'], ['exactly health this', 'often health what'], ['', 'successfully injury prevention'], ['which', 'public protection risk factors'], ['broad  overview', 'program  design'], ['framework', 'social  children'], ['It', 'holistic child maltreatment'], ['Inadequate  access', 'German health system'], ['', 'Sexual Outpatient Clinic St'], ['', ''], ['', ''], ['', 'work'], ['Medical outreach services', 'transmitted  August'], ['clarification', 'free trichomoniasis SW'], ['total', '112  55'], ['', '4 STI Outreach Study'], ['', 'SW'], ['6  %', 'immigrant  background'], ['', ''], ['3  %', 'SW'], ['', ''], ['0  %', 'health insurance'], ['following  STIs', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['results', 'STI Germany'], ['Treatment', 'German STI Society'], ['offer', 'medical  Bochum'], ['further  improvement', 'services'], ['analytically event which', 'noncooperative  game'], ['Next  we', 'pollution control problem'], ['We', 'different parameter values'], ['', ''], ['', ''], ['rights', ''], ['Respiratory tract infections', 'linked  agammaglobulinemia'], ['', 'such bowel patients'], ['aim', 'respiratory XLA individuals'], ['66 Memorial Health boys', 'provisional  agammaglobulinemia'], ['Forty four Forty subjects', 'diagnostic European XLA'], ['retrospective  analysis', 'medical XLA patients'], ['respiratory tract infections', 'common  XLA'], ['GI disorders', 'main  manifestation'], ['6  %', 'respiratory tract infections'], ['GI which', 'generally immunoglobulin therapy introduction'], ['Single  episodes', 'two Campylobacter jejuni individuals'], ['bowel  disease', 'mild  one'], ['Gastrointestinal  disorders', 'respiratory tract infections'], ['usually immunoglobulin therapy', ''], ['Infections', 'Giardia lamblia'], ['exceptionally  which', 'normal T cell immunity'], ['how  interface', 'less  attention'], ['public  patients', 'insured  themselves'], ['choice', 'such user fees payments'], ['I', 'fair access provider integrity'], ['I', 'informed physician patient consent'], ['briefly  that', 'normative health policy'], ['1 expression molecules', 'tumours'], ['solid adhesion molecule expression', 'cells'], ['Inoculation', 'peritoneal immunodeficiency cavity'], ['respectively DNA microarray expression', 'significantly  effusion'], ['Five  genes', 'important adhesion leukocytes'], ['binding  protein', 'solid DNA microarray'], ['coronin 1A', 'solid  lymphomas'], ['lytic  proteins', 'solid effusion lymphoma'], ['gene mouse differences', 'solid effusion lymphoma'], ['protein synthesis', 'strictly mRNA production'], ['', '2006 Great Britain'], ['', 'John Wiley'], ['System inertia reduction', 'primary frequency control'], ['Electrification', 'primary frequency control'], ['paper', 'primary frequency response'], ['dynamic power model', 'primary frequency response EVs'], ['stochastic system scheduling tool', '2030 system scenarios'], ['paper', 'synthetic wind turbines'], ['', ''], ['rights', ''], ['broad  spectrum', 'primary  immunodeficiencies'], ['Management', 'immune  support'], ['growing  ability', 'targeted  therapeutics'], ['review', 'autoimmune cytopenias rheumatologic disease'], ['We', 'complex PID patient population'], ['', ''], ['', 'Elsevier Inc'], ['', 'Allergy Asthma'], ['This', 'open NC ND license'], ['large  majority', 'present  childhood'], ['most  patients', 'large childhood years'], ['cellular antibody disorders', 'older  patients'], ['even  those', 'severe  adulthood'], ['', 'therefore presentation approach'], ['', '2016 Allergy Asthma'], ['Immunocompromised  patients', 'vaccine preventable vaccine infections'], ['Thus vaccination', 'critical  population'], ['Vaccines', 'inactivated  vaccines'], ['when  they', 'immunosuppressive antibody therapy'], ['viable  vaccines', 'immunocompromised  patients'], ['greater  caution', 'adverse  vaccine'], ['we', 'immune immunodeficiency disorders'], ['', '2016 Allergy Asthma'], ['Bluetongue virus', 'occasionally family deer'], ['microRNA expression which', 'viral gene replication'], ['cellular sequencing miRNAs', 'ST sheep BTV'], ['target genes', 'known  miRNAs'], ['differentially mRNA targets', 'reverse polymerase chain reaction'], ['carcinogenesis FoxO JAK STAT', 'pathways'], ['study', 'further BTV replication'], ['', ''], ['', ''], ['rights', ''], ['Primary Syndrome', 'polyclonal autoantibody production'], ['human  homologue', 'negative  p53'], ['autoantibody', 'systemic lupus erythematosus patients'], ['purpose', 'pSS  patients'], ['Methods', 'normal 100 ELISA'], ['Positive  samples', 'western  blotting'], ['Expression', 'normal gland immunohistochemistry'], ['pSS laboratory patients', 'MDM2 laboratory positive'], ['presence', 'pSS  patients'], ['', 'normal  controls'], ['', ''], ['MDM2', 'pSS  patients'], ['pSS patients', 'labial disease gland'], ['Prevalence', 'MDM2 anemia autoantibody'], ['Titer', 'positively disease activity IgG'], ['MDM2 autoantibody', 'serological disease activity evaluation'], ['us', 'pathogenesis mechanism'], ['controlled flyback converter', 'full load range'], ['working  modes', 'main power losses analysis'], ['which', 'light load efficiency'], ['prototype', 'mode control strategy'], ['attractive  attributes', 'flexible form factor'], ['printed  elements', 'largely  silicon'], ['$ 73 intelligence', '$ 73 2027'], ['Nevertheless  many', 'organic  electronics'], ['we', 'mixed  circuits'], ['We', 'associated constituent chain'], ['challenges', 'critical  circuits'], ['contemporary design philosophies', 'organic  electronics'], ['constituent supply that', 'associated penalties thereto'], ['Fibrolamellar  carcinoma', 'often DNAJBI PRKACA'], ['Fibrolamellar  carcinoma', 'cirrhotic  livers'], ['alternate optimal systems', 'future'], ['effective  treatment', 'fibrolamellar  carcinoma'], ['investigation', 'fibrolamellar  carcinoma'], ['', ''], ['rights', ''], ['PRL-1', 'tissue cell types'], ['however  little', 'human cell tissues'], ['PRL-1 expression genes', 'situ adult hybridization'], ['ubiquitously  they', 'different  expression'], ['tissue PRL-1 expression levels', 'both tissue individuals'], ['Widespread  expression', 'normal tissue homeostasis'], ['variable  patterns', 'distinct  tissue'], ['', 'dendritic cytokine cells'], ['Cytokine  production', 'cytometric  analysis'], ['kinetics', 'Northern cytokine blotting'], ['involvement', 'pharmacological signaling inhibitors'], ['studied  bacteria', 'dependent  manner'], ['', 'detailed  S'], ['', 'THS B'], ['', ''], ['', ''], ['bacteria', 'pathogenic HLA class bacteria'], ['However  bacteria', 'cytokine gene expression'], ['', ''], ['thermophilus', '8 IFN breve'], ['lactis', 'inflammatory  IL-10'], ['nuclear NF kappa signaling', 'induced cytokine production'], ['moDC ability', 'bacterial cytokine gene another'], ['', ''], ['rights', ''], ['Spray drying', 'widely food industry'], ['dairy  receiving', 'dry food consumption'], ['Thus  aim', 'physical spray powders'], ['solubility morphological solubility characteristics', '10 moisture content sorption'], ['', 'L'], ['reuteri', '6'], ['log CFU log g', 'bacterial  survival'], ['', ''], ['', ''], ['moisture content', 'gum arabic'], ['gelatin', 'dehydrated  product'], ['', ''], ['rights', ''], ['', 'probiotic vivo purposes'], ['Lactococcus Leuconostoc Lactococcus genera', 'bacterial streptococcus Lactobacillus Bifidobacterium'], ['alpha IFN ELISA', 'alpha IFN gamma'], ['tested  bacteria', 'TNF alpha production'], ['best  inducers', 'Th1 type cytokines'], ['Bifidobacterium  strains', 'studied  bacteria'], ['Stimulation', 'positive host cell interactions'], ['', ''], ['thermophilus', 'probiotic Lactobacillus strains'], ['Bacterial  combinations', 'enhanced cytokine production'], ['', ''], ['rights', ''], ['differences', 'problematic substance nativity'], ['', ''], ['born  foreign', ''], ['', ''], ['legal  resident', 'child abuse'], ['We', 'nativity services status'], ['logistic regression models', 'immigrant service receipt'], ['Rates', 'nativity substance status'], ['Service receipt', 'foreign  born'], ['', '1  U'], ['', ''], ['', ''], ['', ''], ['', 'U'], ['', ''], ['', ''], ['', ''], ['3 services receipt', 'undocumented  parents'], ['', ''], ['Adjusting', '95 services %'], ['disparities', 'undocumented substance use U'], ['', ''], ['', ''], ['protective  effect', 'problematic  i'], ['', ''], ['immigrant  paradox', 'involved child families'], ['', ''], ['rights', ''], ['aimed', 'mental  disorders'], ['process evaluation', 'ECO'], ['delivered recruitment reach dose', 'fidelity satisfaction'], ['online  questionnaire', 'occupational data telephonic researchers'], ['Results Recruitment', 'several  OPs'], ['Reach', '100 OP level'], ['', '3 employee level'], ['Dose', 'OPs'], ['6  %', 'one email message'], ['Dose', '13  %'], ['support', 'ECO'], ['employees', 'intervention'], ['However  employees', 'more  ECO'], ['employee', 'regular  contacts'], ['Conclusion Feasibility', 'ECO'], ['Fidelity', 'OPs'], ['', 'contextual time employees'], ['It', 'clinical emotion anhedonia'], ['positive emotion this', 'extensively memory recall'], ['99 community participants', 'autobiographical  memories'], ['', 'analytical recall condition'], ['HRV heart rate response', 'recall'], ['spontaneous  use', 'greater happiness HRV'], ['experiential  processing', 'analytical sadness experience'], ['', 'significant  conditions'], ['experiential  condition', 'second  memory'], ['engaging', 'positive memory recall'], ['', ''], ['', 'Elsevier Ltd'], ['Procrastination', 'often self regulation'], ['procrastination', 'two  domains'], ['unintentional Unintentional Procrastination this', 'intentional  procrastination'], ['unintentional  that', 'previous  experience'], ['Responses', 'internal components consistency'], ['2 community sample', 'general procrastination procrastination'], ['Data', 'confirmatory factor analysis'], ['UPS', 'then  correlation'], ['six item UPS', 'internal  consistency'], ['UPS', 'existing  study'], ['Results', 'intentional procrastination procrastination'], ['negative  it', 'research  tool'], ['Progesterone', 'experimental animal models'], ['However  effect', 'early  SCI'], ['Here  we', 'behavioral mouse SCI'], ['intravital  imaging', '3 imaging window days'], ['SCI', 'significantly  SCI'], ['', '72 h 48 SCI'], ['densities', 'significantly SCI SCI'], ['', ''], ['Real chain reaction assay', 'cytokines MCP-1 NOS2'], ['', ''], ['PG treatment', 'behavioral performance post injury'], ['PG', 'inflammatory  cytokines'], ['', ''], ['rights', ''], ['checkpoint which', 'basic immunology research'], ['solid  presence', 'TILs'], ['Ipilimumab', 'present T cells'], ['', 'beneficial placebo peptide'], ['However  therapy', 'significant antibody toxicity'], ['therapies', 'PD-1 PD L1'], ['only  benefit', 'patients'], ['', 'first line treatment'], ['many  it', 'drugs  effects'], ['Resistance', 'such tumor JAK1'], ['', 'such monoclonal blinatumomab'], ['The', 'such  precursor'], ['dramatic  costs', 'near health care future'], ['Empathy', 'emotional  experiences'], ['empathy', 'predominant language impairment'], ['current  study', 'progressive  aphasia'], ['16 LPA patients', 'empathy disease onset'], ['healthy control participants', 'empathy  capabilities'], ['Within group analyses', 'patient  groups'], ['affective  empathy', 'similar  LPA'], ['affective  empathy', 'carer  LPA'], ['Between group analyses', 'relative  controls'], ['current  study', 'cognitive  syndromes'], ['Future neuroimaging Future studies', 'empathy  PNFA'], ['spectrum', 'corticotroph cell adenomas'], ['silent corticotroph cell adenomas', 'corticotroph cell disease'], ['aim', 'prohormone CD'], ['We', 'pituitary endoscopic endonasal 2013'], ['CD', '132'], ['', 'recurrent follow tumour'], ['PC1/3 expression', 'primary polymerase chain tumours'], ['strong  expression', 'three tissue CD'], ['immunohistochemical PC1/3 expression', 'strict PC1/3 PCR'], ['immunohistochemical PC1/3 expression', 'recurrent qRT tumours'], ['study', 'crucial PC1/3 CD'], ['RNA interference', 'stranded  RNA'], ['We', 'then M JM109lacY'], ['different Potato resistance', 'different Potato virus'], ['underlying  tumorigenesis', 'permissive  factors'], ['', '2 gene prolactinoma'], ['total', 'healthy  study'], ['Serum prolactin levels', 'immunosorbent  assay'], ['p16', 'restriction fragment polymorphism'], ['', ''], ['G genotype distribution', ''], ['', ''], ['', ''], ['580C genotype distribution', ''], ['', ''], ['0 % %', ''], ['', ''], ['', ''], ['', '6  prolactinoma'], ['Tumor diameter', 'prolactin treatment'], ['719 pG', 'genotype  carriers'], ['', ''], ['', ''], ['', ''], ['', ''], ['decisive MDM2 genotypes', 'follow  prolactinoma'], ['prophenoloxidase', 'important  pathogens'], ['proPO  gene', 'species'], ['novel Litopenaeus which', '72 % identity'], ['mainly  expression', 'white spot syndrome virus'], ['LvproPO-2  LvPO-2', 'L vannamei'], ['LvproPO-2  LvPO-2', 'indirect immunofluorescence assay'], ['findings', 'activating melanization shrimp'], ['', ''], ['rights', ''], ['chemopreventive  agents', 'foods'], ['Artepillin C', 'Brazilian colon carcinogenesis'], ['bioavailable  which', 'intracellular  DNA'], ['Artepillin C', 'human cancer WiDr cells'], ['It', 'inhibited cell G(0)/G(1'], ['events', '4 retinoblastoma Ser'], ['inhibitors', 'Kip1 protein level'], ['artepillin C', 'Kip1  p27'], ['', 'HCT116 lines artepillin cells'], ['Artepillin C', 'chemopreventing colon carcinogenesis'], ['', ''], ['3DOF  cranes', 'industries'], ['It', 'one  place'], ['common  part', 'mostly  cranes'], ['main  tasks', 'trolley jib payload'], ['safety', 'mostly sub tasks'], ['', 'operation trolley crane'], ['jerks', 'usually crane operation'], ['control that', 'reasonable trolley trolley'], ['Moreover reduction', 'payload vibrations'], ['So  it', 'smooth  crane'], ['research we', 'three 3DOF crane'], ['gains', 'two PD methods'], ['performance', 'Matlab  Simulink'], ['results', 'trolley position'], ['former  technique', 'also payload vibrations'], ['It', 'also  trolley'], ['digital  they', 'discrete  domain'], ['Accordingly  article', 'discrete LCL domain'], ['active control delay GRAPHICS', 'digital  plant'], ['controlled damping plant', 'unit circle'], ['resonant controller parameters', 'Nyquist diagrams'], ['theoretical  analysis', 'digital signal processor'], ['we', '56-dehydronorcantharimide linking dimer'], ['Special  attention', 'propylene reaction'], ['covalent g interactions', 'final  rotamers'], ['PES propylene dimers', 'stable crystal structures'], ['internal bond torsional coordinates', 'G gas phase'], ['Then energy minima', 'stable  rotamers'], ['relaxed PES scans', 'reliable energy barriers'], ['method', 'conformational bridging chains'], ['observed  conformation', 'non covalent interactions'], ['', ''], ['', ''], ['rights', ''], ['Early  childhood', 'social language skills'], ['two  processes', 'other'], ['', 'three prosocial age'], ['004  families', 'Millennium Cohort Study'], ['expressive  language', 'standardized prosocial assessments'], ['lagged  models', 'data analysis'], ['expressive  language', 'five prosocial years'], ['support', 'inverse  association'], ['early  ability', 'formal  schooling'], ['expressive toddler language', 'targeted skill development'], ['Therapeutic  interventions', 'signaling androgen pathways'], ['mechanisms', 'primarily AR expression'], ['several AR that', 'alternative  splicing'], ['AR splice variants', 'cell CR PCa tumors'], ['Several AR variants', 'constitutive AR function'], ['ARV7', 'molecular protein characterization'], ['new ARV7 that', 'ARV7'], ['how biology it', 'therapeutic  decisions'], ['body', 'translational AR splice bedside'], ['Prostate cancer', 'new  cases'], ['treatment', 'invasive prostate cancer'], ['hormone  patients', 'resistant prostate which'], ['This', 'new treatment strategies'], ['cell populations', 'CSC cancer stem population'], ['aberrant expression loss', 'fusion genes'], ['notably TMPRSS2-ERG gene fusion', '50 prostate CSCs'], ['However  role', 'other prostate cancer'], ['review', 'conventional cancer therapies'], ['how CSC they', 'therapy'], ['', ''], ['rights', ''], ['microscopic  which', 'serial mount immunohistochemistry'], ['assessment', 'metastatic  spread'], ['histopathological  focus', 'clinical  significance'], ['Prostate cancer', 'related United States'], ['Mesenchymal stem cells', 'tumor tissues'], ['immunosuppressive  application', 'PCa therapy'], ['1 prostate tumor we', 'underlying  mechanisms'], ['MSCs Sirt1', 'significantly tumor growth'], ['NK  cells', 'Sirt1-induced antitumor activity'], ['IFN gamma motif chemokine ligand', 'highly MSCs Sirt1 mice'], ['when MSCs CXCL10', 'MSCs Sirt1'], ['MSCs Sirt1', 'tumor inflammatory tumor microenvironment'], ['aim', 'based biomarker CaP'], ['expression', 'Northern cancer cell blotting'], ['LNCaP', 'different LNCaP AI synthetic'], ['ability', 'Matrigel invasion'], ['Cell growth', 'different CCK-8 cell times'], ['expression', 'neuroendocrine  PCR'], ['level', 'prostate cancer PCR'], ['MiR-221', 'significantly ADPC cell lines'], ['Overexpression', 'significantly NE differentiation'], ['Knocking', 'antagonist AI cell migration'], ['', ''], ['DVL2 protein level', 'up  miR-221'], ['MiR-221', 'up CaP plasma'], ['', ''], ['We', 'significant miR-221 ADPC'], ['NE which', 'AIPC'], ['also  miR-221', 'advanced AIPC CaP'], ['role', 'other  target'], ['urologic  that', 'elderly  men'], ['PH', 'prostatic prostate severity'], ['Oxidative  stress', 'human prostate cancer'], ['also micronutrient supplementation', 'clinical antioxidant BPH'], ['review', 'molecular prostate cancer progression'], ['', 'dependent tumor manner'], ['We', 'clinical prostate cancer'], ['Western polymerase chain blot', 'cancerous prostate tissues'], ['characteristic curve analysis', 'diagnostic  Rab25'], ['Associations', 'free PCa patients'], ['vitro PCa cell proliferation', 'interfering Rab25 RNA'], ['25 protein expression', 'cancerous prostate tissues'], ['', ''], ['area', 'immunoreactive  score'], ['', ''], ['', '74'], ['', ''], ['', ''], ['High Rab25 IRS', 'high Gleason score'], ['', ''], ['', ''], ['PCa patients', 'low Rab25 IRS'], ['', ''], ['Cox regression analysis', 'free PCa patients'], ['', 'cell proliferation migration'], ['High  expression', 'radical PCa prostatectomy'], ['53 tumor suppressor gene', 'multicellular cancer organisms'], ['that', 'TP53 activity'], ['common  findings', 'common  cancer'], ['', 'Iranian prostate population'], ['case control study', 'prostatic  hyperplasia'], ['I D polymorphism', 'chain reaction analysis'], ['I D polymorphism', 'dominant inheritance model'], ['', ''], ['', ''], ['', ''], ['', ''], ['variant', 'dominant  model'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['significant  association', ''], ['I D polymorphism', 'Iranian MDM2 population'], ['Further  investigations', 'larger sample results'], ['based surface engineering', 'molecular protein surfaces'], ['variable  regions', 'surface performance'], ['ProCoS', 'active DNA variants'], ['multiple sequence alignment', 'structural surface model'], ['directed Yersinia Ymphytase', 'ProCoS'], ['mutant ProCoS libraries', '34 amino acid substitutions'], ['engineered  Ymphytase', '3'], ['', 'higher  pH'], ['', 'wild type Ymphytase'], ['pH stability', 'engineered percentage phytase'], ['Knowledge', 'further drug design'], ['Predicting', 'molecular  biology'], ['Determination', 'experimental  methods'], ['', 'new protein sequences'], ['extremely protein techniques', 'experimental protein folding'], ['computational prediction that', 'fold protein categories'], ['Computational  recognition', 'recent research bioinformatics'], ['computational  efforts', 'computational prediction methods'], ['based  methods', 'recognition'], ['review', 'computational protein folds'], ['biological  formation', 'cellular  processes'], ['functional  experimentation', 'molecular animal phenotype'], ['molecular biology that', 'genetic chemical optical'], ['also  us', 'common  dysfunctions'], ['how  tools', 'molecular minute detail'], ['We', 'spatiotemporal  regulation'], ['further  developments', 'clinical  applications'], ['knowledge', 'medical  science'], ['attributes', 'dimensional  proteins'], ['structural  class', 'better protein patterns'], ['Computational  methods', 'structural intelligence proteins'], ['numerical protein representation', 'machine learning methods'], ['binary  representation', 'surrounding hydrophobicity index'], ['which', 'cellular automata images'], ['extracted  features', 'support vector machine'], ['current tenfold approach', 'structural protein class'], ['One', 'primary  structure'], ['machine  combines', 'physical protein properties'], ['traditional  it', 'class sample'], ['actual class membership', 'marginal  subset'], ['', 'molecular  biology'], ['novel  algorithm', 'supervised  learning'], ['namely  TTOSOM', 'known Self Organizing Maps'], ['we', 'human  lysozyme'], ['it', 'molecular system biology'], ['it', 'known  classifiers'], ['prediction', 'historical  data'], ['', ''], ['', 'chemical  substances'], ['ER chaperone that', 'calcium metabolism'], ['Various  implications', 'prophagocytic eat signal'], ['Intriguingly cell surface exposure', 'such Trypanosoma cruzi'], ['only ray structures', 'mammalian CRT lectin domains'], ['CRT', 'host'], ['open chaperone conformation', 'far crystal structures'], ['first  evidence', 'conformational P domain closure'], ['SAXS experiments', 'additional  T'], ['', 'open cruzi conformation'], ['new protein scheme', 'binding  properties'], ['fascinating  features', 'broad CRT sequence conservations'], ['Visualization', 'many chemical students'], ['new  information', 'visually textbook figures'], ['rather  students', 'own'], ['activity', 'iPad molecules application'], ['It', '50-minute class homework'], ['', 'International Biochemistry'], ['Structural  alignment', 'molecular  biology'], ['computationally  structures', 'main  latter'], ['derived 3D models', 'native  structure'], ['way', 'other  structures'], ['structural  alignment', 'protein descriptors'], ['us', 'efficient algorithmic solution'], ['proposed protein 3D approaches', 'computational  view'], ['Efficient  algorithms', 'structural quality assessment'], ['we', 'structural time descriptors'], ['here  it', 'polynomial  time'], ['We', 'backtracking  algorithm'], ['conceptual  we', '3D alignment accuracy'], ['user', 'such  proteins'], ['Crystallographic Information formats', ''], ['aim', 'healthy muscle strength men'], ['specific vastus force', 'Caucasian  men'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['buccal cell DNA', 'real polymerase chain reaction'], ['frequencies', 'Hardy Weinberg equilibrium'], ['', ''], ['specific  force', ''], ['', '% C allele carriers'], ['', ''], ['', 'rs7460 T allele carriers'], ['', ''], ['', 'SNP'], ['', 'MVCKE torque'], ['107', ''], ['findings', 'intrinsic PTK2 muscle'], ['proteasomal  function', 'gene cardiomyocytes'], ['treated control cells', 'cardiac proteasome inhibitor comparison'], ['reproducible protein expression which', 'tryptic TOF mass spectrometry'], ['identified protein alterations', 'such peroxiredoxin-1 superoxide dismutase-1'], ['expression', 'mRNA level'], ['novel disease progression', 'novel mRNA which'], ['', ''], ['rights', ''], ['article', 'labeled RNA riboprobes'], ['presented  protocols', 'successfully  laboratory'], ['Fuel cell', 'powerful energy future'], ['paper', 'dual energy storage unit'], ['digital boost converter', 'FC power generation'], ['digital PSIM controller', 'Microchip  dsPIC33FJ06GS202'], ['efficiency', '85 power %'], ['many  IFN)-I', 'viral  infections'], ['I', 'bacterial tumor immunology'], ['immune  I', 'dramatically protozoan infections'], ['we', 'major Plasmodium Leishmania Trypanosoma'], ['viral protein which', 'fully cell translation machinery'], ['viral protein translation this', 'host  defense'], ['host cell which', 'novel PRRSV genome'], ['1  beta', 'nuclear host protein synthesis'], ['SAF A B motif', 'consensus 126)-LQxxLxxxGL-(135'], ['situ SAP mutants', 'nuclear host protein synthesis'], ['SAP mutants', 'interferon production IFN signaling'], ['Using', 'reverse mutant PRRS viruses'], ['nuclear  retention', 'vL126A  infections'], ['Importantly  vL126A', 'IFN production'], ['nuclear  accumulation', 'LDV  beta'], ['EAV nspl', 'nuclear  export'], ['single  poles', 'rural  India'], ['supported number poles', 'extensive wind storms'], ['incident', 'well safety poles'], ['These', 'about  8'], ['5 m height', '1'], ['', 'standard  practice'], ['failures', 'bearing  failures'], ['full scale poles', 'in case study sites'], ['poles', 'standard back site'], ['poles', 'designed  frame'], ['load capacities', '0'], ['', '1'], ['', 'chosen design wind sites'], ['20  capacity', '54  %'], ['significant brick alteration', 'load capacity'], ['numerical  study', 'observed  behavior'], ['analytical  model', 'fixed base model'], ['FOSM  cohesion', 'chosen soil type'], ['', ''], ['rights', ''], ['Worldwide  increase', 'significant Pseudomonas aeruginosa infections'], ['', 'resistant carbapenemase P'], ['recovered', 'tertiary  hospital'], ['', 'resistant  P'], ['aeruginosa  isolates', ''], ['Carbapenem inactivation method', 'carbapenemase production'], ['bla(VIM  genes', 'polymerase chain reaction'], ['Subtypes', 'detected sequence analysis'], ['Arbitrarily  primed', 'clonal isolates'], ['presence', 'laser desorption flight mass spectrometry'], ['', ''], ['PCR tests', 'three carbapenemase genes'], ['two  gene', 'one  isolate'], ['carbapenemases', ''], ['AP PCR', 'high clonal isolates'], ['TOF MS none', 'high risk clones'], ['', 'VIM-1 GES-5 type P'], ['aeruginosa  isolates', 'second  Turkey'], ['results', 'epidemiological  Turkey'], ['Pseudomonas putida', 'aliphatic fatty acids sugars'], ['substrates', 'C mole ratio'], ['alkanoic acids myristic acid', '28 PHA P'], ['', ''], ['', ''], ['alkanoic acids undecanoic', '40 PHA P'], ['', '46  D'], ['', 'pentadecanoic acid'], ['Sugar', '10 PHA bacteria'], ['', ''], ['tsuruhatensis', 'major monomer unit'], ['', 'P'], ['major hydroxyalkanoates unit', 'even  acids'], ['3-hydrxoynonanoate', 'odd  acids'], ['molecular M w', '107 415 107 P'], ['', ''], ['', ''], ['bacteria', '282 degrees C'], ['', 'International Union International Biochemistry'], ['that', 'suppressive plant i'], ['', ''], ['plants', 'disease symptoms'], ['pseudomonads', 'suppressive disease soils'], ['also antimicrobial that', 'disease'], ['still  abundance', 'agricultural disease soils'], ['pseudomonads', 'agricultural field soils'], ['We', 'pathogens DAPG roots'], ['level', 'strongly pathogen e'], ['', ''], ['that', 'highly Gaeumannomyces Pythium'], ['', 'biosynthetic antimicrobial genes'], ['Correlation analyses', 'macro antimicrobial genes'], ['agricultural DAPG soils', 'various  degrees'], ['pseudomonads', 'agricultural disease soils'], ['Operational  amplifier', 'analog signal circuits'], ['Today use', 'integrated  circuits'], ['operational  amplifiers', 'wide design factors'], ['paper', 'operational amplifier circuit'], ['PSO algorithm', 'two stage op amp'], ['optimization C code', 'Ngspice circuit simulator'], ['circuit', 'BSIM3v3 MOSFET TSMC'], ['', ''], ['35  CMOS', ''], ['complete system test setup', 'Ubuntu operating system'], ['Results', 'earlier PSO works'], ['Health care services', 'increasing  demand'], ['', ''], ['', 'different  periods'], ['', ''], ['', ''], ['cases', 'psychosocial Ninos de la'], ['data', 'frequency analysis'], ['', ''], ['221  records', ''], ['hospitalization rate', ''], ['', '73  year'], ['', '44  2005'], ['', '26  2010'], ['hospitalization rate', 'psychosocial  0'], ['', '0'], ['', 'years'], ['common  reasons', 'suspected child 44'], ['', ''], ['', 'suicidal 18'], ['', 'sexual  10'], ['05  %', '6'], ['', ''], ['psychotic  episode', '2'], ['%  it', '9'], ['5  %', 'psychomotor 5'], ['', 'psychotic  episode'], ['substance abuse', 'more  men'], ['', ''], ['Hospitalizations', 'different  age'], ['Health problems', 'violence'], ['Language', 'social  speakers'], ['instance adults', 'identity geographic group language'], ['2007 Kinzler little', 'social  identity'], ['person', 'social  relationships'], ['two  who', 'two test individuals'], ['two  who', 'different  languages'], ['Thus  infants', 'social  relationships'], ['moral  they', ''], ['why  individuals', ''], ['identity', 'more  memories'], ['', ''], ['', 'preferences'], ['', ''], ['', 'abortion'], ['relationships', 'moral identity belief'], ['social  relationships', 'identity  psychology'], ['Identifying', 'preventive profiles care'], ['Alterations', 'risk depression'], ['current  study', 'maternal depression status'], ['', 'maternal  depression'], ['', ''], ['they', 'regardless fMRI acquisition'], ['temporal  regions', 'significant  Group'], ['', ''], ['', ''], ['', 'whole brain analysis'], ['high risk group', 'blunted activation trials'], ['when  participants', 'target'], ['high risk children', 'activation trials'], ['when risk they', 'target'], ['study', 'existing sample studies'], ['longitudinal  research', 'fully  risk'], ['Children', 'depressed activation mothers'], ['findings', 'earlier  risk'], ['contexts processing that', 'abnormalities'], ['abnormal  features', 'such  effects'], ['Here  we', 'Checklist Revised PCL R'], ['visual  we', 'emotional processing content'], ['Results', 'psychopathic processing traits'], ['antisocial lifestyle features', 'amygdala salience network regions'], ['', 'prefrontal cortex insula'], ['visual processing which', 'angular  gyrus'], ['emotional  that', 'psychopathic  traits'], ['Experiencing', 'social action functioning'], ['patients', 'available action outcomes'], ['', ''], ['', 'based self agency experiences'], ['this', 'familial  disease'], ['outcome that', 'action performance'], ['Positive Syndrome Scale', 'Comprehensive psychopathology'], ['Impairments', 'based  underattribution'], ['However  patients', 'overall self agency experiences'], ['Siblings', 'healthy agency controls'], ['However  differences', ''], ['impairments', 'trait agency schizophrenia'], ['Moreover  study', 'implicit agency inferences'], ['Psychosocial  conditions', 'related partner outcomes'], ['largest HIV little', 'psychosocial  HIV'], ['We', 'psychosocial HIV Y'], ['', ''], ['', 'Chennai India'], ['Thirteen  questions', 'voluntary depression CSA'], ['psychosocial regression outcome', 'demographic  interest'], ['Three hundred eighty persons', '104  models'], ['than  one', 'psychosocial  condition'], ['current alcohol use', 'psychosocial  condition'], ['', ''], ['', ''], ['', 'men'], ['we', 'psychosocial PLHIV alcohol condition'], ['Further  study', 'related alcohol India'], ['Agreement', 'therapeutic  alliance'], ['', 'specific  psychosis'], ['challenges', 'different  condition'], ['Here  we', 'intersubjective  challenges'], ['', ''], ['based  treatment', 'recent  history'], ['defining', 'resident treatment training'], ['several  they', 'psychotherapy'], ['resident treatment manuals', 'simple training requirements'], ['two treatment manuals', 'clinical  practice'], ['clinicians', 'based  treatments'], ['Psychotic  disorders', 'psychiatric  conditions'], ['Patients', 'emotional  distractors'], ['perceptual  load', 'emotional  distractors'], ['when  task', 'attentional  resources'], ['Twenty two Twenty participants', 'irrelevant letter discrimination stimulus'], ['high  participants', 'facial target expression'], ['patients', 'high attention control'], ['neutral  faces', 'less  interference'], ['findings', 'social schizophrenia spectrum disorders'], ['We', 'coupled circuit oscillators'], ['when  system', 'exceptional  point'], ['phenomenon', ''], ['objectives', 'sectional Wenchuan survey'], ['different  that', 'severely  earthquake'], ['Bivariate correlation analysis', 'associated linear regression factors'], ['coping  style', 'later Wenchuan earthquake'], ['coping  style', 'new  possibilities'], ['', ''], ['', ''], ['', 'life'], ['', ''], ['coping  style', 'higher  others'], ['', ''], ['', 'coping  style'], ['depression', 'barrier PTG'], ['', ''], ['rights', ''], ['51 protein level', 'adult Wistar'], ['presence', 'Northern  blotting'], ['Immunostaining', 'parenchymal  cells'], ['cells', 'specific killer antigens'], ['endothelial  cells', 'detectable antibody sinusoidal PTPIP51'], ['Furthermore', 'biliary  tree'], ['subcellular  analysis', 'parenchymal electron cells'], ['yet  some', 'nucleus'], ['Considerable  research', 'posttraumatic stress disorder'], ['negative trauma expectations', 'negative network orientation'], ['current network study', 'intimate partner violence'], ['Additionally  history', 'negative network model'], ['Path analyses', 'indicative network mediation'], ['relative network who', 'only  IPV'], ['findings', 'social IPV survivors'], ['', ''], ['rights', ''], ['posttraumatic stress disorder', 'veterans'], ['trauma difficulties', 'early optimal outcomes'], ['emotional regulation that', 'focused  therapy'], ['mindfulness vivo trauma', 'based combat PTSD'], ['OFF OIF combat veterans', 'N  MBET'], ['PTSD  symptoms', 'PTSD and scale'], ['3  therapy', 'emotional  faces'], ['Patients', 'PTSD  symptoms'], ['effect', 'significantly  PCGT'], ['', ''], ['PTSD  treatment', 'prefrontal anterior amygdala'], ['MBET group', 'Fearful gyrus faces'], ['intriguing MBET group therapy', 'emotional symptom reduction'], ['specifically trauma who', 'prior  pregnancy'], ['that', 'early postpartum adaptation'], ['larger community who', 'past trauma postpartum'], ['first trajectory we', 'distinct trajectory groups'], ['historical  that', 'maternal postpartum adaptation'], ['PTSD symptom trajectory', 'interim  trauma'], ['Women', '6 weeks postpartum'], ['Screening', 'maternal symptom wellbeing'], ['', ''], ['commonly  associated', 'specific  substances'], ['related  problems', 'interpersonal traumas benzodiazepine prescriptions'], ['consecutive trauma we', 'exploratory trauma type PTSSs'], ['several  factors', 'related  problems'], ['', ''], ['', 'alcohol'], ['', 'tobacco'], ['', 'PTSD  diagnosis'], ['', ''], ['', 'alcohol'], ['', 'tobacco'], ['', 'illicit  drugs'], ['', ''], ['', ''], ['', 'related  hypotheses'], ['we', 'further  screening'], ['chronological age criminologists', 'pubertal  development'], ['that', 'White  samples'], ['study', 'Asian  context'], ['current  study', 'ninth South Korea'], ['significant  association', 'mixed girls schools'], ['significant  linkage', 'delinquent peer associations'], ['Mastitis', 'mammary  gland'], ['', 'effective  animals'], ['Puerarin', 'biological Radix activities'], ['potential  that', 'antiinflammatory Staphylococcus aureus'], ['', 'aureus)-induced  mice'], ['puerarin', 'inflammatory  S'], ['', ''], ['ELISA puerarin', 'also  secretion'], ['2  TLR2', 'immune  S'], ['', ''], ['molecular  expression', 'puerarin'], ['activated protein kinase', 'western  blot'], ['puerarin', 'dependent N terminal manner'], ['puerarin', 'potential  mastitis'], ['', ''], ['positively  influences', 'arterial  hypertension'], ['underlying  mechanisms', ''], ['We', 'inflammatory IPAH patients'], ['cardiopulmonary exercise testing', '16 IPAH patients'], ['Phenotypic  characterization', '1 blood mononuclear exercise'], ['Th17 lymphocytes', 'TNF Th1'], ['', 'sustained Th17 IL-1-beta'], ['higher  decrease', 'peak IPAH patients'], ['Exercise', 'immune IPAH patients'], ['exercise', 'immunemodulating IPAH patients'], ['PWM width converter', 'paper'], ['structure', 'passive charge elements'], ['proposed PWM converter', 'operational  amplifier'], ['added feedback path current', 'dynamic input signal'], ['behavior', 'proposed PWM 0'], ['', ''], ['proposed PWM converter', '74dB  linearity'], ['', '1'], ['', '0V 0'], ['', ''], ['special power that', 'flexible operation modes'], ['economic energy demand', 'power grid'], ['nuclear  power', ''], ['Developing', '21st power century'], ['paper', 'PSPS China'], ['two  PSPS', 'two  decades'], ['installed  capacity', '21'], ['83  gigawatts', 'world'], ['27  PSPSs', 'still Fengning PSPS'], ['lot', 'suitable PSPS construction'], ['exploitation suggestions', 'exploitation course'], ['', 'bright PSPS China'], ['Putamen volume', 'neurological disease antipsychotics'], ['establish', 'given states population'], ['study', 'Indian putamen age'], ['Bilateral  symmetry', ''], ['study', '98 MR individuals'], ['Axial  sections', 'spin putamen volume'], ['manually  volume', 'principle'], ['t test', 'data'], ['', 'Bilateral putamen sexes'], ['This', ''], ['', ''], ['Age', ''], ['Hemispherical  asymmetry', 'statistical putamen males'], ['', ''], ['study', 'related  males'], ['rate', 'volume sex'], ['study', 'hemispherical putamen volume'], ['', ''], ['', ''], ['', ''], ['', ''], ['Trombe wall system', 'heating  electricity'], ['Precedent studies', 'low mass thermal'], ['study', 'integrated Trombe wall system'], ['PV blind slat angles', 'term  day'], ['Comparative  assessment', 'thermal Hefei weather performance'], ['BIPVGTW which', 'BIPVGTW system'], ['', 'times BIPVMTW system'], ['BIPVGTW system', 'significantly PVMTW heating PVGTW'], ['total electricity saving', 'BIPVGTW BIPVMTW systems'], ['CO2 emissions reduction', 'BIPVBTW system'], ['', 'BIPVGTW BIPVMTW systems'], ['', ''], ['rights', ''], ['paper', 'maximum power point tracking'], ['goal', 'photovoltaic power generator'], ['sliding mode that', 'boost PVG'], ['system', 'MATLAB SIMULINK environment'], ['maximum power operating that', 'known  perturbation'], ['sliding mode controller performance', 'PS load disturbances'], ['', 'time digital control platform'], ['data acquisition', '1104 controller board'], ['experimental  results', 'photovoltaic control system'], ['', ''], ['rights', ''], ['long RNA PVT1', 'various c cancers'], ['expression', 'colorectal  cancer'], ['far  research', 'extracellular RNAs vesicles'], ['present  we', 'real polymerase chain reaction'], ['Then  we', 'real polymerase chain reaction'], ['PVT1 targeting', '5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H cell proliferation'], ['normal tumor which', 'specific enhancer factor'], ['that  PVT1', 'aggressive cell SW480'], ['cell apoptosis', 'down PVT1 expression'], ['PVT1', 'colorectal cancer cells'], ['', 'current  control'], ['However  it', 'experimental  implementation'], ['classical sampling interval', 'same control current'], ['signal  processor', 'excellent  performance'], ['paper', 'three phase PWM converters'], ['main  objective', 'PCC scheme'], ['proposed control scheme', 'calculation performance'], ['Simulations', 'current control scheme'], ['three phase PWM converter', 'proposed  scheme'], ['', 'calculation time'], ['Transgene  silencing', 'higher  plants'], ['present  we', 'macroalga Pyropia yezoensis'], ['This', 'first  macroalgae'], ['Transgenic  lines', 'PyGUS gene'], ['Histochemical GUS staining', '12 PyGUS lines'], ['PyGUS gene', '9  lines'], ['PyGUS  gene', 'asexual  reproduction'], ['We', 'silencing  P'], ['', ''], ['translational PIWI repression', 'silencing  P'], ['', ''], ['silencing gene gene', 'actively macroalga P'], ['', ''], ['results', 'silencing Pyropia species'], ['metabolic  they', 'prevalence'], ['dynamics', 'biological gene processes'], ['qPCR', 'used gene expression studies'], ['However  reliability', 'directly data normalization'], ['adipose reference I', 'adipose reference type'], ['12  that', 'commonly reference genes'], ['expression', 'experimental  protocols'], ['Gene expression stability', 'different  algorithms'], ['binding  protein', 'adipose control animals'], ['brown adipose tissues', 'control'], ['F1 complex F1 gene', 'subcutaneous adipose control'], ['Moreover  gene', 'treated qPCR animals'], ['results', 'experimental  conditions'], ['selection', 'experimental qPCR protocols'], ['', ''], ['rights', ''], ['Politics Psychology', 'Sexual  Children'], ['that', 'claims'], ['methodological  he', 'sexual Witch Hunt abuse'], ['foundational WHN McMartin he', 'published  lists'], ['other  Cheit', 'WHN'], ['He', 'insufficient witch hunt claim'], ['when research he', 'prominent psychologists Stephen J'], ['', ''], ['sufficient  he', 'claims'], ['I', 'disciplinary journalism law'], ['Nonetheless  scholarship', 'future  research'], ['Renewed  attention', 'randomised control trials'], ['debates', 'based voices policymaking'], ['particularly trustworthiness which', 'research'], ['Adopting', 'ethical  standards'], ['which', 'chip'], ['main measurement error', 'high Q factor measurement'], ['digital control circuit', 'two  i'], ['', ''], ['', ''], ['theoretical measurement analysis', 'given circuit paper'], ['proposed  circuit', '0'], ['', ''], ['operating frequency', '200  0'], ['', ''], ['brief  version', 'subjective WHOQOL patients'], ['', 'normative WHOQOL BREF'], ['present  study', 'health  QOL'], ['11351  participants', 'stratified multistage sampling 2012'], ['laboratory examinations', 'trained disease personnel'], ['Depression symptoms', 'Patient Health Questionnaire-9'], ['multiple linear regression', 'multiple  factors'], ['Females', 'lower QOL males'], ['positive  correlation', 'age'], ['Participants', 'higher QOL scores'], ['regression coefficient', 'stroke'], ['', ''], ['', ''], ['', 'total QOL score'], ['total QOL score', '5'], ['', ''], ['', '-5'], ['physical domain score', '1'], ['', ''], ['', ''], ['psychological domain score', '1'], ['', ''], ['', ''], ['', ''], ['economic  status', 'highly  QOL'], ['Regarding', 'negative diseases QOL'], ['', 'Public Health'], ['', 'Elsevier Ltd'], ['rights', ''], ['human  cytomegalovirus', 'human  malignancies'], ['However  prevalence', 'gastric  cancer'], ['IgG  antibodies', 'healthy microparticle enzyme immunoassay'], ['normal GC tumor specimens', 'polymerase chain PCR'], ['real time PCR', 'viral Q load'], ['Virus localization', 'neoplastic  immunohistochemistry'], ['significant  difference', 'HCMV IgG GC patients'], ['overall DNA positivity rate', 'normal  tissue'], ['', ''], ['HCMV infection', 'tumorous  epithelium'], ['viral copy number', 'normal GC specimens'], ['', ''], ['HCMV load', 'lymphatic GC tumor metastasis'], ['area', 'ROC operating curve'], ['', ''], ['data', 'clearly GC patients'], ['HCMV infection', 'lymphatic  metastasis'], ['', ''], ['rights', ''], ['glutamate transporter', 'multiple  5'], ['We', 'human splice brain'], ['novel RT isoform', 'untranslated UTR GLT1'], ['9 lacking which', 'endoplasmic  reticulum'], ['several  groups', 'normal brain tissue'], ['aberrant  transcript', '0'], ['', ''], ['2  %', 'major  EAAT2'], ['', ''], ['rights', ''], ['CO carbon sensor', 'coating carbon technique'], ['', 'purpose'], ['', ''], ['', 'AC  4'], ['', ''], ['02  MHz', 'piezoelectric  crystal'], ['frequency frequency converter', 'integrated  circuit'], ['Output potential', 'finally pass voltmeter'], ['', '280  million'], ['Detection limit', 'also  5'], ['', ''], ['standard  deviation', 'six replicate analyses'], ['', ''], ['maximum response time', 'maximum  response'], ['', ''], ['Recovery time', '30  1'], ['', ''], ['Calibration sensitivity', '0'], ['', ''], ['significant  interference', 'foreign  diluents'], ['Reliability', 'two  samples'], ['electrical  circuit', 'QMH metal halide lamps'], ['lamp', 'microcontroller  ATmega128'], ['lamp', 'constant environment power'], ['efficiency', 'driving  94'], ['', ''], ['proposed  model', 'cost QMH lamps'], ['We', 'Quasi He'], ['', 'canonical  factorizations'], ['we', 'quadratic matrix QBD'], ['results', 'Poisson QBDs'], ['', ''], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['Queer theories', 'queer time'], ['queer  temporalities', 'ongoing dissociation amnesia time'], ['Resisting', 'mad world justice'], ['Bipolar disorder', 'manic  episodes'], ['Bipolar disorder', 'poor life morbidity'], ['', 'bipolar burden treatment disorder'], ['clinical  trials', 'antipsychotic  condition'], ['However  mechanisms', 'manic  QTP'], ['article', 'manic  QTP'], ['norquetiapine  QTP', 'several serotonin dopamine noradrenaline'], ['QTP', 'immune  system'], ['clinical Expert studies', 'manic  effects'], ['major  problem', 'bipolar  disorder'], ['based  studies', ''], ['QTP norquetiapine', 'neurotransmitter  systems'], ['effective  residue', ''], ['Therefore  isolating', 'scientific  value'], ['We', 'environmental stress quinclorac'], ['bacterial  pathogenicity', 'when  quinclorac'], ['same  quinclorac', 'phthalate dioxygenase reductase'], ['key  which', 'Northern Blotting'], ['we', 'degradation quinclorac'], ['', ''], ['rights', ''], ['Here population we', 'real agr time'], ['technological  that', 'new drug discoveries'], ['expected  benefits', ''], ['academic research that', 'clinical  hospitals'], ['distinct research that', 'different epistemologies practices'], ['predictive  that', 'new  drugs'], ['molecular genetics modeldiscovery feedback', 'late  process'], ['institutional paper that', 'bio medical research landscape'], ['institutional drug discovery that', 'scientific  selection'], ['Implications', 'medical policy initiatives'], ['', 'C Elsevier B'], ['', ''], ['Rabbit', 'reproductive biology fertility'], ['animal species', 'reproductive antibodies organs'], ['aim', 'reproductive  stages'], ['study', 'reproductive  cycle'], ['Histological  stains', 'T- cornu uteri'], ['T lymphocytes', 'anatomical  cycle'], ['estrous  lowest', 'pregnancy'], ['Cervix', 'immunological cornu uteri'], ['distribution', 'hormonal  status'], ['recommended  screening', 'fresh brain tissue'], ['simple formalin that', 'confirmatory  diagnosis'], ['FFPE canine brain', '57 Sri Lanka'], ['presence', 'cortex hippocampus cerebellum'], ['effect', 'artefactual  tissue'], ['Rabies', '93  IHC'], ['IHC labelling', 'more  brainstem'], ['Negri bodies', '53'], ['', 'positive  cases'], ['IHC it', 'Negri bodies'], ['confirmatory Polymerase chain reaction', 'also FFPE samples'], ['PCR detection', 'frozen IHC results'], ['PCR method', 'field cases'], ['artefactual rabies change', 'sole rabies diagnosis'], ['artefactual IHC degeneration', 'IHC labelling'], ['secondary formalin fixation', 'sample degeneration'], ['brain stem', 'necropsy sampling field'], ['PCR testing', 'alternative  test'], ['Rabies virus', 'zoonotic  pathogens'], ['RABV', 'particularly  Asia'], ['molecular laboratory techniques', 'reverse polymerase chain reaction'], ['real RT PCR assays', 'African spectrum isolates'], ['primer  sets', 'L  genes'], ['results', 'taxonomic  family'], ['', ''], ['', 'various host species'], ['Analytical  sensitivity', 'standard N gene'], ['African  they', 'double check strategy'], ['', ''], ['', ''], ['rights', ''], ['Overexpression', 'malignancies'], ['However  relationship', 'hepatocellular  carcinoma'], ['expression', 'reverse polymerase chain reaction'], ['protein expression', 'hepatocellular  immunohistochemistry'], ['Rabl3', 'significantly Rabl3 upto'], ['', 'hepatic  tissues'], ['overexpressions', 'Rabl3'], ['', 'hepatocellular  carcinoma'], ['Rabl3', 'hepatic  tissue'], ['', ''], ['upregulation', 'portal metastasis tumor vein'], ['', ''], ['overexpression', 'significantly cell proliferation'], ['Conversely  silencing', 'small cell proliferation'], ['hepatocellular carcinoma overexpression', 'hepatocellular  carcinoma'], ['', ''], ['', ''], ['', ''], ['', 'sterol  biosynthesis'], ['encoding squalene synthase', 'cancer drug taxol'], ['full length cDNA', '409 amino acids'], ['other crystal I', 'biosynthetic  enzymes'], ['Southern blot analysis', 'one T cuspidata'], ['northern blotting TcSqS', 'highest  roots'], ['acting  elements', 'promoter region'], ['prominent  which', 'E database'], ['current  research', 'interracial  couples'], ['1  bias', 'interracial  disgust'], ['2  images', 'same race couples'], ['interracial couples elicit', 'same race couples'], ['findings', 'antisocial  reactions'], ['', ''], ['aggression perpetration', 'targets'], ['Findings', 'social  units'], ['', ''], ['couples', 'social cognition research'], ['Elsevier rights', ''], ['741', 'neutrons'], ['rate supply current', 'gain factors'], ['experimental  results', 'parameter radiation'], ['advantage', 'damaged voltage power parameters'], ['relationship', 'degraded frequency response parameters'], ['We', 'vanishing Stokes Boltzmann equations'], ['', 'Euler Boltzmann equations'], ['', 'compressible radiation hydrodynamics'], ['far life span', 'vanishing viscosity limit'], ['element', \"2  epsilon(2(1-s'/3\"], ['', ''], ['rights', ''], ['radiative phase contributions', 'solid  phase'], ['porous cell ceramic which', 'interconnected  ligament'], ['Typically  ligaments', 'one hundred one microns'], ['Therefore  ligaments', 'thermal  radiation'], ['experimental  investigations', 'regardless  ligaments'], ['real world beforehand', 'Ray micro paper'], ['Radiative Transfer Equation', 'meshed upwind Petrov Garlekin'], ['particular  attention', 'fast discretization convergence'], ['ceramic silicon carbide which', 'refractory ceramic foams'], ['', ''], ['rights', ''], ['framing  paper', 'gender'], ['recent gender issues', 'radical  right'], ['how  women', 'parties'], ['right  parties', '1980s'], ['right  parties', 'political  concerns'], ['This', 'other  parties'], ['right  symposium', 'right gender politics'], ['hardware simulation system', 'hardware Doppler Radio loop'], ['threshold', 'host computer'], ['system', 'Doppler airfuse fuze'], ['paper', 'low Generation Current voltage'], ['designed  circuit', 'conventional class AB amplifier'], ['Therefore  it', 'wide input signal'], ['new  technique', 'Command Environment script language'], ['level shifter which', 'input stage'], ['design problem', 'program'], ['Therefore  it', 'integrated  circuits'], ['that', 'short micron processes'], ['circuit', 'IBM'], ['', 'single power supply'], ['', ''], ['layout editor tool', 'proposed Mentor circuit'], ['chip', 'proposed MOSIS Educational circuits'], ['measured  results', 'good  agreement'], ['', ''], ['rights', ''], ['paper', 'cascold structure input stage'], ['lowor elsethe amplifier', 'power'], ['', 'SMIC'], ['static power consumption', '140dB'], ['', ''], ['amplifier', 'PGA input sigle 2'], ['when  gain', 'PGA'], ['operational amplifier circuit topology', 'paper'], ['amplifier input stage', 'single NMOS 0'], ['', ''], ['overall gain variation', '+'], ['', 'common mode input range'], ['proposed  design', 'common mode rejection ratio'], ['simulated  value', 'V buffer op CL'], ['variation', 'different corner temperatures'], ['circuit simulation', 'Tanner 1'], ['power which', '6'], ['', ''], ['Recently  determining', 'considerable hyper attention'], ['2-color Ramsey number', 'loose cycle C n(k'], ['Here  we', 'n(k C perpendicular'], ['3', 'authors'], ['conjecture', 'shorter  proof'], ['4  conjecture', '>  ='], ['Finally  we', 'case'], ['', ''], ['', ''], ['rights', ''], ['Measuring', 'physiological gene expression state'], ['general design principles', 'way'], ['digital  that', 'specific  interactions'], ['', ''], ['', 'chromosomal structure'], ['Here  we', 'RNA growth seq'], ['transcriptional time regulators', 'mutant time which'], ['where network we', 'maximum trade detail'], ['real course expression we', 'stationary growth phase'], ['investigation', 'resolved gene expression profiles'], ['method', 'genetic  E'], ['', ''], ['response', 'subsequent  treatment'], ['fifty four fifty outpatients', 'step'], ['randomly step I', '4 step weeks'], ['mirtazapine', '2 remission SSRIs'], ['Somnolence rate', 'mirtazapine  SSRIs'], ['Ila combination therapy', 'course SSRIs monotherapy'], ['I combination therapy', 'better HAM week'], ['', ''], ['', 'SSRIs monotherapy'], ['8  who', 'monotherapy'], ['5 HAM D score', '4  points'], ['While', 'mirtazapine non responders add'], ['Mirtazapine', '4 add SSRIs'], ['', ''], ['rights', ''], ['Radish', 'agronomic Raphanus sativus importance'], ['dsRNAs', 'many  R'], ['', ''], ['large  dsRNAs', 'single primer amplification technique'], ['untranslated terminal each', 'chrysoviral reading replicase'], ['like  particles', 'infected radish plants'], ['dsRNAs', 'VLP'], ['genome segments', 'these'], ['RasCV1', 'putative plant chrysovirus'], ['fungal  mycelia', 'radish trypan blue'], ['RasCV1', 'symbiotic plant fungi'], ['widely monocot endogenization', 'chrysovirus plant genome'], ['', ''], ['', ''], ['rights', ''], ['infectious Hepatitis B that', 'nine  genotypes'], ['aim', 'rare proteins structure'], ['Pfam search tool', 'UniProt database'], ['family accession numbers', 'comprehensive protein domains'], ['It', 'other  resources'], ['genomic Pfam database', 'multiple sequence alignments'], ['that', 'proteins'], ['Sherlocc location', 'nucleotide sequence data library'], ['nucleotide sequence entries', 'yet SWISS PROT'], ['Furthermore  structures', 'Swiss PDB Viewer software'], ['Pfam search tool', 'three protein frames'], ['Sherlocc program', 'antigen HBeAg HBV'], ['RCCs', 'hepatitis core antigen'], ['', ''], ['large protein structures', 'Sherlocc program outputs'], ['RCCs', 'correct drug targets'], ['results', 'new HBV HBV'], ['', 'spintronic  devices'], ['We', 'optical  films'], ['easy  axis', 'in  orientation'], ['400 degrees C', 'thermomagnetic  measurements'], ['occurrence', 'ray diffraction measurements'], ['Pronounced  changes', 'structural sheet relaxation'], ['activation barriers', 'crystallization'], ['', ''], ['', 'Tb  samples'], ['thermal  stability', 'rich  type'], ['results', 'useful device fabrication'], ['', ''], ['', ''], ['rights', ''], ['fractional order integrator', 'continued approximation product'], ['paper', 'half design process'], ['operational amplifier size', 'rational  function'], ['derivative  it', 'fractional design integrator'], ['It', 'regular  capacitors'], ['fractional  integrator', 'industrial  production'], ['fractional  integrator', 'other performance simulations Multisim'], ['aim', 'zoonotic borne pathogens'], ['pathogenic Coxiella burnetii Anaplasma', 'pathogenic polymerase chain rickettsiae'], ['', ''], ['only prevalent pathogen', ''], ['which', '10 cow milk'], ['', 'one goat milk'], ['', 'one sheep milk'], ['', ''], ['One  sample', 'cow C'], ['however sequence analysis', '100 Psychrobacter alimentarius'], ['None', 'examined  A'], ['phagocytophilum', ''], ['results', 'raw cow milk'], ['milk borne spread', 'C'], ['', ''], ['phagocytophilum', ''], ['', 'positive  Coxiella'], ['care', 'PCR method'], ['present  work', 'raw Dhanbad city India'], ['total', 'psychrotrophic counts yeast mould'], ['', ''], ['', ''], ['', 'real polymerase chain isolation'], ['samples', 'total  coliform'], ['coli', '16'], ['', 'total  samples'], ['', 'such  E'], ['', ''], ['', ''], ['', '1'], ['', ''], ['', ''], ['', 'total  samples'], ['However  pathogens', 'cabbage samples'], ['', ''], ['Strain ISM SP', 'first spinach RSV'], ['16S rRNA gene sequencing', 'public % domain'], ['renal cell carcinomas', 'different TFE3 gene'], ['Tumors', 'clinicopathologic gene manifestations'], ['3  RCCs', 'date'], ['Here  we', 'molecular  analyses'], ['Most  tumors', 'typical acinar t(6;11'], ['groove psammoma bodies', 'most  cases'], ['', 'TFEB RCC marker HMB45'], ['CKpan', ''], ['antibody', '% tumor cell nuclei'], ['several  immunostainings', 'different histology patterns'], ['RBM10-TFE3 fusion transcripts', 'reverse polymerase chain reaction'], ['4  cases', 'negative signal results'], ['We', 'poor cell development'], ['4  patients', 'recurrent  disease'], ['report', 'known RBM10-TFE3 RCC'], ['RNA silencing', 'antiviral immunity plants'], ['viral response RNA', 'viral response suppressors'], ['Most  potyviruses', 'two helper component proteinase'], ['function', 'RNA silencing'], ['infection', 'vsiRNA RNA production'], ['only proteins that', 'SGS3'], ['present  expression', 'viral  SGS3'], ['mediated  degradation', 'ubiquitin proteasome ubiquitin pathways'], ['together  data', 'mediated  VPg'], ['IMPORTANCE Potyviruses', 'important plant world'], ['', 'antiviral silencing response'], ['works', 'process'], ['Turnip mosaic which', 'key host pathway'], ['interacting  which', 'essential  RNA'], ['cellular  that', 'mediated  SGS3'], ['antiviral  RNA', 'virus infection'], ['advanced  takingthat', 'cognitive  states'], ['response theory analysis', 'Eyes Test'], ['Italian  version', 'undergraduate Eyes genders'], ['parallel  analysis', 'unidimensionality'], ['maximum likelihood estimation', 'PL  data'], ['Differential Item Functioning', 'independent  methods'], ['MPA', 'unidimensionality'], ['Rasch model', 'two Eyes Test'], ['related Eyes differences', 'real  group'], ['study results', 'one Eyes Test'], ['Performance', 'perspective taking'], ['Researchers', 'selected Eyes Test'], ['Lack', 'empathy gender cognition'], ['integrated imaging circuits', 'key  detectors'], ['quickly Verilog A which', 'behavioral simulation ROIC'], ['essential  parts', 'behavioral  level'], ['ideal  factors', 'gain bandwidth output resistance'], ['that', 'such  resistance'], ['last domain modeling which', 'classical frequency domain difference'], ['1 sample rate', 'times  NIBW'], ['renewable energy feedstocks', 'NPV diversification analysis'], ['NPV', 'relevant landholder decision making'], ['alternative  that', 'fewer climate change risks'], ['influence', 'scarcely land use ROA'], ['we', 'based ROA biomass'], ['explicit  model', 'diverse farming region'], ['underlying  variability', 'when NPV analysis'], ['traditionally  thought', 'production  risks'], ['effects', 'higher rainfall areas'], ['further NPV methods', 'true conversion thresholds'], ['significant DM areas', 'biomass plantings'], ['valuable diversification synchronisation', 'markets'], ['', ''], ['rights', ''], ['protozoan Trypanosoma cruzi', 'public Latin America'], ['TcI typing some', 'ancient hybridization events'], ['biological characterization methods', 'T'], ['', 'different  vectors'], ['available  methods', 'resolution'], ['new genotyping strategy', 'clinical blood samples'], ['nuclear SL IR', 'original 18S primers'], ['method', 'genomic  T'], ['', 'chronic Chagas disease'], ['assays', '1  DTU'], ['selectivity', 'targets mu test'], ['method', '67'], ['9  %', 'high  TcI'], ['original genotyping DTU', 'real time PCR assay'], ['carryover contamination', 'clinical blood samples'], ['', ''], ['', ''], ['rights', ''], ['HRG  expression', 'monoclonal growth antibody'], ['embedded tissue samples', 'herein'], ['Test specimens', 'FFPE normal FFPE lung'], ['embedded  tissue', 'functional  performance'], ['Heregulin distribution', 'commercial  samples'], ['Gene Expression Assays', 'real time PCR platform'], ['efficiency PCR linearity', ''], ['housekeeping HMBS which', 'similar FFPE NSCLC samples'], ['unimodal HRG distribution', 'commercial  samples'], ['Feasibility', 'FFPE NSCLC specimens'], ['receptor', 'various protein isoforms'], ['objective', 'comprehensive RAGE expressome'], ['', ''], ['4  kb', 'cell line cell RAGE'], ['that', 'distinct protein studies'], ['Lung', 'molecular protein 45'], ['', ''], ['', ''], ['', 'four  25'], ['', ''], ['', ''], ['', ''], ['', ''], ['isoforms', 'exclusively  lung'], ['Heart ileum', '44'], ['0-kDa aorta', '53'], ['', ''], ['Each', 'tissue RAGE(-/-'], ['Cell lines', '70'], ['0-kDa isoform', '30'], ['', ''], ['Lung RAGE', 'linked  glycans'], ['Tissue line RAGE isoforms', 'completely PNGase F digestion'], ['numerous RAGE protein isoforms', 'tissues'], ['Canonical  transmembrane', 'solely  lung'], ['pulmonary  tissues', '9 aES RAGE epitope'], ['early  dispute', 'height'], ['Several  subtypes', 'binding  assays'], ['further  we', 'different  receptors'], ['5-HT1  they', 'further cell reality'], ['many  they', 'many  dispute'], ['situ Molecular family', 'ever mammalian time'], ['article', 'Special  Issue'], ['', ''], ['', ''], ['rights', ''], ['however  little', 'intestinal  diseases'], ['aim', 'DSS)-induced dextran sulfate rats'], ['like proinflammatory cytokines', 'blotting RT PCR'], ['effects', 'intestinal wound repair model'], ['MK expression', 'submucosal DSS fibroblasts'], ['1 proinflammatory which', 'MK expression'], ['Results', 'epithelial RPTP beta cells'], ['wound repair', 'treated  groups'], ['RPTP beta which', 'mucosal colitis'], ['Additional  investigations', 'inflammatory bowel diseases'], ['it', 'way'], ['relationships', 'other  cells'], ['Difficulties', 'various nomenclature these'], ['major  changes', 'something'], ['recombinant  it', 'foreign DNA cell'], ['low PCR product it', 'cloning pUC18 site'], ['CCC SmaI restriction which', 'ended vector products'], ['pELMO transformation efficiency', 'commercial pGEM vector'], ['500 pELMO vector', 'insert  sizes'], ['thus sequencing primers', 'sequencing'], ['pELMO', 'molecular biology laboratories'], ['Horseradish  peroxidase', 'biochemical horseradish properties'], ['different glycosylation which', 'stability parameters'], ['glycosylated  which', 'E'], ['', 'hydrogen mutagenesis'], ['Asparagine', '268 megaprimer method'], ['Modification', 'described  E'], ['', ''], ['library', 'reducing substrate'], ['top  variant', 'recombinant hydrogen HRP'], ['Moreover  substitution', '2'], ['', 'catalytic  phenol/4-aminoantipyrine'], ['stable  which', 'medical  diagnostics'], ['', 'International Union International Biochemistry'], ['', ''], ['that', 'significant research community'], ['high privacy which', 'privacy'], ['who', 'tremendous service requirements'], ['we', 'namely cloud environment'], ['us', 'commutative recommendation encryption'], ['theoretically user information', 'recommendation'], ['world dataset world framework', 'preserving  manner'], ['paper', 'current charger design scheme'], ['charger', 'automatic disconnection functions'], ['renewable  battery', 'control unit'], ['also energy demand', 'sockets lights'], ['First ESNs', 'periodic time functions'], ['total Q cost', 'grid'], ['numerical  analysis', 'developed  method'], ['spontaneous  abortion', 'all  world'], ['Recent  studies', 'gynecology  area'], ['purpose', 'potential RSA occurrence'], ['We', 'three circRNA microarray'], ['594  aberrant', 'circRNAs'], ['', ''], ['', ''], ['102424 validation genes', 'reverse polymerase chain reaction'], ['ROC operating curves', 't test'], ['result', 'exactly microarray chip outcome'], ['', 'circRNAs'], ['area', 'all ROC 0'], ['', ''], ['Further  analysis', 'paper comparison'], ['aberrant villi circRNA expression', 'possibly miRNA sponge circRNAs'], ['Deeper  analysis', 'detailed  mechanisms'], ['', ''], ['rights', ''], ['Thrombomodulin', 'mediated protein C pathway'], ['Genetic  aberrations', 'arterial  thrombosis'], ['genetic  changes', 'venous risk thromboembolism'], ['aim', 'based VTE study'], ['We', 'whole polymerase chain reaction'], ['we', '5  %'], ['significant Cox regression analysis', 'significant VTE univariate'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['respectively THBD rs1962 adjusted', 'deep vein thrombophilia'], ['Subanalysis', 'identified VTE recurrence'], ['further VTE studies', 'large sample findings'], ['eukaryotic  genomes', 'coding host sequences'], ['intronic  they', 'regulatory  information'], ['numerous biology segments', 'genomic gene expression'], ['Introns', 'to cell kilobases'], ['flanking stepwise exons', 'cotranscriptionally stepwise manner'], ['process', 'different splicing deployment'], ['transcript maturation which', 'human  disease'], ['more  which', 'wide  attention'], ['So  it', 'problem'], ['friendly phosphoric flame', 'thermoplastic polyurethane elastomer'], ['retardant  properties', 'infrared Fourier spectroscopy'], ['AF P', 'pure  AF'], ['', 'pHRR  1'], ['wt% content', 'AF 48'], ['residual  mass', 'forming  progress'], ['6  which', 'pure  TPU'], ['AF P', 'high  temperature'], ['AF P', 'beginning'], ['above  it', 'friendly  polymer'], ['', ''], ['', ''], ['rights', ''], ['positive input which', 'simultaneously  transconductance'], ['proposed  amplifier', '90 circuit simulator'], ['', ''], ['359 mu DC', 'GBW  dissipation'], ['This', 'load MHz GBW dissipation'], ['Finally  corners', 'supply voltage dimension mismatch variations'], ['analysis', 'many erythrocyte diseases'], ['RBCs Red Blood image', 'molecular  biology'], ['RBCs which', 'red cells segmentation method'], ['Firstly  feasibility', 'successfully RBCs accuracy'], ['', ''], ['watershed algorithm bases', 'original Mathematical image'], ['used  accuracy', 'method'], ['separating extraction rate', '82'], ['', ''], ['', 'counting  96'], ['', ''], ['biosensing  systems', 'rapid nucleic acid detection'], ['electrochemical  biosensor', 'also anticancer drug Daunorubicin'], ['First rGO', 'chemically IR Raman Spectroscopy'], ['Then  quantity', 'passive  adsorption'], ['electrochemical  behavior', 'cyclic rGO voltammetry'], ['rGO PGEs', 'voltammetry  DPV'], ['voltammetric  results', 'impedance spectroscopy impedance technique'], ['Electrochemical  monitoring', 'detection limits'], ['', ''], ['', ''], ['Fluorescent proteins', 'molecular biology research'], ['copies', 'genomes'], ['full  complement', 'coral FP species'], ['we', 'stony coral species'], ['FP cDNA sequences', 'short-/middle wavelength emission'], ['FP gene', 'four  A'], ['digitifera colonies', 'quantitative FP gene PCR'], ['these', 'largest FP genome'], ['fluorescent light', 'live fluorescent A'], ['high  copy', 'coral FP gene fluorescence'], ['FP gene family', 'phylogenetic Acropora analyses'], ['persistence', 'light Acropora species'], ['PCR polymerase chain technique', 'used gene expression studies'], ['transcript qRT which', 'internal data normalization'], ['Plums', 'Lindl'], ['', 'important fruit trees'], ['further qRT PCR', 'postharvest plum processes'], ['statistical  algorithms', 'candidate gene'], ['comprehensive  evaluation', 'final analysis rankings'], ['CAC', 'experimental candidate reference conditions'], ['CAC', 'accurate gene expression quantification'], ['structural  gene', 'selected reference genes'], ['selection', 'accurate gene expression results'], ['', ''], ['', ''], ['rights', ''], ['Ethylene refrigeration system', 'conventional exergoeconomic analyses'], ['investment exergy costs', 'exogenous refrigeration system'], ['Results', 'total  column'], ['', ''], ['', ''], ['', ''], ['$  /h', 'other  components'], ['exergoeconomic  most', 'only  column'], ['', 'components investment exergy destruction costs'], ['', ''], ['endogenous exergy destruction interactions', 'main exergy destruction'], ['appropriate  strategy', 'system performance'], ['above results compressor', 'highest  performance'], ['Sensitivity', 'important operating variables'], ['', ''], ['rights', ''], ['refugee population', 'last  decade'], ['developing  relationship', 'African refugee population'], ['335 adult refugees', 'food insecurity'], ['who', 'enough  less'], ['', ''], ['', ''], ['proportion', 'anxiety  symptomatology'], ['', ''], ['', ''], ['eating', 'significantly  anxiety'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Similarly  eating', 'significantly  anxiety'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['high  prevalence', 'basic food population'], ['exposure', 'psychiatric sequelae'], ['predominantly Sub Saharan who', 'Sweden'], ['We', 'well host country'], ['total', 'stratified quota sampling'], ['Hopkins Checklist', 'Cultural Lifestyle Questionnaire'], ['Pearson correlations analysis', 'logistic  study'], ['Eighty nine Eighty percent', 'prior  emigration'], ['20  %', 'depressive  symptoms'], ['Males', 'traumatic  events'], ['', ''], ['', 'migration  females'], ['', ''], ['', 'financial  discrimination'], ['Females', 'when  males'], ['', ''], ['', ''], ['Those', 'PTSD  F(63'], ['', ''], ['', ''], ['greater  number', 'PTSD  symptoms'], ['', ''], ['', ''], ['Using', 'PTSD migration stress'], ['', 'depressive education symptoms'], ['that', 'Sweden anxiety depression'], ['predictors', 'depressive employment symptoms'], ['Multidimensional  that', 'psychiatric  stress'], ['', ''], ['financial  access', 'health care'], ['focus', 'also  participants'], ['purpose', 'deep life cycle assessment'], ['refurbished  model', 'case study'], ['refurbishment', 'lighting wall window system'], ['study', 'different operation periods'], ['environmental payback period', 'impact category'], ['deep energy refurbishment', 'intensive construction materials'], ['most impact building', 'operational  period'], ['environmental  impacts', 'mainly New coal'], ['environmental electricity benefits', 'avoided electricity consumption'], ['carefully energy they', 'environmental  impacts'], ['', ''], ['rights', ''], ['study', 'public housing UAE'], ['public housing villas', '1980s'], ['VE energy modeling software', 'refurbishment energy villas'], ['technical  configurations', 'Estidama green sustainability assessment system'], ['refurbishment  configurations', 'well  glazing'], ['refurbishment  strategy', 'wall savings'], ['8  %', '11'], ['', 'lastly  3'], ['', ''], ['three  elements', 'simultaneously  36'], ['7  %', ''], ['savings', 'CO2 emission 22'], ['', ''], ['payback  periods', 'between  8'], ['mechanical  it', 'microbial damages attacks'], ['human  dentition', 'dental evacuation tissue'], ['', 'regenerative health dentistry'], ['align utilities', 'distributed system performance'], ['We', 'benchmark distribution errors'], ['UHF RFID that', 'stable output voltage'], ['sub blocks', 'elementary stage rectifier'], ['OPA class it', 'adaptive biasing circuit'], ['CMOS they', 'low power consumption'], ['output', 'regulator'], ['81  that', ''], ['', ''], ['', 'LIR'], ['PSRR', 'regulator'], ['', ''], ['', ''], ['power consumption', '147  W'], ['960  it', 'TSMC'], ['', ''], ['', 'GmbH'], ['rights', ''], ['Recent  development', 'digital network controller'], ['', 'However control inputs'], ['delay', 'control consideration'], ['general  it', 'difficult  delay'], ['also  parameters', 'uncertainty'], ['we', 'digital reinforcement control'], ['First  we', 'state feedback control'], ['where  outputs', 'output feedback control'], ['optimal it', 'delay'], ['current  research', 'well life being'], ['', 'Polish  35'], ['', ''], ['link', 'well relationship mediators'], ['indirect  effect', 'single relationship serial'], ['', ''], ['rights', ''], ['based state estimation which', 'massive data sets'], ['when degeneracy likelihood', 'prior'], ['we', 'entropy density selection principle'], ['various sampling that', 'synthetic  experiments'], ['Finally  performance', 'short Miami FL USA'], ['paper', 'large scale enterprises'], ['Determination', 'accurate load demand forecast'], ['demand forecasting problems', 'various chain management manufacturing'], ['paper', 'posterior  state'], ['', ''], ['', 'prior  states'], ['', ''], ['', ''], ['we', 'entropy  principle'], ['synthetic case study', 'short electricity demand forecasting'], ['other  that', 'literature'], ['future  we', 'distributed power renewables'], ['Blow  solutions', 'numerical Davey Stewartson method'], ['numerical  method', 'second order time'], ['stability', 'numerical plane wave solutions'], ['evaluate', 'several test problems'], ['global gap existence', 'gap interval'], ['monotonicity properties', 'coupling  parameter'], ['', ''], ['', ''], ['rights', ''], ['add  model', 'MOSFET devices'], ['model', 'transient differential SPICE'], ['It', 'transient accuracy analysis'], ['trap', 'two state Markov process'], ['trap designer', 'repeated Monte Carlo circuit'], ['model', 'level modeling circuit modeling'], ['', 'electrical circuit stress'], ['they', 'state space equations'], ['operational  amplifier', 'proposed  art'], ['', ''], ['rights', ''], ['Clergy members', 'personal  complications'], ['occupational  that', 'related  studies'], ['sectional  design', 'psychometric  properties'], ['65  %', 'burnout'], ['mechanism who', 'burnout'], ['occupational clergy burnout', 'occupational clergy which'], ['Psychological  research', 'sizable  scholarship'], ['', 'more health distress'], ['heavily Likert type which', 'cognitive self report processes'], ['Negative cognition God', 'psychological PNG spirituality'], ['N PNG GNAT', 'concurrent consistency test validity'], ['PNG GNAT scores', 'above self report assessment'], ['PNG GNAT', 'negative  God'], ['current  study', 'cultural  factors'], ['', ''], ['religious participation that', 'human  minds'], ['Roman Catholic Muslim', ''], ['Children', 'Muslim  mind'], ['', ''], ['greater  who', 'anthropomorphic  God'], ['other Religious differentiation', 'religious context factors'], ['findings', 'earliest influence formation'], ['CoA reductase inhibition', 'left matrix heart'], ['Sprague Dawley rats', '4 treatment groups'], ['Rats', 'days  surgery'], ['Hemodynamic measurements', 'anesthetized  state'], ['', 'Northern TGF blotting'], ['3 LV that', 'RSV treatment'], ['LV expression', 'similar FN 2'], ['', 'significantly days RSV'], ['Inhibition', 'acute rat heart'], ['', 'interstitial tissue fibroblasts'], ['containing  sera', 'kg  dose'], ['', ''], ['', ''], ['expression', 'human growth factor beta'], ['blotting  blotting', 'type I'], ['same gene which', 'TGF beta'], ['', ''], ['significant human TGF effect', 'also MMP-9 expression'], ['BRT', 'fibrosis type I'], ['aim', 'different RES criteria'], ['pathways', 'main  harmonisation'], ['based  analysis', 'Green X model'], ['results', 'evaluated  effectiveness'], ['policy pathways', 'similarly RESE deployment'], ['', ''], ['', 'feed banding scheme'], ['clearly  differences', 'rather  harmonisation'], ['This', 'socioeconomic CO2 emissions'], ['', 'support countries'], ['strengthened', 'other policy pathways'], ['study', 'renewable energy use'], ['sample', 'eleven Oil Importing period'], ['run Granger causality tests', 'causality variables'], ['empirical  results', 'fixed capital formation'], ['results', 'statistically  elasticities'], ['economic growth that', 'feedback hypothesis'], ['renewable energy which', 'two energy sources'], ['policies implications', 'results'], ['paper', 'stochastic electricity CO2 price'], ['', ''], ['', ''], ['project value', 'optimal subsidy'], ['squares Carlo simulation method', 'model'], ['proposed  model', 'photovoltaic power China'], ['emission trading scheme', 'subsidy'], ['negatively investment cost', 'positively CO2 subsidy'], ['Chinese  governments', 'measures'], ['', ''], ['', 'required electricity subsidy'], ['last  increasing', 'looming climate change'], ['renewable electricity generation', 'anthropogenic  emissions'], ['particular  potential', 'particular  interest'], ['aim', 'Cycle Assessment Life Cycle methodology'], ['main  parameter', 'simplified LCA plant'], ['air pollutant externalities', 'life SHPs'], ['This', 'NEEDS  framework'], ['results', 'biodiversity yield material damage'], ['total investment which', 'financial  project'], ['increase', 'smart side management'], ['renewable  which', 'directly power system'], ['', 'easier power production'], ['paper', 'spatial  DSM'], ['optimal  spatial', 'whole optimal system'], ['optimal state', 'daily energy losses'], ['temporal DSM problem', 'well  solution'], ['proposed  methodology', 'three test networks'], ['overall system performance that', 'voltage system'], ['', ''], ['rights', ''], ['European Directive', 'renewable energy 2020'], ['PV grid systems', 'national Greece targets'], ['This', 'Hellenic Electricity Market'], ['other mass energy production', 'Greek electricity network'], ['issue', 'Transmission Network Operators'], ['RES stabilization techniques', 'high PVs integration level'], ['', ''], ['rights', ''], ['new  paradigm', 'country'], ['Algeria program', 'renewable energy 2030'], ['sustainability which', 'renewable energy options'], ['performance', 'economic sub concerns'], ['final  three', '% decision process'], ['well  Algeria', 'weighted  criteria'], ['Wind power', 'lastly biomass hydropower'], ['Wind', 'than  0'], ['', '1'], ['', 'future results policy research'], ['', ''], ['rights', ''], ['study', 'namely Estonia 1992'], ['study', 'renewable electricity development nexus'], ['findings', 'renewable electricity consumption'], ['economic  development', 'renewable electricity consumption'], ['population', 'faster  urbanization'], ['economic  growth', 'very  future'], ['development', 'continent'], ['well  it', 'limited  sector'], ['thoroughly  which', 'big literature continent'], ['Well  that', 'overall energy policy'], ['Specifically  we', 'electricity price uncertainty'], ['Further  we', 'wide equilibrium relations'], ['permanent electricity what', 'trends'], ['', ''], ['rights', ''], ['natural storage which', 'capital deployment'], ['P2 G systems', 'fossil  heating'], ['economic cycle assessment', 'main gas products'], ['P2 G systems', 'low fossil carbon gas'], ['none', 'only gas production hydrogen'], ['', '1 MW P2H system'], ['levelised biogas upgrading it', 'regardless  services'], ['', 'conventional gas production'], ['90  %', 'cycle environmental hydrogen SNG'], ['', ''], ['rights', ''], ['Satellite Launch Center', 'northwest  China'], ['potential  risk', 'fossil gas emissions fuels'], ['article', 'local HOMER model'], ['cost', 'proposed  options'], ['', ''], ['', ''], ['', ''], ['renewable energy systems', 'existing power grid'], ['positive carbon price', 'different  options'], ['renewable power system', 'environment energy supply JSLC'], ['hybrid RE system', 'special security JSLC'], ['new  fired', 'suitable cost effectiveness'], ['', ''], ['', ''], ['rights', ''], ['renewable energy sources', 'less tariff policy'], ['inclusion', 'overall Micro grid distribution'], ['Programmable Gate Array', 'digital  control'], ['Hardware Description coding', 'professional system designers'], ['digital system which', 'desired HDL codes'], ['architecture', 'MATLAB SIMULINK platform'], ['grid connected wind that', 'close  model'], ['experimental  analysis', 'such PI dq'], ['Island Developing States', 'most climate change'], ['imported petroleum use', 'economic fossil fuels'], ['region', 'renewable  energy'], ['many Pacific barriers', 'larger RE scale'], ['lack', 'human resources v'], ['main Pacific paper', 'qualitative Pacific challenges'], ['', ''], ['rights', ''], ['Large scale deployment', 'solar integration challenges'], ['PtL  configurations', 'intermittent chemical fuels'], ['These', 'such power storage'], ['Here  we', 'low Alpine region'], ['We', 'electricity heating BeWhere model'], ['large scale deployment', 'when carbon prices'], ['', 'carbon fossil fuel price'], ['15 million 15 15 tonnes', 'current fossil fuel transportation'], ['', 'greater energy supply chain'], ['', ''], ['rights', ''], ['Microgrids', 'interconnected energy components'], ['multiple optimization objectives', 'other'], ['', 'optimization problem changes'], ['', 'microgid optimization solution types'], ['We', 'different optimization microgrids'], ['mathematical  formulations', 'used  microgrids'], ['also optimization types', 'various optimization microgrids'], ['approaches', 'relevant simulation tools'], ['We', 'smart application grid'], ['article', 'further multicriteria decision micrgorids'], ['PV  cell', 'solar  energy'], ['regional  differences', 'unbalanced PV cells'], ['paper', 'spatial PV cells perspectives'], ['Data sources', 'renewable energy 1996'], ['spatial  patterns', 'evolution ArcGIS'], ['balanced Southeast exports', 'recent North years'], ['pattern', 'single PV cells pole'], ['international trade intensity', 'scale PV cells region'], ['incentive policy', ''], ['findings', 'connections intensity traders'], ['industrial  practitioners', 'international business strategies'], ['', ''], ['rights', ''], ['', 'solar energy collector'], ['temperature difference', '40 60A degrees C'], ['temperature', 'degrees C'], ['Low grade heat', 'organic Rankine cycle engines'], ['Thermoelectric generators', 'gradient solar salinity gradient ponds'], ['temperature difference', 'solar electricity production'], ['paper', 'solar heat exchanger pond'], ['results', 'remote power supply systems'], ['Flexibility requirements', 'renewable electricity energies'], ['One  option', 'problem'], ['demand quantification', 'thermal optimization dispatch'], ['power plant modeling', 'economic integer unit dispatch'], ['latter', 'large  extent'], ['', ''], ['ramping', 'computational generator units effort'], ['how storage expansion', 'minimizing optimization MILP'], ['Moreover  we', 'power plant MILP'], ['technical  which', 'thermal power plant dispatch'], ['Contrarily storage expansion', 'MILP'], ['deviation', 'renewable generation increases'], ['', ''], ['rights', ''], ['competitive fringe paper', 'renewable portfolio standards'], ['renewable RES E', 'primarily RPS requirement'], ['Nonrenewable  firms', 'increased RES E schemes'], ['RPS requirement', 'renewable energy certificate'], ['NEC they', 'vested RPS benefits'], ['market E generation cost', 'surcharge'], ['connected RES E', 'intermittent RES E technologies'], ['Japanese  government', 'effective electricity manner'], ['', ''], ['rights', ''], ['Wind energy', '456 electricity June'], ['', '500 wind 2016'], ['that', 'utilized wind potentials'], ['', ''], ['', ''], ['Morocco Egypt Tunisia', 'alternative energy mix'], ['South Africa', 'national wind grid'], ['', ''], ['', ''], ['Cameroon', 'behind wind energy development'], ['operational wind Cameroon', 'wind power'], ['issues', 'foreign electricity sector'], ['Cameroon', 'huge implementation research development'], ['future South Africa', 'future energy road improvement'], ['recent technology advancement', 'stability'], ['wind resource', 'Sistan Zabol Zahak Iran'], ['Weibull distribution function', 'meteorological  data'], ['bias absolute bias error', 'fitted  distribution'], ['Windographer software', 'prevailing wind direction'], ['annual energy densities', ''], ['', ''], ['', ''], ['annual mean power densities', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Zabol', 'large scale power generation'], ['250 kW wind turbine', 'more  electricity'], ['However  Mirjaveh', 'off grid applications'], ['It', 'monetary  2016'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['previous portfolio literature', 'spatial  policies'], ['spatial RPS autocorrelation', 'account'], ['RPS laws', 'renewable  state'], ['state RPS laws', 'renewable NERC whole'], ['electricity markets', 'stringent RPS laws'], ['RPS laws', 'economic  development'], ['', ''], ['', 'wild  Iceland'], ['study', 'brackish challenge water'], ['Bacterial isolation ELISA', 'multiple organ samples'], ['', 'forming intraperitoneal units'], ['', 'bacterial kidney injection'], ['simultaneously  infection', '4 detection methods'], ['1  cohabitant', 'BKD'], ['separate experiment infection', '6 intraperitoneal wk'], ['Fish', '3  wk'], ['', ''], ['PCR infection', '3  wk'], ['Arctic charr', 'R'], ['', ''], ['Cohabitation', 'further  R'], ['', 'natural Arctic charr'], ['B  cells', 'human  pathogens'], ['sequencing', 'immune  autoimmunity'], ['However methods', 'immune  repertoires'], ['we', 'rigorously V D'], ['Repertoire Dissimilarity Index', 'average data simulation repertoires'], ['naive T cells', 'CD8(+ memory repertoire'], ['RDI method', 'immune  repertoires'], ['RDI method', 'R Bitbucket'], ['Reproductive  interference', 'womersleyi  N'], ['', ''], ['reciprocal  crosses', 'male  offspring'], ['Details', 'interspecific reproduction process'], ['we', 'nuclear ribosomal RNA'], ['copulation times', 'interspecific  N'], ['', ''], ['longispinosus males', 'female  offspring'], ['', 'female  offspring'], ['', 'Intraspecific  N'], ['', ''], ['longispinosus', 'biased offspring sex ratios'], ['', ''], ['15 womersleyi that', 'N'], ['longispinosus males', ''], ['', 'N'], ['', ''], ['that', 'female  offspring'], ['chain reaction products', '278 rRNA N'], ['', '642  N'], ['three  fragments', '278 F-1 identification'], ['results', 'reproductive  N'], ['', ''], ['female  offspring', ''], ['renewable RES E', 'out support policies'], ['schemes', 'well investor risk'], ['more  penetrations', 'unpreceded  levels'], ['how E support they', 'efficiently RES E'], ['incentive which', 'efficient  integration'], ['major reference benchmark goal', 'good reference benchmark properties'], ['approach', 'future RES E'], ['many  countries', 'malaria elimination malaria'], ['', 'epidemic elimination areas'], ['how malaria China', 'global malaria R&D'], ['2014 invention articles', 'Chinese  2014'], ['data', 'chronological drug comparisons'], ['however malaria R&D activities', 'few  years'], ['10  R&D', 'highest research programmes'], ['', ''], ['', '0  PubMed'], ['', 'Chinese  databases'], ['', ''], ['However R&D activities', 'mainly  artemisinin'], ['public  focus', 'basic  science'], ['R&D', 'rarely efficiency China'], ['China', 'multiple drug resistance immunology'], ['where  China', 'contribution'], ['especially malaria China', 'global malaria control'], ['collaborative  it', 'sole author research'], ['collaborative  researchers', 'more research productive'], ['research productivity', 'subject term areas'], ['number counting system who', 'most  papers'], ['counting  who', '1'], ['that', 'other  ways'], ['Child protection', ''], ['preventative child measures', 'child maltreatment'], ['reports', 'mapping January'], ['purpose', 'future research agenda'], ['maltreatment', 'academic research journals'], ['It', 'methodological child maltreatment'], ['importance', 'strategic  agenda'], ['', ''], ['electricity utilities', 'time energy pricing'], ['measures', 'time demand'], ['how  they', 'residential efficiency investment behaviour'], ['We', 'metering household investment behaviour'], ['time information reducing', 'unintended energy efficiency home'], ['average 23 households', 'less control group'], ['behavioural  interventions', 'other  those'], ['Furthermore  it', 'when time experiment'], ['', 'Adverse child abuse'], ['', ''], ['domestic  violence', 'mental well adulthood'], ['Factors', 'negative  outcomes'], ['much childhood adversity', 'such  resilience'], ['access', 'mental well adults'], ['you', 'four UK regions'], ['Sampling', 'random probability methods'], ['Analyses', 'binary logistic regression'], ['Adult prevalence', 'heavier AAA childhood'], ['such  behaviours', '1'], ['', 'affluent ACEs AAA 21'], ['4  ACEs', 'AAA support'], ['However  increase', '7'], ['', '1 AAA support'], ['mental well being', ''], ['', ''], ['', ''], ['more AAA you', 'childhood'], ['0  ACE', 'AAA 8'], ['', ''], ['', ''], ['', 'more AAA childhood'], ['harming  behaviours', 'dramatically AAA childhood'], ['', ''], ['', ''], ['', 'AAA support'], ['', '0 AAA support'], ['Adverse childhood experiences', 'mental life course'], ['always  you', 'childhood'], ['harming childhood behaviours', 'communicable  disease'], ['Relationships', '70 refugee Netherlands'], ['5-HTTLPR  polymorphism', 'reported  life'], ['findings', 'traumatic age events'], ['who', 'innate health resilience'], ['', ''], ['rights', ''], ['Child abuse', 'mental problems substance abuse'], ['protective  that', 'negative  outcomes'], ['purpose', 'adolescent child welfare'], ['Participants', ''], ['', ''], ['who', 'color'], ['Data', 'three lifetime substance months'], ['forms', 'significantly childhood depression'], ['Higher  levels', 'less  revictimization'], ['Resiliency', 'sexual  abuse'], ['Resiliency', 'emotional  abuse'], ['significant  interactions', 'health  problems'], ['resiliency', 'sexual  adolescence'], ['', ''], ['rights', ''], ['Steroid resistance syndrome', ''], ['Resistance', 'clinical steroid excess'], ['most steroid hormone resistance', 'generally steroid receptor mutations'], ['nonsense  mutations', 'steroid progesterone receptor'], ['number', 'than androgen receptor'], ['Loss', 'also steroid resistance'], ['Therapy', 'impaired  pathway'], ['Identification', 'alternative disease management'], ['', 'C Elsevier Masson SAS'], ['rights', ''], ['drug  resistance', 'broad yeast cells'], ['', 'lepidopteran insect cell lines'], ['Transcripts', 'Northern  blotting'], ['When  cells', 'protein synthesis transformed'], ['CF-203 cell lines', 'increased  chemical'], ['However ecdysone agonist RH5992', 'transformed cell lines'], ['secreted  that', 'monocytes  humans'], ['high  concentrations', 'endothelial  dysfunction'], ['locally  it', 'vascular cell human'], ['normal macrophage arteries', 'staining macrophage infiltration'], ['localization', 'double  aneurysms'], ['Resistin mRNA', 'smooth muscle cells'], ['This', 'aneurysms vessels'], ['', 'similar 24 b'], ['mRNA  levels', 'Northern  blotting'], ['Both', 'significantly resistin 1'], ['', ''], ['', ''], ['', ''], ['Migratory activity', 'scratched wound assay'], ['', ''], ['', ''], ['summary infiltrating', 'endothelial aneurysms secrete function'], ['Resistin', 'smooth muscle humans'], ['', '2005 European Cardiology'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['One', 'resistive 2-D structure'], ['crosstalk', 'readout circuits'], ['measurement which', 'usable sensors values'], ['accuracy', 'significant readout time'], ['first  method', 'operational bias amplifier'], ['second  row', 'finite  gains'], ['Theoretical analysis', 'simulation'], ['improvement', 'other  literature'], ['resistive sensor arrays', 'crosstalk elements'], ['crosstalk', 'adjacent row elements'], ['First  we', 'resistive sensor array'], ['equivalent resistance expression', 'circuit'], ['Then  IIDFC', 'equivalent resistance simulations'], ['IIDFC', 'general resistance IIDFC'], ['Previous  studies', 'resistive voltage divider'], ['expensive shielding method', 'when voltage divider'], ['operational voltage amplifiers', 'cooperatively voltage measurement circuit'], ['Two  photocouplers', 'direct transfer voltage'], ['carefully measurement circuit', 'solar energy system'], ['dc LLC converter', 'input  variations'], ['proposed control design', 'operational converter conditions'], ['pull mode control which', 'switching time performance'], ['mode digital mode which', 'one switching period'], ['resonant  circuit', 'specific frequency selection'], ['design', 'resonant amplification 3'], ['whole 100KHz system', 'stable excitation signal output'], ['main  goal', 'healthy  tissue'], ['Advances', 'accurate  treatments'], ['However todays technology', 'sufficient  precision'], ['One', 'external  fraction'], ['such correlation linear interpolation', 'plenty  improvement'], ['We', 'progress'], ['', ''], ['', 'external  markers'], ['Results', 'cases'], ['We', 'undergraduate life sciences'], ['Skills', 'responsible knowledge research'], ['it', 'scientific  agenda'], ['Developing  abilities', 'somehow life change'], ['present  analysis', 'course Degree study Porto'], ['curricular  unit', 'specific  interest'], ['Mapping topics', 'collaborative  course'], ['We', 'science society dialogue'], ['pedagogical  practice', 'undergraduate  training'], ['', 'International Biochemistry'], ['cognitive  empathy', 'negative  symptoms'], ['Cognitive', 'also medial prefrontal'], ['negative symptoms research', 'hypotheses'], ['functional  connectivity', 'negative schizophrenia subjects'], ['1  We', 'schizophrenia  sample'], ['then component connectivity metrics', 'negative  symptoms'], ['2  We', 'independent schizophrenia sample'], ['medial component metric', 'cognitive  empathy'], ['temporal  metric', 'negative schizophrenia samples'], ['recent  that', 'negative  schizophrenia'], ['', ''], ['resveratrol', 'red anticancer properties'], ['antitumor effects', 'dietary  compound'], ['One', 'oxidative ATP phosphorylation'], ['little energy efforts', 'cancer cells'], ['aim', 'poly colon cancer'], ['consumption ATP levels', 'metabolic colon cancer cells'], ['Paradoxically cytotoxic effects', 'fatty acid oxidation'], ['partial  reversion', 'increased Warburg apoptosis'], ['anticancer mechanisms', 'ultimately ROS production'], ['General  results', 'new anticancer chemotherapy'], ['', ''], ['', ''], ['rights', ''], ['28 TRP channel genes', 'mouse retina'], ['Transcripts', 'RT PCR'], ['Northern  blotting', '12 TRP channel retina'], ['TRPM1 TRPM3', 'clear TRPM7 TRPP2 TRPV2'], ['', 'retinal TRPC1 TRPC3'], ['Striking  localization', 'plexiform inner segment layers'], ['outer  segments', 'TRPM7'], ['TRPC5 immunostaining', 'inner plexiform layer'], ['TRPV2 antibodies', 'outer plexiform layer'], ['ciliary splice TRPM3', 'pigmented  epithelium'], ['', ''], ['rights', ''], ['Fractures', 'associated head infants'], ['retinal  examination', '1  age'], ['aim', 'long bone fractures'], ['1 chart who', 'long bone fracture'], ['Patients', 'accident multiple fracture area'], ['Patients', 'International codes'], ['78  patients', 'retinal eye hemorrhages'], ['', 'retinal  abuse'], ['patients', 'long bone fractures'], ['dilated eye examination', 'additional  information'], ['recent  subset', 'possible eye abuse'], ['', ''], ['rights', ''], ['system', 'retinal laser delivery photocoagulation'], ['ideal mechanism measurement artifacts', 'discrete photodiode element'], ['problem', 'light photodiode detector'], ['operational  amplifier', '10 USB interface kHz'], ['Studies', '577 Streamline laser nm'], ['where Endpoint pulses', 'effective energy lesions'], [\"Management'(TM delivery mode\", 'delivered pulse profile'], ['effect', 'retinal spot laser photocoagulation'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['X receptors', 'pigment epithelial pigment cells'], ['5 mu TO90', '1 beta(1 40'], ['optimum  concentrations', 'cell viability assay'], ['IL-6  MCP-1', 'real polymerase chain reaction'], ['aging  p16INK4a', 'western  blotting'], ['binding cassette transporter ABCA1', 'real time PCR'], ['Phosphorylated kappa B I', 'western kappa B blotting'], ['negative linear relationship', 'dependent cell manner'], ['well protein TO90', 'detrimental  effects'], ['target it', 'LXR beta'], ['Meanwhile  TO90', 'beta(1 stimulation'], ['LXR alpha axis', 'inflammatory RPE cells'], ['beneficial  effect', 'NF kappa pathway'], ['A', 'dividing  cells'], ['These', 'tumorigenesis'], ['Increased  HMGA2', 'benign  tumors'], ['aim', 'HMGA1  retinoblastoma'], ['fixed mRNA expressions', 'reverse polymerase chain reaction'], ['Results', 'clinicopathologic  parameters'], ['Immunohistochemical  HMGA2', '56'], ['', ''], ['', '75 retinoblastoma cases'], ['mRNA  expressions', 'HMGA1'], ['', ''], ['', ''], ['mRNA results', 'well  results'], ['HMGA2', 'significantly choroidal invasion'], ['Conclusions', 'HMGA2 Rb'], ['Expression', 'therapeutic  RB'], ['Further  experiments', 'therapeutic  tumorigenesis'], ['retinoic acid', 'malignancies'], ['effects', 'especially tumor suppressor'], ['However  little', 'endometrial  cancer'], ['we', 'endometrial cancer cell line'], ['We', 'endometrial cancer immunohistochemistry'], ['Results  We', '2 Hec1A cells'], ['RAR', 'simultaneous cell proliferation'], ['dependently RAR knockdown effect', 'more RAR knockdown'], ['RAR gene', 'real polymerase chain reaction'], ['Furthermore RAR agonist', '2  cells'], ['immunohistochemical analysis RAR expression', 'endometrial tumor cancer'], ['multiple antitumor effects', 'endometrial RA cancers'], ['Purpose', 'years 2 stroke'], ['ever 2 who', 'gainfully  stroke'], ['Patients', 'easy Scale life'], ['Caregivers', 'Caregiver Strain Index'], ['Baseline stroke characteristics', ''], ['95 % confidence intervals', 'age'], ['Forty six Results Forty patients', 'mean  47'], ['', ''], ['', '36 mean months'], ['18', '39  RTW'], ['shorter  length', 'RTW'], ['', ''], ['', ''], ['', ''], ['', 'HADS depression score'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'better  FAI'], ['', ''], ['', ''], ['', 'mental component summary SF36'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['92', 'RTW'], ['shorter  duration', 'favorable work outcome'], ['significant  association', 'effective work RTW'], ['Dynamic  pricing', 'considerable network revenue research'], ['major  we', 'heuristic  literature'], ['we', 'dynamic programming decomposition'], ['Dynamic programming decomposition', 'academic  literature'], ['two  variants', 'recent  literature'], ['real base we', 'dynamic network revenue management'], ['', ''], ['', ''], ['', 'other  approaches'], ['varying network performance', 'strongly  both'], ['Overall  paper', 'practical network pricing problems'], ['hardware', 'capacitive  5nF'], ['amplifier', 'forward Nested Miller stage'], ['This', '60 phase loads'], ['circuit', '2V supply'], ['proposed  technique', 'two compensation 1pf'], ['design', 'unity 9'], ['', 'capacitive  load'], ['simulation', '180 Cadence Virtuoso environment'], ['organic  osmosis', 'environmental wastewater treatment risks'], ['aim', 'electrolysis desalination chemical production cell'], ['RO concentrate', 'desalination chamber'], ['production  chambers', '1 L NaCl'], ['acid humic organic', 'acid production chamber'], ['minimum', 'production  1'], ['', ''], ['', ''], ['', ''], ['', ''], ['total energy consumption', ''], ['', ''], ['', ''], ['', ''], ['37%-61  %', 'substrate  utilization'], ['concentrate electricity MEDCC', 'practical  applications'], ['', ''], ['', ''], ['rights', ''], ['sexual  abuse', 'sexual  adulthood'], ['physical  abuse', 'sexual  revictimization'], ['', 'different child abuse'], ['present  study', 'different childhood adulthood'], ['', 'posttraumatic stress disorder'], ['sexual childhood abuse', 'sexual  adulthood'], ['', ''], ['', ''], ['Physical  maltreatment', 'physical  adulthood'], ['', ''], ['', ''], ['particular  subtypes', 'specific childhood adults'], ['result', 'treatment childhood abuse'], ['system', 'operational control module'], ['first  system', 'fixed  OPA847'], ['intermediate  it', '5 times gain'], ['latter  system', '100V//V gain OPA695'], ['gain reduction', 'present output voltage gain'], ['range', '4dB  step'], ['testing', 'stable  performance'], ['', 'pharmacologic  treatments'], ['diagnosed  RA', 'high disease activity'], ['already  HDA', 'conventional  DMARDs'], ['clinical  features', 'drugs'], ['parameters', '6  months'], ['clinical EULAR response criteria', 'gold standard'], ['', ''], ['', 'diagnosed  RA'], ['9 RA who', 'bDMARDs'], ['who', '12 Emilia Romagna Region'], ['Statistical  analyses', 'moderate risk 1'], ['RA who', 'bDMARDs'], ['', ''], ['', 'diagnosed  RA'], ['', ''], ['Health Questionnaire', ''], ['', '2'], ['RA who', 'bDMARDs'], ['', 'good  response'], ['', 'diagnosed  RA'], ['', ''], ['who', 'cDMARDs'], ['when  bDMARD', 'HDA'], ['good safety profile', ''], ['', 'etanercept  therapy'], ['Twenty two RA patients', 'one  year'], ['receiving', 'only  controls'], ['subjects', 'single  dose'], ['', '5  PCV13'], ['Pneumococcal antibody levels', '8  VaccZyme'], ['fold Allergy increase', 'protective antibody responsiveness'], ['', ''], ['', 'postvaccination'], ['different fever infections', '8  vaccination'], ['pneumococcal antibody levels', 'significantly  groups'], ['8 antibody levels', 'significantly  baseline'], ['protective antibody levels', 'control group'], ['', ''], ['', ''], ['Possible  predictors', 'logistic regression model'], ['', 'negative antibody age'], ['', ''], ['medical  condition', 'follow up period'], ['', 'one ETA vaccination'], ['Higher  age', 'impaired  pAR'], ['efficacy', 'younger RA patients'], ['vaccine', 'RA ETA'], ['', ''], ['', 'Elsevier Masson SAS'], ['rights', ''], ['', 'herbal  medicine'], ['potential  mechanism', 'rheumatoid  arthritis'], ['aim', 'synoviocyte inflammation model'], ['24  h', 'like  model'], ['FLSs', 'shikonin'], ['', '30 treatment groups'], ['real polymerase chain reaction', 'immunosorbent protein interleukin'], ['Signal proteins', 'Western  blotting'], ['Shikonin', 'IL-10 kappa B pathway'], ['induced TNF alpha effect', 'markedly IL-10-neutralizing antibody'], ['IL-10-mediated  suppression', 'synthesis inhibitor cyclohexamide'], ['dependent PKC NF study', 'potential  RA'], ['Here  we', 'rheumatoid candidate arthritis'], ['seq)-based expression analysis', 'treated blood RA'], ['treated RA sub groups', 'pathway analysis'], ['set', 'healthy blood controls'], ['qualifying pathway these', 'additional connector molecules'], ['expression', 'seq connector data'], ['Differences', 'healthy ERBB2 controls'], ['', ''], ['THOP1 expression profile', 'independent blood mononuclear samples'], ['Integration', 'new genes ERBB2 RA'], ['Self Efficacy Scale-8', 'specific self efficacy'], ['However  evidence', 'Chinese arthritis patients'], ['', 'Chinese  ASES-8'], ['Chinese ASES-8', 'back English procedures'], ['Validation survey', 'Functional Illness Therapy Fatigue'], ['convenience sample', '134 rheumatoid rheumatology'], ['Validity', 'correlation analysis'], ['Reliability', 'class correlation coefficient'], ['one  that', '71'], ['', ''], ['negative  correlations', 'HADS D HADS A scores'], ['', '-0'], ['', ''], ['positive  correlations', 'ASES-8'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Chinese  version', 'acceptable rheumatoid arthritis'], ['specific  scale', 'Chinese  population'], ['Dishevelled', 'other Wnt pathways'], ['rheumatoid  we', 'like cytokine synoviocytes'], ['Expression', 'synovial  tissue'], ['Dvl2', 'induced arthritis rats'], ['apoptosis', 'inflammatory  cytokines'], ['Genetic  changes', 'corresponding RA FLSs'], ['Dvl2', 'synovial  tissue'], ['inflammatory RA Dvl2', 'antiapoptotic  genes'], ['Dvl2', 'nuclear B target genes'], ['findings', 'Wnt NF kappa pathways'], ['clinical  practitioners', 'based  manner'], ['Korean Academy Korean Allergy', 'Korean Clinical patients'], ['clinical core practitioners', 'first core which'], ['allergists  pediatricians', 'appropriate literature recommendation'], ['we', 'allergic  rhinitis'], ['social  burden', 'significant  AR'], ['Therefore  physicians', 'proper management AR'], ['Korean Academy Korean Allergy', 'Korean Clinical patients'], ['', 'core questions'], ['', ''], ['several  experts', 'systematic allergology literature'], ['Furthermore  we', 'answer'], ['we', 'medical  AR'], ['syncytial  virus', 'respiratory  pathogens'], ['Immoderate inflammation', 'induced  diseases'], ['present watsonianone A', 'Rhodomyrtus tomentosa'], ['Hassk', 'inhibitory  37'], ['', ''], ['', ''], ['markedly protein levels', 'infected chemoattractant RAW264'], ['', ''], ['', 'NF kappa IxBa phosphorylation'], ['ROS oxygen which', 'infected NF KB cells'], ['watsonianone A', 'sensitive  inflammatory'], ['RAC1 activator', 'follicular  development'], ['we', 'Sprague Dawley rat model'], ['transcript  levels', 'theca ovarian cells'], ['effect', 'granulosa flow cytometry'], ['Oocyte', 'optimal  RHOG'], ['maximum  which', 'estrus stage'], ['Mild immunostaining', 'secondary  follicles'], ['weak  that', 'based  investigations'], ['RHOG effectors DOCK1', 'PCOS condition PCOS DHEA'], ['antral SD that', 'human ovarian cells'], ['theca effectors DHEA', 'PCOS'], ['biomechanical piglet that', 'abused thoracic infants'], ['mechanical  fist', 'custom jig'], ['Twenty stillborn piglets', 'thoracic cage'], ['resultant  force', 'indicative rib fracture'], ['correlation', 'impact fractures'], ['', ''], ['parietal thoracic 5', 'butterfly fracture patterning'], ['Scanning electron microscopy', 'complete bone ribs'], ['vertical  fractures', 'contact zone'], ['work', 'accidental rib injury'], ['impact events', 'axial  tests'], ['flexible punch impact event', 'anterolateral transverse fractures'], ['presence', 'manual rib compression'], ['', ''], ['rights', ''], ['encoding', 'principle Escherichia coli'], ['', 'RNase S'], ['meliloti RNA', 'wild RNase 5'], ['like ribosomal RNA', ''], ['mutant RNase J', 'two 23S rRNA 5S'], ['', '2009 European Biochemical Societies'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['Plant microRNAs', 'transcriptional gene level'], ['more  miRNAs', 'powerful  miRNAs'], ['Here  we', 'real polymerase chain reaction'], ['Eight', 'northern blotting assays'], ['miRNAs', 'important rice development'], ['different rice data', 'regulatory rice development'], ['', ''], ['', ''], ['rights', ''], ['Rice stripe virus', 'severe East Asia'], ['systematical RNA research', 'genomic  scale'], ['inverted repeat that', 'nucleocapsid protein RSV nucleocapsid gene'], ['21 blotting which', 'transgenic rice lines'], ['transgenic T DNA fragment', '773 32 158'], ['inverted repeat RSV', 'transgenic  rice'], ['varied expression level', 'future hotspot research'], ['massive  abundance', 'major RSV resistance'], ['therefore  it', 'standardized healing fractures'], ['We', 'mortem  3'], ['diagnostic  tools', 'condition'], ['rachitic  rosary', ''], ['Vitamin D insufficiency', 'correct metaphyseal diagnosis'], ['appropriate  methodology', 'paramount mineralization defects'], ['where  neglect', 'vitamin D insufficiency'], ['43 ubiquitin ligase that', 'important tumor formation'], ['RNF43', 'gastric tumor suppressor cancer'], ['5  Lgr5', 'gastric stem cancer cells'], ['Immunohistochemistry', 'quantitative reverse protein expression RNF43'], ['like Gastric cancer cells', 'gastric tumorsphere culture'], ['associated virus system', 'RNF43 cancer cells'], ['Functional  experiments', 'RNF43 tumor xenograft overexpression'], ['RNF43  loss', 'gastric cancer patients'], ['RNF43 expression', 'even adherent cancer cells'], ['Overexpression', 'sphere formation ability vivo'], ['RNF43-overexpressing Wnt pathway activators', 'extent'], ['RNF43', 'Wnt beta catenin pathway'], ['present  study', 'representative sex youth'], ['47 % male', 'current Adolescent sample'], ['Participants', 'in  waves'], ['sex exchange', '4'], ['', '2  3'], ['n=26  who', 'so  waves'], ['More  males', 'n=237'], ['who', 'more  sex'], ['', ''], ['', ''], ['who', 'other child abuse'], ['ever  who', 'ever  gonorrhea'], ['', ''], ['', ''], ['', ''], ['sex exchange', 'general  population'], ['Reactions', 'initial  exposure'], ['clear rechallenging guidelines', 'rechallenging reaction'], ['', 'rituximab decision reactions'], ['We', 'academic outpatient infusion center'], ['clinical  symptoms', 'reactions'], ['Reaction severity', 'standard  criteria'], ['54 % men', '1 rituximab reaction'], ['Most  reactions', 'first  rituximab'], ['88  %', ''], ['', 'initial Fifty reaction'], ['Most  patients', '1  rechallenge'], ['4  patients', '3  rechallenge'], ['grade', 'reaction'], ['who', '1  rituximab'], ['3  reaction', 'additional rituximab administration'], ['Further  research', '2  reactions'], ['', '2016 Allergy Asthma'], ['Rituximab', 'increasingly optica spectrum disorder'], ['Administration regimen', 'reliable RTX efficacy'], ['most induction RTX', 'most  cases'], ['', 'CD19 memory B detection'], ['French NMO who', 'induction RTX'], ['We', 'mBc g RTX detection'], ['mBc', ''], ['40  patients', ''], ['', ''], ['Aquaporin-4 antibodies', '75 % patients'], ['2  they', '1'], ['', '62  year'], ['mean  interval', 'S2'], ['', 'clinical  efficacy'], ['', 'cumulative personalizing treatment efficacy'], ['', ''], ['', ''], ['rights', ''], ['IgSF  proteins', 'nervous  system'], ['rat which', 'subsequently Drosophila Kirre'], ['new  molecule', 'rat Kirre'], ['We', 'nervous protein system'], ['binding C which', 'rat cortical rat neurons'], ['Main cDNA library screening', 'cDNA'], ['Northern  blotting', 'Western rKirre expression'], ['situ immuno fluorescent staining', 'rKirre'], ['Key rKirre gene', 'spinal adult rats'], ['protein level', 'cerebral  cortex'], ['rat cortical rat amount', 'neuronal  differentiation'], ['rKirre', 'cortical  neurons'], ['rKirre', 'nervous  system'], ['', ''], ['rights', ''], ['exoribonuclease polynucleotide exoribonuclease phosphorylase', 'bacterial RNA decay'], ['PNPase expression', 'transcriptionally mRNA stability'], ['primary  transcript', 'dependent endonuclease RNase manner'], ['linking ribosomal protein', 'mRNA leader region'], ['We', 'potential S1 overexpression'], ['Northern S1 overexpression', 'other  transcripts'], ['it', 'pnp deletion strain'], ['dependent  stabilization', 'however chemical decay bulk'], ['exonucleolytic  activity', 'full PNPase length'], ['mRNA  species', 'fast  turnover'], ['increase', 'treated intron binding wheat'], ['similar  phenomenon', 'rice'], ['unspliced cox2 editing', 'cold  treatment'], ['accumulation', 'COXII protein'], ['23 mitochondrial introns', 'Northern  blotting'], ['cold  treatment', 'adjoining  cDNA'], ['Six RNA editing sites', 'four  cDNA'], ['One', 'cold nad7 treatment'], ['where editing frequency', 'tight  splicing'], ['other  sites', ''], ['spliced  transcripts', 'six  sites'], ['', 'pSilencer'], ['', 'nude laryngeal mice'], ['Hep2 cells', 'then formation growth rates'], ['tumor', 'pSilencer'], ['0-U6-siRNA  stat3', ''], ['growth curves', ''], ['Bcl-2 cyclin D1', 'Western survivin blotting'], ['mRNA levels', 'digoxigenin nick end tumors'], ['', 'nude mice pSilencer'], ['0-U6-siRNA  stat3', 'significantly  controls'], ['', ''], ['', 'stat3 survivin tumor'], ['', 'induced  tumors'], ['', ''], ['0-U6-siRNA  stat3', 'nude laryngeal apoptosis'], ['', 'endothelial RNA interference'], ['we', 'then cancer HT29 lipofectamine'], ['level', 'RT PCR'], ['protein expression', 'immunofluoresence staining'], ['specific expression which', 'efficiently HT29 cells'], ['Western inhibition rate', 'VEGF expression'], ['expression', 'HT29 cells'], ['We', 'signal quality intensity'], ['analysis', 'hot phenol methods'], ['intensity detection sensitivity', 'key  difference'], ['Total RNAs', 'large ribosomal RNAs'], ['TRIzol  which', 'instead tRNA size'], ['sized TRIzol extraction procedures', 'tiny  RNAs'], ['RNA silencing', 'host  defense'], ['Here  we', 'Sugarcane mosaic RNA'], ['replication', 'RNA silencing machinery'], ['HC Pro', 'sense RNA'], ['HC Pro', 'down  3'], ['Meanwhile 2b gene', 'down Tomato aspermy 5'], ['HC Pro', 'down  RDR6'], ['RNA silencing RNA suppressor', 'one  pathway'], ['', ''], ['rights', ''], ['RNA silencing', 'small  RNAs'], ['chapter', 'such blot hybridization plant'], ['control blots', 'oligonucleotide detection probes'], ['endogenous  smRNAs', 'melanogaster Miss musculus'], ['northern  biogenesis', 'particular DNA virus infection'], ['We', 'agarose formaldehyde gels'], ['matched buffer systems', 'conductive  medium'], ['key  advantages', 'long formaldehyde separation'], ['streamlined work that', 'Northern RNA blotting'], ['', ''], ['rights', ''], ['Quantification', 'particular messenger protein'], ['blotting real RNase protection method', 'own  drawbacks'], ['Capillary  electrophoresis', 'dynamic protocol RNA'], ['directly RNA that', 'current  methods'], ['Gene expression', 'given RNA species'], ['direct  approach', 'cardiac domain tissue'], ['', ''], ['rights', ''], ['nop5 sik1 gene which', 'nucleolar  ribonucleoprotein'], ['we', 'polyclonal expression pattern'], ['It', 'different Drosophila development'], ['We', 'UAS binary DNop5 protein'], ['somatic DNop5 protein', 'somatic RNAi which'], ['28S rRNA', '18S DNop5'], ['rRNA processing that', '18S'], ['B2 VSR', 'stranded  RNA'], ['VSRs', 'plant  cells'], ['cytoplasmic N researchers', 'nuclear  siRNAs'], ['chapter', \"3'-end cytidine-3'5'-bis phosphate\"], ['marine  worm', 'bacterial Olavius symbionts'], ['host', 'symbionts'], ['Here  we', 'O'], ['immune  system', 'symbiotic  microbiota'], ['abundant oxygen storage that', 'anoxic  conditions'], ['Additionally  we', 'Toll recognition receptors'], ['how  worm', 'marine expression oligochaete'], ['adaptive  responses', 'biological  innovations'], ['organismal  itself', 'functional  impairments'], ['Insights', 'positively brain health'], ['sequencing chain we', 'whole gene lifespan'], ['most  mice', '24  period'], ['Functional  annotation', 'cancer'], ['24 glutathione those', 'focal  cancer'], ['particular  which', 'organismal  health'], ['', ''], ['rights', ''], ['Contamination', 'molecular  biology'], ['distinct  which', 'same  sequencing'], ['1 cytochrome we', '80  samples'], ['between  that', 'same  company'], ['We', 'when  counts'], ['synonymous  ratio', 'various  extents'], ['published  results', 'probably  contamination'], ['Recommendations', 'population genomics molecular analysis'], ['coding RNAs RNA which', 'increasing gene prokaryotes'], ['automated  method', 'large  datasets'], ['exponential Mycobacterium tuberculosis we', 'containing reads coverage maps'], ['664 reading which', 'northern  blotting'], ['work', 'encoding RNA Seq M'], ['control', 'gene bacteria'], ['', 'immune  i'], ['', ''], ['enhanced  protection', 'invertebrate  species'], ['accumulating', 'mechanistic phenotypic evidence underpinnings'], ['Here  we', 'immune priming phenomenon'], ['how  ingestion', 'whole transcriptome sequencing approach'], ['distinct  many', 'immune  candidates'], ['', 'previous  priming'], ['large  subset', 'inverse  challenge'], ['gene expression', 'immune  priming'], ['shift', 'secondary gene encounter'], ['', ''], ['sdh4 gene cluster', 'heterologous polymorpha sdh4 probe'], ['sdh4  genes', 'potato soybean'], ['genes', 'cauliflower'], ['putative recombination point', 'potato mitochondrial DNA'], ['32 bp which', 'genic Arabidopsis rearrangements'], ['functional mitochondrial which', 'also  potato'], ['performance uncertainty', 'mixed signal circuit design'], ['situation', 'correct system operation'], ['we', 'robust design parameters'], ['we', 'surrogating performance space'], ['proposed Pareto that', 'design robustness'], ['One  advantage', 'nonlinear  performance'], ['nonlinear circuit we', 'operational amplifier circuit'], ['', ''], ['', ''], ['rights', ''], ['', 'uncertain grid inductance'], ['digital discretization procedure', 'accurate discrete timemodel'], ['augmented  that', 'digital control implementation'], ['previous loop that', 'discretized  errors'], ['experimental discretization results', 'proposed  approach'], ['180 eastern sarcocysts', 'wet light microscopy'], ['well PCR amplification', 'two complete18S ribosomal species'], ['major sarcocyst types', 'shaped  sarcocysts'], ['', 'like  protrusions'], ['sarcocysts', 'different  species'], ['like Sarcocystis protrusions', 'Sarcocystis silva'], ['', '19 cox1 S'], ['', 'nucleotide  positions'], ['', ''], ['They', 'previous cox1 S'], ['', 'sika 98'], ['', 'nucleotide  positions'], ['', ''], ['', 'two % interspecific populations'], ['two  populations', 'monophyletic  clusters'], ['', ''], ['separate roe which', 'separate roe species'], ['', ''], ['two 18S rRNA species', 'clearly  other'], ['', 'intraspecific 18S rRNA S'], ['', ''], ['', ''], ['24 % which', 'previously  S'], ['', ''], ['', 'new rRNA gene S'], ['linearis', '97'], ['', ''], ['', '6  S'], ['taeniata', 'two tree species'], ['', 'electron S'], ['linearis', 'like cyst wall protrusions'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'elliptic mu outline'], ['', ''], ['', ''], ['', ''], ['', ''], ['terminal  plates', 'like  seesaw'], ['terminal  plates', 'hexagonal  roof'], ['proximal host which', 'close cyst surface'], ['', 'sarcocyst  S'], ['linearis', 'unnamed Sarcocystis sp'], ['', 'several transmission electron Italy'], ['', 'few  S'], ['', ''], ['silva', 'like  S'], ['like SEM protrusions', 'round  S'], ['', ''], ['', 'new  S'], ['', ''], ['', ''], ['silva', 'intraspecific sequence marker'], ['Similarly  study', 'intragenomic 18S rRNA S'], ['', ''], ['', 'such 18S rRNA S'], ['', ''], ['new  method', 'current  sensors'], ['', 'parasitic transimpedance coil'], ['Using', 'current Rogowski sensor'], ['analyses', 'simulation'], ['special  coil', 'electronic  components'], ['', ''], ['', ''], ['rights', ''], ['main  tendency', 'digital control systems ones'], ['same power section', 'drive'], ['This', 'high control nonlinearity'], ['accepted KP KI KD', 'highest  industry'], ['main  aim', 'reversing rolling mill'], ['transient  consequences', 'learning output layer neurons'], ['Modeling experiments', 'consideration'], ['They', 'optimal winding parameters drift'], ['Such  experiments', 'neural  tuner'], ['second  type', 'based control system'], ['study', 'R  administration'], ['mg  kg', 'beta amyloid rat gonadectomy'], ['GDX beta GDX', 'testosterone  TP'], ['mg kg subcutaneous', ''], ['GDX rats', 'TP'], ['spontaneous locomotor activity', 'open field test'], ['blood FST', 'experimental  groups'], ['Treatment', 'forced swimming test'], ['Coadministration', 'like behavior testing'], ['RoprenA', 'open field test'], ['elevated corticosterone levels', 'forced swimming test'], ['RoprenA', 'altered  androgens'], ['inflammatory  that', 'facial  skin'], ['Clinically  rosacea', 'ocular  rosacea'], ['However phenotypic presentations', 'rosacea'], ['neurovascular  dysregulation', 'clinical  rosacea'], ['we', 'recent  laboratory'], ['associated  diseases', 'molecular management biology'], ['Understanding', 'complex  pathogenesis'], ['paper', 'signal conditioning circuit'], ['rotameter', 'linear  device'], ['display which', 'directly flow rate'], ['new  circuitry', 'remote control areas'], ['ferromagnetic  wire', 'flow sensor'], ['', 'flow rate'], ['based  circuit', 'self inductance'], ['voltage', '4 mA current'], ['wireless  readout', 'microcontroller  unit'], ['results', 'transmitter self rate'], ['theoretical  equations', 'simulation paper'], ['Rotaviruses', '500000  deaths'], ['', ''], ['infection positivity rates', '17'], ['', '39'], ['', '0  children'], ['However  little', 'molecular  Rotavirus'], ['objective', 'Rotavirus children'], ['sectional  study', 'Hospital University Teaching Hospital'], ['Rotavirus antigen detection', 'Rotavirus Microplate Assay'], ['59 Rotavirus samples', 'Rotavirus RNA extraction'], ['Multiplex PCR', 'G12 G1-G4 P[4'], ['total', '59 diarrheal stool age'], ['Rotavirus antigen positive', '=  22'], ['', '9  patients'], ['highest  number', 'January'], ['predominant G Type', '36  G9'], ['', ''], ['predominant P- type', ''], ['', '31  P10'], ['', ''], ['', ''], ['G12P P type 6', 'G P type combinations'], ['', ''], ['', ''], ['', ''], ['Rotavirus diarrhea', 'mostly  winter'], ['circulating  genotypes', 'unusual  G12P[6'], ['It', 'large  country'], ['stool specimens', 'Sukhothai  provinces'], ['2  %', 'polyacrylamide gel electrophoresis'], ['G  types', 'nested RT PCR'], ['', ''], ['5  %', 'most  G2P[4'], ['', ''], ['Unusual', 'high  frequency'], ['', ''], ['133  HuRVAs', 'short RNA PAGE'], ['properties', 'recent  Thailand'], ['', ''], ['rotaviruses', 'young  children'], ['commercial  tests', 'immunochromatographic RVA infection'], ['', 'chromatographic  immunoassays'], ['L Zaragoza Spain', 'Real reference test'], ['Real stool samples', '89  Vikia'], ['', '78 Positive Predictive %'], ['', ''], ['8)', '97 Negative Predictive %'], ['', ''], ['', 'Vikia'], ['However  CerTest', 'substantial  agreement'], ['', 'Real time PCR'], ['correlation', 'viral time PCR load'], ['risk Astrovirus reactions', 'two Norovirus Adenovirus'], ['CerTest', 'G2P[4 G3 G4 G9'], ['results', 'diagnostic  tests'], ['', ''], ['', ''], ['rights', ''], ['Rotavirus A', 'acute  children'], ['5  years', '15-month  period'], ['5  %', '92  %'], ['further  that', 'positive  specimens'], ['', ''], ['3  strains', 'common human RVA genotypes'], ['', ''], ['', ''], ['', ''], ['6  %', 'unusual  G9P[19'], ['phylogenetic G10-P[14]-I2-R2-C2-M2-A3N2- trees', 'old cattle boy'], ['RVA strains', 'necessarily animal host humans'], ['host barrier', 'limited study period'], ['', ''], ['he', 'political  time'], ['social starting that', 'collective  community'], ['we', 'moral cognitivist reasoning'], ['I', 'collective  intentionality'], ['how  interpretation', 'contemporary  republicanism'], ['transcriptional repressor which', 'high  RP58'], ['simiRP58', 'POK Kruppel Zn proteins'], ['simiRP58', 'transcriptional repressor RP58'], ['simiRP58', 'highest  level'], ['situ  simiRP58', 'seminiferous  tubules'], ['', 'seminiferous contrast tubules'], ['that', 'nucleus'], ['', 'induced localization proteins'], ['', ''], ['rights', ''], ['Cervical  cancer', 'great  health'], ['precancerous  two', 'two disease progression'], ['', 'cervical epidemiology cancer'], ['isothermal recombinase polymerase which', '18 papillomavirus DNA'], ['we', 'clinical plasmids standard'], ['It', 'thermal  incubation'], ['products', 'real SYBR Green I'], ['diagnostic  performance', 'cervical  cancer'], ['reaction', 'other RPA copies'], ['20 degrees which', 'satisfactory  performance'], ['agreement', 'RPA'], ['', ''], ['', 'HPV16 positivity'], ['', ''], ['', 'good HPV18 tests'], ['useful HPV which', 'commercial HPV applications'], ['Rice stripe virus', 'economical  significance'], ['It', 'genetic Yunnan China'], ['potential RSV recombination events', 'four RNA RSV'], ['Bayesian coalescent method', 'coding CP gene'], ['nucleotide substitution rate', ''], ['20th RSV RSV', 'long  notice'], ['RSV genes', 'mutational  bias'], ['brown host former', 'dominant codon usage RSV'], ['CpG dinucleotide deficiency', 'RSV'], ['', ''], ['rights', ''], ['noble film which', 'organic  electronics'], ['unclean  rubrene', 'organic semiconducting material'], ['absorption fine structure spectroscopy', 'atomic surface films'], ['adventitious contamination layer', 'molecular Ag substrate layer'], ['injection barrier height interface dipole', 'thin Ag substrate'], ['results', 'thin device performance'], ['', ''], ['', ''], ['rights', ''], ['addition', 'methane emission'], ['mechanism', 'nitrite methanogen proliferation'], ['more anammox methane', 'when  nitrate'], ['Ruminal batch culture model', 'mM methanogens NC10'], ['NC10', 'relative methane NC10'], ['combined  addition', 'nitrate methane removal'], ['We', 'special primer sets'], ['present  study', 'ruminal methane emission'], ['developmental  DD', 'social cognition abilities'], ['fully  they', 'subcortical  structures'], ['cerebellar  dysfunction', 'cerebellar methods oculomotor patterns'], ['aim', 'frontal oculomotor saccade dysfunction'], ['prefrontal  results', 'cerebellar saccade impairments'], ['dyspraxic patients', 'guided  saccades'], ['closer  analysis', 'maximum saccade velocities'], ['pattern', 'cerebellar  dysfunction'], ['', 'warrants alternative saccades warrants hypotheses'], ['unusual  pattern', 'frontal  areas'], ['such cost cells', 'lipid growth media'], ['LIP2 lipolytica gene', 'S'], ['', 'cerevisiae expression S'], ['that', 'Lip2 lipase growth media'], ['Specifically LIP2 expression', 'S'], ['which', 'rapidly fatty acids'], ['all fatty acid cells', 'promoter LIP2 media'], ['', ''], ['cells', 'intracellular fatty lipids'], ['when Lip2p lipids', 'media'], ['necessary yeast that', 'added value TAGs'], ['', ''], ['', 'sugar  production'], ['main stress that', 'negatively sugarcane yield'], ['biological drought gene that', 'water deficit'], ['', 'successful reference qPCR'], ['', 'varying drought tolerance'], ['Eight candidate reference genes', 'field greenhouse conditions'], ['five  genes', 'nutrient solution'], ['NormFinder', 'experimental RefFinder conditions'], ['more reference GAPDH', 'one shoot roots'], ['suitable water which', 'accurate  qPCR'], ['Thus  results', 'varying water conditions'], ['nuclear power plant systems', 'adequate life cycles'], ['Software', 'digital control systems'], ['digital analog which', 'study'], ['aging  management', 'exploratory  stage'], ['aging  evaluation', 'nuclear power plants'], ['effective reliability paper', 'software aging life cycle'], ['aging management scheme', 'aging digital control information'], ['new security that', 'industrial  infrastructures'], ['facility design facility that', 'safety'], ['We', 'different  literature'], ['', ''], ['rights', ''], ['computational saliency few', 'object boundary object account'], ['salient  objects', 'explicit  surroundings'], ['ultrametric contour which', 'robust bias color dissimilarity'], ['final saliency map', 'layer saliency maps'], ['proposed benchmark model', 'state saliency detection models'], ['Salivary diagnostics', 'cancerous  diseases'], ['it', 'earlier survival disease'], ['invasive  that', 'complicated  procedures'], ['diagnostic  many', 'apart  blood'], ['standard  methods', 'gel electrophoresis microarrays'], ['salivary  diagnostics', 'electrochemical diagnostics detection'], ['technologies', 'early detection prognosis assessment'], ['purpose', 'cancerous  saliva'], ['multiple  that', 'molecular  biology'], ['potentially  which', 'adjuvant  radiotherapy'], ['metastatic  tumors', 'poorer  prognosis'], ['molecular  studies', 'mainly salivary duct carcinoma'], ['Successful  treatment', 'such salivary gland cancer'], ['we', 'therapeutic salivary gland cancer'], ['enterica serovar Typhi', 'important endemic pathogens'], ['typhoidal Salmonella serovars', 'such Typhimurium Iran'], ['aim', 'rapid Salmonella spp'], ['', 'common Salmonella Iran'], ['Current  research', 'Medical Sciences'], ['pair', 'chromosomal  sequence'], ['other  sets', 'four Salmonella S'], ['', ''], ['', ''], ['', ''], ['', ''], ['assay specificity', 'different Salmonella serovars'], ['specific  PCR', '404 Salmonella spp'], ['', ''], ['PCR assays', '104  serovars'], ['specific primer pair set', 'other Salmonella serovars'], ['PCR protocols', 'good  specificity'], ['They', 'prevalent Salmonella Iran'], ['Salmonella', 'local food borne animals'], ['rapid  methods', 'efficient Salmonella poultry'], ['', 'simultaneously Salmonella sp'], ['', 'associated Typhimurium Salmonella Pullorum'], ['MqPCR  method', 'specific Salmonella sp'], ['', 'S'], ['', ''], ['', ''], ['', ''], ['', ''], ['MqPCR  method', 'viable Salmonella sp'], ['', 'four chicken carcasses'], ['MqPCR assay', 'specifically Salmonella sp'], ['', ''], ['', ''], ['', ''], ['', ''], ['Gallinarum', '100 % sensitivity'], ['optimized PMA MqPCR assay', 'spiked chicken carcasses'], ['procedure', '2  h'], ['MqPCR  technique', 'viable  Salmonella'], ['Also  assay', 'simultaneous  S'], ['', ''], ['', ''], ['', ''], ['', 'chicken carcasses'], ['assay', 'diagnostic Salmonella poultry'], ['Salmonella  infections', 'malnutrition sickle cell disease'], ['urgently  none', 'iNTS'], ['how Salmonella knowledge', 'vaccines'], ['iNTS  that', 'diagnosis'], ['These', 'fragile endemic countries'], ['Vaccines', 'key iNTS disease'], ['optimise vaccine we', 'widespread  comorbidities'], ['Food', 'bacteriological  safety'], ['However  increase', 'fresh  world'], ['', ''], ['Listeria monocytogenes', 'identified  agents'], ['also  methicillin', 'resistant  strains'], ['aureus', 'public health problems'], ['Therefore  we', 'bacterial Czech Republic'], ['', ''], ['', 'one Enteritidis phage strain'], ['', '3  MRSA'], ['', '0  L'], ['monocytogenes', 'collected  samples'], ['problematic  commodities', ''], ['findings', 'hygiene harvesting commodities'], ['two  samples', 'L monocytogenes'], ['', ''], ['rights', ''], ['oceanic N-2-fixing', 'Trichodesmium'], ['', 'subtropical surface oceans'], ['Trichodesmium IMS101', 'compatible  solute'], ['mass  we', 'compatible  T'], ['erythraeum', 'biosynthetic trimethyl pathway'], ['how  Trichodesmium', 'compatible  solute'], ['', 'further microbial salt acclimation'], ['full S adenosylmethionine synthetase', 'tobacco'], ['', 'mediated Agrobacterium transformation'], ['gene transformation', 'PCR RT PCR'], ['ST overexpressing', 'blank WT vector'], ['induced  damage', 'photosynthetic  rate'], ['PAs', 'important salt plants'], ['expressed salt we', 'subtractive Salsola hybridization'], ['SSH library', '700 insert bp'], ['first  reported', 'Salsola GenBank'], ['novel  that', 'reported  genes'], ['Five cDNA fragments', 'reverse transcription PCR analysis'], ['expression', 'lower sf3d8 sf6d8 level'], ['isolated  ESTs', 'new Salsola ferganica'], ['Salvador relationship', 'such physics mathematics'], ['different  aim', 'painter  career'], ['called DNA period', 'traditionally  1980s'], ['That', 'molecular art history'], ['paper', 'discrete Haar wavelet transform'], ['Basic  element', 'sampled wavelet processor architecture'], ['architecture', 'arbitrary tree structure'], ['presented  architecture', 'input data converter circuits'], ['Simulation results', '90 nm technology'], ['article', 'mismatched chain uncertainties'], ['extended state observer', 'lumped sampling point'], ['sampled data which', 'easier  practices'], ['even  controller', 'two neighbor sampling points'], ['Numerical simulation results', 'proposed  method'], ['sampled data control', 'practical  industries'], ['sampled data paper', 'account asynchronous account switching'], ['conditions exponential gains conditions stability', 'closed loop systems'], ['simple  example', 'proposed  method'], ['', ''], ['rights', ''], ['paper', 'uniform data sampling'], ['like  functional', 'dependent stability results'], ['like  functional', 'three  features'], ['First  it', 'time'], ['Second  it', 'sampling instants'], ['Third  it', 'positive sampling instants'], ['like  functional', 'sampled sampling interval'], ['', 'reduced stability conservatism'], ['dependent stability criterion', 'polytopic data uncertainties'], ['Finally  examples', 'reduced stability criteria'], ['Here  we', 'mRNA cell types'], ['Cytosolic contents', 'defined sampling region'], ['cellular  contents', 'real time PCR'], ['95 % cell sampling', 'long term analysis'], ['measured  quantities', 'actual cell cells'], ['', 'induced pluripotent 41'], ['such NS platform cardiomyocyte', 'vigorous NS platform activity'], ['platform', 'cortical CHO spheroids'], ['same  method', 'induced cell pluripotency'], ['drug some', 'resistant minority populations'], ['drug resistance mutation', 'low income countries'], ['Here  we', 'qualitative K103N mutation'], ['we', 'deep  sequencing'], ['low income countries', 'first line EFV'], ['infectious  agents', 'sarcoidosis pathogenesis'], ['therefore  we', 'possible meta association'], ['review', 'Meta Analyses Cochrane collaboration guidelines'], ['different  databases', 'original Medline Scopus 2015'], ['included case control that', 'culture methods'], ['We', 'fixed odds ratio'], ['Sensitivity', 'subgroup studies'], ['', 'qualified Fifty analysis'], ['present meta analysis', 'etiological Propionibacterium 18'], ['', ''], ['', ''], ['', ''], ['We', 'significant  6'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Rickettsia helvetica Epstein barr virus', 'previous  sarcoidosis'], ['infectious  agents', 'sarcoidosis'], ['microorganisms', 'sarcoidosis'], ['Future investigations', 'global  level'], ['Mesenchymal neoplasms', '2  mediastinum'], ['few histology immunohistochemistry', 'other tissue organs'], ['Characteristic  features', 'differential  diagnoses'], ['virtually stromal entities', 'also  mediastinum'], ['soft tissue sarcomas', 'induced  irradiation'], ['', ''], ['', 'mediastinal germ cell tumors'], ['classic behavior despair tests', 'like Sargassum mice'], ['Saringosterol', 'mg 10 mice'], ['locomotor saringosterol', 'stimulating  effects'], ['like mouse activity', 'neurotransmitters'], ['environmental  impact', 'molecular biology techniques'], ['210 million 210 gallons', 'Macondo environment'], ['two Sargassum natans', 'oil DWH event'], ['Using', 'northern sequence GOM'], ['five  Proteobacteria', 'Actinobacteria Verrucomicrobia'], ['microbial  composition', 'primarily Proteobacteria Firmicutes'], ['spilled  oil', 'Sargassum  waters'], ['higher  abundances', 'microbial DHW seawater'], ['molecular biology this', 'contiguous pelagic GOM'], ['12  years', 'global coronavirus infections'], ['Virus transmission', 'human SARS coronavirus'], ['other  coronaviruses', 'recent East respiratory humans'], ['work', 'MERS coronavirus'], ['T cell immunity', 'important SARS CoV infection'], ['specific MERS which', 'broad coronavirus infections'], ['', ''], ['', ''], ['rights', ''], ['', 'healthy  others'], ['Sasang medicine', 'intrinsic disease susceptibility'], ['physiological  that', 'genetic  patterns'], ['psychological  that', 'various  diseases'], ['progress', 'associated  emotions'], ['study', 'viral disease epidemiology'], ['goal', 'biological donor structures'], ['where  scientists', 'critical health issues'], ['different  fields', 'additive tissue engineering'], ['spectacular  advancements', 'diseased  tissues'], ['Patients', 'thus  rejection'], ['However  challenges', 'such heart liver'], ['well  that', 'further tissue development'], ['metabolic  that', 'nucleoside  diphosphate'], ['NDPK', 'cellular cell proliferation development'], ['ndpk cDNA', 'scallop'], ['', 'molecular amino 16927'], ['', '52  7'], ['', ''], ['unchallenged Cf scallops', 'situ  hybridization'], ['digestive gland foot', 'bacterial expression challenge'], ['Recombinant Cf NDPK', 'terminal Escherichia UDP'], ['Cf NDPK protein', 'muscle digestive gonad mantle gill'], ['It', 'bacterial  challenge'], ['NDPK', 'immune  scallop'], ['Aberrant  expression', 'human class B cancers'], ['Nevertheless  roles', 'renal cell carcinoma'], ['aim', 'renal cell carcinoma'], ['reverse protein level', 'western  blot'], ['lipid  content', 'normal Oil Red O'], ['diagnostic  value', 'characteristic receiver curve'], ['prognostic  significance', '1 Kaplan Meier analysis'], ['expression', 'normal kidney tissues'], ['operating characteristic curve analysis', 'significant  curve'], ['', ''], ['', ''], ['', 'strong  sensitivity'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['patients', 'free survival time'], ['scavenger class B type', ''], ['1', 'renal cell carcinoma'], ['resistant Staphylococcus aureus', 'major health care hospital'], ['purpose', 'molecular burn Iran'], ['106 Staphylococcus isolates', '106 Staphylococcus aureus'], ['Isolates', 'mecA fern'], ['encoding genes', 'PCR method'], ['MRSA isolates', 'multilocus sequence typing'], ['presence', 'Staphylococcus aureus'], ['Antimicrobial susceptibility testing', 'high resistance rate'], ['', '6 ampicillin tetracycline'], ['rates', 'remaining  18'], ['', ''], ['', ''], ['high  level', '19'], ['8  %', 'burn patients'], ['drug resistance', '90'], ['', '6  isolates'], ['', '106 MRSA isolates'], ['', ''], ['majority', 'SCCmec III'], ['', ''], ['ST239-SCCmec III ST239-SCCmec t037', 'III  t030'], ['', ''], ['', ''], ['', ''], ['', ''], ['Mupirocin resistant MRSA isolates', 'IV  t790'], ['', ''], ['', ''], ['diverse  strains', 'high ST239-SCCmec III'], ['findings', 'new MRSA clones'], ['', ''], ['rights', ''], ['low  efficiency', 'high photo irradiations'], ['work', 'PV production technology'], ['transmitted incident photons', 'algal  photosynthesis'], ['Experiments', 'transparent photoconversion PBRs'], ['combining', 'microalgal energy production'], ['', ''], ['rights', ''], ['Thioredoxin peroxidases', 'reactive oxygen species'], ['we', 'Schistosoma japonicum'], ['open reading frame', 'molecular amino 24'], ['', 'isoelectric  6'], ['', ''], ['SjTPx-3', 'old  worms'], ['ORF', 'pET-32a Escherichia coli'], ['Recombinant  SjTPx-3', 'western  blotting'], ['SjTPx-3', 'mainly  parasites'], ['Mice', '37'], ['', ''], ['', '05 worm burden'], ['', ''], ['', 'unvaccinated liver egg mice'], ['rSjTPx-3', 'rSjTPx-3-specific IgG IgG1'], ['Characteristic  Th1', 'immune flow rSjTPx-3'], ['SjTPx-3', 'responsible  S'], ['', 'oxidative  stress'], ['rSjTPx-3', 'new drug schistosomiasis'], ['Schistosomiasis', 'of  people'], ['Recent  advances', 'such health schistosomiasis'], ['latest  that', 'effective  schistosomiasis'], ['We', 'devastating  disease'], ['Different Expert proteins', 'promising  results'], ['', 'Schistosoma spp'], ['proteomes', 'rational vaccine manner'], ['recent  development', 'novel proteome infection'], ['Currently schistosomiasis control program', 'transmission disease'], ['forecast  systems', 'preventive  infection'], ['', 'early surveillance S'], ['', 'sentinel japonicum mice'], ['we', 'repetitive PCR S'], ['', 'experimental japonicum mice'], ['Meanwhile detection efficacy', 'such field ELISA'], ['5 cercariae both', '20 cercariae infection'], ['based  assay', 'early  S'], ['sentinel mice which', 'warning schistosomiasis surveillance system'], ['', 'C Elsevier Inc'], ['Attachment', 'functioning  cognition'], ['current  study', 'social cognitive processes'], ['PAM', 'social  cognitive'], ['variable measurement which', 'previous  literature'], ['unidimensional  subscale', 'psychometric PAM properties'], ['subscale', 'weak symptoms measures'], ['it', 'little construct population'], ['results', 'coherent latent structure'], ['Attachment measures', 'social  psychosis'], ['', ''], ['rights', ''], ['research', 'schizophrenia control group'], ['emotional control impairment', 'personality disorder group'], ['Executive functions', 'social  functioning'], ['brain that', 'social  cognition'], ['', ''], ['rights', ''], ['cancer risk', 'schizophrenia'], ['2  conditions', 'transcriptional  pathways'], ['then  immunology', 'tumor escape'], ['author', 'first tumor suppression'], ['comparison', 'instead tumor equilibrium'], ['clinical  presentation', 'attenuated cancer tumorigenesis'], ['NMDA receptor it', 'small  cases'], ['best cytokine match', 'individual cytokine cancers'], ['schizophrenia', 'attenuated  tumorigenesis'], ['', 'neurocognitive cannabis schizophrenia'], ['neurocognitive  deficits', 'neurocognitive cannabis vulnerability'], ['relationship', 'social cannabis cognition'], ['Eighty seven Eighty patients', 'social  cognition'], ['Social cognition', 'Eyes Hinting mind'], ['Executive function', 'Executive Functioning Scale'], ['relations', 'structural equation modeling'], ['Cannabis', 'negatively  mind'], ['', 'regular cannabis use'], ['Alcohol use', 'worse  recognition'], ['relationship', 'social cannabis cognition'], ['Few  studies', 'processing remediation condition'], ['We', 'visual case population'], ['Method  We', 'brief case schizophrenia'], ['UE', 'low level processes'], ['', ''], ['', ''], ['', '25 research session'], ['Contrast sensitivity', 'untrained  intervention'], ['Levels', 'task'], ['UE', '2 contrast participants'], ['somewhat  all', 'intervention'], ['they', 'training'], ['adaptive  nature', '2  participants'], ['controlled  that', 'social  cognition'], ['everyday  we', 'uncertain  outcomes'], ['unknown  which', 'ambiguity aversion'], ['joint  Patients', 'when gaze direction'], ['current  tasks', 'top  effects'], ['We', 'fine gaze direction'], ['', ''], ['', 'same  deviations'], ['26 CoDG discrimination that', 'fine face deviation'], ['', ''], ['cueing  that', 'grained  deviations'], ['gaze we', 'orienting  response'], ['patients', 'gazed  location'], ['cortical  that', 'cognitive brain performance'], ['Here  we', 'aspartate type glutamate receptor'], ['Cortical plasticity', 'fixed auditory plasticity task'], ['event time frequency measures', 'auditory agonist D serine'], ['Mismatch negativity', 'auditory level function'], ['Clinical trials registration numbers', ''], ['schizoaffective  patients', 'healthy  controls'], ['that', 'occupational  dysfunction'], ['sensory  that', 'underlying theta responses'], ['', 'retention motor preparation intervals'], ['Repeated  administration', 'auditory D plasticity'], ['', ''], ['', 'untrained negativity tones'], ['', ''], ['auditory  that', 'occupational  dysfunction'], ['repeated NMDAR agonist administration', 'cortical  schizophrenia'], ['substantial self that', 'substantial self abilities'], ['study', 'cognitive  tasks'], ['healthy  controls', 'sound emotion recognition'], ['Participants', 'item'], ['possible  time', 'item'], ['Patients', 'accurately  HC'], ['correctly  patients', 'significant  group'], ['patients', 'minimal  adjustment'], ['results', 'cognitive task schizophrenia'], ['', ''], ['', ''], ['rights', ''], ['attributional  style', 'psychometric cognition it'], ['used  assessment', 'attributional  style'], ['2 rater that', 'incremental  validity'], ['present  study', 'scored self report items'], ['hundred sixty One hundred individuals', 'verbal symptoms intelligence'], ['reported blame score', 'distinguished test retest controls'], ['It', 'verbal  intelligence'], ['scored  items', 'additional self AIHQ'], ['', 'C Elsevier Ltd'], ['Relationship perception', 'daily  functioning'], ['people', 'social  interaction'], ['RAD', 'speaking  countries'], ['We', 'Norwegian  version'], ['Methods', 'social schizophrenia cognition'], ['schizophrenia group', 'functional  measures'], ['internal  consistency', 'logistic study correlations'], ['RAD', '25'], ['', '12  vignettes'], ['', ''], ['Schizophrenia participants', 'full  version'], ['Associations', 'functional study measures'], ['Results', 'English version'], ['psychometric  which', 'English version'], ['This', 'cultural  utility'], ['', 'verbal Tone Matching Task'], ['It', 'cognitive  functions'], ['We', 'reliable pitch processing impairment'], ['Relevant  publications', 'systematic  databases'], ['Then  we', 'relevant meta analysis'], ['Effect size', 'mean  difference'], ['eligibility 10', 'meta analysis'], ['effect size', 'correct  patients'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['Meta analysis', 'moderate  studies'], ['', ''], ['', ''], ['', ''], ['relationship', 'clinical  studies'], ['authors', 'cognitive  abilities'], ['review', 'matching meta controls'], ['study', 'pathophysiological  disorder'], ['', ''], ['', ''], ['rights', ''], ['significant  correlation', 'violence'], ['Recent  studies', 'interesting risk treatment'], ['objective', 'violent  SCZ'], ['electronic  databases', 'Pubmed Web SCZ CR'], ['data', 'PRISMA statement'], ['disruptive  researchers', 'CR'], ['Eleven  studies', 'specific CR CR'], ['programs', 'aggressive  attitudes'], ['Therapeutic  targets', 'interpersonal  relationships'], ['Effectiveness', '12  CR'], ['Conclusions', 'methodological  restrictions'], ['current  evidences', 'randomized  studies'], ['', 'SCZ'], ['elementary experimentation investigate', 'whole- class testing procedure'], ['epistemological McNemar development', 'epistemological  understanding'], ['epistemological  understanding', 'experimentation skills'], ['Importantly  relation', 'general information processing'], ['conceptual information processing that', 'scientific  thinking'], ['alternative experimentation which', 'strong  investigation'], ['epistemological  which', 'closely experimentation skills'], ['elementary  they', 'scientific- thinking processes'], ['gate trigger circuit', 'often  SCR'], ['', 'nonlinear gate trigger circuit'], ['nonlinear control compensation', 'control system'], ['double analog which', 'analog circuit'], ['it', 'reliable  SCR'], ['Weihai sea which', 'nutritional Apostichopus values'], ['26  samples', 'polymorphic DNA technology'], ['genetic  diversity', 'three sea cucumbers'], ['genetic  relationship', 'adjacent sea areas'], ['genetic diversity analysis', 'geographical RAPD discrimination'], ['much  it', 'much  attention'], ['Whilst DNA analysis', 'sophisticated  equipment'], ['work', 'real seafood products'], ['MGB TaqMan probe', '81 cyt b gene'], ['reactivity  assays', 'average Molva molva DNA'], ['', ''], ['', 'target species DNA'], ['', ''], ['', 'such Molva dypterygia'], ['', ''], ['', ''], ['proposed  methodology', 'commercial  samples'], ['', ''], ['rights', ''], ['Offshore  cultivation', 'northern  Europe'], ['paper', 'alternative exploitation pathways'], ['second  pathway', 'heterotrophic seaweed microalgae'], ['new  proteins', 'total  output'], ['We', 'industrial scale production processes'], ['scenarios', 'favorable Laminaria -18'], ['', ''], ['', ''], ['scenario', 'cumulative energy demand'], ['', 'net fossil energy fraction'], ['', 'seaweed cultivation'], ['scenarios', 'thanks seaweed growth'], ['material consumption', 'human  energy'], ['', 'minor cultivation design'], ['', ''], ['use', 'human  toxicity'], ['fertilizer', 'agricultural  soil'], ['However concentration', 'Danish  regulation'], ['further production which', 'environmental service restoration'], ['', ''], ['rights', ''], ['reported  information', 'coronary prevention studies'], ['study', 'sectional NORwegian CORonary'], ['CHD heart patients', '249 self report which'], ['Test retest reliability', 'consecutive coronary patients'], ['Intraclass Correlation Coefficient', ''], ['mean  interval', 'test'], ['', ''], ['Reproducibility values', 'first  latter'], ['good', 'good lifestyle factors'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'life'], ['', 'created perceptions motivation needs'], ['present  questionnaire', 'key  items'], ['It', 'coronary CHD patients'], ['We', 'explicit generation attitudes'], ['Participants', ''], ['explicit  we', 'second generation rich'], ['participants', 'second generation rich'], ['However  participants', 'second generation rich'], ['results', 'previous  research'], ['second generation rich', 'other  China'], ['therefore power evaluation', 'long term power usability'], ['paper  we', 'long term SMFCs'], ['3-D  which', 'slowly  lactate'], ['limited  SMFCs', '18 sensor operation'], ['2 mu W', '2 control systems'], ['steady power performance', '18  LW'], ['sized  SMFCs', 'mW power m2'], ['short startup time', 'donor doped anodes'], ['addition', 'practical electron advantage'], ['', 'active anode advantage'], ['', ''], ['rights', ''], ['novel sediment that', 'final source apportionment results'], ['Spatial  variability', 'source fingerprinting investigations'], ['contribution', 'particular surficial sediment sources'], ['It', 'sediment source fingerprinting procedures'], ['Samples', '52 surface field'], ['geochemical surface which', 'sediment source fingerprinting studies'], ['magnitude soil redistribution influence', 'spatial fingerprint properties'], ['', ''], ['rights', ''], ['Many  studies', 'prevention campaigns'], ['soon  they', 'it'], ['cognitive dissonance theory', 'selective  exposure'], ['People', 'inconsistent  one'], ['inconsistent  which', 'attitude'], ['goal', 'implicit smoking attitude'], ['research', 'professional training institute'], ['Participants', 'training addictions'], ['They', 'institute'], ['Forty four Forty smokers', '80  experiment'], ['They', 'harmful tobacco alcohol drugs'], ['kind', 'them'], ['Then  attitudes', 'smoking'], ['smoking we', 'Smoking  Scale'], ['Single Implicit Association Test', 'SC IAT et'], ['', ''], ['Smoking habits', ''], ['smokers', 'negative  smokers'], ['Implicit  attitude', 'selective  exposure'], ['less  people', 'prevention information'], ['already  quitting', 'other  smokers'], ['results', 'explicit prevention training design'], ['', ''], ['', 'Elsevier Masson SAS'], ['rights', ''], ['paper', 'complex designers parts'], ['printed  crack', 'fracture mechanics study purposes'], ['fractured Digital Image surfaces', 'Digital Image Correlation'], ['mechanical  layers', 'crack'], ['other  those', 'preferential crack crack'], ['DIC', 'together printer resolution'], ['internal  that', 'internal  cracks'], ['', ''], ['rights', ''], ['', 'experimental starting self'], ['own  body', 'me'], ['primary  aim', 'three body ways'], ['how  sense', 'multisensory body integration'], ['two  sides', 'bodily  self'], ['multisensorial  understanding', 'other  boundaries'], ['three research strands', 'predictive coding models'], ['mental  representation', 'perceptual  body'], ['different  aspects', 'self'], ['First  we', 'perceptual matching self'], ['conceptual self representation', 'it'], ['bodily self representation', 'new  face'], ['how  they', 'perceptual matching task'], ['Changes', 'bodily self representation'], ['modulatory links', 'bottom self manner'], ['MS self myelin', 'multiple self sclerosis'], ['receptors  pathways', 'autoimmune  humans'], ['regulatory self TLR', 'inflammatory T phenotypes'], ['Complexes', 'based TLR antagonist'], ['however gene complexes', 'tunable  loading'], ['classic analysis we', 'physicochemical signals properties'], ['polyplexes', 'driven cell inflammation'], ['tolerogenic mouse polyplexes', 'progression disease'], ['', ''], ['', 'Elsevier Ltd'], ['Self awareness', 'functioning hampers treatment'], ['self awareness that', 'executive treatment dysfunction'], ['total', '3 time months'], ['Self awareness', 'independent Alderman Burgess other'], ['rehabilitation we', 'Emotion Stimuli'], ['patients', 'better control patients'], ['level', 'emotion recognition'], ['neuropsychological  treatment', 'self  monitoring'], ['learning  impairments', 'social  treatment'], ['article', 'constant  gm'], ['It', 'simple  topology'], ['It', 'large output gain'], ['130 nm CMOS technology', '1'], ['', '215 125dB gain'], ['comparison', 'many power applications'], ['compensated input offset', 'operational  amplifier'], ['digital offset cancellation method', 'process variations'], ['well offset compensation circuitry', '90 nm CMOS process'], ['self calibration improvement', '48 DAC offset error'], ['Growing  evidence', 'health  psychopathology'], ['who', 'resilient  outcomes'], ['adaptive emotion regulation that', 'mental  health'], ['Participants', 'mental time health'], ['Self compassion', 'mental  health'], ['higher  levels', 'negative self affect'], ['mental self compassion that', 'psychopathology'], ['These', 'affective emotion regulation experiences'], ['Enhancing self compassion', 'clinical  practice'], ['It', 'such self kindness'], ['This', 'future  psychopathology'], ['formation', 'developmental self adolescence'], ['neural  structures', 'familiar self others'], ['word', 'friends'], ['Findings', 'related  teachers'], ['', 'higher parietal friends'], ['', 'familiar brain politicians'], ['Results', 'functional brain processes'], ['', ''], ['', ''], ['Maladaptive self criticism', 'diminished goal progress'], ['present  study', 'directed memory performance'], ['Participants', 'working memory measure'], ['Results', 'dependent self criticism'], ['low self critics', 'high self critics'], ['high self critics', 'retest'], ['important  that', 'directed  performance'], ['', ''], ['rights', ''], ['driving  cars', 'otherwise  public'], ['driving  car', 'human control driver'], ['high control which', 'complex  traffic'], ['adequately damage failure', 'stepping control system'], ['Uncertainties', 'technical liability progress'], ['chilling market effects', 'obligatory liability insurance'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['sequential  study', 'generational age trajectory'], ['significant self that', 'birth cohort'], ['', 'continuous birth variable'], ['', 'multiple group Orth'], ['birth cohort', 'measurable self age'], ['', 'later  years'], ['', ''], ['more self they', 'earlier  years'], ['', ''], ['', ''], ['estimated age trajectory', '60  Orth'], ['', 'cohort'], ['Second  comparing', 'higher self 1986'], ['cultural  change', 'sectional time studies'], ['Precise cell positioning', 'biophysics'], ['Acoustic  microbeam', 'particle cell manipulation'], ['AIN film', 'focused ultrasound transducer application'], ['based focused device', '230  MHz'], ['It', 'similar beam 8'], ['', ''], ['only  remote', 'buffered epidermoid carcinoma saline'], ['importantly cell manipulation', 'continuous  mode'], ['AIScN film ultrasound transducer', 'biomedical biology applications'], ['self it', 'sanctioned  aid'], ['permissible  individuals', 'legal government wrong'], ['Indeed self help', 'slower  costlier'], ['civil justice system that', 'merit scholarly expense merit attention'], ['self help', 'just self what'], ['any  behaviour', 'legal  selfhelp'], ['narrower self that', 'dominant  view'], ['so  it', 'self help'], ['properly  understood', 'civil justice system'], ['exercise', 'final  court'], ['Self help', 'own  some'], ['unilateral  action', 'one  another'], ['self it', 'self help'], ['self help', 'access  crisis'], ['then justice specter', 'inefficient  litigation'], ['phenomenon', 'everyday  life'], ['previous  studies', 'selfie'], ['who', 'selfies'], ['social comparison we', 'psychological  factors'], ['we', 'context'], ['participants', 'own self smartphone'], ['Then  they', 'social  smartphone'], ['social  sensitivity', 'social self signatures'], ['they', 'selfie'], ['taking', 'lower selfie takers'], ['', ''], ['rights', ''], ['paper', 'full duplex radio transceiver'], ['self interference coupling channel', 'time antenna matching surroundings'], ['RF interference canceller structure', 'digital control loop'], ['complete demonstrator board', 'RF processing'], ['Comprehensive RF measurements', 'also  2'], ['more  40dBs', 'instantaneous waveform bandwidths'], ['adaptive tracking features', ''], ['Self other Self discrimination', 'social  cognition'], ['Neuroimaging', 'other discrimination tasks'], ['other face recognition research', 'self other face discrimination'], ['other video morphing face', 'familiar  face'], ['20  min', 'area anodal stimulation'], ['Differences', 'other task discrimination'], ['only  we', 'significant self self'], ['findings', 'social domain cognition'], ['Vibration', 'public railway operation system'], ['vibration acceleration', 'key railway equipment'], ['kind', 'powered nano vibration accelerometer'], ['frequency mass vibration model', 'electric  TEVA'], ['prototype', 'vibration simulation platform'], ['TEVA', 'powered acceleration monitoring system'], ['current', 'also vibration 1'], ['', '07  1'], ['', ''], ['Hence  it', 'powered fault diagnosis'], ['generated  electricity', 'lithium 1'], ['', '3'], ['1  which', 'ZigBee module'], ['charged  battery', 'temperature ZigBee it'], ['temperature', 'train'], ['Therefore vibration energy', 'near sensor network future'], ['Wearable healthcare devices', 'interactive  people'], ['electret face nonwoven', 'electrospun face polyetherimide'], ['smart face mask', 'particulate electricity'], ['unique  applications', 'particulate matter removal ability'], ['unique air study', 'wearable  electronics'], ['Rolling circle amplification', 'perfect nucleic acids detection'], ['However RCA technique', 'short  DNA'], ['amplification', 'enzymatic nucleic restriction'], ['isothermal  amplification', 'assisted strand displacement amplification'], ['nicking  amplification', 'nicking  endonuclease'], ['single strand DNA', 'nicking circle endonuclease'], ['amplification', 'one  pot'], ['reaction amplification', 'electrochemical sulfydryl signal'], ['Based', 'satisfied Hela cell results'], ['approach', 'clinical pathogene diagnostics'], ['sustaining sensor platform', 'smart grid systems'], ['However  monitoring', 'same energy time'], ['Here  we', 'varying water motion i'], ['', ''], ['', 'only water motion'], ['contact triboelectric nanogenerator', 'repetitive water droplet'], ['simultaneously water which', 'gathered  energy'], ['proposed  platform', 'ambient sensing elements'], ['One', 'new family context'], ['derived  expectations', 'emotional influence development'], ['largely  we', 'magnetic resonance imaging'], ['We', ''], ['', ''], ['', 'other trait evaluation task'], ['we', 'other Relationship Questionnaire'], ['We', 'also problems schizotypy'], ['participants', 'prefrontal brain cortex'], ['when information it', 'self-'], ['We', 'emotional attachment development'], ['semantic  which', 'clinical  syndrome'], ['Here  we', 'pathological  SD'], ['pole fusiform which', 'pole fusiform gyrus'], ['imaging  studies', 'semantic  SD'], ['', 'preserved memory performance'], ['prefrontal  which', 'behaviour  cognition'], ['', 'pathological TDP43 type subtype'], ['genetic  cause', 'sporadic  disease'], ['pathological  syndrome', 'modifying  interventions'], ['development', 'future disease endeavour'], ['high laser frequency control', 'semiconductor drive system'], ['emission temperature', 'LD'], ['Then  temperature', 'stable  frequency'], ['desired temperature control which', 'PID control circuit'], ['converted platinum temperature', 'liquid crystal display'], ['analog control circuit', 'temperature control'], ['stabilizing reference which', 'operational  amplifier'], ['It', 'stable semiconductor semiconductor'], ['experimental', ''], ['design', 'temperature monitoring'], ['Meanwhile  temperature', '40 degrees C'], ['1', ''], ['output voltage', 'current  source'], ['current', ''], ['semiconductor optical semiconductor amplifiers', 'such conversion amplifiers'], ['approach', 'quantum dot states'], ['important charge carrier heating', 'important hole effect'], ['frequencies', 'dependent light gain'], ['genus Senecavirus', 'closely Cardiovirus genus'], ['when cell culture it', 'first Idiopathic Vesicular Disease'], ['foot animal presence', 'economically United States'], ['foreign animal diseases', 'swine production'], ['Identification', 'foreign animal diseases'], ['We', 'specifically serum SVA'], ['Viral  protein', '1 VP1 VP2 E'], ['', 'indirect coat ELISA'], ['Sera', 'infected VP1 VP2'], ['high  affinity', 'avidity ELISA'], ['ROC analysis', 'SVA VP2 94'], ['', '2  89'], ['', ''], ['ELISA', 'clinical % signs'], ['Immune sera', 'FMDV encephalomyocarditis virus'], ['simple  ELISA', 'foreign animal diseases'], ['made meal packaging', 'independent  living'], ['made  packages', 'older  goal'], ['years meal seniors', 'internet 457'], ['significant  differences', 'senior  groups'], ['four packaging features', 'easy recyclability contents'], ['features', 'regardless age group gender'], ['Older  people', 'directly  package'], ['made  meals', 'promising novel readymade meals'], ['special  attention', 'specific packaging design'], ['', ''], ['rights', ''], ['', ''], ['sensed entity individual', 'social image representation brain'], ['psychometric  experience', 'date'], ['', ''], ['phenomenological  we', 'the'], ['We', 'social population imagery'], ['We', 'internal  SenPQ'], ['', ''], ['', ''], ['', ''], ['SenPQ', 'schizotypical  experiences'], ['factor analysis', ''], ['', 'underlying latent variables'], ['religious  participants', ''], ['', 'relevant  measures'], ['Principal components analysis', 'ensed presence experiences'], ['', ''], ['further presence validation', 'neurological  conditions'], ['electronic  life', 'electronic  which'], ['nominal operating this', 'usually  signals'], ['harmful  effect', 'baseband intermodulation products'], ['', ''], ['that', 'nominal  signals'], ['where  expression', 'operational MOS differential amplifiers'], ['techniques', 'higher immunity levels'], ['common signal conditioning that', 'high  EMI'], ['induced  evidences', 'simulation'], ['resistive sensor it', 'known  problem'], ['potential scanning circuit', 'two row drivers'], ['One  type', 'digital row buffers'], ['read  which', 'digital row driver'], ['other  type', 'operational row amplifiers'], ['therefore sensor it', 'severely power consumption cost'], ['new row which', 'high sensor accuracy'], ['maximum resistor array error', 'proposed  circuit'], ['1  which', 'remarkably  30'], ['', 'previous  counterpart'], ['experimental animal HRV', 'early  sepsis'], ['sensitivity', 'derived  sepsis'], ['we', 'severe organ conditions'], ['', 'fecal sexes peritonitis'], ['therapy', 'multiorgan failure'], ['Experimental  subjects', 'sepsis'], ['', 'inflammatory plasma peritonitis'], ['sepsis', 'most vasopressor animals'], ['pronounced  reduction', 'constant 5h 1'], ['', ''], ['', 'HRV parameter experiment'], ['frequency domain analysis', 'high frequency component'], ['', 'constant heart rate 11'], ['', ''], ['', 'vascular resistance decline'], ['pronounced  reduction', 'experimental organ failure'], ['Inhibition', 'main HRV sepsis'], ['sensitivity', 'moderate organ failure'], ['pronounced Impact reduction', 'experimental organ failure'], ['Dominant  reduction', 'main rate variability reduction'], ['sensitivity', 'moderate organ failure'], ['physeal  which', 'urgent  identification'], ['detection methods', 'pathogens'], ['MRI', 'concurrent  infections'], ['treatment course', 'oral  antibiotics'], ['surgical  treatment', 'concurrent  infections'], ['much  that', 'vital  infrastructures'], ['Ethnographic  explorations', 'manifold EMBL goings'], ['modest  that', 'bioinformational  resources'], ['submissions support assistant', 'deluge'], ['together data labours render', 'lively data convergence'], ['surprising data labours they', 'surprising data labours data'], ['which', 'infrastructural maintenance work'], ['electrogenic  system', 'electrogenic SBR activity'], ['where  influence', 'optimal anode inter electrode distance'], ['2 electrode cm', 'higher power output'], ['Bioelectrokinetics analysis', 'experimental system variation'], ['redox behavior', 'electrode  distance'], ['Spatiometabolic distribution', 'microbial  anode'], ['active  bacteria', 'uniform suspension culture'], ['', ''], ['', ''], ['rights', ''], ['Sericins', 'glue mori silk fibers'], ['They', 'MSG fibroin fibers'], ['however Ser2 proteins', 'major cocoon proteins'], ['We', 'competitive cDNA PCR'], ['fifth  expression', 'fifth  instar'], ['two Ser2 proteins', 'growing larval silk stages'], ['completely cocoon difference', 'two silk fibers'], ['', ''], ['rights', ''], ['we', 'electrical arc faults installation'], ['reference current', 'drill dimmer DC power supplies'], ['proposed  method', 'FPGA III prototyping board'], ['series arc faults', 'very fault detection beginning'], ['', ''], ['', ''], ['rights', ''], ['Bacteriophages', 'molecular  biology'], ['DNA cloning DNA vectors', 'specific DNA recombination phage'], ['', 'synthetic biology applications'], ['Here  we', 'new phi Joe genome'], ['phi Joe', 'serine Streptomyces phage integrase'], ['attB site', 'integrating int attP locus'], ['attB site', 'several Streptomyces S'], ['mobile  that', 'host species'], ['Serine integrases', 'encoded excision reaction'], ['function', 'vivo'], ['integrase', 'vitro recombination assays'], ['specific recombination system', 'genome engineering toolbox'], ['', ''], ['', 'useful  antibiotics'], ['genetic  they', 'heterologous Streptomyces ease'], ['Recently  researchers', 'novel genes biosensors'], ['important  requirement', 'different integration sites'], ['broad  we', 'isolated Streptomyces phage Joe'], ['phi Joe integrase', 'vivo'], ['specific recognition site', 'model bacterium Streptomyces research'], ['study', 'Palestinian  adolescents'], ['several  that', 'study'], ['We', 'physical community others'], ['moderation mediation model', ''], ['they', 'once  study'], ['also  exposure', 'physical  others'], ['similar  trend', 'ethnic  discrimination'], ['correlations', 'normative  violence'], ['poor  who', 'parental  communication'], ['', ''], ['rights', ''], ['', ''], ['IMD  incidence', 'serogroup B sequence'], ['SLSJ Saguenay region', 'particularly  3'], ['', '100 000 person 2006'], ['2014 immunization campaign', 'meningococcal  vaccine'], ['We', 'years  initiation'], ['', ''], ['Immunization registry data', 'multivariate incidence rates'], ['', ''], ['', '20 SLSJ age'], ['unvaccinated adult SLSJ who', 'prior disease 2015'], ['sporadic  cases', 'other  years'], ['multivariate analysis', 'significant SLSJ region'], ['', ''], ['', ''], ['', ''], ['Results', 'regional  level'], ['This', 'current MenB-4C vaccine'], ['study', 'HCV Military Teaching 2010'], ['We', 'male blood predominance'], ['donation interview', 'first selection risk'], ['Biological  screening', 'liquid enzyme immunoassay antibodies'], ['assay  test', 'HCV'], ['Blood Donor Center', 'same  results'], ['tested prevalence rate', 'HBV infections'], ['102 prevalence rate', 'HCV infections'], ['63 prevalence rate', 'HIV infections'], ['', ''], ['', 'single  HBV'], ['association', 'HBV HIV HCV'], ['low seroprevalence rates', 'preventive donor tests'], ['combined  which', 'developing  countries'], ['', 'atherosclerotic foam lesions'], ['potent  that', 'atherosclerotic foam cell plaque'], ['molecular monocyte mechanism', 'enhanced foam cell 5-HT'], ['We', 'human ACAT-1 macrophages'], ['ACAT-1 receptor', 'dependent  manner'], ['5-HT', 'primary monocyte Culture'], ['two protein expression effect', 'completely  5-HT(2A'], ['', ''], ['Northern blotting analysis', 'ACAT-1 mRNA transcripts'], ['', ''], ['', ''], ['', ''], ['', '2'], ['', ''], ['6-kb  transcripts', 'similar  1'], ['', '5-HT'], ['present  5-HT', 'atherosclerotic c plaque'], ['', ''], ['rights', ''], ['previously  serotonin', 'myocardial  depression'], ['we', 'further ginseng fruit depression'], ['Sprague Dawley Sprague rats', 'group'], ['animals', 'four sham MI subgroup'], ['Protein levels', 'brain ELISA'], ['serum 5-HT serum levels', 'treated sham counterparts'], ['', ''], ['GFS pretreatment', 'treated  counterparts'], ['', ''], ['Brain 5-HT levels', 'also GFS MI'], ['', ''], ['', ''], ['', '5-HT2AR MI depression'], ['', ''], ['', ''], ['Similarly brain 5-HT2AR levels', 'four  GFS'], ['', ''], ['', ''], ['GFS', '5-HT2AR  MI'], ['effects', 'much cardiovascular promise'], ['', 'serpiginous  choroiditis'], ['clinical  records', '28  SC'], ['Patients', '2  treatment'], ['12  group', 'conventional IMT interferon'], ['clinical  remission', '1  year'], ['1', '7  ATT'], ['Two  patients', 'resistant  IMT'], ['clinical  remission', '1  treatment'], ['Recurrent inflammation', 'modification systemic 7'], ['', ''], ['', ''], ['Cumulative  dose', 'group'], ['', ''], ['4/9 MSC patients', 'remission'], ['', ''], ['One', '2/2 SC remission'], ['', ''], ['first latent who', 'IMT'], ['certain  BDBE', 'recent  years'], ['whole meltdown scenario', 'researchers'], ['Various design concepts', 'low probability scenario'], ['core catcher concept', 'severe core accident'], ['study', 'degraded decay accident'], ['then collection study', 'different design concepts'], ['Transient  forms', 'finite CFD solver'], ['Boussinesq approximation', 'sodium'], ['single collection tray', '500 pool type SFR'], ['Further  studies', 'multiple collection trays'], ['double  collection', 'decay loads'], ['Provision', 'successive core plates'], ['multiple velocity openings', 'lower  plenum'], ['three core catcher device', 'structural temperature material'], ['Special  attention', 'three core catcher device'], ['', ''], ['rights', ''], ['certain asthma that', 'certain asthma subtypes'], ['biologic  therapy', 'specific  patient'], ['purpose', 'refractory  asthma'], ['We', 'refractory  asthma'], ['eosinophilic  clinicians', 'specific asthma phenotypes'], ['We', 'approved efficacy therapies'], ['biologic  therapies', 'refractory  asthma'], ['', '2017 Allergy Asthma'], ['cognitive growth which', 'sevoflurane exposure'], ['aim', 'molecular  regulation'], ['hepatocyte cell line', '4 alveolar concentrations h'], ['IGF-1  levels', 'western polymerase chain analyses'], ['importance', 'microRNA-98 inhibitor'], ['Sevoflurane treatment', 'IGF-1 levels'], ['Inhibition', 'effect'], ['Therefore sevoflurane', 'microRNA-98 expression'], ['Concrete  corrosion', 'global sewer scale'], ['where  layer', '11 pristine pH'], ['Acidophilic microorganisms', 'concrete corrosion mass'], ['however  biodiversity', 'environmental corrosion conditions'], ['diversity', 'chemolithoautotrophs chemolithoheterotrophs'], ['CO2 organic CO2 matter', 'acidic corrosion ecosystem'], ['briefly  that', 'concrete  environment'], ['review', 'especially corrosion process'], ['acidophilic corrosion microbial ecology', 'acidophilic corrosion microbial which'], ['possible sewer we', 'sewer concrete corrosion layers'], ['microbial  functions', 'acidic acid mine drainage'], ['Sewing needles', 'cardiac  injury'], ['attempt', 'such child injury'], ['Owing', 'rapidly nature tissues'], ['Fatalities', 'peripheral tamponade embolism'], ['', ''], ['major  drawback', '3  age'], ['when  animals', 'age'], ['', ''], ['low cost method', 'directly Coturnix hatching'], ['', ''], ['simple  method', 'internal  error'], ['Males', 'one  amplicons'], ['We', 'everyday abuse contexts'], ['aim', 'research abuse practice'], ['relational  which', 'extended  time'], ['characteristics', 'critical interaction children'], ['publications', 'future  practice'], ['articles', 'enduring Witchhunt Narrative'], ['', 'sufficient  feedback'], ['one  it', 'Scientists  brief'], ['mythical  that', 'false  convictions'], ['three  they', 'detail'], ['sexual  that', 'critics'], ['medical  that', 'dubious Emeregency Room doctor'], ['overwhelming abuse that', 'critics'], ['who', 'predetermined witchhunt result'], ['That', ''], ['dismissive  approach', 'documented  children'], ['article', 'sexual day care'], ['Witch Hunt which', 'case studies'], ['witch hunt narrative', 'two Michael publications'], ['', 'contested Dade County Florida'], ['forensic interview practices', 'cases'], ['methods', 'young  children'], ['', 'ritual day abuse'], ['when Jimmy they', 'TV 2012'], ['Savile  case', 'historical  abuse'], ['historical default we', 'such  stories'], ['case which', 'regard'], ['Accounts', 'objective  reality'], ['former care home views', 'cultural  elites'], ['who', 'natural  justice'], ['when  professionals', 'historical  abuse'], ['Sexual  abuse', 'public health issue'], ['timely  diagnosis', 'forensic term health implications'], ['emergency care providers', 'recommended STI patients'], ['', 'firsthand Behavioral Science book'], ['He', ''], ['some', 'what'], ['however  which', ''], ['basically  Cheit', 'many  allegations'], ['He', 'confusing  definitions'], ['Cheit', 'witch hunt narrative'], ['wide  children', 'wide  which'], ['delayed  reporting', 'inaccurate witch hunt narrative'], ['how  allegations', 'ranging witch hunt narrative'], ['most', 'long term damage'], ['sexual  abuse', 'mental health outcomes'], ['extent community level characteristics', 'effectiveness'], ['present  cluster', 'controlled community level Safe@Lastprogramcomparedtoawaitlistcontrolcondition'], ['intervention', 'unsafe  people'], ['Participants', 'public % Tennessee'], ['large knowledge d', '1'], ['', '2'], ['', ''], ['effectiveness', 'substantiated child community'], ['youth', 'abuse neglect rates'], ['Child characteristics', 'intervention effects'], ['two community level that', 'personal safety skills'], ['based CSA prevention programs', 'higher child abuse'], ['', ''], ['rights', ''], ['brief  he', 'full polygraph outcome juvenile'], ['only research tying', 'actual polygraphy recidivism'], ['He', 'overall  polygraphy'], ['We', 'two  points'], ['explicit question study we', 'study limitations'], ['well  we', 'well  question'], ['response', 'original  study'], ['rational  discussion', 'clinical sex offender treatment'], ['sexual  assault', 'closest  them'], ['how  they', 'assault'], ['child', 'sexually  Illinois'], ['experiences', 'societal  mother'], ['Intimate partner violence', 'increased college attention'], ['Current  studies', 'general campus disabilities'], ['rate', 'general  issue'], ['sexual  that', 'disability'], ['university who', 'disability'], ['This', 'public  university'], ['Experiences', 'Abuse  Assessment'], ['when  incident', 'abuse'], ['22  %', 'physical  17'], ['27  %', 'incident'], ['implications results', 'disabilities'], ['effects', 'negative  outcomes'], ['we', 'sexual Adult Health'], ['sexual  initiation', 'past  gender'], ['results', 'particularly  females'], ['examining', 'exclusively caregiver reports'], ['current  study', 'prospective caregiver reports'], ['second  set', 'interpersonal  SBP'], ['Caregivers', 'when  SBP'], ['Caregiver concerns', 'rarely  teacher'], ['sexual  abuse', 'cases'], ['Physical  abuse', 'interpersonal  SBP'], ['conventional  views', 'children'], ['Fresh  injuries', 'German Penal Code'], ['differentiation', 'sexual  abuse'], ['anal expert opinion', 'anal  penetration'], ['existing  diseases', 'consideration'], ['four  cases', 'relevant  assessment'], ['sexual  development', 'such  partners'], ['longitudinal  study', 'emerging  adulthood'], ['', '22 332 22 participants'], ['8 % females', 'sexual  partners'], ['Measures', '13  predictors'], ['based  modeling', 'four trajectory groups'], ['', ''], ['', ''], ['', ''], ['', ''], ['social  competence', 'multiple abstainers group'], ['Moreover  females', 'medium  groups'], ['results', 'early risk factors'], ['many  people', 'sexual attraction behavior'], ['study', 'sexual orientation discordance'], ['Data', '8915 Adult 54'], ['', ''], ['', ''], ['', ''], ['', ''], ['Multivariable linear regression', 'sexual orientation stress'], ['Models', 'sex'], ['', 'depressive orientation symptomatology'], ['other  subpopulation', 'sexual orientation discordance'], ['association', 'depressive sexuality self concept'], ['poor  infections', 'frequent SS patients'], ['immune  that', 'immune  infections'], ['Th2 TLR I', 'untreated SS patients'], ['TLR4 agonists TNF secretion', 'TLR2 TLR4 agonists'], ['IFN gamma', 'lower control group'], ['positive SS regulation', 'broad  CL097'], ['8  agonist', 'inflammatory  cytokines'], ['extracellular SS which', 'partially TLRs agonists'], ['Growing electricity demand', 'much fault current'], ['normal loading which', 'current  limiter'], ['nonintersecting braid type', 'high temperature superconductors'], ['recovery characteristics', 'ac detail'], ['types', 'several fault seconds'], ['ac loss', 'current braid type regions'], ['new bandpass shadow filter', ''], ['filter', 'feedback operational feedback amplifier'], ['parameters', 'feedback operational feedback amplifier'], ['summing  amplifiers', 'voltage mode realization'], ['Experimental  results', 'feedback operational feedback amplifier'], ['results', 'proposed  circuit'], ['Shaking', 'infant crying'], ['childhood abuse history', 'robust risk offspring'], ['adverse childhood exposures', 'occurrence'], ['caregivers', 'infant'], ['study', 'Japan'], ['ill parents witness', 'economic  infants'], ['Logistic regression analysis', 'cumulative  ACEs'], ['Analyses', '2015'], ['', '28'], ['3  %', 'one  childhood'], ['only  witness', 'significant  infant'], ['', ''], ['', ''], ['', ''], ['total  number', 'ACEs'], ['shaking', 'regardless  ACEs'], ['that', 'infants'], ['', ''], ['rights', ''], ['Coal', 'top power China'], ['replacement', 'environmental  impacts'], ['Natural  gas', 'alternative air fuels'], ['', 'past energy years'], ['shale  it', 'unacceptable energy security'], ['reality', 'shale gas development'], ['We', 'environmental contamination water consumption'], ['China', 'weak water contamination'], ['United States', 'ground water consumption'], ['effectively gas fuel', 'environmental  gains'], ['', ''], ['', ''], ['rights', ''], ['design  evaluation', 'sensor control actuator'], ['dynamic  models', 'square parameter estimation'], ['that', 'TM DS1104 controller identification'], ['effectiveness', 'resonance'], ['human  that', 'social  individuals'], ['We', 'underlying information scale'], ['We', 'related  consequences'], ['', ''], ['domain general value that', 'information'], ['', 'population level virality'], ['41  we', 'functional  neuroimaging'], ['Neural  activity', 'value self value cognitions'], ['activity', '117611 internet articles'], ['', 'neural value system'], ['Neural  activity', 'commonly self report intentions'], ['advance theory', 'effective  intervention'], ['broadly  data', 'social core bonds'], ['animal selection', 'molecular livestock improvement'], ['', 'study'], ['LG beta gene', 'possible milk traits'], ['', '125 PCR RFLP analysis'], ['associations', 'beta LG genotypes'], ['Two  alleles', 'significantly AA P'], ['', 'Hardy Weinberg equilibrium'], ['daily breed effect', 'daily milk yield'], ['several  one', 'short  RNAs'], ['Short  RNAs', 'several  pathways'], ['different  sizes', 'short  RNAs'], ['short  it', 'short  RNAs'], ['commercial RNA extraction kits', 'short  RNAs'], ['RNA extraction which', 'short hybridisation RNAs'], ['Small  RNAs', 'fundamental  organisms'], ['natural heterochromatin microRNAs', 'interacting heterochromatin RNAs'], ['expression pattern', 'biological  function'], ['inexpensive  that', 'most  laboratories'], ['gel electrophoresis hybridisation', 'oligonucleotide  probes'], ['Wind speed forecasting', 'normal power grids'], ['original wind sequence', 'stochastic  signals'], ['conventional forecasting methods', 'local linear optimum'], ['that', 'neural  problems'], ['neural wind speed network', 'forecasting'], ['neural  model', 'rapid learning rate'], ['60-min time series model', 'smart  grids'], ['', ''], ['', ''], ['rights', ''], ['epithelial  cells', 'oral antimicrobial peptides'], ['broad spectrum AMP calprotectin', 'up interleukin-1 alpha'], ['herbal  that', 'epithelial  cells'], ['purpose', 'epithelial  cells'], ['Material', 'IL-1  alpha'], ['expression', 'northern  blotting'], ['Calprotectin expression', 'immunofluorescent alpha staining'], ['IL-1  alpha', 'real time PCR'], ['', 'significantly  S100A8-'], ['Shosaikoto', 'other  AMPs'], ['specific  protein', 'slightly  SST'], ['neutralizing  antibody', 'mRNA receptor expression'], ['SST', 'epithelial  cells'], ['', 'IL-1 SST alpha'], ['we', 'same Silicon substrate'], ['GaAs pHEMTs', '5 mu m'], ['which', 'normal GaAs GaAs'], ['paper', '650 V 1'], ['', '100 DC converter kHz'], ['', 'high peak 98'], ['6  %', '400 V DC output'], ['current bridge spike', 'harmonic  1'], ['83  %', 'full  load'], ['Obesity', 'systemic disease hypertension inflammation'], ['Intercellular  adhesion', 'molecule-1 leukocyte inflammation'], ['elevated  expression', 'abdominal fat deposition'], ['Increases', 'adipose macrophage tissue'], ['Here  we', 'dietary mouse obesity'], ['', 'real time quantitative PCR'], ['6  mo', 'significantly body weight'], ['ICAM-1', 'higher  females'], ['', 'male  mice'], ['Analysis', 'increased surface ICAM-1'], ['F4/80  one', 'high fat diet'], ['adipose cell that', 'obesity'], ['Thermistor', 'high temperature sensitivity'], ['linearity', 'digital readout wireless transmission'], ['effective  lineariser', 'difficulties'], ['based  lineariser', 'operational amplifier circuit'], ['based signal conditioning circuit', 'low degrees linearity'], ['neural perceptron network', 'further thermistor linearity'], ['', '+'], ['3  %', 'high temperature stability'], ['linearity  error', 'dynamic  thermistor'], ['efficacy', 'experimental prototype unit'], ['', ''], ['', 'induced Muller glia'], ['', ''], ['Expression studies', 'Northern RT blotting'], ['dependent  changes', 'vitro Muller cell line'], ['Akt activation', 'TUNEL assay'], ['potential  role', 'knock sh approaches'], ['Effects', 'injected  rats'], ['', ''], ['SIK2 expression', 'nuclear adult layer'], ['Insulin stimulation', '2-fold SIK2 activity'], ['pAkt levels', 'SIK2 activity'], ['enhanced Akt knockdown', 'rapid cell death'], ['SIK2 overexpression', 'opposite  effect'], ['SIK2 activity', '2 rat retina'], ['', ''], ['Results', 'induced Muller vitro'], ['diabetic  it', 'potential control disease progression'], ['paper', 'positive feedback configuration'], ['opamp', 'amplifier relaxation oscillator'], ['closed loop opamp', '540 relaxation kHz'], ['setups', '500 degrees degrees'], ['', ''], ['rights', ''], ['integrated silicon circuits', '500 degrees C'], ['single  MOSFETs', 'stable I V characteristics'], ['27-stage ring oscillator', '300 degrees C'], ['High temperature evaluation', '500 degrees C'], ['Research', '15 IV semiconductor years'], ['exceptional  combination', 'state material know electronics'], ['conduction that', 'new device principles'], ['unconventional  silicon', 'expressive switching value'], ['This', 'silicon  nanowires'], ['fast  development', 'more DC attention'], ['paper tests', 'DC reversal voltages'], ['electrical tree initiation', 'DC polarity voltages'], ['', 'DC reversal voltages'], ['stressing tree time', 'little  influence'], ['Space charge distribution', 'PEA  phenomenon'], ['polarity reversal which', 'DC voltage'], ['existence', 'reasonable  it'], ['transient polarity which', 'true HVDC cables'], ['', ''], ['', ''], ['rights', ''], ['Silver carp', 'cyanobacterial  blooms'], ['balanced gut microbiota', 'complex defense enterocytes'], ['Clostridium XIVab Clostridium communities', 'foregut gradient gel electrophoresis'], ['bacterial  communities', 'well gut contents'], ['Bacterial  diversity', 'local  mucus'], ['sequence analysis', 'conservative Proteobacteria Actinobacteria'], ['gut', 'cellulolytic silver bacteria'], ['foregut segment', 'cellulolytic  midgut'], ['However  proportions', 'gastrointestinal silver carp tract'], ['why silver carp', 'cyanobacterial growth blooms'], ['immunomodulatory  effects', 'silver p catfish'], ['p glucan', 'diet'], ['', ''], ['', 'pathogenic Aeromonas hydrophila'], ['adding', 'blood cells'], ['hemolytic p activity', 'higher  fish'], ['Furthermore  fish', 'p A'], ['hydrophila', 'higher survival fish'], ['feed additive', 'specific silver pathogen'], ['Appropriately  defining', 'tractable data representations'], ['here  object', 'context'], ['', ''], ['', 'other  objects'], ['similarity', 'then  contexts'], ['they', 'data'], ['relevant correlation that', 'similarity graph'], ['graphs', 'structural  objects'], ['similar  that', 'similarity graph'], ['where linguistics numbers', 'very  large'], ['periodontal tooth ligament', 'mechanical  strain'], ['many  researchers', 'cultured PDL cells'], ['we', 'tensile  culture'], ['cytoskeletal HPL structures', 'HPL immunohistochemistry'], ['expression', 'reverse polymerase chain reaction'], ['osteogenic  protein', 'western blot analysis'], ['actin filaments', 'tensile HPL strain'], ['tensile  strain', 'such HPL cells'], ['It', 'also HPL cells'], ['simple  device', 'tensile  cells'], ['embodied language comprehension', 'mental  simulation'], ['What', 'social language psychology'], ['spoken highlights that', 'current simulation theories'], ['language i', 'iv multimodal cues'], ['well process language', 'conversational  turns'], ['Finally  we', 'interactive simulation semantics'], ['bidirectional  transceiver', 'command nm CMOS bus'], ['echo signals', 'operational receiver amplifier'], ['sink source data', 'blind digital oversampling'], ['75  Mbps', 'overall  bandwidth'], ['measured energy efficiency', 'transceiver'], ['pJ  b', 'PRBS bit error directions'], ['guiding  mechanism', 'manufacturing flexure technology'], ['dynamic design task', 'stiffness optimal constraints'], ['more frequency constraint', 'dynamic topology optimization'], ['topology optimization problem', 'discrete optimization variables'], ['stiffening  effect', 'manufacturing errors'], ['design case', 'proposed  method'], ['Child maltreatment', 'significant United States'], ['Single  mothers', 'available  supports'], ['direct child associations', 'direct child which'], ['1158  who', 'social Child control'], ['participants', 'high school participants'], ['', '7  Hispanic'], ['', ''], ['', ''], ['structural equation models', 'social  control'], ['Social cohesion', 'physical  abuse'], ['Maternal depression', 'social  cohesion'], ['parenting stress', 'physical maltreatment parenting abuse'], ['social  cohesion', 'cohabitating child mothers'], ['', ''], ['rights', ''], ['study', 'SSF lighting source LEDs'], ['current  that', 'critical conduction mode'], ['EMI capacitance', 'EMI capacitance'], ['SSF converter', 'continuous conduction mode'], ['S  circuits', 'voltage loop feed path'], ['transient  response', 'output current'], ['Finally operation principles', 'studied LED driver'], ['laboratory prototype', 'also  feasibility'], ['', ''], ['Oxygen vacancies', 'enormous  scientists'], ['bulk  vacancies', 'different photo reaction process'], ['trapped oxygen vacancy', 'different titania precursors'], ['three  kinds', 'TG UV ESR TG techniques'], ['bulk charge SETOVs', 'recombination center'], ['existence', 'synergistic photoreduction CH4'], ['relative photoreduction efficiency', 'bulk surface oxygen SETOVs'], ['', ''], ['', ''], ['rights', ''], ['schematic  method', 'operational ASET effects'], ['method', 'current  mirror'], ['pricing', 'two perturbation decades'], ['case', 'European call options'], ['we', 'stochastic volatility model'], ['Combinations', 'singular perturbation accuracy'], ['us', 'stochastic volatility jumps'], ['', ''], ['', ''], ['rights', ''], ['Singular value decomposition', 'recent  years'], ['basic  idea', 'singular SVD values'], ['energy  which', 'early  fault'], ['RSVD value strategy', 'signal  denoising'], ['novel information index', 'mechanical modulation signal'], ['decomposed  SCs', 'rather information energy'], ['weak  SCs', 'denoised  way'], ['advantages', 'two stage gearbox'], ['proposed  method', 'heavy fault noise'], ['', ''], ['rights', ''], ['Wien bridge oscillator', ''], ['Depending', 'square Wien bridge wave'], ['This', 'passive  components'], ['presented  theory', ''], ['same  circuit', 'passive  components'], ['novel photo detectors', 'conventional Photo Multiplier Tubes'], ['', '3%/degrees gain C'], ['This', 'especially space missions'], ['experimental  setup', 'Pixel Photon Counter'], ['linear which', 'zener diode'], ['measured temperature coefficient', 'breakdown  voltage'], ['', ''], ['', ''], ['analog power supply', 'positive temperature coefficient'], ['measured temperature dependence', 'designed power 63'], ['', ''], ['61  mV', 'different output voltages'], ['designed power supply', 'over temperature C'], ['gain variation', '2 over 2'], ['', '8%/degrees  0'], ['3%/degrees  C', 'designed gain control'], ['', 'similar temperature 42'], ['', '7 degrees 20'], ['9 degrees C', 'paper'], ['RNA interference strategies', 'molecular drug targeting'], ['that', 'effective  protein'], ['', 'suitable therapy cancer'], ['therapy approaches', 'vivo'], ['1 problems delivery', 'desired cell type'], ['review', 'causing  factors'], ['different  that', 'respective Fab cells'], ['coupled siRNA which', 'targeted cancer cells'], ['emergence', 'robust tissue distribution'], ['traditional assay methods', 'key endo protocols'], ['Here  we', 'nonradioactive Xenopus oocytes'], ['method', 'labelled RNA probes'], ['Moreover  it', 'increased hybridization sensitivity'], ['methods', 'signal  intensity'], ['Some', 'half urinary life'], ['how  conjugation', 'variable chain length'], ['PEG chains', 'terminal click chemistry'], ['siRNA conjugate', 'intravenous blood injection'], ['uncoupled Ih siRNA', '90  15min'], ['vivo fluorescent imaging', 'when PEG 20k'], ['Biodistribution studies', 'significant liver kidney degradation'], ['PEG', 'therapeutic delivery applications'], ['', 'cytosol host nucleus'], ['oxidative energy production some', 'even  one'], ['flow we', 'cultured EP neuroblastoma cells'], ['endogenous', 'exogenous SH EP cells'], ['Overexpression', 'balanced salt solution'], ['SIRT5', 'oxidative SH EP cells'], ['molecular EP neuroblastoma mechanisms', 'details'], ['We', 'nonobese animal SS'], ['NOD mice', '12 exocrine age'], ['however tKO NOD proportion', 'Treg Smad4 tKO'], ['Teff Effector cells', 'less Treg cells'], ['IL-17 WT NOD expression', 'inducible tKO NOD mice'], ['Th17 Smad4', 'protective NOD mice'], ['Evidence', 'accidental survey injury'], ['purpose', 'imaging checklists'], ['retrospective  evaluation', 'large General Hospital Trust'], ['Longitudinal assessment', 'two imaging modifications'], ['Examinations', 'body national standards document'], ['121 quality assessment measures', 'period'], ['Examination completeness', 'three  periods'], ['Whitney u Tests', 'significant  period'], ['combined anatomy score', '3'], ['', '1'], ['', 'three  periods'], ['Independent t Tests', 'significant study period'], ['Total percentage examination quality', 'three  periods'], ['Independent t Tests', 'significant  period'], ['use', 'skeletal  results'], ['further  work', 'optimise practice'], ['', 'Radiographers'], ['', 'Elsevier Ltd'], ['rights', ''], ['prevalence', '2 head years'], ['standard  management', '24-h observation period'], ['1  %', 'neurosurgical head intervention'], ['main  objective', 'neurological ISF hospitalization'], ['222  who', 'Coma arrival'], ['We', 'repeated injury fracture imaging'], ['when emergency parents', 'discharge'], ['None', 'neurosurgical  intervention'], ['All', 'month  injury'], ['repeated CT scans', 'new  intervention'], ['Children', 'short skull observation'], ['responsible  who', 'hospital'], ['when child parent', 'hospital'], ['unnecessary  hospitalizations', 'emotional  family'], ['Systemic lupus erythematosus', 'chronic relapsing autoimmune inflammation'], ['environment which', 'main DNA methylation SLE'], ['We', 'healthy control subjects'], ['DNMT3B levels', 'gender age'], ['blood mononuclear cells', '32 SLE patients'], ['RT polymerase chain analyses', 'DNMT1 DNMT3A'], ['', ''], ['', ''], ['transcript  levels', 'healthy SLE controls'], ['DNMT3B mRNA expression levels', 'affected control subjects'], ['Furthermore DNMT1 transcript levels', 'positively disease activity index'], ['', ''], ['DNMT3A transcript levels', 'negatively  patients'], ['', ''], ['', ''], ['analyses', 'epigenetic SLE etiology'], ['presence', 'mRNA expression levels'], ['cell immune cell responses', 'systemic lupus erythematosus'], ['previously  Gaq', 'cell immune cell autoimmunity'], ['SLE expression', 'PBMCs SLE patients'], ['Gaq mRNA expression', 'healthy SLE individuals'], ['Gaq expression', 'Th1 Th2'], ['', 'over Gaq knockout mice'], ['Gaq expression', 'apoptotic SLE T gene'], ['Gaq levels', 'clinical T cell SLE'], ['subsequent mood associations', 'sleep apnea'], ['based  study', 'thus  patients'], ['', 'sleep'], ['cohort study', 'Health Insurance database'], ['sleep apnea enrollees', 'comparison cohort'], ['subjects', '2011'], ['proportional hazard ratio', 'apnea'], ['', '154 sleep apnea'], ['84  %', '27075 follow up individuals'], ['', '13 antecedent sleep'], ['patients', 'sleep 1'], ['', '2'], ['', 'greater  comparisons'], ['unspecified sleep apnea', 'adjusted predisposing 1'], ['', '2'], ['', 'adjusted  2'], ['', '3'], ['', ''], ['greater  MD', 'apnea'], ['Health professionals', 'psychological  sleep'], ['study', 'obstructive sleep center'], ['sleep evaluations', 'first sleep 2008'], ['Inclusion criteria', '9 BDI score'], ['Out', 'combined screening criterion'], ['Eighty one Eighty patients', 'psychiatric sleep specialists'], ['', '21'], ['5  %', 'clinical  depression'], ['7  %', 'psychiatric  diagnosis'], ['prevalence', 'clinical sleep center'], ['', ''], ['Mood scales', 'psychiatric  consultation'], ['Interdisciplinary  cooperation', 'depressed treatment resistance'], ['functioning  that', 'couples'], ['observational  study', 'interpersonal expression cognitive conflict'], ['marital problem who', 'marital problem those'], ['protected reappraisal who', 'inflammatory  reactivity'], ['when  partner', 'emotions'], ['one  partner', 'hostile  way'], ['novel emotion regulation strategies', 'novel data risk'], ['study', 'marital  behavior'], ['', ''], ['rights', ''], ['BACKGROUND Adenoid hypertrophy', 'upper Obstructive Sleep children'], ['administration', 'disordered oxygen breathing'], ['aim', 'disordered adenoid hypertrophy'], ['disordered adenoid parents', 'clinical  trial'], ['symptoms', 'occurrence'], ['intervention x nasopharynx', ''], ['well desaturation events', ''], ['Data', 'paired student t test'], ['RESULTS', '80 study population'], ['8  37', ''], ['', ''], ['Age distribution', 'mean  6'], ['', ''], ['study', 'positive adenoid size'], ['', ''], ['', ''], ['oximetric  parameters', 'significantly drug administration'], ['', ''], ['', 'significant  treatment'], ['aqueous nasal spray therapy', 'disordered adenoid breathing'], ['disordered treatment it', 'morbidity health children'], ['FDA)-approved off grass', 'SLIT United 2014'], ['they', 'approved  products'], ['that', 'United States'], ['patient  populations', 'self administer epinephrine'], ['physicians', 'when emergency care'], ['', '2016 Allergy Asthma'], ['We', 'Horton'], ['', 'More  Geographies'], ['', ''], ['research', 'trivial  lives'], ['how  we', 'methodological  slowness'], ['unexpected  that', 'qualitative research research'], ['Research engagements', 'also  lives'], ['called  we', 'called  answers'], ['how  global', 'children surfaces'], ['brown  planthopper', 'multiple RNA viruses'], ['Rapid  diagnosis', 'viral  disease'], ['Reverse', 'sensitive virus detection'], ['traditional RT PCR', 'widely virus insect'], ['However  using', 'large RNA samples'], ['We', 'single RNA virus SBPH'], ['method', 'directly RT PCR'], ['crude  extract', 'two virus minutes'], ['streaked dwarf virus', 'simplified Himetobi P method'], ['simplified dot method', 'different  insects'], ['when  cDNA', '103  fold'], ['greatly sample processing time', 'RNA isolation'], ['simplified RT PCR method', 'laborious RNA isolation step'], ['It', 'traditional RT PCR method'], ['extracellular  that', 'neoplastic  transformation'], ['commonly proteoglycans Decorin markers', 'various  malignancies'], ['novel  we', 'urothelial  bladder'], ['healthy bladder controls', 'tumour  tissue'], ['Blood', 'normal  patients'], ['Circulatory  levels', 'assay relative protein immunohistochemistry'], ['', 'Circulatory  Biglycan'], ['', ''], ['', 'significantly  Decorin'], ['0001', 'significantly  controls'], ['Protein expression', 'urothelial  bladder'], ['polymerase chain reaction', 'higher tissue Biglycan'], ['', ''], ['', 'lower  Decorin'], ['', 'urothelial  bladder'], ['Out', 'operating characteristic operating curve'], ['ng ml cut off', 'optimum serum sensitivity'], ['', ''], ['', ''], ['Significant  alteration', 'urothelial  bladder'], ['Higher  expression', 'patient Bladder cancer cohort'], ['Nuclear Power Plants', 'historically electricity demand'], ['Nowadays  NPPs', 'daily load cycling operation'], ['', ''], ['', 'rated load power'], ['', 'efficient Load Cogeneration'], ['', ''], ['', 'auxiliary electricity system'], ['suitable cogeneration system', ''], ['', '500'], ['', ''], ['', 'significant market demand'], ['', 'adequate  process'], ['when  request', 'daytime'], ['investment', 'auxiliary  system'], ['paper', 'suitable  load'], ['district heating desalination', ''], ['', ''], ['rights', ''], ['coding  RNAs', 'transcriptional gene levels'], ['a  few', 'these'], ['Northern  blotting', 'small RNA validation'], ['we', 'labeled blot probes'], ['miRNAs', 'Arabidopsis thaliana'], ['5 mu g', 'total  detection'], ['long term storage', 'traditional  probes'], ['protocol', 'small RNA RNAs'], ['Purification', 'purified RNA fragments'], ['study', 'possible  yield'], ['technique', 'siliconized polyacrylamide gel particles'], ['small  RNA', 'also Exponential Enrichment'], ['small  RNAs', 'interacting endo testis'], ['small model RNAs', 'gonads'], ['we', 'small adult chicken testes'], ['small  RNAs', 'slightly  miRNAs'], ['small  RNAs', 'terminal chicken repeats'], ['we', 'them'], ['selected  nine', 'specifically adult testis'], ['poorly pil they', 'adult chicken testis'], ['Further  analysis', 'small animal gonad development'], ['Small  RNAs', ''], ['RNAi cosuppression gene', 'RNA interference'], ['interfering  which', 'biosynthesis'], ['MiRNAs', 'cleavage target RNA'], ['SiRNAs', 'stranded structure transgenes'], ['fundamental  processes', 'small RNA species'], ['we', 'transgenic blot plants'], ['objective', 'experimental bone marrow'], ['free  lambs', 'uninfected culture medium'], ['PCR chain evaluations', ''], ['Two  lambs', '319 days postinfection'], ['Tissues', 'proviral lung PCR'], ['infected  animals', 'highest serologic values'], ['Group lambs', 'carpal lung joints'], ['group B lambs', 'interstitial  CNS'], ['Proviral copies', 'only group B lambs'], ['strain', 'more Rasa Aragonesa lambs'], ['Host factors', 'clinicopathologic SRLV infections'], ['higher resource which', 'sustainability'], ['smart  that', 'more  efficiently'], ['paper', 'European technology assessment cities'], ['main  areas', 'smart electricity meters'], ['use', 'public electricity transportation'], ['main  conclusions', 'successful technology cities'], ['', ''], ['rights', ''], ['power requirement', 'extra  grids'], ['existing  grids', 'Distributed Renewable Energy Sources'], ['Building', 'alone energy shortfall'], ['major  transformation', 'growing electricity electricity'], ['current power management system', 'renewable energy generation'], ['paper', 'smart  grids'], ['robust  strategies', 'detailed  overloads'], ['Also power generation storage', 'operational management sources'], ['Recently  systems', 'smart  grid'], ['Renewable  energy', 'current energy sector'], ['abundantly energy which', 'friendly energy solutions'], ['developing grid that', 'energy crisis'], ['who', 'economic  loss'], ['many detection schemes', 'NTL frauds'], ['existing  schemes', 'more  what'], ['We', 'Technical Loss Smart Grid'], ['', 'multiple  fraud'], ['CNTL methods', 'many  fraudsters'], ['we', 'CNTL frauds'], ['proposed  method', 'tampered  recursive'], ['proposed  scheme', 'mathematical  models'], ['method', 'CNTL frauds'], ['', ''], ['', ''], ['rights', ''], ['DSM demand side techniques', 'industrial  consumers'], ['ignorance', 'conventional DSM grid'], ['smart  grid', 'traditional  grid'], ['paper', 'residential DSM activities'], ['', 'dynamic electricity market'], ['driven  optimization', 'foraging optimization'], ['performance', 'heuristic MATLAB simulations'], ['integration', 'peak electricity 19'], ['', ''], ['', ''], ['energy management system', 'further  25'], ['', '12  24'], ['', ''], ['smart energy which', 'real energy producer'], ['2 energy attackers', 'own  benefits'], ['many security researchers', 'different privacy preservation'], ['existing  studies', 'usually  them'], ['we', 'smart security grid'], ['Specifically  we', 'abnormal bilinear group theory'], ['same  which', 'effectively  time'], ['proposed  scheme', 'efficiently identity confidentiality'], ['further  scheme', 'significantly communication costs'], ['', ''], ['', ''], ['rights', ''], ['smart power supply', 'renewable energy batteries'], ['power which', 'time multiseller power trading system'], ['However  it', 'ordinary trade homes'], ['distributed power cooperation that', 'local  information'], ['proposed  algorithm', 'smart household supply'], ['logically optimization algorithm', 'shorter optimal time'], ['', '2016 Civil Engineers'], ['Efficient power management', 'smart power consumption resident'], ['However  data', 'living electricity habits'], ['paper', 'preserving electricity consumption'], ['dimensional data users', 'n m area'], ['we', 'first Horner parameter'], ['second Horner polynomial', 'Paillier  cryptosystem'], ['m we', 'final area level output'], ['Moreover  we', 'dimensional authentication cost'], ['proposed  scheme', 'smart user grids'], ['smart  which', 'such electricity bill reduction'], ['where  customers', 'low community prices'], ['', 'total electricity customers'], ['paper', 'aware pricing target'], ['certain optimal solution', 'total electricity bill'], ['renewable pricing which', 'smart home scheduling'], ['pricing scheme', 'uniform electricity pricing'], ['wide electricity bill', 'only  0'], ['', 'lower  bound'], ['energy consumers', 'behaviour'], ['belief', 'individualistic behaviour change'], ['how energy use', 'domestic life practices'], ['article', 'smart grid pilot interrelatedness'], ['effects', 'heterogeneous policy practices'], ['what', 'smart grid interventions'], ['solar  it', 'itself'], ['smart photovoltaic system', 'blind shading system'], ['proposed  which', 'three  ways'], ['', ''], ['', ''], ['two self sufficiency rate', 'CIGS PV panel'], ['', ''], ['25  SPSBCIGS&2-axis', 'present  year'], ['', ''], ['', 'savings  year'], ['', ''], ['', 'even  point'], ['', ''], ['', 'renewable energy certificates'], ['SREC  plan', 'proposed  SPSB'], ['', ''], ['rights', ''], ['intensity', 'social judgments warmth'], ['displaying', 'more  warmer'], ['detrimental risk consumption effect', 'high risk consumption situations'], ['further  effects', 'actual consumer behaviors'], ['oral  carcinogenesis', 'molecular smokeless tobacco'], ['we', 'epithelial cell culture'], ['', 'oral khaini consumer'], ['Herein  we', 'molecular differential display'], ['Fourteen  novel', 'differentially  genes'], ['These', ''], ['', ''], ['', 'northern  blotting'], ['Mainly  genes', 'transcriptional  machinery'], ['', ''], ['', 'growth transformation processes'], ['molecular  targets', 'activated cell adhesion molecule'], ['', ''], ['CDIPT', 'important biosynthesis ribosomal protein'], ['', ''], ['quantitative RTPCR analysis', 'oral ST tumorigenesis'], ['studies', 'oral  carcinogenesis'], ['', ''], ['rights', ''], ['SMC cycle reentry', 'arterial T remodeling'], ['present  investigation', 'induced SMC cycle modulation'], ['SMC cultures', 'sensitive  TAg'], ['This', 'restrictive degrees 39'], ['', ''], ['distinguish', 'expressed temperature controls'], ['Northern array blotting', 'polymerase chain reaction'], ['MMP)-3 matrix -11', 'significant matrix metalloprotemase'], ['2(IV procollagen alpha', 'increased procollagen alpha'], ['Studies', 'matrix modulating cytokine'], ['induced cell cycle reentry', 'collageneous  matrix'], ['vessel', 'adaptive vivo conditions'], ['results', 'vascular  diseases'], ['', ''], ['rights', ''], ['Up regulation', 'synthetic phenotypic state'], ['TGF beta', 'key phenotypic state'], ['Here  we', '1 differentiation ECM synthesis'], ['Cx43 expression', 'microinjected ethidium bromide'], ['growth', 'BrdU incorporation'], ['results', 'increased alpha actin calponin'], ['rather TGF beta', 'significant procollagen transcripts'], ['effects', 'growth'], ['1 SMCs TGF treatment', 'also contractile differentiation'], ['', 'GmbH'], ['rights', ''], ['hypometabolic  life', 'environmental  hardship'], ['system  that', 'metabolic land snails'], ['active  17', 'aestivated  animals'], ['buccalin neuropeptide', 'existing muscle contraction'], ['precursor that', 'numerous buccalin peptides'], ['', 'metabolic CNS states'], ['active Tpi regulation', 'translational peptide abundance'], ['widespread  that', 'physiological  roles'], ['associated  that', 'extended gastropod aestivation'], ['', ''], ['rights', ''], ['beta keratins', 'recently reptilian lizards'], ['Here  we', 'first snake Elaphe guttata'], ['Five', \"5'-  analyses\"], ['last cDNA shows', '84  identity'], ['gene', \"single 5'-untranslated region\"], ['genomic  organization', 'beta keratins'], ['snake beta keratins', 'related  geckos'], ['PCR analysis', 'same  chromosome'], ['', 'exclusively renewal phase'], ['longer  transcript', 'lower  skin'], ['coding  sequences', 'isoelectric amino 7'], ['', ''], ['', ''], ['', 'avian scale claw'], ['prediction', 'fibrous beta keratins'], ['basic  that', 'reptiles'], ['', ''], ['', ''], ['interspecific phenotypic which', 'different yeast isolates'], ['Thus  mechanisms', 'genetic  changes'], ['important  task', 'unconsciously wine advent'], ['molecular  that', 'genetic wine fermentation'], ['review', 'biotechnological wine properties'], ['mental  imagery', 'social anxiety literature'], ['it', 'social performance ratings'], ['', 'few  imagery'], ['', 'deliberately  study'], ['undergraduate Thirty students', 'qualitative imagery work'], ['Thematic  analyses', 'generated image others'], ['intrusive  images', 'episodic  memories'], ['Images', 'sensory  modality'], ['who', 'intrusive  intrusions'], ['Emotionality', 'generated  images'], ['phenomenology', 'experimental  research'], ['Theoretical  implications', ''], ['Little', 'romantic  relationships'], ['present  we', 'such  relationships'], ['1  we', '343 anxiety undergraduates'], ['they', 'still  relationship'], ['social  anxiety', 'higher  Time'], ['perceived  support', 'significantly  breakup'], ['Social anxiety', 'support breakup'], ['2  subset', 'social support tasks'], ['trained  observers', 'also support behaviors'], ['anxious  individuals', 'participant observer report'], ['social anxiety couples', 'support'], ['social  anxiety', 'romantic  relationships'], ['Clinical  implications', ''], ['early term that', 'social anxiety disorder'], ['anxious  N=240', 'anxious  adolescents'], ['6  years', 'cognitive bias modification training'], ['multiple  study', 'repeated measures design'], ['social  anxiety', 'regardless treatment condition'], ['who', '6 anxiety conditions'], ['negative prosocial none', 'treatment condition'], ['social threat associations', ''], ['long term effect', 'Adolescent Interpretation'], ['', 'selective follow up'], ['RCT', 'social term anxiety'], ['Rather  it', 'two  years'], ['', ''], ['', 'Elsevier Ltd'], ['related  systems', 'vertebrate  humans'], ['neural  that', 'social  attachment'], ['Individual species variation', 'social  learning'], ['respective target receptors', 'such attachment autism'], ['neural vasopressin that', 'social sociosensory contexts'], ['', 'Elsevier Ltd'], ['traumatic brain injury', 'poor  survivors'], ['injured  mice', 'social  adulthood'], ['social  we', 'male sex adulthood'], ['pediatric  TBI', 'social cortex problems'], ['Morphological  analysis', 'pediatric dentate TBI'], ['most TBI neurons', 'females'], ['previous TBI males', 'sociability'], ['TBI females', 'also  sociability'], ['sex', 'pediatric  TBI'], ['neuronal  complexity', 'social  deficits'], ['specific  alterations', 'pediatric brain TBI'], ['', ''], ['', ''], ['rights', ''], ['intuitive  theories', 'conceptual  domains'], ['social  groups', 'such  allegiances'], ['underlie category membership', 'less  attention'], ['membership', 'mutual  intentions'], ['', ''], ['individual', 'common group intentions'], ['broad age 4', 'early  development'], ['Further  they', 'such  gender'], ['Mutual  intentionality', 'naive  sociology'], ['', ''], ['', ''], ['rights', ''], ['Contemporary China', 'deeper  reform'], ['social  media', 'historical  reform'], ['public  article', 'civic transformation society'], ['study', 'typical media cases'], ['social  media', 'public information events'], ['impact', 'social management innovation'], ['Social media', 'contemporary  China'], ['social  media', 'nationalist breeding discourses'], ['', ''], ['rights', ''], ['well  we', 'well  those'], ['We', 'affective  evaluations'], ['propositional evaluation we', 'automatic  evaluation'], ['mismatch', 'negative exercise automatic'], ['evaluative process mistrusting', 'inflated exercise goals'], ['Mimicry', 'social  interactions'], ['autism spectrum causes', 'differences'], ['people', 'social  context'], ['study', 'established mimicry hypothesis'], ['direct ASC gaze', 'congruent reaction movements'], ['mimicry', 'socially  STORM'], ['contextual  factors', 'perceptual  processes'], ['social  factors', 'earliest  stages'], ['social  factors', 'people'], ['how  framework', 'social  cognition'], ['Finally  we', 'social  cognition'], ['', ''], ['rights', ''], ['Eyes', 'social  interactions'], ['that', 'human eye cues'], ['that', 'ontogenetic  eyes'], ['second  that', 'emotional  states'], ['humans', 'cooperative brain humans'], ['also  oxytocin', 'sensitive eye cues'], ['Viewing eyes', 'deeply hallmark biology'], ['Empathy', 'multiple  components'], ['empathic schizophrenia concern', 'personal  distress'], ['recent meta analysis', 'four  scale'], ['goal', 'healthy meta controls'], ['literature search', 'eligible schizophrenia studies'], ['g standardized difference effect size', 'analytic  model'], ['', 'personal concern perspective distress'], ['such  samples', 'reduced effect sizes'], ['Future work', 'possible emotion regulation'], ['dysexecutive  disorders', 'dysexecutive  impairments'], ['underlying  mechanisms', 'fact'], ['', 'behavioral functioning disorders'], ['we', 'transnosological  study'], ['neurological Seventy disease', 'frontotemporal lobar study'], ['patients', 'facial emotion mind'], ['As', 'socioemotional  diagnosis'], ['facial emotion recognition', 'social behavior disorders'], ['behavioral  disorders', 'executive  apathy'], ['behavioral  disorders', 'socioemotional  processes'], ['observer irrelevant observer that', 'emotion'], ['Participants', 'facial  expressions'], ['Half', 'plausible  expression'], ['related Approach behaviour', 'behavioural Simon tendencies'], ['', 'facial trigger expressions'], ['Participants', 'facial approach expressions'], ['presence', 'disgusted observer expressions'], ['trigger', 'moderating approach avoidance tendencies'], ['Thus  influence', 'automatic  process'], ['established  link', 'social self exclusion'], ['induced self assignment', 'social  participation'], ['', 'social  exclusion'], ['inclusionary ball tossing block', 'partial  participant'], ['vertical  position', 'experimental  groups'], ['', ''], ['', ''], ['subjective brain participants', 'social  needs'], ['', 'even  position'], ['verticality', 'subjective expectancy formation'], ['social  transition', 'social  exclusion'], ['risk that', 'behavior'], ['relations', 'individual  behavior'], ['parent  interventions', 'preschoolers'], ['however  research', 'date'], ['parent  intervention', 'more  behavior'], ['aim', 'experimental group design'], ['20 control who', 'waiting list'], ['four  programs', 'specific target variable'], ['', ''], ['inhibition parental self efficacy beliefs', 'verbal  preschoolers'], ['effective  solutions', 'behavioral  preschoolers'], ['focused  programs', 'cost multimodal children'], ['complex  it', 'better group behaviour'], ['how animal animals', 'such  knowledge'], ['social  we', 'aggressive 15 episodes'], ['Confirming', 'preferentially research aggressor'], ['macaques', 'ongoing group associations'], ['infants', 'third kin parties'], ['selective Inter that', 'social  knowledge'], ['physical  which', 'also  function'], ['Pain', 'such  behavior'], ['social  pain', 'adaptive  behavior'], ['who', 'social  version'], ['We', 'social  stimulus'], ['', 'nonsocial  task'], ['Posttask questionnaires', 'social  pain'], ['that', 'behavior'], ['Moreover participants', 'nonsocial  version'], ['subjective  feelings', 'social  game'], ['social  pain', 'social  behavior'], ['educational  system', 'STEM science technology students'], ['One  way', 'early  age'], ['study', 'minimal cue preschoolers'], ['', ''], ['individual subjects design they', 'spatial math task'], ['Children', 'individual STEM task'], ['we', 'previous meta experiments'], ['incorporating', 'STEM STEM motivation'], ['Background', 'young  adults'], ['Cognitive dysfunction', 'functional disease domains'], ['component  that', 'bodily  cues'], ['Deficits', 'interpersonal  life'], ['little  attention', 'social  cognition'], ['objectives', 'social MS studies'], ['We', 'cognitive  MS'], ['Studies', 'PRISMA guidelines'], ['English PubMed that', 'regardless publication year'], ['We', 'facial  mind'], ['We', 'relevant  studies'], ['26  studies', 'neuroimaging  studies'], ['Available  data', 'early  MS'], ['increase', 'social matters cognition'], ['thorough  screening', 'such  QoL'], ['music music', 'also  perception'], ['', ''], ['music', 'real  agents'], ['listeners', 'social  intention'], ['experimental  we', 'musical expert music interaction'], ['temporal information that', 'interaction'], ['musician channel audio we', 'other control hand'], ['results', 'verbal  whole'], ['', ''], ['', 'Elsevier B'], ['', ''], ['considerable  patients', 'social  deficits'], ['such  deficits', 'clinical episode symptoms'], ['first episode FES', 'neurocognitive test battery'], ['Social perception', 'everyday film interactions'], ['Theory', 'silent  animations'], ['FES subjects', 'several  years'], ['', ''], ['', ''], ['', ''], ['FES patients', 'positive  SANS'], ['Healthy  controls', 'patients'], ['High  levels', 'functional  IQ'], ['Avolition Apathy', 'social  cognition'], ['effects', 'positive  symptoms'], ['High  levels', 'higher premorbid IQ'], ['', 'such  deficits'], ['cognitive  training', 'mentioned  symptoms'], ['underlying  interventions', 'better  outcomes'], ['factors', 'cognitive adjustment family environment'], ['significant  correlation', 'functional  capacity'], ['real life behaviour', 'empathy affect recognition'], ['real life behaviour', 'major  empathy'], ['Results', 'functional rehabilitation outcome'], ['People', 'two  simulation'], ['strong  people', 'simulation'], ['Predictors', '50  pictures'], ['They', 'facial  pictures'], ['they', 'perspective'], ['miscalibrated  confidence', 'given  situation'], ['even  they', 'firsthand strategies'], ['generally  people', 'open  situations'], ['that', 'social  norms'], ['that', 'norms'], ['perceived  desirability', 'attitudinal  convictions'], ['when  it', 'convictions'], ['minded  orientation', 'convictions'], ['perceived  appropriateness', 'attitudinal  convictions'], ['justification effect', 'two  experiments'], ['perceptions', 'societal resource resources'], ['', ''], ['', ''], ['61  years', 'European resource background'], ['economic  inequalities', 'societal  resources'], ['racial minority groups', 'restricted  resources'], ['negatively  who', 'social  inequalities'], ['', ''], ['rights', ''], ['Social  cognition', 'functional executive disease'], ['Th2-associated  cytokines', 'delusional gaze detection patients'], ['We', 'based flow immunoassay'], ['Results', 'partially  hypothesis'], ['inflammatory  cytokine', 'delusional delusional patients'], ['bias', 'hostile schizophrenia environment'], ['elevated delusional levels', 'delusional delusional patients'], ['Rationale Dopamine', 'central reward processing'], ['rewarding  that', 'DA reward circuits'], ['how  DA', 'social  stimuli'], ['we', 'pharmacological DA D1'], ['', 'visual attention macaques'], ['nonsocial  stimuli', 'D1'], ['social  those', 'nonsocial  cues'], ['D1', 'affective D2 valences'], ['nonsocial D2 antagonism', 'effect'], ['D1', 'separate  mechanisms'], ['much  we', 'relevant factor processes'], ['further  progress', 'sociocognitive  processes'], ['several  that', 'empathy spectrum mind'], ['social learning we', 'effortful process processing'], ['We', 'social  cognition'], ['study', 'valid emotion material'], ['depressive FER deficits', 'depressive  symptoms'], ['healthy  FER', 'Social Cognition'], ['Furthermore  activity', 'Zygomaticus Major'], ['confident recognizing it', 'more happiness HC'], ['confident recognizing it', 'more happiness HC'], ['Reduced  mimicry', 'FER deficits'], ['rMDD', 'impaired  reasoning'], ['stimulus material', ''], ['FER deficits', 'more  study'], ['show rMDD', 'emotional  expressions'], ['other  that', 'facial  expressions'], ['purpose', 'aged emotion children'], ['Theory', 'taking emotion task'], ['Child temperament', 'online parent report'], ['', 'socially research temperament'], ['contrast emotion understanding', 'low arousal activities'], ['theory', 'negatively activity level'], ['', 'social preference temperament dimensions'], ['', ''], ['reading  hypotheses', 'social  cognition'], ['It', 'popular  MRHs'], ['complementary  behaviour', 'reading hypotheses'], ['best  strategy', 'social  cognition'], ['based  that', 'teleological  play'], ['new  competitor', 'MRHs'], ['social  they', 'teleological  criterion'], ['theoretical  prospects', 'further  research'], ['cognitive  deficits', 'neuropsychiatric  disorders'], ['', 'broad intervention SC'], ['aim', 'adult neuropsychiatric adult patients'], ['Pubmed PsycINFO Web', '01 SC intervention 2003'], ['Forty one Forty studies', '1508 brain injury'], ['Outcome measures', 'SP emotion Mind'], ['interventions', 'SC'], ['', ''], ['Interventions', 'specific SC function'], ['', 'SC  SC'], ['comprehensive  that', 'multiple SC processes'], ['', ''], ['Targeted  interventions', 'especially  EP'], ['Comprehensive  interventions', 'EP ToM'], ['based  interventions', 'also  EP'], ['Social disinhibition difficulties', 'traumatic brain injury'], ['sensitive  tools', 'objectively  difficulties'], ['', 'social disinhibition task'], ['disinhibited information responses', 'additional  guidance'], ['Participants', 'moderate  TBI'], ['Participants', 'positive Part responses'], ['One  half', \"faux character'smental state\"], ['similarly control participants', 'faux pas items'], ['they', 'automatic  responding'], ['however Part they', 'similarly control participants'], ['group differences', 'reaction time'], ['Overall  SDT', 'new inhibition TBI'], ['Recent  work', 'some stress others'], ['effects', 'only  stress'], ['We', 'social control support'], ['how  variable', 'others'], ['Chaos', 'environmental  stress'], ['carefully  strength', 'psychological stress response'], ['significant  observations', ''], ['', 'complex  periodicity'], ['increasing  that', 'chaos'], ['', ''], ['', ''], ['reached', 'initial  conditions'], ['', ''], ['', ''], ['rights', ''], ['anterior cingulate cortex', 'social decision cognition'], ['region', 'cognitive  functions'], ['usually rostro caudal caudal', 'social  cognition'], ['ventral ACC ACCg', 'social  information'], ['pregenual  ACCg', 'social  interactions'], ['present  activity', 'social ACCg interactions'], ['Single issue protests', 'social  media'], ['political  impact', 'less  attention'], ['last  Greenlanders', 'noteworthy  results'], ['they', 'contested prestige issue'], ['actors', 'alliances'], ['concepts', 'mobilizing parliament building'], ['Finally  paper', 'engaged power Greenland'], ['colonial  they', 'Greenlandic democracy'], ['', 'social  media'], ['0  technologies', 'many  researchers'], ['number', '10  years'], ['social  commerce', ''], ['we', 'extant commerce area'], ['study', 'social media Web'], ['', ''], ['Following', 'social commerce research'], ['semantic text mining approach', 'social commerce research'], ['LSA results', 'social organization mouth'], ['theme', 'generated innovation others'], ['we', 'interesting  trends'], ['major research they', 'slight  decline'], ['online reviews trust', 'more e researchers'], ['', ''], ['rights', ''], ['progressive  role', 'social network attention'], ['work', 'accordingly  tourist'], ['POI reviewers', 'distinct  their'], ['certain  archeology', 'certain  POIs'], ['Further  algorithm', 'corresponding bimodal network'], ['ranking  algorithm', 'given  tourist'], ['similar centrality algorithm', 'certain reviewer prefers'], ['evaluation', 'individual life POIs'], ['Moreover  it', 'further location performance'], ['based  that', 'other'], ['SNS', 'recent  years'], ['', 'higher  education'], ['why faculty members', 'educational  purposes'], ['current faculty SNS', 'faculty education'], ['mixed method approach', 'different state Turkey'], ['SNS they', 'educational  purposes'], ['SNS', 'fast  communication'], ['which', 'faculty privacy'], ['', ''], ['rights', ''], ['aim', 'social  level'], ['female Twenty participants', 'magnetic signals changes'], ['Greater  levels', 'when posterior cingulate cortex'], ['lingual friends individuals', 'closer  network'], ['maintaining', 'cognitively kin relationships'], ['', 'new Traumatic Brain Injury'], ['Fifty one Fifty adults', 'severe SSQ TBI questionnaire'], ['self report', 'divergent  validity'], ['Internal  consistency', 'alpha'], ['', ''], ['Convergent validity', 'significantly Disinhibition sub scales'], ['', ''], ['', ''], ['', ''], ['', ''], ['However  relationship', 'neuropsychological  disinhibition'], ['', 'psychosocial Psythosocid Reintegration Scale-2'], ['', ''], ['Further skills assessment', 'test test reliability'], ['based bioenergy projects', 'economic  problems'], ['different  some', 'scientific  literature'], ['discourses', 'rural fossil jobs'], ['national  that', 'bioenergy feedstock crop'], ['popular Yucatan discourse', 'sustainability development tool'], ['projects', 'social sustainability benefits'], ['We', 'rural bioenergy areas'], ['such policymaking projects', 'popular bioenergy discourses'], ['study', 'child abuse'], ['how  judges', 'parental court orders'], ['one  who', 'professional court actors'], ['', 'informational decision dialogs'], ['softer  that', 'praise'], ['that', 'Family Court system'], ['These', 'decision  praise'], ['social work role', 'such child abuse'], ['article', 'alcohol drug problems'], ['where work problems', 'social work practice'], ['Studies', 'alcohol gender problems'], ['advantage', 'limited  clients'], ['often  men', 'important  change'], ['supportive partners opposite', 'men'], ['', 'often change thinking'], ['more  women', ''], ['This', 'broader  repertoire'], ['practical treatment clients', 'emotion'], ['aim', 'physical  hostility'], ['sample', '6th Primary School'], ['', ''], ['', ''], ['Child Adolescent Scale', 'aggressive Aggression behaviour'], ['students', 'lower Aggression SPP'], ['where  magnitude', 'differences'], ['4  dimensions', 'positively Aggression 1'], ['', '1'], ['', ''], ['results', 'close  aggression'], ['', '2016 European Education'], ['', 'Elsevier Espana S'], ['', ''], ['', ''], ['This', 'open NC ND license'], ['Designing', 'explanatory  mechanisms'], ['We', 'vocational school students'], ['COM B system', 'exploratory Theoretical Domains study'], ['', 'social school activity'], ['determinants', 'COM B domains'], ['outcome measures', 'self report PA'], ['statistical  analyses', 'based mediation procedure'], ['', 'COM B domains'], ['vocational school students', 'high school students'], ['important SES PA candidates', 'self b'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['However  SES', 'most  screentime'], ['Most  determinants', 'major moderation relationships'], ['study', 'socioeconomic PA PA'], ['analyses', 'longitudinal SES PA designs'], ['distinct  that', 'socioeconomic health behaviour disparities'], ['', 'vitro melanoma studies'], ['Immunohistochemical  staining', 'melanoma nevi'], ['real polymerase chain reaction', 'human protein melanocytes'], ['Melanoma cells', 'interfering RNA groups'], ['proliferation cell cycle', 'MV3 assay flow cytometry'], ['expressions', 'western kinase signal blotting'], ['interfering RNA groups', 'interfering xenograft RNA'], ['positive expression rate', 'pigmented melanoma nevi'], ['MV3 cells', 'highest A357 cells'], ['interfering RNA group', 'G2 JAK2 p STAT1'], ['interfering RNA group', 'smaller tumor size'], ['kinase kinase signal transduction', 'pathways'], ['systems Oxide Fuel Cells', 'candidates'], ['suit', 'plant sizes'], ['Oxide Fuel implementation', 'external  reformer'], ['lean Oxide Fuel which', 'small scale installations'], ['', ''], ['', 'biogas  electricity'], ['rather gap system simulations', 'unreformed Oxide Fuel biogas'], ['current  study', 'two Oxide Fuel Cells'], ['prior novel concept', 'upgraded dioxide separation membranes'], ['dioxide separation membranes', 'conventional  51'], ['', '523 % exergy 37'], ['', ''], ['', 'based  system'], ['also heat recovery', 'heat  74'], ['', '8  47'], ['', 'other  system'], ['Moreover  results', 'direct system feeding'], ['based  system', 'heat system 25'], ['', ''], ['', 'based  concept'], ['preliminary capital which', 'higher energy conversion efficiency'], ['', ''], ['rights', ''], ['paper', 'soft DC power converters'], ['smoothly overshoot voltage', 'proposed  coefficients'], ['soft start which', 'only chip 300umx120um'], ['Rhizoctonia cerealis', 'sharp pathogen soil'], ['Chain Reaction Polymerase Chain assays', 'highly TaqMan soil'], ['We', 'first qPCR R'], ['', 'unique Characterised Amplified Region'], ['assay', 'other Rhizoctonia solani'], ['200 mu g sclerotia', '50  soil'], ['DNA', 'asymptomatic wheat plants'], ['', 'different crop rotations R'], ['where  wheat', 'pasture'], ['where  potatoes', 'frequently  fields'], ['assays', 'specific SCAR assays'], ['microbial fuel cell', 'organic  pollutants'], ['Hexachlorobenzene', ''], ['membrane soil MFCs', 'study'], ['HCB', 'reductive soil MFCs'], ['influences', 'rate soil HCB'], ['when  concentration', 'phosphate buffer'], ['anode area', 'significant  HCB'], ['Altering', 'ohmic soil MFCs'], ['ohmic  resistance', 'efficiency  rate'], ['', ''], ['soil performance', 'electrode buffer spacing'], ['recent  disposal', 'different  community'], ['use', 'worldwide varying success'], ['Integrated Phytoremediation which', 'unsaturated Cd soils'], ['combination', 'consequently Eucalyptus contaminants'], ['experimental  study', 'restricted aboveground parts'], ['bacteria  system', 'considerable rhizosphere contamination'], ['application', 'environmentally soil costs'], ['', ''], ['', ''], ['rights', ''], ['billion  people', 'tropical  world'], ['Ancylostoma duodenale', 'main Necator people'], ['infections', 'contaminated sludge agriculture'], ['Different  methods', 'environmental STHs samples'], ['accepted  which', 'well samples locations'], ['emerging detection that', 'detection'], ['It', 'geographical Science locations'], ['Original research articles', 'methodology  sections'], ['Methods', 'main  method'], ['inclusion', 'helminth particulate eggs'], ['relative  densities', 'higher egg recovery'], ['Generally  use', 'human  error'], ['specific  identification', 'based  detection'], ['based nucleic methods', 'limited  resources'], ['isothermal amplification method', 'basic  equipment'], ['development', 'environmental  samples'], ['It', 'different sample matrices'], ['', ''], ['', ''], ['', 'Elsevier B'], ['', ''], ['Abiotic  stresses', 'limiting plant growth'], ['salt DNA cassette', 'mediated Solanum transformation'], ['transgenic  plants', 'PCR analysis'], ['selected  transformants', 'T1 stress generations'], ['Integration', 'Southern blot hybridization'], ['Transgenic  expression', 'northern T1 plants'], ['T1 progenies', 'different water supply'], ['Results', 'wild type plants'], ['transgenic  lines', 'wild stress conditions'], ['clearly  overexpression', 'transgenic tomato plants'], ['electronic  implants', 'significantly  life'], ['typically  which', 'surgical  procedures'], ['light', 'electronic electricity bodies'], ['However  results', 'animal models'], ['electrical  performance', 'solar  cells'], ['we', 'to performance 9'], ['mW  cm(2', '10 skin cadavers'], ['power densities', 'human  skin'], ['', ''], ['higher  power', 'thinner  skin'], ['such  that', 'microwatt'], ['Solar  energy', 'modern energy society'], ['Solar  cells', 'high power conversion efficiency'], ['However power outputs', 'solar photovoltaic radiation'], ['solar  cells', 'simultaneous energy output'], ['review', 'solar structures materials performance'], ['current  challenges', 'future  field'], ['Nanotechnology', 'potential  applications'], ['such  application', 'selectively  light'], ['material it', 'optical  properties'], ['selective energy absorption', 'hybrid  thermal'], ['we', 'ideal Si PV cells'], ['optical transfer model', 'outdoor prototype conditions'], ['more  value', 'same PV illumination'], ['thermal PV it', 'heat  applications'], ['', ''], ['rights', ''], ['paper', 'battery hybrid electricity tariff'], ['system', 'off  chargers'], ['Control system models', 'practical appliance scheduling constraints'], ['resident comfort inconvenience level', 'control system models'], ['objective optimization problem', 'operating cost energy consumption'], ['optimal control strategies', 'integer nonlinear programming problem'], ['cost  consumption', 'proposed  strategies'], ['customers', 'battery hybrid power systems'], ['', ''], ['rights', ''], ['solar  systems', 'poor electricity grid'], ['We', 'solar Uganda d'], ['', 'individual level matching'], ['We', 'substantial treatment households'], ['USD  which', 'weekly energy expenditure'], ['constant  households', 'initial  3'], ['', 'expected D20 g'], ['health treatment households', 'lower  incidence'], ['They', 'such comparison group'], ['We', 'productive time use'], ['annual  consumption', 'metric 221 2015'], ['84  %', ''], ['', '50 temperature degrees'], ['Solar  collectors', 'temperature oil'], ['much process heating applications', 'industrial energy consumption'], ['methodology', 'solar process heating'], ['methodology', 'solar process operating collectors'], ['size', 'solar capacity collectors'], ['proposed  methodology', 'software tool'], ['economic  analysis', 'solar  industries'], ['financial Payback periods Rates', 'Returns'], ['Further  methodology', 'Indian  potential'], ['industries', 'Textile Pulp'], ['wise energy demands', 'monetary fuel benefits'], ['economic  parameters', 'solar market systems'], ['Further sensitivity analyses', 'solar process heating'], ['', 'C Elsevier Ltd'], ['present  paper', 'maximum point tracking capability'], ['1104 Semikron inverter', 'coupling LC filter'], ['system', 'single utility grid'], ['Replacement', 'adequate wind land'], ['Impact assessments', 'current ecosystem services'], ['We', 'Swiss land change scenarios'], ['future  scenario', '69 electricity 16'], ['', 'future land 28'], ['', ''], ['increase', 'solar scenario B2'], ['Wind electricity potential', '29  B2'], ['electricity potential', '98 ecosystem services'], ['Depending', 'renewable energy 2050'], ['This', 'technological  developments'], ['Positive  impacts', 'economic energy development'], ['Economic  dispatch', 'subject system transmission'], ['ED Economic methods', 'improved  cost'], ['increase', 'alternative energy source'], ['new Economic Dispatch algorithm', 'PV Photo plants'], ['', 'solar optimization radiation'], ['Power demand data', 'Thermal Power Station'], ['57 bus comparison', 'better  results'], ['', ''], ['rights', ''], ['PV  system', 'zero energy building'], ['urban PV it', 'solar PV potential'], ['high rise buildings abound', 'solar PV installation'], ['Therefore  it', 'potential rooftop estimation'], ['Therefore  study', 'available Hillshade analysis'], ['solar PV potential', 'technical  potential'], ['', 'geographic PV potential'], ['', ''], ['available rooftop area', 'Hillshade analysis'], ['proposed Seoul South study', 'monthly  bases'], ['geographic  potentials', 'Gangnam district'], ['potential  results', 'monthly PV bases'], ['', ''], ['rights', ''], ['PV storage technologies', 'reduced electricity charges'], ['Currently  savings', 'only volume component'], ['PV demand charge reductions', 'PV storage need'], ['aim', 'PV demand charges'], ['solar electricity consumption PV', 'five electricity 0'], ['', ''], ['', ''], ['', '12 kWh battery storage'], ['', ''], ['02 % reduction', ''], ['Battery utilisation strategy', 'greater battery storage'], ['lower network battery network', 'lower network battery cost'], ['results', 'Australian battery context'], ['', ''], ['rights', ''], ['both', 'solar  systems'], ['thermal  systems', 'solar  buildings'], ['available  area', 'thermal  collectors'], ['simultaneously  which', 'residential buildings application'], ['available  this', 'especially  summer'], ['Moreover buildings', 'different  regions'], ['experiments', 'also simulation results'], ['Using', 'residential models applications'], ['energy comparison', 'solar Hongkong Lhasa China'], ['thermal installation system', 'photovoltaic energy systems'], ['thermal area modules', 'hot water building'], ['', ''], ['rights', ''], ['paper', 'economic chimney power parameters'], ['indicator', 'payback payback reference'], ['optimization model', 'concrete  collector'], ['associated collector area', 'chimney'], ['Relationships', 'power plant'], ['payback  periods', 'studied Chimney power designs'], ['', '100 electricity price'], ['payback  period', 'reference case'], ['', 'floating chimney 23'], ['', ''], ['', 'concrete  chimney'], ['', 'floating MW power 19'], ['', ''], ['', ''], ['24 million 24 USD', 'initial reference case'], ['Sensitivity analysis', 'solar chimney power plant'], ['Floating chimney design', 'annual  revenue'], ['payback electricity period', 'floating chimney design'], ['', ''], ['rights', ''], ['four trillion four barrels', 'currently  U'], ['', ''], ['', ''], ['sustainable  method', 'oil shale'], ['Given', 'alternative shale oil extraction'], ['', 'crude oil oil'], ['electrochemical  model', '4'], ['', 'situ oil shale processing'], ['which', 'three'], ['', 'stack oxide fuel 0'], ['', ''], ['', ''], ['high temperature process heat', 'high value shale oil'], ['steady state system model', 'electrochemical heat module'], ['model', 'single stack performance testing'], ['further model simulations', 'electrical air performance'], ['model', 'physical Fuel Cell operation'], ['operating conditions', 'desired heat flux applications'], ['', ''], ['rights', ''], ['proton', 'conventional Ruddlesden Popper Ni'], ['', ''], ['', ''], ['', 'CO2 dry CO2 methane'], ['roles', 'operational La2NiO4 catalyst anodes'], ['La2NiO4 catalyst layer', 'dry BZCY4 methane'], ['outstanding coking resistance capability', ''], ['consumes', 'conventional power NiO'], ['', 'similar output 0'], ['', 'mA  cm(-2'], ['H+-SOFC', 'potential CO2 electricity'], ['', ''], ['', ''], ['rights', ''], ['Solvent', 'popular surface biophysics'], ['implicit solvent SES', 'Cartesian  mesh'], ['Therefore  it', 'biophysical  modeling'], ['work', 'Cartesian solvent grids'], ['ESES', 'solvent intersection SES'], ['Additionally  interface', 'normal intersection point'], ['', 'atomic surface types'], ['Homology theory', 'such  SES'], ['sizes', 'based  filtration'], ['ESES', 'free computation surface area'], ['We', 'electrostatic solvation energy area'], ['results', 'analytical MSMS software'], ['', ''], ['overgrowth  that', 'Related Overgrowth Spectrum'], ['Southern  blotting', 'Western RNA blotting'], ['Soybeans', 'traditional Asia countries'], ['we', 'putrefactive gut rats'], ['20  diets', '20 % soy protein'], ['caecal  environment', '2 % soy %'], ['indole  content', 'lactic  SFL'], ['', 'denaturing gradient gel electrophoresis'], ['anaerobic Prevotella rods', 'dominant  SFL'], ['fermentable  polysaccharides', 'putrefactive soy microbiota'], ['', ''], ['', ''], ['rights', ''], ['MicroRNA1511', 'deep  sequencing'], ['small  RNA', 'miR1511 precursor stem sequence'], ['We', 'Northern blotting analysis'], ['We', 'target miR1511'], ['first  site', 'second  exon'], ['expression level', 'roots'], ['lowest  level', 'GmRPL4a root'], ['same target level', 'GmRPL4a miR1511/1511'], ['infecting  sobemovirus', 'common mosaic virus'], ['virus', '4152 strand RNA nucleotides'], ['virus', 'nt reading ORF2a'], ['nucleotide  sequence', '31'], ['', ''], ['', 'eleven  sobemovirus'], ['', 'seven Nicotiana virus'], ['SYCMV', 'only Glycine max'], ['', ''], ['Based', 'full length SYCMV'], ['Symptoms', 'symptomatic  plants'], ['Viral RNA accumulation', 'Northern  blotting'], ['full length clones', 'disease symptoms'], ['Genomic organization', 'genus amino acid Sobemovirus'], ['', ''], ['', ''], ['rights', ''], ['Problems', 'two network decades'], ['general  problems', 'designed  network'], ['spanning input upgrading', 'nodes'], ['We', 'considered algorithmic problems'], ['', 'heuristic fixing procedures'], ['two  we', 'devised  enhancements'], ['proposed  approaches', 'small optimality gaps'], ['proposed  enhancements', 'algorithms'], ['', ''], ['rights', ''], ['Little', 'reducing soil bacteria'], ['study', 'community S'], ['', 'successional plant gradient'], ['', 'coastal Eastern China'], ['polymerase chain reaction', 'partial dsrB gene'], ['We', ''], ['alterniflora', 'native plant species'], ['Desulfobacteraceae', 'relative SRB 33'], ['', '6  Desulfobulbaceae'], ['', ''], ['', ''], ['alterniflora', 'relative  Desulfobacteraceae'], ['', 'native  species'], ['', ''], ['', ''], ['alterniflora invasion', 'thermophilic Thermodesulfovibrio yellowstonii'], ['', 'conclusion S'], ['alterniflora invasion', 'greatly SRB structure'], ['This', 'coastal carbon marshes'], ['physical  environment', 'research'], ['physical  attributes', 'spatial environment cognition'], ['numerous  studies', 'social  environment'], ['spatial  behavior', 'spatial  behavior'], ['unfamiliar  rats', 'ultimately  quartet'], ['Specifically group formation', 'forming  duos'], ['shared home they', 'solo duo arena'], ['unfamiliar self rats', 'spatial  behavior'], ['children', 'credible  speakers'], ['how  they', 'credible  speakers'], ['children', 'problematic  sources'], ['children', 'inaccurate  speakers'], ['Children', 'novel  objects'], ['Moreover  they', 'inaccurate  speakers'], ['young  children', 'label'], ['young  children', 'credible  speakers'], ['fits  approach', 'multiple  contradictions'], ['Nevertheless  breakthroughs', 'murine biology'], ['species gender that', 'species gender age'], ['meaningfulness', 'case  basis'], ['review article', 'immunobiological  perspective'], ['Urban  vegetation', 'urban land landscape'], ['strongly land use legacy', 'rapid  urbanization'], ['study', 'functional Haikou China'], ['We', 'distributed sample plots'], ['influence', 'taxonomic woody plants'], ['relative  importance', 'boosted regression tree model'], ['where  lands', 'residential  areas'], ['Remnant trees', 'possibly legacy effect'], ['land place', 'land use'], ['we', 'utilitarian conservation value'], ['', ''], ['', ''], ['rights', ''], ['spectral simulation technique', 'important spectrum fields'], ['rapid LED LED', 'light responding band'], ['', 'therefore Matlab LED'], ['Meanwhile  system', 'main data processor'], ['specific driver which', 'TI Corporation'], ['then target processor', 'integrated  LED'], ['spectrum', 'results'], ['Moreover design method', 'real time scene'], ['It', 'potential  future'], ['transgenic BDD mice', 'mediated gene transfer'], ['transcription', 'transgenic  mice'], ['Sperm', 'artificial BDD bFVIIIcDNA vivo'], ['birth F0 progeny', 'transgenic  mice'], ['F1 progeny', 'transgenic F0 mouse'], ['F1 progeny', 'Southern  blotting'], ['transcription', 'western  blotting'], ['Blood', 'also F1 hFVTIT'], ['2 F1 progeny', 'BDD hFVIIIcDNA'], ['transcription', 'transgenic BDD mice'], ['', 'transgenic F0 progeny'], ['', ''], ['', ''], ['transgenic  mice', '18'], ['', ''], ['', ''], ['hFVIII inhibitors', 'F0'], ['gene transgenic FVIII gene mice', 'human FVIII bodies'], ['properties', 'spermatogonial stem spermatogenesis'], ['', 'vitro SSC culture systems'], ['culture that', 'male stem infertility'], ['current  study', 'adherent culture system'], ['10 G that', 'neurotrophic  factor'], ['like  colonies', 'weeks testis tissue'], ['like  cells', 'reverse germ cell alpha'], ['statistical  significance', 'one way variance'], ['We', 'like  G'], ['Immunocytochemistry flow cytometry', 'confirmed germ cell cells'], ['like  we', 'significant  expression'], ['', '10 testis cells'], ['proliferative  activities', ''], ['like  colonies', ''], ['adherent culture system', 'like cell colonies'], ['', ''], ['activated  that', 'various cell types'], ['platelet  activation', 'gastric  cancer'], ['However  effects', 'gastric cancer cell'], ['aim', 'gastric  cancer'], ['', ''], ['We', 'modified MTS assay'], ['', ''], ['S1P2', 'four cell lines'], ['significant  expression', 'S1P4'], ['dominantly  effect', 'potently pertussis toxin'], ['significantly  that', 'S1P2'], ['balance', 'gastric cancer S1P'], ['three cell effects', 'three cell lines'], ['transient Akt that', 'weak  proliferation'], ['', ''], ['therapeutic  interventions', 'gastric S1P cancer'], ['', ''], ['rights', ''], ['paper', 'new delta control loop'], ['it', 'power microcontroller units'], ['digital Sigma delta that', 'neuronal signal amplitude'], ['detector', 'combined  optogenetics'], ['system', 'transgenic vivo ChannelRhodospin'], ['proposed AP detector', 'detected data reduction APs'], ['proposed thresholding detector', 'more  resource'], ['', ''], ['', 'spinal cord injury'], ['', 'low  concentrations'], ['authors', 'soon kappa B SCI'], ['', ''], ['spinal  cords', 'activated NF kappa B'], ['15 eNOS activity', '15  minutes'], ['', ''], ['15 control 0', '15 control SCI'], ['', ''], ['kappa B levels', '15  injury'], ['hour kappa B activation', ''], ['NOS messenger RNA', '24 hours postinjury'], ['NF kappa B', 'inside  lesion'], ['injured  neurons', 'soon NF kappa injury'], ['', ''], ['kappa B eNOS', 'spinal  cord'], ['Neurons', 'spinal  cord'], ['Spinal cord injury', 'effective  treatments'], ['polyphenolic  compound', 'neurodegenerative  diseases'], ['explicit  effect', 'SCI'], ['downstream protein protein', 'key energy resistance'], ['we', 'AMPK pathway autophagy'], ['spinal cord contusion model', 'SCI recovery'], ['Rats', 'immediately  contusion'], ['BBB Basso scores', 'injured  resveratrol'], ['resveratrol HE treatment', 'treated lesion animals'], ['Spinal cord tissue', 'AMPK pathway autophagy'], ['treated Beclin-1 expression', 'Cleaved Caspase-3 Caspase-9'], ['AMPK SIRT1 treatment', 'positive LC3-B cells'], ['that', 'neuroprotective SIRT1-AMPK signaling pathway'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['Nonaccidental head injury', 'spinal child abuse injury'], ['rare  incidence', 'nonaccidental head injury patients'], ['Epidural  hematomas', 'neurosurgical  intervention'], ['', 'epidural  hematoma'], ['authors', 'domestic child abuse'], ['patient', 'surgical clot evacuation'], ['', 'conservative repeat imaging patients'], ['', ''], ['', ''], ['Pacific Island Country', 'imported fossil fuel'], ['This', 'isolated  system'], ['technical  analysis', 'grid connected Tarawa power system'], ['Variations', 'short power output'], ['utility network', 'PowerFactoty software'], ['state  analyses', 'simulated  scenarios'], ['', 'high PV output'], ['', 'high output dispatch constraints'], ['current grid system', 'maximum PV load'], ['negative  ramps', 'low PV demand'], ['low  loads', '900  kW'], ['', ''], ['rights', ''], ['public health it', 'adolescent  students'], ['Therefore  study', 'adolescent suicidal students'], ['participants', 'depression'], ['adolescent  students', 'less suicidal others'], ['findings', 'adolescent suicidal students'], ['production', 'SPL7 Arabidopsis thaliana'], ['Little', 'regulated copper Arabidopsis'], ['Here  we', 'northern microarray blotting'], ['', 'also miR408 sucrose'], ['Furthermore  induction', 'SPL7'], ['MiR398  induction', 'high  copper'], ['sucrose  treatment', 'strongly copper accumulation'], ['low copper effect', 'high  sucrose'], ['regulated copper accumulation', 'Arabidopsis'], ['', ''], ['rights', ''], ['French football club clubs', 'foreign league investors'], ['Economic  politics', 'closed member associations'], ['public research that', 'further  attention'], ['authors', 'two England France 2014'], ['Results', 'European football clubs'], ['empirical  papers', 'private  investors'], ['studies', 'European rat football'], ['Nevertheless research gaps', 'appropriate  depth'], ['empirical  studies', 'private majority France'], ['future  research', 'additional continental Europe'], ['Finally  article', 'ownership research fields'], ['article', 'managerial club owners managers'], ['strontium SrTiO3', 'thermal research stability'], ['specific fuel cell which', 'fuel conversion efficiency'], ['it', 'short processing times'], ['we', 'mesoporous SrTiO3 SP'], ['surfactant concentration range', 'specific surface particles'], ['various calcination temperatures', 'unreacted  phase'], ['Finally SrTiO3 powder', '103 surface m(2)/g'], ['Rapid  identification', 'squid  interests'], ['isothermal  assays', 'jumbo'], ['', 'D'], ['COI c oxidase gene', 'specific  primers'], ['', '30 A degrees min'], ['visual SYBR I', 'Visual LAMP'], ['detection limits', 'purified  D'], ['', ''], ['', ''], ['', 'homogenized cephalopod mixtures'], ['methods', 'squid  products'], ['They', 'specificity high sensitivity time operation'], ['operational Flux Locked which', 'operational Flux Locked amplifier'], ['', 'flux transfer about'], ['', 'simple SQUID system'], ['We', 'Transient ElectroMagnetic Transient method'], ['SCRE', 'also system bandwidth'], ['difference', 'SCRE'], ['50  that', 'cellular  bacteria'], ['Salmonella enterica', 'broadly starvation stress response'], ['virulent enterica serovar Typhimurium', 'small RNA transcriptomes'], ['potentially sRNA SSR', 'starved log cells'], ['Importantly  expressions', 'select transcriptome candidates'], ['43  share', 'structural sequence conformations'], ['strongly SL1344 they', 'antisense base antisense pairing'], ['also  sRNAs', 'actually  thousands'], ['small  RNAs', 'diverse virulence bacteria'], ['in Pasteurellaceae analysis', 'considerable swine industry'], ['', 'A'], ['we', 'experimental  validation'], ['coding  strand', 'blotting RT PCR'], ['studied  10', 'before trans bacteria'], ['mRNA  many', 'gene regulatory gene network'], ['well  that', 'evolutionarily  A'], ['pleuropneumoniae', 'same  host'], ['combination', 'intricate gene A'], ['novel  that', 'further  studies'], ['Investigations', 'improved bioremediation strategies'], ['goal', 'aerobic benzene groundwater'], ['Benzene degradation', 'well chromatography mass spectrometry'], ['Stable  isotope', '13)Clabled community DNA'], ['', 'metabolizing microbial populations'], ['five', 'laboratory benzene'], ['degrading  organisms', 'identities SIP experiments'], ['Variovorax MAK3', 'hydroxylating benzene degradation'], ['Microcosm experiments', 'Vapar_5383 Variovorax gene'], ['Furthermore  addition', 'community benzene degradation'], ['rRNA  Variovorax', 'added  benzene'], ['how  convergence', 'microbial  communities'], ['human  presence', 'environmental cleanup efforts'], ['aerobic  biodegradation', 'many benzene decades'], ['Here  we', 'active benzene biodegradation'], ['bacterium representative', 'SIP'], ['attacks', 'occurring groundwater microbial community'], ['especially  that', 'bioremediation'], ['paper', 'new  Wheelchair'], ['', 'stair climbing ability'], ['wheelchair', 'triple wheels cluster architecture'], ['new  concept', 'previous improvement versions'], ['functional wheelchair ve', 'functional wheelchair stair'], ['particular  attention', 'stair climbing operation'], ['cam mechanism', 'locomotion unit rotation'], ['design methodology', 'cam profile'], ['cam dimensions', 'suitable pressure curvature'], ['', ''], ['rights', ''], ['main  focus', 'off Western Australia'], ['Existing power systems', 'global fossil fuels'], ['possible electricity supply systems', 'hybrid turbine photovoltaic system'], ['various  combinations', 'supply systems'], ['systems', 'supply system'], ['study', 'Australian demand market'], ['which', 'minimum  energy'], ['based  technique', 'suitable budget investment'], ['aim', 'present power electricity'], ['sensitivity analysis', 'selected  system'], ['', ''], ['rights', ''], ['opportunistic food that', 'severe  blood'], ['', ''], ['aureus', 'aquatic poultry products'], ['Accordingly  we', 'S'], ['', 'retail  China'], ['aquatic food samples', 'provincial  China'], ['results', '119  samples'], ['2 % 119/', '320  S'], ['', 'qualitative  analyses'], ['', 'contamination 78'], ['2  %', '0'], ['10 MPN/ g', '110 MPN/ g'], ['', '119  S'], ['aureus', 'antibiotic virulence resistance'], ['', ''], ['aureus isolates', 'multiplex polymerase chain reaction'], ['', ''], ['', ''], ['', 'aureus enterotoxin 53'], ['', ''], ['4  %', 'major  genes'], ['genes', 'major pvl hl'], ['', ''], ['disk diffusion results', 'high -lactams linezolid'], ['26 sequence types', 'novel multilocus sequence which'], ['', ''], ['', ''], ['4  %', ''], ['staphylococcal cassette chromosome all', 'which'], ['Isolates', 'high  prevalence'], ['aquatic  products', 'virulence genes'], ['', 'public health risk'], ['STs', 'genetic  S'], ['', 'basic  S'], ['', 'aquatic  products'], ['Staphylococcus aureus', 'facultative Staphylococcaceae family'], ['', 'recent alimentary S'], ['worldwide  which', 'public  health'], ['we', 'rapid detection S'], ['aureus', 'method biosensor disadvantages'], ['', 'future  S'], ['aureus detection methods', ''], ['article', 'based Human Services'], ['Staff', 'caregiver care receiver dyads'], ['Mailed  assessments', 'treatment treatment'], ['96', 'intervention'], ['treatment  effects', 'care receiver life'], ['', 'follow caregiver reactivity'], ['Caregivers', 'high  program'], ['STAR C', 'successfully  AAAs'], ['Recommendations', 'training recruitment'], ['Stabilizing', 'recent cationic years'], ['starch', 'hydrothermally fluorescent carbon gelatin'], ['introduction', 'ASA droplet emulsions'], ['sizing  performance', 'CD mass ratio'], ['SNC', '80 mass %'], ['Meanwhile  morphology', 'SNC UV excitation'], ['', ''], ['rights', ''], ['disorganization', 'particular starch retrogradation'], ['approach', 'subsequent model systems'], ['primary progress bottlenecks', ''], ['', ''], ['rights', ''], ['number', 'nodal childhood onset lymphoproliferation'], ['genetic  variants', 'specific  treatment'], ['Novel variants', 'specific  verification'], ['we', 'novel  STAT3'], ['clinical  that', 'STAT3 p'], ['', 'gain  variant'], ['digital  problem', 'one step delay'], ['It', ''], ['minimized step delay', 'superior  performance'], ['aliasing  sampling', 'turn turn IGBT'], ['total harmonics strategy', 'dominant feedback poles'], ['Simulation', 'experimental  scheme'], ['Ignition', 'industrial process safety'], ['different  types', 'such ignition gas'], ['classic brush discharge', 'flammable  613'], ['power', 'too brush ignition'], ['However  doubts', 'super brush discharges'], ['brush discharge', 'charged insulating object'], ['surface charge that', 'super brush discharge'], ['high charge density', 'individually tribo another'], ['who', 'enriched ignition atmospheres'], ['bulk polyethylene that', 'common  powder'], ['direct polyethylene MIE', 'ambient  conditions'], ['1 charge transfer', '1  m'], ['numerical  simulations', 'original surface charge industry'], ['', ''], ['', ''], ['rights', ''], ['simplified  method', 'monoatomic plasmas species'], ['Multicomponent gas systems', 'multiple ionization steps'], ['developed', 'statistical equilibrium physics'], ['Equilibrium concentrations', 'electronic energy levels'], ['functions', 'entropy  maximum'], ['unknown  systems', 'normalization conditions'], ['one equilibrium temperature', 'one algebraic equation'], ['Numeral  method', 'equation'], ['second order ionization', 'when chemical gas'], ['', ''], ['', ''], ['rights', ''], ['so system it', 'critical  emissions'], ['otherwise electricity they', 'pollution'], ['life cycle analysis', 'same coal power plant'], ['conservation CCPP which', 'conservation CCPP system'], ['mathematical programming formulation', 'then optimal scheduling'], ['It', 'changing electricity prices'], ['19 electricity that', 'dynamically price profile'], ['also  emissions', 'by  gases'], ['paper', 'emission cost'], ['Stem cell therapy', 'myocardial cell infarction'], ['cardiac  function', 'based  therapy'], ['functional survival rate which', 'regenerative  medicine'], ['new cell types', 'local cell retention'], ['New  strategies', 'therapeutic cell transplantation'], ['recent  that', 'clinical  settings'], ['dental Surface implants', 'strongly  osseointegration'], ['present  we', 'osteoblastic Pulp Stem Cells'], ['extracellular adhesion molecules production', 'molecular biology analyses'], ['safety', 'analysis Ames test'], ['starting', 'strong cell adhesion molecules'], ['1 Cell Adhesion factor', 'angiogenesis'], ['opposition', 'African Americans'], ['they', 'Black  recipients'], ['We', 'mental welfare recipients'], ['1  we', 'mental welfare recipients'], ['average welfare recipient image', 'more welfare recipients'], ['they', 'welfare welfare Study'], ['Participants', 'welfare recipient image'], ['mental  images', 'welfare policies'], ['voluntary motor that', 'unstable  system'], ['seated time delay', 'seated expert stick balancers'], ['shortest  that', '240  s'], ['', '32  0'], ['', 'saggital displacement plane'], ['switching balance which', 'sensory time movements'], ['feedback gains', 'stability'], ['corrective  forces', 'fingertip'], ['stick balancers', 'quick  manoeuvrability'], ['understanding', 'naval  industries'], ['internal  frame', 'mechanical point force'], ['less  attention', 'experimental  statement'], ['why  paper', 'internal radiation frames'], ['experimental  process', 'laser vibrometer shell'], ['transform', 'vibratory wavenumber domain'], ['estimating', 'stationary  phase'], ['increase', 'low radiation frequencies'], ['Analysis', 'circumferential radiation efficiency'], ['', ''], ['rights', ''], ['where scenario we', 'convergence'], ['We', 'desegregated trade versions'], ['we', 'furthest  tree'], ['first stage that', 'drastically  iteration'], ['first stage variables', 'further  stages'], ['stage  we', 'significant CPU iterations'], ['', 'ring bioinformatics GCRG123'], ['situ  hybridization', 'gastric type mucosa'], ['Northern  blotting', 'ring cell carcinoma'], ['Online software', 'bioinformatics analysis'], ['UCSC Santa databases', 'analyses'], ['blue hybridization precipitates', 'cytoplasm'], ['Ten', 'high GCRG123 expression'], ['Low GCRG123 expression', 'intestinal type adenocarcinoma'], ['GCRG123', 'intestinal type adenocarcinoma tissue'], ['GCRG123 sequence', 'nuclear element retrotransposons'], ['GCRG123', 'chromosomes'], ['GCRG123', '5 factor IX genes'], ['active  member', 'ring cell carcinoma'], ['', ''], ['rights', ''], ['little  information', 'how  patients'], ['Prednisolone', 'infection'], ['We', 'clinical risk SAH'], ['We', 'day  SAH'], ['547  546', 'pentoxifylline'], ['trial', '2011 United February'], ['Data', '90  days'], ['Patients', 'clinical  criteria'], ['separately  patients', 'logistic  regression'], ['Pretreatment blood levels', '731  patients'], ['89  patients', 'treatment'], ['', 'serious pentoxifylline infection'], ['', '084  treatment'], ['', 'treatment'], ['', ''], ['Infections', 'more  prednisolone'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'prednisolone treatment'], ['', ''], ['', ''], ['', ''], ['', ''], ['higher  proportion', '10  prednisolone'], ['', ''], ['', ''], ['', ''], ['', ''], ['Development', 'independent stage liver disease'], ['', ''], ['', ''], ['', ''], ['', ''], ['predicted  that', '7 Stage Liver Disease'], ['', ''], ['', ''], ['', ''], ['', ''], ['who', '90-day prednisolone mortality'], ['', ''], ['', ''], ['', ''], ['', 'OR'], ['', ''], ['', ''], ['', ''], ['', ''], ['serious  which', 'therapeutic  benefit'], ['high  data', 'SAH'], ['', ''], ['solitons', 'waveguide wave parameter elasticity'], ['experimental strain solitons verification', 'available constants polymers'], ['dramatic  improvement', 'solitary wave observation'], ['high speed registration us', 'proper strain soliton accuracy'], ['initial waveguide power', 'single  soliton'], ['', ''], ['', ''], ['rights', ''], ['structural  deformations', 'active  sites'], ['dynamical  experiments', ''], ['more  limited', 'dynamical  analysis'], ['Underused', 'local protein analysis deformations'], ['We', 'crystal NMR structure ensembles'], ['', 'binding shears show sites'], ['deformations', 'allosteric ligand sites'], ['allosteric  that', 'widespread  allostery'], ['particularly  shear', 'local protein deformations'], ['analysis', 'many  proteins'], ['spatial  vision', 'outer Greater Copenhagen Area'], ['paper', 'national policy agenda'], ['paper', 'spatial  planning'], ['', ''], ['Several Streptococcus pneumoniae proteins', 'vaccine targets'], ['acquired  antibodies', 'antigenic  variant'], ['', ''], ['days serum collection', 'genomic antigen data'], ['We', 'particular antigen variant'], ['', ''], ['Antibody titers', 'pediatric  adults'], ['PspC  variants', 'more  variants'], ['', 'specific IgG colonization'], ['', ''], ['We', '1 antibody protein'], ['Further  assessment', 'mediated vaccine development'], ['Streptomyces genetics', 'positive bacteria Streptomyces'], ['course', 'secondary phenol precipitation strains'], ['Thus  course', 'microbiology molecular microbiology biology'], ['students', 'genes proteins'], ['', 'International Biochemistry'], ['Primer  extension', 'major extension products'], ['different extension products', 'null primer rpsO'], ['putative transcription start sites', 'possible promoter sequences'], ['putative  promoters', 'based promoter probe vector'], ['', 'pIPP2 S'], ['cloned  fragments', 'promoter vivo'], ['activities', 'four  S'], ['three factor mutant three', 'promoters'], ['levels', 'relatively rpsO pnp S'], ['molar coelicolor levels', 'considerably  rpsO'], ['PNPase', 'cold shock S'], ['coelicolor', '30 PNPase degrees'], ['', ''], ['', ''], ['rights', ''], ['stress protein response', 'eccentric  humans'], ['healthy  males', 'eccentric quadriceps muscle'], ['Biopsies', '8 168 exercise'], ['Cellular alpha B crystallin', 'immunohistochemistry ELISA technique'], ['mRNA  levels', 'Northern alpha B blotting'], ['8  %', 'strong HSP27 staining'], ['that', 'following  week'], ['alpha B Crystallin', 'HSP27'], ['30 ELISA analysis', 'cytosolic HSP27 fraction'], ['Western  blotting', 'myofibrillar HSP27 fraction'], ['', ''], ['37  %', '24 control exercise'], ['', ''], ['bound  HSP70', '10-fold  P'], ['', 'strong cross sections'], ['mRNA  levels', 'day alpha B exercise'], ['HSP70 mRNA', '8  h'], ['HSP27', 'myofibrillar myofibrillar structures'], ['HSP70  HSPs', 'high force exercise'], ['related  growth', 'affective  stressors'], ['reporting', 'day adaptation basis'], ['Participants', 'consecutive questionnaire days'], ['individual stress differences', 'daily mother child day'], ['study', 'related  adolescence'], ['digital control it', 'high control performance'], ['such time slots', 'different  tasks'], ['periodic time them', 'periodic time tasks'], ['we', 'above  problem'], ['method', 'feasible start time configurations'], ['Finally  we', 'proposed  method'], ['', ''], ['', ''], ['rights', ''], ['large tea estate', 'increased  wages'], ['They', 'massive tea halt'], ['which', 'affiliated tea plantation unions'], ['community radio strike', 'informal  India'], ['broader class identity', 'global  south'], ['when  workers', 'political  action'], ['we', 'bilateral brain damage'], ['later  she', 'ischemic  stroke'], ['she', 'bilateral  insula'], ['However  she', 'sensory attention memory perception'], ['', ''], ['', ''], ['', ''], ['', 'facial emotion recognition'], ['functional  integrity', 'real life tasks'], ['straightforward  extent', 'multidimensional  deficits'], ['potential  case', 'current brain organization'], ['Carbon monoxide', 'nitric  oxide'], ['', 'cerebral heme protein'], ['expression', 'blotting RT PCR'], ['1  immunoreactivity', 'astroglial  cells'], ['', 'striatal glia cells'], ['expression', 'still HO-1 day'], ['expression', 'quantitative RT PCR'], ['mRNA transcription', 'hour  occlusion'], ['6  expression', '7 hours occlusion'], ['operated HO activity', 'operated  group'], ['induction', 'ischemic HO-1 damage'], ['recent  approaches', 'social  cognition'], ['Here  we', 'such  domains'], ['magnetic resonance imaging areas', 'three  systems'], ['level', 'anterior Kernel Density regions'], ['orbitofrontal  frontal', 'subcortical  structures'], ['Second  we', 'temporal fronto damage'], ['Relative', 'cognitive  functions'], ['results', 'frontotemporal interoception emotion'], ['', ''], ['rights', ''], ['Radiological  features', 'long child abuse'], ['', 'vulnerable  child'], ['Four torsional loading tests', 'physiological strain rates'], ['oblique  patterns', 'linearly  cases'], ['results', 'four point bending'], ['spiral torsional fractures', 'significant  energy'], ['only  that', 'higher loading types'], ['history', 'child'], ['biological  studies', 'cells'], ['We', 'Kiviet et al'], ['', '15'], ['rate', 'one  another'], ['biological  we', 'here  states'], ['Malthus we', 'also literature fitness'], ['it', 'exponential growth population'], ['well  maintenance', 'such energy intake'], ['leptin orexin which', 'behavioral energy states'], ['', 'chronic orexin A'], ['', ''], ['leptin', 'distinct Mesocricetus depression'], ['Treatment', 'notable  reduction'], ['stressed body that', 'evident  p'], ['', 'light dark box test'], ['anxiogenic  that', 'LEP'], ['cerebral cortex which', 'dependent  effects'], ['like ORX A which', 'related obesity states'], ['Composing  queries', ''], ['typically graph schemas', 'too query formulation'], ['', 'less research attention'], ['we', 'novel subgraph query autocompletion'], ['initial AutoG returns', 'query output'], ['Users', 'AutoG  queries'], ['First  we', 'query composition'], ['prime  that', 'c prime ways'], ['Third  we', 'candidate suggestions'], ['Fourth  we', 'Dag  ranking'], ['We', 'extensive performance evaluation'], ['40 mouse AutoG', 'large parameter settings'], ['', 'Norwegian health employees'], ['Learned response outcome expectancies', 'important  health'], ['how work conditions', 'influence health'], ['Method survey', 'municipal  employees'], ['', ''], ['', ''], ['', 'controlled % trial'], ['sectional  study', 'baseline  data'], ['logistic regression analysis', ''], ['number', 'SHC'], ['high  number', 'significant  anxiety'], ['', ''], ['', 'anxiety'], ['', ''], ['negative response outcome expectancies', 'significant  depression'], ['', 'anxiety'], ['', ''], ['variance', '41 comorbid anxiety'], ['negative response outcome expectancies', 'anxiety'], ['strongest  association', 'SHC'], ['it', 'SHC'], ['workplace interventions', 'response outcome expectancies'], ['different  subgroups', 'studied MFE variables'], ['', 'dwelling  age'], ['', ''], ['', 'cognitive  impairment'], ['', ''], ['', 'daily Associates Learning'], ['', ''], ['different  dimensions', 'strongly RBMT PAL SMC'], ['SMC predictors', 'effect size'], ['low MFE group', 'GDS age'], ['MFE score', 'variable'], ['SMC', 'lesser health memory'], ['fewer  these', 'depressive  symptomatology'], ['More  SMC', 'depression poor health perception'], ['', ''], ['rights', ''], ['respiratory  that', 'efficacy'], ['Several  formulations', 'allergic  rhinitis'], ['', '3 treatment years'], ['Ragweed pollen tablets', '26 medication %'], ['dust mite tablets', '1 AR 17'], ['', ''], ['', '1 treatment year'], ['different dust mite tablet', 'standardized asthma placebo'], ['', ''], ['', ''], ['', ''], ['adverse  events', 'severity'], ['effective  doses', '1'], ['', 'major mu allergen(s'], ['arbitrary  assays', 'allergen content'], ['Thus  results', 'other  products'], ['Clinical Management Review', 'respiratory  disease'], ['', '2016 Allergy Asthma'], ['', ''], ['inhalant  safety', 'adverse  events'], ['ever  episodes', 'anaphylaxis'], ['adverse  events', 'administration'], ['specific grading system', 'adverse World Allergy events'], ['', 'oral food immunotherapy'], ['adverse  events', 'inhalant  allergens'], ['We', 'declared sample size calculation'], ['Regulatory Activities nomenclature', 'regulatory  agencies'], ['classification  grading', 'adverse  SLIT'], ['', '2016 Allergy Asthma'], ['Allergen immunotherapy', 'allergic  diseases'], ['Sublingual immunotherapy', 'recently United States'], ['Food  Administration', 'allergic  conjunctivitis'], ['', 'polysensitized United States'], ['polysensitized  patient', ''], ['Polysensitization', 'specific IgE testing'], ['Polyallergy', '2  allergens'], ['we', 'polyallergic United SLIT'], ['', '2016 Allergy Asthma'], ['recent  upsurge', 'outstanding energy structure'], ['further PV state', 'fiscal subsidy policies'], ['', 'fiscal subsidy revenue'], ['They', 'many impact factors'], ['distributed calculation which', 'big data mining PSO'], ['duration retail electricity tariff', 'greatest  impacts'], ['study', 'distributed PV projects'], ['', ''], ['rights', ''], ['new  which', 'new  towns'], ['New towns', 'contemporary accumulation regime'], ['new capital towns', 'simultaneously  circuits'], ['municipal  governments', 'metropolitan  structure'], ['Underlying', 'developing investment countries'], ['adjuvant  therapies', 'affective spectrum disorders'], ['However  effects', 'autonomic Sudarshan Kriya population'], ['CAC', 'anxiety depression disorders'], ['Forty six Forty patients', '15 DSM days'], ['Anxiety  levels', 'quantitative  questionnaires'], ['', 'spectral  analysis'], ['we', 'only Treatment group'], ['parasympathetic  modulation', 'significantly Control group'], ['Intensive breathing training', 'depressive SKY disorders'], ['SKY training', 'cardiovascular anxiety/ depression disorders'], ['past  Thailand', 'increasing energy farmers'], ['biophysical sugarcane cultivation factors', 'sugarcane farms'], ['Primary  information', 'structured farm questionnaire'], ['Relevant policy documents', 'secondary policy analysis'], ['sugarcane', 'more  rice'], ['eight regression variables', 'positively sugarcane farms'], ['These', 'sugarcane farming'], ['landholding  majority', 'food security'], ['', 'concerned sugarcane farmers'], ['particularly  who', 'such  services'], ['only suicidal who', 'suicide'], ['We', '3 sex ratio female'], ['age male', '44'], ['', ''], ['1 age male', '30 sex ratio female'], ['', ''], ['comprehensive DSM-4 Axis II', 'Coping Checklist'], ['Several  differences', 'such personality strategies'], ['', ''], ['', ''], ['Personality', 'useful suicidal risk'], ['clinicians', 'when suicidal patients'], ['deficient serotonin which', 'environmental architecture factors'], ['alternative variants rs4819035', 'psychiatric suicide patients'], ['TPH2 rs4290270', 'depressive disorder bipolar disorder'], ['Genotyping data', 'previous ADARB1 study'], ['age', 'Early Inventory Self Report'], ['Generalized linear models', 'psychiatric diagnoses covariates'], ['Childhood general traumas', 'independently suicide attempt'], ['general TT homozygotes', 'increased suicide attempt'], ['suicide who', 'general TT rs4819035'], ['risk', 'TPH2 childhood variants'], ['increased suicide this', 'increased suicide ideation'], ['child who', 'suicide ideation'], ['', 'based Community Health Survey'], ['based  survey', 'mental International Diagnostic illness'], ['who', 'child abuse'], ['increased child abuse', '1'], ['', ''], ['', ''], ['', 'suicide attempts'], ['Most  who', 'experience child abuse'], ['Adopting', 'suicide risk prevention'], ['types', 'suicide attempts'], ['However  association', 'suicidal behavior occurrence'], ['We', 'isolated suicidal behavior severity'], ['ever Suicidal Behavior', 'ever  yourself'], ['', 'serious suicide attempts'], ['', ''], ['', ''], ['', ''], ['We', 'sexual suicide attempts'], ['meaningful  trend', 'physical  abuse'], ['group ideators EA', '95th suicide percentile'], ['', ''], ['', ''], ['', ''], ['We', 'meaningful  EN'], ['when  it', 'relevant  ideation'], ['', ''], ['rights', ''], ['objective', 'validated Afghanistan era instruments'], ['expected  CUD', 'current suicidal ideation'], ['', ''], ['', ''], ['', ''], ['sex posttraumatic disorder depression alcohol', 'abuse combat exposure'], ['significant Afghanistan era limitation', 'present  study'], ['complex  relationship', 'present suicidal time'], ['', 'Elsevier Ltd'], ['specific adult who', 'screen suicide assessment'], ['controlling Thought Control participants', 'punishment reappraisal concealment'], ['thought control questionnaire', 'original factor measure'], ['negatively self punishment', 'positively suicide ideation'], ['Clinical  implications', ''], ['', ''], ['rights', ''], ['Brassica napus', 'developmental  age'], ['whilst  phosphate', 'old  leaves'], ['variable tissue sulfate roots', 'oldest  leaves'], ['unaffected  concentrations', 'oldest  leaves'], ['Expression', 'respective transporter gene tissues'], ['where S expression', 'greatest  roots'], ['A]311389 accession transporters', 'small S deprivation'], ['alone sulfur 4;2', 'observed tissue sulfate concentrations'], ['Expression patterns', 'regulated gene expression'], ['supplemental electron which', 'significant treatment facilities'], ['inorganic sulfur compounds', 'such  sulfide'], ['well electron it', 'low denitrification solubility'], ['which', 'simple combustion process'], ['', 'higher denitrification rates'], ['very  little', 'microbial  denitrification'], ['strong  that', 'toxic  microorganisms'], ['', 'potential chemistry microbiology denitrification'], ['energetic electron it', '-oxidizing community'], ['own lab that', 'effectively electron denitrification'], ['Further  research', 'nitrous  oxide'], ['effect', 'sludge settling efficiency'], ['serious sewer cost', 'problems'], ['Understanding', 'sediment problems'], ['reaction mechanisms', 'situ microelectrode measurements'], ['profile', 'various sediment biofilm'], ['biological  distribution', 'sulfide sediment biofilm'], ['biological sediment techniques', 'future sediment studies'], ['grapevine berry veraison', 'notable  water'], ['significantly gibberellic which', 'commercial berry size'], ['water transport', 'phloem'], ['This', 'possible cell membranes'], ['complementary  approaches', 'aquaporin genes'], ['', 'Northern  blotting'], ['Results', 'lower expression difference'], ['again TIP gene results', 'hormonal  treatment'], ['In', 'GA(3)-treated expression plants'], ['Microarray hybridizations', 'different aquaporin family'], ['when reproducibility one', 'lowest aquaporin genes expression'], ['powerful frequency it', 'pricy hardware'], ['Here  we', 'negative measurement feedback'], ['theory', 'commercial % supercapacitor'], ['test campaign', 'Large Hadron Collider'], ['finite element that', 'magnets'], ['Particular  attention', 'different magnet materials'], ['highly test moduli', 'situ heat cycles'], ['SQUID quantum interference magnetometers', 'shielded  room'], ['large McCumber parameter which', 'additional readout electronics'], ['SQUID transfer magnetometers', 'about noise 5'], ['', ''], ['', 'when  MSR'], ['36 sensing magnetometers', '15 software gradiometer configurations'], ['coverage area', '36 sensing magnetometers'], ['MCG measurements', 'developed  system'], ['destabilizing  effects', 'green enzyme biocatalysis'], ['such enzyme we', 'supercritical protein stabilization condition'], ['Lysine groups', 'new protein solvent'], ['We', 'structural enzyme modifications'], ['Different  modifications', 'model enzyme'], ['acetylated CALB enzyme', '300  K'], ['high lysine which', 'aqueous  solution'], ['However  acetylation', 'supercritical  CO2'], ['contrast methylation', 'supercritical  CO2'], ['Phosphate groups', 'inappropriate enzyme conformation'], ['modification', 'so surface arginine enzyme'], ['finding', 'direct lysine carbamates'], ['new  exploration', 'catalyzed enzyme scCO(2'], ['', ''], ['', ''], ['rights', ''], ['Induction', 'heavy gene metals'], ['inhibition', 'five protein superinduction'], ['Finally  they', 'fractal fracture 2008'], ['Accordingly  estimation', 'maximum design strength f(d'], ['Also steel fiber effect', 'image analysis results'], ['Correlation matrix', 'significant  study'], ['2D image analysis', 'economic surface roughness characterization'], ['', ''], ['rights', ''], ['many research it', 'yet tyre road friction'], ['different rubber feasibility', 'customised roughness patterns'], ['stitching  algorithm', 'large friction experiments'], ['printed  topography', 'down replication 0'], ['', '5  wavelength'], ['Printed  samples', 'random process theory'], ['printed asphalt which', 'rougher asphalt specimen'], ['artificial geometries friction', 'Hurst exponent'], ['roll  that', 'fractal friction surface'], ['social child which', 'highly child humiliation'], ['however exploitation most', 'different child abuse cases'], ['Most', 'most child time'], ['hidden child that', 'effective policy formulation'], ['specific  that', 'specific  proteins'], ['present  study', 'hepatocellular carcinoma MHCC-97H cells'], ['Survivin  nanoliposomes', 'MHCC-97H cells'], ['Survivin expression', 'reverse polymerase chain reaction'], ['Cell viability', 'isothiocyanate propidium iodide'], ['Tumor growth', 'western survivin expression blotting'], ['this', 'significant MHCC-97H cells'], ['survivin nanoliposomes', 'associated MHCC-97H xenograft toxicity'], ['based delivery system', 'vivo studies'], ['well survivin suppression', 'cell apoptosis'], ['environmental  it', 'better accounting performance'], ['we', 'based biogas projects'], ['environmental  methodologies', 'environmental biogas project'], ['cost  flows', 'specific emergy embodiment'], ['environmental efficiency operation aspects', 'composited reduction emission profit'], ['biogas project', 'present  1'], ['', ''], ['total  cost', '5  years'], ['environmental load ratio', 'environmental sustainability load'], ['', ''], ['', ''], ['proposed sustainability accounting framework', 'economic biogas project'], ['', ''], ['rights', ''], ['Ammonia', 'high  CO2'], ['renewable  path', 'potential energy carrier'], ['study', 'renewable energy sources'], ['concept', 'Bosch Reactor ammonia synthesis'], ['air separator', 'pure  nitrogen'], ['SOE', 'high Haber Bosch reactor'], ['Aspen', 'plant'], ['SOE', '650 degrees C'], ['Ammonia production', 'equivalent power plants'], ['', ''], ['rights', ''], ['where  it', 'foot  disease'], ['SVD virus', 'subsequently Hong Kong'], ['it', 'former Germany Belgium 1980s'], ['SVD outbreaks', 'period'], ['almost  it', 'again  Netherlands'], ['again  it', 'such Belgium Spain Portugal'], ['SVD', 'isolated  Portugal'], ['new SVD outbreaks', 'European  country'], ['clinical  resemblance', 'reliable  identification'], ['diagnostic  tests', 'FMD'], ['portable  devices', 'FMDV  site'], ['competent laboratory services', 'originally  FMD'], ['predominantly  it', 'currently  SVD'], ['Therefore SVD chapter', 'Terrestrial January'], ['EU Reference Laboratory', 'financial  support'], ['notification requirements', 'January'], ['Transient gene expression', 'biotechnical gene manipulations'], ['', 'sweet fruit cherry'], ['', ''], ['', 'green marker gene'], ['We', 'protoplast PEG concentration'], ['when  tissue', 'enzymolysis 1'], ['', ''], ['', ''], ['', ''], ['18  h', 'protoplast  4'], ['', 'fresh  84'], ['', ''], ['when transformation protoplasts', '15 % min'], ['transient expression that', 'sweet biology cherry'], ['', ''], ['', ''], ['rights', ''], ['Sweetpotatoes', 'high food starch'], ['However  studies', 'molecular  crops'], ['we', '20 transcriptome analysis'], ['tuberous  roots', '2500 field PE125'], ['', ''], ['nucleotide  bases', ''], ['Following', '176167  transcripts'], ['KOG  unigenes', 'annotated  sequences'], ['sequence repeats sequence analyses', '8334 SSR unigenes'], ['KEGG analysis', 'carotenoid backbone biosynthesis pathways'], ['expressed  unigenes', 'Zhengshu'], ['expressed  unigenes', 'PCR'], ['genomic sweetpotato information', 'two sweetpotato which'], ['new sequence information', 'biological  research'], ['', ''], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['', 'weaned epidemic diarrhea virus'], ['factorial  design', 'experimental  diets'], ['old  pigs', '10 treatment group'], ['Pigs', 'solid floor pens'], ['days PEDV challenge', 'oral  gavage'], ['B that', 'B subtilis treatment'], ['', 'six treatment groups'], ['dynamic switching bias which', 'low power supply voltages'], ['OP amplifier', 'continuous switching operation'], ['It', '51 loop dB'], ['dynamic V which', 'telescopic OP amplifier'], ['high speed switching operation', 'inverting processing video 2'], ['output inaccuracy', 'below capacitor 1'], ['5  which', ''], ['inaccuracy', 'open loop gain'], ['operation principle', 'dual edge paper'], ['Based', 'dual edge modulation'], ['dynamical map behavior', 'dual edge detail'], ['voltage bifurcation diagram', 'bifurcation parameters'], ['bifurcation it', 'similar Hopf bifurcation phenomena'], ['different Hopf bifurcations', 'domain simulation waveforms'], ['different  shapes', 'two Poincare sections'], ['theoretical  eigenvalues', 'stable map evolutions'], ['input existence', 'two Hopf bifurcation phenomena'], ['where operation state', 'buck period'], ['authenticity', 'domain simulation waveforms'], ['equivalent series resistances', 'capacitor'], ['actual  circuit', 'software Psim'], ['comparison', 'theoretical  simulation'], ['theoretical  simulation', 'actual  circuit'], ['research results', 'dual edge modulation'], ['many power it', 'many  shortcomings'], ['low power it', 'significant  advantage'], ['versatile  advantages', 'MCU'], ['', 'hot  spots'], ['digital  we', 'digital structure systems'], ['', 'selected device selection'], ['paper', 'hardware surface design'], ['Most  animals', 'bacterial  symbionts'], ['Understanding', 'fundamental  immunology'], ['Hawaiian  bobtail', 'reproductive Vibrio system'], ['', ''], ['immune  cells', 'light  organ'], ['', 'V'], ['fischeri hemocytes', 'symbiotic nutrient V'], ['', ''], ['Hemocytes', 'pattern recognition receptors'], ['', 'V'], ['binding behavior gene symbiont', 'immune  function'], ['', 'bacterial ANG community'], ['', 'model host'], ['scolopes', 'binary system symbiosis'], ['immune organ cells', 'multiple  symbioses'], ['signals', 'symbols'], ['', ''], ['', ''], ['unsuspected communications that', 'unpredictable  entity'], ['order', 'three  roots'], ['ever  agent', 'explanation'], ['handling  that', 'unpredictable  disturbances'], ['clock agent', 'own tick communication'], ['third  root', 'molecular symbol biology'], ['symbol handling who', 'physical  measurements'], ['symbol handling we', 'cosmic  proof'], ['that', 'physics'], ['specific  implications', 'physics'], ['', ''], ['rights', ''], ['Impeccable  assessment', 'palliative  care'], ['study objectives', 'when PC proxy'], ['AQSA', 'numeric  scale'], ['Symptom scores', 'SA patients'], ['same  procedure', 'symptom proxy'], ['study', 'mean  46'], ['', ''], ['', '8  patients'], ['', ''], ['', '7  sitters'], ['', 'IB correlation patients'], ['', ''], ['', 'drowsiness'], ['', ''], ['', 'pain'], ['SA AQSA', 'positive  r'], ['', ''], ['', 'depression'], ['', ''], ['', 'vomiting'], ['IB former', 'SA'], ['it', 'actual  symptoms'], ['', 'current  fields'], ['digital design scheme', 'forward device choice'], ['', 'prototype'], ['experiment data', 'waveform  curve'], ['One cycle control strategy', ''], ['', 'using intelligence communication interface'], ['high  efficiency', '95  %'], ['synchronous rectification method', 'controlled LLC converters'], ['turn SR turn edges', 'efficiency'], ['current  prevention', 'digital control capabilities'], ['analog SR control method', 'higher system efficiency'], ['control method', 'digital power controller'], ['attachment quality', 'social  situations'], ['tracking  they', 'two parent characters'], ['We', 'two fixation animations'], ['infant attachment disorganization', 'final infant mother reunion'], ['more baby infants', 'parent character'], ['mothers', 'same  character'], ['attentional  representations', 'emotional  experiences'], ['paper', 'operational  amplifier'], ['radiation effects', 'beam gamma ray'], ['characterateristics', 'different experiment results'], ['OP07', 'neutron  irradiation'], ['bipolar  transistor', 'operational radiation amplifier'], ['series', 'different radiation environments'], ['geometric  model', 'bipolar radiation components'], ['effect', 'bipolar radiation transistors'], ['simulated  results', 'experimental  data'], ['radiation effects', 'TID ionizing effects'], ['TID effect', 'displacement damage'], ['synergistic  effect', 'complex radiation environments'], ['', 'C Elsevier B'], ['', ''], ['chemical chemical synthesis', 'fundamental  contribution'], ['poorly  it', 'biochemical  experiments'], ['We', '107-amino acid proline model'], ['We', 'several chemical ligation milligrams'], ['properly  we', 'tridimensional ray diffraction'], ['refolded  enzyme', 'wild type enzyme'], ['whole  we', 'exotic N terminus'], ['Surprisingly  none', 'corresponding  mutants'], ['exotic amino that', 'complete chemical synthesis'], ['growing  prevalence', 'new antimicrobial therapeutics'], ['diagnostic  measures', 'therapeutic  resistance'], ['Discovery platforms', 'novel antimicrobial agents'], ['synthetic engineering that', 'broad spectrum antibiotics'], ['targeted antimicrobial that', 'derived  principles'], ['Further  development', 'diagnostic biology purposes'], ['synthetic biology platform that', 'new antimicrobial therapies diagnostics'], ['', ''], ['', ''], ['rights', ''], ['focus', 'edible stoichiometric hydrodeoxygenation reactions'], ['methodology', 'composition distribution hydrogen consumption'], ['hydrogen gas', 'camelina carinata'], ['yield', 'liquefied fatty acid composition'], ['hydrogen consumption rate', 'incoming bond unsaturation'], ['Thermal energy demand', ''], ['', 'when tonne 5'], ['', ''], ['GJ  tonne', 'additional oil extraction'], ['Electricity demand', 'kWh tonne carinata'], ['', ''], ['rights', ''], ['It', 'infected  individuals'], ['We', '6 baseline therapy'], ['total', 'infected latent study'], ['', 'infected control group groups'], ['level', 'uninfected PSS 25'], ['', ''], ['', ''], ['', '2'], ['', ''], ['', ''], ['', ''], ['', ''], ['uninfected PSS MIP-1b', 'controls'], ['IL-10  levels', '6  PSS'], ['PSS', 'such  IL-10'], ['increase', 'uninfected  individuals'], ['immunological  that', 'infected  individuals'], ['where controller parameters', 'specifically  application'], ['paper', 'conventional frequency response analyzer'], ['Nonlinearities', 'accurate converter parameters'], ['proposed  method', 'controlled V in=12V V'], ['', 'bulk capacitor scenarios'], ['', 'rapid  tuberculosis'], ['detectable chain reaction product', 'bacillary value C burden'], ['', 'individual data meta analysis'], ['Studies', 'systematic C T review'], ['characteristic level curves', 'smear culture'], ['', 'systematic  review'], ['1212 level patients', 'respiratory Xpert sample'], ['ROC analysis', '0'], ['', ''], ['', ''], ['', ''], ['', 'Cut C T 27'], ['', ''], ['8', 'positive  samples'], ['Xpert CT values', ''], ['', 'cut C T 27'], ['', ''], ['8', 'smear'], ['compare', 'microscopy  infectiousness'], ['Craniofacial bone defects', 'maxillofacial  years'], ['', 'genetic delivery disorders'], ['Electronic  searching', 'included hand articles'], ['Nolanguage', ''], ['Meta analysis', 'maxillofacial gene defects'], ['2081  57', '1726  animals'], ['morphogenetic  proteins', 'commonly gene therapy'], ['Viral  vectors', ''], ['Sprague Dawley rats', 'experimental animal studies'], ['quality', 'articles'], ['21  defects', 'gene therapy'], ['Funnel plot', 'publication bias'], ['innovative  that', 'oral gene structures'], ['Child abuse', 'increased childhood offspring'], ['objective', 'controlled child abuse'], ['PsychINFO Web Sociological Abstracts', 'systematically hand search'], ['review', 'high  risk'], ['', 'child protective child services'], ['few risk RCTs', 'high risk families'], ['significant child findings', 'significant child abuse'], ['middle income countries', ''], ['', ''], ['', 'Elsevier Ltd'], ['long prototyping system', 'physical laboratory experiments'], ['emulation', 'complete  system'], ['paper', 'microfluidic SystemC AMS extensions'], ['use', 'external microfluidic digital'], ['whole Chip it', 'digital  control'], ['electromechanical CA701 project they', 'system'], ['that', 'fluidic  system'], ['Two  approaches', 'numerically Smoothed Particle approach'], ['modeling', 'Data Flow SystemC AMS'], ['', ''], ['', ''], ['rights', ''], ['study', 'philosophical reductionism antireductionism'], ['Development', 'biological systems science'], ['Systems biology', 'three  phases'], ['molecular  biology', 'systems molecular systems biology'], ['', 'systems mathematical systems biology'], ['molecular  biology', 'biological  data'], ['successful science process', 'modern systems biology'], ['molecular  views', 'completely  other'], ['Implications', 'reductionist antireductionist debate'], ['analysis', 'epistemological systems antireductionism'], ['methodological  antireductionism', 'systems biology'], ['epistemological  antireductionism', ''], ['', ''], ['', 'Elsevier B'], ['', ''], ['', 'King Saud University'], ['This', 'open NC ND license'], ['Pulse Width Modulation', 'elementary power switch'], ['Hence  it', 'integral  Chips'], ['It', 'broadly power converters'], ['principal  focus', 'based DC Buck SoC'], ['switching control which', 'switching control circuit'], ['coding', 'Xilinx XST'], ['Behavioral  simulation', 'ModelSim'], ['Also power analysis', 'XPower Analyzer'], ['it', '3AN FPGA board'], ['rapid  expansion', 'sufficient  patients'], ['massive  cells', 'induced cell death'], ['independent cognate which', 'reactive oxygen species'], ['transduced T that', 'programmed TCR restimulation'], ['central T EM subset', 'necrotic electron microscopy'], ['interacting  that', 'also T EM fraction'], ['Further T EM cells', 'necroptotic TCR restimulation'], ['pretreated reactive T cells', 'established murine melanoma B16-F10'], ['outcome', 'tumor reactive T immunotherapy'], ['prophylactic  vaccines', 'viral herpes simplex recurrences'], ['even CD8 T evidence', 'immune animal responses'], ['tegument protein we', 'inactivated virus vaccine'], ['We', 'receptor  vivo'], ['CpG  oligodeoxynucleotide', 'neutralizing monophosphoryl lipid A'], ['We', 'NAbs guinea pigs'], ['immunological  responses', 'undetectable dorsal root levels'], ['preclinical prophylactic HSV-2 that', 'elevated T cell responses'], ['IMPORTANCE Millions', 'clinical herpes simplex trials'], ['neutralizing antibody response', 'natural  infection'], ['Individuals', 'symptomatic HSV-2 individuals'], ['novel T cell that', 'asymptomatic HSV-2 disease'], ['Additionally vaccine candidates', 'viral HSV-2 infection'], ['immune  response', 'T cell proliferation'], ['cytoplasmic m inhibitor', 'cytoplasmic calpain calpastatin Ca2'], ['constitutively  calpains', 'human  CD4(+'], ['calpain inhibition', 'multiple T cytokines'], ['mechanistic  reason', 'treated NF kappa cells'], ['calpain calpastatin system activity', 'antigenic human T challenge'], ['Engineered T cells', 'solid organ transplants'], ['However  field', 'still  infancy'], ['design', 'competing T cell groups'], ['Reliable  methods', 'T cell therapies'], ['', 'new FDA technologies'], ['Further  development', 'immunology synthetic biology manufacturing processes'], ['pathologists', 'emerging  field'], ['Immunity', 'intimately defense fitness'], ['Previous  studies', 'ecological  variability'], ['deterioration', 'alter immune alter functions'], ['aim', '6 Tachycineta yr'], ['We', 'killing  E'], ['', ''], ['We', 'agricultural  intensification'], ['where  individuals', 'nonintensive  farmlands'], ['6-yr  we', 'also  time'], ['We', 'agricultural eggshell clutch'], ['differences', 'other study system'], ['beta Glucosidase', 'efficient cellulase enzyme biomass'], ['Pseudomonas lutea BG8', 'important bioethanol production'], ['statistical -glucosidase Taguchi', 'submerged Box Behnken fermentation'], ['medium  composition', 'maximum -glucosidase production'], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'temperature'], ['optimized -glucosidase production', '9'], ['', ''], ['', ''], ['', '24IU shake flask'], ['tank bioreactor', 'higher -glucosidase production'], ['', ''], ['23IU  which', '23IU  incubation'], ['', 'higher flask studies'], ['', ''], ['5L', 'improved sugar release'], ['', ''], ['', '40 degrees saccharification'], ['', ''], ['lutea BG8', 'commercial saccharification efficiency'], ['', 'International Union International Biochemistry'], ['recent  tannase', 'potential  applications'], ['One', 'complex tannic tannins'], ['aim', 'dynamic culture medium'], ['extracellular tannase activity analysis', 'rot pini Fomes fomentarius'], ['inducible acyl hydrolase', '14  culturing'], ['Different  effects', 'fungal tannase strains'], ['rapeseed meal', 'best tannase P'], ['', ''], ['highest  concentrations', 'F'], ['', ''], ['', ''], ['', 'International Union International Biochemistry'], ['macroscopic drug students', 'school science level'], ['multisensory  teaching', 'visual  senses'], ['taste teaching', 'sensory  impairment'], ['guided inquiry that', 'substrate drug design'], ['findings', 'biochemistry student design'], ['', 'International Biochemistry'], ['We', 'Danio rerio D'], ['rerio  Transposon', 'Tc1'], ['338-amino acid that', 'catalytic  domain'], ['available TRT elements', 'commonly  vertebrates'], ['TRT', 'subfamily Tc1 family'], ['TRT', 'current  species'], ['activity', '4 TRT Ma'], ['widespread  distribution', 'probably bony snakes'], ['Finally  mechanisms', 'horizontal TRT elements'], ['T cells', 'different  doses'], ['Previous  attempts', 'canonical T cell signaling'], ['', 'different pMHC doses'], ['incoherent KPL that', 'observations'], ['KPL IFF model', 'correctly antigen copresentation'], ['cellular  that', 'biochemical  pathways'], ['tea consumption', 'related health life'], ['We', 'Chinese tea adults'], ['years  who', 'Geriatric Diseases study'], ['Information', 'Life-5 questionnaires'], ['relationship', 'logistic regression models'], ['EQ-5D index score', 'habitual tea counterparts'], ['', 'ED-5D tea drinking habits'], ['', ''], ['', ''], ['', ''], ['habitual tea drinking', 'EQ-5D dimensions mobility'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['associations', 'green  tea'], ['Habitual tea consumption', 'older  adults'], ['old distribution they', 'covered  ones'], ['all electricity companies', 'compact distribution outages'], ['Therefore  research', 'conventional distribution ones'], ['ATP results', 'three Newton Raphson method'], ['different  topologies', 'covered distribution cables'], ['efficiency', 'second  others'], ['eight WHO guidelines', 'eight vaccine day'], ['Mozambique routine immunization supply we', 'various supply circumstances'], ['annual price cost', '% health facilities'], ['electric health refrigerator', 'holdover outage'], ['solar health refrigerators', 'than health facilities'], ['two day outages', 'once health facilities'], ['study', 'WHO'], ['electrical  outages', 'electrical  refrigerators'], ['solar  refrigerators', 'solar refrigerator prices'], ['', 'C Elsevier Ltd'], ['20  years', 'availability internet'], ['', 'simultaneous child abuse images'], ['ease', 'key  offenders'], ['Technology', 'well child abuse offenders'], ['child abuse who', 'community'], ['Some', 'crime'], ['article', 'evidence each'], ['child sex none', 'child sex offenders'], ['', ''], ['Technology', 'child sex promise'], ['None', 'effective child sex offenders'], ['Offender managers', 'overly  them'], ['Robust  evaluations', 'offenders'], ['passive cooling systems', 'residual power safety'], ['passive  systems', 'driven density system'], ['weak driving which', 'negatively  safety'], ['such heat which', 'natural thermoelectric generator'], ['nuclear power concept', 'cooling  system'], ['temperature electricity', 'cooling  process'], ['Utility sector reform', 'developing  1980s'], ['many  pace', 'national  incumbent'], ['', 'fixed line system'], ['market market', 'market power'], ['public sector reform', 'reduced stakeholders consumers access'], ['experience', 'entrenched state interests'], ['However market that', 'cellular  international'], ['financial  this', 'essential monopoly TE'], ['evidence', 'staggered case competition'], ['inefficient market it', 'efficient  outsiders'], ['', ''], ['', 'Elsevier Ltd'], ['Telomerase activation', 'system  tumors'], ['that', 'enzymatic RNA activity'], ['We', 'recurrent CNS malignancies'], ['high ependymoma undergoing resection', '12  surgery'], ['Telomerase activity', 'fresh  surgery'], ['II study patients', '285  mg'], ['pharmacokinetic  studies', ''], ['evaluable  patients', 'one archival patient'], ['Forty two Forty patients', 'evaluable  toxicity'], ['grade 3/4 grade toxicities', 'thrombocytopenia'], ['', ''], ['', ''], ['', ''], ['', ''], ['Two  patients', 'premature study closure'], ['objective  responses', ''], ['Telomerase inhibition', '8 blood mononuclear days'], ['intratumoral target regimen', 'recurrent CNS tumors'], ['Telomeres', 'cellular genome senescence'], ['containing  that', 'nuclear  RNA'], ['precise  function', 'normal cell development'], ['nuclear TERRA which', 'characterized DNA damage'], ['chronic TERRA RNA', 'situ RNA hybridization'], ['RNA FISH', 'rapidly tumor cells'], ['developing TERRA aggregates', 'proliferating progenitor neurons'], ['purified proliferation signals', 'responsive TERRA tissue'], ['TERRA foci', 'promyelocytic mouse tumor tissue'], ['also  TERRA', 'human  cancers'], ['reflect', 'mammalian TERRA RNA cells'], ['Purpose Telomere length', ''], ['antioxidants', 'shortening'], ['oxidative  association', 'length'], ['We', 'representative US adults'], ['We', 'Health Examination Survey'], ['lutein alphacarotene beta zeaxanthin', 'high performance liquid chromatography'], ['leukocyte', 'T chain reaction method'], ['beta cryptoxanthin', 'longer  telomeres'], ['carotenoid beta length', '8  %'], ['increasing  levels', 'longer US adults'], ['High  intake', 'rich  length'], ['well parenting behaviors', 'adolescent  depression'], ['main  interplay', 'interest'], ['differential  susceptibility', 'temperamental  parenting'], ['differential susceptibility hypothesis', 'mostly  disorders'], ['', 'transactional vice process'], ['176  we', 'difficult self ages'], ['', 'well parenting age'], ['', '5 HOME inventory'], ['linear regression analysis', '11 temperament variable'], ['additionally  parenting', 'child temperament'], ['previously self control', 'depressive  symptoms'], ['', 'interactive  temperament'], ['However  effects', 'partly self control'], ['data', 'temperamental preadolescent depression'], ['parenting', 'regulative  temperament'], ['Evaluation technique', 'operational input bias currents'], ['technique', 'full operation temperature range'], ['Temperature', 'biomedical  systems'], ['important  which', 'respiratory  airflow'], ['paper', 'negative timing resistors'], ['circuit', 'unknown multivibrator output'], ['same system topology', 'respiratory  airflow'], ['performance', 'composite  system'], ['', 'approximately  +'], ['75  %', '30 temperature measurement'], ['', '60  LPM'], ['Better  results', 'computational interpolation cost'], ['complete  it', 'point sleep study'], ['sensory computing information', 'coded  trains'], ['design', 'few temporal years'], ['spike spike which', 'traditional rate encoding scheme'], ['we', 'spiking temporal encoder'], ['We', 'temporal  scales'], ['neural iteration that', 'proposed temporal encoder'], ['free error rate', 'low  level'], ['additional verification which', 'significantly encoding system'], ['neural analog hardware that', 'temporal encoding scheme'], ['simulation', 'proposed temporal encoder exhibits'], ['Spontaneous epileptiform activity', 'temporal lobe epilepsy'], ['synaptic  differences', 'spontaneous epileptiform activity occurrence'], ['Electrical  activity', 'sensitive dye fluorescence'], ['Sites', 'stimulation'], ['Following recordings slices', 'coronal unitary planes'], ['spatial  patterns', 'respective unitary slice'], ['directional  spread', 'lateral  LA'], ['differences', 'active LA slices'], ['', ''], ['evoked', 'functional input output relationship'], ['results', 'epileptic  slices'], ['lack', 'epileptic epileptiform neurons'], ['', ''], ['', 'Elsevier IBRO'], ['Social  bonds', 'essential  life'], ['numerous  factors', 'social  interactions'], ['Psychological  complications', 'social  information'], ['neuropsychological  deficits', 'social speed memory interactions'], ['We', 'temporal lobe epilepsy'], ['main emotion aspects', 'temporal lobe epilepsy'], ['Results', 'daily  life'], ['Furthermore  we', 'future  research'], ['future  research', 'comprehensive  epilepsy'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['representational action observation', 'automatic  others'], ['how  we', 'other  representations'], ['control', 'neural temporo parietal junction'], ['specific  role', 'shared  representations'], ['while action TPJ', 'irrelevant action B'], ['present  we', 'right temporo parietal junction'], ['We', 'primary conflict task'], ['irrelevant response effect', 'motor mirroring'], ['', 'instructed motor plan'], ['TPJ', 'relevant  representations'], ['typically muscle intensity', 'weather changes'], ['significantly  individual', 'ambient  temperature'], ['It', 'everyday  life'], ['study', 'facial weather changes'], ['masticatory muscle 87years', 'consecutive analogue days'], ['portable data which', 'atmospheric  pressure'], ['VAS scores', 'markedly  groups'], ['Pain VAS scores', 'migraine MH patients'], ['2 Pain cm', 'more MP group'], ['Perceived  intensity', 'positively MH group'], ['temporal pain that', 'different weather changes'], ['Central', 'ecological trade immunity'], ['cuticular that', 'fungus Metarhizium anisopliae'], ['two cuticular we', 'fungal  thickness'], ['essential amino acid', 'subsequently adult cuticular colouration'], ['when  they', 'architectural cuticular features'], ['Experimental  supplementation', 'specific darker adult manner'], ['However  it', 'immune  traits'], ['production', 'differential resistance sexes'], ['', ''], ['rights', ''], ['Invertebrate', 'growing  immunology'], ['phenomenon', 'specific  generations'], ['methylation', 'phenomenon'], ['beetle model we', 'methylated cytosine generations'], ['However  we', 'fungus Metarhizium anisopliae'], ['this', 'immune  generations'], ['Rice stripe virus', 'same grassy stunt reovirus'], ['tenuiviruses', 'capped RNA RRSV'], ['chimeric mRNA clones', '245 RRSV RGSV'], ['scenario', 'several end priming'], ['Interestingly  RSV', 'same RRSV RNA'], ['Combining', 'intrinsic  RSV'], ['', ''], ['rights', ''], ['', ''], ['', ''], ['Lauraceae', 'industrial pesticides food additives'], ['properties', 'monoterpenes'], ['', 'expressed fruit L'], ['', ''], ['Here  we', 'digital fruit L'], ['', ''], ['', '19354 expression genes'], ['Fruit', '75 90 105'], ['Pathway analysis', '26 terpenoid biosynthesis pathways'], ['Three  DEGs', 'increasing fruit development'], ['PCR  results', 'expressed  Illumina'], ['molecular fruit that', 'metabolic  L'], ['', ''], ['study', 'packed bed bioreactor'], ['nitrogen removal', 'hydraulic retention times'], ['results', '3 nitrate nitrogen h'], ['total nitrogen removal efficiency', '3-h  HRT'], ['low nitrogen removal efficiency', 'shorter  HRTs'], ['oxidizing  Eubacteria', '2'], ['', ''], ['', 'continuous  operation'], ['oxidizing  bacteria', '0'], ['', '2'], ['when  HRT', '3  h'], ['anammox bacteria', '30'], ['5  %', '3-h  HRT'], ['', 'efficiently SNAD PBR'], ['', ''], ['rights', ''], ['DNA that', 'genome'], ['Transposable elements', 'important  transposition'], ['approximately  half', 'Bombyx mori'], ['BmAGO2-associated  which', 'B'], ['mori', ''], ['Additionally  we', 'small  B'], ['', ''], ['transposon Bm1645', 'small RNA pool'], ['northern expression results', 'developmental BmN stages'], ['four TE siRNAs', 'dual luciferase reporter'], ['overexpression', 'four BmN BmAGO2'], ['small  that', 'expression'], ['', ''], ['Louis Dehner', 'testicular germ cell children'], ['review article', 'pathologic  lesions'], ['', 'Elsevier Inc'], ['aim', 'liver mice'], ['western blot analyses', 'major P450 isoforms'], ['Liver toxicity', 'histopathological serum analysis'], ['THB', 'Cyp1a2'], ['', ''], ['34', ''], ['', ''], ['', ''], ['24', ''], ['', ''], ['', ''], ['97', ''], ['mRNA THP', 'Cyp1a2'], ['', ''], ['12', ''], ['', ''], ['CYP2E1 mouse that', 'THP'], ['THB', 'oral serum aspartate transaminase'], ['pathological tissue changes', 'THP administration'], ['results', 'related drug drug interactions'], ['', ''], ['', ''], ['rights', ''], ['efficient Etch Virus that', 'NIa Nuclear enzyme'], ['27  that', '27  kDa'], ['Nowadays TEVp', 'cellular  studies'], ['number', 'different cleavage stability'], ['Similarly  panel', 'ENLYFQ G S site'], ['we', 'multiple  applications'], ['particular  focus', 'living  cells'], ['', ''], ['', ''], ['rights', ''], ['study', 'integration aids'], ['', ''], ['how  students', 'graphical  representations'], ['', ''], ['', 'multiple science achievement'], ['picture integration type', 'two integration representations'], ['Further  picture', 'item'], ['multiple eye movements', 'multiple choice items'], ['however  this', 'only  diagrams'], ['students', 'integrated format condition'], ['Furthermore relations', 'integrated  format'], ['', ''], ['', 'Elsevier Ltd'], ['Building', 'fundamental texture classification'], ['Local Binary Pattern', 'great texture description'], ['which', 'local orientation pattern'], ['based coordinate which', 'radial  components'], ['First  we', 'different  derivatives'], ['Then  we', 'different  derivatives'], ['Both', 'central  pixel'], ['new  descriptor', 'central  intensity'], ['proposed CRDP descriptor', 'KTH TIPS texture datasets'], ['results', 'aforementioned texture knowledge'], ['', ''], ['rights', ''], ['small cell lung cancer', 'common  cancers'], ['PD-1 PD L1 interaction', 'important NSCLC tumor cells'], ['high PD-1 we', 'inflammatory  NSCLC'], ['T cell population', 'Tfh cells'], ['frequency', 'healthy NSCLC controls'], ['Tfh they', 'NSCLC patients'], ['', 'elevated NSCLC apoptosis'], ['Tfh cells', 'healthy IgA controls'], ['then survival time', 'infiltrating NSCLC subjects'], ['Tfh cells', 'strong antitumor NSCLC'], ['Enhancing', 'therapeutic Tfh cell NSCLC'], ['', ''], ['', ''], ['rights', ''], ['Aims', 'fibrogenic master cytokine beta'], ['We', 'Western reporter gene analysis'], ['active beta receptor', '1 ALK5-receptor culture'], ['However  expression', 'strongly TGF beta'], ['CTGF/ CCN2 expression', 'hepatocytes'], ['Endothelin-1', 'CTGF stellate hepatocytes'], ['signalling  contribution', 'CTGF cell types'], ['hepatic stellate which', 'hepatocytes'], ['', '2007 European Liver'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['', ''], ['We', 'subepithelial IL)-17 family myofibroblasts'], ['', ''], ['inhibitory inflammatory factor', 'immunosorbent matrix assay'], ['Activation', 'activated protein kinase'], ['', ''], ['', ''], ['effects', 'relatively  IL-17F'], ['effects', 'IL-17C  IL-17A'], ['IL-17A', 'induced IL-8 LIF MMP-1'], ['similar  augmentation', 'also tumor necrosis factor'], ['', 'as Jun NH2-terminal stimulation'], ['Inhibitors', 'induced LIF MMP-1'], ['', ''], ['IL-17 family IL-17F', 'inflammatory  responses'], ['Lung cancer', 'related  deaths'], ['cancer risk factors', 'chronic  inflammation'], ['integral  feature', 'immune cell CD4(+'], ['17 T that', 'immune  responses'], ['lung cancer Tregs', 'foci development'], ['Additionally  cells', 'distinct lung tumor phenotypes'], ['CD4 cell subsets', 'active lung cancer progression'], ['We', 'current tumorigenesis progression metastasis'], ['Furthermore  we', 'prognostic lung cancer'], ['hemoglobin  determination', 'additionally Hb A(2'], ['We', '-thalassemia'], ['Hb F Hb A(2', 'between  traits'], ['-TM birth rate', 'real healthcare data'], ['MZE technique', '27724  patients'], ['Previous  criteria', 'molecular biology techniques'], ['predictive  value', ''], ['', ''], ['prevalence', '-thal -thal'], ['', ''], ['prevalent  mutations', '100000  population'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '0  -thalassemias'], ['', ''], ['', ''], ['', ''], ['', '9 Hb variants'], ['We', 'theoretical birth rate'], ['We', 'Hb index 0'], ['', 'between  traits'], ['method', 'cost  -thalassemias'], ['Prevalence results', 'Spanish  population'], ['Heterogeneity', 'markedly  migration'], ['Hb index cutoff', '-thal trait'], ['scanned bypass which', 'zero  potential'], ['Firstly crosstalk we', 'total precision it'], ['improved', 'potential S NSE circuit'], ['improved S NSE effects', 'resistive NI Multisim'], ['Thirdly part features', 'improved prototype circuit'], ['conclusions', ''], ['more op resistor', 'resistive sampling array'], ['Akhism Organization which', 'Anatolia'], ['aim', 'psychological Akhism capital'], ['Akhism Organization', 'psychological  capital'], ['economic  growth', 'sharp  electricity'], ['Electricity price', 'substantial electricity subsidy'], ['Electricity subsidy', 'energy price reform'], ['It', 'sensitive  residents'], ['paper', 'residential electricity 467'], ['17 billion 17 CNY', 'Chinese  1'], ['', '17  year'], ['Subsequently  paper', 'CV electricity subsidy measurement'], ['191  CV', '50'], ['', ''], ['', ''], ['', ''], ['', ''], ['residential electricity subsidy reform', 'rebound electricity consumption'], ['direct rebound effect', 'residential electricity consumption'], ['Electricity subsidy reform', 'residential electricity consumption'], ['Therefore electricity subsidy reform', 'rebound  effect'], ['increasing  need', 'suitable treatment adolescents'], ['brief  it', 'different  cultures'], ['', 'Finnish YP CORE'], ['study', 'University Central Hospital'], ['Finnish  translation', 'professionals'], ['together  92', '3-month  treatment'], ['Analysis', 'reliable validity change'], ['well  rate', 'missing  values'], ['', ''], ['', ''], ['test  reliability', ''], ['results', 'one factor model'], ['YP CORE', 'specific  measures'], ['', ''], ['', ''], ['Gender', 'strong  scores'], ['effect', 'age'], ['measure', 'larger effect size'], ['', 'BDI-21'], ['', ''], ['', ''], ['psychometric  measure', 'clinical outcome adolescents'], ['Bovine theileriosis', 'emerging East Asia'], ['Previous  studies', 'various  Theileria'], ['', 'transplacental  T'], ['orientalis', 'field'], ['opportunistic  samples', 'aborted  foetuses'], ['ELISA  methods', 'Theileria infection herd'], ['pregnant  heifers', 'foetal  T'], ['', 'qPCR'], ['qPCR  results', 'high  T'], ['rate', 'positive abattoir T'], ['', ''], ['aborted stillborn 3', 'negative theileriosis T'], ['', 'qPCR'], ['This', 'utero T'], ['orientalis', 'major theileriosis outbreaks'], ['', '20  T'], ['positive  mothers', 'that'], ['orientalis', 'affected adult herds'], ['maternal ELISA antibodies', 'only  4'], ['', ''], ['only weeks calves', 'adaptive antibody response'], ['findings', 'transplacental  T'], ['orientalis', 'minor  T'], ['however  calves', 'high level T'], ['maternal orientalis antibodies', '4 orientalis age'], ['preserved', 'disease'], ['performance', 'variant Frontotemporal Dementia'], ['however  this', 'cognitive  AD'], ['cognitive data mining study', 'independent AD results'], ['44 bvFTD patients', 'comparison group'], ['patients', 'neuropsychological  examination'], ['Hierarchical clustering analyses', 'executive ToM AD'], ['ToM performance', 'principal component analysis'], ['automated linear modelling', 'ToM performance'], ['8  %', 'executive ToM measures'], ['Similar  findings', 'thereby AD results'], ['Conversely ToM impairments', 'cognitive  impairments'], ['difficulties', 'genuine ToM deficit'], ['mental state which', 'interacting ToM functioning'], ['Finally  study', 'clinical  neurosciences'], ['', ''], ['rights', ''], ['Anger', 'serious risk management'], ['underlying Understanding anger', 'prevention'], ['study', 'different psychosis continuum'], ['first attribution bias episode', 'clinical  participants'], ['insecure  attachment', 'multiple trait regression'], ['Attachment avoidance paranoia', 'significantly attachment mind'], ['paranoia', 'avoidant  attachment'], ['Findings', 'early adult paranoia'], ['', 'mental  states'], ['', ''], ['called  theory', 'social  interaction'], ['false  question', 'little bystander attention'], ['false belief participants', 'three  boxes'], ['human bystander who', 'screen'], ['Importantly bystander beliefs', 'task'], ['even bystander this', 'significantly bystander beliefs'], ['they', 'such behavior regulation'], ['low self propelledness', 'necessary belief attribution'], ['propelled bystander beliefs', 'meaningful  children'], ['', ''], ['rights', ''], ['Introduction', 'social  interactions'], ['', 'functioning depression'], ['However  results', 'other modulating factors'], ['matched  controls', 'animated ToM triangles'], ['Results', 'empathy attachment abilities'], ['depression severity', 'task performance'], ['pharmacological  treatment', 'study'], ['Results', 'specific ToM performance'], ['impairments', 'cognitive risk depression'], ['specific remediation needs', 'account'], ['', 'Mind'], ['', ''], ['people', 'social  intelligence'], ['recently  ToM', 'neurocognitive  components'], ['', ''], ['', ''], ['dual  processes', 'developmental  dynamics'], ['we', 'experimental  notion'], ['cognitive web which', 'ToM  functions'], ['mentalizing  which', 'higher level ToM'], ['individual  differences', 'onwards level ToM i'], ['', ''], ['', 'executive  functions'], ['relative  contribution', 'significantly  age'], ['people', 'when  minds'], ['', ''], ['rights', ''], ['Two  studies', 'late constructivist childhood'], ['new  measure', 'interpretive attention comparison planning'], ['mediational prosocial reasoning', 'high constructivist school'], ['prosocial constructivist which', 'academic behavior performance'], ['girls', 'high constructivist school'], ['', ''], ['rights', ''], ['social information it', 'mental  others'], ['', ''], ['intentions', 'beliefs'], ['automatic belief that', 'mental  states'], ['', ''], ['', 'cognitive profile infants'], ['Here  we', 'broader Phillips et al'], ['adult humans', 'mental  states'], ['However  ability', 'two systems ToM account'], ['', ''], ['', ''], ['rights', ''], ['interdisciplinary 1(4):515 research', 'other theory simulation minds'], ['various  approaches', 'empirical  hypotheses'], ['future', 'social  cognition'], ['ASD autism spectrum challenges', 'extant  research'], ['deficits', 'social motor ASD'], ['', '9 disability 27'], ['5', 'social  cognition'], ['motor function', 'when sex age'], ['better  performance', 'social belief problems'], ['that', 'social  ASD'], ['durable perspective effects', 'rehearsed  situations'], ['', 'C Elsevier Ltd'], ['random texts who', 'Author Recognition Test'], ['response', 'critiques'], ['most  they', 'original  study'], ['thus  replication', 'immediately  mind'], ['reading', 'potential depth claims'], ['document', 'allied American Psychological publishers'], ['article', 'individual  user'], ['We', 'autobiographical  memory'], ['Patients', 'autobiographical fluency task'], ['positive  relationship', 'controls'], ['semantic  ABM', 'still ToM AD'], ['less  which', 'social deficit cognition'], ['Two  populations', 'deaf autism spectrum disorder'], ['early language exposure', 'ToM development'], ['visual sign exposure', 'ASD'], ['We', 'deaf  parents'], ['signing  children', 'social cognition tasks'], ['TD children', 'ASL comprehension'], ['', ''], ['', ''], ['', ''], ['', ''], ['Language', 'strongly  ToM'], ['', ''], ['', ''], ['Native  exposure', 'social  ASD'], ['signing', 'potential benefit sign'], ['results', 'TD  children'], ['', ''], ['', '2016 Wiley Periodicals Inc'], ['lateral  sclerosis', 'executive  dysfunction'], ['cognitive  deficits', 'prominent  ALS'], ['', 'social emotion ALS'], ['In', '389 ToM ALS'], ['ALS', 'medium effect ToM'], ['', ''], ['', ''], ['', 'individual emotions disgust'], ['', 'd'], ['73 ToM PT', 'more  d'], ['', '28  ToM'], ['severity', 'social  cognition'], ['Deficits', 'cognitive  ALS'], ['', ''], ['rights', ''], ['4 ToM children', 'belief'], ['proper  understanding', 'propositional  attitudes'], ['even  infants', 'beliefs'], ['orthodoxy', 'two  attacks'], ['emerges', 'propositional  attitudes'], ['conceptual  capacity', 'mental  ontogeny'], ['refined  version', 'plausibly  mind'], ['basic happiness anger', 'disgust sadness surprise Ekman'], ['Stimuli', 'daily life situations'], ['main  characters', 'distinct scene picture'], ['normative  data', 'healthy  participants'], ['', ''], ['disgust', 'free text scene'], ['social  that', 'social  cognition'], ['It', 'ecological  validity'], ['effects', 'mental  health'], ['executive life which', 'clinical  challenges'], ['executive  who', 'randomized control trial'], ['194 therapist ratings', 'participants'], ['TR interactions', 'treatment groups'], ['therapist  ratings', 'greater  depression'], ['x therapist level interaction', 'statistical  significance'], ['', 'synergistic treatment outcome'], ['Together  Understanding', '21 depression level changes'], ['TR', 'objective therapy evaluator'], ['Assessment', 'psychosocial therapist interventions'], ['human  they', 'culinary  practices'], ['nutritive health which', 'fatty acid compositions'], ['fresh cooking oil', 'various food preparations'], ['Repeated  use', 'also food profit'], ['great  researchers', 'overall antioxidant oils'], ['oxidative kidney which', 'degenerative  diseases'], ['various disease that', 'human  health'], ['floating voltage which', 'consequently electron beam'], ['implementation', 'standard electron 0'], ['', ''], ['described  controller', 'hot  emitters'], ['Cyclic  stability', 'thermochemical heat storage systems'], ['energy storage effect', 'Ca(OH)(2)/CaO  study'], ['water that', 'heat release process'], ['', 'Therefore Ca(OH)(2)/CaO systems system'], ['Mg(OH)(2)/MgO CO2', 'slightly heat storage'], ['carbonic  acid', 'CaO heat release processes'], ['remaining  CO2', 'slight Mg(OH)(2)/MgO systems'], ['carbonate  shell', 'entire process cycle'], ['', ''], ['rights', ''], ['past  men', 'mainly industry life'], ['recent energy crisis researchers', 'especially energy system efficiency'], ['context', 'growing thermoelectric generators'], ['thermal  energy', 'remote  areas'], ['thermal  energy', 'also  electricity'], ['review', 'existing  materials'], ['Design', 'generators'], ['Finally  we', 'developing countries micro sensors'], ['future  which', 'currently research industry'], ['whenever  heat', 'cold  source'], ['', ''], ['rights', ''], ['low temperature that', 'widely  nature'], ['smart management which', 'free power maintenance'], ['', 'prototypical thermoelectric module'], ['', 'thermoelectric  legs'], ['', '2  width'], ['6  mm', 'mechanical machining process'], ['', 'commercial electrode patterns'], ['fabricated  module', 'cold power generation air'], ['', '375 thermoelectric potential'], ['short circuit current', ''], ['5  mA', ''], ['', ''], ['finite element method', 'heat test'], ['different  result', 'relatively test results'], ['study', 'generating heat pipes'], ['', ''], ['', ''], ['recovery generation processes', 'moving  parts'], ['telluride thermoelectric which', 'finned electricity generation'], ['flow heat exchanger', 'separate air ducts'], ['air ducts', 'thermally HPTEG modules'], ['evaporator section', 'hot air duct'], ['heat', 'then TEG surfaces'], ['condenser section', 'cold air duct'], ['electrical  heater', 'hot exhaust gas'], ['air blower', 'ducts'], ['theoretical  model', 'transfer units method'], ['developed  model', 'thermal heat transfer'], ['cold air effectiveness', '58 heat %'], ['', 'maximum power 4'], ['3  W', ''], ['which', 'recent research years'], ['paper', 'synthesized  nanoheterostructures'], ['We', 'given power nanoheterostructures'], ['Then  we', 'thermal  conductivity'], ['thermal power conductivity', 'namely nanowire heterostructure'], ['We', 'telluride thermoelectric nanowire work'], ['possible  ways', 'paper'], ['Thiazolidinediones', 'insulin resistance'], ['However  mechanisms', 'vasoprotective  thiazolidinediones'], ['', 'vasoconstrictive  endothelin'], ['hours  vasoconstriction', 'wire myography'], ['mouse effect', 'B receptor synthase endothelium'], ['upregulated  expression', 'mouse aortas'], ['induction', 'activated receptor gamma antagonism'], ['rosiglitazone', 'gene promoter activity'], ['activated receptor gamma', ''], ['Furthermore', 'also mouse aortas'], ['endothelial ET-1-induced which', 'endothelial ET-1-induced ET(B)R'], ['', ''], ['', ''], ['', ''], ['thin film transistors', 'circuit applications'], ['devices', 'thin polycrystalline cadmium films'], ['devices', 'dimensional element simulation methodology'], ['grain boundary trap distribution approaches', ''], ['traps', 'uniformly grain film'], ['Frenkel mobility model', 'pentacene'], ['experimental SPICE model parameters', 'circuit simulation'], ['devices', 'analog  circuits'], ['inverter circuits', ''], ['results', ''], ['One', 'CdS CMOS TFTs'], ['operational  amplifiers', 'open loop voltage 25'], ['', ''], ['', ''], ['performance', 'pentacene transistor'], ['', ''], ['', ''], ['rights', ''], ['ellipsoidal cell sandwich composite', 'panel preparation process'], ['series', 'different wall ANSYS'], ['Then  effect', 'mechanical cell sandwich composites'], ['deformation process', 'axisymmetric axisymmetric depression'], ['buckling  Epoxy', 'outer epoxy resin'], ['', ''], ['', ''], ['rights', ''], ['we', 'small scale energy harvesting'], ['comprehensive  optimization', 'material device system integration'], ['thin  films', 'annealing  process'], ['Fresnel lens', 'thin energy concentration'], ['heat which', 'thin film thermoelectric device'], ['electricity generation', 'solar sensor application'], ['thin film thermoelectric device', 'greatly voltage responsivity'], ['work', 'thin sunlight intensity'], ['Third party punishment', 'appropriate norm punishment'], ['specific brain little', 'effective  connections'], ['hypothetical  perpetrator', 'criminal  harm'], ['legal  decisions', 'appropriate executive punishment'], ['prefrontal  hubs', 'ventromedial temporo parietal junction'], ['only  activation', 'dorsolateral  punishment'], ['dorsomedial  PFC', 'appropriate TPP activation punishment'], ['results', 'legal TPP brain wrongs'], ['paper', '130 nm CMOS technology'], ['indirect feedback compensation technique', 'open loop schematic'], ['op amp', '40'], ['90 MHz gain degrees', 'margin(PM'], ['', '5 pF load'], ['Furthermore op amp', '15 pF 25'], ['', ''], ['circuit', 'single supply 2'], ['', '5 power 0'], ['977 layout area', ''], ['', ''], ['chaotic  circuits', 'chaotic  systems'], ['', 'operational simulation amplifier'], ['circuit which', 'same Multisim software simulation'], ['Meanwhile feedback synchronization method', 'actual synchronization control'], ['minor simulation which', 'chaotic  systems'], ['recent  research', 'chaotic  system'], ['', 'operational simulation amplifier'], ['circuit which', 'same Multisim software simulation'], ['impulsive synchronization method', 'chaotic synchronization system'], ['minor simulation which', 'chaotic  systems'], ['orthonormal transformation that', 'four voltage source inverter'], ['digital control scheme', 'proposed sinusoidal method'], ['independently optimal controller', 'predefined performance index'], ['phase four leg prototype VSI', 'discrete time modelling'], ['satisfactory time results', '20 kHz switching frequency'], ['mathematical  model', 'main operation principle'], ['oversample', 'lower inverter output voltage'], ['external output voltage execution', 'further output voltage waveform'], ['proposed control method', '20kVA microchip processor'], ['THD', 'inverter output voltage'], ['novel frequency compensation technique', 'three stage amplifiers'], ['second compensation which', 'proposed  amplifier'], ['Detailed design considerations', 'compensation technique'], ['driving', '2-pF load 9'], ['25-GHz  GBW', 'only  16'], ['', '5  1'], ['65 nm CMOS which', 'significant  merits'], ['implemented  amplifier', 'settling  3'], ['35', ''], ['', ''], ['analysis', 'spectral Computing Methods T'], ['', ''], ['', ''], ['', ''], ['focus', 'second Adams time'], ['Careful  distinction', 'first time Euler'], ['latter', 'benchmark aeroacoustic problem'], ['dimensional wave propagation models', ''], ['spatial  discretizations', 'spectral  method'], ['Attention', 'quadratic 1D convection equation'], ['AB2 method', 'numerical EXT2 dissipation'], ['physical  mode', 'numerical  mode'], ['Presented  analysis', 'three time level methods'], ['', ''], ['rights', ''], ['Thymic  atrophy', 'premature  DP'], ['significant bone marrow aplasia', 'common Trypanosoma cruzi'], ['addition depletion', 'DN2 thymocytes'], ['Interestingly  infected', 'similar DN1 thymocytes'], ['Moreover  drop', 'wild type littermates'], ['IL-6-dependent bone that', 'DN thymocytes'], ['Survivin', 'numerous  cancer'], ['PCNA  level', 'cellular  proliferation'], ['', 'splice thyroid cancer'], ['PCNA survivin', 'reverse polymerase chain reaction'], ['', 'higher  survivin'], ['', ''], ['', ''], ['', ''], ['', 'benign thyroid lesions'], ['characteristics curve analysis', 'cut survivin IHC expression'], ['', '100  curve'], ['', ''], ['', 'DEx3 IHC >'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', 'best thyroid cancer'], ['survivin DEx3 expression', 'benign thyroid lesions'], ['Survivin DEx3', 'clinical thyroid practice'], ['results', 'differentiated thyroid cancer'], ['Nevertheless  role', 'prognostic  DTC'], ['', 'clinical RET rearrangements outcome'], ['Unfortunately  accuracy', 'low  specificity'], ['Recently  introduction', 'next TP53 DTC'], ['genetic  abnormalities', 'molecular  prognostication'], ['knowledge', 'clinical TERT outcome'], ['prognostic  effect', 'when  isolation'], ['enough  occurrence', 'clinical driving practice'], ['DTC prognostication', 'molecular  BRAF(V600E'], ['promising  use', 'technical  sight'], ['one obligate that', 'amphibian  metamorphosis'], ['', 'such potassium metamorphosis'], ['D2  enzyme', 'amphibian TH metamorphosis'], ['how  D2', 'lamprey metamorphosis'], ['We', '1'], ['8 marinus D2 that', 'entire protein coding region'], ['lamprey D2 mRNA', 'date'], ['low  that', 'metamorphosis'], ['data', 'reported serum TH levels'], ['', 'significantly  intestine'], ['thyroid D2', 'TH homeostasis'], ['', ''], ['rights', ''], ['Most  patients', 'current thyroid therapies'], ['recurrent  some', 'them'], ['inflammatory  that', 'neoplastic  cells'], ['We', 'clinical thyroid cancer'], ['derived thyroid who', 'papillary thyroid carcinomas'], ['Patients', '150  months'], ['Additionally  we', 'malignant  tissues'], ['We', 'semiquantitative tumor methods'], ['Malignant tissues', 'higher  positivity'], ['', ''], ['', 'malignant  samples'], ['', ''], ['', ''], ['', ''], ['Tumors', 'higher  0'], ['', ''], ['', 'extrathyroidal  invasion'], ['', ''], ['', ''], ['', ''], ['We', 'positive tumor size'], ['', ''], ['', ''], ['free survival tumors', 'median'], ['who', 'intensive  approach'], ['Sub THz pixel', 'low  cost'], ['', ''], ['Each', 'power detection circuit'], ['Efficiency', 'FET detector'], ['pulse  generator', 'signal producing pixel array'], ['measured peak responsivity', ''], ['', '90  GHz'], ['', '155  GHz'], ['pixel', 'load resistor'], ['pixel', 'efficiently pixel output'], ['', 'recent tick borne encephalitis'], ['primary  vectors', 'genus  Ixodes'], ['much', 'cellular tick vector'], ['bacterium Anaplasma phagocytophilum', 'apoptotic  infection'], ['ill encephalitis which', 'tick borne encephalitis'], ['', 'IRE tick cell viruses'], ['phagocytophilum', 'cellular  pathways'], ['tick', 'selective toll genes'], ['viral  which', 'cell survival'], ['they', 'human  health'], ['Vector competence', 'genetic  pathogen'], ['determinants', 'such pathogen infection'], ['tick pathogen that', 'molecular tick borne diseases'], ['we', 'human bacteria health'], ['Additionally  impact', 'tick interactions'], ['different  pathogens', 'immune  multiplication'], ['Furthermore  some', 'tick  hosts'], ['pathogen transmission', 'tick borne diseases'], ['some', 'multiple tick borne diseases'], ['such Rocky Mountain', 'fever'], ['endosymbiotic  bacteria', 'other tick species'], ['We', 'D'], ['occidentalis ticks interference', 'endosymbiotic  bacteria'], ['gene romp we', 'infected  D'], ['', 'San Diego County'], ['We', 'next generation ticks'], ['', ''], ['', ''], ['', ''], ['rhipicephali', '2'], ['', ''], ['', 'respectively  romp'], ['', ''], ['individual rRNA that', 'infecting  ticks'], ['', 'geographic collection locales'], ['female  that', 'similar skin microbiomes'], ['findings', 'other  D'], ['occidentalis', 'certain  SFGR'], ['results', 'vertebrate tick microbiome'], ['cobalt group', 'total ionizing dose'], ['current  rate', 'internal LPNP transistors'], ['when X ray devices', 'more  TID'], ['sensitive mu parameters', 'SPICE'], ['duration', 'pulsed X ray irradiation'], ['several  proposals', 'devices'], ['Laboratory testing', 'hydrodynamic turbine turbines'], ['Such  tests', 'full scale machines'], ['details', 'instrumented turbine model'], ['model', '1'], ['2 m diameter', 'horizontal axis rotor'], ['which', 'overall streamwise rotor'], ['model', 'blade  turbulence'], ['Initial  results', 'wide  flume'], ['', ''], ['', 'Elsevier Ltd'], ['article', 'tidal turbine farm modelling'], ['fluid  solver', 'tidal actuator disc turbines'], ['particular  attention', 'numerical  wakes'], ['', 'experimental Mycek et al'], ['1', 'tidal  turbine'], ['averaged turbulence intensity rates', '1'], ['', 'tidal turbine device'], ['properties', 'industrial accuracy CPU purpose'], ['', ''], ['rights', ''], ['time delay', 'also control performance'], ['uninterruptible power paper', 'analytic Smith analysis'], ['current time compensation', 'practical  view'], ['experimental  results', 'single phase UPS'], ['paper', 'filtered voltage source inverters'], ['phase lag', 'integral LC filter resonance'], ['stability regions', 'alternative voltage controller'], ['active damping approach', 'discrete z domain'], ['Simulations', 'theoretical  approach'], ['sensory  that', 'internal  noise'], ['when  inputs', 'same  source'], ['temporal  features', 'what'], ['such time integration', 'action control'], ['Here  we', 'auditory movement tone'], ['explicitly  Experiments', '950 hand duration'], ['judgments', 'executed tone movements'], ['', ''], ['tones', 'longer  duration'], ['temporal  information', 'well perception action control'], ['independent system operator', 'power process'], ['typical  ISO', 'next electricity demand demand'], ['successful market it', 'electricity demand'], ['weekly linear that', 'seasonal  variations'], ['electricity demand', 'seasonal  characteristics'], ['model', 'climatic sinusoidal information'], ['method', 'MAPE Absolute Percentage norm'], ['We', 'industrial electricity consumption'], ['', ''], ['rights', ''], ['study', 'INGARCH parameter models'], ['well count that', 'overdispersion'], ['Special  attention', 'likelihood ratio likelihood charts'], ['performance', 'average run length'], ['adequately CLR chart', 'increased GLR parameters'], ['Moreover  use', 'false CLR chart'], ['many  representations', 'various series data processing'], ['static transformation they', 'nature'], ['we', 'proposed time series representation'], ['true  we', 'original distance data'], ['We', 'proposed UCR datasets'], ['stream data we', 'unbound data stream'], ['', ''], ['rights', ''], ['we', 'nonlinear time delay systems'], ['generated  kernel', 'appropriate equilibrium point'], ['analysis', 'equivalent LMI conditions'], ['asymptotic  stability', 'commensurate order delays'], ['prey type model', 'immune predator prey population'], ['asymptotic  stability', 'free equilibrium point'], ['neural cancer it', 'right term approach'], ['control method', 'highly voltage source resonance'], ['current  controller', 'high control accuracy'], ['influences', 'three controller gains'], ['analytical  design', 'varying grid inductance'], ['effectiveness', 'optimum control performance'], ['deadbeat controller', 'low filter size'], ['paper', 'state loop control modes'], ['where time optimal control', 'flying charge capacitor'], ['', 'transient load transients'], ['detailed  principle', 'behavioral SC buck model'], ['operation', 'experimentally 12W 12V to-1'], ['', 'well load transients'], ['fuller  understanding', 'social  interaction'], ['temporal  scales', 'personal  analysis'], ['We', 'virtual reality environment'], ['subjective  conditions', 'which'], ['', ''], ['social  coordination', ''], ['interpersonal  interaction', 'social  perception'], ['Clustering statistics', 'fractal Allan scaling'], ['Complexity matching', 'surrogate scaling dyads'], ['This', 'social interaction dynamics'], ['Trials', 'local  coordination'], ['successful PCE performance', 'dyadic PCE task'], ['Variations', 'two research decades'], ['definitions', 'specific examination criteria'], ['state problem lack', 'process'], ['individual examination which', 'existing benchmark considerations'], ['one', 'main  cohort'], ['', ''], ['student', 'immediate examination peers'], ['just student cohort majority', 'fairness'], ['we', 'scientific timetabling problem literature'], ['Fairness', 'objective  problem'], ['benchmarks', 'other Tchebyceff objectives'], ['proposed  model', 'desired trade student'], ['', ''], ['', ''], ['rights', ''], ['majority', 'idiopathic tinnitus tinnitus'], ['present  study', 'chronic  tinnitus'], ['results', 'S3 guideline'], ['systematic  search', 'PubMed'], ['basis', 'based Oxford Medicine'], ['controlled  trials', 'therapeutic  issues'], ['quality meta size', 'account'], ['specific tinnitus counselling', 'patient  counselling'], ['behavioural  therapy', 'high  evidence'], ['concomitant hearing those', 'also  drugs'], ['', 'pharmacological  support'], ['psychiatric  treatment', 'case  basis'], ['simultaneous  CI', 'simultaneous  deafness'], ['available therapy evidence', 'yet  recommendation'], ['TiO2 crystal facets', 'unique surface property'], ['specific linear relationship', 'TiO2'], ['study', '100 facet TiO2'], ['index  TiO2', 'low index TiO2'], ['', 'adsorption OH'], ['', 'TiO2 facets'], ['', 'trapping  experiments'], ['great  OH', 'low index TiO2'], ['high surface which', 'fast  OH)-O-'], ['', ''], ['index  which', 'photocatalytic  rate'], ['', 'low index TiO2'], ['adsorption  mechanism', 'environmental  technologies'], ['', ''], ['rights', ''], ['synthetic  micro-/nanomotors', 'unique  performances'], ['We', 'aqueous dye solutions'], ['', 'pure  water'], ['', ''], ['', ''], ['accelerated  motions', 'g methyl red'], ['We', 'photodegradation rates'], ['paramagnetic TiO2 micromotor', 'magnetic  field'], ['magnetic  micromotors', 'also dye detection'], ['photocatalytic  micro-/nanomotors', 'aqueous dye environments'], ['aim', 'human collagen biomaterials'], ['Col types C1C2CHS', 'I'], ['resulting  constructs', 'molecular  biology'], ['Col', 'binding culture method'], ['hBMSCs', 'extracellular Col C1-OLH3'], ['presence', 'only gene level'], ['Total Col', 'scaffold  cultures'], ['Col that', 'Col C1C2'], ['Electron microscopy', 'shaped  constructs'], ['Col fibers', 'transmission electron microscopy'], ['Col I', 'early cell stage'], ['Constructs', 'other  ones'], ['low  power', 'based frequency identification applications'], ['power voltage', 'elementary regulator sub stages'], ['bandgap reference', 'totally  MOSFET'], ['optimize', 'neural network TLBO algorithm'], ['outputs', 'TLBO'], ['output voltage', 'algorithm'], ['', '8  2'], ['', ''], ['Also quiescent current', '290'], ['chip area', 'Cadence software'], ['960  simulation', 'CMOS technology'], ['histone mobility protein', 'autoimmune  diseases'], ['However  significance', 'autoimmune  thyroiditis'], ['autoimmune HMGB1 glycyrrhizin', 'autoimmune murine thyroiditis'], ['', '80 male NOD'], ['regular NaI group', '0'], ['', ''], ['', ''], ['H-2(h4  mice', 'eight iodine supplementation'], ['', ''], ['h4  mice', '0'], ['', 'eight sodium iodide autoimmune'], ['iodine  mice', 'four intraperitoneal weeks'], ['severity', 'histopathological thyroid studies'], ['beta factor alpha titers', 'immunosorbent  assay'], ['HMGB1 expression', 'immunohistochemical  staining'], ['TLR2 HMGB1 MyD88', 'Western factor kappa blot'], ['16 NaI it', 'control group'], ['significantly NaI they', 'dramatically GL injection'], ['infiltration', 'significantly  NaI'], ['GL administration', 'nuclear thyroid thyroiditis'], ['inflammatory  infiltration', 'autoimmune  thyroiditis'], ['GL', 'induced  NOD'], ['', 'molecular  TLR2-HMGB1'], ['TCP beta tricalcium composites', 'biocompatible bone graft materials'], ['T which', 'important  bone'], ['PBSu TCP that', '8 culture 24'], ['well culture plate', 'control surface'], ['effects', 'flow cytometry chain reaction'], ['biomaterials', 'normal DNA synthesis'], ['transient T which', '72  hours'], ['Proportions', 'CD4 T lymphocyte biomaterials'], ['Moreover PBSu', '35  %'], ['PBSu TCP composite', '17  %'], ['TCP composites', 'unfavorable T lymphocytes'], ['', 'inflammatory T lymphocytes'], ['biomaterials', 'good bone graft materials'], ['', ''], ['TM cell volume', 'aqueous humor outflow resistance'], ['activated I ClI pore', 'LRRC8 proteins'], ['activated  finding', 'activated  anoctamins'], ['', 'other cation cells'], ['anoctamin activity', 'primary TM cell cultures'], ['', ''], ['Gene expression', 'reverse  transcriptase'], ['Currents', 'electronic cell sizing'], ['', ''], ['TM cell cultures', 'other anoctamin CaCCs'], ['macroscopic cell currents', 'same I ClI cells'], ['transient tannic Ano6', 'hyposmotic volume swelling'], ['', ''], ['Ionomycin', 'net TM cells'], ['Swell cell volume', 'Ano6'], ['findings', 'thereby cell Ano6'], ['tumor necrosis factor', 'immune cytokine functions'], ['TNF receptors', 'various T cell homeostasis'], ['Many', 'lymphocyte proliferation'], ['several TNF cytokines', 'Th1 T cell Th2'], ['Four TNF family cytokines', 'IL-9 T cells'], ['4 Th9 1BBL', 'IL-9 Th9 generation'], ['Regulation', 'allergic TNF family lung'], ['T cell production', 'autoimmune family cytokine tumor'], ['also RNA interference', 'mRNA  organisms'], ['pivotal virus that', 'gene'], ['we', 'hot Tobacco mosaic virus'], ['HT115 Escherichia we', 'seven  TMV'], ['different  hpRNAs', 'viral tobacco infection'], ['other TMV resistance', 'other PVY hpRNAs'], ['resistance', 'siRNA'], ['like  receptor', 'human placental trophoblast cells'], ['MALP-2  exerts', 'signaling  which'], ['Human placental trophoblast cells', 'term placenta'], ['multiplex trophoblast MALP-2', 'PCR Western RT PCR blotting'], ['MAP ERK1/2', 'Western  blotting'], ['PGE production', 'inhibitors'], ['TLR2 TLR6', 'human placental trophoblast cells'], ['MALP-2', 'dependent COX-2 manner'], ['MALP-2', 'activation'], ['Inhibitors', ''], ['TLR2-mediated  stimulation', 'placental NF kappa B'], ['', ''], ['rights', ''], ['full length cDNA', 'RT PCR'], ['genomic DNA sequence', 'Le LA'], ['DNA sequence', 'six  introns'], ['Le EIN2 cDNA', 'open reading 142'], ['', '1316 amino acids'], ['amino acid homology', 'protein Arabidopsis'], ['expression level', 'mature  leaves'], ['expression', 'rapidly breaker stage'], ['expression level', 'exogenous type tomato ethylene'], ['objective', 'early yield tomato'], ['specific  crosses', 'early  blight'], ['Biochemical  responses', 'critically  parents'], ['crosses', 'five  EC-520061'], ['susceptible  hybrids', 'early blight resistance'], ['High  level', 'resistant  parents'], ['', 'high EB disease'], ['low inbreeding which', 'better yield capacity'], ['', 'EC-520061'], ['', 'dominant gene effects'], ['Remaining  crosses', 'multiple  genes'], ['fact', 'resistant EB disease'], ['', 'C Elsevier B'], ['', ''], ['We', 'total intestine proctocolectomy'], ['aims', 'mRNA ileal pouch'], ['Differential gene expression', 'Northern cDNA blotting'], ['related cell adhesion molecule', 'reverse polymerase chain reaction'], ['Seventy four Seventy clones', 'threefold  difference'], ['2 microsomal triglyceride', 'coenzyme  synthase'], ['mucosal expression', '1 ileal humans'], ['remnant  ileum', 'total  proctocolectomy'], ['Comparative  study', 'total gene proctocolectomy'], ['sodium glucose cotransporter', 'other  hyperaldosteronism'], ['fecal  stream', 'SGLT-1-mediated sodium transport'], ['Twenty seven Twenty pairs', 'total loop proctocolectomy'], ['Mucosae', 'coupled sodium transport'], ['', 'Northern  blotting'], ['Villous  height', 'mucosal structure'], ['SGLT  I', 'distal  mucosae'], ['villous crypt depth', 'height  function'], ['full sodium transport which', 'total  proctocolectomy'], ['', 'effective Tourette interference'], ['107  controls', '107  patients'], ['Subjective  QoL', 'Chinese Version'], ['total  score', 'component depression control'], ['Patients', 'family life self awareness'], ['it', 'subjective family TS'], ['Peptide  toxins', 'essential target receptors'], ['Venoms', 'physiological  pain'], ['Snake venoms', 'various  enhance'], ['number', 'yet snake venoms'], ['We', 'reversed TRPV1 channels'], ['we', 'biology biochemical biology tools'], ['Echis that', 'outwardly intracellular neurons'], ['Interestingly channel activation', 'binding  sites'], ['Moreover NGF neurotropic activity', 'NGF receptors'], ['Echis coloratus venom', 'ability'], ['activity', 'binding TRPV1 sites'], ['General  results', 'current receptor activation mechanism'], ['Furthermore  findings', 'which'], ['', ''], ['', ''], ['rights', ''], ['Toxocariasis', 'mainly Toxocara canis'], ['knowledge', 'molecular Toxocara species'], ['', 'male adult T'], ['canis', ''], ['two  thirds', 'filtered 66 T'], ['canis', 'five  16196'], ['1  %', 'specifically male T'], ['', ''], ['Genes', 'biological  reproduction'], ['small RNA pathways', 'adult T'], ['', ''], ['results', 'reproductive  T'], ['', ''], ['', ''], ['rights', ''], ['', 'other Toxoplasma theworld'], ['However  little', 'themolecular  T'], ['', 'China'], ['present  study', 'T'], ['', 'common gondii China'], ['2015  total', 'common muscle tissue quails'], ['B1 gene', 'PCR RFLP PCR technology'], ['', 'common Twenty quails'], ['41  %', 'nested  PCR'], ['Three DNA samples', 'completely ToxoDB Genotype'], ['', ''], ['results', 'present  that'], ['common  which', 'T'], ['', 'genetic host species'], ['This', 'genetic  T'], ['which', 'T'], ['', 'gondii quails'], ['', 'C Elsevier B'], ['', ''], ['comparison', 'respectively swine muscle'], ['Diaphragm pillars', 'intensive Central Italy'], ['Genomic DNA', 'tissues'], ['gondii B1', 'specific PCR protocols'], ['Toxoplasma gondii DNA', '165  samples'], ['', ''], ['', ''], ['77', 'higher RE PCR P'], ['', '05  T'], ['', '150 B1-PCR protocol'], ['target PCR approach', 'also food testing'], ['', ''], ['rights', ''], ['Primary  infection', 'Toxoplasma fetus'], ['Women', 'prior  fetus'], ['indicates', 'primary toxoplasma PCR analysis'], ['primary  amniocenteses', 'primary  infection'], ['fetal  amniocentesis', 'concern'], ['correct  procedure', 'indication'], ['', 'primary toxoplasma 1993'], ['neonatal  data', 'clinical records laboratory records'], ['serum samples', 'Oslo University Hospital'], ['amniocenteses', 'experienced Oslo University personnel'], ['Time', 'retrospectively serology results'], ['50  %', 'certainly  pregnancy'], ['74 IgG antibody women', 'IgM  positivity'], ['Fifteen  offspring', 'amniotic  fluid'], ['gestational  age', 'amniocentesis'], ['', 'median sample volume'], ['weeks  procedure', 'GW'], ['One', 'fetal toxoplasma infection'], ['Half', 'study pregnancy'], ['suspect  serology', 'multidisciplinary  staff'], ['Amniocentesis', '15 toxoplasma GW'], ['female Zealand sea lion', 'always hind flippers'], ['2012 sea lion', 'several male sea lions'], ['gross sea lion', 'recent bite wounds'], ['lungs', ''], ['Histological  findings', 'cauda equina myocarditis'], ['Toxoplasmosis gondii organisms', 'spinal  cord'], ['PCR analysis', 'T'], ['', 'uterine gondii tissue'], ['', ''], ['gondii genotype', 'length polymorphism analysis'], ['', ''], ['CLINICAL', 'T'], ['gondii', 'likely sea death'], ['Ultimately  death', 'impaired sea mobility'], ['established mainland that', 'feline  T'], ['gondii', ''], ['Hereditary  cancer', '10 breast cancer cases'], ['preventive  that', 'major cancer therapy'], ['recurrent BRCA1/2 mutations', 'date'], ['heterogeneous cancer We', 'described TP53 mutation c'], ['', 'Arab T families'], ['two  probands', 'wide family tumors'], ['R181C variant', 'pathogenic disease mutation'], ['We', 'Arab TP53 c'], ['PCR polymerase chain approach', 'one BC carrier GBM'], ['carrier', 'recurrent  5/42'], ['', 'selected BC patients'], ['We', 'suggestive TP53 c'], ['', ''], ['paper', '313 2004 313 NoA'], ['tracing  that', 'actual  view'], ['', 'tracing  strategy'], ['', ''], ['it', 'tracing ignorance theorists'], ['paper', 'visual hashing tracking'], ['tracking object', 'sparse measurement matrix'], ['weight map', 'weight map'], ['weight tracker', 'coarse  way'], ['namely  foreground', 'always model drift problem'], ['outperforms state method outperforms methods', 'initial  box'], ['', ''], ['', ''], ['rights', ''], ['AWS train driving', 'human  performance'], ['contextual  that', 'train driving performance'], ['goal conflicts', 'disinhibited driving drivers'], ['impulsive  behavior', 'when goal conflict'], ['competing  which', 'increased driving incidents'], ['experienced train that', 'proposition'], ['eventually train drivers', 'eventually  way'], ['', ''], ['rights', ''], ['study  analysis', 'different personality persons'], ['trait repetition', 'executive control cerebellum'], ['prefrontal posterior cortex', 'left parietal cuneus'], ['cerebellar  activation', 'bilaterally executive control network'], ['significant  patterns', 'left  MTC'], ['addition connectivity', 'right homolog hemisphere'], ['discussion centers', 'presumably cerebello behaviors'], ['', ''], ['rights', ''], ['operational transconductance amplifier', 'high performance applications'], ['produced  amplifier', 'folded feedback cascode'], ['previous phase margin', 'previous FC structures'], ['90 nm CMOS which', '1800 % GBW'], ['2 dB DC', 'conventional FC amplifier'], ['even gene they', 'themselves'], ['R M that', 'viable cell population'], ['establishment', 'fine gene expression'], ['present  we', 'EcoRIR M system'], ['downstream ecoRIM gene', 'upstream ecoRIR gene'], ['extension', 'overlapping ecoRIR gene'], ['mutational  analysis', 'negative  promoters'], ['Simultaneous  substitution', 'transcript RNase protection assay'], ['ecoRIM elements', 'ecoRIM promoters'], ['Possible  roles', 'negative EcoRIR M system'], ['', ''], ['', ''], ['rights', ''], ['high L yields', 'mammalian  hosts'], ['Regardless', 'transgene  expression'], ['However  promoters', 'empirically vector design'], ['viral  we', 'endogenous  elements'], ['genetic cell culture that', 'synthetic model proteins'], ['resulting  promoters', 'endogenous IE promoter components'], ['build test we', 'synthetic binding site promoters'], ['Overall  approach', 'current production hosts'], ['cognitive  skills', 'successful  others'], ['Substantial  research', 'mental  disorders'], ['In', 'social  cognition'], ['symptomatic  patterns', 'cultural  individual'], ['biological  that', 'health'], ['that', 'neuroscience research'], ['authors', 'neuroscience research perspective'], ['Control Systems course', 'all engineering world'], ['method', 'representation  behavior'], ['different  which', 'experimental  applications'], ['solution', 'electronic transfer function circuits'], ['Combining', 'practical laboratory course'], ['growing  list', 'new bioinformatics detection'], ['Small  RNAs', 'random degradation tRNAs'], ['Here  we', 'next generation sequencing libraries'], ['We', 'biochemical purification miRNAs'], ['finally  we', 'reliable  methods'], ['Root resorption', 'orthodontic  issue'], ['1 growth TGF', 'orthodontic  force'], ['Moreover expression level', 'ultimate diagnosis disease'], ['experimental  total', 'male Wistar rats'], ['which', 'first coil molar'], ['left', 'thus control group'], ['21  animals', '21  anesthesia'], ['first  group', 'second polymerase chain reaction'], ['Orthodontic tooth movement', 'applied  force'], ['Statistical  analysis', 'group root group'], ['', 'significant inflammatory cytokine'], ['we', 'orthodontic  force'], ['relationship', 'resorptive TGF lacunae'], ['review paper', 'genetic  epigenetic'], ['informational  processuality', 'biological  processes'], ['communicational  processes', 'Biophysics'], ['essay', 'single  basic'], ['', ''], ['genetic  which', 'twentieth phenotypic variation'], ['heuristic  that', 'such  processes'], ['ability', 'second order work'], ['Particularly  we', '500 nm CMOS technology'], ['We', 'poly resistors capacitors'], ['fault we', 'reported fault model'], ['Different  combinations', 'fault test'], ['simultaneous  monitoring', 'reasonable fault coverage'], ['other test that', 'other test improvement'], ['paper', 'high system detection platform'], ['1 output voltage', 'computer'], ['key  point', 'especially head stage'], ['single molecule amplifier', '1 detection 1'], ['We', 'impedance AD8615 preamplifier circuit'], ['entire amplifier noise', 'high feedback resistor'], ['second  circuit', 'impedance loading capacity'], ['excellent  which', 'biomedical  research'], ['current  noise', 'low noise transimpedance amplifier'], ['R which', 'also  increases'], ['high  bandwidth', 'parasitic R F increases'], ['new  that', 'parasitic feedback resistance'], ['1 G Omega that', 'feedback network'], ['new  approach', 'comparable background noise'], ['', ''], ['layered  materials', 'atomic  properties'], ['layered transition metal dichalcogenides', 'structural  phase'], ['such  TMD', 'about band 1'], ['', ''], ['many metal MoS2 efforts', 'such field effect transistors'], ['', 'ferromagnetic contact metals'], ['Additionally  we', 'various contact applications'], ['Here  we', 'first principles calculations'], ['particular  we', 'electronic chalcogen atoms'], ['Schottky barrier types', 'MoX2'], ['magnetic X moment', 'ferromagnetic  Ni'], ['emerging  that', 'medical  interventions'], ['biomedical  that', 'biomedical  positions'], ['graduate training programs', 'growing employment sector'], ['possible National we', 'Science Training Program'], ['intensive training that', 'translational career science'], ['clinical development teams that', 'translational  field'], ['', 'International Biochemistry'], ['Cardiac allograft vasculopathy', 'heart transplantation'], ['CAV arteries', 'B cells'], ['aim', 'antigenic  ELS'], ['Coronary arteries', '56 transplant recipients'], ['Immunofluorescence', 'producing plasma cells'], ['Immunoglobulin levels', 'specific Luminex assay'], ['Cytokine receptor expression levels', 'quantitative polymerase chain reaction'], ['Plasma cells', 'ELS'], ['', 'epicardial tissue IgG'], ['IgM levels', 'smaller transplant ELS'], ['19  patients', 'specific type II antibodies'], ['Cytokine  expression', 'T vessel wall lymphocytes'], ['ELS', 'major donor graft'], ['Ectopic lymphoid structures', 'high HLA class II'], ['', 'long term graft years'], ['clinical  changes', 'half  life'], ['Evolution', 'transcriptome transplant function'], ['clinical omics era phenotyping', 'complex graft function'], ['holistic  that', 'biological  systems'], ['complexity', 'reductionist human kidney approach'], ['omics  that', 'heterogeneous kidney transplant model'], ['emerging systems biology which', 'kidney  transplantation'], ['review', 'mechanistic kidney graft outcomes'], ['Primary graft dysfunction', 'early lung transplantation'], ['date studies', 'microbial  PGD'], ['mainly teno viruses', 'healthy  controls'], ['We', 'PGD transplant recipient pairs'], ['TTV DNA levels', 'healthy donor adults'], ['', ''], ['smaller control recipients', 'smaller TTV transplant'], ['', ''], ['viral tract taxa', 'PGD controls'], ['immune TTV activation', 'TTV lung'], ['viral transplant who', 'primary graft dysfunction'], ['M  protein', 'transmissible gastroenteritis virus'], ['short hairpin RNAs', 'coding M TGEV'], ['porcine kidney constructs', 'production'], ['cytopathic  pRNAT-2', 'pathological  changes'], ['pRNAT-2', 'protein level'], ['further  amounts', 'three cell 13'], ['This', 'first M gene'], ['results', 'therapeutic TGEV applications'], ['transmission network switching', 'liberalized power markets'], ['extra electricity which', 'appropriate switching policies'], ['mathematical  that', 'economic market power'], ['strategic  Gecnos', 'Cournot game'], ['Nash equilibrium', 'equilibrium constraint'], ['EPEC problem', 'mixed linear feasibility problem'], ['multiple solution concept', 'extremal Nash equilibrium'], ['mixed integer linear program', 'ENE'], ['transmission switching decisions', 'binary system operator'], ['TSO', 'ENE network cost'], ['TSO', 'transmission switching decisions'], ['problem', 'upper bilevel linear levels'], ['upper  level', 'oligopolistic Cournot game'], ['branch  technique', 'developed MIBLP model'], ['3-bus example RTS96', ''], ['developed system operator', 'strategic  Gecnos'], ['', ''], ['', ''], ['rights', ''], ['increasing  interest', 'transparent  electrodes'], ['conductive Zinc reliability', 'great  attention'], ['low  which', 'electrical  conductivity'], ['single nm/10 nm/45 thickness', 'flexible polyethylene naphthalate'], ['structural  damage', 'Scanning Electron Microscopy'], ['single AZO resistivity', 'single AZO films'], ['key ductile Ag that', 'mechanical  strain'], ['regulatory T that', 'autoimmunity'], ['previously  Tregs', 'conventional allograft CD4+CD25'], ['However  mechanisms', 'alloimmunity'], ['suppression', 'transferred T cells'], ['when effector T cells', 'Fas receptor'], ['Indeed  FasL+Tregs', 'dependent T cell manner'], ['However  suppression', 'FasL expression'], ['Fas recipients', 'transferred  recipients'], ['Thus  study', 'clinical Treg transplantation'], ['biofuel production efficiencies', 'one boreal climate zone'], ['Efficient biofuel production', 'especially land use biodiversity'], ['Grass methane', 'longest cruising ranges'], ['However electricity production', 'efficient  biofuels'], ['methane straw ethanol', 'other fuel options'], ['carefully boreal climate electricity', 'transportation'], ['', ''], ['rights', ''], ['We', '2 lamprey Petromyzon marinus'], ['sequences', 'first TTR fishes'], ['other  cDNAs', 'like  vertebrates'], ['evolutionary N termini', 'other amino vertebrates'], ['longer N terminal region', 'previous splice studies'], ['TTR mRNA', 'highest larval lamprey liver'], ['TTR mRNA', 'significantly  metamorphosis'], ['upregulation', 'other TTR gene vertebrates'], ['other hormone distributor protein', 'normal thyroid hormone development'], ['when thyroid hormone concentrations', 'lowest'], ['', ''], ['rights', ''], ['authors', 'MRSw pathogen Pseudomonas aeruginosa'], ['', 'P'], ['aeruginosa', 'superparamagnetic iron oxide nanoparticles'], ['', 'P'], ['this', 'SPIO aggregates'], ['strong  increase', 'analytical spin relaxation bacteria'], ['linear that', '100  cfuai'], ['', '10(6  cfuai'], ['', '50 detection cfuai'], ['', 'S N 3'], ['method', 'P'], ['', 'established plate counting method'], ['aptasensor', 'promising  P'], ['', ''], ['respective  aptamers', 'borne  which'], ['combined  effect', 'neurocognition'], ['We', 'urban  effects'], ['284  adults', 'current  depression'], ['diagnostic trauma history', 'Trauma'], ['Ns', ''], ['principal component analysis', 'cognitive  70'], ['', '21  variance'], ['Trauma', 'worse VERBAL LMR performance'], ['Trauma association', 'verbal  list'], ['Trauma association', 'older  adults'], ['main  effects', 'Depression'], ['Trauma', 'verbal  learning'], ['trauma exposure', 'negatively  neurocognition'], ['Clinicians', 'older  adults'], ['', ''], ['rights', ''], ['Purpose Traumatic injury', 'leading work disability'], ['Receiving compensation injury', 'poorer  work'], ['relationship', 'psychological  distress'], ['', ''], ['', 'posttraumatic stress injustice'], ['who', 'State Trauma Registry'], ['Participants', 'traumatic Injustice Experience injury'], ['', 'perceived Results injustice'], ['', ''], ['', 'compensable  injury'], ['', ''], ['', 'hospital care rehabilitation'], ['', ''], ['anxiety depression PTSD', 'sevenfold work'], ['traumatic  stress', 'compensable  injury'], ['Perceived  injustice', 'intensive hospital location'], ['greater  attention', 'smoother  work'], ['Traumatic brain injury', 'long term health'], ['face', 'immune  system'], ['inflammatory  which', 'secondary cell death neurodegeneration'], ['inflammatory  cells', 'injury  response'], ['development', 'immune TBI models'], ['inflammatory  that', 'injured  brain'], ['targeting', 'promising  TBI'], ['that', 'immune TBI pathogenesis'], ['study', 'traumatic brain injury'], ['on  that', 'professional brain injury organisations'], ['', 'medical health nursing'], ['social  that', 'routinely  disciplines'], ['assessed  areas', 'mind'], ['8 Social Inference %', 'question'], ['Clinicians', 'social cognition rehabilitation goals'], ['Higher  levels', 'standardised assessment modalities'], ['overall TBI Express', 'social cognition rehabilitation'], ['Considering', 'formal cognition assessment'], ['under utilisation', 'rehabilitation TBI'], ['results', 'brain injury rehabilitation'], ['perceived health that', 'mental health symptoms'], ['passive combat experiences', 'such  destruction'], ['3 months postdeployment', 'posttraumatic stress disorder'], ['PTSD  portion', 'active combat experiences'], ['that', 'mental health symptoms'], ['chronic health who', 'sufficiently  treatment'], ['superiority trial', 'resistant Dynamic depression'], ['community mental health who', 'Rating Scale HAM scores'], ['effects', 'secondary care CMHT treatment'], ['primary  outcome', '6 HAM months'], ['Secondary  outcomes', 'HAM D HAM score'], ['Sixty patients', '6  months'], ['change', 'significantly ISTDP TAU'], ['between treatment differences', 'favouring  Cohen'], ['', ''], ['', 'depression'], ['Relative', 'complete ISTDP remission'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['results', 'geographical  locations'], ['effective treatment TRD', 'secondary care services'], ['lignocellulosic  that', 'recent  years'], ['studies', 'specifically Baden Wuerttemberg'], ['OSM airborne Light data', 'federal Baden 35'], ['', 'western  Germany'], ['available TOF we', 'annual Baden Wuerttemberg'], ['combination', '730000 Baden Wuerttemberg'], ['classification congruence', 'made OSM data'], ['available  literature', 'high inventory system'], ['applicability', 'made Baden objects'], ['', ''], ['', ''], ['rights', ''], ['oriental moth Spodoptera litura', 'southeast  Asia'], ['distinct  trehalases', 'currently  S'], ['', ''], ['', 'cDNAs Treh S'], ['', ''], ['1758 reading which', 'approximately amino 67'], ['', 'isoelectric  4'], ['', ''], ['SpoliTreh2 cDNA', 'approximately amino 73'], ['', 'isoelectric  5'], ['', ''], ['SpoliTreh1 transcripts', 'brain fat body S'], ['SpoliTreh2 transcripts', '6  tissues'], ['pupal  stage', '2nd SpoliTreh2 day'], ['SpoliTreh1', 'third instar larvae'], ['superstructural  loads', 'weaker  subsoil'], ['Piles', 'axial  loads'], ['lateral  loads', 'vertical  loads'], ['proper  attention', 'lateral  loads'], ['many  investigations', 'concrete polymer structures'], ['paper', 'lateral  loads'], ['effects', 'RC piles'], ['degradation  dissipation', 'piles'], ['', '2017 Civil Engineers'], ['Social  knowledge', 'social  world'], ['social group which', 'social group companions'], ['Evidence', 'mainly triadic management'], ['whereby Macaca a', 'affiliative receiver male'], ['social  that', 'bridging adult interactions'], ['more  receiver', 'available infant male'], ['human  primates', 'affiliative infant context'], ['results', 'complex triadic cognition'], ['human pathogen it', 'vector'], ['causal agent', 'disease'], ['Reduviidae Triatoma specimens', 'different  altitudes'], ['', ''], ['', ''], ['', 'Chiapas Mexico'], ['parasite', 'uninfected  T'], ['', 'same  altitudes'], ['response variables', 'immune heart oesophagus rodents'], ['highest  levels', 'PO activity Tryp'], ['cruzi', '700  a'], ['', ''], ['', ''], ['', 'particularly mouse brain'], ['based  analysis', ''], ['cruzi', 'Tryp'], ['I', ''], ['', ''], ['', '700  m'], ['', ''], ['', ''], ['', 'other  altitudes'], ['', 'T'], ['apparently  conditions', 'more  development'], ['Control strategies', 'altitudes'], ['', ''], ['', ''], ['', 'present study sites'], ['magnetic  force', 'portable triboelectric electrics'], ['hybrid  nanogenerator', 'peak output 3'], ['', 'peak output 0'], ['', '25 M Omega'], ['PVDF fibers membrane', 'triboelectric layer'], ['triboelectric separation mode EMG', 'copper coils'], ['good output it', 'portable energy storage electronics'], ['work', 'powered  systems'], ['human  TENGs', 'traditional  batteries'], ['easily  which', 'human  health'], ['composite ACF that', 'composite triboelectric layer'], ['composite surface charge which', 'ACF TENG'], ['transferred I charge', 'ACF TENG'], ['', ''], ['', ''], ['', 'pure PP film'], ['ACF TENG', 'effectively Escherichia coli'], ['When ACF TENG', 'light -emitting diodes'], ['ACF TENG', 'medical application electronics'], ['worldwide  that', 'agricultural  productivity'], ['enhance', 'salt stress'], ['Here  we', 'biochemical salt levels'], ['Wheat seedlings', 'inoculated  controls'], ['height root length', 'controlled wheat NaCl'], ['number', 'salt stress'], ['significantly root accumulation', 'markedly saline condition'], ['relative salt expression', 'POD wheat seedlings'], ['strain', 'significantly growth period'], ['T6', 'stressed wheat plants'], ['typically cellulase use', 'other over proteins'], ['Identifying transformants', 'variable expression transformants'], ['western  all', 'which'], ['we', 'foot disease T'], ['screenable marker that', 'target protein'], ['independent  genes', 'single  mRNA'], ['2A peptide sequence', 'independent gene products'], ['When 2A peptide', 'downstream N protein'], ['we', 'green marker protein'], ['we', 'efficiently target Cel7A protein'], ['expression', 'successful test T'], ['', ''], ['Separation', '% 2A efficient'], ['efficiently  eGFP', ''], ['proteins', 'when  order'], ['', ''], ['expression eGFP-2A functionality', 'transcription'], ['eGFP C2 G expression', 'reliably G2C construct'], ['gene order Cel7A', 'G2C G orientations'], ['unrelated  proteins', 'T'], ['however 2A peptide order', 'genes'], ['single C2 G which', 'well Cel7A expression'], ['fluorescence G2C which', 'Cel7A expression'], ['we', 'heterologous  T'], ['', 'polycistronic gene expression cassette'], ['polycistronic ribosome entry cistron', 'equimolarly ribosomal cistrons'], ['', 'cleavable enzyme complex'], ['better  mode', 'over Trichophyton rubrum drug'], ['differential  expressions', 'previously  dermatophyte'], ['Functional  grouping', 'possibly iron transport'], ['results', 'molecular stress T'], ['', ''], ['Diversity', 'opposed immunology results'], ['we', 'like  dermatophyte'], ['J774 cells', 'fungal  growth'], ['Nevertheless  they', 'IL-1  dermatophyte'], ['induced peritoneal macrophages', 'IL-1 beta production'], ['abundance', 'fungal  interaction'], ['cell line', 'interesting  T'], ['', ''], ['Trichosanthin', 'human cancer cells'], ['However  mechanism', 'molecular  level'], ['cancer  mechanism', 'such cytometry western blotting'], ['We', 'ovarian cancer cells'], ['TCS', 'ovarian cancer cells apoptosis'], ['firstly TCS triggers which', 'increased ATG5 expression'], ['apoptotic cell death', 'pharmacological  autophagy'], ['3-MA  functions', 'ovarian cancer cells'], ['also  inhibition', 'induced OVCAR-3 cells'], ['ovarian cancer which', 'drug therapy'], ['plastic  changes', 'chronic  pain'], ['pathogenic  mechanisms', 'pain hypersensitivity'], ['Here  authors', 'mechanical  MS'], ['controlled min 2', '14  d'], ['Mechanical allodynia', 'glucocorticoid receptor antagonist mifepristone'], ['Corticosterone levels', 'mechanical whisker pad skin'], ['TG  neurons', 'subcutaneous MS mifepristone'], ['number', 'naive whisker pad rats'], ['mechanical  allodynia', 'P2X(3)R whisker pad MS'], ['increase', 'mechanical whisker pad adulthood'], ['Here  we', 'residential oxide fuel cluster'], ['', ''], ['', ''], ['energy system', 'solid oxide fuel boiler'], ['We', 'chilling refrigeration demand'], ['', ''], ['', ''], ['plant performances', 'rated energy converter'], ['optimization', 'based system operating methodology'], ['Results', 'different fuel cell'], ['', ''], ['rights', ''], ['We', 'tumor  osteosarcoma'], ['size tumor weight', 'osteosarcoma cells'], ['adjacent osteosarcoma tissues', 'reverse polymerase chain reaction'], ['target gene', 'luciferase report'], ['last osteosarcoma cells', 'microRNA-181a triptolide'], ['apoptosis', 'osteosarcoma cells'], ['relative osteosarcoma level', 'adjacent osteosarcoma tissues'], ['PTEN', 'direct target microRNA-181a'], ['overexpression', 'osteosarcoma apoptosis'], ['', 'inhibited PTEN vivo'], ['prevalence', 'pregnant  women'], ['that', 'pregnant Tropaeolum majus L'], ['Tropaeolaceae', 'converting  enzyme'], ['Herein  we', 'T'], ['majus  extract', 'possible ACE inhibitory activity'], ['rats', 'gestational HETM days'], ['live aldosterone fetuses', 'dead percentage fetus weight'], ['pregnant  rats', 'significant serum aldosterone levels'], ['significant  changes', '20 growth gestation'], ['Thus  data', 'fetal  pregnancy'], ['Trust', 'mutual  benefit'], ['Several fMRI studies', 'shot investment game'], ['overall  characterization', 'neural  networks'], ['meta-  analysis', 'consistent IG stages'], ['', ''], ['', ''], ['one shot IG', 'aversive  feelings'], ['Moreover  decisions', 'probably reciprocity options'], ['', 'likely prediction error signals'], ['Finally dorsal striatum', 'likely reinforcement learning'], ['results', 'neural trust learning'], ['learning  they', 'untrustworthy  partners'], ['', ''], ['susceptible Trypanosoma cruzi BZ', 'differential  expression'], ['hypothetical  others', 'very  T'], ['cruzi genes', 'mucin'], ['approximately  half', 'encoded proteins ribosomal proteins'], ['', 'eight mRNA T'], ['cruzi genes', 'differential  sequences'], ['', 'resistant thiol T'], ['cruzi population', 'susceptible  population'], ['levels', 'fold TcHSP70 T'], ['corresponding cruzi increase', 'TcHSP70 protein expression'], ['TcHSP70', 'directly  T'], ['', ''], ['', ''], ['', ''], ['rights', ''], ['Tuberculosis', ''], ['', 'epidemiological  tuberculosis'], ['diagnosis', 'clinical  arguments'], ['Culture', ''], ['Technological  progress', 'new tuberculosis diagnostics'], ['', ''], ['rights', ''], ['Millennium Development which', 'worldwide  tuberculosis'], ['emergence', 'worldwide TB control'], ['aim', 'resistant  TB'], ['Scopus database', 'TDR study period'], ['number', 'productive  countries'], ['2260 journal articles', ''], ['mean SD citations', 'article'], ['', ''], ['', ''], ['h index', 'retrieved  data'], ['number', 'same study period'], ['100 million South Africa', 'one trillion Gross Domestic Product'], ['India China', 'productive South countries'], ['High  percentage', 'most HBC MDR TB'], ['active Plos journals', 'general XDR TDR medicine'], ['cited  articles', 'such New Medicine'], ['themes', 'new TB drugs'], ['Publications', 'past TDR decade'], ['International  collaboration', ''], ['African  countries', 'diagnostic  TB'], ['exchange', 'paramount expertise field'], ['', 'different health countries'], ['', 'high burden countries'], ['', 'public health Brazil'], ['Cost analysis', 'Mycobacteria Molecular 2013'], ['based  cost', ''], ['', ''], ['', 'centrifuged Ziehl Neelsen'], ['', ''], ['', 'direct  ZN'], ['', ''], ['', 'solid  medium'], ['', ''], ['', 'TB  R'], ['calculation', 'real  tests'], ['So  it', 'new health institutions'], ['Introduction', ''], ['End TB strategy', 'TB 2030'], ['accurate  diagnosis', 'goal'], ['Innovative  strategies', 'TB diagnostics'], ['unavailable  methods', 'diagnosis'], ['Unique properties', 'disease biomarkers'], ['based thirty assays', ''], ['cost  time', 'proposed  platforms'], ['TB nanodiagnostics', 'tuberculous mycobacteria rifampicin'], ['review', 'last TB 10years'], ['Special  consideration', 'clinical concepts detection specimens'], ['potential', 'ideal MTB testing'], ['ideal detection that', 'rigorous TB 2030'], ['Paradoxical  reaction', 'paediatric antituberculosis population'], ['We', 'three  weeks'], ['were', 'mm polymerase chain M'], ['negative chest X ray', 'right  mediastinum'], ['Tuberculosis', 'standard rifampicin isoniazid pyrazinamide'], ['later Twenty she', 'radiological symptoms findings'], ['kg day fever', '24  hours'], ['other  causes', 'unnecessary  tests'], ['Tuberculosis', 'various health countries'], ['how  they', 'seasonality'], ['ecologic  study', 'outdoor  PM2'], ['', 'monthly TB notification'], ['', '5 Hong Kong'], ['descriptive  analysis', ''], ['5  concentration', 'potential TB disease'], ['', 'significant TB cases'], ['when regression models', 'sunshine duration'], ['regression analysis', 'g  PM2'], ['5  concentrations', '3  %'], ['', ''], ['18  cases', 'coming TB Beijing'], ['potential  mechanisms', 'significant  relationship'], ['5  exposure', 'outdoor respiratory PM2'], ['5  episodes', 'seasonal TB PM2'], ['5  concentration', 'potential TB seasonality'], ['Preliminary  evidence', 'first  PM2'], ['', ''], ['potential TB which', 'TB disease'], ['', ''], ['rights', ''], ['Tuberculosis', 'main lymphocyte pleurisy'], ['time  that', 'biopsy  gesture'], ['literature review', 'tuberculous biomarkers pleurisy'], ['biochemical interferon- gamma', '89 adenosine %'], ['', '2  98'], ['', '97  %'], ['', ''], ['', '96'], ['Xpert MTB PCR Xpert RIF', '46'], ['', ''], ['', '67'], ['which', 'diagnostic  99'], ['', ''], ['', '99'], ['', ''], ['release assay', 'pleural 74 fluid'], ['Other  biomarkers', 'still  evaluation'], ['particularly  determination', 'diagnostic TB pleurisy'], ['primary  manifestations', 'various  brain'], ['TSC patients', 'retardation spectrum disorder'], ['Therefore  TSC', 'epilepsy  ASD'], ['functional Tsc1-Tsc2 which', 'cellular Rapamycin Complex'], ['mTORC1', 'eukaryotic  cells'], ['Consequently mTORC1 inhibitors', 'several TSC symptoms'], ['chronically therapy discontinuation', 'tumor regrowth'], ['Tsc1-Tsc2 features', 'potentially TSC symptoms'], ['newest TSC cell that', 'other mTORC1 hyperactivation'], ['', 'Wiley Periodicals Inc'], ['', '962 Molecular 2016'], ['Tumor ablation', 'localized  malignancies'], ['primary  goal', 'designated target energy'], ['high temperature ablation', 'focal radiofrequency microwave malignancies'], ['large  volume', 'tumor tumor reactions'], ['situ release cross tumor', 'situ release cross DAMPS'], ['Tumor tissue destruction', 'inflammatory  milieu'], ['attracted', 'molecular tumor pattern'], ['Mature  DCs', 'processed T cells'], ['immunomodulatory  properties', 'immunotherapeutic  measures'], ['', 'related ablation response'], ['certain  population', 'itself'], ['T we', 'silico simulations'], ['they', 'which'], ['mathematical  function', 'lysis'], ['fractional cell kill', ''], ['', ''], ['', ''], ['rights', ''], ['better inhibitor understanding', 'oncologic human tumor agents'], ['leukocytic  we', 'immune xenotransplantation vivo'], ['We', 'autologous tumor tumor'], ['immune  we', 'tumor compartment'], ['increased tumor which', 'slower tumor growth rate'], ['novel myeloid suppressor that', 'leukocytic  tumor'], ['together  we', 'individualized allogeneic responses'], ['antiapoptotic factor kappa molecule', 'human  malignancies'], ['However  relationship', 'ductal  breast'], ['TNFAIP8 expression', '351 IDC paraffin'], ['TNFAIP8 messenger RNA', 'noncancerous IDC tissues'], ['TNFAIP8 expression', 'axillary lymph node metastasis'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['TNFAIP8 overexpression', 'axillary lymph node metastasis'], ['', ''], ['', ''], ['', ''], ['', ''], ['low multivariate TNFAIP8', 'free  IDC'], ['', ''], ['', ''], ['tumor it', 'prognostic  IDC'], ['', ''], ['rights', ''], ['nucleotide  sequence', 'full turkey 540'], ['two  latter', 'frameshift  translation'], ['TCoV pp1ab', 'structure  nsp1'], ['ClustalW analysis', '88'], ['', ''], ['', 'acid bronchitis level'], ['whole  genome', '540  tail'], ['total', '13  TCoV'], ['subgenomic  RNAs', 'Northern  blotting'], ['whole genome sequence', '86'], ['TCoV', 'TCoV'], ['', ''], ['', ''], ['rights', ''], ['operational  amplifier', 'analog signal circuit design'], ['performance', 'overall OP system'], ['designs', 'parasitic power supply elements'], ['requirements', 'fast settling 0'], ['', ''], ['fast Unity Gain Bandwidth', 'capacitor feedback path'], ['proposed OP AMP', 'only power 20'], ['', ''], ['simulations', '45 nm technology'], ['2 diabetes mellitus development', 'shorter  leukocyte'], ['different insulin length', 'different insulin leukocyte'], ['glucose who', 'treatment'], ['aged  45', 'oral glucose tolerance test'], ['length', 'real polymerase chain time'], ['rank correlation', '2-h plasma glucose length'], ['Logistical regression models', '2-h plasma glucose levels'], ['2-h plasma glucose levels', 'negative  correlation'], ['', 'leukocyte'], ['Waist circumference', ''], ['', 'men'], ['glycemic tolerance test categories', 'normal fasting plasma glucose'], ['correlation relationship', '2-h plasma glucose NGT'], ['', ''], ['', ''], ['respectively  association', 'length DM group'], ['', ''], ['2-h plasma level', 'short  telomeres'], ['', ''], ['', ''], ['', ''], ['', ''], ['circumference systolic plasma phenomena', 'circumference systolic plasma glucose'], ['2-h plasma glucose', 'inversely  length'], ['epidemiologic Impact statement data', 'leucocyte'], ['2hPG plasma levels', 'pathophysiologically  LTL'], ['different LTL that', 'largely  T2D'], ['increase', 'short  telomeres'], ['obtained  data', 'high tissue 2hPG'], ['paper', 'fuzzy  controllers'], ['when  case', 'study'], ['proposed  method', 'global  result'], ['proposed flight that', 'individual  controllers'], ['proposed control strategy', 'fuzzy control approach'], ['Finally optimization method', 'fuzzy  systems'], ['', ''], ['rights', ''], ['human infection model', 'development'], ['Here  we', 'human culture PCR S'], ['', 'performed blood cultures'], ['Principal Culture PCR amplification', 'typhoid blood challenge'], ['Study endpoints', 'typhoid  diagnosis'], ['TD', 'positive blood culture'], ['9  %', 'positive PCR assay result'], ['', ''], ['sensitivity  specificity', 'study endpoints'], ['We', 'significant culture PCR cases'], ['', ''], ['overall attack rate', 'true blood culture'], ['Several  participants', 'primary culture PCR bacteraemia'], ['Overall culture PCR assay', 'routine blood culture'], ['faster blood assay', 'research applications'], ['', ''], ['', 'British Infection Association'], ['', 'TAM receptors'], ['', ''], ['whereby migration chemo expression', 'clinical  outcomes'], ['', 'well tumor immunology'], ['monoclonal tyrosine kinase receptors', 'novel TAM ligands'], ['paper', 'clinical Gas6 practice'], ['', 'U'], ['', ''], ['highway system', 'several scholars industry decades'], ['growing  interest', 'long system term'], ['government agencies', 'maintenance manner deterioration activities'], ['current  work', 'maintenance U'], ['', ''], ['', ''], ['sustained capability authorities', 'long term proactive actions'], ['existing feedback that', 'aging  processes'], ['incentivizing', 'long capacity expansion'], ['Conclusions', 'reactive highway system'], ['', '2017 Civil Engineers'], ['nucleolar  RNAs', 'eukaryotic  cells'], ['Genes', 'diversely  genome'], ['They', 'nuclear  RNAs'], ['They', 'H ACA snoRNAs'], ['snoRNA', 'early D box rRNA'], ['which', 'target RNA'], ['often  they', 'sequence'], ['computational Entamoeba we', '5 Eh_U3 snoRNAs'], ['intergenic  some', 'coding  intron'], ['computationally  snoRNAs', 'RT PCR'], ['expected  sizes', 'shorter ACA products'], ['results', 'E'], ['histolytica', 'structural branching E'], ['histolytica snoRNAs', 'when  yeast'], ['study', 'phylogenetic  groups'], ['Ubiquitination', 'cellular protein degradation'], ['key degradation that', 'many  tumors'], ['However  expression', 'prognostic brain glioma'], ['how  level', 'brain glioma'], ['high brain glioma samples', 'two tissue microarrays'], ['Levels', 'E2-EPF immunohistochemistry'], ['real polymerase chain reaction', '60  glioma'], ['relationship', 'Kaplan Meier survival curves'], ['E2-EPF levels', 'normal glioma nuclei'], ['gradually glioma grade', 'p'], ['', ''], ['Ectopic E2-EPF levels', 'low grade glioma'], ['', ''], ['5-year survival rate', 'low E2-EPF expression'], ['', ''], ['5-year survival rate', 'nuclear ectopic E2-EPF'], ['', ''], ['especially  ectopic', 'higher grade glioma'], ['E2-EPF levels', 'key brain glioma'], ['ubiquitous  manufacturing', 'wide  academia'], ['efficient material handling system', 'ubiquitous manufacturing system'], ['mobile  robots', 'materials'], ['paper', 'ubiquitous manufacturing environment'], ['processing rate', 'material supply'], ['thus  problem', 'material supply production'], ['nonlinear  program', 'required material quantity'], ['heuristic  algorithm', 'genetic  problem'], ['proposed  algorithm', 'large scale problems'], ['', ''], ['rights', ''], ['work', 'Low Drop Radio Frequency IDentification'], ['LDO design approach', 'FSM tag Digital Control'], ['flat output voltage', 'transient LDO response'], ['DE LDO', 'quiescent 1'], ['', '8 mu A'], ['', ''], ['76 % Power Efficiency', ''], ['Circuit design', '0'], ['', ''], ['underlying rat UC', 'rat models'], ['Rats', 'following  groups'], ['UC rat model', '246-trinitro benzene sulfonic acid'], ['general  status', 'histological disease activity index'], ['expression', 'reverse polymerase chain reaction'], ['expression', 'healthy control group'], ['when  that', 'TLR4 expression P'], ['', ''], ['development', 'immune  intestines'], ['Probiotics', 'inflammatory  UC'], ['underlying  mechanism', 'inflammatory  cytokines'], ['Transmission towers', 'important power grid'], ['P Delta P delta', 'commonly eccentricities slippage analysis'], ['Great  discrepancy', 'first order linear analysis'], ['semirigid connection behavior', 'account'], ['present  which', 'voltage lattice transmission tower'], ['technique', 'full scale paper'], ['Furthermore  influences', 'studied load towers'], ['', '2017 Civil Engineers'], ['operational stage which', '60  pF'], ['flipped voltage which', 'rail gain configuration'], ['second input stage', 'overall source 100'], ['', '1  mHz'], ['Instead compensation cascode compensation', '4 C OTA'], ['It', 'identical Miller load'], ['It', '74 nW 74 +'], ['also  which', 'additional C shunt load'], ['buffered  OTA', 'nested C 0'], ['', ''], ['enhances', 'buffered  power'], ['', 'Cadence VIRTUOSO UMC'], ['18 CMOS process technology', 'proposed  circuits'], ['', ''], ['rights', ''], ['based  beamformer', 'low area applications'], ['current  consumption', 'linearly memory size'], ['This', 'conventional SI memory'], ['This', 'delay sum approach'], ['memory cell', 'SI circuits'], ['', '16 memory 35'], ['', ''], ['signal  ratio', '16  channels'], ['9  mA', 'bias'], ['', ''], ['', ''], ['rights', ''], ['Arabidopsis thaliana', 'widely plant biology'], ['agronomic  it', 'genetically  lines'], ['seeds', 'low  germination'], ['influence', 'ultrasonic  A'], ['', ''], ['', ''], ['experiments', 'constant  temperature'], ['germination rate differences', 'collected  seeds'], ['ultrasonic  stimulation', 'significantly  germination'], ['Ultrasonic stimulation application', '30  s'], ['significant  increase', 'ultrasonic germination stimulation'], ['seed that', 'least  germination'], ['ultrasound', 'fertile  plants'], ['Ultrasound technology', 'negatively seedling development'], ['effect', 'least seed coat'], ['use', 'stored Arabidopsis lines'], ['epigenetics', 'more hES architecture'], ['We', 'special electron nucleus'], ['We', 'human  cells'], ['peripheral  that', 'somatic cell types'], ['absence', 'nuclear  lamina'], ['Lamins  A', 'embryoid  bodies'], ['nuclear  they', 'annulate  lamellae'], ['early hES cells', 'early germ which'], ['Subnuclear structures', 'nuclear Cajal interior'], ['architectural  organization', 'important gene expression pluripotency'], ['', ''], ['', ''], ['Dermatitis bullosa pratensis', 'ultraviolet radiation exposure'], ['', 'even reaction burns'], ['', ''], ['We', 'Heracleum sosnowskyi'], ['Heracleum sosnowskyi', 'botanical  I'], ['', ''], ['', ''], ['', ''], ['skin lesions', 'erythema  multiforme'], ['Implemented therapy corticosteroids antihistamines', ''], ['inflammatory  hyperpigmentations', ''], ['', ''], ['Appropriate  diagnosis', 'everyday phytophototoxic practice'], ['green Ulva clathrata', 'magnetic  resonance'], ['percentage', 'dry quantitative algae'], ['dietary  effect', 'hematology tilapia'], ['negative control diet', 'three  ulvan'], ['', ''], ['1  kg(-1', ''], ['Saccharomyces', 'yeast'], ['globulin serum Gb', 'white blood cell'], ['60th  Pa', '60th  day'], ['', 'diets'], ['', ''], ['', ''], ['', ''], ['', '30 WBC diets'], ['', ''], ['1  which', '15  0'], ['', 'dietary  suspension'], ['', ''], ['', 'growth diets'], ['This', 'dietary  U'], ['', 'Nile tilapia'], ['immune  activity', 'supplementation'], ['immunoregulatory  function', 'multiple  sclerosis'], ['Recent  studies', 'immune UC cells'], ['UC MSCs', 'impaired MS patients'], ['cultures', '3 MS days'], ['Flow cytometry', 'Tregs'], ['cell proliferation assay', 'suppressive  Tregs'], ['ELISA', 'cytokine cultures'], ['UC MSCs', 'significantly  CD4(+'], ['', 'reduced interferon gamma'], ['', 'cultures'], ['', ''], ['', ''], ['primed UC Tregs', 'same MS patients'], ['', ''], ['stimulated  CD25(-)Teffs', 'healthy MS subjects'], ['suppressive  function', 'completely UC MSC modulation'], ['functional  defects', 'simple MSC priming approach'], ['uncanny valley model', 'various  expertise'], ['like  characters', 'controversy'], ['Many  experiments', 'psychological  theories'], ['recently  studies', 'mental  discomfort'], ['we', 'emotional chat dialogue'], ['3D  we', 'depicted control characters'], ['', 'alleged  autonomy'], ['', ''], ['stronger  they', 'empathic  characters'], ['uncanny  that', 'human  entities'], ['human  concept', 'human  distinctiveness'], ['', ''], ['', ''], ['rights', ''], ['paper', 'undergraduate laboratory class'], ['experimental  module', 'experimental level biochemistry proteins'], ['Students', 'cooled crystallization synchrotron'], ['Students', 'remote Biology Consortium beamline'], ['', ''], ['', 'Berkeley CA USA'], ['Processed diffraction data sets', 'partial protein refinement'], ['laboratory component', '2  MX'], ['module', 'remote synchrotron source'], ['Participating', 'pivotal life science disciplines'], ['oral thinking students', 'scientific  knowledge'], ['Modernizing', 'experiential sciences research learning'], ['more  students', 'high impact research experience'], ['students', 'molecular modeling lab'], ['Students', 'solving research lab'], ['', 'future career paths'], ['undergraduate learning students', 'publishable  research'], ['Future areas', 'top  biochemistry'], ['independent life scientists', 'well graduate schools'], ['', 'International Biochemistry'], ['sports who', 'emotional child allegation'], ['such  research', 'lived  this'], ['largely  they', 'child protection'], ['Using', 'literary coach techniques'], ['story', 'emotionally  it'], ['dangerous  story', 'available child sport'], ['Early  adversity', 'unipolar risk depression'], ['unipolar  effects', 'gender'], ['We', 'national cohort registers'], ['sample', '1980'], ['Exposure', 'early  ages'], ['Types', 'out family home'], ['psychiatric December whichever', 'psychiatric hospital death emigration'], ['Hazard ratios', 'Cox regressions'], ['adversities', 'adolescent adult depression'], ['', ''], ['effects', 'mutual  adjustment'], ['', ''], ['', ''], ['None', 'gender'], ['effect', 'family ages'], ['', ''], ['', ''], ['effect', 'out  ages'], ['', ''], ['', ''], ['', ''], ['treated  depression', ''], ['multiple  types', 'unipolar  adolescence'], ['more  they', 'developmental time periods'], ['sectional depression little', 'neurobiological  other'], ['only time few', 'long time window'], ['article', 'methodological brain MDD'], ['MRI resonance that', 'longitudinal  designs'], ['15  studies', 'minimal  standards'], ['analysis', 'spatial imaging restrictions'], ['longitudinal mood studies', 'depressive brain outcome'], ['longitudinal  studies', 'neurobiological  time'], ['Future studies', 'large sample sizes'], ['Cooperation', 'possible sample confounders'], ['article', 'economic China Hong Kong'], ['that', 'financial  crisis'], ['Additionally  allowing', 'unit root Taiwan'], ['Important  implications', ''], ['important  conclusions', 'nonstationarity'], ['only  investors', 'when world economy Taiwan'], ['Hong it', 'Hong shock'], ['economic  it', 'more Mainland China'], ['Citizen Science approach', 'engaging Food Control'], ['Real  samples', '2014 Food Production'], ['Molecular  genetics', 'nine seafood BMA'], ['undeclared GM maize', 'six seafood products'], ['postLaboratory survey', 'Laboratory Genetics'], ['that', 'Genetic control students'], ['', ''], ['', ''], ['citizen science approaches', 'active food control'], ['', 'International Biochemistry'], ['paper', 'porous water retention media'], ['Models', 'extensive parameter identification'], ['approach', 'solely void reference'], ['Particular  attention', 'rarely evolution literature'], ['Incremental  expressions', 'wetting  drying'], ['Validity', 'mechanical  paths'], ['Good agreement', 'experimental model cases'], ['', '2017 Civil Engineers'], ['Unsteady  friction', 'transient pressure waves'], ['extreme pressure values', 'different pressure sections'], ['paper', 'available friction literature'], ['', '1D  models'], ['investigation', 'simple pipeline systems'], ['Realistic  ranges', 'pretransient  conditions'], ['data', 'unsteady friction investigation'], ['validated  models', 'respective  applicability'], ['differences', 'such  paper'], ['practical  implications', 'transient pipe flow paper'], ['', '2017 Civil Engineers'], ['UC  material', 'high Stokes process'], ['', 'ultraviolet conversion photo emission'], ['visible UC it', 'well UC material'], ['work', 'theoretical research perspective'], ['intrinsic  mechanisms', 'visible  UC'], ['material design strategies', 'visible UC phosphors'], ['reasonable UC expectation', 'potential  material'], ['', ''], ['', ''], ['rights', ''], ['open reading frames', \"translational 5'-untranslated control\"], ['However  little', 'translational  control'], ['MKKS McKusick Kaufman that', 'genetic  disorder'], ['Northern', 'transcripts'], ['', 'regulatory Luciferase uORFs'], ['Immunoblotting', 'derived protein products'], ['short  that', \"alternative polyadenylation 5'-UTR\"], ['simultaneous  disruption', 'downstream initiation ORF'], ['Furthermore protein products', 'two HeLa cells'], ['such  uORFs', 'human polyadenylation transcripts'], ['', 'translational transcript MKKS'], ['Two  uORFs', 'mitochondrial membrane'], ['General  findings', 'derived  uORFs'], ['', ''], ['rights', ''], ['little psychology attention', 'urban place identity'], ['largest  work', 'urban identity behaviors'], ['urban order identity', 'personal  norms'], ['', ''], ['rights', ''], ['rapid  urbanization', 'substantial  world'], ['various  that', 'consistent urbanization conclusions'], ['urban urbanization it', 'regional urbanization level'], ['normal  that', 'economic development stage'], ['certain  problems', 'narrow urbanization rate'], ['low urbanization rate', 'central development China'], ['results', 'Chinese  policymakers'], ['Local  governments', 'too urbanization quantity'], ['', '2016 Civil Engineers'], ['Calmette Guerin', 'recurrence'], ['tremendously  patients', 'immunotherapeutic bladder horizon'], ['reported response rates', 'improvement'], ['immune resistance we', 'specific bladder cancer'], ['critical tumor we', 'immune  response'], ['Many', 'therapeutic  interventions'], ['new  immunotherapies', 'better tumor biology'], ['potential  biomarkers', 'molecular gene expression luminalThasal'], ['highly UBC that', 'patients'], ['', ''], ['rights', ''], ['Tremendous  advances', 'advanced tumor disease'], ['small checkpoint subset', 'durable  remissions'], ['optimal antitumor response', 'likely cells novel combination'], ['addition discovery', 'maximum UC immunotherapy'], ['', ''], ['rights', ''], ['industrial  which', 'important  nation'], ['Four regime shifts', '2014  U'], ['', ''], ['', ''], ['genetic  algorithm', 'evolution'], ['correlations', 'three electricity departments'], ['which', 'further  market'], ['four regime shifts', 'different price level'], ['fluctuation', 'four regime shifts'], ['final  part', 'research'], ['', ''], ['rights', ''], ['Light', 'human  body'], ['we', 'surroundings'], ['', 'light  physiology'], ['new lighting aspect', 'control'], ['they', 'commonplace  us'], ['apart  what', 'technology'], ['unprecedented  flexibility', 'interactive  light'], ['we', 'attentional  attention'], ['peripheral  interaction', 'digital lighting presents'], ['Uveal  melanoma', 'iris ciliary iris body'], ['local  survival', 'primary tumor size'], ['50  %', 'metastatic  diagnosis'], ['adjuvant  therapy', 'date'], ['PI3K subunit Akt', 'new  disease'], ['Studies', 'novel  development'], ['We', 'adjuvant therapy way'], ['chorioretinal  infection', 'many posterior countries'], ['atypical  presentations', 'misdiagnosis  treatment'], ['Molecular biology techniques', 'many laboratory countries'], ['Aqueous  humor', 'rapid polymerase chain diagnosis'], ['Oral  pyrimethamine', 'ocular  toxoplasmosis'], ['Recent  data', 'intravitreal treatment antibiotics'], ['aim', 'ocular  toxoplasmosis'], ['', ''], ['', ''], ['new  that', 'infectious  disease'], ['We', 'immune polyelectrolyte multilayers'], ['like receptor that', 'molecular  adjuvants'], ['Gold nanoparticles', 'specific T mice'], ['Here  we', 'tumor T cell mice'], ['injection routesintradermal injection subcutaneous', 'iPEM dosing levels'], ['specific T cell level', 'response'], ['specific cell recall responses', 'prime boost immunization regimen'], ['exogenous iPEM vaccines', 'mixed tumor formulations'], ['', 'potent  polyIC'], ['immune vaccine that', 'self  substrates'], ['', ''], ['', ''], ['', ''], ['', ''], ['immune  responses', 'foreign antitumor immunity'], ['size', 'effective glutamic loading'], ['', ''], ['', 'immune lymph nodes'], ['inflammatory TNF I', 'alpha IFN OVA'], ['higher inflammatory I', 'other SVNP groups'], ['treated  mice', 'cell expansion cell activation'], ['', 'innate T cell immunity'], ['preventive  vaccination', 'higher tumor growth'], ['', ''], ['rights', ''], ['general  rules', 'viral  vaccine'], ['', 'unique virus U'], ['', ''], ['', ''], ['structural  information', 'potential  pathogens'], ['Here  I', 'immunogenic vaccine antigen vaccine'], ['humoral  immunity', 'immune antigen system'], ['important antigen that', 'vaccine'], ['', ''], ['', 'Elsevier Inc'], ['rights', ''], ['particular  qualities', 'valenced  objects'], ['People', 'thus George Hitler'], ['social  traces', 'also  value'], ['simply consumer products', 'generic mugs strangers'], ['', ''], ['', 'machines'], ['', 'perceived  value'], ['other  which', 'social  qualities'], ['', ''], ['', ''], ['social  these', 'everyday  value'], ['variable gain amplifier', 'improved dB linearity'], ['traditional cascade VGA', 'mismatch cancelation'], ['paper switch arrays', 'integral gain errors'], ['shaping  DEM', 'useful dB linearity performance'], ['cascade', 'shaping  2'], ['4-GHz receiver which', '0'], ['', 'supply 1'], ['', ''], ['gain errors', 'thermometric temperature C'], ['', ''], ['torque control bandwidth', 'control system stability'], ['control dynamics', 'digital control events'], ['', ''], ['', 'motor currents'], ['Reflecting', 'therefore vehicle traction systems'], ['paper', 'digital control events timing'], ['aim', 'Motor Permanent PMSM'], ['Bode characteristics', 'analytical reference model'], ['comparison', 'used  PMSM'], ['presented  frameworks', 'specific  models'], ['fractional  derivative', 'quantum Riesz Feller definition'], ['numerical  method', ''], ['Special  attention', 'proposed stability method'], ['method', ''], ['', '2 HIV infection'], ['multiple T cell recurrences', 'antiretroviral  therapy'], ['Ageing', 'systemic  functions'], ['greater  susceptibility', 'endothelial progenitor cells'], ['They', 'important neo angiogenesis'], ['Vascular  ageing', 'wall'], ['', 'possible  damage'], ['', 'nitric  oxide'], ['elderly  people', 'major cardiovascular disease'], ['Nutraceutical', 'new  field'], ['vascular  second', 'therapeutic  interventions'], ['we', 'vascular  it'], ['', ''], ['rights', ''], ['older  effect', '65 incident depression'], ['medical  who', '2011'], ['proportional hazards models', 'obese incident depression'], ['Adjustment covariates', ''], ['analysis', '44175 follow up'], ['', 'vascular risk factor age'], ['', ''], ['', ''], ['90', 'incident depression age'], ['magnitude', '65 depression 8'], ['', 'additional  age'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '65 incident depression age'], ['Men', '65  2'], ['', 'times incident age'], ['', ''], ['', ''], ['medical  which', 'study generalizability'], ['Results', 'vascular depression hypothesis'], ['Depression screening', 'late onset depression'], ['electrogenic proton pump', 'human Plasmodium malaria'], ['overall  features', 'gene organization'], ['Here  we', 'highly V ATPase'], ['Northern RT PCR blotting', 'proteolipid parasite cells'], ['deduced amino acid sequence', 'yeast  counterparts'], ['Southern blot analysis', '5  exons'], ['yeast null cells', 'vesicular  quinacrine'], ['mutated  proteolipid', 'vesicular growth quinacrine'], ['actually P proteolipid', 'yeast'], ['', ''], ['', ''], ['rights', ''], ['', ''], ['granulocytic Lyme anaplasmosis', 'babesiosis'], ['when  prevalence', 'persistent  population'], ['', ''], ['partial  which', 'pathogen'], ['infection which', 'infection'], ['Research', 'many disease control these'], ['', ''], ['rights', ''], ['Intranasal  infection', 'functional beta T cells'], ['viral response gene transcripts', 'acute type infection'], ['infectious WT virus', '92 beta dpi'], ['Persistent brain infection', 'later time points'], ['Persistent brain infection', 'viral  brain'], ['potential', 'specific ancillary service work'], ['real world which', 'vehicles buildings'], ['Key  parameters', ''], ['vehicle  scenarios', 'commercial electricity building'], ['Results', '8400 capacity market pound'], ['This', 'vehicle hour infrastructure'], ['net income generation', 'vehicle battery degradation cycling'], ['', ''], ['rights', ''], ['Venous  malformations', 'perivascular cell coverage'], ['miR-145', 'smooth muscle cells'], ['potential  roles', 'VMs'], ['10 treatment samples', 'situ alpha hybridization'], ['Subsequently  correlations', 'endothelial testin vitro cells'], ['miR-145', 'decreased beta expression level'], ['miR145 expression', 'perivascular SMA+ cell VMs'], ['TGF beta miR-145', 'concurrently bleomycin A5'], ['human TGF beta', 'increasing TGF tendency'], ['present  study', 'disorganized TGF beta vessels'], ['Moreover  miR-145', 'target potential'], ['', ''], ['', ''], ['rights', ''], ['ohm', 'derivative  ohm'], ['which', 'boundary  conditions'], ['abstract Cauchy problem', 'subdifferential'], ['strong  solution', 'derivative parabolic ohm'], ['it', 'nonlinear semigroup T p'], ['elliptic  we', 'weak existence solutions'], ['', ''], ['rights', ''], ['VP  children', 'social autism spectrum disorder'], ['viewing eye that', 'difficulties'], ['birth weight', '25  ASD'], ['multidimensional  median', 'VP children'], ['Time', 'face'], ['comparable VP other', 'comparable ASD group'], ['VP -large', 'less ASD face'], ['1  they', 'face'], ['VP children', 'two gaze behaviors'], ['TD other', 'similar ASD group'], ['method', 'social VP difficulties'], ['', 'Japanese Child Neurology'], ['', 'Elsevier B'], ['', ''], ['rights', ''], ['OEF population OIF', 'mental Posttraumatic Stress Disorder'], ['distinct  profiles', 'mental health symptoms'], ['current  study', 'alcohol use'], ['', ''], ['drinks', 'centered alcohol risk approach'], ['We', 'mental health symptoms'], ['', ''], ['PTSD  depression', 'related alcohol risk profiles'], ['252  who', 'past  month'], ['four class solution', 'respective alcohol use'], ['Mental health symptoms', 'four  profiles'], ['who', 'related  problems'], ['', ''], ['Severe alcohol behavior', 'PTSD  depression'], ['Binge drinkers', 'mental health symptoms'], ['Findings', 'distinct alcohol risk profiles'], ['interventions  options', 'OEF OIF veterans'], ['', ''], ['rights', ''], ['Suicide rates', 'perhaps trauma exposure'], ['', 'highlights depressive literature highlights risk'], ['PTSD  symptoms', 'emotional suicide factors'], ['sample', 'Multidimensional Health ProfilePsychosocial Functioning'], ['serial  analyses', 'PTSD suicide risk'], ['', 'positively suicide risk'], ['', 'PTSD suicide models'], ['PTSD  symptoms', 'internal suicidal hostility'], ['Anger', ''], ['prospective  studies', 'diverse  veterans'], ['findings', 'veteran suicide prevention'], ['effects', 'PTSD suicide linkage'], ['cognitive suicide who', 'trauma'], ['role', 'forensic animal evidence'], ['often law enforcement crimes', 'interpersonal  violence'], ['understanding', 'appropriate animal questions'], ['authors', 'various animal cruelty'], ['alleged  perpetrator', 'other  animals'], ['Design', 'operational gain amplifier'], ['proposed VGA topology', 'main circuit parameters'], ['VGA', '0'], ['', 'BSIM3 Cadence models'], ['', 'Designed power 3'], ['', ''], ['100  mV', '1  input'], ['Implemented feedback circuit', 'phase 68'], ['', ''], ['victimization', 'psychological  wellbeing'], ['', '564  participants'], ['', ''], ['', ''], ['social  exclusion', 'virtual ball tossing game'], ['perceptions', 'more well inclusion'], ['reported victimi zation', 'regardless Cyberball game'], ['reported  victimization', 'negative exclusion condition'], ['who', 'social  situations'], ['results', 'social  cognition'], ['', ''], ['rights', ''], ['use', 'aggressive video behavior'], ['', 'violent game playing'], ['desensitization', 'empathy'], ['only media little', 'long term effects'], ['social fMRI activations', 'social control interaction'], ['mind groups', 'brain responses'], ['desensitization impact', 'emotional  processing'], ['that', 'renewable  Brazil'], ['organic sugarcane which', 'Brazilian  economy'], ['high sugarcane production', 'high ethanol Brazil'], ['anaerobic carbon dioxide that', 'sugar Brazil'], ['Based', 'anaerobic energy potential'], ['following plantation areas', 'autonomous sugarcane plants'], ['total energy potential', '3'], ['which', '0'], ['', 'domestic energy 2014'], ['potential', 'same  1'], ['Mt CO2 Mt which', ''], ['', 'whole  2014'], ['environmental  that', 'Brazilian energy matrix'], ['', ''], ['rights', ''], ['objective', 'formal partner education'], ['This', 'mother Pernambuco Brazil'], ['intimate partner who', '2005'], ['educational  practice', 'Health World Health Organization'], ['Intimate partner violence', 'physical  partner'], ['crude prevalence ratios', 'log binomial log regression'], ['prevalence', 'intimate partner violence'], ['4  %', ''], ['', ''], ['use', 'violent  97'], ['', 'violent  discipline'], ['mothers', 'psychological partner aggression'], ['', ''], ['', ''], ['', ''], ['violence', 'parental  education'], ['educational  that', 'women'], ['emotional  abuse', 'negative South survivors'], ['known  studies', 'based child abuse victimisation'], ['study', 'prevalence multicommunity sample'], ['', ''], ['6 % female', 'African census enumeration provinces'], ['self report questionnaires', '1-year follow up'], ['', ''], ['Results Prevalence', ''], ['', 'physical  abuse'], ['', ''], ['', 'emotional  abuse'], ['', 'sexual % abuse'], ['', ''], ['', ''], ['9  %', 'lifetime victimisation'], ['1  %', 'multiple abuse victimisation'], ['Main  perpetrators', 'girlfriend abuse boyfriends'], ['This', 'based South Africa'], ['Findings', 'targeted  incidence'], ['Accurate  definitions', 'scientific  enterprise'], ['definition', 'sexual self offenses'], ['social  psychology', 'public health approach'], ['distinguish  violence', 'other  them'], ['essential  that', 'essential  elements'], ['sophisticated  recognition', 'elements'], ['serious child that', 'few  days'], ['other violence that', 'prototypical  exemplars'], ['precise  definitions', 'other prevention benefits'], ['Objectives Inappropriate discipline', 'social  health'], ['that', 'discipline strategies'], ['old multimedia that', 'appropriate discipline strategies'], ['Play', 'Nicely exam visit'], ['viewing discipline time', '20 discipline choosing'], ['31  %', '96  study'], ['they', 'personal family beliefs'], ['program', 'individual  questions'], ['', ''], ['program', 'family values'], ['primary care that', 'culturally  parents'], ['results', 'primary child abuse'], ['Violence', 'elderly people children'], ['they', 'more  violence'], ['such  area', ''], ['domestic  which', 'generation'], ['official video that', 'related  topics'], ['reference we', 'categories'], ['40 video ten', '40 video which'], ['complete  we', '-generational  children'], ['critical  reflections', 'educational  Generations'], ['GAS microbial causes', 'children'], ['We', 'pathogenic interferon response'], ['observational blood samples', '16 febrile pharyngitis'], ['Microbial cause', 'bacterial polymerase chain reaction'], ['Blood MxA level', ''], ['potential  pathogen', '59 G cases'], ['rhinoviruses', ''], ['Blood MxA levels', 'sole 150 GAS'], ['Detection', 'causative blood MxA pharyngitis'], ['', ''], ['', 'Elsevier Ltd'], ['rights', ''], ['HDV hepatitis D infections', 'major liver disease'], ['250 million 250 patients', 'chronically  HBV'], ['Current  antivirals', ''], ['great  absence', 'HBV virus host interactions'], ['natural host cell', 'virus host interactions'], ['taurocholate', 'overexpressing hepatoma HBV'], ['major cell culture models', 'future highlight developments'], ['good model systems', 'various plant viruses'], ['simple tuber which', 'Nicotiana benthamiana'], ['PSTVd loop19', 'mesophyll RNA N'], ['benthamiana', ''], ['findings', 'biological RNA systems'], ['HBV hepatitis B therapies', 'breakthrough patients'], ['surface antigen loss', 'HBs  therapy'], ['additionally  loss', 'circular  DNA'], ['available  endpoints', 'new  therapeutics'], ['new  ways', 'virologic  endpoints'], ['new  markers', 'various HBV infection'], ['patient  selection', 'HBV  cure'], ['Immunodeficiency Virus Human Immunodeficiency infection', 'public  health'], ['approaches', 'immune virus complexity'], ['aim', 'primary HIV infection'], ['immune Lymph that', 'blood'], ['temporal population dynamics', 'intercellular cytokine fields'], ['We', 'IL-2 gene IFNa'], ['Distinct activation thresholds', 'relative  cytokines'], ['fundamental lymph that', 'viral T cell blood'], ['Capripoxviruses', 'notifiable Animal Health'], ['diagnostic Enigma Field that', 'real capripoxvirus laboratory'], ['lyophilized field that', 'diagnostic PCR assay'], ['based PCR which', 'based PCR assay'], ['mobile PCR system', 'clinical Africa sheep'], ['Morogoro which', 'lumpy skin disease'], ['data', 'rapid endemic field settings'], ['VL collection samples', 'patients'], ['work', 'time quantitative PCR'], ['detection limit', 'similar qPCR 0'], ['', '025 mu L'], ['', 'urine'], ['', 'serological concordance 96'], ['08  %', ''], ['', ''], ['Kappa coefficient', 'diagnostic % criteria'], ['', ''], ['', ''], ['detection', 'renal Leishmania impairment'], ['Fast  depletion', 'therapeutic meglumine approaches'], ['good  sample', 'suspected VL patients'], ['', ''], ['', ''], ['rights', ''], ['Humans', 'social attention gaze'], ['social  knowledge', 'phenomenon'], ['different  faces', 'positive  behaviours'], ['same  faces', 'cueing  task'], ['faces', 'sociable  behaviours'], ['especially  who', 'positive  behaviours'], ['attentional  responses', 'us'], ['paper', 'novel Extreme Learning Machines'], ['contextual  information', 'visual eye movement experience'], ['saliency', 'similar input image'], ['given saliency predictor', 'retrieved  ensemble'], ['saliency', 'predicted saliency members'], ['', ''], ['', ''], ['rights', ''], ['Secure parent child attachment', 'visual  impairment'], ['that', 'parental  attachment'], ['Video feedback Intervention', 'Positive blueprint'], ['it', 'additional risk populations adjustments'], ['that', 'VIPP'], ['Delphi consultation', 'focused  intervention'], ['themes', 'systematic literature search'], ['intersubjectivity joint attention exploration play', 'specific Delphi group'], ['74  articles', 'six  themes'], ['rich  literature', 'specific themes interaction intersubjectivity'], ['such intervention which', 'higher order sensitivity'], ['first order it', 'first order schizophrenia'], ['Here  we', 'healthy firstepisode controls'], ['We', 'high order visibility'], ['paranoid episode it', 'primarily  metacognition'], ['present  study', 'average growth 37'], ['', '08 % citation 8'], ['', 'collaborative publication 15'], ['', ''], ['productive Vitamin D countries', '73'], ['', 'global % publications'], ['', 'global % 2006'], ['15 Vitamin D organizations', '15  47'], ['', ''], ['', ''], ['', ''], ['', 'Indian % citation output'], ['Medicine', 'largest publications 88'], ['62  %', 'biochemistry genetics'], ['', ''], ['', ''], ['', ''], ['', ''], ['', ''], ['', '68  2006'], ['15  journals', '31'], ['', '72 % output'], ['cited  papers', 'average  118'], ['', ''], ['', 'more healthcare area'], ['that', 'metabolic  pathways'], ['It', 'mostly calcium metabolism'], ['also  it', 'such heart failure'], ['vitamin', 'extensively angiotensin aldosterone system'], ['metabolic cardiovascular we', 'well  literature'], ['review', 'molecular  biology'], ['', 'full length ticks'], ['This', 'binding  Vg'], ['nt Accession number which', 'molecular  208'], ['single RXXR cleavage that', 'two  subunits'], ['', 'N terminal type D domains'], ['Tryptic digest MS analysis', 'tick yolk protein'], ['', 'Apparently  D'], ['uncleaved  that', 'single RXXR cleavage signal'], ['close Vg genes', 'tick'], ['', ''], ['', ''], ['variant', 'partial Boophilus microplus'], ['Phylogenic analysis', 'full Vg D'], ['', 'partial  B'], ['microplus', 'insects'], ['Vg message', 'Northern body blotting'], ['ovipositing egg laying', 'ovipositing  females'], ['endocrine regulation', 'Vg mRNA'], ['tissue sources', 'Vg message'], ['American dog which', 'further  study'], ['', ''], ['rights', ''], ['paper', 'basic Feedback Operational Amplifier'], ['Additionally  it', 'closed loop voltage gain'], ['it', 'operational voltage amplifier'], ['Additionally  paper', 'black  box'], ['that  parameters', 'particular circuit configuration'], ['test that', 'normally silicon CFOAs'], ['zero test that', 'd'], ['', 'GHz'], ['Also  we', 'Ohmic  value'], ['practical test methods', 'physical laboratory prototypes'], ['continental  that', 'Atlantic Ocean'], ['formation', 'large  magnitude'], ['', ''], ['10  s', 'volcanic fault flows'], ['that', 'magmatic  loading'], ['do', 'volcanic flow structures'], ['plates', 'volcanic dike solidification'], ['elastic plate flexure approximation', 'closed form flows'], ['model', 'independent  parameters'], ['reasonable  model', 'observed reflector dip'], ['numerical  scheme', 'volcanic  infill'], ['jumps', 'normal fault offset'], ['When  jumps', 'spreading  center'], ['', ''], ['they', 'other  side'], ['This', 'volcanic conjugate margins'], ['', ''], ['', ''], ['rights', ''], ['volcano Neogene characteristic', 'boron bearing stratum'], ['formed boron deposits', 'electrical  resistivity'], ['boron we', 'geophysical  exploration'], ['We', 'high Bouguer anomalies'], ['audio magnetotelluric audio sounding', 'underground study area'], ['geological study we', 'sedimentary volcanosedimentary boron deposits'], ['drilling test results', 'predicted  results'], ['controlled flyback study', 'sampling drop compensation'], ['important  that', 'output voltage'], ['that', 'output diode'], ['RC resistance compensation', 'cable voltage drop'], ['software simulation prototype test results', 'constant voltage prototype'], ['', ''], ['', ''], ['MOS', 'reference output'], ['paper', 'final V REF output'], ['temperature stability', 'less power consumption'], ['proposed temperature compensation circuit', 'output 1'], ['that', 'C'], ['output reference voltage', 'line 2'], ['', '4mV supply 1'], ['', '1'], ['', 'typical process corner'], ['cascode op that', 'common mode range'], ['closed  reference', 'final V REF'], ['PSRR', '70 op amp'], ['96 mu V', 'closed op BGR'], ['total  current', 'overall  BGR'], ['', ''], ['proposed bandgap reference', '130 nm CMOS technology'], ['LDO regulator that', '3'], ['', 'regulated 3V 1'], ['', ''], ['which', 'frequency range'], ['VCO topology', 'negative inductance converter'], ['oscillator', ''], ['designed  VCO', 'low covers frequency 786'], ['', ''], ['', 'in phase 141'], ['', '1 carrier frequency'], ['Power consumption', '57 VCO +'], ['', ''], ['that', 'low noise signal'], ['study', 'robust start up'], ['that', 'robust wideband operation'], ['proposed controlling technique', 'phase noise degradation'], ['start ACCPs which', 'boost'], ['', '0'], ['VCO', 'wide frequency tuning 21'], ['', ''], ['', ''], ['', ''], ['', '1  25'], ['', ''], ['', '1'], ['power consumption', 'core circuit'], ['', ''], ['', 'entire output frequency range'], ['operational  amplifier', 'multifunctional  filter'], ['designed  circuit', 'theoretical analysis PSPICE simulation'], ['high  pass', 'filter function'], ['pass band', 'input frequency'], ['Furthermore  it', 'theoretical  significance'], ['voltage  converter', 'modulated duty cycles'], ['voltage  circuit', 'charge  comparator'], ['50 duty cycle signal', 'external voltage level'], ['proposed VFC circuit', 'practical  application'], ['errors', 'trade performance'], ['which', 'modulated duty standard'], ['CMOS 18-m 1P6 technology', 'active 210mx190 m'], ['proposed  converter', 'output 2'], ['', 'input voltage 0'], ['', ''], ['', 'power 0'], ['', ''], ['', 'coding Volvariella sequences'], ['GC content', 'several codon V'], ['', 'base composition'], ['', 'such codon V'], ['similar codon usage pattern', 'V'], ['', ''], ['', ''], ['', 'different codon usage C'], ['', ''], ['separately gene chip most', 'predicted optimal codons'], ['study', 'useful gene V'], ['', ''], ['', 'International Union International Biochemistry'], ['means', 'angular  momentum'], ['approach', 'spatial light modulator'], ['We', 'optical coherence elements'], ['cross correlation which', 'good  theory'], ['low tire cavity it', 'dynamic product manufacturing tire'], ['useless heat transfer which', 'thermal themal conductivity'], ['curing precision manufacturing technology', 'generation tire energy'], ['intelligent heating realizedwhich', 'high performance tire'], ['51%utility 255/30R22 cost', '64  process'], ['Recent  advances', 'forgotten cell cancer'], ['incidence', 'squamous cell 1990s'], ['most  women', 'disease'], ['', 'therapeutic VSCC human options'], ['literature review', 'molecular cell cycle apoptosis'], ['targeted  agents', 'HPV  VSCC'], ['Recent  advances', 'targeted  therapies'], ['Aberrant cell cycle activity', 'HPV protein products'], ['Extracellular regulators', 'clinically  VSCC'], ['independent  VSCC', 'actionable PI3 K CDKN2A'], ['therapeutic  vaccines', 'based E7 HPV investigation'], ['', 'neglected  cancer'], ['Directed  therapy', 'therapeutic cell cycle VSCC'], ['that', 'actionable  mutations'], ['associated VSCC novel that', 'immune  response'], ['Resource Efficient waste', 'resource'], ['that', 'special  attention'], ['special  they', 'low reuse rate'], ['paper', 'mechanical glass AACB performance'], ['Microstructure', ''], ['10 % waste glass', 'compressive % calcium strength'], ['also  mortars', 'compressive biopolymer carrageenan 0'], ['1  %', 'most  mixtures'], ['use', 'compressive AACB mortars'], ['Several  mixtures', 'compressive  strength'], ['highly  preconditions', 'environmental energy system assessment'], ['different  aspects', 'other'], ['potentially energy design', 'avoided waste management'], ['CO2 emissions', 'combustible  waste'], ['one', 'avoided electricity generation'], ['novel  aspect', 'different electricity fuels'], ['lower  this', 'other waste management practises'], ['recovered landfill energy', 'high polluting plants'], ['it', 'overall electricity results'], ['WWT wastewater developments', '25  years'], ['These', 'especially nutrient removal'], ['number', '33  %'], ['sized  WWTPs', 'technical energy aspects'], ['comprehensive investigation that', '21  PE'], ['investigations', 'quality  efficiency'], ['These', 'electrical energy consumption'], ['extension', 'anaerobic digester gas'], ['prospect', 'sized  WWTPs'], ['results', 'international data research'], ['upgrading  requirements', 'design'], ['', '2017 Civil Engineers'], ['Special  attention', 'treated  wastewaters'], ['', 'high  investment'], ['other microalgae growth', 'rich  biomass'], ['cultivation', 'appropriate Rate Algae system'], ['that', 'lipid biomass'], ['effect', 'two  CO2'], ['microbial kinetic that', 'continuous  operation'], ['Nutrient removal', 'lipid biomass'], ['best  conditions', '03 biomass 26'], ['', 'lipid TSSm-2 6'], ['', 'continuous g lipids mode'], ['concentration', 'restrictive wastewater discharge'], ['', ''], ['', ''], ['rights', ''], ['5 expression AQP5', 'submandibular Sprague Dawley rats'], ['Pflugers', ''], ['', 'inbred AQP5 offspring'], ['low producer rats', '18th  experiments'], ['low AQP5 they', 'genetic water channel'], ['AQP5 mRNA AQP5 levels', 'transcriptional  diversity'], ['', 'two  groups'], ['third transmembrane alteration', 'Kozak area'], ['existence', 'genomic  DNA'], ['ineffective membrane rats', 'salivary water glands'], ['water which', 'water intoxication'], ['PMCT  examination', 'intestinal  contents'], ['who', 'house'], ['He', 'large  death'], ['PMCT findings', 'low radiodensity content'], ['right  atrium', 'low radiodensity content'], ['Autopsy results', 'duodenum brownish jejunum'], ['respectively  drugs', 'blood'], ['autopsy  we', 'water death'], ['various PMCT radiodensities', 'fresh water drowning'], ['PMCT', 'excessive water drinking'], ['PMCT', 'water autopsy'], ['water  consumption', 'year  countries'], ['perpetual  increase', 'sustainable  way'], ['usually  it', 'efficient  improvement'], ['water efficiency that', 'unintentional energy efficiency field'], ['efforts', 'effective  paths'], ['paper', 'interdependent end user level'], ['where  influence', 'two  variables'], ['presence', 'electric bath duration'], ['', 'water consumption water duration'], ['it', 'electric water consumption'], ['', ''], ['', 'Elsevier B'], ['', ''], ['present  paper', 'architectural waterfront planning'], ['Moreover  attitude', 'spiritual water nation'], ['cultural  field', 'hydro waterfront measures'], ['algorithm', 'cultural waterfront paper'], ['such  territories', 'modern climate world'], ['Overtopping  BReakwater', 'traditional rubble mound breakwaters'], ['device', 'front  electricity'], ['energy', 'low water reservoir'], ['paper', 'various wave structure'], ['results', 'same wave 2012'], ['', ''], ['formulas', '2016 Naples Harbour'], ['current  operating', 'resistance time conversion'], ['which', 'capacitive voltage sensors'], ['interface circuit', 'operational Analog Devices'], ['frequency period which', 'passive  components'], ['Experimental  measurement', 'proposed interface circuit'], ['interface circuit', 'wide humidity sensor'], ['Wavelength stabilization', 'continuous wave laser'], ['We', 'pulsed detection lidar system'], ['Wavelength calibration', 'digital control software'], ['Optimization', 'better laser wavelength discrimination'], ['Test results', 'atomic multimode broadband 589'], ['well  temperature', 'laboratory'], ['maximum wavelength drift', '5  0'], ['42  pm', 'maximum wavelength drift 3'], ['', '3  0'], ['3  It', 'efficient fluorescence lidar detection'], ['other wavelength which', 'atomic resonance transition references'], ['', ''], ['', ''], ['rights', ''], ['Soil', 'different  scales'], ['dependent  variability', 'soil soils'], ['advent', 'digital soil properties'], ['we', 'different wavelet transform'], ['We', '25 gamma 3'], ['', ''], ['we', 'key soil properties'], ['', ''], ['Wavelet spectra', 'significant  P'], ['', 'different gamma ray'], ['', 'localized  elevation'], ['global Pearson correlation', 'gamma ray'], ['wavelet coherency', 'selected soil properties'], ['18  %', '% gamma area'], ['first  which', 'Bushy Creek Granodiorite'], ['findings', 'spatial ray soil relationships'], ['significant soil property that', 'digital soil mapping'], ['soil formation it', 'future soil sampling strategies'], ['', ''], ['', ''], ['rights', ''], ['Waxy starches', 'exclusively amylose molecules'], ['former  production', 'high amylopectin starches'], ['This', 'chemical heat moisture modification'], ['', ''], ['', 'amylopectin hydrolysis'], ['Great  attention', 'nanoparticles'], ['food  uses', 'wheat barley potato waxy starches'], ['', ''], ['rights', ''], ['which', 'UV level'], ['common mode rejection', 'input differential signal'], ['center frequency Q', 'strapped  inputs'], ['automatic gain control amplifier', 'appropriate  signal'], ['operational D amplifier', 'AGC amplifier'], ['high  it', 'engineering'], ['new car that', 'electric drivetrain technologies'], ['However  targets', 'therefore vehicle weight reduction'], ['we', 'electricity generation material production'], ['We', 'evolving car use'], ['fostering', 'extreme electricity grid'], ['Savings', 'electricity grid'], ['mild  steel', 'high strength steel'], ['article', 'themed Material demand reduction'], ['such ash ground', 'crushed mix aggregates'], ['mixtures', 'ternary silica fume'], ['Potential  implications', 'rheological WMS mixtures'], ['silica fume', 'effective  WMS'], ['Fly ash', 'markedly torque viscosity'], ['significant  it', 'strongly ion penetration WMS'], ['5 % metakaolin', 'chloride penetration WMS'], ['high ion penetration dosage', '50 steel fibers'], ['', ''], ['rights', ''], ['mesenchymal stem cells', 'ectodermal differentiation potential'], ['when  WJMSC', 'ectodermal induction WJMSCs'], ['we', 'western biology blotting'], ['live  that', 'smooth muscle actin'], ['up  regulation', 'ectodermal TGF differentiation'], ['', ''], ['rights', ''], ['Drought', 'major plant growth'], ['Plants', 'biochemical gene modulation'], ['Studying', 'new drought response cultivars'], ['', 'four  wheat'], ['landraces', 'mM seedling stage'], ['Reverse polymerase chain reaction', 'stress responsive drought stress gene'], ['', ''], ['', 'root T'], ['durum landraces', 'significantly drought stress'], ['However drought stress', 'lipid peroxidation level'], ['', ''], ['studied Karak landrace', 'relative proline control'], ['Karak', 'prone wheat breeding environments'], ['MicroRNAs', 'various gene stressors'], ['UV B UV radiation', 'major crop growth'], ['we', 'novel UV B treatments'], ['six  miRNAs', 'highly UV B wheat'], ['three miR159 miRNAs', 'time points UV B treatment'], ['miRNAs', 'UV B stress'], ['UV B UV genes', 'such I box'], ['wheat miRNAs', 'important UV B stress'], ['infectious  that', ''], ['bacterium Tropheryma that', 'Tropheryma whipplei'], ['it', 'infection'], ['', 'differential symptoms diagnosis'], ['biopsy PAS staining', 'poor  specificity'], ['development', 'convenient  T'], ['this', 'missed  infection'], ['', 'molecular  T'], ['review', 'pathogenesis clinical Tropheryma whipplei infections'], ['Dietary  lipids', 'chronic inflammation states'], ['Haptoglobin', 'liver blood body'], ['dietary  which', '2 adipose days'], ['fatty that', 'dietary  fats'], ['Mice', '8 oil coconut oil'], ['3T3-L1 cells', 'different fatty acids'], ['Haptoglobin gene expression', 'northern  blotting'], ['which', 'epidydimal adipose tissues'], ['coconut  which', 'epidydimal haptoglobin depots'], ['', 'haptoglobin gene expression'], ['saturated fatty acids', 'inflammatory  environment'], ['response', 'pad  treatment'], ['Italian white certificate scheme', 'primary energy consumption'], ['mechanism', 'other  parties'], ['that', 'industrial energy efficiency'], ['Italian  system', 'payback investment time'], ['energy service which', 'ground'], ['other  mechanism', 'insufficient market information'], ['Core challenges', 'regulatory  finance'], ['White spot syndrome virus', 'crustacean aquaculture industry'], ['serious WSSV outbreaks', 'Chinese Province Eastern China'], ['', 'natural infection host'], ['study', 'temporal  E'], ['', ''], ['that', 'logarithmic 72hpi'], ['viral plateau which', 'heavy crab mortality'], ['viral  load', 'different growth degrees'], ['viral copy numbers', 'significant time points'], ['', ''], ['Infection', 'early  tissues'], ['which', 'diagnostic  testing'], ['study', 'theoretically  WSSV'], ['paper', 'additionally electricity world'], ['main market processes', 'European  markets'], ['various  markets', 'needs'], ['trends', 'well derivatives markets'], ['We', 'common Wien bridge methods'], ['results', 'well oscillator measurements'], ['effect', 'high oscillator frequencies'], ['analysis', 'undergraduate  laboratory'], ['study', 'Russian wife abuse'], ['sample', '1028 multistage cluster sampling'], ['study', 'immigration acculturation'], ['corporal punishment attitudes', 'wife abuse attitudes'], ['attitudinal wife abuse system', 'two  violence'], ['great  part', 'mammalian laboratory settings'], ['use', 'defined mouse settings'], ['studies', 'standardized  conditions'], ['', 'continuously pathogen life'], ['influences', 'experimental  outcomes'], ['Thus  transferability', 'always  debate'], ['elucidating', 'clean lab mice'], ['Here  we', 'wild pet shop mice'], ['31-antibody  leukocyte', 'various  cytokines'], ['immune  signatures', 'SPF SPF mice'], ['distinct  that', 'activated NK cells'], ['study', 'drug laboratory testing'], ['', '2016 International Cytometry'], ['relationship', 'sustainability'], ['explanatory  that', 'sustainable  destinations'], ['WTP', 'sustainable  destination'], ['mature sand that', 'developmental  sustainability'], ['assessment', 'critical wind power China'], ['1995 wind resource paper', 'onshore wind electricity'], ['Furthermore  it', 'various wind farms'], ['economic  potential', 'onshore wind electricity'], ['', 'feed  0'], ['', ''], ['', ''], ['', ''], ['', 'kilowatt hour'], ['', ''], ['', ''], ['rights', ''], ['two measurement we', 'low wind power conditions'], ['correlation', 'significantly  literature'], ['complex  which', 'meteorological  parameters'], ['extreme value we', 'low wind power periods'], ['Large  differences', '10 return years'], ['that', 'values'], ['However  length', 'increasing production elevation'], ['different wind speed patterns', 'local  topography'], ['increasing  elevation', 'lower air density'], ['relative  increase', 'summer'], ['Notable  exceptions', 'wind power development'], ['electricity findings', 'higher wind power elevations'], ['', ''], ['rights', ''], ['which', 'about  65'], ['', 'electric energy matrix'], ['last wind energy', '19  2'], ['', ''], ['intermittent energy source', 'extreme wind power winds'], ['IPCC AR5', 'latitude wind regions'], ['study', 'm wind Brazil'], ['cluster it', 'climatic  similarities'], ['goodness fit we', 'better Kolmogorov Smirnov test'], ['', 'maximum wind speed'], ['minimum wind speed it', 'homogeneous  regions'], ['other  analysis', 'positive wind Group#2'], ['', 'positive  Group#4'], ['way', 'mainly  latitudes'], ['', 'C Elsevier Ltd'], ['Wind energy', 'renewable  sources'], ['stochastic  nature', 'great power system operations'], ['probabilistic  techniques', 'substantial wind generation'], ['paper', 'level wind farms'], ['level optimization model', 'mathematical Algebraic Modeling System'], ['cases  studies', 'different wind farms'], ['Moreover  scenarios', 'practical wind farms'], ['', 'Elsevier Ltd'], ['rights', ''], ['article', '13 wind countries'], ['projects', 'installed 39 capacity'], ['We', 'iv construction cost configuration'], ['mean cost escalation', 'project'], ['20 63 projects', '39 cost overruns'], ['offshore wind results', 'larger  spread'], ['significant  relationship', 'individual cost overrun'], ['Nonetheless  risk', 'new wind turbines'], ['mean cost escalation', 'onshore  projects'], ['', ''], ['6  %', 'other energy infrastructure'], ['', ''], ['layout optimization problem', 'two  decades'], ['wind farm that', 'annual  energy'], ['that', 'Jensen wake model'], ['However  model', 'field measurements'], ['approach', 'Gaussian wake model'], ['exponential Jensen wake that', 'uniform velocity wake'], ['proposed  approach', 'genetic wind algorithm'], ['application', 'computational wind study'], ['complex wind improvement', 'complex wind scenario'], ['use', 'real wind cases'], ['', ''], ['rights', ''], ['study', 'temporal wind generation scope'], ['long term data', 'real  systems'], ['Republic', 'measured wind production period'], ['installed power capacity', '500  MW'], ['higher resolution wind dataset', 'higher frequency variability'], ['Finally  model', 'installed wind capacity'], ['relationship', 'capacity factor ramping'], ['', ''], ['rights', ''], ['promising Laguna Verde', 'southern  region'], ['small scale wind farm', '90 production kW'], ['facility', 'national wind turbine market'], ['where  energy', 'different  prices'], ['study', 'residential  households'], ['software tool', 'Multiple Energy Resources'], ['results', 'proposed Net Present projects'], ['sensitivity analysis', ''], ['NPC', 'average wind speed'], ['few government policies', ''], ['', ''], ['rights', ''], ['wind turbine system', 'high wind energy applications'], ['predictive  control', 'viable power electronics'], ['work', 'back wind turbine systems'], ['presented  DMPCC', 'based alpha beta platform'], ['Experimental  results', 'conventional DTC DPC technique'], ['Pitch control', 'current load control approaches'], ['cyclic  that', 'fatigue turbines'], ['conventional pitching that', 'short term pitch action'], ['present  study', 'aeroelastic wind rotor'], ['We', 'physics wind turbine rotor'], ['adaptive ODE it', 'structural control rotor'], ['Reference Wind significance', 'wind turbine rotors'], ['', ''], ['rights', ''], ['adolescent  face', 'depression'], ['diathesis that', 'brain  development'], ['FST plasma corticosterone levels', 'prefrontal cortex striatum'], ['Significantly  immobility', 'induced corticosterone stress'], ['large dopamine storage pool', 'greater dopamine release'], ['increased norepinephrine which', 'adolescent  WKY'], ['social  stimuli', 'implicated  pathways'], ['present  study', 'better tumor suppressor leukemia'], ['western Wnt5a blotting', 'normal myeloid controls'], ['relationship', 'protein expression'], ['Chromatin immunoprecipitation', 'promoter  regions'], ['expression levels', 'lymphocytic Wnt leukemia'], ['most protein expression', 'most Wnt5a promoter'], ['overall  level', 'normal H4K20mel controls'], ['Wnt5a expression', 'positively methylation promoter'], ['Moreover H4K20mel', 'Wnt5a promoter region'], ['Wnt5a expression', 'normal H4K20mel controls'], ['particularly Wnt extent', 'patients'], ['Wnt5a expression', 'promoter  regions'], ['H4K20mel', 'transcription initiation'], ['dinoflagellate Woloszynskia pascheri', 'frozen Ontario Canada'], ['New  information', 'cell organelles'], ['', ''], ['pascheri', 'similar Gymnodinium cryophilum'], ['Hansen', ''], ['process', 'environmental ice factors'], ['winter  that', 'melted swimming ice'], ['', 'bound  W'], ['biochemical air that', 'research'], ['continuing  assignment', 'similar  species'], ['Worry', 'psychiatric  patients'], ['Worry', 'emotional  experiences'], ['where treatment we', 'catastrophic worry thoughts'], ['aim', 'controlled  trial'], ['We', 'based waiting list condition'], ['IbET', 'large effect d'], ['', ''], ['', ''], ['', 'PSWQ'], ['58 IbET %', 'responders'], ['corresponding  figure', 'WL participants'], ['IbET', 'cognitions cognitive meta cognitions life'], ['Overall treatment results', '12-month follow up'], ['worry', 'accessible  worry'], ['Replication trials', 'active control group'], ['Wound healing', 'diabetic  animals'], ['Matrix metalloproteases', 'physiological growth factor'], ['different  they', 'fewer side effects'], ['specific  aim', 'diabetic wound animals'], ['Plant materials', '60 degrees C'], ['dried  leaves', 'equal  preservative'], ['diabetic  that', 'agent  treatments'], ['Necrotic  tissue', 'periodically wound healing'], ['7 14 cDNA synthesis', 'real time PCR'], ['Tnf alpha', 'wound tissue'], ['05', '14 Mmp9 gene days'], ['expression', 'Mmp9 gene'], ['herbal  mixture', 'Vaseline'], ['herbal  treatment', 'diabetic  patients'], ['Fault detection', 'motor current signature analysis'], ['current space vector', 'variation'], ['motor current signature analysis', 'drawbacks'], ['slip', 'harmonic  component'], ['new  technique', 'varying Rotor Induction conditions'], ['performance', 'proposed  simulation'], ['proposed  technique', 'modern wind power plants'], ['We', 'office child treatment interventions'], ['Study', 'general  supervisors'], ['two  116', 'mandatory reporting events'], ['first wraparound clinicians', 'based  counterparts'], ['Additionally wraparound clinicians', 'direct client supervisors'], ['second wraparound clinicians', 'based child counterparts'], ['mandatory wraparound clinicians', 'based  clinicians'], ['studies', 'clinician child abuse'], ['300 million 300 it', 'mental  functions'], ['', 'visuospatial  skills'], ['linked  genes', 'pseudoautosomal  inactivation'], ['social  that', 'sex chromosome aneuploidies'], ['', ''], ['such  phenomenon', 'parallel distance operation'], ['corrosion which', 'vital pipeline safety'], ['influence', 'electrochemical analysis techniques'], ['Results', 'many density corrosion pits'], ['cathodic  which', 'iron dissolution'], ['AC', 'hydrogen induced X80 steel surface'], ['pitting', 'half wave AC'], ['various corrosion products', 'X80 steel surface'], ['alpha which', 'protective  substrates'], ['Model animals', 'biomedical  research'], ['experimental  advantages', 'evolutionary  tetrapod'], ['fundamental  it', 'immunology molecular biology neurobiology'], ['experimental  Xenopus', 'biological  mechanisms'], ['easily genome editing Xenopus', 'human systems level'], ['hemicellulose  which', 'cellular cell wall relaxation'], ['three XET genes', 'cultivar development Huaizhi'], ['1267 bp encoding', 'rapid cDNA methods'], ['LcXET1 mRNA accumulation', '73 pericarp Nuomici'], ['However  it', '66 aril Huaizhi'], ['differential  accumulation', 'closely fruit cracking'], ['LcXET2 mRNA accumulation', 'differential accumulation pericarp'], ['weak signal bands', 'pericarp tissues'], ['moderate signal bands', 'Huaizhi aril fruits'], ['Furthermore LeXET3', 'Nuomici litchi fruit'], ['only XETs LcXET1', 'different XETs litchi'], ['further  fruit', 'acetic fruit cracking'], ['LcXET2', 'treated aril fruits'], ['Thus  LcXET1', 'more litchi fruit LcXET2'], ['', ''], ['rights', ''], ['emerging XPO1 inhibition', 'key  cancer'], ['clinical  validation', 'hematological export malignancies'], ['Recent  reports', 'similar E571 phenotypes'], ['variant', 'digital biology PCR'], ['E571 K variant', 'residual disease setting'], ['hematological  we', 'hematological B malignancies'], ['', ''], ['932  nA', 'weak air pressure sensor'], ['main  parts', 'ASIC'], ['matching  chip', 'matching  techniques'], ['Sex chromosome aneuploidies', 'live  births'], ['frequent  abnormalities', ''], ['', 'extra sex chromosome'], ['', ''], ['48  XXYY', ''], ['However  literature', 'natural  disease'], ['We', '49 XYYYY syndrome'], ['Case patient', 'limited spectrum interests'], ['social anxiety disorder', 'mutism separation anxiety disorder'], ['49  XYYYY', 'neurodevelopmental  characteristics'], ['Interestingly ASD', 'more Y chromosome aneuploidy'], ['understanding', 'cognitive  remediation'], ['eukaryotic quality control which', 'premature translation termination codons'], ['I', 'Saccharomyces cerevisiae'], ['descriptions', 'growing RNA isolation'], ['methods', 'mRNA decay pathways'], ['social body image that', 'successful treatment completion'], ['Compassion  interventions', 'personal distress inadequacies'], ['telehealth intervention modality', 'dispersed  population'], ['We', 'recruited YA survivors'], ['MSC intervention', 'supplemented home practice'], ['Feasibility', 'attendance rate'], ['Baseline', 'paired t tests'], ['25', 'videoconference group'], ['least  six', 'eight  sessions'], ['', ''], ['', ''], ['psychosocial  outcomes', 'significant  changes'], ['', ''], ['YA survivors', 'MSC videoconference intervention'], ['Feasibility acceptance', 'psychosocial  intervention'], ['Findings', 'controlled cancer treatment'], ['that', 'limited home food attention'], ['how decision making', 'transformative  motherhood'], ['that', 'home motherhood status'], ['In  interviews', '20 southwest Georgia'], ['qualitative  children', 'home'], ['numerous  Which', 'groups'], ['frequently shopping women', 'other household members'], ['convenience weight control', 'salient  groups'], ['social food sources factors', 'only  children'], ['only  factor', 'only  children'], ['making  that', 'young home food environments'], ['Interventions', 'healthy  meals'], ['', ''], ['rights', ''], ['regulatory gene that', 'coactivator YY1AP'], ['Here  we', 'human SK N SH'], ['which', '739 amino acids'], ['Two splice variants YARP2', ''], ['10 YARP which', '10 YARP kb'], ['', 'neural  cells'], ['Presence', 'such heart brain'], ['Bioinformatic analysis', 'binding YY1AP homology domain'], ['YARP', 'such  transcription'], ['study', 'potential Zanthoxylum streptozotocin'], ['Diabetic  rats', '28  days'], ['Alkylamides', 'significantly urea nitrogen levels'], ['', 'ALB proteins globulin protein serum'], ['TP RNA content', 'diabetic DNA rats'], ['alkylamides', '1 growth liver'], ['significantly PI3 K those', 'skeletal muscle ring muscle'], ['Alkylamides', 'PKB ubiquitin proteasome pathway'], ['alkylamides', 'diabetic mTOR pathway'], ['clinical  symptoms', 'dengue chikungunya virus infections'], ['Korea Centers', 'reverse polymerase chain January'], ['nine', 'imported Zika virus July'], ['travel destinations', 'infected  individuals'], ['partial envelope viruses', 'Asian South America'], ['viral  RNA', 'specific symptom onset'], ['Zika virus', '58  semen'], ['41 Immunoglobulin G', '52 symptom days'], ['diagnostic  laboratories', 'Zika virus infection'], ['Distribution', 'Zika world'], ['Zika virus disease', ''], ['tropical  Indonesia', 'Zika virus'], ['letter', 'single Molecular Biology'], ['which', 'appropriate Zika virus'], ['', 'finger CCCH type'], ['ZC3H15', 'subcellular protein fractions'], ['expression', 'effectively HeLa 5'], ['', 'interfering  RNA'], ['Affymetrix microarray analysis', 'expressed  114'], ['', ''], ['GO gene categories', 'expressed cell cycle arrest'], ['', '2 receptor associated immunoprecipitation'], ['ZC3H15 expression', 'Gene Atlas Leukemia Gene LGA'], ['ZC3H15', 'potential kappa B AML'], ['intercalation', 'direct reaction method'], ['synthesised intercalation compound zinc', 'OES TGA DTG FESEM'], ['intense intercalation peak', 'ordered  structure'], ['', 'low basal 16'], ['A', 'successful interlayer host'], ['intercalation', 'also FTIR spectroscopy'], ['LP intercalation compound', 'thermal pristine L phenylalanine'], ['observed  percentage', 'accumulated release 84'], ['', ''], ['', ''], ['', ''], ['', 'PBS buffer pH'], ['', 'deionised water PBS pH'], ['', ''], ['', 'deionised PBS pH'], ['8', 'second PBS pH'], ['it', 'parabolic diffusion model'], ['synthesised LP intercalation compound', 'controlled release properties'], ['', 'immunological nano particles'], ['pIC  RNA', 'ZnO melanoma'], ['Direct RNA association', 'fluorescence spectra fluorescence complexation'], ['RNA corona', 'first transmission electron time'], ['', ''], ['', ''], ['', 'Stern Volmer Stern absorption'], ['ZnO NP complex', 'BALB mouse melanoma model'], ['such  JNK', 'such  phosphoproteins'], ['specific zinc that', 'anticancer  melanoma'], ['mammalian host restriction it', 'vitro HBV RNA experiments'], ['However  role', 'vivo environment'], ['ZAP', 'tansgenic mouse model'], ['', ''], ['transgenic ICR mouse', 'controls'], ['HBV RNA', 'Northern DNA replication blotting'], ['expression', 'immunohistochemical liver staining'], ['', 'ICR control 3'], ['', 'transgenic  8'], ['4  level', '82 DNA replication %'], ['expression', 'significantly ICR control mouse'], ['HBV which', 'HBV drug development'], ['present  article', 'Koenig ex A'], ['', ''], ['', ''], ['Studies', 'mainly tissue culture techniques'], ['genomic  which', 'different gene pools'], ['present  review', 'medicinal biology plant'], ['review', 'phylogenetic  analysis'], ['Moreover  it', 'secondary breeding metabolites'], ['paper', 'neural  networks'], ['It', 'artificial linear activation neuron'], ['extension', 'new  areas'], ['ordinary  description', 'special  paper'], ['It', 'digital control system'], ['', ''], ['', ''], ['rights', '']]\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "nKSh4TgtuVZ-"
      },
      "source": [
        ""
      ],
      "execution_count": null,
      "outputs": []
    }
  ]
}